,mention,obj,prob,pmid
0,arterial thromboembolic events,disease,0.9907,35436315
1,glaucoma,disease,1.0,35436315
2,aflibercept,gene,0.991,35436315
3,ranibizumab,gene,0.8594,35436315
4,arterial thromboembolic events,disease,0.9634,35436315
5,ATEs,disease,0.926,35436315
6,glaucoma,disease,1.0,35436315
7,patients,species,0.984,35436315
8,ranibizumab,gene,0.573,35436315
9,aflibercept,gene,0.973,35436315
10,ranibizumab,gene,0.9253,35436315
11,aflibercept,gene,0.976,35436315
12,ischemic stroke,disease,1.0,35436315
13,acute myocardial infarction,disease,1.0,35436315
14,patients,species,0.9746,35436315
15,coronary artery disease,disease,1.0,35436315
16,aflibercept,gene,0.9937,35436315
17,ranibizumab,gene,0.919,35436315
18,glaucoma,disease,1.0,35436315
19,glaucoma,disease,1.0,35436315
20,ranibizumab,gene,0.772,35436315
21,aflibercept,gene,0.9517,35436315
22,aflibercept,gene,0.9565,35436315
23,patients,species,0.981,35436315
24,Diabetic Macular Edema,disease,1.0,35422607
25,Aflibercept,gene,0.9263,35422607
26,aflibercept,gene,0.97,35422607
27,diabetic macular edema,disease,0.998,35422607
28,CI-DME,disease,0.9995,35422607
29,patients,species,0.9727,35422607
30,CI-DME,disease,1.0,35422607
31,aflibercept,gene,0.985,35422607
32,AFL,gene,0.9497,35422607
33,aflibercept,gene,0.9746,35422607
34,Retinal,cell_type,0.4521,35419572
35,Retinal pigment epithelial tear,disease,0.996,35419572
36,brolucizumab,gene,0.909,35419572
37,macular edema,disease,1.0,35417511
38,serous retinal detachment,disease,1.0,35417511
39,aflibercept,gene,0.988,35417511
40,macular edema,disease,1.0,35417511
41,serous retinal detachment,disease,1.0,35417511
42,branch retinal vein occlusion,disease,1.0,35417511
43,aflibercept,gene,0.9863,35417511
44,macular edema,disease,1.0,35417511
45,patients,species,0.9907,35417511
46,serous retinal detachment,disease,0.9995,35417511
47,aflibercept,gene,0.9624,35417511
48,patients,species,0.9766,35417511
49,serous retinal detachment,disease,1.0,35417511
50,macular edema,disease,1.0,35417511
51,non-serous retinal detachment,disease,0.94,35417511
52,serous retinal detachment,disease,1.0,35417511
53,aflibercept,gene,0.984,35417511
54,patients,species,0.964,35417511
55,branch retinal vein occlusion,disease,0.9995,35417511
56,serous retinal detachment,disease,1.0,35417511
57,macular oedema,disease,1.0,35416615
58,age-related macular INTRODUCTION,disease,0.994,35416615
59,Neovascular age-related macular degeneration,disease,1.0,35416615
60,nAMD,disease,1.0,35416615
61,diabetic macular oedema,disease,1.0,35416615
62,DME,disease,1.0,35416615
63,macular oedema,disease,1.0,35416615
64,central retinal vein occlusion,disease,1.0,35416615
65,CRVO,disease,1.0,35416615
66,vision loss,disease,0.998,35416615
67,anti-VEGF,gene,0.976,35416615
68,patients,species,0.9316,35416615
69,nAMD,disease,1.0,35416615
70,DME,disease,1.0,35416615
71,CRVO,disease,1.0,35416615
72,VEGF,gene,0.927,35416615
73,patients,species,0.9893,35416615
74,patients,species,0.9746,35416615
75,macular oedema,disease,1.0,35416615
76,nAMD,disease,1.0,35416615
77,DME,disease,1.0,35416615
78,CRVO,disease,1.0,35416615
79,VEGF,gene,0.6494,35416615
80,ranibizumab,gene,0.878,35416615
81,aflibercept,gene,0.9697,35416615
82,nAMD,disease,1.0,35416615
83,DME,disease,1.0,35416615
84,CRVO,disease,1.0,35416615
85,nAMD,disease,1.0,35416615
86,DME,disease,1.0,35416615
87,CRVO,disease,1.0,35416615
88,Exogeneous Endophthalmitis,disease,1.0,35413214
89,exogeneous endophthalmitis,disease,1.0,35413214
90,man,species,0.9277,35413214
91,decreased vision,disease,0.9414,35413214
92,aflibercept,gene,0.985,35413214
93,anterior chamber cells,cell_type,0.595,35413214
94,intraretinal hemorrhages,disease,0.999,35413214
95,Roth,disease,0.5146,35413214
96,methicillin-sensitive coagulase-negative Staphylococcus,cell_line,0.8374,35413214
97,methicillin,drug,0.999,35413214
98,coagulase,gene,0.9224,35413214
99,Staphylococcus,species,0.5166,35413214
100,post-injection endophthalmitis,disease,0.9995,35413214
101,Roth,DNA,0.433,35413214
102,bacterial endophthalmitis,disease,1.0,35413214
103,Aflibercept,gene,0.9146,35412227
104,Diabetic Macular Edema,disease,1.0,35412227
105,aflibercept,gene,0.974,35412227
106,AFL,gene,0.63,35412227
107,patients,species,0.944,35412227
108,diabetic macular edema,disease,1.0,35412227
109,DME,disease,1.0,35412227
110,patients,species,0.947,35412227
111,DME,disease,1.0,35412227
112,Patients,species,0.9644,35412227
113,patients,species,0.974,35412227
114,Patients,species,0.9805,35412227
115,AFL,drug,0.761,35412227
116,DME,disease,0.9995,35412227
117,AFL,drug,0.9478,35412227
118,Anti-Vascular Endothelial Growth Factor,gene,0.99,35407439
119,anti-vascular endothelial growth factor,gene,0.9854,35407439
120,anti-VEGF,gene,0.9917,35407439
121,age-related macular degeneration,disease,1.0,35407439
122,AMD,disease,1.0,35407439
123,aflibercept,gene,0.953,35407439
124,ranibizumab,gene,0.6533,35407439
125,brolucizumab,gene,0.713,35407439
126,IVI,DNA,0.639,35407439
127,Aflibercept,gene,0.959,35407439
128,brolucizumab,gene,0.633,35407439
129,AMD,disease,1.0,35407439
130,aflibercept,gene,0.99,35407439
131,anti-VEGF,gene,0.9644,35396574
132,neovascular age-related macular degeneration,disease,1.0,35396574
133,nAMD,disease,1.0,35396574
134,AMD,disease,0.9995,35396574
135,patients,species,0.995,35396574
136,ranibizumab,gene,0.8037,35396574
137,aflibercept,gene,0.986,35396574
138,patients,species,0.9814,35396574
139,patients,species,0.9814,35396574
140,polypoidal choroidal vasculopathy,disease,1.0,35391819
141,polypoidal choroidal vasculopathy,disease,1.0,35391819
142,PCV,disease,1.0,35391819
143,patients,species,0.9814,35391819
144,anti-,gene,0.5967,35391819
145,vascular endothelial growth factors,gene,0.892,35391819
146,VEGF,gene,0.9966,35391819
147,bevacizumab,gene,0.876,35391819
148,ranibizumab,gene,0.7495,35391819
149,aflibercept,gene,0.9233,35391819
150,ziv-aflibercept,gene,0.9746,35391819
151,verteporfin,drug,0.998,35391819
152,patients,species,0.9814,35391819
153,BCVA,DNA,0.4998,35391819
154,PED,DNA,0.56,35391819
155,anti-VEGF,gene,0.879,35391819
156,PCV,disease,1.0,35391819
157,polypoidal choroidal vasculopathy,disease,1.0,35391816
158,ziv-aflibercept,gene,0.9873,35391816
159,ziv-aflibercept,gene,0.9897,35391816
160,polypoidal choroidal vasculopathy,disease,1.0,35391816
161,PCV,disease,1.0,35391816
162,polyp,disease,0.969,35391816
163,indocyanine green,drug,0.9927,35391816
164,ICGA,drug,0.975,35391816
165,patients,species,0.97,35391816
166,PCV,disease,1.0,35391816
167,Patients,species,0.9756,35391816
168,branching,DNA,0.486,35391816
169,polyps,disease,0.9863,35391816
170,pigment epithelial detachment,disease,1.0,35391816
171,PED,disease,0.997,35391816
172,polyps,disease,0.9985,35391816
173,polyp,disease,0.988,35391816
174,PED,disease,0.916,35391816
175,IVZ,drug,0.9683,35391816
176,PCV,disease,0.7954,35391816
177,autosomal recessive best vitelliform macular dystrophy,disease,1.0,35391813
178,autosomal recessive Best vitelliform macular dystrophy,disease,1.0,35391813
179,BEST1,gene,0.97,35391813
180,cystoid macular edema,disease,1.0,35391813
181,aflibercept,gene,0.957,35391813
182,BEST1,gene,0.9653,35391813
183,blurry andreduced vision,disease,0.9966,35391813
184,vitelliform macular lesions,disease,1.0,35391813
185,patient,species,0.989,35391813
186,BEST1 gene,gene,0.993,35391813
187,aflibercept,gene,0.9546,35391813
188,patient,species,0.984,35391813
189,RPE,disease,0.8706,35391813
190,Cystoid macular edema,disease,1.0,35391813
191,vision,disease,0.98,35391813
192,aflibercept,gene,0.989,35391813
193,c.695T,RNA,0.4954,35391813
194,exon 6,DNA,0.722,35391813
195,BEST1 mutations,gene,0.8784,35391813
196,Human Genome,DNA,0.7056,35391813
197,Human,species,0.996,35391813
198,cystoid macular edema,disease,1.0,35391813
199,transferrin,DNA,0.514,35388745
200,transferrin receptor,gene,0.996,35388745
201,Glioblastoma,disease,1.0,35388745
202,GBM,disease,1.0,35388745
203,brain cancer,disease,1.0,35388745
204,brain tumors,disease,1.0,35388745
205,GBM,disease,1.0,35388745
206,bevacizumab,gene,0.85,35388745
207,aflibercept,gene,0.976,35388745
208,GBM,disease,1.0,35388745
209,patients,species,0.996,35388745
210,transferrin receptor,gene,0.997,35388745
211,TfR,gene,0.996,35388745
212,mouse TfR,gene,0.9766,35388745
213,mouse,species,0.9956,35388745
214,transferrin,gene,0.9976,35388745
215,Tf,gene,0.9995,35388745
216,TfR,gene,0.97,35388745
217,vascular endothelial growth factor (,gene,0.995,35388745
218,VEGF,gene,0.6265,35388745
219,TfR-,gene,0.9976,35388745
220,TfR,gene,0.932,35388745
221,human umbilical vein endothelial cell,cell_line,0.914,35388745
222,human,species,0.9756,35388745
223,VEGF-Trap,gene,0.98,35388745
224,TfR,gene,0.957,35388745
225,VEGF-Trap,gene,0.9897,35388745
226,moAb4,gene,0.944,35388745
227,TfR,gene,0.992,35388745
228,VEGF-Trap,gene,0.945,35388745
229,moAb4,gene,0.9937,35388745
230,VEGF-Trap,gene,0.9863,35388745
231,mice,species,0.973,35388745
232,VEGF-Trap,gene,0.9775,35388745
233,moAb4,gene,0.992,35388745
234,VEGF,gene,0.9966,35388745
235,U,cell_type,0.908,35388745
236,U-87 MG GBM tumors,disease,0.9995,35388745
237,mouse,species,0.868,35388745
238,Hypotony,disease,1.0,35385431
239,hypotony,disease,0.9995,35385431
240,choroidal detachments,disease,1.0,35385431
241,glaucoma,disease,0.9966,35385431
242,C3F8,drug,0.999,35385431
243,cycloplegia,disease,1.0,35385431
244,PATIENT,species,0.938,35385431
245,Patient,species,0.877,35385431
246,central retinal vein occlusion,disease,1.0,35385431
247,hyphema,disease,1.0,35385431
248,vitreous hemorrhage,disease,1.0,35385431
249,neovascular glaucoma,disease,1.0,35385431
250,aflibercept,gene,0.989,35385431
251,hypotony,disease,1.0,35385431
252,inflammation,disease,0.9995,35385431
253,choroidal detachments,disease,1.0,35385431
254,corneal edema,disease,1.0,35385431
255,perfluorpropane,drug,0.999,35385431
256,C3F8,drug,0.9995,35385431
257,hypotony,disease,1.0,35385431
258,choroid detachment,disease,1.0,35385431
259,hypotony,disease,1.0,35385431
260,choroidal detachment,disease,1.0,35385431
261,hypotony,disease,1.0,35385431
262,patients,species,0.9775,35384550
263,RAS,gene,0.998,35384550
264,colorectal cancer,disease,0.981,35384550
265,CRC,disease,1.0,35384550
266,anti-,gene,0.8115,35384550
267,epidermal growth factor receptor,gene,0.9,35384550
268,EGFR,gene,0.9976,35384550
269,patients,species,0.9375,35384550
270,CRC,disease,0.999,35384550
271,Patients,species,0.9297,35384550
272,CRC,disease,0.998,35384550
273,RAS,gene,0.994,35384550
274,leucovorin,drug,0.9995,35384550
275,5-fluorouracil,drug,0.9995,35384550
276,oxaliplatin,drug,0.9995,35384550
277,EGFR,gene,0.66,35384550
278,irinotecan,drug,0.9985,35384550
279,patients,species,0.9756,35384550
280,patients,species,0.985,35384550
281,CRC,disease,0.548,35384550
282,FOLFOX,drug,0.813,35384550
283,panitumumab,gene,0.853,35384550
284,patients,species,0.9824,35384550
285,bevacizumab,gene,0.808,35384550
286,aflibercept beta,gene,0.9854,35384550
287,bevacizumab,gene,0.6665,35384550
288,aflibercept beta,gene,0.9927,35384550
289,CRC,disease,0.998,35384550
290,anti-EGFR antibodies,gene,0.9004,35384550
291,aflibercept,gene,0.992,35382900
292,aflibercept,gene,0.9883,35382900
293,aflibercept,gene,0.9814,35382900
294,PFS,DNA,0.522,35382900
295,Neovascular Age-Related Macular Degeneration,disease,1.0,35368240
296,nAMD,disease,1.0,35368240
297,Neovascular age-related macular degeneration,disease,1.0,35368240
298,nAMD,disease,1.0,35368240
299,visual loss,disease,1.0,35368240
300,anti-vascular endothelial growth factor,gene,0.9434,35368240
301,anti-VEGF,gene,0.887,35368240
302,nAMD,disease,1.0,35368240
303,anti-VEGF,gene,0.7095,35368240
304,ranibizumab,gene,0.7285,35368240
305,aflibercept,gene,0.9683,35368240
306,brolucizumab,gene,0.7695,35368240
307,bevacizumab,gene,0.6987,35368240
308,nAMD,disease,1.0,35368240
309,VEGF,gene,0.8726,35368240
310,nAMD,disease,1.0,35368240
311,patients,species,0.9795,35368240
312,patients,species,0.989,35368240
313,nAMD,disease,1.0,35368240
314,geographic atrophy,disease,0.9673,35368240
315,patients,species,0.9834,35368240
316,angiopoietin,gene,0.995,35368240
317,nAMD,disease,1.0,35368240
318,nAMD,disease,1.0,35368240
319,retinal cells,cell_type,0.7783,35368240
320,anti-VEGF proteins,gene,0.9824,35368240
321,patients,species,0.9907,35366082
322,patients,species,0.963,35365223
323,diabetic macular BACKGROUND,disease,1.0,35365223
324,patients,species,0.9756,35365223
325,diabetic macular oedema,disease,1.0,35365223
326,DMO,disease,0.9863,35365223
327,ranibizumab,gene,0.7656,35365223
328,aflibercept,gene,0.9214,35365223
329,patients,species,0.9775,35365223
330,DMO,disease,1.0,35365223
331,ranibizumab,gene,0.875,35365223
332,aflibercept,gene,0.9414,35365223
333,patients,species,0.97,35365223
334,aflibercept,gene,0.975,35365223
335,ranibizumab,gene,0.8745,35365223
336,aflibercept,gene,0.965,35365223
337,DMO,disease,1.0,35365223
338,vascular endothelial growth factor,gene,0.8965,35357641
339,myopic choroidal neovascularization,disease,0.9414,35357641
340,mCNV,disease,1.0,35357641
341,patients,species,0.9883,35357641
342,vascular endothelial growth factor,gene,0.8438,35357641
343,VEGF,gene,0.997,35357641
344,patients,species,0.974,35357641
345,mCNV,disease,0.9995,35357641
346,bevacizumab,gene,0.874,35357641
347,ranibizumab,gene,0.7915,35357641
348,aflibercept,gene,0.96,35357641
349,patients,species,0.9814,35357641
350,BCVA,cell_type,0.4265,35357641
351,SFCT,DNA,0.4897,35357641
352,IVR,cell_line,0.4866,35357641
353,IVA,disease,0.998,35357641
354,anti-VEGFs,gene,0.9243,35357641
355,patients,species,0.97,35357641
356,mCNV,disease,1.0,35357641
357,anti-VEGF,gene,0.9634,35357641
358,patients,species,0.986,35357641
359,aflibercept,gene,0.971,35357637
360,ranibizumab,gene,0.8545,35357637
361,patients,species,0.9785,35357637
362,superotemporal quadrant,DNA,0.549,35357637
363,age-related macular degeneration,disease,1.0,35357637
364,diabetic,disease,1.0,35357637
365,macular edema,disease,1.0,35357637
366,lens,DNA,0.4517,35357637
367,patient,species,0.9897,35357637
368,superotemporal quadrant,DNA,0.497,35357637
369,Brolucizumab,gene,0.6353,35348844
370,patients,species,0.987,35348844
371,choroidal neovascularization,disease,1.0,35348844
372,choroidal neovascularization,disease,1.0,35348844
373,age-related macular degeneration,disease,1.0,35348844
374,patients,species,0.9883,35348844
375,anti-VEGF antibody,gene,0.992,35348844
376,brolucizumab,gene,0.6553,35348844
377,patients,species,0.9756,35348844
378,aflibercept,gene,0.933,35348844
379,bevacizumab,gene,0.661,35348844
380,patients,species,0.982,35348844
381,anti-VEGF,gene,0.983,35348844
382,retinal fluid,disease,0.997,35348844
383,aflibercept,gene,0.985,35348844
384,bevacizumab,gene,0.8184,35348844
385,brolucizumab,gene,0.838,35348844
386,brolucizumab,gene,0.89,35348844
387,brolucizumab,gene,0.785,35348844
388,brolucizumab,gene,0.6865,35348844
389,intra-and subretinal fluid,disease,0.962,35348844
390,brolucizumab,gene,0.9014,35348844
391,intraocular inflammation,disease,1.0,35348844
392,retinal vasculitis,disease,1.0,35348844
393,brolucizumab,gene,0.878,35348844
394,Brolucizumab,gene,0.84,35348844
395,patients,species,0.9834,35348844
396,patients,species,0.9834,35348844
397,brolucizumab,gene,0.6836,35348844
398,patients,species,0.985,35348844
399,VEGF,gene,0.617,35348844
400,aflibercept,gene,0.9917,35344080
401,FOLFIRI,drug,0.8706,35344080
402,aflibercept,gene,0.9907,35344080
403,fluorouracil,drug,0.9995,35344080
404,leucovorin,drug,0.999,35344080
405,irinotecan,drug,0.999,35344080
406,FOLFIRI,drug,0.951,35344080
407,patients,species,0.945,35344080
408,metastatic colorectal cancer,disease,1.0,35344080
409,mCRC,disease,1.0,35344080
410,oxaliplatin,drug,0.9995,35344080
411,Patients,species,0.952,35344080
412,mCRC,disease,0.9927,35344080
413,aflibercept,gene,0.9727,35344080
414,FOLFIRI,drug,0.8857,35344080
415,oxaliplatin,drug,0.999,35344080
416,patients,species,0.989,35344080
417,right,DNA,0.5024,35344080
418,factor1,gene,0.826,35344080
419,patients,species,0.975,35344080
420,adverse,disease,0.7583,35344080
421,pneumonia,disease,1.0,35344080
422,neutropenia,disease,1.0,35344080
423,nausea,disease,0.999,35344080
424,Right,DNA,0.57,35344080
425,bevacizumab,gene,0.875,35344080
426,Aflibercept,gene,0.966,35344080
427,FOLFIRI,drug,0.894,35344080
428,patients,species,0.9478,35344080
429,mCRC,disease,0.9976,35344080
430,Aflibercept,gene,0.9907,35343355
431,Dexamethasone,drug,0.999,35343355
432,anti-vascular endothelial growth factors,gene,0.995,35343355
433,anti-VEGF,gene,0.991,35343355
434,patients,species,0.9775,35343355
435,choroidal neovascularization,disease,1.0,35343355
436,CNV,disease,1.0,35343355
437,age-related macular degeneration,disease,1.0,35343355
438,AMD,disease,1.0,35343355
439,patients,species,0.992,35343355
440,VEGF,gene,0.507,35343355
441,patients,species,0.9834,35343355
442,VEGF,gene,0.817,35343355
443,anti-VEGF,gene,0.971,35343355
444,patients,species,0.9893,35343355
445,aflibercept,gene,0.995,35343355
446,dexamethasone,drug,0.995,35343355
447,Dexamethasone,drug,0.999,35343355
448,aflibercept,gene,0.9873,35343355
449,poly(ethylene glycol)-co-(L-lactic acid) diacrylate,drug,0.9995,35343355
450,PEG-,drug,0.9995,35343355
451,PLLA-DA,drug,0.9966,35343355
452,N-isopropylacrylamide,drug,0.99,35343355
453,NIPAAm,drug,0.998,35343355
454,aflibercept,gene,0.9917,35343355
455,dexamethasone,drug,0.989,35343355
456,aflibercept,gene,0.994,35343355
457,AFL,gene,0.856,35343355
458,dexamethasone,drug,0.9927,35343355
459,DEX,drug,0.9937,35343355
460,aflibercept,gene,0.989,35343355
461,aflibercept,gene,0.991,35343355
462,dexamethasone,drug,0.996,35343355
463,anti-VEGF,gene,0.924,35343355
464,wet AMD,disease,0.9995,35343355
465,patients,species,0.996,35343355
466,Aflibercept,gene,0.9873,35329868
467,Bevacizumab,gene,0.781,35329868
468,aflibercept,gene,0.991,35329868
469,bevacizumab,gene,0.7446,35329868
470,patients,species,0.9478,35329868
471,neovascular age-related macular degeneration,disease,0.9995,35329868
472,AMD,disease,1.0,35329868
473,patients,species,0.9644,35329868
474,neovascular AMD,disease,0.9995,35329868
475,aflibercept,gene,0.962,35329868
476,bevacizumab,gene,0.8486,35329868
477,aflibercept,gene,0.993,35329868
478,aflibercept,gene,0.969,35329868
479,intraretinal fluid,disease,0.956,35329868
480,bevacizumab,gene,0.634,35329868
481,geographic atrophy,disease,1.0,35329868
482,disciform scar,disease,1.0,35329868
483,polypoidal choroidal vasculopathy,disease,1.0,35329868
484,aflibercept,gene,0.9927,35329868
485,neovascular AMD,disease,1.0,35329868
486,anti-vascular endothelial growth factor,gene,0.982,35323843
487,VEGF,gene,0.9976,35323843
488,macular edema,disease,0.9995,35323843
489,hemiretinal vein occlusion,disease,1.0,35323843
490,HRVO,disease,1.0,35323843
491,central retinal vein occlusion,disease,1.0,35323843
492,CRVO,disease,1.0,35323843
493,VEGF,gene,0.631,35323843
494,macular edema,disease,1.0,35323843
495,participants,species,0.9487,35323843
496,HRVO,disease,1.0,35323843
497,participants,species,0.9717,35323843
498,CRVO,disease,1.0,35323843
499,PARTICIPANTS,species,0.642,35323843
500,Retinal Vein Occlusion,disease,1.0,35323843
501,participants,species,0.955,35323843
502,macular edema,disease,1.0,35323843
503,HRVO,disease,1.0,35323843
504,CRVO,disease,1.0,35323843
505,aflibercept,gene,0.989,35323843
506,bevacizumab,gene,0.8833,35323843
507,patients,species,0.971,35323843
508,patients,species,0.9844,35323843
509,participants,species,0.9746,35323843
510,HRVO,disease,1.0,35323843
511,CRVO,disease,1.0,35323843
512,patients,species,0.9673,35323843
513,CRVO,disease,1.0,35323843
514,patients,species,0.963,35323843
515,HRVO,disease,0.9995,35323843
516,HRVO,disease,1.0,35323843
517,CRVO,disease,1.0,35323843
518,CRVO,disease,0.9995,35323843
519,HRVO,disease,0.9995,35323843
520,CRVO,disease,1.0,35323843
521,macular edema,disease,1.0,35323843
522,HRVO,disease,1.0,35323843
523,participants,species,0.9644,35323843
524,HRVO,disease,1.0,35323843
525,CRVO,disease,0.9995,35323843
526,macular edema,disease,1.0,35323843
527,CRVO,disease,1.0,35323843
528,HRVO,disease,1.0,35323843
529,CRVO,disease,1.0,35323843
530,macular edema,disease,0.9995,35323843
531,HRVO,disease,1.0,35323843
532,VEGF,gene,0.5933,35323843
533,submacular haemorrhage,disease,1.0,35322568
534,submacular haemorrhage,disease,1.0,35322568
535,SMH,disease,1.0,35322568
536,loss of vision,disease,0.996,35322568
537,neovascular age-related macular degeneration,disease,1.0,35322568
538,nAMD,disease,1.0,35322568
539,vascular endothelial growth factor,gene,0.9985,35322568
540,VEGF,gene,0.9985,35322568
541,VEGF,gene,0.994,35322568
542,ranibizumab,gene,0.949,35322568
543,aflibercept,gene,0.9644,35322568
544,bevacizumab,gene,0.8237,35322568
545,nAMD,disease,1.0,35322568
546,Retinal Blindness,disease,1.0,35322568
547,SMH,disease,1.0,35322568
548,loss of vision,disease,0.995,35322568
549,patients,species,0.9834,35322568
550,IVT,disease,0.985,35322568
551,SMH,disease,1.0,35322568
552,loss of vision,disease,0.9995,35322568
553,SMH,disease,0.999,35322568
554,loss of vision,disease,0.998,35322568
555,patients,species,0.994,35322568
556,SMH,drug,0.952,35322568
557,patient,species,0.988,35322568
558,SMH,disease,1.0,35322568
559,Submacular haemorrhage,disease,1.0,35322568
560,SMH,disease,1.0,35322568
561,loss of vision,disease,0.9995,35322568
562,nAMD,disease,1.0,35322568
563,Bevacizumab,gene,0.7324,35317911
564,blinding eye disease,disease,1.0,35317911
565,Anti-vascular endothelial growth factor,gene,0.9956,35317911
566,blindness,disease,0.9995,35317911
567,Aflibercept,gene,0.988,35317911
568,Eylea; Bayer,gene,0.752,35317911
569,ranibizumab,gene,0.876,35317911
570,Bevacizumab,gene,0.9214,35317911
571,Avastin,gene,0.6997,35317911
572,cancer,disease,1.0,35317911
573,retinal vascular disease,disease,1.0,35317911
574,Bevacizumab,gene,0.864,35317911
575,PBS,cell_type,0.5923,35317911
576,patient,species,0.964,35317911
577,bevacizumab,gene,0.766,35317911
578,Macular Edema,disease,1.0,35313554
579,anti-VEGF,gene,0.7197,35313554
580,patients,species,0.9565,35313554
581,macular edema,disease,1.0,35313554
582,retinal vein occlusion,disease,1.0,35313554
583,RVO,disease,1.0,35313554
584,ME,disease,0.9995,35313554
585,PATIENTS,species,0.913,35313554
586,patients,species,0.9863,35313554
587,RVO,disease,1.0,35313554
588,ME,disease,0.9995,35313554
589,anti-VEGF,gene,0.9316,35313554
590,patients,species,0.9795,35313554
591,fluorescein,drug,0.922,35313554
592,anti-VEGF antibodies,gene,0.945,35313554
593,Lucentis,gene,0.8926,35313554
594,Aflibercept,gene,0.933,35313554
595,dexamethasone,drug,0.9946,35313554
596,Ozurdex,drug,0.996,35313554
597,serous retinal detachment,disease,1.0,35313554
598,SRD,disease,1.0,35313554
599,HRD,DNA,0.752,35313554
600,VEGF,gene,0.9297,35313554
601,RVO,disease,0.9995,35313554
602,ME,disease,0.979,35313554
603,VEGF,gene,0.815,35313554
604,SRD,disease,1.0,35313554
605,HRD,disease,1.0,35313554
606,Aflibercept,gene,0.968,35310546
607,aflibercept,gene,0.995,35310546
608,diabetic macular edema,disease,0.8936,35310546
609,DME,disease,1.0,35310546
610,diabetic,disease,1.0,35310546
611,patients,species,0.987,35310546
612,DME,disease,1.0,35310546
613,aflibercept,gene,0.994,35310546
614,aflibercept,gene,0.981,35310546
615,Participants,species,0.9243,35310546
616,DME,disease,1.0,35310546
617,aflibercept,gene,0.9824,35310546
618,macular edema,disease,1.0,35310546
619,aflibercept,gene,0.9595,35310546
620,vitrectomized,disease,0.9834,35310546
621,intraretinal fluid,disease,0.9087,35303285
622,IRF,disease,0.861,35303285
623,subretinal fluid,disease,0.982,35303285
624,SRF,disease,0.979,35303285
625,patients,species,0.9585,35303285
626,neovascular age-related macular degeneration,disease,1.0,35303285
627,nAMD,disease,1.0,35303285
628,aflibercept,gene,0.9297,35303285
629,IVT,drug,0.9375,35303285
630,patients,species,0.9844,35303285
631,nAMD,disease,1.0,35303285
632,IRF,gene,0.821,35303285
633,patients,species,0.9893,35303285
634,IRF,gene,0.894,35303285
635,SRF,gene,0.923,35303285
636,IRF,gene,0.9863,35303285
637,SRF,gene,0.9277,35303285
638,IRF,gene,0.959,35303285
639,SRF,gene,0.997,35303285
640,IRF,gene,0.9946,35303285
641,patients,species,0.975,35303285
642,nAMD,disease,1.0,35303285
643,SRF,gene,0.8667,35303285
644,IRF,gene,0.898,35303285
645,IRF,gene,0.9663,35303285
646,SRF,gene,0.955,35303285
647,IRF,gene,0.9946,35303285
648,SRF,gene,0.9946,35303285
649,Neovascular Age-Related Macular Degeneration,disease,1.0,35303285
650,BROLUCIZUMAB,drug,0.9927,35300497
651,NEOVASCULAR Vascular endothelial growth factor,gene,0.9214,35300497
652,VEGF,gene,0.993,35300497
653,choroidal neovascularization,disease,0.997,35300497
654,age-related macular degeneration,disease,1.0,35300497
655,choroidal neovascularization,disease,0.999,35300497
656,vascular endothelial growth factor,gene,0.9985,35300497
657,VEGF receptor-2,gene,0.854,35300497
658,vascular endothelial cells,cell_type,0.898,35300497
659,neovascular age-related macular degeneration,disease,1.0,35300497
660,VEGF,gene,0.995,35300497
661,patient,species,0.987,35300497
662,brolucizumab,gene,0.949,35300497
663,RTH 258,gene,0.715,35300497
664,ESBA 1008,gene,0.831,35300497
665,humanized,species,0.599,35300497
666,VEGF-A,gene,0.995,35300497
667,brolucizumab,gene,0.758,35300497
668,aflibercept,gene,0.961,35300497
669,patients,species,0.9883,35300497
670,patients,species,0.9863,35300497
671,Faricimab,gene,0.542,35294428
672,age-related macular degeneration,disease,1.0,35294428
673,diabetic macular,disease,1.0,35294428
674,macular macroaneurysm,disease,1.0,35282602
675,macular macroaneurysm,disease,1.0,35282602
676,MAR,disease,1.0,35282602
677,patient,species,0.9385,35282602
678,Coats disease,disease,1.0,35282602
679,man,species,0.849,35282602
680,decrease of vision,disease,0.961,35282602
681,aneurysms,disease,1.0,35282602
682,vascular telangiectasias,disease,1.0,35282602
683,Coats disease,disease,1.0,35282602
684,CD,disease,1.0,35282602
685,fluorescein,drug,0.9907,35282602
686,macular edema,disease,1.0,35282602
687,vessels abnormalities,disease,0.999,35282602
688,non,DNA,0.4805,35282602
689,blood flow abnormalities,disease,0.768,35282602
690,aflibercept,gene,0.978,35282602
691,macular edema,disease,1.0,35282602
692,macular macroaneurysm,disease,0.9956,35282602
693,intravitreal hemorrhage,disease,0.9043,35282602
694,macular edema,disease,1.0,35282602
695,CD,disease,,35282602
696,patient,species,0.933,35282602
697,anti-VEGF,gene,0.9746,35282602
698,macular edema,disease,1.0,35282602
699,telomerase,gene,0.87,35281880
700,human,species,0.9277,35281880
701,CD4/,cell_line,0.825,35281880
702,CD4,gene,0.989,35281880
703,CD8 T-cell,cell_line,0.753,35281880
704,CD8,gene,0.997,35281880
705,cancer cells,cell_type,0.543,35281880
706,cancer,disease,0.9985,35281880
707,tumor,disease,0.787,35281880
708,patients,species,0.961,35281880
709,metastatic colorectal cancer,disease,1.0,35281880
710,recurrent or metastatic colorectal cancer,disease,0.994,35281880
711,patients,species,0.987,35281880
712,Patients,species,0.979,35281880
713,bevacizumab,gene,0.976,35281880
714,cetuximab,gene,0.9595,35281880
715,aflibercept,gene,0.9907,35281880
716,serum eotaxin,gene,0.829,35281880
717,T,cell_line,0.667,35281880
718,T-cell,cell_type,0.551,35281880
719,patients,species,0.984,35281880
720,colorectal cancer,disease,0.984,35281880
721,patient,species,0.973,35281880
722,men,species,0.9004,35281880
723,patients,species,0.99,35281880
724,colorectal cancer,disease,0.8555,35281880
725,RAS,DNA,0.658,35281880
726,RAS mutation,gene,0.959,35281880
727,neutropenia,disease,1.0,35281880
728,nausea,disease,0.999,35281880
729,neuropathy,disease,1.0,35281880
730,stomatitis,disease,1.0,35281880
731,diarrhea,disease,1.0,35281880
732,patient,species,0.961,35281880
733,T-cell,cell_type,0.8413,35281880
734,patients,species,0.981,35281880
735,eotaxin,gene,0.983,35281880
736,GV1001,DNA,0.5415,35281880
737,Retinal Diseases,disease,1.0,35278204
738,retinal diseases,disease,1.0,35278204
739,patient,species,0.9707,35278204
740,ranibizumab,gene,0.7935,35278204
741,aflibercept,gene,0.98,35278204
742,ranibizumab,gene,0.6353,35278204
743,patient,species,0.9883,35278204
744,patient,species,0.9897,35278204
745,patients,species,0.988,35278204
746,osteonecrosis of the jaw,disease,1.0,35277242
747,medication-related osteonecrosis of the jaw,disease,1.0,35277242
748,MRONJ,disease,1.0,35277242
749,MRONJ,disease,1.0,35277242
750,metastatic carcinoma,disease,1.0,35277242
751,osteoporosis,disease,1.0,35277242
752,bisphosphonates,drug,0.996,35277242
753,denosumab,gene,0.785,35277242
754,bisphosphonates,drug,0.998,35277242
755,MRONJ,disease,1.0,35277242
756,diabetes,disease,1.0,35277242
757,autoimmune disease,disease,1.0,35277242
758,MRONJ,disease,1.0,35277242
759,cancer,disease,1.0,35277242
760,Patients,species,0.9673,35277242
761,malignancy,disease,1.0,35277242
762,MRONJ,disease,0.9995,35277242
763,osteoporosis,disease,1.0,35277242
764,bevacizumab,gene,0.832,35277242
765,aflibercept,gene,0.982,35277242
766,tyrosine,drug,0.996,35277242
767,tyrosine kinase,gene,0.984,35277242
768,sunitinib,drug,0.994,35277242
769,MRONJ,disease,1.0,35277242
770,Patients,species,0.984,35277242
771,MRONJ,disease,1.0,35277242
772,VEGF,gene,0.9854,35270241
773,VEGF,gene,0.9326,35270241
774,patients,species,0.978,35270241
775,wet age-related macular degeneration,disease,0.9995,35270241
776,wAMD,disease,1.0,35270241
777,ocular diseases,disease,0.9995,35270241
778,patients,species,0.99,35270241
779,anti-VEGFs,gene,0.856,35270241
780,wAMD,disease,1.0,35270241
781,patients,species,0.991,35270241
782,wAMD,disease,1.0,35270241
783,ocular diseases,disease,0.965,35270241
784,patients,species,0.9775,35270241
785,ocular disorders,disease,0.9365,35270241
786,diabetes,disease,1.0,35270241
787,dexamethasone,drug,0.9927,35270241
788,wAMD,disease,1.0,35270241
789,patients,species,0.955,35270241
790,Ranibizumab,gene,0.884,35270241
791,Aflibercept,gene,0.8916,35270241
792,Pegaptanib,drug,0.998,35270241
793,anti-VEGF,gene,0.9375,35270241
794,ocular diseases,disease,0.9966,35270241
795,patients,species,0.988,35270241
796,Ranibizumab,gene,0.911,35270241
797,Aflibercept,gene,0.8374,35270241
798,Pegaptanib,drug,0.9985,35270241
799,anti-VEGF,gene,0.945,35270241
800,anti-VEGF,gene,0.9106,35270241
801,patients,species,0.981,35270241
802,Brolucizumab,gene,0.6997,35266896
803,diabetic macular edema,disease,1.0,35266896
804,brolucizumab,gene,0.773,35266896
805,diabetic macular edema,disease,1.0,35266896
806,DME,disease,1.0,35266896
807,Brolucizumab,gene,0.653,35266896
808,humanized single- chain variable antibody fragment,gene,0.958,35266896
809,humanized,species,0.751,35266896
810,scFv,gene,0.9404,35266896
811,brolucizumab,gene,0.881,35266896
812,brolucizumab,gene,0.8823,35266896
813,aflibercept,gene,0.944,35266896
814,retinal fluid,disease,0.772,35266896
815,brolucizumab,gene,0.9395,35266896
816,aflibercept,gene,0.929,35266896
817,Brolucizumab,gene,0.766,35266896
818,VEGF,gene,0.683,35266896
819,intraocular inflammatory,disease,0.954,35266896
820,brolucizumab,gene,0.676,35266896
821,DME,disease,1.0,35266896
822,DME,disease,1.0,35266896
823,intraocular inflammation,disease,1.0,35266896
824,retinal vasculitis,disease,1.0,35266896
825,retinal vascular occlusion,disease,1.0,35266896
826,ziv-aflibercept,gene,0.9785,35264434
827,patients,species,0.9663,35264434
828,advanced BACKGROUND,disease,0.837,35264434
829,tumor,disease,0.998,35264434
830,ziv-aflibercept,gene,0.944,35264434
831,patients,species,0.9736,35264434
832,advanced solid tumors,disease,0.987,35264434
833,ziv-aflibercept,gene,0.9863,35264434
834,pembrolizumab,drug,0.568,35264434
835,programmed cell death protein 1,gene,0.954,35264434
836,PD-1,gene,0.999,35264434
837,programmed death-ligand 1,gene,0.9893,35264434
838,PD-L1,gene,0.9956,35264434
839,nave melanoma,disease,1.0,35264434
840,renal cell carcinoma,disease,1.0,35264434
841,RCC,disease,1.0,35264434
842,microsatellite stable colorectal cancer,disease,0.988,35264434
843,CRC,disease,1.0,35264434
844,ovarian cancer,disease,1.0,35264434
845,tumor,disease,0.594,35264434
846,peripheral immune population,cell_type,0.682,35264434
847,patients,species,0.976,35264434
848,Ziv-aflibercept,gene,0.9653,35264434
849,patients,species,0.943,35264434
850,hypertension,disease,0.9995,35264434
851,proteinuria,disease,1.0,35264434
852,melanoma,disease,1.0,35264434
853,RCC,disease,0.9995,35264434
854,mesothelioma,disease,1.0,35264434
855,melanoma,disease,0.9995,35264434
856,melanoma,disease,1.0,35264434
857,RCC,disease,0.999,35264434
858,CRC,disease,0.949,35264434
859,solid tumors,disease,1.0,35264434
860,tumor-infiltrating CD8 T cells,cell_type,0.8716,35264434
861,tumor,disease,0.8853,35264434
862,CD8,gene,0.988,35264434
863,PD1,gene,0.9336,35264434
864,CD40L,gene,0.992,35264434
865,peripheral memory CD8 T cells,cell_type,0.774,35264434
866,ziv-aflibercept,gene,0.9854,35264434
867,pembrolizumab,drug,0.7686,35264434
868,solid tumors,disease,1.0,35264434
869,sarcoma,disease,1.0,35264434
870,anti-PD-1-resistant melanoma,cell_line,0.649,35264434
871,anti-PD-1,gene,0.836,35264434
872,melanoma,disease,0.961,35264434
873,VEGF,gene,0.603,35263409
874,Anti-vascular endothelial growth factor,gene,0.998,35263409
875,anti-VEGF,gene,0.9883,35263409
876,tumor cell lines,cell_line,0.933,35263409
877,tumor,disease,1.0,35263409
878,VEGF,gene,0.936,35263409
879,Bevacizumab,gene,0.679,35263409
880,Avastin,gene,0.787,35263409
881,Aflibercept,gene,0.9307,35263409
882,malignant diseases,disease,1.0,35263409
883,Bevacizumab,gene,0.8823,35263409
884,Aflibercept,gene,0.989,35263409
885,human melanoma cell lines,cell_line,0.9355,35263409
886,human,species,0.99,35263409
887,melanoma,disease,0.9966,35263409
888,A375,cell_line,0.967,35263409
889,SK-Mel-28,cell_line,0.892,35263409
890,healthy cell line,cell_line,0.9233,35263409
891,HaCaT human keratinocytes,cell_line,0.954,35263409
892,human,species,0.987,35263409
893,Bevacizumab,gene,0.944,35263409
894,Aflibercept,gene,0.9873,35263409
895,human melanoma cells,cell_line,0.845,35263409
896,human,species,0.996,35263409
897,melanoma,disease,0.9893,35263409
898,Aflibercept,gene,0.9927,35263409
899,vascular,cell_type,0.683,35263409
900,Retinal nonperfusion,disease,0.9355,35257962
901,RNP,disease,0.9316,35257962
902,diabetic retinopathy,disease,1.0,35257962
903,DR,disease,1.0,35257962
904,aflibercept,gene,0.9795,35257962
905,Eylea,gene,0.778,35257962
906,RNP,RNA,0.765,35257962
907,proliferative DR,disease,0.932,35257962
908,PDR,disease,0.967,35257962
909,PDR,disease,0.998,35257962
910,aflibercept,gene,0.9897,35257962
911,RNP,RNA,0.514,35257962
912,Diabetic Retinopathy,disease,1.0,35257962
913,RNP,RNA,0.547,35257962
914,RNP,RNA,0.5503,35257962
915,RNP,RNA,0.425,35257962
916,RNP,RNA,0.687,35257962
917,RNP,RNA,0.6904,35257962
918,RNP,RNA,0.517,35257962
919,DRSS,DNA,0.5,35257962
920,Aflibercept,gene,0.9414,35256840
921,Macular Edema,disease,1.0,35256840
922,aflibercept,gene,0.985,35256840
923,AFL,gene,0.722,35256840
924,macular edema,disease,1.0,35256840
925,central retinal vein occlusion,disease,1.0,35256840
926,CRVO,disease,1.0,35256840
927,PATIENTS,species,0.8867,35256840
928,patients,species,0.9575,35256840
929,AFL,drug,0.8604,35256840
930,macular edema,disease,1.0,35256840
931,CRVO,disease,1.0,35256840
932,patients,species,0.971,35256840
933,patients,species,0.9893,35256840
934,patients,species,0.989,35256840
935,patients,species,0.9927,35256840
936,AFL,drug,0.8306,35256840
937,macular edema,disease,1.0,35256840
938,CRVO,disease,1.0,35256840
939,AFL,disease,0.998,35256840
940,anti-VEGF,gene,0.8203,35253456
941,macular oedema,disease,1.0,35253456
942,retinal vein PURPOSE,disease,0.998,35253456
943,retinal vein occlusion,disease,1.0,35253456
944,RVO,disease,1.0,35253456
945,RVO,disease,0.9927,35253456
946,macular oedema,disease,1.0,35253456
947,MO,disease,1.0,35253456
948,RVO,disease,1.0,35253456
949,anti-vascular endothelial growth factor,gene,0.9805,35253456
950,anti-VEGF,gene,0.932,35253456
951,aflibercept,gene,0.961,35253456
952,RVO,disease,1.0,35253456
953,patients,species,0.9956,35253456
954,VEGF,gene,0.704,35253456
955,patients,species,0.9644,35253456
956,RVO,disease,1.0,35253456
957,VEGF,gene,0.599,35253456
958,CRVO,disease,1.0,35253456
959,BRVO,disease,1.0,35253456
960,ranibizumab,gene,0.735,35253456
961,BRVO,disease,0.9995,35253456
962,aflibercept,gene,0.9956,35253456
963,CRVO,disease,1.0,35253456
964,BRVO,disease,0.9995,35253456
965,patients,species,0.975,35253456
966,patients,species,0.9897,35253456
967,RVO,disease,1.0,35253456
968,ranibizumab,drug,0.543,35253456
969,aflibercept,gene,0.9795,35253456
970,patient,species,0.9727,35253456
971,Polypoidal Choroidal Vasculopathy,disease,1.0,35252267
972,Patients,species,0.986,35252267
973,patients,species,0.9536,35252267
974,polypoidal choroidal vasculopathy,disease,1.0,35252267
975,PCV,disease,1.0,35252267
976,aflibercept,gene,0.992,35252267
977,conbercept,gene,0.8696,35252267
978,patients,species,0.984,35252267
979,PCV,disease,1.0,35252267
980,patients,species,0.993,35252267
981,aflibercept,gene,0.9897,35252267
982,conbercept,gene,0.659,35252267
983,aflibercept,gene,0.9814,35252267
984,patients,species,0.978,35252267
985,patients,species,0.9873,35252267
986,patients,species,0.9873,35252267
987,polyp,disease,0.5815,35252267
988,Folinic Acid,drug,0.9995,35248464
989,Fluorouracil,drug,0.9995,35248464
990,Irinotecan,drug,0.9985,35248464
991,FOLFIRI,drug,0.994,35248464
992,folinic acid,drug,0.9995,35248464
993,fluorouracil,drug,1.0,35248464
994,irinotecan,drug,0.9985,35248464
995,FOLFIRI,drug,0.9844,35248464
996,bevacizumab,gene,0.904,35248464
997,aflibercept,gene,0.972,35248464
998,metastatic colorectal cancer,disease,1.0,35248464
999,mCRC,disease,1.0,35248464
1000,patients,species,0.9844,35248464
1001,oxaliplatin,drug,1.0,35248464
1002,patients,species,0.972,35248464
1003,FOLFIRI,drug,0.7764,35248464
1004,bevacizumab,gene,0.9087,35248464
1005,aflibercept,gene,0.93,35248464
1006,mCRC,disease,0.976,35248464
1007,patients,species,0.986,35248464
1008,FOLFIRI,drug,0.9346,35248464
1009,aflibercept,gene,0.9766,35248464
1010,FOLFIRI,drug,0.9644,35248464
1011,bevacizumab,gene,0.8535,35248464
1012,aflibercept,gene,0.9653,35248464
1013,bevacizumab,gene,0.974,35248464
1014,bevacizumab,gene,0.9927,35248464
1015,aflibercept,gene,0.9956,35248464
1016,Patients,species,0.971,35248464
1017,bevacizumab,gene,0.994,35248464
1018,patients,species,0.988,35248464
1019,aflibercept,gene,0.9976,35248464
1020,hypertension,disease,0.983,35248464
1021,FOLFIRI,drug,0.7583,35248464
1022,aflibercept,gene,0.997,35248464
1023,FOLFIRI,drug,0.9907,35248464
1024,bevacizumab,gene,0.9644,35248464
1025,FOLFIRI,drug,0.9917,35248464
1026,aflibercept,gene,0.989,35248464
1027,tumour,disease,0.9556,35248464
1028,mCRC,disease,0.992,35248464
1029,patients,species,0.99,35248464
1030,aflibercept,gene,0.992,35248464
1031,bevacizumab,gene,0.8364,35248464
1032,FOLFIRI,drug,0.737,35248464
1033,mCRC,disease,0.9805,35248464
1034,Nesvacumab,gene,0.535,35234673
1035,Anti-Angiopoietin 2,gene,0.993,35234673
1036,Aflibercept,gene,0.984,35234673
1037,Diabetic,disease,0.971,35234673
1038,nesvacumab,gene,0.77,35234673
1039,anti-angiopoietin 2,gene,0.994,35234673
1040,aflibercept,gene,0.9844,35234673
1041,aflibercept,gene,0.9917,35234673
1042,diabetic macular edema,disease,1.0,35234673
1043,DME,disease,1.0,35234673
1044,nesvacumab,gene,0.628,35234673
1045,aflibercept,gene,0.9883,35234673
1046,nesvacumab,gene,0.6274,35234673
1047,aflibercept,gene,0.994,35234673
1048,Nesvacumab,gene,0.814,35234673
1049,aflibercept,gene,0.9966,35234673
1050,aflibercept,gene,0.992,35233693
1051,brolucizumab,gene,0.897,35233693
1052,brolucizumab,gene,0.88,35233693
1053,nAMD,disease,1.0,35233693
1054,aflibercept,gene,0.847,35233693
1055,nAMD,disease,1.0,35233693
1056,brolucizumab,gene,0.881,35233693
1057,aflibercept,gene,0.988,35233693
1058,patients,species,0.986,35233693
1059,aflibercept,gene,0.9893,35233693
1060,patients,species,0.9873,35233693
1061,intraocular inflammation,disease,1.0,35233693
1062,IOI,disease,1.0,35233693
1063,aflibercept,gene,0.9307,35233693
1064,brolucizumab,gene,0.929,35233693
1065,aflibercept,gene,0.9697,35233693
1066,brolucizumab,gene,0.8516,35233693
1067,anti-vascular endothelial growth factor,gene,0.9824,35230656
1068,anti-VEGF,gene,0.943,35230656
1069,thromboembolic adverse events,disease,0.997,35230656
1070,TAEs,disease,0.996,35230656
1071,patients,species,0.9814,35230656
1072,anti-VEGF,gene,0.86,35230656
1073,neovascular age-related macular degeneration,disease,0.9404,35230656
1074,nAMD,disease,1.0,35230656
1075,diabetic macular edema,disease,1.0,35230656
1076,DME,disease,1.0,35230656
1077,patients,species,0.9785,35230656
1078,aflibercept,gene,0.981,35230656
1079,ranibizumab,gene,0.787,35230656
1080,patients,species,0.9766,35230656
1081,TAEs,disease,0.983,35230656
1082,ischemic heart disease,disease,1.0,35230656
1083,ischemic stroke,disease,1.0,35230656
1084,transient ischemic attack,disease,1.0,35230656
1085,deep vein thrombosis,disease,1.0,35230656
1086,pulmonary embolism,disease,1.0,35230656
1087,TAEs,disease,0.7197,35230656
1088,patients,species,0.966,35230656
1089,aflibercept,gene,0.977,35230656
1090,ranibizumab,gene,0.5938,35230656
1091,ranibizumab,gene,0.8965,35230656
1092,aflibercept,gene,0.9795,35230656
1093,nAMD,disease,1.0,35230656
1094,nAMD,disease,1.0,35230656
1095,DME,disease,1.0,35230656
1096,patients,species,0.9893,35230656
1097,nAMD,disease,1.0,35230656
1098,patients,species,0.9917,35230656
1099,aflibercept,gene,0.968,35230656
1100,ranibizumab,gene,0.743,35230656
1101,DME,disease,1.0,35230656
1102,patients,species,0.9946,35230656
1103,aflibercept,gene,0.963,35230656
1104,ranibizumab,gene,0.5317,35230656
1105,patients,species,0.9326,35230656
1106,ranibizumab,gene,0.6616,35230656
1107,DME,disease,0.9995,35230656
1108,TAEs,disease,0.6562,35230656
1109,nAMD,disease,1.0,35230656
1110,patients,species,0.975,35230656
1111,aflibercept,gene,0.923,35230656
1112,DME,disease,1.0,35230656
1113,patients,species,0.9946,35230656
1114,aflibercept,gene,0.9653,35230656
1115,nAMD,disease,1.0,35230656
1116,patients,species,0.99,35230656
1117,anti-VEGF,gene,0.8887,35230656
1118,Patients,species,0.975,35230656
1119,aflibercept,gene,0.9863,35230656
1120,ranibizumab,gene,0.792,35230656
1121,TAE,disease,0.8135,35230656
1122,aflibercept,gene,0.985,35230472
1123,neovascular age-related macular degeneration,disease,1.0,35230472
1124,nAMD,disease,1.0,35230472
1125,aflibercept,gene,0.9893,35230472
1126,aflibercept,gene,0.9844,35230472
1127,aflibercept,gene,0.919,35230472
1128,ranibizumab,gene,0.4788,35230472
1129,intraocular inflammation,disease,1.0,35230472
1130,IOI,disease,0.9995,35230472
1131,aflibercept,gene,0.9204,35230472
1132,aflibercept,gene,0.9336,35230472
1133,aflibercept,gene,0.8467,35230472
1134,CFT,cell_type,0.4663,35230472
1135,aflibercept,gene,0.992,35230472
1136,CFT,cell_type,0.477,35230472
1137,nAMD,disease,1.0,35230472
1138,aflibercept,gene,0.985,35230472
1139,ranibizumab,gene,0.7554,35230472
1140,aflibercept,gene,0.9536,35230472
1141,aflibercept,gene,0.9873,35229901
1142,metastatic colorectal,disease,0.9995,35229901
1143,Aflibercept,gene,0.9663,35229901
1144,vascular endothelial growth factor,gene,0.9976,35229901
1145,VEGF,gene,0.9976,35229901
1146,patients,species,0.9644,35229901
1147,metastatic colorectal cancer,disease,1.0,35229901
1148,mCRC,disease,1.0,35229901
1149,aflibercept,gene,0.983,35229901
1150,mCRC,disease,0.9326,35229901
1151,aflibercept,gene,0.985,35229901
1152,mCRC,disease,0.8813,35229901
1153,patients,species,0.986,35229901
1154,diarrhoea,disease,0.9165,35229901
1155,hypertension,disease,0.9946,35229901
1156,neutropenia,disease,0.886,35229901
1157,proteinuria,disease,0.977,35229901
1158,oral mucositis,disease,0.9966,35229901
1159,aflibercept,gene,0.988,35229901
1160,mCRC,disease,0.9897,35229901
1161,Retinal Vein Occlusion,disease,0.97,35221977
1162,Messenger RNA,RNA,0.7163,35221977
1163,COVID-19,disease,0.988,35221977
1164,messenger RNA,RNA,0.7944,35221977
1165,COVID-19,disease,0.999,35221977
1166,man,species,0.854,35221977
1167,BRVO,disease,1.0,35221977
1168,thrombophilia,disease,1.0,35221977
1169,retinal hemorrhage,disease,0.999,35221977
1170,superotemporal region,DNA,0.494,35221977
1171,subfoveal fluid accumulation,disease,0.905,35221977
1172,retinal thickening,disease,0.9995,35221977
1173,aflibercept,gene,0.964,35221977
1174,retinal hemorrhage,disease,1.0,35221977
1175,macular edema,disease,1.0,35221977
1176,BRVO,disease,0.999,35221977
1177,BNT162b2,cell_line,0.868,35221977
1178,RVO,disease,0.9995,35221977
1179,aflibercept,gene,0.963,35218455
1180,cone,cell_type,0.5015,35218455
1181,age-related macular degeneration,disease,1.0,35218455
1182,nAMD,disease,1.0,35218455
1183,patients,species,0.9727,35218455
1184,nAMD,disease,1.0,35218455
1185,aflibercept,gene,0.9385,35218455
1186,CRT,DNA,0.494,35218455
1187,cone,cell_type,0.583,35218455
1188,rods,cell_type,0.531,35218455
1189,neovascular age-related macular,disease,1.0,35217515
1190,neovascular age-related macular degeneration,disease,1.0,35217515
1191,nAMD,disease,1.0,35217515
1192,patients,species,0.948,35217515
1193,chronic nAMD,disease,0.9834,35217515
1194,ranibizumab,gene,0.8457,35217515
1195,Participants,species,0.9395,35217515
1196,ranibizumab,gene,0.688,35217515
1197,participants,species,0.974,35217515
1198,ranibizumab,gene,0.822,35217515
1199,aflibercept,gene,0.942,35217515
1200,participants,species,0.9575,35217515
1201,EMB,drug,0.9536,35217515
1202,ranibizumab,gene,0.713,35217515
1203,EMB,drug,0.9966,35217515
1204,participants,species,0.984,35217515
1205,microvascular abnormalities,disease,1.0,35217515
1206,MVAs,disease,1.0,35217515
1207,EMB,drug,0.9966,35217515
1208,participants,species,0.9844,35217515
1209,MVAs,disease,1.0,35217515
1210,EMB,drug,0.809,35217515
1211,anti-vascular endothelial growth factor,gene,0.9683,35217515
1212,VEGF,gene,0.997,35217515
1213,VEGF,gene,0.75,35217515
1214,VEGF,gene,0.9365,35213999
1215,ranibizumab,gene,0.8755,35213999
1216,bevacizumab,gene,0.827,35213999
1217,aflibercept,gene,0.967,35213999
1218,brolucizumab,gene,0.897,35213999
1219,vascular endothelial growth factor,gene,0.9985,35213999
1220,VEGF,gene,0.9956,35213999
1221,VEGF,gene,0.9946,35213999
1222,anti-VEGFs,gene,0.911,35213999
1223,ranibizumab,gene,0.8716,35213999
1224,bevacizumab,gene,0.8145,35213999
1225,aflibercept,gene,0.9785,35213999
1226,brolucizumab,gene,0.8936,35213999
1227,VEGF,gene,0.9727,35213999
1228,VEGF,gene,0.524,35213999
1229,VEGF,gene,0.6177,35213999
1230,VEGF,gene,0.995,35213999
1231,ranibizumab,gene,0.8086,35213999
1232,bevacizumab,gene,0.922,35213999
1233,aflibercept,gene,0.9917,35213999
1234,brolucizumab,gene,0.927,35213999
1235,VEGF,gene,0.9946,35213999
1236,ranibizumab,gene,0.7915,35213999
1237,bevacizumab,gene,0.922,35213999
1238,aflibercept,gene,0.989,35213999
1239,brolucizumab,gene,0.9355,35213999
1240,VEGF,gene,0.972,35213999
1241,VEGF,gene,0.993,35211322
1242,Neovascular age-related macular degeneration,disease,1.0,35211322
1243,AMD,disease,1.0,35211322
1244,eye disease,disease,0.8228,35211322
1245,vision loss,disease,0.9985,35211322
1246,Vascular endothelial growth factor,gene,0.9976,35211322
1247,neovascular AMD,disease,1.0,35211322
1248,aflibercept,gene,0.9897,35211322
1249,ranibizumab,gene,0.9204,35211322
1250,brolucizumab,gene,0.9663,35211322
1251,bevacizumab,gene,0.9663,35211322
1252,bevacizumab,gene,0.8745,35211322
1253,neovascular AMD,disease,1.0,35211322
1254,AMD,disease,1.0,35211322
1255,bevacizumab,gene,0.8667,35211322
1256,AMD,disease,1.0,35211322
1257,patient,species,0.9688,35211322
1258,Vascular Endothelial Growth Factor,gene,0.8525,35207218
1259,anti-vascular endothelial growth factor,gene,0.979,35207218
1260,VEGF,gene,0.9946,35207218
1261,patients,species,0.992,35207218
1262,VEGF,gene,0.7246,35207218
1263,patients,species,0.9937,35207218
1264,aflibercept,gene,0.9927,35207218
1265,bevacizumab,gene,0.924,35207218
1266,ranibizumab,gene,0.7324,35207218
1267,Ranibizumab,gene,0.75,35207218
1268,Ranibizumab,gene,0.804,35207218
1269,Brolucizumab,gene,0.7954,35206485
1270,Aflibercept,gene,0.9634,35206485
1271,Patients,species,0.9907,35206485
1272,Neovascular Age-related macular degeneration,disease,1.0,35206485
1273,AMD,disease,1.0,35206485
1274,blindness,disease,1.0,35206485
1275,VEGF,gene,0.521,35206485
1276,brolucizumab,gene,0.8887,35206485
1277,aflibercept,gene,0.9834,35206485
1278,patients,species,0.919,35206485
1279,neovascular AMD,disease,1.0,35206485
1280,nAMD,disease,1.0,35206485
1281,patients,species,0.989,35206485
1282,neovascular age-related macular degeneration,disease,1.0,35206485
1283,patients,species,0.9785,35206485
1284,aflibercept,gene,0.974,35206485
1285,Eylea,gene,0.782,35206485
1286,patients,species,0.9897,35206485
1287,brolucizumab,gene,0.7563,35206485
1288,patient,species,0.9907,35206485
1289,Snellen,DNA,0.4746,35206485
1290,patients,species,0.989,35206485
1291,brolucizumab,gene,0.7246,35206485
1292,brolucizumab,gene,0.804,35206485
1293,patients,species,0.9497,35206485
1294,aflibercept,gene,0.955,35206485
1295,brolucizumab,gene,0.8623,35206485
1296,aflibercept,gene,0.967,35206485
1297,patients,species,0.9795,35206485
1298,nAMD,disease,1.0,35206485
1299,VEGF-Trap,gene,0.816,35203414
1300,Murine,species,0.7812,35203414
1301,Oxygen-Induced Retinopathy,disease,0.9976,35203414
1302,Oxygen,drug,0.9937,35203414
1303,Vascular Endothelial Growth Factor,gene,0.9824,35203414
1304,VEGF,gene,0.995,35203414
1305,retinal neovascular diseases,disease,1.0,35203414
1306,acquired,disease,0.538,35203414
1307,vision loss,disease,0.9717,35203414
1308,VEGF-Trap,gene,0.984,35203414
1309,Aflibercept,gene,0.996,35203414
1310,AFL,gene,0.9946,35203414
1311,VEGFR-1 and -2,gene,0.998,35203414
1312,diabetic macular edema,disease,1.0,35203414
1313,mouse,species,0.984,35203414
1314,oxygen-induced retinopathy,disease,0.97,35203414
1315,oxygen,drug,0.999,35203414
1316,OIR,disease,0.9995,35203414
1317,retinopathies,disease,1.0,35203414
1318,diabetic retinopathy,disease,0.9956,35203414
1319,PDR,disease,1.0,35203414
1320,retinopathy of prematurity,disease,1.0,35203414
1321,ROP,disease,1.0,35203414
1322,diabetic macular edema,disease,1.0,35203414
1323,DME,disease,1.0,35203414
1324,microglial cells,cell_type,0.9272,35203414
1325,AFL,drug,0.9272,35203414
1326,OIR,disease,0.9614,35203414
1327,ramified Iba1(+) microglial cells,cell_line,0.814,35203414
1328,Iba1(+),gene,0.845,35203414
1329,/,cell_type,0.7007,35203414
1330,macrophages,cell_type,0.549,35203414
1331,post-ischemic retinal inflammation,disease,0.81,35203414
1332,Non-proliferative Diabetic Retinopathy,disease,0.9927,35194501
1333,Diabetic Diabetic retinopathy,disease,1.0,35194501
1334,DR,disease,1.0,35194501
1335,visual impairment,disease,1.0,35194501
1336,blindness,disease,1.0,35194501
1337,nonproliferative diabetic retinopathy,disease,1.0,35194501
1338,NPDR,disease,1.0,35194501
1339,diabetic macular edema,disease,1.0,35194501
1340,DME,disease,1.0,35194501
1341,Diabetic Retinopathy,disease,0.9995,35194501
1342,NPDR,disease,0.999,35194501
1343,patients,species,0.9688,35194501
1344,NPDR,disease,0.9985,35194501
1345,anti-vascular endothelial growth factor,gene,0.9644,35194501
1346,anti-VEGF,gene,0.9854,35194501
1347,DME,disease,0.998,35194501
1348,DR,disease,,35194501
1349,aflibercept,gene,0.969,35194501
1350,NPDR,disease,0.9995,35194501
1351,DR,disease,,35194501
1352,NPDR,disease,1.0,35194501
1353,anti-VEGF,gene,0.872,35194501
1354,VEGF,gene,0.818,35194501
1355,NPDR,disease,1.0,35194501
1356,aflibercept,gene,0.885,35194501
1357,NPDR,disease,0.999,35194501
1358,aflibercept,gene,0.9307,35194501
1359,DR,disease,,35194501
1360,DME,disease,1.0,35194501
1361,anti-VEGF,gene,0.8745,35194501
1362,NPDR,disease,1.0,35194501
1363,PCV,disease,1.0,35194070
1364,VEGF,gene,0.684,35194070
1365,participants,species,0.962,35194070
1366,PCV,disease,1.0,35194070
1367,aflibercept,gene,0.9487,35194070
1368,participants,species,0.966,35194070
1369,diabetic retinopathy,disease,0.9985,35194070
1370,PED,disease,0.999,35194070
1371,CRT,DNA,0.5967,35194070
1372,CRT,DNA,0.5435,35194070
1373,PED,DNA,0.6265,35194070
1374,PED,disease,0.997,35194070
1375,CVH,disease,0.9995,35194070
1376,PCV,disease,1.0,35194070
1377,VEGF,gene,0.683,35194070
1378,PEDs,cell_type,0.4824,35194070
1379,ziv-aflibercept,gene,0.971,35194061
1380,ziv-aflibercept,gene,0.9634,35194061
1381,tuberculin,gene,0.966,35194061
1382,ziv-aflibercept,gene,0.9873,35194061
1383,anti-VEGF,gene,0.9834,35194061
1384,VEGF,gene,0.9937,35194061
1385,ziv-aflibercept,gene,0.996,35194061
1386,ziv-aflibercept,gene,0.9907,35194061
1387,ziv-aflibercept,gene,0.989,35194061
1388,VEGF,gene,0.6465,35194061
1389,ziv-aflibercept,gene,0.9897,35194061
1390,Fluorescein,drug,0.9966,35191353
1391,Retinopathy,disease,1.0,35191353
1392,fluorescein,drug,0.9976,35191353
1393,patients,species,0.9795,35191353
1394,VEGF,gene,0.9985,35191353
1395,bevacizumab,gene,0.713,35191353
1396,aflibercept,gene,0.9717,35191353
1397,retinopathy of prematurity,disease,0.9995,35191353
1398,ROP,disease,1.0,35191353
1399,Infants,species,0.894,35191353
1400,ROP,disease,0.988,35191353
1401,fluorescein,drug,0.9927,35191353
1402,patients,species,0.9863,35191353
1403,VEGF,gene,0.8296,35191353
1404,Vascular abnormalities,disease,1.0,35191353
1405,vascular leakage,disease,0.881,35191353
1406,hypoperfusion,disease,0.996,35191353
1407,infants,species,0.7905,35191353
1408,anti-VEGF,gene,0.9287,35191353
1409,vascular,DNA,0.4988,35191353
1410,periarteriolar,DNA,0.4941,35191353
1411,hypoperfusion,disease,0.909,35191353
1412,Vascular abnormalities,disease,1.0,35191353
1413,ROP,disease,1.0,35191353
1414,infants,species,0.833,35191353
1415,ROP,disease,0.9927,35191353
1416,patients,species,0.9873,35191353
1417,anti-VEGF,gene,0.895,35191353
1418,VEGF,gene,0.503,35191353
1419,Vascular Endothelial Growth Factor,gene,0.9746,35180922
1420,Conbercept,gene,0.869,35180922
1421,Age-related macular degeneration,disease,1.0,35180922
1422,AMD,disease,1.0,35180922
1423,blindness,disease,0.997,35180922
1424,nAMD,disease,1.0,35180922
1425,visual loss,disease,0.9897,35180922
1426,legal blindness,disease,1.0,35180922
1427,AMD,disease,1.0,35180922
1428,Choroidal neovascularization,disease,1.0,35180922
1429,CNV,disease,1.0,35180922
1430,nAMD,disease,1.0,35180922
1431,nAMD,disease,1.0,35180922
1432,VEGF,gene,0.9966,35180922
1433,VEGF,gene,0.9956,35180922
1434,CNV,disease,1.0,35180922
1435,VEGF,gene,0.894,35180922
1436,ranibizumab,gene,0.546,35180922
1437,bevacizumab,gene,0.8447,35180922
1438,aflibercept,gene,0.9497,35180922
1439,Conbercept,drug,0.9883,35180922
1440,conbercept,DNA,0.4587,35180922
1441,HREC,cell_type,0.8486,35180922
1442,HREC,cell_line,0.84,35180922
1443,HREC,cell_type,0.705,35180922
1444,VEGF,gene,0.9897,35180922
1445,nAMD,disease,0.9985,35180922
1446,RANIBIZUMAB,drug,0.9844,35174799
1447,aflibercept,gene,0.9263,35174799
1448,DME,disease,1.0,35174799
1449,DME,disease,1.0,35174799
1450,ranibizumab,gene,0.6743,35174799
1451,aflibercept,gene,0.935,35174799
1452,Retinal Blindness,disease,1.0,35174799
1453,ranibizumab,drug,0.925,35174799
1454,aflibercept,gene,0.8564,35174799
1455,patients,species,0.988,35174799
1456,ranibizumab,gene,0.963,35174799
1457,aflibercept,gene,0.571,35174799
1458,aflibercept,gene,0.928,35174799
1459,ranibizumab,gene,0.9814,35174799
1460,aflibercept,gene,0.6655,35174799
1461,visual impairment,disease,1.0,35174799
1462,aflibercept,gene,0.9844,35174799
1463,ranibizumab,gene,0.9565,35174799
1464,visual impairment,disease,1.0,35174799
1465,Aflibercept,gene,0.8115,35174799
1466,ranibizumab,gene,0.9565,35174799
1467,DME,disease,1.0,35174799
1468,Bilateral blindness,disease,0.998,35172763
1469,brolucizumab,gene,0.8325,35172763
1470,bilateral panuveitis,disease,0.8804,35172763
1471,ischemic vasculitis,disease,1.0,35172763
1472,perineural inflammation,disease,1.0,35172763
1473,brolucizumab,gene,0.9536,35172763
1474,patient,species,0.936,35172763
1475,neovascular age-related macular degeneration,disease,1.0,35172763
1476,nAMD,disease,1.0,35172763
1477,woman,species,0.897,35172763
1478,loss of vision,disease,0.9517,35172763
1479,brolucizumab,gene,0.709,35172763
1480,anti-vascular endothelial growth factor (,gene,0.998,35172763
1481,VEGF) single-chain variable region,gene,0.792,35172763
1482,scFv,gene,0.831,35172763
1483,neovascular age-related macular degeneration,disease,1.0,35172763
1484,nAMD,disease,1.0,35172763
1485,panocular vasculitis,disease,0.9736,35172763
1486,ischemia,disease,0.881,35172763
1487,choroidal detachment,disease,1.0,35172763
1488,vasculitis,disease,1.0,35172763
1489,panuveitis,disease,0.9014,35172763
1490,vasculitis,disease,0.9863,35172763
1491,interleukin six,gene,0.982,35172763
1492,interleukin ten,gene,0.8887,35172763
1493,panuveitis,disease,1.0,35172763
1494,ischemic vasculitis,disease,1.0,35172763
1495,perineural inflammation,disease,1.0,35172763
1496,brolucizumab,gene,0.9824,35172763
1497,brolucizumab,gene,0.95,35172763
1498,vasculitis,disease,1.0,35172763
1499,brolucizumab,gene,0.6997,35172763
1500,aflibercept,gene,0.93,35172763
1501,neovascular age-related macular degeneration,disease,1.0,35157713
1502,nARMD,disease,1.0,35157713
1503,patients,species,0.971,35157713
1504,nARMD,disease,1.0,35157713
1505,serous pigment epithelium detachments,disease,0.903,35157713
1506,PEDs,disease,0.916,35157713
1507,SRF,disease,0.5493,35157713
1508,IRF,cell_type,0.531,35157713
1509,BCVA,DNA,0.471,35157713
1510,choroidal neovascular membranes,disease,0.9995,35157713
1511,CNVM,disease,0.998,35157713
1512,Wet Age-Related Macular Degeneration,disease,1.0,35149964
1513,neovascular age-related macular degeneration,disease,1.0,35149964
1514,nAMD,disease,1.0,35149964
1515,nAMD,disease,1.0,35149964
1516,patients,species,0.9883,35149964
1517,patients,species,0.988,35149964
1518,anti-,gene,0.6475,35149964
1519,vascular endothelial growth factor,gene,0.8696,35149964
1520,VEGF,gene,0.997,35149964
1521,patients,species,0.9897,35149964
1522,Patients,species,0.96,35149964
1523,patients,species,0.9683,35149964
1524,nAMD,disease,1.0,35149964
1525,VEGF,gene,0.852,35149964
1526,nAMD,disease,1.0,35149964
1527,MH,disease,1.0,35146199
1528,age-related macular degeneration,disease,1.0,35146199
1529,nAMD,disease,1.0,35146199
1530,woman,species,0.887,35146199
1531,sudden visual impairment,disease,0.853,35146199
1532,floaters,disease,0.9478,35146199
1533,retinal hemorrhages,disease,1.0,35146199
1534,hemorrhagic pigment epithelial detachment,disease,1.0,35146199
1535,type 1,disease,0.8013,35146199
1536,nAMD,disease,0.785,35146199
1537,MH,disease,,35146199
1538,aflibercept,gene,0.989,35146199
1539,MH,disease,,35146199
1540,patient,species,0.994,35146199
1541,nAMD,disease,1.0,35146199
1542,aflibercept,gene,0.988,35146199
1543,MH,disease,,35146199
1544,MH,disease,,35146199
1545,nAMD,disease,1.0,35146199
1546,MH,disease,,35146199
1547,vascular endothelial growth factor,gene,0.9946,35146199
1548,nAMD,disease,1.0,35146199
1549,patients,species,0.9883,35144686
1550,neovascular age-related macular degeneration,disease,0.999,35144686
1551,patients,species,0.9814,35144686
1552,aflibercept,gene,0.975,35144686
1553,VEGF,gene,0.6533,35144686
1554,neovascular age-related macular degeneration,disease,1.0,35144686
1555,nAMD,disease,1.0,35144686
1556,Patients,species,0.9834,35144686
1557,nAMD,disease,1.0,35144686
1558,VEGF,gene,0.6104,35144686
1559,patients,species,0.9937,35144686
1560,patients,species,0.9917,35144686
1561,IAI,disease,0.9937,35144686
1562,VEGF,gene,0.79,35144686
1563,IAI,disease,0.994,35144686
1564,patients,species,0.985,35144686
1565,patients,species,0.987,35144686
1566,Patients,species,0.9614,35144686
1567,Patients,species,0.9736,35144686
1568,IAI,disease,0.7476,35144686
1569,human,species,0.995,35143514
1570,porcine,species,0.903,35143514
1571,Fluorescein isothiocyanate,drug,0.9995,35143514
1572,FITC,drug,1.0,35143514
1573,FITC,drug,1.0,35143514
1574,bovine serum albumin,gene,0.969,35143514
1575,bovine,species,0.893,35143514
1576,BSA,gene,0.9595,35143514
1577,porcine,species,0.963,35143514
1578,BSA,gene,0.9297,35143514
1579,vascular endothelial growth factor,gene,0.998,35141350
1580,VEGF,gene,0.9956,35141350
1581,nAMD,disease,1.0,35141350
1582,VEGF,gene,0.6646,35141350
1583,anti-VEGF,gene,0.984,35141350
1584,VEGF Trap,gene,0.986,35141350
1585,nVEGFi,gene,0.972,35141350
1586,VEGFR1,gene,0.9746,35141350
1587,VEGFR2,gene,0.9556,35141350
1588,Fc,gene,,35141350
1589,human IgG,gene,0.9795,35141350
1590,human,species,0.9966,35141350
1591,nVEGFi,gene,0.9893,35141350
1592,aflibercept,gene,0.9927,35141350
1593,expression cassettes,DNA,0.749,35141350
1594,nVEGFi,gene,0.987,35141350
1595,aflibercept,gene,0.986,35141350
1596,VEGF,gene,0.995,35141350
1597,nVEGFi,gene,0.963,35141350
1598,mice,species,0.9434,35141350
1599,mouse,species,0.93,35141350
1600,choroidal neovascularization,disease,0.998,35141350
1601,CNV,disease,1.0,35141350
1602,nVEGFi,gene,0.9956,35141350
1603,CNV,disease,1.0,35141350
1604,aflibercept,gene,0.99,35141350
1605,nVEGFi,gene,0.9946,35141350
1606,nAMD,disease,1.0,35141350
1607,vascular endothelial growth,gene,0.7544,35140311
1608,vascular endothelial growth factor,gene,0.826,35140311
1609,anti-VEGF,gene,0.8022,35140311
1610,macular edema,disease,1.0,35140311
1611,central retinal vein occlusion,disease,1.0,35140311
1612,CRVO,disease,1.0,35140311
1613,patients,species,0.9644,35140311
1614,CRVO,disease,1.0,35140311
1615,VEGF,gene,0.5317,35140311
1616,patient,species,0.9507,35140311
1617,men,species,0.9565,35140311
1618,macular edema,disease,1.0,35140311
1619,macular edema,disease,1.0,35140311
1620,macular edema,disease,1.0,35140311
1621,CRVO,disease,1.0,35140311
1622,VEGF,gene,0.669,35140311
1623,patients,species,0.989,35140311
1624,VEGF,gene,0.8804,35140311
1625,ganglion cell layer,cell_type,0.646,35135401
1626,aflibercept,gene,0.905,35135401
1627,neovascular age-related macular degeneration,disease,1.0,35135401
1628,nAMD,disease,1.0,35135401
1629,patients,species,0.9717,35135401
1630,patients,species,0.993,35135401
1631,aflibercept,gene,0.9575,35135401
1632,nAMD,disease,1.0,35135401
1633,aflibercept,gene,0.979,35135401
1634,aflibercept,gene,0.966,35135401
1635,GCLT,gene,0.921,35135401
1636,aflibercept,gene,0.9688,35135401
1637,ganglion cell layer,cell_type,0.606,35135401
1638,aflibercept,gene,0.9175,35135401
1639,nAMD,disease,1.0,35135401
1640,patients,species,0.997,35135401
1641,diabetic macular edema,disease,1.0,35133337
1642,macular edema,disease,1.0,35133337
1643,patients,species,0.95,35133337
1644,diabetic macular edema,disease,1.0,35133337
1645,DME,disease,1.0,35133337
1646,ziv-aflibercept,gene,0.973,35133337
1647,ziv,gene,0.821,35133337
1648,AFL,gene,0.573,35133337
1649,DME,disease,1.0,35133337
1650,patients,species,0.9946,35133337
1651,ziv-AFL,drug,0.9077,35133337
1652,BCVA,DNA,0.636,35133337
1653,BCVA,DNA,0.5195,35133337
1654,DME,disease,1.0,35133337
1655,patients,species,0.9844,35133337
1656,ziv-AFL,drug,0.992,35133337
1657,Central Retinal Vein Occlusion,disease,1.0,35125806
1658,COVID-19,disease,1.0,35125806
1659,Patient,species,0.9844,35125806
1660,Coronavirus disease,disease,1.0,35125806
1661,COVID-19,disease,1.0,35125806
1662,COVID-19,disease,0.998,35125806
1663,patients,species,0.974,35125806
1664,multisystem,disease,0.582,35125806
1665,thromboembolic events,disease,0.869,35125806
1666,pulmonary emboli,disease,1.0,35125806
1667,deep vein thrombosis,disease,1.0,35125806
1668,man,species,0.817,35125806
1669,COVID-19 infection,disease,1.0,35125806
1670,central retinal vein occlusion,disease,1.0,35125806
1671,CRVO,disease,1.0,35125806
1672,macular edema,disease,1.0,35125806
1673,thromboembolic events,disease,0.998,35125806
1674,aflibercept,gene,0.978,35125806
1675,CRVO,disease,1.0,35125806
1676,macular edema,disease,1.0,35125806
1677,CRVO,disease,1.0,35125806
1678,COVID-19,disease,0.9995,35125806
1679,Oman,species,0.694,35125806
1680,age-related macular degeneration,disease,1.0,35123015
1681,neovascular age-related macular degeneration,disease,0.9995,35123015
1682,nAMD,disease,1.0,35123015
1683,anti-,gene,0.6494,35123015
1684,vascular endothelial growth factor,gene,0.8936,35123015
1685,verteporfin,drug,0.998,35123015
1686,Patients,species,0.982,35123015
1687,aflibercept,gene,0.9673,35123015
1688,aflibercept,gene,0.9683,35123015
1689,macular atrophy,disease,1.0,35123015
1690,macular atrophy,disease,1.0,35123015
1691,nAMD,disease,1.0,35123015
1692,patients,species,0.959,35123015
1693,macular atrophy,disease,1.0,35123015
1694,Rubeosis Iridis,disease,1.0,35111032
1695,woman,species,0.905,35111032
1696,decreased vision,disease,0.9062,35111032
1697,rubeosis iridis,disease,1.0,35111032
1698,RBCs,cell_type,0.5435,35111032
1699,rubeosis iridis,disease,1.0,35111032
1700,neovascular glaucoma,disease,1.0,35111032
1701,central retinal vein occlusion,disease,1.0,35111032
1702,aflibercept,gene,0.984,35111032
1703,rubeosis iridis,disease,1.0,35111032
1704,RBCs,cell_type,0.664,35111032
1705,neovascular age-related macular degeneration,disease,1.0,35106882
1706,neovascular AMD,disease,1.0,35106882
1707,nAMD,disease,1.0,35106882
1708,VEGF,gene,0.9995,35106882
1709,nAMD,disease,1.0,35106882
1710,anti-VEGF,gene,0.8564,35106882
1711,ranibizumab,gene,0.958,35106882
1712,aflibercept,gene,0.9536,35106882
1713,bevacizumab,gene,0.78,35106882
1714,ETDRS,DNA,0.4834,35106882
1715,Retinal Blindness,disease,0.9995,35106882
1716,patients,species,0.9907,35106882
1717,PT,disease,,35106882
1718,PT,disease,,35106882
1719,PT,disease,,35106882
1720,PT,disease,,35106882
1721,ranibizumab,gene,0.8203,35106882
1722,aflibercept,gene,0.9854,35106882
1723,bevacizumab,gene,0.8457,35106882
1724,health care professionals,cell_type,0.492,35106882
1725,nAMD,disease,1.0,35106882
1726,Brolucizumab,gene,0.841,35102497
1727,Vascular Endothelial Growth Factor-,gene,0.9966,35102497
1728,neurovascular age-related macular degeneration,disease,1.0,35102497
1729,Brolucizumab,gene,0.845,35102497
1730,brolucizumab,gene,0.882,35102497
1731,aflibercept,gene,0.8975,35102497
1732,brolucizumab,gene,0.837,35102497
1733,aflibercept,gene,0.98,35102497
1734,brolucizumab,gene,0.914,35102497
1735,aflibercept,gene,0.9863,35102497
1736,brolucizumab,gene,0.8945,35102497
1737,aflibercept,gene,0.9316,35102497
1738,intraocular inflammation,disease,1.0,35102497
1739,IOI,disease,1.0,35102497
1740,brolucizumab,gene,0.853,35102497
1741,brolucizumab,gene,0.8945,35102497
1742,IOI,disease,0.997,35102497
1743,patients,species,0.9795,35102497
1744,IOI,disease,0.9976,35102497
1745,brolucizumab,gene,0.8247,35102497
1746,IOI,disease,0.999,35102497
1747,brolucizumab,gene,0.5757,35102497
1748,vision loss,disease,0.999,35102497
1749,brolucizumab,gene,0.858,35102497
1750,Tissue plasminogen activator,gene,0.98,35101110
1751,Neovascular (wet) age-related macular degeneration,disease,1.0,35101110
1752,AMD,disease,1.0,35101110
1753,SMH,disease,1.0,35101110
1754,SMH,disease,1.0,35101110
1755,anti-,gene,0.6216,35101110
1756,vascular endothelial growth factor,gene,0.9346,35101110
1757,SMH,disease,0.9966,35101110
1758,alteplase,gene,0.941,35101110
1759,tissue plasminogen,gene,0.9976,35101110
1760,TPA,drug,0.895,35101110
1761,TPA,drug,0.9595,35101110
1762,participants,species,0.901,35101110
1763,SMH,disease,0.9985,35101110
1764,neovascular AMD,disease,1.0,35101110
1765,idiopathic polypoidal choroidal vasculopathy,disease,1.0,35101110
1766,retinal angiomatous proliferation,disease,1.0,35101110
1767,participants,species,0.9614,35101110
1768,TPA,drug,0.925,35101110
1769,sulfahexafluoride,drug,0.9995,35101110
1770,aflibercept,gene,0.984,35101110
1771,aflibercept,gene,0.9863,35101110
1772,Aflibercept,gene,0.8906,35101110
1773,participants,species,0.9653,35101110
1774,Diabetic Retinopathy,disease,0.999,35101110
1775,participants,species,0.96,35101110
1776,scotoma,disease,1.0,35101110
1777,subfoveal fibrosis,disease,1.0,35101110
1778,atrophy,disease,0.863,35101110
1779,SMH,disease,0.992,35101110
1780,SMH,disease,0.9995,35101110
1781,aflibercept,gene,0.9775,35101110
1782,Angiopoietin,gene,0.998,35098845
1783,Tie,gene,0.9844,35098845
1784,age-related macular degeneration,disease,0.9995,35098845
1785,AMD,disease,0.9644,35098845
1786,diabetic macular edema,disease,1.0,35098845
1787,DME,disease,1.0,35098845
1788,retinal vein occlusions,disease,1.0,35098845
1789,RVOs,disease,1.0,35098845
1790,exudative retinal diseases,disease,1.0,35098845
1791,vascular endothelial growth factor,gene,0.9316,35098845
1792,VEGF,gene,0.9976,35098845
1793,patients,species,0.9917,35098845
1794,angiopoietin,gene,0.9985,35098845
1795,Tie,gene,0.9883,35098845
1796,Ang,gene,0.999,35098845
1797,Tie,gene,0.9907,35098845
1798,exudative retinal diseases,disease,1.0,35098845
1799,ARP- 1536,drug,0.999,35098845
1800,aflibercept,gene,0.9844,35098845
1801,nesvacumab,gene,0.796,35098845
1802,AKB-9778,drug,0.998,35098845
1803,Ang,gene,0.9946,35098845
1804,Tie,gene,0.983,35098845
1805,VEGF-A,gene,0.9985,35098845
1806,Ang-2,gene,0.994,35098845
1807,VEGF,gene,0.9976,35098845
1808,Ang,gene,0.9883,35098845
1809,Tie,gene,0.9897,35098845
1810,patients,species,0.923,35098845
1811,exudative retinal diseases,disease,1.0,35098845
1812,Ang,gene,0.998,35098845
1813,Tie,gene,0.9897,35098845
1814,faricimab,gene,0.534,35098845
1815,exudative macular diseases,disease,0.9995,35098845
1816,bevacizumab,gene,0.803,35094229
1817,ranibizumab,gene,0.562,35094229
1818,aflibercept,gene,0.979,35094229
1819,retinopathy,disease,1.0,35094229
1820,bevacizumab,gene,0.768,35094229
1821,aflibercept,gene,0.9688,35094229
1822,retinopathy of prematurity,disease,1.0,35094229
1823,ROP,disease,0.9985,35094229
1824,patients,species,0.993,35094229
1825,bevacizumab,gene,0.8623,35094229
1826,ranibizumab,gene,0.891,35094229
1827,aflibercept,gene,0.9653,35094229
1828,ROP,disease,0.929,35094229
1829,patients,species,0.9736,35094229
1830,patients,species,0.985,35094229
1831,bevacizumab,drug,0.562,35094229
1832,patients,species,0.9814,35094229
1833,ranibizumab,drug,0.85,35094229
1834,patients,species,0.977,35094229
1835,aflibercept,gene,0.559,35094229
1836,Bevacizumab,gene,0.9814,35094229
1837,ranibizumab,gene,0.871,35094229
1838,aflibercept,gene,0.851,35094229
1839,ROP,disease,0.986,35094229
1840,ranibizumab,gene,0.9385,35094229
1841,bevacizumab,gene,0.6846,35094229
1842,infants,species,0.649,35094229
1843,VEGF,gene,0.6763,35094229
1844,VEGF,gene,0.56,35092447
1845,bevacizumab,gene,0.803,35092447
1846,ranibizumab,gene,0.513,35092447
1847,aflibercept,gene,0.882,35092447
1848,neovascular age-related macular degeneration,disease,1.0,35092447
1849,nAMD,disease,1.0,35092447
1850,patients,species,0.9717,35092447
1851,nAMD,disease,1.0,35092447
1852,aflibercept,gene,0.981,35092447
1853,ranibizumab,gene,0.9004,35092447
1854,bevacizumab,gene,0.8877,35092447
1855,nAMD,disease,1.0,35092447
1856,anti-VEGF,gene,0.8994,35092447
1857,ranibizumab,gene,0.4988,35092447
1858,aflibercept,gene,0.966,35092447
1859,aflibercept,gene,0.9517,35092447
1860,vascular endothelial growth factor,gene,0.9854,35091863
1861,insulin-like growth factor-1,gene,0.9985,35091863
1862,vascular endothelial growth factor,gene,0.998,35091863
1863,VEGF,gene,0.9946,35091863
1864,insulin-like growth factor-1,gene,0.999,35091863
1865,IGF-1,gene,0.997,35091863
1866,aflibercept,gene,0.985,35091863
1867,aflibercept,gene,0.9873,35091863
1868,infants,species,0.843,35091863
1869,retinopathy of prematurity,disease,1.0,35091863
1870,ROP,disease,1.0,35091863
1871,infants,species,0.799,35091863
1872,type 1 ROP,disease,0.966,35091863
1873,VEGF,gene,0.996,35091863
1874,IGF-1,gene,0.9976,35091863
1875,aflibercept,gene,0.987,35091863
1876,infants,species,0.835,35091863
1877,Serum VEGF,gene,0.644,35091863
1878,Serum aflibercept,gene,0.7534,35091863
1879,serum IGF-1,gene,0.9775,35091863
1880,infant,species,0.704,35091863
1881,aflibercept,gene,0.9844,35091863
1882,VEGF,gene,0.9854,35091863
1883,infants,species,0.9053,35091863
1884,neovascular glaucoma,disease,1.0,35087972
1885,Neovascular glaucoma,disease,1.0,35087972
1886,NVG,disease,1.0,35087972
1887,secondary glaucoma,disease,0.8457,35087972
1888,iridocorneal,DNA,0.442,35087972
1889,NVG,disease,1.0,35087972
1890,central retinal vein occlusion,disease,1.0,35087972
1891,proliferative diabetic retinopathy,disease,0.999,35087972
1892,ocular ischemic syndrome,disease,1.0,35087972
1893,fluorescein,drug,0.9897,35087972
1894,VEGF,gene,0.8574,35087972
1895,patient,species,0.99,35087972
1896,NVG,disease,1.0,35087972
1897,ocular ischemia,disease,0.9937,35087972
1898,patients,species,0.988,35087972
1899,NVG,disease,1.0,35087972
1900,NVG,disease,1.0,35087972
1901,neovascular glaucoma,disease,1.0,35087972
1902,aqueous humor,disease,0.8477,35087972
1903,VEGF,gene,0.992,35087972
1904,vascular endothelial growing factor,gene,0.9946,35087972
1905,Anti-VEGF,gene,0.9956,35087972
1906,anti- vascular endothelial growing factor,gene,0.9976,35087972
1907,PAS,disease,1.0,35087972
1908,peripheral anterior synechiae,disease,0.9995,35087972
1909,CRVO,disease,1.0,35087972
1910,central retinal vein occlusion,disease,1.0,35087972
1911,PDR,disease,1.0,35087972
1912,proliferative diabetic retinopathy,disease,1.0,35087972
1913,DR,disease,,35087972
1914,diabetic retinopathy,disease,1.0,35087972
1915,OIS,disease,1.0,35087972
1916,ocular ischemic syndrome,disease,1.0,35087972
1917,CRAO,disease,0.9995,35087972
1918,central retinal artery occlusion,disease,0.999,35087972
1919,ROP,disease,1.0,35087972
1920,retinopathy of prematurity,disease,1.0,35087972
1921,FEVR,disease,1.0,35087972
1922,familial exudative vitreoretinopathy,disease,1.0,35087972
1923,PVR,disease,1.0,35087972
1924,proliferative vitreoretinopathy,disease,1.0,35087972
1925,MMPs,gene,0.6226,35087972
1926,matrix metalloproteinases,gene,0.9956,35087972
1927,VEGFR,gene,0.992,35087972
1928,vascular endothelial growing factor receptor,gene,0.9966,35087972
1929,PDGF,gene,0.995,35087972
1930,platelet-derived growth factor,gene,0.998,35087972
1931,PIGF,gene,0.994,35087972
1932,placental growth factor,gene,0.9976,35087972
1933,NRP,gene,0.982,35087972
1934,neuropilins,gene,0.9907,35087972
1935,HIF,gene,0.9956,35087972
1936,hypoxia-inducible factor,gene,0.9946,35087972
1937,SDF1,gene,0.9897,35087972
1938,stromal cell-derived factor 1,gene,0.994,35087972
1939,DDL4,gene,0.9937,35087972
1940,delta like ligand 4,gene,0.997,35087972
1941,NICD,gene,0.953,35087972
1942,Notch intracellular domain,gene,0.99,35087972
1943,TIMMPs,gene,0.9175,35087972
1944,matrix metalloproteinases,gene,0.9956,35087972
1945,ANGPT,gene,0.9907,35087972
1946,angiopoietin,gene,0.979,35087972
1947,Tie 2,gene,0.9907,35087972
1948,tyrosine,drug,0.8247,35087972
1949,tyrosine-protein kinase receptor,gene,0.9985,35087972
1950,angiopoietins,gene,0.9414,35087972
1951,IGF-1,gene,0.997,35087972
1952,insulin-like growth factor,gene,0.999,35087972
1953,RPE,cell_type,0.601,35087972
1954,retinal pigment epithelium,cell_type,0.6006,35087972
1955,IL,gene,,35087972
1956,interleukin,gene,0.9272,35087972
1957,TNF,gene,0.98,35087972
1958,tumor,disease,0.962,35087972
1959,tumor necrosis factor,gene,0.995,35087972
1960,bFGF,gene,0.9873,35087972
1961,basic fibroblast growth factor,gene,0.996,35087972
1962,TGF,gene,0.987,35087972
1963,transforming growth factor,gene,0.9937,35087972
1964,HGF,gene,0.989,35087972
1965,hepatocyte growth factor,gene,0.9966,35087972
1966,TNFR 2,gene,0.9873,35087972
1967,tumor necrosis factor receptor 2,gene,0.996,35087972
1968,OIR,disease,1.0,35087972
1969,oxygen induced retinopathy,disease,0.919,35087972
1970,oxygen,drug,0.9995,35087972
1971,NVI,disease,0.9507,35087972
1972,NVA,disease,1.0,35087972
1973,neovascularization of the iridocorneal angle,disease,1.0,35087972
1974,fluorescein,drug,0.9937,35087972
1975,RAPD,disease,0.9985,35087972
1976,relative afferent pupillary defect,disease,0.999,35087972
1977,CNP,disease,0.9893,35087972
1978,capillary non-,disease,0.998,35087972
1979,NVD,disease,1.0,35087972
1980,neovascularization of the optic disc,disease,0.9634,35087972
1981,fluorescein,drug,0.9326,35087972
1982,BVZ,gene,0.85,35087972
1983,bevacizumab,gene,0.8774,35087972
1984,RBZ,gene,0.8315,35087972
1985,ranibizumab,gene,0.868,35087972
1986,AFB,gene,0.986,35087972
1987,aflibercept,gene,0.9873,35087972
1988,AMD,disease,1.0,35087972
1989,ARMD,disease,1.0,35087972
1990,age related macular degeneration,disease,1.0,35087972
1991,DME,disease,1.0,35087972
1992,diabetic macular edema,disease,1.0,35087972
1993,glaucoma,disease,1.0,35087972
1994,MMC,drug,0.999,35087972
1995,mitomycin C,drug,0.9995,35087972
1996,5-FU,drug,0.998,35087972
1997,5-fluorouracil,drug,0.998,35087972
1998,glaucoma,disease,0.992,35087972
1999,faricimab,gene,0.8877,35085503
2000,patient,species,0.953,35085503
2001,diabetic macular oedema,disease,1.0,35085503
2002,angiopoietin-2,gene,0.9985,35085503
2003,vascular endothelial growth factor-A,gene,0.9756,35085503
2004,YOSEMITE,drug,0.997,35085503
2005,RHINE,drug,0.991,35085503
2006,vision loss,disease,0.9985,35085503
2007,diabetic macular oedema,disease,0.9995,35085503
2008,faricimab,gene,0.6045,35085503
2009,faricimab,gene,0.8687,35085503
2010,aflibercept,gene,0.882,35085503
2011,Diabetic Retinopathy,disease,1.0,35085503
2012,patients,species,0.959,35085503
2013,patients,species,0.983,35085503
2014,patients,species,0.991,35085503
2015,patients,species,0.9907,35085503
2016,patients,species,0.9775,35085503
2017,faricimab,gene,0.6626,35085503
2018,aflibercept,gene,0.8286,35085503
2019,faricimab,gene,0.893,35085503
2020,aflibercept,gene,0.932,35085503
2021,RHINE,DNA,0.527,35085503
2022,PTI,DNA,0.5225,35085503
2023,ETDRS,DNA,0.556,35085503
2024,ETDRS,DNA,0.5015,35085503
2025,faricimab,gene,0.821,35085503
2026,faricimab,gene,0.938,35085503
2027,faricimab,gene,0.657,35085503
2028,faricimab,gene,0.646,35085503
2029,patients,species,0.9717,35085503
2030,diabetic macular oedema,disease,1.0,35085503
2031,faricimab,gene,0.7056,35085502
2032,Faricimab,gene,0.7246,35085502
2033,angiopoietin-2,gene,0.9966,35085502
2034,vascular endothelial growth factor A,gene,0.9976,35085502
2035,faricimab,gene,0.9004,35085502
2036,neovascular age-related macular degeneration,disease,1.0,35085502
2037,nAMD,disease,1.0,35085502
2038,patients,species,0.9634,35085502
2039,nAMD,disease,1.0,35085502
2040,faricimab,gene,0.7734,35085502
2041,aflibercept,gene,0.5015,35085502
2042,Patients,species,0.9844,35085502
2043,patients,species,0.9854,35085502
2044,LUCERNE,DNA,0.571,35085502
2045,patients,species,0.983,35085502
2046,aflibercept,gene,0.991,35085502
2047,faricimab,gene,0.978,35085502
2048,aflibercept,gene,0.991,35085502
2049,faricimab,gene,0.9287,35085502
2050,aflibercept,gene,0.983,35085502
2051,faricimab,gene,0.9688,35085502
2052,aflibercept,gene,0.9834,35085502
2053,LUCERNE,DNA,0.5513,35085502
2054,faricimab,gene,0.629,35085502
2055,patients,species,0.9756,35085502
2056,nAMD,disease,1.0,35085502
2057,Ischemic Optic Neuropathy,disease,1.0,35079224
2058,central retinal vein and artery occlusion,disease,0.9595,35079224
2059,ischemic optic,disease,0.9995,35079224
2060,neuropathy,disease,0.908,35079224
2061,COVID,species,0.642,35079224
2062,Patient,species,0.885,35079224
2063,fluorescein,drug,0.996,35079224
2064,Patient,species,0.9263,35079224
2065,aflibercept,gene,0.9883,35079224
2066,steroidal,drug,0.8325,35079224
2067,acetazolamide,drug,1.0,35079224
2068,aspirin,drug,0.9995,35079224
2069,pentoxifylline,drug,0.9995,35079224
2070,apixaban,drug,0.9995,35079224
2071,COVID-19,species,0.5303,35079224
2072,ocular thrombotic conditions,disease,0.991,35079224
2073,anti-VEGF,gene,0.631,35075918
2074,dexamethasone,drug,0.993,35075918
2075,retinal diseases,disease,1.0,35075918
2076,VEGF,gene,0.665,35075918
2077,dexamethasone,drug,0.9844,35075918
2078,retinal disease,disease,0.9995,35075918
2079,retinal disease,disease,1.0,35075918
2080,patients,species,0.992,35075918
2081,VEGF,gene,0.683,35075918
2082,dexamethasone,drug,0.9546,35075918
2083,Patients,species,0.959,35075918
2084,patients,species,0.994,35075918
2085,patients,species,0.975,35075918
2086,age-related macular degeneration,disease,1.0,35075918
2087,AMD,disease,1.0,35075918
2088,diabetic macular oedema,disease,1.0,35075918
2089,retinal vein occlusion,disease,1.0,35075918
2090,myopic choroidal neovascularization,disease,1.0,35075918
2091,Patients,species,0.9,35075918
2092,patient,species,0.947,35075918
2093,Ranibizumab,gene,0.923,35075918
2094,aflibercept,gene,0.934,35075918
2095,AMD,disease,1.0,35075918
2096,RVO,disease,0.9995,35075918
2097,ranibizumab,gene,0.8716,35075918
2098,retinal diseases,disease,1.0,35075918
2099,Patients,species,0.965,35075918
2100,VEGF,gene,0.8276,35075918
2101,AMD,disease,1.0,35075918
2102,RVO,disease,1.0,35075918
2103,Myocardial Infarction,disease,1.0,35072917
2104,Stroke,disease,0.9995,35072917
2105,thromboembolic events,disease,0.757,35072917
2106,patients,species,0.993,35072917
2107,vascular endothelial growth factor,gene,0.9976,35072917
2108,IVT anti-VEGF,gene,0.8955,35072917
2109,myocardial infarction,disease,1.0,35072917
2110,MI,disease,1.0,35072917
2111,stroke,disease,1.0,35072917
2112,aflibercept,gene,0.704,35072917
2113,ranibizumab,gene,0.6323,35072917
2114,patients,species,0.9854,35072917
2115,ranibizumab,gene,0.63,35072917
2116,aflibercept,gene,0.9297,35072917
2117,Patients,species,0.9443,35072917
2118,MI,disease,,35072917
2119,stroke,disease,0.9985,35072917
2120,aflibercept,gene,0.995,35072917
2121,ranibizumab,gene,0.771,35072917
2122,cardiovascular disease,disease,1.0,35072917
2123,ischemic heart disease,disease,1.0,35072917
2124,stroke,disease,1.0,35072917
2125,diabetes,disease,1.0,35072917
2126,VEGF,gene,0.994,35072917
2127,aflibercept,gene,0.9683,35072917
2128,stroke,disease,0.9995,35072917
2129,strokes,disease,0.99,35072917
2130,stroke,disease,0.9927,35072917
2131,aflibercept,gene,0.9844,35072917
2132,ranibizumab,gene,0.798,35072917
2133,patients,species,0.96,35072917
2134,diabetes,disease,1.0,35072917
2135,diabetic macular edema,disease,1.0,35072917
2136,Aflibercept,gene,0.9585,35072917
2137,ranibizumab,gene,0.5537,35072917
2138,MI,disease,,35072917
2139,stroke,disease,0.999,35072917
2140,brolucizumab,gene,0.5493,35067611
2141,neovascular age-related macular degeneration,disease,0.9995,35067611
2142,brolucizumab,gene,0.6025,35067611
2143,bevacizumab,gene,0.8965,35067611
2144,ranibizumab,gene,0.811,35067611
2145,aflibercept,gene,0.9727,35067611
2146,intraocular inflammation,disease,1.0,35067611
2147,brolucizumab,gene,0.964,35067611
2148,brolucizumab,gene,0.946,35067611
2149,brolucizumab,gene,0.944,35067611
2150,SRF,gene,0.9883,35067611
2151,IRF,gene,0.956,35067611
2152,PED,DNA,0.5713,35067611
2153,IRF,gene,0.823,35067611
2154,PED,disease,0.7646,35067611
2155,brolucizumab,gene,0.8564,35067611
2156,intraocular inflammation,disease,1.0,35067611
2157,retinal vasculitis,disease,1.0,35067611
2158,brolucizumab,gene,0.8237,35067611
2159,anti-VEGF,gene,0.764,35067611
2160,Anti-Vascular Endothelial Growth Factor,gene,0.9844,35066801
2161,Neovascular,disease,0.7637,35066801
2162,anti-vascular endothelial growth factor,gene,0.961,35066801
2163,patients,species,0.9785,35066801
2164,neovascular age-related macular degeneration,disease,1.0,35066801
2165,nAMD,disease,1.0,35066801
2166,patients,species,0.9507,35066801
2167,nAMD,disease,1.0,35066801
2168,aflibercept,gene,0.9517,35066801
2169,Patients,species,0.849,35066801
2170,intraretinal and/or subretinal fluid,disease,0.948,35066801
2171,patients,species,0.9863,35066801
2172,BCVA,disease,0.992,35066801
2173,nAMD,disease,1.0,35066801
2174,patients,species,0.99,35066801
2175,Anti-Vascular Endothelial Growth Factor,gene,0.9927,35066801
2176,Neovascular Age-Related Macular Degeneration,disease,1.0,35066801
2177,Tocilizumab,gene,0.8687,35060816
2178,Aflibercept,gene,0.9614,35060816
2179,Refractory Macular Edema,disease,0.977,35060816
2180,acute retinal necrosis,disease,1.0,35060816
2181,ARN,disease,1.0,35060816
2182,cystoid macular edema,disease,1.0,35060816
2183,CME,disease,1.0,35060816
2184,intra- and subretinal fluid,disease,0.9565,35060816
2185,CME,disease,0.9995,35060816
2186,ARN,disease,1.0,35060816
2187,patients,species,0.996,35060816
2188,CME,disease,0.997,35060816
2189,valacyclovir,drug,0.9966,35060816
2190,prednisone,drug,0.97,35060816
2191,ranibizumab,gene,0.9014,35060816
2192,tocilizumab,gene,0.9453,35060816
2193,interleukin-6 receptor,gene,0.9956,35060816
2194,aflibercept,gene,0.933,35060816
2195,CME,disease,0.999,35060816
2196,patients,species,0.9814,35060816
2197,CME,disease,1.0,35060816
2198,tocilizumab,gene,0.9404,35060816
2199,aflibercept,gene,0.935,35060816
2200,Patients,species,0.989,35059578
2201,Exudative Age-Related Macular Degeneration,disease,1.0,35059578
2202,patients,species,0.983,35059578
2203,age-related macular degeneration,disease,0.9976,35059578
2204,AMD,disease,1.0,35059578
2205,patients,species,0.974,35059578
2206,exudative AMD,disease,0.997,35059578
2207,vascular endothelial growth factor,gene,0.911,35059578
2208,VEGF,gene,0.712,35059578
2209,ranibizumab,gene,0.771,35059578
2210,aflibercept,gene,0.978,35059578
2211,bevacizumab,gene,0.7227,35059578
2212,Patient,species,0.983,35059578
2213,fluorescein,drug,0.6084,35059578
2214,patients,species,0.9863,35059578
2215,patient,species,0.9717,35059578
2216,BCVA,DNA,0.4592,35059578
2217,Wet Age-Related Macular Degeneration,disease,1.0,35056350
2218,Wet age-related macular degeneration,disease,1.0,35056350
2219,wAMD,disease,1.0,35056350
2220,progressive disease of the central part of the retina,disease,0.999,35056350
2221,wAMD,disease,0.998,35056350
2222,vascular endothelial growth factor,gene,0.979,35056350
2223,wAMD,disease,0.998,35056350
2224,aflibercept,gene,0.989,35056350
2225,ranibizumab,gene,0.4897,35056350
2226,patients,species,0.9873,35056350
2227,wAMD,disease,0.9995,35056350
2228,patients,species,0.9863,35056350
2229,Diabetic Retinopathy,disease,1.0,35056350
2230,age-related macular degeneration,disease,1.0,35056350
2231,Neovascular Age-Related Macular Degeneration,disease,1.0,35054021
2232,vascular endothelial growth factor,gene,0.9326,35054021
2233,VEGF,gene,0.9976,35054021
2234,neovascular age-related macular degeneration,disease,1.0,35054021
2235,nAMD,disease,1.0,35054021
2236,patients,species,0.884,35054021
2237,nAMD,disease,1.0,35054021
2238,BCVA,DNA,0.5117,35054021
2239,VEGFs,gene,0.9087,35054021
2240,ETDRS,cell_type,0.4492,35054021
2241,VEGFs,gene,0.5938,35054021
2242,patients,species,0.9297,35054021
2243,nAMD,disease,1.0,35054021
2244,proliferative diabetic RATIONALE,disease,1.0,35049178
2245,Proliferative diabetic retinopathy,disease,1.0,35049178
2246,PDR,disease,1.0,35049178
2247,visual impairment,disease,1.0,35049178
2248,patients,species,0.9854,35049178
2249,PDR,disease,1.0,35049178
2250,vitreous hemorrhage,disease,1.0,35049178
2251,tractional retinal detachment,disease,0.9995,35049178
2252,VF defects,disease,0.9985,35049178
2253,patient,species,0.948,35049178
2254,PDR,disease,0.9995,35049178
2255,PATIENT,species,0.8687,35049178
2256,PDR,disease,1.0,35049178
2257,vitreous hemorrhage,disease,1.0,35049178
2258,aflibercept,gene,0.9683,35049178
2259,fibrovascular membrane,disease,0.999,35049178
2260,VF defects,disease,0.9985,35049178
2261,Proliferative diabetic retinopathy,disease,0.9995,35049178
2262,patient,species,0.9844,35049178
2263,VF defects,disease,0.7173,35049178
2264,patients,species,0.9604,35049178
2265,PDR,disease,0.998,35049178
2266,Aflibercept,gene,0.978,35048330
2267,neovascular age-related macular degeneration,disease,0.9995,35048330
2268,nAMD,disease,1.0,35048330
2269,aflibercept,gene,0.978,35048330
2270,patients,species,0.9844,35048330
2271,subfoveal fibrosis,disease,0.945,35048330
2272,nAMD,disease,1.0,35048330
2273,aflibercept,gene,0.9873,35048330
2274,fovea-involving fibrosis,disease,1.0,35048330
2275,nAMD,disease,1.0,35048330
2276,patients,species,0.9854,35048330
2277,retinal neovascularization,disease,0.8945,35047351
2278,rabbit,species,0.988,35047351
2279,rabbit,species,0.985,35047351
2280,retinal neovascularization,disease,1.0,35047351
2281,RNV,disease,1.0,35047351
2282,DL-2-aminoadipic acid,drug,1.0,35047351
2283,DL-AAA,drug,0.9995,35047351
2284,retinal glial (Mller) cell,cell_type,0.7456,35047351
2285,DL-AAA,drug,0.9995,35047351
2286,ocular vascular diseases,disease,0.9873,35047351
2287,DL-AAA,drug,0.9985,35047351
2288,AAA,drug,0.8037,35047351
2289,fluorescein,drug,0.998,35047351
2290,retinal,disease,0.602,35047351
2291,vascular endothelial growth factor,gene,0.908,35047351
2292,VEGF,gene,0.9956,35047351
2293,bevacizumab,gene,0.903,35047351
2294,ranibizumab,gene,0.835,35047351
2295,aflibercept,gene,0.9697,35047351
2296,triamcinolone,drug,0.9995,35047351
2297,TAA,drug,0.9976,35047351
2298,Fluorescein,drug,0.8906,35047351
2299,DL-AAA,disease,1.0,35047351
2300,rabbit,species,0.978,35047351
2301,DL,drug,,35047351
2302,retinal/choroidal inflammation,disease,1.0,35047351
2303,vitreous flare,disease,0.99,35047351
2304,vitreous humor,disease,1.0,35047351
2305,Retinal hemorrhage,disease,0.9985,35047351
2306,RNV,disease,1.0,35047351
2307,bevacizumab,gene,0.86,35047351
2308,ranibizumab,gene,0.793,35047351
2309,aflibercept,gene,0.984,35047351
2310,TAA,drug,0.8945,35047351
2311,bevacizumab,gene,0.9126,35047351
2312,TAA,drug,0.9863,35047351
2313,ranibizumab,gene,0.893,35047351
2314,aflibercept,gene,0.9893,35047351
2315,bevacizumab,gene,0.729,35047351
2316,ranibizumab,gene,0.7295,35047351
2317,TAA,drug,0.925,35047351
2318,aflibercept,gene,0.9814,35047351
2319,DL-AAA,disease,1.0,35047351
2320,rabbit,species,0.9863,35047351
2321,RNV,disease,1.0,35047351
2322,RNV,disease,1.0,35047351
2323,chronic retinal leakage,disease,0.974,35047351
2324,DL-AAA,disease,1.0,35047351
2325,rabbit,species,0.985,35047351
2326,patient,species,0.9775,35042547
2327,patients,species,0.9946,35042547
2328,patient,species,0.94,35042547
2329,patients,species,0.991,35042547
2330,aflibercept,gene,0.976,35042547
2331,ranibizumab,gene,0.8257,35042547
2332,bevacizumab,gene,0.7334,35042547
2333,dexamethasone,drug,0.982,35042547
2334,triamcinolone acetonide,drug,0.9995,35042547
2335,brolucizumab,gene,0.852,35042547
2336,fluocinolone acetonide,drug,0.999,35042547
2337,fluocinolone acetonide,drug,0.999,35042547
2338,aflibercept,gene,0.989,35042547
2339,bevacizumab,gene,0.876,35042547
2340,ranibizumab,gene,0.6353,35042547
2341,dexamethasone,drug,0.999,35042547
2342,brolucizumab,gene,0.755,35042547
2343,triamcinolone acetonide,drug,0.999,35042547
2344,blurred vision,disease,0.9995,35042547
2345,patients,species,0.988,35042547
2346,posterior vitreous detachment,disease,1.0,35042547
2347,PVD,disease,1.0,35042547
2348,corneal abrasions,disease,1.0,35042547
2349,subconjunctival hemorrhages,disease,0.9985,35042547
2350,corneal dryness,disease,1.0,35042547
2351,endophthalmitis,disease,1.0,35042547
2352,vitreous hemorrhages,disease,1.0,35042547
2353,iritis,disease,1.0,35042547
2354,uveitis,disease,1.0,35042547
2355,choroidal neovascular membrane,disease,1.0,35042547
2356,retinal detachments,disease,1.0,35042547
2357,traumatic cataracts,disease,0.9995,35042547
2358,blurred vision,disease,1.0,35042547
2359,PVD,disease,1.0,35042547
2360,VEGF,gene,0.9365,35040348
2361,ROP,disease,0.9834,35040348
2362,Retinopathy of Prematurity,disease,1.0,35040348
2363,ROP,disease,1.0,35040348
2364,premature,cell_type,0.4722,35040348
2365,childhood blindness,disease,1.0,35040348
2366,visual impairment,disease,1.0,35040348
2367,Vascular Endothelial Growth Factor,gene,0.998,35040348
2368,VEGF,gene,0.997,35040348
2369,VEGF,gene,0.8784,35040348
2370,ROP,disease,0.9985,35040348
2371,Pegabtanib,drug,0.998,35040348
2372,ROP,disease,0.9897,35040348
2373,Ranibizumab,gene,0.894,35040348
2374,anti-VEGF,gene,0.663,35040348
2375,Aflibercept,gene,0.9565,35040348
2376,infants,species,0.7896,35040348
2377,Ranibizumab,gene,0.9014,35040348
2378,ROP,disease,0.99,35040348
2379,ROP,disease,0.9985,35040348
2380,VEGF-A,gene,0.997,35038456
2381,VEGF-A,gene,0.9985,35038456
2382,endothelial cells,cell_type,0.91,35038456
2383,REC,cell_line,0.8916,35038456
2384,VEGF-binding protein,gene,0.997,35038456
2385,VEGF receptor 2,gene,0.9985,35038456
2386,VEGFR2,gene,0.9956,35038456
2387,VEGF-A(165),gene,0.9946,35038456
2388,immortalized bovine REC,cell_line,0.98,35038456
2389,bovine,species,0.833,35038456
2390,iBREC,cell_line,0.944,35038456
2391,VEGF-A(165),gene,0.997,35038456
2392,VEGF-A-binding proteins,gene,0.984,35038456
2393,ranibizumab,gene,0.608,35038456
2394,brolucizumab,gene,0.7305,35038456
2395,iBREC,cell_line,0.9507,35038456
2396,VEGF,gene,0.528,35038456
2397,VEGFR2,gene,0.998,35038456
2398,nintedanib,drug,0.9927,35038456
2399,iBREC,cell_line,0.9478,35038456
2400,VEGF-A(165),gene,0.9966,35038456
2401,claudin-5,gene,0.6875,35038456
2402,VEGF-A(165),gene,0.996,35038456
2403,TJ-protein,gene,0.725,35038456
2404,claudin-1,gene,0.5513,35038456
2405,plasmalemma vesicle-associated protein,gene,0.995,35038456
2406,PLVAP,gene,0.9907,35038456
2407,claudin-1,gene,0.9893,35038456
2408,claudin-5,gene,0.99,35038456
2409,claudin-5,gene,0.9854,35038456
2410,control cells,cell_type,0.868,35038456
2411,claudin-1,gene,0.994,35038456
2412,VEGF-A(165),gene,0.997,35038456
2413,brolucizumab,gene,0.81,35038456
2414,ranibizumab,gene,0.5166,35038456
2415,VEGF,gene,0.996,35038456
2416,VEGF,gene,0.992,35038456
2417,iBREC,cell_line,0.8423,35038456
2418,VEGF-A(165),gene,0.998,35038456
2419,VEGF,gene,0.9966,35038456
2420,VEGF-A(165)-challenged iBREC,cell_line,0.9497,35038456
2421,VEGF-A(165),gene,0.931,35038456
2422,ranibizumab,gene,0.6855,35038456
2423,brolucizumab,gene,0.6504,35038456
2424,claudin-1,gene,0.9805,35038456
2425,claudin-5,gene,0.9795,35038456
2426,PLVAP,gene,0.8423,35038456
2427,VEGF-A(165),gene,0.9976,35038456
2428,claudin-1,gene,0.9873,35038456
2429,VEGF,gene,0.994,35038456
2430,VEGF-A(165),gene,0.9966,35038456
2431,VEGF-A(165),gene,0.9937,35038456
2432,VEGF-A,gene,0.9966,35038456
2433,brolucizumab,gene,0.8804,35038415
2434,aflibercept,gene,0.958,35038415
2435,patients,species,0.918,35038415
2436,diabetic macular edema,disease,1.0,35038415
2437,DME,disease,1.0,35038415
2438,brolucizumab,gene,0.931,35038415
2439,aflibercept,gene,0.9385,35038415
2440,brolucizumab,gene,0.8804,35038415
2441,aflibercept,gene,0.9556,35038415
2442,Brolucizumab,gene,0.791,35038415
2443,Diabetic Retinopathy,disease,1.0,35038415
2444,brolucizumab,gene,0.7847,35038415
2445,aflibercept,gene,0.9683,35038415
2446,KITE,DNA,0.524,35038415
2447,aflibercept,gene,0.917,35038415
2448,brolucizumab,gene,0.846,35038415
2449,brolucizumab,gene,0.7954,35038415
2450,aflibercept,gene,0.9517,35038415
2451,brolucizumab,gene,0.959,35038415
2452,brolucizumab,gene,0.94,35038415
2453,aflibercept,gene,0.9927,35038415
2454,brolucizumab,gene,0.942,35038415
2455,aflibercept,gene,0.995,35038415
2456,Brolucizumab,gene,0.685,35038415
2457,patients,species,0.906,35038415
2458,DME,disease,1.0,35038415
2459,secretogranin III,gene,0.9956,35038348
2460,Choroidal neovascularization,disease,1.0,35038348
2461,CNV,disease,1.0,35038348
2462,vision loss,disease,0.998,35038348
2463,CNV,disease,1.0,35038348
2464,vascular endothelial growth factor,gene,0.998,35038348
2465,VEGF,gene,0.998,35038348
2466,CNV,disease,0.9995,35038348
2467,VEGF,gene,0.9976,35038348
2468,mice,species,0.9854,35038348
2469,CNV,disease,0.991,35038348
2470,Secretogranin III,gene,0.9956,35038348
2471,Scg3,gene,0.9937,35038348
2472,diabetes,disease,1.0,35038348
2473,CNV,disease,1.0,35038348
2474,Scg3,gene,0.991,35038348
2475,CNV,disease,1.0,35038348
2476,VEGF,gene,0.9927,35038348
2477,CNV,disease,1.0,35038348
2478,Scg3,gene,0.995,35038348
2479,CNV,disease,0.9985,35038348
2480,CNV,cell_type,0.4495,35038348
2481,anti-Scg3 humanized antibody Fab fragment,gene,0.9546,35038348
2482,humanized,species,0.928,35038348
2483,hFab,gene,0.995,35038348
2484,hFab,gene,0.9893,35038348
2485,CNV,disease,0.7866,35038348
2486,VEGF,gene,0.96,35038348
2487,aflibercept,gene,0.967,35038348
2488,Scg3 gene,gene,0.997,35038348
2489,mice,species,0.98,35038348
2490,CNV,disease,0.994,35038348
2491,anti-Scg3 hFab,gene,0.9927,35038348
2492,aflibercept,gene,0.989,35038348
2493,Scg3(-/-),gene,0.9126,35038348
2494,mice,species,0.9653,35038348
2495,Scg3,gene,0.983,35038348
2496,hFab,gene,0.997,35038348
2497,Scg3,gene,0.99,35038348
2498,CNV,disease,1.0,35038348
2499,CNV,disease,1.0,35038348
2500,Polypoidal choroidal vasculopathy,disease,1.0,35034223
2501,pachychoroid,disease,0.997,35034223
2502,Aflibercept,gene,0.953,35034223
2503,polypoidal choroidal vasculopathy,disease,1.0,35034223
2504,pachychoroid disease,disease,1.0,35034223
2505,PPCV,disease,1.0,35034223
2506,Patients,species,0.945,35034223
2507,PPCV,disease,1.0,35034223
2508,intraretinal and subretinal fluid,disease,0.985,35034223
2509,Aflibercept,gene,0.9155,35034223
2510,PPCV,disease,0.9985,35034223
2511,VEGF,gene,0.7754,35034223
2512,aneurysmal vessel,DNA,0.5186,35034223
2513,aneurysmal,disease,0.9043,35034223
2514,choroidal congestion,disease,1.0,35034223
2515,proliferative diabetic retinopathy,disease,1.0,35032522
2516,patients,species,0.975,35032522
2517,VEGF,gene,0.574,35032522
2518,proliferative diabetic retinopathy,disease,1.0,35032522
2519,PDR,disease,1.0,35032522
2520,patients,species,0.981,35032522
2521,patients,species,0.993,35032522
2522,anti-VEGF,gene,0.8994,35032522
2523,VEGF,gene,0.9956,35032522
2524,PDR,disease,1.0,35032522
2525,PDR,disease,0.9995,35032522
2526,patients,species,0.988,35032522
2527,ranibizumab,gene,0.9297,35032522
2528,aflibercept,gene,0.99,35032522
2529,conbercept,gene,0.8213,35032522
2530,PDR,disease,0.9995,35032522
2531,patients,species,0.9907,35032522
2532,anti-VEGF,gene,0.8633,35032522
2533,conbercept,gene,0.728,35032522
2534,aflibercept,gene,0.969,35032522
2535,patients,species,0.992,35032522
2536,AH,disease,,35032522
2537,patient,species,0.9487,35032522
2538,RARRES1,gene,0.9966,35032522
2539,ALDH3A1,gene,0.96,35032522
2540,RBP4,gene,0.9897,35032522
2541,VEGFR1,gene,0.9985,35032522
2542,VEGFR2,gene,0.996,35032522
2543,APOM,gene,0.987,35032522
2544,hornerin,gene,0.98,35032522
2545,HSP90B1,gene,0.993,35032522
2546,VEGF,gene,0.6475,35032522
2547,ALDH3A1,gene,0.963,35032522
2548,anti-VEGF,gene,0.978,35032522
2549,PDR,disease,0.9995,35032522
2550,PDR,disease,1.0,35032522
2551,patients,species,0.9863,35032522
2552,VEGF,gene,0.711,35032522
2553,VEGF,gene,0.595,35032522
2554,patients,species,0.9893,35032522
2555,PDR,disease,1.0,35032522
2556,Diabetic macular edema,disease,1.0,35027613
2557,proliferative diabetic retinopathy,disease,1.0,35027613
2558,diabetic macular edema,disease,1.0,35027613
2559,DME,disease,1.0,35027613
2560,proliferative diabetic retinopathy,disease,1.0,35027613
2561,PDR,disease,1.0,35027613
2562,aflibercept,gene,0.986,35027613
2563,ranibizumab,gene,0.6416,35027613
2564,fluorescein,drug,0.995,35027613
2565,CRT,DNA,0.536,35027613
2566,microaneurysms,disease,0.951,35027613
2567,microaneurysms,disease,0.9863,35027613
2568,aflibercept,gene,0.9766,35027613
2569,BCVA,DNA,0.4053,35027613
2570,CRT,DNA,0.534,35027613
2571,CRT,DNA,0.635,35027613
2572,aflibercept,gene,0.9873,35027613
2573,ranibizumab,gene,0.844,35027613
2574,DME,disease,1.0,35027613
2575,PDR,disease,0.998,35027613
2576,aflibercept,gene,0.985,35027613
2577,ranibizumab,gene,0.7397,35027613
2578,CRT,DNA,0.4702,35027613
2579,CRT,DNA,0.4583,35027613
2580,Humanized Anti-Scg3 Antibody,gene,0.9336,35008775
2581,Humanized,species,0.9507,35008775
2582,retinopathy of prematurity,disease,1.0,35008775
2583,ROP,disease,1.0,35008775
2584,neovascular retinal disorder,disease,1.0,35008775
2585,blindness,disease,0.9995,35008775
2586,children,species,0.981,35008775
2587,ROP,disease,0.985,35008775
2588,Secretogranin III,gene,0.996,35008775
2589,Scg3,gene,0.9946,35008775
2590,Scg3,gene,0.9937,35008775
2591,monoclonal antibodies,gene,0.557,35008775
2592,mouse models,cell_line,0.5845,35008775
2593,mouse,species,0.9907,35008775
2594,full-length humanized anti-Scg3 antibody,gene,0.94,35008775
2595,humanized,species,0.868,35008775
2596,oxygen,drug,1.0,35008775
2597,OIR,disease,0.9995,35008775
2598,mice,species,0.9624,35008775
2599,ROP,disease,1.0,35008775
2600,anti-Scg3 hAb,gene,0.9956,35008775
2601,vascular endothelial,DNA,0.481,35008775
2602,vascular endothelial growth factor,gene,0.999,35008775
2603,aflibercept,gene,0.9375,35008775
2604,OIR,disease,0.9766,35008775
2605,mice,species,0.984,35008775
2606,anti-Scg3 hAb,gene,0.99,35008775
2607,Secretogranin III,gene,0.995,35006382
2608,vascular endothelial growth factor,gene,0.9985,35006382
2609,VEGF,gene,0.9976,35006382
2610,Secretogranin III,gene,0.9966,35006382
2611,Scg3,gene,0.9917,35006382
2612,diabetes,disease,0.999,35006382
2613,VEGF-independent,gene,0.717,35006382
2614,Scg3,gene,0.991,35006382
2615,retinopathy of prematurity,disease,1.0,35006382
2616,ROP,disease,1.0,35006382
2617,retinal disease,disease,1.0,35006382
2618,infants,species,0.564,35006382
2619,oxygen,drug,0.9995,35006382
2620,OIR,disease,0.9985,35006382
2621,mice,species,0.968,35006382
2622,ROP,disease,1.0,35006382
2623,Scg3,gene,0.986,35006382
2624,neovessels,cell_type,0.5146,35006382
2625,VEGF,gene,0.996,35006382
2626,Scg3,gene,0.9907,35006382
2627,VEGF,gene,0.9946,35006382
2628,Scg3 gene,gene,0.9976,35006382
2629,OIR,disease,0.889,35006382
2630,anti-Scg3 humanized antibody Fab,gene,0.927,35006382
2631,hFab,gene,0.9956,35006382
2632,anti-VEGF aflibercept,gene,0.9956,35006382
2633,Aflibercept,gene,0.9707,35006382
2634,neonatal,cell_type,0.4668,35006382
2635,anti-Scg3 hFab,gene,0.9883,35006382
2636,aflibercept,gene,0.9756,35006382
2637,Scg3,gene,0.9956,35006382
2638,anti-Scg3 hFab,gene,0.972,35006382
2639,ROP,disease,0.926,35006382
2640,VEGF,gene,0.997,35005499
2641,patients,species,0.986,35005499
2642,VEGF,gene,0.525,35005499
2643,bevacizumab,gene,0.89,35005499
2644,ranibizumab,gene,0.876,35005499
2645,aflibercept,gene,0.8955,35005499
2646,vascular disorders,disease,1.0,35005499
2647,patients,species,0.9883,35005499
2648,fluorescein,drug,0.9395,35005499
2649,anti-VEGF,gene,0.9707,35005499
2650,vascular endothelial growth factor,gene,0.845,35002773
2651,anti-VEGF,gene,0.9404,35002773
2652,diabetic macular edema,disease,1.0,35002773
2653,DME,disease,1.0,35002773
2654,patients,species,0.968,35002773
2655,DME,disease,1.0,35002773
2656,aflibercept,gene,0.9766,35002773
2657,HRF,DNA,0.726,35002773
2658,foveal,DNA,0.476,35002773
2659,cystoid edema,disease,1.0,35002773
2660,SRF,DNA,0.686,35002773
2661,cystoid edema,disease,1.0,35002773
2662,DCP,disease,0.997,35002773
2663,HRF,gene,0.97,35002773
2664,FAZ,DNA,0.5127,35002773
2665,VEGF,gene,0.7856,35002773
2666,DME,disease,1.0,35002773
2667,macular edema,disease,1.0,35002773
2668,HRF,gene,0.996,35002773
2669,aflibercept,gene,0.968,35002773
2670,retinal microglia,cell_type,0.7383,35002773
2671,/macrophages,cell_type,0.6094,35002773
2672,cystoid edema,disease,1.0,35002773
2673,Mller glial cells,cell_type,0.831,35002773
2674,aflibercept,gene,0.991,35001091
2675,polypoidal,disease,1.0,35001091
2676,anti-vascular endothelial growth factor,gene,0.9077,34992542
2677,anti-VEGF,gene,0.9263,34992542
2678,patients,species,0.968,34992542
2679,neovascular age-related macular degeneration,disease,1.0,34992542
2680,nAMD,disease,1.0,34992542
2681,anti-VEGF,gene,0.806,34992542
2682,ranibizumab,gene,0.8975,34992542
2683,bevacizumab,gene,0.8594,34992542
2684,aflibercept,gene,0.9624,34992542
2685,brolucizumab,gene,0.791,34992542
2686,conbercept,gene,0.5083,34992542
2687,patients,species,0.9893,34992542
2688,participants,species,0.956,34992542
2689,The,gene,0.516,34992542
2690,aflibercept,gene,0.952,34992542
2691,ranibizumab,gene,0.678,34992542
2692,brolucizumab,gene,0.801,34992542
2693,Brolucizumab,gene,0.8604,34992542
2694,aflibercept,gene,0.9663,34992542
2695,Bevacizumab,gene,0.9443,34992542
2696,anti-VEGF,gene,0.7637,34992542
2697,anti-VEGF,gene,0.8477,34992542
2698,brolucizumab,gene,0.8403,34992542
2699,aflibercept,gene,0.8467,34992542
2700,nAMD,disease,1.0,34992542
2701,patients,species,0.993,34992542
2702,Macular Edema,disease,1.0,34989804
2703,macular edema,disease,1.0,34989804
2704,ME,disease,1.0,34989804
2705,central retinal vein occlusion,disease,1.0,34989804
2706,CRVO,disease,1.0,34989804
2707,patients,species,0.9126,34989804
2708,vascular endothelial growth factor,gene,0.979,34989804
2709,CRVO,disease,1.0,34989804
2710,ME,disease,,34989804
2711,PARTICIPANTS,species,0.6777,34989804
2712,LEAVO,disease,0.9995,34989804
2713,aflibercept,gene,0.9854,34989804
2714,bevacizumab,gene,0.631,34989804
2715,ranibizumab,gene,0.682,34989804
2716,patients,species,0.968,34989804
2717,CRVO,disease,1.0,34989804
2718,ME,disease,,34989804
2719,Diabetic Retinopathy,disease,0.95,34989804
2720,aflibercept,gene,0.99,34989804
2721,bevacizumab,gene,0.9077,34989804
2722,ranibizumab,gene,0.635,34989804
2723,ME,disease,,34989804
2724,dry macula,disease,0.6665,34989804
2725,ME,disease,,34989804
2726,ME,disease,,34989804
2727,participants,species,0.983,34989804
2728,participants,species,0.987,34989804
2729,men,species,0.9785,34989804
2730,participants,species,0.9785,34989804
2731,ME,disease,,34989804
2732,ME,disease,,34989804
2733,ME,disease,,34989804
2734,ME,disease,,34989804
2735,dry macula,disease,0.8696,34989804
2736,ME,disease,,34989804
2737,bevacizumab,gene,0.8364,34989804
2738,wet macula,disease,0.9995,34989804
2739,aflibercept,gene,0.9756,34989804
2740,aflibercept,gene,0.972,34986714
2741,patients,species,0.9697,34986714
2742,colorectal cancer,disease,0.9995,34986714
2743,mCRC,disease,0.999,34986714
2744,Aflibercept,gene,0.9863,34986714
2745,vascular endothelial growth factor,gene,0.999,34986714
2746,VEGF,gene,0.992,34986714
2747,VEGF-A,gene,0.9927,34986714
2748,VEGF-B,gene,0.9985,34986714
2749,placental growth factor,gene,0.998,34986714
2750,PIGF,gene,0.995,34986714
2751,FOLFIRI,drug,0.5713,34986714
2752,oxaliplatin,drug,0.999,34986714
2753,mCRC,disease,0.9873,34986714
2754,aflibercept,gene,0.9824,34986714
2755,FOLFIRI,drug,0.556,34986714
2756,5FU,drug,0.9995,34986714
2757,leucovorin,drug,0.999,34986714
2758,irinotecan,drug,0.999,34986714
2759,aflibercept,gene,0.942,34986714
2760,Aflibercept,gene,0.9624,34986714
2761,FOLFIRI,drug,0.8013,34986714
2762,mCRC,disease,0.96,34986714
2763,patient,species,0.977,34986714
2764,anti-VEGF,gene,0.9717,34983660
2765,Anti- VEGFs,gene,0.7656,34983660
2766,Ranibizumab,gene,0.9854,34983660
2767,Eylea,gene,0.4907,34983660
2768,Aflibercept,gene,0.995,34983660
2769,Avastin,gene,0.5083,34983660
2770,Bevacizumab,gene,0.963,34983660
2771,patients,species,0.9316,34983660
2772,neovascular Age Related Macular Degeneration,disease,1.0,34983660
2773,nARMD,disease,1.0,34983660
2774,Diabetic Macular Edema,disease,1.0,34983660
2775,DME,disease,1.0,34983660
2776,Retinal Vein Occlusion,disease,1.0,34983660
2777,RVO,disease,1.0,34983660
2778,Ranibizumab,gene,0.9253,34983660
2779,Aflibercept,gene,0.969,34983660
2780,neovascular age-related macular degeneration,disease,1.0,34982296
2781,nAMD,disease,1.0,34982296
2782,aflibercept,gene,0.989,34982296
2783,ranibizumab,gene,0.85,34982296
2784,patients,species,0.9834,34982296
2785,nAMD,disease,0.9214,34982296
2786,aflibercept,gene,0.982,34982296
2787,ranibizumab,gene,0.579,34982296
2788,fluorescein,drug,0.9937,34982296
2789,Aflibercept,gene,0.927,34982296
2790,CC,cell_line,,34982296
2791,Sattler layer,cell_line,0.593,34982296
2792,aflibercept,gene,0.9854,34982296
2793,CC,cell_type,,34982296
2794,aflibercept,gene,0.991,34977967
2795,sterile endophthalmitis,disease,1.0,34977967
2796,sterile endophthalmitis,disease,1.0,34977967
2797,aflibercept,gene,0.988,34977967
2798,aflibercept,gene,0.968,34977967
2799,patients,species,0.991,34977967
2800,aflibercept,gene,0.9917,34977967
2801,sterile endophthalmitis,disease,1.0,34977967
2802,sterile endophthalmitis,disease,1.0,34977967
2803,sterile endophthalmitis,disease,1.0,34977967
2804,sterile endophthalmitis,disease,1.0,34977967
2805,aflibercept,gene,0.991,34977967
2806,sterile endophthalmitis,disease,0.9995,34977967
2807,polypropylene,drug,0.9585,34977967
2808,sterile endophthalmitis,disease,1.0,34977967
2809,aflibercept,gene,0.979,34974510
2810,aflibercept,gene,0.9756,34974510
2811,diabetic macular edema,disease,1.0,34974510
2812,DME,disease,1.0,34974510
2813,aflibercept,gene,0.9463,34974510
2814,participants,species,0.926,34974510
2815,DME,disease,1.0,34974510
2816,diabetes mellitus,disease,1.0,34974510
2817,DME,disease,0.9995,34974510
2818,Diabetic Retinopathy,disease,1.0,34974510
2819,Participants,species,0.9385,34974510
2820,aflibercept,gene,0.8667,34974510
2821,CRT,DNA,0.5063,34974510
2822,participants,species,0.9775,34974510
2823,patients,species,0.974,34974510
2824,participants,species,0.9614,34974510
2825,diabetic retinopathy,disease,1.0,34974510
2826,dry,disease,0.6196,34974510
2827,patients,species,0.9595,34974510
2828,patients,species,0.982,34974510
2829,aflibercept,gene,0.9834,34974510
2830,DME,disease,0.9937,34974510
2831,Anti-VEGF,gene,0.975,34974177
2832,anti-VEGF,gene,0.966,34974177
2833,VEGF,gene,0.855,34974177
2834,patients,species,0.9614,34974177
2835,diabetes,disease,1.0,34974177
2836,anti-VEGF,gene,0.904,34974177
2837,VEGF,gene,0.6895,34974177
2838,diabetic macular edema,disease,1.0,34974177
2839,DME,disease,1.0,34974177
2840,anti-VEGF,gene,0.867,34974177
2841,patients,species,0.983,34974177
2842,DME,disease,1.0,34974177
2843,Brolucizumab,gene,0.9146,34968756
2844,Aflibercept,gene,0.98,34968756
2845,brolucizumab,gene,0.9404,34968756
2846,aflibercept,gene,0.9805,34968756
2847,patients,species,0.9463,34968756
2848,neovascular age-related macular degeneration,disease,1.0,34968756
2849,PARTICIPANTS,species,0.7637,34968756
2850,patients,species,0.9814,34968756
2851,brolucizumab,gene,0.863,34968756
2852,patients,species,0.977,34968756
2853,aflibercept,gene,0.7856,34968756
2854,patients,species,0.986,34968756
2855,intraretinal fluid,disease,0.991,34968756
2856,IRF,disease,0.9937,34968756
2857,subretinal fluid,disease,0.9746,34968756
2858,SRF,disease,0.957,34968756
2859,patients,species,0.9834,34968756
2860,brolucizumab,gene,0.849,34968756
2861,neovascular age-related macular degeneration,disease,1.0,34968756
2862,patients,species,0.981,34968756
2863,aflibercept,gene,0.9844,34968756
2864,patients,species,0.974,34968756
2865,brolucizumab,gene,0.786,34968756
2866,patients,species,0.991,34968756
2867,brolucizumab,gene,0.8003,34968756
2868,patients,species,0.9595,34968756
2869,aflibercept,gene,0.973,34968756
2870,brolucizumab,gene,0.88,34968756
2871,aflibercept,gene,0.927,34968756
2872,brolucizumab,gene,0.9126,34968756
2873,aflibercept,gene,0.9526,34968756
2874,patients,species,0.9463,34968756
2875,brolucizumab,gene,0.868,34968756
2876,patients,species,0.9805,34968756
2877,brolucizumab,gene,0.8267,34968756
2878,IRF,gene,0.9307,34968756
2879,SRF,gene,0.9805,34968756
2880,patients,species,0.9854,34968756
2881,aflibercept,gene,0.9688,34968756
2882,patients,species,0.9663,34968756
2883,brolucizumab,gene,0.78,34968756
2884,aflibercept,gene,0.989,34968756
2885,anti-VEGF,gene,0.9307,34968756
2886,vascular endothelial growth factor,gene,0.893,34967833
2887,age-related macular degeneration,disease,1.0,34967833
2888,IDB0062,drug,0.6606,34967833
2889,anti-vascular endothelial growth factor A Fab,gene,0.971,34967833
2890,neuropilin 1,gene,0.998,34967833
2891,IDB0062,drug,0.999,34967833
2892,IDB0062,drug,0.9995,34967833
2893,mouse,species,0.989,34967833
2894,choroidal neovascularization,disease,1.0,34967833
2895,oxygen-induced retinopathy,disease,0.959,34967833
2896,oxygen,drug,0.9995,34967833
2897,IDB0062,drug,0.9995,34967833
2898,IDB0062,drug,0.9995,34967833
2899,ranibizumab,gene,0.9336,34967833
2900,cynomolgus monkeys,species,0.717,34967833
2901,IDB0062,drug,0.998,34967833
2902,vascular endothelial growth factor A,gene,0.996,34967833
2903,placenta growth factor 2,gene,0.9985,34967833
2904,vascular endothelial growth factor B,gene,0.9976,34967833
2905,platelet-derived growth factor BB,gene,0.963,34967833
2906,vascular endothelial growth factor A,gene,0.999,34967833
2907,IDB0062,drug,0.9985,34967833
2908,aflibercept,gene,0.9766,34967833
2909,mouse vascular endothelial growth factor A,gene,0.9863,34967833
2910,mouse,species,0.9956,34967833
2911,IDB0062,drug,0.998,34967833
2912,ranibizumab,gene,0.676,34967833
2913,IDB0062,drug,0.998,34967833
2914,vitreous humor,disease,1.0,34967833
2915,neuropilin 1,gene,0.997,34967833
2916,IDB0062,drug,0.998,34967833
2917,macular degeneration,disease,1.0,34967833
2918,patients,species,0.9844,34967833
2919,IDB0062,drug,0.9985,34967833
2920,vascular endothelial growth factor,gene,0.867,34967833
2921,dexamethasone,drug,0.9917,34965061
2922,dexamethasone,drug,0.9956,34965061
2923,VEGF,gene,0.946,34965061
2924,macular edema,disease,1.0,34965061
2925,patients,species,0.9185,34965061
2926,diabetes mellitus,disease,1.0,34965061
2927,patients,species,0.993,34965061
2928,diabetic macular edema,disease,1.0,34965061
2929,patients,species,0.9927,34965061
2930,diabetic macular edema,disease,1.0,34965061
2931,patients,species,0.993,34965061
2932,VEGF,gene,0.77,34965061
2933,aflibercept,gene,0.97,34965061
2934,patients,species,0.964,34965061
2935,dexamethasone,drug,0.9907,34965061
2936,retinal edema,disease,1.0,34965061
2937,patients,species,0.9736,34965061
2938,dexamethasone,drug,0.9976,34965061
2939,diabetic macular edema,disease,1.0,34965061
2940,macular edema,disease,1.0,34965061
2941,patients,species,0.9883,34965061
2942,central retina artery occlusion,disease,0.9956,34962172
2943,patients,species,0.966,34962172
2944,central retinal artery occlusion,disease,0.999,34962172
2945,anti-vascular endothelial growth factor,gene,0.981,34962172
2946,patients,species,0.9927,34962172
2947,ranibizumab,gene,0.917,34962172
2948,aflibercept,gene,0.957,34962172
2949,retinal vascular diseases,disease,1.0,34962172
2950,Patients,species,0.9854,34962172
2951,central retinal artery occlusion,disease,0.9995,34962172
2952,patients,species,0.9883,34962172
2953,central retinal artery occlusion,disease,0.9995,34962172
2954,transient central retinal artery occlusion,disease,1.0,34962172
2955,transient central retinal artery occlusion,disease,1.0,34962172
2956,carotid artery obstruction,disease,1.0,34962172
2957,atheroma plaque,disease,0.9976,34962172
2958,carotid artery obstruction,disease,1.0,34962172
2959,atheroma plaque,disease,0.956,34962172
2960,pseudophakic lens,disease,0.7754,34962172
2961,central retinal artery occlusion,disease,0.9663,34962172
2962,patient,species,0.9453,34962172
2963,transient central retinal artery occlusion,disease,0.9844,34962172
2964,diabetic macular edema,disease,1.0,34962172
2965,central retinal artery occlusion,disease,0.9956,34962172
2966,patients,species,0.9526,34962172
2967,retinal vascular disease,disease,1.0,34962172
2968,vascular endothelial growth factor,gene,0.9707,34962172
2969,atheroma plaque,disease,0.895,34962172
2970,Aflibercept,gene,0.9917,34956670
2971,Insulin-like Growth Factor-I,gene,0.9985,34956670
2972,aflibercept,gene,0.9883,34956670
2973,insulin,gene,0.971,34956670
2974,vascular endothelial growth factor-A,gene,0.9985,34956670
2975,patients,species,0.9585,34956670
2976,diabetic retinopathy,disease,1.0,34956670
2977,age-related macular degeneration,disease,1.0,34956670
2978,Vascular endothelial growth factor-A,gene,0.997,34956670
2979,insulin-like growth factor-1,gene,0.999,34956670
2980,aflibercept,gene,0.973,34956670
2981,patients,species,0.9893,34956670
2982,age-related macular degeneration,disease,1.0,34956670
2983,patients,species,0.984,34956670
2984,diabetic retinopathy,disease,1.0,34956670
2985,vascular endothelial growth factor-A,gene,0.998,34956670
2986,age-related macular degeneration,disease,1.0,34956670
2987,diabetic retinopathy,disease,1.0,34956670
2988,vascular endothelial growth factor-A,gene,0.997,34956670
2989,insulin-like growth factor-1,gene,0.997,34956670
2990,diabetic retinopathy,disease,1.0,34956670
2991,age-related macular degeneration,disease,1.0,34956670
2992,patients,species,0.96,34956670
2993,proliferative diabetic retinopathy,disease,0.9863,34956670
2994,insulin-like growth factor-1,gene,0.987,34956670
2995,nonproliferative diabetic retinopathy,disease,0.8374,34956670
2996,insulin-like growth factor-1,gene,0.9917,34956670
2997,age-related macular degeneration,disease,1.0,34956670
2998,diabetic retinopathy,disease,1.0,34956670
2999,insulin-like growth factor-1,gene,0.999,34956670
3000,proliferative diabetic retinopathy,disease,0.9976,34956670
3001,aflibercept,gene,0.961,34956670
3002,insulin-like growth factor-1,gene,0.999,34956670
3003,diabetic retinopathy,disease,1.0,34956670
3004,Macular Edema,disease,1.0,34955825
3005,macular edema,disease,1.0,34955825
3006,retinal vein occlusion,disease,1.0,34955825
3007,RVO,disease,1.0,34955825
3008,patients,species,0.986,34955825
3009,patients,species,0.9727,34955825
3010,RVO,disease,1.0,34955825
3011,anti-,gene,0.5874,34955825
3012,vascular endothelial growth factor,gene,0.906,34955825
3013,VEGF,gene,0.9976,34955825
3014,ranibizumab,drug,0.8677,34955825
3015,bevacizumab,gene,0.8975,34955825
3016,aflibercept,gene,0.9507,34955825
3017,ranibizumab,drug,0.7817,34955825
3018,dexamethasone,drug,0.997,34955825
3019,ranibizumab,gene,0.735,34955825
3020,RVO,disease,0.982,34955825
3021,ranibizumab,gene,0.5703,34955825
3022,bevacizumab,gene,0.767,34955825
3023,aflibercept,gene,0.9644,34955825
3024,Ranibizumab,gene,0.7627,34955825
3025,CRT,DNA,0.473,34955825
3026,RVO,disease,0.6816,34955825
3027,Dexamethasone,drug,0.997,34955825
3028,RVO,disease,0.993,34955825
3029,RVO,disease,0.994,34955825
3030,VEGF,gene,0.6826,34955825
3031,RVO,disease,0.953,34955825
3032,dexamethasone,drug,0.994,34955825
3033,Patients,species,0.9795,34955825
3034,polyps,disease,1.0,34954774
3035,polypoidal lesions,disease,1.0,34954774
3036,polypoidal,disease,1.0,34954774
3037,choroidal vasculopathy,disease,1.0,34954774
3038,PCV,disease,1.0,34954774
3039,aflibercept,gene,0.9717,34954774
3040,patients,species,0.9873,34954774
3041,PCV,disease,1.0,34954774
3042,subretinal,disease,0.6943,34954774
3043,polyps,disease,0.9995,34954774
3044,recombinant human opticin,gene,0.9966,34954204
3045,human,species,0.4495,34954204
3046,Opticin,gene,0.961,34954204
3047,proliferative,disease,0.7144,34954204
3048,diabetic retinopathy,disease,0.98,34954204
3049,retinopathy of prematurity,disease,1.0,34954204
3050,recombinant human opticin,gene,0.9966,34954204
3051,human,species,0.564,34954204
3052,recombinant human opticin,gene,0.996,34954204
3053,human,species,0.6133,34954204
3054,murine,species,0.926,34954204
3055,oxygen,drug,0.9995,34954204
3056,mice,species,0.955,34954204
3057,oxygen,drug,0.9995,34954204
3058,human recombinant opticin,gene,0.9316,34954204
3059,human,species,0.9883,34954204
3060,retinal neovascularization,disease,0.941,34954204
3061,aflibercept,gene,0.965,34954204
3062,VEGF,gene,0.9937,34954204
3063,Opticin,drug,0.974,34954204
3064,aflibercept,gene,0.986,34954204
3065,human recombinant opticin,gene,0.991,34954204
3066,human,species,0.9907,34954204
3067,mice,species,0.968,34954204
3068,recombinant human opticin,gene,0.9946,34954204
3069,human,species,0.66,34954204
3070,mice,species,0.9644,34954204
3071,Aflibercept,gene,0.9854,34946238
3072,Ranibizumab,gene,0.95,34946238
3073,Patients,species,0.9834,34946238
3074,patients,species,0.98,34946238
3075,AMD,disease,0.9995,34946238
3076,ranibizumab,gene,0.908,34946238
3077,aflibercept,gene,0.98,34946238
3078,patients,species,0.9893,34946238
3079,Aflibercept,gene,0.9443,34946238
3080,Ranibizumab,gene,0.86,34946238
3081,exudative AMD,disease,1.0,34946238
3082,patients,species,0.9907,34946238
3083,patients,species,0.9897,34946238
3084,patient,species,0.995,34946238
3085,Patients,species,0.956,34946238
3086,Aflibercept,gene,0.879,34946238
3087,Ranibizumab,gene,0.8125,34946238
3088,CRT,DNA,0.563,34946238
3089,CRT,DNA,0.5513,34946238
3090,patients,species,0.9717,34946238
3091,Aflibercept,gene,0.9863,34946238
3092,Ranibizumab,gene,0.957,34946238
3093,aflibercept,gene,0.992,34946238
3094,ranibizumab,gene,0.7974,34946238
3095,exudative AMD,disease,0.9956,34946238
3096,anti-vascular endothelial growth factor,gene,0.9937,34945035
3097,VEGF,gene,0.9976,34945035
3098,diabetic macular edema,disease,1.0,34945035
3099,DME,disease,1.0,34945035
3100,edema,disease,0.9814,34945035
3101,patients,species,0.99,34945035
3102,ranibizumab,gene,0.6914,34945035
3103,aflibercept,gene,0.9517,34945035
3104,patients,species,0.9873,34945035
3105,DME,disease,1.0,34945035
3106,VEGF,gene,0.966,34945035
3107,DME,disease,1.0,34945035
3108,Ranibizumab,gene,0.7656,34945034
3109,Polypoidal Choroidal BACKGROUND,disease,0.972,34945034
3110,ranibizumab,gene,0.6123,34945034
3111,aflibercept,gene,0.973,34945034
3112,polypoidal choroidal vasculopathy,disease,1.0,34945034
3113,PCV,disease,1.0,34945034
3114,aflibercept,gene,0.908,34945034
3115,PCV,disease,1.0,34945034
3116,patients,species,0.9834,34945034
3117,ranibizumab,gene,0.682,34945034
3118,ranibizumab,gene,0.6743,34945034
3119,aflibercept,gene,0.9805,34945034
3120,ranibizumab,gene,0.8276,34945034
3121,CRT,DNA,0.525,34945034
3122,ranibizumab,gene,0.806,34945034
3123,aflibercept,gene,0.9844,34945034
3124,polypoidal choroidal vasculopathy,disease,1.0,34945034
3125,patients,species,0.97,34945034
3126,age-related macular degeneration,disease,1.0,34940343
3127,AMD,disease,1.0,34940343
3128,Aflibercept,gene,0.9795,34940343
3129,Eylea,gene,0.773,34940343
3130,AMD,disease,1.0,34940343
3131,rats,species,0.9766,34940343
3132,choroidal neovascularization,disease,0.9907,34940343
3133,CNV,disease,1.0,34940343
3134,Rats,species,0.984,34940343
3135,rats,species,0.9756,34940343
3136,rats,species,0.9917,34940343
3137,rats,species,0.986,34940343
3138,rats,species,0.9766,34940343
3139,Aflibercept,gene,0.991,34940343
3140,sucrose,drug,0.9893,34940343
3141,fluorescein,drug,0.998,34940343
3142,Aflibercept,gene,0.987,34940343
3143,Aflibercept,gene,0.9785,34940343
3144,AMD,disease,0.5015,34940343
3145,Aflibercept,gene,0.995,34938191
3146,MicroRNA,RNA,0.5786,34938191
3147,Vascular endothelial growth factor-A,gene,0.9976,34938191
3148,VEGF-A,gene,0.9966,34938191
3149,proliferative diabetic retinopathy,disease,1.0,34938191
3150,PDR,disease,1.0,34938191
3151,aflibercept,gene,0.9844,34938191
3152,Eylea,gene,0.7505,34938191
3153,VEGF,gene,0.6367,34938191
3154,microRNA,RNA,0.84,34938191
3155,miRNA,RNA,0.5938,34938191
3156,idiopathic macular hole,disease,0.999,34938191
3157,patients,species,0.9814,34938191
3158,PDR,disease,1.0,34938191
3159,patients,species,0.987,34938191
3160,PDR,disease,0.9985,34938191
3161,patients,species,0.994,34938191
3162,aflibercept,gene,0.982,34938191
3163,miRNA,RNA,0.633,34938191
3164,miRNAs,RNA,0.5615,34938191
3165,mRNA profile,RNA,0.8145,34938191
3166,PDR,disease,1.0,34938191
3167,patients,species,0.994,34938191
3168,miRNAs,RNA,0.5244,34938191
3169,mRNAs,RNA,0.813,34938191
3170,target mRNAs,RNA,0.715,34938191
3171,Hsa-miR-3184-3p,gene,0.988,34938191
3172,hsa-miR-24-3p,gene,0.9907,34938191
3173,hsa-miR-197-3p,gene,0.986,34938191
3174,protein-coding mRNAs,RNA,0.5435,34938191
3175,overlapped mRNAs,RNA,0.604,34938191
3176,deregulated mRNAs,RNA,0.6143,34938191
3177,aflibercept,gene,0.987,34938191
3178,miRNAs,RNA,0.737,34938191
3179,critical,RNA,0.7114,34938191
3180,mRNAs,RNA,0.4697,34938191
3181,retinal fibrosis,disease,0.9995,34938191
3182,Hsa,RNA,0.3596,34938191
3183,Hsa-miR-3184-3p,gene,0.9917,34938191
3184,hsa-miR-24-3p,gene,0.9927,34938191
3185,hsa-miR-197-3p,gene,0.9893,34938191
3186,PDR,disease,0.9995,34938191
3187,patients,species,0.9976,34938191
3188,aflibercept,gene,0.98,34938191
3189,aflibercept,gene,0.9956,34938191
3190,retinal fibrosis,disease,1.0,34938191
3191,aflibercept,gene,0.989,34937947
3192,FOLFIRI,drug,0.6724,34937947
3193,patients,species,0.9834,34937947
3194,Aflibercept,gene,0.939,34937947
3195,metastatic colorectal cancer,disease,1.0,34937947
3196,mCRC,disease,1.0,34937947
3197,5-fluorouracil,drug,0.9966,34937947
3198,leucovorin,drug,0.9985,34937947
3199,irinotecan,drug,0.999,34937947
3200,FOLFIRI,drug,0.9937,34937947
3201,aflibercept,gene,0.954,34937947
3202,vascular endothelial growth factor A,gene,0.999,34937947
3203,VEGF-A,gene,0.9985,34937947
3204,angiotensin-converting enzyme,gene,0.9976,34937947
3205,ACE,gene,0.991,34937947
3206,oxaliplatin,drug,1.0,34937947
3207,mCRC,disease,0.9873,34937947
3208,patients,species,0.9844,34937947
3209,aflibercept,gene,0.961,34937947
3210,FOLFIRI,drug,0.8315,34937947
3211,VEGF-A,gene,0.9966,34937947
3212,patients,species,0.962,34937947
3213,VEGF-A,gene,0.997,34937947
3214,VEGF-A,gene,0.9956,34937947
3215,Patients,species,0.9194,34937947
3216,VEGF-A,gene,0.995,34937947
3217,ACE,gene,0.9814,34937947
3218,aflibercept,gene,0.9854,34937947
3219,FOLFIRI,drug,0.69,34937947
3220,VEGF-A,gene,0.998,34937947
3221,neovascular age-related macular degeneration,disease,1.0,34930502
3222,AMD,disease,1.0,34930502
3223,aflibercept,gene,0.9526,34930502
3224,patients,species,0.9727,34930502
3225,neovascular AMD,disease,1.0,34930502
3226,IVA,drug,0.7114,34930502
3227,vascular endothelial growth factor,gene,0.9795,34930439
3228,age-related macular BACKGROUND,disease,0.9995,34930439
3229,vascular endothelial growth factor,gene,0.876,34930439
3230,VEGFs,gene,0.994,34930439
3231,patients,species,0.98,34930439
3232,neovascular age-related macular degeneration,disease,1.0,34930439
3233,nAMD,disease,1.0,34930439
3234,nAMD,disease,1.0,34930439
3235,patients,species,0.99,34930439
3236,Diabetic Retinopathy,disease,1.0,34930439
3237,patients,species,0.988,34930439
3238,vision loss,disease,0.9985,34930439
3239,patients,species,0.9424,34930439
3240,patients,species,0.9785,34930439
3241,patients,species,0.98,34930439
3242,conbercept,gene,0.825,34930439
3243,conbercept,gene,0.6577,34930439
3244,conbercept,gene,0.756,34930439
3245,aflibercept,gene,0.988,34930439
3246,conbercept,gene,0.5215,34930439
3247,bevacizumab,gene,0.578,34930439
3248,patients,species,0.9575,34930439
3249,patients,species,0.992,34930439
3250,vision loss,disease,0.904,34930439
3251,conbercept,gene,0.9336,34930439
3252,aflibercept,gene,0.985,34930439
3253,conbercept,gene,0.94,34930439
3254,brolucizumab,gene,0.8877,34930439
3255,conbercept,gene,0.499,34930439
3256,conbercept,gene,0.658,34930439
3257,ranibizumab,gene,0.648,34930439
3258,bevacizumab,gene,0.794,34930439
3259,aflibercept,gene,0.9854,34930439
3260,brolucizumab,gene,0.834,34930439
3261,conbercept,gene,0.655,34930439
3262,patients,species,0.99,34930439
3263,nAMD,disease,1.0,34930439
3264,neovascular age-related macular BACKGROUND,disease,0.9873,34926990
3265,patients,species,0.9443,34926990
3266,neovascular age-related macular degeneration,disease,1.0,34926990
3267,nAMD,disease,1.0,34926990
3268,IRF,cell_type,0.63,34926990
3269,VEGF,gene,0.8867,34926990
3270,brolucizumab,gene,0.926,34926990
3271,patients,species,0.958,34926990
3272,nAMD,disease,1.0,34926990
3273,IRF,gene,0.985,34926990
3274,SRF,gene,0.9927,34926990
3275,nAMD,disease,1.0,34926990
3276,aflibercept,gene,0.989,34926990
3277,bevacizumab,gene,0.5522,34926990
3278,IVBr,drug,0.9956,34926990
3279,IRF,gene,0.9985,34926990
3280,SRF,gene,0.998,34926990
3281,IVBe,drug,0.898,34926990
3282,IVBr,drug,1.0,34926990
3283,nAMD,disease,1.0,34926990
3284,IVBr,drug,0.7666,34926990
3285,RETINAL THICKNESS,disease,0.711,34923515
3286,neovascular age-related macular degeneration,disease,0.9966,34923515
3287,vascular endothelial growth factor,gene,0.996,34923515
3288,patients,species,0.9824,34923515
3289,Diabetic Retinopathy,disease,0.999,34923515
3290,neovascular age-related macular degeneration,disease,1.0,34923515
3291,patients,species,0.9946,34923515
3292,branch retinal vein occlusion,disease,1.0,34918688
3293,SARS-CoV2,species,0.639,34918688
3294,patients,species,0.9897,34918688
3295,branch retinal vein occlusion,disease,1.0,34918688
3296,BRVO,disease,0.9697,34918688
3297,SARS-CoV,disease,0.8945,34918688
3298,SARS-CoV-2,species,0.7476,34918688
3299,PATIENT,species,0.905,34918688
3300,vision loss,disease,0.9937,34918688
3301,CoV-2 mRNA,RNA,0.673,34918688
3302,CoV,species,0.77,34918688
3303,patient,species,0.9766,34918688
3304,macular edema,disease,1.0,34918688
3305,ME,disease,1.0,34918688
3306,ME,disease,,34918688
3307,aflibercept,gene,0.9375,34918688
3308,ME,disease,,34918688
3309,man,species,0.926,34918688
3310,vision loss,disease,0.9087,34918688
3311,SARS-CoV-2 mRNA,RNA,0.8296,34918688
3312,SARS,species,0.566,34918688
3313,patient,species,0.9717,34918688
3314,ME,disease,,34918688
3315,patient,species,0.983,34918688
3316,BRVO,disease,0.903,34918688
3317,ME,disease,,34918688
3318,BRVO,disease,0.999,34918688
3319,ME,disease,,34918688
3320,BCVA,DNA,0.4924,34918688
3321,IVA,drug,0.948,34918688
3322,ranibizumab,gene,0.896,34918688
3323,SARS-CoV,species,0.6265,34918688
3324,BRVO,disease,1.0,34918688
3325,secretogranin III,gene,0.9966,34918375
3326,choroidal Choroidal neovascularization,disease,0.999,34918375
3327,CNV,disease,1.0,34918375
3328,blindness,disease,0.995,34918375
3329,VEGF,gene,0.9985,34918375
3330,secretogranin III,gene,0.9966,34918375
3331,Scg3,gene,0.992,34918375
3332,diabetic retinopathy,disease,1.0,34918375
3333,VEGF,gene,0.997,34918375
3334,Scg3,gene,0.996,34918375
3335,diabetic retinopathy,disease,1.0,34918375
3336,Scg3,gene,0.9917,34918375
3337,CNV,disease,0.9946,34918375
3338,mice,species,0.9624,34918375
3339,choriocapillaris,cell_type,0.52,34918375
3340,Scg3-neutralizing antibody,gene,0.9897,34918375
3341,VEGF,gene,0.9937,34918375
3342,anti-Scg3 humanized antibody Fab,gene,0.9297,34918375
3343,hFab,gene,0.9956,34918375
3344,CNV,disease,0.938,34918375
3345,VEGF,gene,0.611,34918375
3346,aflibercept,gene,0.927,34918375
3347,anti-Scg3 hFab,gene,0.995,34918375
3348,aflibercept,gene,0.9775,34918375
3349,CNV,disease,0.9917,34918375
3350,Scg3 gene,gene,0.997,34918375
3351,CNV,disease,0.999,34918375
3352,anti-Scg3 hFab,gene,0.9834,34918375
3353,aflibercept,gene,0.989,34918375
3354,Scg3,gene,0.9927,34918375
3355,VEGF,gene,0.997,34918375
3356,CNV,disease,0.9995,34918375
3357,Scg3,gene,0.9937,34918375
3358,anti-Scg3 hFab,gene,0.958,34918375
3359,CNV,disease,1.0,34918375
3360,metastatic colorectal cancer,disease,0.9995,34916122
3361,patients,species,0.9746,34916122
3362,colorectal cancer,disease,0.957,34916122
3363,mCRC,disease,0.9985,34916122
3364,mCRC,disease,0.995,34916122
3365,patients,species,0.992,34916122
3366,panitumumab,gene,0.9165,34916122
3367,aflibercept,gene,0.945,34916122
3368,tumour,disease,0.999,34916122
3369,tumour,disease,0.977,34916122
3370,tumour,disease,0.993,34916122
3371,patients,species,0.988,34916122
3372,patients,species,0.984,34916122
3373,patients,species,0.985,34916122
3374,Patients,species,0.952,34910154
3375,patients,species,0.9653,34910154
3376,metastatic colorectal cancer,disease,1.0,34910154
3377,mCRC,disease,1.0,34910154
3378,patients,species,0.9854,34910154
3379,patients,species,0.981,34910154
3380,patients,species,0.978,34910154
3381,PARTICIPANTS,species,0.5264,34910154
3382,patients,species,0.977,34910154
3383,mCRC,disease,0.9956,34910154
3384,Patient,species,0.975,34910154
3385,patients,species,0.984,34910154
3386,oxaliplatin,drug,1.0,34910154
3387,irinotecan,drug,0.9995,34910154
3388,5-fluorouracil,drug,0.9995,34910154
3389,capecitabine,drug,0.999,34910154
3390,bevacizumab,gene,0.8857,34910154
3391,cetuximab,gene,0.8555,34910154
3392,panitumumab,gene,0.8784,34910154
3393,ramucirumab,gene,0.5347,34910154
3394,aflibercept,gene,0.944,34910154
3395,patients,species,0.9707,34910154
3396,mCRC,disease,0.993,34910154
3397,patients,species,0.9717,34910154
3398,patients,species,0.991,34910154
3399,patients,species,0.9883,34910154
3400,patients,species,0.9873,34910154
3401,patients,species,0.99,34910154
3402,patients,species,0.993,34910154
3403,patients,species,0.979,34910154
3404,patients,species,0.972,34910154
3405,patients,species,0.9893,34910154
3406,patients,species,0.9893,34910154
3407,mCRC,disease,0.9976,34910154
3408,patients,species,0.9565,34910154
3409,patients,species,0.986,34910154
3410,Aflibercept,gene,0.743,34908485
3411,Retinopathy of Prematurity,disease,1.0,34908485
3412,aflibercept,gene,0.979,34908485
3413,retinopathy of prematurity,disease,1.0,34908485
3414,ROP,disease,1.0,34908485
3415,PATIENTS,species,0.9766,34908485
3416,aflibercept,gene,0.9604,34908485
3417,ROP,disease,0.995,34908485
3418,infants,species,0.5576,34908485
3419,aflibercept,gene,0.977,34908485
3420,aflibercept,gene,0.97,34908485
3421,ROP,disease,0.991,34908485
3422,aflibercept,gene,0.973,34908485
3423,vascular endothelial growth factor,gene,0.9277,34908485
3424,VEGF,gene,0.9976,34908485
3425,ROP,disease,0.9272,34908485
3426,Aflibercept,gene,0.95,34908485
3427,ROP,disease,0.9927,34908485
3428,aflibercept,gene,0.981,34908485
3429,VEGF,gene,0.829,34908485
3430,ranibizumab,gene,0.894,34889791
3431,aflibercept,gene,0.986,34889791
3432,patients,species,0.959,34889791
3433,ranibizumab,gene,0.7554,34889791
3434,neovascular age-related macular degeneration,disease,1.0,34889791
3435,n-AMD,disease,1.0,34889791
3436,aflibercept,gene,0.968,34889791
3437,n-AMD,drug,0.982,34889791
3438,patients,species,0.982,34889791
3439,patients,species,0.979,34889791
3440,IVA,drug,0.855,34889791
3441,patients,species,0.984,34889791
3442,patients,species,0.982,34889791
3443,IVA,drug,0.895,34889791
3444,IVA,disease,0.827,34889791
3445,IVA,disease,0.8604,34889791
3446,n-AMD,disease,1.0,34889791
3447,patients,species,0.994,34889791
3448,ranibizumab,gene,0.976,34889791
3449,aflibercept,gene,0.946,34889791
3450,diabetic macular edema,disease,1.0,34882334
3451,Ranibizumab,gene,0.492,34882334
3452,Aflibercept,gene,0.938,34882334
3453,diabetic macular edema,disease,1.0,34882334
3454,aflibercept,gene,0.9873,34876232
3455,aflibercept,gene,0.9756,34876232
3456,neovascular age-related macular degeneration,disease,1.0,34876232
3457,patients,species,0.987,34876232
3458,neovascular age-related macular degeneration,disease,1.0,34876232
3459,aflibercept,gene,0.9746,34876232
3460,aflibercept,gene,0.982,34876232
3461,aflibercept,gene,0.9756,34876232
3462,aflibercept,gene,0.989,34876232
3463,human,species,0.9194,34876232
3464,participants,species,0.9575,34876232
3465,Radiation retinopathy,disease,0.9995,34874814
3466,Radiation retinopathy,disease,1.0,34874814
3467,vision,disease,0.9414,34874814
3468,patient,species,0.934,34874814
3469,patients,species,0.987,34874814
3470,patient,species,0.9897,34874814
3471,radiation retinopathy,disease,0.9995,34874814
3472,Ranibizumab,gene,0.8516,34871637
3473,Aflibercept,gene,0.9126,34871637
3474,anti-,gene,0.799,34871637
3475,vascular endothelial growth factor,gene,0.8867,34871637
3476,VEGF,gene,0.995,34871637
3477,anti-VEGF,gene,0.9614,34871637
3478,VEGF,gene,0.806,34871637
3479,neovascular age-related macular degeneration,disease,1.0,34871637
3480,retinal vein occlusions,disease,1.0,34871637
3481,diabetic macular edema,disease,1.0,34871637
3482,patients,species,0.988,34871637
3483,Aflibercept,gene,0.9883,34871637
3484,bevacizumab,gene,0.9497,34871637
3485,ranibizumab,gene,0.5923,34871637
3486,VEGF,gene,0.847,34871637
3487,Ranibizumab,gene,0.863,34871637
3488,bevacizumab,gene,0.7554,34871637
3489,VEGF,gene,0.837,34871637
3490,Ranibizumab,gene,0.8706,34871637
3491,VEGF,gene,0.9062,34871637
3492,wet age-related macular,disease,0.878,34863677
3493,patients,species,0.9893,34863677
3494,anti-,gene,0.796,34863677
3495,VEGF,gene,0.658,34863677
3496,age-related macular degeneration,disease,1.0,34863677
3497,AMD,disease,1.0,34863677
3498,PARTICIPANTS,species,0.5034,34863677
3499,Patients,species,0.9614,34863677
3500,wet AMD,disease,0.9937,34863677
3501,patients,species,0.986,34863677
3502,wet AMD,disease,0.9995,34863677
3503,anti-VEGF,gene,0.9595,34863677
3504,Patients,species,0.945,34863677
3505,Patient,species,0.986,34863677
3506,ranibizumab,gene,0.6665,34863677
3507,aflibercept,gene,0.8804,34863677
3508,anti-VEGF,gene,0.8667,34863677
3509,Diabetic Retinopathy,disease,1.0,34863677
3510,ranibizumab,gene,0.7134,34863677
3511,aflibercept,gene,0.9785,34863677
3512,wet AMD,disease,0.9937,34863677
3513,patients,species,0.992,34863677
3514,DIABETIC CHOROIDOPATHY,disease,1.0,34861657
3515,proliferative diabetic retinopathy,disease,1.0,34861657
3516,PDR,disease,1.0,34861657
3517,Patients,species,0.9653,34861657
3518,PDR,disease,0.998,34861657
3519,PRP,cell_type,0.484,34861657
3520,PDR,disease,1.0,34861657
3521,PDR,disease,1.0,34861657
3522,PDR,disease,0.9995,34861657
3523,PRP,cell_type,0.5356,34861657
3524,PDR,disease,1.0,34861657
3525,PRP,cell_type,0.6064,34861657
3526,PDR,disease,1.0,34861657
3527,PRP,cell_type,0.4841,34861657
3528,diabetic choroidopathy,disease,1.0,34861657
3529,VEGF,gene,0.5137,34853203
3530,patients,species,0.9854,34853203
3531,exudative age-related macular degeneration,disease,1.0,34853203
3532,diabetic retinopathy,disease,1.0,34853203
3533,retinal vein occlusion,disease,1.0,34853203
3534,diabetes,disease,1.0,34853203
3535,patients,species,0.995,34853203
3536,intraocular neovascularization,disease,1.0,34853203
3537,vascular endothelial growth factor,gene,0.9614,34853203
3538,VEGF,gene,0.998,34853203
3539,macular edema,disease,1.0,34853203
3540,patients,species,0.972,34853203
3541,VEGF,gene,0.834,34853203
3542,VEGF,gene,0.9937,34853203
3543,VEGF,gene,0.9307,34853203
3544,VEGF,gene,0.996,34853203
3545,VEGF,gene,0.997,34853203
3546,ischemic retina,disease,0.993,34853203
3547,neovascular age-related macular degeneration,disease,1.0,34848169
3548,vascular endothelial growth factor,gene,0.9893,34848169
3549,participants,species,0.9697,34848169
3550,ranibizumab,gene,0.6357,34848169
3551,aflibercept,gene,0.9663,34848169
3552,aflibercept,gene,0.9663,34848169
3553,Rq4,DNA,0.88,34848169
3554,2q4,DNA,0.847,34848169
3555,2q8 arms,DNA,0.8423,34848169
3556,Rq4,DNA,0.5522,34848169
3557,2q4,DNA,0.4692,34848169
3558,2q8,DNA,0.847,34848169
3559,neovascular age-related macular degeneration,disease,1.0,34848169
3560,Myopic,disease,0.9956,34843086
3561,patients,species,0.983,34843086
3562,high myopia,disease,0.967,34843086
3563,cataract,disease,1.0,34843086
3564,maculopathy,disease,1.0,34843086
3565,patients,species,0.981,34843086
3566,ASPIRA,DNA,0.482,34843086
3567,aflibercept,gene,0.9873,34843086
3568,patients,species,0.9834,34843086
3569,central scotoma,disease,1.0,34843086
3570,maculopathy,disease,1.0,34843086
3571,Patients,species,0.9834,34843086
3572,dysphotopsia,disease,0.9995,34843086
3573,Retinal diseases,disease,1.0,34843086
3574,patient,species,0.9927,34843086
3575,cataract,disease,0.975,34843086
3576,patient,species,0.9233,34843086
3577,dysphotopsia,disease,0.999,34843086
3578,patients,species,0.9653,34842984
3579,macular edema,disease,1.0,34842984
3580,ME,disease,1.0,34842984
3581,central (CRVO) or hemiretinal vein occlusion,disease,0.999,34842984
3582,HRVO,disease,0.9966,34842984
3583,aflibercept,gene,0.9785,34842984
3584,bevacizumab,gene,0.6367,34842984
3585,patients,species,0.9434,34842984
3586,ME,disease,,34842984
3587,CRVO,disease,1.0,34842984
3588,HRVO,disease,1.0,34842984
3589,aflibercept,gene,0.9805,34842984
3590,bevacizumab,gene,0.811,34842984
3591,participant,species,0.974,34842984
3592,participant,species,0.9756,34842984
3593,bevacizumab,gene,0.8193,34842984
3594,aflibercept,gene,0.9517,34842984
3595,CST,DNA,0.4846,34842984
3596,VALS,disease,0.9995,34842984
3597,VALS,disease,1.0,34842984
3598,Brolucizumab,gene,0.61,34840689
3599,Age-related macular degeneration,disease,1.0,34840689
3600,subretinal neovascularization,disease,1.0,34840689
3601,impairment of central vision,disease,1.0,34840689
3602,vascular endothelial growth factor,gene,0.8677,34840689
3603,retinal disease,disease,1.0,34840689
3604,VEGF,gene,0.58,34840689
3605,pegaptanib,drug,0.9585,34840689
3606,ranibizumab,gene,0.764,34840689
3607,aflibercept,gene,0.9653,34840689
3608,bevacizumab,gene,0.774,34840689
3609,VEGF,gene,0.663,34840689
3610,brolucizumab,gene,0.659,34840689
3611,age-related macular degeneration,disease,1.0,34840689
3612,single-chain fragment variable antibody,gene,0.731,34840689
3613,VEGF-A,gene,0.997,34840689
3614,patients,species,0.993,34840689
3615,Brolucizumab,gene,0.741,34840689
3616,occlusive retinal vasculitis,disease,1.0,34840689
3617,intraocular inflammation,disease,1.0,34840689
3618,VEGF,gene,0.506,34840689
3619,brolucizumab,gene,0.758,34840689
3620,Neovascular Age-related Macular PURPOSE,disease,0.9917,34839342
3621,neovascular age-related macular degeneration,disease,0.9995,34839342
3622,nAMD,disease,1.0,34839342
3623,polypoidal choroidal vasculopathy,disease,1.0,34839342
3624,PCV,disease,1.0,34839342
3625,nAMD,disease,1.0,34839342
3626,nAMD,disease,0.9995,34839342
3627,PCV,disease,1.0,34839342
3628,aflibercept,gene,0.977,34839342
3629,ranibizumab,gene,0.5605,34839342
3630,bevacizumab,gene,0.721,34839342
3631,nAMD,disease,1.0,34839342
3632,aflibercept,gene,0.959,34839342
3633,PCV,disease,1.0,34839342
3634,Intraretinal fluid,disease,0.984,34839342
3635,nAMD,disease,1.0,34839342
3636,PCV,disease,1.0,34839342
3637,patients,species,0.9937,34839342
3638,cancer cells,cell_type,0.8145,34838486
3639,cancer,disease,1.0,34838486
3640,Vascular Endothelial Growth Factor,gene,0.999,34838486
3641,VEGF,gene,0.9985,34838486
3642,cancer,disease,1.0,34838486
3643,patients,species,0.9863,34838486
3644,Vascular Endothelial Growth Factor,gene,0.9985,34838486
3645,bevacizumab,gene,0.5894,34838486
3646,anti-Vascular Endothelial Growth Factor monoclonal antibody,gene,0.9937,34838486
3647,aflibercept,gene,0.9766,34838486
3648,recombinant anti-Vascular Endothelial Growth Factor fusion protein,gene,0.9927,34838486
3649,tyrosine,drug,0.9897,34838486
3650,tyrosine kinase,gene,0.9707,34838486
3651,sunitinib,drug,0.998,34838486
3652,sorafenib,drug,0.9985,34838486
3653,anti,disease,0.5186,34838486
3654,cancer,disease,0.9785,34838486
3655,patient,species,0.9917,34838486
3656,hypertension,disease,1.0,34838486
3657,proteinuria,disease,1.0,34838486
3658,acute kidney injury,disease,1.0,34838486
3659,glomerular and/or vascular insults,disease,1.0,34838486
3660,thrombotic microangiopathy,disease,1.0,34838486
3661,tubulointerstitial damage,disease,1.0,34838486
3662,Microaneurysm,disease,0.5933,34834478
3663,proliferative diabetic retinopathy,disease,1.0,34834478
3664,PDR,disease,1.0,34834478
3665,microaneurysm,disease,1.0,34834478
3666,MA,disease,1.0,34834478
3667,aflibercept,gene,0.9697,34834478
3668,fluorescein,drug,0.997,34834478
3669,PDR,disease,0.989,34834478
3670,Arm,DNA,0.4746,34834478
3671,Diabetic Retinopathy,disease,1.0,34834478
3672,Ranibizumab,gene,0.78,34834388
3673,High Myopia,disease,1.0,34834388
3674,Patients,species,0.991,34834388
3675,High myopia,disease,1.0,34834388
3676,ophthalmic,disease,0.9126,34834388
3677,choroidal neovascularization,disease,1.0,34834388
3678,CNV,disease,1.0,34834388
3679,Ranibizumab,gene,0.6406,34834388
3680,recombinant,gene,0.656,34834388
3681,humanized,species,0.517,34834388
3682,anti-,gene,0.5986,34834388
3683,vascular endothelial growth factor,gene,0.919,34834388
3684,VEGF,gene,0.701,34834388
3685,CNV,disease,1.0,34834388
3686,genetic polymorphisms,DNA,0.695,34834388
3687,ranibizumab,gene,0.5713,34834388
3688,patients,species,0.9688,34834388
3689,high myopia,disease,0.9995,34834388
3690,CNV,disease,1.0,34834388
3691,genetic polymorphisms,DNA,0.455,34834388
3692,ranibizumab,gene,0.712,34834388
3693,patients,species,0.98,34834388
3694,CNV,disease,0.9995,34834388
3695,high myopia,disease,1.0,34834388
3696,mCNV,disease,1.0,34834388
3697,genetic polymorphisms,DNA,0.661,34834388
3698,CNV,disease,1.0,34834388
3699,patients,species,0.9946,34834388
3700,bevacizumab,gene,0.956,34834388
3701,ranibizumab,gene,0.924,34834388
3702,aflibercept,gene,0.9824,34834388
3703,VEGFA gene,gene,0.9966,34834388
3704,ARMS2,gene,0.9956,34834388
3705,rs10490924,DNA,0.933,34834388
3706,rs10490924,mutation,,34834388
3707,CFH,gene,0.9956,34834388
3708,rs1061170,DNA,0.799,34834388
3709,rs1061170,mutation,,34834388
3710,ranibizumab,gene,0.629,34834388
3711,high myopia,disease,0.9995,34834388
3712,patients,species,0.9893,34834388
3713,VEGFA,gene,0.995,34834388
3714,ranibizumab,gene,0.4836,34834388
3715,CNV,disease,1.0,34834388
3716,Diabetic Macular BACKGROUND,disease,0.993,34830624
3717,Diabetic macular edema,disease,1.0,34830624
3718,DME,disease,1.0,34830624
3719,visual loss,disease,0.9995,34830624
3720,DME,disease,1.0,34830624
3721,patients,species,0.992,34830624
3722,DME,disease,1.0,34830624
3723,patients,species,0.9927,34830624
3724,Ranibizumab,gene,0.8506,34830624
3725,Aflibercept,gene,0.946,34830624
3726,Dexamethasone,drug,0.9995,34830624
3727,Fluocinolone Acetonide,drug,0.999,34830624
3728,DME,disease,1.0,34830624
3729,patients,species,0.9937,34830624
3730,Ranibizumab,gene,0.882,34830624
3731,Aflibercept,gene,0.907,34830624
3732,Dexamethasone,drug,0.991,34830624
3733,patients,species,0.978,34830624
3734,Ranibizumab,gene,0.8984,34830624
3735,Aflibercept,gene,0.9575,34830624
3736,Dexamethasone,drug,0.9937,34830624
3737,DME,disease,1.0,34830624
3738,Dexamethasone,drug,0.988,34830624
3739,patients,species,0.9575,34830624
3740,Aflibercept,gene,0.959,34830624
3741,Ranibizumab,gene,0.7915,34830624
3742,Aflibercept,gene,0.977,34821882
3743,ranibizumab,gene,0.5825,34821882
3744,bevacizumab,gene,0.751,34821882
3745,vascular endothelial growth factors,gene,0.94,34821882
3746,neovascular age-related macular degeneration,disease,1.0,34821882
3747,nAMD,disease,1.0,34821882
3748,retinal vascular disorders,disease,1.0,34821882
3749,retinal diseases,disease,1.0,34821882
3750,Brolucizumab,gene,0.674,34817566
3751,Neovascular Age-Related Macular Degeneration,disease,1.0,34817566
3752,patients,species,0.981,34817566
3753,neovascular age-,disease,0.9937,34817566
3754,macular degeneration,disease,1.0,34817566
3755,brolucizumab,gene,0.8535,34817566
3756,intraocular inflammation,disease,1.0,34817566
3757,IOI,disease,1.0,34817566
3758,retinal vasculitis,disease,1.0,34817566
3759,RV,disease,1.0,34817566
3760,retinal vascular occlusion,disease,1.0,34817566
3761,RO,disease,1.0,34817566
3762,patients,species,0.978,34817566
3763,neovascular age-related macular degeneration,disease,1.0,34817566
3764,brolucizumab,gene,0.805,34817566
3765,PARTICIPANTS,species,0.6807,34817566
3766,patients,species,0.98,34817566
3767,neovascular age-related macular degeneration,disease,0.9995,34817566
3768,Patients,species,0.9214,34817566
3769,brolucizumab,gene,0.7627,34817566
3770,Brolucizumab,gene,0.891,34817566
3771,IOI,disease,0.9995,34817566
3772,RV,disease,,34817566
3773,RO,disease,,34817566
3774,RV,disease,,34817566
3775,RO,disease,,34817566
3776,IRIS,disease,0.9863,34817566
3777,vascular endothelial growth factor,gene,0.925,34817566
3778,aflibercept,gene,0.972,34817566
3779,women,species,0.9683,34817566
3780,IOI,disease,0.9995,34817566
3781,RO,disease,,34817566
3782,RV,disease,,34817566
3783,RO,disease,,34817566
3784,Patients,species,0.9224,34817566
3785,IOI,disease,0.9995,34817566
3786,RO,disease,,34817566
3787,brolucizumab,gene,0.872,34817566
3788,IOI,disease,0.9985,34817566
3789,RO,disease,,34817566
3790,brolucizumab,gene,0.941,34817566
3791,patients,species,0.987,34817566
3792,IOI,disease,0.999,34817566
3793,women,species,0.9673,34817566
3794,men,species,0.975,34817566
3795,patients,species,0.9844,34817566
3796,RV,disease,,34817566
3797,RO,disease,,34817566
3798,IOI,disease,0.9995,34817566
3799,RO,disease,,34817566
3800,Patient,species,0.9824,34817566
3801,IOI,disease,1.0,34817566
3802,RO,disease,,34817566
3803,brolucizumab,gene,0.908,34817566
3804,IOI,disease,1.0,34817566
3805,RO,disease,,34817566
3806,brolucizumab,gene,0.91,34817566
3807,IOI,disease,0.999,34817566
3808,RO,disease,,34817566
3809,brolucizumab,gene,0.6807,34817566
3810,Sudden hearing loss,disease,0.942,34817029
3811,aflibercept,gene,0.991,34817029
3812,Metastatic Colorectal Cancer,disease,1.0,34816395
3813,Colorectal cancer,disease,1.0,34816395
3814,CRC,disease,1.0,34816395
3815,patients,species,0.977,34816395
3816,metastatic CRC,disease,1.0,34816395
3817,mCRC,disease,0.9995,34816395
3818,mCRC,disease,0.9995,34816395
3819,mCRC,disease,0.988,34816395
3820,cetuximab,gene,0.831,34816395
3821,panitumumab,gene,0.979,34816395
3822,bevacizumab,gene,0.7104,34816395
3823,cetuximab,gene,0.8516,34816395
3824,bevacizumab,gene,0.786,34816395
3825,aflibercept,gene,0.993,34816395
3826,cetuximab,gene,0.8433,34816395
3827,panitumumab,gene,0.87,34816395
3828,cetuximab,gene,0.662,34816395
3829,panitumumab,gene,0.828,34816395
3830,RAS,gene,0.9854,34816395
3831,epidermal growth factor receptor,gene,0.884,34816395
3832,EGFR,gene,0.9966,34816395
3833,Bevacizumab,gene,0.926,34816395
3834,bevacizumab,gene,0.8564,34816395
3835,KRAS,gene,0.966,34816395
3836,RAS mutations,gene,0.8945,34816395
3837,EGFR,gene,0.705,34816395
3838,RAS,gene,0.995,34816395
3839,mCRCs,disease,0.9985,34816395
3840,anti-EGFR,gene,0.9263,34816395
3841,panitumumab,gene,0.8755,34816395
3842,cetuximab,gene,0.584,34816395
3843,anti-VEGF,gene,0.991,34816395
3844,Cetuximab,gene,0.8438,34816395
3845,EGFR,gene,0.741,34816395
3846,RAS,gene,0.994,34816395
3847,mCRCs,disease,0.991,34816395
3848,Aflibercept,gene,0.9663,34816395
3849,ramucirumab,gene,0.4631,34816395
3850,patients,species,0.8013,34811522
3851,polypoidal choroidal vasculopathy,disease,1.0,34811522
3852,PCV,disease,1.0,34811522
3853,anti-VEGF,gene,0.8447,34811522
3854,anti-VEGF,gene,0.907,34811522
3855,PCV,disease,1.0,34811522
3856,patients,species,0.9917,34811522
3857,patients,species,0.988,34811522
3858,aflibercept,gene,0.99,34811522
3859,bevacizumab,gene,0.672,34811522
3860,ranibizumab,gene,0.701,34811522
3861,verteporfin,drug,0.983,34811522
3862,PCV,disease,1.0,34811522
3863,patient,species,0.9917,34811522
3864,VEGF,gene,0.589,34803132
3865,fluorescein,drug,0.9688,34803132
3866,proliferative diabetic retinopathy,disease,0.8804,34803132
3867,antivascular endothelial growth factor,gene,0.951,34803132
3868,fluorescein,drug,0.984,34803132
3869,proliferative diabetic retinopathy,disease,0.922,34803132
3870,fluorescein,drug,0.9976,34803132
3871,RVBA,DNA,0.5205,34803132
3872,VEGF,gene,0.8706,34803132
3873,anti-VEGF,gene,0.9834,34803132
3874,RVBA,DNA,0.494,34803132
3875,anti-VEGF,gene,0.879,34803132
3876,RVBA,DNA,0.5205,34803132
3877,anti-VEGF,gene,0.934,34803132
3878,proliferative diabetic retinopathy,disease,0.996,34803132
3879,VEGF,gene,0.7886,34803132
3880,Patients,species,0.935,34795492
3881,Polypoidal Choroidal PURPOSE,disease,1.0,34795492
3882,polypoidal choroidal vasculopathy,disease,1.0,34795492
3883,PCV,disease,1.0,34795492
3884,PCV,disease,0.989,34795492
3885,patients,species,0.9854,34795492
3886,bevacizumab,gene,0.822,34795492
3887,verteporfin,drug,0.991,34795492
3888,aflibercept,gene,0.9604,34795492
3889,ranibizumab,gene,0.824,34795492
3890,verteporfin,drug,0.996,34795492
3891,patients,species,0.947,34795492
3892,PCV,disease,1.0,34795492
3893,IVR,drug,0.667,34795492
3894,IVA,drug,0.5425,34795492
3895,verteporfin,drug,0.997,34795492
3896,PCV,disease,1.0,34795492
3897,verteporfin,drug,0.9985,34795492
3898,PCV,disease,1.0,34795492
3899,Diabetic Macular Edema,disease,1.0,34795475
3900,patients,species,0.9775,34795475
3901,diabetic macular edema,disease,1.0,34795475
3902,CDME,disease,1.0,34795475
3903,aflibercept,gene,0.983,34795475
3904,PATIENTS,species,0.9185,34795475
3905,aflibercept,gene,0.9795,34795475
3906,CDME,disease,1.0,34795475
3907,patients,species,0.972,34795475
3908,aflibercept,gene,0.9326,34795475
3909,patients,species,0.966,34795475
3910,CDME,disease,1.0,34795475
3911,CRT,DNA,0.4998,34795475
3912,BCVA,DNA,0.4749,34795475
3913,patients,species,0.994,34795475
3914,patients,species,0.9873,34795475
3915,CRT,DNA,0.5537,34795475
3916,patients,species,0.933,34795475
3917,CDME,disease,1.0,34795475
3918,dexamethasone,drug,0.8057,34786634
3919,aflibercept,gene,0.984,34786634
3920,dexamethasone,drug,0.9795,34786634
3921,DEX,drug,0.9917,34786634
3922,aflibercept,gene,0.979,34786634
3923,diabetic macular edema,disease,0.9946,34786634
3924,DME,disease,1.0,34786634
3925,patients,species,0.942,34786634
3926,DME,disease,1.0,34786634
3927,Patients,species,0.9897,34786634
3928,aflibercept,gene,0.989,34786634
3929,aflibercept,gene,0.987,34786634
3930,Pseudophakic,disease,0.9966,34786634
3931,phakic,disease,0.5713,34786634
3932,aflibercept,gene,0.9224,34786634
3933,aflibercept,gene,0.968,34786634
3934,aflibercept,gene,0.8867,34786634
3935,DME,disease,1.0,34786634
3936,pseudophakic,disease,0.989,34786634
3937,DME,disease,1.0,34786634
3938,COVID-19,disease,0.999,34786634
3939,VEGF,gene,0.8457,34783362
3940,Neovascular Age,disease,1.0,34783362
3941,VEGF,gene,0.9985,34783362
3942,neovascular age-related macular degeneration,disease,1.0,34783362
3943,VEGFs,gene,0.54,34783362
3944,VEGF,gene,0.724,34783362
3945,age-related macular degeneration,disease,1.0,34783362
3946,aflibercept,gene,0.9717,34783362
3947,brolucizumab,gene,0.8203,34783362
3948,ranibizumab,gene,0.6543,34783362
3949,anti-VEGF,gene,0.942,34783362
3950,aflibercept,gene,0.988,34783362
3951,abicipar,gene,0.8003,34783362
3952,bevacizumab,gene,0.867,34783362
3953,brolucizumab,gene,0.7534,34783362
3954,pegaptanib,drug,0.987,34783362
3955,ranibizumab,gene,0.507,34783362
3956,anti-VEGF,gene,0.92,34783362
3957,patients,species,0.9897,34783362
3958,abicipar,drug,0.7124,34783362
3959,ranibizumab,gene,0.739,34783362
3960,aflibercept,gene,0.929,34783362
3961,brolucizumab,gene,0.6587,34783362
3962,abicipar,drug,0.561,34783362
3963,ranibizumab,gene,0.4976,34783362
3964,aflibercept,gene,0.934,34783362
3965,brolucizumab,gene,0.9414,34783362
3966,aflibercept,gene,0.6733,34783362
3967,brolucizumab,gene,0.955,34783362
3968,abicipar,gene,0.6826,34783362
3969,brolucizumab,gene,0.5156,34783362
3970,VEGF,gene,0.6777,34783362
3971,endopthalmitis,disease,1.0,34773936
3972,anti-VEGF,gene,0.859,34773936
3973,endophthalmitis,disease,1.0,34773936
3974,anti-vascular endothelial growth factor,gene,0.9883,34773936
3975,VEGF,gene,0.9966,34773936
3976,Patients,species,0.9824,34773936
3977,endophthalmitis,disease,1.0,34773936
3978,anti-VEGF,gene,0.855,34773936
3979,patients,species,0.9893,34773936
3980,anti-VEGF,gene,0.8105,34773936
3981,endophthalmitis,disease,1.0,34773936
3982,patients,species,0.975,34773936
3983,endophthalmitis,disease,1.0,34773936
3984,bevacizumab,gene,0.9136,34773936
3985,ranibizumab,gene,0.9053,34773936
3986,aflibercept,gene,0.985,34773936
3987,anti-VEGF,gene,0.94,34773936
3988,Bevacizumab,gene,0.8745,34773936
3989,endophthalmitis,disease,1.0,34773936
3990,ranibizumab,gene,0.8696,34773936
3991,aflibercept,gene,0.9854,34773936
3992,endophthalmitis,disease,1.0,34773936
3993,anti-VEGF,gene,0.9805,34773936
3994,anti-VEGF,gene,0.984,34773936
3995,bevacizumab,gene,0.846,34773936
3996,endophthalmitis,disease,1.0,34773936
3997,Patients,species,0.989,34765822
3998,patients,species,0.9863,34765822
3999,patients,species,0.99,34765822
4000,Patients,species,0.985,34765822
4001,hospital anxiety and depression,disease,0.9175,34765822
4002,participants,species,0.9824,34765822
4003,diabetic retinopathy,disease,1.0,34765822
4004,DR,disease,1.0,34765822
4005,macular degeneration,disease,1.0,34765822
4006,retinal vein occlusion,disease,1.0,34765822
4007,DR,disease,,34765822
4008,bevacizumab,gene,0.917,34765822
4009,bevacizumab,gene,0.8584,34765822
4010,aflibercept,gene,0.9854,34765822
4011,ranibizumab,gene,0.663,34765822
4012,bevacizumab,gene,0.608,34765822
4013,patients,species,0.9683,34765822
4014,DR,disease,,34765822
4015,idiopathic macular telangiectasia type 1,disease,1.0,34756283
4016,Idiopathic macular telangiectasia type 1,disease,1.0,34756283
4017,MacTel 1,disease,1.0,34756283
4018,man,species,0.9253,34756283
4019,MacTel 1,disease,1.0,34756283
4020,macular telangectasia type 2,disease,1.0,34756283
4021,MacTel 2,disease,1.0,34756283
4022,patient,species,0.988,34756283
4023,cystoid macular edema,disease,1.0,34756283
4024,CME,disease,1.0,34756283
4025,dexamethasone,drug,0.981,34756283
4026,aflibercept,gene,0.9844,34756283
4027,vascular endothelial growth factors,gene,0.9927,34750330
4028,hypertension,disease,1.0,34750330
4029,proteinuria,disease,1.0,34750330
4030,vascular endothelial growth factor,gene,0.9985,34750330
4031,VEGF,gene,0.996,34750330
4032,VEGFi,gene,0.945,34750330
4033,bevacizumab,gene,0.797,34750330
4034,murine immunoglobulin,gene,0.9946,34750330
4035,murine,species,0.9536,34750330
4036,diabetic macular edema,disease,1.0,34750330
4037,age-related macular degeneration,disease,1.0,34750330
4038,aflibercept,gene,0.9873,34750330
4039,ranibizumab,gene,0.887,34750330
4040,VEGF,gene,0.995,34750330
4041,VEGF,gene,0.995,34750330
4042,renal dysfunction,disease,1.0,34750330
4043,glomerular disease,disease,1.0,34750330
4044,VEGFi,gene,0.975,34750330
4045,glomerular disease,disease,1.0,34750330
4046,proteinuria,disease,1.0,34750330
4047,proteinuria,disease,1.0,34750330
4048,patients,species,0.97,34750330
4049,nephrotic syndrome,disease,1.0,34750330
4050,VEGF depletion,disease,0.838,34750330
4051,VEGF,gene,0.994,34750330
4052,VEGFi,gene,0.972,34750330
4053,nephrotoxicity,disease,0.526,34750330
4054,thrombotic microangiopathy,disease,1.0,34750330
4055,VEGFi,gene,0.9595,34750330
4056,Fungal Necrotizing Scleritis,disease,1.0,34749383
4057,infectious necrotizing scleritis,disease,1.0,34749383
4058,Aspergillus terreus,disease,0.927,34749383
4059,woman,species,0.9165,34749383
4060,aflibercept,gene,0.9824,34749383
4061,neovascular age-related macular degeneration,disease,1.0,34749383
4062,ocular pain,disease,0.6616,34749383
4063,anterior necrotizing scleritis,disease,1.0,34749383
4064,scleral necrotic area,disease,0.9995,34749383
4065,voriconazole,drug,0.994,34749383
4066,A. terreus,species,0.956,34749383
4067,voriconazole,drug,0.997,34749383
4068,voriconazole,drug,0.994,34749383
4069,fungal necrotizing scleritis,disease,1.0,34749383
4070,AflibeRcept,drug,0.9805,34747231
4071,diabetiC macular,disease,1.0,34747231
4072,diabetes,disease,1.0,34747231
4073,diabetic macular oedema,disease,1.0,34747231
4074,DME,disease,1.0,34747231
4075,aflibercept,gene,0.9204,34747231
4076,patients,species,0.976,34747231
4077,aflibercept,gene,0.9766,34747231
4078,patients,species,0.9663,34747231
4079,DME,disease,1.0,34747231
4080,aflibercept,gene,0.96,34747231
4081,DME,disease,0.999,34747231
4082,patient,species,0.9727,34747231
4083,polypoidal choroidal vasculopathy,disease,1.0,34732787
4084,patients,species,0.924,34732787
4085,polypoidal choroidal vasculopathy,disease,1.0,34732787
4086,PCV,disease,1.0,34732787
4087,Patients,species,0.9653,34732787
4088,ranibizumab,gene,0.9043,34732787
4089,aflibercept,gene,0.954,34732787
4090,Patients,species,0.95,34732787
4091,choroidal vascular hyperpermeability,disease,1.0,34732787
4092,CVH,disease,1.0,34732787
4093,Patients,species,0.948,34732787
4094,CVH,disease,0.999,34732787
4095,patients,species,0.988,34732787
4096,cluster,disease,0.974,34732787
4097,polyps,disease,0.528,34732787
4098,PCV,disease,1.0,34732787
4099,brolucizumab,gene,0.837,34731094
4100,aflibercept,gene,0.938,34731094
4101,vascular endothelial growth factor,gene,0.997,34731094
4102,VEGF)-A,gene,0.9927,34731094
4103,patients,species,0.9688,34731094
4104,neovascular age-related macular degeneration,disease,1.0,34731094
4105,brolucizumab,gene,0.9536,34731094
4106,aflibercept,gene,0.975,34731094
4107,patients,species,0.987,34731094
4108,VEGF-A,gene,0.994,34731094
4109,VEGF-A,gene,0.9707,34731094
4110,brolucizumab,gene,0.952,34731094
4111,aflibercept,gene,0.9775,34731094
4112,brolucizumab,gene,0.7954,34731094
4113,VEGF-A,gene,0.994,34731094
4114,aflibercept,gene,0.974,34731094
4115,VEGF-A,gene,0.997,34731094
4116,Vascular endothelial growth factor-A,gene,0.9966,34731094
4117,brolucizumab,gene,0.912,34731094
4118,VEGF-A,gene,0.979,34731094
4119,Aflibercept,gene,0.979,34726299
4120,antivascular endothelial growth factor,gene,0.9976,34726299
4121,anti-VEGF,gene,0.9927,34726299
4122,retinal diseases,disease,1.0,34726299
4123,aflibercept,gene,0.985,34726299
4124,poly(ethylene glycol),drug,1.0,34726299
4125,PEG,drug,1.0,34726299
4126,poly(propylene glycol),drug,0.9995,34726299
4127,PPG,drug,0.9995,34726299
4128,polycaprolactone,drug,0.9995,34726299
4129,PCL,drug,0.9995,34726299
4130,aflibercept,gene,0.9946,34726299
4131,nEPCs,cell_type,0.7456,34726299
4132,nEPCs,cell_line,0.756,34726299
4133,nEPCs,cell_type,0.824,34726299
4134,porcine,species,0.777,34726299
4135,aflibercept,gene,0.9854,34726299
4136,choroidal neovascularization,disease,0.9966,34726299
4137,CNV,disease,1.0,34726299
4138,CNV,disease,1.0,34726299
4139,nEPCs,cell_type,0.848,34726299
4140,A,gene,0.6846,34726299
4141,nEPCs,cell_line,0.823,34726299
4142,nEPCs,cell_type,0.8857,34726299
4143,VEGF,gene,0.8794,34726299
4144,nEPCs,cell_type,0.831,34726299
4145,nEPCs,cell_type,0.8555,34726299
4146,anti-VEGF,gene,0.9575,34726299
4147,retinal diseases,disease,0.9995,34726299
4148,Peripapillary Neuroendocrine Carcinoma,disease,1.0,34722486
4149,Peripapillary and circumpapillary retinal intraocular metastases,disease,0.9644,34722486
4150,patient,species,0.944,34722486
4151,large,cell_type,0.483,34722486
4152,large-cell neuroendocrine carcinoma,disease,1.0,34722486
4153,aflibercept,gene,0.9707,34722486
4154,topotecan,drug,0.7515,34722486
4155,aflibercept,gene,0.9834,34722486
4156,intraocular metastases,disease,0.992,34722486
4157,patients,species,0.975,34722486
4158,Macular Atrophy,disease,1.0,34721402
4159,Neovascular,disease,0.6245,34721402
4160,Neovascular age-related macular degeneration,disease,1.0,34721402
4161,nAMD,disease,1.0,34721402
4162,blindness,disease,0.999,34721402
4163,people,species,0.978,34721402
4164,nAMD,disease,1.0,34721402
4165,vascular endothelial growth factor,gene,0.934,34721402
4166,VEGF,gene,0.9976,34721402
4167,nAMD,disease,1.0,34721402
4168,macula atrophy,disease,1.0,34721402
4169,MA,disease,1.0,34721402
4170,VEGF,gene,0.7144,34721402
4171,visual function impairment,disease,1.0,34721402
4172,nAMD,disease,1.0,34721402
4173,MA,disease,,34721402
4174,aflibercept,gene,0.9844,34721402
4175,IVA,gene,0.757,34721402
4176,MA,disease,,34721402
4177,nAMD,disease,1.0,34721402
4178,nAMD,disease,1.0,34721402
4179,patients,species,0.989,34721402
4180,MA,disease,,34721402
4181,nAMD,disease,0.9995,34721402
4182,MA,disease,,34721402
4183,monocyte chemoattractant protein-1,gene,0.9917,34721402
4184,MCP-1,gene,0.996,34721402
4185,macrophage,cell_type,0.8125,34721402
4186,VEGF,gene,0.9927,34721402
4187,MCP-1,gene,0.988,34721402
4188,nAMD,disease,1.0,34721402
4189,MCP-1,gene,0.984,34721402
4190,VEGF,gene,0.991,34721402
4191,MCP-1,gene,0.978,34721402
4192,pre-IVA interferon--inducible protein 10,gene,0.9897,34721402
4193,IP-10,gene,0.995,34721402
4194,IP-10,gene,0.964,34721402
4195,MCP-1,gene,0.978,34721402
4196,MIP-1,gene,0.9854,34721402
4197,VEGF,gene,0.99,34721402
4198,interleukin-6,gene,0.899,34721402
4199,MCP-1,gene,0.9937,34721402
4200,MIP-1,gene,0.9727,34721402
4201,MA,disease,,34721402
4202,pre-IVA MIP-1,gene,0.637,34721402
4203,VEGF,gene,0.9917,34721402
4204,IP-10,gene,0.977,34721402
4205,inflammation,disease,0.822,34721402
4206,MA,disease,,34721402
4207,MA,disease,,34721402
4208,nAMD,disease,1.0,34721402
4209,VEGF,gene,0.922,34721402
4210,brolucizumab,gene,0.867,34720980
4211,intraocular inflammation,disease,0.9824,34720980
4212,IOI,disease,1.0,34720980
4213,patient,species,0.99,34720980
4214,decreased right vision,disease,0.9907,34720980
4215,patient,species,0.979,34720980
4216,pachychoroidal neovasculopathy,disease,1.0,34720980
4217,aflibercept,gene,0.9014,34720980
4218,serous retinal detachment,disease,1.0,34720980
4219,SRD,disease,1.0,34720980
4220,patient,species,0.968,34720980
4221,brolucizumab,gene,0.822,34720980
4222,IVBr,drug,0.9976,34720980
4223,SRD,DNA,0.5312,34720980
4224,patient,species,0.9824,34720980
4225,IVBr,drug,0.8423,34720980
4226,vitreous inflammatory cells,cell_type,0.88,34720980
4227,patient,species,0.9775,34720980
4228,brolucizumab,gene,0.885,34720980
4229,IOI,disease,0.9937,34720980
4230,IOI,disease,0.907,34720980
4231,IVBr,drug,0.8647,34720980
4232,IVBr,drug,0.9717,34720980
4233,patients,species,0.9873,34720980
4234,IOI,disease,0.993,34720980
4235,Anti-Vascular Endothelial Growth Factor,gene,0.989,34709363
4236,anti-vascular endothelial growth factor,gene,0.99,34709363
4237,anti-VEGF,gene,0.9907,34709363
4238,glaucoma,disease,1.0,34709363
4239,macular edema,disease,1.0,34709363
4240,central retinal vein occlusion,disease,1.0,34709363
4241,CRVO,disease,1.0,34709363
4242,VEGF,gene,0.881,34709363
4243,participants,species,0.8184,34709363
4244,Retinal Vein Occlusion,disease,1.0,34709363
4245,PARTICIPANTS,species,0.66,34709363
4246,participants,species,0.967,34709363
4247,macular edema,disease,1.0,34709363
4248,CRVO,disease,1.0,34709363
4249,hemiretinal vein occlusion,disease,1.0,34709363
4250,HRVO,disease,1.0,34709363
4251,participants,species,0.985,34709363
4252,aflibercept,gene,0.9844,34709363
4253,bevacizumab,gene,0.729,34709363
4254,participants,species,0.976,34709363
4255,participants,species,0.989,34709363
4256,participants,species,0.982,34709363
4257,aflibercept,gene,0.9805,34709363
4258,bevacizumab,gene,0.692,34709363
4259,participants,species,0.987,34709363
4260,participants,species,0.9844,34709363
4261,glaucoma,disease,0.948,34709363
4262,anti-VEGF,gene,0.8833,34709363
4263,glaucoma,disease,1.0,34709363
4264,macular edema,disease,1.0,34709363
4265,CRVO,disease,0.999,34709363
4266,VEGF,gene,0.942,34709363
4267,macular edema,disease,1.0,34709363
4268,CRVO,disease,1.0,34709363
4269,HRVO,disease,1.0,34709363
4270,aflibercept,gene,0.979,34703742
4271,diabetic macular,disease,1.0,34703742
4272,aflibercept,gene,0.9854,34703742
4273,patients,species,0.9834,34703742
4274,diabetic macular edema,disease,1.0,34703742
4275,DME,disease,1.0,34703742
4276,bevacizumab,gene,0.888,34703742
4277,Patients,species,0.972,34703742
4278,DME,disease,1.0,34703742
4279,bevacizumab,gene,0.791,34703742
4280,aflibercept,gene,0.948,34703742
4281,patients,species,0.987,34703742
4282,aflibercept,gene,0.9644,34703742
4283,aflibercept,gene,0.988,34703742
4284,patients,species,0.9844,34703742
4285,participants,species,0.98,34703742
4286,Aflibercept,gene,0.9536,34703742
4287,patients,species,0.977,34703742
4288,DME,disease,1.0,34703742
4289,bevacizumab,gene,0.899,34703742
4290,BCVA,disease,1.0,34695400
4291,patients,species,0.988,34695400
4292,brolucizumab,gene,0.7773,34695400
4293,aflibercept,gene,0.978,34695400
4294,ERF,cell_type,0.5156,34695400
4295,intraretinal fluid,disease,0.6196,34695400
4296,subretinal fluid,disease,0.9443,34695400
4297,SRF,disease,0.9316,34695400
4298,ERF,disease,0.999,34695400
4299,ERF,disease,1.0,34695400
4300,patients,species,0.99,34695400
4301,patients,species,0.9766,34695400
4302,ERF,disease,0.658,34695400
4303,ERF,disease,1.0,34695400
4304,patients,species,0.992,34695400
4305,ERF,disease,0.9746,34695400
4306,ERF,disease,1.0,34695400
4307,patients,species,0.99,34695400
4308,patients,species,0.985,34695400
4309,ERF,disease,0.9863,34695400
4310,patients,species,0.9863,34695400
4311,ERF,disease,0.9956,34695400
4312,patients,species,0.9863,34695400
4313,ERF,disease,1.0,34695400
4314,patients,species,0.993,34695400
4315,ERF,gene,0.98,34695400
4316,vascular endothelial growth factor,gene,0.864,34695400
4317,pigment epithelial detachment,disease,1.0,34693076
4318,aflibercept,gene,0.9536,34693076
4319,patient,species,0.958,34693076
4320,retinal pigment epithelial detachment,disease,1.0,34693076
4321,PED,disease,0.9937,34693076
4322,neovascular aged-macular degeneration,disease,1.0,34693076
4323,nAMD,disease,1.0,34693076
4324,aflibercept,gene,0.9775,34693076
4325,bevacizumab,gene,0.7036,34693076
4326,PED,DNA,0.542,34693076
4327,bevacizumab,gene,0.6187,34693076
4328,aflibercept,gene,0.968,34693076
4329,bevacizumab,gene,0.754,34693076
4330,bevacizumab,gene,0.695,34693076
4331,anti-VEGFs,gene,0.917,34693076
4332,nAMD,disease,1.0,34693076
4333,PED,disease,0.9946,34693076
4334,patient,species,0.9556,34693076
4335,aflibercept,gene,0.9746,34693076
4336,nAMD,disease,1.0,34693076
4337,anti-VEGF,gene,0.7764,34683165
4338,neovascular age-related macular degeneration,disease,1.0,34683165
4339,nAMD,disease,1.0,34683165
4340,nAMD,disease,1.0,34683165
4341,VEGF,gene,0.592,34683165
4342,bevacizumab,gene,0.936,34683165
4343,ranibizumab,gene,0.922,34683165
4344,aflibercept,gene,0.971,34683165
4345,nAMD,disease,1.0,34683165
4346,anti-VEGF,gene,0.978,34683165
4347,nAMD,disease,1.0,34683165
4348,nAMD,disease,1.0,34683165
4349,ARPE-19 Cells,cell_line,0.952,34680450
4350,RPE,cell_type,0.658,34680450
4351,ARPE-19 cells,cell_line,0.8853,34680450
4352,aflibercept,gene,0.988,34680450
4353,ranibizumab,gene,0.545,34680450
4354,vascular endothelial growth factor,gene,0.9976,34680450
4355,VEGF,gene,0.9917,34680450
4356,light-irradiated culture,cell_line,0.6577,34680450
4357,IL-9,gene,0.9927,34680450
4358,IL-17A,gene,0.9966,34680450
4359,bFGF,gene,0.976,34680450
4360,IL-6,gene,0.934,34680450
4361,IL-7,gene,0.975,34680450
4362,IL-8,gene,0.901,34680450
4363,MCP-1,gene,0.9683,34680450
4364,VEGF-,gene,0.996,34680450
4365,light-irradiated culture,cell_line,0.7837,34680450
4366,bFGF,gene,0.993,34680450
4367,bFGF,gene,0.993,34680450
4368,aflibercept,gene,0.9883,34680450
4369,IL-6,gene,0.98,34680450
4370,IL-8,gene,0.9307,34680450
4371,bFGF,gene,0.985,34680450
4372,MCP-1,gene,0.984,34680450
4373,IL-12,gene,0.9907,34680450
4374,VEGF-A,gene,0.9966,34680450
4375,VEGF,gene,0.996,34680450
4376,human RPE cells,cell_line,0.8867,34680450
4377,human,species,0.941,34680450
4378,triamcinolone acetonide,drug,0.973,34678906
4379,Brolucizumab,gene,0.726,34678906
4380,anti-,gene,0.523,34678906
4381,vascular endothelial growth factor,gene,0.9077,34678906
4382,age-related macular degeneration,disease,1.0,34678906
4383,AMD,disease,1.0,34678906
4384,intraocular inflammation,disease,1.0,34678906
4385,IOI,disease,0.9995,34678906
4386,triamcinolone acetonide,drug,0.996,34678906
4387,IOI,disease,0.997,34678906
4388,PATIENT,species,0.945,34678906
4389,man,species,0.9297,34678906
4390,aflibercept,gene,0.978,34678906
4391,neovascular AMD,disease,1.0,34678906
4392,aflibercept,gene,0.9614,34678906
4393,brolucizumab,gene,0.9136,34678906
4394,patient,species,0.974,34678906
4395,decreased vision,disease,0.973,34678906
4396,vitritis,disease,1.0,34678906
4397,Brolucizumab,gene,0.9106,34678906
4398,IOI,disease,0.995,34678906
4399,neovascular AMD,disease,1.0,34678906
4400,aflibercept,gene,0.922,34678906
4401,brolucizumab,gene,0.908,34678906
4402,vascular endothelial growth factor,gene,0.8765,34678906
4403,aflibercept,gene,0.9395,34678906
4404,STTA,DNA,0.4868,34678906
4405,brolucizumab,gene,0.7817,34678906
4406,IOI,disease,1.0,34678906
4407,IOI,disease,1.0,34678906
4408,brolucizumab,gene,0.8257,34678906
4409,IOI,disease,0.998,34678906
4410,Vascular Endothelial Growth Factor,gene,0.904,34678098
4411,VEGF,gene,0.997,34678098
4412,patients,species,0.974,34678098
4413,vitreous hemorrhage,disease,1.0,34678098
4414,polypoidal choroidal vasculopathy,disease,1.0,34678098
4415,PCV,disease,1.0,34678098
4416,patients,species,0.994,34678098
4417,vitreous hemorrhage,disease,1.0,34678098
4418,patients,species,0.9927,34678098
4419,PCV,disease,1.0,34678098
4420,vitreous hemorrhage,disease,0.9995,34678098
4421,anti-VEGF,gene,0.984,34678098
4422,hyphema,disease,1.0,34678098
4423,vitreous hemorrhage,disease,1.0,34678098
4424,patients,species,0.946,34678098
4425,PCV,disease,1.0,34678098
4426,vitreous hemorrhage,disease,1.0,34678098
4427,anti-VEGF,gene,0.9897,34678098
4428,anti-VEGF,gene,0.871,34678098
4429,Bevacizumab,gene,0.7817,34676113
4430,Patients,species,0.9893,34676113
4431,Aflibercept,gene,0.9727,34676113
4432,bevacizumab,gene,0.8257,34676113
4433,patients,species,0.921,34676113
4434,aflibercept,gene,0.9683,34676113
4435,nAMD,disease,0.998,34676113
4436,patients,species,0.9736,34676113
4437,nAMD,disease,1.0,34676113
4438,aflibercept,gene,0.977,34676113
4439,bevacizumab,gene,0.801,34676113
4440,patients,species,0.9844,34676113
4441,patients,species,0.987,34676113
4442,bevacizumab,gene,0.6357,34676113
4443,patients,species,0.973,34676113
4444,patients,species,0.9897,34676113
4445,anti-VEGF,gene,0.9614,34676113
4446,aflibercept,gene,0.9727,34674724
4447,Diabetic papillopathy,disease,1.0,34674724
4448,unilateral or bilateral optic disc edema,disease,0.9155,34674724
4449,visual loss,disease,1.0,34674724
4450,disc edema,disease,0.9976,34674724
4451,macular edema,disease,1.0,34674724
4452,aflibercept,gene,0.877,34674724
4453,triamcinolone acetonide,drug,0.986,34674724
4454,patients,species,0.977,34674724
4455,diabetic papillopathy,disease,1.0,34674724
4456,macular edema,disease,1.0,34674724
4457,woman,species,0.739,34674724
4458,type II diabetes mellitus,disease,1.0,34674724
4459,visual loss in,disease,0.9966,34674724
4460,patient,species,0.9795,34674724
4461,diabetic,disease,0.9966,34674724
4462,visual loss,disease,0.937,34674724
4463,diabetic papillopathy,disease,1.0,34674724
4464,patients,species,0.9883,34674724
4465,optic disc edema,disease,1.0,34674724
4466,aflibercept,gene,0.9556,34674724
4467,triamcinolone acetonide,drug,0.9023,34674724
4468,Bevacizumab,gene,0.888,34664108
4469,aflibercept,gene,0.9756,34664108
4470,metastatic colorectal cancer,disease,0.9995,34664108
4471,bevacizumab,gene,0.8887,34664108
4472,aflibercept,gene,0.9785,34664108
4473,metastatic colorectal cancer,disease,1.0,34664108
4474,mCRC,disease,1.0,34664108
4475,patients,species,0.981,34664108
4476,bevacizumab,gene,0.9087,34664108
4477,BFIR,gene,0.8535,34664108
4478,aflibercept,gene,0.98,34664108
4479,AFIR,gene,0.9688,34664108
4480,mCRC,disease,0.9927,34664108
4481,Patients,species,0.975,34664108
4482,oxaliplatin,drug,0.9995,34664108
4483,patients,species,0.966,34664108
4484,AFIR,disease,0.9976,34664108
4485,BFIR,disease,0.998,34664108
4486,FOLFOX,DNA,0.5117,34664108
4487,neutropenia,disease,1.0,34664108
4488,AFIR,DNA,0.629,34664108
4489,BFIR,DNA,0.6426,34664108
4490,thrombopenia,disease,1.0,34664108
4491,BFIR,DNA,0.4707,34664108
4492,MT,DNA,0.822,34664108
4493,BFIR,DNA,0.507,34664108
4494,OS,disease,,34664108
4495,Diabetic Macular Edema,disease,1.0,34660813
4496,patients,species,0.9585,34660813
4497,diabetic macular edema,disease,1.0,34660813
4498,DME,disease,1.0,34660813
4499,patients,species,0.9546,34660813
4500,DME,disease,1.0,34660813
4501,VEGF,gene,0.5107,34660813
4502,patients,species,0.974,34660813
4503,DME,disease,1.0,34660813
4504,patients,species,0.994,34660813
4505,VEGF,gene,0.5503,34660813
4506,DME,disease,1.0,34660813
4507,patients,species,0.995,34660813
4508,VA,disease,,34660813
4509,Neovascular Age-Related Macular,disease,1.0,34655434
4510,Age-related macular degeneration,disease,0.9287,34655434
4511,AMD,disease,1.0,34655434
4512,visual impairment,disease,1.0,34655434
4513,blindness,disease,1.0,34655434
4514,advanced AMD,disease,0.9995,34655434
4515,bevacizumab,gene,0.7295,34655434
4516,loss of,disease,0.836,34655434
4517,vascular endothelial growth factor,gene,0.9985,34655434
4518,VEGF,gene,0.997,34655434
4519,AMD,disease,0.9995,34655434
4520,ranibizumab,gene,0.779,34655434
4521,aflibercept,gene,0.9854,34655434
4522,brolucizumab,gene,0.7725,34655434
4523,VEGF,gene,0.792,34655434
4524,AMD,disease,1.0,34655434
4525,VEGF,gene,0.594,34655434
4526,neovascular AMD,disease,1.0,34655434
4527,aflibercept,gene,0.994,34648995
4528,aflibercept,gene,0.99,34648995
4529,neovascular age-related macular degeneration,disease,1.0,34648995
4530,nARMD,disease,1.0,34648995
4531,patients,species,0.985,34648995
4532,nARMD,disease,0.9995,34648995
4533,aflibercept,gene,0.9683,34648995
4534,patients,species,0.992,34648995
4535,Patients,species,0.9824,34648995
4536,patients,species,0.9844,34648995
4537,Aflibercept,gene,0.9375,34648995
4538,aflibercept,gene,0.978,34645516
4539,bevacizumab,gene,0.7256,34645516
4540,type 1 retinopathy,disease,1.0,34645516
4541,bevacizumab,gene,0.5586,34645516
4542,aflibercept,gene,0.9614,34645516
4543,patients,species,0.925,34645516
4544,retinopathy of prematurity,disease,1.0,34645516
4545,ROP,disease,1.0,34645516
4546,infants,species,0.9194,34645516
4547,bevacizumab,gene,0.95,34645516
4548,aflibercept,gene,0.971,34645516
4549,infants,species,0.714,34645516
4550,patients,species,0.9927,34645516
4551,bevacizumab,gene,0.6646,34645516
4552,patients,species,0.9897,34645516
4553,aflibercept,gene,0.9497,34645516
4554,infants,species,0.8237,34645516
4555,infants,species,0.673,34645516
4556,infants,species,0.672,34645516
4557,ROP,DNA,0.5146,34645516
4558,ROP,disease,0.795,34645516
4559,IVB,drug,0.637,34645516
4560,bevacizumab,gene,0.884,34645516
4561,aflibercept,gene,0.9146,34645516
4562,anti-VEGFs,gene,0.9697,34643793
4563,anti-vascular endothelial growth factors,gene,0.962,34643793
4564,VEGFs,gene,0.78,34643793
4565,neovascular age-related macular degeneration,disease,1.0,34643793
4566,nAMD,disease,1.0,34643793
4567,nAMD,disease,1.0,34643793
4568,patient,species,0.973,34643793
4569,nAMD,disease,1.0,34643793
4570,aflibercept,gene,0.979,34643793
4571,bevacizumab,gene,0.846,34643793
4572,patient,species,0.981,34643793
4573,anti-VEGFs,gene,0.989,34643793
4574,aflibercept,gene,0.9927,34643793
4575,bevacizumab,gene,0.8296,34643793
4576,bevacizumab,gene,0.899,34643793
4577,aflibercept,gene,0.979,34643793
4578,patient,species,0.9526,34643793
4579,aflibercept,gene,0.988,34643793
4580,ranibizumab,gene,0.905,34643793
4581,patient,species,0.964,34643793
4582,bevacizumab,gene,0.7812,34643793
4583,aflibercept,gene,0.992,34643793
4584,ranibizumab,gene,0.57,34643793
4585,Brolucizumab,gene,0.7666,34643793
4586,aflibercept,gene,0.974,34643793
4587,Brolucizumab,gene,0.844,34643793
4588,aflibercept,gene,0.964,34643793
4589,Bevacizumab,gene,0.794,34643793
4590,VEGF,gene,0.743,34643793
4591,anti-VEGFs,gene,0.9663,34643793
4592,bevacizumab,gene,0.573,34643793
4593,Aflibercept,gene,0.9727,34643793
4594,brolucizumab,gene,0.7915,34643793
4595,patients,species,0.9917,34642497
4596,Aflibercept,gene,0.9473,34642497
4597,neovascular age-related macular degeneration,disease,1.0,34642497
4598,patients,species,0.978,34642497
4599,patients,species,0.985,34642497
4600,Vascular Endothelial Growth Factor,gene,0.9624,34640613
4601,vascular endothelial growth factor,gene,0.9478,34640613
4602,VEGF,gene,0.9976,34640613
4603,patients,species,0.946,34640613
4604,neovascular age-related macular degeneration,disease,1.0,34640613
4605,nAMD,disease,1.0,34640613
4606,Patients,species,0.9883,34640613
4607,ranibizumab,gene,0.835,34640613
4608,aflibercept,gene,0.9287,34640613
4609,systemic arterial,disease,0.96,34640613
4610,hypertension,disease,1.0,34640613
4611,diabetes mellitus,disease,1.0,34640613
4612,total hypercholesterolemia,disease,1.0,34640613
4613,low-density lipoprotein hypercholesterolemia,disease,1.0,34640613
4614,low-density lipoprotein,gene,0.9365,34640613
4615,high-density lipoprotein,gene,0.997,34640613
4616,atherogenic dyslipidemia,disease,1.0,34640613
4617,cardiovascular disease,disease,1.0,34640613
4618,chronic kidney disease,disease,1.0,34640613
4619,patients,species,0.9785,34640613
4620,patients,species,0.974,34640613
4621,arterial hypertension,disease,1.0,34640613
4622,patients,species,0.9907,34640613
4623,cholesterol,drug,0.994,34640613
4624,Systemic arterial hypertension,disease,0.9995,34640613
4625,VEGF,gene,0.9233,34640613
4626,patients,species,0.928,34640613
4627,nAMD,disease,1.0,34640613
4628,VEGF,gene,0.6865,34640613
4629,patients,species,0.9844,34640613
4630,cholesterol,drug,0.8677,34640613
4631,polypoidal choroidal vasculopathy,disease,1.0,34635762
4632,PCV,disease,1.0,34635762
4633,patients,species,0.9834,34635762
4634,ranibizumab,gene,0.9224,34635762
4635,aflibercept,gene,0.9775,34635762
4636,patients,species,0.985,34635762
4637,PCV,disease,1.0,34635762
4638,PCV,disease,1.0,34635762
4639,patients,species,0.9946,34635762
4640,ranibizumab,gene,0.945,34635762
4641,aflibercept,gene,0.987,34635762
4642,patients,species,0.966,34635762
4643,ranibizumab,gene,0.868,34635762
4644,aflibercept,gene,0.9707,34635762
4645,pachychoroid,disease,0.999,34635762
4646,pachychoroid,disease,0.998,34635762
4647,patients,species,0.9565,34635762
4648,patients,species,0.987,34635762
4649,vascular endothelial growth factor,gene,0.878,34635762
4650,Aflibercept,gene,0.944,34635762
4651,ranibizumab,gene,0.8506,34635762
4652,PCV,disease,1.0,34635762
4653,patients,species,0.9917,34635762
4654,PCV,disease,1.0,34635762
4655,pachychoroid,disease,0.8164,34635762
4656,pachychoroid,disease,0.8237,34635762
4657,patients,species,0.907,34635762
4658,pachychoroid,disease,1.0,34635762
4659,patients,species,0.991,34635762
4660,aflibercept,gene,0.9604,34635762
4661,bevacizumab,gene,0.6724,34628544
4662,cystoid macular edema,disease,1.0,34628544
4663,central retinal vein occlusion,disease,1.0,34628544
4664,bevacizumab,gene,0.528,34628544
4665,BCVA,DNA,0.568,34628544
4666,Patients,species,0.9736,34628544
4667,BCVA,cell_type,0.4211,34628544
4668,anti-VEGF,gene,0.847,34628544
4669,patients,species,0.9863,34628544
4670,IDIOPATHIC CHOROIDAL,disease,0.9995,34620799
4671,patients,species,0.924,34620799
4672,idiopathic choroidal neovascularization,disease,1.0,34620799
4673,aflibercept,gene,0.951,34620799
4674,patients,species,0.9863,34620799
4675,patients,species,0.986,34620799
4676,aflibercept,gene,0.982,34620799
4677,idiopathic choroidal neovascularization,disease,1.0,34620799
4678,neovessels,cell_type,0.5093,34620799
4679,metastatic colorectal cancer,disease,1.0,34619647
4680,mCRC,disease,1.0,34619647
4681,patients,species,0.9927,34619647
4682,metastatic colorectal cancer,disease,1.0,34619647
4683,mCRC,disease,0.991,34619647
4684,patients,species,0.9873,34619647
4685,mCRC,disease,0.984,34619647
4686,patients,species,0.9946,34619647
4687,mCRC,disease,0.997,34619647
4688,patients,species,0.994,34619647
4689,patients,species,0.991,34619647
4690,Aflibercept,gene,0.9956,34619647
4691,Aflibercept,gene,0.9927,34619647
4692,Ramucirumab,gene,0.742,34619647
4693,panitumumab,gene,0.955,34619647
4694,patients,species,0.954,34619647
4695,mCRC,disease,0.9883,34619647
4696,VEGF,gene,0.72,34616189
4697,Neovascular Age-Related Macular Age-related macular degeneration,disease,0.9995,34616189
4698,AMD,disease,1.0,34616189
4699,legal blindness,disease,1.0,34616189
4700,AMD,disease,0.901,34616189
4701,bevacizumab,gene,0.8916,34616189
4702,ranibizumab,gene,0.9214,34616189
4703,aflibercept,gene,0.983,34616189
4704,anti-VEGF,gene,0.8584,34616189
4705,brolucizumab,gene,0.8735,34616189
4706,conbercept,gene,0.5967,34616189
4707,ranibizumab,gene,0.7324,34616189
4708,VEGF,gene,0.5684,34616189
4709,VEGF,gene,0.9653,34603693
4710,FSGS,disease,1.0,34603693
4711,vascular endothelial growth factor,gene,0.9976,34603693
4712,VEGF,gene,0.9927,34603693
4713,age-related macular degeneration,disease,1.0,34603693
4714,AMD,disease,1.0,34603693
4715,diabetic macular edema,disease,1.0,34603693
4716,DME,disease,1.0,34603693
4717,central retinal vein obstruction,disease,1.0,34603693
4718,VEGF,gene,0.993,34603693
4719,hypertension,disease,1.0,34603693
4720,proteinuria,disease,1.0,34603693
4721,renal dysfunction,disease,1.0,34603693
4722,glomerular disease,disease,1.0,34603693
4723,VEGF,gene,0.993,34603693
4724,thrombotic microangiopathies,disease,1.0,34603693
4725,TMAs,disease,1.0,34603693
4726,TMAs,disease,0.9995,34603693
4727,collapsing focal segmental glomerulosclerosis,disease,1.0,34603693
4728,cFSGS,disease,0.997,34603693
4729,cFSGS,disease,0.9463,34603693
4730,TMA,disease,1.0,34603693
4731,glomerular hypoxia,disease,0.9927,34603693
4732,VEGF,gene,0.985,34603693
4733,cFSGS,disease,0.9893,34603693
4734,VEGF,gene,0.9937,34603693
4735,TMA,disease,1.0,34603693
4736,patient,species,0.986,34603693
4737,aflibercept,gene,0.9707,34603693
4738,AMD,disease,1.0,34603693
4739,cFSGS,disease,0.9575,34603693
4740,VEGF,gene,0.9917,34603693
4741,AMD,disease,1.0,34603693
4742,DME,disease,1.0,34603693
4743,cFSGS,disease,0.967,34603693
4744,chronic TMA,disease,0.8247,34603693
4745,patients,species,0.9844,34603693
4746,VEGF,gene,0.9736,34603693
4747,neovascular age related macular degeneration,disease,1.0,34598731
4748,Age related macular degeneration,disease,1.0,34598731
4749,AMD,disease,1.0,34598731
4750,vision loss,disease,0.997,34598731
4751,Neovascular AMD,disease,1.0,34598731
4752,visual loss,disease,0.9966,34598731
4753,choroidal neovascularization,disease,1.0,34598731
4754,CNV,disease,1.0,34598731
4755,CNV,DNA,0.8467,34598731
4756,verteporfin,drug,0.999,34598731
4757,Visudyne,drug,0.9995,34598731
4758,choroidal neovascular membranes,disease,1.0,34598731
4759,AMD,disease,0.9995,34598731
4760,VEGF-A,gene,0.996,34598731
4761,bevacizumab,gene,0.527,34598731
4762,Lucentis,gene,0.7363,34598731
4763,aflibercept,gene,0.9536,34598731
4764,Eylea,gene,0.7744,34598731
4765,VEGF,gene,0.8496,34598731
4766,wet AMD,disease,0.9985,34598731
4767,patients,species,0.9824,34598731
4768,ranibizumab,gene,0.8125,34598731
4769,FYB,drug,0.7783,34598731
4770,SB-11,drug,0.996,34598731
4771,xlucane,drug,0.9937,34598731
4772,PF582,drug,0.9404,34598731
4773,CHS3551,drug,0.9917,34598731
4774,aflibercept,gene,0.972,34598731
4775,FYB203,drug,0.522,34598731
4776,ALT-L9,gene,0.7856,34598731
4777,MYL1710,drug,0.9985,34598731
4778,CHS-2020,drug,0.9985,34598731
4779,VEGF,gene,0.9937,34598731
4780,abicipar pegol,drug,0.9766,34598731
4781,Abicipar,drug,0.9976,34598731
4782,OPT-,drug,0.9873,34598731
4783,Opthea,drug,0.9336,34598731
4784,conbercept,drug,0.9526,34598731
4785,Lumitin,drug,0.9956,34598731
4786,KSI,drug,0.6597,34598731
4787,VEGF,gene,0.998,34598731
4788,PDGF,gene,0.9966,34598731
4789,VEGF,gene,0.998,34598731
4790,tissue factor,gene,0.989,34598731
4791,VEGF,gene,0.998,34598731
4792,Tie-2,gene,0.991,34598731
4793,ranibizumab,gene,0.8477,34598731
4794,neovascular AMD,disease,1.0,34598731
4795,aflibercept,gene,0.982,34579771
4796,neovascular age-related macular degeneration,disease,1.0,34579771
4797,nvAMD,disease,1.0,34579771
4798,aflibercept,gene,0.747,34579771
4799,nvAMD,disease,1.0,34579771
4800,intraretinal,disease,0.6733,34579771
4801,patients,species,0.976,34579771
4802,patients,species,0.9897,34579771
4803,BCVA,cell_type,0.4045,34579771
4804,patient,species,0.927,34579771
4805,aflibercept,gene,0.987,34579771
4806,CRT,DNA,0.491,34579771
4807,aflibercept,gene,0.6753,34579771
4808,nvAMD,disease,0.8057,34579771
4809,nvAMD,disease,1.0,34579771
4810,aflibercept,gene,0.4822,34579771
4811,Diabetic Retinopathy,disease,1.0,34575662
4812,aflibercept,gene,0.927,34575662
4813,diabetic retinopathy,disease,1.0,34575662
4814,DR,disease,1.0,34575662
4815,DR,disease,,34575662
4816,diabetic macular edema,disease,1.0,34575662
4817,DR,disease,,34575662
4818,patients,species,0.988,34575662
4819,DR,disease,,34575662
4820,Brolucizumab,gene,0.957,34572350
4821,Aflibercept,gene,0.983,34572350
4822,aflibercept,gene,0.9893,34572350
4823,brolucizumab,gene,0.935,34572350
4824,choroidal vasculopathy,disease,1.0,34572350
4825,PCV,disease,1.0,34572350
4826,Patients,species,0.946,34572350
4827,aflibercept,gene,0.9673,34572350
4828,brolucizumab,gene,0.907,34572350
4829,Indocyanine green,drug,0.9985,34572350
4830,VEGF,gene,0.6455,34572350
4831,brolucizumab,gene,0.8037,34572350
4832,aflibercept,gene,0.9834,34572350
4833,brolucizumab,gene,0.9297,34572350
4834,aflibercept,gene,0.9873,34572350
4835,polypoidal,DNA,0.4246,34572350
4836,polypoidal lesions,disease,1.0,34572350
4837,brolucizumab,gene,0.7666,34572350
4838,aflibercept,gene,0.9775,34572350
4839,Intraocular inflammation,disease,1.0,34572350
4840,brolucizumab,gene,0.898,34572350
4841,brolucizumab,gene,0.924,34572350
4842,aflibercept,gene,0.9644,34572350
4843,polypoidal,cell_type,0.481,34572350
4844,polypoidal lesion,disease,0.9937,34572350
4845,aflibercept,gene,0.993,34551746
4846,myopic choroidal BACKGROUND,disease,0.9883,34551746
4847,aflibercept,gene,0.9873,34551746
4848,myopic choroidal neovascularization,disease,1.0,34551746
4849,CNV,disease,1.0,34551746
4850,patients,species,0.991,34551746
4851,CNV,disease,0.9946,34551746
4852,patients,species,0.984,34551746
4853,subfoveal/juxtafoveal myopic CNV,disease,1.0,34551746
4854,aflibercept,gene,0.9634,34551746
4855,patients,species,0.973,34551746
4856,CNV,disease,0.9688,34551746
4857,patients,species,0.9854,34551746
4858,aflibercept,gene,0.9946,34551746
4859,CNV,disease,0.9995,34551746
4860,patients,species,0.9883,34551746
4861,myopic CNV,disease,0.9995,34551746
4862,CNV area,DNA,0.748,34551746
4863,CNV,disease,0.503,34551746
4864,aflibercept,gene,0.9927,34551746
4865,patients,species,0.959,34551746
4866,myopic CNV,disease,1.0,34551746
4867,aflibercept,gene,0.9927,34551746
4868,participant,species,0.9673,34551746
4869,Aflibercept,gene,0.9526,34547529
4870,diabetic macular edema,disease,0.9995,34547529
4871,CI-DME,disease,0.9883,34547529
4872,proliferative diabetic retinopathy,disease,0.9995,34547529
4873,PDR,disease,1.0,34547529
4874,diabetic retinopathy,disease,1.0,34547529
4875,anti-VEGF,gene,0.8237,34547529
4876,aflibercept,gene,0.92,34547529
4877,Diabetic Retinopathy,disease,1.0,34547529
4878,PDR,disease,0.994,34547529
4879,CI-DME,disease,1.0,34547529
4880,PDR,disease,0.9917,34547529
4881,CI-DME,disease,1.0,34547529
4882,PDR,disease,0.8784,34547529
4883,aflibercept,gene,0.9814,34547529
4884,aflibercept,gene,0.9604,34547529
4885,CI-DME,disease,1.0,34547529
4886,vision loss,disease,0.9756,34547529
4887,CI-DME,disease,0.9995,34547529
4888,vision loss,disease,0.933,34547529
4889,DRSS,DNA,0.849,34547529
4890,DRSS,DNA,0.7427,34547529
4891,DRSS,DNA,0.6133,34547529
4892,PDR,disease,0.999,34547529
4893,CI-DME,disease,1.0,34547529
4894,aflibercept,gene,0.9644,34547529
4895,DRSS,DNA,0.6216,34547529
4896,neovascular age-related macular degeneration,disease,0.957,34543243
4897,OCT,gene,0.883,34543243
4898,patients,species,0.9927,34543243
4899,neovascular age-related macular degeneration,disease,1.0,34543243
4900,vascular endothelial growth factor,gene,0.8936,34543243
4901,fluorescein,drug,0.998,34543243
4902,reticular pseudodrusen,disease,0.884,34543243
4903,polypoidal choroidal vasculopathy,disease,1.0,34543243
4904,neovascular membrane,disease,0.9985,34543243
4905,geographic atrophy,disease,1.0,34543243
4906,vascular endothelial growth factor,gene,0.9004,34543243
4907,choroidal,DNA,0.4875,34543243
4908,VEGF,gene,0.997,34542556
4909,Anti-VEGF,gene,0.986,34542556
4910,vascular endothelial,cell_type,0.7373,34542556
4911,VEGF,gene,0.998,34542556
4912,anti-VEGF,gene,0.976,34542556
4913,endothelial cell,cell_type,0.8774,34542556
4914,High glucose-treated primary human retinal endothelial cells,cell_line,0.7427,34542556
4915,glucose,drug,0.9966,34542556
4916,primary,cell_type,0.4739,34542556
4917,human,species,0.631,34542556
4918,HRECs,cell_line,0.876,34542556
4919,VEGF,gene,0.995,34542556
4920,VEGF,gene,0.994,34542556
4921,anti-VEGF,gene,0.9727,34542556
4922,Wnt,gene,0.877,34542556
4923,LiCl,drug,0.962,34542556
4924,HRECs,cell_line,0.904,34542556
4925,TCF/LEF-driven reporter,DNA,0.802,34542556
4926,TCF,gene,0.997,34542556
4927,LEF,gene,0.992,34542556
4928,VEGF,gene,0.991,34542556
4929,anti-VEGF,gene,0.99,34542556
4930,genes,DNA,0.8374,34542556
4931,Wnt,gene,0.9346,34542556
4932,genes,DNA,0.662,34542556
4933,endothelial cell barrier,cell_type,0.73,34542556
4934,VEGF,gene,0.9946,34542556
4935,genes,DNA,0.816,34542556
4936,anti-VEGF,gene,0.8525,34542556
4937,Wnt,gene,0.8716,34542556
4938,VEGF,gene,0.995,34542556
4939,anti-VEGF,gene,0.9126,34542556
4940,Wnt,gene,0.944,34542556
4941,VEGF,gene,0.994,34542556
4942,anti-VEGF,gene,0.994,34542556
4943,Wnt,gene,0.7944,34542556
4944,endothelial barrier,cell_type,0.8574,34542556
4945,VEGF,gene,0.9917,34542556
4946,LiCl,drug,0.992,34542556
4947,VEGF,gene,0.9116,34542556
4948,patients,species,0.962,34542556
4949,blinding conditions,disease,1.0,34542556
4950,diabetic retinopathy,disease,1.0,34542556
4951,vascular-endothelial growth factor,gene,0.952,34540863
4952,neovascular age-related macular degeneration,disease,1.0,34540863
4953,nAMD,disease,1.0,34540863
4954,nAMD,disease,1.0,34540863
4955,ranibizumab,gene,0.9023,34540863
4956,aflibercept,gene,0.9653,34540863
4957,PED,disease,0.9995,34540863
4958,Blindness,disease,1.0,34534144
4959,Age-Related Macular Degeneration,disease,1.0,34534144
4960,blindness,disease,0.999,34534144
4961,age-related macular degeneration,disease,0.9995,34534144
4962,AMD,disease,1.0,34534144
4963,patients,species,0.9946,34534144
4964,PARTICIPANTS,species,0.955,34534144
4965,blindness,disease,0.999,34534144
4966,blindness,disease,0.999,34534144
4967,person,species,0.9077,34534144
4968,person,species,0.9263,34534144
4969,AMD blindness,disease,1.0,34534144
4970,blindness,disease,0.999,34534144
4971,AMD,disease,1.0,34534144
4972,verteporfin,drug,0.9985,34534144
4973,bevacizumab,gene,0.8535,34534144
4974,ranibizumab,gene,0.7627,34534144
4975,aflibercept,gene,0.9517,34534144
4976,Pachychoroid,disease,1.0,34533280
4977,anti-vascular endothelial growth factor,gene,0.8853,34533280
4978,VEGF,gene,0.9956,34533280
4979,polypoidal choroidal vasculopathy,disease,1.0,34533280
4980,PCV,disease,1.0,34533280
4981,patients,species,0.969,34533280
4982,PCV,disease,1.0,34533280
4983,VEGF,gene,0.722,34533280
4984,pachy-PCV,disease,1.0,34533280
4985,pachychoroid,disease,1.0,34533280
4986,pachy-PCV,disease,0.9844,34533280
4987,pachychoroid,disease,1.0,34533280
4988,pachy-PCV,disease,0.9985,34533280
4989,pachy-PCV,disease,0.994,34533280
4990,pachy-PCV,disease,0.9995,34533280
4991,pachy-PCV,disease,0.9907,34533280
4992,BCVA,DNA,0.4863,34533280
4993,pachy-PCV,disease,1.0,34533280
4994,pachy-PCV,disease,0.999,34533280
4995,SFCT,DNA,0.4966,34533280
4996,VEGF,gene,0.5503,34533280
4997,PCV,disease,1.0,34533280
4998,Aflibercept,gene,0.9565,34529744
4999,diabetic macula oedema,disease,1.0,34529744
5000,non,disease,0.7695,34529134
5001,anti-vascular endothelial growth factors,gene,0.984,34529134
5002,anti-VEGFs,gene,0.9805,34529134
5003,PATIENTS,species,0.93,34529134
5004,patients,species,0.981,34529134
5005,drug hypersensitivity reactions,disease,0.805,34529134
5006,anti-VEGF,gene,0.8965,34529134
5007,ranibizumab,gene,0.6206,34529134
5008,bevacizumab,gene,0.7363,34529134
5009,aflibercept,gene,0.9785,34529134
5010,maculopapular rash,disease,0.9995,34529134
5011,purpura,disease,1.0,34529134
5012,erythroderma,disease,0.9375,34529134
5013,proteinuria,disease,1.0,34529134
5014,fever,disease,1.0,34529134
5015,patients,species,0.989,34529134
5016,VEGF,gene,0.9087,34529134
5017,drug hypersensitivity reaction,disease,0.999,34529134
5018,patients,species,0.994,34529134
5019,anti-VEGF,gene,0.9565,34529134
5020,patient,species,0.984,34529134
5021,Ranibizumab,gene,0.942,34520251
5022,Aflibercept,gene,0.9824,34520251
5023,ranibizumab,gene,0.8267,34520251
5024,aflibercept,gene,0.986,34520251
5025,neovascular age-related macular degeneration,disease,1.0,34520251
5026,AMD,disease,1.0,34520251
5027,polypoidal choroidal vasculopathy,disease,1.0,34520251
5028,PCV,disease,1.0,34520251
5029,patients,species,0.9956,34520251
5030,neovascular AMD,disease,1.0,34520251
5031,PCV,disease,1.0,34520251
5032,ranibizumab,gene,0.894,34520251
5033,aflibercept,gene,0.947,34520251
5034,patients,species,0.9927,34520251
5035,antivascular endothelial growth factor,gene,0.9927,34520251
5036,PCV,cell_type,0.525,34520251
5037,patients,species,0.994,34520251
5038,patients,species,0.967,34520251
5039,patients,species,0.9814,34520251
5040,PCV,disease,1.0,34520251
5041,neovascular AMD,disease,1.0,34520251
5042,aflibercept,gene,0.963,34519167
5043,macular oedema,disease,1.0,34519167
5044,aflibercept,gene,0.965,34519167
5045,macular oedema,disease,0.975,34519167
5046,central retinal vein occlusion,disease,1.0,34519167
5047,CRVO,disease,1.0,34519167
5048,aflibercept,gene,0.987,34519167
5049,oedema,disease,0.9873,34519167
5050,CRVO,disease,1.0,34519167
5051,FRB,DNA,0.509,34519167
5052,aflibercept,gene,0.987,34519167
5053,ranibizumab,gene,0.799,34519167
5054,aflibercept,gene,0.9604,34519167
5055,aflibercept,gene,0.992,34519167
5056,ranibizumab,gene,0.8765,34519167
5057,Aflibercept,gene,0.768,34519167
5058,ranibizumab,gene,0.5527,34519167
5059,ranibizumab,gene,0.583,34519167
5060,aflibercept,gene,0.9077,34519167
5061,aflibercept,gene,0.991,34519167
5062,ranibizumab,gene,0.706,34519167
5063,CRVO,disease,1.0,34519167
5064,aflibercept,gene,0.9844,34519167
5065,dysphonia,disease,0.9985,34503645
5066,Dysphonia,disease,1.0,34503645
5067,Dysphonia,disease,1.0,34503645
5068,patients,species,0.9717,34503645
5069,cancer,disease,1.0,34503645
5070,vascular endothelial growth factor receptor,gene,0.998,34503645
5071,dysphonia,disease,1.0,34503645
5072,patients,species,0.996,34503645
5073,dysphonia,disease,1.0,34503645
5074,panitumumab,gene,0.8384,34503645
5075,Peripheral edema,disease,0.9873,34503645
5076,dysphonia,disease,1.0,34503645
5077,aflibercept,gene,0.986,34503645
5078,bevacizumab,gene,0.7944,34503645
5079,panitumumab,gene,0.894,34503645
5080,peripheral edema,disease,0.843,34503645
5081,dysphonia,disease,1.0,34503645
5082,Aflibercept,gene,0.977,34496977
5083,rat,species,0.9805,34496977
5084,anti-VEGF,gene,0.899,34496977
5085,retinal diseases,disease,1.0,34496977
5086,Aflibercept,gene,0.9814,34496977
5087,rat,species,0.952,34496977
5088,Choroidal neovascular lesions,disease,1.0,34496977
5089,CNV,disease,1.0,34496977
5090,Aflibercept,gene,0.991,34496977
5091,CNV,disease,0.9824,34496977
5092,Rats,species,0.929,34496977
5093,Aflibercept,gene,0.98,34496977
5094,Aflibercept,gene,0.996,34496977
5095,Rabbit anti human IgG,gene,0.9316,34496977
5096,Rabbit,species,0.99,34496977
5097,human,species,0.993,34496977
5098,Anti rabbit antibodies,gene,0.842,34496977
5099,rabbit,species,0.8564,34496977
5100,Aflibercept,gene,0.9873,34496977
5101,Aflibercept,gene,0.9883,34496977
5102,Aflibercept,gene,0.983,34496977
5103,Aflibercept,gene,0.989,34496977
5104,rat,species,0.942,34496977
5105,Aflibercept,gene,0.98,34496977
5106,Aflibercept,gene,0.992,34496977
5107,Bevacizumab,gene,0.753,34496977
5108,rat,species,0.9683,34496977
5109,Arterial Thromboembolic Events,disease,1.0,34495526
5110,Aflibercept,gene,0.985,34495526
5111,patients,species,0.9854,34495526
5112,maculopathy,disease,1.0,34495526
5113,arterial thromboembolic events,disease,1.0,34495526
5114,ATEs,disease,0.999,34495526
5115,VEGF,gene,0.998,34495526
5116,aflibercept,gene,0.988,34495526
5117,ranibizumab,gene,0.5835,34495526
5118,maculopathy,disease,1.0,34495526
5119,patients,species,0.9673,34495526
5120,aflibercept,gene,0.9775,34495526
5121,ranibizumab,gene,0.709,34495526
5122,ATEs,disease,1.0,34495526
5123,ischemic heart disease,disease,1.0,34495526
5124,IHD,disease,1.0,34495526
5125,ischemic stroke,disease,1.0,34495526
5126,IS,disease,1.0,34495526
5127,transient ischemic attack,disease,0.9277,34495526
5128,TIA,disease,1.0,34495526
5129,ATE,disease,1.0,34495526
5130,aflibercept,gene,0.9683,34495526
5131,ranibizumab,gene,0.487,34495526
5132,aflibercept,gene,0.9907,34495526
5133,ATE,disease,0.988,34495526
5134,IHD,disease,0.9995,34495526
5135,IS,disease,,34495526
5136,TIA,disease,0.888,34495526
5137,aflibercept,gene,0.9854,34495526
5138,ranibizumab,gene,0.8755,34495526
5139,aflibercept,gene,0.988,34495526
5140,patients,species,0.973,34495526
5141,maculopathy,disease,1.0,34495526
5142,ATE,disease,0.9897,34495526
5143,ranibizumab,gene,0.7383,34495526
5144,neovascular age-related macular degeneration,disease,1.0,34491474
5145,nAMD,disease,1.0,34491474
5146,nAMD,disease,1.0,34491474
5147,VEGF,gene,0.6206,34491474
5148,VEGF,gene,0.649,34491474
5149,nAMD,disease,1.0,34491474
5150,ranibizumab,drug,0.627,34491474
5151,aflibercept,gene,0.984,34491474
5152,brolucizumab,gene,0.7334,34491474
5153,nAMD,disease,1.0,34491474
5154,VEGF,gene,0.792,34491474
5155,nAMD,disease,1.0,34491474
5156,macular atrophy,disease,1.0,34491474
5157,macular atrophy,disease,1.0,34491474
5158,ranibizumab,gene,0.905,34491474
5159,aflibercept,gene,0.9795,34491474
5160,aflibercept,gene,0.9683,34491474
5161,choroidal thinning,disease,1.0,34491474
5162,macular atrophy,disease,1.0,34491474
5163,ranibizumab,gene,0.4897,34491474
5164,Dexamethasone,drug,0.9893,34482532
5165,Patients,species,0.989,34482532
5166,patients,species,0.969,34482532
5167,diabetic macular edema,disease,1.0,34482532
5168,DME,disease,1.0,34482532
5169,anti-vascular endothelial growth factor,gene,0.98,34482532
5170,VEGF,gene,0.997,34482532
5171,aflibercept,gene,0.9526,34482532
5172,dexamethasone,drug,0.969,34482532
5173,DEX,drug,0.9507,34482532
5174,anti-VEGF,gene,0.902,34482532
5175,coronavirus disease,disease,1.0,34482532
5176,COVID-19,disease,0.995,34482532
5177,patients,species,0.9873,34482532
5178,DME,disease,1.0,34482532
5179,anti-VEGF,gene,0.9644,34482532
5180,DEX,drug,0.834,34482532
5181,anti-VEGF,gene,0.9365,34482532
5182,DEX,drug,0.8564,34482532
5183,anti-VEGF,gene,0.86,34482532
5184,DEX,drug,0.872,34482532
5185,patients,species,0.979,34482532
5186,anti-VEGF,gene,0.926,34482532
5187,COVID-19,disease,0.9966,34482532
5188,bilateral pachychoroid disease,disease,0.9004,34481477
5189,polypoidal choroidal vasculopathy,disease,1.0,34481477
5190,bilateral pachychoroid disease,disease,0.9917,34481477
5191,polypoidal choroidal vasculopathy,disease,1.0,34481477
5192,PCV,disease,1.0,34481477
5193,peripheral exudative hemorrhagic choroidal retinopathy,disease,1.0,34481477
5194,PEHCR,disease,1.0,34481477
5195,serous chorioretinopathy,disease,0.975,34481477
5196,CSC,disease,1.0,34481477
5197,PHS,disease,0.9146,34481477
5198,woman,species,0.8276,34481477
5199,blurred vision,disease,0.999,34481477
5200,orange-red nodular lesion,disease,0.7817,34481477
5201,polypoidal lesions,disease,1.0,34481477
5202,PCV,gene,0.579,34481477
5203,aflibercept,gene,0.9854,34481477
5204,indocyanine green,drug,0.9985,34481477
5205,polypoidal lesions,disease,0.9995,34481477
5206,PHS,disease,1.0,34481477
5207,choroidal vascular hyperpermeability,disease,1.0,34481477
5208,PHS,disease,1.0,34481477
5209,PCV,disease,1.0,34481477
5210,PHS,disease,1.0,34481477
5211,vision loss,disease,0.9927,34481477
5212,vitreous hemorrhage,disease,0.9966,34481477
5213,fluorescein,drug,0.9976,34481477
5214,CSC,disease,1.0,34481477
5215,pachychoroid,disease,1.0,34481477
5216,PHS,disease,1.0,34481477
5217,polypoidal lesions,disease,1.0,34481477
5218,PEHCR,disease,0.999,34481477
5219,CSC,disease,1.0,34481477
5220,PHS,disease,1.0,34481477
5221,aflibercept,gene,0.9893,34481477
5222,vitreous hemorrhage,disease,1.0,34481477
5223,PCV,disease,1.0,34481477
5224,PHS,disease,1.0,34481477
5225,PEHCR,disease,1.0,34481477
5226,CSC,disease,1.0,34481477
5227,PHS,disease,1.0,34481477
5228,PCV,disease,1.0,34481477
5229,PEHCR,disease,0.802,34481477
5230,CSC,disease,1.0,34481477
5231,pachychoroid spectrum disease,disease,1.0,34481477
5232,Aflibercept,gene,0.9536,34471345
5233,Neovascular Age,disease,0.9995,34471345
5234,aflibercept,gene,0.985,34471345
5235,AFL,gene,0.59,34471345
5236,patients,species,0.926,34471345
5237,neovascular age-related macular degeneration,disease,1.0,34471345
5238,nAMD,disease,1.0,34471345
5239,PATIENTS,species,0.895,34471345
5240,patients,species,0.963,34471345
5241,nAMD,disease,1.0,34471345
5242,patients,species,0.9746,34471345
5243,Patients,species,0.946,34471345
5244,polypoidal choroidal vasculopathy,disease,1.0,34471345
5245,PCV,disease,1.0,34471345
5246,nAMD,disease,1.0,34471345
5247,BCVA,DNA,0.4502,34471345
5248,patients,species,0.9473,34471345
5249,nAMD,disease,1.0,34471345
5250,oxygen,drug,0.9976,34468834
5251,diabetic macular edema,disease,1.0,34468834
5252,VEGF,gene,0.817,34468834
5253,diabetic macular edema,disease,1.0,34468834
5254,DME,disease,1.0,34468834
5255,oxygen,drug,0.999,34468834
5256,O(2),drug,1.0,34468834
5257,patients,species,0.968,34468834
5258,DME,disease,1.0,34468834
5259,aflibercept,gene,0.9487,34468834
5260,vO(2),drug,0.9595,34468834
5261,oxygen,drug,0.998,34468834
5262,BCVA,DNA,0.566,34468834
5263,CRT,DNA,0.4949,34468834
5264,DME,disease,1.0,34468834
5265,aflibercept,gene,0.959,34468834
5266,O(2)S,drug,1.0,34468834
5267,bevacizumab,gene,0.901,34454473
5268,aflibercept,gene,0.9897,34454473
5269,anti-vascular endothelial growth factors,gene,0.975,34454473
5270,anti-VEGF,gene,0.969,34454473
5271,bevacizumab,gene,0.9272,34454473
5272,aflibercept,gene,0.9805,34454473
5273,patients,species,0.953,34454473
5274,wet,disease,0.6846,34454473
5275,age-related macular degeneration,disease,0.9863,34454473
5276,wAMD,disease,1.0,34454473
5277,patients,species,0.989,34454473
5278,VEGF,gene,0.5933,34454473
5279,wAMD,disease,1.0,34454473
5280,anti-VEGF,gene,0.976,34454473
5281,aflibercept,gene,0.941,34454473
5282,aflibercept,gene,0.981,34454473
5283,anti-VEGF,gene,0.914,34454473
5284,patients,species,0.988,34454473
5285,patients,species,0.9907,34454473
5286,anti-VEGF,gene,0.881,34454473
5287,anti-VEGF,gene,0.944,34454473
5288,Neovascular Age-Related Macular Degeneration,disease,1.0,34454123
5289,neovascular age-related macular degeneration,disease,1.0,34454123
5290,nAMD,disease,1.0,34454123
5291,anti-vascular endothelial growth factor,gene,0.892,34454123
5292,ranibizumab,drug,0.507,34454123
5293,aflibercept,gene,0.9907,34454123
5294,brolucizumab,gene,0.9277,34454123
5295,patients,species,0.989,34454123
5296,PARTICIPANTS,species,0.758,34454123
5297,patients,species,0.9653,34454123
5298,nAMD,disease,1.0,34454123
5299,patient,species,0.9883,34454123
5300,patient,species,0.9854,34454123
5301,bevacizumab,gene,0.8013,34454123
5302,brolucizumab,gene,0.807,34454123
5303,aflibercept,gene,0.9697,34454123
5304,patients,species,0.995,34454123
5305,patient,species,0.993,34454123
5306,brolucizumab,gene,0.742,34454123
5307,bevacizumab,gene,0.795,34454123
5308,blindness,disease,0.996,34454123
5309,brolucizumab,gene,0.9087,34454123
5310,aflibercept,gene,0.9756,34454123
5311,ranibizumab,gene,0.571,34454123
5312,diabetic macular edema,disease,1.0,34454123
5313,Human,species,0.712,34452268
5314,cKIT,gene,0.988,34452268
5315,Stem cell factor,gene,0.997,34452268
5316,SCF,gene,0.9976,34452268
5317,cKIT,gene,0.995,34452268
5318,SCF,gene,0.997,34452268
5319,cKIT,gene,0.994,34452268
5320,neovascular age-related macular degeneration,disease,0.998,34452268
5321,AMD,disease,1.0,34452268
5322,human,species,0.663,34452268
5323,cKIT,gene,0.9927,34452268
5324,neovascular AMD,disease,1.0,34452268
5325,hypoxic human endothelial cells,cell_line,0.9365,34452268
5326,human,species,0.7837,34452268
5327,NN2101,drug,0.958,34452268
5328,SCF,gene,0.9966,34452268
5329,cKIT,gene,0.996,34452268
5330,neovascular AMD,disease,1.0,34452268
5331,SCF,gene,0.9976,34452268
5332,cKIT,gene,0.9985,34452268
5333,choroidal neovascularization,disease,1.0,34452268
5334,CNV,disease,1.0,34452268
5335,aflibercept,gene,0.8096,34452268
5336,vascular endothelial growth factor,gene,0.998,34452268
5337,aflibercept,gene,0.9766,34452268
5338,CNV,disease,0.9976,34452268
5339,NN2101,drug,0.985,34452268
5340,mice,species,0.9697,34452268
5341,rabbits,species,0.93,34452268
5342,anti-cKIT,gene,0.9185,34452268
5343,neovascular AMD,disease,1.0,34452268
5344,Vascular Endothelial Growth Factor,gene,0.9907,34452097
5345,Diabetic retinopathy,disease,1.0,34452097
5346,DR,disease,1.0,34452097
5347,blindness,disease,0.998,34452097
5348,vascular endothelial growth,gene,0.757,34452097
5349,VEGF,gene,0.556,34452097
5350,diabetic retinopathy,disease,1.0,34452097
5351,ranibizumab,gene,0.9004,34452097
5352,aflibercept,gene,0.9863,34452097
5353,anti-VEGF,gene,0.993,34452097
5354,VEGF,gene,0.6904,34452097
5355,patients,species,0.971,34452097
5356,diabetic macular edema,disease,1.0,34452097
5357,DME,disease,1.0,34452097
5358,patients,species,0.978,34452097
5359,DR,disease,,34452097
5360,DR,disease,,34452097
5361,patients,species,0.944,34452097
5362,NPDR,disease,0.996,34452097
5363,VEGF,gene,0.64,34452097
5364,patients,species,0.9453,34452097
5365,DME,disease,1.0,34452097
5366,VEGF,gene,0.6235,34452097
5367,patients,species,0.9316,34452097
5368,proliferative DR,disease,0.9355,34452097
5369,PDR,DNA,0.6816,34452097
5370,fluorescein,drug,0.976,34452097
5371,VEGF,gene,0.861,34452097
5372,retinal non-perfusion,disease,0.9927,34452097
5373,patients,species,0.957,34452097
5374,DR,disease,,34452097
5375,patients,species,0.9575,34452097
5376,PDR,disease,0.971,34452097
5377,VEGF,gene,0.9062,34452097
5378,PRP,cell_type,0.5703,34452097
5379,patients,species,0.9805,34452097
5380,PDR,disease,0.9976,34452097
5381,VEGF,gene,0.8604,34452097
5382,PRP,cell_type,0.5947,34452097
5383,vitreous hemorrhage,disease,1.0,34452097
5384,tractional retinal detachment,disease,1.0,34452097
5385,PDR,disease,1.0,34452097
5386,VEGF,gene,0.8086,34452097
5387,vitreous hemorrhage,disease,1.0,34452097
5388,VEGF,gene,0.788,34452097
5389,patients,species,0.969,34452097
5390,DR,disease,,34452097
5391,VEGF,gene,0.928,34452097
5392,DME,disease,1.0,34452097
5393,DR,disease,,34452097
5394,Diabetic Macular Edema,disease,1.0,34446301
5395,vascular endothelial growth factor,gene,0.9395,34446301
5396,VEGF,gene,0.996,34446301
5397,diabetic macular edema,disease,1.0,34446301
5398,DME,disease,1.0,34446301
5399,VEGF,gene,0.9097,34446301
5400,ranibizumab,drug,0.4983,34446301
5401,aflibercept,gene,0.9487,34446301
5402,DME,disease,1.0,34446301
5403,DME,disease,1.0,34446301
5404,triamcinolone,drug,0.9995,34446301
5405,dexamethasone,drug,0.999,34446301
5406,fluocinolone acetonide,drug,0.999,34446301
5407,VEGF,gene,0.6045,34446301
5408,DME,disease,1.0,34446301
5409,cataract,disease,1.0,34446301
5410,patient,species,0.8613,34446301
5411,patients,species,0.975,34446301
5412,Vascular Endothelial Growth Factor,gene,0.87,34441876
5413,ranibizumab,gene,0.555,34441876
5414,aflibercept,gene,0.956,34441876
5415,neovascular age-related macular degeneration,disease,0.999,34441876
5416,AMD,disease,1.0,34441876
5417,polypoidal choroidal vasculopathy,disease,1.0,34441876
5418,PCV,disease,1.0,34441876
5419,patients,species,0.996,34441876
5420,neovascular AMD,disease,1.0,34441876
5421,PCV,disease,1.0,34441876
5422,ranibizumab,gene,0.7847,34441876
5423,aflibercept,gene,0.8564,34441876
5424,patients,species,0.987,34441876
5425,ranibizumab,gene,0.829,34441876
5426,aflibercept,gene,0.963,34441876
5427,patients,species,0.9937,34441876
5428,macular neovascularization,disease,1.0,34441876
5429,MNV,disease,1.0,34441876
5430,Patients,species,0.972,34441876
5431,ranibizumab,gene,0.9004,34441876
5432,aflibercept,gene,0.9697,34441876
5433,ranibizumab,gene,0.8896,34441876
5434,MNV,disease,0.999,34441876
5435,MNV,disease,0.9985,34441876
5436,PCV,disease,1.0,34441876
5437,aflibercept,gene,0.9897,34441876
5438,MNV,disease,1.0,34441876
5439,ranibizumab,gene,0.882,34441876
5440,aflibercept,gene,0.979,34441876
5441,Ranibizumab,gene,0.767,34441876
5442,patients,species,0.9854,34441876
5443,type 3 MNVs,disease,0.8843,34441876
5444,patients,species,0.988,34441876
5445,PCV,disease,1.0,34441876
5446,aflibercept,gene,0.9805,34441876
5447,patients,species,0.983,34441876
5448,Ranibizumab,gene,0.8115,34441876
5449,patients,species,0.967,34441876
5450,type 3 MNV,disease,0.994,34441876
5451,aflibercept,gene,0.949,34441876
5452,patients,species,0.9175,34441876
5453,PCV,disease,1.0,34441876
5454,Long,DNA,0.664,34429633
5455,Long Non-Coding RNAs,RNA,0.7593,34429633
5456,Diabetic Retinopathy,disease,1.0,34429633
5457,Long non-coding RNAs,RNA,0.7827,34429633
5458,lncRNAs,RNA,0.774,34429633
5459,lncRNAs,RNA,0.716,34429633
5460,TUG1,gene,0.9893,34429633
5461,rs7284767G,DNA,0.6333,34429633
5462,MIAT,gene,0.996,34429633
5463,rs1061540T,DNA,0.701,34429633
5464,MALAT1,gene,0.9966,34429633
5465,rs3200401C,DNA,0.6777,34429633
5466,and SENCR (rs,mutation,,34429633
5467,SENCR,gene,0.9976,34429633
5468,rs12420823C,DNA,0.7363,34429633
5469,diabetic retinopathy,disease,1.0,34429633
5470,DR,disease,1.0,34429633
5471,anti-vascular endothelial growth factor aflibercept,gene,0.9478,34429633
5472,PATIENTS,species,0.9385,34429633
5473,patients,species,0.974,34429633
5474,type 2 diabetes,disease,1.0,34429633
5475,polymorphism,DNA,0.699,34429633
5476,TUG1,gene,0.9927,34429633
5477,TUG1 A,mutation,,34429633
5478,MIAT,gene,0.995,34429633
5479,DR,disease,,34429633
5480,MALAT1 T,RNA,0.5957,34429633
5481,MALAT1,gene,0.9844,34429633
5482,TUG1,gene,0.9893,34429633
5483,MALAT1,gene,0.9985,34429633
5484,MIAT,gene,0.9985,34429633
5485,SENCR,gene,0.9976,34429633
5486,MIAT,gene,0.996,34429633
5487,patients,species,0.9883,34429633
5488,SENCR T variant,DNA,0.6455,34429633
5489,SENCR,RNA,0.548,34429633
5490,aflibercept,gene,0.9746,34429633
5491,TUG1 A,gene,0.988,34429633
5492,TUG1 A,mutation,,34429633
5493,MIAT,gene,0.9375,34429633
5494,lncRNAs,RNA,0.544,34429633
5495,TUG1,gene,0.9263,34429633
5496, and MIAT (r,mutation,,34429633
5497,MIAT,gene,0.997,34429633
5498,DR,disease,,34429633
5499,aflibercept,gene,0.9644,34429633
5500,MALAT1,gene,0.996,34429633
5501,DR,gene,,34429633
5502,vascular endothelial growth factor,gene,0.9805,34427220
5503,vascular endothelial growth factor,gene,0.914,34427220
5504,neovascular age-related macular degeneration,disease,1.0,34427220
5505,nAMD,disease,1.0,34427220
5506,ranibizumab,gene,0.6943,34427220
5507,Diabetic Retinopathy,disease,1.0,34427220
5508,ranibizumab,gene,0.943,34427220
5509,aflibercept,gene,0.956,34427220
5510,patients,species,0.973,34427220
5511,ranibizumab,gene,0.8223,34427220
5512,aflibercept,gene,0.984,34427220
5513,Patients,species,0.958,34427220
5514,Ranibizumab,gene,0.718,34422404
5515,ranibizumab,gene,0.7915,34422404
5516,ranibizumab,gene,0.91,34422404
5517,ranibizumab,gene,0.883,34422404
5518,IRF,disease,0.9814,34422404
5519,ranibizumab,gene,0.784,34422404
5520,nAMD,disease,1.0,34422404
5521,aflibercept,gene,0.981,34422404
5522,aflibercept,gene,0.9854,34422404
5523,neovascular age-related macular degeneration,disease,1.0,34420480
5524,nAMD,disease,1.0,34420480
5525,anti-vascular endothelial growth factor,gene,0.901,34420480
5526,anti-VEGF,gene,0.8643,34420480
5527,neovascular age-related macular degeneration,disease,1.0,34420480
5528,nAMD,disease,1.0,34420480
5529,anti-VEGF,gene,0.8784,34420480
5530,nAMD,disease,1.0,34420480
5531,PATIENTS,species,0.903,34420480
5532,nAMD,disease,1.0,34420480
5533,patients,species,0.9785,34420480
5534,ranibizumab,gene,0.9507,34420480
5535,aflibercept,gene,0.969,34420480
5536,bevacizumab,gene,0.8193,34420480
5537,nAMD,disease,1.0,34420480
5538,patients,species,0.9844,34420480
5539,patients,species,0.9624,34420480
5540,patients,species,0.9873,34420480
5541,anti-VEGF,gene,0.962,34420480
5542,patients,species,0.9756,34420480
5543,ranibizumab,gene,0.818,34420480
5544,aflibercept,gene,0.9585,34420480
5545,nAMD,disease,1.0,34420480
5546,patients,species,0.9966,34420480
5547,cataract,disease,0.9995,34420480
5548,nAMD,disease,1.0,34420480
5549,patients,species,0.9946,34420480
5550,nAMD,disease,1.0,34420480
5551,patients,species,0.9946,34420480
5552,anti-VEGF,gene,0.9497,34420480
5553,diabetic retinopathy,disease,1.0,34419979
5554,diabetic macular edema,disease,0.999,34419979
5555,CI-DME,disease,1.0,34419979
5556,vision loss,disease,1.0,34419979
5557,proliferative,disease,0.9995,34419979
5558,diabetic retinopathy,disease,0.7837,34419979
5559,PDR,disease,1.0,34419979
5560,aflibercept,gene,0.951,34419979
5561,CI-DME,disease,1.0,34419979
5562,PDR,disease,1.0,34419979
5563,Diabetic Retinopathy,disease,1.0,34419979
5564,CI-DME,disease,0.9995,34419979
5565,PDR,disease,1.0,34419979
5566,aflibercept,gene,0.971,34419979
5567,non-PDR,disease,1.0,34419979
5568,NPDR,disease,1.0,34419979
5569,aflibercept,gene,0.9897,34419979
5570,VTCs,disease,0.998,34419979
5571,NPDR,disease,0.9995,34419979
5572,aflibercept,gene,0.9746,34414086
5573,neovascular age-related macular degeneration,disease,1.0,34414086
5574,nAMD,DNA,0.745,34414086
5575,nAMD,disease,1.0,34414086
5576,nAMD,disease,1.0,34414086
5577,patients,species,0.995,34414086
5578,nAMD,disease,1.0,34414086
5579,aflibercept,gene,0.9624,34414086
5580,nAMD,disease,0.9985,34414086
5581,Central Retinal Vein Occlusion,disease,1.0,34413756
5582,Man,species,0.7266,34413756
5583,COVID-19,disease,1.0,34413756
5584,man,species,0.7905,34413756
5585,hypertension,disease,1.0,34413756
5586,central retinal vein occlusion,disease,1.0,34413756
5587,CRVO,disease,1.0,34413756
5588,cystoid macular edema,disease,1.0,34413756
5589,patient,species,0.988,34413756
5590,muscle aches,disease,0.999,34413756
5591,hypercoagulability,disease,0.9995,34413756
5592,CRVO,disease,1.0,34413756
5593,patient,species,0.986,34413756
5594,COVID-19 antibody,gene,0.97,34413756
5595,patient,species,0.9897,34413756
5596,aflibercept,gene,0.983,34413756
5597,macular edema,disease,1.0,34413756
5598,COVID-19,disease,0.9995,34413756
5599,CRVO,disease,1.0,34413756
5600,POLYPOIDAL LESION,disease,1.0,34412103
5601,polypoidal lesion,disease,1.0,34412103
5602,PL,disease,1.0,34412103
5603,polypoidal choroidal vasculopathy,disease,1.0,34412103
5604,aflibercept,gene,0.95,34412103
5605,Polypoidal lesion,disease,1.0,34412103
5606,indocyanine green,drug,0.9976,34412103
5607,polypoidal choroidal vasculopathy,disease,1.0,34412103
5608,polypoidal choroidal vasculopathy,disease,1.0,34412103
5609,aflibercept,gene,0.943,34412103
5610,indocyanine green,drug,0.998,34412103
5611,PLs,cell_type,0.4546,34412103
5612,patients,species,0.9893,34412103
5613,indocyanine green,drug,0.994,34412103
5614,retinal pigment epithelial,cell_type,0.5283,34412103
5615,Polypoidal lesion,disease,0.9663,34412103
5616,polypoidal choroidal vasculopathy,disease,1.0,34412103
5617,indocyanine green,drug,0.996,34412103
5618,age-related macular degeneration,disease,1.0,34410060
5619,AMD,disease,1.0,34410060
5620,photoreceptors,cell_type,0.6953,34410060
5621,choroidal neovascularization,disease,1.0,34410060
5622,CNV,disease,1.0,34410060
5623,geographic atrophy,disease,1.0,34410060
5624,ORTs,DNA,0.5283,34410060
5625,outer retinal atrophy,disease,1.0,34410060
5626,photoreceptors,cell_type,0.7295,34410060
5627,patients,species,0.967,34410060
5628,patients,species,0.9844,34410060
5629,AMD,disease,1.0,34410060
5630,women,species,0.9624,34410060
5631,men,species,0.9673,34410060
5632,dry AMD,disease,1.0,34410060
5633,CNV,disease,1.0,34410060
5634,exudative AMD,disease,1.0,34410060
5635,patients,species,0.9814,34410060
5636,patients,species,0.9785,34410060
5637,exudative AMD,disease,0.9883,34410060
5638,Aflibercept,gene,0.9614,34410060
5639,patients,species,0.9766,34410060
5640,CNV,disease,1.0,34410060
5641,exudative AMD,disease,1.0,34410060
5642,disciform scar,disease,0.9995,34410060
5643,ORTs,DNA,0.5146,34410060
5644,ellipsoid,DNA,0.4727,34410060
5645,ORT,DNA,0.568,34410060
5646,cystic macular edema,disease,1.0,34410060
5647,patients,species,0.9805,34410060
5648,Aflibercept,gene,0.9727,34410060
5649,Outer retinal tubulations,disease,0.9966,34410060
5650,AMD,disease,1.0,34410060
5651,photoreceptors,cell_type,0.474,34410060
5652,exudative AMD,disease,0.9995,34410060
5653,aflibercept,gene,0.953,34408845
5654,Submacular hemorrhage,disease,1.0,34408845
5655,SMH,disease,1.0,34408845
5656,trauma,disease,0.9873,34408845
5657,age-related macular degeneration,disease,1.0,34408845
5658,blindness,disease,1.0,34408845
5659,hemoglobin,gene,0.9956,34408845
5660,photoreceptors,cell_type,0.7397,34408845
5661,aflibercept,gene,0.9834,34408845
5662,SMH,disease,1.0,34408845
5663,idiopathic polypoidal choroidal vasculopathy,disease,1.0,34408845
5664,IPCV,disease,1.0,34408845
5665,sudden loss of vision,disease,0.9805,34408845
5666,HM,disease,1.0,34408845
5667,subretinal hemorrhage,disease,0.9995,34408845
5668,IPCV,disease,1.0,34408845
5669,aflibercept,gene,0.988,34408845
5670,aflibercept,gene,0.9893,34408845
5671,SMH,disease,0.9995,34408845
5672,VEGF,gene,0.7656,34408845
5673,SMH,disease,0.9995,34408845
5674,VEGF,gene,0.8477,34407298
5675,age-related macular degeneration,disease,1.0,34407298
5676,nAMD,disease,1.0,34407298
5677,patients,species,0.9775,34407298
5678,fluorescein,drug,0.9946,34407298
5679,indocyanine green,drug,0.9976,34407298
5680,nAMD,disease,1.0,34407298
5681,patients,species,0.99,34407298
5682,Patients,species,0.9307,34407298
5683,ranibizumab,gene,0.891,34407298
5684,aflibercept,gene,0.9673,34407298
5685,neovascular,DNA,0.4578,34407298
5686,neovascular lesion,disease,0.999,34407298
5687,VEGF,gene,0.6104,34407298
5688,patients,species,0.9863,34407298
5689,nAMD,disease,1.0,34407298
5690,nAMD,disease,1.0,34407298
5691,patients,species,0.9907,34407298
5692,VEGF,gene,0.6875,34406342
5693,vascular endothelial growth factor,gene,0.996,34406342
5694,aflibercept,gene,0.998,34406342
5695,brolucizumab,gene,0.976,34406342
5696,bevacizumab,gene,0.6694,34406342
5697,bevacizumab,gene,0.8677,34406342
5698,bevacizumab,gene,0.9683,34406342
5699,aflibercept,gene,0.9917,34406342
5700,brolucizumab,gene,0.906,34406342
5701,silicon,drug,0.993,34406342
5702,bevacizumab,gene,0.918,34406342
5703,brolucizumab,gene,0.9844,34406342
5704,silicone,drug,0.6655,34406342
5705,patients,species,0.978,34392710
5706,patients,species,0.9634,34392710
5707,neovascular age related macular degeneration,disease,1.0,34392710
5708,nAMD,disease,1.0,34392710
5709,CRT,DNA,0.5464,34392710
5710,patients,species,0.967,34392710
5711,nAMD,disease,1.0,34392710
5712,aflibercept,gene,0.974,34392710
5713,aflibercept,gene,0.9683,34392710
5714,CRT,DNA,0.6284,34392710
5715,CRT,DNA,0.756,34392710
5716,BCVA,DNA,0.4775,34392710
5717,CRT,DNA,0.667,34392710
5718,BCVA,DNA,0.4692,34392710
5719,patients,species,0.994,34392710
5720,CRT,DNA,0.6597,34392710
5721,patients,species,0.995,34392710
5722,Patients,species,0.988,34392710
5723,CRT,DNA,0.6133,34392710
5724,patients,species,0.989,34392710
5725,patients,species,0.981,34392710
5726,BCVA,cell_type,0.4282,34392710
5727,CRT,DNA,0.5137,34392710
5728,patients,species,0.9644,34392710
5729,nAMD,disease,1.0,34392710
5730,patients,species,0.954,34391401
5731,age-related macular degeneration,disease,0.9956,34391401
5732,AMD,disease,1.0,34391401
5733,patients,species,0.991,34391401
5734,anti-vascular endothelial growth factors,gene,0.934,34391401
5735,VEGFs,gene,0.996,34391401
5736,wet-AMD,disease,1.0,34391401
5737,patients,species,0.9893,34391401
5738,Aflibercept,gene,0.9863,34391401
5739,Ranibizumab,gene,0.8975,34391401
5740,Bevacizumab,gene,0.8726,34391401
5741,patients,species,0.9697,34391401
5742,patients,species,0.9717,34391401
5743,patients,species,0.9614,34391401
5744,Patients,species,0.9834,34391401
5745,Bevacizumab,gene,0.815,34391401
5746,Ranibizumab,gene,0.836,34391401
5747,patient,species,0.971,34391401
5748,anti-VEGF,gene,0.8696,34391401
5749,wet-AMD,disease,1.0,34391401
5750,patients,species,0.9956,34391401
5751,glaucoma,disease,1.0,34385697
5752,bevacizumab,gene,0.7046,34385697
5753,ranibizumab,gene,0.5176,34385697
5754,aflibercept,gene,0.9673,34385697
5755,neovascular age-related macular degeneration,disease,1.0,34385697
5756,nAMD,disease,1.0,34385697
5757,patients,species,0.946,34385697
5758,glaucoma,disease,1.0,34385697
5759,patients,species,0.98,34385697
5760,nAMD,disease,1.0,34385697
5761,Patients,species,0.9644,34385697
5762,glaucoma,disease,1.0,34385697
5763,open-angle glaucoma,disease,1.0,34385697
5764,open-angle glaucoma,disease,1.0,34385697
5765,ocular hypertension,disease,1.0,34385697
5766,narrow-,disease,1.0,34385697
5767,angle glaucoma,disease,0.91,34385697
5768,glaucoma,disease,1.0,34385697
5769,patients,species,0.9834,34385697
5770,IVB,drug,0.9956,34385697
5771,IVR,drug,0.9907,34385697
5772,glaucoma,disease,1.0,34385697
5773,glaucoma,disease,1.0,34385697
5774,glaucoma,disease,0.9946,34385697
5775,patients,species,0.981,34385697
5776,IVB,drug,0.81,34385697
5777,IVR,drug,0.9126,34385697
5778,patients,species,0.958,34385697
5779,glaucoma,disease,1.0,34385697
5780,glaucoma,disease,1.0,34385697
5781,patients,species,0.9907,34385697
5782,glaucoma,disease,1.0,34385697
5783,patients,species,0.993,34385697
5784,glaucoma,disease,0.9995,34385697
5785,IVA,drug,0.543,34385697
5786,patients,species,0.951,34385697
5787,nAMD,disease,1.0,34385697
5788,patients,species,0.9585,34385697
5789,glaucoma,disease,1.0,34385697
5790,exudative retinal diseases,disease,1.0,34371793
5791,anti-vascular endothelial growth factors,gene,0.9727,34371793
5792,anti-VEGF,gene,0.9927,34371793
5793,corticosteroids,drug,0.8076,34371793
5794,retinal diseases,disease,1.0,34371793
5795,VEGF,gene,0.6973,34371793
5796,Bevacizumab,gene,0.7197,34371793
5797,Pegaptanib,drug,0.9795,34371793
5798,Ranibizumab,gene,0.7686,34371793
5799,Aflibercept,gene,0.964,34371793
5800,Conbercept,gene,0.683,34371793
5801,Brolucizumab,gene,0.7627,34371793
5802,Abicipar-pegol,gene,0.9,34371793
5803,Faricimab,gene,0.819,34371793
5804,triamcinolone acetonide,drug,0.9995,34371793
5805,dexamethasone,drug,0.999,34371793
5806,fluocinolone acetonide,drug,0.999,34371793
5807,exudative retinal diseases,disease,0.999,34371793
5808,retinal diseases,disease,0.999,34371793
5809,Aflibercept,gene,0.9395,34359764
5810,FOLFIRI,drug,0.9453,34359764
5811,Metastatic Colorectal,disease,0.885,34359764
5812,aflibercept,gene,0.9805,34359764
5813,FOLFIRI,drug,0.981,34359764
5814,patients,species,0.8945,34359764
5815,metastatic colorectal cancer,disease,0.9985,34359764
5816,mCRC,disease,0.9985,34359764
5817,oxaliplatin,drug,0.9995,34359764
5818,mCRC,disease,0.9917,34359764
5819,patients,species,0.9937,34359764
5820,aflibercept,gene,0.9316,34359764
5821,FOLFIRI,drug,0.838,34359764
5822,patients,species,0.977,34359764
5823,aflibercept,gene,0.981,34359764
5824,FOLFIRI,drug,0.9766,34359764
5825,patients,species,0.987,34359764
5826,bevacizumab,gene,0.8726,34359764
5827,bone metastases,disease,0.9473,34359764
5828,Hypertension,disease,0.9995,34359764
5829,Thromboembolic events,disease,0.949,34359764
5830,patients,species,0.9126,34359764
5831,hemorrhagic events,disease,0.8975,34359764
5832,proteinuria,disease,1.0,34359764
5833,Neutropenia,disease,1.0,34359764
5834,Aflibercept,gene,0.976,34359764
5835,FOLFIRI,drug,0.985,34359764
5836,mCRC,disease,0.96,34359764
5837,Aflibercept,gene,0.9507,34351414
5838,nonproliferative diabetic retinopathy,disease,1.0,34351414
5839,NPDR,disease,1.0,34351414
5840,vascular endothelial growth factor,gene,0.9985,34351414
5841,aflibercept,gene,0.982,34351414
5842,NPDR,disease,0.9985,34351414
5843,diabetic macular edema,disease,1.0,34351414
5844,DME,disease,1.0,34351414
5845,PARTICIPANTS,species,0.6978,34351414
5846,Aflibercept,gene,0.9556,34351414
5847,Nonproliferative Diabetic Retinopathy,disease,1.0,34351414
5848,Diabetic Retinopathy,disease,1.0,34351414
5849,DME,disease,0.9956,34351414
5850,aflibercept,gene,0.9727,34351414
5851,aflibercept,gene,0.985,34351414
5852,aflibercept,gene,0.968,34351414
5853,aflibercept,gene,0.8965,34351414
5854,DME,disease,0.9404,34351414
5855,participants,species,0.976,34351414
5856,participant,species,0.9634,34351414
5857,the,gene,0.507,34351414
5858,aflibercept,gene,0.9565,34351414
5859,aflibercept,gene,0.973,34351414
5860,aflibercept,gene,0.9775,34351414
5861,aflibercept,gene,0.9854,34351414
5862,aflibercept 2q16,DNA,0.635,34351414
5863,aflibercept,gene,0.9917,34351414
5864,aflibercept,gene,0.788,34351414
5865,aflibercept,gene,0.981,34351414
5866,DME,disease,0.999,34351414
5867,2q16,DNA,0.8423,34351414
5868,NPDR,disease,1.0,34351414
5869,aflibercept,gene,0.959,34351414
5870,aflibercept,gene,0.9863,34351414
5871,DME,cell_line,0.479,34351414
5872,vascular endothelial growth factor,gene,0.9966,34351414
5873,Diabetic macular edema,disease,1.0,34350068
5874,DME,disease,1.0,34350068
5875,retinal vein occlusion,disease,1.0,34350068
5876,RVO,disease,1.0,34350068
5877,visual impairments,disease,1.0,34350068
5878,Vascular endothelial growth factor,gene,0.9985,34350068
5879,VEGF,gene,0.997,34350068
5880,VEGF,gene,0.891,34350068
5881,patients,species,0.9863,34350068
5882,retinal tissue,DNA,0.5923,34350068
5883,IRF,cell_type,0.6274,34350068
5884,DME,disease,1.0,34350068
5885,patients,species,0.9946,34350068
5886,Aflibercept,gene,0.9688,34348351
5887,Polypoidal choroidal vasculopathy,disease,1.0,34348351
5888,PCV,disease,1.0,34348351
5889,patients,species,0.93,34348351
5890,PCV,disease,1.0,34348351
5891,aflibercept,gene,0.962,34348351
5892,aflibercept,gene,0.9756,34348351
5893,Patients,species,0.9463,34348351
5894,verteporfin,drug,0.996,34348351
5895,polyp occlusion,disease,0.7974,34348351
5896,IVAI,DNA,0.5913,34348351
5897,patients,species,0.9814,34348351
5898,patients,species,0.9927,34348351
5899,Diabetic Retinopathy,disease,1.0,34348351
5900,patients,species,0.9893,34348351
5901,indocyanine green,drug,0.9966,34348351
5902,polypoidal,DNA,0.4543,34348351
5903,polypoidal lesions,disease,1.0,34348351
5904,aflibercept,gene,0.956,34348351
5905,BCVA,DNA,0.48,34348351
5906,CRT,DNA,0.6753,34348351
5907,polyp,disease,0.9736,34348351
5908,aflibercept,drug,0.516,34348351
5909,verteporfin,drug,0.9883,34348351
5910,PCV,disease,1.0,34348351
5911,Aflibercept,gene,0.955,34348351
5912,polypoidal,cell_type,0.435,34348351
5913,polypoidal lesions,disease,1.0,34348351
5914,PCV,disease,1.0,34348351
5915,patients,species,0.962,34348351
5916,Endophthalmitis,disease,0.9995,34348344
5917,post-injection endophthalmitis,disease,0.958,34348344
5918,VEGF,gene,0.999,34348344
5919,anti-VEGF,gene,0.9067,34348344
5920,endophthalmitis,disease,1.0,34348344
5921,endophthalmitis,disease,1.0,34348344
5922,endophthalmitis,disease,1.0,34348344
5923,endophthalmitis,disease,1.0,34348344
5924,post-injection endophthalmitis,disease,0.9917,34348344
5925,Ranibizumab,gene,0.958,34336421
5926,Aflibercept,gene,0.9805,34336421
5927,Neovascular Age-Related Introduction,disease,0.9907,34336421
5928,ranibizumab,gene,0.5454,34336421
5929,aflibercept,gene,0.974,34336421
5930,patients,species,0.9897,34336421
5931,neovascular age-related macular degeneration,disease,1.0,34336421
5932,AMD,disease,1.0,34336421
5933,ranibizumab,gene,0.6836,34336421
5934,aflibercept,gene,0.97,34336421
5935,ranibizumab,gene,0.538,34336421
5936,Diabetic Retinopathy,disease,0.9995,34336421
5937,aflibercept,gene,0.947,34336421
5938,ranibizumab,gene,0.8115,34336421
5939,aflibercept,gene,0.979,34336421
5940,ranibizumab,gene,0.7173,34336421
5941,aflibercept,gene,0.954,34336421
5942,Inflammatory Choroidal Neovascular Membranes,disease,1.0,34336264
5943,patients,species,0.983,34336264
5944,inflammatory choroidal neovascularization,disease,1.0,34336264
5945,I-CNV,disease,1.0,34336264
5946,patients,species,0.992,34336264
5947,I-CNV,disease,1.0,34336264
5948,patients,species,0.9717,34336264
5949,patients,species,0.9907,34336264
5950,CNV,disease,1.0,34336264
5951,Punctate inner choroidopathy,disease,1.0,34336264
5952,multifocal choroiditis,disease,1.0,34336264
5953,patients,species,0.9893,34336264
5954,Neovascularization,disease,0.94,34336264
5955,anti-VEGF,gene,0.9443,34336264
5956,bevacizumab,gene,0.9644,34336264
5957,aflibercept,gene,0.964,34336264
5958,ranibizumab,gene,0.8823,34336264
5959,inflammation,disease,0.7744,34336264
5960,cyclosporine,drug,0.999,34336264
5961,methotrexate,drug,0.9995,34336264
5962,VEGF,gene,0.6147,34336264
5963,cataract,disease,1.0,34336264
5964,patients,species,0.987,34336264
5965,ocular hypertension,disease,1.0,34336264
5966,patients,species,0.989,34336264
5967,VEGF,gene,0.5747,34336264
5968,I-CNV,disease,1.0,34336264
5969,neovascular conditions,disease,0.999,34336264
5970,Choroidal Folds,disease,0.993,34326758
5971,choroidal neovascularization,disease,0.9995,34326758
5972,CNV,disease,1.0,34326758
5973,patient,species,0.924,34326758
5974,pattern dystrophy,disease,1.0,34326758
5975,painless,disease,0.7837,34326758
5976,blurry central vision,disease,0.9805,34326758
5977,fluorescein,drug,0.9985,34326758
5978,pattern dystrophy,disease,1.0,34326758
5979,CNV,disease,1.0,34326758
5980,CF,disease,,34326758
5981,CNV,disease,0.9995,34326758
5982,bevacizumab,gene,0.96,34326758
5983,aflibercept,gene,0.9805,34326758
5984,Aflibercept,gene,0.957,34321818
5985,Dexamethasone,drug,0.9873,34321818
5986,aflibercept,gene,0.976,34321818
5987,Eylea,drug,0.9976,34321818
5988,dexamethasone,drug,0.9907,34321818
5989,Ozurdex,drug,0.9966,34321818
5990,dexamethasone,drug,0.9976,34321818
5991,macular edema,disease,1.0,34321818
5992,ME,disease,1.0,34321818
5993,retinal vein occlusion,disease,1.0,34321818
5994,RVO,disease,1.0,34321818
5995,patients,species,0.9844,34321818
5996,ME,disease,,34321818
5997,RVO,disease,1.0,34321818
5998,Patients,species,0.96,34321818
5999,dexamethasone,drug,0.9985,34321818
6000,Ozurdex,drug,0.968,34321818
6001,patients,species,0.9634,34321818
6002,Eylea,drug,0.973,34321818
6003,Ozurdex,drug,0.6606,34321818
6004,BCVA,DNA,0.4778,34321818
6005,Patients,species,0.9697,34321818
6006,Aflibercept,gene,0.9736,34321818
6007,dexamethasone,drug,0.998,34321818
6008,dexamethasone,drug,0.9976,34321818
6009,ME,disease,,34321818
6010,RVO,disease,0.9995,34321818
6011,murine,species,0.976,34321516
6012,Ischemic retinal dystrophies,disease,1.0,34321516
6013,vision loss,disease,0.9136,34321516
6014,VEGF-A,gene,0.932,34321516
6015,ischemic retinopathies,disease,1.0,34321516
6016,VEGF-family members,gene,0.987,34321516
6017,VEGFR1,gene,0.9937,34321516
6018,VEGFR2,gene,0.9917,34321516
6019,Aflibercept,gene,0.98,34321516
6020,Aflibercept,gene,0.9473,34321516
6021,oxygen,drug,0.9995,34321516
6022,OIR,disease,0.998,34321516
6023,mouse,species,0.9746,34321516
6024,murine,species,0.974,34321516
6025,OIR,disease,0.995,34321516
6026,Aflibercept,gene,0.989,34321516
6027,leukocyte,cell_type,0.7607,34321516
6028,Angiopoietin-2,gene,0.9937,34321516
6029,diabetic retinopathy,disease,1.0,34321516
6030,OIR,disease,0.997,34321516
6031,Aflibercept,gene,0.9106,34321516
6032,Aflibercept,gene,0.9756,34321516
6033,Aflibercept,gene,0.94,34321516
6034,ischemic retinopathies,disease,1.0,34321516
6035,Hypertensive cerebral hemorrhage,disease,1.0,34311786
6036,plasma,cell_type,0.5176,34311786
6037,anti-vascular endothelial growth factor,gene,0.875,34311786
6038,macular diseases,disease,1.0,34311786
6039,diabetic macular edema,disease,0.9995,34311786
6040,vascular endothelial growth factor,gene,0.9946,34311786
6041,vascular endothelial growth factor,gene,0.997,34311786
6042,man,species,0.803,34311786
6043,diabetic macular edema,disease,1.0,34311786
6044,vascular endothelial growth factor,gene,0.8896,34311786
6045,aflibercept,gene,0.9346,34311786
6046,diabetic macular edema,disease,1.0,34311786
6047,acute headache,disease,0.866,34311786
6048,patient,species,0.9707,34311786
6049,hypertensive cerebral hemorrhage of the occipital lobe,disease,0.994,34311786
6050,patient,species,0.985,34311786
6051,nicardipine hydrochloride,drug,0.992,34311786
6052,stroke,disease,0.988,34311786
6053,patient,species,0.989,34311786
6054,telmisartan,drug,0.993,34311786
6055,telmisartan,drug,0.992,34311786
6056,headache,disease,0.9995,34311786
6057,cerebrovascular stroke,disease,1.0,34311786
6058,telmisartan,drug,0.9976,34311786
6059,vascular endothelial growth factor,gene,0.991,34311786
6060,aflibercept,gene,0.9727,34311786
6061,vascular endothelial growth factor,gene,0.9985,34311786
6062,cerebral hemorrhage,disease,1.0,34311786
6063,vascular endothelial growth factor,gene,0.9824,34311786
6064,stroke,disease,0.997,34311786
6065,vascular endothelial growth factor,gene,0.9976,34311786
6066,hypertension,disease,1.0,34311786
6067,cerebral hemorrhage,disease,1.0,34311786
6068,patients,species,0.9346,34311786
6069,diabetic macular edema,disease,1.0,34311786
6070,plasma,gene,0.6133,34311786
6071,vascular endothelial growth factor,gene,0.877,34311786
6072,vascular endothelial growth factor,gene,0.899,34311786
6073,vascular endothelial growth factor,gene,0.9585,34311786
6074,stroke,disease,0.9995,34311786
6075,plasma,gene,0.4915,34311786
6076,vascular endothelial growth factor,gene,0.8784,34311786
6077,vascular endothelial growth factor,gene,0.936,34311786
6078,polypoidal choroidal vasculopathy,disease,1.0,34303031
6079,patients,species,0.9497,34303031
6080,polypoidal choroidal vasculopathy,disease,1.0,34303031
6081,PCV,disease,1.0,34303031
6082,ranibizumab,gene,0.6514,34303031
6083,aflibercept,gene,0.5625,34303031
6084,patients,species,0.9443,34303031
6085,PCV,disease,1.0,34303031
6086,BCVA,DNA,0.4373,34303031
6087,risk,DNA,0.51,34303031
6088,ARMS2,DNA,0.602,34303031
6089,ARMS2 A69S,gene,0.8574,34303031
6090,A69S,mutation,,34303031
6091,PCV,disease,1.0,34303031
6092,brolucizumab,gene,0.895,34301613
6093,aflibercept,gene,0.9844,34301613
6094,brolucizumab,gene,0.9106,34301613
6095,aflibercept,gene,0.978,34301613
6096,polypoidal choroidal vasculopathy,disease,1.0,34301613
6097,participants,species,0.9424,34301613
6098,neovascular age-related macular degeneration,disease,1.0,34301613
6099,participants,species,0.9365,34301613
6100,PCV,disease,1.0,34301613
6101,brolucizumab,gene,0.9404,34301613
6102,aflibercept,gene,0.977,34301613
6103,brolucizumab,gene,0.841,34301613
6104,Aflibercept,gene,0.9326,34301613
6105,participants,species,0.966,34301613
6106,diabetic retinopathy,disease,0.9893,34301613
6107,brolucizumab,gene,0.895,34301613
6108,aflibercept,gene,0.9785,34301613
6109,brolucizumab,gene,0.715,34301613
6110,brolucizumab,gene,0.9116,34301613
6111,aflibercept,gene,0.969,34301613
6112,intraretinal fluid,disease,0.992,34301613
6113,subretinal fluid,disease,0.993,34301613
6114,Brolucizumab,gene,0.8325,34301613
6115,intraocular inflammation,disease,1.0,34301613
6116,aflibercept,gene,0.9785,34301613
6117,PCV,disease,1.0,34301613
6118,brolucizumab,gene,0.9033,34301613
6119,aflibercept,gene,0.987,34301613
6120,brolucizumab,gene,0.935,34301613
6121,aflibercept,gene,0.9893,34301613
6122,brolucizumab,gene,0.9316,34301613
6123,participants,species,0.978,34301613
6124,Aflibercept,gene,0.9316,34300328
6125,Macular Edema,disease,1.0,34300328
6126,aflibercept,gene,0.9663,34300328
6127,macular edema,disease,1.0,34300328
6128,ME,disease,1.0,34300328
6129,branch retinal vein occlusion,disease,1.0,34300328
6130,BRVO,disease,1.0,34300328
6131,patients,species,0.9707,34300328
6132,ME,disease,,34300328
6133,BRVO,disease,0.9995,34300328
6134,patients,species,0.9897,34300328
6135,aflibercept,gene,0.748,34300328
6136,BCVA,cell_type,0.4539,34300328
6137,ME,disease,,34300328
6138,BRVO,disease,1.0,34300328
6139,patients,species,0.977,34298010
6140,inflammatory choroidal neovascularization,disease,1.0,34298010
6141,CNV,disease,1.0,34298010
6142,anti-,gene,0.7544,34298010
6143,vascular endothelial growth factor,gene,0.891,34298010
6144,anti-VEGF,gene,0.9517,34298010
6145,patients,species,0.9673,34298010
6146,inflammatory CNV,disease,0.9995,34298010
6147,VEGF,gene,0.557,34298010
6148,participants,species,0.9634,34298010
6149,Patients,species,0.979,34298010
6150,bevacizumab,gene,0.8687,34298010
6151,ranibizumab,gene,0.8687,34298010
6152,aflibercept,gene,0.962,34298010
6153,anti-VEGF,gene,0.9033,34298010
6154,choroidal hypertransmission,disease,0.986,34298010
6155,retinal pigment epithelium atrophy or absence,disease,1.0,34298010
6156,RPEA,disease,1.0,34298010
6157,HRF,disease,0.9995,34298010
6158,choroidal vessel engorgement,disease,0.976,34298010
6159,choroidal excavation,disease,0.9976,34298010
6160,BCVA,DNA,0.5063,34298010
6161,patients,species,0.9883,34298010
6162,intraretinal HRF,disease,0.7305,34298010
6163,Inflammatory CNV,disease,0.9756,34298010
6164,BCVA,cell_type,0.4177,34298010
6165,RPEA,DNA,0.4963,34298010
6166,anti-VEGF,gene,0.6914,34298010
6167,Aflibercept,gene,0.9824,34285463
6168,Ranibizumab,gene,0.878,34285463
6169,Bevacizumab,gene,0.75,34285463
6170,aflibercept,gene,0.989,34285463
6171,diabetic macular edema,disease,1.0,34285463
6172,DME,disease,1.0,34285463
6173,bevacizumab,gene,0.8657,34285463
6174,patients,species,0.9697,34285463
6175,DMEof,disease,1.0,34285463
6176,bevacizumab,gene,0.58,34285463
6177,ranibizumab,gene,0.799,34285463
6178,aflibercept,gene,0.95,34285463
6179,anti-VEGF,gene,0.9897,34285463
6180,anti-VEGF,gene,0.973,34285463
6181,patients,species,0.9893,34285463
6182,patients,species,0.9897,34285463
6183,bevacizumab,gene,0.937,34285463
6184,Dry macula,disease,1.0,34285463
6185,DME,disease,1.0,34285463
6186,bevacizumab,gene,0.9062,34285463
6187,aflibercept,gene,0.9907,34285463
6188,ranibizumab,gene,0.797,34285463
6189,Aflibercept,gene,0.9707,34285463
6190,DME,disease,1.0,34285463
6191,ranibizumab,gene,0.787,34285463
6192,diabetic macular edema,disease,1.0,34284605
6193,aflibercept,gene,0.9785,34284605
6194,ranibizumab,gene,0.7783,34284605
6195,patients,species,0.976,34284605
6196,diabetic macular edema,disease,1.0,34284605
6197,DME,disease,1.0,34284605
6198,aflibercept,gene,0.9873,34284605
6199,AFL,gene,0.994,34284605
6200,dexamethasone,drug,0.997,34284605
6201,ranibizumab,gene,0.55,34284605
6202,RAN,gene,0.838,34284605
6203,patient,species,0.989,34284605
6204,AFL,drug,0.989,34284605
6205,DXI,drug,0.994,34284605
6206,RAN,drug,0.994,34284605
6207,AFL,drug,0.952,34284605
6208,DXI,drug,0.979,34284605
6209,patients,species,0.9863,34284605
6210,RAN,drug,0.9946,34284605
6211,AFL,drug,0.992,34284605
6212,DXI,drug,0.9946,34284605
6213,RAN,drug,0.9824,34284605
6214,AFL,drug,0.994,34284605
6215,DXI,drug,0.985,34284605
6216,RAN,drug,0.9863,34284605
6217,IVI,disease,0.823,34284605
6218,DXI,drug,0.9883,34284605
6219,AFL,drug,0.9907,34284605
6220,AFL,drug,0.994,34284605
6221,DXI,drug,0.9937,34284605
6222,RAN,drug,0.9854,34284605
6223,patients,species,0.952,34283294
6224,patients,species,0.986,34283294
6225,aflibercept,gene,0.96,34283294
6226,AFL,gene,0.545,34283294
6227,patients,species,0.994,34283294
6228,exudative age-related macular degeneration,disease,0.9995,34283294
6229,AMD,disease,1.0,34283294
6230,Diabetic Retinopathy,disease,0.9995,34283294
6231,patients,species,0.984,34283294
6232,patients,species,0.987,34283294
6233,patients,species,0.9766,34283294
6234,patients,species,0.987,34283294
6235,IRF,gene,0.9395,34283294
6236,patients,species,0.989,34283294
6237,SRF,gene,0.9717,34283294
6238,IRF,gene,0.881,34283294
6239,SRF,gene,0.996,34283294
6240,patients,species,0.9873,34283294
6241,IRF,gene,0.9927,34283294
6242,SRF,gene,0.9976,34283294
6243,IRF,gene,0.9854,34283294
6244,SRF,gene,0.9937,34283294
6245,IRF,gene,0.9917,34283294
6246,IRF,gene,0.992,34283294
6247,SRF,gene,0.9956,34283294
6248,SRF,gene,0.9937,34283294
6249,patients,species,0.9204,34283294
6250,exudative AMD,disease,0.9995,34283294
6251,Patients,species,0.948,34283294
6252,patients,species,0.9824,34283294
6253,patients,species,0.961,34283294
6254,IRF,disease,0.9873,34283294
6255,patients,species,0.965,34283294
6256,SRF,disease,0.9404,34283294
6257,ranibizumab,gene,0.912,34282403
6258,aflibercept,gene,0.9746,34282403
6259,patient,species,0.883,34277827
6260,metastatic colorectal cancer,disease,1.0,34277827
6261,MCRC,disease,1.0,34277827
6262,FIr-B,drug,0.9985,34277827
6263,FOx,drug,0.95,34277827
6264,bevacizumab,gene,0.6636,34277827
6265,woman,species,0.8843,34277827
6266,rectal cancer,disease,1.0,34277827
6267,lymph nodes involvement,disease,0.8496,34277827
6268,liver metastases,disease,0.966,34277827
6269,FIr-B,drug,0.996,34277827
6270,FOx,drug,0.9395,34277827
6271,FIr-B,drug,0.9814,34277827
6272,FIr,drug,0.672,34277827
6273,Patient,species,0.9546,34277827
6274,limiting toxicity syndrome,disease,0.8857,34277827
6275,LTS,disease,0.93,34277827
6276,diarrhea,disease,0.9995,34277827
6277,asthenia,disease,0.9995,34277827
6278,nausea,disease,0.997,34277827
6279,irinotecan,drug,0.997,34277827
6280,5-fluorouracil,drug,0.999,34277827
6281,oxaliplatin,drug,0.9995,34277827
6282,infusional hypersensitivity reaction,disease,0.99,34277827
6283,aflibercept,gene,0.9385,34277827
6284,irinotecan,drug,0.999,34277827
6285,panitumumab,gene,0.902,34277827
6286,KRAS,gene,0.9497,34277827
6287,NRAS,gene,0.997,34277827
6288,BRAF,gene,0.998,34277827
6289,EGFR c,DNA,0.7104,34277827
6290,EGFR c.2156,gene,0.7656,34277827
6291,G719A,mutation,,34277827
6292,regorafenib,drug,0.9917,34277827
6293,trifluridine,drug,0.999,34277827
6294,tipiracil,drug,0.999,34277827
6295,leucopenia,disease,0.7627,34277827
6296,neutropenia,disease,0.941,34277827
6297,thrombocytopenia,disease,1.0,34277827
6298,asthenia,disease,1.0,34277827
6299,anemia,disease,0.994,34277827
6300,diarrhea,disease,1.0,34277827
6301,hypotension,disease,1.0,34277827
6302,patient,species,0.975,34277827
6303,patient,species,0.9917,34277827
6304,RAS,gene,0.999,34277827
6305,BRAF,gene,0.998,34277827
6306,patient,species,0.9395,34277827
6307,MCRC,disease,0.993,34277827
6308,anti-vascular endothelial growth factor,gene,0.961,34275395
6309,anti-vascular endothelial growth factor,gene,0.967,34275395
6310,anti-VEGF,gene,0.993,34275395
6311,diabetic macular edema,disease,1.0,34275395
6312,DME,disease,1.0,34275395
6313,patients,species,0.9814,34275395
6314,VEGF,gene,0.9033,34275395
6315,DME,disease,1.0,34275395
6316,patients,species,0.994,34275395
6317,BCVA,DNA,0.5005,34275395
6318,central,DNA,0.4692,34275395
6319,patients,species,0.9775,34275395
6320,MT,DNA,0.591,34275395
6321,MT,DNA,0.6826,34275395
6322,diabetic macular edema,disease,1.0,34275395
6323,anti-VEGF,gene,0.8315,34275395
6324,ranibizumab,gene,0.717,34272419
6325,aflibercept,gene,0.9766,34272419
6326,neovascular age,disease,0.999,34272419
6327,ranibizumab,gene,0.535,34272419
6328,RBZ,gene,0.774,34272419
6329,aflibercept,gene,0.953,34272419
6330,neovascular age-related macular degeneration,disease,1.0,34272419
6331,nAMD,disease,1.0,34272419
6332,polypoidal choroidal vasculopathy,disease,1.0,34272419
6333,PCV,disease,1.0,34272419
6334,nAMD,disease,1.0,34272419
6335,PCV,disease,1.0,34272419
6336,nAMD,disease,1.0,34272419
6337,nAMD,disease,1.0,34272419
6338,PCV,disease,1.0,34272419
6339,patients,species,0.9795,34272419
6340,RBZ,disease,1.0,34272419
6341,AFL,disease,1.0,34272419
6342,RBZ,drug,0.9897,34272419
6343,AFL,drug,0.9873,34272419
6344,nAMD,disease,1.0,34272419
6345,PCV,disease,1.0,34272419
6346,RBZ,drug,0.944,34272419
6347,AFL,drug,0.9805,34272419
6348,nAMD,disease,1.0,34272419
6349,PCV,disease,1.0,34272419
6350,aflibercept,gene,0.939,34266844
6351,aflibercept,gene,0.93,34266844
6352,aflibercept,gene,0.8584,34266844
6353,polypoidal choroidal vasculopathy,disease,1.0,34266844
6354,PCV,disease,1.0,34266844
6355,patients,species,0.9746,34266844
6356,PCV,disease,0.9985,34266844
6357,indocyanine green,drug,0.9927,34266844
6358,patients,species,0.987,34266844
6359,aflibercept,gene,0.988,34266844
6360,aflibercept,gene,0.9844,34266844
6361,patients,species,0.983,34266844
6362,BRAF,gene,0.997,34259881
6363,metastatic colorectal carcinoma,disease,1.0,34259881
6364,metastatic colorectal cancer,disease,1.0,34259881
6365,mCRC,disease,1.0,34259881
6366,irinotecan,drug,0.9995,34259881
6367,oxaliplatin,drug,0.9995,34259881
6368,epidermal,gene,0.8613,34259881
6369,EGFR,gene,0.9966,34259881
6370,cetuximab,gene,0.9004,34259881
6371,panitumumab,gene,0.8955,34259881
6372,bevacizumab,gene,0.686,34259881
6373,aflibercept,gene,0.9365,34259881
6374,mCRC,disease,0.995,34259881
6375,mCRC,disease,0.975,34259881
6376,patients,species,0.9946,34259881
6377,RAS,gene,0.991,34259881
6378,cetuximab,gene,0.7964,34259881
6379,panitumumab,gene,0.78,34259881
6380,BRAF,gene,0.993,34259881
6381,BRAF,gene,0.9927,34259881
6382,encorafenib,drug,0.9517,34259881
6383,cetuximab,gene,0.56,34259881
6384,BRAF-V600E,DNA,0.7603,34259881
6385,BRAF-V600E mutation,gene,0.913,34259881
6386,V600E,mutation,,34259881
6387,BRAF,gene,0.998,34259881
6388,mCRC,disease,0.996,34259881
6389,BRAF,gene,0.994,34259881
6390,mCRC,disease,0.998,34259881
6391,patients,species,0.9897,34259881
6392,BRAF,DNA,0.771,34259881
6393,BRAF mutations,gene,0.7783,34259881
6394,mCRC,disease,0.9985,34259881
6395,patients,species,0.994,34259881
6396,VEGF,gene,0.6265,34258656
6397,Patients,species,0.9917,34258656
6398,ranibizumab,gene,0.8887,34258656
6399,bevacizumab,gene,0.8926,34258656
6400,aflibercept,gene,0.9795,34258656
6401,patients,species,0.987,34258656
6402,patients,species,0.9873,34258656
6403,Diabetic retinopathy,disease,1.0,34256400
6404,Diabetic retinopathy,disease,1.0,34256400
6405,proliferative diabetic retinopathy,disease,1.0,34256400
6406,PDR,disease,1.0,34256400
6407,diabetic macular edema,disease,1.0,34256400
6408,DME,disease,1.0,34256400
6409,vascular endothelial growth factor,gene,0.999,34256400
6410,VEGF,gene,0.997,34256400
6411,macular edema,disease,1.0,34256400
6412,VEGF,gene,0.996,34256400
6413,Bevacizumab,gene,0.8975,34256400
6414,Ranibizumab,gene,0.9487,34256400
6415,VEGF,gene,0.9976,34256400
6416,Aflibercept,gene,0.99,34256400
6417,DME,disease,0.999,34256400
6418,VEGF,gene,0.992,34256400
6419,DME,disease,1.0,34256400
6420,PDR,disease,1.0,34256400
6421,diabetologists,disease,0.9917,34256400
6422,diabetes,disease,1.0,34256400
6423,patients,species,0.967,34255798
6424,age-related macular degeneration,disease,1.0,34255798
6425,diabetic,disease,0.9653,34255798
6426,anti-vascular endothelial growth factor,gene,0.966,34255798
6427,VEGF,gene,0.9985,34255798
6428,patients,species,0.9854,34255798
6429,neovascular age-related macular degeneration,disease,1.0,34255798
6430,nAMD,disease,1.0,34255798
6431,diabetic macular edema,disease,1.0,34255798
6432,DME,disease,1.0,34255798
6433,patients,species,0.982,34255798
6434,nAMD,disease,1.0,34255798
6435,DME,disease,1.0,34255798
6436,ranibizumab,gene,0.798,34255798
6437,aflibercept,gene,0.955,34255798
6438,patients,species,0.976,34255798
6439,ranibizumab,gene,0.816,34255798
6440,aflibercept,gene,0.9316,34255798
6441,nAMD,disease,1.0,34255798
6442,DME,disease,1.0,34255798
6443,patients,species,0.99,34255798
6444,DME,disease,1.0,34255798
6445,ranibizumab,drug,0.848,34255798
6446,aflibercept,gene,0.8047,34255798
6447,nAMD,disease,1.0,34255798
6448,ranibizumab,gene,0.982,34255798
6449,aflibercept,gene,0.9316,34255798
6450,ranibizumab,gene,0.975,34255798
6451,aflibercept,gene,0.8765,34255798
6452,nAMD,disease,1.0,34255798
6453,ranibizumab,gene,0.9946,34255798
6454,DME,disease,0.994,34255798
6455,patients,species,0.9814,34255798
6456,anti-VEGF,gene,0.7705,34255798
6457,patients,species,0.9873,34255798
6458,VEGF,gene,0.8916,34255798
6459,patients,species,0.9893,34255798
6460,diabetes,disease,1.0,34255798
6461,patients,species,0.9478,34255798
6462,nAMD,disease,1.0,34255798
6463,DME,disease,1.0,34255798
6464,VEGF,gene,0.693,34255798
6465,patient,species,0.964,34255798
6466,Aflibercept,gene,0.988,34250732
6467,endothelial cells,cell_type,0.894,34250732
6468,Aflibercept,gene,0.9526,34250732
6469,wet AMD,disease,0.9497,34250732
6470,colorectal cancer,disease,1.0,34250732
6471,Aflibercept,gene,0.959,34250732
6472,VEGFR2,gene,0.9937,34250732
6473,candidate genes,DNA,0.6626,34250732
6474,VEGFA,gene,0.9976,34250732
6475,VEGFR2,gene,0.9917,34250732
6476,candidate genes,DNA,0.669,34250732
6477,genes,DNA,0.628,34250732
6478,Aflibercept,gene,0.953,34250732
6479,HUVEC cells,cell_line,0.934,34250732
6480,genes,DNA,0.5957,34250732
6481,Aflibercept,gene,0.984,34250732
6482,VEGF,gene,0.998,34250732
6483,PI3KA,gene,0.9985,34250732
6484,AKT,gene,0.9985,34250732
6485,mTOR,gene,0.9956,34250732
6486,MMP14,gene,0.998,34250732
6487,MMP9,gene,0.997,34250732
6488,IL-6,gene,0.9727,34250732
6489,STAT3,gene,0.997,34250732
6490,Aflibercept,gene,0.94,34250732
6491,Aflibercept,gene,0.976,34250732
6492,candidate genes,DNA,0.5015,34250732
6493,Aflibercept,gene,0.9854,34250732
6494,HUVEC,cell_line,0.9536,34250732
6495,HUVEC cells,cell_type,0.773,34250732
6496,Aflibercept,gene,0.9707,34244672
6497,patients,species,0.994,34244672
6498,aflibercept,gene,0.958,34244672
6499,diabetic macular oedema,disease,1.0,34244672
6500,patients,species,0.972,34244672
6501,IMD,disease,0.772,34244672
6502,aflibercept,gene,0.9927,34244670
6503,diabetic,disease,0.953,34244670
6504,DRAKO,DNA,0.4734,34244670
6505,patients,species,0.985,34244670
6506,diabetic macular oedema,disease,1.0,34244670
6507,DMO,disease,1.0,34244670
6508,aflibercept,gene,0.99,34244670
6509,AFL,gene,0.7876,34244670
6510,anti-vascular endothelial growth factor,gene,0.9795,34244670
6511,anti-VEGF,gene,0.9756,34244670
6512,patient,species,0.9326,34244670
6513,patients,species,0.9844,34244670
6514,patients,species,0.99,34244670
6515,BCVA70,DNA,0.4734,34244670
6516,patients,species,0.9775,34244670
6517,DMO,disease,1.0,34244670
6518,patients,species,0.9736,34244670
6519,patients,species,0.984,34244670
6520,diabetic retinopathy,disease,1.0,34244670
6521,VEGF,gene,0.9785,34228553
6522,patients,species,0.969,34228553
6523,myopic choroidal INTRODUCTION,disease,0.994,34228553
6524,VEGF,gene,0.5654,34228553
6525,myopic choroidal neovascularization,disease,1.0,34228553
6526,CNV,disease,1.0,34228553
6527,myopic CNV,disease,1.0,34228553
6528,ranibizumab,gene,0.5693,34228553
6529,aflibercept,gene,0.9517,34228553
6530,conbercept,gene,0.7134,34228553
6531,bevacizumab,gene,0.8154,34228553
6532,ziv-aflibercept,gene,0.9644,34228553
6533,VEGF,gene,0.9214,34228553
6534,myopic CNV,disease,1.0,34228553
6535,VEGF,gene,0.597,34228553
6536,VEGF,gene,0.711,34228553
6537,myopic CNV,disease,1.0,34228553
6538,myopic traction maculopathy,disease,1.0,34228553
6539,retinal detachment,disease,1.0,34228553
6540,chorioretinal atrophy,disease,1.0,34228553
6541,VEGF,gene,0.6206,34228553
6542,patients,species,0.9663,34226158
6543,gastrointestinal cancers,disease,1.0,34226158
6544,malignancies,disease,1.0,34226158
6545,gastrointestinal cancers,disease,1.0,34226158
6546,patients,species,0.9805,34226158
6547,patients,species,0.9834,34226158
6548,patients,species,0.9863,34226158
6549,patients,species,0.9854,34226158
6550,patients,species,0.967,34226158
6551,gastrointestinal cancer,disease,1.0,34226158
6552,colorectal cancer,disease,1.0,34226158
6553,patients,species,0.962,34226158
6554,gastrointestinal carcinomas,disease,1.0,34226158
6555,colon and rectum,disease,0.9966,34226158
6556,esophagus,disease,0.689,34226158
6557,cetuximab,gene,0.9644,34226158
6558,panitumumab,gene,0.9463,34226158
6559,bevacizumab,gene,0.852,34226158
6560,ramucirumab,gene,0.564,34226158
6561,aflibercept,gene,0.987,34226158
6562,regorafenib,drug,0.9976,34226158
6563,encorafenib,drug,0.9966,34226158
6564,trastuzumab,gene,0.95,34226158
6565,sorafenib,drug,0.9995,34226158
6566,lenvatinib,drug,0.9985,34226158
6567,cabozantinib,drug,0.999,34226158
6568,erlotinib,drug,0.999,34226158
6569,olaparib,drug,0.9995,34226158
6570,Human Platelets,cell_type,0.8394,34221496
6571,Human,species,0.861,34221496
6572,Anti-VEGF Agents,gene,0.709,34221496
6573,vascular endothelial growth factor,gene,0.8774,34221496
6574,VEGF,gene,0.5103,34221496
6575,VEGF,gene,0.698,34221496
6576,anti-VEGF,gene,0.984,34221496
6577,nonresident platelets,cell_type,0.6826,34221496
6578,platelets,cell_type,0.8477,34221496
6579,VEGF,gene,0.551,34221496
6580,ranibizumab,gene,0.837,34221496
6581,aflibercept,gene,0.982,34221496
6582,bevacizumab,gene,0.9097,34221496
6583,VEGF,gene,0.9336,34221496
6584,VEGF,gene,0.992,34221496
6585,human platelets,cell_type,0.8535,34221496
6586,human,species,0.813,34221496
6587,actin filaments,gene,0.799,34221496
6588,clathrin,gene,0.994,34221496
6589,ranibizumab,gene,0.9194,34221496
6590,aflibercept,gene,0.9824,34221496
6591,bevacizumab,gene,0.8843,34221496
6592,staurosporine,drug,0.997,34221496
6593,cytochalasin D,drug,0.9995,34221496
6594,VEGF,gene,0.7656,34221496
6595,platelets,cell_type,0.846,34221496
6596,VEGF,gene,0.992,34221496
6597,Ranibizumab,gene,0.9004,34221496
6598,aflibercept,gene,0.9873,34221496
6599,bevacizumab,gene,0.7344,34221496
6600,platelet vesicles,cell_type,0.62,34221496
6601,staurosporine,drug,0.998,34221496
6602,cytochalasin D,drug,0.9995,34221496
6603,aflibercept,gene,0.9814,34221496
6604,platelets,cell_type,0.798,34221496
6605,ranibizumab,gene,0.911,34221496
6606,bevacizumab,gene,0.7437,34221496
6607,platelets,cell_type,0.8154,34221496
6608,Bevacizumab,gene,0.7026,34221496
6609,clathrin,gene,0.993,34221496
6610,ranibizumab,gene,0.654,34221496
6611,aflibercept,gene,0.991,34221496
6612,anti-VEGF,gene,0.882,34221496
6613,platelets,cell_type,0.8345,34221496
6614,platelets,cell_type,0.8223,34221496
6615,arterial thromboembolic events,disease,0.996,34221496
6616,Clathrin,gene,0.9956,34221496
6617,bevacizumab,gene,0.8066,34221496
6618,ranibizumab,gene,0.7744,34221496
6619,aflibercept,gene,0.9937,34221496
6620,bevacizumab,gene,0.8604,34221496
6621,Vascular endothelial growth factor,gene,0.998,34219948
6622,VEGF,gene,0.998,34219948
6623,cancers,disease,1.0,34219948
6624,diabetic retinopathy,disease,1.0,34219948
6625,hypertension,disease,1.0,34219948
6626,proteinuria,disease,1.0,34219948
6627,renal,disease,0.6797,34219948
6628,hypertension,disease,1.0,34219948
6629,thrombotic microangiopathy,disease,1.0,34219948
6630,glomerular disease,disease,1.0,34219948
6631,bevacizumab,gene,0.9326,34219948
6632,aflibercept,gene,0.9844,34219948
6633,ranibizumab,gene,0.8774,34219948
6634,patient,species,0.988,34219948
6635,bevacizumab,gene,0.8213,34219948
6636,diabetic retinopathy,disease,1.0,34219948
6637,high blood pressure,disease,0.9976,34219948
6638,nephrotic,disease,0.997,34219948
6639,proteinuria,disease,0.9995,34219948
6640,Aflibercept,gene,0.9316,34213757
6641,Macular Disease,disease,1.0,34213757
6642,cancer,disease,0.9985,34212275
6643,differentiated,cell_type,0.48,34212275
6644,endothelial cells,cell_type,0.7964,34212275
6645,tumour,disease,1.0,34212275
6646,cancer,disease,0.9995,34212275
6647,tumour,disease,1.0,34212275
6648,cancer,disease,0.9985,34212275
6649,Vascular endothelial growth factor,gene,0.9985,34212275
6650,VEGF,gene,0.997,34212275
6651,cancers,disease,1.0,34212275
6652,VEGF,gene,0.996,34212275
6653,HIF,gene,0.9873,34212275
6654,VEGF,gene,0.933,34212275
6655,bevacizumab,gene,0.5874,34212275
6656,tyrosine,drug,0.9927,34212275
6657,tyrosine kinase,gene,0.979,34212275
6658,sorafenib,drug,0.996,34212275
6659,VEGF,gene,0.9937,34212275
6660,aflibercept,gene,0.9854,34212275
6661,VEGFR2,gene,0.995,34212275
6662,tumour cell,cell_type,0.7,34212275
6663,tumour,disease,0.999,34212275
6664,tumour,disease,1.0,34212275
6665,tumour,disease,1.0,34212275
6666,Tumour,disease,1.0,34212275
6667,cancer,disease,1.0,34212275
6668,Tumour,disease,1.0,34212275
6669,HIF,DNA,0.5347,34212275
6670,HIF- gene,gene,0.9746,34212275
6671,miRNAs,RNA,0.6953,34212275
6672,tumour,disease,1.0,34212275
6673,mesenchymal,cell_type,0.456,34212275
6674,cancer,disease,0.999,34212275
6675,anti-vascular endothelial growth factor,gene,0.97,34211264
6676,VEGF,gene,0.649,34211264
6677,choroidal neovascularization,disease,1.0,34211264
6678,CNV,disease,1.0,34211264
6679,pathological myopia,disease,1.0,34211264
6680,PATIENTS,species,0.9263,34211264
6681,patients,species,0.9863,34211264
6682,myopic CNV,disease,1.0,34211264
6683,ranibizumab,gene,0.8506,34211264
6684,aflibercept,gene,0.861,34211264
6685,patients,species,0.984,34211264
6686,patients,species,0.9775,34211264
6687,patients,species,0.989,34211264
6688,patient,species,0.9795,34211264
6689,myopic CNV,disease,0.9995,34211264
6690,ranibizumab,gene,0.7944,34211264
6691,aflibercept,gene,0.957,34211264
6692,patients,species,0.986,34211264
6693,Myopic CNV,disease,1.0,34211264
6694,neovascular age-related macular degeneration,disease,1.0,34211264
6695,diabetic macular edema,disease,0.9995,34211264
6696,patients,species,0.9893,34211264
6697,Aflibercept,gene,0.911,34204557
6698,aflibercept,gene,0.9785,34204557
6699,macular edema,disease,1.0,34204557
6700,ME,disease,1.0,34204557
6701,branch retinal vein occlusion,disease,1.0,34204557
6702,BRVO,disease,1.0,34204557
6703,patients,species,0.977,34204557
6704,BRVO-ME,disease,0.9263,34204557
6705,patients,species,0.99,34204557
6706,patients,species,0.978,34204557
6707,ME,disease,,34204557
6708,BRVO,disease,1.0,34204557
6709,ME,disease,,34204557
6710,choroidal thinning,disease,0.9565,34204557
6711,SCT,cell_type,0.462,34204557
6712,BRVO,disease,0.99,34204557
6713,Brolucizumab,gene,0.577,34204266
6714,Neovascular Age-Related Macular Degeneration,disease,1.0,34204266
6715,nAMD,disease,1.0,34204266
6716,brolucizumab,gene,0.87,34204266
6717,retinal fluid,disease,0.9937,34204266
6718,aflibercept,gene,0.9834,34204266
6719,ranibizumab,gene,0.606,34204266
6720,brolucizumab,gene,0.84,34204266
6721,brolucizumab,gene,0.8394,34204266
6722,ETDRS,DNA,0.4817,34204266
6723,intraocular inflammations,disease,1.0,34204266
6724,vascular occlusion,disease,0.9995,34204266
6725,vision loss,disease,0.9824,34204266
6726,stroke,disease,0.997,34204266
6727,brolucizumab,gene,0.7935,34204266
6728,nAMD,disease,1.0,34204266
6729,intraocular inflammation,disease,1.0,34204266
6730,Brolucizumab,gene,0.705,34200829
6731,PED,disease,0.966,34200829
6732,Brolucizumab,gene,0.735,34200829
6733,macular neovascularization,disease,1.0,34200829
6734,exudative age-related macular degeneration,disease,1.0,34200829
6735,e-AMD,disease,1.0,34200829
6736,patients,species,0.9883,34200829
6737,PED,disease,1.0,34200829
6738,e-AMD,disease,1.0,34200829
6739,MNV,drug,0.957,34200829
6740,Ranibizumab,gene,0.9624,34200829
6741,Aflibercept,gene,0.968,34200829
6742,HMD,DNA,0.508,34200829
6743,PED,drug,0.697,34200829
6744,MNV,cell_line,0.4543,34200829
6745,ocular inflammation,disease,0.9995,34200829
6746,Brolucizumab,gene,0.882,34200829
6747,PEDs,disease,0.5884,34200829
6748,AMD,disease,0.9985,34200829
6749,Pseudomyxoma Peritonei,disease,1.0,34198773
6750,Pseudomyxoma peritonei,disease,1.0,34198773
6751,PMP,disease,1.0,34198773
6752,slow-growing cancer,disease,0.92,34198773
6753,mucinous tumor,disease,0.9985,34198773
6754,patients,species,0.9766,34198773
6755,PMP,disease,1.0,34198773
6756,patient,species,0.972,34198773
6757,CD31,gene,0.9873,34198773
6758,CD105,gene,0.9844,34198773
6759,human,species,0.914,34198773
6760,umbilical cord vascular endothelial cells,cell_line,0.8,34198773
6761,HUVEC,cell_line,0.9463,34198773
6762,patient,species,0.949,34198773
6763,PMP,disease,1.0,34198773
6764,PMP,cell_type,0.7417,34198773
6765,PMP tumor,disease,0.9873,34198773
6766,vascular endothelial growth factor,gene,0.9985,34198773
6767,VEGF,gene,0.998,34198773
6768,fibroblast growth factor 2,gene,0.9985,34198773
6769,HUVEC,cell_line,0.7104,34198773
6770,tumor,disease,1.0,34198773
6771,VEGF,gene,0.9927,34198773
6772,bevacizumab,gene,0.6685,34198773
6773,xenograft models,cell_line,0.5615,34198773
6774,VEGF,gene,0.996,34198773
6775,bevacizumab,gene,0.86,34198773
6776,aflibercept,gene,0.9766,34198773
6777,tumor,disease,1.0,34198773
6778,PMP,disease,0.9995,34198773
6779,patients,species,0.9907,34198773
6780,Neovascular Age-Related Macular Degeneration,disease,1.0,34198354
6781,Age-related macular degeneration,disease,1.0,34198354
6782,AMD,disease,1.0,34198354
6783,visual impairment,disease,1.0,34198354
6784,blindness,disease,1.0,34198354
6785,patients,species,0.989,34198354
6786,AMD,disease,0.9976,34198354
6787,AMD,disease,1.0,34198354
6788,nAMD,disease,1.0,34198354
6789,ranibizumab,gene,0.849,34198354
6790,aflibercept,gene,0.974,34198354
6791,brolucizumab,gene,0.9355,34198354
6792,bevacizumab,gene,0.928,34198354
6793,patients,species,0.9907,34198354
6794,patient,species,0.988,34198354
6795,patients,species,0.9883,34198354
6796,patients,species,0.9854,34198354
6797,patients,species,0.988,34198354
6798,nAMD,disease,1.0,34198354
6799,patients,species,0.992,34198354
6800,Aflibercept,gene,0.9727,34192895
6801,VEGF,gene,0.999,34192895
6802,Vascular Endothelial Growth Factor,gene,0.991,34192895
6803,Brain edema,disease,1.0,34192895
6804,acute stroke,disease,1.0,34192895
6805,VEGF,gene,0.9976,34192895
6806,Vascular endothelial growth factor,gene,0.9976,34192895
6807,edema,disease,1.0,34192895
6808,obesity,disease,0.999,34192895
6809,VEGF,gene,0.994,34192895
6810,brain edema,disease,1.0,34192895
6811,VEGF,gene,0.9927,34192895
6812,stroke,disease,0.9854,34192895
6813,obese,disease,0.9404,34192895
6814,obese,disease,0.7183,34192895
6815,mice,species,0.9697,34192895
6816,VEGF-A,gene,0.9956,34192895
6817,VEGFR2,gene,0.988,34192895
6818,infarct,disease,0.5146,34192895
6819,aflibercept,gene,0.9907,34192895
6820,VEGF-binding domain,gene,0.9946,34192895
6821,human umbilical vein endothelial cells,cell_line,0.9355,34192895
6822,human,species,0.9727,34192895
6823,rVEGF,gene,0.9946,34192895
6824,recombinant VEGF,gene,0.997,34192895
6825,aflibercept,gene,0.9873,34192895
6826,IgG,gene,0.9697,34192895
6827,obese,disease,0.754,34192895
6828,mice,species,0.9365,34192895
6829,IgG,gene,0.9956,34192895
6830,mice,species,0.9746,34192895
6831,aflibercept,gene,0.98,34192895
6832,malignant infarction,disease,0.9077,34192895
6833,mice,species,0.9746,34192895
6834,obese,disease,0.9766,34192895
6835,mice,species,0.9673,34192895
6836,VEGF-A,gene,0.9966,34192895
6837,VEGFR2,gene,0.987,34192895
6838,Aflibercept,gene,0.9614,34192895
6839,VEGF-A,gene,0.9946,34192895
6840,human umbilical vein endothelial cells,cell_line,0.913,34192895
6841,human,species,0.972,34192895
6842,IgG,gene,0.922,34192895
6843,mice,species,0.9585,34192895
6844,aflibercept,gene,0.9814,34192895
6845,hemorrhagic transformation,disease,0.8623,34192895
6846,brain swelling,disease,0.9995,34192895
6847,mice,species,0.9604,34192895
6848,stroke,disease,0.9976,34192895
6849,aflibercept,gene,0.985,34192895
6850,stroke,disease,0.9917,34192895
6851,aflibercept,gene,0.9907,34192895
6852,stroke,disease,0.9995,34192895
6853,brain edema,disease,0.9985,34192895
6854,mice,species,0.9253,34192895
6855,aflibercept,gene,0.975,34192895
6856,obesity,disease,1.0,34192895
6857,brain edema,disease,0.9927,34192895
6858,acute stroke,disease,0.999,34192895
6859,Aflibercept,gene,0.9263,34187151
6860,aflibercept,gene,0.9565,34187151
6861,age-related macular degeneration,disease,1.0,34187151
6862,nvAMD,disease,1.0,34187151
6863,patients,species,0.9863,34187151
6864,nvAMD,disease,1.0,34187151
6865,fluorescein,drug,0.996,34187151
6866,indocyanine green,drug,0.9976,34187151
6867,IVA,disease,0.512,34187151
6868,pigment epithelial detachment,disease,1.0,34187151
6869,PED,disease,1.0,34187151
6870,serous PED,disease,0.9165,34187151
6871,IVA,drug,0.776,34187151
6872,nvAMD,disease,1.0,34187151
6873,PED,disease,1.0,34187151
6874,serous PED,disease,0.9307,34187151
6875,Endophthalmitis,disease,1.0,34185586
6876,Anti-VEGF,gene,0.722,34185586
6877,infectious endophthalmitis,disease,0.999,34185586
6878,vascular endothelial growth factor,gene,0.974,34185586
6879,VEGF,gene,0.995,34185586
6880,PATIENTS,species,0.937,34185586
6881,patients,species,0.9863,34185586
6882,endophthalmitis,disease,1.0,34185586
6883,anti-VEGF IV,gene,0.938,34185586
6884,endophthalmitis,disease,1.0,34185586
6885,endophthalmitis,disease,1.0,34185586
6886,aflibercept,gene,0.9795,34185586
6887,ranibizumab,gene,0.856,34185586
6888,bevacizumab,gene,0.677,34185586
6889,brolucizumab,gene,0.825,34185586
6890,endophthalmitis,disease,1.0,34185586
6891,endophthalmitis,disease,1.0,34185586
6892,coagulase,gene,0.927,34185586
6893,Streptococcus species,species,0.7036,34185586
6894,Abiotrophia defectiva,species,0.931,34185586
6895,Endophthalmitis,disease,1.0,34185586
6896,anti-VEGF,gene,0.9766,34185586
6897,Endophthalmitis,disease,0.9995,34185585
6898,endophthalmitis,disease,1.0,34185585
6899,aflibercept,gene,0.975,34185585
6900,bevacizumab,gene,0.911,34185585
6901,ranibizumab,gene,0.7246,34185585
6902,dexamethasone,drug,0.999,34185585
6903,triamcinolone,drug,0.999,34185585
6904,PATIENTS,species,0.9727,34185585
6905,endophthalmitis,disease,1.0,34185585
6906,endophthalmitis,disease,1.0,34185585
6907,aflibercept,gene,0.9663,34185585
6908,ranibizumab,gene,0.6504,34185585
6909,dexamethasone,drug,0.9976,34185585
6910,triamcinolone,drug,0.9995,34185585
6911,bevacizumab,gene,0.8525,34185585
6912,ranibizumab,drug,0.534,34185585
6913,aflibercept,gene,0.983,34185585
6914,dexamethasone,drug,0.999,34185585
6915,triamcinolone,drug,0.999,34185585
6916,Triamcinolone,drug,0.998,34185585
6917,endophthalmitis,disease,1.0,34185585
6918,anti-vascular endothelial growth factor,gene,0.9697,34185585
6919,endophthalmitis,disease,1.0,34185585
6920,triamcinolone,drug,0.9917,34185585
6921,Aflibercept,gene,0.959,34174497
6922,Central Retinal Vein Occlusion,disease,1.0,34174497
6923,neovascular age-related macular degeneration,disease,0.997,34172943
6924,Aflibercept,gene,0.937,34172943
6925,neovascular age-related macular,disease,1.0,34164606
6926,aflibercept,gene,0.8804,34164606
6927,neovascular age-related macular degeneration,disease,1.0,34164606
6928,patients,species,0.9814,34164606
6929,neovascular age-related macular degeneration,disease,1.0,34164606
6930,aflibercept,gene,0.9897,34164606
6931,patients,species,0.986,34164606
6932,aflibercept,gene,0.875,34164606
6933,aflibercept,gene,0.969,34164606
6934,aflibercept,gene,0.959,34164606
6935,macular degeneration,disease,1.0,34164606
6936,Ranibizumab,gene,0.8984,34162188
6937,Aflibercept,gene,0.938,34162188
6938,aflibercept,gene,0.979,34162188
6939,neovascular age-related macular degeneration,disease,0.9985,34162188
6940,age-related macular degeneration,disease,1.0,34162188
6941,patients,species,0.99,34162188
6942,Patients,species,0.944,34162188
6943,BCVA,DNA,0.4778,34162188
6944,choroidal vascular,DNA,0.4827,34159829
6945,patients,species,0.9473,34159829
6946,patients,species,0.9517,34159829
6947,diabetic macular edema,disease,1.0,34159829
6948,DME,disease,1.0,34159829
6949,DME,disease,1.0,34159829
6950,patients,species,0.9766,34159829
6951,triamcinolone acetonide,drug,0.95,34159829
6952,aflibercept,gene,0.9893,34159829
6953,patients,species,0.9634,34159829
6954,DME,disease,1.0,34159829
6955,patients,species,0.985,34159829
6956,DME,disease,1.0,34159829
6957,Retinal pigment epithelial tear,disease,1.0,34156786
6958,age-related macular degeneration,disease,1.0,34156786
6959,Retinal pigment epithelial tear,disease,1.0,34156786
6960,RPET,disease,1.0,34156786
6961,age-related macular degeneration,disease,1.0,34156786
6962,AMD,disease,1.0,34156786
6963,RPET,disease,1.0,34156786
6964,RPE atrophy,disease,1.0,34156786
6965,RPET,disease,0.995,34156786
6966,indocyanine green,drug,0.9985,34156786
6967,ICG,drug,0.9883,34156786
6968,RPET,DNA,0.6436,34156786
6969,RPET,disease,0.761,34156786
6970,ranibizumab,gene,0.938,34156786
6971,aflibercept,gene,0.9683,34156786
6972,bevacizumab,gene,0.7847,34156786
6973,patients,species,0.9844,34156786
6974,age-related macular degeneration,disease,1.0,34156786
6975,ziv-aflibercept,gene,0.971,34153938
6976,Vascular Endothelial Growth Factor,gene,0.998,34153938
6977,VEGF,gene,0.9956,34153938
6978,aflibercept,gene,0.9976,34153938
6979,AFL,gene,0.998,34153938
6980,ziv-aflibercept,gene,0.9966,34153938
6981,ziv-AFL,gene,0.995,34153938
6982,ophthalmological diseases,disease,0.851,34153938
6983,neovascular (wet) age-related macular degeneration,disease,1.0,34153938
6984,metastatic colorectal cancer,disease,0.974,34153938
6985,AFL,drug,0.9897,34153938
6986,ziv-AFL,drug,0.9966,34153938
6987,polyolefin,drug,0.998,34153938
6988,ziv-AFL,drug,0.9917,34153938
6989,Zaltrap,drug,0.996,34153938
6990,polyolefin,drug,0.9937,34153938
6991,ziv-AFL,drug,0.96,34153938
6992,Tryptophan,drug,0.989,34153938
6993,ziv-AFL,drug,0.7954,34153938
6994,VEGF,gene,0.9966,34153938
6995,ziv-AFL,drug,0.9443,34153938
6996,anti-vascular endothelial growth factor,gene,0.958,34151383
6997,anti-vascular endothelial growth factor,gene,0.97,34151383
6998,anti-VEGF,gene,0.9775,34151383
6999,posterior retinopathy of prematurity,disease,0.9927,34151383
7000,ROP,disease,1.0,34151383
7001,infants,species,0.905,34151383
7002,patients,species,0.9854,34151383
7003,VEGF,gene,0.5625,34151383
7004,VEGF,gene,0.8853,34151383
7005,VEGF,gene,0.8955,34151383
7006,ROP,disease,0.995,34151383
7007,anti-VEGF,gene,0.6963,34151383
7008,infants,species,0.8276,34151383
7009,Ranibizumab,gene,0.8945,34148190
7010,Aflibercept,gene,0.8677,34148190
7011,Bevacizumab,gene,0.671,34148190
7012,patients,species,0.9624,34145756
7013,diabetic macular oedema,disease,1.0,34145756
7014,patients,species,0.9595,34145756
7015,non-proliferative diabetic retinopathy,disease,1.0,34145756
7016,NPDR,disease,0.9995,34145756
7017,diabetic macular oedema,disease,1.0,34145756
7018,DME,disease,1.0,34145756
7019,aflibercept,gene,0.9854,34145756
7020,patients,species,0.99,34145756
7021,patients,species,0.99,34145756
7022,patients,species,0.978,34145756
7023,patients,species,0.9917,34145756
7024,aflibercept,gene,0.986,34145756
7025,patients,species,0.9917,34145756
7026,patients,species,0.989,34145756
7027,patient,species,0.988,34145756
7028,patients,species,0.99,34145756
7029,Patients,species,0.9873,34145756
7030,Patients,species,0.9805,34145756
7031,aflibercept,gene,0.973,34145756
7032,DME,disease,1.0,34145756
7033,patients,species,0.984,34145756
7034,patients,species,0.9478,34145756
7035,LTFU,disease,0.998,34145756
7036,patients,species,0.9863,34145756
7037,aflibercept,gene,0.9756,34139964
7038,dexamethasone,drug,0.9463,34139964
7039,aflibercept,gene,0.9653,34139964
7040,dexamethasone,drug,0.9033,34139964
7041,central retinal vein occlusion,disease,0.9985,34139964
7042,central retinal vein occlusion,disease,1.0,34139964
7043,serous macular detachment,disease,1.0,34139964
7044,aflibercept,gene,0.9844,34139964
7045,dexamethasone,drug,0.971,34139964
7046,central retinal vein occlusion,disease,1.0,34139964
7047,serous retinal detachment,disease,1.0,34139964
7048,patients,species,0.9414,34139964
7049,macular oedema,disease,1.0,34139964
7050,central retinal vein occlusion,disease,0.9097,34139964
7051,patients,species,0.9897,34139964
7052,serous retinal detachment,disease,1.0,34139964
7053,patients,species,0.9854,34139964
7054,aflibercept,gene,0.9688,34139964
7055,aflibercept,gene,0.9795,34139964
7056,dexamethasone,drug,0.996,34139964
7057,dexamethasone,drug,0.9995,34139964
7058,serous retinal detachment,disease,1.0,34139964
7059,aflibercept,gene,0.9854,34139964
7060,aflibercept,gene,0.986,34139964
7061,serous retinal detachment,disease,1.0,34139964
7062,patients,species,0.9897,34139964
7063,aflibercept,gene,0.9507,34139964
7064,patients,species,0.9834,34139964
7065,dexamethasone,drug,0.963,34139964
7066,aflibercept,gene,0.901,34139964
7067,dexamethasone,drug,0.913,34139964
7068,central retinal vein occlusion,disease,1.0,34139964
7069,serous retinal detachment,disease,1.0,34139964
7070,aflibercept,gene,0.9927,34139964
7071,Polypoidal choroidal vasculopathy,disease,1.0,34136721
7072,retinitis pigmentosa,disease,1.0,34136721
7073,Polypoidal choroidal vasculopathy,disease,1.0,34136721
7074,PCV,disease,1.0,34136721
7075,age-related macular degeneration,disease,1.0,34136721
7076,retinitis pigmentosa,disease,1.0,34136721
7077,RP,disease,1.0,34136721
7078,patient,species,0.9473,34136721
7079,aflibercept,gene,0.9653,34136721
7080,patient,species,0.9653,34136721
7081,woman,species,0.82,34136721
7082,RP,disease,,34136721
7083,PCV,disease,1.0,34136721
7084,decrease,disease,0.747,34136721
7085,indocyanine green,drug,0.996,34136721
7086,serous retinal detachment,disease,1.0,34136721
7087,SRD,disease,1.0,34136721
7088,PCV,disease,1.0,34136721
7089,SRD,disease,1.0,34136721
7090,IVA,drug,0.9077,34136721
7091,IVA,drug,0.9336,34136721
7092,PCV,disease,1.0,34136721
7093,RP,disease,,34136721
7094,PCV,disease,1.0,34136721
7095,RP,disease,,34136721
7096,patients,species,0.987,34136721
7097,RP,disease,,34136721
7098,patient,species,0.989,34135566
7099,subconjunctival hemorrhage,disease,0.9077,34135566
7100,Patients,species,0.9814,34135566
7101,IVI,disease,1.0,34135566
7102,subconjunctival hemorrhage,disease,0.999,34135566
7103,patient,species,0.9736,34135566
7104,ranibizumab,gene,0.8867,34132192
7105,aflibercept,gene,0.9883,34132192
7106,bevacizumab,gene,0.7456,34132192
7107,macular oedema,disease,1.0,34132192
7108,ranibizumab,gene,0.828,34132192
7109,aflibercept,gene,0.99,34132192
7110,Eylea,gene,0.5513,34132192
7111,bevacizumab,gene,0.8184,34132192
7112,Avastin,drug,0.868,34132192
7113,macula oedema,disease,1.0,34132192
7114,central retinal vein occlusion,disease,0.9995,34132192
7115,macula oedema,disease,1.0,34132192
7116,central retinal vein occlusion,disease,1.0,34132192
7117,PARTICIPANTS,species,0.7686,34132192
7118,patients,species,0.985,34132192
7119,visual impairment,disease,1.0,34132192
7120,macula oedema,disease,1.0,34132192
7121,central retinal vein occlusion,disease,1.0,34132192
7122,participants,species,0.9404,34132192
7123,ranibizumab,gene,0.8677,34132192
7124,aflibercept,gene,0.961,34132192
7125,aflibercept,gene,0.994,34132192
7126,bevacizumab,gene,0.906,34132192
7127,ranibizumab,gene,0.705,34132192
7128,ranibizumab,gene,0.666,34132192
7129,aflibercept,gene,0.9834,34132192
7130,bevacizumab,gene,0.7954,34132192
7131,Aflibercept,gene,0.98,34132192
7132,ranibizumab,gene,0.803,34132192
7133,bevacizumab,gene,0.585,34132192
7134,aflibercept,gene,0.9663,34132192
7135,aflibercept,gene,0.981,34132192
7136,ranibizumab,gene,0.645,34132192
7137,bevacizumab,gene,0.888,34132192
7138,aflibercept,gene,0.967,34132192
7139,bevacizumab,gene,0.5796,34132192
7140,aflibercept,gene,0.9917,34132192
7141,bevacizumab,gene,0.8325,34132192
7142,aflibercept,gene,0.9946,34132192
7143,bevacizumab,gene,0.5435,34132192
7144,ranibizumab,gene,0.6523,34132192
7145,aflibercept,gene,0.9673,34132192
7146,Bevacizumab,gene,0.8647,34132192
7147,patients,species,0.986,34132192
7148,patient,species,0.9897,34132192
7149,bevacizumab,gene,0.6255,34132192
7150,patients,species,0.993,34130228
7151,patients,species,0.9863,34130228
7152,metastatic colorectal cancer,disease,1.0,34130228
7153,mCRC,disease,1.0,34130228
7154,PATIENTS,species,0.9707,34130228
7155,patient,species,0.9673,34130228
7156,patients,species,0.9907,34130228
7157,Patients,species,0.951,34130228
7158,5-FU,drug,0.995,34130228
7159,VEGF,gene,0.782,34130228
7160,patients,species,0.9854,34130228
7161,5-FU,drug,0.998,34130228
7162,Irinotecan,drug,0.995,34130228
7163,Oxaliplatin,drug,0.999,34130228
7164,Bevacizumab,gene,0.6304,34130228
7165,Aflibercept,gene,0.9814,34130228
7166,patients,species,0.9883,34130228
7167,patients,species,0.9897,34130228
7168,patients,species,0.9883,34130228
7169,biological abnormalities,disease,0.9995,34130228
7170,"gastrointestinal, general and vascular disorders",disease,1.0,34130228
7171,alkaline phosphatase,gene,0.992,34130228
7172,tumour,disease,0.9185,34130228
7173,patients,species,0.974,34130228
7174,ET3,DNA,0.5586,34130228
7175,patients,species,0.977,34130228
7176,ET3,DNA,0.525,34130228
7177,ET3,gene,0.9756,34130228
7178,mCRC,disease,0.996,34130228
7179,anti-VEGF,gene,0.9453,34126649
7180,patients,species,0.9854,34126649
7181,anti-vascular endothelial growth factors,gene,0.931,34126649
7182,VEGF,gene,0.997,34126649
7183,patients,species,0.983,34126649
7184,ranibizumab,gene,0.9463,34126649
7185,aflibercept,gene,0.9463,34126649
7186,Patients,species,0.9614,34126649
7187,Patients,species,0.9487,34126649
7188,patient,species,0.962,34126649
7189,anti-VEGF,gene,0.9917,34126649
7190,age-related macular degeneration,disease,1.0,34126649
7191,diabetic macular oedema,disease,1.0,34126649
7192,anti-VEGF,gene,0.993,34126649
7193,anti-VEGF,gene,0.9175,34126649
7194,anti-VEGF,gene,0.984,34126649
7195,anti-VEGF,gene,0.9907,34126649
7196,endophthalmitis,disease,1.0,34125768
7197,anti VEGF,gene,0.9614,34125768
7198,anti-vascular endothelial growth factor,gene,0.9863,34125768
7199,patients,species,0.9907,34125768
7200,anti-vascular endothelial growth factor,gene,0.9307,34125768
7201,patients,species,0.986,34125768
7202,bevacizumab,gene,0.52,34125768
7203,ranibizumab,gene,0.9717,34125768
7204,aflibercept,gene,0.9917,34125768
7205,infectious endophthalmitis,disease,1.0,34125768
7206,infectious endophthalmitis,disease,1.0,34125768
7207,aflibercept,gene,0.844,34125326
7208,diabetic macular edema,disease,1.0,34125326
7209,DME,disease,1.0,34125326
7210,DME,disease,1.0,34125326
7211,patients,species,0.992,34125326
7212,aflibercept,gene,0.9727,34125326
7213,Diabetic Retinopathy,disease,0.9565,34125326
7214,aflibercept,gene,0.992,34125326
7215,aflibercept,gene,0.9883,34125326
7216,aflibercept,gene,0.962,34125326
7217,Aflibercept,gene,0.9517,34125326
7218,DME,disease,1.0,34125326
7219,patients,species,0.992,34125326
7220,aflibercept,gene,0.989,34125326
7221,DME,disease,1.0,34125326
7222,patients,species,0.996,34125326
7223,aflibercept,gene,0.9688,34125326
7224,DME,disease,1.0,34125326
7225,VEGF,gene,0.703,34124243
7226,Neovascular AMD,disease,0.9976,34124243
7227,VEGF,gene,0.7935,34124243
7228,neovascular age-related macular degeneration,disease,1.0,34124243
7229,nAMD,disease,0.9966,34124243
7230,nAMD,disease,1.0,34124243
7231,patients,species,0.994,34124243
7232,aflibercept,gene,0.9814,34124243
7233,ranibizumab,gene,0.812,34124243
7234,patient,species,0.987,34124243
7235,Patients,species,0.906,34124243
7236,macular neovascularization,disease,0.9995,34124243
7237,VEGF,gene,0.838,34124243
7238,BCVA,DNA,0.4832,34124243
7239,patients,species,0.987,34124243
7240,AMD,disease,0.996,34124243
7241,macular neovascularization,disease,0.998,34124243
7242,BCVA,DNA,0.471,34124243
7243,polypoidal choroidal vasculopathy,disease,1.0,34124243
7244,VEGF,gene,0.975,34124243
7245,nAMD,disease,1.0,34124243
7246,patients,species,0.988,34124243
7247,ranibizumab,gene,0.9443,34124243
7248,aflibercept,gene,0.967,34124243
7249,patients,species,0.961,34124243
7250,Small Cell Lung Cancer,disease,1.0,34123809
7251,tumors,disease,1.0,34123809
7252,Vascular endothelial growth factor,gene,0.9985,34123809
7253,VEGF,gene,0.9976,34123809
7254,small cell lung cancer,disease,1.0,34123809
7255,SCLC,disease,1.0,34123809
7256,Bevacizumab,gene,0.6475,34123809
7257,VEGF,gene,0.994,34123809
7258,etoposide,drug,0.984,34123809
7259,cisplatin,drug,0.998,34123809
7260,patients,species,0.9565,34123809
7261,ES,cell_line,0.893,34123809
7262,ES)-SCLC,disease,0.9253,34123809
7263,bevacizumab,gene,0.7847,34123809
7264,endostar,drug,0.997,34123809
7265,sunitinib,drug,0.999,34123809
7266,sorafenib,drug,0.9995,34123809
7267,vandetanib,drug,0.999,34123809
7268,thalidomide,drug,0.999,34123809
7269,sunitinib,drug,0.998,34123809
7270,sunitinib,drug,0.999,34123809
7271,cediranib,drug,0.999,34123809
7272,nintedanib,drug,0.999,34123809
7273,ziv-aflibercept,gene,0.978,34123809
7274,topotecan,drug,0.937,34123809
7275,anlotinib,drug,0.9937,34123809
7276,patients,species,0.9673,34123809
7277,SCLC,disease,0.9985,34123809
7278,SCLC,disease,0.9976,34123809
7279,patients,species,0.9893,34123809
7280,Aflibercept,gene,0.911,34120317
7281,Macular Disease,disease,1.0,34120317
7282,Aflibercept,gene,0.9727,34120317
7283,human,species,0.931,34120317
7284,human VEGF receptor 1,gene,0.963,34120317
7285,human,species,0.9927,34120317
7286,human VEGF receptor 2,gene,0.9556,34120317
7287,human,species,0.9893,34120317
7288,VEGF,gene,0.993,34120317
7289,VEGF,gene,0.9897,34120317
7290,hyperpermeability of,disease,1.0,34120317
7291,retinal endothelial cells,cell_type,0.899,34120317
7292,aflibercept,gene,0.971,34120317
7293,retinal diseases,disease,0.9995,34120317
7294,aflibercept,gene,0.959,34120317
7295,neovascular age-related macular degeneration,disease,1.0,34120317
7296,diabetic macular oedema,disease,1.0,34120317
7297,macular oedema,disease,1.0,34120317
7298,retinal vein occlusion,disease,1.0,34120317
7299,myopic choroidal neovascularization,disease,1.0,34120317
7300,VEGF,gene,0.85,34119535
7301,Ranibizumab,gene,0.9346,34119535
7302,Aflibercept,gene,0.9424,34119535
7303,Conbercept,gene,0.611,34119535
7304,Choroidal neovascularization,disease,1.0,34119535
7305,CNV,disease,1.0,34119535
7306,VEGF,gene,0.975,34119535
7307,CNV,disease,1.0,34119535
7308,VEGF,gene,0.8203,34119535
7309,CNV,disease,1.0,34119535
7310,VEGF,gene,0.9146,34119535
7311,VEGF,gene,0.9536,34119535
7312,RF/6A cells,cell_line,0.866,34119535
7313,O(2),drug,0.9956,34119535
7314,CO(2),drug,0.9785,34119535
7315,N(2),drug,0.9907,34119535
7316,anti-VEGF,gene,0.881,34119535
7317,Ranibizumab,gene,0.9243,34119535
7318,Aflibercept,gene,0.9175,34119535
7319,RFP,gene,0.9336,34119535
7320,GFP,gene,0.984,34119535
7321,LC3,gene,0.936,34119535
7322,3-MA,drug,0.998,34119535
7323,endothelial cells,cell_type,0.9224,34119535
7324,p53,gene,0.997,34119535
7325,DRAM,gene,0.994,34119535
7326,damage-regulated autophagy modulator,gene,0.995,34119535
7327,Beclin-1,gene,0.9893,34119535
7328,LC3-2/1,gene,0.9917,34119535
7329,Ranibizumab,gene,0.6665,34119535
7330,Conbercept,gene,0.5283,34119535
7331,P62,gene,0.9937,34119535
7332,Aflibercept,gene,0.988,34119535
7333,3-MA,drug,0.9966,34119535
7334,Conbercept,drug,0.998,34119535
7335,3-MA,drug,0.999,34119535
7336,3-MA,drug,0.9985,34119535
7337,master,DNA,0.4724,34119535
7338,Conbercept,drug,0.869,34119535
7339,3-MA,drug,0.9985,34119535
7340,master,DNA,0.5195,34119535
7341,P53,gene,0.9985,34119535
7342,DRAM,gene,0.936,34119535
7343,Conbercept,drug,0.7417,34119535
7344,LC-3,gene,0.966,34119535
7345,Beclin-1,gene,0.995,34119535
7346,DRAM,gene,0.992,34119535
7347,P53,gene,0.9976,34119535
7348,Pifithrin-,drug,0.9985,34119535
7349,PFT,drug,0.9995,34119535
7350,Ranibizumab,gene,0.9053,34119535
7351,Conbercept,gene,0.697,34119535
7352,vascular endothelial cells,cell_type,0.915,34119535
7353,Aflibercept,gene,0.9307,34119535
7354,p53,gene,0.999,34119535
7355,DRAM,gene,0.9976,34119535
7356,Corneal Neovascularization,disease,1.0,34116541
7357,Corneal neovascularization,disease,1.0,34116541
7358,vascular endothelial growth factor,gene,0.917,34116541
7359,collagen,gene,0.964,34116541
7360,corneal neovascularization,disease,0.9956,34116541
7361,vascular endothelial growth factor,gene,0.9927,34116541
7362,corneal neovascularization,disease,0.9946,34116541
7363,corneal neovascularization,disease,0.9053,34116541
7364,corneal neovascularization,disease,0.9907,34116541
7365,corneal neovascularization,disease,1.0,34116541
7366,aflibercept,gene,0.9766,34111885
7367,ranibizumab,gene,0.7656,34111885
7368,aflibercept,gene,0.9766,34111885
7369,PFS,DNA,0.5083,34111885
7370,ranibizumab,gene,0.8467,34111885
7371,ranibizumab,gene,0.7954,34111885
7372,aflibercept,gene,0.9736,34111885
7373,ranibizumab,gene,0.9478,34111885
7374,aflibercept,gene,0.9756,34111885
7375,Type 1 Macular Neovascularization,disease,1.0,34111264
7376,type 1 macular neovascularizations,disease,0.9995,34111264
7377,MNVs,disease,1.0,34111264
7378,aflibercept,gene,0.967,34111264
7379,patients,species,0.9785,34111264
7380,MNV,disease,1.0,34111264
7381,patients,species,0.985,34111264
7382,MNV,disease,0.969,34111264
7383,MNV,disease,0.771,34111264
7384,MNV,disease,0.976,34111264
7385,MNV,disease,0.8267,34111264
7386,MNVs,species,0.5674,34111264
7387,MNV,species,0.7227,34111264
7388,MNV,species,0.7363,34111264
7389,A-MNV,disease,0.999,34111264
7390,I-MNV,disease,0.997,34111264
7391,A-MNV,disease,1.0,34111264
7392,MNV,disease,0.9785,34111264
7393,MNV,disease,0.9995,34111264
7394,I-MNV,disease,0.9277,34111264
7395,MNV,disease,0.948,34111264
7396,age-related macular degeneration,disease,1.0,34110547
7397,age-related macular degeneration,disease,1.0,34110547
7398,AMD,disease,1.0,34110547
7399,patients,species,0.991,34110547
7400,patients,species,0.9937,34110547
7401,AMD,disease,1.0,34110547
7402,AMD,disease,0.9995,34110547
7403,patients,species,0.9937,34110547
7404,patients,species,0.993,34110547
7405,patients,species,0.991,34110547
7406,patient,species,0.9854,34110547
7407,vascular endothelial growth factor,gene,0.997,34110547
7408,Bevacizumab,gene,0.848,34110547
7409,patients,species,0.9785,34110547
7410,ranibizumab,gene,0.8633,34110547
7411,aflibercept,gene,0.968,34110547
7412,patients,species,0.9893,34110547
7413,anti-VEGF,gene,0.773,34110547
7414,anti-VEGF,gene,0.937,34110547
7415,patient,species,0.9854,34110547
7416,patients,species,0.9937,34110547
7417,patients,species,0.9927,34110547
7418,cataract,disease,0.9995,34110547
7419,endophthalmitis,disease,1.0,34110547
7420,AMD,disease,1.0,34110547
7421,VEGF,gene,0.7344,34110547
7422,aflibercept,gene,0.9766,34102332
7423,aflibercept,gene,0.9795,34102332
7424,macular,cell_type,0.469,34102332
7425,patients,species,0.939,34102332
7426,neovascular age-related macular degeneration,disease,1.0,34102332
7427,nAMD,disease,1.0,34102332
7428,patients,species,0.959,34102332
7429,nAMD,disease,1.0,34102332
7430,GCC,cell_type,0.498,34102332
7431,ETDRS,DNA,0.4807,34102332
7432,patient,species,0.926,34102332
7433,Ganglion cell,cell_type,0.6543,34102332
7434,nAMD,disease,1.0,34102332
7435,retinal nerve fiber,cell_type,0.479,34102332
7436,ganglion cell,cell_type,0.5347,34102332
7437,aflibercept,gene,0.984,34102332
7438,patients,species,0.929,34102332
7439,nAMD,disease,1.0,34102332
7440,aflibercept,gene,0.9897,34085884
7441,colorectal cancer,disease,1.0,34085884
7442,Colorectal cancer,disease,1.0,34085884
7443,CRC,disease,1.0,34085884
7444,tumor,disease,0.9995,34085884
7445,aflibercept,gene,0.975,34085884
7446,humanized,species,0.5127,34085884
7447,aflibercept,gene,0.9883,34085884
7448,FOLFIRI,drug,0.763,34085884
7449,aflibercept,gene,0.965,34085884
7450,mCRC,disease,0.998,34085884
7451,aflibercept,gene,0.9746,34085884
7452,FOLFIRI,drug,0.7466,34085884
7453,patients,species,0.989,34085884
7454,Pseudoxanthoma elasticum,disease,1.0,34085378
7455,null,cell_type,0.4902,34085378
7456,null cell adenoma of the pituitary gland,disease,1.0,34085378
7457,Non-Neovascular Pachychoroid Disease,disease,1.0,34084962
7458,Exudative Age-Related Macular PURPOSE,disease,1.0,34084962
7459,pachychoroid disease,disease,1.0,34084962
7460,central serous chorioretinopathy,disease,1.0,34084962
7461,CSC,disease,1.0,34084962
7462,retinal pigment epithelial detachment,disease,1.0,34084962
7463,PED,disease,1.0,34084962
7464,macular drusen in,disease,1.0,34084962
7465,patient,species,0.9717,34084962
7466,neovascular age-related macular degeneration,disease,1.0,34084962
7467,AMD,disease,1.0,34084962
7468,fluorescein,drug,0.8916,34084962
7469,indocyanine green,drug,0.9976,34084962
7470,PED,disease,0.9995,34084962
7471,macular drusen,disease,0.9995,34084962
7472,woman,species,0.866,34084962
7473,PED,disease,1.0,34084962
7474,pachychoroid diseases,disease,1.0,34084962
7475,pachyvessels,disease,0.9995,34084962
7476,choroidal hyperpermeability,disease,1.0,34084962
7477,PED,disease,1.0,34084962
7478,SRF,disease,0.9995,34084962
7479,anti-VEGF,gene,0.8955,34084962
7480,aflibercept,gene,0.9854,34084962
7481,anti-VEGF,gene,0.9824,34084962
7482,choroidal neovascularization,disease,1.0,34084962
7483,polyps,disease,1.0,34084962
7484,PED,DNA,0.5024,34084962
7485,PED,disease,0.9717,34084962
7486,SRF,gene,0.9263,34084962
7487,CSC,disease,0.9854,34084962
7488,neovascular AMD,disease,1.0,34084962
7489,anti-vascular endothelial growth factor,gene,0.977,34084960
7490,anti-VEGF,gene,0.8486,34084960
7491,inflammatory choroidal neovascularization,disease,1.0,34084960
7492,iCNV,disease,1.0,34084960
7493,patients,species,0.98,34084960
7494,choroidal neovascularization,disease,1.0,34084960
7495,CNV,disease,1.0,34084960
7496,ocular inflammatory disease,disease,1.0,34084960
7497,bevacizumab,gene,0.9487,34084960
7498,ranibizumab,gene,0.929,34084960
7499,aflibercept,gene,0.945,34084960
7500,patients,species,0.983,34084960
7501,patients,species,0.9727,34084960
7502,patients,species,0.985,34084960
7503,patients,species,0.9893,34084960
7504,Bevacizumab,gene,0.8623,34084960
7505,ranibizumab,gene,0.792,34084960
7506,aflibercept,gene,0.9614,34084960
7507,anti-VEGF,gene,0.981,34084960
7508,CNV,disease,1.0,34084960
7509,uveitis,disease,1.0,34084960
7510,anti-VEGF,gene,0.9365,34084960
7511,iCNV,disease,1.0,34084960
7512,FOLFIRI,drug,0.9165,34083302
7513,Ramucirumab,gene,0.7666,34083302
7514,Aflibercept,gene,0.9834,34083302
7515,folinic acid,drug,0.9995,34083302
7516,fluorouracil,drug,0.9995,34083302
7517,irinotecan,drug,0.999,34083302
7518,FOLFIRI,drug,0.8784,34083302
7519,aflibercept,gene,0.9785,34083302
7520,F-AFL,gene,0.8794,34083302
7521,metastatic colorectal cancer,disease,1.0,34083302
7522,mCRC,disease,1.0,34083302
7523,F-RAM,drug,0.9966,34083302
7524,AFL,drug,0.991,34083302
7525,bevacizumab,gene,0.8955,34083302
7526,mCRC,disease,0.9883,34083302
7527,PATIENTS,species,0.9604,34083302
7528,F-RAM,drug,0.9976,34083302
7529,AFL,drug,0.9917,34083302
7530,trifluridine,drug,0.997,34083302
7531,tipiracil,drug,0.999,34083302
7532,TAS-102,drug,0.994,34083302
7533,F-RAM,drug,0.9897,34083302
7534,AFL,drug,0.99,34083302
7535,TAS-102,drug,0.991,34083302
7536,F-RAM,drug,0.9976,34083302
7537,AFL,drug,0.9927,34083302
7538,mCRC,disease,0.9644,34083302
7539,F-RAM,drug,0.998,34083302
7540,AFL,drug,0.9946,34083302
7541,TAS-102,drug,0.9976,34083302
7542,Aflibercept,gene,0.961,34075564
7543,Neovascular BACKGROUND,disease,0.93,34075564
7544,aflibercept,gene,0.9688,34075564
7545,AFL,gene,0.723,34075564
7546,neovascular age-related macular degeneration,disease,1.0,34075564
7547,nAMD,disease,1.0,34075564
7548,patients,species,0.91,34075564
7549,nAMD,disease,1.0,34075564
7550,patients,species,0.9775,34075564
7551,nAMD,disease,1.0,34075564
7552,AFL,drug,0.8804,34075564
7553,patients,species,0.985,34075564
7554,Diabetic,disease,0.995,34075564
7555,Retinopathy,disease,0.522,34075564
7556,Patients,species,0.962,34075564
7557,patients,species,0.9526,34075564
7558,patients,species,0.9497,34075564
7559,patients,species,0.979,34075564
7560,Patients,species,0.951,34075564
7561,NO,drug,,34069173
7562,IL-6,gene,0.979,34069173
7563,IL-18,gene,0.9844,34069173
7564,aflibercept,gene,0.977,34069173
7565,IVA,gene,0.7803,34069173
7566,prothrombin,gene,0.9927,34069173
7567,thromboplastin,gene,0.9937,34069173
7568,thrombin,gene,0.834,34069173
7569,dimethylarginine,drug,0.998,34069173
7570,nitric oxide,drug,0.9995,34069173
7571,NO,drug,1.0,34069173
7572,interleukin 6,gene,0.993,34069173
7573,IL-6,gene,0.994,34069173
7574,interleukin 18,gene,0.9863,34069173
7575,IL-18,gene,0.9917,34069173
7576,patients,species,0.9697,34069173
7577,neovascular AMD,disease,1.0,34069173
7578,nAMD,disease,1.0,34069173
7579,patients,species,0.9556,34069173
7580,nAMD,disease,1.0,34069173
7581,IL-18,gene,0.991,34069173
7582,IL-6,gene,0.9663,34069173
7583,Vascular Endothelial Growth Factor,gene,0.9985,34064508
7584,tumor,disease,1.0,34064508
7585,oxygen,drug,0.923,34064508
7586,tumor,disease,1.0,34064508
7587,Vascular endothelial growth factor,gene,0.9985,34064508
7588,VEGF,gene,0.997,34064508
7589,tumor,disease,0.965,34064508
7590,VEGF,gene,0.9937,34064508
7591,endothelial cells,cell_type,0.9434,34064508
7592,VEGF,gene,0.996,34064508
7593,cancers,disease,1.0,34064508
7594,VEGF,gene,0.9956,34064508
7595,tumor,disease,0.9995,34064508
7596,VEGF,gene,0.995,34064508
7597,tumor,disease,0.991,34064508
7598,Brolucizumab,gene,0.759,34057392
7599,aflibercept,gene,0.9775,34057392
7600,ranibizumab,gene,0.501,34057392
7601,neovascular age-related macular,disease,1.0,34057392
7602,Age-related macular degeneration,disease,1.0,34057392
7603,AMD,disease,1.0,34057392
7604,blindness,disease,0.993,34057392
7605,blindness,disease,0.9995,34057392
7606,Brolucizumab-dbll,gene,0.8315,34057392
7607,brolucizumab,gene,0.868,34057392
7608,VEGF,gene,0.9956,34057392
7609,neovascular (wet) AMD,disease,1.0,34057392
7610,wet AMD,disease,0.9688,34057392
7611,brolucizumab,gene,0.9053,34057392
7612,aflibercept,gene,0.982,34057392
7613,ranibizumab,gene,0.5938,34057392
7614,wet AMD,disease,0.9995,34057392
7615,patients,species,0.99,34057392
7616,brolucizumab,gene,0.8506,34057392
7617,aflibercept,gene,0.9673,34057392
7618,ranibizumab,gene,0.52,34057392
7619,Markov,cell_line,0.4653,34057392
7620,vision impairment,disease,1.0,34057392
7621,blindness,disease,1.0,34057392
7622,Diabetic Retinopathy,disease,1.0,34057392
7623,brolucizumab,gene,0.7236,34057392
7624,aflibercept,gene,0.9854,34057392
7625,brolucizumab,gene,0.932,34057392
7626,aflibercept,gene,0.9766,34057392
7627,brolucizumab,gene,0.8804,34057392
7628,aflibercept,gene,0.9336,34057392
7629,brolucizumab,gene,0.794,34057392
7630,brolucizumab,gene,0.794,34057392
7631,brolucizumab,gene,0.899,34057392
7632,aflibercept,gene,0.977,34057392
7633,brolucizumab,gene,0.704,34057392
7634,brolucizumab,gene,0.802,34057392
7635,brolucizumab,gene,0.662,34057392
7636,brolucizumab,gene,0.813,34057392
7637,brolucizumab,gene,0.5957,34057392
7638,Brolucizumab,gene,0.7734,34057392
7639,aflibercept,gene,0.9834,34057392
7640,ranibizumab,gene,0.7725,34057392
7641,wet AMD,disease,0.998,34057392
7642,vision loss,disease,0.9077,34055435
7643,endophthalmitis,disease,1.0,34055435
7644,Aflibercept,gene,0.961,34055435
7645,Aflibercept,gene,0.986,34055435
7646,whitish,cell_line,0.5557,34055435
7647,Fluorescein,drug,0.997,34055266
7648,Patient,species,0.9736,34055266
7649,fluorescein,drug,0.999,34055266
7650,central retinal vein occlusion,disease,1.0,34055266
7651,CRVO,disease,1.0,34055266
7652,blurred vision,disease,0.9995,34055266
7653,CRVO,disease,0.9775,34055266
7654,aflibercept,gene,0.983,34055266
7655,CRVO,disease,1.0,34055266
7656,retinal ischemia,disease,0.969,34055266
7657,Neovascular AMD,disease,0.9995,34055255
7658,anti-VEGF,gene,0.981,34055255
7659,neovascular,disease,0.994,34055255
7660,age-related macular degeneration,disease,1.0,34055255
7661,nAMD,disease,1.0,34055255
7662,nAMD,disease,1.0,34055255
7663,VEGF,gene,0.9414,34055255
7664,patients,species,0.984,34055255
7665,bevacizumab,gene,0.688,34055255
7666,patients,species,0.9766,34055255
7667,patients,species,0.9897,34055255
7668,aflibercept,gene,0.9536,34055255
7669,bevacizumab,gene,0.6597,34055255
7670,Patients,species,0.9683,34055255
7671,nAMD,disease,1.0,34055255
7672,patients,species,0.996,34055255
7673,Aflibercept,gene,0.9487,34045845
7674,Diabetic Macular Oedema,disease,1.0,34045845
7675,Patients,species,0.9946,34045845
7676,Diabetic macular oedema,disease,1.0,34045845
7677,DMO,disease,1.0,34045845
7678,sight impairment,disease,1.0,34045845
7679,DMO,disease,1.0,34045845
7680,anti,gene,0.5425,34045845
7681,DMO,disease,1.0,34045845
7682,patients,species,0.9824,34045845
7683,aflibercept,gene,0.965,34045845
7684,DMO,disease,1.0,34045845
7685,patients,species,0.9883,34045845
7686,aflibercept,gene,0.96,34045845
7687,DMO,disease,1.0,34045845
7688,patients,species,0.991,34045845
7689,HbA1c,gene,0.9956,34045845
7690,aflibercept,gene,0.984,34045845
7691,epiretinal membrane,disease,1.0,34045845
7692,ERM,disease,1.0,34045845
7693,retinopathy,disease,0.9966,34045845
7694,aflibercept,gene,0.9316,34045845
7695,DMO,disease,1.0,34045845
7696,diabetic retinopathy,disease,1.0,34045845
7697,patients,species,0.987,34045845
7698,VEGF,gene,0.761,34044715
7699,Patients,species,0.961,34044715
7700,Wet Age-Related Macular,disease,1.0,34044715
7701,anti-vascular endothelial growth factor,gene,0.9976,34044715
7702,VEGF,gene,0.9946,34044715
7703,patients,species,0.9917,34044715
7704,wet,disease,0.962,34044715
7705,age-related macular degeneration,disease,0.969,34044715
7706,AMD,disease,1.0,34044715
7707,PATIENTS,species,0.983,34044715
7708,patients,species,0.9956,34044715
7709,AMD,disease,0.993,34044715
7710,anti-VEGF,gene,0.9604,34044715
7711,patients,species,0.992,34044715
7712,VEGF,gene,0.797,34044715
7713,ranibizumab,gene,0.961,34044715
7714,aflibercept,gene,0.9683,34044715
7715,bevacizumab,gene,0.7554,34044715
7716,aflibercept,gene,0.969,34044715
7717,ranibizumab,gene,0.807,34044715
7718,ranibizumab,gene,0.622,34044715
7719,aflibercept,gene,0.983,34044715
7720,patient,species,0.987,34044715
7721,patients,species,0.9805,34044715
7722,Aflibercept,gene,0.9688,34043607
7723,dexamethasone,drug,0.9834,34043607
7724,diabetic macular edema,disease,1.0,34043607
7725,Diabetic macular edema,disease,1.0,34043607
7726,deterioration,disease,0.565,34043607
7727,vascular endothelial growth factor,gene,0.898,34043607
7728,anti-,gene,0.756,34043607
7729,VEGF,gene,0.6084,34043607
7730,aflibercept,gene,0.9717,34043607
7731,dexamethasone,drug,0.9976,34043607
7732,aflibercept,gene,0.977,34043607
7733,dexamethasone,drug,0.9907,34043607
7734,Aflibercept,gene,0.954,34042958
7735,aflibercept,gene,0.9746,34042958
7736,vitreous hemorrhage,disease,1.0,34042958
7737,proliferative diabetic retinopathy,disease,1.0,34042958
7738,tumor,disease,0.9995,34041019
7739,colorectal cancer,disease,0.7627,34041019
7740,mCRC,disease,0.9995,34041019
7741,mCRC,disease,0.969,34041019
7742,patients,species,0.9927,34041019
7743,anti-placental growth factor,gene,0.9136,34041019
7744,aflibercept,gene,0.978,34041019
7745,human vascular endothelial,cell_type,0.5405,34041019
7746,human,species,0.972,34041019
7747,growth factor receptor (VEGFR)-1,gene,0.987,34041019
7748,VEGFR-2,gene,0.993,34041019
7749,aflibercept,gene,0.99,34041019
7750,mCRC,disease,0.9985,34041019
7751,patients,species,0.9775,34041019
7752,oxaliplatin,drug,0.9995,34041019
7753,bevacizumab,gene,0.8516,34041019
7754,aflibercept,gene,0.9424,34040188
7755,anti-vascular endothelial growth factor,gene,0.9907,34039186
7756,VEGF,gene,0.994,34039186
7757,patients,species,0.988,34039186
7758,PATIENTS,species,0.9478,34039186
7759,patients,species,0.9883,34039186
7760,age-related macular degeneration,disease,0.9995,34039186
7761,AMD,disease,1.0,34039186
7762,diabetic retinopathy,disease,1.0,34039186
7763,CRVO,disease,1.0,34039186
7764,branch retinal vein occlusion,disease,1.0,34039186
7765,BRVO,disease,1.0,34039186
7766,anti-VEGF,gene,0.692,34039186
7767,ranibizumab,gene,0.823,34039186
7768,aflibercept,gene,0.9155,34039186
7769,patients,species,0.985,34039186
7770,bevacizumab,gene,0.794,34039186
7771,patients,species,0.9897,34039186
7772,patients,species,0.993,34039186
7773,patients,species,0.99,34039186
7774,patients,species,0.986,34039186
7775,patients,species,0.9805,34039186
7776,anti-VEGF,gene,0.9233,34039186
7777,patients,species,0.9824,34039186
7778,patients,species,0.9937,34039186
7779,patients,species,0.992,34039186
7780,ranibizumab,gene,0.8286,34039186
7781,aflibercept,gene,0.9746,34039186
7782,patients,species,0.989,34039186
7783,patients,species,0.994,34039186
7784,patients,species,0.982,34039186
7785,bevacizumab,gene,0.865,34039186
7786,patients,species,0.9927,34039186
7787,aflibercept,gene,0.9624,34039186
7788,VEGF,gene,0.7163,34039186
7789,patients,species,0.977,34039186
7790,wet AMD,disease,0.9995,34039186
7791,diabetic retinopathy,disease,1.0,34039186
7792,CRVO,disease,1.0,34039186
7793,patients,species,0.9863,34039186
7794,patients,species,0.984,34039186
7795,Neovascular AMD,disease,1.0,34039184
7796,patient,species,0.9917,34039184
7797,PATIENTS,species,0.941,34039184
7798,bevacizumab,gene,0.7954,34039184
7799,ranibizumab,gene,0.848,34039184
7800,aflibercept,gene,0.8804,34039184
7801,neovascular age-related macular degeneration,disease,0.9526,34039184
7802,nAMD,disease,1.0,34039184
7803,patients,species,0.9736,34039184
7804,Patients,species,0.9893,34039184
7805,patients,species,0.991,34039184
7806,patients,species,0.9883,34039184
7807,patients,species,0.988,34039184
7808,Patients,species,0.968,34039184
7809,VA,disease,,34039184
7810,patients,species,0.961,34039184
7811,Patients,species,0.9404,34039184
7812,patients,species,0.98,34039184
7813,patients,species,0.9883,34039184
7814,Patients,species,0.949,34039184
7815,EYLEA,drug,0.936,34036951
7816,Wet,disease,0.9946,34036951
7817,Age-related Macular Degeneration,disease,0.9023,34036951
7818,vascular endothelial growth factor,gene,0.939,34024227
7819,VEGF,gene,0.998,34024227
7820,aflibercept,gene,0.969,34024227
7821,ranibizumab,drug,0.767,34024227
7822,anti-VEGF,gene,0.877,34024227
7823,Men,species,0.892,34024227
7824,women,species,0.968,34024227
7825,Men,species,0.936,34024227
7826,Men,species,0.975,34024227
7827,women,species,0.9873,34024227
7828,anti-VEGF,gene,0.973,34024227
7829,patients,species,0.9883,34023820
7830,age-related macular degeneration,disease,1.0,34023820
7831,nAMD,disease,1.0,34023820
7832,anti-VEGF,gene,0.855,34023820
7833,DMP,disease,1.0,34023820
7834,bevacizumab,gene,0.9263,34023820
7835,aflibercept,gene,0.974,34023820
7836,patients,species,0.9863,34023820
7837,patients,species,0.9746,34023820
7838,aflibercept,gene,0.967,34023820
7839,nAMD,disease,1.0,34023820
7840,Aflibercept,gene,0.974,34015785
7841,aflibercept,gene,0.991,34015785
7842,neovascular age-related macular degeneration,disease,1.0,34015785
7843,nAMD,disease,1.0,34015785
7844,polypoidal choroidal vasculopathy,disease,1.0,34015785
7845,PCV,disease,1.0,34015785
7846,nAMD,disease,0.9985,34015785
7847,PCV,drug,0.8184,34015785
7848,patients,species,0.9756,34015785
7849,PCV,disease,0.9946,34015785
7850,patients,species,0.991,34015785
7851,BCVA,cell_type,0.4363,34015785
7852,patients,species,0.963,34015785
7853,IVA,drug,0.9165,34015785
7854,nAMD,disease,1.0,34015785
7855,PCV,drug,0.6113,34015785
7856,PCV,species,0.8447,34015785
7857,PCV,species,0.547,34015785
7858,IVA,disease,0.997,34015785
7859,antivascular endothelial growth factor,gene,0.998,34014104
7860,VEGF,gene,0.9976,34014104
7861,anti-VEGF,gene,0.8247,34014104
7862,Cynomolgus monkeys,species,0.8247,34014104
7863,single-chain variable fragment,gene,0.926,34014104
7864,scFv,gene,0.982,34014104
7865,brolucizumab,gene,0.9194,34014104
7866,antigen,gene,0.566,34014104
7867,Fab,gene,0.976,34014104
7868,ranibizumab,gene,0.886,34014104
7869,fragment crystallizable-fusion protein,gene,0.9854,34014104
7870,Fc-fusion,gene,0.988,34014104
7871,aflibercept,gene,0.9917,34014104
7872,immunoglobulin G monoclonal antibody,gene,0.996,34014104
7873,IgG,gene,0.995,34014104
7874,VA2 CrossMAb,gene,0.8955,34014104
7875,scFv,gene,0.9766,34014104
7876,Fab,gene,0.9883,34014104
7877,Fc-fusion,gene,0.8726,34014104
7878,IgG,gene,0.9897,34014104
7879,human,species,0.996,34014104
7880,cynomolgus monkey,species,0.9287,34014104
7881,Aflibercept,gene,0.9756,34007150
7882,Aflibercept,gene,0.991,34007150
7883,diabetic macular edema,disease,0.8994,34007150
7884,DME,disease,1.0,34007150
7885,diabetic,disease,1.0,34007150
7886,patients,species,0.983,34007150
7887,HbA1c,gene,0.9917,34007150
7888,DME,disease,1.0,34007150
7889,aflibercept,gene,0.9917,34007150
7890,aflibercept,gene,0.981,34007150
7891,epiretinal membrane,disease,1.0,34007150
7892,intravitreal hemorrhage,disease,1.0,34007150
7893,vitreomacular traction,disease,1.0,34007150
7894,retinal detachment,disease,1.0,34007150
7895,macular edema,disease,1.0,34007150
7896,triamcinolone,drug,0.991,34007150
7897,dexamethasone,drug,0.9937,34007150
7898,bevacizumab,gene,0.5503,34007150
7899,DME,disease,1.0,34007150
7900,VEGF,gene,0.9927,34003985
7901,Aflibercept,gene,0.9863,34003985
7902,Brolucizumab,gene,0.8623,34003985
7903,vascular endothelial growth factor,gene,0.998,34003985
7904,VEGF,gene,0.9956,34003985
7905,aflibercept,gene,0.895,34003985
7906,IVT-AFL,gene,0.962,34003985
7907,brolucizumab,gene,0.911,34003985
7908,IVT-BRO,gene,0.9453,34003985
7909,ranibizumab,gene,0.5957,34003985
7910,IVT-RAN,gene,0.9014,34003985
7911,VEGF,gene,0.9897,34003985
7912,AFL,drug,0.956,34003985
7913,BRO,drug,0.9526,34003985
7914,VEGF,gene,0.992,34003985
7915,IVT-BRO,drug,0.8384,34003985
7916,IVT,drug,0.9155,34003985
7917,26,RNA,0.852,34003985
7918,VEGF,gene,0.9946,34003985
7919,AFL,drug,0.7695,34003985
7920,BRO,drug,0.995,34003985
7921,AFL,drug,0.874,34003985
7922,IVT-BRO,drug,0.874,34003985
7923,IVT-BRO,drug,0.9863,34003985
7924,IVT-AFL,drug,0.982,34003985
7925,VEGF,gene,0.995,34003985
7926,VEGF,gene,0.996,34003985
7927,BRO,drug,0.9966,34003985
7928,AFL,drug,0.946,34003985
7929,VEGF,gene,0.989,34003985
7930,patients,species,0.9756,34003985
7931,IVT,drug,0.9966,34003985
7932,AFL,drug,0.735,34003985
7933,IVT-BRO,drug,0.797,34003985
7934,neovascular age-related macular degeneration,disease,1.0,34003963
7935,nAMD,disease,1.0,34003963
7936,brolucizumab,gene,0.89,34003963
7937,aflibercept,gene,0.942,34003963
7938,nAMD,disease,1.0,34003963
7939,brolucizumab,gene,0.89,34003963
7940,aflibercept,gene,0.9883,34003963
7941,brolucizumab,gene,0.9346,34003963
7942,participants,species,0.989,34003963
7943,aflibercept,gene,0.882,34003963
7944,participants,species,0.9854,34003963
7945,brolucizumab,gene,0.892,34003963
7946,aflibercept,gene,0.97,34003963
7947,nAMD,disease,1.0,34003963
7948,nAMD,disease,1.0,34003963
7949,Aflibercept,gene,0.971,34003937
7950,diabetic macular edema,disease,1.0,34003937
7951,aflibercept,gene,0.9707,34003937
7952,Participants,species,0.926,34003937
7953,diabetes,disease,1.0,34003937
7954,diabetic macular edema,disease,1.0,34003937
7955,aflibercept,gene,0.8955,34003937
7956,aflibercept,gene,0.918,34003937
7957,Participants,species,0.976,34003937
7958,aflibercept,gene,0.985,34003937
7959,aflibercept,gene,0.91,34003937
7960,aflibercept,gene,0.911,34003937
7961,diabetic macular edema,disease,1.0,34003937
7962,RPE Cells,cell_type,0.8784,33998943
7963,Vascular endothelial growth factor,gene,0.996,33998943
7964,VEGF,gene,0.9985,33998943
7965,retinal pigment epithelium (RPE) cells,cell_type,0.841,33998943
7966,VEGF,gene,0.996,33998943
7967,bevacizumab,gene,0.8623,33998943
7968,aflibercept,gene,0.978,33998943
7969,primary RPE cells,cell_line,0.604,33998943
7970,primary porcine RPE,cell_line,0.9097,33998943
7971,porcine,species,0.986,33998943
7972,bevacizumab,gene,0.9165,33998943
7973,aflibercept,gene,0.9824,33998943
7974,MTT,drug,0.9995,33998943
7975,TGF-,gene,0.983,33998943
7976,RPE65,gene,0.977,33998943
7977,bevacizumab,gene,0.9023,33998943
7978,transwell-cultured cells,cell_line,0.651,33998943
7979,TGF-,gene,0.9736,33998943
7980,RPE65,gene,0.982,33998943
7981,aflibercept,gene,0.9746,33998943
7982,RPE cells,cell_type,0.8286,33998943
7983,anti-vascular endothelial growth factors,gene,0.9585,33997473
7984,anti-vascular endothelial growth factor,gene,0.8105,33997473
7985,VEGF,gene,0.998,33997473
7986,exudative cuticular drusen,disease,0.897,33997473
7987,CD,disease,1.0,33997473
7988,patient,species,0.9805,33997473
7989,subretinal hyperreflective exudation,disease,1.0,33997473
7990,SHE,disease,1.0,33997473
7991,patient,species,0.88,33997473
7992,exudative CD,disease,0.9985,33997473
7993,macular neovascularization,disease,0.9966,33997473
7994,MNV,disease,1.0,33997473
7995,type I MNV,disease,0.978,33997473
7996,pigment epithelial detachments,disease,0.8765,33997473
7997,aflibercept,gene,0.759,33997473
7998,Henle&,cell_type,0.4607,33997473
7999,patient,species,0.9336,33997473
8000,SHE,disease,0.999,33997473
8001,Fluorescein,drug,0.9844,33997473
8002,SHE,DNA,0.551,33997473
8003,SHE,disease,0.997,33997473
8004,SHE,disease,0.984,33997473
8005,juxtafoveal type I MNV,disease,0.8887,33997473
8006,ranibizumab,gene,0.7935,33997473
8007,distorted vision,disease,1.0,33997473
8008,SHE,disease,0.999,33997473
8009,subfoveal fluid accumulation,disease,0.907,33997473
8010,SSPiM,disease,0.998,33997473
8011,patient,species,0.9253,33997473
8012,exudative CD,disease,0.996,33997473
8013,SHE,disease,0.9995,33997473
8014,I MNV,disease,0.942,33997473
8015,aflibercept,gene,0.982,33992471
8016,Peripapillary Choroidal Neovascular Membrane,disease,1.0,33976680
8017,Sarcoidosis,disease,1.0,33976680
8018,peripapillary choroidal neovascular membrane,disease,1.0,33976680
8019,PCNM,disease,1.0,33976680
8020,sarcoidosis-related panuveitis,disease,0.999,33976680
8021,vascular,DNA,0.737,33976680
8022,vascular endothelial growth factor,gene,0.9985,33976680
8023,fluorescein,drug,0.99,33976680
8024,patient,species,0.9688,33976680
8025,blurring of vision,disease,0.859,33976680
8026,bilateral,disease,0.591,33976680
8027,granulomatous panuveitis,disease,0.984,33976680
8028,solitary peripheral granuloma,disease,1.0,33976680
8029,PCNM,disease,1.0,33976680
8030,sarcoidosis,disease,1.0,33976680
8031,PCNM,disease,1.0,33976680
8032,aflibercept,gene,0.9507,33976680
8033,methotrexate,drug,0.9917,33976680
8034,aflibercept,gene,0.986,33976680
8035,aflibercept,gene,0.9937,33976680
8036,anti-VEGF,gene,0.957,33976680
8037,NV,disease,,33976680
8038,aflibercept,gene,0.99,33976680
8039,PCNM,disease,1.0,33976680
8040,sarcoidosis,disease,1.0,33976680
8041,Pachychoroid Neovasculopathy,disease,1.0,33976667
8042,Age-Related Macular Degeneration,disease,1.0,33976667
8043,neovascular age-related macular degeneration,disease,1.0,33976667
8044,nAMD,disease,1.0,33976667
8045,anti-vascular endothelial growth factor,gene,0.942,33976667
8046,VEGF,gene,0.8564,33976667
8047,AMD,disease,1.0,33976667
8048,nAMD,disease,1.0,33976667
8049,pachychoroid neovasculopathy,disease,1.0,33976667
8050,PNV,disease,1.0,33976667
8051,spironolactone,drug,0.998,33976667
8052,patient,species,0.9634,33976667
8053,nAMD,disease,1.0,33976667
8054,aflibercept,gene,0.9688,33976667
8055,indocyanine green,drug,0.9985,33976667
8056,Drusen,disease,0.9976,33976667
8057,serous chorioretinopathy,disease,1.0,33976667
8058,choroidal neovascularization,disease,1.0,33976667
8059,PNV,disease,1.0,33976667
8060,pachychoroid disease,disease,1.0,33976667
8061,spironolactone,drug,0.999,33976667
8062,anti-VEGF,gene,0.911,33976667
8063,subretinal fluid,disease,0.993,33976667
8064,PNV,disease,1.0,33976667
8065,nAMD,disease,1.0,33976667
8066,anti-VEGF,gene,0.7812,33976667
8067,vascular endothelial growth factor,gene,0.9473,33966647
8068,retinal diseases,disease,1.0,33966647
8069,age-related macular degeneration,disease,1.0,33966647
8070,AMD,disease,1.0,33966647
8071,sterile inflammation,disease,0.9414,33962696
8072,Intraocular inflammation,disease,1.0,33962696
8073,VEGF,gene,0.638,33962696
8074,VEGF,gene,0.559,33962696
8075,Brolucizumab,gene,0.5967,33962696
8076,anti-VEGF,gene,0.8237,33962696
8077,inflammatory retinal vasculitis,disease,1.0,33962696
8078,intraocular inflammation,disease,1.0,33962696
8079,sterile inflammation,disease,1.0,33962696
8080,inflammatory vasculitis,disease,1.0,33962696
8081,anterior chamber inflammation,disease,1.0,33962696
8082,sterile uveitis,disease,0.9995,33962696
8083,endophthalmitis,disease,1.0,33962696
8084,anterior chamber inflammation,disease,1.0,33962696
8085,anti-VEGF,gene,0.9688,33962696
8086,sterile uveitis,disease,1.0,33962696
8087,endophthalmitis,disease,1.0,33962696
8088,VEGF,gene,0.5513,33962696
8089,Inflammatory vasculitis,disease,1.0,33962696
8090,brolucizumab,gene,0.7812,33962696
8091,intraocular inflammation,disease,0.9985,33962696
8092,anti-VEGF,gene,0.7695,33962696
8093,patient,species,0.9634,33962696
8094,patients,species,0.976,33962696
8095,hypopyon,disease,0.788,33962696
8096,hyperemia,disease,0.9985,33962696
8097,vision loss,disease,0.7725,33962696
8098,post,disease,0.8945,33962696
8099,SO,drug,,33962696
8100,intraocular inflammation,disease,0.9995,33962696
8101,brolucizumab,gene,0.8047,33962696
8102,retinal vasculitis,disease,0.7173,33962696
8103,hypersensitivity reaction,disease,1.0,33962696
8104,patients,species,0.9136,33956397
8105,BRAF,DNA,0.8745,33956173
8106,BRAF-V600E,gene,0.9346,33956173
8107,V600E,DNA,0.4207,33956173
8108,V600E,mutation,,33956173
8109,metastatic colorectal cancer,disease,1.0,33956173
8110,metastatic colorectal cancer,disease,1.0,33956173
8111,mCRC,disease,1.0,33956173
8112,irinotecan,drug,0.9995,33956173
8113,oxaliplatin,drug,0.9995,33956173
8114,epidermal,gene,0.8613,33956173
8115,EGFR,gene,0.9966,33956173
8116,cetuximab,gene,0.9004,33956173
8117,panitumumab,gene,0.8955,33956173
8118,bevacizumab,gene,0.686,33956173
8119,aflibercept,gene,0.9365,33956173
8120,mCRC,disease,0.995,33956173
8121,mCRC,disease,0.975,33956173
8122,patients,species,0.9946,33956173
8123,RAS,gene,0.991,33956173
8124,cetuximab,gene,0.7964,33956173
8125,panitumumab,gene,0.78,33956173
8126,BRAF,gene,0.993,33956173
8127,BRAF,gene,0.9927,33956173
8128,encorafenib,drug,0.9517,33956173
8129,cetuximab,gene,0.56,33956173
8130,BRAF-V600E,DNA,0.771,33956173
8131,BRAF-V600E mutation,gene,0.913,33956173
8132,V600E,mutation,,33956173
8133,BRAF,gene,0.998,33956173
8134,mCRC,disease,0.996,33956173
8135,BRAF,gene,0.994,33956173
8136,mCRC,disease,0.998,33956173
8137,patients,species,0.9897,33956173
8138,BRAF,DNA,0.802,33956173
8139,BRAF mutations,gene,0.7783,33956173
8140,mCRC,disease,0.9985,33956173
8141,patients,species,0.994,33956173
8142,Vitreous Hemorrhage,disease,1.0,33956075
8143,aflibercept,gene,0.969,33956075
8144,vitreous hemorrhage,disease,1.0,33956075
8145,proliferative diabetic retinopathy,disease,1.0,33956075
8146,PDR,disease,1.0,33956075
8147,patients,species,0.97,33956075
8148,vitreous hemorrhage,disease,1.0,33956075
8149,PDR,disease,0.9976,33956075
8150,PARTICIPANTS,species,0.5474,33956075
8151,vision loss,disease,0.9985,33956075
8152,PDR,disease,1.0,33956075
8153,vitreous hemorrhage,disease,0.999,33956075
8154,aflibercept,gene,0.982,33956075
8155,PRP,cell_type,0.518,33956075
8156,aflibercept,gene,0.9644,33956075
8157,vitreous hemorrhage,disease,0.8115,33956075
8158,participants,species,0.9663,33956075
8159,aflibercept,gene,0.971,33956075
8160,aflibercept,gene,0.9644,33956075
8161,aflibercept,gene,0.9795,33956075
8162,aflibercept,gene,0.983,33956075
8163,aflibercept,gene,0.9385,33956075
8164,vitreous hemorrhage,disease,1.0,33956075
8165,aflibercept,gene,0.9673,33956075
8166,aflibercept,gene,0.8403,33956075
8167,PDR,disease,1.0,33956075
8168,vitreous hemorrhage,disease,0.999,33956075
8169,PRP,gene,0.6655,33956075
8170,vitreous hemorrhage,disease,1.0,33956075
8171,aflibercept,gene,0.9897,33956075
8172,PRP,cell_type,0.4958,33956075
8173,patients,species,0.9917,33956075
8174,PDR,disease,0.999,33956075
8175,vitreous hemorrhage,disease,0.9995,33956075
8176,aflibercept,gene,0.9663,33951982
8177,polypoidal choroidal vasculopathy,disease,1.0,33951982
8178,PCV,disease,1.0,33951982
8179,polypoidal lesions,disease,1.0,33951982
8180,fibrosis,disease,0.945,33951982
8181,PCV,gene,0.579,33951982
8182,PCV,disease,1.0,33951982
8183,patients,species,0.991,33951982
8184,aflibercept,gene,0.9897,33951982
8185,patients,species,0.9927,33951982
8186,patients,species,0.99,33951982
8187,patients,species,0.9893,33951982
8188,patients,species,0.986,33951982
8189,subfoveal fibrosis,disease,0.9985,33951982
8190,macular telangiectasia type 2,disease,1.0,33948521
8191,patient,species,0.9287,33948521
8192,MacTel 2,disease,1.0,33948521
8193,patient,species,0.9277,33948521
8194,aflibercept,gene,0.9653,33948521
8195,MacTel,DNA,0.56,33948521
8196,MacTel 2,disease,0.9985,33948521
8197,girl,species,0.8555,33948521
8198,systemic disease,disease,0.9873,33948521
8199,MacTel 2,disease,1.0,33948521
8200,aflibercept,gene,0.9365,33948521
8201,patient,species,0.986,33948521
8202,MacTel 2,disease,1.0,33948521
8203,patients,species,0.978,33948521
8204,aflibercept,gene,0.985,33948521
8205,MacTel 2,disease,1.0,33948521
8206,aflibercept,gene,0.9854,33945883
8207,aflibercept,gene,0.9785,33945883
8208,macular degeneration,disease,1.0,33945883
8209,age-related macular degeneration,disease,1.0,33945883
8210,patients,species,0.989,33945883
8211,fluorescein,drug,0.9883,33945883
8212,patients,species,0.9863,33945883
8213,aflibercept,gene,0.977,33945883
8214,afibercept,gene,0.9673,33945883
8215,aflibercept,gene,0.9893,33945883
8216,anti-vascular endothelial growth factor,gene,0.9775,33944638
8217,anti-vascular endothelial growth factor,gene,0.9385,33944638
8218,VEGF,gene,0.995,33944638
8219,neovascular age-related macular degeneration,disease,1.0,33944638
8220,nAMD,disease,1.0,33944638
8221,VEGF,gene,0.611,33944638
8222,patients,species,0.9805,33944638
8223,nAMD,disease,1.0,33944638
8224,aflibercept,gene,0.976,33944638
8225,ranibizumab,gene,0.8525,33944638
8226,dry AMD,disease,1.0,33944638
8227,anti-VEGF,gene,0.993,33944638
8228,retinal nerve fiber,cell_type,0.4563,33944638
8229,ganglion cell,cell_type,0.4578,33944638
8230,ETDRS grid,DNA,0.4744,33944638
8231,nAMD,disease,1.0,33944638
8232,dry AMD,disease,1.0,33944638
8233,nAMD,disease,1.0,33944638
8234,anti-VEGF,gene,0.9385,33944638
8235,nAMD,disease,1.0,33944638
8236,anti-VEGF,gene,0.827,33944638
8237,nAMD,disease,1.0,33944638
8238,diabetic macular,disease,1.0,33942162
8239,diabetic macular oedema,disease,1.0,33942162
8240,DME,disease,1.0,33942162
8241,Patients,species,0.973,33942162
8242,DME,disease,1.0,33942162
8243,ranibizumab,gene,0.5303,33942162
8244,DME,disease,1.0,33942162
8245,patients,species,0.9536,33942162
8246,patients,species,0.9805,33942162
8247,DME,disease,1.0,33942162
8248,patients,species,0.989,33942162
8249,Diabetic,RNA,0.4292,33942162
8250,Diabetic Retinopathy,disease,1.0,33942162
8251,patients,species,0.99,33942162
8252,Diabetic Macular Edema,disease,1.0,33935727
8253,diabetic,disease,1.0,33935727
8254,macular edema,disease,1.0,33935727
8255,conbercept,gene,0.734,33935727
8256,bevacizumab,gene,0.727,33935727
8257,aflibercept,gene,0.9893,33935727
8258,triamcinolone acetonide,drug,0.9976,33935727
8259,bevacizumab,gene,0.7725,33935727
8260,aflibercept,gene,0.9893,33935727
8261,triamcinolone acetonide,drug,0.9985,33935727
8262,bevacizumab,gene,0.6978,33935727
8263,triamcinolone acetonide,drug,0.998,33935727
8264,ranibizumab,gene,0.753,33935727
8265,Anti-VEGF,gene,0.8315,33935487
8266,anti-VEGF,gene,0.812,33935487
8267,neovascular aged-related macular degeneration,disease,1.0,33935487
8268,nAMD,disease,1.0,33935487
8269,Ranibizumab,gene,0.8525,33935487
8270,Ranibizumab,gene,0.8877,33935487
8271,Ranibizumab,gene,0.5513,33935487
8272,Ranibizumab,gene,0.922,33935487
8273,Aflibercept,gene,0.8823,33935487
8274,Aflibercept,gene,0.932,33935487
8275,nAMD,disease,1.0,33935487
8276,patients,species,0.9937,33935487
8277,Patients,species,0.9595,33935487
8278,patients,species,0.942,33935487
8279,patients,species,0.9883,33935487
8280,Ranibizumab,gene,0.893,33935487
8281,Ranibizumab,gene,0.888,33935487
8282,Aflibercept,gene,0.972,33935487
8283,Ranibizumab,gene,0.804,33935487
8284,Ranibizumab,gene,0.815,33935487
8285,Aflibercept,gene,0.907,33935487
8286,Ranibizumab,gene,0.914,33935487
8287,Ranibizumab,gene,0.977,33935487
8288,Aflibercept,gene,0.989,33935487
8289,Ranibizumab,gene,0.909,33935487
8290,Ranibizumab,gene,0.7407,33935487
8291,Aflibercept,gene,0.982,33935487
8292,Ranibizumab,gene,0.9326,33935487
8293,Aflibercept,gene,0.9375,33935487
8294,Ranibizumab,gene,0.8496,33935487
8295,Aflibercept,gene,0.978,33935487
8296,Ranibizumab,gene,0.904,33935487
8297,Aflibercept,gene,0.9907,33935487
8298,Ranibizumab,gene,0.9644,33935487
8299,Ranibizumab,gene,0.872,33935487
8300,VEGF,gene,0.7964,33930919
8301,Exudative Age-Related Macular BACKGROUND,disease,1.0,33930919
8302,anti-vascular endothelial growth factor,gene,0.9624,33930919
8303,anti-VEGF,gene,0.9893,33930919
8304,exudative age-related macular degeneration,disease,0.999,33930919
8305,AMD,disease,1.0,33930919
8306,PATIENTS,species,0.9595,33930919
8307,patients,species,0.97,33930919
8308,ranibizumab,gene,0.9316,33930919
8309,aflibercept,gene,0.9707,33930919
8310,monolateral or bilateral exudative AMD,disease,0.984,33930919
8311,retinal hemorrhage,disease,1.0,33930919
8312,pigment epithelial detachment,disease,1.0,33930919
8313,ETDRS,DNA,0.531,33930919
8314,patients,species,0.9683,33930919
8315,men,species,0.9824,33930919
8316,women,species,0.9756,33930919
8317,ETDRS,DNA,0.5337,33930919
8318,Atrophy,disease,0.9897,33930919
8319,fibrosis,disease,0.996,33930919
8320,cardiovascular,disease,0.8535,33930919
8321,intraocular inflammation,disease,1.0,33930919
8322,VEGF,gene,0.9077,33930919
8323,aflibercept,gene,0.991,33929648
8324,arsenic trioxide,drug,0.9995,33929648
8325,Aflibercept,gene,0.9688,33929648
8326,arsenic trioxide,drug,0.9995,33929648
8327,human cancer cell lines,cell_line,0.9595,33929648
8328,human,species,0.9907,33929648
8329,cancer,disease,0.976,33929648
8330,arsenic trioxide,drug,0.9995,33929648
8331,oral squamous cell carcinoma,disease,1.0,33929648
8332,OCC,disease,1.0,33929648
8333,OCC lines,cell_line,0.946,33929648
8334,OCC,disease,0.902,33929648
8335,human OCC cell lines,cell_line,0.961,33929648
8336,human,species,0.9194,33929648
8337,OCC,disease,0.978,33929648
8338,patients,species,0.973,33929648
8339,cell lines,cell_line,0.9478,33929648
8340,methyl thiazolyl tetrazolium,drug,0.9985,33929648
8341,MTT,drug,1.0,33929648
8342,OCC lines,cell_line,0.927,33929648
8343,OCC,disease,0.9844,33929648
8344,Aflibercept,gene,0.979,33929648
8345,OCC cell lines,cell_line,0.8975,33929648
8346,OCC,disease,1.0,33929648
8347,Arsenic trioxide,drug,0.9995,33929648
8348,cell lines,cell_line,0.922,33929648
8349,endoglin,gene,0.9927,33929648
8350,VEGFA,gene,0.998,33929648
8351,VEGFB,gene,0.9985,33929648
8352,oral carcinoma cells,cell_line,0.69,33929648
8353,oral carcinoma,disease,1.0,33929648
8354,oral cancer,disease,0.9995,33929648
8355,patients,species,0.9937,33929648
8356,VEGF,gene,0.695,33921543
8357,AMD,disease,1.0,33921543
8358,VEGF,gene,0.641,33921543
8359,Vascular Endothelial Growth Factor,gene,0.9985,33921543
8360,Trichostatin A,drug,0.999,33921543
8361,TSA,drug,0.9995,33921543
8362,histone deacetylase,gene,0.997,33921543
8363,HDAC,gene,0.9956,33921543
8364,cultured ARPE-19 (Adult Retinal Pigment Epithelial-19) cells,cell_line,0.935,33921543
8365,ARPE-19 (Adult Retinal Pigment Epithelial-19) cells,cell_type,0.606,33921543
8366,immortalized human retinal pigment epithelial cells,cell_line,0.956,33921543
8367,human,species,0.92,33921543
8368,ARPE-19 cells,cell_line,0.8105,33921543
8369,VEGF,gene,0.6484,33921543
8370,aflibercept,gene,0.9824,33921543
8371,ranibizumab,gene,0.939,33921543
8372,bevacizumab,gene,0.7354,33921543
8373,genes,DNA,0.874,33921543
8374,AMD,disease,1.0,33921543
8375,HDAC,gene,0.9717,33921543
8376,Histone Deacetylase,gene,0.9956,33921543
8377,TSA,drug,0.9995,33921543
8378,HIF-1 and IL-1 genes,DNA,0.8467,33921543
8379,HIF-1,gene,0.997,33921543
8380,IL-1 genes,gene,0.989,33921543
8381,"BCL2L13, CASPASE-9, and IL-18 genes",DNA,0.877,33921543
8382,BCL2L13,gene,0.995,33921543
8383,CASPASE-9,gene,0.982,33921543
8384,IL-18 genes,gene,0.932,33921543
8385,TSA,drug,0.9976,33921543
8386,bevacizumab,gene,0.8774,33921543
8387,TSA,drug,0.997,33921543
8388,HDAC,gene,0.9854,33921543
8389,ARPE-19 cells,cell_line,0.8755,33921543
8390,ARPE-19 cells,cell_type,0.649,33921543
8391,Bevacizumab,gene,0.6377,33921543
8392,HDAC,gene,0.9844,33921543
8393,SOD2,gene,0.9966,33921543
8394,BCL2L13,gene,0.9966,33921543
8395,CASPASE-3,gene,0.986,33921543
8396,IL-18,gene,0.989,33921543
8397,HIF-1,gene,0.991,33921543
8398,IL-18,gene,0.9907,33921543
8399,bevacizumab,gene,0.868,33921543
8400,TSA,drug,0.998,33921543
8401,SOD2,gene,0.994,33921543
8402,HIF-1,gene,0.997,33921543
8403,GPX3A,gene,0.9956,33921543
8404,BCL2L13,gene,0.9976,33921543
8405,CASPASE-3,gene,0.976,33921543
8406,CASPASE-9,gene,0.966,33921543
8407,IL-,gene,0.6094,33921543
8408,VEGF,gene,0.942,33921543
8409,genes,DNA,0.7925,33921543
8410,GPX3A,gene,0.996,33921543
8411,SOD2,gene,0.994,33921543
8412,IL-18,gene,0.9956,33921543
8413,IL-1,gene,0.993,33921543
8414,BCL2L13,gene,0.9966,33921543
8415,CASPASE-3,gene,0.984,33921543
8416,CASPASE-9,gene,0.9907,33921543
8417,TSA,drug,0.9985,33921543
8418,HIF-1,gene,0.998,33921543
8419,inflammation genes,DNA,0.8193,33921543
8420,Acetylated Tetrapeptide,drug,0.996,33918777
8421,tetrapeptide,drug,0.965,33918777
8422,Arg-Leu-Tyr-Glu,drug,0.9995,33918777
8423,RLYE,drug,0.9834,33918777
8424,human plasminogen,gene,0.994,33918777
8425,human,species,0.9795,33918777
8426,vascular endothelial growth factor,gene,0.998,33918777
8427,VEGF,gene,0.998,33918777
8428,mice,species,0.932,33918777
8429,VEGF receptor,gene,0.992,33918777
8430,VEGFR-2,gene,0.9985,33918777
8431,tetrapeptide,drug,0.9507,33918777
8432,Ac,drug,1.0,33918777
8433,choroidal neovascularization,disease,1.0,33918777
8434,CNV,disease,1.0,33918777
8435,neovascular age-related macular degeneration,disease,0.9995,33918777
8436,AMD,disease,1.0,33918777
8437,rat,species,0.9893,33918777
8438,rabbit,species,0.9897,33918777
8439,minipig,species,0.9443,33918777
8440,Ac,drug,,33918777
8441,ranibizumab,gene,0.7847,33918777
8442,aflibercept,gene,0.9126,33918777
8443,Ac-RLYE,drug,0.9995,33918777
8444,rabbits,species,0.8354,33918777
8445,plasma,cell_type,0.5034,33918777
8446,Ac-RLYE,drug,0.9497,33918777
8447,neovascular (wet) AMD,disease,1.0,33918777
8448,amino acids,drug,0.9956,33918777
8449,human VEGFR-2,gene,0.9946,33918777
8450,human,species,0.973,33918777
8451,Ac,drug,,33918777
8452,Ac-RLYE,gene,0.9053,33918777
8453,human,species,0.993,33918777
8454,patients,species,0.9805,33918777
8455,retinal degenerative diseases,disease,1.0,33918777
8456,aflibercept,gene,0.9478,33914158
8457,aflibercept,gene,0.962,33914158
8458,macular edema,disease,1.0,33914158
8459,ME,disease,1.0,33914158
8460,branch retinal vein occlusion,disease,1.0,33914158
8461,BRVO,disease,1.0,33914158
8462,patients,species,0.988,33914158
8463,aflibercept,gene,0.9766,33914158
8464,patient,species,0.9927,33914158
8465,patients,species,0.9873,33914158
8466,patients,species,0.989,33914158
8467,aflibercept,gene,0.9775,33914158
8468,patients,species,0.9907,33914158
8469,aflibercept,gene,0.971,33914158
8470,ME,disease,,33914158
8471,BRVO,disease,1.0,33914158
8472,aflibercept,gene,0.979,33905838
8473,aflibercept,gene,0.9214,33905838
8474,retinopathy of prematurity,disease,1.0,33905838
8475,ROP,disease,1.0,33905838
8476,patients,species,0.9873,33905838
8477,posterior retinopathy of prematurity,disease,0.9575,33905838
8478,AP-ROP,disease,1.0,33905838
8479,retinal detachment,disease,1.0,33905838
8480,patients,species,0.9824,33905838
8481,patients,species,0.9756,33905838
8482,Retinal detachment,disease,1.0,33905838
8483,Ranibizumab,gene,0.961,33900585
8484,Aflibercept,gene,0.9106,33900585
8485,Bevacizumab,gene,0.581,33900585
8486,ranibizumab,gene,0.5977,33900585
8487,aflibercept,gene,0.9688,33900585
8488,Eylea,gene,0.751,33900585
8489,bevacizumab,gene,0.64,33900585
8490,Avastin,gene,0.77,33900585
8491,macular oedema,disease,1.0,33900585
8492,central retinal vein occlusion,disease,1.0,33900585
8493,bevacizumab,gene,0.863,33900585
8494,Bevacizumab,gene,0.861,33900585
8495,aflibercept,gene,0.971,33900585
8496,bevacizumab,gene,0.887,33900585
8497,ranibizumab,drug,0.5444,33900585
8498,aflibercept,gene,0.9863,33900585
8499,bevacizumab,gene,0.899,33900585
8500,aflibercept,gene,0.9795,33900585
8501,bevacizumab,gene,0.6685,33900585
8502,Bevacizumab,gene,0.915,33900585
8503,bevacizumab,gene,0.8765,33900585
8504,macular oedema,disease,1.0,33900585
8505,central retinal vein occlusion,disease,1.0,33900585
8506,patients,species,0.986,33900585
8507,bevacizumab,gene,0.8276,33900585
8508,Polypoidal choroidal vasculopathy,disease,1.0,33898862
8509,patient,species,0.9424,33898862
8510,patient,species,0.9297,33898862
8511,polypoidal choroidal vasculopathy,disease,1.0,33898862
8512,PCV,disease,1.0,33898862
8513,large colloid drusen,disease,0.9976,33898862
8514,LCD,disease,1.0,33898862
8515,aflibercept,gene,0.981,33898862
8516,PCV,disease,1.0,33898862
8517,anti-vascular endothelial growth factor,gene,0.971,33898862
8518,VEGF,gene,0.999,33898862
8519,woman,species,0.9385,33898862
8520,retinal drusen,disease,1.0,33898862
8521,LCD,disease,1.0,33898862
8522,PVC,disease,1.0,33898862
8523,ranibizumab,gene,0.551,33898862
8524,patient,species,0.979,33898862
8525,aflibercept,gene,0.9834,33898862
8526,PCV,disease,1.0,33898862
8527,LCD,disease,0.771,33898862
8528,aflibercept,gene,0.955,33898862
8529,patients,species,0.99,33898862
8530,anti-VEGF,gene,0.877,33898862
8531,silicone oil,drug,0.913,33890418
8532,SO,drug,,33890418
8533,SO,drug,0.999,33890418
8534,VEGF,gene,0.8345,33890418
8535,aflibercept,gene,0.9937,33890418
8536,bevacizumab,gene,0.9434,33890418
8537,ziv-aflibercept,gene,0.9897,33890418
8538,SO,drug,,33890418
8539,SO,drug,,33890418
8540,SO,drug,,33890418
8541,ziv-aflibercept,gene,0.96,33890418
8542,aflibercept,gene,0.992,33890418
8543,bevacizumab,gene,0.731,33890418
8544,SO,drug,,33890418
8545,Silicone,drug,0.9214,33890418
8546,Silicone oil,drug,0.753,33890418
8547,SO,drug,,33890418
8548,aflibercept,gene,0.982,33889280
8549,patients,species,0.9043,33889280
8550,colorectal cancer,disease,1.0,33889280
8551,CRC,disease,1.0,33889280
8552,Aflibercept,gene,0.986,33889280
8553,AFL,gene,0.9956,33889280
8554,CRC,disease,0.9966,33889280
8555,bevacizumab,gene,0.804,33889280
8556,AFL,gene,0.5454,33889280
8557,AFL,drug,0.9614,33889280
8558,patients,species,0.979,33889280
8559,AFL,drug,0.976,33889280
8560,patients,species,0.968,33889280
8561,advanced CRC,disease,0.9985,33889280
8562,AFL,drug,0.983,33889280
8563,folinic acid,drug,0.9985,33889280
8564,fluorouracil,drug,0.9995,33889280
8565,irinotecan,drug,0.999,33889280
8566,FOLFIRI,drug,0.9297,33889280
8567,Patient,species,0.983,33889280
8568,tumor,disease,0.899,33889280
8569,RAS,gene,0.9976,33889280
8570,RAF,gene,0.999,33889280
8571,AI,disease,,33889280
8572,AFL,disease,1.0,33889280
8573,AFL,disease,0.999,33889280
8574,patients,species,0.981,33889280
8575,AFL,drug,0.967,33889280
8576,FOLFIRI,drug,0.986,33889280
8577,advanced CRC,disease,0.9985,33889280
8578,cancer,disease,0.9224,33889280
8579,patients,species,0.9805,33889280
8580,AFL,drug,0.982,33889280
8581,patient,species,0.987,33889280
8582,patients,species,0.9863,33889280
8583,patients,species,0.9897,33889280
8584,advanced CRC,disease,0.9883,33889280
8585,patients,species,0.9907,33889280
8586,Aflibercept,gene,0.9546,33883872
8587,Pachychoroid Neovasculopathy,disease,1.0,33883872
8588,aflibercept,gene,0.9424,33883872
8589,pachychoroid neovasculopathy,disease,1.0,33883872
8590,neovascular age-related macular degeneration,disease,1.0,33883872
8591,AMD,disease,1.0,33883872
8592,pachychoroid neovasculopathy,disease,1.0,33883872
8593,neovascular AMD,disease,1.0,33883872
8594,patients,species,0.9863,33883872
8595,pachychoroid neovasculopathy,disease,1.0,33883872
8596,neovascular AMD,disease,1.0,33883872
8597,pachychoroid neovasculopathy,disease,1.0,33883872
8598,polyps,disease,0.8267,33883872
8599,pachychoroid neovasculopathy,disease,1.0,33883872
8600,neovascular AMD,disease,1.0,33883872
8601,CRT,DNA,0.55,33883872
8602,pachychoroid neovasculopathy,disease,1.0,33883872
8603,neovascular AMD,disease,1.0,33883872
8604,pachychoroid neovasculopathy,disease,1.0,33883872
8605,neovascular AMD,disease,1.0,33883872
8606,VEGF,gene,0.9595,33881265
8607,age-related macular degeneration,disease,0.999,33881265
8608,patients,species,0.971,33881265
8609,Patients,species,0.9893,33881265
8610,patients,species,0.9937,33881265
8611,wet age-related macular degeneration,disease,0.9995,33881265
8612,wAMD,disease,1.0,33881265
8613,patients,species,0.9746,33881265
8614,wAMD,disease,1.0,33881265
8615,VEGF,gene,0.9146,33881265
8616,ranibizumab,gene,0.969,33881265
8617,aflibercept,gene,0.967,33881265
8618,patients,species,0.9937,33881265
8619,patients,species,0.996,33881265
8620,wAMD,disease,0.999,33881265
8621,VEGF,gene,0.7,33881265
8622,Metastatic Colorectal Cancer,disease,1.0,33875364
8623,fluoropyrimidine,drug,0.999,33875364
8624,irinotecan,drug,0.996,33875364
8625,metastatic colorectal cancer,disease,1.0,33875364
8626,mCRC,disease,1.0,33875364
8627,PATIENTS,species,0.9277,33875364
8628,fluorouracil,drug,0.9995,33875364
8629,irinotecan,drug,0.999,33875364
8630,FOLFIRI,drug,0.9985,33875364
8631,RAM,drug,0.9907,33875364
8632,FOLFIRI,drug,0.9805,33875364
8633,aflibercept,gene,0.9863,33875364
8634,AFL,gene,0.993,33875364
8635,irinotecan,drug,0.999,33875364
8636,S-1,drug,0.981,33875364
8637,IRIS,drug,0.9966,33875364
8638,capecitabine,drug,0.9995,33875364
8639,irinotecan,drug,0.9976,33875364
8640,CAPIRI,drug,0.999,33875364
8641,FOLFIRI,drug,0.9697,33875364
8642,mCRC,disease,0.9893,33875364
8643,patients,species,0.9917,33875364
8644,fluoropyrimidine,drug,0.999,33875364
8645,oxaliplatin,drug,1.0,33875364
8646,BEV,drug,0.9956,33875364
8647,patients,species,0.9404,33875364
8648,FOLFIRI,drug,0.9834,33875364
8649,RAM,drug,0.9966,33875364
8650,FOLFIRI,drug,0.968,33875364
8651,AFL,drug,0.9683,33875364
8652,IRIS,disease,0.9897,33875364
8653,BEV,drug,0.9136,33875364
8654,FOLFIRI,drug,0.9937,33875364
8655,RAM,drug,0.997,33875364
8656,neutropenia,disease,1.0,33875364
8657,granulocyte colony-stimulating factor,gene,0.998,33875364
8658,IRIS,drug,0.9937,33875364
8659,BEV,drug,0.9824,33875364
8660,CAPIRI,drug,0.9966,33875364
8661,BEV,drug,0.9854,33875364
8662,BEV,drug,0.998,33875364
8663,RAM,drug,0.999,33875364
8664,AFL,drug,0.994,33875364
8665,FOLFIRI,drug,0.9985,33875364
8666,IRIS,drug,0.9985,33875364
8667,FOLFIRI,drug,0.996,33875364
8668,BEV,drug,0.9854,33875364
8669,patients,species,0.9927,33875364
8670,fluoropyrimidine,drug,0.9995,33875364
8671,oxaliplatin,drug,1.0,33875364
8672,BEV,drug,0.996,33875364
8673,Focal choroidal excavation,disease,0.9995,33869893
8674,focal choroidal excavation,disease,1.0,33869893
8675,FCE,disease,1.0,33869893
8676,type 2 choroidal neovascularization,disease,0.9854,33869893
8677,CNV,disease,1.0,33869893
8678,CNV,disease,0.927,33869893
8679,aflibercept,gene,0.952,33869893
8680,FCE,disease,0.9995,33869893
8681,man,species,0.844,33869893
8682,type 2 CNV,disease,0.9995,33869893
8683,FCE,DNA,0.6064,33869893
8684,aflibercept,gene,0.982,33869893
8685,CNV,disease,0.9893,33869893
8686,FCE,disease,0.974,33869893
8687,FCE,disease,0.9995,33869893
8688,CNV,DNA,0.8066,33869893
8689,Neovascular Age-Related Macular PURPOSE,disease,0.9995,33866023
8690,neovascular age-related macular degeneration,disease,1.0,33866023
8691,nAMD,disease,1.0,33866023
8692,patients,species,0.984,33866023
8693,PARTICIPANTS,species,0.688,33866023
8694,patients,species,0.986,33866023
8695,anti-vascular endothelial growth factor,gene,0.9546,33866023
8696,VEGF,gene,0.9976,33866023
8697,nAMD,disease,1.0,33866023
8698,Patients,species,0.9644,33866023
8699,patients,species,0.9766,33866023
8700,patients,species,0.981,33866023
8701,COVID-19,disease,0.9937,33864577
8702,neovascular AMD,disease,1.0,33864577
8703,patients,species,0.9907,33864577
8704,neovascular age-related macular degeneration,disease,1.0,33864577
8705,nAMD,disease,1.0,33864577
8706,patients,species,0.985,33864577
8707,anti-vascular endothelial growth factor,gene,0.9927,33864577
8708,anti-VEGF,gene,0.9854,33864577
8709,patients,species,0.9814,33864577
8710,coronavirus disease,disease,1.0,33864577
8711,COVID-19,disease,0.999,33864577
8712,restriction period,DNA,0.4993,33864577
8713,patients,species,0.9707,33864577
8714,nAMD,disease,1.0,33864577
8715,patients,species,0.9937,33864577
8716,patients,species,0.9917,33864577
8717,RP,disease,1.0,33864577
8718,Patients,species,0.9746,33864577
8719,anti-VEGF,gene,0.9727,33864577
8720,Aflibercept,gene,0.9824,33864577
8721,patients,species,0.985,33864577
8722,patients,species,0.975,33864577
8723,hypertension,disease,0.9995,33864577
8724,V(0),drug,0.98,33864577
8725,nAMD,disease,1.0,33864577
8726,patients,species,0.9946,33864577
8727,patients,species,0.9927,33864577
8728,OCT,gene,0.99,33864577
8729,Aflibercept,gene,0.948,33854566
8730,bevacizumab,gene,0.843,33854566
8731,FOLFIRI,drug,0.981,33854566
8732,metastatic colorectal cancer,disease,1.0,33854566
8733,mCRC,disease,1.0,33854566
8734,patients,species,0.993,33854566
8735,mRAS,gene,0.9683,33854566
8736,mutated,RNA,0.607,33854566
8737,mutated RAS,gene,0.9604,33854566
8738,mCRC,disease,0.9995,33854566
8739,patients,species,0.993,33854566
8740,EGFR,gene,0.8716,33854566
8741,cetuximab,gene,0.769,33854566
8742,panitumumab,gene,0.759,33854566
8743,patients,species,0.985,33854566
8744,bevacizumab,gene,0.9644,33854566
8745,aflibercept,gene,0.985,33854566
8746,bevacizumab,gene,0.929,33854566
8747,bevacizumab,gene,0.8794,33854566
8748,aflibercept,gene,0.968,33854566
8749,fluorouracil,drug,0.9995,33854566
8750,irinotecan,drug,0.9995,33854566
8751,FOLFIRI,drug,0.9966,33854566
8752,bevacizumab,gene,0.9805,33854566
8753,FOLFIRI,drug,0.871,33854566
8754,aflibercept,gene,0.995,33854566
8755,fluoropyrimidines,drug,0.999,33854566
8756,oxaliplatin,drug,0.999,33854566
8757,mRAS,gene,0.994,33854566
8758,mCRC,disease,0.998,33854566
8759,patients,species,0.995,33854566
8760,patients,species,0.9907,33854566
8761,patients,species,0.995,33854566
8762,FOLFIRI,drug,0.989,33854566
8763,bevacizumab,gene,0.912,33854566
8764,FOLFIRI,drug,0.5913,33854566
8765,aflibercept,gene,0.991,33854566
8766,mRAS,gene,0.988,33854566
8767,mCRC,disease,0.9746,33854566
8768,patients,species,0.9956,33854566
8769,oncologists,cell_type,0.4006,33854566
8770,VEGF,gene,0.7544,33854294
8771,VEGF,gene,0.621,33854294
8772,retinal diseases,disease,1.0,33854294
8773,bevacizumab,gene,0.874,33854294
8774,aflibercept,gene,0.9727,33854294
8775,ranibizumab,drug,0.5283,33854294
8776,ophthalmologists,cell_type,0.4482,33854294
8777,patients,species,0.99,33854294
8778,Dexamethasone,drug,0.9976,33843438
8779,dexamethasone,drug,0.997,33843438
8780,Ozurdex,drug,0.973,33843438
8781,antivascular endothelial growth factor,gene,0.957,33843438
8782,anti-VEGF,gene,0.9565,33843438
8783,patients,species,0.966,33843438
8784,branched retinal vein occlusion,disease,1.0,33843438
8785,BRVO,disease,1.0,33843438
8786,patients,species,0.9844,33843438
8787,BRVO,disease,0.9966,33843438
8788,anti-VEGF,gene,0.7026,33843438
8789,bevacizumab,gene,0.8594,33843438
8790,ranibizumab,gene,0.928,33843438
8791,aflibercept,gene,0.9414,33843438
8792,patients,species,0.9917,33843438
8793,men,species,0.984,33843438
8794,BRVO,disease,0.999,33843438
8795,Ozurdex,drug,0.9565,33843438
8796,anti-VEGF,gene,0.9824,33843438
8797,Ozurdex,drug,0.9463,33843438
8798,Diabetic Retinopathy,disease,0.9985,33843438
8799,Ozurdex,drug,0.935,33843438
8800,BRVO,disease,1.0,33843438
8801,Neovascular,disease,0.7993,33840491
8802,patients,species,0.9873,33840491
8803,anti-VEGF,gene,0.957,33840491
8804,ranibizumab,gene,0.9717,33840491
8805,aflibercept,gene,0.9766,33840491
8806,macular degeneration,disease,1.0,33840491
8807,AMD,disease,1.0,33840491
8808,patient,species,0.987,33840491
8809,anti-VEGF,gene,0.9834,33840491
8810,patients,species,0.989,33840491
8811,patients,species,0.991,33840491
8812,anti-VEGF,gene,0.899,33840491
8813,exudative AMD,disease,0.9995,33840491
8814,patient,species,0.987,33840491
8815,patients,species,0.9707,33840491
8816,women,species,0.9443,33840491
8817,anti-VEGF,gene,0.939,33840491
8818,anti-VEGF molecule,gene,0.8936,33840491
8819,patients,species,0.987,33840491
8820,exudative AMD,disease,0.999,33840491
8821,patients,species,0.995,33840491
8822,patients,species,0.985,33840491
8823,patients,species,0.9795,33840491
8824,ADVM-022,drug,0.95,33835848
8825,Anti-VEGF Gene,gene,0.9272,33835848
8826,vascular endothelial growth factor,gene,0.997,33835848
8827,aflibercept,gene,0.982,33835848
8828,neovascular age-related macular degeneration,disease,1.0,33835848
8829,nAMD,disease,1.0,33835848
8830,diabetic macular edema,disease,1.0,33835848
8831,DME,disease,1.0,33835848
8832,vision impairment,disease,0.9995,33835848
8833,anti-VEGF,gene,0.995,33835848
8834,ADVM,DNA,0.7896,33835848
8835,adeno,DNA,0.4546,33835848
8836,aflibercept,gene,0.9844,33835848
8837,ADVM-022,gene,0.81,33835848
8838,aflibercept,gene,0.6953,33835848
8839,CNV,disease,1.0,33835848
8840,human,species,0.797,33835848
8841,VEGF,gene,0.996,33835848
8842,ADVM,drug,0.781,33835848
8843,aflibercept,gene,0.9927,33835848
8844,ADVM,drug,0.844,33835848
8845,CNV,DNA,0.4578,33835848
8846,CNV lesions,disease,0.8447,33835848
8847,aflibercept,gene,0.9585,33835848
8848,ADVM-022,drug,0.964,33835848
8849,nAMD,disease,1.0,33835848
8850,DME,disease,1.0,33835848
8851,patients,species,0.99,33835848
8852,ADVM,drug,0.6304,33835848
8853,aflibercept,gene,0.9897,33832114
8854,aflibercept,gene,0.9893,33832114
8855,proliferative diabetic retinopathy,disease,1.0,33832114
8856,PDR,disease,1.0,33832114
8857,patients,species,0.9834,33832114
8858,aflibercept,gene,0.9907,33832114
8859,PDR,disease,0.9995,33832114
8860,patients,species,0.994,33832114
8861,retinal nonperfusion,disease,0.7446,33832114
8862,vascular endothelial growth factor,gene,0.974,33822670
8863,VEGF,gene,0.999,33822670
8864,MIDAS,DNA,0.702,33822670
8865,VEGF,gene,0.6943,33822670
8866,VEGF,gene,0.9727,33822670
8867,aflibercept,gene,0.983,33822670
8868,bevacizumab,gene,0.791,33822670
8869,ranibizumab,gene,0.5127,33822670
8870,ranibizumab,gene,0.91,33813015
8871,aflibercept,gene,0.9824,33813015
8872,ranibizumab,gene,0.8945,33813015
8873,aflibercept,gene,0.974,33813015
8874,patients,species,0.9233,33813015
8875,diabetic macular edema,disease,1.0,33813015
8876,DME,disease,1.0,33813015
8877,patients,species,0.973,33813015
8878,DME,disease,1.0,33813015
8879,ranibizumab,gene,0.869,33813015
8880,aflibercept,gene,0.9478,33813015
8881,ranibizumab,gene,0.703,33813015
8882,aflibercept,gene,0.9863,33813015
8883,STA,DNA,0.5674,33813015
8884,inferotemporal,DNA,0.4402,33813015
8885,ranibizumab,gene,0.517,33813015
8886,aflibercept,gene,0.8438,33813015
8887,ranibizumab,drug,0.7456,33813015
8888,aflibercept,gene,0.955,33813015
8889,retinal,DNA,0.4585,33813015
8890,ranibizumab,gene,0.8936,33813015
8891,aflibercept,gene,0.977,33813015
8892,patients,species,0.932,33813015
8893,DME,disease,1.0,33813015
8894,Aflibercept,gene,0.9746,33807964
8895,Exudative Age-Related Macular,disease,0.999,33807964
8896,aflibercept,gene,0.9683,33807964
8897,AMD,disease,1.0,33807964
8898,patients,species,0.989,33807964
8899,BCVA,DNA,0.4434,33807964
8900,exudative AMD,disease,1.0,33807964
8901,neovascular AMD,disease,1.0,33807964
8902,nAMD,disease,1.0,33807964
8903,polypoidal choroidal vasculopathy,disease,1.0,33807964
8904,PCV,disease,1.0,33807964
8905,BCVA,cell_type,0.4285,33807964
8906,nAMD,disease,0.9976,33807964
8907,PCV,disease,1.0,33807964
8908,nAMD,disease,0.9014,33807964
8909,protective allele,DNA,0.691,33807964
8910,ARMS2,DNA,0.568,33807964
8911,ARMS2 A69S,gene,0.8916,33807964
8912,A69S,mutation,,33807964
8913,aflibercept,gene,0.99,33807964
8914,exudative AMD,disease,0.9966,33807964
8915,nAMD,disease,1.0,33807964
8916,PCV,disease,1.0,33807964
8917,Vancomycin,drug,0.997,33806541
8918,endophthalmitis,disease,1.0,33806541
8919,aflibercept,gene,0.977,33806541
8920,Patients,species,0.9795,33806541
8921,endophthalmitis,disease,1.0,33806541
8922,aflibercept,gene,0.9663,33806541
8923,Streptococcus mitis,species,0.955,33806541
8924,patients,species,0.9897,33806541
8925,vancomycin,drug,0.996,33806541
8926,age-related macular degeneration,disease,1.0,33806541
8927,AMD,disease,1.0,33806541
8928,patients,species,0.991,33806541
8929,Streptococcus mitis-,disease,0.809,33806541
8930,Streptococcus mitis,species,0.9067,33806541
8931,endophthalmitis,disease,0.71,33806541
8932,Anti-VEGF,gene,0.895,33801185
8933,anti-vascular endothelial growth factor,gene,0.881,33801185
8934,retinal diseases,disease,0.9985,33801185
8935,bevacizumab,gene,0.776,33801185
8936,ranibizumab,gene,0.825,33801185
8937,aflibercept,gene,0.9614,33801185
8938,brolucizumab,gene,0.747,33801185
8939,sterile intraocular inflammation,disease,1.0,33801185
8940,brolucizumab,gene,0.8516,33801185
8941,retinal vasculitis,disease,0.762,33801185
8942,post-injection endophthalmitis,disease,1.0,33801185
8943,Aflibercept,gene,0.9375,33795022
8944,exudative age-related macular degeneration,disease,1.0,33795022
8945,neovascular age-related macular degeneration,disease,0.9824,33795022
8946,AMD,disease,1.0,33795022
8947,patients,species,0.9897,33795022
8948,patients,species,0.9893,33795022
8949,neovascular AMD,disease,1.0,33795022
8950,patients,species,0.9893,33795022
8951,bevacizumab,gene,0.938,33795022
8952,ranibizumab,gene,0.948,33795022
8953,aflibercept,gene,0.9805,33795022
8954,patients,species,0.991,33795022
8955,neovascular AMD,disease,1.0,33795022
8956,bevacizumab,gene,0.872,33795022
8957,ranibizumab,gene,0.4902,33795022
8958,aflibercept,gene,0.984,33795022
8959,patients,species,0.9873,33795022
8960,aflibercept,gene,0.972,33795022
8961,pigment epithelial detachment,disease,1.0,33795022
8962,PED,disease,1.0,33795022
8963,patients,species,0.9834,33795022
8964,IRF,disease,0.7104,33795022
8965,bevacizumab,gene,0.8813,33795022
8966,ranibizumab,gene,0.753,33795022
8967,aflibercept,gene,0.9805,33795022
8968,IRF,disease,0.999,33795022
8969,IRF,disease,0.9985,33795022
8970,aflibercept,gene,0.991,33795022
8971,neovascular AMD,disease,1.0,33795022
8972,patients,species,0.992,33795022
8973,bevacizumab,gene,0.828,33795022
8974,Aflibercept,gene,0.9897,33784736
8975,Diabetic Retinopathy,disease,1.0,33784736
8976,Anti-Vascular Endothelial Growth Factor,gene,0.993,33784735
8977,anti-vascular endothelial growth factor,gene,0.9893,33784735
8978,nonproliferative diabetic retinopathy,disease,1.0,33784735
8979,NPDR,disease,1.0,33784735
8980,diabetic macular edema,disease,1.0,33784735
8981,CI-DME,disease,0.998,33784735
8982,aflibercept,gene,0.985,33784735
8983,NPDR,disease,0.9995,33784735
8984,PARTICIPANTS,species,0.5854,33784735
8985,NPDR,disease,0.998,33784735
8986,Diabetic,disease,0.9297,33784735
8987,Retinopathy,disease,1.0,33784735
8988,aflibercept,gene,0.98,33784735
8989,NPDR,disease,0.9995,33784735
8990,Aflibercept,gene,0.895,33784735
8991,CI-DME,disease,1.0,33784735
8992,vision,disease,0.6777,33784735
8993,proliferative diabetic retinopathy,disease,1.0,33784735
8994,PDR,disease,1.0,33784735
8995,CI-DME,disease,1.0,33784735
8996,vision loss,disease,0.9995,33784735
8997,PDR,disease,1.0,33784735
8998,participants,species,0.9746,33784735
8999,men,species,0.9688,33784735
9000,CI-DME,disease,1.0,33784735
9001,vision loss,disease,0.99,33784735
9002,PDR,disease,1.0,33784735
9003,aflibercept,gene,0.908,33784735
9004,aflibercept,gene,0.979,33784735
9005,PDR,disease,0.997,33784735
9006,aflibercept,gene,0.9927,33784735
9007,CI-DME,disease,1.0,33784735
9008,vision,disease,0.986,33784735
9009,aflibercept,gene,0.99,33784735
9010,aflibercept,gene,0.9644,33784735
9011,NPDR,disease,0.9917,33784735
9012,PDR,disease,0.9956,33784735
9013,vision,disease,0.757,33784735
9014,CI,disease,,33784735
9015,aflibercept,gene,0.9326,33784735
9016,aflibercept,gene,0.955,33784735
9017,PDR,disease,0.9995,33784735
9018,CI-DME,drug,0.9497,33784735
9019,ziv-aflibercept,gene,0.99,33782846
9020,patients,species,0.9834,33782846
9021,macular edema,disease,1.0,33782846
9022,ziv-aflibercept,gene,0.9883,33782846
9023,patients,species,0.951,33782846
9024,macular edema,disease,1.0,33782846
9025,ME,disease,1.0,33782846
9026,retinal vein occlusion,disease,1.0,33782846
9027,RVO,disease,1.0,33782846
9028,patients,species,0.984,33782846
9029,ME,disease,,33782846
9030,RVO,disease,1.0,33782846
9031,ziv-aflibercept,gene,0.978,33782846
9032,primary,disease,0.824,33782846
9033,open-angle glaucoma,disease,0.9746,33782846
9034,IVZ,drug,0.642,33782846
9035,ME,disease,,33782846
9036,BRVO,disease,0.9995,33782846
9037,CRVO,disease,1.0,33782846
9038,HRVO,disease,1.0,33782846
9039,RVO,disease,1.0,33782846
9040,IVZ,drug,0.901,33782846
9041,IVZ,drug,0.9297,33782846
9042,AFLIBERCEPT,gene,0.65,33782365
9043,neovascular age-related macular degeneration,disease,1.0,33782365
9044,aflibercept,gene,0.9546,33782365
9045,aflibercept,gene,0.9795,33782365
9046,patients,species,0.9814,33782365
9047,Diabetic Retinopathy,disease,1.0,33782365
9048,choroidal neovascularization,disease,1.0,33782365
9049,AMD,disease,1.0,33782365
9050,Patients,species,0.935,33782365
9051,aflibercept,gene,0.9756,33782365
9052,patients,species,0.9497,33782365
9053,patients,species,0.9727,33782365
9054,W16,cell_line,0.7173,33782365
9055,patients,species,0.983,33782365
9056,patients,species,0.9688,33782365
9057,neovascular age-related macular degeneration,disease,1.0,33782365
9058,aflibercept,gene,0.931,33782365
9059,Aflibercept,gene,0.972,33781929
9060,indocyanine green,drug,0.997,33781929
9061,aflibercept,gene,0.9907,33781929
9062,polypoidal choroidal vasculopathy,disease,1.0,33781929
9063,PCV,disease,1.0,33781929
9064,PARTICIPANTS,species,0.769,33781929
9065,PCV,disease,1.0,33781929
9066,participants,species,0.964,33781929
9067,PCV,disease,1.0,33781929
9068,Verteporfin,drug,0.9985,33781929
9069,Ranibizumab,gene,0.7563,33781929
9070,Ranibizumab,gene,0.64,33781929
9071,Patients,species,0.8936,33781929
9072,Macular Polypoidal Choroidal,disease,0.987,33781929
9073,Vasculopathy,disease,1.0,33781929
9074,aflibercept,gene,0.9927,33781929
9075,Indocyanine green,drug,0.997,33781929
9076,polypoidal lesions,disease,0.9995,33781929
9077,participants,species,0.9683,33781929
9078,women,species,0.9614,33781929
9079,polypoidal,DNA,0.4773,33781929
9080,polypoidal lesions,disease,1.0,33781929
9081,aflibercept,gene,0.9863,33781929
9082,Polypoidal,disease,0.999,33781929
9083,NEI,DNA,0.4954,33781929
9084,polypoidal,disease,0.785,33781929
9085,aflibercept,gene,0.9893,33781929
9086,PCV,disease,1.0,33781929
9087,aflibercept,gene,0.9907,33781929
9088,Bevacizumab,gene,0.533,33781113
9089,dexamethasone,drug,0.992,33781113
9090,dexamethasone,drug,0.9824,33781113
9091,retinal pigment epithelial detachment,disease,0.9995,33781113
9092,PED,disease,1.0,33781113
9093,neovascular age-related macular degeneration,disease,1.0,33781113
9094,nAMD,disease,1.0,33781113
9095,patient,species,0.9565,33781113
9096,bevacizumab,gene,0.8916,33781113
9097,aflibercept,gene,0.979,33781113
9098,neovascular serous PED,disease,0.9404,33781113
9099,nAMD,disease,1.0,33781113
9100,neovascular PED,disease,1.0,33781113
9101,patient,species,0.953,33781113
9102,bevacizumab,gene,0.7935,33781113
9103,dexamethasone,drug,0.974,33781113
9104,patient,species,0.9907,33781113
9105,bevacizumab,gene,0.562,33781113
9106,aflibercept,gene,0.985,33781113
9107,patient,species,0.994,33781113
9108,PED,DNA,0.543,33781113
9109,bevacizumab,gene,0.7476,33781113
9110,dexamethasone,drug,0.9893,33781113
9111,PED,disease,0.872,33781113
9112,bevacizumab,gene,0.744,33781113
9113,dexamethasone,drug,0.995,33781113
9114,neovascular serous PED,disease,0.93,33781113
9115,neovascular serous PED,disease,0.9917,33781113
9116,nAMD,disease,1.0,33781113
9117,fibrovascular,cell_type,0.6016,33781111
9118,fibrovascular,cell_type,0.585,33781111
9119,fibrovascular PED,disease,0.9976,33781111
9120,ranibizumab,gene,0.834,33781111
9121,aflibercept,gene,0.9487,33781111
9122,PED,DNA,0.554,33781111
9123,PED,disease,0.514,33781111
9124,aflilbercept,drug,0.9116,33781111
9125,PED,DNA,0.55,33781111
9126,VEGF,gene,0.9116,33781111
9127,PEDs,disease,0.959,33781111
9128,aflibercept,gene,0.987,33781111
9129,Bilateral,disease,0.613,33780313
9130,Diabetic Macular Edema,disease,0.888,33780313
9131,diabetic macular edema,disease,1.0,33780313
9132,DME,disease,1.0,33780313
9133,DME,disease,1.0,33780313
9134,patients,species,0.9873,33780313
9135,anti-VEGF,gene,0.895,33780313
9136,ranibizumab,gene,0.9854,33780313
9137,aflibercept,gene,0.996,33780313
9138,DME,cell_type,0.6074,33780313
9139,vitreoretinal interface anomalies,disease,1.0,33780313
9140,disorganization of the inner retinal layers,disease,1.0,33780313
9141,DRIL,disease,1.0,33780313
9142,anti-VEGF,gene,0.99,33780313
9143,SRF,disease,0.999,33780313
9144,simple epiretinal membrane,disease,0.998,33780313
9145,ERM,disease,1.0,33780313
9146,ERM,cell_type,0.4592,33780313
9147,anti-VEGF,gene,0.7466,33780313
9148,DRIL,disease,0.9834,33780313
9149,Aflibercept,gene,0.9683,33779324
9150,age-related macular degeneration,disease,1.0,33779324
9151,nAMD,disease,1.0,33779324
9152,patients,species,0.968,33779324
9153,aflibercept,gene,0.925,33779324
9154,patients,species,0.9834,33779324
9155,nAMD,disease,1.0,33779324
9156,women,species,0.9307,33779324
9157,aflibercept,gene,0.9795,33779324
9158,patients,species,0.9824,33779324
9159,nAMD,disease,1.0,33779324
9160,Transient Ischemic Attack,disease,1.0,33777575
9161,Hypoventilation,disease,1.0,33777575
9162,vascular endothelial growth factor,gene,0.9985,33777575
9163,VEGF,gene,0.9946,33777575
9164,VEGF,gene,0.9287,33777575
9165,thromboembolic events,disease,0.7593,33777575
9166,patients,species,0.994,33777575
9167,atherosclerosis,disease,1.0,33777575
9168,transient ischemic attack,disease,1.0,33777575
9169,TIA,disease,1.0,33777575
9170,hypoventilation,disease,1.0,33777575
9171,aflibercept,gene,0.985,33777575
9172,TIA,disease,0.9976,33777575
9173,hypoventilation,disease,0.997,33777575
9174,aflibercept,gene,0.952,33777575
9175,VEGF,gene,0.996,33777575
9176,diabetic macular edema,disease,0.8877,33777575
9177,DME,disease,1.0,33777575
9178,right-sided weakness,disease,0.9995,33777575
9179,diabetic retinopathy,disease,0.9995,33777575
9180,macular edema,disease,1.0,33777575
9181,Hypoventilation,disease,1.0,33777575
9182,thromboembolic,disease,0.9995,33777575
9183,aflibercept,gene,0.9507,33777575
9184,Neovascular Age-Related Macular Degeneration,disease,1.0,33775926
9185,patients,species,0.916,33775926
9186,neovascular age-related macular degeneration,disease,1.0,33775926
9187,nAMD,disease,1.0,33775926
9188,PARTICIPANTS,species,0.779,33775926
9189,patients,species,0.9717,33775926
9190,nAMD,disease,1.0,33775926
9191,aflibercept,gene,0.9272,33775926
9192,patients,species,0.989,33775926
9193,dry macula,disease,0.997,33775926
9194,Patients,species,0.9536,33775926
9195,patients,species,0.9854,33775926
9196,nAMD,disease,1.0,33775926
9197,patients,species,0.969,33775926
9198,Diabetic Retinopathy,disease,0.9834,33775926
9199,Patients,species,0.9126,33775926
9200,pigment epithelial detachment,disease,1.0,33775926
9201,PED,disease,1.0,33775926
9202,patients,species,0.9897,33775926
9203,PED,disease,0.9946,33775926
9204,patients,species,0.989,33775926
9205,visual loss,disease,0.9966,33775926
9206,metamorphopsia,disease,0.9995,33775926
9207,nAMD,disease,1.0,33775926
9208,patients,species,0.969,33775926
9209,anti-VEGF,gene,0.7705,33775926
9210,patients,species,0.9844,33775926
9211,patients,species,0.975,33775926
9212,aflibercept,gene,0.9814,33772699
9213,vascular endothelial growth factor,gene,0.9775,33772699
9214,VEGF,gene,0.9976,33772699
9215,diabetic retinopathy,disease,1.0,33772699
9216,DR,disease,1.0,33772699
9217,patients,species,0.982,33772699
9218,DR,disease,,33772699
9219,microaneurysms,disease,0.8965,33772699
9220,patients,species,0.9917,33772699
9221,retinal neovascularization,disease,0.9966,33772699
9222,VEGF,gene,0.897,33772699
9223,DR,disease,,33772699
9224,diabetes mellitus,disease,1.0,33772699
9225,VEGF,gene,0.9976,33770015
9226,retinal disease,disease,0.9995,33770015
9227,retinal vascular diseases,disease,1.0,33770015
9228,patients,species,0.994,33770015
9229,bevacizumab,gene,0.921,33770015
9230,ranibizumab,gene,0.938,33770015
9231,aflibercept,gene,0.985,33770015
9232,brolucizumab,gene,0.7676,33770015
9233,intraocular inflammation,disease,1.0,33770015
9234,IOI,disease,1.0,33770015
9235,brolucizumab,gene,0.7607,33770015
9236,VEGF,gene,0.7295,33770015
9237,brolucizumab,gene,0.7676,33770015
9238,occlusive retinal vasculitis,disease,0.9995,33770015
9239,IOI,disease,1.0,33770015
9240,VEGF,gene,0.5015,33770015
9241,abicipar,drug,0.686,33770015
9242,IOI,disease,1.0,33770015
9243,patients,species,0.988,33770015
9244,VEGF,gene,0.9087,33770015
9245,VEGF,gene,0.7974,33770015
9246,VEGF,gene,0.8022,33770015
9247,aflibercept,gene,0.9575,33769696
9248,Bevacizumab,gene,0.709,33767407
9249,diabetic macular oedema,disease,1.0,33767407
9250,bevacizumab,gene,0.662,33767407
9251,diabetic macular oedema,disease,1.0,33767407
9252,DMO,drug,0.884,33767407
9253,patients,species,0.9766,33767407
9254,DMO,disease,1.0,33767407
9255,Retinal Blindness,disease,1.0,33767407
9256,bevacizumab,gene,0.642,33767407
9257,bevacizumab,gene,0.798,33767407
9258,VEGF,gene,0.997,33767407
9259,steroid,drug,0.5547,33767407
9260,triamcinolone,drug,0.9995,33767407
9261,ranibizumab,gene,0.8687,33767407
9262,aflibercept,gene,0.926,33767407
9263,triamcinolone,drug,0.981,33767407
9264,Bevacizumab,gene,0.837,33767407
9265,DMO,disease,1.0,33767407
9266,Ranibizumab,gene,0.9785,33760698
9267,Aflibercept,gene,0.969,33760698
9268,Diabetic Macular Edema,disease,1.0,33760698
9269,ranibizumab,gene,0.915,33760698
9270,aflibercept,gene,0.9766,33760698
9271,diabetic macular edema,disease,1.0,33760698
9272,diabetic macular edema,disease,1.0,33760698
9273,Patients,species,0.9585,33760698
9274,ranibizumab,gene,0.4966,33760698
9275,aflibercept,gene,0.9785,33760698
9276,BCVA,DNA,0.4739,33760698
9277,ranibizumab,gene,0.7676,33760698
9278,aflibercept,gene,0.9614,33760698
9279,diabetic macular edema,disease,1.0,33760698
9280,aflibercept,gene,0.9873,33760698
9281,aflibercept,gene,0.991,33760698
9282,macular edema,disease,1.0,33760698
9283,dexamethasone,drug,0.971,33757333
9284,diabetic macular edema,disease,1.0,33757333
9285,patients,species,0.981,33757333
9286,diabetic macular edema,disease,1.0,33757333
9287,DME,disease,1.0,33757333
9288,endothelial growth factor,gene,0.957,33757333
9289,VEGF,gene,0.999,33757333
9290,patients,species,0.9775,33757333
9291,dexamethasone,drug,0.9795,33757333
9292,DME,disease,1.0,33757333
9293,DME,disease,0.9995,33757333
9294,VEGF,gene,0.5376,33757333
9295,IDI,drug,0.976,33757333
9296,anti-VEGF,gene,0.9443,33757333
9297,glaucoma,disease,1.0,33757333
9298,steroid-responsive ocular hypertension,disease,0.9995,33757333
9299,Patient,species,0.983,33757333
9300,patients,species,0.959,33757333
9301,patients,species,0.9937,33757333
9302,aflibercept,gene,0.947,33757333
9303,anti-VEGF,gene,0.9453,33757333
9304,dexamethasone,drug,0.9688,33757333
9305,person,species,0.9434,33757333
9306,anti-VEGF,gene,0.959,33757333
9307,glaucoma,disease,1.0,33757333
9308,dexamethasone,drug,0.9644,33757333
9309,DME,disease,0.9995,33757333
9310,vascular endothelial growth factor,gene,0.996,33755678
9311,vascular endothelial growth factor,gene,0.9824,33755678
9312,VEGF,gene,0.997,33755678
9313,pachychoroid neovasculopathy,disease,1.0,33755678
9314,PNV,disease,1.0,33755678
9315,patients,species,0.9766,33755678
9316,PNV,disease,1.0,33755678
9317,VEGF,gene,0.695,33755678
9318,ranibizumab,gene,0.9116,33755678
9319,aflibercept,gene,0.8403,33755678
9320,VEGF,gene,0.756,33755678
9321,polypoidal,DNA,0.442,33755678
9322,polypoidal lesions,disease,1.0,33755678
9323,CRT,DNA,0.521,33755678
9324,polypoidal lesions,disease,1.0,33755678
9325,polypoidal lesions,disease,1.0,33755678
9326,PNV,disease,1.0,33755678
9327,VEGF,gene,0.9805,33755678
9328,Aflibercept,gene,0.9634,33747556
9329,Branch Retinal Vein Occlusion,disease,0.926,33747556
9330,Aflibercept,gene,0.9766,33747556
9331,vascular endothelial growth factor,gene,0.9985,33747556
9332,VEGF,gene,0.9966,33747556
9333,macular edema,disease,1.0,33747556
9334,branch retinal vein occlusion,disease,0.898,33747556
9335,BRVO,disease,1.0,33747556
9336,aflibercept,gene,0.9766,33747556
9337,BRVO,disease,1.0,33747556
9338,BRVO,disease,0.9995,33747556
9339,argon,drug,0.987,33747556
9340,BRVO,disease,0.9985,33747556
9341,BRVO,disease,1.0,33747556
9342,BRVO,disease,0.9995,33747556
9343,aflibercept,gene,0.9907,33747556
9344,BRVO,disease,1.0,33747556
9345,aflibercept,gene,0.969,33747556
9346,BRVO,disease,0.996,33747556
9347,DnaJ homolog subfamily C member 17,gene,0.995,33747556
9348,DNAJC17,gene,0.989,33747556
9349,N-myc downstream regulated gene 2,gene,0.996,33747556
9350,NDRG2,gene,0.997,33747556
9351,NDRG2,gene,0.99,33747556
9352,aflibercept,gene,0.937,33747556
9353,heat shock protein DNAJC17,gene,0.973,33747556
9354,heat shock proteins,gene,0.9897,33747556
9355,BRVO,disease,0.9995,33747556
9356,anti-VEGF,gene,0.8774,33741068
9357,diabetic macular edema,disease,1.0,33741068
9358,VEGF,gene,0.7246,33741068
9359,diabetic macular,disease,1.0,33741068
9360,edema,disease,0.654,33741068
9361,DME,disease,1.0,33741068
9362,patients,species,0.98,33741068
9363,DME,disease,1.0,33741068
9364,VMA,disease,1.0,33741068
9365,VMA,disease,0.9976,33741068
9366,patients,species,0.9873,33741068
9367,VEGF,gene,0.899,33741068
9368,VMA,drug,0.9883,33741068
9369,patient,species,0.968,33741068
9370,aflibercept,gene,0.9897,33741068
9371,ranibizumab,gene,0.8916,33741068
9372,bevacizumab,gene,0.8506,33741068
9373,VMA,disease,0.9995,33741068
9374,VMA,disease,1.0,33741068
9375,VMA,drug,0.9956,33741068
9376,VMA,disease,1.0,33741068
9377,VMA,disease,1.0,33741068
9378,VMA,drug,0.987,33741068
9379,VMA,drug,0.996,33741068
9380,VMA,drug,0.9233,33741068
9381,patients,species,0.9233,33741068
9382,DME,disease,1.0,33741068
9383,VEGF,gene,0.9814,33741068
9384,CRT,DNA,0.5273,33741068
9385,Aflibercept,gene,0.962,33734306
9386,vascular endothelial growth factor,gene,0.972,33734306
9387,VEGF,gene,0.999,33734306
9388,dry age-related macular degeneration,disease,0.9165,33734306
9389,AMD,disease,1.0,33734306
9390,exudative AMD,disease,1.0,33734306
9391,eAMD,disease,1.0,33734306
9392,vision loss,disease,0.993,33734306
9393,aflibercept,gene,0.9893,33734306
9394,eAMD,disease,0.9995,33734306
9395,PARTICIPANTS,species,0.673,33734306
9396,patients,species,0.961,33734306
9397,retinal,disease,0.505,33734306
9398,eAMD,disease,1.0,33734306
9399,Patients,species,0.978,33734306
9400,aflibercept,gene,0.99,33734306
9401,patients,species,0.937,33734306
9402,eAMD,disease,0.9946,33734306
9403,choroidal neovascularization,disease,0.997,33734306
9404,fluorescein,drug,0.999,33734306
9405,patients,species,0.9683,33734306
9406,patients,species,0.9824,33734306
9407,eAMD,disease,0.9966,33734306
9408,Patients,species,0.948,33734306
9409,eAMD,disease,1.0,33734306
9410,eAMD,disease,1.0,33734306
9411,eAMD,disease,1.0,33734306
9412,anti-VEGF,gene,0.934,33734306
9413,anti-VEGF,gene,0.993,33734306
9414,dry AMD,disease,0.999,33734306
9415,eAMD,disease,1.0,33734306
9416,eAMD,disease,0.9995,33734306
9417,VISION LOSS,disease,1.0,33734192
9418,DIABETIC MACULAR EDEMA,disease,1.0,33734192
9419,vision loss,disease,1.0,33734192
9420,diabetic macular edema,disease,1.0,33734192
9421,diabetic macular edema,disease,0.9995,33734192
9422,diabetes,disease,1.0,33734192
9423,hemoglobin A1c,gene,0.9966,33734192
9424,diabetic retinopathy,disease,1.0,33734192
9425,intraretinal cyst,disease,0.9883,33734192
9426,aflibercept,gene,0.97,33734192
9427,patients,species,0.9805,33734192
9428,diabetic macular edema,disease,1.0,33734192
9429,NPDR,disease,0.999,33734192
9430,proliferative,disease,0.976,33734192
9431,diabetic retinopathy,disease,0.84,33734192
9432,vision loss,disease,0.96,33734192
9433,diabetic macular edema,disease,1.0,33734192
9434,diabetic retinopathy,disease,1.0,33734192
9435,vision loss,disease,1.0,33734192
9436,Circulating Tumor DNA,RNA,0.561,33727257
9437,patients,species,0.9824,33727257
9438,LARC,disease,1.0,33727257
9439,circulating tumor DNA,DNA,0.5186,33727257
9440,ctDNA,DNA,0.79,33727257
9441,tumor,disease,0.8364,33727257
9442,patients,species,0.8716,33727257
9443,LARC,disease,1.0,33727257
9444,GEMCAD 1402,DNA,0.8867,33727257
9445,patients,species,0.9087,33727257
9446,LARC,disease,0.9995,33727257
9447,fluorouracil,drug,0.9976,33727257
9448,leucovorin,drug,0.9985,33727257
9449,oxaliplatin,drug,0.9995,33727257
9450,aflibercept,gene,0.9844,33727257
9451,cancer,disease,0.9995,33727257
9452,ctDNA,DNA,0.51,33727257
9453,ctDNA,DNA,0.7036,33727257
9454,tumor,disease,1.0,33727257
9455,patients,species,0.974,33727257
9456,ctDNA,DNA,0.632,33727257
9457,patients,species,0.958,33727257
9458,TNT,DNA,0.822,33727257
9459,ctDNA,DNA,0.6074,33727257
9460,ctDNA,DNA,0.753,33727257
9461,patients,species,0.9194,33727257
9462,LARC,disease,0.9995,33727257
9463,ctDNA,DNA,0.6484,33727257
9464,patients,species,0.939,33727257
9465,Ranibizumab,gene,0.9224,33719869
9466,Aflibercept,gene,0.938,33719869
9467,vascular endothelial growth factor,gene,0.9976,33719869
9468,age-related macular degeneration,disease,1.0,33719869
9469,patients,species,0.99,33719869
9470,neovascular age-related macular degeneration,disease,1.0,33719869
9471,vascular endothelial growth factor,gene,0.9976,33719869
9472,neovascular age-related macular degeneration,disease,0.9985,33719869
9473,patients,species,0.9863,33719869
9474,aflibercept,gene,0.993,33719869
9475,ranibizumab,gene,0.7676,33719869
9476,neovascular age-related macular degeneration,disease,1.0,33719869
9477,patients,species,0.9897,33719869
9478,aflibercept,gene,0.9844,33719869
9479,ranibizumab,gene,0.7617,33719869
9480,aflibercept,gene,0.9883,33719869
9481,ranibizumab,gene,0.511,33719869
9482,neovascular age-related macular degeneration,disease,1.0,33719869
9483,Diabetic Macular Edema,disease,1.0,33713680
9484,diabetic macular edema,disease,1.0,33713680
9485,CI-DME,disease,0.998,33713680
9486,aflibercept,gene,0.9106,33713680
9487,participants,species,0.9634,33713680
9488,CI-DME,disease,1.0,33713680
9489,aflibercept,gene,0.8643,33713680
9490,aflibercept,gene,0.9067,33713680
9491,aflibercept,gene,0.987,33713680
9492,persons,species,0.8403,33713680
9493,CI-DME,disease,1.0,33713680
9494,patients,species,0.981,33713680
9495,CI-DME,disease,1.0,33713680
9496,aflibercept,gene,0.9355,33713680
9497,aflibercept,gene,0.9805,33713680
9498,CI-DME,disease,0.9995,33713680
9499,aflibercept,gene,0.9683,33713680
9500,ranibizumab,gene,0.597,33712484
9501,aflibercept,gene,0.964,33712484
9502,macular oedema,disease,1.0,33712484
9503,ranibizumab,gene,0.5356,33712484
9504,aflibercept,gene,0.9624,33712484
9505,cystoid macular oedema,disease,1.0,33712484
9506,branch retinal vein occlusion,disease,1.0,33712484
9507,BRVO,disease,1.0,33712484
9508,EDTRS,DNA,0.4993,33712484
9509,ranibizumab,gene,0.803,33712484
9510,aflibercept,gene,0.9453,33712484
9511,aflibercept,gene,0.993,33712484
9512,ranibizumab,gene,0.6353,33712484
9513,aflibercept,gene,0.983,33712484
9514,aflibercept,gene,0.894,33712484
9515,ranibizumab,gene,0.6465,33712484
9516,aflibercept,gene,0.974,33712484
9517,BRVO,disease,0.9985,33712484
9518,aflibercept,gene,0.981,33712484
9519,aflibercept,gene,0.978,33706554
9520,aneurysmal type 1 neovascularization,disease,1.0,33706554
9521,AT1,gene,0.809,33706554
9522,patients,species,0.9375,33706554
9523,aflibercept,gene,0.9233,33706554
9524,patients,species,0.906,33706554
9525,AT1,disease,1.0,33706554
9526,patients,species,0.9766,33706554
9527,nave AT1,disease,0.6885,33706554
9528,aflibercept,gene,0.9575,33706554
9529,dry macula,disease,1.0,33706554
9530,polypoidal,cell_type,0.4666,33706554
9531,polypoidal lesions,disease,1.0,33706554
9532,PED,DNA,0.758,33706554
9533,polypoidal,cell_type,0.4524,33706554
9534,polypoidal lesions,disease,1.0,33706554
9535,aflibercept,gene,0.9775,33706554
9536,patients,species,0.9575,33706554
9537,wet macula,disease,0.9995,33706554
9538,polypoidal lesions,disease,1.0,33706554
9539,Anti-,disease,0.8286,33705807
9540,VEGF,gene,0.7754,33705807
9541,proliferative diabetic retinopathy,disease,0.907,33705807
9542,Anti,disease,0.8647,33705807
9543,Anti-vascular endothelial growth factor,gene,0.992,33705807
9544,anti-VEGF,gene,0.979,33705807
9545,tractional retinal detachment,disease,1.0,33705807
9546,anti-VEGF,gene,0.9663,33705807
9547,proliferative,disease,0.938,33705807
9548,diabetic retinopathy,disease,0.9834,33705807
9549,anti-VEGF,gene,0.9785,33705807
9550,Anti-VEGF,gene,0.965,33705807
9551,sudden vision loss,disease,0.991,33705807
9552,anti-VEGF,gene,0.9873,33705807
9553,anti-VEGF,gene,0.9814,33705807
9554,diabetic retinopathy,disease,1.0,33705807
9555,fibrosis,disease,0.8965,33705807
9556,patients,species,0.963,33705807
9557,diabetic retinopathy,disease,0.9966,33705807
9558,intraocular fibrosis,disease,1.0,33705807
9559,patients,species,0.9805,33705807
9560,anti-VEGF,gene,0.83,33705807
9561,tractional retinal detachment,disease,0.9995,33705807
9562,anti-VEGF,gene,0.6406,33705807
9563,anti-VEGF,gene,0.9946,33705807
9564,anti-VEGF,gene,0.9854,33705807
9565,Retinal Neovascularization,disease,0.9873,33704351
9566,Aflibercept,gene,0.831,33704351
9567,proliferative diabetic retinopathy,disease,1.0,33704351
9568,vascular endothelial growth factor,gene,0.9155,33704351
9569,patients,species,0.9814,33704351
9570,disc,disease,0.6836,33704351
9571,NVD,disease,0.997,33704351
9572,patients,species,0.9272,33704351
9573,proliferative,disease,0.958,33704351
9574,diabetic retinopathy,disease,0.8037,33704351
9575,NV,disease,,33704351
9576,aflibercept,gene,0.967,33704351
9577,PARTICIPANTS,species,0.696,33704351
9578,Aflibercept,gene,0.898,33704351
9579,Proliferative Diabetic Retinopathy,disease,0.999,33704351
9580,patients,species,0.9697,33704351
9581,proliferative diabetic retinopathy,disease,0.8936,33704351
9582,NVD,drug,0.972,33704351
9583,NVE,drug,0.979,33704351
9584,patients,species,0.9785,33704351
9585,aflibercept,gene,0.9644,33704351
9586,PRP,cell_type,0.538,33704351
9587,NV,disease,,33704351
9588,patients,species,0.979,33704351
9589,men,species,0.928,33704351
9590,proliferative,disease,0.86,33704351
9591,diabetic retinopathy,disease,0.9746,33704351
9592,patients,species,0.9917,33704351
9593,NVD,disease,1.0,33704351
9594,NVE,disease,0.997,33704351
9595,NVE,disease,0.999,33704351
9596,NVE,disease,1.0,33704351
9597,NVD,disease,1.0,33704351
9598,NVD,disease,1.0,33704351
9599,NVE,drug,0.9873,33704351
9600,aflibercept,gene,0.989,33704351
9601,NVE,disease,1.0,33704351
9602,PRP,cell_type,0.62,33704351
9603,NVD,disease,1.0,33704351
9604,NVE,disease,1.0,33704351
9605,Aflibercept,gene,0.973,33704351
9606,PRP,cell_type,0.6606,33704351
9607,NVE,disease,1.0,33704351
9608,NVD,disease,1.0,33704351
9609,NVD,disease,1.0,33704351
9610,VEGF,gene,0.9946,33694304
9611,pegaptanib,drug,0.9917,33694304
9612,ranibizumab,gene,0.619,33694304
9613,aflibercept,gene,0.9336,33694304
9614,bevacizumab,gene,0.62,33694304
9615,anti-VEGF,gene,0.5947,33694304
9616,VEGF,gene,0.757,33694304
9617,Diabetic Macular Edema,disease,1.0,33688431
9618,Diabetic macular edema,disease,1.0,33688431
9619,DME,disease,1.0,33688431
9620,disabling eye condition,disease,0.9893,33688431
9621,DME,disease,1.0,33688431
9622,vascular endothelial growth factor,gene,0.9985,33688431
9623,vascular,DNA,0.5054,33688431
9624,vascular endothelial growth factor,gene,0.9985,33688431
9625,patients,species,0.991,33688431
9626,corticosteroid,drug,0.6226,33688431
9627,steroids,drug,0.743,33688431
9628,DME,disease,1.0,33688431
9629,DME,disease,1.0,33688431
9630,anti-VEGF,gene,0.976,33688431
9631,aflibercept,gene,0.99,33688431
9632,anti-VEGFs,gene,0.96,33688431
9633,bevacizumab,gene,0.914,33688431
9634,ranibizumab,gene,0.7603,33688431
9635,aflibercept,gene,0.979,33688431
9636,DEX,drug,0.949,33688431
9637,DME,disease,1.0,33688431
9638,anti-VEGF,gene,0.9824,33688431
9639,anti-VEGF,gene,0.982,33688431
9640,Patient,species,0.8896,33688173
9641,Patient,species,0.9927,33688173
9642,patients,species,0.9785,33688173
9643,aflibercept,gene,0.937,33688173
9644,neovascular age-related macular degeneration,disease,1.0,33688173
9645,nAMD,disease,1.0,33688173
9646,patient,species,0.9873,33688173
9647,patients,species,0.9907,33688173
9648,patient,species,0.988,33688173
9649,patients,species,0.9756,33688173
9650,nAMD,disease,1.0,33688173
9651,patient,species,0.978,33688173
9652,PARTICIPANTS,species,0.885,33688173
9653,Participants,species,0.967,33688173
9654,AFL,drug,0.9565,33688173
9655,nAMD,disease,1.0,33688173
9656,patients,species,0.9736,33688173
9657,patients,species,0.9893,33688173
9658,patients,species,0.988,33688173
9659,AFL,drug,0.8477,33688173
9660,nAMD,disease,1.0,33688173
9661,patients,species,0.9785,33688173
9662,patients,species,0.9775,33688173
9663,patients,species,0.9927,33688173
9664,patients,species,0.978,33688173
9665,Patients,species,0.955,33688173
9666,nAMD,disease,1.0,33688173
9667,patient,species,0.9863,33688173
9668,ziv-aflibercept,gene,0.9946,33684428
9669,Ziv-aflibercept,gene,0.993,33684428
9670,aflibercept,gene,0.9917,33684428
9671,human,species,0.981,33684428
9672,growth factor receptors,gene,0.972,33684428
9673,Fc,gene,,33684428
9674,human IgG1,gene,0.9453,33684428
9675,human,species,0.992,33684428
9676,N,drug,0.999,33684428
9677,aflibercept,gene,0.987,33684428
9678,N-glycosylation sites,DNA,0.3643,33684428
9679,N,drug,0.995,33684428
9680,sialic acids,drug,0.981,33684428
9681,N-glycosylation sites,DNA,0.5977,33684428
9682,N,drug,0.9976,33684428
9683,N(68) site,DNA,0.7065,33684428
9684,N,drug,0.521,33684428
9685,NANA,drug,0.997,33684428
9686,sialic acid,drug,0.9995,33684428
9687,sialic acids,drug,0.999,33684428
9688,G0F,gene,0.995,33684428
9689,Man5,gene,0.9897,33684428
9690,G1F,gene,0.9956,33684428
9691,G2F,gene,0.994,33684428
9692,aflibercept,gene,0.9805,33684428
9693,Fc,gene,,33684428
9694,aflibercept,gene,0.9736,33684428
9695,CNV,disease,1.0,33681530
9696,Staphylococcus aureus infective endocarditis,disease,0.987,33681530
9697,Staphylococcus aureus,species,0.9272,33681530
9698,man,species,0.9014,33681530
9699,visual impairment,disease,0.9883,33681530
9700,infective endocarditis,disease,0.866,33681530
9701,methicillin,drug,0.9985,33681530
9702,fluorescein,drug,0.9976,33681530
9703,CNV,disease,0.9985,33681530
9704,CNV,disease,1.0,33681530
9705,aflibercept,gene,0.9844,33681530
9706,patients,species,0.939,33681530
9707,infective endocarditis,disease,1.0,33681530
9708,CNV,disease,1.0,33681530
9709,vision loss,disease,0.9355,33681530
9710,anti-vascular endothelial growth factor,gene,0.941,33681530
9711,CNV,disease,1.0,33681530
9712,infective endocarditis,disease,1.0,33681530
9713,VEGF,gene,0.746,33678125
9714,anti-VEGF,gene,0.898,33678125
9715,aflibercept,gene,0.9844,33678125
9716,Aflibercept,gene,0.992,33661709
9717,Ranibizumab,gene,0.699,33661709
9718,Diabetic Macular Edema,disease,1.0,33661709
9719,aflibercept,gene,0.994,33661709
9720,diabetic macular edemaMethods,disease,1.0,33661709
9721,patients,species,0.986,33661709
9722,aflibercept,gene,0.995,33661709
9723,ranibizumab,gene,0.8716,33661709
9724,aflibercept,gene,0.9746,33661709
9725,ranibizumab,gene,0.744,33661709
9726,aflibercept,gene,0.955,33661709
9727,Ranibizumab,gene,0.751,33661709
9728,Ranibizumab,gene,0.925,33661709
9729,subretinal fluid,disease,0.9907,33661709
9730,aflibercept,gene,0.9854,33661709
9731,subretinal fluid,disease,0.968,33661709
9732,aflibercept,gene,0.9927,33661709
9733,ranibizumab,gene,0.657,33661709
9734,vitreous hemorrhage,disease,1.0,33661709
9735,aflibercept,gene,0.9175,33661709
9736,subretinal fluid,disease,0.7847,33661709
9737,diabetic macular,disease,1.0,33658601
9738,diabetic macular oedema,disease,1.0,33658601
9739,DME,disease,0.9805,33658601
9740,vascular endothelial growth factor,gene,0.9326,33658601
9741,VEGF,gene,0.9976,33658601
9742,patients,species,0.964,33658601
9743,DME,disease,1.0,33658601
9744,ranibizumab,gene,0.9,33658601
9745,aflibercept,gene,0.9346,33658601
9746,patients,species,0.984,33658601
9747,HRF,gene,0.983,33658601
9748,epiretinal membrane,disease,0.999,33658601
9749,subretinal,disease,0.5693,33658601
9750,HRF,cell_type,0.8213,33658601
9751,haemoglobin A1C,gene,0.986,33658601
9752,A1C,mutation,,33658601
9753,Patients,species,0.94,33658601
9754,proliferative,disease,0.8535,33658601
9755,diabetic retinopathy,disease,0.914,33658601
9756,HRF,gene,0.6606,33658601
9757,HRF,gene,0.9937,33658601
9758,DME,disease,1.0,33658601
9759,VEGF,gene,0.9966,33658601
9760,ranibizumab,gene,0.8174,33658584
9761,aflibercept,gene,0.9717,33658584
9762,ranibizumab,gene,0.8906,33658584
9763,aflibercept,gene,0.9536,33658584
9764,retinal nerve fiber layer,cell_type,0.5996,33658584
9765,patients,species,0.942,33658584
9766,exudative age-related macular degeneration,disease,1.0,33658584
9767,AMD,disease,1.0,33658584
9768,patients,species,0.9727,33658584
9769,monocular exudative AMD,disease,0.9478,33658584
9770,peripapillary,DNA,0.4995,33658584
9771,inferior,DNA,0.4329,33658584
9772,patients,species,0.9263,33658584
9773,exudative AMD,disease,1.0,33658584
9774,macular lesions,disease,0.9956,33658584
9775,Branch Retinal Vein Occlusion,disease,0.9995,33654606
9776,Antisynthetase Syndrome,disease,1.0,33654606
9777,woman,species,0.929,33654606
9778,branch retinal vein occlusion,disease,1.0,33654606
9779,BRVO,disease,1.0,33654606
9780,blurred vision,disease,1.0,33654606
9781,patient,species,0.9595,33654606
9782,aflibercept,gene,0.9834,33654606
9783,interstitial lung disease,disease,1.0,33654606
9784,ILD,disease,1.0,33654606
9785,patient,species,0.9883,33654606
9786,antisynthetase syndrome,disease,1.0,33654606
9787,antisynthetase,gene,0.6973,33654606
9788,ASS,disease,1.0,33654606
9789,PL-7 auto-antibodies,gene,0.968,33654606
9790,ASS,disease,0.999,33654606
9791,BRVO,disease,1.0,33654606
9792,ASS,disease,0.9995,33654606
9793,patients,species,0.9785,33654606
9794,ILD,disease,1.0,33654606
9795,ASS,disease,1.0,33654606
9796,retinal vaso-occlusive episodes,disease,0.9995,33654606
9797,patients,species,0.9546,33651313
9798,anti-vascular endothelial growth factor,gene,0.983,33651313
9799,VEGF,gene,0.9917,33651313
9800,choroidal neovascularization,disease,1.0,33651313
9801,CNV,disease,1.0,33651313
9802,pachychoroid neovasculopathy,disease,1.0,33651313
9803,PNV,disease,1.0,33651313
9804,patients,species,0.991,33651313
9805,bevacizumab,gene,0.7764,33651313
9806,ranibizumab,gene,0.672,33651313
9807,aflibercept,gene,0.973,33651313
9808,CNV,disease,1.0,33651313
9809,PNV,disease,1.0,33651313
9810,BCVA,DNA,0.4775,33651313
9811,VEGF,gene,0.9727,33651313
9812,PNV,disease,1.0,33651313
9813,patients,species,0.981,33651313
9814,anti-VEGFs,gene,0.81,33651313
9815,anti-vascular endothelial growth factor,gene,0.9775,33640493
9816,VEGF,gene,0.9966,33640493
9817,nAMD,disease,1.0,33640493
9818,brolucizumab,gene,0.939,33640493
9819,aflibercept,gene,0.9043,33640493
9820,PARTICIPANTS,species,0.847,33640493
9821,Participants,species,0.977,33640493
9822,nAMD,disease,1.0,33640493
9823,patients,species,0.994,33640493
9824,photoreceptor outer segment,cell_type,0.523,33640493
9825,RPE,cell_type,0.6807,33640493
9826,BCVA,cell_type,0.3987,33640493
9827,nAMD,disease,1.0,33640493
9828,anti-VEGF,gene,0.7656,33640493
9829,SHRM,disease,0.9937,33640493
9830,Echinomycin,drug,0.999,33639134
9831,Echinomycin,drug,0.999,33639134
9832,EKN,drug,0.999,33639134
9833,hypoxia-inducible factor (HIF)-1,gene,0.9976,33639134
9834,ischemic diseases,disease,1.0,33639134
9835,EKN,gene,0.989,33639134
9836,human primary adult retinal pigment epithelium cells,cell_line,0.92,33639134
9837,human,species,0.977,33639134
9838,aRPE,cell_line,0.8906,33639134
9839,retinal endothelial cells,cell_type,0.565,33639134
9840,hREC,cell_type,0.888,33639134
9841,mouse,species,0.979,33639134
9842,choroidal neovascularization,disease,1.0,33639134
9843,CNV,disease,1.0,33639134
9844,EKN,drug,0.987,33639134
9845,HIF-1 protein,gene,0.995,33639134
9846,HIF-target genes,gene,0.9585,33639134
9847,EKN,drug,0.9824,33639134
9848,hREC,cell_line,0.731,33639134
9849,EKN,drug,0.9863,33639134
9850,mouse,species,0.943,33639134
9851,CNV,disease,0.993,33639134
9852,HIF,gene,0.9927,33639134
9853,CNV,disease,1.0,33639134
9854,fluorescein,drug,0.8804,33639134
9855,aRPE,cell_line,0.8774,33639134
9856,EKN,drug,0.9414,33639134
9857,HIF-mediated transcripts,gene,0.9453,33639134
9858,hypoxic aRPE cells,cell_line,0.508,33639134
9859,aRPE cells,cell_type,0.7573,33639134
9860,EKN,drug,0.984,33639134
9861,non-treated controls,cell_type,0.571,33639134
9862,hREC,cell_line,0.9077,33639134
9863,Mice,species,0.86,33639134
9864,CNV,disease,0.956,33639134
9865,EKN,drug,0.9785,33639134
9866,mouse,species,0.946,33639134
9867,aflibercept,gene,0.981,33639134
9868,EKN,drug,0.9937,33639134
9869,HIF,gene,0.992,33639134
9870,retinal cells,cell_type,0.637,33639134
9871,mouse,species,0.8438,33639134
9872,CNV,disease,0.9995,33639134
9873,patients,species,0.984,33639134
9874,neovascular age-related macular degeneration,disease,1.0,33639134
9875,aflibercept,gene,0.9863,33638291
9876,bevacizumab,gene,0.501,33638291
9877,neovascular age,disease,0.998,33638291
9878,nAMD,disease,1.0,33638291
9879,aflibercept,gene,0.9883,33638291
9880,bevacizumab,gene,0.552,33638291
9881,nAMD,disease,1.0,33638291
9882,patients,species,0.991,33638291
9883,aflibercept,gene,0.9946,33638291
9884,aflibercept,gene,0.991,33638291
9885,bevacizumab,gene,0.8184,33638291
9886,aflibercept,gene,0.969,33638291
9887,Patient,species,0.9907,33638291
9888,aflibercept,gene,0.91,33638291
9889,BCVA,DNA,0.4675,33638291
9890,CRT,DNA,0.5024,33638291
9891,CRT,DNA,0.551,33638291
9892,nAMD,disease,1.0,33638291
9893,aflibercept,gene,0.9785,33638291
9894,bevacizumab,gene,0.927,33638291
9895,Aflibercept,gene,0.976,33633901
9896,Macular Hole,disease,0.737,33633901
9897,Aflibercept,gene,0.977,33633901
9898,anti-vascular endothelial growth factor,gene,0.9917,33633901
9899,patients,species,0.9717,33633901
9900,retinal pathologies,disease,0.8994,33633901
9901,neovascular age-related macular degeneration,disease,1.0,33633901
9902,patients,species,0.9897,33633901
9903,aflibercept,gene,0.9185,33633901
9904,neovascular age-related macular degeneration,disease,1.0,33633901
9905,vitreomacular traction,disease,0.937,33633901
9906,aflibercept,gene,0.99,33633901
9907,cataract,disease,0.9995,33633901
9908,macular hole,disease,0.9956,33633901
9909,patients,species,0.9863,33633901
9910,aflibercept,gene,0.9873,33633901
9911,macular hole,disease,1.0,33633901
9912,Acute Retinal Necrosis,disease,1.0,33633018
9913,Ranibizumab,gene,0.903,33633018
9914,Acute retinal necrosis,disease,1.0,33633018
9915,ARN,disease,1.0,33633018
9916,patients,species,0.993,33633018
9917,age-related macular degeneration,disease,0.999,33633018
9918,AMD,disease,1.0,33633018
9919,visual loss,disease,0.9985,33633018
9920,ARN,disease,0.999,33633018
9921,patient,species,0.938,33633018
9922,exudative AMD,disease,1.0,33633018
9923,patient,species,0.9556,33633018
9924,blurred vision,disease,0.9985,33633018
9925,patient,species,0.976,33633018
9926,exudative AMD,disease,0.997,33633018
9927,varicella-zoster virus,disease,1.0,33633018
9928,ARN,disease,0.9897,33633018
9929,patient,species,0.981,33633018
9930,patient,species,0.9883,33633018
9931,aflibercept,gene,0.9775,33633018
9932,aflibercept,gene,0.9717,33633018
9933,retinal detachment,disease,1.0,33633018
9934,patient,species,0.984,33633018
9935,varicella-zoster virus,disease,1.0,33633018
9936,ARN,disease,0.9976,33633018
9937,ARN,disease,1.0,33633018
9938,intraocular inflammation,disease,0.9995,33633018
9939,viral DNA,DNA,0.883,33633018
9940,visual loss,disease,0.998,33633018
9941,Non-infectious Intraocular Inflammation,disease,1.0,33631912
9942,patients,species,0.93,33631912
9943,non-infectious intraocular inflammation,disease,1.0,33631912
9944,IOI,disease,1.0,33631912
9945,anti-vascular endothelial growth factor,gene,0.992,33631912
9946,anti-VEGF,gene,0.9727,33631912
9947,neovascular age-related macular degeneration,disease,1.0,33631912
9948,nAMD,disease,1.0,33631912
9949,patients,species,0.9907,33631912
9950,VEGF,gene,0.728,33631912
9951,nAMD,disease,1.0,33631912
9952,patients,species,0.9717,33631912
9953,non-infectious IOI,disease,0.9854,33631912
9954,VEGF,gene,0.907,33631912
9955,IOI,disease,0.8047,33631912
9956,aflibercept,gene,0.9863,33631912
9957,ranibizumab,gene,0.9014,33631912
9958,patients,species,0.991,33631912
9959,anti-VEGF,gene,0.9814,33631912
9960,aflibercept,gene,0.99,33631912
9961,ranibizumab,gene,0.9165,33631912
9962,vitritis,disease,1.0,33631912
9963,patients,species,0.989,33631912
9964,hypopyon,disease,0.919,33631912
9965,fibrin,gene,0.995,33631912
9966,Vitritis,disease,1.0,33631912
9967,patients,species,0.968,33631912
9968,IOI,disease,1.0,33631912
9969,patients,species,0.9785,33631912
9970,IOI,disease,0.698,33631912
9971,anti-VEGF,gene,0.9873,33631912
9972,conjunctival injection,disease,0.999,33631912
9973,hypopyon,disease,0.981,33631912
9974,fibrin,gene,0.7725,33631912
9975,Patient,species,0.9785,33630242
9976,Colorectal cancer,disease,1.0,33630242
9977,cancer,disease,0.9995,33630242
9978,metastatic colorectal cancer,disease,1.0,33630242
9979,mCRC,disease,1.0,33630242
9980,patients,species,0.984,33630242
9981,fluorouracil,drug,0.993,33630242
9982,leucovorin,drug,0.999,33630242
9983,irinotecan,drug,0.999,33630242
9984,FOLFIRI,drug,0.989,33630242
9985,fluorouracil,drug,0.9995,33630242
9986,leucovorin,drug,0.999,33630242
9987,oxaliplatin,drug,0.9995,33630242
9988,FOLFOX,drug,0.9966,33630242
9989,mCRC,disease,0.996,33630242
9990,patients,species,0.993,33630242
9991,Aflibercept,gene,0.9487,33630242
9992,patient,species,0.99,33630242
9993,RAS mutant,gene,0.8228,33630242
9994,RAS wild,gene,0.825,33630242
9995,BRAF,DNA,0.592,33630242
9996,BRAF mutant,gene,0.8857,33630242
9997,patients,species,0.9844,33630242
9998,mCRC,disease,0.9834,33630242
9999,Aflibercept,gene,0.98,33630242
10000,Aflibercept,gene,0.9717,33628832
10001,Diabetic,disease,1.0,33628832
10002,aflibercept,gene,0.983,33628832
10003,diabetic macular edema,disease,1.0,33628832
10004,DME,disease,1.0,33628832
10005,DME,disease,1.0,33628832
10006,aflibercept,gene,0.8726,33628832
10007,patients,species,0.9844,33628832
10008,DME,disease,1.0,33628832
10009,Aflibercept,gene,0.993,33628552
10010,Retinal Neovascularization,disease,0.9995,33628552
10011,aflibercept,gene,0.989,33628552
10012,retinal neovascularization,disease,1.0,33628552
10013,macular edema,disease,1.0,33628552
10014,Eales disease,disease,1.0,33628552
10015,aflibercept,gene,0.9946,33628552
10016,retinal neovascularization,disease,1.0,33628552
10017,triamcinolone,drug,0.5605,33628552
10018,Retinal neovascularization,disease,1.0,33628552
10019,macular edema,disease,1.0,33628552
10020,aflibercept,gene,0.975,33628552
10021,retinal neovascularization,disease,1.0,33628552
10022,macular edema,disease,1.0,33628552
10023,aflibercept,gene,0.9785,33628552
10024,retinal neovascularization,disease,1.0,33628552
10025,macular edema,disease,1.0,33628552
10026,triamcinolone,drug,0.633,33628552
10027,macular edema,disease,1.0,33628552
10028,aflibercept,gene,0.99,33628552
10029,patient,species,0.974,33628552
10030,aflibercept,gene,0.9863,33628552
10031,Eales disease,disease,1.0,33628552
10032,retinal neovascularization,disease,0.836,33628552
10033,aflibercept,gene,0.9756,33627712
10034,diabetic,disease,0.8467,33627712
10035,aflibercept,gene,0.99,33627712
10036,diabetic macula edema,disease,1.0,33627712
10037,DME,disease,1.0,33627712
10038,patients,species,0.9805,33627712
10039,DME,disease,1.0,33627712
10040,Participants,species,0.9185,33627712
10041,patients,species,0.9795,33627712
10042,patients,species,0.9775,33627712
10043,aflibercept,gene,0.681,33627712
10044,DME,disease,1.0,33627712
10045,patients,species,0.987,33617401
10046,anti-,gene,0.6113,33617401
10047,vascular endothelial growth factor,gene,0.9155,33617401
10048,VEGF,gene,0.9976,33617401
10049,neovascular age-related macular degeneration,disease,1.0,33617401
10050,N-,disease,1.0,33617401
10051,N-AMD,disease,0.9995,33617401
10052,patients,species,0.9937,33617401
10053,aflibercept,gene,0.9824,33617401
10054,ranibizumab,gene,0.843,33617401
10055,aflibercept,gene,0.993,33617401
10056,aflibercept,gene,0.9736,33617401
10057,patients,species,0.9233,33617401
10058,N-AMD,disease,1.0,33617401
10059,Patient,species,0.993,33616665
10060,aflibercept,gene,0.949,33616665
10061,ocular neovascular diseases,disease,0.9673,33616665
10062,patients,species,0.9956,33616665
10063,eye disease,disease,0.997,33616665
10064,patients,species,0.995,33616665
10065,PARTICIPANTS,species,0.662,33616665
10066,patients,species,0.9927,33616665
10067,vascular endothelial growth factor,gene,0.9707,33616665
10068,Patients,species,0.981,33616665
10069,ocular vascular disease,disease,1.0,33616665
10070,aflibercept,gene,0.7954,33616665
10071,ocular vascular disease,disease,1.0,33616665
10072,bevacizumab,gene,0.856,33616665
10073,patients,species,0.975,33616665
10074,patients,species,0.9897,33616665
10075,patients,species,0.994,33616665
10076,ocular disease,disease,0.9995,33616665
10077,patients,species,0.9834,33616665
10078,women,species,0.9614,33616665
10079,aflibercept,gene,0.983,33616665
10080,patients,species,0.9834,33616665
10081,bevacizumab,gene,0.549,33616665
10082,patient,species,0.988,33616665
10083,patient,species,0.9873,33616665
10084,bevacizumab,gene,0.5938,33616665
10085,bevacizumab,gene,0.811,33616665
10086,patients,species,0.9956,33616665
10087,diabetes,disease,1.0,33616665
10088,eye disease,disease,0.927,33616665
10089,patients,species,0.9893,33616665
10090,Desferrioxamine,drug,0.9985,33613246
10091,Pseudo-Vitelliform Dystrophy,disease,0.986,33613246
10092,bilateral pseudo-vitelliform dystrophy,disease,0.942,33613246
10093,desferrioxamine,drug,0.999,33613246
10094,iron,drug,0.9976,33613246
10095,patient,species,0.9653,33613246
10096,right superior hemiretinal vein occlusion,disease,0.988,33613246
10097,intraretinal fluid,disease,0.9897,33613246
10098,aflibercept,gene,0.971,33613246
10099,anti-VEGF,gene,0.9204,33613246
10100,desferrioxamine-related maculopathy,disease,0.9556,33613246
10101,desferrioxamine,drug,0.9517,33613246
10102,a vein occlusion,disease,1.0,33613246
10103,anti-VEGF,gene,0.798,33613246
10104,desferrioxamine,drug,0.9995,33613246
10105,pseudo-vitelliform retinal lesions,disease,0.9814,33613246
10106,patients,species,0.988,33610836
10107,vascular endothelial growth factor,gene,0.8525,33610836
10108,VEGF,gene,0.9937,33610836
10109,macular edema,disease,1.0,33610836
10110,ME,disease,1.0,33610836
10111,central retinal vein occlusion,disease,1.0,33610836
10112,CRVO,disease,1.0,33610836
10113,PARTICIPANTS,species,0.8667,33610836
10114,participants,species,0.9663,33610836
10115,Diabetic Retinopathy,disease,0.9927,33610836
10116,participants,species,0.9604,33610836
10117,ranibizumab,gene,0.6543,33610836
10118,aflibercept,gene,0.969,33610836
10119,bevacizumab,gene,0.531,33610836
10120,patients,species,0.977,33610836
10121,Diabetic Retinopathy,disease,1.0,33610836
10122,neovascular age-related macular degeneration,disease,1.0,33610155
10123,retinal diseases,disease,1.0,33610155
10124,age-related macular degeneration,disease,1.0,33610155
10125,AMD,disease,1.0,33610155
10126,retinal diseases,disease,0.9995,33610155
10127,glaucoma,disease,1.0,33610155
10128,conjunctival lesions,disease,1.0,33610155
10129,AMD,disease,1.0,33610155
10130,irreversible,disease,0.9663,33610155
10131,vision loss,disease,0.7954,33610155
10132,blindness,disease,0.9995,33610155
10133,blindness,disease,0.9995,33610155
10134,nAMD,disease,1.0,33610155
10135,patient,species,0.9834,33610155
10136,VEGF,gene,0.994,33610155
10137,patients,species,0.9883,33610155
10138,Choroidal neovascularization,disease,1.0,33607835
10139,chronic RATIONALE,disease,0.9976,33607835
10140,verteporfin,drug,0.997,33607835
10141,chronic central serous chorioretinopathy,disease,1.0,33607835
10142,CSC,disease,1.0,33607835
10143,choroidal neovascularization,disease,1.0,33607835
10144,CNV,disease,1.0,33607835
10145,PATIENT,species,0.9653,33607835
10146,man,species,0.8916,33607835
10147,Fluorescein,drug,0.9985,33607835
10148,indocyanine green,drug,0.9985,33607835
10149,PED,disease,0.998,33607835
10150,patient,species,0.9873,33607835
10151,chronic CSC,disease,0.9995,33607835
10152,patient,species,0.983,33607835
10153,verteporfin,drug,0.996,33607835
10154,patient,species,0.9883,33607835
10155,sudden blurred vision,disease,0.973,33607835
10156,macular hemorrhages,disease,0.999,33607835
10157,CNV,disease,0.9824,33607835
10158,CNV,disease,1.0,33607835
10159,patient,species,0.9893,33607835
10160,aflibercept,gene,0.971,33607835
10161,macular hemorrhages,disease,0.9995,33607835
10162,CNV,disease,1.0,33607835
10163,Patients,species,0.94,33607835
10164,chronic CSC,disease,0.9995,33607835
10165,CNV,disease,1.0,33607835
10166,vascular endothelial growth factor,gene,0.9897,33607835
10167,patients,species,0.871,33606153
10168,diabetic macular edema,disease,1.0,33606153
10169,DME,disease,1.0,33606153
10170,vascular endothelial growth factor,gene,0.905,33606153
10171,VEGF,gene,0.997,33606153
10172,aflibercept,gene,0.971,33606153
10173,patients,species,0.9873,33606153
10174,DME,disease,1.0,33606153
10175,patients,species,0.9785,33606153
10176,aflibercept,gene,0.9785,33606153
10177,fluorescein,drug,0.9443,33606153
10178,Patients,species,0.9146,33606153
10179,DME,disease,1.0,33606153
10180,aflibercept,gene,0.988,33606153
10181,DME,disease,1.0,33606153
10182,neurodegeneration,disease,1.0,33606153
10183,VEGF,gene,0.771,33606153
10184,Aflibercept,gene,0.985,33602156
10185,Polypoidal choroidal vasculopathy,disease,1.0,33602156
10186,PCV,disease,1.0,33602156
10187,age-related,disease,0.9316,33602156
10188,macular degeneration,disease,1.0,33602156
10189,vision loss,disease,0.9995,33602156
10190,aflibercept,gene,0.996,33602156
10191,PCV,disease,1.0,33602156
10192,PCV,disease,1.0,33602156
10193,patients,species,0.995,33602156
10194,patients,species,0.986,33602156
10195,patients,species,0.9893,33602156
10196,patient,species,0.989,33602156
10197,aflibercept,gene,0.931,33602156
10198,Fluorescein,drug,0.9966,33602156
10199,indocyanine green,drug,0.997,33602156
10200,aflibercept,gene,0.9746,33602156
10201,patients,species,0.9785,33602156
10202,patients,species,0.9917,33602156
10203,polyp,disease,0.999,33602156
10204,patients,species,0.987,33602156
10205,aflibercept,gene,0.9927,33602156
10206,patients,species,0.9688,33602156
10207,PCV,disease,1.0,33602156
10208,patients,species,0.9893,33602156
10209,patients,species,0.987,33602156
10210,aflibercept,gene,0.986,33600134
10211,patients,species,0.941,33600134
10212,neovascular age-related macular degeneration,disease,1.0,33600134
10213,patients,species,0.97,33600134
10214,neovascular age-related macular degeneration,disease,1.0,33600134
10215,aflibercept,gene,0.9614,33600134
10216,patients,species,0.9663,33600134
10217,intraretinal edema,disease,1.0,33600134
10218,intraretinal cysts,disease,1.0,33600134
10219,patients,species,0.981,33600134
10220,aflibercept,gene,0.993,33600134
10221,anti-vascular endothelial growth factor,gene,0.9854,33599552
10222,patients,species,0.936,33599552
10223,diabetic macular oedema,disease,1.0,33599552
10224,DME,disease,1.0,33599552
10225,anti-vascular endothelial growth factor,gene,0.965,33599552
10226,anti-VEGF,gene,0.912,33599552
10227,Participants,species,0.594,33599552
10228,patients,species,0.9604,33599552
10229,DME,disease,1.0,33599552
10230,ranibizumab,gene,0.759,33599552
10231,aflibercept,gene,0.7173,33599552
10232,participants,species,0.9473,33599552
10233,endothelial cell,cell_type,0.833,33599552
10234,patients,species,0.9717,33599552
10235,DME,disease,1.0,33599552
10236,anti-VEGF,gene,0.963,33599552
10237,patients,species,0.8887,33599552
10238,DME,disease,1.0,33599552
10239,aflibercept,gene,0.991,33596867
10240,ranibizumab,drug,0.6255,33596867
10241,vascular endothelial growth factor,gene,0.866,33596867
10242,VEGF,gene,0.621,33596867
10243,neovascular age-related macular degeneration,disease,1.0,33596867
10244,nAMD,disease,1.0,33596867
10245,VEGF,gene,0.612,33596867
10246,patients,species,0.9873,33596867
10247,nAMD,disease,1.0,33596867
10248,VEGF,gene,0.762,33596867
10249,aflibercept,gene,0.9873,33596867
10250,AFL,gene,0.703,33596867
10251,patients,species,0.9473,33596867
10252,nAMD,disease,1.0,33596867
10253,ranibizumab,gene,0.7783,33596867
10254,AFL,disease,0.994,33596867
10255,ranibizumab,gene,0.8335,33596867
10256,Patients,species,0.9575,33596867
10257,nAMD,disease,1.0,33596867
10258,ranibizumab,gene,0.852,33596867
10259,Patients,species,0.936,33596867
10260,ranibizumab,gene,0.509,33596867
10261,patients,species,0.973,33596867
10262,patients,species,0.9863,33596867
10263,Diabetic Retinopathy,disease,1.0,33596867
10264,patients,species,0.984,33596867
10265,patients,species,0.9844,33596867
10266,patients,species,0.988,33596867
10267,patients,species,0.9785,33596867
10268,eye pain,disease,0.9624,33596867
10269,ranibizumab,drug,0.722,33596867
10270,patients,species,0.969,33596867
10271,nAMD,disease,1.0,33596867
10272,patients,species,0.9604,33596867
10273,Ziv-aflibercept,gene,0.9727,33577373
10274,Neovascular Age-Related Macular,disease,1.0,33577373
10275,ziv-aflibercept,gene,0.9834,33577373
10276,nAMD,disease,1.0,33577373
10277,nAMD,disease,1.0,33577373
10278,anti-VEGF,gene,0.852,33577373
10279,ziv-aflibercept,gene,0.9463,33577373
10280,VEGF,gene,0.6704,33577373
10281,BCVA,cell_type,0.3767,33577373
10282,BCVA,cell_type,0.3953,33577373
10283,Ziv-aflibercept,gene,0.9683,33577373
10284,patients,species,0.963,33577373
10285,nAMD,disease,1.0,33577373
10286,aflibercept,gene,0.9893,33577373
10287,bevacizumab,gene,0.8506,33577373
10288,ranibizumab,gene,0.644,33577373
10289,retinal macrovessel,disease,0.7773,33575540
10290,Congenital retinal macrovessel,disease,1.0,33575540
10291,CRM,disease,1.0,33575540
10292,aberrant,cell_type,0.4614,33575540
10293,vascular,disease,0.7593,33575540
10294,visual impairment,disease,1.0,33575540
10295,choroidal nonvascular membrane,disease,1.0,33575540
10296,CNV,disease,1.0,33575540
10297,aflibercept,gene,0.9814,33575540
10298,aflibercept,gene,0.905,33574033
10299,aflibercept,gene,0.9756,33574033
10300,participants,species,0.973,33574033
10301,polypoidal choroidal vasculopathy,disease,1.0,33574033
10302,PCV,disease,1.0,33574033
10303,participants,species,0.919,33574033
10304,PCV,disease,1.0,33574033
10305,Participants,species,0.941,33574033
10306,aflibercept,gene,0.9917,33574033
10307,participants,species,0.9663,33574033
10308,polypoidal lesions,disease,1.0,33574033
10309,PL,disease,1.0,33574033
10310,indocyanine green,drug,0.9946,33574033
10311,PL,disease,,33574033
10312,participants,species,0.9775,33574033
10313,PL,disease,,33574033
10314,Aflibercept,gene,0.956,33571295
10315,diabetic macula oedema,disease,1.0,33571295
10316,patients,species,0.9844,33571295
10317,diabetic macula oedema,disease,1.0,33571295
10318,DMO,disease,1.0,33571295
10319,Aflibercept,gene,0.955,33571295
10320,patients,species,0.978,33571295
10321,Aflibercept,gene,0.8857,33571295
10322,NWL,cell_line,0.5435,33571295
10323,participants,species,0.925,33571295
10324,HbA1c,gene,0.99,33571295
10325,proliferative,disease,0.7407,33571295
10326,diabetic retinopathy,disease,0.996,33571295
10327,NWL,cell_line,0.525,33571295
10328,CSFT,DNA,0.4922,33571295
10329,Aflibercept,gene,0.9395,33571295
10330,patients,species,0.9873,33571295
10331,NWL,disease,1.0,33571295
10332,patients,species,0.9736,33571295
10333,diabetic retinopathy,disease,1.0,33571295
10334,aflibercept,gene,0.9893,33567025
10335,neovascular age-related macular PURPOSE,disease,0.92,33567025
10336,patients,species,0.9614,33567025
10337,neovascular age-related macular degeneration,disease,1.0,33567025
10338,ranibizumab,gene,0.727,33567025
10339,Lucentis,gene,0.7485,33567025
10340,aflibercept,gene,0.935,33567025
10341,Eylea,gene,0.7515,33567025
10342,patients,species,0.934,33567025
10343,neovascular age-related macular degeneration,disease,1.0,33567025
10344,aflibercept,gene,0.9546,33567025
10345,ranibizumab,gene,0.666,33567025
10346,patients,species,0.962,33567025
10347,aflibercept,gene,0.9795,33567025
10348,aflibercept,gene,0.9937,33567025
10349,aflibercept,gene,0.9897,33567025
10350,patients,species,0.959,33567025
10351,patients,species,0.9854,33567025
10352,patients,species,0.991,33567025
10353,ranibizumab,gene,0.9214,33567025
10354,aflibercept,gene,0.9614,33567025
10355,aflibercept,gene,0.9556,33567025
10356,aflibercept,gene,0.984,33567025
10357,Patients,species,0.919,33567025
10358,neovascular age-related macular degeneration,disease,1.0,33567025
10359,aflibercept,gene,0.987,33567025
10360,aflibercept,gene,0.994,33566381
10361,Retinopathy of prematurity,disease,1.0,33566381
10362,ROP,disease,1.0,33566381
10363,childhood blindness,disease,1.0,33566381
10364,vascular endothelial,cell_type,0.578,33566381
10365,VEGF,gene,0.9956,33566381
10366,ROP,disease,0.8135,33566381
10367,VEGF,gene,0.9014,33566381
10368,VEGF,gene,0.557,33566381
10369,anti-VEGF,gene,0.963,33566381
10370,mouse,species,0.9097,33566381
10371,ROP,disease,0.997,33566381
10372,aflibercept,gene,0.7935,33566381
10373,VEGF,gene,0.943,33566381
10374,ROP,disease,0.964,33566381
10375,diabetic retinopathy,disease,1.0,33566149
10376,Vascular Endothelial Growth Factor,gene,0.9985,33566149
10377,VEGF,gene,0.997,33566149
10378,Diabetic Retinopathy,disease,1.0,33566149
10379,ETDRS,DNA,0.4578,33566149
10380,DME,disease,1.0,33566149
10381,aflibercept,gene,0.973,33566149
10382,bevacizumab,gene,0.8584,33566149
10383,aflibercept,gene,0.9907,33566149
10384,bevacizumab,gene,0.704,33566149
10385,bevacizumab,gene,0.862,33566149
10386,aflibercept,gene,0.9146,33566149
10387,ranibizumab,drug,0.778,33566149
10388,anti-VEGF,gene,0.7686,33566149
10389,aflibercept,gene,0.973,33559843
10390,diabetic macular edema,disease,1.0,33559843
10391,aflibercept,gene,0.941,33559843
10392,diabetic macular edema,disease,1.0,33559843
10393,DME,disease,1.0,33559843
10394,patients,species,0.967,33559843
10395,DME,disease,1.0,33559843
10396,aflibercept,gene,0.954,33559843
10397,patients,species,0.9775,33559843
10398,patients,species,0.9697,33559843
10399,aflibercept,gene,0.904,33559843
10400,participants,species,0.9487,33559843
10401,patients,species,0.9927,33559843
10402,aflibercept,gene,0.7446,33559843
10403,DME,disease,0.869,33559843
10404,Aflibercept,gene,0.9717,33556381
10405,aflibercept,gene,0.993,33556381
10406,AFL,gene,0.9272,33556381
10407,patients,species,0.9614,33556381
10408,macular edema,disease,1.0,33556381
10409,central retinal vein occlusion,disease,1.0,33556381
10410,CRVO,disease,1.0,33556381
10411,Aflibercept,gene,0.948,33556381
10412,Macular Edema,disease,1.0,33556381
10413,CRVO,disease,0.9995,33556381
10414,Patients,species,0.869,33556381
10415,IVT,drug,0.943,33556381
10416,patients,species,0.9775,33556381
10417,patients,species,0.9907,33556381
10418,patients,species,0.9785,33556381
10419,patients,species,0.9883,33556381
10420,IVT-AFL,drug,0.933,33556381
10421,patients,species,0.9526,33556381
10422,patients,species,0.991,33556095
10423,advanced colorectal cancer,disease,1.0,33556095
10424,advanced colorectal cancer,disease,1.0,33556095
10425,CRC,disease,1.0,33556095
10426,leucovorin,drug,0.9995,33556095
10427,5-fluorouracil,drug,0.9995,33556095
10428,irinotecan,drug,0.999,33556095
10429,bevacizumab,gene,0.9395,33556095
10430,ramucirumab,gene,0.532,33556095
10431,aflibercept beta,gene,0.9917,33556095
10432,Patients,species,0.964,33556095
10433,advanced CRC,disease,0.9985,33556095
10434,FOLFIRI,drug,0.979,33556095
10435,FOLFOX,drug,0.8994,33556095
10436,leucovorin,drug,0.9995,33556095
10437,5-fluorouracil,drug,0.9995,33556095
10438,oxaliplatin,drug,0.9995,33556095
10439,CAPOX,drug,0.9966,33556095
10440,capecitabine,drug,0.9995,33556095
10441,oxaliplatin,drug,0.9995,33556095
10442,RAS,DNA,0.5376,33556095
10443,RAS-,gene,0.9634,33556095
10444,FOLFOX,drug,0.6616,33556095
10445,panitumumab,gene,0.5684,33556095
10446,RAS,gene,0.9976,33556095
10447,CRC,disease,0.6387,33556095
10448,FOLFIRI,drug,0.99,33556095
10449,patients,species,0.9946,33556095
10450,patients,species,0.983,33556095
10451,RAS-mutant CRC,disease,0.8735,33556095
10452,RAS,gene,0.994,33556095
10453,CRC,disease,0.918,33556095
10454,FOLFIRI,drug,0.8813,33556095
10455,patients,species,0.979,33556095
10456,RAS,gene,0.9966,33556095
10457,CRC,disease,0.7676,33556095
10458,fluoropyrimidines,drug,0.999,33556095
10459,proteinuria,disease,1.0,33556095
10460,advanced CRC,disease,0.943,33556095
10461,hypertension,disease,1.0,33556095
10462,proteinuria,disease,0.9995,33556095
10463,Intraocular inflammation,disease,1.0,33555415
10464,brolucizumab,gene,0.74,33555415
10465,Patient,species,0.9326,33555415
10466,anti-vascular endothelial growth factor,gene,0.971,33555415
10467,anti-VEGF,gene,0.8457,33555415
10468,brolucizumab,gene,0.8257,33555415
10469,neovascular age-related macular degeneration,disease,1.0,33555415
10470,nAMD,disease,1.0,33555415
10471,patients,species,0.9863,33555415
10472,Brolucizumab,gene,0.6914,33555415
10473,aflibercept,gene,0.885,33555415
10474,brolucizumab,gene,0.8154,33555415
10475,retinal vasculitis,disease,1.0,33555415
10476,retinal vascular,disease,0.998,33555415
10477,loss of vision,disease,0.9995,33555415
10478,intraocular inflammation,disease,1.0,33555415
10479,IOI,disease,1.0,33555415
10480,brolucizumab,gene,0.855,33555415
10481,IOI,disease,0.9966,33555415
10482,patients,species,0.981,33555415
10483,IOI,disease,0.9995,33555415
10484,patients,species,0.9863,33555415
10485,IOI,disease,0.9995,33555415
10486,patient,species,0.9854,33555415
10487,IOI,disease,1.0,33555415
10488,retinal vasculitis,disease,1.0,33555415
10489,retinal vascular occlusive events,disease,1.0,33555415
10490,brolucizumab,gene,0.8555,33555415
10491,Diabetic Macular Edema,disease,1.0,33551641
10492,vascular endothelial growth factor,gene,0.853,33551641
10493,VEGF,gene,0.996,33551641
10494,dexamethasone,drug,0.9897,33551641
10495,diabetic macular edema,disease,1.0,33551641
10496,DME,disease,1.0,33551641
10497,patients,species,0.9614,33551641
10498,DME,disease,1.0,33551641
10499,anti-VEGF,gene,0.82,33551641
10500,dexamethasone,drug,0.937,33551641
10501,patient,species,0.9946,33551641
10502,BCVA,DNA,0.524,33551641
10503,dexamethasone,drug,0.99,33551641
10504,anti-VEGFs,gene,0.7925,33551641
10505,Dexamethasone,drug,0.9863,33551641
10506,aflibercept,gene,0.988,33551641
10507,diabetes,disease,1.0,33551641
10508,VEGFs,gene,0.6094,33551641
10509,dexamethasone,drug,0.966,33551641
10510,patients,species,0.888,33551641
10511,DME,disease,1.0,33551641
10512,aflibercept,gene,0.9595,33550508
10513,choroidal neovascular membranes,disease,0.9985,33550508
10514,CNVMs,disease,0.999,33550508
10515,age-related macular degeneration,disease,0.9995,33550508
10516,wARMD,disease,0.9995,33550508
10517,patients,species,0.98,33550508
10518,aflibercept,gene,0.9673,33550508
10519,Patients,species,0.9673,33550508
10520,patients,species,0.978,33550508
10521,patients,species,0.9854,33550508
10522,CNVM,disease,0.9893,33550508
10523,CNVM,disease,0.9834,33550508
10524,aflibercept,gene,0.97,33550508
10525,CNVMs,disease,1.0,33550508
10526,CNVMs,disease,1.0,33550508
10527,CNVMs,disease,0.8647,33550508
10528,wARMD,disease,0.7,33550508
10529,CNVM,disease,0.7334,33550508
10530,aflibercept,gene,0.9785,33547967
10531,patients,species,0.9775,33547967
10532,neovascular age-related macular degeneration,disease,1.0,33547967
10533,patients,species,0.98,33547967
10534,Patients,species,0.9585,33547967
10535,patients,species,0.991,33547967
10536,patients,species,0.992,33547967
10537,LOCF,disease,0.9995,33547967
10538,OC,disease,,33547967
10539,patients,species,0.979,33547967
10540,patients,species,0.9927,33547967
10541,patients,species,0.9863,33547967
10542,patients,species,0.984,33547967
10543,VA,disease,,33547967
10544,patients,species,0.9863,33547967
10545,brolucizumab,gene,0.9595,33543352
10546,retinal vasculitis,disease,0.9595,33543352
10547,retinal vasculitis,disease,1.0,33543352
10548,brolucizumab,gene,0.9336,33543352
10549,patients,species,0.9785,33543352
10550,intraocular inflammation,disease,1.0,33543352
10551,IOI,disease,1.0,33543352
10552,retinal vasculitis,disease,1.0,33543352
10553,brolucizumab,gene,0.903,33543352
10554,age-related macular degeneration,disease,1.0,33543352
10555,aflibercept,gene,0.993,33543352
10556,brolucizumab,gene,0.8667,33543352
10557,patients,species,0.9854,33543352
10558,blurry vision,disease,0.9956,33543352
10559,floaters,disease,0.875,33543352
10560,brolucizumab,gene,0.853,33543352
10561,anterior chamber cells,cell_type,0.5483,33543352
10562,retinal hemorrhage,disease,1.0,33543352
10563,vascular sheathing,disease,0.974,33543352
10564,fluorescein,drug,0.997,33543352
10565,optic,DNA,0.4878,33543352
10566,Brolucizumab,gene,0.948,33543352
10567,prednisolone,drug,0.6006,33543352
10568,triamcinolone acetonide,drug,0.99,33543352
10569,betamethasone sodium phosphate,drug,0.997,33543352
10570,Brolucizumab,gene,0.837,33543352
10571,IOI,disease,0.9995,33543352
10572,retinal vasculitis,disease,1.0,33543352
10573,retinal occlusion,disease,1.0,33543352
10574,vision loss,disease,0.7676,33543352
10575,aflibercept,gene,0.9863,33542603
10576,choroidal neovascularization,disease,1.0,33542603
10577,blurred vision,disease,0.9995,33542603
10578,patient,species,0.9863,33542603
10579,yellow lesion,disease,0.7754,33542603
10580,fluorescein,drug,0.944,33542603
10581,classic,disease,0.564,33542603
10582,choroidal neovascularization,disease,0.861,33542603
10583,CNV,disease,1.0,33542603
10584,aflibercept,gene,0.9854,33542603
10585,CNV,disease,0.9976,33542603
10586,aflibercept,gene,0.955,33542603
10587,CNV,disease,0.994,33542603
10588,Aflibercept,gene,0.983,33532145
10589,vascular endothelial growth factor,gene,0.9985,33532145
10590,VEGF,gene,0.997,33532145
10591,aflibercept,gene,0.993,33532145
10592,human,species,0.563,33532145
10593,human,species,0.679,33532145
10594,ADVM-022,DNA,0.566,33532145
10595,gene therapy vector,DNA,0.6074,33532145
10596,aflibercept,gene,0.987,33532145
10597,VEGF,gene,0.9946,33532145
10598,Aflibercept,gene,0.986,33532145
10599,Ocular inflammation,disease,0.997,33532145
10600,aflibercept,gene,0.9927,33532145
10601,RPE,cell_type,0.5894,33532145
10602,histologic abnormalities,disease,0.7075,33532145
10603,ADVM,DNA,0.4482,33532145
10604,aflibercept,gene,0.9946,33532145
10605,VEGF,gene,0.9937,33532145
10606,ADVM,drug,0.9756,33532145
10607,VEGF-mediated ophthalmic disorders,disease,0.7275,33532145
10608,VEGF,gene,0.9897,33532145
10609,Fluorescein,drug,0.939,33529593
10610,aflibercept,gene,0.9004,33529593
10611,diabetic retinopathy,disease,1.0,33529593
10612,DR,disease,1.0,33529593
10613,DR,disease,,33529593
10614,diabetic macular edema,disease,1.0,33529593
10615,DME,disease,1.0,33529593
10616,DR,disease,,33529593
10617,PDR,disease,0.9673,33529593
10618,DRSS,DNA,0.5405,33529593
10619,DRSS,disease,0.8047,33529593
10620,PDR,disease,0.654,33529593
10621,PDR,disease,0.9834,33529593
10622,DR,disease,,33529593
10623,DME,disease,0.651,33529593
10624,patients,species,0.976,33529593
10625,anti-VEGF,gene,0.9644,33528645
10626,intra- and/or subretinal,disease,0.7075,33528645
10627,exudative age-related macular degeneration,disease,1.0,33528645
10628,AMD,disease,1.0,33528645
10629,ranibizumab,gene,0.6475,33528645
10630,aflibercept,gene,0.7583,33528645
10631,brolucizumab,gene,0.527,33528645
10632,exudative AMD,disease,0.95,33528645
10633,patients,species,0.994,33528645
10634,Ranibizumab,gene,0.745,33528645
10635,aflibercept,gene,0.975,33528645
10636,brolucizumab,gene,0.789,33528645
10637,aldosterone,drug,0.998,33525896
10638,papillophlebitis,disease,1.0,33525896
10639,retinal artery PURPOSE,disease,0.9946,33525896
10640,aldosterone,drug,0.9844,33525896
10641,papillophlebitis,disease,1.0,33525896
10642,retinal artery occlusion,disease,1.0,33525896
10643,woman,species,0.935,33525896
10644,woman,species,0.9087,33525896
10645,visual loss,disease,0.9834,33525896
10646,retinal whitening,disease,0.9443,33525896
10647,splinter hemorrhages,disease,0.765,33525896
10648,disc swelling,disease,0.994,33525896
10649,tortuous vessels,disease,0.851,33525896
10650,aldosterone,drug,0.964,33525896
10651,aldosterone,drug,0.963,33525896
10652,renin,gene,0.754,33525896
10653,patient,species,0.9785,33525896
10654,dexamethasone,drug,0.9795,33525896
10655,aflibercept,gene,0.9644,33525896
10656,aldosterone,drug,0.9844,33525896
10657,retinal vasculopathy,disease,1.0,33525896
10658,impaired vision,disease,0.9985,33525896
10659,retinal vascular occlusion,disease,0.9995,33525896
10660,Endophthalmitis,disease,0.9995,33522314
10661,Anti-Vascular Endothelial Growth Factor,gene,0.9863,33522314
10662,endophthalmitis,disease,1.0,33522314
10663,endophthalmitis,disease,1.0,33522314
10664,anti-vascular endothelial growth factor,gene,0.9214,33522314
10665,infectious endophthalmitis,disease,1.0,33522314
10666,endophthalmitis,disease,1.0,33522314
10667,endophthalmitis,disease,1.0,33522314
10668,endophthalmitis,disease,1.0,33522314
10669,endophthalmitis,disease,1.0,33522314
10670,endophthalmitis,disease,1.0,33522314
10671,ranibizumab,gene,0.8867,33522314
10672,endophthalmitis,disease,1.0,33522314
10673,endophthalmitis,disease,1.0,33522314
10674,Ranibizumab,gene,0.9653,33519187
10675,Aflibercept,gene,0.9165,33519187
10676,Bevacizumab,gene,0.5786,33519187
10677,Diabetic Macular AIM,disease,0.9814,33519187
10678,bevacizumab,gene,0.708,33519187
10679,ranibizumab,gene,0.807,33519187
10680,aflibercept,gene,0.942,33519187
10681,diabetic macular edema,disease,1.0,33519187
10682,DME,disease,0.908,33519187
10683,bevacizumab,gene,0.796,33519187
10684,patients,species,0.961,33519187
10685,DME,disease,1.0,33519187
10686,bevacizumab,gene,0.7397,33519187
10687,ranibizumab,gene,0.8228,33519187
10688,aflibercept,gene,0.9604,33519187
10689,patients,species,0.9785,33519187
10690,ranibizumab,gene,0.726,33519187
10691,aflibercept,gene,0.945,33519187
10692,ranibizumab,gene,0.524,33519187
10693,ranibizumab,gene,0.9414,33519187
10694,aflibercept,gene,0.9883,33519187
10695,DME,disease,1.0,33519187
10696,bevacizumab,gene,0.892,33519187
10697,ranibizumab,gene,0.8657,33519187
10698,aflibercept,gene,0.9604,33519187
10699,VEGF,gene,0.9106,33511955
10700,Myopic CNV,disease,1.0,33511955
10701,vascular endothelial growth factor,gene,0.9893,33511955
10702,myopic choroidal neovascularization,disease,1.0,33511955
10703,mCNV,disease,1.0,33511955
10704,Myopic CNV,disease,1.0,33511955
10705,pathologic myopia,disease,0.959,33511955
10706,mCNV,disease,1.0,33511955
10707,macular atrophy,disease,1.0,33511955
10708,fibrosis,disease,0.9995,33511955
10709,visual loss,disease,0.999,33511955
10710,anti-,gene,0.639,33511955
10711,vascular endothelial growth factor,gene,0.9224,33511955
10712,VEGF,gene,0.607,33511955
10713,mCNV,disease,0.9995,33511955
10714,mCNV,disease,0.9995,33511955
10715,VEGF,gene,0.781,33511955
10716,diabetic retinal disease,disease,1.0,33509565
10717,aflibercept,gene,0.994,33506176
10718,aflibercept,gene,0.9634,33506176
10719,neovascular age-related macular degeneration,disease,1.0,33506176
10720,AMD,disease,1.0,33506176
10721,patients,species,0.965,33506176
10722,neovascular AMD,disease,1.0,33506176
10723,aflibercept,gene,0.9453,33506176
10724,BCVAs,DNA,0.475,33506176
10725,Diabetic Retinopathy,disease,0.869,33506176
10726,ETDRS,DNA,0.5225,33506176
10727,patients,species,0.9907,33506176
10728,patients,species,0.9663,33506176
10729,aflibercept,gene,0.9863,33506176
10730,patients,species,0.972,33506176
10731,neovascular AMD,disease,1.0,33506176
10732,neovascular AMD,disease,1.0,33506176
10733,VEGF,gene,0.8237,33503815
10734,Diabetic Macular Diabetic macular edema,disease,1.0,33503815
10735,DME,disease,1.0,33503815
10736,visual impairment,disease,1.0,33503815
10737,patients,species,0.9897,33503815
10738,diabetes,disease,1.0,33503815
10739,anti-vascular endothelial growth factor,gene,0.9727,33503815
10740,VEGF,gene,0.998,33503815
10741,patients,species,0.981,33503815
10742,patients,species,0.99,33503815
10743,anti-VEGF,gene,0.9497,33503815
10744,DME,disease,1.0,33503815
10745,patients,species,0.9897,33503815
10746,glycosylated hemoglobin,gene,0.9863,33503815
10747,macular ischemia,disease,1.0,33503815
10748,anti-VEGF,gene,0.941,33503815
10749,PD-1,gene,0.985,33500624
10750,Follicular Lymphoma,disease,1.0,33500624
10751,Follicular lymphoma,disease,1.0,33500624
10752,FL,disease,1.0,33500624
10753,neoplasia,disease,0.9995,33500624
10754,FL,disease,,33500624
10755,patients,species,0.9907,33500624
10756,lymphoma,disease,1.0,33500624
10757,diffuse large B-cell lymphoma,disease,0.9893,33500624
10758,B-cell,cell_type,0.4692,33500624
10759,DLBCL,disease,1.0,33500624
10760,patients,species,0.977,33500624
10761,HT,disease,,33500624
10762,programmed death 1,gene,0.785,33500624
10763,HT,disease,,33500624
10764,PATIENTS,species,0.945,33500624
10765,PD-1,gene,0.995,33500624
10766,tumor,disease,0.981,33500624
10767,FL,disease,,33500624
10768,patients,species,0.9883,33500624
10769,transformed lymphoma,cell_line,0.8076,33500624
10770,lymphoma,disease,0.9326,33500624
10771,FL,disease,,33500624
10772,patients,species,0.979,33500624
10773,HT,disease,,33500624
10774,PD-1,gene,0.99,33500624
10775,FL,cell_type,,33500624
10776,patients,species,0.9907,33500624
10777,HT,disease,,33500624
10778,PD-1,gene,0.9917,33500624
10779,PD-1,gene,0.978,33500624
10780,FL,disease,,33500624
10781,patients,species,0.948,33500624
10782,PD-1,gene,0.9946,33500624
10783,tumor,cell_type,0.4585,33500624
10784,PD-1,gene,0.9736,33500624
10785,DLBCL,disease,0.9995,33500624
10786,FL,disease,,33500624
10787,vascular,DNA,0.579,33500611
10788,vascular endothelial growth factor,gene,0.9966,33500611
10789,VEGF,gene,0.9995,33500611
10790,VEGF,gene,0.789,33500611
10791,neovascular age-related macular degeneration,disease,1.0,33500611
10792,nAMD,disease,1.0,33500611
10793,bevacizumab,gene,0.818,33500611
10794,ranibizumab,gene,0.7407,33500611
10795,aflibercept,gene,0.986,33500611
10796,brolucizumab,gene,0.8677,33500611
10797,VRV,DNA,0.509,33500611
10798,VEGF,gene,0.996,33500611
10799,nAMD,disease,1.0,33500611
10800,nAMD,disease,1.0,33500611
10801,aflibercept,gene,0.992,33499698
10802,diabetic,disease,0.8013,33499698
10803,diabetic retinopathy,disease,1.0,33499698
10804,aflibercept,gene,0.986,33499698
10805,diabetic macular edema,disease,1.0,33499698
10806,hard exudates,disease,0.863,33499698
10807,HEs,disease,0.9424,33499698
10808,retinal microaneurysms,disease,1.0,33499698
10809,MAs,disease,1.0,33499698
10810,patients,species,0.9907,33499698
10811,non-proliferative diabetic retinopathy,disease,1.0,33499698
10812,NPDR,disease,1.0,33499698
10813,patient,species,0.9595,33499698
10814,patients,species,0.9917,33499698
10815,men,species,0.959,33499698
10816,patient,species,0.989,33499698
10817,HEs,disease,0.892,33499698
10818,Diabetic retinopathy,disease,1.0,33499698
10819,aflibercept,gene,0.982,33499698
10820,MAs,cell_type,0.4673,33499698
10821,HEs,cell_type,0.4722,33499698
10822,Polypoidal Choroidal Vasculopathy,disease,1.0,33499644
10823,Faricimab,gene,0.587,33499644
10824,Diabetic Macular Oedema,disease,1.0,33499644
10825,neovascular Age Related Macular Degeneration,disease,1.0,33499644
10826,nAMD,disease,1.0,33499644
10827,Brolucizumab,gene,0.455,33499644
10828,Aflibercept,gene,0.9814,33499644
10829,nAMD,disease,1.0,33499644
10830,Cutaneous Cell-Mediated Delayed Hypersensitivity,disease,1.0,33488016
10831,Bevacizumab,gene,0.4487,33488016
10832,autoimmune reactions,disease,0.9746,33488016
10833,bevacizumab,gene,0.672,33488016
10834,Type-IV delayed hypersensitivity reactions,disease,0.9985,33488016
10835,bevacizumab,gene,0.6113,33488016
10836,subfoveal choroidal melanoma,disease,0.9985,33488016
10837,patient,species,0.9595,33488016
10838,bevacizumab,gene,0.7534,33488016
10839,macular edema,disease,1.0,33488016
10840,retinal detachment,disease,1.0,33488016
10841,radiation retinopathy,disease,0.9946,33488016
10842,patient,species,0.9775,33488016
10843,pruritus,disease,0.9995,33488016
10844,rashes,disease,0.989,33488016
10845,bevacizumab,gene,0.8354,33488016
10846,aflibercept,gene,0.9697,33488016
10847,bevacizumab,gene,0.604,33488016
10848,vascular endothelial growth factor,gene,0.9585,33481151
10849,patients,species,0.9893,33481151
10850,pigment epithelial detachment,disease,1.0,33481151
10851,PED,disease,1.0,33481151
10852,ranibizumab,gene,0.818,33481151
10853,aflibercept,gene,0.96,33481151
10854,patients,species,0.9795,33481151
10855,ranibizumab,gene,0.7983,33481151
10856,aflibercept,gene,0.9497,33481151
10857,patients,species,0.975,33481151
10858,PED,DNA,0.523,33481151
10859,PED,DNA,0.5625,33481151
10860,ranibizumab,drug,0.5244,33481151
10861,aflibercept,gene,0.5244,33481151
10862,aflibercept,gene,0.9585,33481151
10863,PED,DNA,0.508,33481151
10864,PED,DNA,0.5894,33481151
10865,aflibercept,gene,0.988,33481151
10866,aflibercept,gene,0.9683,33481151
10867,aflibercept,gene,0.966,33481151
10868,choroidal neovascularization,disease,0.969,33481151
10869,PED,disease,0.999,33481151
10870,aflibercept,gene,0.954,33481151
10871,Low Luminance Deficit,disease,0.9453,33477954
10872,Proliferative Diabetic,disease,1.0,33477954
10873,proliferative diabetic retinopathy,disease,1.0,33477954
10874,PDR,disease,1.0,33477954
10875,aflibercept,gene,0.9854,33477954
10876,PDR,disease,0.999,33477954
10877,patients,species,0.9937,33477954
10878,aflibercept,gene,0.9814,33477954
10879,PRP,cell_type,0.5547,33477954
10880,PDR,disease,1.0,33477954
10881,Diabetic Retinopathy,disease,0.9995,33477954
10882,ETDRS),DNA,0.764,33477954
10883,aflibercept,gene,0.993,33477954
10884,aflibercept,gene,0.991,33477954
10885,PRP,cell_type,0.552,33477954
10886,PDR,disease,0.999,33477954
10887,aflibercept,gene,0.9893,33474611
10888,polypoidal choroidal PURPOSE,disease,0.9995,33474611
10889,aflibercept,gene,0.981,33474611
10890,AFL,gene,0.6025,33474611
10891,AFL,gene,0.8994,33474611
10892,patients,species,0.955,33474611
10893,polypoidal choroidal vasculopathy,disease,1.0,33474611
10894,PCV,disease,1.0,33474611
10895,PATIENTS,species,0.944,33474611
10896,Patients,species,0.9434,33474611
10897,PCV,disease,1.0,33474611
10898,IVT,drug,0.9688,33474611
10899,patients,species,0.982,33474611
10900,Patients,species,0.946,33474611
10901,patients,species,0.9697,33474611
10902,BCVA,cell_type,0.4038,33474611
10903,patients,species,0.9707,33474611
10904,patients,species,0.961,33474611
10905,patients,species,0.9893,33474611
10906,polyps,disease,1.0,33474611
10907,AFL,drug,0.8623,33474611
10908,AFL,drug,0.82,33474611
10909,AFL,drug,0.9214,33474611
10910,AFL,drug,0.8877,33474611
10911,patients,species,0.978,33474611
10912,AFL,drug,0.984,33474611
10913,patients,species,0.958,33474611
10914,PCV,disease,1.0,33474611
10915,Aflibercept,gene,0.9883,33471564
10916,Ranibizumab,gene,0.8374,33471564
10917,aflibercept,gene,0.985,33471564
10918,patients,species,0.97,33471564
10919,neovascular age-related macular degeneration,disease,1.0,33471564
10920,nAMD,disease,1.0,33471564
10921,patients,species,0.981,33471564
10922,ranibizumab,gene,0.877,33471564
10923,patients,species,0.9834,33471564
10924,aflibercept,gene,0.981,33471564
10925,C-reactive protein,gene,0.995,33471564
10926,CRP,gene,0.9946,33471564
10927,low-density lipoprotein cholesterol,gene,0.9937,33471564
10928,cholesterol,drug,0.9995,33471564
10929,LDL-c,gene,0.998,33471564
10930,high-density lipoprotein cholesterol,gene,0.9873,33471564
10931,cholesterol,drug,0.9995,33471564
10932,HDL,gene,0.996,33471564
10933,uric acid,drug,0.998,33471564
10934,albumin,gene,0.991,33471564
10935,fibrinogen,gene,0.996,33471564
10936,Neutrophil,cell_type,0.755,33471564
10937,lymphocyte,cell_type,0.554,33471564
10938,monocyte,cell_type,0.693,33471564
10939,HDL-c,gene,0.9824,33471564
10940,CRP,gene,0.9966,33471564
10941,albumin,gene,0.996,33471564
10942,monocyte,cell_type,0.7866,33471564
10943,lymphocyte,cell_type,0.4194,33471564
10944,platelet,cell_type,0.741,33471564
10945,lymphocyte,cell_type,0.5854,33471564
10946,CRP,gene,0.992,33471564
10947,LDL-c,gene,0.996,33471564
10948,white blood cell,cell_type,0.8843,33471564
10949,WBC,cell_type,0.7666,33471564
10950,neutrophil,cell_type,0.745,33471564
10951,monocyte,cell_type,0.771,33471564
10952,NLR,cell_type,0.4683,33471564
10953,CAR,DNA,0.651,33471564
10954,IVA,disease,0.9346,33471564
10955,fibrinogen,gene,0.9966,33471564
10956,lymphocyte,cell_type,0.7427,33471564
10957,HDL-c,gene,0.955,33471564
10958,platelet,cell_type,0.592,33471564
10959,VEGF,gene,0.7026,33469129
10960,VEGF,gene,0.8457,33469129
10961,corneal neovascularization,disease,0.9927,33469129
10962,CoNV,disease,1.0,33469129
10963,rabbits,species,0.9775,33469129
10964,CoNV,disease,1.0,33469129
10965,rabbits,species,0.949,33469129
10966,rabbits,species,0.964,33469129
10967,rabbits,species,0.94,33469129
10968,rabbits,species,0.943,33469129
10969,aflibercept,gene,0.994,33469129
10970,rabbits,species,0.9116,33469129
10971,bevacizumab,gene,0.7495,33469129
10972,rabbits,species,0.9077,33469129
10973,aflibercept,gene,0.9927,33469129
10974,CoNV,disease,1.0,33469129
10975,rabbits,species,0.945,33469129
10976,vascular endothelial growth factor (VEGF)-A,gene,0.992,33469129
10977,VEGF-B,gene,0.998,33469129
10978,placental growth factor,gene,0.9985,33469129
10979,PIGF,gene,0.9956,33469129
10980,CoNV,disease,0.759,33469129
10981,CoNV,disease,1.0,33469129
10982,aflibercept,gene,0.9883,33469129
10983,bevacizumab,gene,0.5425,33469129
10984,aflibercept,gene,0.988,33469129
10985,VEGF,gene,0.911,33469129
10986,CoNV,disease,1.0,33469129
10987,VEGF,gene,0.641,33469129
10988,ranibizumab,gene,0.6025,33464022
10989,aflibercept,gene,0.9443,33464022
10990,neovascular age-related macular degeneration,disease,1.0,33464022
10991,ranibizumab,gene,0.9883,33464022
10992,aflibercept,gene,0.9897,33464022
10993,neovascular age-related macular degeneration,disease,1.0,33464022
10994,vascular endothelial growth factor,gene,0.8667,33463594
10995,Aflibercept,gene,0.938,33463593
10996,diabetic macular edema,disease,1.0,33463593
10997,patients,species,0.9756,33463593
10998,diabetic macular edema,disease,1.0,33463593
10999,DME,disease,1.0,33463593
11000,Bevacizumab,gene,0.9297,33463593
11001,Aflibercept,gene,0.9585,33463593
11002,DME,disease,1.0,33463593
11003,Bevacizumab,gene,0.939,33463593
11004,Aflibercept,gene,0.9756,33463593
11005,Bevacizumab,gene,0.9233,33463593
11006,chronic DME,disease,0.961,33463593
11007,DME,disease,1.0,33463593
11008,Aflibercept,gene,0.802,33463593
11009,Bevacizumab,gene,0.6313,33463593
11010,patients,species,0.9937,33463593
11011,Aflibercept,gene,0.956,33463593
11012,Bevacizumab,gene,0.9546,33463593
11013,Aflibercept,gene,0.9463,33463593
11014,Aflibercept,gene,0.9487,33463593
11015,Aflibercept,gene,0.9795,33463593
11016,DME,disease,1.0,33463593
11017,Bevacizumab,gene,0.936,33463593
11018,ranibizumab,gene,0.838,33451290
11019,choroidal neovascularization,disease,0.9917,33451290
11020,patient,species,0.968,33451290
11021,choroidal neovascular membrane,disease,0.995,33451290
11022,CNV,disease,1.0,33451290
11023,ranibizumab,gene,0.5205,33451290
11024,decreased vision,disease,0.995,33451290
11025,Diabetic Retinopathy,disease,0.994,33451290
11026,Macular edema,disease,1.0,33451290
11027,CNV,disease,0.6807,33451290
11028,ranibizumab,gene,0.857,33451290
11029,ranibizumab,gene,0.8223,33451290
11030,intraretinal edema,disease,1.0,33451290
11031,patient,species,0.9873,33451290
11032,aflibercept,gene,0.946,33451290
11033,aflibercept,gene,0.993,33451290
11034,CNV,disease,0.989,33451290
11035,aflibercept,gene,0.9785,33451290
11036,intraretinal edema,disease,1.0,33451290
11037,atrophy,disease,0.999,33451290
11038,Ranibizumab,gene,0.8774,33451290
11039,neovascular age-related macular degeneration,disease,1.0,33451290
11040,ranibizumab,gene,0.7373,33451290
11041,CNV,disease,0.9907,33451290
11042,ranibizumab,gene,0.968,33451290
11043,ranibizumab,gene,0.744,33451290
11044,aflibercept,gene,0.9775,33451290
11045,Aflibercept,gene,0.9355,33447009
11046,Diabetic Macular Edema,disease,1.0,33447009
11047,aflibercept,gene,0.663,33447009
11048,patients,species,0.9746,33447009
11049,diabetic macular edema,disease,1.0,33447009
11050,DME,disease,1.0,33447009
11051,patients,species,0.9927,33447009
11052,bevacizumab,gene,0.8286,33447009
11053,IVA,RNA,0.474,33447009
11054,IVA,disease,1.0,33447009
11055,vascular endothelial growth factor,gene,0.8813,33438364
11056,VEGF,gene,0.9976,33438364
11057,neovascular age-related macular degeneration,disease,1.0,33438364
11058,nAMD,disease,1.0,33438364
11059,nAMD,disease,1.0,33438364
11060,patients,species,0.993,33438364
11061,VEGF,gene,0.891,33438364
11062,patients,species,0.983,33438364
11063,ranibizumab,gene,0.73,33438364
11064,bevacizumab,gene,0.89,33438364
11065,aflibercept,gene,0.9585,33438364
11066,VEGF,gene,0.9,33438364
11067,cardiocerebral vascular adverse,disease,0.838,33438364
11068,ranibizumab,gene,0.7246,33438364
11069,bevacizumab,gene,0.7207,33438364
11070,aflibercept,gene,0.8564,33438364
11071,Ziv-aflibercept,gene,0.985,33437603
11072,bevacizumab,gene,0.5137,33437603
11073,exudative age-related macular degeneration,disease,0.985,33437603
11074,ziv-aflibercept,gene,0.9937,33437603
11075,patients,species,0.9707,33437603
11076,exudative age-related macular degeneration,disease,1.0,33437603
11077,eAMD,disease,1.0,33437603
11078,Patients,species,0.959,33437603
11079,IVZ,drug,0.9473,33437603
11080,patients,species,0.9775,33437603
11081,patients,species,0.9834,33437603
11082,IVZ,cell_line,0.5186,33437603
11083,IVB,cell_line,0.5356,33437603
11084,IVZ,drug,0.95,33437603
11085,IVB,drug,0.9775,33437603
11086,IVZ,drug,0.9517,33437603
11087,IVB,drug,0.9697,33437603
11088,Endophthalmitis,disease,1.0,33425413
11089,Retinopathy of Prematurity,disease,1.0,33425413
11090,Aflibercept,gene,0.982,33425413
11091,infant,species,0.898,33425413
11092,anti-VEGF,gene,0.9966,33425413
11093,aflibercept,gene,0.9956,33425413
11094,retinopathy of prematurity,disease,1.0,33425413
11095,endophthalmitis,disease,1.0,33425413
11096,retinal lesion,disease,0.961,33425413
11097,Retinal Features,DNA,0.565,33422464
11098,Age-Related Macular,disease,0.9995,33422464
11099,neovascular and atrophic age-related macular degeneration,disease,1.0,33422464
11100,AMD,disease,1.0,33422464
11101,patients,species,0.9883,33422464
11102,neovascular AMD,disease,1.0,33422464
11103,human,species,0.9556,33422464
11104,zebrafish,species,0.9507,33421732
11105,diabetic retinopathy,disease,1.0,33421732
11106,zebrafish,species,0.932,33421732
11107,diabetic retinopathy,disease,1.0,33421732
11108,aflibercept,gene,0.955,33421732
11109,diabetic retinopathy,disease,1.0,33421732
11110,glucose,drug,0.994,33421732
11111,glucose,drug,0.9985,33421732
11112,zebrafish,species,0.9927,33421732
11113,at aflibercept,gene,0.975,33421732
11114,Aflibercept,gene,0.959,33421732
11115,zebrafish,species,0.9634,33421732
11116,diabetic retinopathy,disease,1.0,33421732
11117,diabetic retinopathy,disease,1.0,33421732
11118,hyperglycemia,disease,1.0,33421732
11119,inflammation,disease,0.845,33421732
11120,aflibercept,gene,0.9893,33421732
11121,zebrafish,species,0.9824,33421732
11122,zebrafish,species,0.927,33421732
11123,diabetic retinopathy,disease,1.0,33421732
11124,aflibercept,gene,0.986,33421732
11125,diabetic retinopathy,disease,1.0,33421732
11126,bevacizumab,gene,0.7397,33421321
11127,aflibercept,gene,0.947,33421321
11128,neovascular age-related macular degeneration,disease,1.0,33421321
11129,bevacizumab,gene,0.903,33421321
11130,aflibercept,gene,0.8867,33421321
11131,Diabetic Retinopathy,disease,0.883,33421321
11132,ETDRS,DNA,0.4348,33421321
11133,bevacizumab,gene,0.921,33421321
11134,aflibercept,gene,0.99,33421321
11135,Patients,species,0.9736,33419853
11136,FOLFIRI,drug,0.787,33419853
11137,bevacizumab,gene,0.682,33419853
11138,Bmab,gene,0.852,33419853
11139,aflibercept,gene,0.9937,33419853
11140,AFL,gene,0.9966,33419853
11141,patients,species,0.9746,33419853
11142,metastatic colorectal cancer,disease,0.9995,33419853
11143,mCRC,disease,1.0,33419853
11144,PATIENTS,species,0.933,33419853
11145,patients,species,0.9795,33419853
11146,mCRC,disease,0.9834,33419853
11147,FOLFIRI,drug,0.923,33419853
11148,Bmab,drug,0.6206,33419853
11149,AFL,drug,0.967,33419853
11150,patients,species,0.983,33419853
11151,Bmab,gene,0.64,33419853
11152,AFL,disease,0.8213,33419853
11153,AFL,gene,0.7583,33419853
11154,Bmab,gene,0.6675,33419853
11155,AFL,drug,0.8926,33419853
11156,diarrhea,disease,1.0,33419853
11157,proteinuria,disease,1.0,33419853
11158,patients,species,0.95,33419853
11159,FOLFIRI,drug,0.6333,33419853
11160,mCRC,disease,0.9746,33419853
11161,AFL,gene,0.841,33419853
11162,Bmab,gene,0.6753,33419853
11163,aflibercept,gene,0.9634,33417914
11164,proliferative vitreoretinopathy,disease,1.0,33417914
11165,proliferative vitreoretinopathy,disease,1.0,33417914
11166,PVR,disease,0.997,33417914
11167,aflibercept,gene,0.815,33417914
11168,dispase,gene,0.977,33417914
11169,PVR,disease,1.0,33417914
11170,rat,species,0.969,33417914
11171,rats,species,0.6934,33417914
11172,PVR,DNA,0.5166,33417914
11173,dispase,gene,0.7837,33417914
11174,PVR,DNA,0.5034,33417914
11175,aflibercept,gene,0.985,33417914
11176,dispase,gene,0.9946,33417914
11177,aflibercept,gene,0.9956,33417914
11178,PVR,disease,0.977,33417914
11179,dispase,gene,0.5854,33417914
11180,aflibercept,gene,0.9946,33417914
11181,aflibercept,gene,0.9897,33417914
11182,aflibercept,gene,0.9976,33417914
11183,aflibercept,gene,0.995,33417914
11184,ENO1,gene,0.9976,33417914
11185,ENO2,gene,0.9966,33417914
11186,LDH-B,gene,0.9946,33417914
11187,PEBP-1,gene,0.9966,33417914
11188,GS,gene,,33417914
11189,PVR,disease,0.9404,33417914
11190,UCHL,gene,0.991,33417914
11191,PEBP1,gene,0.987,33417914
11192,PDHB,gene,0.99,33417914
11193,ENO1,gene,0.996,33417914
11194,PVR,gene,0.9956,33417914
11195,carbon,drug,0.9995,33417914
11196,nucleotide,drug,0.997,33417914
11197,inflammation,disease,0.999,33417914
11198,gliosis,disease,1.0,33417914
11199,retinal damage,disease,0.999,33417914
11200,PVR,disease,1.0,33417914
11201,Aflibercept,gene,0.9624,33417914
11202,inflammation,disease,0.8906,33417914
11203,retinal damage,disease,0.843,33417914
11204,gliosis,disease,1.0,33417914
11205,aflibercept,gene,0.9727,33417914
11206,PVR,disease,0.9956,33417914
11207,aflibercept,gene,0.9775,33417914
11208,VALS,disease,1.0,33415354
11209,macular edema,disease,1.0,33415354
11210,central or hemiretinal vein occlusion,disease,1.0,33415354
11211,aflibercept,gene,0.978,33415354
11212,participants,species,0.9775,33415354
11213,VALS,disease,1.0,33415354
11214,aflibercept,gene,0.993,33415354
11215,bevacizumab,gene,0.8955,33415354
11216,CPT,drug,0.9346,33415354
11217,CPT,drug,0.8906,33415354
11218,bevacizumab,gene,0.902,33415354
11219,VALS,disease,1.0,33415354
11220,aflibercept,gene,0.9956,33415354
11221,bevacizumab,gene,0.879,33415354
11222,CPT,drug,0.5073,33415354
11223,aflibercept,gene,0.8394,33415354
11224,bevacizumab,gene,0.6484,33415354
11225,aflibercept,gene,0.9824,33415354
11226,bevacizumab,gene,0.6426,33415354
11227,aflibercept,gene,0.987,33415354
11228,bevacizumab,gene,0.5747,33415354
11229,CPT,drug,0.869,33415354
11230,aflibercept,gene,0.997,33415354
11231,bevacizumab,gene,0.9653,33415354
11232,VALS,disease,0.999,33415354
11233,CPT,DNA,0.5127,33415354
11234,VEGF,gene,0.8423,33415353
11235,wet AMD,disease,0.9985,33415353
11236,ranibizumab,gene,0.898,33415353
11237,aflibercept,gene,0.9814,33415353
11238,age-related macular degeneration,disease,1.0,33415353
11239,AMD,disease,1.0,33415353
11240,VEGF,gene,0.5625,33415353
11241,patient,species,0.9814,33415353
11242,anti-VEGF,gene,0.8574,33415353
11243,pigment epithelial detachment,disease,1.0,33415353
11244,ranibizumab,gene,0.9565,33415353
11245,aflibercept,gene,0.9795,33415353
11246,ranibizumab,gene,0.6484,33415353
11247,aflibercept,gene,0.973,33415353
11248,anti-VEGF,gene,0.764,33415353
11249,ranibizumab,gene,0.8403,33415353
11250,endothelial growth factor,gene,0.9927,33411472
11251,wet age-related macular degeneration,disease,0.998,33411472
11252,patients,species,0.992,33411472
11253,age-related macular degeneration,disease,0.9985,33411472
11254,patients,species,0.9917,33411472
11255,ranibizumab,gene,0.6685,33411472
11256,aflibercept,gene,0.986,33411472
11257,retinal exudation,disease,0.999,33411472
11258,intraretinal,disease,0.722,33411472
11259,patients,species,0.984,33411472
11260,men,species,0.9565,33411472
11261,Patients,species,0.9707,33411472
11262,choroidal neovascular membranes,disease,1.0,33411472
11263,choroidal neovascular membranes,disease,0.9976,33411472
11264,aflibercept,gene,0.989,33411472
11265,patients,species,0.986,33411472
11266,wet age-related macular degeneration,disease,1.0,33411472
11267,choroidal neovascular membrane,disease,0.8623,33411472
11268,antivascular endothelial growth factor,gene,0.899,33411472
11269,geographic atrophy,disease,1.0,33411472
11270,Cancer,disease,0.9995,33392444
11271,cancer,disease,1.0,33392444
11272,hypertension,disease,0.9487,33392444
11273,bevacizumab,gene,0.8604,33392444
11274,axitinib,drug,0.998,33392444
11275,cediranib,drug,0.998,33392444
11276,pazopanib,drug,0.999,33392444
11277,sorafenib,drug,0.9995,33392444
11278,sunitinib,drug,0.999,33392444
11279,vandetanib,drug,0.9985,33392444
11280,aflibercept,gene,0.9854,33392444
11281,hypertension,disease,0.963,33392444
11282,nintedanib,drug,0.999,33392444
11283,arterial thromboembolism,disease,1.0,33392444
11284,bevacizumab,gene,0.9014,33392444
11285,abiraterone,drug,0.5513,33392444
11286,arterial thromboembolism,disease,1.0,33392444
11287,trastuzumab,gene,0.8374,33392444
11288,arterial thromboembolism,disease,1.0,33392444
11289,sorafenib,drug,0.9995,33392444
11290,tamoxifen,drug,1.0,33392444
11291,venous thromboembolism,disease,1.0,33392444
11292,VTE,disease,1.0,33392444
11293,lenalidomide,drug,0.9995,33392444
11294,thalidomide,drug,0.9995,33392444
11295,VTE,disease,0.9014,33392444
11296,cetuximab,gene,0.9536,33392444
11297,panitumumab,gene,0.9565,33392444
11298,VTE,disease,0.7246,33392444
11299,bevacizumab,gene,0.891,33392444
11300,congestive heart failure,disease,0.9946,33392444
11301,bevacizumab,gene,0.761,33392444
11302,trastuzumab,gene,0.9727,33392444
11303,congestive heart failure,disease,1.0,33392444
11304,pazopanib,drug,0.9985,33392444
11305,sunitinib,drug,0.999,33392444
11306,vandetanib,drug,0.998,33392444
11307,patients,species,0.9785,33392444
11308,proteinuria,disease,0.999,33391740
11309,vascular endothelial growth factor,gene,0.9966,33391740
11310,VEGF,gene,0.9976,33391740
11311,hypertension,disease,1.0,33391740
11312,proteinuria,disease,1.0,33391740
11313,glomerular diseases,disease,1.0,33391740
11314,ophthalmic diseases,disease,0.9927,33391740
11315,proliferative diabetic retinopathy,disease,1.0,33391740
11316,diabetic macular edema,disease,1.0,33391740
11317,central retinal vein occlusion,disease,1.0,33391740
11318,age-related macular degeneration,disease,1.0,33391740
11319,VEGF,gene,0.6484,33391740
11320,VEGF,gene,0.9937,33391740
11321,VEGF,gene,0.9917,33391740
11322,proteinuria,disease,0.9995,33391740
11323,chronic kidney disease,disease,1.0,33391740
11324,patients,species,0.9854,33391740
11325,patient,species,0.9824,33391740
11326,diabetic nephropathy,disease,1.0,33391740
11327,focal and segmental glomerulosclerosis,disease,1.0,33391740
11328,FSGS,disease,1.0,33391740
11329,acute interstitial nephritis,disease,1.0,33391740
11330,AIN,disease,1.0,33391740
11331,patient,species,0.989,33391740
11332,AIN,disease,0.9995,33391740
11333,diabetic glomerulosclerosis,disease,1.0,33391740
11334,patient,species,0.908,33391740
11335,segmental glomerulosclerosis,disease,0.999,33391740
11336,VEGF,gene,0.982,33391740
11337,FSGS,disease,1.0,33391740
11338,AIN,disease,1.0,33391740
11339,VEGF,gene,0.9897,33391740
11340,VEGF,gene,0.9683,33391740
11341,VEGF,gene,0.9717,33391740
11342,pathological disorders,disease,0.7456,33391740
11343,Aflibercept,gene,0.9854,33391442
11344,FOLFIRI,drug,0.993,33391442
11345,fluorouracil,drug,1.0,33391442
11346,Aflibercept,gene,0.9844,33391442
11347,fluorouracil,drug,1.0,33391442
11348,leucovorin,drug,0.9985,33391442
11349,irinotecan,drug,0.9985,33391442
11350,FOLFIRI,drug,0.9976,33391442
11351,metastatic colorectal cancer,disease,0.8643,33391442
11352,CRC,disease,1.0,33391442
11353,Patients,species,0.856,33391442
11354,patients,species,0.957,33391442
11355,aflibercept,gene,0.949,33391442
11356,FOLFIRI,drug,0.947,33391442
11357,metastatic CRC,disease,0.9985,33391442
11358,Patient,species,0.988,33391442
11359,patients,species,0.944,33391442
11360,bevacizumab,gene,0.892,33391442
11361,fluorouracil,drug,0.9995,33391442
11362,leucovorin,drug,0.999,33391442
11363,oxaliplatin,drug,0.9995,33391442
11364,FOLFOX,drug,0.9526,33391442
11365,patients,species,0.954,33391442
11366,aflibercept,gene,0.9897,33391442
11367,FOLFIRI,drug,0.6055,33391442
11368,patients,species,0.9736,33391442
11369,CEA,gene,0.993,33391442
11370,RAS,gene,0.9956,33391442
11371,RAF,gene,0.9985,33391442
11372,aflibercept,gene,0.982,33391442
11373,FOLFIRI,drug,0.9854,33391442
11374,patients,species,0.98,33391442
11375,aflibercept,gene,0.93,33391442
11376,FOLFIRI,drug,0.9673,33391442
11377,REtinal Vein Occlusion,disease,0.9995,33373715
11378,PARTICIPANTS,species,0.866,33373715
11379,participants,species,0.9854,33373715
11380,macular edema,disease,1.0,33373715
11381,central retinal (CRVO,disease,0.994,33373715
11382,hemiretinal vein occlusion,disease,0.976,33373715
11383,HRVO,disease,1.0,33373715
11384,vitreoretinal interface abnormalities,disease,0.998,33373715
11385,RVO,disease,1.0,33373715
11386,patients,species,0.9673,33373715
11387,RVO,disease,1.0,33373715
11388,neovascular Age-related Macular Degeneration,disease,1.0,33354933
11389,neovascular age-related macular degeneration,disease,0.9995,33354933
11390,nAMD,disease,1.0,33354933
11391,bevacizumab,gene,0.597,33354933
11392,aflibercept,gene,0.893,33354933
11393,Retinal Blindness,disease,1.0,33354933
11394,VEGF,gene,0.545,33354933
11395,nAMD,disease,1.0,33354933
11396,VEGF,gene,0.7637,33354933
11397,nAMD,disease,1.0,33354933
11398,aflibercept,gene,0.9453,33354933
11399,hypertension,disease,1.0,33347731
11400,neutropenia,disease,1.0,33347731
11401,vascular endothelial growth factor,gene,0.9985,33347731
11402,VEGF,gene,0.997,33347731
11403,RAM,drug,0.9897,33347731
11404,aflibercept,gene,0.9893,33347731
11405,AFL,gene,0.9956,33347731
11406,metastatic colorectal cancer,disease,1.0,33347731
11407,mCRC,disease,1.0,33347731
11408,patients,species,0.9883,33347731
11409,epidermal growth,DNA,0.4712,33347731
11410,epidermal growth factor receptor,gene,0.9985,33347731
11411,VEGF,gene,0.9937,33347731
11412,mCRC,disease,0.985,33347731
11413,patients,species,0.9917,33347731
11414,patients,species,0.9893,33347731
11415,FOLFIRI,drug,0.9707,33347731
11416,BEV,drug,0.998,33347731
11417,RAM,drug,0.9985,33347731
11418,AFL,drug,0.994,33347731
11419,FOLFIRI,drug,0.96,33347731
11420,AFL,drug,0.9907,33347731
11421,Patients,species,0.957,33347731
11422,hypertension,disease,0.999,33347731
11423,neutropenia,disease,1.0,33347731
11424,VEGF,gene,0.993,33347731
11425,patients,species,0.991,33347731
11426,patients,species,0.9897,33347731
11427,BEV,drug,0.964,33347731
11428,mCRC,disease,0.999,33347731
11429,patients,species,0.9766,33347731
11430,VEGF,gene,0.995,33347731
11431,Choroidal Neovascularization,disease,1.0,33345998
11432,RUNX1,gene,0.9893,33345998
11433,Choroidal neovascularization,disease,1.0,33345998
11434,CNV,disease,1.0,33345998
11435,vision loss,disease,0.99,33345998
11436,patients,species,0.9263,33345998
11437,age-related macular degeneration,disease,1.0,33345998
11438,Runt-related transcription factor 1,gene,0.9985,33345998
11439,RUNX1,gene,0.996,33345998
11440,diabetic retinopathy,disease,0.999,33345998
11441,oxygen,drug,1.0,33345998
11442,CNV,DNA,0.5757,33345998
11443,RUNX1,gene,0.9956,33345998
11444,CNV,disease,0.9995,33345998
11445,mice,species,0.979,33345998
11446,Ro5-3335,drug,0.9995,33345998
11447,RUNX1,gene,0.988,33345998
11448,CNV,disease,1.0,33345998
11449,RUNX1,gene,0.9917,33345998
11450,Ro5-3335,drug,0.999,33345998
11451,aflibercept,gene,0.913,33345998
11452,vascular endothelial growth factor,gene,0.999,33345998
11453,VEGF,gene,0.9976,33345998
11454,CNV,disease,1.0,33345998
11455,isolectin B4,gene,0.9844,33345998
11456,fluorescein,drug,0.9897,33345998
11457,Ro5-3335,drug,0.9995,33345998
11458,CNV,disease,0.8853,33345998
11459,aflibercept,gene,0.9717,33345998
11460,aflibercept,gene,0.9414,33345998
11461,RUNX1,gene,0.9956,33345998
11462,VEGF,gene,0.9604,33345998
11463,patients,species,0.9463,33345998
11464,macular degeneration,disease,1.0,33345998
11465,Diabetic Macular Edema,disease,1.0,33339050
11466,Aflibercept,gene,0.827,33339050
11467,aflibercept,gene,0.9272,33339050
11468,ranibizumab,gene,0.5264,33339050
11469,diabetic macular edema,disease,1.0,33339050
11470,DME,disease,1.0,33339050
11471,PATIENTS,species,0.974,33339050
11472,DME,disease,1.0,33339050
11473,macular edema,disease,1.0,33339050
11474,DME,disease,1.0,33339050
11475,aflibercept,gene,0.905,33339050
11476,ranibizumab,gene,0.667,33339050
11477,endophthalmitis,disease,1.0,33335269
11478,VEGF,gene,0.9653,33335269
11479,anti-vascular endothelial growth factor,gene,0.962,33335269
11480,VEGF,gene,0.9937,33335269
11481,retinal diseases,disease,1.0,33335269
11482,endophthalmitis,disease,1.0,33335269
11483,endophthalmitis,disease,1.0,33335269
11484,patients,species,0.9805,33335269
11485,VEGF,gene,0.5234,33335269
11486,endophthalmitis,disease,1.0,33335269
11487,endophthalmitis,disease,1.0,33335269
11488,aflibercept,gene,0.9907,33335269
11489,patients,species,0.993,33335269
11490,endophthalmitis,disease,1.0,33335269
11491,TGF- Serum,gene,0.894,33334029
11492,Diabetic Retinopathy,disease,1.0,33334029
11493,Patients,species,0.99,33334029
11494,Anti-VEGF,gene,0.9673,33334029
11495,Transforming growth factor 1,gene,0.9946,33334029
11496,TGF1,gene,0.998,33334029
11497,diabetic retinopathy,disease,1.0,33334029
11498,DR,disease,1.0,33334029
11499,serum TGF1,gene,0.5806,33334029
11500,diabetic,disease,1.0,33334029
11501,DR,disease,,33334029
11502,non-proliferative diabetic retinopathy,disease,1.0,33334029
11503,NPDR,disease,1.0,33334029
11504,NPDR,disease,1.0,33334029
11505,aflibercept,gene,0.99,33334029
11506,proliferative diabetic retinopathy,disease,1.0,33334029
11507,PDR,disease,1.0,33334029
11508,PDR,disease,1.0,33334029
11509,aflibercept,gene,0.983,33334029
11510,vascular endothelial growth factor A,gene,0.9976,33334029
11511,VEGF-A,gene,0.997,33334029
11512,placental growth factor,gene,0.9985,33334029
11513,PlGF,gene,0.9956,33334029
11514,TGF1,gene,0.9985,33334029
11515,VEGF-A,gene,0.991,33334029
11516,NPDR,disease,0.8564,33334029
11517,PDR,disease,0.9575,33334029
11518,patients,species,0.9893,33334029
11519,aflibercept,gene,0.952,33334029
11520,nave DR,disease,0.9185,33334029
11521,patients,species,0.9927,33334029
11522,PlGF,gene,0.989,33334029
11523,aflibercept,gene,0.9507,33334029
11524,NPDR,disease,1.0,33334029
11525,patients,species,0.9917,33334029
11526,TGF1,gene,0.9985,33334029
11527,PDR,disease,0.8867,33334029
11528,glycated hemoglobin,gene,0.966,33334029
11529,HbA1c,gene,0.998,33334029
11530,TGF1,gene,0.8857,33334029
11531,diabetes,disease,1.0,33334029
11532,TGF1,gene,0.9985,33334029
11533,diabetic retinopathy,disease,1.0,33334029
11534,Vascular Endothelial Growth Factor Receptor,gene,0.998,33333800
11535,Vascular endothelial growth factors,gene,0.9985,33333800
11536,VEGFs,gene,0.9966,33333800
11537,cells,cell_type,0.3442,33333800
11538,VEGF,DNA,0.5103,33333800
11539,VEGF-A family member,gene,0.9463,33333800
11540,tumour,disease,1.0,33333800
11541,VEGF-A,gene,0.9976,33333800
11542,VEGF-A,gene,0.988,33333800
11543,VEGF receptor tyrosine kinases,gene,0.9937,33333800
11544,tyrosine,drug,0.9116,33333800
11545,VEGFR1,gene,0.993,33333800
11546,VEGFR2,gene,0.9897,33333800
11547,neuropilin-1,gene,0.989,33333800
11548,neuropilin-2,gene,0.9966,33333800
11549,NRP1,gene,0.998,33333800
11550,NRP2,gene,0.9976,33333800
11551,VEGF,gene,0.996,33333800
11552,VEGFR,gene,0.993,33333800
11553,VEGF,gene,0.9976,33333800
11554,VEGFR,gene,0.995,33333800
11555,tyrosine,drug,0.9614,33333800
11556,tyrosine kinase,gene,0.687,33333800
11557,VEGFR,gene,0.991,33333800
11558,VEGF,gene,0.9966,33333800
11559,VEGFR,gene,0.9844,33333800
11560,Brolucizumab,gene,0.6973,33332477
11561,wet,disease,0.9043,33332477
11562,age-related maculopathy,disease,0.939,33332477
11563,vascular endothelial growth factor,gene,0.866,33332477
11564,VEGF,gene,0.9985,33332477
11565,VEGF,gene,0.7876,33332477
11566,patient,species,0.982,33332477
11567,anti-VEGF,gene,0.9976,33332477
11568,brolucizumab,gene,0.7524,33332477
11569,26-kDa IgG single-chain antibody fragment,gene,0.976,33332477
11570,anti-VEGF,gene,0.9956,33332477
11571,aflibercept,gene,0.988,33332477
11572,Brolucizumab,gene,0.7285,33332477
11573,age-related macular degeneration,disease,1.0,33332477
11574,brolucizumab,gene,0.825,33332477
11575,anti-VEGF,gene,0.798,33332477
11576,brolucizumab,gene,0.844,33332477
11577,brolucizumab,gene,0.8022,33332477
11578,Anti-Vascular Endothelial Growth Factor,gene,0.964,33331873
11579,antivascular endothelial growth factors,gene,0.897,33331873
11580,Aflibercept,gene,0.982,33330959
11581,Patients,species,0.9424,33330959
11582,Neovascular glaucoma,disease,1.0,33330959
11583,neovascularization,disease,0.757,33330959
11584,vascular endothelial growth factor,gene,0.9053,33330959
11585,aflibercept,gene,0.989,33330959
11586,AFL,gene,0.6255,33330959
11587,patients,species,0.9106,33330959
11588,neovascular glaucoma,disease,1.0,33330959
11589,patients,species,0.935,33330959
11590,anterior segment neovascularization,disease,1.0,33330959
11591,Patients,species,0.949,33330959
11592,patients,species,0.981,33330959
11593,patients,species,0.975,33330959
11594,patients,species,0.983,33330959
11595,patients,species,0.969,33330959
11596,patients,species,0.9863,33330959
11597,patients,species,0.9795,33330959
11598,eye pain,disease,0.9917,33330959
11599,patients,species,0.985,33330959
11600,PRP,cell_type,0.637,33330959
11601,IVT-AFL,drug,0.843,33330959
11602,patients,species,0.9463,33330959
11603,neovascular glaucoma,disease,1.0,33330959
11604,Aflibercept,gene,0.9824,33330958
11605,Patients,species,0.9736,33330958
11606,Neovascular Glaucoma,disease,1.0,33330958
11607,Neovascular glaucoma,disease,1.0,33330958
11608,vascular endothelial growth factor,gene,0.887,33330958
11609,aflibercept,gene,0.9917,33330958
11610,AFL,gene,0.686,33330958
11611,patients,species,0.9487,33330958
11612,neovascular glaucoma,disease,1.0,33330958
11613,patients,species,0.9556,33330958
11614,anterior segment neovascularization,disease,1.0,33330958
11615,Patients,species,0.9565,33330958
11616,Patients,species,0.945,33330958
11617,patients,species,0.987,33330958
11618,patients,species,0.989,33330958
11619,AFL,drug,0.773,33330958
11620,patients,species,0.9575,33330958
11621,Patients,species,0.916,33330958
11622,patients,species,0.98,33330958
11623,patients,species,0.974,33330958
11624,punctate keratitis,disease,1.0,33330958
11625,AFL,disease,0.98,33330958
11626,AFL,disease,0.99,33330958
11627,patients,species,0.9165,33330958
11628,glaucoma,disease,1.0,33330958
11629,aflibercept,gene,0.968,33328488
11630,aflibercept,gene,0.9727,33328488
11631,diabetic macular oedema,disease,1.0,33328488
11632,DME,disease,1.0,33328488
11633,patients,species,0.9634,33328488
11634,DME,disease,1.0,33328488
11635,visual impairment,disease,0.9927,33328488
11636,patients,species,0.986,33328488
11637,aflibercept,gene,0.979,33328488
11638,diabetic retinopathy,disease,1.0,33328488
11639,patients,species,0.9863,33328488
11640,aflibercept,gene,0.954,33328488
11641,DME,disease,0.9995,33328488
11642,oedema,disease,0.9775,33326191
11643,vascular endothelial growth factor,gene,0.89,33326191
11644,diabetic macular oedema,disease,1.0,33326191
11645,DMO,disease,1.0,33326191
11646,Patients,species,0.97,33326191
11647,DMO,disease,1.0,33326191
11648,residual oedema,disease,0.9995,33326191
11649,oedema,disease,0.5244,33326191
11650,aflibercept,gene,0.983,33326191
11651,ranibizumab,gene,0.866,33326191
11652,RO,disease,,33326191
11653,CRT,DNA,0.505,33326191
11654,oedema,disease,1.0,33326191
11655,oedema,disease,1.0,33326191
11656,RO,disease,,33326191
11657,DMO,disease,1.0,33326191
11658,aflibercept,gene,0.9634,33326191
11659,ranibizumab,gene,0.923,33326191
11660,anti-vascular endothelial growth factors,gene,0.925,33326183
11661,vascular endothelial growth factor,gene,0.9277,33326183
11662,VEGF,gene,0.997,33326183
11663,proliferative diabetic retinopathy,disease,1.0,33326183
11664,anti,gene,0.5835,33326183
11665,patients,species,0.994,33326183
11666,diabetic macular oedema,disease,1.0,33326183
11667,DME,disease,1.0,33326183
11668,vitreous haemorrhage,disease,1.0,33326183
11669,anti-VEGF,gene,0.9775,33326183
11670,PRP,cell_type,0.5933,33326183
11671,-VEGF,gene,0.873,33326183
11672,PRP,cell_type,0.8086,33326183
11673,PRP,cell_type,0.8213,33326183
11674,anti-VEGF,gene,0.925,33326183
11675,PRP,cell_type,0.6685,33326183
11676,anti-VEGF,gene,0.9653,33326183
11677,PRP,cell_type,0.6836,33326183
11678,patients,species,0.9863,33326183
11679,DME,disease,0.9995,33326183
11680,PRP,cell_type,0.7085,33326183
11681,PRP,cell_type,0.7427,33326183
11682,anti-VEGF,gene,0.739,33326183
11683,VEGF,gene,0.734,33326183
11684,PRP,cell_type,0.666,33326183
11685,angiopoietin-2,gene,0.99,33326179
11686,aflibercept,gene,0.986,33326179
11687,aflibercept,gene,0.981,33326179
11688,angiopoietin-2,gene,0.985,33326179
11689,Ang2,gene,0.9966,33326179
11690,vascular endothelial growth factor (VEGF)-A,gene,0.996,33326179
11691,patients,species,0.9756,33326179
11692,neovascular age-related macular degeneration,disease,1.0,33326179
11693,nAMD,disease,1.0,33326179
11694,aflibercept,gene,0.989,33326179
11695,ranibizumab,gene,0.8325,33326179
11696,patients,species,0.9834,33326179
11697,Ang2,gene,0.99,33326179
11698,VEGF,RNA,0.4758,33326179
11699,VEGF-A,gene,0.996,33326179
11700,aflibercept,gene,0.9854,33326179
11701,Ang2,gene,0.8955,33326179
11702,VEGF-A,gene,0.99,33326179
11703,aflibercept,gene,0.9907,33326179
11704,VEGF-A,gene,0.997,33326179
11705,Ang2,gene,0.9897,33326179
11706,Ang2,gene,0.994,33326179
11707,aflibercept,gene,0.9883,33326179
11708,Aflibercept,gene,0.962,33320223
11709,Vitreous hemorrhage,disease,0.9995,33320223
11710,proliferative diabetic retinopathy,disease,1.0,33320223
11711,loss of vision,disease,0.995,33320223
11712,aflibercept,gene,0.907,33320223
11713,vitreous hemorrhage,disease,0.9995,33320223
11714,proliferative diabetic retinopathy,disease,1.0,33320223
11715,PARTICIPANTS,species,0.5913,33320223
11716,vison loss due to vitreous hemorrhage,disease,0.9595,33320223
11717,proliferative diabetic retinopathy,disease,0.9995,33320223
11718,participant,species,0.955,33320223
11719,aflibercept,gene,0.934,33320223
11720,participants,species,0.9614,33320223
11721,participants,species,0.9736,33320223
11722,Participants,species,0.9688,33320223
11723,aflibercept,gene,0.9336,33320223
11724,aflibercept,gene,0.973,33320223
11725,participants,species,0.988,33320223
11726,men,species,0.899,33320223
11727,aflibercept,gene,0.988,33320223
11728,aflibercept,gene,0.993,33320223
11729,aflibercept,gene,0.9556,33320223
11730,aflibercept,gene,0.9736,33320223
11731,participants,species,0.9673,33320223
11732,vitreous hemorrhage,disease,1.0,33320223
11733,proliferative diabetic retinopathy,disease,1.0,33320223
11734,aflibercept,gene,0.916,33320223
11735,VEGF,gene,0.914,33320207
11736,Vitreous Hemorrhage,disease,1.0,33320207
11737,Retinal Diseases,disease,0.9995,33309691
11738,vascular endothelial growth factor,gene,0.8755,33309691
11739,retinal diseases,disease,0.9985,33309691
11740,Razumab,gene,0.574,33309691
11741,retinal,disease,0.669,33309691
11742,bevacizumab,gene,0.8877,33309691
11743,idiopathic macular telangiectasia type 1,disease,1.0,33309502
11744,Idiopathic macular telangiectasia type 1,disease,1.0,33309502
11745,MacTel 1,disease,1.0,33309502
11746,man,species,0.9253,33309502
11747,MacTel 1,disease,1.0,33309502
11748,macular telangectasia type 2,disease,1.0,33309502
11749,MacTel 2,disease,1.0,33309502
11750,patient,species,0.988,33309502
11751,cystoid macular edema,disease,1.0,33309502
11752,CME,disease,1.0,33309502
11753,dexamethasone,drug,0.981,33309502
11754,aflibercept,gene,0.9844,33309502
11755,Retinal arterial macroaneurysm,disease,1.0,33309178
11756,anti-Vascular Endothelial Growth Factor,gene,0.8696,33309178
11757,Aflibercept,gene,0.9385,33307629
11758,Polypoidal Choroidal Vasculopathy,disease,1.0,33307629
11759,aflibercept,gene,0.995,33307629
11760,polypoidal choroidal vasculopathy,disease,1.0,33307629
11761,PCV,disease,1.0,33307629
11762,patients,species,0.985,33307629
11763,PCV,disease,1.0,33307629
11764,Patients,species,0.974,33307629
11765,aflibercept,gene,0.987,33307629
11766,Patients,species,0.9717,33307629
11767,pigment,cell_type,0.498,33307629
11768,pigment epithelial detachment,disease,0.987,33307629
11769,BCVA,cell_type,0.416,33307629
11770,Pigment epithelial detachment,disease,0.9917,33307629
11771,Subretinal fluid,disease,0.913,33307629
11772,PCV,disease,1.0,33307629
11773,aflibercept,gene,0.9834,33307629
11774,vascular endothelial,DNA,0.551,33303990
11775,vascular endothelial growth factor,gene,0.9985,33303990
11776,aflibercept,gene,0.9526,33303990
11777,Aflibercept,gene,0.964,33303990
11778,vascular endothelial growth factor receptor,gene,0.999,33303990
11779,cancers,disease,1.0,33303990
11780,Aflibercept,gene,0.979,33303990
11781,cardiovascular toxicities,disease,0.9976,33303990
11782,hypertension,disease,1.0,33303990
11783,aflibercept,gene,0.9946,33303990
11784,hypertension,disease,0.9995,33303990
11785,aflibercept,gene,0.9785,33303990
11786,NO,drug,,33303990
11787,endothelin 1,gene,0.9956,33303990
11788,ET-1,gene,0.9966,33303990
11789,mice,species,0.9727,33303990
11790,cultured endothelial cells,cell_line,0.942,33303990
11791,aflibercept,gene,0.9707,33303990
11792,mice,species,0.9873,33303990
11793,Aflibercept,gene,0.8535,33303990
11794,endothelial,cell_type,0.669,33303990
11795,NADPH,drug,1.0,33303990
11796,NADPH oxidases 1,gene,0.9565,33303990
11797,NOX1,gene,0.998,33303990
11798,NADPH,drug,0.9985,33303990
11799,NADPH oxidases 4,gene,0.9,33303990
11800,NOX4,gene,0.9985,33303990
11801,protein kinase B,gene,0.9976,33303990
11802,Akt,gene,0.9937,33303990
11803,endothelial nitric oxide synthase,gene,0.988,33303990
11804,nitric oxide,drug,0.9473,33303990
11805,eNOS,gene,0.9966,33303990
11806,nitric oxide,drug,1.0,33303990
11807,NO,drug,1.0,33303990
11808,ET-1,gene,0.9937,33303990
11809,mouse,species,0.9956,33303990
11810,L-arginine,drug,0.9995,33303990
11811,L-arg,drug,0.9995,33303990
11812,aflibercept,gene,0.9844,33303990
11813,L-arg-pretreated cultured endothelial cells,cell_line,0.8003,33303990
11814,L,cell_type,0.5396,33303990
11815,L-arg,drug,0.9863,33303990
11816,AKT,gene,0.9956,33303990
11817,eNOS,gene,0.995,33303990
11818,NO,drug,1.0,33303990
11819,aflibercept,gene,0.973,33303990
11820,aflibercept,gene,0.9385,33303990
11821,hypertension,disease,1.0,33303990
11822,L-arg,drug,0.8594,33303990
11823,mice,species,0.983,33303990
11824,aflibercept,gene,0.963,33303990
11825,NOX1,gene,0.9976,33303990
11826,NOX4,gene,0.998,33303990
11827,ET-1,gene,0.974,33303990
11828,AKT,gene,0.9966,33303990
11829,eNOS,gene,0.995,33303990
11830,NO,drug,1.0,33303990
11831,cationic amino acid transporter,gene,0.9624,33303990
11832,amino acid,drug,0.9854,33303990
11833,CAT-1,gene,0.9927,33303990
11834,L-arg,drug,0.994,33303990
11835,aflibercept,gene,0.9805,33303990
11836,vascular dysfunction,disease,0.9995,33303990
11837,hypertension,disease,1.0,33303990
11838,CAT-1,gene,0.995,33303990
11839,AKT,gene,0.998,33303990
11840,eNOS,gene,0.9956,33303990
11841,NO,drug,1.0,33303990
11842,ET-1,gene,0.978,33303990
11843,NOX1,gene,0.9976,33303990
11844,NOX4,gene,0.9985,33303990
11845,L-arg,drug,0.9976,33303990
11846,L-arg,drug,0.986,33303990
11847,aflibercept,gene,0.958,33303990
11848,hypertension,disease,0.927,33303990
11849,Aflibercept,gene,0.95,33279910
11850,macrophage polarization gene,DNA,0.893,33279910
11851,choroidal neovascularization,disease,1.0,33279910
11852,CNV,disease,1.0,33279910
11853,mouse,species,0.9795,33279910
11854,aflibercept,gene,0.9863,33279910
11855,CNV,disease,1.0,33279910
11856,mouse,species,0.975,33279910
11857,mouse,species,0.993,33279910
11858,macrophage polarization genes,DNA,0.7964,33279910
11859,CNV,disease,0.999,33279910
11860,MIP-1a,gene,0.975,33279910
11861,MCP-5,gene,0.991,33279910
11862,Fas-L,gene,0.9927,33279910
11863,IL-15,gene,0.9917,33279910
11864,IL-,gene,0.912,33279910
11865,aflibercept,gene,0.986,33279910
11866,GM-CSF,gene,0.9985,33279910
11867,MCP-1,gene,0.9946,33279910
11868,TIMP-1,gene,0.9814,33279910
11869,MIP-1,gene,0.9487,33279910
11870,IL-13,gene,0.992,33279910
11871,Fas-L,gene,0.991,33279910
11872,Fas-L,gene,0.968,33279910
11873,aflibercept,gene,0.9526,33279910
11874,M2,cell_type,,33279910
11875,VEGFA genes,gene,0.983,33279910
11876,CNV,disease,0.9995,33279910
11877,aflibercept,gene,0.961,33279910
11878,M2,cell_type,,33279910
11879,VEGFA genes,gene,0.97,33279910
11880,IL-7,gene,0.989,33279910
11881,CNV,disease,0.9834,33279910
11882,aflibercept,gene,0.978,33279910
11883,M1/M2 macrophage genes,DNA,0.6416,33279910
11884,CNV,disease,1.0,33279910
11885,mouse,species,0.9854,33279910
11886,macrophages,cell_type,0.8643,33279910
11887,CNV,disease,1.0,33279910
11888,Diabetic Macular Edema,disease,1.0,33274237
11889,Diabetic retinopathy,disease,1.0,33274237
11890,DR,disease,1.0,33274237
11891,diabetes mellitus,disease,1.0,33274237
11892,DM,disease,1.0,33274237
11893,DR,disease,,33274237
11894,diabetic eye disease,disease,1.0,33274237
11895,diabetic macular edema,disease,1.0,33274237
11896,DME,disease,1.0,33274237
11897,central vision,disease,0.857,33274237
11898,DR,disease,,33274237
11899,patients,species,0.992,33274237
11900,DR,disease,,33274237
11901,susceptibility genes,DNA,0.7427,33274237
11902,DME,disease,1.0,33274237
11903,DME,disease,1.0,33274237
11904,antivascular endothelial growth factor,gene,0.9976,33274237
11905,anti-VEGF,gene,0.9907,33274237
11906,DME,disease,1.0,33274237
11907,DME,disease,1.0,33253664
11908,vascular endothelial growth factor,gene,0.8765,33253664
11909,VEGF,gene,0.9976,33253664
11910,aflibercept,gene,0.9844,33253664
11911,macular cube,DNA,0.4985,33253664
11912,RFI,DNA,0.502,33253664
11913,RFI,DNA,0.497,33253664
11914,DME,disease,1.0,33253664
11915,aflibercept,gene,0.971,33249110
11916,wet,disease,0.8765,33249110
11917,age-related macular,disease,0.8955,33249110
11918,neovascular age-related macular degeneration,disease,0.999,33245426
11919,neovascular age-related macular degeneration,disease,1.0,33245426
11920,nAMD,disease,1.0,33245426
11921,anti-VEGF,gene,0.9634,33245426
11922,nAMD,disease,1.0,33245426
11923,anti-VEGF,gene,0.9463,33245426
11924,anti-VEGF,gene,0.9805,33245426
11925,CRT,DNA,0.4949,33245426
11926,patients,species,0.976,33245426
11927,CRT,DNA,0.554,33245426
11928,nAMD,disease,1.0,33245426
11929,anti-VEGF,gene,0.9272,33245426
11930,CRT,DNA,0.562,33245426
11931,CRT,DNA,0.546,33245426
11932,ovarian cancer,disease,1.0,33240446
11933,cancer,disease,1.0,33240446
11934,ovarian cancer,disease,1.0,33240446
11935,ovarian cancer,disease,1.0,33240446
11936,poly ADP ribose,drug,0.995,33240446
11937,poly ADP ribose polymerase,gene,0.956,33240446
11938,PARP,gene,0.9893,33240446
11939,ovarian cancer,disease,1.0,33240446
11940,Anti-Vascular Endothelial Growth Factor,gene,0.9,33235428
11941,anti-vascular endothelial growth factor,gene,0.9688,33235428
11942,anti-VEGF,gene,0.9907,33235428
11943,foveal,DNA,0.4905,33235428
11944,patients,species,0.947,33235428
11945,diabetic macular edema,disease,1.0,33235428
11946,DME,disease,1.0,33235428
11947,patients,species,0.9634,33235428
11948,DME,disease,1.0,33235428
11949,VEGF,gene,0.735,33235428
11950,aflibercept,gene,0.9883,33235428
11951,ranibizumab,gene,0.9146,33235428
11952,bevacizumab,gene,0.7896,33235428
11953,anti-VEGF,gene,0.916,33235428
11954,microaneurysms,disease,0.998,33235428
11955,patients,species,0.9937,33235428
11956,Bevacizumab,gene,0.915,33235428
11957,ranibizumab,gene,0.837,33235428
11958,aflibercept,gene,0.9795,33235428
11959,DCP,DNA,0.4976,33235428
11960,VEGF,gene,0.8276,33235428
11961,microaneurysms,disease,0.9995,33235428
11962,DCP,DNA,0.5527,33235428
11963,Microaneurysms,disease,0.7524,33235428
11964,anti-VEGF,gene,0.891,33235428
11965,neovascular age-related macular degeneration,disease,1.0,33219442
11966,Retinal Blindness,disease,0.9673,33219442
11967,aflibercept,gene,0.992,33219442
11968,aflibercept,gene,0.98,33219442
11969,FB,disease,,33219442
11970,aflibercept,gene,0.988,33219242
11971,aflibercept,gene,0.9814,33219242
11972,neovascular AMD,disease,1.0,33219242
11973,patients,species,0.9937,33219242
11974,patients,species,0.9897,33219242
11975,patients,species,0.9463,33219242
11976,patients,species,0.9844,33219242
11977,aflibercept,gene,0.974,33219242
11978,aflibercept,gene,0.9194,33219242
11979,nAMD,disease,1.0,33219242
11980,nAMD CNV,disease,0.999,33211556
11981,CNV,disease,0.9995,33211556
11982,patients,species,0.9834,33211556
11983,anti-VEGF,gene,0.8105,33211556
11984,Aflibercept,gene,0.884,33211556
11985,CNV,disease,1.0,33211556
11986,patients,species,0.9814,33211556
11987,CNV,disease,1.0,33211556
11988,TNJ,cell_line,0.7583,33211556
11989,TNJ,cell_line,0.7725,33211556
11990,CNV,disease,1.0,33211556
11991,patients,species,0.971,33211556
11992,nAMD,disease,1.0,33211556
11993,PARTICIPANTS,species,0.7246,33211064
11994,neovascular age-related macular degeneration,disease,0.9985,33211064
11995,vascular endothelial growth factor,gene,0.9673,33211064
11996,VEGF,gene,0.9976,33211064
11997,VEGF,gene,0.6714,33211064
11998,VEGF,gene,0.6284,33211064
11999,ranibizumab,gene,0.8706,33211064
12000,aflibercept,gene,0.9854,33211064
12001,Diabetic Retinopathy,disease,0.999,33211064
12002,patients,species,0.984,33211064
12003,women,species,0.971,33211064
12004,anti-VEGF,gene,0.9497,33211064
12005,patients,species,0.9893,33211064
12006,ETDRS,DNA,0.5176,33211064
12007,patients,species,0.971,33211064
12008,neovascular age-related macular degeneration,disease,1.0,33211064
12009,VEGF,gene,0.583,33211064
12010,poor vision,disease,0.8228,33211064
12011,patients,species,0.99,33211064
12012,Inflammation,disease,0.977,33207259
12013,Retinal Vasculitis,disease,1.0,33207259
12014,Retinal Occlusion-Related Events,disease,0.998,33207259
12015,intraocular inflammation,disease,1.0,33207259
12016,IOI,disease,1.0,33207259
12017,endophthalmitis,disease,1.0,33207259
12018,retinal arterial occlusion,disease,1.0,33207259
12019,brolucizumab,gene,0.906,33207259
12020,aflibercept,gene,0.9624,33207259
12021,neovascular age-related macular degeneration,disease,1.0,33207259
12022,nAMD,disease,1.0,33207259
12023,PARTICIPANTS,species,0.819,33207259
12024,Patients,species,0.9814,33207259
12025,choroidal neovascularization,disease,1.0,33207259
12026,age-related macular degeneration,disease,1.0,33207259
12027,IOI,disease,0.999,33207259
12028,brolucizumab,gene,0.964,33207259
12029,aflibercept,gene,0.8667,33207259
12030,fluorescein,drug,0.9946,33207259
12031,IOI,disease,1.0,33207259
12032,endophthalmitis,disease,1.0,33207259
12033,patient,species,0.8877,33207259
12034,IOI,disease,1.0,33207259
12035,retinal vasculitis,disease,1.0,33207259
12036,retinal vascular occlusion,disease,1.0,33207259
12037,visual acuity,disease,0.7197,33207259
12038,brolucizumab,gene,0.962,33207259
12039,IOI,disease,0.998,33207259
12040,brolucizumab,gene,0.938,33207259
12041,IOI,disease,0.9995,33207259
12042,brolucizumab,gene,0.861,33207259
12043,IOI,disease,1.0,33207259
12044,retinal vasculitis,disease,1.0,33207259
12045,vascular occlusion,disease,1.0,33207259
12046,IOI,disease,1.0,33207259
12047,IOI,disease,1.0,33207259
12048,vasculitis,disease,1.0,33207259
12049,IOI,disease,1.0,33207259
12050,vasculitis,disease,0.976,33207259
12051,IOI,disease,1.0,33207259
12052,IOI,disease,0.999,33207259
12053,vasculitis,disease,1.0,33207259
12054,IOI,disease,0.997,33207259
12055,brolucizumab,gene,0.926,33207259
12056,IOI,disease,0.999,33207259
12057,aflibercept,gene,0.9746,33207259
12058,IOI,disease,1.0,33207259
12059,brolucizumab,gene,0.8647,33207259
12060,retinal vasculitis,disease,1.0,33207259
12061,retinal vascular occlusion,disease,1.0,33207259
12062,brolucizumab,gene,0.79,33207259
12063,nAMD,disease,1.0,33207259
12064,aflibercept,gene,0.9873,33203393
12065,bevacizumab,gene,0.9033,33203393
12066,patients,species,0.9507,33203393
12067,colorectal cancer,disease,1.0,33203393
12068,bevacizumab,gene,0.917,33203393
12069,aflibercept,gene,0.993,33203393
12070,bevacizumab,gene,0.8574,33203393
12071,mCRC,disease,0.9106,33203393
12072,aflibercept,gene,0.988,33203393
12073,bevacizumab,gene,0.894,33203393
12074,mCRC,disease,0.993,33203393
12075,Patients,species,0.9424,33203393
12076,colorectal cancer,disease,1.0,33203393
12077,bevacizumab,gene,0.9194,33203393
12078,aflibercept,gene,0.96,33203393
12079,FOLFIRI,drug,0.8853,33203393
12080,aflibercept,gene,0.9785,33203393
12081,irinotecan,drug,0.996,33203393
12082,levofolinate,drug,0.997,33203393
12083,fluorouracil,drug,0.996,33203393
12084,fluorouracil,drug,0.93,33203393
12085,patients,species,0.9907,33203393
12086,VEGF,gene,0.8525,33203393
12087,metastatic colorectal cancer,disease,0.999,33203393
12088,aflibercept,gene,0.986,33203393
12089,bevacizumab,gene,0.909,33203393
12090,colorectal cancer,disease,1.0,33203393
12091,VEGF,gene,0.656,33203393
12092,bevacizumab,gene,0.733,33203393
12093,aflibercept,gene,0.878,33198503
12094,aflibercept,gene,0.859,33198503
12095,patients,species,0.983,33198503
12096,age-related macular degeneration,disease,1.0,33198503
12097,nAMD,disease,1.0,33198503
12098,choroidal neovascular membranes,disease,1.0,33198503
12099,CNV,disease,1.0,33198503
12100,Patients,species,0.954,33198503
12101,AMD,disease,0.996,33198503
12102,Diabetic Retinopathy,disease,0.999,33198503
12103,patients,species,0.987,33198503
12104,CNV,disease,0.9976,33198503
12105,CNV,disease,0.9946,33198503
12106,CNV,disease,0.997,33198503
12107,Type 1 CNV,disease,0.9995,33198503
12108,CRTSD,DNA,0.501,33198503
12109,Type 2 CNV,disease,1.0,33198503
12110,Type 4 CNV,disease,0.9976,33198503
12111,aflibercept,gene,0.9746,33198503
12112,patients,species,0.977,33198503
12113,AMD,disease,0.993,33198503
12114,CRT,gene,0.883,33198503
12115,CNV,disease,1.0,33198503
12116,Patients,species,0.9585,33198503
12117,age-related macular degeneration,disease,0.9985,33198503
12118,aflibercept,gene,0.91,33198503
12119,choroidal neovascular membrane,disease,0.894,33198503
12120,VEGF,gene,0.5933,33198211
12121,Polypoidal Choroidal Polypoidal choroidal vasculopathy,disease,1.0,33198211
12122,PCV,disease,1.0,33198211
12123,choroidal neovascularization,disease,1.0,33198211
12124,CNV,disease,1.0,33198211
12125,age-related macular degeneration,disease,1.0,33198211
12126,AMD,disease,1.0,33198211
12127,choroidal,DNA,0.5376,33198211
12128,polypoidal lesions,disease,1.0,33198211
12129, the,mutation,,33198211
12130,PCV,disease,1.0,33198211
12131,neovascular AMD,disease,1.0,33198211
12132,patients,species,0.989,33198211
12133,anti-VEGF,gene,0.8286,33198211
12134,ranibizumab,gene,0.6704,33198211
12135,bevacizumab,gene,0.8784,33198211
12136,aflibercept,gene,0.9473,33198211
12137,CNV,disease,0.9985,33198211
12138,patients,species,0.996,33198211
12139,PCV,disease,0.9995,33198211
12140,VEGF,gene,0.659,33198211
12141,genetic polymorphisms,DNA,0.668,33198211
12142,exudative/wet AMD,disease,0.9043,33198211
12143,patients,species,0.9946,33198211
12144,VEGF,gene,0.8784,33198211
12145,PCV,disease,1.0,33198211
12146,patients,species,0.99,33198211
12147,CFH,gene,0.993,33198211
12148,I62V,mutation,,33198211
12149,CFH,gene,0.992,33198211
12150,Y402H,mutation,,33198211
12151,ARMS2,gene,0.991,33198211
12152,A69S,mutation,,33198211
12153,HTRA1-62A,gene,0.792,33198211
12154,ARMS2 A69S variant,gene,0.973,33198211
12155,A69S,mutation,,33198211
12156,VEGF,gene,0.6763,33198211
12157,PCV,disease,0.9995,33198211
12158,AMD,drug,0.9995,33198211
12159,genetic variants,DNA,0.681,33198211
12160,Aflibercept,gene,0.958,33197922
12161,Mouse,species,0.9404,33197922
12162,aflibercept,gene,0.984,33197922
12163,mouse,species,0.958,33197922
12164,type 3 neovascularization,disease,0.993,33197922
12165,neoretinal vascularization (NRV) 2 mouse line,cell_line,0.7554,33197922
12166,neoretinal vascularization (NRV) 2,gene,0.887,33197922
12167,mouse,species,0.963,33197922
12168,NRV2 mice,cell_line,0.582,33197922
12169,mice,species,0.9585,33197922
12170,mice,species,0.97,33197922
12171,aflibercept,gene,0.9526,33197922
12172,aflibercept,gene,0.9917,33197922
12173,mice,species,0.9854,33197922
12174,mice,species,0.9697,33197922
12175,mice,species,0.93,33197922
12176,depigmentation,disease,0.9976,33197922
12177,hyperfluorescent lesions,disease,0.994,33197922
12178,fluorescein,drug,0.995,33197922
12179,intraretinal neovascularizations,disease,0.9946,33197922
12180,intraretinal,DNA,0.4617,33197922
12181,intraretinal neovascular lesions,disease,1.0,33197922
12182,aflibercept,gene,0.974,33197922
12183,intraretinal lesions,disease,0.9395,33197922
12184,aflibercept,gene,0.9873,33197922
12185,Aflibercept,gene,0.794,33197922
12186,NRV2,disease,0.786,33197922
12187,mouse,species,0.9766,33197922
12188,VEGF-Grab,gene,0.834,33196778
12189,VEGF,gene,0.8643,33196778
12190,VEGF-Grab,gene,0.9443,33196778
12191,VEGF,gene,0.9985,33196778
12192,VEGF,gene,0.9976,33196778
12193,placental growth factor,gene,0.9966,33196778
12194,PlGF,gene,0.9893,33196778
12195,aflibercept,gene,0.979,33196778
12196,VEGF,gene,0.9927,33196778
12197,aflibercept,gene,0.98,33196778
12198,anti-VEGF,gene,0.714,33196778
12199,VEGF,gene,0.9683,33196778
12200,VEGF,gene,0.9937,33196778
12201,VEGF,gene,0.9966,33196778
12202,Grab,gene,0.7817,33196778
12203,aflibercept,gene,0.9824,33196778
12204,mouse,species,0.9897,33196778
12205,oxygen-induced retinopathy,disease,0.9795,33196778
12206,oxygen,drug,0.999,33196778
12207,OIR,disease,0.9897,33196778
12208,rat,species,0.988,33196778
12209,choroidal neovascularization,disease,0.9985,33196778
12210,CNV,disease,1.0,33196778
12211,mouse,species,0.9844,33196778
12212,VEGF-Grab,gene,0.9365,33196778
12213,VEGF,gene,0.996,33196778
12214,aflibercept,gene,0.99,33196778
12215,OIR,disease,0.999,33196778
12216,VEGF,gene,0.994,33196778
12217,aflibercept,gene,0.965,33196778
12218,VEGF,gene,0.9946,33196778
12219,aflibercept,gene,0.9785,33196778
12220,CNV,disease,0.9956,33196778
12221,CNV,disease,0.714,33196778
12222,mouse,species,0.992,33196778
12223,VEGF,gene,0.997,33196778
12224,Grab,gene,0.9595,33196778
12225,aflibercept,gene,0.99,33196778
12226,aflibercept,gene,0.9883,33196778
12227,VEGF,gene,0.995,33196778
12228,VEGF,gene,0.738,33196778
12229,VEGF,gene,0.998,33196778
12230,PlGF,gene,0.9946,33196778
12231,aflibercept,gene,0.9883,33196778
12232,VEGF,gene,0.9917,33196778
12233,neovascular retinal diseases,disease,1.0,33196778
12234,to aflibercept,gene,0.4456,33196778
12235,Vascular Endothelial Growth Factor,gene,0.998,33184574
12236,retinal diseases,disease,1.0,33184574
12237,neovascular age-related macular degeneration,disease,1.0,33184574
12238,diabetic retinopathy,disease,0.768,33184574
12239,blindness,disease,0.9985,33184574
12240,vascular endothelial growth factor,gene,0.9985,33184574
12241,VEGF,gene,0.9937,33184574
12242,VEGFR,gene,0.993,33184574
12243,VEGF,gene,0.997,33184574
12244,VEGF,gene,0.761,33184574
12245,patients,species,0.9834,33184574
12246,VEGF,gene,0.9937,33184574
12247,anti-VEGF antagonist,gene,0.8926,33184574
12248,aflibercept,gene,0.753,33184574
12249,yeast,species,0.9727,33184574
12250,VEGF,gene,0.9956,33184574
12251,rat,species,0.9688,33184574
12252,anti-VEGF,gene,0.9897,33184574
12253,convergent sequence,DNA,0.5356,33184574
12254,rats,species,0.993,33184574
12255,anti-VEGF protein,gene,0.9937,33184574
12256,retinal diseases,disease,1.0,33184574
12257,rats,species,0.9663,33184574
12258,aflibercept,gene,0.9805,33179193
12259,macular edema,disease,1.0,33179193
12260,aflibercept,gene,0.976,33179193
12261,branch retinal vein occlusion,disease,1.0,33179193
12262,BRVO-ME,disease,0.98,33179193
12263,BRVO-ME,disease,0.9814,33179193
12264,patients,species,0.9927,33179193
12265,ME,disease,,33179193
12266,ME,disease,,33179193
12267,patients,species,0.985,33179193
12268,patients,species,0.9844,33179193
12269,men,species,0.9683,33179193
12270,women,species,0.983,33179193
12271,ME,disease,,33179193
12272,IVA,drug,0.583,33179193
12273,ME,disease,,33179193
12274,BRVO,disease,1.0,33179193
12275,Streptococcus intermedius Endophthalmitis,disease,0.9023,33165298
12276,Streptococcus intermedius,species,0.8745,33165298
12277,Endophthalmitis,disease,1.0,33165298
12278,anti-VEGF,gene,0.96,33165298
12279,Streptococcus viridans,species,0.955,33165298
12280,Streptococcus viridans endophthalmitis,disease,0.973,33165298
12281,Streptococcus viridans,species,0.7925,33165298
12282,PATIENTS,species,0.887,33165298
12283,Aflibercept,gene,0.9336,33165298
12284,exudative age-related macular degeneration,disease,1.0,33165298
12285,pigmented,cell_line,0.7007,33165298
12286,pigmented anterior chamber cells,cell_type,0.79,33165298
12287,systemic infection,disease,0.949,33165298
12288,vitreous haemorrhage,disease,1.0,33165298
12289,vitritis,disease,0.9995,33165298
12290,endophthalmitis,disease,1.0,33165298
12291,Vancomycin,drug,0.998,33165298
12292,Ceftazidime,drug,0.998,33165298
12293,Streptococcus intermedius,species,0.935,33165298
12294,head and neck abscesses,disease,1.0,33165298
12295,patient,species,0.99,33165298
12296,post-injection endophthalmitis,disease,0.955,33165298
12297,intraocular inflammation,disease,1.0,33165298
12298,Occlusive Retinal Vasculitis,disease,1.0,33165295
12299,aflibercept,gene,0.983,33159611
12300,aflibercept,gene,0.9775,33159611
12301,neovascular age-related macular degeneration,disease,1.0,33159611
12302,AMD,disease,1.0,33159611
12303,AMD,disease,1.0,33159611
12304,vascular endothelial growth factor,gene,0.89,33159611
12305,aflibercept,gene,0.9507,33159611
12306,Exudative changes,disease,0.973,33159611
12307,aflibercept,gene,0.9834,33159611
12308,AMD,disease,0.999,33159611
12309,patients,species,0.93,33135487
12310,patients,species,0.9517,33135487
12311,myopic choroidal neovascularization,disease,1.0,33135487
12312,CNV,disease,1.0,33135487
12313,anti-vascular endothelial growth factors,gene,0.9004,33135487
12314,VEGFs,gene,0.9966,33135487
12315,myopic-CNV,disease,1.0,33135487
12316,patients,species,0.989,33135487
12317,Aflibercept,gene,0.985,33135487
12318,Ranibizumab,gene,0.8735,33135487
12319,Bevacizumab,gene,0.8325,33135487
12320,patients,species,0.988,33135487
12321,patients,species,0.9795,33135487
12322,Ranibizumab,gene,0.9326,33135487
12323,Bevacizumab,gene,0.696,33135487
12324,Ranibizumab,gene,0.853,33135487
12325,Bevacizumab,gene,0.815,33135487
12326,Coats&,disease,1.0,33133822
12327,aflibercept,gene,0.975,33133822
12328,Coats&,disease,1.0,33133822
12329,vision reduction,disease,0.883,33133822
12330,temporal retinal telangiectasia,disease,1.0,33133822
12331,patient,species,0.989,33133822
12332,exudative thickening,disease,0.934,33133822
12333,patient,species,0.934,33133822
12334,aflibercept,gene,0.986,33133822
12335,Aflibercept,gene,0.95,33133822
12336,vascular endothelial growth factor,gene,0.9985,33133822
12337,VEGF,gene,0.9985,33133822
12338,placental growth factor,gene,0.998,33133822
12339,anti-VEGF,gene,0.641,33133822
12340,aflibercept,gene,0.97,33133822
12341,Coats&#39; disease,disease,1.0,33133822
12342,macular edema,disease,1.0,33133822
12343,aflibercept,gene,0.963,33133822
12344,aflibercept,gene,0.9844,33133822
12345,Coats&#39; disease,disease,0.998,33133822
12346,Interferon Alpha 2b,gene,0.989,33133435
12347,Diabetic Macular Edema,disease,1.0,33133435
12348,interferon alpha 2b,gene,0.9976,33133435
12349,diabetic macular edema,disease,1.0,33133435
12350,diabetic macular edema,disease,1.0,33133435
12351,anti-vascular endothelial growth factor,gene,0.882,33133435
12352,bevacizumab,gene,0.7085,33133435
12353,bevacizumab,gene,0.618,33133435
12354,triamcinolone,drug,0.9985,33133435
12355,aflibercept,gene,0.9775,33133435
12356,ranibizumab,gene,0.9463,33133435
12357,patient,species,0.9863,33133435
12358,diabetic macular edema,disease,1.0,33133435
12359,rhegmatogenous retinal detachment,disease,1.0,33133435
12360,interferon alpha 2b,gene,0.998,33133435
12361,patients,species,0.9785,33133435
12362,interferon alpha 2b,gene,0.996,33133435
12363,Conjunctival injection,disease,0.9995,33133435
12364,follicular conjunctivitis,disease,1.0,33133435
12365,interferon alpha 2b,gene,0.998,33133435
12366,interferon alpha 2b,gene,0.997,33133435
12367,diabetic macular edema,disease,1.0,33133435
12368,patients,species,0.992,33133435
12369,neovascular age-related macular degeneration,disease,0.996,33130553
12370,vascular endothelial growth factor,gene,0.9873,33130553
12371,VEGF,gene,0.998,33130553
12372,neovascular age-related macular degeneration,disease,1.0,33130553
12373,nAMD,disease,0.9995,33130553
12374,VEGF,gene,0.998,33130553
12375,aflibercept,gene,0.9893,33130553
12376,ranibizumab,gene,0.9443,33130553
12377,nAMD,disease,1.0,33130553
12378,anti-VEGF,gene,0.685,33130553
12379,nAMD,disease,1.0,33130553
12380,patients,species,0.984,33130553
12381,nAMD,disease,1.0,33130553
12382,patients,species,0.963,33130553
12383,nAMD,disease,1.0,33130553
12384,Aflibercept,gene,0.923,33127830
12385,age-related macular degeneration,disease,1.0,33127830
12386,patients,species,0.961,33127830
12387,neovascular age-related macular degeneration,disease,0.9995,33127830
12388,nAMD,disease,1.0,33127830
12389,patients,species,0.9775,33127830
12390,nAMD,disease,1.0,33127830
12391,aflibercept,gene,0.934,33127830
12392,patients,species,0.958,33127830
12393,patients,species,0.9795,33127830
12394,patients,species,0.9707,33127830
12395,Aflibercept,gene,0.923,33126803
12396,Vascularised Serous Pigment Epithelial Detachment,disease,1.0,33126803
12397,aflibercept,gene,0.9907,33126803
12398,pigment epithelial detachment,disease,1.0,33126803
12399,PED,disease,1.0,33126803
12400,choroidal neovascularization,disease,1.0,33126803
12401,CNV,disease,1.0,33126803
12402,patients,species,0.9766,33126803
12403,PATIENTS,species,0.8804,33126803
12404,patients,species,0.9717,33126803
12405,aflibercept,gene,0.818,33126803
12406,Eylea,gene,0.775,33126803
12407,patients,species,0.979,33126803
12408,Diabetic Retinopathy,disease,0.999,33126803
12409,PED,DNA,0.5493,33126803
12410,PED,DNA,0.537,33126803
12411,PED,DNA,0.6113,33126803
12412,PED,disease,0.9604,33126803
12413,Aflibercept,gene,0.9546,33126803
12414,patients,species,0.9307,33126803
12415,PED,disease,0.998,33126803
12416,CNV,disease,1.0,33126803
12417,PED,DNA,0.554,33126803
12418,Pseudophakic macular edema,disease,1.0,33120707
12419,epiretinal proliferation,disease,1.0,33120707
12420,macular hole,disease,0.9424,33120707
12421,MH,disease,1.0,33120707
12422,MH,disease,,33120707
12423,epiretinal proliferation,disease,1.0,33120707
12424,EP,disease,1.0,33120707
12425,MH,disease,,33120707
12426,MH,disease,,33120707
12427,cataract,disease,0.9956,33120707
12428,aflibercept,gene,0.9805,33120707
12429,pseudophakic macular edema,disease,1.0,33120707
12430,Thrombotic Microangiopathy,disease,1.0,33117836
12431,Acute Kidney Injury,disease,1.0,33117836
12432,Vascular endothelial growth factor,gene,0.9956,33117836
12433,VEGF,gene,0.997,33117836
12434,hypertension,disease,1.0,33117836
12435,proteinuria,disease,1.0,33117836
12436,chronic kidney injury,disease,1.0,33117836
12437,Thrombotic microangiopathy,disease,1.0,33117836
12438,TMA,disease,1.0,33117836
12439,nephrotic disorders,disease,1.0,33117836
12440,VEGF,gene,0.993,33117836
12441,age-related macular degeneration,disease,1.0,33117836
12442,AMD,disease,1.0,33117836
12443,diabetic retinopathy,disease,1.0,33117836
12444,DR,disease,1.0,33117836
12445,VEGF,gene,0.9893,33117836
12446,VEGF,gene,0.9824,33117836
12447,hypertension,disease,1.0,33117836
12448,proteinuria,disease,1.0,33117836
12449,glomerular diseases,disease,1.0,33117836
12450,TMA,disease,1.0,33117836
12451,focal and segmental glomerulosclerosis,disease,1.0,33117836
12452,TMA,disease,0.9966,33117836
12453,VEGF,gene,0.6157,33117836
12454,patients,species,0.988,33117836
12455,VEGF,gene,0.9946,33117836
12456,VEGF,gene,0.9863,33117836
12457,VEGF,gene,0.9883,33117836
12458,patients,species,0.9863,33117836
12459,patients,species,0.981,33117836
12460,patients,species,0.991,33117836
12461,hypertension,disease,1.0,33117836
12462,proteinuria,disease,1.0,33117836
12463,glomerular diseases,disease,1.0,33117836
12464,VEGF,gene,0.9873,33117836
12465,VEGF,gene,0.9946,33117607
12466,F6H8,drug,0.999,33117607
12467,Semifluorinated alkanes,drug,0.887,33117607
12468,vascular endothelial growth factor,gene,0.999,33117607
12469,VEGF,gene,0.9985,33117607
12470,perfluorohexyloctane,drug,0.9985,33117607
12471,F6H8,drug,0.9927,33117607
12472,corneal neovascularization,disease,0.9995,33117607
12473,mice,species,0.973,33117607
12474,F6H8,drug,0.998,33117607
12475,VEGF Trap,gene,0.9536,33117607
12476,phosphate,drug,0.9927,33117607
12477,F6H8,drug,0.997,33117607
12478,phosphate,drug,0.993,33117607
12479,CD31,gene,0.989,33117607
12480,LYVE-1,gene,0.986,33117607
12481,inflammatory,cell_type,0.4546,33117607
12482,corneal CD45,cell_line,0.542,33117607
12483,corneal CD45+ cells,cell_type,0.6895,33117607
12484,CD45+,gene,0.9336,33117607
12485,fluorescein,drug,0.9316,33117607
12486,Trap,gene,0.7734,33117607
12487,F6H8,gene,0.903,33117607
12488,Trap,gene,0.7173,33117607
12489,Trap,gene,0.6016,33117607
12490,F6H8,gene,0.875,33117607
12491,corneal,cell_type,0.572,33117607
12492,CD45+,gene,0.9287,33117607
12493,Trap,gene,0.916,33117607
12494,F6H8,gene,0.959,33117607
12495,Trap,gene,0.828,33117607
12496,F6H8,drug,0.994,33117607
12497,VEGF Trap,gene,0.951,33117607
12498,corneal neovascularization,disease,0.9995,33117607
12499,F6H8,drug,0.999,33117607
12500,Aflibercept,gene,0.997,33117605
12501,aflibercept,gene,0.9873,33117605
12502,choroidal neovascularization,disease,0.899,33117605
12503,CNV,disease,1.0,33117605
12504,rat,species,0.9707,33117605
12505,CNV,disease,0.993,33117605
12506,aflibercept,gene,0.9907,33117605
12507,aflibercept,gene,0.99,33117605
12508,CNV,disease,1.0,33117605
12509,CNV,disease,0.9995,33117605
12510,aflibercept,gene,0.981,33117605
12511,CNV,disease,1.0,33117605
12512,CNV,disease,0.9766,33117605
12513,CNV,disease,1.0,33117605
12514,chronic inflammation,disease,0.965,33117605
12515,ocular abnormalities,disease,0.992,33117605
12516,aflibercept,gene,0.995,33117605
12517,CNV lesions,disease,0.9834,33117605
12518,anti-,gene,0.607,33117605
12519,vascular endothelial growth factor,gene,0.8813,33117605
12520,angioid streak,disease,1.0,33117488
12521,angioid streak associated CNV,disease,0.9995,33117488
12522,AS-CNV,disease,0.9893,33117488
12523,patients,species,0.98,33117488
12524,patients,species,0.982,33117488
12525,patient,species,0.9844,33117488
12526,CNV,disease,1.0,33117488
12527,patient,species,0.9697,33117488
12528,patients,species,0.984,33117488
12529,patients,species,0.9824,33117488
12530,anti-VEGF,gene,0.9,33117488
12531,ranibizumab,gene,0.918,33117488
12532,aflibercept,gene,0.956,33117488
12533,CNV,disease,0.9995,33117488
12534,AS-CNV,disease,1.0,33117488
12535,VEGF,gene,0.5854,33117488
12536,Neovascular AMD,disease,1.0,33116384
12537,vascular endothelial growth factor,gene,0.91,33116384
12538,neovascular age-related macular degeneration,disease,0.9995,33116384
12539,nAMD,disease,1.0,33116384
12540,ranibizumab,gene,0.672,33116384
12541,aflibercept,gene,0.9395,33116384
12542,patients,species,0.9927,33116384
12543,VEGF,gene,0.9985,33116371
12544,PATIENTS,species,0.941,33116371
12545,patients,species,0.986,33116371
12546,bevacizumab,gene,0.7812,33116371
12547,ranibizumab,gene,0.6685,33116371
12548,aflibercept,gene,0.9595,33116371
12549,patients,species,0.986,33116371
12550,patients,species,0.989,33116371
12551,anti-VEGF,gene,0.8657,33116371
12552,patients,species,0.994,33116371
12553,age-related macular degeneration,disease,0.999,33116371
12554,diabetic retinopathy,disease,1.0,33116371
12555,retinal vein occlusion,disease,1.0,33116371
12556,chorioretinopathy,disease,0.9995,33116371
12557,subconjunctival hemorrhage,disease,1.0,33116371
12558,endophthalmitis,disease,1.0,33116371
12559,patients,species,0.985,33116371
12560,intraocular inflammation,disease,0.832,33116371
12561,patients,species,0.988,33116371
12562,anti-VEGF,gene,0.813,33116371
12563,patient,species,0.99,33116371
12564,patients,species,0.9834,33116208
12565,age-related macular degeneration,disease,1.0,33116208
12566,AMD,disease,1.0,33116208
12567,blindness,disease,0.997,33116208
12568,patients,species,0.9683,33116208
12569,AMD,disease,1.0,33116208
12570,AMD,disease,1.0,33116208
12571,pachychoroid,disease,0.5605,33116208
12572,AMD,disease,1.0,33116208
12573,AMD,disease,1.0,33116208
12574,polypoidal choroidal vasculopathy,disease,1.0,33106565
12575,Polypoidal choroidal vasculopathy,disease,1.0,33106565
12576,PCV,disease,1.0,33106565
12577,choroidal vascular disease,disease,1.0,33106565
12578,PCV,disease,1.0,33106565
12579,PCV,disease,1.0,33106565
12580,PCV,disease,0.9995,33106565
12581,indocyanine green,drug,0.998,33106565
12582,patients,species,0.989,33106565
12583,PCV,disease,0.9956,33106565
12584,participants,species,0.965,33106565
12585,PCV,disease,1.0,33106565
12586,CVD,disease,0.9995,33106565
12587,choroidal hyperpermeability,disease,1.0,33106565
12588,PCV,disease,1.0,33106565
12589,choroidal congestion,disease,0.9995,33106565
12590,CVD,disease,0.8086,33106565
12591,PCV,disease,1.0,33106565
12592,HIF-1,gene,0.996,33106407
12593,retinal Retinal neovascularization,disease,1.0,33106407
12594,NV,disease,1.0,33106407
12595,vision loss,disease,0.9995,33106407
12596,hypoxia,disease,0.939,33106407
12597,HIF-1,gene,0.563,33106407
12598,HIF-2,gene,0.9956,33106407
12599,oxygen,drug,0.9995,33106407
12600,HIF,gene,0.9956,33106407
12601,C,drug,0.953,33106407
12602,CBP,gene,0.9937,33106407
12603,p300,gene,0.995,33106407
12604,HIF,gene,0.99,33106407
12605,CITED2,gene,0.7935,33106407
12606,HIF,gene,0.9966,33106407
12607,HIF-1,gene,0.993,33106407
12608,CBP,gene,0.996,33106407
12609,p300,gene,0.996,33106407
12610,CITED2,gene,0.9805,33106407
12611,retinal cells,cell_type,0.816,33106407
12612,ischemic retinopathy,disease,1.0,33106407
12613,vaso-obliteration,disease,1.0,33106407
12614,VO,disease,1.0,33106407
12615,NV,disease,,33106407
12616,oxygen-induced retinopathy,disease,0.9976,33106407
12617,oxygen,drug,0.999,33106407
12618,OIR,disease,1.0,33106407
12619,CITED2 peptide,gene,0.8574,33106407
12620,CITED2 peptide,gene,0.6875,33106407
12621,retinal neurons,cell_type,0.785,33106407
12622,glia,cell_type,0.4097,33106407
12623,HIF target genes,gene,0.977,33106407
12624,Aflibercept,gene,0.959,33106407
12625,retinal neovascular diseases,disease,0.9995,33106407
12626,NV,disease,,33106407
12627,VO,disease,,33106407
12628,OIR,disease,0.9985,33106407
12629,CITED2 peptide,gene,0.9785,33106407
12630,aflibercept,gene,0.977,33106407
12631,VEGF,gene,0.705,33106407
12632,CITED2,gene,0.739,33106407
12633,retinal NV,disease,0.972,33106407
12634,HIF,gene,0.995,33106407
12635,CBP,gene,0.9697,33106407
12636,p300,gene,0.9556,33106407
12637,ischemic retinal diseases,disease,1.0,33106407
12638,neovascular disorders,disease,1.0,33106407
12639,Aflibercept,gene,0.979,33101780
12640,Macular Edema,disease,1.0,33101780
12641,Diabetic Retinopathy,disease,1.0,33101780
12642,aflibercept,gene,0.9644,33101780
12643,diabetic macular edema,disease,1.0,33101780
12644,DME,disease,1.0,33101780
12645,DME,disease,1.0,33101780
12646,IVA,drug,0.734,33101780
12647,microaneurysms,disease,1.0,33101780
12648,MAs,disease,0.997,33101780
12649,MA,DNA,0.4807,33101780
12650,CMT,DNA,0.4739,33101780
12651,aflibercept,gene,0.982,33101780
12652,DME,disease,1.0,33101780
12653,polyps,disease,1.0,33095843
12654,vascular endothelial growth factor,gene,0.9824,33095843
12655,polyps,disease,0.996,33095843
12656,indocyanine green,drug,0.9966,33095843
12657,patients,species,0.8477,33095843
12658,polypoidal choroidal vasculopathy,disease,1.0,33095843
12659,PCV,disease,1.0,33095843
12660,patients,species,0.97,33095843
12661,PCV,disease,1.0,33095843
12662,aflibercept,gene,0.966,33095843
12663,A,gene,0.968,33095843
12664,polyp,disease,0.9995,33095843
12665,polyps,disease,1.0,33095843
12666,Polyps,disease,1.0,33095843
12667,polyp,disease,1.0,33095843
12668,polyps,disease,1.0,33095843
12669,PCV,disease,1.0,33095843
12670,patients,species,0.992,33095843
12671,polyps,disease,0.9995,33095843
12672,low-flow polyps,disease,0.8794,33095843
12673,polyps,disease,0.999,33095843
12674,persistent,disease,0.8306,33095843
12675,polyps,disease,0.853,33095843
12676,polyps,disease,0.9937,33095843
12677,patients,species,0.93,33095843
12678,PCV,disease,1.0,33095843
12679,VEGF,gene,0.992,33086850
12680,macular retinal degeneration,disease,1.0,33086850
12681,vascular endothelial growth factor,gene,0.9985,33086850
12682,VEGF,gene,0.9985,33086850
12683,central retinal vein occlusion,disease,1.0,33086850
12684,diabetic macular edema,disease,1.0,33086850
12685,VEGF,gene,0.995,33086850
12686,aflibercept,gene,0.985,33084817
12687,diabetic macular edema,disease,1.0,33084817
12688,aflibercept,gene,0.965,33084817
12689,aflibercept,gene,0.9595,33084817
12690,diabetic macular edema,disease,1.0,33084817
12691,macular edema,disease,1.0,33084817
12692,aflibercept,gene,0.9907,33084817
12693,aflibercept,gene,0.944,33084817
12694,aflibercept,gene,0.8223,33084817
12695,aflibercept,gene,0.974,33084817
12696,macular edema,disease,1.0,33084817
12697,Neovascular Age-Related Macular Degeneration,disease,1.0,33079789
12698,Endophthalmitis,disease,1.0,33079789
12699,neovascular age-related macular degeneration,disease,1.0,33079789
12700,nAMD,disease,1.0,33079789
12701,endophthalmitis,disease,1.0,33079789
12702,anti-VEGF,gene,0.8374,33079789
12703,endophthalmitis,disease,1.0,33079789
12704,anti-VEGF,gene,0.6416,33079789
12705,povidone,drug,0.998,33079789
12706,endophthalmitis,disease,1.0,33079789
12707,endophthalmitis,disease,1.0,33079789
12708,nAMD,disease,1.0,33079789
12709,anti-VEGF,gene,0.9634,33079789
12710,endophthalmitis,disease,1.0,33079789
12711,endophthalmitis,disease,1.0,33079789
12712,nAMD,disease,1.0,33079789
12713,streptococcal,species,0.523,33079789
12714,endophthalmitis,disease,1.0,33079789
12715,VEGF,gene,0.6973,33079789
12716,aflibercept,gene,0.9844,33079789
12717,ranibizumab,gene,0.894,33079789
12718,bevacizumab,gene,0.902,33079789
12719,nAMD,disease,1.0,33079789
12720,endophthalmitis,disease,1.0,33079789
12721,nAMD,disease,1.0,33079789
12722,vascular endothelial growth factor,gene,0.939,33078109
12723,Irvine-Gass syndrome,disease,1.0,33078109
12724,bevacizumab,gene,0.7437,33078109
12725,ranibizumab,gene,0.683,33078109
12726,aflibercept,gene,0.971,33078109
12727,cystoid macular edema,disease,0.864,33078109
12728,CME,disease,1.0,33078109
12729,Irvine-Gass syndrome,disease,1.0,33078109
12730,IGS,disease,1.0,33078109
12731,pseudophakic CME,disease,0.957,33078109
12732,vascular endothelial growth factor,gene,0.9873,33078109
12733,VEGF,gene,0.993,33078109
12734,retinal nerve fiber,cell_type,0.5103,33078109
12735,ganglion cell layer,cell_type,0.5356,33078109
12736,CME,disease,1.0,33078109
12737,bevacizumab,gene,0.8423,33078109
12738,ranibizumab,gene,0.806,33078109
12739,aflibercept,gene,0.9893,33078109
12740,CME,disease,0.9976,33078109
12741,CME,disease,1.0,33078109
12742,CME,disease,1.0,33078109
12743,bevacizumab,gene,0.5527,33078109
12744,AFlibercept,gene,0.9907,33077475
12745,diabeTic retinopathY,disease,1.0,33077475
12746,aflibercept,gene,0.9927,33077475
12747,diabetic retinopathy,disease,1.0,33077475
12748,DR,disease,0.9995,33077475
12749,fluorescein,drug,0.9937,33077475
12750,DR,disease,0.9995,33077475
12751,retinal nonperfusion,disease,0.9907,33077475
12752,macular edema,disease,1.0,33077475
12753,aflibercept,gene,0.988,33077475
12754,retinal nonperfusion,disease,0.999,33077475
12755,aflibercept,gene,0.983,33077475
12756,nonproliferative diabetic retinopathy,disease,1.0,33077475
12757,NPDR,disease,0.9976,33077475
12758,PDR,disease,0.9995,33077475
12759,aflibercept,gene,0.9873,33077475
12760,capillary nonperfusion,disease,0.9985,33077475
12761,DR,disease,0.9995,33077475
12762,macular edema,disease,1.0,33077475
12763,NPDR,disease,1.0,33077475
12764,aflibercept,gene,0.963,33077475
12765,Aflibercept,gene,0.967,33077473
12766,retinal pericyte,cell_type,0.8247,33077473
12767,streptozotocin,drug,1.0,33077473
12768,diabetic,disease,0.973,33077473
12769,mice,species,0.9214,33077473
12770,vascular endothelial growth factor,gene,0.9946,33077473
12771,VEGF,gene,0.996,33077473
12772,diabetic retinopathy,disease,1.0,33077473
12773,DR,disease,0.9995,33077473
12774,glucose,drug,0.987,33077473
12775,DR,disease,0.584,33077473
12776,pericyte,cell_type,0.8335,33077473
12777,aflibercept,gene,0.9775,33077473
12778,DR,disease,0.995,33077473
12779,streptozotocin,drug,1.0,33077473
12780,STZ,drug,0.9995,33077473
12781,DR,disease,0.6504,33077473
12782,STZ,drug,0.998,33077473
12783,mice,species,0.961,33077473
12784,mice,species,0.9565,33077473
12785,aflibercept,gene,0.9907,33077473
12786,STZ,drug,0.995,33077473
12787,fluorescein,drug,0.9976,33077473
12788,mice,species,0.99,33077473
12789,STZ,drug,0.9985,33077473
12790,platelet-derived growth factor receptor-,gene,0.995,33077473
12791,pericyte,cell_type,0.7666,33077473
12792,CD45,gene,0.9917,33077473
12793,fluorescein isothiocyanate,drug,0.999,33077473
12794,VEGF,gene,0.993,33077473
12795,aflibercept,gene,0.984,33077473
12796,pericyte,cell_type,0.745,33077473
12797,mice,species,0.9233,33077473
12798,diabetes retina,disease,0.975,33077473
12799,DR,disease,0.9946,33077473
12800,pericytes,cell_type,0.862,33077473
12801,hyperpermeability,disease,0.9883,33077473
12802,leukocytes,cell_type,0.88,33077473
12803,leukocyte,cell_type,0.608,33077473
12804,diabetic,disease,0.9976,33077473
12805,pericyte,cell_type,0.8184,33077473
12806,aflibercept,gene,0.983,33077473
12807,mice,species,0.897,33077473
12808,diabetes,disease,1.0,33077473
12809,VEGF,gene,0.994,33077473
12810,Aflibercept,gene,0.91,33077473
12811,pericyte,cell_type,0.791,33077473
12812,diabetic,disease,1.0,33077473
12813,VEGF,gene,0.9507,33077473
12814,aflibercept,gene,0.9844,33077473
12815,leukocyte,cell_type,0.7646,33077473
12816,retinal hypoperfusion,disease,0.9985,33077473
12817,hyperpermeability,disease,0.9966,33077473
12818,mice,species,0.9194,33077473
12819,diabetes,disease,1.0,33077473
12820,pericyte,cell_type,0.811,33077473
12821,VEGF,gene,0.935,33077473
12822,DR,disease,0.9985,33077473
12823,ziv-aflibercept,gene,0.9795,33076864
12824,myopic choroidal neovascularisation,disease,1.0,33076864
12825,patients,species,0.9893,33076864
12826,Myopic choroidal neovascularization,disease,1.0,33076864
12827,CNV,disease,1.0,33076864
12828,high myopia,disease,1.0,33076864
12829,ziv-aflibercept,gene,0.98,33076864
12830,patients,species,0.9556,33076864
12831,myopic CNV,disease,1.0,33076864
12832,patients,species,0.986,33076864
12833,myopic CNV,disease,1.0,33076864
12834,patients,species,0.987,33076864
12835,patients,species,0.973,33076864
12836,CNV,disease,0.9756,33076864
12837,Patients,species,0.984,33076864
12838,myopic CNV,disease,1.0,33076864
12839,patients,species,0.9917,33076864
12840,CNV,disease,1.0,33076864
12841,BCVA,cell_type,0.4226,33076864
12842,Ziv-aflibercept,gene,0.9663,33076864
12843,myopic CNV,disease,1.0,33076864
12844,patients,species,0.9893,33076864
12845,macular edema,disease,1.0,33070137
12846,branch retinal vein occlusion,disease,0.999,33070137
12847,vascular endothelial growth factor,gene,0.9985,33070137
12848,VEGF,gene,0.989,33070137
12849,macular edema,disease,1.0,33070137
12850,branch retinal vein occlusion,disease,0.999,33070137
12851,Macular edema,disease,1.0,33070137
12852,branch retinal vein occlusion,disease,1.0,33070137
12853,macular edema,disease,1.0,33070137
12854,aflibercept,gene,0.9727,33070137
12855,macular edema,disease,1.0,33070137
12856,branch retinal vein occlusion,disease,1.0,33070137
12857,aflibercept,gene,0.993,33070137
12858,aflibercept,gene,0.993,33070137
12859,branch retinal vein occlusion,disease,0.9995,33070137
12860,macular edema,disease,1.0,33070137
12861,macular edema,disease,1.0,33070137
12862,aflibercept,gene,0.9756,33069198
12863,neovascular age related macular degeneration,disease,1.0,33069198
12864,anti-vascular endothelial growth factors,gene,0.939,33069198
12865,anti-VEGFs,gene,0.93,33069198
12866,oncologic,disease,0.9966,33069198
12867,aflibercept,gene,0.985,33069198
12868,cardiovascular disease,disease,1.0,33069198
12869,PATIENTS,species,0.804,33069198
12870,neovascular age related macular degeneration,disease,1.0,33069198
12871,aflibercept,gene,0.967,33069198
12872,cardiovascular disease,disease,1.0,33069198
12873,aflibercept,gene,0.9897,33069198
12874,aflibercept,gene,0.9814,33069198
12875,homocysteine,drug,0.999,33069198
12876,cholesterol,drug,0.9995,33069198
12877,triglycerides,drug,1.0,33069198
12878,high density lipoprotein cholesterol,gene,0.992,33069198
12879,cholesterol,drug,0.998,33069198
12880,low density lipoprotein cholesterol,gene,0.987,33069198
12881,cholesterol,drug,0.999,33069198
12882,C-reactive protein,gene,0.9966,33069198
12883,aflibercept,gene,0.986,33069198
12884,aflibercept,gene,0.979,33069198
12885,neovascular age-related macular degeneration,disease,1.0,33069198
12886,cardiovascular disease,disease,1.0,33069198
12887,VEGF-A,gene,0.9985,33065984
12888,ERK,gene,0.996,33065984
12889,PLA2,gene,0.9946,33065984
12890,Retinal Endothelial Cell,cell_type,0.843,33065984
12891,Glucose,drug,0.9985,33065984
12892,Diabetic Retinopathy,disease,1.0,33065984
12893,hyperglycemia,disease,1.0,33065984
12894,phospholipase A2,gene,0.9946,33065984
12895,PLA2,gene,0.992,33065984
12896,endothelial,DNA,0.521,33065984
12897,endothelial growth factor A,gene,0.974,33065984
12898,VEGF-A,gene,0.998,33065984
12899,VEGF-A,gene,0.9976,33065984
12900,glucose,drug,0.9893,33065984
12901,human retinal endothelial cells,cell_type,0.9023,33065984
12902,HRECs,cell_type,0.7964,33065984
12903,Ca++,drug,0.977,33065984
12904,Ca++,drug,0.9917,33065984
12905,Ca++-independent (iPLA2),gene,0.8003,33065984
12906,PLA2s,gene,0.8086,33065984
12907,HRECs,cell_line,0.809,33065984
12908,glucose,drug,0.997,33065984
12909,glucose,drug,0.996,33065984
12910,VEGF,gene,0.9893,33065984
12911,Aflibercept,gene,0.5376,33065984
12912,Afl,gene,0.95,33065984
12913,cPLA2,gene,0.9834,33065984
12914,arachidonoyl trifluoromethyl ketone,drug,0.9995,33065984
12915,AACOCF3,drug,0.999,33065984
12916,iPLA2,gene,0.89,33065984
12917,bromoenol lactone,drug,0.9688,33065984
12918,BEL,drug,0.933,33065984
12919,VEGF-A,gene,0.997,33065984
12920,Afl,drug,0.988,33065984
12921,AACOCF3,drug,0.999,33065984
12922,MTT,drug,0.9995,33065984
12923,LDH,gene,0.982,33065984
12924,VEGF-A mRNA,gene,0.8984,33065984
12925,Afl,drug,0.9946,33065984
12926,phospho,drug,0.955,33065984
12927,phospho-ERK,gene,0.9707,33065984
12928,phospho,drug,0.7837,33065984
12929,phospho-cPLA2,gene,0.953,33065984
12930,VEGF-A,gene,0.994,33065984
12931,glucose,drug,0.9985,33065984
12932,phospho,drug,0.8477,33065984
12933,phospho-ERK,gene,0.9883,33065984
12934,phospho-cPLA2,gene,0.9937,33065984
12935,iPLA2,gene,0.9717,33065984
12936,cPLA2,gene,0.984,33065984
12937,VEGF-A,gene,0.9966,33065984
12938,iPLA2,gene,0.9854,33065984
12939,VEGF-A,gene,0.997,33065984
12940,glucose,drug,0.9995,33065984
12941,ERK1/2,gene,0.977,33065984
12942,PLA2,gene,0.993,33065984
12943,pterygium,disease,0.9893,33063967
12944,pterygium,disease,0.5986,33063967
12945,pterygium,DNA,0.668,33063967
12946,mitomycin C,drug,0.973,33063967
12947,aflibercept,gene,0.9937,33063967
12948,VEGF,gene,0.7183,33063961
12949,pterygium,disease,0.497,33063961
12950,pterygium,disease,0.708,33063961
12951,aflibercept,gene,0.8613,33063961
12952,pterygium,disease,0.843,33063961
12953,PLK,gene,0.816,33063961
12954,aflibercept,gene,0.978,33063961
12955,VEGF,gene,0.9526,33063961
12956,BCVA,DNA,0.507,33063961
12957,VEGF,gene,0.8916,33063961
12958,pterygium,DNA,0.461,33063961
12959,fibrovascular proliferation,disease,0.8315,33063961
12960,Aflibercept,gene,0.741,33058069
12961,aflibercept,gene,0.971,33058069
12962,polypoidal choroidal vasculopathy,disease,1.0,33058069
12963,PCV,disease,1.0,33058069
12964,patients,species,0.988,33058069
12965,PCV,disease,1.0,33058069
12966,patients,species,0.9795,33058069
12967,IVA,drug,0.641,33058069
12968,patients,species,0.981,33058069
12969,retinal exudation,disease,1.0,33058069
12970,patient,species,0.986,33058069
12971,CRT,DNA,0.5522,33058069
12972,CRT,DNA,0.4868,33058069
12973,polypoidal lesions,disease,1.0,33058069
12974,patients,species,0.9727,33058069
12975,PCV,disease,1.0,33058069
12976,patient,species,0.9795,33058069
12977,Endophthalmitis,disease,1.0,33055554
12978,retinal vasculitis,disease,1.0,33055554
12979,aflibercept,gene,0.9805,33055554
12980,endophthalmitis,disease,1.0,33055554
12981,streptococcus salivarius,species,0.966,33055554
12982,retinal vasculitis,disease,1.0,33055554
12983,hemorrhagic retinal vasculitis,disease,1.0,33055554
12984,endophthalmitis,disease,1.0,33055554
12985,aflibercept,gene,0.994,33055554
12986,Streptococcus salivarius,species,0.974,33055554
12987,endophthalmitis,disease,1.0,33055554
12988,hemorrhagic retinal,disease,0.9995,33055554
12989,vasculitis,disease,0.726,33055554
12990,infectious endophthalmitis,disease,0.9995,33055554
12991,ocular inflammation,disease,1.0,33055554
12992,aflibercept,gene,0.983,33048236
12993,neovascular age-related macular degeneration,disease,1.0,33048236
12994,neovascular age-related macular degeneration,disease,1.0,33048236
12995,nAMD,disease,1.0,33048236
12996,aflibercept,gene,0.9824,33048236
12997,nAMD,disease,1.0,33048236
12998,aflibercept,gene,0.9746,33048236
12999,nAMD,disease,1.0,33048236
13000,TCA,drug,0.918,33048236
13001,dry macula,disease,0.999,33048236
13002,aflibercept,gene,0.978,33048236
13003,nAMD,disease,1.0,33048236
13004,neovascular lesion,disease,0.999,33048236
13005,aflibercept,gene,0.9814,33048236
13006,vascular endothelial growth factor,gene,0.8184,33044671
13007,vascular endothelial growth factor,gene,0.9043,33044671
13008,VEGF,gene,0.999,33044671
13009,vitreoretinal disorders,disease,1.0,33044671
13010,VEGF,gene,0.985,33044671
13011,VEGF,gene,0.728,33044671
13012,choroidal neovascularization,disease,1.0,33044671
13013,CNV,disease,1.0,33044671
13014,retinal vascular occlusion,disease,1.0,33044671
13015,RVO,disease,1.0,33044671
13016,neovascular glaucoma,disease,1.0,33044671
13017,diabetic retinopathy,disease,1.0,33044671
13018,DR,disease,1.0,33044671
13019,diabetic macular edema,disease,1.0,33044671
13020,DME,disease,1.0,33044671
13021,VEGF,gene,0.9175,33044671
13022,ranibizumab,gene,0.6997,33044671
13023,Women,species,0.8975,33044671
13024,VEGF,gene,0.9717,33044671
13025,ranibizumab,gene,0.8384,33044671
13026,aflibercept,gene,0.9893,33044671
13027,bevacizumab,gene,0.8096,33044671
13028,Vascular Endothelial Growth Factor,gene,0.96,33039592
13029,Anti-Vascular Endothelial Growth Factor,gene,0.9976,33031788
13030,a-VEGF,gene,0.994,33031788
13031,ranibizumab,gene,0.5127,33031788
13032,ranibizumab,gene,0.831,33031788
13033,anti-VEGF,gene,0.675,33031788
13034,vitreous humor,disease,0.9995,33031788
13035,anti-VEGF,gene,0.8843,33031788
13036,ranibizumab,gene,0.692,33031788
13037,bevacizumab,gene,0.9243,33031788
13038,aflibercept,gene,0.984,33031788
13039,phosphate,drug,0.995,33031788
13040,bevacizumab,gene,0.9673,33031788
13041,aflibercept,gene,0.9883,33031788
13042,ranibizumab,gene,0.7544,33031788
13043,Ranibizumab,gene,0.8716,33031788
13044,bevacizumab,gene,0.9688,33031788
13045,aflibercept,gene,0.994,33031788
13046,VEGF,gene,0.9937,33031788
13047,Vascular Endothelial Growth Factor,gene,0.998,33026900
13048,Post-injection Endophthalmitis,disease,0.8545,33026900
13049,vascular endothelial growth factor,gene,0.974,33026900
13050,VEGF,gene,0.8037,33026900
13051,bevacizumab,gene,0.8784,33026900
13052,ranibizumab,gene,0.8594,33026900
13053,aflibercept,gene,0.9487,33026900
13054,post-injection endophthalmitis,disease,1.0,33026900
13055,PIE,disease,0.9995,33026900
13056,PIE,disease,0.842,33026900
13057,anti-VEGF,gene,0.9634,33026900
13058,PIE,disease,0.9995,33026900
13059,PIE,disease,0.999,33026900
13060,PIE,disease,0.999,33026900
13061,PIE,disease,0.944,33026900
13062,VEGF,gene,0.702,33026900
13063,PIE,disease,0.9946,33026900
13064,aflibercept,gene,0.9766,33024885
13065,submacular vascularized pigment epithelial detachment,disease,1.0,33024885
13066,neovascular AMD,disease,1.0,33024885
13067,PED,disease,0.999,33024885
13068,aflibercept,gene,0.978,33024885
13069,neovascular age-related macular degeneration,disease,1.0,33024885
13070,nAMD,disease,1.0,33024885
13071,aflibercept,gene,0.983,33024885
13072,AMD,disease,1.0,33024885
13073,aflibercept,gene,0.9575,33024885
13074,aflibercept,gene,0.9663,33024885
13075,aflibercept,gene,0.9785,33024885
13076,fluorescein,drug,0.9854,33024885
13077,Indocyanine-green,drug,0.9966,33024885
13078,PED,DNA,0.4963,33024885
13079,PED,DNA,0.5205,33024885
13080,fibrovascular PED,DNA,0.5205,33024885
13081,SRF,disease,0.7095,33024885
13082,PED,disease,0.6274,33024885
13083,SHRM,disease,0.6274,33024885
13084,anti-VEGF,gene,0.9126,33024885
13085,RPE tears,disease,0.999,33024885
13086,Geographic atrophy,disease,1.0,33024885
13087,GA,disease,1.0,33024885
13088,vPED,disease,1.0,33024885
13089,aflibercept,gene,0.967,33024885
13090,PED,disease,0.959,33024885
13091,PED,disease,0.9863,33024885
13092,RPE,cell_type,0.4297,33024885
13093,RPE tears,disease,0.9434,33024885
13094,vPED,disease,1.0,33024885
13095,PED,disease,0.7905,33024885
13096,GA,disease,0.999,33024885
13097,VEGF,gene,0.52,33024885
13098,DMO,disease,1.0,33020570
13099,aflibercept,gene,0.921,33020570
13100,diabetic macular oedema,disease,1.0,33020570
13101,DMO,disease,1.0,33020570
13102,aflibercept,gene,0.899,33020570
13103,DMO,disease,0.994,33020570
13104,aflibercept,gene,0.954,33020570
13105,aflibercept,gene,0.927,33020570
13106,patients,species,0.965,33020570
13107,DMO,disease,1.0,33020570
13108,aflibercept,gene,0.9214,33020570
13109,Patients,species,0.9863,33020570
13110,patients,species,0.986,33020570
13111,patients,species,0.9814,33020570
13112,DMO,disease,1.0,33020570
13113,aflibercept,gene,0.9756,33020570
13114,Bevacizumab,gene,0.929,33011724
13115,Aflibercept,gene,0.9907,33011724
13116,RPE,cell_type,0.775,33011724
13117,VEGF,gene,0.862,33011724
13118,age-related macular degeneration,disease,1.0,33011724
13119,retinal pigment epithelial cells,cell_type,0.913,33011724
13120,VEGF,gene,0.5283,33011724
13121,bevacizumab,gene,0.868,33011724
13122,aflibercept,gene,0.9844,33011724
13123,primary porcine RPE cells,cell_type,0.876,33011724
13124,porcine,species,0.772,33011724
13125,ARPE-19 cell line,cell_line,0.97,33011724
13126,bevacizumab,gene,0.7666,33011724
13127,aflibercept,gene,0.9805,33011724
13128,VEGF,gene,0.997,33011724
13129,rituximab,gene,0.7905,33011724
13130,MTT,drug,0.9995,33011724
13131,actin,gene,0.9346,33011724
13132,phalloidin,drug,0.9946,33011724
13133,Lamp2,gene,0.9834,33011724
13134,exosomes,cell_type,0.7773,33011724
13135,CD63,gene,0.9946,33011724
13136,RPE cells,cell_type,0.874,33011724
13137,bevacizumab,gene,0.9644,33011724
13138,aflibercept,gene,0.994,33011724
13139,bevacizumab,gene,0.971,33011724
13140,aflibercept,gene,0.9907,33011724
13141,primary RPE,cell_line,0.658,33011724
13142,aflibercept,gene,0.996,33011724
13143,Lamp2,gene,0.9814,33011724
13144,aflibercept,gene,0.994,33011724
13145,primary RPE cells,cell_line,0.795,33011724
13146,CD63,gene,0.9927,33011724
13147,bevacizumab,gene,0.826,33011724
13148,aflibercept,gene,0.99,33011724
13149,Actin,gene,0.9883,33011724
13150,bevacizumab,gene,0.9487,33011724
13151,aflibercept,gene,0.992,33011724
13152,RPE cells,cell_type,0.893,33011724
13153,actin,gene,0.998,33011724
13154,aflibercept,gene,0.993,33011724
13155,RPE cells,cell_type,0.9004,33011724
13156,aflibercept,gene,0.9937,33011724
13157,Lamp2,gene,0.9824,33011724
13158,bevacizumab,gene,0.6133,33011724
13159,RPE cells,cell_type,0.912,33011724
13160,aflibercept,gene,0.994,33011724
13161,patients,species,0.9795,33009973
13162,neovascular exudative AMD,disease,1.0,33009973
13163,coronavirus disease,disease,1.0,33009973
13164,COVID,disease,0.9995,33009973
13165,patients,species,0.9897,33009973
13166,neovascular age-related macular degeneration,disease,1.0,33009973
13167,AMD,disease,1.0,33009973
13168,patients,species,0.991,33009973
13169,neovascular AMD,disease,1.0,33009973
13170,COVID-19,disease,0.6978,33009973
13171,patients,species,0.983,33009973
13172,patients,species,0.977,33009973
13173,neovascular AMD,disease,1.0,33009973
13174,COVID-19,disease,0.9834,33009973
13175,patient,species,0.925,33009973
13176,patients,species,0.984,33009973
13177,pachychoroid neovasculopathy,disease,1.0,33004959
13178,choroidal neovascularization,disease,1.0,33004959
13179,pachychoroid neovasculopathy,disease,1.0,33004959
13180,pachychoroid neovasculopathy,disease,1.0,33004959
13181,patients,species,0.9697,33004959
13182,pachychoroid neovasculopathy,disease,1.0,33004959
13183,Subretinal hemorrhage,disease,1.0,33004959
13184,SRH,disease,1.0,33004959
13185,SRH,disease,0.9995,33004959
13186,aflibercept,gene,0.9893,33004959
13187,SRH,gene,0.934,33004959
13188,Polypoidal lesions,disease,1.0,33004959
13189,SRH,disease,0.9995,33004959
13190,SRH,disease,0.999,33004959
13191,risk allele,DNA,0.6714,33004959
13192,ARMS2,gene,0.993,33004959
13193,A69,mutation,,33004959
13194,CFH I62V,gene,0.8022,33004959
13195,I62V,DNA,0.4387,33004959
13196,I62,mutation,,33004959
13197,CFH,gene,0.9907,33004959
13198,Y402,mutation,,33004959
13199,SRH,disease,0.9995,33004959
13200,choroidal vascular hyperpermiability,disease,1.0,33004959
13201,polypoidal lesion,disease,1.0,33004959
13202,polypoidal lesion,disease,1.0,33004959
13203,patients,species,0.96,33004959
13204,pachychoroid neovasculopathy,disease,1.0,33004959
13205,SRH,disease,0.6553,33004959
13206,BCVA,DNA,0.4487,33004959
13207,Vascular Endothelial Growth Factor,gene,0.9604,33002672
13208,Macular Edema,disease,1.0,33002672
13209,Central Retinal Vein Occlusion,disease,1.0,33002672
13210,macular edema,disease,1.0,33002672
13211,central retinal vein occlusion,disease,1.0,33002672
13212,CRVO,disease,1.0,33002672
13213,vascular,gene,0.647,33002672
13214,VEGF,gene,0.996,33002672
13215,bevacizumab,gene,0.7935,33002672
13216,ranibizumab,gene,0.91,33002672
13217,aflibercept,gene,0.9663,33002672
13218,PARTICIPANTS,species,0.688,33002672
13219,Eylea,drug,0.7554,33002672
13220,Vein Occlusion,disease,0.999,33002672
13221,bevacizumab,gene,0.511,33002672
13222,ranibizumab,gene,0.888,33002672
13223,aflibercept,gene,0.981,33002672
13224,macular edema,disease,1.0,33002672
13225,CRVO,disease,1.0,33002672
13226,macular edema,disease,1.0,33002672
13227,CRVO,disease,1.0,33002672
13228,VEGF,gene,0.7363,33002672
13229,aflibercept,gene,0.926,33002672
13230,aflibercept,gene,0.9834,32999475
13231,central retinal artery occlusions,disease,0.994,32999475
13232,fluocinolone acetonide,drug,0.9995,32995665
13233,Iluvien,drug,0.999,32995665
13234,pseudophakic,disease,0.7114,32995665
13235,fluocinolone acetonide,drug,0.9995,32995665
13236,Iluvien,drug,0.999,32995665
13237,pseudophakic,disease,0.9185,32995665
13238,proliferative,disease,0.813,32995665
13239,diabetic retinopathy,disease,0.911,32995665
13240,diabetic macular edema,disease,1.0,32995665
13241,DME,disease,1.0,32995665
13242,Aflibercept,gene,0.9595,32995665
13243,Iluvien,drug,0.9697,32995665
13244,DME,disease,1.0,32995665
13245,dexamethasone,drug,0.9707,32995665
13246,Ozurdex,drug,0.981,32995665
13247,Iluvien,drug,0.8306,32995665
13248,Iluvien,drug,0.9385,32995665
13249,glaucoma,disease,0.8765,32995665
13250,glaucoma,disease,0.799,32995665
13251,Iluvien,drug,0.9604,32995665
13252,Metastatic Colorectal Cancer,disease,1.0,32988968
13253,Tumor,disease,0.5923,32988968
13254,cancer,disease,1.0,32988968
13255,tumor,disease,0.979,32988968
13256,aflibercept,gene,0.985,32988968
13257,panitumumab,gene,0.93,32988968
13258,advanced colorectal cancer,disease,1.0,32988968
13259,metastatic lesions,disease,0.882,32988968
13260,panitumumab,gene,0.8877,32988968
13261,aflibercept,gene,0.9746,32988968
13262,tumor,disease,0.947,32988968
13263,tumor,disease,0.8906,32988968
13264,tumor,disease,0.875,32988968
13265,colorectal cancer,disease,1.0,32988968
13266,Vascular Endothelial Growth Factor,gene,0.862,32983733
13267,diabetic macular edema,disease,1.0,32983733
13268,DMO,disease,1.0,32983733
13269,vascular endothelial growth factor,gene,0.893,32983733
13270,VEGF,gene,0.8447,32983733
13271,patients,species,0.986,32983733
13272,anti-VEGF,gene,0.9546,32983733
13273,patient,species,0.989,32983733
13274,patients,species,0.9883,32983733
13275,DMO,drug,0.946,32983733
13276,Patients,species,0.989,32983733
13277,patients,species,0.988,32983733
13278,Patient,species,0.9795,32983733
13279,VEGF,gene,0.674,32983733
13280,DMO,disease,1.0,32983733
13281,VEGF,gene,0.988,32983733
13282,patient,species,0.9897,32983733
13283,patients,species,0.976,32983733
13284,congenital hypertrophy of the retinal pigment epithelium,disease,1.0,32971696
13285,CHRPE,disease,1.0,32971696
13286,woman,species,0.925,32971696
13287,visual loss,disease,0.997,32971696
13288,CHRPE,disease,1.0,32971696
13289,CNVM,disease,1.0,32971696
13290,patient,species,0.981,32971696
13291,aflibercept,gene,0.8804,32971696
13292,CNVM,DNA,0.5835,32971696
13293,CHRPE,disease,1.0,32971696
13294,CNVM,disease,1.0,32971696
13295,Non-arteritic anterior ischemic optic neuropathy,disease,1.0,32969978
13296,aflibercept,gene,0.989,32969978
13297,non-arteritic anterior ischemic optic neuropathy,disease,1.0,32969978
13298,NAION,disease,1.0,32969978
13299,patient,species,0.911,32969978
13300,NAION,disease,0.993,32969978
13301,woman,species,0.9097,32969978
13302,NAION,disease,0.9995,32969978
13303,aflibercept,gene,0.974,32969978
13304,neovascular age-related macular degeneration,disease,1.0,32969978
13305,AMD,disease,1.0,32969978
13306,optic disc edema,disease,1.0,32969978
13307,NAION,disease,1.0,32969978
13308,vasoconstriction,disease,0.6885,32969978
13309,vascular endothelial growth factor,gene,0.9126,32969978
13310,NAION,disease,0.9995,32969978
13311,patients,species,0.986,32969978
13312,NAION,disease,1.0,32969978
13313,Glaucomatous,disease,0.9995,32964169
13314,Anti-vascular endothelial growth factor,gene,0.918,32964169
13315,VEGF,gene,0.998,32964169
13316,retinal vascular conditions,disease,0.999,32964169
13317,ocular hypertension,disease,0.998,32964169
13318,normal-tension glaucoma,disease,1.0,32964169
13319,NTG,disease,1.0,32964169
13320,anti-VEGF,gene,0.9434,32964169
13321,HRVO,disease,0.8296,32964169
13322,macular edema,disease,1.0,32964169
13323,patient,species,0.9756,32964169
13324,aflibercept,gene,0.984,32964169
13325,aflibercept,gene,0.9883,32964169
13326,retinal nerve fiber,cell_type,0.4995,32964169
13327,patient,species,0.9756,32964169
13328,normal tension glaucoma,disease,0.9785,32964169
13329,patient,species,0.9893,32964169
13330,timolol,drug,0.9937,32964169
13331,glaucomatous,disease,0.9844,32964169
13332,NTG,disease,1.0,32964169
13333,patient,species,0.964,32964169
13334,NTG,disease,0.926,32964169
13335,glaucoma optic neuropathy,disease,1.0,32964169
13336,Polygenic,DNA,0.47,32962278
13337,polygenic,DNA,0.538,32962278
13338,aflibercept,gene,0.98,32962278
13339,exudative age-related macular degeneration,disease,0.9976,32962278
13340,AMD,disease,1.0,32962278
13341,AMD,disease,1.0,32962278
13342,polypoidal choroidal vasculopathy,disease,1.0,32962278
13343,patients,species,0.9805,32962278
13344,aflibercept,gene,0.99,32962278
13345,ARMS2,DNA,0.5376,32962278
13346,ARMS2 A69S,gene,0.8267,32962278
13347,A69S,mutation,,32962278
13348,rs10490924,DNA,0.8325,32962278
13349,rs10490924,mutation,,32962278
13350, CFH I62,mutation,,32962278
13351,CFH I62V,gene,0.8315,32962278
13352,I62V,mutation,,32962278
13353,rs800292,gene,0.785,32962278
13354,rs800292,mutation,,32962278
13355,SKIV2L,gene,0.9844,32962278
13356,C2,gene,0.998,32962278
13357,CFB,gene,0.9956,32962278
13358,rs429608,DNA,0.8477,32962278
13359,rs429608,mutation,,32962278
13360,C3,gene,,32962278
13361,rs2241394,DNA,0.799,32962278
13362,rs2241394,mutation,,32962278
13363,ADAMTS-9,DNA,0.807,32962278
13364,ADAMTS-,gene,0.942,32962278
13365,rs6795735,DNA,0.5845,32962278
13366,rs6795735,mutation,,32962278
13367, and CETP,mutation,,32962278
13368,CETP,gene,0.984,32962278
13369,rs3764261,DNA,0.8584,32962278
13370,rs3764261,mutation,,32962278
13371,participants,species,0.981,32962278
13372,PRSs,DNA,0.7783,32962278
13373,PRS,DNA,0.865,32962278
13374,ARMS2,gene,0.991,32962278
13375,CFH,gene,0.993,32962278
13376,C3,gene,,32962278
13377,ADAMTS-9,gene,0.9893,32962278
13378,patients,species,0.9873,32962278
13379,patients,species,0.988,32962278
13380,patients,species,0.992,32962278
13381,patients,species,0.992,32962278
13382,PRS,DNA,0.5938,32962278
13383,ARMS2,gene,0.9863,32962278
13384,CFH,gene,0.9824,32962278
13385,PRSs,DNA,0.845,32962278
13386,PRS,DNA,0.7046,32962278
13387,ARMS2,gene,0.9897,32962278
13388,CFH,gene,0.99,32962278
13389,PRS,DNA,0.5703,32962278
13390,high,DNA,0.847,32962278
13391,exudative AMD,disease,1.0,32962278
13392,conbercept,gene,0.885,32953739
13393,conbercept,gene,0.8467,32953739
13394,aflibercept,gene,0.9453,32953739
13395,ranibizumab,gene,0.5034,32953739
13396,patients,species,0.982,32953739
13397,age-related macular degeneration,disease,1.0,32953739
13398,wAMD,disease,1.0,32953739
13399,conbercept,gene,0.742,32953739
13400,aflibercept,gene,0.9893,32953739
13401,ranibizumab,gene,0.761,32953739
13402,patients,species,0.98,32953739
13403,wAMD,disease,0.9995,32953739
13404,patient,species,0.9897,32953739
13405,anti-vascular endothelial growth factor,gene,0.966,32953739
13406,VEGF,gene,0.997,32953739
13407,AFL,gene,0.9844,32953739
13408,aflibercept,gene,0.9453,32953739
13409,ranibizumab,gene,0.8755,32953739
13410,ranibizumab,gene,0.905,32953739
13411,blindness,disease,0.9106,32953739
13412,wAMD,disease,0.931,32953739
13413,vascular endothelial growth factor,gene,0.915,32953000
13414,debilitating neurodegenerative disease,disease,1.0,32953000
13415,neovascular age-related macular degeneration,disease,1.0,32953000
13416,nAMD,disease,1.0,32953000
13417,visual loss,disease,0.999,32953000
13418,legal blindness,disease,1.0,32953000
13419,AMD,disease,1.0,32953000
13420,patients,species,0.9937,32953000
13421,vascular endothelial growth factor,gene,0.9517,32953000
13422,VEGF,gene,0.996,32953000
13423,nAMD,disease,0.982,32953000
13424,nAMD,disease,1.0,32953000
13425,nAMD,disease,1.0,32953000
13426,VEGF,gene,0.508,32953000
13427,ISRCTN,DNA,0.5195,32953000
13428,VEGF,gene,0.847,32953000
13429,patients,species,0.9746,32953000
13430,arterial thromboembolic,disease,1.0,32953000
13431,ATC,disease,0.979,32953000
13432,participants,species,0.9404,32953000
13433,patients,species,0.9824,32953000
13434,participants,species,0.9663,32953000
13435,ranibizumab,gene,0.5054,32953000
13436,ranibizumab,gene,0.7236,32953000
13437,ATC,disease,1.0,32953000
13438,participants,species,0.962,32953000
13439,ranibizumab,gene,0.798,32953000
13440,aflibercept,gene,0.9736,32953000
13441,VEGF,gene,0.6377,32953000
13442,nAMD,disease,1.0,32953000
13443,Bevacizumab,gene,0.8086,32953000
13444,VEGF,gene,0.928,32953000
13445,Pegaptanib,drug,0.9937,32953000
13446,Conbercept,drug,0.5044,32953000
13447,nAMD,disease,1.0,32953000
13448,patients,species,0.996,32953000
13449,Aflibercept,gene,0.9683,32946007
13450,aflibercept,gene,0.9106,32946007
13451,AFL,gene,0.693,32946007
13452,patients,species,0.9824,32946007
13453,anti-vascular endothelial growth factor,gene,0.981,32946007
13454,VEGF,gene,0.9966,32946007
13455,neovascular age-related macular degeneration,disease,1.0,32946007
13456,nAMD,disease,1.0,32946007
13457,Patients,species,0.9814,32946007
13458,patients,species,0.9775,32946007
13459,patients,species,0.9814,32946007
13460,patients,species,0.9834,32946007
13461,patients,species,0.98,32946007
13462,patients,species,0.991,32946007
13463,Diabetic Retinopathy,disease,0.9995,32946007
13464,ETDRS,DNA,0.4844,32946007
13465,BCVA,cell_type,0.4026,32946007
13466,patients,species,0.9873,32946007
13467,patients,species,0.99,32946007
13468,ETDRS,DNA,0.5713,32946007
13469,ETDRS,DNA,0.4773,32946007
13470,patients,species,0.981,32946007
13471,nAMD,disease,1.0,32946007
13472,patients,species,0.956,32946007
13473,anti-VEGF,gene,0.8066,32943041
13474,VEGF,gene,0.8574,32943041
13475,aflibercept,gene,0.964,32943041
13476,ranibizumab,gene,0.882,32943041
13477,bevacizumab,gene,0.6865,32943041
13478,diabetic macular edema,disease,1.0,32943041
13479,DME,disease,1.0,32943041
13480,DME,disease,0.998,32943041
13481,patients,species,0.977,32943041
13482,anti-VEGF,gene,0.9424,32943041
13483,patients,species,0.963,32943041
13484,DME,disease,1.0,32943041
13485,aflibercept,gene,0.989,32943041
13486,ranibizumab,gene,0.961,32943041
13487,bevacizumab,gene,0.8716,32943041
13488,DME,disease,0.9995,32943041
13489,aflibercept,gene,0.969,32943041
13490,patients,species,0.981,32943041
13491,bevacizumab,gene,0.5337,32943041
13492,patients,species,0.941,32943041
13493,bevacizumab,drug,0.9683,32943041
13494,patients,species,0.9766,32943041
13495,aflibercept,gene,0.978,32943041
13496,ranibizumab,gene,0.514,32943041
13497,patients,species,0.988,32943041
13498,patients,species,0.9727,32943041
13499,DME,disease,0.9995,32943041
13500,aflibercept,gene,0.922,32943041
13501,ranibizumab,gene,0.7153,32943041
13502,bevacizumab,gene,0.744,32943041
13503,anti-VEGF,gene,0.9814,32943041
13504,patient,species,0.9805,32943041
13505,aflibercept,gene,0.9844,32943041
13506,ranibizumab,gene,0.895,32943041
13507,bevacizumab,gene,0.822,32943041
13508,patients,species,0.993,32943041
13509,patient,species,0.9893,32943041
13510,Colorectal Carcinoma,disease,1.0,32933095
13511,colorectal cancer,disease,1.0,32933095
13512,CRC,disease,1.0,32933095
13513,CRC,disease,0.998,32933095
13514,cancer,disease,1.0,32933095
13515,unresectable tumors,disease,0.88,32933095
13516,CRC cells,cell_line,0.7896,32933095
13517,CRC,disease,0.9995,32933095
13518,pyrimidine,drug,0.9995,32933095
13519,5-fluorouracil,drug,0.9995,32933095
13520,capecitabine,drug,0.999,32933095
13521,trifluridine,drug,0.999,32933095
13522,tipiracil,drug,0.9985,32933095
13523,oxaliplatin,drug,0.9995,32933095
13524,irinotecan,drug,0.998,32933095
13525,tyrosine,drug,0.995,32933095
13526,tyrosine kinase receptors,gene,0.996,32933095
13527,regorafenib,drug,0.997,32933095
13528,aflibercept,gene,0.9746,32933095
13529,bevacizumab,gene,0.883,32933095
13530,cetuximab,gene,0.8945,32933095
13531,panitumumab,gene,0.9014,32933095
13532,genes,DNA,0.4895,32933095
13533,CRC,disease,0.9995,32933095
13534,MOC-7,cell_line,0.5713,32933095
13535,cancer cell,cell_type,0.762,32933095
13536,cancer,disease,0.9995,32933095
13537,liposomes,cell_type,0.4268,32933095
13538,exosomes,cell_type,0.6357,32933095
13539,tumor,disease,0.9966,32933095
13540,oncogenes,DNA,0.8833,32933095
13541,MicroRNA,RNA,0.7085,32927780
13542,VEGF,gene,0.807,32927780
13543,Diabetic Macular Edema,disease,1.0,32927780
13544,vascular endothelial growth factor,gene,0.996,32927780
13545,anti-VEGF,gene,0.9004,32927780
13546,diabetic macular edema,disease,0.9927,32927780
13547,ci-DME,disease,0.974,32927780
13548,miRNAs,RNA,0.7334,32927780
13549,anti-VEGF,gene,0.803,32927780
13550,DME,disease,1.0,32927780
13551,DME,disease,1.0,32927780
13552,miRNA,RNA,0.705,32927780
13553,miRNAs,RNA,0.671,32927780
13554,Gene,DNA,0.4692,32927780
13555,miRNAs,RNA,0.5625,32927780
13556,bevacizumab,gene,0.556,32927780
13557,aflibercept,gene,0.924,32927780
13558,miRNA species,RNA,0.6655,32927780
13559,MiRNAs,RNA,0.536,32927780
13560,miR-214,RNA,0.515,32927780
13561,miR-214-3p,gene,0.9463,32927780
13562,miR-320d,gene,0.501,32927780
13563,hsa,DNA,0.592,32927780
13564,hsa-miR-874-3p,gene,0.5137,32927780
13565,miR-98-,RNA,0.5513,32927780
13566,miR-98-5p,gene,0.702,32927780
13567,miR-196b-5p,gene,0.5127,32927780
13568,miR-454-3p,gene,0.5566,32927780
13569,VEGF,gene,0.997,32927780
13570,angiogenin,gene,0.998,32927780
13571,PRI,gene,0.987,32927780
13572,transforming growth factor-,gene,0.97,32927780
13573,insulin-like growth factor,gene,0.993,32927780
13574,DME,disease,0.9995,32927780
13575,patients,species,0.9536,32923942
13576,neovascular age-related macular PURPOSE,disease,0.97,32923942
13577,aflibercept,gene,0.9883,32923942
13578,neovascular age-related macular degeneration,disease,1.0,32923942
13579,patients,species,0.974,32923942
13580,neovascular age-related macular degeneration,disease,0.9995,32923942
13581,patient,species,0.989,32923942
13582,aflibercept,gene,0.975,32923942
13583,patient,species,0.9785,32923942
13584,aflibercept,gene,0.9907,32923942
13585,aflibercept,gene,0.9844,32923942
13586,Patients,species,0.957,32923937
13587,diabetic macular edema,disease,1.0,32923937
13588,patient,species,0.9834,32923937
13589,patients,species,0.982,32923937
13590,ziv-aflibercept,gene,0.962,32923937
13591,ziv-aflibercept,gene,0.9795,32923937
13592,patients,species,0.9746,32923937
13593,diabetic macular edema,disease,1.0,32923937
13594,pERK,gene,0.9917,32923607
13595,FosB,gene,0.9985,32923607
13596,FosB,gene,0.9443,32923607
13597,VCAM-1,gene,0.9956,32923607
13598,neovascular age,disease,0.8457,32923607
13599,macular degeneration,disease,0.992,32923607
13600,diabetic retinopathy,disease,1.0,32923607
13601,VEGF,gene,0.9326,32923607
13602,dibenzoxazepinone,drug,0.9995,32923607
13603,BT2,drug,0.976,32923607
13604,endothelial cell,cell_type,0.9233,32923607
13605,mice,species,0.7993,32923607
13606,BT2,gene,0.992,32923607
13607,MEK1,gene,0.996,32923607
13608,ERK,gene,0.991,32923607
13609,FosB,gene,0.9976,32923607
13610,FosB,gene,0.9883,32923607
13611,VCAM-1,gene,0.994,32923607
13612,inflammation,disease,0.905,32923607
13613,rat,species,0.9937,32923607
13614,rabbit,species,0.99,32923607
13615,VEGF-A165,gene,0.988,32923607
13616,BT2,drug,0.983,32923607
13617,CD31,gene,0.8325,32923607
13618,pERK,gene,0.948,32923607
13619,VCAM-1,gene,0.9897,32923607
13620,VEGF-A165,gene,0.995,32923607
13621,rats,species,0.984,32923607
13622,aflibercept,gene,0.98,32923607
13623,nAMD,disease,1.0,32923607
13624,DR,disease,0.9995,32923607
13625,BT2,cell_line,0.5938,32923607
13626,BT2,drug,0.9927,32923607
13627,Aflibercept,gene,0.9307,32921581
13628,Patients,species,0.9795,32921581
13629,irinotecan,drug,0.9995,32921581
13630,5-fluorouracil,drug,0.9995,32921581
13631,leucovorin,drug,0.999,32921581
13632,aflibercept,gene,0.977,32921581
13633,patients,species,0.9736,32921581
13634,metastatic colorectal cancer,disease,1.0,32921581
13635,mCRC,disease,1.0,32921581
13636,PATIENTS,species,0.9336,32921581
13637,Patients,species,0.9385,32921581
13638,mCRC,disease,0.9927,32921581
13639,aflibercept,gene,0.9707,32921581
13640,FOLFIRI,drug,0.968,32921581
13641,patients,species,0.9834,32921581
13642,RAS,gene,0.991,32921581
13643,BRAF,DNA,0.7407,32921581
13644,BRAF mutations,gene,0.967,32921581
13645,patients,species,0.9707,32921581
13646,FOLFIRI,drug,0.9927,32921581
13647,aflibercept,gene,0.971,32921581
13648,patients,species,0.9946,32921581
13649,aflibercept,gene,0.9873,32921581
13650,mCRC,disease,0.9517,32921581
13651,fluorescein,drug,0.9893,32915904
13652,fluorescein,drug,0.9214,32915904
13653,patients,species,0.9824,32915904
13654,proliferative diabetic retinopathy,disease,1.0,32915904
13655,PDR,disease,1.0,32915904
13656,retinal,DNA,0.4485,32915904
13657,patients,species,0.98,32915904
13658,patients,species,0.9937,32915904
13659,Aflibercept,gene,0.928,32915904
13660,Retinal Non-Perfusion,disease,0.999,32915904
13661,Proliferative Diabetic Retinopathy,disease,1.0,32915904
13662,patients,species,0.9487,32915904
13663,PDR,disease,1.0,32915904
13664,diabetic macular edema,disease,1.0,32915904
13665,PDR,disease,1.0,32915904
13666,patients,species,0.989,32915904
13667,macular edema,disease,1.0,32915904
13668,ischemic eye diseases,disease,1.0,32915904
13669,Ranibizumab,gene,0.9526,32887464
13670,ranibizumab,gene,0.73,32887464
13671,aflibercept,gene,0.9585,32887464
13672,diabetic macular edema,disease,1.0,32887464
13673,DME,disease,1.0,32887464
13674,PATIENTS,species,0.9062,32887464
13675,DME,disease,1.0,32887464
13676,patients,species,0.9937,32887464
13677,anti-VEGF,gene,0.803,32887464
13678,diabetic retinopathy,disease,1.0,32887464
13679,patients,species,0.9883,32887464
13680,ranibizumab,gene,0.6772,32887464
13681,patients,species,0.9917,32887464
13682,aflibercept,gene,0.979,32887464
13683,CRT,DNA,0.461,32887464
13684,patients,species,0.9775,32887464
13685,DME,disease,1.0,32887464
13686,Aflibercept,gene,0.9805,32882447
13687,Diabetic Retinopathy,disease,1.0,32882447
13688,aflibercept,gene,0.994,32882447
13689,diabetic retinopathy,disease,1.0,32882447
13690,DR,disease,1.0,32882447
13691,patients,species,0.9824,32882447
13692,proliferative DR,disease,0.999,32882447
13693,PDR,disease,1.0,32882447
13694,diabetic macular edema,disease,1.0,32882447
13695,DME,disease,1.0,32882447
13696,PARTICIPANTS,species,0.7,32882447
13697,patients,species,0.9873,32882447
13698,PDR,disease,0.8975,32882447
13699,DME,disease,0.997,32882447
13700,Patients,species,0.9683,32882447
13701,aflibercept,gene,0.9814,32882447
13702,patients,species,0.972,32882447
13703,fluorescein,drug,0.9746,32882447
13704,DR,disease,,32882447
13705,DR,disease,,32882447
13706,patients,species,0.98,32882447
13707,diabetes mellitus,disease,1.0,32882447
13708,glycated,gene,0.954,32882447
13709,hemoglobin,gene,0.5986,32882447
13710,PDR,disease,0.997,32882447
13711,DME,disease,0.999,32882447
13712,aflibercept,gene,0.9775,32882447
13713,DR,disease,,32882447
13714,diabetic macular edema,disease,1.0,32880140
13715,diabetic macula edema,disease,1.0,32880140
13716,DME,disease,1.0,32880140
13717,VEGF,gene,0.9136,32880140
13718,DME,disease,1.0,32880140
13719,DME,disease,1.0,32880140
13720,diabetes,disease,1.0,32880140
13721,type 1 diabetes,disease,1.0,32880140
13722,type 2 diabetes,disease,1.0,32880140
13723,diabetes,disease,1.0,32880140
13724,glycated,gene,0.9624,32880140
13725,hemoglobin,gene,0.5186,32880140
13726,Aflibercept,gene,0.9683,32880140
13727,retinal nerve fiber layer,cell_type,0.5605,32880140
13728,ganglion cell,cell_type,0.7,32880140
13729,RNFL,gene,0.892,32880140
13730,GCL+,gene,0.6465,32880140
13731,CRT,DNA,0.4753,32880140
13732,diabetes,disease,0.996,32880140
13733,diabetic retinopathy,disease,1.0,32880140
13734,GCL,gene,0.8267,32880140
13735,GCL,gene,0.8286,32880140
13736,Aflibercept,gene,0.939,32880140
13737,DME,disease,1.0,32880140
13738,VEGF,gene,0.6177,32880140
13739,diabetic macular edema,disease,1.0,32874835
13740,vascular endothelial growth factor,gene,0.998,32874835
13741,VEGF,gene,0.9976,32874835
13742,diabetic macular edema,disease,1.0,32874835
13743,DME,disease,1.0,32874835
13744,fluorescein,drug,0.9946,32874835
13745,ischemic areas,disease,0.917,32874835
13746,VEGF,gene,0.909,32874835
13747,DME,disease,1.0,32874835
13748,RPE,cell_type,0.6914,32874835
13749,edematous,disease,0.974,32874835
13750,ST-MLP,gene,0.9834,32874835
13751,activated microglial cells,cell_type,0.679,32874835
13752,Mller cells,cell_line,0.948,32874835
13753,anti-VEGF,gene,0.9106,32874835
13754,DME,disease,1.0,32874835
13755,RPE,cell_type,0.761,32874835
13756,RPE,cell_line,0.502,32874835
13757,RPE,cell_type,0.623,32874835
13758,patient,species,0.969,32874533
13759,gastric cancer,disease,1.0,32874533
13760,necrotizing fasciitis,disease,1.0,32874533
13761,thrombosis of the feeding arteries,disease,0.917,32874533
13762,gangrene of,disease,1.0,32874533
13763,multiple organ failure,disease,0.9995,32874533
13764,recombinant human immunoglobulin G1 monoclonal antibody,gene,0.9746,32874533
13765,human,species,0.7637,32874533
13766,vascular endothelial growth factor receptor-2,gene,0.991,32874533
13767,VEGFR-2,gene,0.9927,32874533
13768,VEGFR ligands,gene,0.893,32874533
13769,bevacizumab,gene,0.799,32874533
13770,aflibercept,gene,0.9766,32874533
13771,regorafenib,drug,0.9805,32874533
13772,patients,species,0.966,32874533
13773,colorectal cancer,disease,1.0,32874533
13774,FG,disease,,32874533
13775,patient,species,0.951,32874533
13776,gastric cancer,disease,1.0,32874533
13777,Platelet,cell_type,0.625,32871798
13778,to,cell_type,0.4766,32871798
13779,Patients,species,0.9785,32871798
13780,aflibercept,gene,0.973,32871798
13781,5-fluorouracil,drug,0.999,32871798
13782,leucovorin,drug,0.9995,32871798
13783,irinotecan,drug,0.998,32871798
13784,FOLFIRI,drug,0.954,32871798
13785,patients,species,0.984,32871798
13786,metastatic colorectal cancer,disease,1.0,32871798
13787,mCRC,disease,1.0,32871798
13788,PATIENTS,species,0.8955,32871798
13789,patients,species,0.973,32871798
13790,mCRC,disease,0.9653,32871798
13791,aflibercept,gene,0.941,32871798
13792,FOLFIRI,drug,0.858,32871798
13793,neutrophil,cell_type,0.7866,32871798
13794,platelet,cell_type,0.5977,32871798
13795,lymphocyte-monocyte,cell_type,0.542,32871798
13796,patients,species,0.989,32871798
13797,aflibercept,gene,0.9565,32871798
13798,aflibercept,gene,0.9546,32871798
13799,patients,species,0.958,32871798
13800,DC,disease,,32871798
13801,DC,disease,,32871798
13802,aflibercept,gene,0.951,32871798
13803,patients,species,0.9526,32871798
13804,mCRC,disease,0.994,32871798
13805,patient,species,0.9307,32871798
13806,IL1RL1 and IL1RAP Genes,DNA,0.77,32871771
13807,IL1RL1,gene,0.997,32871771
13808,and IL1R,mutation,,32871771
13809,IL1RAP Genes,gene,0.9873,32871771
13810,Age-related Macular Degeneration,disease,1.0,32871771
13811,Age-related macular degeneration,disease,1.0,32871771
13812,AMD,disease,1.0,32871771
13813,blindness,disease,1.0,32871771
13814,AMD,disease,1.0,32871771
13815,people,species,0.9917,32871771
13816,AMD,disease,0.9995,32871771
13817,IL1RL1 rs1041973,gene,0.863,32871771
13818,rs104197,mutation,,32871771
13819,and IL1R,mutation,,32871771
13820,IL1RAP rs4624606,DNA,0.6875,32871771
13821,IL1RAP rs4624606,gene,0.8657,32871771
13822,rs462460,mutation,,32871771
13823,single nucleotide polymorphisms,DNA,0.6113,32871771
13824,AMD,disease,0.9995,32871771
13825,aflibercept,gene,0.98,32871771
13826,bevacizumab,gene,0.9224,32871771
13827,PATIENTS,species,0.9634,32871771
13828,patients,species,0.987,32871771
13829,AMD,disease,1.0,32871771
13830,Patients,species,0.876,32871771
13831,exudative AMD,disease,0.995,32871771
13832,bevacizumab,gene,0.8037,32871771
13833,aflibercept,gene,0.9893,32871771
13834,IL1RL1 rs1041973,gene,0.809,32871771
13835,rs104197,mutation,,32871771
13836,IL1RAP,DNA,0.8374,32871771
13837,IL1RAP rs4624606,gene,0.716,32871771
13838,rs4624606,DNA,0.4473,32871771
13839,rs462460,mutation,,32871771
13840,allele,DNA,0.6284,32871771
13841,gene polymorphisms,DNA,0.731,32871771
13842,exudative,disease,0.949,32871771
13843,atrophic AMD,disease,1.0,32871771
13844,IL1RAP rs4624606,gene,0.8345,32871771
13845,rs462460,mutation,,32871771
13846,atrophic AMD,disease,1.0,32871771
13847,exudative AMD,disease,0.9995,32871771
13848,patients,species,0.9863,32871771
13849,IL1RL1 rs1041973,DNA,0.614,32871771
13850,IL1RL1 rs1041973,gene,0.897,32871771
13851,rs104197,mutation,,32871771
13852,IL1RAP rs4624606,gene,0.8193,32871771
13853,rs462460,mutation,,32871771
13854,atrophic AMD,disease,1.0,32871771
13855,IL1RL1 rs1041973,DNA,0.6016,32871771
13856,IL1RL1 rs1041973,gene,0.802,32871771
13857,rs104197,mutation,,32871771
13858,macular thickening,disease,0.9985,32871771
13859,exudative AMD,disease,1.0,32871771
13860,patients,species,0.987,32871771
13861,small,disease,0.8877,32867452
13862,SCLC,disease,1.0,32867452
13863,lung cancer,disease,1.0,32867452
13864,neuroendocrine,cell_type,0.4814,32867452
13865,neuroendocrine tumor,disease,1.0,32867452
13866,SCLC,disease,0.9966,32867452
13867,SCLC,cell_line,0.68,32867452
13868,SCLC,cell_type,0.508,32867452
13869,SCLC,disease,0.985,32867452
13870,bevacizumab,gene,0.575,32867452
13871,endostar,drug,0.6924,32867452
13872,aflibercept,gene,0.9883,32867452
13873,tyrosine,drug,0.997,32867452
13874,tyrosine kinase,gene,0.9873,32867452
13875,anlotinib,drug,0.9614,32867452
13876,Anti-,gene,0.6475,32864064
13877,vascular Endothelial Growth Factor,gene,0.8926,32864064
13878,Neovascular Age-related Macular Degeneration,disease,1.0,32864064
13879,anti-vascular endothelial growth factor,gene,0.937,32864064
13880,VEGF,gene,0.995,32864064
13881,neovascular age-related macular degeneration,disease,1.0,32864064
13882,NV-AMD,disease,1.0,32864064
13883,VEGF,gene,0.7095,32864064
13884,bevacizumab,gene,0.7056,32864064
13885,ranibizumab,gene,0.7915,32864064
13886,aflibercept,gene,0.9097,32864064
13887,sub-retinal fluid,disease,0.911,32864064
13888,SRF,disease,0.927,32864064
13889,intra-retinal fluid,disease,0.9624,32864064
13890,IRF,disease,0.9253,32864064
13891,Polypoidal Choroidal Vasculopathy,disease,1.0,32855818
13892,polyp,disease,0.9995,32855818
13893,ranibizumab,gene,0.7183,32855818
13894,aflibercept,gene,0.9727,32855818
13895,polyp,disease,0.999,32855818
13896,conbercept,gene,0.798,32855818
13897,ranibizumab,gene,0.6357,32855818
13898,aflibercept,gene,0.9644,32855818
13899,polyp,disease,0.9893,32855818
13900,metastatic colorectal cancer,disease,1.0,32850329
13901,MCRC,cell_line,0.811,32850329
13902,tumoral,disease,0.994,32850329
13903,Patients,species,0.965,32850329
13904,MCRC,disease,0.996,32850329
13905,oxaliplatin,drug,0.9995,32850329
13906,aflibercept,gene,0.965,32850329
13907,FOLFIRI,drug,0.949,32850329
13908,aflibercept,gene,0.977,32850329
13909,patient,species,0.9644,32850329
13910,KRAS,DNA,0.5303,32850329
13911,KRAS mutant,gene,0.8057,32850329
13912,colorectal cancer,disease,0.993,32850329
13913,aflibercept,gene,0.965,32850329
13914,patient,species,0.9727,32850329
13915,KRAS c.,DNA,0.79,32850329
13916,KRAS c.35 G,gene,0.935,32850329
13917,T,RNA,0.4858,32850329
13918,colorectal cancer,disease,0.9995,32850329
13919,aflibercept,gene,0.977,32850329
13920,irinotecan,drug,0.997,32850329
13921,5-fluorouracil,drug,0.9985,32850329
13922,limiting toxicity syndrome,disease,0.9937,32850329
13923,LTS,disease,0.9443,32850329
13924,5-fluorouracil,drug,0.9985,32850329
13925,aflibercept,gene,0.971,32850329
13926,hand-foot syndrome,disease,1.0,32850329
13927,HFS,disease,1.0,32850329
13928,hypertension,disease,1.0,32850329
13929,fluoropyrimidine,drug,0.9985,32850329
13930,irinotecan,drug,0.9985,32850329
13931,deficiency of fluorouracil degradation rate,disease,0.9756,32850329
13932,fluorouracil,drug,0.9053,32850329
13933,UGT1A1 (*),DNA,0.59,32850329
13934,UGT1A1 (*)28,gene,0.9834,32850329
13935,variable number of tandem repeats,DNA,0.833,32850329
13936,VNTR,DNA,0.6924,32850329
13937,ABCB1,gene,0.985,32850329
13938,c.C3435,mutation,,32850329
13939,c.C1236,mutation,,32850329
13940,C1236T,RNA,0.5166,32850329
13941,MTHFR,gene,0.9634,32850329
13942,c.C667,mutation,,32850329
13943,C667T,RNA,0.4592,32850329
13944,DPYD,gene,0.9937,32850329
13945,c.A166,mutation,,32850329
13946,A166G,RNA,0.6294,32850329
13947,TSER 28bp VNTR 2R/3R,DNA,0.7544,32850329
13948,TSER 28bp VNTR 2R/3R,gene,0.879,32850329
13949,RAS,gene,0.994,32850329
13950,/,DNA,0.3855,32850329
13951,BRAF genotype,DNA,0.52,32850329
13952,BRAF,gene,0.99,32850329
13953,patient,species,0.954,32850329
13954,MCRC,disease,0.999,32850329
13955,Ranibizumab,gene,0.94,32850142
13956,Aflibercept,gene,0.9624,32850142
13957,ranibizumab,gene,0.819,32850142
13958,aflibercept,gene,0.968,32850142
13959,patients,species,0.9883,32850142
13960,diabetic macular edema,disease,1.0,32850142
13961,DME,disease,1.0,32850142
13962,Patients,species,0.954,32850142
13963,DME,disease,1.0,32850142
13964,Retinopathy,disease,0.9688,32850142
13965,DME,disease,1.0,32850142
13966,Patients,species,0.957,32850142
13967,ranibizumab,gene,0.605,32850142
13968,aflibercept,gene,0.882,32850142
13969,patients,species,0.982,32850142
13970,patients,species,0.987,32850142
13971,ranibizumab,gene,0.7603,32850142
13972,aflibercept,gene,0.958,32850142
13973,type 2 diabetes,disease,1.0,32850142
13974,aflibercept,gene,0.9893,32850142
13975,aflibercept,gene,0.956,32850142
13976,ranibizumab,drug,0.502,32850142
13977,DME,disease,1.0,32850142
13978,patients,species,0.993,32850142
13979,anti-VEGF,gene,0.8345,32850142
13980,aflibercept,gene,0.969,32850142
13981,Peripapillary pachychoroid neovasculopathy,disease,1.0,32842763
13982,Peripapillary pachychoroid syndrome,disease,1.0,32842763
13983,pachychoroid disease,disease,1.0,32842763
13984,type 1 neovascularization,disease,0.7915,32842763
13985,peripapillary pachychoroid neovasculopathy,disease,0.9995,32842763
13986,pachychoroid spectrum disease,disease,1.0,32842763
13987,woman,species,0.9243,32842763
13988,macula,disease,0.7344,32842763
13989,macular pigmentary changes,disease,0.8735,32842763
13990,pachyvessels,DNA,0.502,32842763
13991,Indocyanine green,drug,0.997,32842763
13992,pachyvessels,disease,1.0,32842763
13993,choroidal hyper-permeability,disease,1.0,32842763
13994,peripapillary pachychoroid neovasculopathy,disease,1.0,32842763
13995,aflibercept,gene,0.9707,32842763
13996,pachychoroid spectrum disease,disease,1.0,32842763
13997,peripapillary pachychoroid neovasculopathy,disease,1.0,32842763
13998,choroidal neovascularization,disease,0.998,32842763
13999,pachychoroid disorders,disease,1.0,32842763
14000,VEGF Gene Family Variants,gene,0.935,32836220
14001,Diabetic retinopathy,disease,1.0,32836220
14002,DR,disease,1.0,32836220
14003,vision-,disease,0.994,32836220
14004,vascular endothelial growth factor (VEGF) gene family,DNA,0.9116,32836220
14005,vascular endothelial growth factor,gene,0.9985,32836220
14006,VEGF,gene,0.992,32836220
14007,rs833069,DNA,0.8394,32836220
14008,rs833069,mutation,,32836220
14009,rs12366035,DNA,0.616,32836220
14010,rs1236603,mutation,,32836220
14011,rs7664413,DNA,0.8267,32836220
14012,rs766441,mutation,,32836220
14013,rs7993418,DNA,0.772,32836220
14014,rs799341,mutation,,32836220
14015,rs2305948,DNA,0.7983,32836220
14016,rs230594,mutation,,32836220
14017,DR,disease,,32836220
14018,aflibercept,gene,0.9775,32836220
14019,type 2 diabetes mellitus,disease,1.0,32836220
14020,T2DM,disease,1.0,32836220
14021,patients,species,0.984,32836220
14022,T2DM,disease,1.0,32836220
14023,aflibercept,gene,0.9844,32836220
14024,both VEGF,mutation,,32836220
14025,VEGFB rs12366035,gene,0.8887,32836220
14026,rs1236603,mutation,,32836220
14027,VEGFC rs7664413,DNA,0.754,32836220
14028,VEGFC rs7664413,gene,0.8647,32836220
14029,rs766441,mutation,,32836220
14030,DR,disease,,32836220
14031,VEGFR1,DNA,0.629,32836220
14032,VEGFR1 rs7993418,gene,0.7695,32836220
14033,rs7993418,DNA,0.4102,32836220
14034,rs799341,mutation,,32836220
14035,DR,disease,,32836220
14036,rs12366035*,DNA,0.8423,32836220
14037,rs1236603,mutation,,32836220
14038,patients,species,0.9746,32836220
14039,rs7993418,DNA,0.6514,32836220
14040,rs799341,mutation,,32836220
14041,VEGFR1,gene,0.984,32836220
14042,aflibercept,gene,0.9624,32836220
14043,VEGF/receptors,gene,0.9053,32836220
14044,DM,disease,,32836220
14045,DR,disease,1.0,32836220
14046,aflibercept,gene,0.901,32836220
14047,DR,disease,,32836220
14048,patients,species,0.995,32836220
14049,Vascular Endothelial Growth Factor,gene,0.9165,32832234
14050,vascular endothelial growth factor,gene,0.9985,32832234
14051,rat,species,0.9497,32832234
14052,choroidal neovascularization,disease,0.9033,32832234
14053,CNV,DNA,0.6826,32832234
14054,fluorescein,drug,0.9946,32832234
14055,aflibercept,gene,0.991,32832234
14056,AF564,gene,0.547,32832234
14057,NaCl,drug,0.979,32832234
14058,rats,species,0.63,32832234
14059,CNV,disease,0.659,32832234
14060,CNV,disease,1.0,32832234
14061,aflibercept,gene,0.9814,32832234
14062,NaCl,drug,0.9844,32832234
14063,CNV,disease,0.9985,32832234
14064,vascular endothelial growth factor,gene,0.9966,32832234
14065,VEGF,gene,0.9976,32832234
14066,fluorescein,drug,0.998,32829304
14067,microaneurysms,disease,0.99,32829304
14068,MAs,disease,0.9487,32829304
14069,diabetic retinopathy,disease,1.0,32829304
14070,fluorescein,drug,0.993,32829304
14071,aflibercept,gene,0.987,32829304
14072,proliferative diabetic retinopathy,disease,0.974,32829304
14073,PDR,disease,1.0,32829304
14074,Aflibercept,gene,0.949,32829304
14075,Retinal Non-Perfusion,disease,0.9443,32829304
14076,Proliferative Diabetic Retinopathy,disease,1.0,32829304
14077,PDR,disease,0.8823,32829304
14078,MAs,disease,0.8545,32829304
14079,PDR,disease,0.9985,32829304
14080,MAs,disease,0.859,32829304
14081,Aflibercept,gene,0.9673,32829027
14082,Diabetic Macular Edema,disease,1.0,32829027
14083,triamcinolone acetonide,drug,0.9688,32829027
14084,aflibercept,gene,0.966,32829027
14085,aflibercept,gene,0.971,32829027
14086,diabetic macular edema,disease,0.9946,32829027
14087,DME,disease,1.0,32829027
14088,Patients,species,0.959,32829027
14089,CLS,drug,0.744,32829027
14090,aflibercept,gene,0.987,32829027
14091,aflibercept,gene,0.92,32829027
14092,PARTICIPANTS,species,0.703,32829027
14093,DME,disease,1.0,32829027
14094,patients,species,0.986,32829027
14095,Patients,species,0.9473,32829027
14096,aflibercept,gene,0.972,32829027
14097,Patients,species,0.956,32829027
14098,aflibercept,gene,0.969,32829027
14099,patients,species,0.9805,32829027
14100,aflibercept,gene,0.918,32829027
14101,Cataract,disease,1.0,32829027
14102,aflibercept,gene,0.976,32829027
14103,DME,disease,1.0,32829027
14104,aflibercept,gene,0.901,32829027
14105,Intraretinal Hemorrhage,disease,1.0,32828880
14106,intraretinal macular hemorrhage,disease,1.0,32828880
14107,hemiretinal vein occlusion,disease,1.0,32828880
14108,aflibercept,gene,0.956,32828880
14109,bevacizumab,gene,0.6743,32828880
14110,participants,species,0.985,32828880
14111,Retinal Vein Occlusion,disease,1.0,32828880
14112,participants,species,0.985,32828880
14113,Retinal Vein Occlusion,disease,1.0,32828880
14114,Participants,species,0.913,32828880
14115,aflibercept,gene,0.989,32828880
14116,aflibercept,gene,0.9614,32828880
14117,bevacizumab,gene,0.89,32828880
14118,hemorrhage,disease,0.9575,32828880
14119,aflibercept,gene,0.9844,32828880
14120,bevacizumab,gene,0.918,32828880
14121,hemorrhage,disease,0.992,32828880
14122,hemorrhage,disease,0.9873,32828880
14123,VALS,disease,1.0,32828880
14124,intraretinal macular hemorrhage,disease,0.987,32828880
14125,retinal vein occlusion,disease,1.0,32828880
14126,patients,species,0.985,32823822
14127,submacular hemorrhage,disease,0.999,32823822
14128,polypoidal choroidal vasculopathy,disease,1.0,32823822
14129,PCV,disease,1.0,32823822
14130,patients,species,0.984,32823822
14131,submacular hemorrhage,disease,0.9995,32823822
14132,PCV,disease,1.0,32823822
14133,aflibercept,gene,0.9717,32823822
14134,patients,species,0.994,32823822
14135,anti-vascular endothelial growth factor,gene,0.955,32823822
14136,VEGF,gene,0.998,32823822
14137,BCVA,DNA,0.594,32823822
14138,patients,species,0.9897,32823822
14139,patients,species,0.981,32823822
14140,patients,species,0.986,32823822
14141,Diabetic Macular Edema,disease,1.0,32822291
14142,DME,disease,1.0,32822291
14143,macular edema,disease,1.0,32822291
14144,retinal occlusion,disease,1.0,32822291
14145,RVO,disease,1.0,32822291
14146,retinal vascular,disease,0.843,32822291
14147,visual impairment,disease,1.0,32822291
14148,vision loss,disease,0.9995,32822291
14149,Vascular Endothelial Growth Factor,gene,0.9976,32822291
14150,VEGF,gene,0.997,32822291
14151,VEGF,gene,0.7065,32822291
14152,macular thickening,disease,0.9917,32822291
14153,patients,species,0.985,32822291
14154,fluorescein,drug,0.99,32822291
14155,leakage,cell_line,0.568,32822291
14156,Vascular,DNA,0.5586,32818623
14157,vascular endothelial growth factor,gene,0.8857,32818623
14158,VEGF,gene,0.9985,32818623
14159,neovascular age-related macular degeneration,disease,1.0,32818623
14160,nAMD,disease,1.0,32818623
14161,PARTICIPANTS,species,0.7437,32818623
14162,anti-VEGF,gene,0.8257,32818623
14163,nAMD,disease,1.0,32818623
14164,anti,gene,0.51,32818623
14165,nAMD,disease,0.9985,32818623
14166,patient,species,0.957,32818623
14167,anti-VEGF,gene,0.675,32818623
14168,nAMD,disease,1.0,32818623
14169,aflibercept,gene,0.972,32818623
14170,ranibizumab,gene,0.7627,32818623
14171,bevacizumab,gene,0.6274,32818623
14172,VEGF,gene,0.668,32818623
14173,patient,species,0.9844,32818623
14174,bevacizumab,gene,0.896,32818623
14175,age-related macular degeneration,disease,1.0,32818623
14176,VEGF,gene,0.7915,32818623
14177,patient,species,0.9414,32818623
14178,aflibercept,gene,0.99,32818623
14179,ranibizumab,gene,0.9214,32818623
14180,bevacizumab,gene,0.8394,32818623
14181,Diabetic,disease,1.0,32818277
14182,Patients,species,0.985,32818277
14183,patients,species,0.9443,32818277
14184,diabetic macular edema,disease,0.999,32818277
14185,DME,disease,1.0,32818277
14186,aflibercept,gene,0.9824,32818277
14187,PATIENTS,species,0.939,32818277
14188,patients,species,0.973,32818277
14189,DME,disease,1.0,32818277
14190,Patients,species,0.9604,32818277
14191,DME,disease,1.0,32818277
14192,CPD,DNA,0.684,32818277
14193,CPD,disease,0.9985,32818277
14194,fluorescein,drug,0.986,32816791
14195,retinal vascular disease,disease,1.0,32816791
14196,aflibercept,gene,0.9604,32816791
14197,Diabetic Macular Edema,disease,1.0,32816791
14198,Retinal Venous Occlusions,disease,1.0,32816791
14199,Aflibercept,gene,0.9565,32816791
14200,diabetic macular oedema,disease,1.0,32816791
14201,macular oedema,disease,1.0,32816791
14202,retinal vascular occlusion,disease,0.9995,32816791
14203,UWFA,disease,0.954,32816791
14204,Aflibercept,gene,0.9546,32816045
14205,Peripapillary Choroidal Neovascularization,disease,1.0,32816045
14206,Choroidal neovascularization,disease,1.0,32816045
14207,optic nerve head,disease,0.9976,32816045
14208,drusen,disease,0.9478,32816045
14209,vision loss,disease,0.9976,32816045
14210,aflibercept,gene,0.9746,32816045
14211,children,species,0.982,32816045
14212,boy,species,0.593,32816045
14213,aflibercept,gene,0.9604,32816045
14214,age-related macular degeneration,disease,1.0,32802487
14215,nAMD,disease,1.0,32802487
14216,antivascular endothelial growth factor,gene,0.9585,32802487
14217,anti-VEGF,gene,0.9814,32802487
14218,patients,species,0.9756,32802487
14219,nAMD,disease,1.0,32802487
14220,anti-VEGF,gene,0.903,32802487
14221,Patients,species,0.9873,32802487
14222,nAMD,disease,1.0,32802487
14223,Patients,species,0.9824,32802487
14224,bevacizumab,gene,0.7563,32802487
14225,aflibercept,gene,0.9062,32802487
14226,patients,species,0.981,32802487
14227,nAMD,disease,1.0,32802487
14228,patients,species,0.9863,32802487
14229,anti-VEGF,gene,0.827,32802487
14230,nAMD,disease,1.0,32802487
14231,patients,species,0.9854,32802487
14232,anti-VEGF,gene,0.9844,32802487
14233,Anti-Vascular Endothelial Growth Factor,gene,0.948,32796446
14234,anti-vascular endothelial growth factor,gene,0.882,32796446
14235,VEGF,gene,0.996,32796446
14236,VEGF,gene,0.823,32796446
14237,Bevacizumab,gene,0.677,32796446
14238,aflibercept,gene,0.987,32796446
14239,Fc,gene,0.9893,32796446
14240,FcRn,gene,0.995,32796446
14241,ranibizumab,gene,0.524,32796446
14242,Fc,gene,0.9795,32796446
14243,ranibizumab,gene,0.7783,32796446
14244,VEGF,gene,0.9766,32796446
14245,VEGF,DNA,0.387,32796446
14246,ranibizumab,drug,0.6133,32796446
14247,maternal,cell_type,0.467,32796446
14248,VEGF,gene,0.6675,32796446
14249,bevacizumab,gene,0.669,32796446
14250,aflibercept,gene,0.9663,32796446
14251,anti-VEGF,gene,0.8022,32796446
14252,aflibercept,gene,0.9717,32795527
14253,choroidal neovascularization,disease,1.0,32795527
14254,aflibercept,gene,0.9785,32795527
14255,choroidal neovascularization,disease,1.0,32795527
14256,CNV,disease,1.0,32795527
14257,Age-Related,disease,0.995,32795527
14258,Macular Degeneration,disease,1.0,32795527
14259,AMD,disease,1.0,32795527
14260,rabbits,species,0.8013,32795527
14261,aflibercept,gene,0.9863,32795527
14262,aflibercept,gene,0.9917,32795527
14263,Retinal Pigment Epithelium,cell_type,0.5337,32795527
14264,RPE,cell_type,0.504,32795527
14265,aflibercept,gene,0.9907,32795527
14266,serum,cell_type,0.546,32795527
14267,aflibercept,gene,0.983,32795527
14268,aflibercept,gene,0.9727,32795527
14269,CNV,disease,0.96,32795527
14270,aflibercept,gene,0.986,32795527
14271,CNV,disease,0.9995,32795527
14272,AMD,disease,1.0,32795527
14273,Choroidal osteoma,disease,1.0,32791764
14274,CO,disease,1.0,32791764
14275,benign ocular tumor,disease,1.0,32791764
14276,ossifying choroid lesions,disease,0.963,32791764
14277,choroidal neovascularization,disease,1.0,32791764
14278,CNV,disease,1.0,32791764
14279,aflibercept,gene,0.9917,32791764
14280,PATIENT,species,0.8525,32791764
14281,woman,species,0.9263,32791764
14282,fluorescein,drug,0.966,32791764
14283,indocyanine green,drug,0.992,32791764
14284,CO,disease,,32791764
14285,CNV,DNA,0.4282,32791764
14286,patient,species,0.924,32791764
14287,aflibercept,gene,0.9873,32791764
14288,CNV,disease,0.9414,32791764
14289,CNV,disease,0.995,32791764
14290,aflibercept,gene,0.9907,32791764
14291,CO,disease,,32791764
14292,CNV,disease,0.979,32791764
14293,aflibercept,gene,0.9795,32791764
14294,CO,disease,,32791764
14295,CNV,disease,0.998,32791764
14296,aflibercept,gene,0.918,32789651
14297,aflibercept,gene,0.9683,32789651
14298,AFL,gene,0.993,32789651
14299,patients,species,0.9634,32789651
14300,neovascular age-related macular degeneration,disease,1.0,32789651
14301,nAMD,disease,1.0,32789651
14302,patients,species,0.966,32789651
14303,nAMD,disease,1.0,32789651
14304,AFL,drug,0.8384,32789651
14305,patients,species,0.989,32789651
14306,patients,species,0.989,32789651
14307,patients,species,0.9893,32789651
14308,patients,species,0.9893,32789651
14309,Diabetic Retinopathy,disease,1.0,32789651
14310,patients,species,0.9907,32789651
14311,patients,species,0.9873,32789651
14312,patients,species,0.9844,32789651
14313,patients,species,0.9883,32789651
14314,patients,species,0.988,32789651
14315,patients,species,0.974,32789651
14316,patients,species,0.9805,32789651
14317,Age-related macular degeneration,disease,1.0,32785436
14318,Age-related macular degeneration,disease,1.0,32785436
14319,vision loss,disease,0.999,32785436
14320,dry age-related macular degeneration,disease,0.9995,32785436
14321,atrophic macula,disease,0.999,32785436
14322,neovascular age-related macular degeneration,disease,0.9995,32785436
14323,vascular endothelial growth factor,gene,0.9844,32785436
14324,ranibizumab,gene,0.8804,32785436
14325,aflibercept,gene,0.98,32785436
14326,bevacizumab,gene,0.863,32785436
14327,visual impairment,disease,1.0,32785436
14328,anti,gene,0.532,32785436
14329,vascular endothelial growth factor,gene,0.985,32785436
14330,nucleoside,drug,0.981,32785436
14331,nucleoside reverse transcriptase,gene,0.9956,32785436
14332,sphingosine-1-phosphate,drug,0.9995,32785436
14333,platelet,cell_type,0.3955,32785436
14334,age-related macular degeneration,disease,1.0,32785436
14335,Aflibercept,gene,0.954,32783421
14336,Diabetic Macular Edema,disease,1.0,32783421
14337,aflibercept,gene,0.981,32783421
14338,diabetic macular edema,disease,1.0,32783421
14339,aflibercept,gene,0.9834,32783421
14340,CRT,DNA,0.5234,32783421
14341,diabetic retinopathy,disease,1.0,32783421
14342,CRT,DNA,0.485,32783421
14343,aflibercept,gene,0.928,32783421
14344,diabetic macular edema,disease,1.0,32783421
14345,Bevacizumab,gene,0.8135,32781110
14346,Ranibizumab,gene,0.7993,32781110
14347,anti-vascular endothelial growth factor,gene,0.9097,32781110
14348,VEGF,gene,0.998,32781110
14349,neovascular age-related macular degeneration,disease,1.0,32781110
14350,nAMD,disease,1.0,32781110
14351,diabetic retinal disease,disease,1.0,32781110
14352,DRD,disease,1.0,32781110
14353,retinal venous occlusive disease,disease,1.0,32781110
14354,RVO,disease,1.0,32781110
14355,VEGF,gene,0.6787,32781110
14356,VEGF,gene,0.636,32781110
14357,bevacizumab,gene,0.853,32781110
14358,ranibizumab,gene,0.8145,32781110
14359,aflibercept,gene,0.9775,32781110
14360,PARTICIPANTS,species,0.8086,32781110
14361,anti-VEGF,gene,0.951,32781110
14362,nAMD,disease,1.0,32781110
14363,DRD,disease,1.0,32781110
14364,RVO,disease,1.0,32781110
14365,patients,species,0.99,32781110
14366,VEGF,gene,0.936,32781110
14367,Patients,species,0.9546,32781110
14368,acute myocardial infarction,disease,0.9946,32781110
14369,MI,disease,1.0,32781110
14370,cerebrovascular disease,disease,0.9746,32781110
14371,CVD,disease,1.0,32781110
14372,patients,species,0.9897,32781110
14373,anti-VEGF,gene,0.8755,32781110
14374,nAMD,disease,1.0,32781110
14375,DRD,disease,1.0,32781110
14376,RVO,disease,1.0,32781110
14377,bevacizumab,gene,0.906,32781110
14378,ranibizumab,gene,0.9214,32781110
14379,aflibercept,gene,0.978,32781110
14380,patients,species,0.9893,32781110
14381,MI,disease,,32781110
14382,CVD,disease,0.9995,32781110
14383,bevacizumab,gene,0.757,32781110
14384,aflibercept,gene,0.9717,32781110
14385,MI,disease,,32781110
14386,CVD,disease,0.998,32781110
14387,bevacizumab,gene,0.758,32781110
14388,ranibizumab,gene,0.5674,32781110
14389,bevacizumab,gene,0.779,32781110
14390,aflibercept,gene,0.9795,32781110
14391,aflibercept,gene,0.984,32781110
14392,acute MI,disease,0.9893,32781110
14393,CVD,disease,0.9995,32781110
14394,bevacizumab,gene,0.7725,32781110
14395,ranibizumab,gene,0.534,32781110
14396,aflibercept,gene,0.9624,32781110
14397,aflibercept,gene,0.962,32780752
14398,polypoidal choroidal vasculopathy,disease,1.0,32780752
14399,aflibercept,gene,0.9937,32780752
14400,polypoidal choroidal vasculopathy,disease,1.0,32780752
14401,PCV,disease,1.0,32780752
14402,PCV,disease,1.0,32780752
14403,pachydrusen,disease,1.0,32780752
14404,PCV,disease,1.0,32780752
14405,fibrovascular scarring,disease,1.0,32780752
14406,PCV,disease,1.0,32780752
14407,pachydrusen,disease,0.999,32780752
14408,VEGF,gene,0.995,32779452
14409,keratoconus,disease,1.0,32779452
14410,corneal neovascularization,disease,0.999,32779452
14411,corneal opacifications,disease,1.0,32779452
14412,corneal neovascularization,disease,0.9995,32779452
14413,CNV,DNA,0.433,32779452
14414,CNV,disease,0.9937,32779452
14415,VEGF,gene,0.8633,32779452
14416,stem cell,cell_type,0.7803,32779452
14417,CNV,disease,1.0,32779452
14418,CNV,disease,0.9995,32779452
14419,Aflibercept,gene,0.9834,32779452
14420,neovascular age-related macular degeneration,disease,1.0,32778909
14421,age-related macular degeneration,disease,1.0,32778909
14422,AMD,disease,1.0,32778909
14423,ranibizumab,gene,0.8394,32778909
14424,aflibercept,gene,0.9653,32778909
14425,neovascular AMD,disease,1.0,32778909
14426,ranibizumab,gene,0.823,32778909
14427,intra- or subretinal fluid,disease,0.865,32778909
14428,aflibercept,gene,0.9644,32778909
14429,aflibercept,gene,0.977,32778909
14430,ELM,cell_type,0.446,32778909
14431,Regorafenib,drug,0.997,32770529
14432,metastatic colorectal cancer,disease,1.0,32770529
14433,mCRC,disease,1.0,32770529
14434,regorafenib,drug,0.9756,32770529
14435,patients,species,0.934,32770529
14436,mCRC,disease,0.937,32770529
14437,regorafenib,drug,0.992,32770529
14438,bevacizumab,gene,0.811,32770529
14439,regorafenib,drug,0.9907,32770529
14440,panitumumab,gene,0.851,32770529
14441,cetuximab,gene,0.8276,32770529
14442,conatumumab,gene,0.5825,32770529
14443,ganitumab,gene,0.687,32770529
14444,aflibercept,gene,0.966,32770529
14445,patients,species,0.9507,32770529
14446,mCRC,disease,0.9263,32770529
14447,patients,species,0.992,32770529
14448,bevacizumab,drug,0.5625,32770529
14449,regorafenib,drug,0.9966,32770529
14450,panitumumab,gene,0.519,32770529
14451,cetuximab,gene,0.827,32770529
14452,ramucirumab,drug,0.5737,32770529
14453,ganitumab,gene,0.8584,32770529
14454,aflibercept,gene,0.8965,32770529
14455,regorafenib,drug,0.9946,32770529
14456,aflibercept,gene,0.9595,32770529
14457,ganitumab,gene,0.9443,32770529
14458,panitumumab,gene,0.5386,32770529
14459,Regorafenib,drug,0.9976,32770529
14460,bevacizumab,gene,0.555,32770529
14461,tumor,disease,0.7295,32770529
14462,regorafenib,drug,0.996,32770529
14463,cetuximab,gene,0.827,32770529
14464,conatumumab,gene,0.827,32770529
14465,neutropenia,disease,1.0,32770529
14466,conatumumab,gene,0.7256,32770529
14467,fatigue,disease,0.9956,32770529
14468,cetuximab,gene,0.8467,32770529
14469,Regorafenib,drug,0.996,32770529
14470,patients,species,0.9556,32770529
14471,metastatic colorectal cancer,disease,1.0,32770529
14472,patients,species,0.989,32770529
14473,KRAS,gene,0.867,32770529
14474,BRAF,gene,0.985,32770529
14475,mCRC,disease,0.999,32770529
14476,Alcohol,drug,0.97,32768034
14477,Aflibercept,gene,0.9756,32768034
14478,Macular Edema,disease,1.0,32762995
14479,EQ-5D,DNA,0.513,32762995
14480,macular edema,disease,1.0,32762995
14481,central retinal vein occlusion,disease,1.0,32762995
14482,Lucentis,drug,0.651,32762995
14483,vein occlusion,disease,0.998,32762995
14484,ranibizumab,gene,0.609,32762995
14485,aflibercept,gene,0.9546,32762995
14486,bevacizumab,gene,0.6143,32762995
14487,EQ-5D,DNA,0.5254,32762995
14488,VFQ,DNA,0.4927,32762995
14489,Macular atrophy,disease,1.0,32755234
14490,neovascular age-related macular degeneration,disease,1.0,32755234
14491,Pachydrusen,disease,0.993,32752023
14492,Aflibercept,gene,0.8613,32752023
14493,Polypoidal Choroidal Vasculopathy,disease,1.0,32752023
14494,aflibercept,gene,0.981,32752023
14495,polypoidal choroidal vasculopathy,disease,1.0,32752023
14496,PCV,disease,1.0,32752023
14497,PCV,disease,1.0,32752023
14498,pachydrusen,disease,0.9883,32752023
14499,drusen,disease,0.775,32752023
14500,PCV,disease,0.82,32752023
14501,scarring,disease,0.806,32752023
14502,pachydrusen,disease,1.0,32752023
14503,aflibercept,gene,0.973,32752023
14504,Aflibercept,gene,0.992,32742760
14505,aflibercept,gene,0.99,32742760
14506,aflibercept,gene,0.995,32742760
14507,aflibercept,gene,0.9897,32742760
14508,rhesus macaques,species,0.977,32742760
14509,aflibercept,gene,0.994,32742760
14510,aflibercept,gene,0.993,32742760
14511,aflibercept,gene,0.987,32742760
14512,aflibercept,gene,0.9907,32742760
14513,aflibercept,gene,0.991,32742760
14514,rhesus macaques,species,0.9517,32742760
14515,Aflibercept,gene,0.974,32742760
14516,Silicone,drug,0.906,32735904
14517,silicone oil,drug,0.8105,32735904
14518,anti-,gene,0.714,32735904
14519,vascular endothelial growth factor,gene,0.865,32735904
14520,VEGF,gene,0.9985,32735904
14521,PARTICIPANTS,species,0.795,32735904
14522,anti-,gene,0.51,32735904
14523,VEGF,gene,0.546,32735904
14524,choroidal neovascularization,disease,1.0,32735904
14525,diabetic macular edema,disease,1.0,32735904
14526,venous occlusive disease,disease,1.0,32735904
14527,bevacizumab,gene,0.8745,32735904
14528,polypropylene,drug,0.999,32735904
14529,ranibizumab,gene,0.8154,32735904
14530,polypropylene,drug,0.999,32735904
14531,aflibercept,gene,0.978,32735904
14532,polycarbonate,drug,0.9976,32735904
14533,polypropylene,drug,0.9995,32735904
14534,polypropylene,drug,0.9995,32735904
14535,polycarbonate,drug,0.9995,32735904
14536,polycarbonate,drug,0.9995,32735904
14537,polypropylene,drug,0.9995,32735904
14538,silicone,drug,0.7036,32735904
14539,polypropylene,drug,0.9985,32735904
14540,polypropylene,drug,0.999,32735904
14541,bevacizumab,gene,0.92,32735904
14542,polycarbonate,drug,0.999,32735904
14543,aflibercept,gene,0.9854,32735904
14544,anti-VEGF,gene,0.9233,32735904
14545,Pachychoroid neovasculopathy,disease,1.0,32729062
14546,type-1 choroidal neovascularization,disease,0.9995,32729062
14547,pachychoroid neovasculopathy,disease,1.0,32729062
14548,PNV,disease,1.0,32729062
14549,pachychoroid neovasculopathy,disease,1.0,32729062
14550,PNV,disease,1.0,32729062
14551,type-1 choroidal neovascularization,disease,1.0,32729062
14552,choroidal thickening,disease,1.0,32729062
14553,dilated choroidal vessels,cell_type,0.4805,32729062
14554,patients,species,0.979,32729062
14555,pachychoroid pigment epitheliopathy,disease,1.0,32729062
14556,chronic central serous chorioretinopathy,disease,1.0,32729062
14557,choroidal thickening,disease,1.0,32729062
14558,neovascular age-related macular degeneration,disease,1.0,32729062
14559,AMD,disease,1.0,32729062
14560,PNV,disease,1.0,32729062
14561,neovascular AMD,disease,0.9976,32729062
14562,PNV,disease,1.0,32729062
14563,PNV,disease,1.0,32729062
14564,PNV,disease,1.0,32729062
14565,vein enlargement,disease,0.968,32729062
14566,pachyvessels,disease,0.7764,32729062
14567,choriocapillaris,disease,0.8677,32729062
14568,PNV,disease,0.9995,32729062
14569,PNV,disease,0.9995,32729062
14570,vascular endothelial growth factor,gene,0.999,32729062
14571,aflibercept,gene,0.9937,32729062
14572,patient,species,0.4836,32729062
14573,PNV,disease,0.9995,32729062
14574,Nephrotic Syndrome,disease,1.0,32727981
14575,Focal Segmental Glomerulosclerosis,disease,1.0,32727981
14576,woman,species,0.915,32727981
14577,vascular endothelial growth factor,gene,0.998,32727981
14578,VEGF,gene,0.98,32727981
14579,aflibercept,gene,0.994,32727981
14580,nephrotic syndrome,disease,1.0,32727981
14581,focal segmental glomerulosclerosis,disease,1.0,32727981
14582,foam cells,cell_type,0.799,32727981
14583,nephrotic syndrome,disease,1.0,32727981
14584,aflibercept,gene,0.8965,32727981
14585,ophthalmic diseases,disease,0.9688,32727981
14586,VEGF,gene,0.9966,32727981
14587,aflibercept,gene,0.98,32727727
14588,diabetic,disease,0.6826,32727727
14589,aflibercept,gene,0.964,32727727
14590,diabetic macular oedema,disease,1.0,32727727
14591,DME,disease,1.0,32727727
14592,patients,species,0.968,32727727
14593,DME,disease,1.0,32727727
14594,patients,species,0.9897,32727727
14595,PVD,disease,0.9995,32727727
14596,PVD,disease,0.9756,32727727
14597,PVD,disease,1.0,32727727
14598,aflibercept,gene,0.988,32727727
14599,patients,species,0.9863,32727727
14600,aflibercept,gene,0.85,32727727
14601,DME,disease,1.0,32727727
14602,CRT,gene,0.887,32727727
14603,CRT,DNA,0.5225,32727727
14604,CRT,DNA,0.5107,32727727
14605,ETDRS,DNA,0.5273,32727727
14606,PVD,disease,1.0,32727727
14607,CRT,DNA,0.5483,32727727
14608,BCVA,DNA,0.4583,32727727
14609,aflibercept,gene,0.964,32727727
14610,patients,species,0.967,32727727
14611,DME,disease,1.0,32727727
14612,PVD,disease,1.0,32727727
14613,Ranibizumab,gene,0.8345,32722955
14614,aflibercept,gene,0.9663,32722955
14615,diabetic macular edema,disease,1.0,32722955
14616,ranibizumab,gene,0.4824,32722955
14617,aflibercept,gene,0.9766,32722955
14618,diabetic macular edema,disease,1.0,32722955
14619,DME,disease,1.0,32722955
14620,patients,species,0.9814,32722955
14621,DME,disease,1.0,32722955
14622,ranibizumab,gene,0.619,32722955
14623,aflibercept,gene,0.8164,32722955
14624,ranibizumab,gene,0.7036,32722955
14625,aflibercept,gene,0.9536,32722955
14626,ranibizumab,drug,0.541,32722955
14627,ranibizumab,gene,0.4949,32722955
14628,aflibercept,gene,0.5254,32722955
14629,HbA1c,gene,0.9165,32722955
14630,Ranibizumab,gene,0.9976,32722955
14631,aflibercept,gene,0.819,32722955
14632,patients,species,0.9434,32722955
14633,DME,disease,1.0,32722955
14634,Patients,species,0.988,32722799
14635,diabetic macular edema,disease,1.0,32722799
14636,DME,disease,1.0,32722799
14637,DME,disease,1.0,32722799
14638,vascular endothelial growth factor,gene,0.932,32722799
14639,PARTICIPANTS,species,0.6772,32722799
14640,Diabetic Retinopathy,disease,1.0,32722799
14641,participants,species,0.9575,32722799
14642,DME,disease,1.0,32722799
14643,Participants,species,0.9375,32722799
14644,aflibercept,gene,0.981,32722799
14645,ranibizumab,gene,0.835,32722799
14646,bevacizumab,gene,0.6914,32722799
14647,participants,species,0.9746,32722799
14648,IRF,gene,0.981,32722799
14649,SRF,gene,0.9883,32722799
14650,IRF,gene,0.956,32722799
14651,SRF,gene,0.9736,32722799
14652,SRF,disease,0.9775,32722799
14653,Diabetic Retinopathy,disease,0.944,32722799
14654,SRF,disease,0.582,32722799
14655,ETDRS,DNA,0.525,32722799
14656,SRF,disease,0.995,32722799
14657,BCVA,DNA,0.4688,32722799
14658,Aflibercept,gene,0.958,32722799
14659,bevacizumab,gene,0.69,32722799
14660,Ranibizumab,gene,0.7793,32722799
14661,bevacizumab,gene,0.781,32722799
14662,DME,disease,1.0,32722799
14663,endothelial growth factor,gene,0.992,32722799
14664,Aflibercept,gene,0.903,32718095
14665,Macular Edema,disease,1.0,32718095
14666,aflibercept,gene,0.9644,32718095
14667,macular edema,disease,1.0,32718095
14668,ME,disease,1.0,32718095
14669,branch retinal vein occlusion,disease,1.0,32718095
14670,BRVO,disease,1.0,32718095
14671,patients,species,0.964,32718095
14672,patients,species,0.9873,32718095
14673,aflibercept,gene,0.6562,32718095
14674,ME,disease,,32718095
14675,BRVO,disease,1.0,32718095
14676,Ranibizumab,gene,0.9097,32715820
14677,Aflibercept,gene,0.955,32715820
14678,patients,species,0.97,32715820
14679,ARMD,disease,1.0,32715820
14680,neovascular ARMD,disease,0.866,32715820
14681,vascular endothelial growth factor,gene,0.8916,32715820
14682,VEGF,gene,0.868,32715820
14683,VEGF,gene,0.8984,32715820
14684,ranibizumab,gene,0.6567,32715820
14685,aflibercept,gene,0.9106,32715820
14686,VEGF,gene,0.609,32715820
14687,aflibercept,gene,0.979,32715820
14688,ranibizumab,gene,0.732,32715820
14689,neovascular ARMD,disease,0.6523,32715820
14690,ranibizumab,gene,0.5044,32715820
14691,patients,species,0.976,32715820
14692,unilateral and bilateral neovascular ARMD,disease,0.998,32715820
14693,ranibizumab,gene,0.622,32715820
14694,neovascular ARMD,disease,0.971,32715820
14695,aflibercept,gene,0.976,32715820
14696,ranibizumab,gene,0.846,32715820
14697,diabetic retinopathy,disease,1.0,32715794
14698,Diabetic retinopathy,disease,1.0,32715794
14699,DR,disease,1.0,32715794
14700,diabetes mellitus spectrum,disease,0.929,32715794
14701,people,species,0.947,32715794
14702,blindness,disease,1.0,32715794
14703,visual impairment,disease,1.0,32715794
14704,DR,disease,,32715794
14705,patients,species,0.993,32715794
14706,diabetic retinopathy,disease,1.0,32715794
14707,steroids,drug,0.931,32715794
14708,anti-VEGF,gene,0.9824,32715794
14709,sunitinib,drug,0.998,32715794
14710,imatinib,drug,0.9966,32715794
14711,Brolucizumab,gene,0.7007,32715794
14712,aflibercept,gene,0.9766,32715794
14713,ranibizumab,gene,0.7495,32715794
14714,Tie-2 receptors,gene,0.996,32715794
14715,diabetic retinopathy,disease,1.0,32715794
14716,Aflibercept,gene,0.9746,32714608
14717,Rabbit,species,0.9775,32714608
14718,aflibercept,gene,0.9614,32714608
14719,rabbit,species,0.982,32714608
14720,rabbits,species,0.7383,32714608
14721,rabbits,species,0.905,32714608
14722,aflibercept,gene,0.844,32714608
14723,rabbits,species,0.9233,32714608
14724,rabbits,species,0.954,32714608
14725,retinal,disease,0.5493,32714608
14726,Choroidal congestion,disease,1.0,32714608
14727,aflibercept,gene,0.948,32714608
14728,chronic vitritis,disease,1.0,32714608
14729,lymphoplasmocytic reaction,disease,1.0,32714608
14730,aflibercept,gene,0.931,32714608
14731,rabbit,species,0.9727,32714608
14732,human,species,0.995,32714608
14733,Macula,disease,0.759,32712708
14734,COVID-19,disease,0.9893,32712708
14735,anti-VEGF,gene,0.822,32712708
14736,neovascular age-related macular degeneration,disease,1.0,32712708
14737,nAMD,disease,1.0,32712708
14738,diabetic macular oedema,disease,0.999,32712708
14739,DMO,disease,1.0,32712708
14740,retinal vein occlusion,disease,1.0,32712708
14741,RVO,disease,1.0,32712708
14742,aflibercept,gene,0.983,32712708
14743,nAMD,disease,1.0,32712708
14744,RVO,disease,1.0,32712708
14745,DMO,disease,1.0,32712708
14746,COVID-19,disease,0.997,32712708
14747,aflibercept,gene,0.9863,32712182
14748,VEGF-A165-challenged retinal endothelial cells,cell_line,0.698,32712182
14749,VEGF-A165,gene,0.9805,32712182
14750,Fc,gene,0.975,32712182
14751,Fc fusion protein,gene,0.977,32712182
14752,aflibercept,gene,0.761,32712182
14753,unchallenged immortalized bovine retinal endothelial cells,cell_line,0.717,32712182
14754,bovine,species,0.759,32712182
14755,iBREC,cell_line,0.6523,32712182
14756,neonatal Fc receptor,gene,0.998,32712182
14757,FcRn,gene,0.9927,32712182
14758,Fc fusion protein,gene,0.9194,32712182
14759,Aflibercept,gene,0.9023,32712182
14760,VEGF-A,gene,0.9985,32712182
14761,REC,cell_line,0.8164,32712182
14762,Fc fusion protein,gene,0.9243,32712182
14763,FcRn,gene,0.9946,32712182
14764,aflibercept,gene,0.9795,32712182
14765,VEGF-A165-challenged iBREC,cell_line,0.9395,32712182
14766,VEGF-A165,gene,0.4836,32712182
14767,aflibercept,gene,0.9873,32712182
14768,iBREC,cell_line,0.7793,32712182
14769,iBREC monolayer,cell_line,0.683,32712182
14770,claudin-1,gene,0.901,32712182
14771,iBREC,cell_line,0.9023,32712182
14772,claudin-5,gene,0.994,32712182
14773,vascular endothelial cadherin,gene,0.994,32712182
14774,VEGF-binding proteins,gene,0.9956,32712182
14775,iBREC,cell_line,0.8066,32712182
14776,VEGF-A165,gene,0.998,32712182
14777,TJ-protein claudin-1,gene,0.808,32712182
14778,aflibercept,gene,0.961,32712182
14779,aflibercept,gene,0.9824,32712182
14780,iBREC,cell_line,0.8647,32712182
14781,VEGF-A,gene,0.9985,32712182
14782,FcRn,gene,0.9893,32712182
14783,aflibercept,gene,0.992,32712182
14784,VEGF-A-exposed iBREC,cell_line,0.908,32712182
14785,VEGF-A,gene,0.9795,32712182
14786,aflibercept,gene,0.9937,32712182
14787,iBREC,cell_line,0.694,32712182
14788,VEGF-A,gene,0.9976,32712182
14789,aflibercept,gene,0.8706,32712182
14790,tyrosine,drug,0.8105,32712182
14791,tyrosine kinase,gene,0.9907,32712182
14792,VEGF receptor,gene,0.9937,32712182
14793,VEGF-A,gene,0.9956,32712182
14794,VEGF-A,gene,0.9976,32712182
14795,Fc fusion protein,gene,0.9536,32712182
14796,FcRn,gene,0.997,32712182
14797,aflibercept,gene,0.9824,32712182
14798,REC,cell_line,0.827,32712182
14799,aflibercept,gene,0.99,32712182
14800,VEGF-A-exposed iBREC,cell_line,0.882,32712182
14801,VEGF,cell_type,0.597,32712182
14802,VEGF-A,gene,0.9927,32712182
14803,VEGF-A,gene,0.991,32712182
14804,aflibercept,gene,0.9907,32712182
14805,VEGF-A,gene,0.991,32712182
14806,gene expression signatures,DNA,0.618,32711453
14807,cancer,disease,0.986,32711453
14808,metastatic colorectal cancer,disease,1.0,32711453
14809,CRC,disease,1.0,32711453
14810,aflibercept,gene,0.9824,32711453
14811,triple negative breast cancer,disease,1.0,32711453
14812,TNBC,disease,0.9995,32711453
14813,iniparib,drug,0.883,32711453
14814,tumors,disease,1.0,32711453
14815,CRC,disease,1.0,32711453
14816,aflibercept,gene,0.9644,32711453
14817,CRC,disease,1.0,32711453
14818,VEGF,gene,0.9937,32710087
14819,injured,cell_type,0.4702,32710087
14820,retinal ganglion neurons,cell_type,0.7075,32710087
14821,Vascular endothelial growth factor-A,gene,0.9985,32710087
14822,VEGF,gene,0.9937,32710087
14823,age-related macular degeneration,disease,1.0,32710087
14824,AMD,disease,1.0,32710087
14825,diabetic macular edema,disease,1.0,32710087
14826,DME,drug,0.845,32710087
14827,VEGF,gene,0.9946,32710087
14828,VEGF,gene,0.996,32710087
14829,purified adult retinal ganglion cells,cell_line,0.6777,32710087
14830,RGCs,cell_type,0.8413,32710087
14831,VEGF,gene,0.9966,32710087
14832,RGCs,cell_type,0.854,32710087
14833,VEGF,gene,0.988,32710087
14834,RGC,cell_type,0.9,32710087
14835,VEGF,gene,0.995,32710087
14836,RGCs,cell_type,0.8535,32710087
14837,VEGF,gene,0.9956,32710087
14838,mixed retinal cells,cell_type,0.6772,32710087
14839,mesenchymal stem cells,cell_type,0.805,32710087
14840,RGCs,cell_type,0.7905,32710087
14841,recombinant VEGF-B,gene,0.919,32710087
14842,VEGF-R1,gene,0.851,32710087
14843,VEGF,gene,0.988,32710087
14844,RGC,cell_type,0.8374,32710087
14845,glaucomatous,disease,1.0,32710087
14846,VEGF,gene,0.994,32710087
14847,ranibizumab,gene,0.9644,32710087
14848,aflibercept,gene,0.975,32710087
14849,AMD,disease,1.0,32710087
14850,DME,disease,1.0,32710087
14851,RGC,cell_type,0.6777,32710087
14852,VEGF,gene,0.9937,32710087
14853,RGCs,cell_type,0.8384,32710087
14854,VEGF,gene,0.9937,32710087
14855,RGCs,cell_type,0.7505,32710087
14856,RGCs,cell_type,0.7275,32710087
14857,glaucomatous,disease,1.0,32710087
14858,neovascular age-related macular degeneration,disease,1.0,32706171
14859,choroidal neovascularization,disease,0.991,32706171
14860,vascular endothelial growth factor,gene,0.989,32706171
14861,choroidal neovascularization,disease,1.0,32706171
14862,CNV,disease,1.0,32706171
14863,neovascular age-related macular degeneration,disease,1.0,32706171
14864,nAMD,disease,1.0,32706171
14865,VEGF,gene,0.938,32706171
14866,aflibercept,gene,0.9863,32706171
14867,anti-VEGF,gene,0.7324,32706171
14868,Aflibercept,gene,0.9,32706171
14869,CNV,disease,0.999,32706171
14870,CNV lesions,DNA,0.4976,32706171
14871,CNV,disease,0.974,32706171
14872,CNV,disease,0.514,32706171
14873,aflibercept,gene,0.988,32706171
14874,VEGF,gene,0.689,32706171
14875,CNV,disease,0.9995,32706171
14876,CNV,disease,0.9995,32706171
14877,Ranibizumab,gene,0.938,32703021
14878,aflibercept,gene,0.978,32703021
14879,Hypertension,disease,1.0,32694921
14880,Ischemic Stroke,disease,1.0,32694921
14881,Aflibercept,gene,0.9624,32694921
14882,Retinopathy of Prematurity,disease,1.0,32694921
14883,Retinopathy of prematurity,disease,1.0,32694921
14884,preterm infants,disease,0.98,32694921
14885,anti-vascular endothelial growth factor,gene,0.9463,32694921
14886,anti-VEGF,gene,0.987,32694921
14887,VEGF,gene,0.959,32694921
14888,infant,species,0.4573,32694921
14889,hypertension,disease,1.0,32694921
14890,aflibercept,gene,0.975,32694921
14891,posterior retinopathy of prematurity,disease,1.0,32694921
14892,ROP,disease,1.0,32694921
14893,aflibercept,gene,0.9883,32694921
14894,hypertension crisis,disease,1.0,32694921
14895,ischemic stroke,disease,1.0,32694921
14896,infant,species,0.931,32694921
14897,hypertension,disease,1.0,32694921
14898,ischemic stroke,disease,1.0,32694921
14899,aflibercept,gene,0.9834,32694921
14900,preterm infants,cell_type,0.4587,32694921
14901,infants,species,0.585,32694921
14902,systemic comorbidities,disease,0.989,32694921
14903,hypertension,disease,0.977,32694921
14904,patients,species,0.9683,32694921
14905,thromboembolic,disease,0.6577,32694921
14906,thromboembolic events,disease,0.972,32694921
14907,vascular endothelial growth factor,gene,0.9175,32694921
14908,VEGF,gene,0.6064,32694921
14909,aflibercept,gene,0.9663,32694921
14910,VEGF,gene,0.991,32681907
14911,Neovascular Age-Related Macular Degeneration,disease,1.0,32681907
14912,bevacizumab,gene,0.821,32681907
14913,Avastin,gene,0.689,32681907
14914,ranibizumab,gene,0.87,32681907
14915,Lucentis,gene,0.582,32681907
14916,aflibercept,gene,0.9697,32681907
14917,Eylea,gene,0.6025,32681907
14918,neovascular,disease,0.582,32681907
14919,age-related macular degeneration,disease,1.0,32681907
14920,NVAMD,disease,1.0,32681907
14921,PATIENT,species,0.919,32681907
14922,NVAMD,disease,1.0,32681907
14923,bevacizumab,gene,0.5615,32681907
14924,ranibizumab,gene,0.756,32681907
14925,aflibercept,gene,0.9136,32681907
14926,Bevacizumab,gene,0.938,32681907
14927,Ranibizumab,gene,0.9233,32681907
14928,aflibercept,gene,0.9727,32681907
14929,NVAMD,disease,1.0,32681907
14930,bevacizumab,gene,0.8916,32681907
14931,ranibizumab,gene,0.8975,32681907
14932,aflibercept,gene,0.948,32681907
14933,bevacizumab,gene,0.783,32681907
14934,ranibizumab,gene,0.61,32681907
14935,aflibercept,gene,0.981,32681907
14936,NVAMD,disease,1.0,32681907
14937,Vascular endothelial growth factor-,gene,0.998,32681907
14938,VEGF-I,gene,0.987,32681907
14939,NVAMD,disease,1.0,32681907
14940,bevacizumab,gene,0.8403,32681907
14941,ranibizumab,gene,0.7847,32681907
14942,aflibercept,gene,0.9443,32681907
14943,aflibercept,gene,0.9736,32676268
14944,choroidal neovascular membrane,disease,0.99,32676268
14945,Vogt-Koyanagi-Harada syndrome,disease,1.0,32676268
14946,choroidal neovascular membrane,disease,1.0,32676268
14947,Vogt-Koyanagi-Harada (VKH) syndrome,disease,1.0,32676268
14948,aflibercept,gene,0.9805,32676268
14949,VKH syndrome,disease,1.0,32676268
14950,mycophenolate mofetil,drug,0.999,32676268
14951,aflibercept,gene,0.954,32676268
14952,choroidal neovascular membranes,disease,0.999,32676268
14953,VEGF,gene,0.9814,32676268
14954,vascular endothelial growth factor,gene,0.998,32676268
14955,aflibercept,gene,0.981,32676268
14956,Aflibercept,gene,0.9907,32671137
14957,ADVM,DNA,0.4768,32671137
14958,nAMD,disease,1.0,32671137
14959,retinal disease,disease,1.0,32671137
14960,aflibercept,gene,0.9688,32671137
14961,vascular endothelial growth factor,gene,0.9985,32671137
14962,VEGFA,gene,0.9946,32671137
14963,anti-VEGFA proteins,gene,0.9736,32671137
14964,ADVM,DNA,0.4712,32671137
14965,aflibercept,gene,0.981,32671137
14966,anti-VEGFA protein,gene,0.9443,32671137
14967,aflibercept recombinant protein,gene,0.9644,32671137
14968,aflibercept,gene,0.981,32671137
14969,aflibercept recombinant protein,gene,0.951,32671137
14970,ADVM,DNA,0.518,32671137
14971,ADVM,drug,0.735,32671137
14972,aflibercept,gene,0.9863,32671137
14973,aflibercept,gene,0.9917,32671137
14974,retinal disease,disease,0.9995,32671137
14975,VEGF,gene,0.751,32671137
14976,Nephrotoxicity,disease,0.9946,32664269
14977,Aflibercept,gene,0.9062,32664269
14978,Dasatinib,drug,0.9897,32664269
14979,Nivolumab,gene,0.508,32664269
14980,Cancer,disease,1.0,32664269
14981,kidney disease,disease,1.0,32664269
14982,renal damage,disease,0.8325,32664269
14983,Kidney disease,disease,0.9995,32664269
14984,nephrotoxicity,disease,0.6187,32664269
14985,neoplasms,disease,1.0,32664269
14986,nephrotoxicity,disease,0.9536,32664269
14987,renal toxicities,disease,0.9995,32664269
14988,proteinuria,disease,1.0,32664269
14989,renal failure,disease,1.0,32664269
14990,aflibercept,gene,0.9907,32664269
14991,dasatinib,drug,0.989,32664269
14992,bevacizumab,gene,0.843,32659326
14993,aflibercept,gene,0.9844,32659326
14994,rats,species,0.988,32659326
14995,anti-VEGF antibodies,gene,0.9033,32659326
14996,age-related macular degeneration,disease,1.0,32659326
14997,89Zr,drug,0.999,32659326
14998,bevacizumab,gene,0.9546,32659326
14999,89Zr,drug,0.9995,32659326
15000,aflibercept,gene,0.983,32659326
15001,zirconium,drug,0.9995,32659326
15002,bevacizumab,gene,0.947,32659326
15003,aflibercept,gene,0.9854,32659326
15004,89Zr,drug,0.9985,32659326
15005,89Zr,drug,0.999,32659326
15006,bevacizumab,gene,0.8213,32659326
15007,89Zr,drug,0.9995,32659326
15008,aflibercept,gene,0.9478,32659326
15009,89Zr,drug,0.9995,32659326
15010,bevacizumab,gene,0.955,32659326
15011,89Zr,drug,0.9995,32659326
15012,aflibercept,gene,0.9907,32659326
15013,89Zr,drug,0.9995,32659326
15014,bevacizumab,gene,0.948,32659326
15015,89Zr,drug,0.9995,32659326
15016,aflibercept,gene,0.99,32659326
15017,aflibercept,gene,0.9927,32659326
15018,bevacizumab,gene,0.8687,32659326
15019,rats,species,0.983,32659326
15020,Choroidal Neovascularization,disease,0.996,32652314
15021,Age-Related Macular Degeneration,disease,1.0,32652314
15022,choroidal neovascularization,disease,1.0,32652314
15023,CNV,disease,1.0,32652314
15024,anti-vascular endothelial growth factor,gene,0.9663,32652314
15025,VEGF,gene,0.993,32652314
15026,neovascular age-related macular degeneration,disease,1.0,32652314
15027,nAMD,disease,1.0,32652314
15028,Vascular Endothelial Growth Factor,gene,0.9976,32652314
15029,VEGF Trap-Eye,gene,0.7593,32652314
15030,Age-Related Macular Degeneration,disease,0.9937,32652314
15031,AMD,disease,1.0,32652314
15032,PARTICIPANTS,species,0.617,32652314
15033,nAMD,disease,1.0,32652314
15034,aflibercept,gene,0.974,32652314
15035,CNV,disease,0.553,32652314
15036,Diabetic Retinopathy,disease,0.999,32652314
15037,Diabetic Retinopathy,disease,0.9995,32652314
15038,CNV,disease,0.965,32652314
15039,CNV,disease,1.0,32652314
15040,CNV,disease,0.996,32652314
15041,CNV,disease,0.9995,32652314
15042,CNV,DNA,0.6885,32652314
15043,CNV,DNA,0.597,32652314
15044,nAMD,disease,1.0,32652314
15045,anti-VEGF,gene,0.6313,32652314
15046,aflibercept,gene,0.9863,32650757
15047,patients,species,0.928,32650757
15048,aflibercept,gene,0.987,32650757
15049,age-related macular degeneration,disease,1.0,32650757
15050,nAMD,disease,1.0,32650757
15051,nAMD,disease,1.0,32650757
15052,patients,species,0.9937,32650757
15053,patients,species,0.9707,32650757
15054,nAMD,disease,1.0,32650757
15055,AMD,disease,1.0,32650757
15056,polypoidal choroidal vasculopathy,disease,1.0,32650757
15057,CRT,DNA,0.5225,32650757
15058,SFCT,DNA,0.5093,32650757
15059,AMD,disease,0.9995,32650757
15060,PCV,disease,1.0,32650757
15061,aflibercept,gene,0.9937,32650757
15062,nAMD,disease,1.0,32650757
15063,Vascular Endothelial Growth Factor,gene,0.84,32640254
15064,Diabetic macular edema,disease,1.0,32640254
15065,DME,disease,1.0,32640254
15066,diabetics,disease,1.0,32640254
15067,vascular endothelial growth factor,gene,0.987,32640254
15068,VEGF,gene,0.9976,32640254
15069,DME,disease,1.0,32640254
15070,patients,species,0.9463,32640254
15071,DME,disease,1.0,32640254
15072,VEGF,gene,0.6807,32640254
15073,patients,species,0.9556,32640254
15074,DME,disease,1.0,32640254
15075,DME,disease,1.0,32640254
15076,patients,species,0.9956,32640254
15077,anti-VEGF,gene,0.753,32640254
15078,patients,species,0.991,32640254
15079,patients,species,0.9946,32640254
15080,patients,species,0.993,32640254
15081,patients,species,0.926,32640254
15082,DME,disease,1.0,32640254
15083,vascular endothelial growth factor,gene,0.9966,32633861
15084,macular oedema,disease,1.0,32633861
15085,Branch retinal vein occlusion,disease,1.0,32633861
15086,BRVO,disease,1.0,32633861
15087,retinal vascular abnormalities,disease,0.9893,32633861
15088,visual loss,disease,0.993,32633861
15089,people,species,0.9844,32633861
15090,BRVO,disease,1.0,32633861
15091,macular oedema,disease,1.0,32633861
15092,MO,disease,1.0,32633861
15093,anti-vascular endothelial growth factor,gene,0.9126,32633861
15094,anti-VEGF,gene,0.9575,32633861
15095,MO,disease,,32633861
15096,anti-vascular endothelial growth factor,gene,0.837,32633861
15097,VEGF,gene,0.9976,32633861
15098,macular oedema,disease,1.0,32633861
15099,MO,disease,1.0,32633861
15100,branch retinal vein occlusion,disease,1.0,32633861
15101,BRVO,disease,1.0,32633861
15102,BRVO,disease,1.0,32633861
15103,participants,species,0.9697,32633861
15104,Diabetic Retinopathy,disease,1.0,32633861
15105,participants,species,0.9814,32633861
15106,participants,species,0.9556,32633861
15107,participants,species,0.9355,32633861
15108,VEGF,gene,0.842,32633861
15109,bevacizumab,gene,0.9473,32633861
15110,ranibizumab,gene,0.943,32633861
15111,aflibercept,gene,0.9697,32633861
15112,triamcinolone,drug,1.0,32633861
15113,dexamethasone,drug,0.9985,32633861
15114,participants,species,0.9736,32633861
15115,anti-VEGF,gene,0.9526,32633861
15116,anti-VEGF,gene,0.9062,32633861
15117,participants,species,0.952,32633861
15118,participants,species,0.953,32633861
15119,participants,species,0.9546,32633861
15120,CRT,DNA,0.4878,32633861
15121,endophthalmitis,disease,1.0,32633861
15122,people,species,0.9736,32633861
15123,people,species,0.988,32633861
15124,participants,species,0.94,32633861
15125,anti,gene,0.515,32633861
15126,participants,species,0.9497,32633861
15127,anti-VEGF,gene,0.817,32633861
15128,participants,species,0.891,32633861
15129,participants,species,0.9233,32633861
15130,participants,species,0.933,32633861
15131,endophthalmitis,disease,1.0,32633861
15132,anti-VEGF,gene,0.8643,32633861
15133,participants,species,0.9326,32633861
15134,ETDRS,DNA,0.533,32633861
15135,anti-VEGF,gene,0.889,32633861
15136,participants,species,0.9507,32633861
15137,participants,species,0.9326,32633861
15138,participants,species,0.954,32633861
15139,participants,species,0.8584,32633861
15140,participants,species,0.937,32633861
15141,People,species,0.869,32633861
15142,anti-VEGF,gene,0.8887,32633861
15143,participants,species,0.9277,32633861
15144,cataract,disease,1.0,32633861
15145,endophthalmitis,disease,1.0,32633861
15146,MO,disease,,32633861
15147,BRVO,disease,1.0,32633861
15148,Capecitabine,drug,0.999,32631787
15149,Aflibercept,gene,0.824,32631787
15150,capecitabine,drug,0.998,32631787
15151,fluoropyrimidine,drug,0.9966,32631787
15152,aflibercept,gene,0.9854,32631787
15153,PATIENTS,species,0.9595,32631787
15154,Patients,species,0.9565,32631787
15155,gastrointestinal and breast cancer,disease,1.0,32631787
15156,capecitabine,drug,0.9985,32631787
15157,dosing arm,DNA,0.53,32631787
15158,Aflibercept,gene,0.947,32631787
15159,patients,species,0.9653,32631787
15160,colorectal cancer,disease,1.0,32631787
15161,gastric cancer,disease,1.0,32631787
15162,breast cancer,disease,1.0,32631787
15163,DLTs,disease,0.9995,32631787
15164,hand-foot syndrome,disease,1.0,32631787
15165,anorexia,disease,1.0,32631787
15166,patient,species,0.9663,32631787
15167,hypertension,disease,1.0,32631787
15168,capecitabine,drug,0.9985,32631787
15169,patients,species,0.9585,32631787
15170,patients,species,0.9766,32631787
15171,capecitabine,drug,0.999,32631787
15172,aflibercept,gene,0.9795,32631787
15173,patients,species,0.9434,32631787
15174,gastrointestinal and breast cancer,disease,1.0,32631787
15175,VEGF,gene,0.564,32622633
15176,neovascular age-related macular degeneration,disease,1.0,32622633
15177,retinal blindness,disease,1.0,32622633
15178,neovascular age-related macular degeneration,disease,1.0,32622633
15179,nAMD,disease,1.0,32622633
15180,VEGF,gene,0.9443,32622633
15181,nAMD,disease,1.0,32622633
15182,Retinal Blindness,disease,1.0,32622633
15183,aflibercept,gene,0.9756,32622633
15184,ranibizumab,gene,0.856,32622633
15185,bevacizumab,gene,0.5977,32622633
15186,aflibercept,gene,0.9736,32622633
15187,ranibizumab,gene,0.5967,32622633
15188,VEGF,gene,0.859,32622633
15189,nAMD,disease,1.0,32622633
15190,bevacizumab,gene,0.9395,32621894
15191,aflibercept,gene,0.988,32621894
15192,DFE,DNA,0.6216,32621894
15193,DFE,DNA,0.5776,32621894
15194,bevacizumab,gene,0.8184,32621894
15195,aflibercept,gene,0.956,32621894
15196,aflibercept,gene,0.9844,32620686
15197,retinal vein occlusion,disease,0.9995,32620686
15198,retinal vein occlusion,disease,1.0,32620686
15199,RVO,disease,1.0,32620686
15200,aflibercept,gene,0.6934,32620686
15201,RVO,disease,0.999,32620686
15202,RVO,disease,0.9766,32620686
15203,oedema,disease,0.9956,32620686
15204,stromal oedema,disease,1.0,32620686
15205,vascular endothelial growth factor,gene,0.95,32620686
15206,RVO,disease,1.0,32620686
15207,Aflibercept,gene,0.99,32616433
15208,Ramucirumab,gene,0.5986,32616433
15209,Irinotecan,drug,0.9614,32616433
15210,Fluorouracil,drug,0.998,32616433
15211,Metastatic Colorectal Cancer,disease,1.0,32616433
15212,aflibercept,gene,0.988,32616433
15213,AFL,gene,0.986,32616433
15214,RAM,drug,0.882,32616433
15215,folinic acid,drug,0.999,32616433
15216,fluorouracil,drug,0.9995,32616433
15217,irinotecan,drug,0.999,32616433
15218,FOLFIRI,drug,0.9956,32616433
15219,FOLFIRI,drug,0.976,32616433
15220,metastatic colorectal cancer,disease,1.0,32616433
15221,mCRC,disease,1.0,32616433
15222,AFL,drug,0.994,32616433
15223,RAM,drug,0.9976,32616433
15224,Aflibercept,gene,0.831,32616433
15225,Irinotecan,drug,0.954,32616433
15226,5-FU,drug,0.995,32616433
15227,Metastatic Colorectal Cancer,disease,1.0,32616433
15228,Oxaliplatin,drug,0.9995,32616433
15229,Ramucirumab,gene,0.542,32616433
15230,Metastatic Colorectal Carcinoma,disease,1.0,32616433
15231,Bevacizumab,gene,0.8584,32616433
15232,Oxaliplatin,drug,0.9995,32616433
15233,Fluoropyrimidine,drug,0.997,32616433
15234,FOLFIRI,drug,0.978,32616433
15235,AFL,drug,0.9956,32616433
15236,RAM,drug,0.962,32616433
15237,mCRC,disease,0.9663,32616433
15238,AFL or,drug,0.913,32616433
15239,RAM,drug,0.934,32616433
15240,FOLFIRI,drug,0.999,32616433
15241,FOLFIRI,drug,0.9985,32616433
15242,FOLFIRI,drug,0.998,32616433
15243,AFL or RAM,drug,0.9937,32616433
15244,FOLFIRI,drug,0.9985,32616433
15245,AFL,drug,0.998,32616433
15246,RAM,drug,0.9985,32616433
15247,AFL,drug,0.9966,32616433
15248,RAM,drug,0.9966,32616433
15249,FOLFIRI,drug,0.9907,32616433
15250,mCRC,disease,0.9854,32616433
15251,mCRC,disease,0.991,32616433
15252,AFL,drug,0.997,32616433
15253,RAM,drug,0.9966,32616433
15254,AFL,drug,0.9956,32616433
15255,RAM,drug,0.999,32616433
15256,Irvine Gass syndrome,disease,0.999,32613461
15257,anti-vascular endothelial growth factor,gene,0.9863,32613461
15258,anti-VEGF,gene,0.9937,32613461
15259,Irvine Gass syndrome,disease,1.0,32613461
15260,patients,species,0.977,32613461
15261,Irvine Gass syndrome,disease,1.0,32613461
15262,Patients,species,0.9854,32613461
15263,anti-VEGF,gene,0.8584,32613461
15264,Ranibizumab,gene,0.962,32613461
15265,Razumab,gene,0.7764,32613461
15266,Bevacizumab,gene,0.7324,32613461
15267,Avastin,gene,0.71,32613461
15268,Aflibercept,gene,0.9214,32613461
15269,Eylea,gene,0.817,32613461
15270,Dexamethasone,drug,0.9995,32613461
15271,Ozurdex,drug,0.9976,32613461
15272,triamcinolone,drug,0.9585,32613461
15273,dexamethasone,drug,0.995,32613461
15274,patients,species,0.9814,32613461
15275,VEGF,gene,0.774,32613461
15276,dexamethasone,drug,0.8965,32613461
15277,ETDRS,DNA,0.4912,32613461
15278,dexamethasone,drug,0.987,32613461
15279,dexamethasone,drug,0.979,32613461
15280,Patients,species,0.911,32613461
15281,Neovascular Age-Related Macular Degeneration,disease,1.0,32606571
15282,Neovascular age-related macular degeneration,disease,1.0,32606571
15283,nv-AMD,disease,1.0,32606571
15284,blindness,disease,0.997,32606571
15285,vascular endothelial growth factor,gene,0.8853,32606571
15286,anti-VEGF,gene,0.802,32606571
15287,VA,disease,0.942,32606571
15288,nv-AMD,disease,1.0,32606571
15289,bevacizumab,gene,0.7886,32606571
15290,ranibizumab,gene,0.7524,32606571
15291,aflibercept,gene,0.9087,32606571
15292,nv-AMD,disease,0.9995,32606571
15293,Choroidal Neovascularization,disease,1.0,32601568
15294,Aflibercept,gene,0.938,32601568
15295,choroidal neovascularization,disease,0.9995,32601568
15296,fluorescein,drug,0.999,32601568
15297,anti-,gene,0.795,32601568
15298,vascular endothelial growth factor,gene,0.9023,32601568
15299,VEGF,gene,0.9966,32601568
15300,aflibercept,gene,0.9556,32601568
15301,Contrast nephropathy,disease,0.986,32591963
15302,cancer,disease,1.0,32591963
15303,patients,species,0.9824,32591963
15304,VEGF,gene,0.8594,32591963
15305,Contrast nephropathy,disease,0.9595,32591963
15306,cancer,disease,1.0,32591963
15307,patients,species,0.988,32591963
15308,vascular endothelial growth factor/receptor,gene,0.8706,32591963
15309,VEGF/R,gene,0.825,32591963
15310,VEGF/R,gene,0.94,32591963
15311,contrast-induced nephropathy,disease,0.997,32591963
15312,CIN,disease,1.0,32591963
15313,patients,species,0.9717,32591963
15314,cancers,disease,1.0,32591963
15315,patients,species,0.9863,32591963
15316,Patients,species,0.97,32591963
15317,hemoglobin,gene,0.9946,32591963
15318,CIN,disease,0.9927,32591963
15319,creatinine,drug,0.984,32591963
15320,CIN,disease,0.9995,32591963
15321,anti-VEGF/R,gene,0.972,32591963
15322,CIN,disease,0.999,32591963
15323,bevacizumab,gene,0.753,32591963
15324,VEGF/R,gene,0.873,32591963
15325,patients,species,0.995,32591963
15326,anti-VEGF/R,gene,0.993,32591963
15327,patients,species,0.9956,32591963
15328,anti-VEGF/R,gene,0.9907,32591963
15329,patients,species,0.996,32591963
15330,anti-VEGF/R,gene,0.939,32591963
15331,patients,species,0.9946,32591963
15332,VEGF/R,gene,0.961,32591963
15333,CIN,disease,0.995,32591963
15334,patients,species,0.9893,32591963
15335,patients,species,0.987,32591963
15336,VEGF/R,gene,0.7603,32591963
15337,sunitinib,drug,0.9985,32591963
15338,axitinib,drug,0.991,32591963
15339,regorafenib,drug,0.9917,32591963
15340,aflibercept,gene,0.8237,32591963
15341,CIN,disease,0.9995,32591963
15342,patients,species,0.9927,32591963
15343,bevacizumab,gene,0.744,32591963
15344,VEGFR,gene,0.873,32591963
15345,patients,species,0.9873,32591963
15346,patient,species,0.9907,32591963
15347,acute kidney injury,disease,1.0,32591963
15348,CIN,disease,0.9976,32591963
15349,cancer,disease,1.0,32591963
15350,patients,species,0.99,32591963
15351,VEGF/R,gene,0.8325,32591963
15352,VEGF/R,gene,0.9365,32591963
15353,Aflibercept,gene,0.92,32589498
15354,aflibercept,gene,0.9595,32589498
15355,patients,species,0.9683,32589498
15356,diabetic macular edema,disease,1.0,32589498
15357,DME,disease,1.0,32589498
15358,patients,species,0.982,32589498
15359,DME,disease,1.0,32589498
15360,Patients,species,0.9805,32589498
15361,aflibercept,gene,0.965,32589498
15362,patients,species,0.985,32589498
15363,transforming growth factor-beta (TGF-)1,gene,0.9917,32589498
15364,TGF-2,gene,0.9907,32589498
15365,inducible protein (IP)-10,gene,0.991,32589498
15366,hepatocyte growth factor,gene,0.9966,32589498
15367,HGF,gene,0.995,32589498
15368,vascular endothelial growth factor,gene,0.9966,32589498
15369,VEGF,gene,0.9976,32589498
15370,placental growth factor,gene,0.9976,32589498
15371,PlGF),gene,0.993,32589498
15372,interleukin (IL)-6,gene,0.9927,32589498
15373,platelet-derived growth factor-,gene,0.998,32589498
15374,PDGF-AA,gene,0.9976,32589498
15375,patients,species,0.9736,32589498
15376,DME,disease,1.0,32589498
15377,aflibercept,gene,0.962,32589498
15378,VEGF,gene,0.995,32589498
15379,PlGF,gene,0.995,32589498
15380,IL-6,gene,0.9395,32589498
15381,PDGF-AA,gene,0.989,32589498
15382,TGF-1,gene,0.9956,32589498
15383,TGF-2,gene,0.9976,32589498
15384,HGF,gene,0.9946,32589498
15385,IP-10,gene,0.977,32589498
15386,Ranibizumab,gene,0.959,32587759
15387,Aflibercept,gene,0.956,32587759
15388,ranibizumab,gene,0.8887,32587759
15389,aflibercept,gene,0.9624,32587759
15390,patients,species,0.959,32587759
15391,age-related macular degeneration,disease,1.0,32587759
15392,AMD,disease,1.0,32587759
15393,patients,species,0.9873,32587759
15394,patient,species,0.9893,32587759
15395,ranibizumab,gene,0.9287,32587759
15396,aflibercept,gene,0.9717,32587759
15397,patient,species,0.9893,32587759
15398,corneal endothelial cell,cell_type,0.676,32587759
15399,hexagonal,cell_type,0.622,32587759
15400,ECD,cell_type,0.5845,32587759
15401,VEGF,gene,0.6885,32587759
15402,hexagonal cells,cell_type,0.8984,32587759
15403,polymegathism,disease,0.975,32587759
15404,Ranibizumab,gene,0.8467,32587759
15405,aflibercept,gene,0.9834,32587759
15406,ranibizumab,gene,0.8716,32587759
15407,aflibercept,gene,0.98,32587759
15408,aflibercept,gene,0.986,32586117
15409,neovascular age-related macular,disease,1.0,32586117
15410,aflibercept,gene,0.99,32586117
15411,Eylea,gene,0.8584,32586117
15412,neovascular macular degeneration,disease,1.0,32586117
15413,nAMD,disease,1.0,32586117
15414,patients,species,0.981,32586117
15415,nAMD,disease,1.0,32586117
15416,aflibercept,gene,0.9805,32586117
15417,patients,species,0.95,32586117
15418,aflibercept,gene,0.987,32586117
15419,ETDRS,DNA,0.7095,32586117
15420,aflibercept,gene,0.973,32586117
15421,nAMD,disease,1.0,32586117
15422,Aflibercept,gene,0.892,32584384
15423,vascular endothelial growth factor,gene,0.897,32584384
15424,macular edema,disease,1.0,32584384
15425,aflibercept,gene,0.9507,32584384
15426,patients,species,0.9004,32584384
15427,proliferative diabetic retinopathy,disease,1.0,32584384
15428,diabetic macular edema,disease,1.0,32584384
15429,PARTICIPANTS,species,0.6016,32584384
15430,patients,species,0.9775,32584384
15431,proliferative,disease,0.701,32584384
15432,diabetic retinopathy,disease,0.982,32584384
15433,macular edema,disease,1.0,32584384
15434,Aflibercept,gene,0.9834,32584384
15435,Retinal Nonperfusion,disease,0.9976,32584384
15436,Proliferative Diabetic Retinopathy,disease,1.0,32584384
15437,patients,species,0.9746,32584384
15438,patients,species,0.9805,32584384
15439,patients,species,0.984,32584384
15440,patients,species,0.977,32584384
15441,aflibercept,gene,0.916,32584384
15442,patients,species,0.9785,32584384
15443,superficial,DNA,0.575,32584384
15444,aflibercept,gene,0.974,32584384
15445,diabetic retinopathy,disease,1.0,32584384
15446,vascular endothelial growth factor,gene,0.9814,32584384
15447,ranibizumab,gene,0.686,32579608
15448,aflibercept,gene,0.8936,32579608
15449,polypoidal choroidal vasculopathy,disease,1.0,32579608
15450,ranibizumab,gene,0.781,32579608
15451,aflibercept,gene,0.888,32579608
15452,polypoidal choroidal vasculopathy,disease,1.0,32579608
15453,PCV,disease,1.0,32579608
15454,PCV,disease,1.0,32579608
15455,polypoidal lesions,disease,1.0,32579608
15456,indocyanine green,drug,0.997,32579608
15457,polyp,disease,0.984,32579608
15458,PCV,gene,0.579,32579608
15459,Vascular Endothelial Growth Factor,gene,0.9985,32574830
15460,Retinal Diseases,disease,0.999,32574830
15461,Retinal Blindness,disease,0.9995,32574830
15462,vascular endothelial growth factor,gene,0.9985,32574830
15463,VEGF,gene,0.9927,32574830
15464,retinal conditions,disease,0.9463,32574830
15465,Retinal Blindness,disease,0.9995,32574830
15466,PARTICIPANTS,species,0.904,32574830
15467,VEGF,gene,0.992,32574830
15468,ranibizumab,gene,0.9106,32574830
15469,aflibercept,gene,0.943,32574830
15470,bevacizumab,gene,0.652,32574830
15471,mercury,drug,0.9985,32574830
15472,bevacizumab,gene,0.8213,32574830
15473,aflibercept,gene,0.96,32574830
15474,aflibercept,gene,0.9883,32574830
15475,bevacizumab,gene,0.6978,32574830
15476,glaucoma,disease,1.0,32574830
15477,VEGF,gene,0.9907,32574830
15478,Aflibercept,gene,0.96,32574830
15479,glaucoma,disease,1.0,32574830
15480,Brolucizumab,gene,0.7456,32574761
15481,Neovascular Age-Related Macular Degeneration,disease,1.0,32574761
15482,brolucizumab,gene,0.9,32574761
15483,aflibercept,gene,0.975,32574761
15484,neovascular age-related macular degeneration,disease,1.0,32574761
15485,nAMD,disease,1.0,32574761
15486,PARTICIPANTS,species,0.934,32574761
15487,nAMD,disease,1.0,32574761
15488,brolucizumab,gene,0.8643,32574761
15489,brolucizumab,gene,0.799,32574761
15490,aflibercept,gene,0.937,32574761
15491,brolucizumab,gene,0.8994,32574761
15492,aflibercept,gene,0.893,32574761
15493,brolucizumab,gene,0.906,32574761
15494,Aflibercept,gene,0.9526,32574761
15495,Diabetic Retinopathy,disease,0.9995,32574761
15496,brolucizumab,gene,0.937,32574761
15497,brolucizumab,gene,0.935,32574761
15498,aflibercept,gene,0.988,32574761
15499,brolucizumab,gene,0.8467,32574761
15500,aflibercept,gene,0.982,32574761
15501,brolucizumab,gene,0.8813,32574761
15502,aflibercept,gene,0.9795,32574761
15503,intraretinal fluid,disease,0.991,32574761
15504,subretinal fluid,disease,0.901,32574761
15505,IRF,disease,0.8247,32574761
15506,SRF,disease,0.506,32574761
15507,brolucizumab,gene,0.9097,32574761
15508,aflibercept,gene,0.968,32574761
15509,brolucizumab,gene,0.8896,32574761
15510,aflibercept,gene,0.988,32574761
15511,brolucizumab,gene,0.8823,32574761
15512,Brolucizumab,gene,0.6777,32574761
15513,Brolucizumab,gene,0.9316,32574761
15514,aflibercept,gene,0.9854,32574761
15515,q12w,DNA,0.807,32574761
15516,brolucizumab,gene,0.9507,32574761
15517,VEGF,gene,0.994,32565050
15518,Neovascular Age-Related Macular Degeneration,disease,1.0,32565050
15519,bevacizumab,gene,0.7407,32565050
15520,aflibercept,gene,0.946,32565050
15521,neovascular age-related macular degeneration,disease,1.0,32565050
15522,NVAMD,disease,1.0,32565050
15523,bevacizumab,gene,0.9287,32565050
15524,ranibizumab,gene,0.808,32565050
15525,aflibercept,gene,0.95,32565050
15526,neovascular age-related macular degeneration,disease,1.0,32565050
15527,NVAMD,disease,1.0,32565050
15528,vision,disease,0.7983,32565050
15529,Age-Related Macular Degeneration,disease,1.0,32565050
15530,VEGF Trap-Eye,gene,0.8384,32565050
15531,NVAMD,disease,1.0,32565050
15532,Bevacizumab,gene,0.8647,32565050
15533,Aflibercept,gene,0.955,32565050
15534,Aflibercept,gene,0.977,32565050
15535,ranibizumab,gene,0.6504,32565050
15536,bevacizumab,gene,0.794,32565050
15537,bevacizumab,gene,0.7393,32565050
15538,aflibercept,gene,0.979,32565050
15539,bevacizumab,gene,0.9355,32565050
15540,ranibizumab,gene,0.8574,32565050
15541,aflibercept,gene,0.981,32565050
15542,bevacizumab,gene,0.892,32565050
15543,ranibizumab,gene,0.7905,32565050
15544,aflibercept,gene,0.8174,32565050
15545,NVAMD,disease,0.9995,32565050
15546,bevacizumab,gene,0.708,32565050
15547,aflibercept,gene,0.95,32565050
15548,bevacizumab,gene,0.791,32565050
15549,ranibizumab,gene,0.6523,32565050
15550,aflibercept,gene,0.989,32565050
15551,NEOVASCULAR AMD,disease,0.9263,32558673
15552,Aflibercept,gene,0.9897,32557181
15553,Non-ocular Haemorrhage,disease,0.996,32557181
15554,anti-,gene,0.9165,32557181
15555,vascular endothelial growth factor,gene,0.9014,32557181
15556,VEGF,gene,0.9985,32557181
15557,aflibercept,gene,0.965,32557181
15558,ranibizumab,gene,0.6084,32557181
15559,retinal diseases,disease,1.0,32557181
15560,non-ocular haemorrhage,disease,1.0,32557181
15561,non-ocular haemorrhage,disease,0.9995,32557181
15562,aflibercept,gene,0.988,32557181
15563,ranibizumab,gene,0.7437,32557181
15564,anti-VEGFs,gene,0.9473,32557181
15565,aflibercept,gene,0.969,32557181
15566,ranibizumab,drug,0.706,32557181
15567,non-ocular haemorrhage,disease,0.9995,32557181
15568,person,species,0.8335,32557181
15569,Patients,species,0.92,32557181
15570,aflibercept,gene,0.982,32557181
15571,dexamethasone,drug,0.9976,32557181
15572,ranibizumab,gene,0.617,32557181
15573,dexamethasone,drug,0.9976,32557181
15574,ranibizumab,gene,0.766,32557181
15575,aflibercept,gene,0.947,32557181
15576,dexamethasone,drug,0.995,32557181
15577,haemorrhage,disease,0.9995,32557181
15578,Aflibercept,gene,0.9683,32557181
15579,aflibercept,gene,0.972,32557181
15580,ranibizumab,gene,0.7554,32557181
15581,dexamethasone,drug,0.9946,32557181
15582,aflibercept,gene,0.983,32557181
15583,non-ocular haemorrhage,disease,1.0,32557181
15584,ranibizumab,gene,0.6064,32557181
15585,anti-VEGFs,gene,0.908,32557181
15586,dexamethasone,drug,0.8154,32557181
15587,Neovascular Age-Related Macular Degeneration,disease,1.0,32557168
15588,Diabetic Retinopathy,disease,0.9985,32557168
15589,BCVA,DNA,0.7,32557168
15590,patients,species,0.969,32557168
15591,neovascular age-related macular degeneration,disease,1.0,32557168
15592,nAMD,disease,1.0,32557168
15593,aflibercept,gene,0.977,32557168
15594,Patients,species,0.981,32557168
15595,aflibercept,gene,0.9814,32557168
15596,patients,species,0.9883,32557168
15597,ETDRS,DNA,0.602,32557168
15598,patients,species,0.9844,32557168
15599,CRT,DNA,0.551,32557168
15600,Aflibercept,gene,0.9287,32557168
15601,nAMD,disease,1.0,32557168
15602,patients,species,0.956,32552280
15603,macular degeneration,disease,1.0,32552280
15604,AMD,disease,1.0,32552280
15605,neovascular AMD,disease,1.0,32552280
15606,VEGF,gene,0.998,32552280
15607,Patients,species,0.985,32552280
15608,anti-VEGF,gene,0.978,32552280
15609,ranibizumab,gene,0.872,32552280
15610,aflibercept,gene,0.966,32552280
15611,ovarian cancer,disease,1.0,32552175
15612,ovarian cancer,disease,1.0,32552175
15613,Bevacizumab,gene,0.7744,32552175
15614,ovarian malignancy,disease,1.0,32552175
15615,bevacizumab,gene,0.963,32552175
15616,PARP,gene,0.993,32552175
15617,Macular Atrophy,disease,1.0,32544561
15618,Neovascular Age-Related Macular Degeneration,disease,1.0,32544561
15619,Vascular Endothelial Growth Factor,gene,0.9985,32544561
15620,macular atrophy,disease,1.0,32544561
15621,MA,disease,1.0,32544561
15622,neovascular age-related macular degeneration,disease,1.0,32544561
15623,nAMD,disease,1.0,32544561
15624,VEGF,gene,0.998,32544561
15625,nAMD,disease,1.0,32544561
15626,nAMD,disease,1.0,32544561
15627,VEGF,gene,0.768,32544561
15628,anti-VEGF,gene,0.9194,32544561
15629,MA,disease,0.999,32544561
15630,MA,disease,1.0,32544561
15631,Macular atrophy,disease,1.0,32544561
15632,MA,disease,0.947,32544561
15633,MA,disease,0.582,32544561
15634,MA,disease,0.9805,32544561
15635,retinal angiomatous proliferation,disease,1.0,32544561
15636,MA,disease,0.9624,32544561
15637,MA,disease,0.998,32544561
15638,MA,disease,0.996,32544561
15639,MA,disease,0.9995,32544561
15640,nAMD,disease,1.0,32544561
15641,anti-VEGF,gene,0.832,32544561
15642,Anti-Vascular Endothelial Growth Factor,gene,0.9233,32544559
15643,Bevacizumab,drug,0.815,32544559
15644,bevacizumab,gene,0.696,32544559
15645,anti-vascular endothelial growth factor,gene,0.8906,32544559
15646,VEGF,gene,0.997,32544559
15647,PARTICIPANTS,species,0.53,32544559
15648,VEGF,gene,0.8413,32544559
15649,bevacizumab,gene,0.8394,32544559
15650,ranibizumab,gene,0.587,32544559
15651,aflibercept,gene,0.8906,32544559
15652,VEGF,gene,0.658,32544559
15653,bevacizumab,gene,0.9526,32544559
15654,aflibercept,gene,0.9834,32544559
15655,bevacizumab,gene,0.7666,32544559
15656,bevacizumab,gene,0.6553,32544559
15657,anti-VEGF,gene,0.8643,32544559
15658,aflibercept,gene,0.9634,32541440
15659,Coats' Disease,disease,1.0,32541440
15660,aflibercept,gene,0.9834,32541440
15661,Coats' disease,disease,1.0,32541440
15662,blurred vision,disease,0.9995,32541440
15663,macular edema,disease,1.0,32541440
15664,macular edema,disease,1.0,32541440
15665,Peripheral,disease,0.977,32541440
15666,telangiectasias,disease,0.7183,32541440
15667,light bulb aneurysms,disease,1.0,32541440
15668,fluorescein,drug,0.997,32541440
15669,Coats' disease,disease,0.9995,32541440
15670,anti-VEGF,gene,0.9004,32541440
15671,OD,disease,1.0,32541440
15672,aflibercept,gene,0.991,32541440
15673,aflibercept,gene,0.9775,32541440
15674,macular edema,disease,1.0,32541440
15675,aneurysms,disease,0.996,32541440
15676,aflibercept,gene,0.9624,32541440
15677,vascular endothelial growth factor,gene,0.9976,32541440
15678,VEGF,gene,0.992,32541440
15679,vascular permeability,disease,0.94,32541440
15680,Coats',disease,1.0,32541440
15681,VEGFs,gene,0.7744,32541440
15682,Coats' disease,disease,1.0,32541440
15683,Aflibercept,gene,0.961,32541433
15684,Idiopathic Retinal Vasculitis,disease,1.0,32541433
15685,Aneurysms,disease,1.0,32541433
15686,Neuroretinitis Syndrome,disease,1.0,32541433
15687,IRVAN syndrome,disease,1.0,32541433
15688,aflibercept,gene,0.975,32541433
15689,IRVAN syndrome,disease,1.0,32541433
15690,cystoid macular edema,disease,1.0,32541433
15691,CME,disease,1.0,32541433
15692,CME,disease,0.9336,32541433
15693,idiopathic retinal vasculitis,disease,1.0,32541433
15694,aneurysms,disease,1.0,32541433
15695,neuroretinitis (,disease,0.9927,32541433
15696,IRVAN) syndrome,disease,0.98,32541433
15697,aflibercept,gene,0.9795,32541433
15698,aflibercept,gene,0.977,32541433
15699,IRVAN syndrome,disease,1.0,32541433
15700,Aflibercept,gene,0.9453,32535604
15701,Oxygen-Induced Retinopathy,disease,0.9907,32535604
15702,Oxygen,drug,0.998,32535604
15703,Mouse,species,0.9795,32535604
15704,Retinopathy of Prematurity,disease,1.0,32535604
15705,Bevacizumab,gene,0.6846,32535604
15706,VEGF,gene,0.78,32535604
15707,retinopathy of prematurity,disease,1.0,32535604
15708,ROP,disease,1.0,32535604
15709,Aflibercept,gene,0.971,32535604
15710,VEGF,gene,0.9966,32535604
15711,aflibercept,gene,0.982,32535604
15712,oxygen-induced retinopathy,disease,0.946,32535604
15713,oxygen,drug,0.9995,32535604
15714,OIR,disease,0.9995,32535604
15715,mouse,species,0.955,32535604
15716,ROP,disease,1.0,32535604
15717,mice,species,0.966,32535604
15718,oxygen,drug,0.9824,32535604
15719,mice,species,0.9756,32535604
15720,aflibercept,gene,0.9844,32535604
15721,anti-collagen IV antibody,gene,0.8896,32535604
15722,aflibercept,gene,0.99,32535604
15723,hyperoxic controls,cell_line,0.4548,32535604
15724,aflibercept,gene,0.9854,32535604
15725,oxygen,drug,0.9985,32524033
15726,diabetic macular oedema,disease,1.0,32524033
15727,DMO,disease,1.0,32524033
15728,aflibercept,gene,0.9526,32524033
15729,patients,species,0.9473,32524033
15730,DMO,disease,1.0,32524033
15731,patients,species,0.986,32524033
15732,DMO,disease,1.0,32524033
15733,Patients,species,0.9746,32524033
15734,aflibercept,gene,0.9634,32524033
15735,patients,species,0.9165,32524033
15736,aflibercept,gene,0.949,32524033
15737,oxygen,drug,0.995,32524033
15738,oxygen,drug,0.9976,32524033
15739,oxygen,drug,0.998,32524033
15740,oxygen,drug,0.9985,32524033
15741,oxygen,drug,0.999,32524033
15742,aflibercept,gene,0.767,32524033
15743,DMO,disease,1.0,32524033
15744,aflibercept,gene,0.9917,32518833
15745,patients,species,0.975,32518833
15746,patients,species,0.9604,32518833
15747,neovascular (wet) age-related macular degeneration,disease,0.8237,32518833
15748,AMD,disease,1.0,32518833
15749,aflibercept,gene,0.9067,32518833
15750,AFL,gene,0.771,32518833
15751,Patients,species,0.892,32518833
15752,Aflibercept,gene,0.956,32518833
15753,Wet AMD,disease,0.967,32518833
15754,IVT,drug,0.9395,32518833
15755,patients,species,0.9907,32518833
15756,BCVA,cell_type,0.4119,32518833
15757,patients,species,0.978,32518833
15758,patients,species,0.955,32518833
15759,neovascular AMD,disease,1.0,32518833
15760,idiopathic macular telangectasia type 1,disease,1.0,32507720
15761,ozurdex,drug,0.8384,32507720
15762,ranibizumab,gene,0.8633,32507720
15763,aflibercept,gene,0.9634,32507720
15764,idiopathic macular telangiectasia type 1,disease,1.0,32507720
15765,capillary macroanaeurysm,disease,0.9985,32507720
15766,macular edema,disease,1.0,32507720
15767,anti-VEGF,gene,0.945,32507032
15768,dexamethasone,drug,0.9956,32507032
15769,RAN,drug,0.978,32507032
15770,aflibercept,gene,0.9863,32507032
15771,Eylea,gene,0.86,32507032
15772,AFL,gene,0.991,32507032
15773,dexamethasone,drug,0.9976,32507032
15774,Ozurdex,drug,0.9937,32507032
15775,DXI,drug,0.643,32507032
15776,diabetic macular oedema,disease,1.0,32507032
15777,DME,disease,1.0,32507032
15778,RAN,drug,0.993,32507032
15779,AFL,drug,0.9766,32507032
15780,DXI,drug,0.987,32507032
15781,RAN,drug,0.904,32507032
15782,AFL,drug,0.552,32507032
15783,patients,species,0.9785,32507032
15784,DME,disease,1.0,32507032
15785,Brolucizumab,gene,0.851,32494207
15786,Patients,species,0.979,32494207
15787,brolucizumab,gene,0.759,32494207
15788,patients,species,0.8916,32494207
15789,VEGF,gene,0.959,32494207
15790,age-related macular degeneration,disease,1.0,32494207
15791,patients,species,0.992,32494207
15792,wet,disease,0.9536,32494207
15793,age-related macular degeneration,disease,0.966,32494207
15794,VEGF,gene,0.9814,32494207
15795,aflibercept,gene,0.9805,32494207
15796,Patients,species,0.9385,32494207
15797,brolucizumab,gene,0.881,32494207
15798,patients,species,0.981,32494207
15799,vasculitis,disease,1.0,32494207
15800,patients,species,0.983,32494207
15801,brolucizumab,gene,0.9385,32494207
15802,patients,species,0.9395,32494207
15803,CNV,disease,0.9995,32494207
15804,wet AMD,disease,1.0,32494207
15805,dexamethasone,drug,0.489,32490978
15806,dexamethasone,drug,0.9854,32490978
15807,dexamethasone,drug,0.991,32490978
15808,dexamethasone,drug,0.995,32490978
15809,central retina vein occlusion,disease,1.0,32490978
15810,cystoid macular edema,disease,1.0,32490978
15811,tSreatment,disease,1.0,32490978
15812,anti-,gene,0.641,32490978
15813,vascular endothelial growth factor,gene,0.911,32490978
15814,dexamethasone,drug,0.985,32490978
15815,aflibercept,gene,0.9517,32490978
15816,Crystalline lens,disease,0.938,32490978
15817,dexamethasone,drug,0.9927,32490978
15818,Inflammatory Choroidal Neovascular Membranes,disease,1.0,32490018
15819,Noninfectious Uveitis,disease,1.0,32490018
15820,Inflammatory choroidal neovascularization,disease,1.0,32490018
15821,iCNV,disease,1.0,32490018
15822,non-infectious uveitis,disease,1.0,32490018
15823,uveitis,disease,0.6216,32490018
15824,Punctate inner choroiditis,disease,1.0,32490018
15825,Vogt-Koyanagi-Harada disease,disease,1.0,32490018
15826,multifocal choroiditis,disease,1.0,32490018
15827,uveitis,disease,1.0,32490018
15828,iCNVs,disease,0.9995,32490018
15829,iCNVs,disease,0.9985,32490018
15830,fluorescein,drug,0.9995,32490018
15831,indocyanine green,drug,0.9995,32490018
15832,iCNVs,disease,0.551,32490018
15833,iCNV,DNA,0.7593,32490018
15834,inflammation,disease,0.9688,32490018
15835,steroids,drug,0.7905,32490018
15836,vascular endothelial growth factor,gene,0.9985,32490018
15837,VEGF,gene,0.996,32490018
15838,CNV,DNA,0.7236,32490018
15839,anti-VEGF,gene,0.9795,32490018
15840,iCNVs,cell_type,0.554,32490018
15841,aflibercept,gene,0.9946,32483995
15842,choroidal neovascularization,disease,1.0,32483995
15843,aflibercept,gene,0.9907,32483995
15844,patients,species,0.854,32483995
15845,choroidal neovascularization,disease,1.0,32483995
15846,angioid,disease,1.0,32483995
15847,Patients,species,0.941,32483995
15848,choroidal neovascularization,disease,1.0,32483995
15849,angioid streaks,disease,1.0,32483995
15850,patients,species,0.9863,32483995
15851,aflibercept,gene,0.978,32483995
15852,patients,species,0.9824,32483995
15853,patient,species,0.9814,32483995
15854,endophthalmitis,disease,1.0,32483995
15855,acute gastritis,disease,1.0,32483995
15856,aflibercept,gene,0.9634,32483995
15857,choroidal neovascularization,disease,1.0,32483995
15858,angioid streaks,disease,1.0,32483995
15859,Patient,species,0.9644,34703739
15860,aflibercept,gene,0.9604,34703739
15861,patients,species,0.954,34703739
15862,patient,species,0.9365,34703739
15863,patients,species,0.944,34703739
15864,macular edema,disease,1.0,34703739
15865,retinal vein occlusion,disease,1.0,34703739
15866,RVO,disease,1.0,34703739
15867,aflibercept,gene,0.97,34703739
15868,cystoid macular edema,disease,1.0,34703739
15869,RVO,disease,1.0,34703739
15870,bevacizumab,gene,0.797,34703739
15871,ranibizumab,gene,0.648,34703739
15872,aflibercept,gene,0.9546,34703739
15873,aflibercept,gene,0.977,34703739
15874,patients,species,0.9834,34703739
15875,RVO,disease,1.0,34703739
15876,Diabetic Retinopathy,disease,1.0,34703739
15877,VFQ,DNA,0.4832,34703739
15878,macular edema,disease,1.0,34703739
15879,RVO,disease,1.0,34703739
15880,aflibercept,gene,0.9663,34703739
15881,patient,species,0.9707,34703739
15882,Aflibercept,gene,0.9683,32473901
15883,Retinal Hemorrhages,disease,1.0,32473901
15884,Intravitreal Microvascular Abnormalities,disease,1.0,32473901
15885,Venous Beading,disease,1.0,32473901
15886,vascular endothelial growth factor,gene,0.8955,32473901
15887,VEGF,gene,0.992,32473901
15888,diabetic retinopathy,disease,1.0,32473901
15889,nonproliferative,disease,0.984,32473901
15890,diabetic retinopathy,disease,0.818,32473901
15891,deep hemorrhages,disease,0.98,32473901
15892,DH,disease,0.9663,32473901
15893,venous beading,disease,0.8154,32473901
15894,intraretinal microvascular abnormalities,disease,1.0,32473901
15895,IRMAs,disease,1.0,32473901
15896,VEGF,gene,0.8945,32473901
15897,Aflibercept,gene,0.518,32473901
15898,Proliferative Diabetic Retinopathy,disease,1.0,32473901
15899,PARTICIPANTS,species,0.5146,32473901
15900,aflibercept,gene,0.957,32473901
15901,aflibercept,gene,0.957,32473901
15902,aflibercept,gene,0.9624,32473901
15903,aflibercept,gene,0.968,32473901
15904,DH,disease,1.0,32473901
15905,IRMA,disease,1.0,32473901
15906,IRMA,disease,1.0,32473901
15907,anti-VEGF,gene,0.935,32473901
15908,PDR,disease,0.9966,32473901
15909,epiretinal membranes,disease,0.866,32472420
15910,epiretinal membrane,disease,0.986,32472420
15911,ERM,disease,0.9365,32472420
15912,diabetic macular edema,disease,1.0,32472420
15913,DME,disease,1.0,32472420
15914,aflibercept,gene,0.985,32472420
15915,DME,disease,1.0,32472420
15916,DME,disease,1.0,32472420
15917,ERM,disease,1.0,32472420
15918,IAIs,DNA,0.466,32472420
15919,CMV,species,0.7827,32472420
15920,CVA,disease,0.9995,32472420
15921,CMT,disease,0.9995,32472420
15922,DME,disease,1.0,32472420
15923,Ranibizumab,gene,0.964,32467776
15924,Aflibercept,gene,0.966,32467776
15925,aflibercept,gene,0.992,32467776
15926,AFL,gene,0.996,32467776
15927,patients,species,0.983,32467776
15928,RBZ,drug,0.854,32467776
15929,patients,species,0.9907,32467776
15930,RBZ,drug,0.9155,32467776
15931,neovascular age-related macular degeneration,disease,1.0,32467776
15932,nAMD,disease,1.0,32467776
15933,RBZ,drug,0.98,32467776
15934,RBZ,drug,0.9834,32467776
15935,nAMD,disease,1.0,32467776
15936,patients,species,0.9937,32467776
15937,RBZ,drug,0.9097,32467776
15938,RBZ,drug,0.8975,32467776
15939,vascular endothelial growth factor,gene,0.998,32463528
15940,vascular endothelial growth factor,gene,0.9966,32463528
15941,VEGF,gene,0.9985,32463528
15942,neovascular age-related macular degeneration,disease,1.0,32463528
15943,nAMD,disease,1.0,32463528
15944,patients,species,0.988,32463528
15945,VEGF,gene,0.9897,32463528
15946,nAMD,disease,1.0,32463528
15947,aflibercept,gene,0.9946,32463528
15948,bevacizumab,gene,0.9385,32463528
15949,ranibizumab,gene,0.802,32463528
15950,PARTICIPANTS,species,0.763,32463528
15951,nAMD,disease,1.0,32463528
15952,patients,species,0.9927,32463528
15953,VEGF,gene,0.9917,32463528
15954,bevacizumab,gene,0.745,32463528
15955,ranibizumab,drug,0.515,32463528
15956,aflibercept,gene,0.9873,32463528
15957,ranibizumab,gene,0.9326,32463528
15958,aflibercept,gene,0.983,32463528
15959,Dexamethasone,drug,0.99,32460600
15960,Aflibercept,gene,0.8574,32460600
15961,Patients,species,0.9814,32460600
15962,dexamethasone,drug,0.958,32460600
15963,aflibercept,gene,0.9824,32460600
15964,patients,species,0.969,32460600
15965,diabetic macular edema,disease,1.0,32460600
15966,DME,disease,1.0,32460600
15967,ranibizumab,gene,0.61,32460600
15968,patients,species,0.979,32460600
15969,DME,disease,1.0,32460600
15970,patients,species,0.991,32460600
15971,IVA,drug,0.823,32460600
15972,patients,species,0.9795,32460600
15973,DME,disease,1.0,32460600
15974,aflibercept,gene,0.963,32454495
15975,neovascular age-related macular degeneration,disease,1.0,32454495
15976,BIOIMAGE,DNA,0.48,32454495
15977,vascular endothelial growth factor (VEGF) pathway genes,DNA,0.9014,32454495
15978,vascular endothelial growth factor,gene,0.999,32454495
15979,VEGF,gene,0.9966,32454495
15980,neovascular,cell_type,0.525,32454495
15981,nAMD,disease,1.0,32454495
15982,aflibercept,gene,0.9,32454495
15983,Aflibercept,gene,0.967,32454495
15984,single-nucleotide polymorphisms,DNA,0.7188,32454495
15985,SNPs,DNA,0.6016,32454495
15986,90 genes,DNA,0.588,32454495
15987,nAMD,disease,1.0,32454495
15988,SNPs,DNA,0.6987,32454495
15989,SNPs,DNA,0.494,32454495
15990,rs12366035,DNA,0.7266,32454495
15991,VEGFB,gene,0.869,32454495
15992,rs25681,DNA,0.7715,32454495
15993,C5,gene,0.9624,32454495
15994,rs17793056,DNA,0.837,32454495
15995,CX3CR1,gene,0.737,32454495
15996,rs1800775,DNA,0.807,32454495
15997,CETP,gene,0.5664,32454495
15998,rs2069845,DNA,0.7065,32454495
15999,IL6,gene,0.521,32454495
16000,rs13900,DNA,0.828,32454495
16001,CCL2,gene,0.5996,32454495
16002,aflibercept,gene,0.896,32454495
16003,VEGFB and C5 genes,DNA,0.8057,32454495
16004,VEGFB,gene,0.997,32454495
16005,C5 genes,gene,0.968,32454495
16006,aflibercept,gene,0.977,32454495
16007,aflibercept,gene,0.9766,32452251
16008,patients,species,0.9634,32452251
16009,aflibercept,gene,0.9937,32452251
16010,Eylea,gene,0.843,32452251
16011,diabetic macular oedema,disease,1.0,32452251
16012,patients,species,0.9814,32452251
16013,ranibizumab,gene,0.8115,32452251
16014,Lucentis,gene,0.715,32452251
16015,PARTICIPANTS,species,0.6436,32452251
16016,patients,species,0.9775,32452251
16017,vascular endothelial growth factor,gene,0.9014,32452251
16018,patient,species,0.988,32452251
16019,aflibercept,gene,0.974,32452251
16020,Diabetic Retinopathy,disease,1.0,32452251
16021,aflibercept,gene,0.955,32452251
16022,Diabetic Retinopathy,disease,1.0,32452251
16023,Diabetic Retinopathy,disease,0.999,32452251
16024,aflibercept,gene,0.9673,32452251
16025,diabetic macular oedema,disease,1.0,32452251
16026,aflibercept,gene,0.991,32450838
16027,patients,species,0.9917,32450838
16028,patients,species,0.981,32450838
16029,nAMD,disease,1.0,32450838
16030,aflibercept,gene,0.982,32450838
16031,AFL,gene,0.848,32450838
16032,IVT,drug,0.714,32450838
16033,patients,species,0.9814,32450838
16034,nAMD,disease,1.0,32450838
16035,patients,species,0.986,32450838
16036,nAMD,disease,1.0,32450838
16037,AFL,drug,0.8843,32450838
16038,patients,species,0.988,32450838
16039,patients,species,0.9795,32450838
16040,AFL,disease,0.993,32450838
16041,AFL,gene,0.795,32450838
16042,vitreous floaters,disease,1.0,32450838
16043,increased lacrimation,disease,0.903,32450838
16044,patients,species,0.985,32450838
16045,AFL,drug,0.839,32450838
16046,AFL,drug,0.8984,32450838
16047,patients,species,0.994,32450838
16048,fluorescein,drug,0.998,35070663
16049,macular edema,disease,1.0,35070663
16050,retinal vein occlusions,disease,1.0,35070663
16051,RVO,disease,1.0,35070663
16052,aflibercept,gene,0.92,35070663
16053,Patients,species,0.9644,35070663
16054,macular edema,disease,1.0,35070663
16055,bevacizumab,gene,0.7983,35070663
16056,aflibercept,gene,0.9116,35070663
16057,fluorescein,drug,0.998,35070663
16058,foveal,DNA,0.472,35070663
16059,patients,species,0.9897,35070663
16060,BRVO,disease,0.7993,35070663
16061,CRVO,disease,0.9014,35070663
16062,DCP,DNA,0.546,35070663
16063,macular ischemia,disease,1.0,35070663
16064,macular edema,disease,1.0,35070663
16065,aflibercept,gene,0.903,35070663
16066,chronic macular edema,disease,0.9985,35070663
16067,retinal vein occlusion,disease,0.9995,35070663
16068,retinal ischemia,disease,0.998,35070663
16069,Macular atrophy,disease,1.0,32447586
16070,aflibercept,gene,0.98,32447586
16071,neovascular age-related macular PURPOSE,disease,0.9814,32447586
16072,macular atrophy,disease,1.0,32447586
16073,aflibercept,gene,0.9844,32447586
16074,neovascular age-related macular degeneration,disease,1.0,32447586
16075,AMD,disease,1.0,32447586
16076,patients,species,0.9824,32447586
16077,AMD,disease,0.9995,32447586
16078,patients,species,0.979,32447586
16079,macular atrophy,disease,1.0,32447586
16080,macular atrophy,disease,1.0,32447586
16081,AMD,disease,1.0,32447586
16082,polypoidal choroidal vasculopathy,disease,1.0,32447586
16083,macular atrophy,disease,1.0,32447586
16084,macular atrophy,disease,1.0,32447586
16085,intraretinal fluid,disease,0.883,32447586
16086,macular atrophy,disease,1.0,32447586
16087,macular atrophy,disease,1.0,32447586
16088,macular atrophy,disease,1.0,32447586
16089,neovascular AMD,disease,1.0,32447586
16090,vision reduction,disease,0.999,32447586
16091,intraretinal fluid,disease,0.9995,32447586
16092,macular atrophy,disease,1.0,32447586
16093,neovascular AMD,disease,1.0,32447586
16094,Neovascular Age-Related Macular Degeneration,disease,1.0,32446840
16095,VEGF,gene,0.994,32446840
16096,neovascular age-related macular degeneration,disease,1.0,32446840
16097,nAMD,disease,1.0,32446840
16098,PARTICIPANTS,species,0.5464,32446840
16099,nAMD,disease,1.0,32446840
16100,bevacizumab,gene,0.8613,32446840
16101,ranibizumab,gene,0.8555,32446840
16102,aflibercept,gene,0.9614,32446840
16103,anti-VEGF,gene,0.935,32446840
16104,Bevacizumab,gene,0.9146,32443612
16105,Ranibizumab,gene,0.9165,32443612
16106,Aflibercept,gene,0.9814,32443612
16107,Neovascular Age-Related Macular Degeneration,disease,1.0,32443612
16108,AMD,disease,1.0,32443612
16109,ranibizumab,gene,0.7446,32443612
16110,RBZ,gene,0.754,32443612
16111,bevacizumab,gene,0.893,32443612
16112,BVZ,gene,0.8228,32443612
16113,aflibercept,gene,0.9766,32443612
16114,AFB,gene,0.9854,32443612
16115,neovascular age-related macular degeneration,disease,1.0,32443612
16116,AMD,disease,1.0,32443612
16117,RBZ,drug,0.9893,32443612
16118,BVZ,drug,0.991,32443612
16119,AFB,drug,0.9966,32443612
16120,endophthalmitis,disease,1.0,32443612
16121,pseudo-endophthalmitis,disease,1.0,32443612
16122,retinal pigment epithelium tear,disease,1.0,32443612
16123,macular atrophy,disease,1.0,32443612
16124,RBZ,drug,0.9766,32443612
16125,BVZ,DNA,0.51,32443612
16126,RBZ,DNA,0.465,32443612
16127,AFB,drug,0.586,32443612
16128,BVZ,drug,0.998,32443612
16129,RBZ,drug,0.9917,32443612
16130,AFB,drug,0.999,32443612
16131,Macular atrophy,disease,1.0,32443612
16132,RBZ,drug,0.9937,32443612
16133,BVZ,drug,0.993,32443612
16134,AFB,drug,0.997,32443612
16135,anti-vascular endothelial growth factor,gene,0.9463,32443612
16136,AMD,disease,0.9995,32443612
16137,RBZ,drug,0.9004,32443612
16138,macular atrophy,disease,1.0,32443612
16139,Aflibercept,gene,0.983,32443011
16140,aflibercept,gene,0.975,32443011
16141,corneal neovascularization,disease,0.9995,32443011
16142,corneal pathologies,disease,0.997,32443011
16143,corneal neovascularization,disease,1.0,32443011
16144,vascular endothelial growth factor,gene,0.9565,32443011
16145,Aflibercept,gene,0.988,32443011
16146,Eylea,gene,0.4985,32443011
16147,aflibercept,gene,0.967,32443011
16148,corneal neovascularization,disease,1.0,32443011
16149,Ranibizumab,gene,0.964,32439930
16150,pachychoroid neovasculopathy,disease,1.0,32439930
16151,ranibizumab,gene,0.7495,32439930
16152,pachychoroid neovasculopathy,disease,1.0,32439930
16153,PNV,disease,1.0,32439930
16154,aflibercept,gene,0.97,32439930
16155,patients,species,0.981,32439930
16156,PNV,disease,1.0,32439930
16157,ranibizumab,gene,0.9204,32439930
16158,ranibizumab,gene,0.4988,32439930
16159,aflibercept,gene,0.983,32439930
16160,dry macula,disease,0.998,32439930
16161,aflibercept,gene,0.994,32439930
16162,patients,species,0.977,32439930
16163,aflibercept,gene,0.9854,32439930
16164,ranibizumab,gene,0.682,32439930
16165,dry macula,disease,0.9707,32439930
16166,ranibizumab,gene,0.92,32439930
16167,aflibercept,gene,0.982,32439930
16168,dry macula,disease,0.9746,32439930
16169,ranibizumab,gene,0.7124,32439930
16170,aflibercept,gene,0.9873,32439930
16171,aflibercept,gene,0.9907,32439930
16172,SRF,gene,0.971,32439930
16173,SFCT,gene,0.6665,32439930
16174,PNV,disease,1.0,32439930
16175,ranibizumab,gene,0.8804,32439930
16176,aflibercept,gene,0.9707,32439930
16177,aflibercept,gene,0.976,32436085
16178,neovascular age-related macular degeneration,disease,1.0,32436085
16179,neovascular age-related macular degeneration,disease,1.0,32436085
16180,nAMD,disease,1.0,32436085
16181,nAMD,disease,1.0,32436085
16182,aflibercept,gene,0.9775,32436085
16183,chronic macular edema,disease,1.0,32429784
16184,dexamethasone,drug,0.843,32429784
16185,familial retinal arterial macroaneurysm,disease,1.0,32429784
16186,dexamethasone,drug,0.9326,32429784
16187,Familial Retinal Arterial Macroaneurysms,disease,1.0,32429784
16188,FRAM,disease,1.0,32429784
16189,retinal macroaneurysms,disease,0.997,32429784
16190,c,RNA,0.4697,32429784
16191,Insulin Growth Factor Binding Protein 7 (IGFBP7) gene,DNA,0.9053,32429784
16192,Insulin Growth Factor Binding Protein 7,gene,0.9985,32429784
16193,IGFBP7,gene,0.996,32429784
16194,FRAM,disease,0.488,32429784
16195,macular edema,disease,1.0,32429784
16196,retinal arterial macroaneurysms,disease,1.0,32429784
16197,ranibizumab,gene,0.802,32429784
16198,aflibercept,gene,0.973,32429784
16199,dexamethasone,drug,0.9766,32429784
16200,dexamethasone,drug,0.991,32429784
16201,FRAM,disease,1.0,32429784
16202,macular edema,disease,1.0,32429784
16203,aflibercept,gene,0.987,32429690
16204,diabetic macular oedema,disease,1.0,32429690
16205,aflibercept,gene,0.973,32429690
16206,Eylea,drug,0.8594,32429690
16207,diabetic macular oedema,disease,1.0,32429690
16208,patients,species,0.983,32429690
16209,vascular endothelial growth factor,gene,0.8687,32429690
16210,patient,species,0.9775,32429690
16211,Diabetic Retinopathy,disease,1.0,32429690
16212,Patients,species,0.985,32429690
16213,aflibercept,gene,0.9673,32429690
16214,aflibercept,gene,0.9834,32429690
16215,Diabetic Retinopathy,disease,1.0,32429690
16216,Diabetic,RNA,0.4316,32429690
16217,Diabetic Retinopathy,disease,1.0,32429690
16218,aflibercept,gene,0.9517,32429690
16219,diabetic macular oedema,disease,1.0,32429690
16220,VEGF,gene,0.5195,32429380
16221,EGFR,gene,0.807,32429380
16222,RAS Wild-Type Metastatic Colorectal Cancer,disease,0.976,32429380
16223,RAS,gene,0.9624,32429380
16224,RAS,gene,0.593,32429380
16225,metastatic colorectal cancer,disease,0.994,32429380
16226,mCRC,disease,1.0,32429380
16227,Epidermal Growth Factor Receptor,gene,0.998,32429380
16228,Bevacizumab,gene,0.515,32429380
16229,Aflibercept,gene,0.977,32429380
16230,mCRC,disease,0.9966,32429380
16231,Bevacizumab,gene,0.954,32429380
16232,Aflibercept,gene,0.871,32429380
16233,Aflibercept,gene,0.984,32429380
16234,Bevacizumab,gene,0.8896,32429380
16235,Bevacizumab,gene,0.9565,32429380
16236,Aflibercept,gene,0.9844,32429380
16237,primary tumor,disease,0.9536,32429380
16238,Bevacizumab,gene,0.9346,32429380
16239,Aflibercept,gene,0.927,32429380
16240,VEGF,gene,0.986,32429380
16241,Bevacizumab,gene,0.9243,32429380
16242,Aflibercept,gene,0.9575,32429380
16243,Bevacizumab,gene,0.912,32429380
16244,Aflibercept,gene,0.954,32429380
16245,RAS,gene,0.4873,32429380
16246,mCRC,disease,0.8247,32429380
16247,anti-EGFR,gene,0.954,32429380
16248,neovascular age-related macular degeneration,disease,1.0,32428539
16249,Pigment epithelial detachment,disease,1.0,32428539
16250,PED,disease,1.0,32428539
16251,retinal,cell_type,0.4966,32428539
16252,chorioretinal diseases,disease,1.0,32428539
16253,neovascular,disease,0.554,32428539
16254,PED,disease,0.9995,32428539
16255,neovascular age-related macular degeneration,disease,1.0,32428539
16256,PED,DNA,0.5176,32428539
16257,PED,disease,0.9995,32428539
16258,PED,DNA,0.5903,32428539
16259,PED,disease,0.952,32428539
16260,PED,disease,0.9995,32428539
16261,PED,disease,0.9966,32428539
16262,PED,disease,0.9985,32428539
16263,PED,disease,0.981,32428539
16264,PED,disease,0.9897,32428539
16265,Aflibercept,gene,0.8467,32417356
16266,Exudative Age-Related Macular Degeneration,disease,1.0,32417356
16267,aflibercept,gene,0.9854,32417356
16268,neovascular age-related macular degeneration,disease,1.0,32417356
16269,AMD,disease,1.0,32417356
16270,PARTICIPANTS,species,0.491,32417356
16271,AMD,disease,0.999,32417356
16272,CRT,DNA,0.5625,32417356
16273,aflibercept,gene,0.9497,32417356
16274,Aflibercept,gene,0.992,32402554
16275,Bevacizumab,gene,0.8633,32402554
16276,Ranibizumab,gene,0.876,32402554
16277,Diabetic Macular Edema,disease,1.0,32402554
16278,VEGF,gene,0.908,32402554
16279,diabetic macular edema,disease,0.9917,32402554
16280,DME,disease,0.999,32402554
16281,PARTICIPANTS,species,0.7603,32402554
16282,diabetic macular edema,disease,1.0,32402554
16283,DME,disease,1.0,32402554
16284,aflibercept,gene,0.9766,32402554
16285,bevacizumab,gene,0.616,32402554
16286,ranibizumab,drug,0.6685,32402554
16287,vascular endothelial growth factor,gene,0.927,32402554
16288,VEGF,gene,0.9966,32402554
16289,anti-VEGF,gene,0.8237,32402554
16290,DME,disease,1.0,32402554
16291,aflibercept,gene,0.983,32399582
16292,ranibizumab,gene,0.8096,32399582
16293,ranibizumab,gene,0.6987,32399582
16294,patients,species,0.953,32399582
16295,neovascular age-related macular degeneration,disease,1.0,32399582
16296,nAMD,disease,1.0,32399582
16297,aflibercept,gene,0.949,32399582
16298,patients,species,0.988,32399582
16299,nAMD,disease,1.0,32399582
16300,aflibercept,gene,0.97,32399582
16301,ranibizumab,gene,0.75,32399582
16302,pigment epithelial detachment,disease,1.0,32399582
16303,PED,disease,1.0,32399582
16304,CRT,DNA,0.558,32399582
16305,PED,DNA,0.6304,32399582
16306,Patients,species,0.9644,32399582
16307,nAMD,disease,1.0,32399582
16308,aflibercept,gene,0.957,32399582
16309,ranibizumab,gene,0.8276,32399582
16310,aflibercept,gene,0.987,32399582
16311,patient,species,0.9785,32399582
16312,Type 1 Choroidal Neovascularization,disease,1.0,32382551
16313,antivascular endothelial growth factor,gene,0.9883,32382551
16314,anti-VEGF,gene,0.9736,32382551
16315,CNV,disease,1.0,32382551
16316,CNV,DNA,0.5107,32382551
16317,type,DNA,0.537,32382551
16318,type 1 CNV,disease,0.996,32382551
16319,chorioretinal atrophy,disease,1.0,32382551
16320,hemorrhage,disease,1.0,32382551
16321,RPE tears,disease,0.9995,32382551
16322,type 1 CNV,disease,1.0,32382551
16323,CNV,DNA,0.7812,32382551
16324,type 1 CNV,disease,1.0,32382551
16325,type 1 CNV,disease,1.0,32382551
16326,endophthalmitis,disease,1.0,32377417
16327,patients,species,0.9883,32377417
16328,patient,species,0.9917,32377417
16329,endophthalmitis,disease,1.0,32377417
16330,patients,species,0.97,32377417
16331,ranibizumab,gene,0.8286,32377417
16332,aflibercept,gene,0.97,32377417
16333,dexamethasone,drug,0.9985,32377417
16334,pegaptanib,drug,0.996,32377417
16335,bevacizumab,gene,0.6885,32377417
16336,ocriplasmin,gene,0.852,32377417
16337,neovascular age-related macular degeneration,disease,1.0,32377417
16338,myopic choroidal neovascularization,disease,1.0,32377417
16339,diabetic macular edema,disease,1.0,32377417
16340,retinal vein occlusion,disease,1.0,32377417
16341,endophthalmitis,disease,1.0,32377417
16342,ocular hypertension,disease,1.0,32377417
16343,subconjunctival hemorrhage,disease,0.9995,32377417
16344,ranibizumab,gene,0.741,32375502
16345,aflibercept,gene,0.982,32375502
16346,bevacizumab,gene,0.841,32375502
16347,neovascular age-related macular degeneration,disease,1.0,32375502
16348,vascular endothelial growth factor,gene,0.993,32374423
16349,neovascular age-related macular degeneration,disease,1.0,32374423
16350,Age-related macular degeneration,disease,1.0,32374423
16351,AMD,disease,1.0,32374423
16352,permanent blindness,disease,1.0,32374423
16353,neovascular AMD,disease,1.0,32374423
16354,nAMD,disease,1.0,32374423
16355,anti-vascular endothelial growth factor,gene,0.931,32374423
16356,anti-VEGF,gene,0.784,32374423
16357,aflibercept,gene,0.9893,32374423
16358,ranibizumab,gene,0.599,32374423
16359,bevacizumab,gene,0.821,32374423
16360,nAMD,disease,1.0,32374423
16361,VEGF,gene,0.855,32374423
16362,nAMD,disease,1.0,32374423
16363,VEGF,gene,0.871,32374423
16364,nAMD,disease,1.0,32374423
16365,ranibizumab,gene,0.891,32374423
16366,bevacizumab,gene,0.9106,32374423
16367,aflibercept,gene,0.9756,32374423
16368,BCVA,DNA,0.4949,32374423
16369,bevacizumab,gene,0.8584,32374423
16370,aflibercept,gene,0.9805,32374423
16371,ranibizumab,gene,0.6997,32374423
16372,bevacizumab,gene,0.7334,32374423
16373,endophthalmitis,disease,1.0,32374423
16374,endophthalmitis,disease,1.0,32374423
16375,endophthalmitis,disease,1.0,32374423
16376,endophthalmitis,disease,1.0,32374423
16377,Endophthalmitis,disease,1.0,32374423
16378,aflibercept,gene,0.982,32374423
16379,ranibizumab,gene,0.75,32374423
16380,bevacizumab,gene,0.8105,32374423
16381,Neovascular Age Macular Degeneration,disease,1.0,32370878
16382,neovascular age macular degeneration,disease,1.0,32370878
16383,AMD,disease,1.0,32370878
16384,ETDRS,DNA,0.541,32370878
16385,PRN -104,drug,0.96,32370878
16386,T&E -103,drug,0.989,32370878
16387,BCVA,cell_type,0.4114,32370878
16388,RPE and outer retinal atrophy,disease,0.9907,32369500
16389,neovascular age-related macular degeneration,disease,1.0,32369500
16390,Neovascular age-related macular degeneration,disease,1.0,32369500
16391,nAMD,disease,1.0,32369500
16392,blindness,disease,0.999,32369500
16393,vascular endothelial growth factor,gene,0.8794,32369500
16394,anti-VEGF,gene,0.937,32369500
16395,aflibercept,gene,0.986,32369500
16396,bevacizumab,gene,0.892,32369500
16397,ranibizumab,gene,0.7593,32369500
16398,retinal,cell_type,0.4785,32369500
16399,nAMD,disease,1.0,32369500
16400,aflibercept,gene,0.97,32369500
16401,bevacizumab,gene,0.866,32369500
16402,ranibizumab,gene,0.638,32369500
16403,aflibercept,gene,0.9756,32369500
16404,bevacizumab,gene,0.8525,32369500
16405,cRORA,cell_type,0.5103,32369500
16406,VEGF,gene,0.5015,32369500
16407,anti-VEGF,gene,0.946,32369500
16408,cRORA,disease,0.926,32369500
16409,VEGF,gene,0.653,32369500
16410,nAMD,disease,1.0,32369500
16411,aflibercept,gene,0.9775,32369500
16412,bevacizumab,gene,0.7295,32369500
16413,cRORA,DNA,0.493,32369500
16414,ranibizumab,gene,0.7007,32361804
16415,aflibercept,gene,0.982,32361804
16416,ranibizumab,gene,0.7217,32361804
16417,aflibercept,gene,0.974,32361804
16418,patients,species,0.9956,32361804
16419,neovascular age-related macular degeneration,disease,1.0,32361804
16420,AMD,disease,1.0,32361804
16421,polypoidal choroidal vasculopathy,disease,1.0,32361804
16422,PCV,disease,1.0,32361804
16423,ranibizumab,gene,0.703,32361804
16424,ranibizumab,gene,0.924,32361804
16425,aflibercept,gene,0.9463,32361804
16426,aflibercept,gene,0.9854,32361804
16427,ranibizumab,gene,0.9375,32361804
16428,aflibercept,gene,0.975,32361804
16429,ranibizumab,gene,0.7827,32361804
16430,the,gene,0.696,32361804
16431,aflibercept,gene,0.669,32361804
16432,PCV,disease,0.9995,32361804
16433,ranibizumab,gene,0.518,32361804
16434,patients,species,0.9946,32361804
16435,aflibercept,gene,0.982,32361804
16436,patients,species,0.994,32361804
16437,ranibizumab,gene,0.798,32361804
16438,aflibercept,gene,0.9663,32361804
16439,ranibizumab,gene,0.8657,32361804
16440,PCV,disease,1.0,32361804
16441,aflibercept,gene,0.993,32361804
16442,patients,species,0.987,32361804
16443,ranibizumab,gene,0.9043,32361804
16444,aflibercept,gene,0.9424,32361804
16445,PCV,disease,1.0,32361804
16446,patients,species,0.992,32361804
16447,ranibizumab,gene,0.903,32361804
16448,VEGF,gene,0.981,32359843
16449,Age-related Choroidal Neovascularisation,disease,1.0,32359843
16450,vascular endothelial growth factor,gene,0.989,32359843
16451,neovascular age-related macular degeneration,disease,1.0,32359843
16452,nAMD,disease,1.0,32359843
16453,bevacizumab,gene,0.8613,32359843
16454,ranibizumab,gene,0.636,32359843
16455,PARTICIPANTS,species,0.8823,32359843
16456,VEGF,gene,0.9844,32359843
16457,Age-related choroidal Neovascularisation,disease,1.0,32359843
16458,nAMD,disease,1.0,32359843
16459,DVA,DNA,0.51,32359843
16460,vascular endothelial growth factor,gene,0.9624,32359843
16461,VEGF,gene,0.998,32359843
16462,IVAN,drug,0.8457,32359843
16463,DVA,DNA,0.4517,32359843
16464,ranibizumab,gene,0.5825,32359843
16465,aflibercept,gene,0.9673,32359843
16466,DVA,DNA,0.5527,32359843
16467,IVAN,drug,0.908,32359843
16468,Anti-VEGF,gene,0.957,32359843
16469,aflibercept,gene,0.9834,32356367
16470,macular oedema,disease,1.0,32356367
16471,immune recovery uveitis,disease,1.0,32356367
16472,aflibercept,gene,0.9346,32355826
16473,diabetic macular edema,disease,1.0,32355826
16474,vascular endothelial growth factor,gene,0.9194,32355826
16475,bevacizumab,gene,0.6885,32355826
16476,ranibizumab,gene,0.6543,32355826
16477,aflibercept,gene,0.969,32355826
16478,diabetic macular edema,disease,1.0,32355826
16479,DME,disease,1.0,32355826
16480,DME,disease,1.0,32355826
16481,anti-VEGF,gene,0.823,32355826
16482,aflibercept,gene,0.9375,32355826
16483,aflibercept,gene,0.981,32355826
16484,macular edema,disease,1.0,32355826
16485,DME,disease,1.0,32355826
16486,ellipsoid,DNA,0.4775,32353052
16487,macular edema,disease,1.0,32353052
16488,macular edema,disease,1.0,32353052
16489,central retinal or hemi-retinal vein occlusion,disease,1.0,32353052
16490,vascular endothelial growth factor,gene,0.929,32353052
16491,EZ,disease,0.7925,32353052
16492,EZ,disease,0.7485,32353052
16493,EZ area defect,DNA,0.4846,32353052
16494,aflibercept,gene,0.98,32350452
16495,diabetic macular oedema,disease,1.0,32350452
16496,DMO,disease,1.0,32350452
16497,bevacizumab,gene,0.894,32350452
16498,patients,species,0.9805,32350452
16499,Patients,species,0.9756,32350452
16500,bevacizumab,gene,0.8335,32350452
16501,aflibercept,gene,0.9834,32350452
16502,aflibercept,gene,0.9883,32350452
16503,DMO,disease,1.0,32350452
16504,bevacizumab,gene,0.906,32350452
16505,aflibercept,gene,0.974,32350452
16506,patients,species,0.99,32350452
16507,patients,species,0.99,32350452
16508,diabetic macular edema,disease,1.0,32349686
16509,macular hole,disease,0.9883,32349686
16510,macular hole,disease,0.7275,32349686
16511,diabetic macular edema,disease,1.0,32349686
16512,DME,disease,1.0,32349686
16513,perifoveal,disease,0.527,32349686
16514,retinoschisis,disease,0.8325,32349686
16515,RS,disease,1.0,32349686
16516,cystoid macular edema,disease,1.0,32349686
16517,serous retinal detachment,disease,1.0,32349686
16518,SRD,disease,1.0,32349686
16519,MH,disease,1.0,32349686
16520,proliferative diabetic retinopathy,disease,1.0,32349686
16521,PDR,disease,1.0,32349686
16522,RS,disease,0.9985,32349686
16523,ERM,disease,0.9683,32349686
16524,SRD,disease,1.0,32349686
16525,MH,disease,0.9995,32349686
16526,DME,disease,1.0,32349686
16527,SRD,disease,0.9873,32349686
16528,RS,disease,0.9756,32349686
16529,MH,disease,0.998,32349686
16530,MH,disease,1.0,32349686
16531,Dipeptidyl Peptidase-4,gene,0.9766,32348539
16532,Diabetic Macular Edema,disease,1.0,32348539
16533,dipeptidyl peptidase-4,gene,0.9956,32348539
16534,DPP-4,gene,0.9966,32348539
16535,diabetic macular edema,disease,1.0,32348539
16536,DME,disease,1.0,32348539
16537,PATIENTS,species,0.913,32348539
16538,DME,disease,1.0,32348539
16539,aflibercept,gene,0.982,32348539
16540,DPP-4,gene,0.99,32348539
16541,Diabetic Retinopathy,disease,1.0,32348539
16542,DPP-4,gene,0.985,32348539
16543,DPP-4,gene,0.9243,32348539
16544,DME,disease,1.0,32348539
16545,aflibercept,gene,0.9893,32347762
16546,age-related macular degeneration,disease,1.0,32347762
16547,patients,species,0.979,32347762
16548,aflibercept,gene,0.9785,32346038
16549,age-related macular degeneration,disease,1.0,32346038
16550,AMD,disease,1.0,32346038
16551,aflibercept,gene,0.983,32346038
16552,exudative AMD,disease,0.9995,32346038
16553,neovascular AMD,disease,1.0,32346038
16554,polypoidal choroidal vasculopathy,disease,1.0,32346038
16555,patients,species,0.971,32346038
16556,exudative AMD,disease,0.912,32346038
16557,ARMS2,DNA,0.5293,32346038
16558,ARMS2 A69S,gene,0.9854,32346038
16559,A69,mutation,,32346038
16560,rs10490924,DNA,0.8516,32346038
16561,rs1049092,mutation,,32346038
16562, CFH (I,mutation,,32346038
16563,CFH,gene,0.9956,32346038
16564,I62,mutation,,32346038
16565,rs800292,DNA,0.778,32346038
16566,rs80029,mutation,,32346038
16567,rs1329428,DNA,0.5625,32346038
16568,rs132942,mutation,,32346038
16569,C2,gene,,32346038
16570,CFB,gene,0.9907,32346038
16571,CFB-SKI,mutation,,32346038
16572,-SKIV2L,DNA,0.473,32346038
16573,SKIV2L,gene,0.996,32346038
16574,rs429608,DNA,0.8394,32346038
16575,rs42960,mutation,,32346038
16576,C3,gene,,32346038
16577,rs2241394,DNA,0.847,32346038
16578,rs224139,mutation,,32346038
16579,CETP,gene,0.9976,32346038
16580,rs3764261,DNA,0.866,32346038
16581,rs376426,mutation,,32346038
16582,ADAMTS-9,gene,0.998,32346038
16583,rs6795735,DNA,0.826,32346038
16584,rs679573,mutation,,32346038
16585,participants,species,0.9736,32346038
16586,AMD,disease,1.0,32346038
16587,C2-CFB-SKIV2L rs429608,DNA,0.5874,32346038
16588,C2,gene,,32346038
16589,CFB,gene,0.9775,32346038
16590,CFB-SKI,mutation,,32346038
16591,SKIV2L,gene,0.993,32346038
16592,rs42960,mutation,,32346038
16593,T,DNA,0.5264,32346038
16594,ARMS2 A69S,gene,0.9434,32346038
16595,A69,mutation,,32346038
16596,CFH rs1329428,DNA,0.709,32346038
16597,CFH rs1329428,gene,0.944,32346038
16598,rs132942,mutation,,32346038
16599,ARMS2 A69S,gene,0.9165,32346038
16600,A69,mutation,,32346038
16601,CFH,gene,0.9897,32346038
16602,rs1329428,DNA,0.79,32346038
16603,rs132942,mutation,,32346038
16604,ARMS2,gene,0.9917,32346038
16605,CFH,gene,0.994,32346038
16606,patients,species,0.9863,32346038
16607,Neovascular Age-Related Macular Degeneration,disease,1.0,32345477
16608,anti-vascular endothelial growth factor,gene,0.9004,32345477
16609,VEGF,gene,0.993,32345477
16610,nAMD,disease,1.0,32345477
16611,PARTICIPANTS,species,0.62,32345477
16612,anti-VEGF,gene,0.817,32345477
16613,nAMD,disease,1.0,32345477
16614,fluorescein,drug,0.9937,32345477
16615,anti-VEGF,gene,0.9546,32345477
16616,Diabetic Retinopathy,disease,0.995,32345477
16617,bevacizumab,gene,0.865,32345477
16618,ranibizumab,gene,0.793,32345477
16619,aflibercept,gene,0.961,32345477
16620,anti-VEGF,gene,0.9565,32345477
16621,CRT,DNA,0.5215,32345477
16622,anti-VEGF,gene,0.946,32345477
16623,anti-VEGF,gene,0.9526,32345477
16624,ETDRS,cell_type,0.462,32345477
16625,anti-VEGF,gene,0.7163,32345477
16626,nAMD,disease,1.0,32345477
16627,anti-VEGF,gene,0.9873,32345477
16628,VEGF,gene,0.9824,32342813
16629,Retinal Vein Occlusions,disease,1.0,32342813
16630,Retinal vein occlusion,disease,1.0,32342813
16631,RVO,disease,1.0,32342813
16632,visual loss,disease,0.9995,32342813
16633,Chronic macular edema,disease,0.998,32342813
16634,ischemia,disease,0.9995,32342813
16635,Antivascular endothelial growth factor,gene,0.9893,32342813
16636,anti-VEGF,gene,0.989,32342813
16637,patients,species,0.9805,32332680
16638,retinal nerve fiber,cell_type,0.632,32332680
16639,patients,species,0.945,32332680
16640,exudative age-related macular degeneration,disease,1.0,32332680
16641,AMD,disease,1.0,32332680
16642,vascular endothelial growth factor,gene,0.896,32332680
16643,VEGF,gene,0.9976,32332680
16644,Patients,species,0.9775,32332680
16645,exudative AMD,disease,1.0,32332680
16646,ranibizumab,gene,0.871,32332680
16647,aflibercept,gene,0.9756,32332680
16648,patients,species,0.9756,32332680
16649,anti-VEGF,gene,0.9443,32332680
16650,exudative AMD,disease,0.959,32332680
16651,ranibizumab,drug,0.563,32332680
16652,aflibercept,gene,0.789,32332680
16653,aflibercept,gene,0.9956,32332680
16654,patients,species,0.9565,32332680
16655,exudative AMD,disease,0.9995,32332680
16656,anti-VEGF,gene,0.9575,32332680
16657,BRAF-Mutant Colorectal Cancer,disease,0.97,32326305
16658,BRAF,gene,0.513,32326305
16659,FOLFOXIRI,drug,0.6743,32326305
16660,Bevacizumab,gene,0.8315,32326305
16661,BRAF,gene,0.609,32326305
16662,colorectal cancer,disease,0.8945,32326305
16663,CRC,disease,1.0,32326305
16664,BRAF-mutant CRC,disease,0.955,32326305
16665,BRAF,gene,0.436,32326305
16666,advanced CRC,disease,0.996,32326305
16667,Bevacizumab,gene,0.954,32326305
16668,Aflibercept,gene,0.933,32326305
16669,BRAF,gene,0.4917,32326305
16670,Bevacizumab,gene,0.828,32326305
16671,BRAF,gene,0.765,32326305
16672,BRAF-mutant CRC,disease,0.643,32326305
16673,BRAF,gene,0.4438,32326305
16674,Bevacizumab,gene,0.6816,32326305
16675,Aflibercept,gene,0.9443,32326305
16676,Aflibercept,gene,0.9478,32318284
16677,Patients,species,0.9546,32318284
16678,Neovascular,disease,0.788,32318284
16679,Aflibercept,gene,0.9453,32318284
16680,neovascular age-related macular degeneration,disease,1.0,32318284
16681,nAMD,disease,1.0,32318284
16682,Patients,species,0.954,32318284
16683,patients,species,0.982,32318284
16684,nAMD,disease,1.0,32318284
16685,Diabetic Retinopathy,disease,1.0,32318284
16686,Patients,species,0.9785,32318284
16687,nAMD,disease,1.0,32318284
16688,macular atrophy,disease,1.0,32318284
16689,Aflibercept,gene,0.9717,32318284
16690,choroidal neovascularization,disease,1.0,32316922
16691,choroidal neovascularization,disease,1.0,32316922
16692,CNV,disease,1.0,32316922
16693,aflibercept,gene,0.97,32316922
16694,choroidal neovascularization,disease,1.0,32316922
16695,CNV,disease,1.0,32316922
16696,patient,species,0.963,32316922
16697,cataract,disease,0.9126,32316922
16698,traumatic cataract,disease,1.0,32316922
16699,phacolytic glaucoma,disease,0.979,32316922
16700,metamorphopsia,disease,0.9995,32316922
16701,whitish,cell_line,0.558,32316922
16702,retinal hemorrhage,disease,0.999,32316922
16703,sensory elevation,disease,0.951,32316922
16704,Fluorescein,drug,0.9956,32316922
16705,CNV,disease,1.0,32316922
16706,patient,species,0.994,32316922
16707,aflibercept,gene,0.953,32316922
16708,CNV,DNA,0.686,32316922
16709,anti-VEGF,gene,0.9604,32316922
16710,aflibercept,gene,0.975,32316922
16711,aflibercept,gene,0.9917,32306096
16712,aflibercept,gene,0.928,32306096
16713,patients,species,0.979,32306096
16714,vascular pigment epithelium detachment,disease,1.0,32306096
16715,vPED,disease,1.0,32306096
16716,age-related macular degeneration,disease,1.0,32306096
16717,subretinal fluid,disease,0.8125,32306096
16718,patients,species,0.9844,32306096
16719,subretinal fluid,disease,0.9795,32306096
16720,vPED,disease,1.0,32306096
16721,VEGF,gene,0.9937,32306096
16722,patients,species,0.978,32306096
16723,aflibercept,gene,0.93,32306096
16724,Fluorescein,drug,0.997,32306096
16725,indocyanine green,drug,0.998,32306096
16726,PED,DNA,0.4521,32306096
16727,vPED,disease,1.0,32306096
16728,patients,species,0.9966,32306096
16729,vPED lesions,disease,0.7544,32306096
16730,vPED,disease,1.0,32306096
16731,RPE,cell_type,0.6387,32306096
16732,patients,species,0.988,32306096
16733,patients,species,0.983,32306096
16734,patients,species,0.9736,32306096
16735,PED,disease,0.8477,32306096
16736,patients,species,0.985,32306096
16737,patients,species,0.985,32306096
16738,patients,species,0.9893,32306096
16739,aflibercept,gene,0.9873,32306096
16740,vPED,disease,1.0,32306096
16741,PED,disease,0.6963,32306096
16742,PED,disease,1.0,32306096
16743,RPE,cell_type,0.643,32306096
16744,VEGF,gene,0.914,32280530
16745,Diabetic Macular Edema,disease,1.0,32280530
16746,patients,species,0.9824,32280530
16747,diabetic macular edema,disease,1.0,32280530
16748,DME,disease,1.0,32280530
16749,VEGF,gene,0.94,32280530
16750,patients,species,0.992,32280530
16751,ranibizumab,gene,0.8345,32280530
16752,aflibercept,gene,0.9395,32280530
16753,DME,disease,1.0,32280530
16754,patients,species,0.9937,32280530
16755,CRT,DNA,0.5723,32280530
16756,Patients,species,0.9414,32280530
16757,VEGF,gene,0.5664,32280530
16758,patients,species,0.988,32280530
16759,Aflibercept,gene,0.953,32277343
16760,aflibercept,gene,0.9043,32277343
16761,wAMD,disease,1.0,32277343
16762,patients,species,0.9844,32277343
16763,wAMD,disease,0.9956,32277343
16764,aflibercept,gene,0.989,32277343
16765,patients,species,0.9756,32277343
16766,aflibercept,gene,0.9844,32277343
16767,aflibercept,gene,0.989,32277343
16768,Post-intravitreal injection endophthalmitis,disease,0.975,32276621
16769,Turicella otitidis,disease,0.9243,32276621
16770,Endophthalmitis,disease,1.0,32276621
16771,endophthalmitis,disease,1.0,32276621
16772,Turicella otitidis endophthalmitis,disease,1.0,32276621
16773,Turicella otitidis,species,0.9224,32276621
16774,aflibercept,gene,0.9824,32276621
16775,neovascular age-related macular degeneration,disease,1.0,32276621
16776,endophthalmitis,disease,1.0,32276621
16777,Turicella otitidis,species,0.6523,32276621
16778,endophthalmitis,disease,1.0,32276621
16779,endophthalmitis,disease,1.0,32276621
16780,endophthalmitis,disease,1.0,32276621
16781,corynebacterium,cell_line,0.506,32276621
16782,Turicella otitidis,species,0.9175,32276621
16783,endophthalmitis,disease,0.9854,32276621
16784,Turicella otitidis,disease,0.9087,32276621
16785,Turicella,disease,0.565,32276621
16786,Turicella otitidis,species,0.961,32276621
16787,chronic retinal neovascularization,disease,1.0,32275921
16788,vascular leakage,disease,0.999,32275921
16789,chronic retinal neovascularization,disease,1.0,32275921
16790,vascular leakage,disease,0.989,32275921
16791,retinal ischemic and neovascular diseases,disease,0.9995,32275921
16792,DL-alpha-aminoadipic acid,drug,0.9995,32275921
16793,DLAAA,drug,0.9917,32275921
16794,fluorescein,drug,0.999,32275921
16795,retinal vascular pathology,disease,0.87,32275921
16796,Aflibercept,gene,0.9766,32275921
16797,Eylea,gene,0.6304,32275921
16798,glial fibrillary acidic protein,gene,0.995,32275921
16799,GFAP,gene,0.995,32275921
16800,von Willebrand,disease,0.9995,32275921
16801,von Willebrand Factor,gene,0.9834,32275921
16802,vWF,gene,0.9883,32275921
16803,CD105,gene,0.9946,32275921
16804,endoglin,gene,0.997,32275921
16805,VEGF,gene,0.9946,32275921
16806,CD68,gene,0.9824,32275921
16807,retinal degeneration,disease,1.0,32275921
16808,retinal vascular leakage,disease,0.9995,32275921
16809,inner retinal edema,disease,1.0,32275921
16810,Neovascular lesion,disease,0.9995,32275921
16811,retinal degeneration,disease,1.0,32275921
16812,vWF,gene,0.995,32275921
16813,CD105,gene,0.997,32275921
16814,endoglin,gene,0.998,32275921
16815,VEGF,gene,0.9966,32275921
16816,CD68,gene,0.9434,32275921
16817,Mller cell,cell_type,0.6987,32275921
16818,M,disease,0.606,32275921
16819,Aflibercept,gene,0.926,32275921
16820,anti-VEGF,gene,0.888,32275921
16821,DLAAA,DNA,0.55,32275921
16822,retinal vascular leakage,disease,0.6357,32275921
16823,exudative AMD,disease,0.9995,32275921
16824,diabetic retinopathy,disease,1.0,32275921
16825,macular telangiectasia,disease,1.0,32275921
16826,retinal ischemic and neovascular diseases,disease,1.0,32275921
16827,DLAAA,gene,0.694,32275921
16828,primate,species,0.4731,32275921
16829,retinal vascular disease,disease,1.0,32275921
16830,vascular and metabolic insults,disease,0.7373,32275921
16831,neovascular age-related macular degeneration,disease,1.0,32266472
16832,neovascular age-related macular degeneration,disease,1.0,32266472
16833,nAMD,disease,1.0,32266472
16834,macula,disease,0.995,32266472
16835,nAMD,disease,1.0,32266472
16836,patients,species,0.9917,32266472
16837,patients,species,0.9844,32266472
16838,VEGF,gene,0.499,32266472
16839,ranibizumab,gene,0.698,32266472
16840,aflibercept,gene,0.9775,32266472
16841,macula,disease,0.8916,32266472
16842,patients,species,0.981,32266472
16843,CRT,DNA,0.614,32266472
16844,subretinal fluid,disease,0.914,32266472
16845,pigment epithelial detachment,disease,1.0,32266472
16846,nAMD,disease,1.0,32266472
16847,patients,species,0.961,32265509
16848,aflibercept,gene,0.961,32265509
16849,neovascular age-related macular degeneration,disease,1.0,32265509
16850,nAMD,disease,1.0,32265509
16851,PARTICIPANTS,species,0.8315,32265509
16852,nAMD,disease,1.0,32265509
16853,patients,species,0.989,32265509
16854,aflibercept,gene,0.971,32265509
16855,patients,species,0.9927,32265509
16856,aflibercept,gene,0.9595,32265509
16857,nAMD,disease,1.0,32265509
16858,Diabetic Retinopathy,disease,0.997,32265509
16859,patients,species,0.991,32265509
16860,patients,species,0.9575,32265509
16861,ETDRS,DNA,0.4646,32265509
16862,Aflibercept,gene,0.9355,32265509
16863,neovascular AMD,disease,1.0,32265509
16864,VEGF,gene,0.821,32265201
16865,diabetic macular,disease,1.0,32265201
16866,antivascular endothelial growth factor,gene,0.976,32265201
16867,diabetic macular oedema,disease,1.0,32265201
16868,DMO,disease,1.0,32265201
16869,patients,species,0.982,32265201
16870,DMO,disease,1.0,32265201
16871,patient,species,0.9854,32265201
16872,anti-VEGF,gene,0.8535,32265201
16873,VEGF,gene,0.5415,32265201
16874,anti-VEGF,gene,0.93,32265201
16875,patients,species,0.9375,32265201
16876,DMO,disease,1.0,32265201
16877,anti-VEGF,gene,0.921,32265201
16878,patients,species,0.983,32265201
16879,Aflibercept,gene,0.981,32252674
16880,aflibercept,gene,0.991,32252674
16881,diabetic vitreous hemorrhage,disease,1.0,32252674
16882,VH,disease,1.0,32252674
16883,diabetic VH,disease,1.0,32252674
16884,PRP,cell_type,0.507,32252674
16885,hemorrhage,disease,0.784,32252674
16886,PRP,cell_type,0.4685,32252674
16887,VH,disease,,32252674
16888,VH,disease,,32252674
16889,aflibercept,gene,0.9873,32252674
16890,diabetic vitreous hemorrhage,disease,1.0,32252674
16891,neovascular age-related macular degeneration,disease,1.0,32252053
16892,VEGF,gene,0.8853,32252053
16893,VASCULAR DENSITY,disease,0.7773,32251239
16894,PATIENTS,species,0.9507,32251239
16895,POLYPOIDAL CHOROIDAL VASCULOPATHY,disease,1.0,32251239
16896,polypoidal choroidal vasculopathy,disease,1.0,32251239
16897,aflibercept,gene,0.971,32251239
16898,polypoidal choroidal vasculopathy,disease,1.0,32251239
16899,patents,species,0.7275,32251239
16900,aflibercept,gene,0.9585,32251239
16901,polypoidal choroidal vasculopathy,disease,1.0,32251239
16902,stenosis of the large vessels,disease,1.0,32251239
16903,Ranibizumab,gene,0.9385,32247191
16904,Aflibercept,gene,0.968,32247191
16905,Visual Impairment,disease,1.0,32247191
16906,Age-Related Macular Degeneration,disease,1.0,32247191
16907,Diabetic Macular Edema,disease,1.0,32247191
16908,age-related macular degeneration,disease,1.0,32247191
16909,AMD,disease,1.0,32247191
16910,diabetic macular edema,disease,1.0,32247191
16911,DME,disease,1.0,32247191
16912,macular edema,disease,1.0,32247191
16913,swelling,disease,0.922,32247191
16914,vascular endothelial growth factor,gene,0.9946,32247191
16915,ranibizumab,gene,0.5767,32247191
16916,aflibercept,gene,0.889,32247191
16917,ranibizumab,gene,0.795,32247191
16918,aflibercept,gene,0.916,32247191
16919,visual impairment,disease,1.0,32247191
16920,AMD,disease,1.0,32247191
16921,DME,disease,1.0,32247191
16922,ranibizumab,gene,0.773,32247191
16923,aflibercept,gene,0.967,32247191
16924,DME,disease,1.0,32247191
16925,AMD,disease,1.0,32247191
16926,AMD,disease,1.0,32247191
16927,DME,disease,1.0,32247191
16928,Aflibercept,gene,0.9155,32247191
16929,aflibercept,gene,0.9595,32247191
16930,aflibercept,gene,0.941,32247191
16931,ranibizumab,gene,0.522,32247191
16932,AMD,disease,1.0,32247191
16933,DME,disease,1.0,32247191
16934,Aflibercept,gene,0.96,32244546
16935,Metastatic Colorectal Cancer,disease,1.0,32244546
16936,Metastatic colorectal cancer,disease,1.0,32244546
16937,mCRC,disease,1.0,32244546
16938,vascular endothelial growth factor,gene,0.998,32244546
16939,VEGF,gene,0.998,32244546
16940,bevacizumab,gene,0.691,32244546
16941,aflibercept,gene,0.9365,32244546
16942,epidermal growth factor receptor,gene,0.941,32244546
16943,EGFR,gene,0.9937,32244546
16944,Aflibercept,gene,0.941,32244546
16945,mCRC,disease,0.994,32244546
16946,FOLFIRI,drug,0.6475,32244546
16947,oxaliplatin,drug,0.9966,32244546
16948,aflibercept,gene,0.9746,32244546
16949,aflibercept,gene,0.9517,32244546
16950,CRC,disease,0.721,32244546
16951,aflibercept,gene,0.9873,32244546
16952,hypertension,disease,0.997,32244546
16953,proteinuria,disease,1.0,32244546
16954,aflibercept,gene,0.957,32244546
16955,patient,species,0.964,32231830
16956,choroidal neovascularization,disease,1.0,32231830
16957,CNV,disease,1.0,32231830
16958,optic disc drusen,disease,1.0,32231830
16959,ODD,disease,1.0,32231830
16960,aflibercept,gene,0.9854,32231830
16961,girl,species,0.829,32231830
16962,visual loss,disease,0.9995,32231830
16963,metamorphopsia,disease,1.0,32231830
16964,patient,species,0.972,32231830
16965,fluorescein,drug,0.99,32231830
16966,CNV,disease,0.9995,32231830
16967,CNV,disease,1.0,32231830
16968,CNV,disease,1.0,32231830
16969,ODD,disease,1.0,32231830
16970,aflibercept,gene,0.9907,32231830
16971,irregularity,disease,0.881,32231830
16972,optic,DNA,0.4636,32231830
16973,CNV,disease,0.9985,32231830
16974,CNV,disease,1.0,32231830
16975,CNV,disease,0.9995,32231830
16976,ODD,disease,1.0,32231830
16977,CNV,disease,0.9917,32231830
16978,patient,species,0.9824,32231830
16979,Endophthalmitis,disease,1.0,32231556
16980,Agrobacterium radiobacter,species,0.96,32231556
16981,Agrobacterium (Rhizobium) radiobacter,species,0.8457,32231556
16982,gram-negative bacillus,cell_type,0.61,32231556
16983,aflibercept,gene,0.989,32231556
16984,diabetic macular edema,disease,1.0,32231556
16985,endophthalmitis,disease,1.0,32231556
16986,Agrobacterium radiobacter,species,0.962,32231556
16987,patient,species,0.9404,32231556
16988,vancomycin,drug,0.9985,32231556
16989,ceftazidime,drug,0.996,32231556
16990,macular edema,disease,1.0,32228517
16991,nAMD,disease,1.0,32228517
16992,DME,cell_line,0.4912,32228517
16993,VEGF,gene,0.922,32228517
16994,patients,species,0.986,32228517
16995,patients,species,0.9795,32228517
16996,patient,species,0.9824,32228517
16997,patient,species,0.98,32228517
16998,nAMD,disease,1.0,32228517
16999,DME,drug,0.7397,32228517
17000,RVO,disease,0.915,32228517
17001,nAMD,disease,1.0,32228517
17002,patients,species,0.982,32228517
17003,nAMD,disease,1.0,32228517
17004,DME,disease,1.0,32228517
17005,RVO,disease,0.999,32228517
17006,Patients,species,0.995,32228517
17007,patients,species,0.9834,32228517
17008,patient,species,0.9663,32228517
17009,choroidal neovascularization,disease,0.909,32228025
17010,neovascular age-related macular degeneration,disease,1.0,32228025
17011,polypoidal,disease,0.9966,32228025
17012,polypoidal choroidal vasculopathy,disease,1.0,32228025
17013,vascular endothelial growth factor,gene,0.95,32228025
17014,patients,species,0.98,32228025
17015,neovascular age-related macular degeneration,disease,1.0,32228025
17016,polypoidal choroidal vasculopathy,disease,1.0,32228025
17017,vascular endothelial growth factor,gene,0.9927,32228025
17018,patients,species,0.977,32228025
17019,patients,species,0.9883,32228025
17020,neovascular age-related macular degeneration,disease,0.967,32228025
17021,patients,species,0.9893,32228025
17022,polypoidal choroidal vasculopathy,disease,1.0,32228025
17023,neovascular age-related macular degeneration,disease,1.0,32228025
17024,polypoidal complex,disease,1.0,32228025
17025,polypoidal choroidal vasculopathy,disease,1.0,32228025
17026,neovascular age-related macular degeneration,disease,1.0,32228025
17027,polypoidal choroidal vasculopathy,disease,1.0,32228025
17028,anti-,gene,0.6387,32228025
17029,vascular endothelial growth factor,gene,0.878,32228025
17030,neovascular age-related macular degeneration,disease,1.0,32228025
17031,polypoidal choroidal vasculopathy,disease,1.0,32228025
17032,neovascular age-related macular degeneration,disease,1.0,32228025
17033,polypoidal choroidal vasculopathy,disease,1.0,32228025
17034,vascular endothelial growth factor,gene,0.8896,32228025
17035,aflibercept,gene,0.988,32228025
17036,ranibizumab,gene,0.9185,32228025
17037,bevacizumab,gene,0.7964,32228025
17038,polypoidal choroidal vasculopathy,disease,1.0,32228025
17039,vascular endothelial growth factor,gene,0.9155,32228025
17040,choroidal neovascularization,disease,0.8843,32228025
17041,macular degeneration,disease,1.0,32228025
17042,polypoidal choroidal vasculopathy,disease,1.0,32228025
17043,VEGF,gene,0.743,32226387
17044,Dementia,disease,1.0,32226387
17045,Parkinson-Like Events,disease,1.0,32226387
17046,vascular endothelial growth factor,gene,0.9985,32226387
17047,VEGF,gene,0.9863,32226387
17048,dopaminergic neurons,cell_type,0.8535,32226387
17049,VEGF,gene,0.9937,32226387
17050,Parkinson-,disease,1.0,32226387
17051,dementia,disease,1.0,32226387
17052,VEGF,gene,0.7236,32226387
17053,Parkinson's disease,disease,1.0,32226387
17054,PD,disease,1.0,32226387
17055,dementia,disease,1.0,32226387
17056,VEGF,gene,0.8706,32226387
17057,PD,disease,1.0,32226387
17058,dementia,disease,1.0,32226387
17059,ICSRs,disease,0.8184,32226387
17060,ranibizumab,gene,0.6763,32226387
17061,aflibercept,gene,0.92,32226387
17062,pegaptanib,drug,0.9814,32226387
17063,Parkinson-like events,disease,0.999,32226387
17064,Dementia,disease,1.0,32226387
17065,VEGF,gene,0.8354,32226387
17066,Dementia,disease,1.0,32226387
17067,Parkinson-like events,disease,1.0,32226387
17068,VEGF,gene,0.888,32226387
17069,ranibizumab,gene,0.867,32226387
17070,Parkinson's disease,disease,1.0,32226387
17071,ICSRs,DNA,0.77,32226387
17072,ICSR,DNA,0.679,32226387
17073,Parkinson's disease,disease,1.0,32226387
17074,ranibizumab,gene,0.5806,32226387
17075,Aflibercept,gene,0.9097,32222903
17076,aflibercept,gene,0.9946,32222903
17077,AFL,gene,0.8604,32222903
17078,RBZ,drug,0.978,32222903
17079,patients,species,0.962,32222903
17080,wet age-related macular degeneration,disease,0.972,32222903
17081,wAMD,disease,1.0,32222903
17082,patient,species,0.9883,32222903
17083,ALTAIR,DNA,0.8564,32222903
17084,polypoidal choroidal vasculopathy,disease,1.0,32222903
17085,PCV,disease,0.8213,32222903
17086,IVT,drug,0.986,32222903
17087,ALTAIR,DNA,0.7856,32222903
17088,RBZ T,drug,0.9927,32222903
17089,CANTREAT,DNA,0.7725,32222903
17090,ALTAIR,DNA,0.748,32222903
17091,CATT,DNA,0.5264,32222903
17092,CANTREAT,DNA,0.635,32222903
17093,TREX,DNA,0.543,32222903
17094,IVT-,drug,0.967,32222903
17095,RBZ,drug,0.853,32222903
17096,RBZ,drug,0.91,32222903
17097,Diabetic Retinopathy,disease,0.999,32222903
17098,IVT-AFL T&amp;,drug,0.875,32222903
17099,RBZ-T&amp;E,drug,0.9326,32222903
17100,Patients,species,0.9204,32222903
17101,wAMD,disease,0.9995,32222903
17102,RBZ T,drug,0.9917,32222903
17103,AFL,drug,0.9546,32222903
17104,wAMD,disease,0.999,32222903
17105,aflibercept,gene,0.9463,32215778
17106,patients,species,0.97,32215778
17107,macular edema,disease,1.0,32215778
17108,central retinal vein occlusion,disease,1.0,32215778
17109,CRVO,disease,1.0,32215778
17110,patients,species,0.979,32215778
17111,non-ischemic CRVO,disease,0.9023,32215778
17112,patients,species,0.9717,32215778
17113,patients,species,0.9424,32215778
17114,ME,disease,,32215778
17115,CRVO,disease,0.9995,32215778
17116,Macular Edema,disease,1.0,32211907
17117,Diabetic Retinopathy,disease,1.0,32211907
17118,Cataract,disease,0.804,32211907
17119,aflibercept,gene,0.994,32211907
17120,diabetic retinopathy,disease,1.0,32211907
17121,DR,disease,1.0,32211907
17122,macular edema,disease,1.0,32211907
17123,cataract,disease,0.9985,32211907
17124,PATIENTS,species,0.9746,32211907
17125,DR,disease,0.903,32211907
17126,cataract,disease,0.999,32211907
17127,aflibercept,gene,0.984,32211907
17128,cataract,disease,0.912,32211907
17129,ME,disease,1.0,32211907
17130,retinal thickening,disease,0.752,32211907
17131,DR,disease,0.9824,32211907
17132,ME,disease,0.9263,32211907
17133,cataract,disease,0.646,32211907
17134,ME,disease,0.9995,32211907
17135,Ziv-Aflibercept,gene,0.955,32211904
17136,Diabetic Macular Edema,disease,1.0,32211904
17137,Bevacizumab,gene,0.807,32211904
17138,ziv-aflibercept,gene,0.991,32211904
17139,diabetic macular edema,disease,1.0,32211904
17140,DME,disease,1.0,32211904
17141,bevacizumab,gene,0.5923,32211904
17142,PATIENTS,species,0.887,32211904
17143,DME,disease,1.0,32211904
17144,IVZ,drug,0.9634,32211904
17145,BCVA,cell_type,0.4368,32211904
17146,IVZ,drug,0.917,32211904
17147,IVZ,drug,0.905,32211904
17148,IVZ,drug,0.977,32211904
17149,DME,disease,1.0,32211904
17150,bevacizumab,gene,0.833,32211904
17151,DME,disease,1.0,32211904
17152,Aflibercept,gene,0.912,32210527
17153,Diabetic Macular Edema,disease,1.0,32210527
17154,diabetes,disease,1.0,32210527
17155,diabetes,disease,1.0,32210527
17156,diabetic macular edema,disease,1.0,32210527
17157,DME,disease,1.0,32210527
17158,DME,disease,1.0,32210527
17159,aflibercept,gene,0.9795,32210527
17160,AFL,gene,0.625,32210527
17161,2q4,DNA,0.7974,32210527
17162,2q8 groups,DNA,0.6206,32210527
17163,conjunctival hemorrhage,disease,1.0,32210527
17164,retinal hemorrhage,disease,1.0,32210527
17165,retinal aneurysm,disease,1.0,32210527
17166,retinal exudates,disease,1.0,32210527
17167,DME,drug,0.9,32210527
17168,polypoidal choroidal vasculopathy,disease,1.0,32206935
17169,polypoidal,disease,0.9546,32206935
17170,VEGF,gene,0.9956,32206935
17171,polypoidal,disease,0.9995,32206935
17172,choroidal vasculopathy,disease,1.0,32206935
17173,PCV,disease,1.0,32206935
17174,polyps,disease,0.9854,32206935
17175,PATIENTS,species,0.961,32206935
17176,PCV,disease,1.0,32206935
17177,polypoidal lesion,disease,0.937,32206935
17178,aflibercept,gene,0.961,32206935
17179,PCV,disease,0.9688,32206935
17180,aflibercept,gene,0.9736,32206935
17181,aflibercept,gene,0.9805,32206935
17182,PCV,disease,1.0,32206935
17183,AMD,disease,1.0,32200797
17184,VEGF-A,gene,0.9785,32200797
17185,Brolucizumab,gene,0.4734,32200797
17186,VEGF-A,gene,0.9966,32200797
17187,aflibercept,gene,0.9766,32200797
17188,VEGF-A,gene,0.998,32200797
17189,brolucizumab,gene,0.682,32200797
17190,Aflibercept,gene,0.9253,32184551
17191,aflibercept,gene,0.984,32184551
17192,VR,disease,0.9727,32184551
17193,macular hole,disease,0.9946,32183733
17194,Macular hole,disease,0.9985,32183733
17195,MH,disease,1.0,32183733
17196,neural retinal,cell_type,0.486,32183733
17197,visual deformation,disease,1.0,32183733
17198,secondary MH,disease,0.856,32183733
17199,submacular hemorrhage,disease,1.0,32183733
17200,SMH,disease,1.0,32183733
17201,polypoidal choroidal vasculopathy,disease,1.0,32183733
17202,PCV,disease,1.0,32183733
17203,man,species,0.9,32183733
17204,SMH,disease,0.997,32183733
17205,aflibercept,gene,0.985,32183733
17206,MH,disease,,32183733
17207,MH,disease,,32183733
17208,serous retinal detachment,disease,1.0,32183733
17209,SRD,disease,1.0,32183733
17210,MH,disease,,32183733
17211,SRD,disease,1.0,32183733
17212,MH,disease,,32183733
17213,PCV,disease,0.9614,32183733
17214,Ziv-Aflibercept,gene,0.9155,32175924
17215,Aflibercept,gene,0.9053,32175924
17216,aflibercept,gene,0.872,32175924
17217,aflibercept,gene,0.979,32175924
17218,neovascular age-related macular degeneration,disease,1.0,32175924
17219,nAMD,disease,1.0,32175924
17220,nAMD,disease,1.0,32175924
17221,patients,species,0.994,32175924
17222,ziv-aflibercept,gene,0.9473,32175924
17223,aflibercept,gene,0.9473,32175924
17224,ziv-aflibercept,gene,0.9883,32175924
17225,aflibercept,gene,0.9873,32175924
17226,neurosensory detachment,disease,0.988,32175924
17227,patients,species,0.9707,32175924
17228,neurosensory detachment,disease,1.0,32175924
17229,pigment epithelial detachment,disease,0.997,32175924
17230,ziv-aflibercept,gene,0.838,32175924
17231,aflibercept,gene,0.9893,32175924
17232,ziv-aflibercept,gene,0.9717,32175924
17233,nAMD,disease,0.9985,32175924
17234,ziv-aflibercept,gene,0.993,32169790
17235,Ziv-aflibercept,gene,0.9937,32169790
17236,ziv-AFL,gene,0.994,32169790
17237,colorectal metastatic cancer,disease,1.0,32169790
17238,patients,species,0.9937,32169790
17239,ziv-AFL,drug,0.996,32169790
17240,Zaltrap,drug,0.9927,32169790
17241,AFL,disease,0.797,32169790
17242,ziv-AFL,gene,0.976,32169790
17243,Aflibercept,gene,0.9844,32168980
17244,Fluorouracil,drug,0.9995,32168980
17245,Leucovorin,drug,0.9985,32168980
17246,Irinotecan,drug,0.9976,32168980
17247,FOLFIRI,drug,0.63,32168980
17248,Metastatic Colorectal Cancer,disease,1.0,32168980
17249,mCRC,disease,1.0,32168980
17250,metastatic colorectal cancer,disease,1.0,32168980
17251,mCRC,disease,1.0,32168980
17252,oxaliplatin,drug,0.9995,32168980
17253,irinotecan,drug,0.9976,32168980
17254,aflibercept,gene,0.99,32168980
17255,fluorouracil,drug,0.9995,32168980
17256,leucovorin,drug,0.999,32168980
17257,irinotecan,drug,0.999,32168980
17258,FOLFIRI,drug,0.51,32168980
17259,mCRC,disease,0.9927,32168980
17260,oxaliplatin,drug,0.9995,32168980
17261,renal impairment,disease,1.0,32168980
17262,hepatic impairment,disease,1.0,32168980
17263,oxaliplatin,drug,0.9995,32168980
17264,bevacizumab,gene,0.848,32168980
17265,Neutropenia,disease,1.0,32168980
17266,hypertension,disease,1.0,32168980
17267,diarrhea,disease,1.0,32168980
17268,asthenia,disease,1.0,32168980
17269,Antivascular endothelial growth factor,gene,0.9834,32168980
17270,Aflibercept,gene,0.971,32168980
17271,FOLFIRI,drug,0.9287,32168980
17272,mCRC,disease,0.997,32168980
17273,oxaliplatin,drug,0.9995,32168980
17274,Diabetic Macular Oedema,disease,1.0,32161438
17275,Aflibercept,gene,0.8745,32161438
17276,aflibercept,gene,0.973,32161438
17277,diabetic macular oedema,disease,1.0,32161438
17278,DME,disease,1.0,32161438
17279,aflibercept,gene,0.937,32161438
17280,DME,disease,0.999,32161438
17281,DME,disease,1.0,32161438
17282,aflibercept,gene,0.9644,32161438
17283,DME,disease,1.0,32161438
17284,ranibizumab,gene,0.831,32160267
17285,aflibercept,gene,0.966,32160267
17286,polypoidal choroidal vasculopathy,disease,1.0,32160267
17287,age-related macular BACKGROUND,disease,0.9956,32159640
17288,Age-related macular degeneration,disease,1.0,32159640
17289,AMD,disease,1.0,32159640
17290,blindness,disease,0.999,32159640
17291,AMD,disease,1.0,32159640
17292,AMD,disease,1.0,32159640
17293,vitamins,drug,0.9927,32159640
17294,bevacizumab,gene,0.693,32159640
17295,ranibizumab,gene,0.701,32159640
17296,pegaptanib,drug,0.7837,32159640
17297,AMD,disease,1.0,32159640
17298,aflibercept,gene,0.6455,32159640
17299,interferon alfa,gene,0.9946,32159640
17300,statins,drug,0.9907,32159640
17301,fatty acids,drug,0.99,32159640
17302,AMD,disease,1.0,32159640
17303,AMD,disease,1.0,32159640
17304,AMD,disease,1.0,32159640
17305,Aflibercept Beta,gene,0.9927,32157052
17306,FOLFIRI,drug,0.939,32157052
17307,Aflibercept beta,gene,0.9854,32157052
17308,FOLFIRI,drug,0.954,32157052
17309,metastatic colorectal cancer,disease,0.9995,32157052
17310,Aflibercept beta,gene,0.983,32157052
17311,vascular endothelial growth factor(VEGF)- A,gene,0.9966,32157052
17312,VEGF-B,gene,0.9976,32157052
17313,placental growth factor,gene,0.997,32157052
17314,PlGF,gene,0.995,32157052
17315,aflibercept beta,gene,0.993,32157052
17316,FOLFIRI,drug,0.934,32157052
17317,metastatic colorectal cancer,disease,1.0,32157052
17318,patients,species,0.9893,32157052
17319,pts,species,0.948,32157052
17320,Afliber- cept beta,gene,0.931,32157052
17321,FOLFIRI,drug,0.978,32157052
17322,pts,species,0.965,32157052
17323,aflibercept beta,gene,0.987,32157052
17324,FOLFIRI,drug,0.8335,32157052
17325,pts,species,0.984,32157052
17326,pts,species,0.9814,32157052
17327,Aflibercept beta,gene,0.975,32157052
17328,FOLFIRI,drug,0.8433,32157052
17329,pts,species,0.968,32157052
17330,pts,species,0.974,32157052
17331,aflibercept beta,gene,0.9907,32157052
17332,FOLFIRI,drug,0.9673,32157052
17333,neutropenia,disease,0.995,32157052
17334,pts,species,0.936,32157052
17335,Aflibercept beta,gene,0.9883,32157052
17336,FOLFIRI,drug,0.94,32157052
17337,metastatic colorectal cancer,disease,1.0,32157052
17338,patients,species,0.9893,32157052
17339,patients,species,0.9893,32156487
17340,sterile endophthalmitis,disease,1.0,32156487
17341,patients,species,0.987,32156487
17342,sterile endophthalmitis,disease,1.0,32156487
17343,growth factor,gene,0.5327,32156487
17344,patients,species,0.974,32156487
17345,sterile endophthalmitis,disease,1.0,32156487
17346,patients,species,0.9863,32156487
17347,sterile endophthalmitis,disease,1.0,32156487
17348,patients,species,0.984,32156487
17349,sterile endophthalmitis,disease,1.0,32156487
17350,aflibercept,gene,0.991,32156487
17351,ranibizumab,gene,0.9326,32156487
17352,patients,species,0.9854,32156487
17353,age related macular degeneration,disease,1.0,32156487
17354,myopic choroidal neovascularization,disease,1.0,32156487
17355,macular edema,disease,1.0,32156487
17356,diabetic macular edema,disease,1.0,32156487
17357,branch retinal vein occlusion,disease,1.0,32156487
17358,vision loss,disease,0.993,32156487
17359,vitreous cell,cell_type,0.611,32156487
17360,hypopyon,disease,0.9937,32156487
17361,patients,species,0.961,32156487
17362,infectious endophthalmitis,disease,0.8394,32156487
17363,Patients,species,0.9897,32148945
17364,Neovascular Age-Related Macular Degeneration,disease,1.0,32148945
17365,patients,species,0.9907,32148945
17366,nAMD,disease,1.0,32148945
17367,aflibercept,gene,0.9663,32148945
17368,Patients,species,0.9795,32148945
17369,nAMD,disease,1.0,32148945
17370,aflibercept,gene,0.9746,32148945
17371,patients,species,0.9727,32148945
17372,nAMD,disease,1.0,32148945
17373,patients,species,0.982,32148945
17374,patients,species,0.97,32148945
17375,patients,species,0.985,32148945
17376,patients,species,0.9873,32148945
17377,patients,species,0.9917,32148945
17378,patients,species,0.985,32148945
17379,retinal pigment epithelial detachment,disease,1.0,32148945
17380,patients,species,0.976,32148945
17381,nAMD,disease,1.0,32148945
17382,patients,species,0.993,32148945
17383,Macular hole,disease,0.9326,32140615
17384,serous pigment epithelial detachment,disease,1.0,32140615
17385,Acquired vitelliform lesions,disease,1.0,32140615
17386,AVLs,disease,1.0,32140615
17387,age-related macular degeneration,disease,1.0,32140615
17388,AVLs,disease,1.0,32140615
17389,outer retinal atrophy,disease,0.9907,32140615
17390,macular hole,disease,0.9995,32140615
17391,choroidal neovascularization,disease,1.0,32140615
17392,AVLs,disease,1.0,32140615
17393,macular hole,disease,0.9956,32140615
17394,pigment epithelial detachment,disease,0.872,32140615
17395,sPED,disease,0.9546,32140615
17396,woman,species,0.8906,32140615
17397,bilateral metamorphopsia,disease,0.6606,32140615
17398,AVLs,disease,1.0,32140615
17399,flat sPED,disease,0.9424,32140615
17400,Fluorescein,drug,0.991,32140615
17401,pattern dystrophy,disease,0.771,32140615
17402,hypofluorescence,disease,0.808,32140615
17403,sPED,disease,1.0,32140615
17404,AVLs,disease,0.926,32140615
17405,aflibercept,gene,0.9707,32140615
17406,triamcinolone acetonide,drug,0.9985,32140615
17407,sPED,disease,0.703,32140615
17408,ranibizumab,gene,0.5938,32140615
17409,tissue plasminogen activator,gene,0.994,32140615
17410,macular hole,disease,0.9995,32140615
17411,metamorphopsia,disease,0.992,32140615
17412,subretinal fibrotic scar,disease,0.997,32140615
17413,outer,disease,0.976,32140615
17414,retinal atrophy,disease,0.8057,32140615
17415,sPED,disease,1.0,32140615
17416,AVLs,disease,0.9995,32140615
17417,macular hole,disease,0.9995,32140615
17418,AVLs,disease,1.0,32140615
17419,retinal atrophy,disease,1.0,32140615
17420,visual loss,disease,0.999,32140615
17421,Claudin-5,gene,0.984,32139595
17422,Anti-VEGF,gene,0.659,32139595
17423,patients,species,0.9814,32139595
17424,diabetic macular edema,disease,1.0,32139595
17425,DME,disease,1.0,32139595
17426,vascular endothelial growth factor,gene,0.965,32139595
17427,VEGF,gene,0.999,32139595
17428,VEGF,gene,0.994,32139595
17429,DME,disease,0.999,32139595
17430,patients,species,0.962,32139595
17431,rDME,disease,0.953,32139595
17432,VEGF,gene,0.9907,32139595
17433,mouse,species,0.9478,32139595
17434,CD11b(+) Ly6C(+) CCR2(+) cells,cell_line,0.9775,32139595
17435,CD11b,gene,0.793,32139595
17436,CCR2,gene,0.594,32139595
17437,macrophage,cell_type,0.6924,32139595
17438,microglia,cell_type,0.5337,32139595
17439,CD11b(+) CD80(+) cells,cell_line,0.957,32139595
17440,CD11b,gene,0.9473,32139595
17441,CD80,gene,0.724,32139595
17442,claudin-5,gene,0.9844,32139595
17443,VEGF,gene,0.9795,32139595
17444,VEGF,gene,0.997,32139595
17445,retinas,cell_type,0.414,32139595
17446,rho-associated coiled-coil-containing protein kinase,gene,0.9985,32139595
17447,ROCK,gene,0.9985,32139595
17448,ripasudil,drug,0.9985,32139595
17449,ROCK,gene,0.9937,32139595
17450,retinal inflammation,disease,0.9956,32139595
17451,claudin,DNA,0.6074,32139595
17452,claudin-5,gene,0.9824,32139595
17453,Ripasudil,drug,0.9995,32139595
17454,claudin,DNA,0.543,32139595
17455,claudin-5,gene,0.9795,32139595
17456,inflammatory cytokine-stimulated endothelium,cell_line,0.5415,32139595
17457,VEGF,gene,0.811,32139595
17458,ROCK,gene,0.994,32139595
17459,monocyte,cell_type,0.653,32139595
17460,macrophage,cell_type,0.445,32139595
17461,claudin,DNA,0.6426,32139595
17462,claudin-5,gene,0.99,32139595
17463,ROCK2,gene,0.9956,32139595
17464,ROCK1,gene,0.9976,32139595
17465,human,species,0.996,32139595
17466,rDME,disease,0.996,32139595
17467,ROCK,gene,0.996,32139595
17468,claudin,DNA,0.6343,32139595
17469,claudin-5,gene,0.9883,32139595
17470,VEGF,gene,0.5664,32139595
17471,DME,drug,0.95,32139595
17472,Brolucizumab,gene,0.7124,32131127
17473,single-chain variable antibody fragment,gene,0.9854,32131127
17474,scVF,gene,0.9883,32131127
17475,VEGF-A,gene,0.9976,32131127
17476,Brolucizumab,gene,0.937,32131127
17477,Aflibercept,gene,0.944,32131127
17478,neovascular age-related degeneration,disease,1.0,32131127
17479,neovascular age-related macular degeneration,disease,1.0,32131127
17480,nAMD,disease,1.0,32131127
17481,Brolucizumab,gene,0.94,32131127
17482,Aflibercept,gene,0.952,32131127
17483,Brolucizumab,gene,0.5405,32131127
17484,DME,disease,1.0,32131127
17485,diabetic retinopathy,disease,1.0,32131127
17486,DRP,disease,1.0,32131127
17487,vision loss,disease,0.9897,32131127
17488,hemorrhagic complications,disease,0.9995,32131127
17489,Brolucizumab,gene,0.72,32131127
17490,Aflibercept,gene,0.9585,32131127
17491,anti-VEGF,gene,0.7783,32111177
17492,cystoid macular edema,disease,1.0,32111177
17493,cystoid macular edema,disease,1.0,32111177
17494,Henoch-Schonleinpurpura,disease,1.0,32111177
17495,man,species,0.898,32111177
17496,blurred vision,disease,0.9565,32111177
17497,cystoid macular edema,disease,1.0,32111177
17498,retinal hemorrhages,disease,0.9927,32111177
17499,dexamethasone,drug,0.9946,32111177
17500,macular edema,disease,1.0,32111177
17501,prednisone,drug,0.9976,32111177
17502,anti-VEGF,gene,0.971,32111177
17503,edema,disease,0.995,32111177
17504,bilateral cystoid macular edema,disease,0.9985,32111177
17505,Henoch-Schonlein purpura,disease,1.0,32111177
17506,bevacizumab,gene,0.9263,32110410
17507,proteinuria,disease,0.9995,32110410
17508,diabetic nephropathy,disease,1.0,32110410
17509,ranibizumab,gene,0.8833,32110410
17510,diabetic,disease,1.0,32110410
17511,vascular endothelial growth factor,gene,0.9946,32110410
17512,diabetic retinopathy,disease,1.0,32110410
17513,hypertension,disease,1.0,32110410
17514,proteinuria,disease,1.0,32110410
17515,vascular endothelial growth factor,gene,0.999,32110410
17516,renal disease,disease,1.0,32110410
17517,hypertension,disease,1.0,32110410
17518,proteinuria,disease,1.0,32110410
17519,renal function,disease,0.9805,32110410
17520,thrombotic microangiopathy,disease,1.0,32110410
17521,glomerular disease,disease,1.0,32110410
17522,hypertension,disease,1.0,32110410
17523,proteinuria,disease,1.0,32110410
17524,bevacizumab,gene,0.6313,32110410
17525,proteinuria,disease,0.997,32110410
17526,ranibizumab,gene,0.896,32110410
17527,creatinine,drug,0.992,32110410
17528,bevacizumab,gene,0.8926,32110410
17529,creatinine,drug,0.9966,32110410
17530,ranibizumab,gene,0.66,32110410
17531,creatinine,drug,0.9946,32110410
17532,proteinuria,disease,1.0,32110410
17533,proteinuria,disease,1.0,32110410
17534,vascular endothelial growth factor,gene,0.9985,32110410
17535,proteinuria,disease,1.0,32110410
17536,ranibizumab,gene,0.8525,32110410
17537,proteinuria,disease,0.994,32110410
17538,vascular endothelial growth factor,gene,0.998,32110410
17539,diabetic,disease,0.9985,32110410
17540,retinopathy,disease,0.932,32110410
17541,diabetic macular edema,disease,1.0,32108920
17542,vascular endothelial growth factor,gene,0.9873,32108920
17543,diabetic macular edema,disease,1.0,32108920
17544,DME,disease,1.0,32108920
17545,patients,species,0.9624,32108920
17546,DME,disease,1.0,32108920
17547,aflibercept,gene,0.959,32108920
17548,patients,species,0.982,32108920
17549,IVA,drug,0.516,32108920
17550,DME,disease,1.0,32108920
17551,Brolucizumab,gene,0.555,32107066
17552,Neovascular Age-Related Macular Degeneration,disease,1.0,32107066
17553,neovascular age-related macular degeneration,disease,1.0,32107066
17554,nAMD,disease,1.0,32107066
17555,nAMD,disease,1.0,32107066
17556,anti-vascular endothelial growth factor,gene,0.943,32107066
17557,VEGF,gene,0.9956,32107066
17558,Brolucizumab,gene,0.494,32107066
17559,anti-VEGF molecule,gene,0.9087,32107066
17560,nAMD,disease,1.0,32107066
17561,nAMD,disease,1.0,32107066
17562,brolucizumab,gene,0.756,32107066
17563,Brolucizumab,gene,0.613,32107066
17564,humanized,species,0.725,32107066
17565,single-chain variable fragment,gene,0.9365,32107066
17566,scFv,gene,0.6284,32107066
17567,VEGF-A,gene,0.9966,32107066
17568,brolucizumab,gene,0.73,32107066
17569,RPE,cell_type,0.437,32107066
17570,brolucizumab,gene,0.9116,32107066
17571,nAMD,disease,1.0,32107066
17572,brolucizumab,gene,0.7905,32107066
17573,aflibercept,gene,0.984,32107066
17574,brolucizumab,gene,0.808,32107066
17575,Brolucizumab,gene,0.835,32107066
17576,brolucizumab,gene,0.817,32107066
17577,aflibercept,gene,0.938,32107066
17578,brolucizumab,gene,0.939,32107066
17579,aflibercept,gene,0.967,32107066
17580,brolucizumab,gene,0.873,32107066
17581,brolucizumab,gene,0.91,32107066
17582,brolucizumab,gene,0.8657,32107066
17583,nAMD,disease,1.0,32107066
17584,Macular atrophy,disease,1.0,32103681
17585,neovascular age-related macular degeneration,disease,1.0,32103681
17586,macular atrophy,disease,1.0,32103681
17587,patients,species,0.973,32103681
17588,neovascular age-related macular degeneration,disease,1.0,32103681
17589,ranibizumab,gene,0.938,32103681
17590,aflibercept,gene,0.96,32103681
17591,atrophy,disease,0.9995,32103681
17592,neovascular age-related macular degeneration,disease,1.0,32103681
17593,fluorescein,drug,0.997,32103681
17594,macular atrophy,disease,1.0,32103681
17595,macular atrophy,disease,1.0,32103681
17596,patients,species,0.9854,32103681
17597,macular atrophy,disease,1.0,32103681
17598,incomplete retinal,disease,0.798,32103681
17599,outer retinal atrophy,disease,1.0,32103681
17600,outer retinal atrophy,disease,1.0,32103681
17601,outer retinal atrophy,disease,1.0,32103681
17602,atrophy,disease,0.9985,32103681
17603,age-related macular degeneration,disease,1.0,32101581
17604,neovascular age-related macular degeneration,disease,1.0,32101581
17605,nAMD,disease,1.0,32101581
17606,VEGF,gene,0.9854,32101581
17607,dry AMD,disease,0.9995,32101581
17608,patients,species,0.98,32101581
17609,ranibizumab,gene,0.927,32101581
17610,aflibercept,gene,0.976,32101581
17611,dry AMD,disease,0.9995,32101581
17612,anti-VEGF,gene,0.904,32101581
17613,aflibercept,gene,0.9883,32100141
17614,patients,species,0.934,32100141
17615,age-related macular degeneration,disease,1.0,32100141
17616,AMD,disease,1.0,32100141
17617,aflibercept,gene,0.9683,32100141
17618,patients,species,0.978,32100141
17619,AMD,disease,1.0,32100141
17620,patients,species,0.9746,32100141
17621,aflibercept,gene,0.9766,32100141
17622,cone,cell_type,0.4146,32100141
17623,aflibercept,gene,0.912,32100141
17624,cone,cell_type,0.4639,32100141
17625,aflibercept,gene,0.9404,32100141
17626,aflibercept,gene,0.952,32100141
17627,cone,cell_type,0.4558,32100141
17628,aflibercept,gene,0.969,32100141
17629,aflibercept,gene,0.985,32096347
17630,visual impairment,disease,1.0,32096347
17631,wet AMD,disease,0.9995,32096347
17632,anti-VEGF,gene,0.9683,32096347
17633,aflibercept,gene,0.976,32096347
17634,visual impairment,disease,1.0,32096347
17635,VEGF,gene,0.874,32096347
17636,bevacizumab,gene,0.6226,32096347
17637,aflibercept,gene,0.984,32096347
17638,visual impairments,disease,1.0,32096347
17639,age-related macular degeneration,disease,1.0,32096347
17640,AMD,disease,1.0,32096347
17641,anti-VEGF,gene,0.9663,32096347
17642,aflibercept,gene,0.968,32096347
17643,anti-VEGF,gene,0.938,32096347
17644,aflibercept,gene,0.969,32096347
17645,wet AMD,disease,0.991,32096347
17646,anti-VEGF,gene,0.9023,32096347
17647,aflibercept,gene,0.989,32096347
17648,anti-VEGF,gene,0.992,32096347
17649,bevacizumab,gene,0.5854,32096347
17650,visual impairments,disease,1.0,32096347
17651,visual impairments,disease,0.997,32096347
17652,aflibercept,gene,0.7715,32096347
17653,visual impairments,disease,1.0,32096347
17654,aflibercept,gene,0.98,32095777
17655,vascular endothelial growth factor,gene,0.871,32095777
17656,arterial thromboembolic events,disease,0.999,32095777
17657,aflibercept,gene,0.989,32095777
17658,patients,species,0.977,32095777
17659,age-related macular degeneration,disease,1.0,32095777
17660,aflibercept,gene,0.933,32095777
17661,patients,species,0.988,32095777
17662,arterial thromboembolic event,disease,1.0,32095777
17663,aflibercept,gene,0.9873,32095777
17664,platelet,cell_type,0.7773,32095777
17665,fibrinogen,gene,0.79,32095777
17666,D-dimer,RNA,0.4944,32095777
17667,prothrombin,gene,0.9873,32095777
17668,thromboplastin,gene,0.995,32095777
17669,Proteins S and C,gene,0.9976,32095777
17670,aflibercept,gene,0.979,32095777
17671,aflibercept,gene,0.984,32095777
17672,patients,species,0.954,32095777
17673,exudative age-related macular degeneration,disease,1.0,32095777
17674,aflibercept,gene,0.9805,32095777
17675,aflibercept,gene,0.989,32095777
17676,Aflibercept,gene,0.933,32093666
17677,cystoid macular oedema,disease,1.0,32093666
17678,aflibercept,gene,0.9385,32093666
17679,cystoid macular oedema,disease,1.0,32093666
17680,CMO,disease,1.0,32093666
17681,central retinal vein occlusion,disease,1.0,32093666
17682,CRVO,disease,1.0,32093666
17683,patients,species,0.9746,32093666
17684,CMO,disease,1.0,32093666
17685,CRVO,disease,1.0,32093666
17686,patients,species,0.98,32093666
17687,Diabetic Retinopathy,disease,0.9995,32093666
17688,patients,species,0.947,32093666
17689,ETDRS,DNA,0.534,32093666
17690,Patients,species,0.978,32093666
17691,aflibercept,gene,0.784,32093666
17692,CMO,disease,1.0,32093666
17693,CRVO,disease,1.0,32093666
17694,ranibizumab,gene,0.8706,32092094
17695,aflibercept,gene,0.9805,32092094
17696,polypoidal choroidal vasculopathy,disease,1.0,32092094
17697,PCV,disease,1.0,32092094
17698,PCV,disease,1.0,32092094
17699,ranibizumab,gene,0.573,32092094
17700,aflibercept,gene,0.888,32092094
17701,ARMS2,gene,0.993,32092094
17702,A69S,DNA,0.4539,32092094
17703,A69,mutation,,32092094
17704,CFH,gene,0.9897,32092094
17705,I62V,DNA,0.477,32092094
17706,I62,mutation,,32092094
17707,G allele,RNA,0.4714,32092094
17708,protective allele,DNA,0.6846,32092094
17709,ARMS2,gene,0.9917,32092094
17710,A69S,DNA,0.4253,32092094
17711,A69,mutation,,32092094
17712,GLD,disease,0.9937,32092094
17713,ARMS2,DNA,0.711,32092094
17714,ARMS2 A69S,gene,0.947,32092094
17715,A69S,DNA,0.3757,32092094
17716,A69,mutation,,32092094
17717,PCV,disease,1.0,32092094
17718,NEOVASCULAR AGE-RELATED MACULAR DEGENERATION,disease,0.9814,32091488
17719,AFLIBERCEPT,disease,0.976,32091488
17720,neovascular age-related macular degeneration,disease,1.0,32091488
17721,aflibercept,gene,0.98,32091488
17722,polypoidal choroidal vasculopathy,disease,1.0,32091488
17723,PCV,disease,1.0,32091488
17724,hemorrhagic choroidal neovascularization,disease,1.0,32091488
17725,hCNV,disease,1.0,32091488
17726,pigment epithelium detachment,disease,1.0,32091488
17727,PED,disease,1.0,32091488
17728,retinal angiomatous proliferation,disease,1.0,32091488
17729,RAP,disease,1.0,32091488
17730,aflibercept,gene,0.973,32091488
17731,PCV,disease,0.9995,32091488
17732,Diabetic Retinopathy,disease,1.0,32091488
17733,hCNV,disease,0.9487,32091488
17734,RAP lesions,disease,0.997,32091488
17735,PED,disease,1.0,32091488
17736,PCV,disease,0.998,32091488
17737,RAP,DNA,0.6064,32091488
17738,hCNV,disease,0.511,32091488
17739,PCV,disease,1.0,32091488
17740,hCNV,disease,0.9995,32091488
17741,RAP lesions,disease,0.908,32091488
17742,atrophy,disease,0.89,32091488
17743,PED,disease,1.0,32091488
17744,neovascular age-related macular degeneration,disease,1.0,32091488
17745,ranibizumab,gene,0.9346,32090034
17746,aflibercept,gene,0.9785,32090034
17747,wet AMD,disease,0.998,32090034
17748,ranibizumab,gene,0.673,32090034
17749,aflibercept,gene,0.961,32090034
17750,AMD,disease,1.0,32090034
17751,aflibercept,gene,0.924,32090034
17752,ranibizumab,gene,0.926,32090034
17753,aflibercept,gene,0.9673,32090034
17754,Macular Atrophy,disease,1.0,32084278
17755,macular atrophy,disease,1.0,32084278
17756,MA,disease,1.0,32084278
17757,anti-vascular endothelial growth factor,gene,0.881,32084278
17758,VEGF,gene,0.993,32084278
17759,neovascular age-related macular degeneration,disease,1.0,32084278
17760,nAMD,disease,1.0,32084278
17761,PATIENTS,species,0.9443,32084278
17762,MA,disease,0.8184,32084278
17763,MA,disease,0.9614,32084278
17764,MA,disease,0.8306,32084278
17765,VEGF,gene,0.8174,32084278
17766,Foveal MA,disease,0.9883,32084278
17767,ETDRS,DNA,0.51,32084278
17768,MA,disease,0.998,32084278
17769,ETDRS,DNA,0.473,32084278
17770,ETDRS,DNA,0.4707,32084278
17771,nAMD,disease,1.0,32084278
17772,anti-VEGF,gene,0.959,32084278
17773,Aflibercept,gene,0.977,32082619
17774,Ranibizumab,gene,0.89,32082619
17775,aflibercept,gene,0.9907,32082619
17776,myopic choroidal neovascularization,disease,1.0,32082619
17777,mCNV,disease,1.0,32082619
17778,mCNV,disease,1.0,32082619
17779,IVA,disease,0.8486,32082619
17780,mCNV,disease,0.9995,32082619
17781,diabetic macular edema,disease,1.0,32077907
17782,CI-DME,disease,0.997,32077907
17783,aflibercept,gene,0.9814,32077907
17784,aflibercept,gene,0.9854,32077907
17785,aflibercept,gene,0.986,32077907
17786,patient,species,0.966,32077907
17787,aflibercept,gene,0.9575,32077907
17788,PARTICIPANTS,species,0.637,32077907
17789,Participants,species,0.788,32077907
17790,type 1 or 2 diabetes,disease,1.0,32077907
17791,CI-DME,disease,1.0,32077907
17792,aflibercept,gene,0.868,32077907
17793,aflibercept,gene,0.9688,32077907
17794,aflibercept,gene,0.9585,32077907
17795,aflibercept,gene,0.9663,32077907
17796,nonproliferative,disease,0.7456,32077907
17797,diabetic retinopathy,disease,0.906,32077907
17798,Diabetic Retinopathy,disease,1.0,32077907
17799,nonproliferative diabetic retinopathy,disease,0.9736,32077907
17800,retinopathy,disease,1.0,32077907
17801,participants,species,0.9614,32077907
17802,DME,drug,0.622,32077907
17803,aflibercept,gene,0.9004,32077907
17804,aflibercept,gene,0.894,32077907
17805,aflibercept,gene,0.979,32077907
17806,diabetic retinopathy,disease,1.0,32077907
17807,DME,disease,1.0,32077907
17808,VEGF,gene,0.993,32065066
17809,Pancreatic Tumor,disease,0.9985,32065066
17810,tumors,disease,1.0,32065066
17811,vascular endothelial growth factor,gene,0.998,32065066
17812,ectopic subcutaneous xenograft model,cell_line,0.6704,32065066
17813,pancreatic tumor,disease,1.0,32065066
17814,tumor,disease,0.998,32065066
17815,mice,species,0.9287,32065066
17816,tumor,disease,0.997,32065066
17817,Mice,species,0.9062,32065066
17818,sorafenib,drug,0.9995,32065066
17819,ziv-aflibercept,gene,0.9834,32065066
17820,Sorafenib,drug,0.999,32065066
17821,BAY 43-9006,drug,0.9995,32065066
17822,Nexavar,drug,0.9814,32065066
17823,Raf kinase,gene,0.9937,32065066
17824,receptor tyrosine kinases,gene,0.995,32065066
17825,tyrosine,drug,0.9893,32065066
17826,vascular endothelial growth factor receptors 2,gene,0.994,32065066
17827,Ziv-aflibercept,gene,0.9844,32065066
17828,ZALTRAP,gene,0.927,32065066
17829,vascular endothelial growth factor A,gene,0.999,32065066
17830,vascular endothelial growth factor B,gene,0.9985,32065066
17831,placental growth factor,gene,0.9966,32065066
17832,tumor,disease,0.9976,32065066
17833,aflibercept,gene,0.9824,32062727
17834,wt RAS,gene,0.917,32062727
17835,mCRC,disease,0.9507,32062727
17836,patients,species,0.9917,32062727
17837,aflibercept,gene,0.9785,32062727
17838,FOLFIRI,drug,0.971,32062727
17839,wt RAS,gene,0.96,32062727
17840,mCRC,disease,0.9053,32062727
17841,patients,species,0.9824,32062727
17842,EGFR,gene,0.603,32062727
17843,wt RAS,gene,0.9756,32062727
17844,mCRC,disease,0.998,32062727
17845,patients,species,0.9883,32062727
17846,aflibercept,gene,0.9927,32062727
17847,EGFR,gene,0.997,32062727
17848,patients,species,0.985,32062727
17849,tumor,disease,0.9126,32062727
17850,patients,species,0.9653,32062727
17851,patients,species,0.981,32062727
17852,wild,cell_line,0.6445,32062727
17853,wild-type RAS tumors,disease,0.9727,32062727
17854,patients,species,0.989,32062727
17855,BRAF mutations,gene,0.8613,32062727
17856,EGFR,gene,0.6797,32062727
17857,aflibercept,gene,0.9785,32062727
17858,patients,species,0.988,32062727
17859,FOLFIRI,drug,0.9717,32062727
17860,aflibercept,gene,0.978,32062727
17861,patients,species,0.983,32062727
17862,TAS-102,drug,0.9966,32062727
17863,regorafenib,drug,0.9727,32062727
17864,capecitabine,drug,0.9995,32062727
17865,patients,species,0.9873,32062727
17866,hypertension,disease,0.9614,32062727
17867,Aflibercept,gene,0.9497,32062727
17868,patients,species,0.9854,32062727
17869,patients,species,0.9653,32062727
17870,wt RAS,gene,0.886,32062727
17871,mCRC,disease,0.9985,32062727
17872,EGFR,gene,0.5405,32062727
17873,OS,disease,,32062727
17874,FOLFIRI,drug,0.653,32062727
17875,aflibercept,gene,0.9766,32062727
17876,anti-,gene,0.685,32062727
17877,EGFR,gene,0.765,32062727
17878,RAS,DNA,0.6577,32062727
17879,RAS wt,gene,0.987,32062727
17880,mCRC,disease,0.997,32062727
17881,ziv-aflibercept,gene,0.967,32060315
17882,Aflibercept,gene,0.991,32060315
17883,AFL,gene,0.9966,32060315
17884,Fc fusion protein,gene,0.993,32060315
17885,colorectal cancers,disease,1.0,32060315
17886,ophthalmological diseases,disease,1.0,32060315
17887,AFL,drug,0.9985,32060315
17888,Zaltrap,drug,0.9985,32060315
17889,Eylea,drug,0.9907,32060315
17890,ziv-AFL,drug,0.9927,32060315
17891,AFL,drug,0.99,32060315
17892,AFL,drug,0.997,32060315
17893,ziv-AFL,drug,0.9946,32060315
17894,ziv,gene,0.6953,32060315
17895,AFL,gene,0.777,32060315
17896,tryptophan,drug,0.992,32060315
17897,VEGF,gene,0.9937,32060315
17898,Bevacizumab,gene,0.892,32052341
17899,Aflibercept,gene,0.9688,32052341
17900,Metastatic Colorectal,disease,0.925,32052341
17901,Bevacizumab,gene,0.8564,32052341
17902,aflibercept,gene,0.9834,32052341
17903,metastatic colorectal carcinoma,disease,0.9995,32052341
17904,mCRC,disease,1.0,32052341
17905,patients,species,0.973,32052341
17906,RAS-mutated tumours,disease,0.993,32052341
17907,RAS,gene,0.9956,32052341
17908,patients,species,0.969,32052341
17909,mCRC,disease,0.9756,32052341
17910,bevacizumab,gene,0.9653,32052341
17911,aflibercept,gene,0.998,32052341
17912,PATIENTS,species,0.969,32052341
17913,mCRC,disease,0.96,32052341
17914,patients,species,0.9883,32052341
17915,bevacizumab,gene,0.921,32052341
17916,aflibercept,gene,0.9365,32052341
17917,patients,species,0.994,32052341
17918,RAS,gene,0.997,32052341
17919,tumours,disease,0.898,32052341
17920,bevacizumab,gene,0.904,32052341
17921,aflibercept,gene,0.966,32052341
17922,bevacizumab,gene,0.904,32052341
17923,aflibercept,gene,0.98,32052341
17924,aflibercept,gene,0.99,32052341
17925,bevacizumab,gene,0.8076,32052341
17926,bevacizumab,gene,0.829,32052341
17927,Patients,species,0.9805,32052341
17928,aflibercept,gene,0.966,32052341
17929,mCRC,disease,0.9873,32052341
17930,patients,species,0.981,32051764
17931,aflibercept,gene,0.9873,32051764
17932,ranibizumab,gene,0.907,32051764
17933,Patients,species,0.942,32051764
17934,patients,species,0.989,32051764
17935,aflibercept,gene,0.9795,32051764
17936,ranibizumab,gene,0.9053,32051764
17937,diabetic macular edema,disease,1.0,32051764
17938,DME,disease,1.0,32051764
17939,age-related macular degeneration,disease,0.9927,32051764
17940,AMD,disease,1.0,32051764
17941,macular edema,disease,1.0,32051764
17942,retinal vein occlusion,disease,1.0,32051764
17943,RVO,disease,1.0,32051764
17944,patients,species,0.984,32051764
17945,ranibizumab,gene,0.8994,32051764
17946,aflibercept,gene,0.995,32051764
17947,retinal nerve fibre,cell_type,0.4968,32051764
17948,AMD,disease,1.0,32051764
17949,vein occlusion,disease,0.9995,32051764
17950,ranibizumab,gene,0.7495,32051764
17951,bevacizumab,gene,0.7715,32051764
17952,ranibizumab,gene,0.909,32051764
17953,glaucoma,disease,1.0,32051764
17954,patient,species,0.9565,32051764
17955,patient,species,0.9546,32051764
17956,glaucomatous changes,disease,0.9844,32051764
17957,inflammation,disease,0.953,32049159
17958,panuveitis,disease,1.0,32049159
17959,aflibercept,gene,0.99,32049159
17960,bevacizumab,gene,0.833,32049159
17961,ranibizumab,gene,0.755,32049159
17962,inflammation,disease,0.6357,32049159
17963,silicone,drug,0.714,32049159
17964,vitreous opacities,disease,1.0,32049159
17965,inflammatory,disease,0.826,32049159
17966,inflammation,disease,0.896,32049159
17967,inflammation,disease,0.7666,32049159
17968,Aflibercept,gene,0.9634,32049159
17969,inflammation,disease,0.8975,32049159
17970,Aflibercept,gene,0.9795,32045141
17971,Ranibizumab,gene,0.8325,32045141
17972,Retinal Pigment Epithelial Cells,cell_type,0.8374,32045141
17973,Vascular Endothelial Cells,cell_type,0.838,32045141
17974,human RPE cells,cell_line,0.889,32045141
17975,ARPE-19,cell_line,0.9297,32045141
17976,human umbilical vascular endothelial cells,cell_type,0.877,32045141
17977,HUVEC,cell_type,0.8228,32045141
17978,VEGF,gene,0.9463,32045141
17979,NO,drug,0.9976,32045141
17980,RPE cells,cell_type,0.9116,32045141
17981,vascular endothelial cells,cell_type,0.7153,32045141
17982,co-culture HUVEC/RPE,cell_line,0.698,32045141
17983,Ranibizumab,gene,0.954,32045141
17984,Aflibercept,gene,0.9766,32045141
17985,NO,drug,0.9995,32045141
17986,NO synthase,gene,0.882,32045141
17987,NOS,gene,0.9004,32045141
17988,phosphatidylinositol,drug,0.9976,32045141
17989,phosphatidylinositol 3'-kinase,gene,0.994,32045141
17990,PI3K,gene,0.992,32045141
17991,extracellular-signal-regulated kinases 1/2,gene,0.9956,32045141
17992,ERK1/2,gene,0.99,32045141
17993,p38,DNA,0.4846,32045141
17994,p38 mitogen-activated protein kinase,gene,0.9956,32045141
17995,p38 MAPK,gene,0.877,32045141
17996,NO,drug,0.998,32045141
17997,GSH,drug,0.9966,32045141
17998,NOS isoforms,gene,0.97,32045141
17999,RPE cells,cell_type,0.8804,32045141
18000,HUVEC,cell_line,0.7236,32045141
18001,Aflibercept,gene,0.9966,32045141
18002,Ranibizumab,gene,0.9824,32045141
18003,NO,drug,0.996,32045141
18004,anti-VEGF,gene,0.7065,32045141
18005,Aflibercept,gene,0.9824,32045141
18006,Ranibizumab,gene,0.957,32045141
18007,NOS,gene,0.988,32045141
18008,PI3K,gene,0.988,32045141
18009,ERK1/2,gene,0.913,32045141
18010,Aflibercept,gene,0.987,32045141
18011,Ranibizumab,gene,0.967,32045141
18012,RPE cells,cell_type,0.902,32045141
18013,HUVEC,cell_line,0.9526,32045141
18014,Aflibercept,gene,0.9956,32045141
18015,Ranibizumab,gene,0.9766,32045141
18016,RPE cells,cell_type,0.8774,32045141
18017,aflibercept,gene,0.9854,32041720
18018,aflibercept,gene,0.976,32041720
18019,Eylea,gene,0.7954,32041720
18020,retinitis pigmentosa-associated cystoid macular oedema,disease,1.0,32041720
18021,RP-CMO,disease,1.0,32041720
18022,patients,species,0.9893,32041720
18023,patients,species,0.9663,32041720
18024,patient,species,0.9897,32041720
18025,participants,species,0.982,32041720
18026,patients,species,0.9277,32041720
18027,RP-CMO,disease,0.9995,32041720
18028,patients,species,0.988,32041720
18029,patients,species,0.994,32041720
18030,CMO,disease,0.9995,32041720
18031,anti-VEGF,gene,0.899,32041720
18032,patients,species,0.9775,32041720
18033,CMO,disease,0.9995,32041720
18034,VEGF,gene,0.9927,32041720
18035,RP-CMO,disease,0.956,32041720
18036,Ganglion Cell,cell_type,0.686,32037745
18037,Anti-vascular Endothelial Growth Factor,gene,0.991,32037745
18038,Age-related Macular Degeneration,disease,1.0,32037745
18039,anti-vascular endothelial growth factor,gene,0.98,32037745
18040,VEGF,gene,0.9966,32037745
18041,ganglion cell,cell_type,0.5835,32037745
18042,age-related macular degeneration,disease,1.0,32037745
18043,AMD,disease,1.0,32037745
18044,anti-VEGF,gene,0.7935,32037745
18045,anti-VEGF,gene,0.948,32037745
18046,anti-VEGF,gene,0.9497,32037745
18047,GCIPL,cell_type,0.4314,32037745
18048,GCIPL,cell_type,0.5386,32037745
18049,anti-VEGF,gene,0.9526,32037745
18050,AMD,disease,1.0,32037745
18051,Aflibercept,gene,0.85,32036821
18052,Diabetic Macular Edema,disease,1.0,32036821
18053,aflibercept,gene,0.9526,32036821
18054,diabetic macular edema,disease,1.0,32036821
18055,DME,disease,1.0,32036821
18056,aflibercept,gene,0.92,32036821
18057,DME,disease,1.0,32036821
18058,diffuse retinal thickening,disease,1.0,32036821
18059,DRT,disease,1.0,32036821
18060,cystoid macular edema,disease,1.0,32036821
18061,CME,disease,1.0,32036821
18062,serous retinal detachment,disease,1.0,32036821
18063,SRD,disease,1.0,32036821
18064,aflibercept,gene,0.9663,32036821
18065,Aflibercept,gene,0.7617,32036821
18066,DME,disease,1.0,32036821
18067,Bevacizumab,gene,0.8574,32029959
18068,eye diseases,disease,0.9805,32029959
18069,Vascular endothelial growth factor,gene,0.997,32029959
18070,VEGF,gene,0.9956,32029959
18071,ranibizumab,gene,0.701,32029959
18072,aflibercept,gene,0.946,32029959
18073,pegaptanib,drug,0.917,32029959
18074,eye diseases,disease,0.997,32029959
18075,Bevacizumab,gene,0.6387,32029959
18076,VEGF,gene,0.9976,32029959
18077,cancer,disease,1.0,32029959
18078,eye diseases,disease,0.988,32029959
18079,bevacizumab,gene,0.862,32029959
18080,ranibizumab,gene,0.7373,32029959
18081,bevacizumab,gene,0.87,32029959
18082,bevacizumab,gene,0.7744,32029959
18083,ranibizumab,gene,0.7354,32029959
18084,bevacizumab,gene,0.849,32029959
18085,bevacizumab,gene,0.9165,32029959
18086,eye diseases,disease,0.9946,32029959
18087,proteinuria,disease,0.999,32029849
18088,cancer,disease,1.0,32029849
18089,patients,species,0.991,32029849
18090,proteinuria,disease,0.9995,32029849
18091,proteinuria,disease,0.9985,32029849
18092,proteinuria,disease,0.9995,32029849
18093,cancer,disease,1.0,32029849
18094,patients,species,0.9883,32029849
18095,cancer,disease,1.0,32029849
18096,patients,species,0.988,32029849
18097,bevacizumab,gene,0.8,32029849
18098,aflibercept,gene,0.9575,32029849
18099,proteinuria,disease,1.0,32029849
18100,patients,species,0.992,32029849
18101,proteinuria,disease,1.0,32029849
18102,proteinuria,disease,0.9995,32029849
18103,calcium,drug,0.9985,32029849
18104,cancer,disease,1.0,32029849
18105,proteinuria,disease,1.0,32029849
18106,calcium,drug,0.989,32029849
18107,proteinuria,disease,0.9775,32029849
18108,cancer,disease,1.0,32029849
18109,vascular endothelial growth factor,gene,0.997,32027392
18110,neovascular glaucoma,disease,1.0,32027392
18111,Neovascular glaucoma,disease,1.0,32027392
18112,NVG,disease,1.0,32027392
18113,glaucoma,disease,0.9985,32027392
18114,vascular endothelial growth factor,gene,0.9717,32027392
18115,VEGF,gene,0.5166,32027392
18116,VEGF,gene,0.567,32027392
18117,NVG,disease,1.0,32027392
18118,VEGF,gene,0.8335,32027392
18119,NVG,disease,1.0,32027392
18120,VEGF,gene,0.629,32027392
18121,NVG,disease,0.9995,32027392
18122,Ahmed,DNA,0.4897,32027392
18123,Ahmed,DNA,0.4995,32027392
18124,VEGF,gene,0.501,32027392
18125,PRP,cell_type,0.4683,32027392
18126,ranibizumab,gene,0.649,32027392
18127,VEGF,gene,0.876,32027392
18128,VEGF,gene,0.8633,32027392
18129,VEGF,gene,0.8623,32027392
18130,VEGF,gene,0.75,32027392
18131,VEGF,gene,0.855,32027392
18132,VEGF,gene,0.852,32027392
18133,anterior chamber bleeding,disease,0.971,32027392
18134,conjunctival hemorrhage,disease,1.0,32027392
18135,retinal detachment,disease,1.0,32027392
18136,phthisis bulbi,disease,1.0,32027392
18137,VEGF,gene,0.8926,32027392
18138,ranibizumab,gene,0.6978,32027392
18139,bevacizumab,gene,0.6914,32027392
18140,aflibercept,gene,0.962,32027392
18141,NVG,disease,1.0,32027392
18142,Brolucizumab,gene,0.775,32022789
18143,age-related macular degeneration,disease,1.0,32022789
18144,Ranibizumab,gene,0.927,32020843
18145,Aflibercept,gene,0.974,32020843
18146,Neovascular Age-Related Macular Degeneration,disease,1.0,32020843
18147,Diabetic Macular Edema,disease,1.0,32020843
18148,Ranibizumab,gene,0.7964,32020843
18149,aflibercept,gene,0.9395,32020843
18150,neovascular age-related macular degeneration,disease,1.0,32020843
18151,nAMD,disease,1.0,32020843
18152,diabetic macular edema,disease,1.0,32020843
18153,DME,disease,1.0,32020843
18154,ranibizumab,gene,0.7285,32020843
18155,aflibercept,gene,0.97,32020843
18156,nAMD,disease,1.0,32020843
18157,DME,disease,1.0,32020843
18158,nAMD,disease,1.0,32020843
18159,ranibizumab,gene,0.9487,32020843
18160,aflibercept,gene,0.9663,32020843
18161,DME,disease,1.0,32020843
18162,ranibizumab,gene,0.909,32020843
18163,aflibercept,gene,0.94,32020843
18164,aflibercept,gene,0.9805,32020843
18165,ranibizumab,gene,0.5957,32020843
18166,ranibizumab,gene,0.8,32020843
18167,aflibercept,gene,0.9736,32020843
18168,nAMD,disease,1.0,32020843
18169,DME,disease,1.0,32020843
18170,nAMD,disease,1.0,32020843
18171,aflibercept,gene,0.9478,32020843
18172,nAMD,disease,1.0,32020843
18173,ranibizumab,gene,0.8916,32020843
18174,aflibercept,gene,0.9834,32020843
18175,DME,disease,1.0,32020843
18176,ranibizumab,gene,0.8604,32020843
18177,aflibercept,gene,0.9473,32020843
18178,DME,disease,1.0,32020843
18179,ranibizumab,gene,0.7773,32020843
18180,aflibercept,gene,0.7705,32020843
18181,ranibizumab,gene,0.8823,32020843
18182,aflibercept,gene,0.975,32020843
18183,nAMD,disease,1.0,32020843
18184,DME,disease,1.0,32020843
18185,Fortress,DNA,0.456,32020843
18186,endophthalmitis,disease,1.0,32019339
18187,endophthalmitis,disease,1.0,32019339
18188,patients,species,0.9907,32019339
18189,ranibizumab,gene,0.85,32019339
18190,bevacizumab,gene,0.769,32019339
18191,aflibercept,gene,0.9746,32019339
18192,retinal vascular diseases,disease,1.0,32019339
18193,patients,species,0.994,32019339
18194,Endophthalmitis,disease,1.0,32019339
18195,endophthalmitis,disease,0.8906,32019339
18196,endophthalmitis,disease,1.0,32019339
18197,endophthalmitis,disease,1.0,32019339
18198,endophthalmitis,disease,1.0,32019339
18199,endophthalmitis,disease,1.0,32019339
18200,Aflibercept,gene,0.981,32016788
18201,aflibercept,gene,0.99,32016788
18202,AFL,gene,0.994,32016788
18203,patients,species,0.965,32016788
18204,exudative age-related macular degeneration,disease,1.0,32016788
18205,AMD,disease,1.0,32016788
18206,exudative AMD,disease,1.0,32016788
18207,Diabetic Retinopathy,disease,1.0,32016788
18208,Patients,species,0.9775,32016788
18209,IVT,drug,0.9507,32016788
18210,AFL,drug,0.7725,32016788
18211,patients,species,0.9463,32016788
18212,patients,species,0.978,32016788
18213,IVT-AFL,drug,0.9185,32016788
18214,exudative AMD,disease,0.978,32016788
18215,aflibercept,gene,0.9688,32016666
18216,pachychoroid neovasculopathy,disease,1.0,32016666
18217,polypoidal lesions,disease,1.0,32016666
18218,aflibercept,gene,0.979,32016666
18219,pachychoroid neovasculopathy,disease,0.91,32016666
18220,PNV,disease,1.0,32016666
18221,polypoidal lesions,disease,1.0,32016666
18222,PATIENTS,species,0.9683,32016666
18223,PNV,disease,1.0,32016666
18224,pachyvessel,DNA,0.5415,32016666
18225,choroidal neovascularization,disease,0.93,32016666
18226,pachyvessel,cell_type,0.5576,32016666
18227,pachyvessel,DNA,0.664,32016666
18228,CNV,disease,0.5356,32016666
18229,aflibercept,gene,0.9814,32016666
18230,PNV,disease,1.0,32016666
18231,polypoidal lesions,disease,1.0,32016666
18232,anti-vascular endothelial growth factor,gene,0.959,32009630
18233,Age-related macular degeneration,disease,1.0,32009630
18234,AMD,disease,1.0,32009630
18235,visual loss,disease,0.988,32009630
18236,people,species,0.9604,32009630
18237,vascular endothelial growth factor,gene,0.9673,32009630
18238,VEGF,gene,0.9966,32009630
18239,exudative AMD,disease,0.9995,32009630
18240,tachyphylaxis,disease,0.603,32009630
18241,VEGF,gene,0.953,32009630
18242,patients,species,0.9014,32009630
18243,exudative AMD,disease,0.999,32009630
18244,AMD,disease,0.9995,32009630
18245,patients,species,0.992,32009630
18246,ranibizumab,gene,0.924,32009630
18247,aflibercept,gene,0.9775,32009630
18248,participants,species,0.9756,32009630
18249,Exudative AMD,disease,0.9995,32009630
18250,VEGF,gene,0.994,32009630
18251,patients,species,0.977,32009630
18252,tachyphylaxis,disease,0.993,32009630
18253,aflibercept,gene,0.9604,32009630
18254,serous pigment epithelium detachment,disease,1.0,32009630
18255,sPED,disease,1.0,32009630
18256,aflibercept,gene,0.9795,32009630
18257,ranibizumab,gene,0.819,32009630
18258,CRT,DNA,0.4648,32009630
18259,aflibercept,gene,0.9795,32009630
18260,VEGF,gene,0.92,32009630
18261,exudative AMD,disease,0.999,32009630
18262,patients,species,0.99,32009630
18263,AMD,disease,1.0,32009630
18264,patients,species,0.993,32009630
18265,VEGF,gene,0.9937,32009630
18266,Ranibizumab,gene,0.885,32009462
18267,aflibercept,gene,0.9634,32009462
18268,Branch retinal vein occlusion,disease,1.0,32009462
18269,macular oedema,disease,1.0,32009462
18270,vascular endothelial growth factor,gene,0.996,32009462
18271,vascular endothelial growth factor,gene,0.8564,32009462
18272,patients,species,0.9834,32009462
18273,ranibizumab,gene,0.7954,32009462
18274,aflibercept,gene,0.9053,32009462
18275,macular oedema,disease,1.0,32009462
18276,ranibizumab,gene,0.6997,32009462
18277,aflibercept,gene,0.972,32009462
18278,ranibizumab,gene,0.847,32009462
18279,aflibercept,gene,0.9766,32009462
18280,Diabetic Retinopathy,disease,1.0,32009462
18281,macular oedema,disease,1.0,32009462
18282,ranibizumab,gene,0.5283,32009462
18283,aflibercept,gene,0.938,32009462
18284,macular oedema,disease,1.0,32009462
18285,ranibizumab,gene,0.8706,32009462
18286,aflibercept,gene,0.923,32009462
18287,vascular endothelial growth factor,gene,0.9883,32009462
18288,ranibizumab,gene,0.7603,32009462
18289,aflibercept,gene,0.9805,32009462
18290,aflibercept,gene,0.984,32009462
18291,Aflibercept,gene,0.9746,32005079
18292,Diabetic Macular Edema,disease,1.0,32005079
18293,Aflibercept,gene,0.9517,32005079
18294,diabetic macular edema,disease,1.0,32005079
18295,DME,disease,1.0,32005079
18296,aflibercept,gene,0.9927,32005079
18297,DME,disease,1.0,32005079
18298,bevacizumab,gene,0.808,32005079
18299,bevacizumab,gene,0.8765,32005079
18300,ranibizumab,gene,0.852,32005079
18301,aflibercept,gene,0.9775,32005079
18302,DME,disease,1.0,32005079
18303,aflibercept,gene,0.9062,32005079
18304,bevacizumab,gene,0.8823,32005079
18305,ranibizumab,gene,0.7285,32005079
18306,aflibercept,gene,0.9272,32005079
18307,patients,species,0.984,32005079
18308,DME,disease,1.0,32005079
18309,TAS-102,drug,0.98,31999946
18310,bevacizumab,gene,0.6826,31999946
18311,metastatic colorectal cancer,disease,0.999,31999946
18312,TAS-102,drug,0.995,31999946
18313,trifluridine,drug,0.9995,31999946
18314,tipiracil,drug,0.998,31999946
18315,metastatic colorectal cancer,disease,0.997,31999946
18316,TAS-102,drug,0.9956,31999946
18317,bevacizumab,gene,0.8423,31999946
18318,metastatic colorectal cancer,disease,1.0,31999946
18319,TAS-102,drug,0.997,31999946
18320,bevacizumab,gene,0.882,31999946
18321,TAS-102,drug,0.9966,31999946
18322,metastatic colorectal cancer,disease,1.0,31999946
18323,metastatic colorectal,disease,1.0,31999946
18324,cancer,disease,1.0,31999946
18325,metastatic colorectal cancer,disease,1.0,31999946
18326,fluoropyrimidine,drug,0.9995,31999946
18327,irinotecan,drug,0.9995,31999946
18328,oxaliplatin,drug,0.9995,31999946
18329,cetuximab,gene,0.512,31999946
18330,panitumumab,gene,0.6763,31999946
18331,RAS,gene,0.495,31999946
18332,bevacizumab,gene,0.8438,31999946
18333,aflibercept,gene,0.969,31999946
18334,regorafenib,drug,0.9707,31999946
18335,TAS-102,drug,0.998,31999946
18336,bevacizumab,gene,0.712,31999946
18337,RAS,DNA,0.684,31999946
18338,RAS mutation,gene,0.9727,31999946
18339,TAS-102,drug,0.9897,31999946
18340,TAS-102,drug,0.983,31999946
18341,bevacizumab,gene,0.7017,31999946
18342,TAS-102,drug,0.987,31999946
18343,TAS-102,drug,0.9844,31999946
18344,bevacizumab,gene,0.853,31999946
18345,neutropenia,disease,1.0,31999946
18346,TAS-102,drug,0.993,31999946
18347,TAS-102,drug,0.9897,31999946
18348,bevacizumab,gene,0.8687,31999946
18349,TAS-102,drug,0.9536,31999946
18350,TAS-102,drug,0.9336,31999946
18351,bevacizumab,gene,0.9146,31999946
18352,metastatic colorectal cancer,disease,0.999,31999946
18353,TAS-102,drug,0.9966,31999946
18354,bevacizumab,gene,0.751,31999946
18355,TAS-102,drug,0.996,31999946
18356,TAS-102,drug,0.998,31999946
18357,bevacizumab,gene,0.871,31999946
18358,metastatic colorectal cancer,disease,1.0,31999946
18359,long noncoding RNAs,RNA,0.805,31999937
18360,H19,gene,0.841,31999937
18361,GAS5,gene,0.7666,31999937
18362,type 2 diabetes,disease,1.0,31999937
18363,diabetic retinopathy,disease,1.0,31999937
18364,long noncoding RNAs,RNA,0.7646,31999937
18365,lncRNAs,RNA,0.6675,31999937
18366,lncRNAs,RNA,0.65,31999937
18367,H19,gene,0.8394,31999937
18368,GAS5,gene,0.8184,31999937
18369,type 2 diabetes mellitus,disease,1.0,31999937
18370,T2DM,disease,1.0,31999937
18371,diabetic retinopathy,disease,1.0,31999937
18372,DR,disease,1.0,31999937
18373,H19,gene,0.6133,31999937
18374,GAS5,DNA,0.5645,31999937
18375,GAS5 lncRNAs,gene,0.9937,31999937
18376,T2DM,disease,1.0,31999937
18377,H19,gene,0.59,31999937
18378,GAS5,gene,0.4973,31999937
18379,aflibercept,gene,0.9775,31999937
18380,Plasma lncRNA,RNA,0.658,31999937
18381,T2DM,disease,1.0,31999937
18382,lncRNA,RNA,0.6025,31999937
18383,aflibercept,gene,0.87,31999937
18384,DR,disease,0.9966,31999937
18385,H19,gene,0.922,31999937
18386,T2DM,disease,1.0,31999937
18387,GAS5,gene,0.6987,31999937
18388,T2DM,disease,1.0,31999937
18389,H19,gene,0.922,31999937
18390,GAS5,gene,0.798,31999937
18391,DR,cell_type,0.4717,31999937
18392,DR,gene,0.4753,31999937
18393,H19,gene,0.915,31999937
18394,GAS5,gene,0.833,31999937
18395,aflibercept,gene,0.93,31999937
18396,lncRNAs,RNA,0.4553,31999937
18397,H19,gene,0.851,31999937
18398,GAS5,gene,0.763,31999937
18399,T2DM,disease,1.0,31999937
18400,aflibercept,gene,0.9766,31999937
18401,DR,disease,0.998,31999937
18402,lncRNA,RNA,0.538,31999937
18403,T2DM,disease,1.0,31999937
18404,TYPE 1,disease,0.9976,31996587
18405,RETINOPATHY OF PREMATURITY,disease,0.9536,31996587
18406,Type 1 retinopathy of prematurity,disease,1.0,31996587
18407,aflibercept,gene,0.9766,31996587
18408,Type 1 retinopathy of prematurity,disease,1.0,31996587
18409,retinopathy of prematurity,disease,1.0,31996587
18410,pulmonary infection,disease,1.0,31996587
18411,Aflibercept,gene,0.799,31996587
18412,Type 1 retinopathy of prematurity,disease,1.0,31996587
18413,retinopathy of prematurity,disease,1.0,31995115
18414,VEGF,gene,0.596,31995115
18415,aflibercept,gene,0.9907,31995115
18416,aflibercept,gene,0.9844,31995115
18417,retinopathy of prematurity,disease,0.8843,31995115
18418,ROP,disease,0.9995,31995115
18419,aflibercept,gene,0.976,31995115
18420,IVA,disease,0.722,31995115
18421,diastolic dysfunction,disease,1.0,31995115
18422,LPC,disease,0.9854,31995115
18423,IVA,disease,0.997,31995115
18424,vascular endothelial growth factor,gene,0.9766,31995115
18425,ROP,disease,0.9507,31995115
18426,right,DNA,0.481,31995115
18427,Galectin-1,gene,0.992,31991407
18428,Aflibercept,gene,0.7637,31991407
18429,Neuroendocrine,cell_type,0.4639,31991407
18430,Neuroendocrine Carcinomas,disease,1.0,31991407
18431,Galectin-1,gene,0.9736,31991407
18432,Gal-1,gene,0.995,31991407
18433,cancer,disease,1.0,31991407
18434,tumor,disease,1.0,31991407
18435,anticancer,disease,0.5933,31991407
18436,aflibercept,gene,0.972,31991407
18437,Gal-1,gene,0.99,31991407
18438,aflibercept,gene,0.9893,31991407
18439,Gal-1,gene,0.9893,31991407
18440,neuroendocrine carcinomas,disease,1.0,31991407
18441,NECs,disease,1.0,31991407
18442,NEC,cell_line,0.4778,31991407
18443,NEC tumor,disease,0.9966,31991407
18444,xenografts,cell_line,0.4802,31991407
18445,aflibercept,gene,0.811,31991407
18446,Gal-1,gene,0.9927,31991407
18447,Aflibercept,gene,0.9756,31991407
18448,Gal-1,gene,0.9937,31991407
18449,lung NEC,cell_line,0.764,31991407
18450,colon NECs,cell_type,0.834,31991407
18451,Gal-1,gene,0.983,31991407
18452,aflibercept,gene,0.959,31991407
18453,p-VEGFR2 protein,gene,0.9624,31991407
18454,cancer-associated fibroblast,cell_type,0.6934,31991407
18455,cancer,disease,0.4812,31991407
18456,lung NEC,cell_line,0.7295,31991407
18457,colon NEC,cell_line,0.713,31991407
18458,Gal-1,gene,0.991,31991407
18459,human NECs,cell_line,0.6616,31991407
18460,pulmonary and pancreatic tumors,disease,1.0,31991407
18461,Gal-1,gene,0.9946,31991407
18462,colon NECs,cell_type,0.7876,31991407
18463,aflibercept,gene,0.964,31991407
18464,aflibercept,gene,0.9756,31991407
18465,aflibercept,gene,0.9287,31991407
18466,Gal-1,gene,0.978,31991407
18467,tumors,disease,1.0,31991407
18468,Gal-1,gene,0.9946,31991407
18469,aflibercept,gene,0.911,31991407
18470,Gal-1,gene,0.9937,31991407
18471,tumor,disease,0.639,31991407
18472,stroma,cell_type,0.447,31991407
18473,aflibercept,gene,0.964,31991407
18474,tumors,disease,1.0,31991407
18475,Gal-1,gene,0.9937,31991407
18476,NECs,cell_line,0.8647,31991407
18477,tumors,disease,1.0,31991407
18478,Aflibercept,gene,0.9365,31990746
18479,Macular Edema,disease,1.0,31990746
18480,bevacizumab,gene,0.622,31990746
18481,aflibercept,gene,0.9883,31990746
18482,cystoid macular edema,disease,1.0,31990746
18483,retinal vein occlusion,disease,1.0,31990746
18484,RVO,disease,1.0,31990746
18485,RVO,disease,1.0,31990746
18486,aflibercept,gene,0.796,31990746
18487,macular edema,disease,1.0,31990746
18488,bevacizumab,gene,0.851,31990746
18489,ranibizumab,gene,0.587,31990746
18490,diabetic retinopathy,disease,1.0,31990746
18491,patients,species,0.978,31990746
18492,RVO,disease,0.86,31990746
18493,anti-vascular endothelial growth factor,gene,0.981,31990746
18494,VEGF,gene,0.9985,31990746
18495,aflibercept,gene,0.964,31990746
18496,cystoid macular edema,disease,1.0,31990746
18497,CME,disease,1.0,31990746
18498,RVO,disease,1.0,31990746
18499,Diabetic Macular Edema,disease,1.0,31982388
18500,VEGF,gene,0.746,31980748
18501,neovascular age-related macular degeneration,disease,1.0,31980748
18502,AMD,disease,1.0,31980748
18503,patients,species,0.982,31980748
18504,Neovascular AMD,disease,1.0,31980748
18505,patients,species,0.9873,31980748
18506,anti-VEGF,gene,0.918,31980748
18507,patients,species,0.9907,31980748
18508,neovascular AMD,disease,1.0,31980748
18509,Early,disease,0.9453,31980748
18510,Diabetic Retinopathy,disease,0.851,31980748
18511,fluorescein,drug,0.9453,31980748
18512,physicians,cell_type,0.4365,31980748
18513,VEGF,gene,0.619,31980748
18514,ETDRS,cell_type,0.5674,31980748
18515,ranibizumab,gene,0.928,31980748
18516,aflibercept,gene,0.947,31980748
18517,patients,species,0.892,31980748
18518,atrophy,disease,0.693,31980748
18519,macular atrophy,disease,1.0,31980748
18520,atrophy,disease,0.969,31980748
18521,fovea-involving atrophy,disease,1.0,31980748
18522,atrophy,disease,0.991,31980748
18523,patients,species,0.891,31980748
18524,neovascular AMD,disease,1.0,31980748
18525,visual decline,disease,0.868,31980748
18526,macular atrophy,disease,1.0,31980748
18527,Pazopanib,drug,0.9985,31976338
18528,Choroidal Vascular Endothelial Cell,cell_type,0.857,31976338
18529,Exudative age related macular degeneration,disease,0.9297,31976338
18530,AMD,disease,1.0,31976338
18531,choroidal neovascularization,disease,1.0,31976338
18532,CNV,disease,1.0,31976338
18533,disciform,disease,0.73,31976338
18534,Vascular endothelial growth factor,gene,0.9985,31976338
18535,VEGF,gene,0.997,31976338
18536,choroidal vascular endothelial cell,cell_type,0.909,31976338
18537,CVECs,cell_type,0.787,31976338
18538,CNV,disease,1.0,31976338
18539,bevacizumab,gene,0.658,31976338
18540,ranibizumab,gene,0.7993,31976338
18541,aflibercept,gene,0.915,31976338
18542,anti-VEGF monoclonal antibodies,gene,0.969,31976338
18543,exudative AMD,disease,0.9985,31976338
18544,Pazopanib,drug,0.9985,31976338
18545,tyrosine,drug,0.959,31976338
18546,tyrosine kinase,gene,0.965,31976338
18547,tyrosine,drug,0.9053,31976338
18548,tyrosine kinase,gene,0.918,31976338
18549,VEGF receptor,gene,0.9785,31976338
18550,platelet-derived growth factor receptor,gene,0.998,31976338
18551,pazopanib,drug,0.996,31976338
18552,VEGF-enriched CVECs,cell_line,0.7773,31976338
18553,VEGF,gene,0.691,31976338
18554,-enriched CVECs,cell_type,0.5,31976338
18555,VEGF,gene,0.466,31976338
18556,CVECs,cell_line,0.6914,31976338
18557,pazopanib,drug,0.9966,31976338
18558,trypan blue,drug,0.997,31976338
18559,oxygen,drug,1.0,31976338
18560,caspase 3,gene,0.9644,31976338
18561,VEGF enriched CVECs,cell_line,0.696,31976338
18562,VEGF,gene,0.5493,31976338
18563,CVECs,cell_type,0.545,31976338
18564,pazopanib,drug,0.997,31976338
18565,trypan blue,drug,0.998,31976338
18566,pazopanib,drug,0.998,31976338
18567,VEGF-enriched CVECs,cell_line,0.8145,31976338
18568,VEGF,gene,0.6426,31976338
18569,caspase 3,gene,0.9404,31976338
18570,VEGF-enriched CVECs,cell_line,0.8145,31976338
18571,VEGF,gene,0.676,31976338
18572,-enriched CVECs,cell_type,0.467,31976338
18573,pazopanib,drug,0.9966,31976338
18574,caspase 3,gene,0.9873,31976338
18575,Aflibercept,gene,0.9478,31972042
18576,Retinopathy of Prematurity,disease,1.0,31972042
18577,aflibercept,gene,0.975,31972042
18578,retinopathy of prematurity,disease,1.0,31972042
18579,ROP,disease,1.0,31972042
18580,type 1 ROP,disease,0.999,31972042
18581,aggressive posterior ROP,disease,0.9976,31972042
18582,APROP,disease,0.9995,31972042
18583,aflibercept,gene,0.9746,31972042
18584,rubeosis,disease,1.0,31972042
18585,ROP,disease,0.995,31972042
18586,aflibercept,gene,0.979,31972042
18587,aflibercept,gene,0.944,31972042
18588,ROP,disease,0.9307,31972042
18589,aflibercept,gene,0.9795,31972042
18590,ROP,disease,0.763,31972042
18591,APROP,disease,0.9995,31972042
18592,aflibercept,gene,0.987,31972042
18593,aflibercept,gene,0.985,31972042
18594,aflibercept,gene,0.954,31972042
18595,ROP,disease,0.4775,31972042
18596,diabetic macular edema,disease,1.0,31957495
18597,Diabetic macular edema,disease,1.0,31957495
18598,DME,disease,1.0,31957495
18599,blindness,disease,0.9995,31957495
18600,DME,drug,0.9546,31957495
18601,vascular endothelial growth factor,gene,0.9976,31957495
18602,VEGF,gene,0.9927,31957495
18603,VEGF,gene,0.9795,31957495
18604,steroids,drug,0.9985,31957495
18605,VEGF,gene,0.991,31957495
18606,DME,disease,1.0,31957495
18607,DME,disease,1.0,31957495
18608,diabetic macular edema,disease,1.0,31957495
18609,VEGF,gene,0.9956,31957495
18610,DME,disease,1.0,31957495
18611,neovascular age-related macular degeneration,disease,0.999,31956577
18612,anti-vascular endothelial growth factor,gene,0.9766,31956577
18613,anti-VEGF,gene,0.955,31956577
18614,neovascular age-related macular degeneration,disease,1.0,31956577
18615,nAMD,disease,1.0,31956577
18616,nAMD,disease,1.0,31956577
18617,aflibercept,gene,0.9927,31956577
18618,ranibizumab,drug,0.788,31956577
18619,ranibizumab,gene,0.8276,31956577
18620,aflibercept,gene,0.9746,31956577
18621,nAMD,disease,1.0,31956577
18622,ziv-aflibercept,gene,0.985,31956432
18623,diabetic vitreous hemorrhage,disease,1.0,31956432
18624,ziv-aflibercept,gene,0.992,31956432
18625,vitreous hemorrhage,disease,1.0,31956432
18626,VH,disease,1.0,31956432
18627,proliferative diabetic retinopathy,disease,0.9995,31956432
18628,PDR,disease,1.0,31956432
18629,VH,disease,,31956432
18630,PDR,disease,0.9995,31956432
18631,ziv-aflibercept,gene,0.981,31956432
18632,aflibercept,gene,0.9116,31956432
18633,patients,species,0.989,31956432
18634,patients,species,0.972,31956432
18635,patients,species,0.984,31956432
18636,diabetes mellitus,disease,1.0,31956432
18637,EDTRS,DNA,0.553,31956432
18638,VH,disease,,31956432
18639,IVZ,drug,0.887,31956432
18640,VH,disease,,31956432
18641,PDR,disease,0.992,31956432
18642,Age-Related Macular Degeneration,disease,1.0,31954711
18643,neovascular age-related macular degeneration,disease,0.9995,31954711
18644,aflibercept,gene,0.938,31954711
18645,type 1 NV,disease,0.9463,31954711
18646,open,DNA,0.4885,31954711
18647,NV,cell_type,0.5205,31954711
18648,exudative age-related macular degeneration,disease,0.998,31954711
18649,NV,disease,0.99,31954711
18650,Diabetic Macular Edema,disease,1.0,31951761
18651,Aflibercept,gene,0.937,31951761
18652,diabetic macular edema,disease,1.0,31951761
18653,DME,disease,1.0,31951761
18654,aflibercept,gene,0.981,31951761
18655,DME,disease,1.0,31951761
18656,aflibercept,gene,0.9697,31951761
18657,DCP,DNA,0.4846,31951761
18658,DCP,DNA,0.5576,31951761
18659,DCP,cell_line,0.52,31951761
18660,Parafoveal VD,disease,0.98,31951761
18661,DCP ischemia,disease,0.9785,31951761
18662,aflibercept,gene,0.9204,31951761
18663,retinal vein thromboses,disease,0.9985,31943800
18664,aflibercept,gene,0.975,31943800
18665,age-related macular degeneration,disease,1.0,31943800
18666,antivascular endothelial growth factors,gene,0.874,31942430
18667,neovascular age-related macular degeneration,disease,1.0,31942430
18668,neovascular age-related macular degeneration,disease,1.0,31942430
18669,nAMD,disease,1.0,31942430
18670,VEGF,gene,0.996,31942430
18671,nAMD,disease,1.0,31942430
18672,anti-VEGF,gene,0.95,31942430
18673,bevacizumab,gene,0.7876,31942430
18674,ranibizumab,gene,0.601,31942430
18675,aflibercept,gene,0.981,31942430
18676,IVIs,disease,0.579,31942430
18677,BCVA,cell_type,0.4058,31942430
18678,aflibercept,gene,0.942,31942430
18679,nAMD,disease,1.0,31942430
18680,diabetic macular edema,disease,1.0,31942427
18681,Diabetic macular edema,disease,1.0,31942427
18682,DME,disease,1.0,31942427
18683,visual loss,disease,0.999,31942427
18684,diabetic,disease,1.0,31942427
18685,DME,disease,1.0,31942427
18686,vascular endothelial growth factor,gene,0.9946,31942427
18687,VEGF,gene,0.997,31942427
18688,VEGF,gene,0.7744,31942427
18689,DME,disease,1.0,31942427
18690,DME,drug,0.673,31942427
18691,vitreomacular traction,disease,1.0,31942427
18692,DME,disease,1.0,31942427
18693,Vascular endothelial growth factor,gene,0.9956,31942426
18694,diabetic retinopathy,disease,1.0,31942426
18695,proliferative diabetic retinopathy,disease,0.983,31942426
18696,PDR,disease,1.0,31942426
18697,blindness,disease,0.992,31942426
18698,diabetic,disease,1.0,31942426
18699,diabetic retinopathy,disease,1.0,31942426
18700,PDR,disease,1.0,31942426
18701,PRP,cell_type,0.4934,31942426
18702,PDR,disease,0.9995,31942426
18703,vascular endothelial growth factor,gene,0.9976,31942426
18704,VEGF,gene,0.9946,31942426
18705,diabetic macular edema,disease,1.0,31942426
18706,DME,disease,1.0,31942426
18707,VEGF,gene,0.878,31942426
18708,DME,disease,1.0,31942426
18709,diabetic retinopathy,disease,1.0,31942426
18710,ranibizumab,gene,0.5815,31942426
18711,PRP,cell_type,0.5303,31942426
18712,aflibercept,gene,0.9697,31942426
18713,PRP,cell_type,0.519,31942426
18714,VEGF,gene,0.9956,31942426
18715,intraocular neovascularization,disease,0.908,31942426
18716,PDR,disease,1.0,31942426
18717,VEGF,gene,0.911,31942426
18718,irreversible blindness,disease,0.9766,31942426
18719,PRP,cell_type,0.7476,31942426
18720,VEGF,gene,0.948,31942426
18721,PDR,disease,0.9995,31942426
18722,Choroidal,disease,0.7744,31935304
18723,Choroidal Neovascular Membrane,disease,1.0,31935304
18724,focal choroidal excavation,disease,1.0,31935304
18725,FCE,disease,0.9995,31935304
18726,choroidal neovascular membrane,disease,1.0,31935304
18727,CNVM,disease,1.0,31935304
18728,type 2 CNVM,disease,1.0,31935304
18729,aflibercept,gene,0.974,31935304
18730,FCE,disease,1.0,31935304
18731,pachychoroid,disease,1.0,31935304
18732,CNVM,disease,0.9966,31935304
18733,aflibercept,gene,0.9556,31935304
18734,Aflibercept,gene,0.8975,31933288
18735,aflibercept,gene,0.984,31933288
18736,aflibercept,gene,0.9907,31933288
18737,aflibercept,gene,0.9697,31933288
18738,aflibercept,gene,0.9727,31933288
18739,physicians,cell_type,0.5337,31933288
18740,aflibercept,gene,0.982,31933288
18741,aflibercept,gene,0.9697,31933288
18742,aflibercept,gene,0.9775,31933288
18743,aflibercept,gene,0.9785,31933288
18744,aflibercept,gene,0.9766,31933288
18745,physicians,cell_type,0.447,31933288
18746,Aflibercept,gene,0.9404,31933286
18747,aflibercept,gene,0.9673,31933286
18748,aflibercept,gene,0.9756,31933286
18749,aflibercept,gene,0.9746,31933286
18750,aflibercept,gene,0.982,31933286
18751,aflibercept,gene,0.994,31933286
18752,aflibercept,gene,0.9785,31933286
18753,neovascular (wet) age-related macular degeneration,disease,1.0,31933286
18754,aflibercept,gene,0.9644,31933286
18755,aflibercept,gene,0.988,31933286
18756,aflibercept,gene,0.9595,31933286
18757,Ranibizumab,gene,0.86,31932092
18758,Aflibercept,gene,0.943,31932092
18759,Diabetic Macular Edema,disease,1.0,31932092
18760,Retinal Blindness,disease,0.9995,31932092
18761,ranibizumab,gene,0.807,31932092
18762,aflibercept,gene,0.944,31932092
18763,diabetic macular edema,disease,1.0,31932092
18764,DME,disease,1.0,31932092
18765,Retinal Blindness,disease,0.9995,31932092
18766,PARTICIPANTS,species,0.855,31932092
18767,ranibizumab,gene,0.741,31932092
18768,aflibercept,gene,0.962,31932092
18769,DME,disease,1.0,31932092
18770,ranibizumab,drug,0.956,31932092
18771,aflibercept,gene,0.9844,31932092
18772,aflibercept,gene,0.9756,31932092
18773,ranibizumab,gene,0.7593,31932092
18774,ranibizumab,gene,0.7637,31932092
18775,aflibercept,gene,0.9126,31932092
18776,aflibercept,gene,0.9907,31932092
18777,ranibizumab,gene,0.644,31932092
18778,ranibizumab,gene,0.5947,31932092
18779,aflibercept,gene,0.949,31932092
18780,aflibercept,gene,0.9927,31932092
18781,DME,disease,0.9995,31932092
18782,Aflibercept,gene,0.9478,31932092
18783,aflibercept,gene,0.9775,31932092
18784,Patients,species,0.973,31924543
18785,Diabetic Macular Edema,disease,1.0,31924543
18786,cataract,disease,0.895,31924543
18787,patients,species,0.941,31924543
18788,diabetic,disease,1.0,31924543
18789,macular edema,disease,1.0,31924543
18790,aflibercept,gene,0.9854,31924543
18791,Aflibercept,gene,0.8193,31924543
18792,Patients,species,0.9414,31924543
18793,Diabetic Macular Edema,disease,1.0,31924543
18794,Aflibercept,gene,0.8115,31924543
18795,Vision Impairment,disease,1.0,31924543
18796,DME,disease,1.0,31924543
18797,VIVID,disease,1.0,31924543
18798,PARTICIPANTS,species,0.638,31924543
18799,patients,species,0.979,31924543
18800,cataract,disease,0.9995,31924543
18801,patients,species,0.9795,31924543
18802,IAI,disease,0.999,31924543
18803,patients,species,0.987,31924543
18804,patients,species,0.968,31924543
18805,IAI,drug,0.675,31924543
18806,Patients,species,0.9766,31924543
18807,cataract,disease,0.9937,31924543
18808,IAI,disease,0.984,31924543
18809,cataract,disease,1.0,31924543
18810,cataract,disease,0.9985,31924543
18811,IAI,disease,0.996,31924543
18812,cataract,disease,0.9985,31924543
18813,cataract,disease,0.9995,31924543
18814,CRT,DNA,0.583,31924543
18815,cataract,disease,0.9897,31924543
18816,Aflibercept,gene,0.979,31919773
18817,aflibercept,gene,0.9897,31919773
18818,aflibercept,gene,0.9883,31919773
18819,patients,species,0.992,31919773
18820,DME,disease,1.0,31919773
18821,Patients,species,0.97,31919773
18822,aflibercept,gene,0.983,31919773
18823,aflibercept,gene,0.9424,31919773
18824,patients,species,0.986,31919773
18825,aflibercept,gene,0.986,31919773
18826,patients,species,0.987,31919773
18827,aflibercept,gene,0.9834,31919773
18828,patients,species,0.9897,31919773
18829,aflibercept,gene,0.931,31919773
18830,DME,disease,1.0,31919773
18831,fluorescein,drug,0.9907,31917731
18832,diabetic retinopathy,disease,0.9927,31917731
18833,aflibercept,gene,0.8833,31917731
18834,proliferative diabetic retinopathy,disease,0.9995,31917731
18835,aflibercept,gene,0.926,31917731
18836,fluorescein,drug,0.9917,31917731
18837,2q4 arm,DNA,0.8687,31917731
18838,2q12 arm,DNA,0.854,31917731
18839,2q4,DNA,0.8096,31917731
18840,2q12 groups,DNA,0.6636,31917731
18841,2q12,DNA,0.798,31917731
18842,2q4 group,DNA,0.633,31917731
18843,2q12 group,DNA,0.665,31917731
18844,Proliferative diabetic retinopathy,disease,1.0,31917731
18845,aflibercept,gene,0.9717,31917731
18846,Diabetic Macular Edema,disease,1.0,31914437
18847,Aflibercept,gene,0.8877,31914437
18848,diabetic macular edema,disease,1.0,31914437
18849,DME,disease,1.0,31914437
18850,aflibercept,gene,0.9155,31914437
18851,aflibercept,gene,0.961,31914437
18852,CSMT,DNA,0.4795,31914437
18853,BCVA,DNA,0.46,31914437
18854,patients,species,0.971,31914437
18855,macular edema,disease,1.0,31914437
18856,Macular Atrophy of the Retinal Pigment Epithelium,disease,1.0,31907843
18857,Patients,species,0.967,31907843
18858,macular atrophy,disease,1.0,31907843
18859,MA,disease,1.0,31907843
18860,RPE,cell_line,0.749,31907843
18861,patients,species,0.959,31907843
18862,neovascular age-related macular degeneration,disease,1.0,31907843
18863,nAMD,disease,1.0,31907843
18864,vascular endothelial growth factor,gene,0.878,31907843
18865,anti-VEGF,gene,0.9146,31907843
18866,anti-VEGF,gene,0.8887,31907843
18867,MA,disease,,31907843
18868,nAMD,disease,1.0,31907843
18869,anti-VEGF,gene,0.649,31907843
18870,MA,disease,,31907843
18871,VEGF,gene,0.545,31907843
18872,MA,disease,,31907843
18873,anti-VEGF,gene,0.709,31907843
18874,atrophy,disease,0.9995,31907843
18875,VEGF,gene,0.5195,31907843
18876,MA,disease,,31907843
18877,Aflibercept,gene,0.978,31907738
18878,VEGF-A,gene,0.998,31907738
18879,VEGF-B,gene,0.998,31907738
18880,placental growth factor,gene,0.996,31907738
18881,tumor,disease,1.0,31907738
18882,aflibercept,gene,0.9805,31907738
18883,S-1,drug,0.88,31907738
18884,patients,species,0.9746,31907738
18885,solid tumors,disease,1.0,31907738
18886,Patients,species,0.703,31907738
18887,patients,species,0.9697,31907738
18888,solid tumors,disease,0.9966,31907738
18889,aflibercept,gene,0.968,31907738
18890,S-1,drug,0.937,31907738
18891,aflibercept,gene,0.9927,31907738
18892,patients,species,0.955,31907738
18893,proteinuria,disease,0.9805,31907738
18894,aflibercept,gene,0.985,31907738
18895,patients,species,0.969,31907738
18896,pleural effusion,disease,0.996,31907738
18897,patient,species,0.9736,31907738
18898,posterior leukoencephalopathy syndrome,disease,1.0,31907738
18899,patients,species,0.973,31907738
18900,patients,species,0.9893,31907738
18901,aflibercept,gene,0.9814,31907738
18902,S-1,drug,0.625,31907738
18903,patients,species,0.911,31907738
18904,advanced solid tumors,disease,0.9995,31907738
18905,human retinal Mller cells,cell_line,0.9575,31904361
18906,human,species,0.993,31904361
18907,aflibercept,gene,0.991,31904267
18908,aflibercept,gene,0.9873,31904267
18909,diabetic macular edema,disease,1.0,31904267
18910,DME,disease,1.0,31904267
18911,DME,disease,1.0,31904267
18912,patients,species,0.9976,31904267
18913,aflibercept,gene,0.9136,31904267
18914,ranibizumab,gene,0.4949,31904267
18915,aflibercept,gene,0.885,31904267
18916,aflibercept,gene,0.9644,31904267
18917,DME,disease,0.9995,31904267
18918,ranibizumab,gene,0.75,31904267
18919,aflibercept,gene,0.956,31900438
18920,aflibercept,gene,0.9595,31900438
18921,neovascular age-related macular degeneration,disease,1.0,31900438
18922,nAMD,disease,1.0,31900438
18923,patients,species,0.9937,31900438
18924,aflibercept,gene,0.9585,31900438
18925,nAMD,disease,0.9995,31900438
18926,dexamethasone,drug,0.6865,31897703
18927,aflibercept,gene,0.988,31897703
18928,macular,disease,0.9844,31897703
18929,aflibercept,gene,0.989,31897703
18930,dexamethasone,drug,0.998,31897703
18931,DEX,drug,0.996,31897703
18932,patients,species,0.947,31897703
18933,macular edema,disease,1.0,31897703
18934,ME,disease,1.0,31897703
18935,retinal vein occlusion,disease,1.0,31897703
18936,RVO,disease,1.0,31897703
18937,patients,species,0.9844,31897703
18938,ME,disease,,31897703
18939,RVO,disease,1.0,31897703
18940,aflibercept,gene,0.9697,31897703
18941,DEX,drug,0.92,31897703
18942,SD,drug,,31897703
18943,patients,species,0.9146,31897703
18944,RVO,disease,1.0,31897703
18945,CRT,DNA,0.5654,31897703
18946,ME,disease,,31897703
18947,patient,species,0.966,31897703
18948,ME,disease,,31897703
18949,RVO,disease,1.0,31897703
18950,aflibercept,gene,0.9844,31897703
18951,aflibercept,gene,0.9834,31897703
18952,DEX,drug,0.5664,31897703
18953,ME,disease,,31897703
18954,aflibercept,gene,0.9395,31897562
18955,vascular endothelial growth factor,gene,0.998,31897562
18956,VEGF,gene,0.5396,31897562
18957,aflibercept,gene,0.9946,31897562
18958,aflibercept,gene,0.9873,31897562
18959,aflibercept,gene,0.992,31897562
18960,plasma,cell_type,0.5215,31897562
18961,aflibercept,gene,0.9946,31897562
18962,VEGF-A,gene,0.9976,31897562
18963,aflibercept,gene,0.995,31897562
18964,aflibercept,gene,0.986,31897562
18965,VEGF,gene,0.982,31897562
18966,aflibercept,gene,0.994,31897562
18967,cynomolgus monkey,species,0.9414,31897562
18968,aflibercept,gene,0.9937,31897562
18969,aflibercept,gene,0.984,31897562
18970,Retinal pigment epithelial atrophy,disease,1.0,31896542
18971,anti-vascular endothelial growth factor,gene,0.842,31896542
18972,retinal pigment epithelial,cell_type,0.615,31896542
18973,atrophy,disease,0.7993,31896542
18974,anti-vascular endothelial growth factor,gene,0.9805,31896542
18975,VEGF,gene,0.9946,31896542
18976,polypoidal choroidal vasculopathy,disease,1.0,31896542
18977,PCV,disease,1.0,31896542
18978,patients,species,0.9683,31896542
18979,PCV,disease,1.0,31896542
18980,patients,species,0.9834,31896542
18981,anti-VEGF,gene,0.961,31896542
18982,fluorescein,drug,0.999,31896542
18983,indocyanine green,drug,0.999,31896542
18984,RPE atrophy,disease,1.0,31896542
18985,RPE atrophy,disease,1.0,31896542
18986,anti-VEGF,gene,0.7905,31896542
18987,RPE atrophy,disease,1.0,31896542
18988,polyp,disease,0.9946,31896542
18989,polyp-associated,disease,0.9937,31896542
18990,pigment epithelial detachment,disease,0.8735,31896542
18991,subretinal drusenoid deposits,disease,0.9985,31896542
18992,RPE atrophy,disease,1.0,31896542
18993,RPE atrophy,disease,1.0,31896542
18994,patients,species,0.9453,31896542
18995,PCV,disease,1.0,31896542
18996,RPE atrophy,disease,1.0,31896542
18997,anti-VEGF,gene,0.886,31896542
18998,choroidal thinning,disease,0.76,31896542
18999,RPE atrophy,disease,0.9995,31896542
19000,aflibercept,gene,0.9707,31894377
19001,aflibercept,gene,0.988,31894377
19002,AFL,gene,0.868,31894377
19003,diabetic macular edema,disease,1.0,31894377
19004,patients,species,0.958,31894377
19005,DME,disease,1.0,31894377
19006,patients,species,0.9854,31894377
19007,anti-vascular endothelial growth factor,gene,0.873,31894377
19008,patients,species,0.9917,31894377
19009,VEGF,gene,0.6226,31894377
19010,patients,species,0.9595,31894377
19011,patients,species,0.983,31894377
19012,Diabetic Retinopathy,disease,0.995,31894377
19013,patients,species,0.986,31894377
19014,patients,species,0.983,31894377
19015,patients,species,0.974,31894377
19016,patients,species,0.9805,31894377
19017,patient,species,0.9834,31894377
19018,AFL,gene,0.793,31894377
19019,patients,species,0.988,31894377
19020,patients,species,0.9863,31894377
19021,patients,species,0.948,31894377
19022,patients,species,0.9443,31894377
19023,AFL,drug,0.862,31894377
19024,patients,species,0.9272,31894377
19025,DME,disease,1.0,31894377
19026,Aflibercept,gene,0.9556,31891353
19027,dexamethasone,drug,0.9365,31891353
19028,macular edema,disease,1.0,31891353
19029,central retinal vein occlusion,disease,1.0,31891353
19030,Macular edema,disease,1.0,31891353
19031,central retinal vein occlusion,disease,1.0,31891353
19032,dexamethasone,drug,0.9946,31891353
19033,vascular endothelial growth factor,gene,0.9927,31891353
19034,aflibercept,gene,0.936,31891353
19035,aflibercept,gene,0.973,31891353
19036,dexamethasone,drug,0.983,31891353
19037,neovascular age-related macular degeneration,disease,1.0,31882702
19038,nAMD,disease,1.0,31882702
19039,polypoidal,disease,1.0,31882702
19040,choroidal vasculopathy,disease,0.996,31882702
19041,PCV,disease,1.0,31882702
19042,pachychoroid,disease,1.0,31882702
19043,nAMD,disease,1.0,31882702
19044,PCV,disease,1.0,31882702
19045,ranibizumab,gene,0.8853,31882702
19046,aflibercept,gene,0.974,31882702
19047,pigment epithelial detachment,disease,1.0,31882702
19048,PED,disease,1.0,31882702
19049,nAMD,disease,1.0,31882702
19050,SHRM,DNA,0.4836,31882702
19051,nAMD,disease,1.0,31882702
19052,pachychoroid,disease,1.0,31882702
19053,nAMD,disease,1.0,31882702
19054,pachychoroid,disease,1.0,31882702
19055,PCV,disease,1.0,31882702
19056,nAMD,disease,1.0,31882702
19057,pachychoroid,disease,0.9995,31882702
19058,nAMD,disease,1.0,31882702
19059,pachychoroid,disease,0.9985,31882702
19060,PCV,disease,1.0,31882702
19061,osteonecrosis of the BACKGROUND,disease,0.999,31880288
19062,Medication,disease,0.753,31880288
19063,MRONJ,disease,1.0,31880288
19064,bisphosphonates,drug,0.9844,31880288
19065,denosumab,gene,0.7793,31880288
19066,sunitinib,drug,0.9966,31880288
19067,bevacizumab,gene,0.673,31880288
19068,aflibercept,gene,0.964,31880288
19069,osteonecrosis of the jaw,disease,1.0,31880288
19070,ONJ,disease,1.0,31880288
19071,ONJ,disease,1.0,31880288
19072,VEGF,gene,0.638,31880288
19073,ONJ,disease,1.0,31880288
19074,MRONJ,disease,1.0,31880288
19075,Polypoidal choroidal vasculopathy,disease,1.0,31879067
19076,Polypoidal choroidal vasculopathy,disease,1.0,31879067
19077,PCV,disease,1.0,31879067
19078,exudative age-related macular degeneration,disease,0.975,31879067
19079,AMD,disease,1.0,31879067
19080,vision loss,disease,0.9985,31879067
19081,PCV,disease,1.0,31879067
19082,PCV,disease,1.0,31879067
19083,AMD,disease,1.0,31879067
19084,indocyanine green,drug,0.9966,31879067
19085,vascular endothelial growth factor,gene,0.9526,31879067
19086,VEGF,gene,0.6157,31879067
19087,bevacizumab,gene,0.7856,31879067
19088,ranibizumab,gene,0.816,31879067
19089,aflibercept,gene,0.931,31879067
19090,ranibizumab,gene,0.693,31879067
19091,ranibizumab,gene,0.6934,31879067
19092,aflibercept,gene,0.969,31879067
19093,aflibercept,gene,0.9795,31879067
19094,PCV,disease,1.0,31879067
19095,anti-vascular endothelial growth factor,gene,0.9854,31878889
19096,anti-vascular endothelial growth factor,gene,0.998,31878889
19097,anti-VEGF,gene,0.994,31878889
19098,acute kidney injury,disease,1.0,31878889
19099,anti-VEGF,gene,0.825,31878889
19100,anti-VEGF,gene,0.8853,31878889
19101,patients,species,0.9233,31878889
19102,diabetes,disease,1.0,31878889
19103,albumin,gene,0.6255,31878889
19104,creatinine,drug,0.933,31878889
19105,patients,species,0.9917,31878889
19106,diabetic macular oedema,disease,1.0,31878889
19107,DMO,disease,1.0,31878889
19108,creatinine,drug,0.997,31878889
19109,anti-VEGF,gene,0.9214,31878889
19110,anti-VEGF,gene,0.964,31878889
19111,patients,species,0.975,31878889
19112,DMO,disease,1.0,31878889
19113,type 2 diabetes mellitus,disease,1.0,31878889
19114,T2DM,disease,1.0,31878889
19115,anti-VEGF,gene,0.905,31878889
19116,patient,species,0.9907,31878889
19117,anti-VEGF,gene,0.9707,31878889
19118,hypertension,disease,1.0,31878889
19119,cerebrovascular disease,disease,1.0,31878889
19120,T2DM,disease,1.0,31878889
19121,VEGF,gene,0.99,31878889
19122,Ziv-Aflibercept,gene,0.9814,31877224
19123,ziv-aflibercept,gene,0.993,31877224
19124,rabbits,species,0.9478,31877224
19125,IVZ,drug,0.7583,31877224
19126,ziv-aflibercept,gene,0.972,31877224
19127,rabbits,species,0.9653,31877224
19128,rabbits,species,0.962,31877224
19129,rabbits,species,0.9507,31877224
19130,aflibercept,gene,0.9907,31877224
19131,ocular inflammation,disease,0.9897,31877224
19132,ziv-aflibercept,gene,0.987,31877224
19133,aflibercept,gene,0.9883,31877224
19134,ziv-aflibercept,gene,0.974,31877224
19135,IVZ,drug,0.9434,31877224
19136,retinal vascular diseases,disease,1.0,31877224
19137,ziv-aflibercept,gene,0.9907,31877224
19138,Fluorescein,drug,0.987,31877222
19139,peripheral ischemia,disease,0.997,31877222
19140,fluorescein,drug,0.999,31877222
19141,bevacizumab,gene,0.9434,31877222
19142,aflibercept,gene,0.975,31877222
19143,diabetic macular edema,disease,1.0,31877222
19144,DME,disease,1.0,31877222
19145,PATIENTS,species,0.947,31877222
19146,patients,species,0.9707,31877222
19147,bevacizumab,gene,0.84,31877222
19148,DME,disease,1.0,31877222
19149,Patients,species,0.946,31877222
19150,aflibercept,gene,0.898,31877222
19151,patients,species,0.971,31877222
19152,Patients,species,0.9624,31877222
19153,patients,species,0.9575,31877222
19154,patients,species,0.986,31877222
19155,Patients,species,0.9604,31877222
19156,DME,disease,1.0,31877222
19157,bevacizumab,gene,0.6523,31877222
19158,macular ischemia,disease,0.9995,31877222
19159,patients,species,0.939,31877222
19160,peripheral ischemia,disease,0.98,31877222
19161,aflibercept,gene,0.934,31877222
19162,Humans,species,0.991,31876425
19163,retinal diseases,disease,0.9985,31876425
19164,humans,species,0.9946,31876425
19165,rat,species,0.985,31876425
19166,rabbit,species,0.9814,31876425
19167,monkey,species,0.792,31876425
19168,pig,species,0.9644,31876425
19169,IgG antibodies,gene,0.9834,31876425
19170,Fab fragments,gene,0.813,31876425
19171,Fab,gene,0.9863,31876425
19172,IgG,gene,0.99,31876425
19173,vitreous globe,cell_type,0.7036,31876425
19174,rat,species,0.9883,31876425
19175,human,species,0.997,31876425
19176,aflibercept,gene,0.991,31876425
19177,brolucizumab,gene,0.923,31876425
19178,Ziv-aflibercept,gene,0.981,31863550
19179,vascular endothelial growth factor,gene,0.9966,31863550
19180,Ziv-aflibercept,gene,0.9727,31863550
19181,Zaltrap,gene,0.518,31863550
19182,vascular endothelial growth factor,gene,0.997,31863550
19183,VEGF,gene,0.996,31863550
19184,colorectal carcinoma,disease,1.0,31863550
19185,aflibercept,gene,0.988,31863550
19186,Eylea,gene,0.5547,31863550
19187,chorioretinal vascular conditions,disease,1.0,31863550
19188,Ziv-aflibercept,gene,0.9736,31863550
19189,bevacizumab,gene,0.922,31863550
19190,retinal,cell_type,0.4812,31863550
19191,ziv-aflibercept,gene,0.9736,31863550
19192,anti-VEGF,gene,0.8354,31863550
19193,Aflibercept,gene,0.8716,31863395
19194,choroidal neovascularizations,disease,1.0,31863395
19195,pseudoxanthoma elasticum,disease,1.0,31863395
19196,aflibercept,gene,0.9897,31863395
19197,choroidal neovascularization,disease,1.0,31863395
19198,CNV,disease,1.0,31863395
19199,angioid,cell_type,0.4717,31863395
19200,angioid streaks,disease,0.9956,31863395
19201,patients,species,0.9487,31863395
19202,pseudoxanthoma elasticum,disease,1.0,31863395
19203,PXE,disease,1.0,31863395
19204,PXE,disease,1.0,31863395
19205,patients,species,0.9907,31863395
19206,CNV,disease,0.999,31863395
19207,aflibercept,gene,0.985,31863395
19208,CNV,disease,0.973,31863395
19209,CNV,disease,0.9995,31863395
19210,participants,species,0.979,31863395
19211,CNV,DNA,0.754,31863395
19212,aflibercept,gene,0.983,31863395
19213,aflibercept,gene,0.937,31863395
19214,CNV,disease,0.999,31863395
19215,PXE,disease,1.0,31863395
19216,aflibercept,gene,0.981,31856493
19217,diabetic macular edema,disease,1.0,31856493
19218,DME,disease,1.0,31856493
19219,patients,species,0.9897,31856493
19220,SMYL,drug,0.998,31856493
19221,IAI,drug,0.9,31856493
19222,patients,species,0.991,31856493
19223,IAI,drug,0.965,31856493
19224,patients,species,0.977,31856493
19225,patients,species,0.9946,31856493
19226,SMYL,drug,0.997,31856493
19227,SMYL,drug,0.849,31856493
19228,BCVA,cell_type,0.4177,31856493
19229,patients,species,0.961,31856493
19230,SMYL,drug,0.9946,31856493
19231,patients,species,0.9507,31856493
19232,DME,disease,1.0,31856493
19233,aflibercept,gene,0.9897,31850170
19234,acute,disease,0.518,31850170
19235,central serous chorioretinopathy,disease,0.7876,31850170
19236,aflibercept,gene,0.987,31850170
19237,acute central serous chorioretinopathy,disease,0.9976,31850170
19238,CSC,disease,1.0,31850170
19239,CSC,disease,1.0,31850170
19240,IAI,disease,0.9717,31850170
19241,CSC,disease,0.9814,31850170
19242,CSC,disease,1.0,31850170
19243,Aflibercept,gene,0.9834,35187448
19244,Ranibizumab,gene,0.806,35187448
19245,Dexamethasone,drug,0.9897,35187448
19246,aflibercept,gene,0.968,35187448
19247,dexamethasone,drug,0.9966,35187448
19248,DEX,drug,0.9473,35187448
19249,macular edema,disease,1.0,35187448
19250,ME,disease,1.0,35187448
19251,branch retinal vein occlusion,disease,1.0,35187448
19252,BRVO,disease,1.0,35187448
19253,patients,species,0.9805,35187448
19254,ME,disease,,35187448
19255,BRVO,disease,0.999,35187448
19256,Patients,species,0.9253,35187448
19257,anti-VEGF,gene,0.8936,35187448
19258,dexamethasone,drug,0.988,35187448
19259,patients,species,0.9937,35187448
19260,person,species,0.949,35187448
19261,people,species,0.976,35187448
19262,glaucomatous,disease,0.8813,35187448
19263,patient,species,0.9893,35187448
19264,patients,species,0.985,35187448
19265,cataract,disease,1.0,35187448
19266,patients,species,0.9824,35187448
19267,ME,disease,,35187448
19268,BRVO,disease,1.0,35187448
19269,VEGF,gene,0.9126,35187448
19270,dex,drug,0.8735,35187448
19271,cataract,disease,1.0,35187448
19272,macular atrophy,disease,1.0,31843790
19273,macular atrophy,disease,1.0,31843790
19274,MA,disease,1.0,31843790
19275,nAMD,disease,1.0,31843790
19276,vascular endothelial growth factor,gene,0.9985,31843790
19277,VEGF,gene,0.9985,31843790
19278,nAMD,disease,1.0,31843790
19279,MA,disease,,31843790
19280,MA,disease,,31843790
19281,MA,disease,,31843790
19282,MA,disease,,31843790
19283,subfoveal MA,disease,0.7173,31843790
19284,MA,disease,,31843790
19285,choroidal neovascularisation,disease,1.0,31843790
19286,MA,disease,,31843790
19287,bevacizumab,gene,0.9683,31830075
19288,cetuximab,gene,0.9473,31830075
19289,panitumumab,gene,0.945,31830075
19290,aflibercept,gene,0.9536,31830075
19291,regorafenib,drug,0.981,31830075
19292,metastatic colorectal cancer,disease,0.999,31830075
19293,patient,species,0.9897,31830075
19294,cetuximab,gene,0.849,31830075
19295,bevacizumab,gene,0.7017,31830075
19296,panitumumab,gene,0.812,31830075
19297,aflibercept,gene,0.9814,31830075
19298,regorafenib,drug,0.9907,31830075
19299,neovascular age-related macular degeneration,disease,1.0,31828425
19300,neovascular age-related macular degeneration,disease,1.0,31828425
19301,anti-VEGF,gene,0.77,31828425
19302,subretinal,cell_type,0.4612,31828425
19303,HF,disease,0.9814,31828425
19304,SRF,DNA,0.543,31828425
19305,anti-VEGF,gene,0.691,31828425
19306,vascular endothelial growth factor,gene,0.99,31826853
19307,neovascular age-related macular degeneration,disease,1.0,31826853
19308,nAMD,disease,1.0,31826853
19309,vascular endothelial growth factor,gene,0.889,31826853
19310,VEGF,gene,0.627,31826853
19311,nAMD,disease,1.0,31826853
19312,aflibercept,gene,0.975,31826853
19313,ranibizumab,gene,0.678,31826853
19314,fluorescein,drug,0.9995,31826853
19315,PC,disease,0.9995,31826853
19316,MC,disease,0.9995,31826853
19317,VEGF,gene,0.883,31826853
19318,VEGF,gene,0.5137,31826853
19319,occult lesions,disease,0.6836,31826853
19320,Anti-VEGF,gene,0.893,31824134
19321,Wet Age-Related Macular Degeneration,disease,1.0,31824134
19322,VEGF,gene,0.6626,31824134
19323,exudative age-related macular degeneration,disease,1.0,31824134
19324,eAMD,disease,1.0,31824134
19325,intraretinal fluid,disease,0.9087,31824134
19326,anti-VEGF,gene,0.9434,31824134
19327,eAMD,disease,1.0,31824134
19328,intraretinal fluid,disease,0.9297,31824134
19329,anti-VEGF,gene,0.951,31824134
19330,Ozurdex,drug,0.932,31824134
19331,Triamcinolone,drug,0.9976,31824134
19332,VEGF,gene,0.915,31824134
19333,VEGF,gene,0.843,31824134
19334,eAMD,disease,1.0,31824134
19335,intraretinal fluid,disease,0.7793,31824134
19336,anti-VEGF,gene,0.7803,31824134
19337,VEGF,gene,0.752,31824134
19338,exudative AMD,disease,0.9995,31824134
19339,choroidal neovascularisation,disease,1.0,31813301
19340,choroidal osteoma,disease,1.0,31813301
19341,choroidal neovascularisation,disease,1.0,31813301
19342,patient,species,0.985,31813301
19343,choroidal osteoma,disease,1.0,31813301
19344,fluorescein,drug,0.983,31813301
19345,choroidal osteoma,disease,1.0,31813301
19346,choroidal neovascularisation,disease,1.0,31813301
19347,choroidal osteoma,disease,1.0,31813301
19348,hyper,DNA,0.5586,31813301
19349,tumour,disease,0.998,31813301
19350,patient,species,0.991,31813301
19351,Aflibercept,gene,0.984,31813301
19352,choroidal excavation,disease,0.847,31813301
19353,choroidal neovascularisation,disease,0.9976,31813301
19354,choroidal osteoma,disease,1.0,31813301
19355,patients,species,0.9883,31813301
19356,choroidal neovascular,disease,0.629,31806631
19357,central serous chorioretinopathy,disease,0.9995,31806631
19358,type 1 choroidal neovascularisation,disease,0.998,31806631
19359,CNV,disease,1.0,31806631
19360,central serous chorioretinopathy,disease,0.999,31806631
19361,CNV,disease,1.0,31806631
19362,type 2 CNV,disease,0.999,31806631
19363,type 1 CNV,DNA,0.618,31806631
19364,ziv-aflibercept,gene,0.99,31806631
19365,type 2 CNV,disease,0.999,31806631
19366,aflibercept,gene,0.9536,31802046
19367,neovascular age-related macular degeneration,disease,1.0,31802046
19368,aflibercept,gene,0.975,31802046
19369,neovascular age-related macular degeneration,disease,1.0,31802046
19370,aflibercept,gene,0.979,31802046
19371,aflibercept,gene,0.9663,31802046
19372,aflibercept,gene,0.958,31802046
19373,aflibercept,gene,0.902,31802046
19374,subretinal fluid,disease,0.997,31802046
19375,SRF,disease,0.996,31802046
19376,intraretinal fluid,disease,0.999,31802046
19377,IRF,disease,0.998,31802046
19378,pigment epithelium detachment,disease,0.999,31802046
19379,PED,disease,1.0,31802046
19380,SRF,disease,1.0,31802046
19381,IRF,disease,1.0,31802046
19382,PED,disease,1.0,31802046
19383,SRF,disease,1.0,31802046
19384,IRF,disease,1.0,31802046
19385,PED,disease,1.0,31802046
19386,aflibercept,gene,0.9673,31802046
19387,aflibercept,gene,0.7812,31802045
19388,diabetic macular edema,disease,1.0,31802045
19389,anti-,gene,0.548,31802045
19390,vascular endothelial growth factors,gene,0.936,31802045
19391,aflibercept,gene,0.931,31802045
19392,diabetic macular edema,disease,1.0,31802045
19393,aflibercept,gene,0.9644,31802045
19394,diabetic macular edema,disease,1.0,31802045
19395,diabetic,disease,1.0,31802045
19396,aflibercept,gene,0.9624,31802045
19397,aflibercept,gene,0.9854,31802045
19398,aflibercept,gene,0.9785,31802045
19399,aflibercept,gene,0.9624,31802045
19400,type-II diabetes,disease,1.0,31802045
19401,type-I,disease,0.996,31802045
19402,diabetic macular edema,disease,1.0,31802045
19403,aflibercept,gene,0.9546,31802045
19404,BCVA,DNA,0.4426,31802045
19405,aflibercept,gene,0.941,31802045
19406,aflibercept,gene,0.9697,31802045
19407,aflibercept,gene,0.9756,31802045
19408,aflibercept,gene,0.944,31802045
19409,CONCLUSION Aflibercept,gene,0.6353,31802045
19410,diabetic macular,disease,1.0,31802045
19411,edema eyes,disease,1.0,31802045
19412,aflibercept,gene,0.971,31802045
19413,Lucentis,drug,0.897,31801969
19414,Vein Occlusion,disease,0.998,31801969
19415,dexamethasone,drug,0.9727,31797409
19416,ranibizumab,gene,0.73,31797409
19417,aflibercept,gene,0.9717,31797409
19418,VEGF,gene,0.7476,31792234
19419,vascular endothelial growth factor,gene,0.997,31792234
19420,VEGF,gene,0.9946,31792234
19421,visual impairment,disease,0.999,31792234
19422,retinal diseases,disease,1.0,31792234
19423,neovascular age-related macular degeneration,disease,1.0,31792234
19424,diabetes macular oedema,disease,1.0,31792234
19425,patients,species,0.9907,31792234
19426,aflibercept,gene,0.9917,31792234
19427,Eylea,gene,0.8022,31792234
19428,anti-VEGF,gene,0.916,31792234
19429,patient,species,0.982,31792234
19430,VEGF,gene,0.764,31792234
19431,silicone oil,drug,0.739,31792234
19432,silicone,drug,0.739,31792234
19433,aflibercept,gene,0.9937,31792234
19434,ranibizumab,gene,0.6367,31792234
19435,Lucentis,gene,0.7153,31792234
19436,bevacizumab,gene,0.761,31792234
19437,VEGF,gene,0.8335,31792234
19438,Aflibercept,gene,0.99,31791663
19439,Anti-Platelet-Derived Growth Factor Receptor ,gene,0.961,31791663
19440,Neovascular Age-Related Macular Degeneration,disease,1.0,31791663
19441,aflibercept,gene,0.958,31791663
19442,anti-,gene,0.669,31791663
19443,platelet-derived growth factor receptor ,gene,0.9287,31791663
19444,PDGFR,gene,0.9946,31791663
19445,aflibercept,gene,0.9473,31791663
19446,neovascular age-related macular degeneration,disease,1.0,31791663
19447,nAMD,disease,1.0,31791663
19448,PARTICIPANTS,species,0.6987,31791663
19449,nAMD,disease,1.0,31791663
19450,aflibercept,gene,0.903,31791663
19451,anti-PDGFR 3,gene,0.9907,31791663
19452,aflibercept,gene,0.7593,31791663
19453,intraocular inflammation,disease,1.0,31791663
19454,Anti,gene,0.5635,31791663
19455,arterial thromboembolic events,disease,0.995,31791663
19456,aflibercept,gene,0.676,31791663
19457,anti-PDGFR,gene,0.823,31791663
19458,intraocular inflammation,disease,1.0,31791663
19459,diabetic macular oedema,disease,1.0,31784500
19460,diabetic macular oedema,disease,1.0,31784500
19461,DME,disease,1.0,31784500
19462,retinal diseases,disease,0.9927,31784500
19463,DME,disease,1.0,31784500
19464,DME,disease,1.0,31784500
19465,vascular endothelial growth factor,gene,0.899,31784500
19466,VEGF,gene,0.9966,31784500
19467,VEGF,gene,0.7944,31784500
19468,VEGF,gene,0.8823,31784500
19469,DME,disease,1.0,31784500
19470,DME,disease,1.0,31784500
19471,Anti-VEGF,gene,0.9395,31772259
19472,vascular endothelial growth factor,gene,0.9976,31772259
19473,corneal vascularisation,disease,1.0,31772259
19474,rabbit,species,0.984,31772259
19475,aflibercept,gene,0.989,31772259
19476,ranibizumab,gene,0.9536,31772259
19477,anti-VEGFs,gene,0.6147,31772259
19478,indocyanine green,drug,0.998,31772259
19479,anti-VEGF,gene,0.915,31772259
19480,aflibercept,gene,0.9834,31772259
19481,Patient,species,0.9814,31770790
19482,Visual Impairment,disease,0.9995,31770790
19483,aflibercept,gene,0.973,31770790
19484,patients,species,0.983,31770790
19485,neovascular age related macular degeneration,disease,1.0,31770790
19486,nAMD,disease,1.0,31770790
19487,patients,species,0.9946,31770790
19488,patients,species,0.9927,31770790
19489,patients,species,0.97,31770790
19490,nAMD,disease,1.0,31770790
19491,visual impairment,disease,1.0,31770790
19492,Patients,species,0.9756,31770790
19493,patients,species,0.992,31770790
19494,visual impairment,disease,1.0,31770790
19495,patients,species,0.991,31770790
19496,aflibercept,gene,0.977,31770790
19497,nAMD,disease,1.0,31770790
19498,patients,species,0.9893,31770790
19499,patient,species,0.9517,31770790
19500,visual impairment,disease,1.0,31770790
19501,eye disorders,disease,0.8677,31770361
19502,vascular endothelial growth factor,gene,0.945,31768680
19503,subretinal neovascular membrane,disease,1.0,31768680
19504,type 2 proliferative macular telangiectasia,disease,1.0,31768680
19505,anti-vascular endothelial growth factor,gene,0.972,31768680
19506,VEGF,gene,0.994,31768680
19507,subretinal neovascular membrane,disease,1.0,31768680
19508,SRNVM,disease,1.0,31768680
19509,type 2 proliferative macular telangiectasia,disease,1.0,31768680
19510,Mac Tel 2,disease,1.0,31768680
19511,aflibercept,gene,0.9673,31768680
19512,ranibizumab,gene,0.733,31768680
19513,SRNVM,disease,0.9995,31768680
19514,type 2 proliferative MacTel,disease,0.987,31768680
19515,Mac Tel type 2,disease,0.994,31768680
19516,SRNVM,disease,1.0,31768680
19517,Macular Hole,disease,0.6465,31762770
19518,Wet,disease,0.9395,31762770
19519,Age-Related Macular Degeneration,disease,0.972,31762770
19520,Aflibercept,gene,0.9595,31762770
19521,aflibercept,gene,0.985,31762770
19522,Eylea,gene,0.5405,31762770
19523,choroidal neovascularization,disease,1.0,31762770
19524,CNV,disease,1.0,31762770
19525,full-thickness macular,disease,0.801,31762770
19526,MH,disease,1.0,31762770
19527,MH,disease,0.9995,31762770
19528,SF6,drug,0.9956,31762770
19529,MH,disease,0.9854,31762770
19530,CNV,disease,0.615,31762770
19531,VEGF,gene,0.5522,31762770
19532,Eylea,drug,0.853,31762770
19533,wet,disease,0.9507,31762770
19534,age-related macular degeneration,disease,0.9175,31762770
19535,Retinal Vascular Disease,disease,1.0,31757691
19536,Aflibercept,gene,0.9224,31757691
19537,diabetic macular edema,disease,1.0,31757691
19538,DME,disease,1.0,31757691
19539,retinal vein occlusion,disease,1.0,31757691
19540,RVO,disease,1.0,31757691
19541,aflibercept,gene,0.967,31757691
19542,PARTICIPANTS,species,0.752,31757691
19543,retinal edema,disease,0.9434,31757691
19544,DME,disease,1.0,31757691
19545,RVO,disease,1.0,31757691
19546,fluorescein,drug,0.9956,31757691
19547,RVO,disease,0.9995,31757691
19548,aflibercept,gene,0.9805,31757691
19549,Ranibizumab,gene,0.9194,31757494
19550,Aflibercept,gene,0.9478,31757494
19551,Neovascular Age-Related Macular Degeneration,disease,1.0,31757494
19552,Retinal Blindness,disease,0.998,31757494
19553,Ranibizumab,gene,0.826,31757494
19554,aflibercept,gene,0.9663,31757494
19555,neovascular age-related macular degeneration,disease,1.0,31757494
19556,nAMD,disease,1.0,31757494
19557,Retinal Blindness,disease,1.0,31757494
19558,PARTICIPANTS,species,0.9126,31757494
19559,nAMD,disease,1.0,31757494
19560,ranibizumab,gene,0.7583,31757494
19561,aflibercept,gene,0.972,31757494
19562,ranibizumab,drug,0.8936,31757494
19563,aflibercept,gene,0.926,31757494
19564,choroidal neovascularization,disease,1.0,31757494
19565,CNV,disease,1.0,31757494
19566,ranibizumab,gene,0.817,31757494
19567,aflibercept,gene,0.963,31757494
19568,CNV,disease,0.987,31757494
19569,ranibizumab,drug,0.5996,31757494
19570,aflibercept,gene,0.915,31757494
19571,ranibizumab,gene,0.8916,31757494
19572,aflibercept,gene,0.975,31757494
19573,ranibizumab,gene,0.6914,31757494
19574,nor,gene,0.512,31757494
19575,aflibercept,gene,0.7666,31757494
19576,nAMD,disease,1.0,31757494
19577,DME,disease,1.0,31755967
19578,Ziv-Aflibercept,gene,0.9634,31755967
19579,Bevacizumab,gene,0.724,31755967
19580,ziv-aflibercept,gene,0.992,31755967
19581,diabetic macular edema,disease,0.9956,31755967
19582,DME,disease,1.0,31755967
19583,PATIENTS,species,0.961,31755967
19584,BCVA,DNA,0.5005,31755967
19585,IVZ,drug,0.9775,31755967
19586,IVB,drug,0.9937,31755967
19587,IVZ,drug,0.9136,31755967
19588,Ziv-aflibercept,gene,0.859,31755967
19589,DME,disease,0.997,31755967
19590,Ranibizumab,gene,0.982,31755809
19591,Aflibercept,gene,0.9727,31755809
19592,ranibizumab,gene,0.793,31755809
19593,aflibercept,gene,0.9814,31755809
19594,patients,species,0.9736,31755809
19595,myopic choroidal neovascularization,disease,1.0,31755809
19596,CNV,disease,1.0,31755809
19597,patients,species,0.9814,31755809
19598,myopic CNV,disease,1.0,31755809
19599,Patients,species,0.974,31755809
19600,aflibercept,gene,0.9414,31755809
19601,patients,species,0.9854,31755809
19602,patients,species,0.9873,31755809
19603,ranibizumab,gene,0.7563,31755809
19604,aflibercept,gene,0.977,31755809
19605,patients,species,0.9585,31755809
19606,myopic CNV,disease,1.0,31755809
19607,Aflibercept,gene,0.955,31755040
19608,anti-vascular endothelial growth factor,gene,0.885,31755040
19609,VEGF,gene,0.998,31755040
19610,patients,species,0.986,31755040
19611,macular edema,disease,1.0,31755040
19612,aflibercept,gene,0.8765,31755040
19613,patients,species,0.9556,31755040
19614,diabetic macular edema,disease,0.853,31755040
19615,DME,disease,1.0,31755040
19616,anti-VEGF,gene,0.958,31755040
19617,anti-VEGF,gene,0.9653,31755040
19618,patients,species,0.9585,31755040
19619,DME,disease,1.0,31755040
19620,Participants,species,0.9463,31755040
19621,aflibercept,gene,0.921,31755040
19622,patient,species,0.975,31755040
19623,patients,species,0.984,31755040
19624,patients,species,0.992,31755040
19625,patients,species,0.9844,31755040
19626,aflibercept,gene,0.9507,31755040
19627,patients,species,0.982,31755040
19628,DME,disease,1.0,31755040
19629,aflibercept,gene,0.939,31755040
19630,Creatinine,drug,0.822,31748484
19631,proteinuria,disease,1.0,31748484
19632,creatinine,drug,0.826,31748484
19633,patients,species,0.988,31748484
19634,patients,species,0.986,31748484
19635,bevacizumab,gene,0.957,31748484
19636,aflibercept,gene,0.979,31748484
19637,patients,species,0.9927,31748484
19638,colorectal cancer,disease,1.0,31748484
19639,lung cancer,disease,1.0,31748484
19640,gastric cancer,disease,1.0,31748484
19641,breast cancer,disease,1.0,31748484
19642,patients,species,0.9766,31748484
19643,patients,species,0.9897,31748484
19644,patients,species,0.99,31748484
19645,patients,species,0.9863,31748484
19646,patients,species,0.983,31748484
19647,patient,species,0.985,31748484
19648,patients,species,0.9927,31748484
19649,patients,species,0.9946,31748484
19650,patients,species,0.992,31748484
19651,patients,species,0.9927,31748484
19652,proteinuria,disease,0.999,31748484
19653,inflammatory choroidal neovascularisation,disease,1.0,31744798
19654,inflammatory choroidal neovascularisation,disease,1.0,31744798
19655,iCNV,disease,0.9985,31744798
19656,anti-vascular endothelial growth factor,gene,0.9526,31744798
19657,VEGF,gene,0.998,31744798
19658,anti-VEGF,gene,0.855,31744798
19659,iCNV,disease,0.9995,31744798
19660,iCNV,disease,0.9995,31744798
19661,anti-VEGF,gene,0.952,31744798
19662,iCNV,disease,1.0,31744798
19663,iCNV,disease,0.897,31744798
19664,iCNV,disease,0.9995,31744798
19665,anti-VEGF,gene,0.787,31744798
19666,aflibercept,gene,0.99,31741044
19667,submacular hemorrhage,disease,0.962,31741044
19668,aflibercept,gene,0.983,31741044
19669,submacular hemorrhage,disease,0.9907,31741044
19670,neovascular age-related macular degeneration,disease,1.0,31741044
19671,AMD,disease,1.0,31741044
19672,polypoidal choroidal vasculopathy,disease,1.0,31741044
19673,PCV,disease,1.0,31741044
19674,patients,species,0.977,31741044
19675,neovascular AMD,disease,1.0,31741044
19676,patients,species,0.948,31741044
19677,PCV,disease,1.0,31741044
19678,patients,species,0.9844,31741044
19679,Patients,species,0.981,31741044
19680,aflibercept,gene,0.9814,31741044
19681,Diabetic Retinopathy,disease,0.998,31741044
19682,patients,species,0.987,31741044
19683,patients,species,0.989,31741044
19684,patients,species,0.9717,31741044
19685,CRT,DNA,0.52,31741044
19686,retinal,disease,0.5586,31741044
19687,patient,species,0.968,31741044
19688,aflibercept,gene,0.972,31741044
19689,submacular hemorrhage,disease,1.0,31741044
19690,AMD,disease,0.9966,31741044
19691,VEGF,gene,0.8315,31735842
19692,nAMD,disease,1.0,31735842
19693,neovascular age-related macular degeneration,disease,1.0,31735842
19694,nAMD,disease,1.0,31735842
19695,anti-VEGFs,gene,0.9165,31735842
19696,nAMD,disease,1.0,31735842
19697,ranibizumab,gene,0.905,31735842
19698,aflibercept,gene,0.981,31735842
19699,bevacizumab,gene,0.7437,31735842
19700,Aflibercept,gene,0.6826,31728825
19701,Ranibizumab,gene,0.587,31728825
19702,Neovascular Age-Related Macular Degeneration,disease,1.0,31728825
19703,neovascular age-related macular degeneration,disease,1.0,31728825
19704,nAMD,disease,1.0,31728825
19705,vascular endothelial growth factor,gene,0.9614,31728825
19706,aflibercept,gene,0.9897,31728825
19707,ranibizumab,gene,0.547,31728825
19708,RBZ,gene,0.6533,31728825
19709,nAMD,disease,1.0,31728825
19710,aflibercept,gene,0.991,31728825
19711,RBZ,drug,0.8267,31728825
19712,nAMD,disease,1.0,31728825
19713,aflibercept,gene,0.9907,31728825
19714,nAMD,disease,1.0,31728825
19715,aflibercept,gene,0.978,31728825
19716,RBZ,drug,0.9307,31728825
19717,aflibercept,gene,0.988,31728825
19718,RBZ,drug,0.8613,31728825
19719,aflibercept,gene,0.9893,31728825
19720,aflibercept,gene,0.9766,31728825
19721,Diabetic Retinopathy,disease,0.981,31728825
19722,aflibercept,gene,0.9575,31728825
19723,RBZ,drug,0.9507,31728825
19724,aflibercept,gene,0.98,31728825
19725,RBZ,drug,0.968,31728825
19726,aflibercept,gene,0.9795,31728825
19727,RBZ,drug,0.9683,31728825
19728,aflibercept,gene,0.985,31728825
19729,aflibercept,gene,0.9907,31728825
19730,RBZ,drug,0.8564,31728825
19731,aflibercept,gene,0.9863,31728825
19732,aflibercept,gene,0.976,31728825
19733,RBZ,drug,0.973,31728825
19734,RBZ,drug,0.921,31728825
19735,RBZ,drug,0.924,31728825
19736,aflibercept,gene,0.983,31728825
19737,RBZ,drug,0.5015,31728825
19738,nAMD,disease,1.0,31728825
19739,aflibercept,gene,0.9795,31728825
19740,RBZ,drug,0.914,31728825
19741,Bevacizumab,gene,0.8257,31727675
19742,VEGF-A,gene,0.9976,31727675
19743,PlGF,gene,0.9863,31727675
19744,Aflibercept,gene,0.952,31727675
19745,Aflibercept,gene,0.8477,31727675
19746,VEGF,gene,0.6846,31727675
19747,metastatic colorectal cancer,disease,1.0,31727675
19748,mCRC,disease,1.0,31727675
19749,oxaliplatin,drug,0.9995,31727675
19750,bevacizumab,gene,0.5527,31727675
19751,aflibercept,gene,0.9893,31727675
19752,bevacizumab,gene,0.933,31727675
19753,aflibercept,gene,0.973,31727675
19754,bevacizumab,gene,0.75,31727675
19755,bevacizumab,drug,0.628,31727675
19756,bevacizumab,gene,0.749,31727675
19757,VEGF-A,gene,0.997,31727675
19758,placental growth factor,gene,0.9985,31727675
19759,PlGF,gene,0.988,31727675
19760,bevacizumab,drug,0.873,31727675
19761,bevacizumab,gene,0.91,31727675
19762,VEGF-A,gene,0.9976,31727675
19763,PlGF,gene,0.9956,31727675
19764,aflibercept,gene,0.979,31727675
19765,VEGF-A,gene,0.999,31727675
19766,PlGF,gene,0.996,31727675
19767,VEGF-A,gene,0.996,31727675
19768,PlGF,gene,0.9937,31727675
19769,bevacizumab,gene,0.8433,31727675
19770,mCRC,disease,0.9985,31727675
19771,Aflibercept,gene,0.9663,31727675
19772,VEGF-A,gene,0.999,31727675
19773,PlGF,gene,0.9956,31727675
19774,bevacizumab,gene,0.856,31727675
19775,Ranibizumab,gene,0.9116,31718358
19776,Aflibercept,gene,0.973,31718358
19777,Macular Edema,disease,1.0,31718358
19778,ranibizumab,gene,0.9214,31718358
19779,aflibercept,gene,0.973,31718358
19780,macular edema,disease,1.0,31718358
19781,ME,disease,1.0,31718358
19782,serous retinal detachment,disease,1.0,31718358
19783,SRD,disease,1.0,31718358
19784,branch retinal vein occlusion,disease,1.0,31718358
19785,BRVO,disease,1.0,31718358
19786,patients,species,0.9824,31718358
19787,aflibercept,gene,0.9546,31718358
19788,patients,species,0.9683,31718358
19789,SRD,disease,0.996,31718358
19790,SRD,DNA,0.5317,31718358
19791,SRD,DNA,0.5527,31718358
19792,Aflibercept,gene,0.9634,31718358
19793,ranibizumab,gene,0.6294,31718358
19794,ME,disease,,31718358
19795,SRD,disease,0.9995,31718358
19796,BRVO,disease,0.999,31718358
19797,Diabetic Retinopathy,disease,1.0,31715608
19798,Oxygen,drug,0.9995,31715608
19799,diabetic retinopathy,disease,1.0,31715608
19800,DR,disease,1.0,31715608
19801,diabetic macular edema,disease,1.0,31715608
19802,DME,disease,0.965,31715608
19803,vascular endothelial growth factor,gene,0.998,31715608
19804,oxygen,drug,0.999,31715608
19805,DR,disease,,31715608
19806,anti-VEGF,gene,0.8833,31715608
19807,oxygen,drug,0.999,31715608
19808,DR,disease,,31715608
19809,aflibercept,gene,0.9673,31715608
19810,patients,species,0.975,31715608
19811,DME,disease,1.0,31715608
19812,DR lesions,disease,0.9814,31715608
19813,DR,disease,,31715608
19814,oxygen,drug,0.9985,31715608
19815,Patients,species,0.9487,31715608
19816,aflibercept,gene,0.985,31715608
19817,Patients,species,0.936,31715608
19818,proliferative DR,disease,0.9517,31715608
19819,oxygen,drug,0.999,31715608
19820,DR,disease,,31715608
19821,microaneurysms,disease,1.0,31715608
19822,hemorrhages,disease,0.9634,31715608
19823,DR lesions,disease,0.9966,31715608
19824,oxygen,drug,0.9985,31715608
19825,aflibercept,gene,0.984,31715608
19826,DR lesions,disease,0.9688,31715608
19827,oxygen,drug,0.995,31715608
19828,DR lesions,disease,0.999,31715608
19829,oxygen,drug,0.9644,31715608
19830,patients,species,0.9336,31715608
19831,DME,disease,1.0,31715608
19832,anti-VEGF,gene,0.7104,31715608
19833,DR,disease,,31715608
19834,oxygen,drug,0.9985,31715608
19835,DR,disease,,31715608
19836,wet-AMD,disease,0.9995,31714521
19837,patients,species,0.9956,31714521
19838,Age-related macular degeneration,disease,1.0,31714521
19839,visual deterioration,disease,1.0,31714521
19840,people,species,0.988,31714521
19841,corneal edema,disease,1.0,31714521
19842,hypoxic,disease,0.941,31714521
19843,patients,species,0.9736,31714521
19844,VEGF factors,gene,0.985,31714521
19845,anti-VEGF,gene,0.787,31714521
19846,VEGF,gene,0.717,31714521
19847,VEGF,gene,0.9136,31714521
19848,VEGF,gene,0.5234,31714521
19849,aflibercept,gene,0.9863,31714521
19850,aflibercept,gene,0.9697,31714521
19851,VEGF,gene,0.8574,31714511
19852,ranibizumab,gene,0.8516,31714511
19853,aflibercept,gene,0.9756,31714511
19854,patients,species,0.983,31714511
19855,neovascular age-related macular degeneration,disease,1.0,31714511
19856,nAMD,disease,1.0,31714511
19857,primary open-angle glaucoma,disease,1.0,31714511
19858,POAG,disease,1.0,31714511
19859,patients,species,0.9917,31714511
19860,nAMD,disease,1.0,31714511
19861,POAG,disease,1.0,31714511
19862,patients,species,0.9814,31714511
19863,patients,species,0.9927,31714511
19864,POAG,disease,0.9985,31714511
19865,patients,species,0.99,31714511
19866,POAG,disease,0.998,31714511
19867,patients,species,0.9873,31714511
19868,POAG,disease,0.999,31714511
19869,patients,species,0.9834,31714511
19870,nAMD,disease,1.0,31714511
19871,POAG,disease,0.9995,31714511
19872,VEGF,gene,0.8677,31714511
19873,patients,species,0.9917,31714511
19874,ranibizumab,gene,0.7715,31714511
19875,patients,species,0.9917,31714511
19876,aflibercept,gene,0.935,31714511
19877,anti-VEGF,gene,0.9336,31714511
19878,VEGF,gene,0.593,31714511
19879,ranibizumab,gene,0.6997,31714511
19880,aflibercept,gene,0.969,31714511
19881,ranibizumab,gene,0.809,31714511
19882,aflibercept,gene,0.9766,31714511
19883,patients,species,0.8955,31714511
19884,nAMD,disease,1.0,31714511
19885,POAG,disease,1.0,31714511
19886,ranibizumab,gene,0.896,31714511
19887,aflibercept,gene,0.9775,31714511
19888,patients,species,0.9575,31714511
19889,nAMD,disease,1.0,31714511
19890,POAG,disease,1.0,31714511
19891,Wet age-related macular degeneration,disease,1.0,31712027
19892,aflibercept,gene,0.8823,31712027
19893,Ranibizumab,gene,0.9497,31705192
19894,aflibercept,gene,0.988,31705192
19895,diabetic macular edema,disease,1.0,31705192
19896,ranibizumab,gene,0.702,31705192
19897,aflibercept,gene,0.959,31705192
19898,patients,species,0.968,31705192
19899,diabetic macular edema,disease,1.0,31705192
19900,DME,disease,1.0,31705192
19901,ranibizumab,gene,0.942,31705192
19902,aflibercept,gene,0.977,31705192
19903,Patients,species,0.972,31705192
19904,DME,disease,1.0,31705192
19905,Patients,species,0.957,31705192
19906,ranibizumab,gene,0.6943,31705192
19907,aflibercept,gene,0.9634,31705192
19908,fluorescein,drug,0.9976,31705192
19909,patients,species,0.965,31705192
19910,DME,disease,1.0,31705192
19911,ranibizumab,gene,0.5864,31705192
19912,aflibercept,gene,0.976,31705192
19913,ranibizumab,gene,0.676,31705192
19914,aflibercept,gene,0.96,31705192
19915,ranibizumab,drug,0.551,31705192
19916,aflibercept,gene,0.985,31705192
19917,patients,species,0.9775,31705192
19918,ranibizumab,gene,0.905,31705192
19919,aflibercept,gene,0.9727,31705192
19920,patients,species,0.9854,31705192
19921,ranibizumab,gene,0.857,31705192
19922,aflibercept,gene,0.9736,31705192
19923,DME,disease,1.0,31705192
19924,aflibercept,gene,0.937,31705192
19925,rosacea keratitis,disease,1.0,31691663
19926,corneal perforation,disease,0.9995,31691663
19927,Rosacea,disease,1.0,31691663
19928,polyethiologic chronic inflammatory disease,disease,0.9375,31691663
19929,dermatologic disease,disease,0.9976,31691663
19930,cornea,disease,0.936,31691663
19931,conjunctiva,disease,0.9946,31691663
19932,metalloproteinases,gene,0.8916,31691663
19933,vascular endothelial growth factor,gene,0.9966,31691663
19934,VEGF,gene,0.9956,31691663
19935,dry eye disease,disease,1.0,31691663
19936,severe rosacea,disease,0.9116,31691663
19937,VEGF,gene,0.9707,31691663
19938,rosacea keratitis,disease,1.0,31691663
19939,ranibizumab,gene,0.8926,31691657
19940,aflibercept,gene,0.959,31691657
19941,ranibizumab,gene,0.8804,31691657
19942,aflibercept,gene,0.952,31691657
19943,retinal nerve fiber layer,cell_type,0.627,31691657
19944,patients,species,0.977,31691657
19945,neovascular age-related macular degeneration,disease,1.0,31691657
19946,nAMD,disease,1.0,31691657
19947,primary open-angle glaucoma,disease,1.0,31691657
19948,POAG,disease,1.0,31691657
19949,patients,species,0.9917,31691657
19950,nAMD,disease,1.0,31691657
19951,POAG,disease,1.0,31691657
19952,Patients,species,0.991,31691657
19953,VEGF,gene,0.6626,31691657
19954,patients,species,0.9956,31691657
19955,ranibizumab,gene,0.843,31691657
19956,patients,species,0.995,31691657
19957,aflibercept,gene,0.977,31691657
19958,patients,species,0.9814,31691657
19959,ranibizumab,gene,0.8735,31691657
19960,aflibercept,gene,0.9644,31691657
19961,patients,species,0.952,31691657
19962,VEGF,gene,0.9253,31691657
19963,patients,species,0.977,31691657
19964,macular edema,disease,1.0,31691657
19965,peripapillary,DNA,0.491,31691657
19966,macular edema,disease,1.0,31691657
19967,ranibizumab,gene,0.905,31691657
19968,aflibercept,gene,0.9624,31691657
19969,patients,species,0.97,31691657
19970,nAMD,disease,1.0,31691657
19971,POAG,disease,1.0,31691657
19972,dexamethasone,drug,0.985,31691370
19973,ranibizumab,gene,0.6284,31691370
19974,aflibercept,gene,0.97,31691370
19975,patients,species,0.987,31691370
19976,aflibercept,gene,0.987,31691370
19977,dexamethasone,drug,0.9976,31691370
19978,patients,species,0.988,31691370
19979,ranibizumab,gene,0.9087,31691370
19980,aflibercept,gene,0.973,31691370
19981,dexamethasone,drug,0.9883,31691370
19982,patients,species,0.987,31691370
19983,ranibizumab,gene,0.7397,31691370
19984,aflibercept,gene,0.977,31691370
19985,dexamethasone,drug,0.992,31691370
19986,patients,species,0.989,31691370
19987,patients,species,0.992,31691370
19988,patients,species,0.993,31691370
19989,pseudophakic,disease,0.7944,31691370
19990,patients,species,0.9927,31691370
19991,dexamethasone,drug,0.996,31691370
19992,ranibizumab,gene,0.888,31691370
19993,aflibercept,gene,0.931,31691370
19994,Ziv-Aflibercept,gene,0.9707,31690175
19995,ziv,drug,0.7485,31690175
19996,aflibercept,gene,0.706,31690175
19997,IVZ,gene,0.9404,31690175
19998,patients,species,0.989,31690175
19999,chorioretinal conditions,disease,0.964,31690175
20000,IVZ,drug,0.9814,31690175
20001,IVZ,drug,0.9683,31690175
20002,IVZ,drug,0.774,31690175
20003,acute iridocyclitis,disease,1.0,31690175
20004,endophthalmitis,disease,1.0,31690175
20005,cataract,disease,1.0,31690175
20006,epiretinal membrane,disease,1.0,31690175
20007,IVZ,drug,0.984,31690175
20008,ziv-aflibercept,gene,0.9785,31690175
20009,IVZ,drug,0.868,31690175
20010,chorioretinal diseases,disease,1.0,31690175
20011,aflibercept,gene,0.973,31690105
20012,aflibercept,gene,0.9385,31690105
20013,choroidal neovascularization,disease,1.0,31690105
20014,PATIENTS,species,0.9536,31690105
20015,patients,species,0.9663,31690105
20016,myopic choroidal neovascularization,disease,1.0,31690105
20017,Patients,species,0.97,31690105
20018,aflibercept,gene,0.9834,31690105
20019,myopic,disease,0.9995,31690105
20020,patients,species,0.9756,31690105
20021,myopic choroidal neovascularization,disease,1.0,31690105
20022,aflibercept,gene,0.97,31690105
20023,ranibizumab,gene,0.523,31690105
20024,aflibercept,gene,0.9897,31690105
20025,ranibizumab,gene,0.7075,31690105
20026,patients,species,0.933,31690105
20027,myopic choroidal neovascularization,disease,1.0,31690105
20028,neovascular age-related macular,disease,1.0,31689763
20029,patients,species,0.9697,31689763
20030,age-related macular degeneration,disease,1.0,31689763
20031,AMD,disease,1.0,31689763
20032,vascular endothelial growth factor,gene,0.882,31689763
20033,VEGF,gene,0.9985,31689763
20034,aflibercept,gene,0.9688,31689763
20035,patients,species,0.985,31689763
20036,anti-VEGF,gene,0.9946,31689763
20037,aflibercept,gene,0.9956,31689763
20038,neovascular AMD,disease,1.0,31689763
20039,patients,species,0.9854,31689763
20040,BCVA,DNA,0.4766,31689763
20041,aflibercept,gene,0.9307,31689763
20042,VEGF,gene,0.5312,31689763
20043,BCVA,cell_type,0.4272,31689763
20044,BCVA,cell_type,0.4165,31689763
20045,RIP1 kinase,gene,0.924,31685620
20046,macrophages,cell_type,0.8623,31685620
20047,Receptor-interacting protein 1,gene,0.998,31685620
20048,RIP1,gene,0.994,31685620
20049,inflammatory cells,cell_type,0.9263,31685620
20050,RIP1,gene,0.994,31685620
20051,infiltrating,cell_type,0.4705,31685620
20052,macrophages,cell_type,0.4124,31685620
20053,RIP1 kinase,gene,0.9487,31685620
20054,kinase,gene,0.567,31685620
20055,RIP1,gene,0.5586,31685620
20056,K45A,gene,0.8096,31685620
20057,K45,mutation,,31685620
20058,K45,mutation,,31685620
20059,mice,species,0.9136,31685620
20060,necrostatin-1,drug,0.9756,31685620
20061,alkali injury,disease,0.9487,31685620
20062,mice,species,0.969,31685620
20063,caspase,gene,0.8975,31685620
20064,RIP1,gene,0.998,31685620
20065,RIP3,gene,0.9946,31685620
20066,macrophages,cell_type,0.748,31685620
20067,RIP1 kinase,gene,0.9805,31685620
20068,RIP1 kinase,gene,0.981,31685620
20069,caspase,gene,0.7256,31685620
20070,infiltrating macrophages,cell_type,0.5547,31685620
20071,RIP1,gene,0.993,31685620
20072,interleukin-4-activated bone marrow-derived macrophages,cell_line,0.956,31685620
20073,interleukin,disease,0.545,31685620
20074,interleukin-4,gene,0.982,31685620
20075,caspase,gene,0.9717,31685620
20076,RIP1 kinase,gene,0.956,31685620
20077,RIP1,gene,0.9976,31685620
20078,macrophage,cell_type,0.814,31685620
20079,capecitabine,drug,0.9995,31675952
20080,ziv-aflibercept,gene,0.9604,31675952
20081,Patients,species,0.928,31675952
20082,metastatic colorectal cancer,disease,0.991,31675952
20083,CRC,disease,1.0,31675952
20084,capecitabine,drug,0.998,31675952
20085,ziv-aflibercept,gene,0.965,31675952
20086,patients,species,0.9707,31675952
20087,metastatic CRC,disease,0.989,31675952
20088,patients,species,0.972,31675952
20089,patients,species,0.983,31675952
20090,advanced solid tumors,disease,1.0,31675952
20091,patients,species,0.9473,31675952
20092,metastatic CRC,disease,0.9976,31675952
20093,fluoropyrimidine,drug,0.9995,31675952
20094,oxaliplatin,drug,0.9995,31675952
20095,irinotecan,drug,0.9985,31675952
20096,bevacizumab,gene,0.7476,31675952
20097,EGFR antibody,gene,0.914,31675952
20098,RAS,gene,0.992,31675952
20099,patients,species,0.98,31675952
20100,capecitabine,drug,0.999,31675952
20101,ziv-aflibercept,gene,0.9443,31675952
20102,patients,species,0.9624,31675952
20103,patients,species,0.988,31675952
20104,erythrodysesthesia,disease,1.0,31675952
20105,hypertension,disease,1.0,31675952
20106,mucositis,disease,1.0,31675952
20107,RNA,RNA,0.579,31675952
20108,tumor specimens,cell_type,0.4622,31675952
20109,tumor,disease,1.0,31675952
20110,capecitabine,drug,0.999,31675952
20111,ziv-aflibercept,gene,0.953,31675952
20112,patients,species,0.9785,31675952
20113,metastatic CRC,disease,0.885,31675952
20114,patients,species,0.9116,31673841
20115,age-related macular,disease,1.0,31673841
20116,age-related macular degeneration,disease,0.999,31673841
20117,wAMD,disease,0.999,31673841
20118,patients,species,0.973,31673841
20119,aflibercept,gene,0.9756,31673841
20120,AFL,gene,0.5835,31673841
20121,patients,species,0.991,31673841
20122,patients,species,0.9956,31673841
20123,patients,species,0.9946,31673841
20124,AFL,gene,0.7705,31673841
20125,BCVA,cell_type,0.4282,31673841
20126,patients,species,0.9814,31673841
20127,patients,species,0.9106,31673841
20128,wAMD,disease,0.9995,31673841
20129,Retinal vein occlusion,disease,1.0,31670978
20130,cardiovascular diseases,disease,1.0,31670978
20131,vascular endothelial growth factor,gene,0.994,31670978
20132,anti-vascular endothelial growth factor,gene,0.9517,31670978
20133,retinal vein occlusion,disease,1.0,31670978
20134,patients,species,0.993,31670978
20135,retinal vein occlusion,disease,1.0,31670978
20136,patients,species,0.989,31670978
20137,anti-,gene,0.754,31670978
20138,vascular endothelial growth factor,gene,0.8716,31670978
20139,patients,species,0.9897,31670978
20140,vascular endothelial growth factor,gene,0.9897,31670978
20141,hypertension,disease,0.9995,31670978
20142,heart,DNA,0.52,31670978
20143,heart rate disorders,disease,0.979,31670978
20144,aflibercept,gene,0.978,31670978
20145,ranibizumab,gene,0.5034,31670978
20146,ranibizumab,gene,0.7646,31670978
20147,ranibizumab,gene,0.7812,31670978
20148,central retinal vein occlusion,disease,1.0,31670978
20149,anti-vascular endothelial growth factor,gene,0.9365,31670978
20150,hypertension,disease,1.0,31670978
20151,heart,disease,0.943,31670978
20152,retinal vein occlusion,disease,1.0,31670978
20153,patients,species,0.991,31670978
20154,anti-VEGF,gene,0.734,31669558
20155,age-related macular degeneration,disease,1.0,31669558
20156,Age-related macular degeneration,disease,1.0,31669558
20157,vision loss,disease,0.999,31669558
20158,people,species,0.9683,31669558
20159,anti-VEGF,gene,0.6333,31669558
20160,bevacizumab,gene,0.95,31669558
20161,aflibercept,gene,0.974,31669558
20162,ranibizumab,gene,0.789,31669558
20163,VEGF,gene,0.7305,31669558
20164,liposomes,cell_type,0.4368,31669558
20165,anti-VEGF,gene,0.963,31669558
20166,diabetic retinopathy,disease,1.0,31669065
20167,diabetes,disease,1.0,31669065
20168,diabetic retinopathy,disease,1.0,31669065
20169,DR,disease,1.0,31669065
20170,DR,disease,,31669065
20171,macular edema,disease,1.0,31669065
20172,DR,disease,,31669065
20173,vision loss,disease,0.986,31669065
20174,Vascular endothelial growth factor (VEGF)-A,gene,0.9966,31669065
20175,diabetic,disease,1.0,31669065
20176,DR,disease,,31669065
20177,VEGF,gene,0.9575,31669065
20178,DR,disease,,31669065
20179,Diabetic Retinopathy,disease,1.0,31669065
20180,Diabetic Retinopathy,disease,0.999,31669065
20181,patients,species,0.9937,31669065
20182,DR,disease,,31669065
20183,macular edema,disease,1.0,31669065
20184,ranibizumab,gene,0.9004,31669065
20185,aflibercept,gene,0.9536,31669065
20186,DR,disease,,31669065
20187,ranibizumab,gene,0.8394,31669065
20188,patients,species,0.9863,31669065
20189,nonproliferative DR,disease,0.9976,31669065
20190,macular edema,disease,1.0,31669065
20191,VEGF,gene,0.9946,31669065
20192,DR,disease,,31669065
20193,Wet Age-Related Macular Degeneration,disease,0.9995,31662900
20194,wet AMD,disease,1.0,31662900
20195,wAMD,disease,1.0,31662900
20196,wAMD,disease,0.9995,31662900
20197,Retina,cell_type,0.4507,31662900
20198,wAMD,disease,1.0,31662900
20199,anti-VEGF,gene,0.8457,31662900
20200,aflibercept,gene,0.9775,31662900
20201,ranibizumab,gene,0.592,31662900
20202,patients,species,0.936,31662900
20203,wAMD,disease,0.997,31662900
20204,VEGF,gene,0.6143,31662900
20205,Retinal Vein Occlusion,disease,1.0,31660113
20206,retinal vein occlusion,disease,0.9995,31660113
20207,central retinal vein occlusion,disease,1.0,31660113
20208,CRVO,disease,1.0,31660113
20209,branch retinal vein occlusion,disease,1.0,31660113
20210,BRVO,disease,0.9995,31660113
20211,anti-Vascular Endothelial Growth Factor,gene,0.9873,31660113
20212,VEGF,gene,0.996,31660113
20213,steroids,drug,0.9062,31660113
20214,CRVO,disease,0.9995,31660113
20215,BRVO,disease,0.999,31660113
20216,triamcinolone,drug,0.9995,31660113
20217,dexamethasone,drug,0.999,31660113
20218,ranibizumab,gene,0.9507,31660113
20219,bevacizumab,gene,0.9395,31660113
20220,aflibercept,gene,0.978,31660113
20221,RVO,disease,1.0,31660113
20222,ranibizumab,gene,0.4958,31660113
20223,Diabetic Retinopathy,disease,1.0,31660113
20224,ranibizumab,gene,0.597,31660113
20225,bevacizumab,gene,0.5464,31660113
20226,triamcinolone,drug,0.9985,31660113
20227,Triamcinolone,drug,0.9985,31660113
20228,VEGF,gene,0.908,31660113
20229,RVO,disease,1.0,31660113
20230,bevacizumab,gene,0.685,31660113
20231,triamcinolone,drug,0.995,31660113
20232,retinal,DNA,0.4956,31654501
20233,diabetic macular oedema,disease,1.0,31654501
20234,aflibercept,gene,0.974,31654501
20235,diabetic macular oedema,disease,1.0,31654501
20236,DME,disease,1.0,31654501
20237,DME,disease,0.9976,31654501
20238,aflibercept,gene,0.9805,31654501
20239,aflibercept,gene,0.9746,31654501
20240,M12,cell_line,0.4463,31654501
20241,DME,drug,0.9795,31654501
20242,diabetic macular oedema,disease,1.0,31654481
20243,neovascular age-related macular degeneration,disease,1.0,31654481
20244,vascular endothelial growth factor,gene,0.9976,31654481
20245,ranibizumab,gene,0.8003,31654481
20246,aflibercept,gene,0.971,31654481
20247,oxygen,drug,0.9956,31654481
20248,oxygen,drug,0.999,31654481
20249,diabetic macular oedema,disease,1.0,31654481
20250,DME,disease,1.0,31654481
20251,choroidal neovascularization,disease,1.0,31654481
20252,CNV,disease,1.0,31654481
20253,age-related macular degeneration,disease,1.0,31654481
20254,oxygen,drug,0.993,31654481
20255,ranibizumab,gene,0.9287,31654481
20256,aflibercept,gene,0.9766,31654481
20257,CNV,disease,0.9995,31654481
20258,DME,disease,0.995,31654481
20259,DME,disease,1.0,31654481
20260,CNV,disease,0.9985,31654481
20261,DME,disease,1.0,31654481
20262,CNV,DNA,0.8027,31654481
20263,DME,disease,0.685,31654481
20264,DME,disease,1.0,31654481
20265,oxygen,drug,0.999,31654481
20266,diabetic,disease,0.9995,31654481
20267,oxygen,drug,0.9995,31654481
20268,Aflibercept,gene,0.9385,31648924
20269,Metastatic Colorectal Carcinoma,disease,1.0,31648924
20270,aflibercept,gene,0.9014,31648924
20271,aflibercept,gene,0.9834,31648924
20272,metastatic colorectal cancer,disease,0.9995,31648924
20273,PATIENTS,species,0.9717,31648924
20274,Metastatic colorectal cancer,disease,1.0,31648924
20275,aflibercept,gene,0.9673,31648924
20276,leucovorin,drug,0.9995,31648924
20277,5-fluorouracil,drug,0.9995,31648924
20278,irinotecan,drug,0.9995,31648924
20279,oxaliplatin,drug,0.9995,31648924
20280,bevacizumab,gene,0.899,31648924
20281,aflibercept,gene,0.978,31648924
20282,bevacizumab,gene,0.8804,31648924
20283,bevacizumab,gene,0.9067,31648924
20284,aflibercept,gene,0.9487,31648924
20285,ziv-aflibercept,gene,0.9927,31647843
20286,choroido-retinal vascular diseases,disease,1.0,31647843
20287,ziv-aflibercept,gene,0.9917,31647843
20288,choroido-retinal vascular diseases,disease,1.0,31647843
20289,patients,species,0.987,31647843
20290,macular oedema,disease,1.0,31647843
20291,diabetic retinopathy,disease,1.0,31647843
20292,retinal vein occlusion,disease,1.0,31647843
20293,neovascular age-related macular degeneration,disease,1.0,31647843
20294,IVZ,drug,0.968,31647843
20295,IVZ,drug,0.9824,31647843
20296,subconjunctival haemorrhage,disease,0.9995,31647843
20297,IVZ,drug,0.968,31647843
20298,Macular Degeneration,disease,1.0,31643677
20299,Macular degeneration,disease,1.0,31643677
20300,age-related disease of the retina,disease,1.0,31643677
20301,vascular endothelial growth factor,gene,0.9976,31643677
20302,VEGF,gene,0.997,31643677
20303,VEGF,gene,0.994,31643677
20304,neovascular or &quot;wet&quot; macular degeneration,disease,1.0,31643677
20305,VEGF,gene,0.95,31643677
20306,bevacizumab,gene,0.919,31643677
20307,ranibizumab,gene,0.8677,31643677
20308,VEGF,gene,0.9893,31643677
20309,pegaptanib,drug,0.941,31643677
20310,fusion VEGF receptor proteins,gene,0.841,31643677
20311,circulating growth factor,gene,0.9956,31643677
20312,aflibercept,gene,0.9956,31643677
20313,cerebrovascular thromoembolic events,disease,0.8574,31643677
20314,macular degeneration,disease,1.0,31643677
20315,liver injury,disease,0.999,31643677
20316,neoplastic conditions,disease,1.0,31643677
20317,liver injury,disease,0.9517,31643677
20318,Lectin,gene,0.975,31645047
20319,Aqueous Humor,disease,1.0,31645047
20320,Neovascular Age-Related Macular Degeneration,disease,1.0,31645047
20321,lectin,gene,0.9756,31645047
20322,neovascular age-related macular degeneration,disease,1.0,31645047
20323,nAMD,disease,1.0,31645047
20324,complement,gene,0.52,31645047
20325,nAMD,disease,1.0,31645047
20326,cataract,disease,1.0,31645047
20327,nAMD,disease,0.9995,31645047
20328,cataract,disease,1.0,31645047
20329,aflibercept,gene,0.9883,31645047
20330,ranibizumab,gene,0.9263,31645047
20331,nAMD,disease,1.0,31645047
20332,cataract,disease,0.7725,31645047
20333,cataract,disease,1.0,31645047
20334,complement C4,gene,0.945,31645047
20335,complement C3,gene,0.908,31645047
20336,mannose,drug,0.9995,31645047
20337,mannose-binding lectin-associated serine protease,gene,0.9937,31645047
20338,MASP)-2,gene,0.9854,31645047
20339,LP,cell_type,0.6143,31645047
20340,C4a,gene,0.985,31645047
20341,C3a,gene,0.989,31645047
20342,C4,gene,0.9844,31645047
20343,C3,gene,0.9907,31645047
20344,C4a,gene,0.992,31645047
20345,C4,gene,0.9897,31645047
20346,C3a,gene,0.9927,31645047
20347,C3,gene,0.991,31645047
20348,C4,gene,0.991,31645047
20349,C3,gene,0.978,31645047
20350,C4,gene,0.9834,31645047
20351,C3,gene,0.9824,31645047
20352,MASP-2,gene,0.9893,31645047
20353,nAMD,disease,1.0,31645047
20354,C4a,gene,0.98,31645047
20355,C3a,gene,0.989,31645047
20356,C4a,gene,0.997,31645047
20357,C4,gene,0.9873,31645047
20358,C3a,gene,0.9937,31645047
20359,C3,gene,0.986,31645047
20360,nAMD,disease,1.0,31645047
20361,nAMD,disease,1.0,31645047
20362,nAMD,disease,1.0,31645047
20363,MASP-2,gene,0.992,31645047
20364,nAMD,disease,1.0,31645047
20365,MASP-2,gene,0.993,31645047
20366,LP,cell_type,0.519,31645047
20367,ranibizumab,gene,0.7725,31644594
20368,aflibercept,gene,0.956,31644594
20369,diabetic macular edema,disease,1.0,31644594
20370,ranibizumab,gene,0.8965,31644594
20371,aflibercept,gene,0.976,31644594
20372,diabetic macular edema,disease,1.0,31644594
20373,diabetic macular edema,disease,1.0,31644594
20374,ranibizumab,gene,0.91,31644594
20375,aflibercept,gene,0.984,31644594
20376,fluorescein,drug,0.984,31644594
20377,ranibizumab,gene,0.754,31644594
20378,aflibercept,gene,0.9907,31644594
20379,ranibizumab,gene,0.816,31644594
20380,aflibercept,gene,0.9844,31644594
20381,glycosylated hemoglobin,gene,0.9487,31644594
20382,ranibizumab,gene,0.83,31644594
20383,aflibercept,gene,0.9805,31644594
20384,ranibizumab,gene,0.7524,31644594
20385,aflibercept,gene,0.951,31644594
20386,diabetic macular edema,disease,1.0,31644594
20387,vascular endothelial growth factor,gene,0.9985,31642333
20388,ranibizumab,gene,0.6943,31642333
20389,aflibercept,gene,0.9385,31642333
20390,bevacizumab,gene,0.748,31642333
20391,patients,species,0.9717,31642333
20392,wet,disease,0.602,31642333
20393,age-related macular degeneration,disease,0.9917,31642333
20394,patients,species,0.989,31642333
20395,age-related macular degeneration,disease,1.0,31642333
20396,Diabetic Retinopathy,disease,1.0,31642333
20397,ranibizumab,gene,0.5693,31642333
20398,aflibercept,gene,0.9355,31642333
20399,Diabetic Retinopathy,disease,1.0,31642333
20400,ranibizumab,gene,0.6514,31642333
20401,aflibercept,gene,0.984,31642333
20402,ranibizumab,gene,0.749,31642333
20403,aflibercept,gene,0.9893,31642333
20404,patients,species,0.9873,31642333
20405,ranibizumab,gene,0.918,31642333
20406,aflibercept,gene,0.979,31642333
20407,patients,species,0.9453,31642333
20408,neovascular age-related macular degeneration,disease,1.0,31642333
20409,ranibizumab,gene,0.91,31642333
20410,aflibercept,gene,0.9756,31642333
20411,bevacizumab,gene,0.812,31642333
20412,patients,species,0.9907,31642333
20413,Ozurdex,drug,0.914,31638037
20414,anti-,gene,0.915,31638037
20415,vascular endothelial growth factor,gene,0.8955,31638037
20416,dexamethasone,drug,0.9985,31638037
20417,DEX,drug,0.998,31638037
20418,vascular endothelial growth factor,gene,0.845,31638037
20419,VEGF,gene,0.998,31638037
20420,macular edema,disease,1.0,31638037
20421,ME,disease,1.0,31638037
20422,retinal vein occlusion,disease,1.0,31638037
20423,RVO,disease,1.0,31638037
20424,central retinal vein occlusion,disease,1.0,31638037
20425,CRVO,disease,1.0,31638037
20426,branch retinal vein occlusion,disease,1.0,31638037
20427,BRVO,disease,1.0,31638037
20428,DEX,drug,0.8564,31638037
20429,VEGF,gene,0.8228,31638037
20430,patients,species,0.9746,31638037
20431,RVO,disease,1.0,31638037
20432,ME,disease,,31638037
20433,DEX,drug,0.9624,31638037
20434,VEGF,gene,0.9517,31638037
20435,CRT,DNA,0.512,31638037
20436,VEGF,gene,0.881,31638037
20437,DEX,drug,0.762,31638037
20438,VEGF,gene,0.9243,31638037
20439,cataract,disease,1.0,31638037
20440,VEGF,gene,0.9556,31638037
20441,cataract,disease,1.0,31638037
20442,RVO,disease,1.0,31638037
20443,ME,disease,,31638037
20444,DEX,drug,0.929,31638037
20445,cataract,disease,1.0,31638037
20446,VEGF,gene,0.976,31638037
20447,Vascular Endothelial Growth Factor,gene,0.9243,31631966
20448,Retinal Angiomatous Proliferation,disease,1.0,31631966
20449,anti-vascular endothelial growth factor,gene,0.865,31631966
20450,VEGF,gene,0.989,31631966
20451,retinal angiomatous proliferation,disease,1.0,31631966
20452,RAP,disease,1.0,31631966
20453,VEGF,gene,0.9077,31631966
20454,BCVA,cell_type,0.4175,31631966
20455,subretinal hemorrhage,disease,0.9985,31631966
20456,fibrotic scars,disease,0.9995,31631966
20457,macular atrophy,disease,1.0,31631966
20458,RAP,disease,0.9995,31631966
20459,VEGF,gene,0.688,31631966
20460,RAP,disease,1.0,31631966
20461,aflibercept,gene,0.9727,31619777
20462,diabetic macular oedema,disease,1.0,31619777
20463,DMO,disease,1.0,31619777
20464,aflibercept,gene,0.9834,31619777
20465,SmPC,cell_line,0.7974,31619777
20466,patients,species,0.9707,31619777
20467,aflibercept,gene,0.982,31619777
20468,Patients,species,0.965,31619777
20469,aflibercept,gene,0.965,31619777
20470,aflibercept,gene,0.956,31619777
20471,patients,species,0.99,31619777
20472,vascular endothelial growth factor,gene,0.9893,31619777
20473,aflibercept,gene,0.9604,31619777
20474,DMO,disease,1.0,31619777
20475,Macular Atrophy,disease,1.0,31619357
20476,Neovascular Age-Related Macular Degeneration,disease,1.0,31619357
20477,Ranibizumab,gene,0.8755,31619357
20478,Aflibercept,gene,0.84,31619357
20479,macular atrophy,disease,1.0,31619357
20480,MA,disease,1.0,31619357
20481,ranibizumab,gene,0.7026,31619357
20482,aflibercept,gene,0.944,31619357
20483,neovascular age-related macular degeneration,disease,1.0,31619357
20484,nAMD,disease,1.0,31619357
20485,PARTICIPANTS,species,0.5977,31619357
20486,subfoveal choroidal neovascularization,disease,1.0,31619357
20487,nAMD,disease,1.0,31619357
20488,ranibizumab,gene,0.506,31619357
20489,aflibercept,gene,0.9146,31619357
20490,BCVA,DNA,0.4585,31619357
20491,ranibizumab,gene,0.712,31619357
20492,aflibercept,gene,0.975,31619357
20493,aflibercept,gene,0.673,31619357
20494,MA,disease,0.5244,31619357
20495,ranibizumab,gene,0.631,31619357
20496,aflibercept,gene,0.98,31619357
20497,ranibizumab,gene,0.7876,31619357
20498,aflibercept,gene,0.98,31619357
20499,BCVA,DNA,0.458,31619357
20500,aflibercept,gene,0.966,31619357
20501,MA,disease,0.9995,31619357
20502,ranibizumab,gene,0.9214,31619357
20503,aflibercept,gene,0.9688,31619357
20504,nAMD,disease,1.0,31619357
20505,anti-vascular endothelial growth factor,gene,0.8574,31615761
20506,choroidal neovascularisation,disease,1.0,31615761
20507,chronic central serous chorioretinopathy,disease,1.0,31615761
20508,vascular endothelial growth factor,gene,0.987,31615761
20509,VEGF,gene,0.997,31615761
20510,choroidal neovascularisation,disease,1.0,31615761
20511,CNV,disease,1.0,31615761
20512,serous chorioretinopathy,disease,0.982,31615761
20513,CSC,disease,1.0,31615761
20514,CNV,disease,0.9976,31615761
20515,CSC,disease,1.0,31615761
20516,VEGF,gene,0.786,31615761
20517,ranibizumab,gene,0.847,31615761
20518,aflibercept,gene,0.9536,31615761
20519,CNV,disease,0.998,31615761
20520,CNV,DNA,0.6875,31615761
20521,CNV,DNA,0.5215,31615761
20522,CNV,DNA,0.5293,31615761
20523,retinal fluid,disease,0.768,31615761
20524,CRT,DNA,0.5264,31615761
20525,CNV,DNA,0.7017,31615761
20526,VEGF,gene,0.859,31615761
20527,CNV,disease,0.5557,31615761
20528,CNV,disease,0.9995,31615761
20529,CSC,disease,0.532,31615761
20530,VASCULAR ENDOTHELIAL GROWTH,disease,0.9844,31613840
20531,NEOVASCULAR AGE-RELATED MACULAR DEGENERATION,disease,0.959,31613840
20532,vascular endothelial growth factor,gene,0.999,31613840
20533,neovascular age-related macular degeneration,disease,1.0,31613840
20534,neovascular age-related macular degeneration,disease,1.0,31613840
20535,Retinal Blindness,disease,0.9985,31613840
20536,vascular endothelial growth factor,gene,0.998,31613840
20537,choroidal neovascular membrane,disease,1.0,31613840
20538,vascular endothelial growth factor,gene,0.998,31613840
20539,neovascular age-related macular degeneration,disease,1.0,31613840
20540,AMD,disease,1.0,31611234
20541,Neovascular age-related macular degeneration,disease,1.0,31611234
20542,nAMD,disease,1.0,31611234
20543,nAMD,disease,1.0,31611234
20544,macular scarring,disease,1.0,31611234
20545,AMD,disease,0.9995,31611234
20546,patients,species,0.985,31611234
20547,nAMD,disease,1.0,31611234
20548,PIGF,gene,0.9927,31608707
20549,colorectal cancer,disease,1.0,31608707
20550,colorectal cancer,disease,1.0,31608707
20551,VEGF,gene,0.8574,31608707
20552,VEGFR,gene,0.9927,31608707
20553,placental growth factor,gene,0.9976,31608707
20554,PlGF,gene,0.983,31608707
20555,PlGF,gene,0.9785,31608707
20556,aflibercept,gene,0.9873,31608707
20557,regorafenib,drug,0.934,31608707
20558,Aflibercept,gene,0.9834,31608707
20559,VEGFs,gene,0.9976,31608707
20560,PlGF,gene,0.994,31608707
20561,VEGFR,gene,0.9556,31608707
20562,Bevacizumab,gene,0.53,31608707
20563,VEGF-A,gene,0.9976,31608707
20564,VEGFR,gene,0.986,31608707
20565,FOLFIRI,drug,0.8867,31608707
20566,aflibercept,gene,0.979,31608707
20567,metastatic CRC,disease,0.9907,31608707
20568,oxaliplatin,drug,0.9995,31608707
20569,humanized,species,0.7153,31608707
20570,immunoglobulin G1,gene,0.9385,31608707
20571,IgG-1,gene,0.949,31608707
20572,regorafenib,drug,0.9707,31608707
20573,choroidal neovascularization,disease,1.0,31607068
20574,pathological myopia,disease,0.9995,31607068
20575,Pathological myopia,disease,0.822,31607068
20576,high myopia,disease,0.991,31607068
20577,Choroidal neovascularization,disease,1.0,31607068
20578,visual loss,disease,0.9985,31607068
20579,VEGF,gene,0.8486,31607068
20580,VEGF,gene,0.5576,31607068
20581,bevacizumab,gene,0.7383,31607068
20582,ranibizumab,gene,0.8286,31607068
20583,aflibercept,gene,0.967,31607068
20584,conbercept,gene,0.5864,31607068
20585,VEGF,gene,0.786,31607068
20586,Aflibercept,gene,0.9204,31602811
20587,diabetic macular oedema,disease,1.0,31602811
20588,aflibercept,gene,0.988,31602811
20589,aflibercept,gene,0.989,31602811
20590,diabetic macular oedema,disease,1.0,31602811
20591,DME,disease,1.0,31602811
20592,patients,species,0.978,31602811
20593,DME,disease,1.0,31602811
20594,aflibercept,gene,0.9736,31602811
20595,patients,species,0.976,31602811
20596,Diabetic Retinopathy,disease,0.9946,31602811
20597,patients,species,0.9873,31602811
20598,aflibercept,gene,0.9375,31602811
20599,Scleral Dehiscence,disease,0.999,31600373
20600,Aflibercept,gene,0.8745,31600373
20601,Vascular Endothelial,gene,0.8945,31600368
20602,aflibercept,gene,0.9814,31600368
20603,vascular endothelial growth factor,gene,0.94,31600368
20604,VEGF,gene,0.9956,31600368
20605,macular edema,disease,1.0,31600368
20606,central retinal vein occlusion,disease,1.0,31600368
20607,CRVO,disease,1.0,31600368
20608,hemiretinal vein occlusion,disease,1.0,31600368
20609,HRVO,disease,0.999,31600368
20610,participants,species,0.9395,31600368
20611,Retinal Vein Occlusion,disease,1.0,31600368
20612,PARTICIPANTS,species,0.686,31600368
20613,participants,species,0.949,31600368
20614,aflibercept,gene,0.8994,31600368
20615,participants,species,0.9746,31600368
20616,bevacizumab,gene,0.774,31600368
20617,participants,species,0.967,31600368
20618,participants,species,0.975,31600368
20619,aflibercept,gene,0.988,31600368
20620,bevacizumab,gene,0.6855,31600368
20621,aflibercept,gene,0.9717,31600368
20622,bevacizumab,gene,0.842,31600368
20623,aflibercept,gene,0.969,31600368
20624,bevacizumab,gene,0.8486,31600368
20625,aflibercept,gene,0.974,31600368
20626,bevacizumab,gene,0.7607,31600368
20627,aflibercept,gene,0.986,31600368
20628,bevacizumab,gene,0.891,31600368
20629,participants,species,0.9546,31600368
20630,aflibercept,gene,0.9604,31600368
20631,bevacizumab,gene,0.803,31600368
20632,CRVO,disease,1.0,31600368
20633,HRVO,disease,1.0,31600368
20634,VEGF,gene,0.785,31600368
20635,Proliferative Diabetic Retinopathy,disease,1.0,31595210
20636,proliferative,disease,0.719,31595210
20637,diabetic retinopathy,disease,0.823,31595210
20638,proliferative diabetic retinopathy,disease,1.0,31595210
20639,PDR,disease,1.0,31595210
20640,anti-,gene,0.634,31595210
20641,vascular endothelial growth factor,gene,0.916,31595210
20642,PDR,disease,0.9995,31595210
20643,PRP,cell_type,0.728,31595210
20644,PDR,disease,0.874,31595210
20645,PDR,disease,0.793,31595210
20646,PRP,cell_type,0.727,31595210
20647,anti-VEGF,gene,0.771,31595210
20648,Aflibercept,gene,0.988,31593948
20649,Bevacizumab,gene,0.819,31593948
20650,Retinopathy of Prematurity,disease,1.0,31593948
20651,aflibercept,gene,0.989,31593948
20652,bevacizumab,gene,0.7173,31593948
20653,retinopathy of prematurity,disease,1.0,31593948
20654,fluorescein,drug,0.968,31593948
20655,VEGF,gene,0.5537,31593948
20656,RVDB,DNA,0.6333,31593948
20657,RVDB,DNA,0.574,31593948
20658,aflibercept,gene,0.9614,31593948
20659,bevacizumab,gene,0.691,31593948
20660,anti-VEGF,gene,0.9404,31593948
20661,temporal,DNA,0.578,31593948
20662,IVA,drug,0.7705,31593948
20663,RVDB,DNA,0.4836,31593948
20664,Anti-Vascular Endothelial Growth Factor,gene,0.991,31589766
20665,Neovascular Age,disease,0.9844,31589766
20666,anti-vascular endothelial growth factor,gene,0.995,31589766
20667,neovascular age-related macular degeneration,disease,1.0,31589766
20668,nAMD,disease,1.0,31589766
20669,PATIENTS,species,0.965,31589766
20670,nAMD,disease,1.0,31589766
20671,exudative disease,disease,0.999,31589766
20672,nAMD,disease,1.0,31589766
20673,retinal diseases,disease,1.0,31587508
20674,retinal diseases,disease,1.0,31587508
20675,age-related macular degeneration,disease,1.0,31587508
20676,AMD,disease,1.0,31587508
20677,diabetic macular oedema,disease,1.0,31587508
20678,retinal venous occlusions,disease,1.0,31587508
20679,Patient,species,0.907,31587508
20680,patient,species,0.9854,31587508
20681,patients,species,0.993,31587508
20682,wet AMD,disease,0.999,31587508
20683,patients,species,0.9854,31587508
20684,wet AMD,disease,0.998,31587508
20685,aflibercept,gene,0.987,31564356
20686,pigment epithelial detachments,disease,1.0,31564356
20687,aflibercept,gene,0.9844,31564356
20688,visual,disease,0.744,31564356
20689,patients,species,0.9404,31564356
20690,PED,disease,1.0,31564356
20691,neovascular age-related macular degeneration,disease,1.0,31564356
20692,nAMD,disease,1.0,31564356
20693,Participants,species,0.9185,31564356
20694,PED,disease,0.995,31564356
20695,nAMD,disease,1.0,31564356
20696,aflibercept,gene,0.9834,31564356
20697,fluorescein,drug,0.9873,31564356
20698,participants,species,0.9785,31564356
20699,PED,DNA,0.5938,31564356
20700,Participant,species,0.934,31564356
20701,PED,DNA,0.5527,31564356
20702,PED,DNA,0.532,31564356
20703,Diabetic Retinopathy,disease,0.9775,31564356
20704,aflibercept,gene,0.99,31564356
20705,patients,species,0.9155,31564356
20706,PEDs,disease,0.9995,31564356
20707,nAMD,disease,1.0,31564356
20708,vascular endothelial growth factor,gene,0.997,35116988
20709,bevacizumab,gene,0.4888,35116988
20710,vascular endothelial growth factor,gene,0.998,35116988
20711,VEGFis,gene,0.8394,35116988
20712,bevacizumab,gene,0.789,35116988
20713,aflibercept,gene,0.97,35116988
20714,patients,species,0.9507,35116988
20715,metastatic colorectal cancer,disease,0.9976,35116988
20716,mCRC,disease,0.999,35116988
20717,bevacizumab,gene,0.853,35116988
20718,patients,species,0.976,35116988
20719,mCRC,disease,0.9985,35116988
20720,VEGFi,gene,0.989,35116988
20721,VEGFi,gene,0.9844,35116988
20722,VEGFi,gene,0.9824,35116988
20723,VEGFi,gene,0.991,35116988
20724,mutant-type RAS,gene,0.954,35116988
20725,mCRC,disease,0.998,35116988
20726,Patients,species,0.973,35116988
20727,VEGFi,gene,0.959,35116988
20728,VEGFi,gene,0.981,35116988
20729,bevacizumab,gene,0.8657,35116988
20730,OCS,disease,1.0,35116988
20731,Bevacizumab,gene,0.939,35116988
20732,aflibercept,gene,0.9907,35116988
20733,mCRC,disease,0.9814,35116988
20734,RAS gene type,DNA,0.7686,35116988
20735,RAS gene,gene,0.99,35116988
20736,VEGFi,gene,0.969,35116988
20737,FOLOFX6,drug,0.9824,35116988
20738,FLFOX6,drug,0.9087,35116988
20739,left-sided lesions,disease,0.7207,35116988
20740,right,DNA,0.4746,35116988
20741,Diabetic Retinopathy,disease,1.0,31554001
20742,Diabetic Retinopathy,disease,1.0,31554001
20743,Diabetic Retinopathy,disease,1.0,31554001
20744,diabetic eye disease,disease,1.0,31554001
20745,vascular endothelial growth factor,gene,0.9873,31554001
20746,VEGF,gene,0.994,31554001
20747,proliferative diabetic retinopathy,disease,1.0,31554001
20748,PDR,disease,1.0,31554001
20749,visual impairment,disease,1.0,31554001
20750,diabetic macular edema,disease,1.0,31554001
20751,DME,disease,1.0,31554001
20752,diabetic,disease,1.0,31554001
20753,VEGF,gene,0.9146,31554001
20754,non-proliferative diabetic retinopathy,disease,0.993,31554001
20755,DME,disease,1.0,31554001
20756,DME,disease,1.0,31554001
20757,bevacizumab,gene,0.87,31554001
20758,aflibercept,gene,0.9775,31554001
20759,aflibercept,gene,0.9746,31554001
20760,non-diabetic eye disease,disease,1.0,31554001
20761,age-related macular degeneration,disease,1.0,31554001
20762,VEGF-Trap,gene,0.919,31550048
20763,dopaminergic,cell_type,0.46,31550048
20764,degenerative ischemic neovascular retinopathy,disease,1.0,31550048
20765,microvascular hyper-permeability,disease,0.999,31550048
20766,ischemic retinopathies,disease,1.0,31550048
20767,vascular endothelial growth factor A,gene,0.999,31550048
20768,VEGF-A,gene,0.998,31550048
20769,retinal neurons,cell_type,0.785,31550048
20770,oxygen,drug,0.9995,31550048
20771,OIR,disease,0.997,31550048
20772,mice,species,0.97,31550048
20773,retinal microvascular malformations,disease,0.9995,31550048
20774,neuronal dysfunction,disease,0.9995,31550048
20775,OIR,cell_line,0.5146,31550048
20776,mice,species,0.9824,31550048
20777,retinopathy of prematurity,disease,1.0,31550048
20778,proliferative,disease,0.982,31550048
20779,diabetic retinopathy,disease,0.8696,31550048
20780,OIR,disease,0.97,31550048
20781,ischemic retina,disease,0.6816,31550048
20782,VEGF-Trap,gene,0.979,31550048
20783,Aflibercept,gene,0.993,31550048
20784,VEGF receptors 1 and 2,gene,0.997,31550048
20785,neovascular age-related macular degeneration,disease,1.0,31550048
20786,macular edema,disease,1.0,31550048
20787,retinal vein occlusion,disease,0.9995,31550048
20788,diabetic macular edema,disease,1.0,31550048
20789,Aflibercept,gene,0.986,31550048
20790,retinal microvascular aberrations,disease,0.9937,31550048
20791,Aflibercept,gene,0.984,31550048
20792,dopaminergic amacrine cells,cell_type,0.854,31550048
20793,transcripts,RNA,0.6416,31550048
20794,amacrine cell,cell_type,0.8394,31550048
20795,Aflibercept,gene,0.979,31550048
20796,ischemic retinal neurovasculopathies,disease,1.0,31550048
20797,Ranibizumab,gene,0.902,31543660
20798,Aflibercept,gene,0.9346,31543660
20799,ranibizumab,gene,0.772,31543660
20800,aflibercept,gene,0.9746,31543660
20801,ranibizumab,gene,0.529,31543660
20802,aflibercept,gene,0.9233,31543660
20803,ranibizumab,gene,0.759,31543660
20804,aflibercept,gene,0.913,31543660
20805,aflibercept,gene,0.868,31543660
20806,diabetic macular oedema,disease,1.0,31542758
20807,patients,species,0.9194,31542758
20808,patients,species,0.95,31542758
20809,diabetic macular oedema,disease,1.0,31542758
20810,DME,disease,1.0,31542758
20811,antivascular endothelial growth factor,gene,0.9067,31542758
20812,dexamethasone,drug,0.997,31542758
20813,DEX,drug,0.9854,31542758
20814,PARTICIPANTS,species,0.6387,31542758
20815,patients,species,0.972,31542758
20816,DME,disease,1.0,31542758
20817,diabetic retinopathy,disease,1.0,31542758
20818,DME,disease,1.0,31542758
20819,ranibizumab,gene,0.7705,31542758
20820,aflibercept,gene,0.951,31542758
20821,DEX,drug,0.504,31542758
20822,Patients,species,0.978,31542758
20823,age-related macular degeneration,disease,1.0,31542758
20824,retinal vein occlusion,disease,1.0,31542758
20825,DME,disease,0.9995,31542758
20826,patients,species,0.991,31542758
20827,patients,species,0.988,31542758
20828,anti-VEGF,gene,0.8374,31542758
20829,DEX,drug,0.9346,31542758
20830,anti-VEGF,gene,0.9077,31542758
20831,anti-VEGF,gene,0.917,31542758
20832,DEX,drug,0.9155,31542758
20833,anti-VEGF,gene,0.8433,31542758
20834,DEX,drug,0.941,31542758
20835,DEX,drug,0.8135,31542758
20836,VEGF,gene,0.7305,31542758
20837,Aflibercept,gene,0.985,31542339
20838,Retinal Nonperfusion,disease,0.9966,31542339
20839,Proliferative Diabetic,disease,1.0,31542339
20840,aflibercept,gene,0.997,31542339
20841,Eylea,gene,0.835,31542339
20842,retinal nonperfusion,disease,0.9966,31542339
20843,proliferative diabetic retinopathy,disease,1.0,31542339
20844,PDR,disease,1.0,31542339
20845,PARTICIPANTS,species,0.795,31542339
20846,PDR,disease,0.998,31542339
20847,RNP,disease,0.9995,31542339
20848,diabetic macular edema,disease,1.0,31542339
20849,Patients,species,0.957,31542339
20850,aflibercept,gene,0.9727,31542339
20851,RNP,RNA,0.5083,31542339
20852,diabetic retinopathy,disease,1.0,31542339
20853,aflibercept,gene,0.9585,31542339
20854,patients,species,0.979,31542339
20855,patients,species,0.971,31542339
20856,RNP,RNA,0.7715,31542339
20857,Retinal nonperfusion,disease,0.9995,31542339
20858,RNP,RNA,0.596,31542339
20859,RNP,RNA,0.65,31542339
20860,aflibercept,gene,0.98,31542339
20861,PDR,disease,1.0,31542339
20862,RNP,RNA,0.603,31542339
20863,patients,species,0.958,31542339
20864,RNP,RNA,0.722,31542339
20865,Neovascular Age-Related Macular Degeneration,disease,1.0,31540854
20866,Anti-Vascular Endothelial Growth Factor,gene,0.9365,31540854
20867,neovascular age-related macular degeneration,disease,1.0,31540854
20868,nAMD,disease,1.0,31540854
20869,anti-vascular endothelial growth factor,gene,0.8394,31540854
20870,VEGF,gene,0.9946,31540854
20871,PARTICIPANTS,species,0.6133,31540854
20872,bevacizumab,gene,0.7324,31540854
20873,aflibercept,gene,0.842,31540854
20874,nAMD,disease,1.0,31540854
20875,intraretinal fluid,disease,0.8027,31540854
20876,bevacizumab,gene,0.589,31540854
20877,aflibercept,gene,0.9824,31540854
20878,nAMD,disease,1.0,31540854
20879,anti-VEGF,gene,0.92,31540854
20880,CFT,cell_type,0.4863,31540854
20881,age-related macular degeneration,disease,1.0,31540558
20882,macular edema,disease,1.0,31540558
20883,Macular degeneration,disease,1.0,31540558
20884,MD,disease,1.0,31540558
20885,macular edema,disease,1.0,31540558
20886,ME,disease,1.0,31540558
20887,ophthalmologic diseases,disease,0.9995,31540558
20888,age-related MD,disease,1.0,31540558
20889,AMD,disease,1.0,31540558
20890,verteporfin,drug,0.996,31540558
20891,VEGF,gene,0.641,31540558
20892,pegaptanib,drug,0.9707,31540558
20893,ranibizumab,gene,0.891,31540558
20894,Lucentis,gene,0.4688,31540558
20895,bevacizumab,gene,0.83,31540558
20896,Avastin,gene,0.423,31540558
20897,aflibercept,gene,0.829,31540558
20898,Eylea,gene,0.5176,31540558
20899,AMD,disease,1.0,31540558
20900,ME,disease,0.9995,31540558
20901,carbonic anhydrase,gene,0.9976,31540558
20902,CA,gene,0.639,31540558
20903,ranibizumab,gene,0.907,31540558
20904,bevacizumab,gene,0.78,31540558
20905,cystoid,disease,0.997,31540558
20906,diabetic ME,disease,0.999,31540558
20907,Tumor,disease,0.9995,31540455
20908,tumor,disease,1.0,31540455
20909,solid tumors,disease,1.0,31540455
20910,vascular endothelial growth factor,gene,0.9985,31540455
20911,VEGF,gene,0.995,31540455
20912,VEGF,gene,0.994,31540455
20913,tumor,disease,1.0,31540455
20914,VEGF,gene,0.8945,31540455
20915,solid tumors,disease,1.0,31540455
20916,tumors,disease,1.0,31540455
20917,tumor,disease,0.9995,31540455
20918,VEGF,gene,0.597,31540455
20919,solid tumors,disease,1.0,31540455
20920,solid tumors,disease,1.0,31540455
20921,Ranibizumab,gene,0.9053,31526521
20922,Aflibercept,gene,0.986,31526521
20923,aflibercept,gene,0.9556,31520559
20924,FOLFIRI,drug,0.7207,31520559
20925,metastatic colorectal cancer,disease,1.0,31520559
20926,Aflibercept,gene,0.977,31520559
20927,5-fluorouracil,drug,0.9995,31520559
20928,levofolinate,drug,0.996,31520559
20929,irinotecan,drug,0.9976,31520559
20930,FOLFIRI,drug,0.762,31520559
20931,metastatic colorectal cancer,disease,0.999,31520559
20932,aflibercept,gene,0.7363,31520559
20933,FOLFIRI,drug,0.734,31520559
20934,metastatic colorectal cancer,disease,0.999,31520559
20935,aflibercept,gene,0.9688,31520559
20936,FOLFIRI,drug,0.825,31520559
20937,tumor,disease,1.0,31520559
20938,tumor,disease,0.9995,31520559
20939,placental growth factor,gene,0.996,31520559
20940,vascular endothelial growth factor receptor 1,gene,0.997,31520559
20941,insulin-like growth factor-binding protein 1,gene,0.999,31520559
20942,interleukin-8,gene,0.9673,31520559
20943,kallikrein 5,gene,0.992,31520559
20944,pulmonary surfactant-associated protein D,gene,0.9966,31520559
20945,tissue inhibitor of metalloproteinases 1,gene,0.8237,31520559
20946,tenascin-C,gene,0.9897,31520559
20947,tumor necrosis factor receptor 2,gene,0.9956,31520559
20948,Skin ulceration,disease,0.9995,31519726
20949,aflibercept,gene,0.98,31519726
20950,neovascular age-related macular degeneration,disease,1.0,31517440
20951,nAMD,disease,1.0,31517440
20952,Macula,disease,0.998,31517440
20953,Diabetic Retinopathy,disease,1.0,31517440
20954,ETDRS,DNA,0.5054,31517440
20955,nAMD,disease,1.0,31517440
20956,wet AMD,disease,0.997,31517440
20957,Tie-2,gene,0.9956,31513439
20958,Angiopoietin,gene,0.9863,31513439
20959,retinal disease,disease,1.0,31513439
20960,Tie-2,gene,0.997,31513439
20961,Angiopoietin,gene,0.983,31513439
20962,neovascular age-related macular degeneration,disease,1.0,31513439
20963,nAMD,disease,1.0,31513439
20964,diabetic macular edema,disease,1.0,31513439
20965,DME,drug,0.845,31513439
20966,Tie-2 receptor,gene,0.9956,31513439
20967,Ang-1,gene,0.996,31513439
20968,Ang-2,gene,0.9985,31513439
20969,Ang-1,gene,0.9985,31513439
20970,VE-PTP,gene,0.995,31513439
20971,Tie-2,gene,0.986,31513439
20972,Ang,DNA,0.5693,31513439
20973,Ang-1,gene,0.9946,31513439
20974,Faricimab,gene,0.6914,31513439
20975,VEGF-A,gene,0.9985,31513439
20976,Ang-2,gene,0.9976,31513439
20977,nAMD,disease,1.0,31513439
20978,DME,disease,1.0,31513439
20979,Nesvacumab,gene,0.6074,31513439
20980,Ang-2,gene,0.999,31513439
20981,aflibercept,gene,0.988,31513439
20982,aflibercept,gene,0.979,31513439
20983,nAMD,drug,0.4773,31513439
20984,ARP-1536,drug,0.9995,31513439
20985,VE,DNA,0.466,31513439
20986,VE-PTP,gene,0.9956,31513439
20987,AKB-9778,drug,0.9995,31513439
20988,VE-PTP,gene,0.996,31513439
20989,DME,disease,0.997,31513439
20990,AKB-9778,drug,0.9985,31513439
20991,diabetic retinopathy,disease,1.0,31513439
20992,AXT107,drug,0.92,31513439
20993,Ang-2,gene,0.998,31513439
20994,Tie-2,gene,0.9966,31513439
20995,VEGFR2,gene,0.996,31513439
20996,receptor tyrosine-,gene,0.5776,31513439
20997,tyrosine,drug,0.9883,31513439
20998,Tie-2,gene,0.9927,31513439
20999,Angiopoietin,gene,0.9893,31513439
21000,nAMD,disease,1.0,31513439
21001,DME,disease,1.0,31513439
21002,Ziv-aflibercept,gene,0.95,31511273
21003,peripheral exudative haemorrhagic chorioretinopathy,disease,0.9966,31511273
21004,Peripheral exudative haemorrhagic chorioretinopathy,disease,1.0,31511273
21005,PEHCR,disease,1.0,31511273
21006,polypoidal choroidal vasculopathy,disease,1.0,31511273
21007,PEHCR,disease,0.9995,31511273
21008,ziv-aflibercept,gene,0.9614,31511273
21009,ziv-aflibercept,gene,0.912,31511273
21010,systemic,disease,0.594,31511273
21011,Branch retinal artery occlusion,disease,0.998,31508535
21012,branch retinal artery occlusion,disease,1.0,31508535
21013,BRAO,disease,1.0,31508535
21014,aflibercept,gene,0.98,31508535
21015,woman,species,0.8867,31508535
21016,diabetic macular edema,disease,1.0,31508535
21017,VEGF,gene,0.5674,31508535
21018,ranibizumab,gene,0.941,31508535
21019,aflibercept,gene,0.9785,31508535
21020,aflibercept,gene,0.9897,31508535
21021,blurred vision,disease,0.963,31508535
21022,patient,species,0.9785,31508535
21023,BRAO,disease,0.9995,31508535
21024,Fc,gene,,31508535
21025,anti-,gene,0.7983,31508535
21026,VEGF,gene,0.691,31508535
21027,platelets,cell_type,0.7427,31508535
21028,VEGF,gene,0.704,31508535
21029,Idiopathic polypoidal choroidal vasculopathy,disease,1.0,31505993
21030,Polypoidal choroidal vasculopathy,disease,1.0,31505993
21031,patients,species,0.961,31505993
21032,polypoidal choroidal vasculopathy,disease,1.0,31505993
21033,patients,species,0.987,31505993
21034,Patients,species,0.9297,31505993
21035,patients,species,0.9834,31505993
21036,vascular endothelial growth factor,gene,0.8794,31505993
21037,Patient,species,0.9746,31505993
21038,patients,species,0.993,31505993
21039,age-related macular degeneration,disease,1.0,31505993
21040,polypoidal choroidal vasculopathy,disease,1.0,31505993
21041,Patients,species,0.8486,31505993
21042,ranibizumab,gene,0.7646,31502893
21043,aflibercept,gene,0.9717,31502893
21044,diabetic macular edema,disease,1.0,31502893
21045,Diabetic Retinopathy,disease,1.0,31502893
21046,aflibercept,gene,0.992,31502893
21047,bevacizumab,gene,0.905,31502893
21048,ranibizumab,gene,0.7827,31502893
21049,diabetic macular edema,disease,1.0,31502893
21050,DME,disease,1.0,31502893
21051,aflibercept,gene,0.992,31502893
21052,patients,species,0.9927,31502893
21053,patient,species,0.9673,31502893
21054,vascular endothelial growth factor,gene,0.9033,31502893
21055,ranibizumab,gene,0.9683,31502893
21056,aflibercept,gene,0.976,31502893
21057,aflibercept,gene,0.9893,31502893
21058,VA,disease,,31502893
21059,VA,disease,,31502893
21060,Patients,species,0.954,31502893
21061,aflibercept,gene,0.9775,31502893
21062,ranibizumab,gene,0.679,31502893
21063,aflibercept,gene,0.9814,31502893
21064,ranibizumab,gene,0.699,31502893
21065,patients,species,0.9336,31502893
21066,DME,disease,1.0,31502893
21067,aflibercept,gene,0.986,31498950
21068,macular oedema,disease,1.0,31498950
21069,bevacizumab,gene,0.8105,31498950
21070,ranibizumab,gene,0.87,31498950
21071,aflibercept,gene,0.9727,31498950
21072,macular oedema,disease,1.0,31498950
21073,retinal vein occlusion,disease,1.0,31498950
21074,RVO,disease,1.0,31498950
21075,aflibercept,gene,0.9873,31498950
21076,macular oedema,disease,1.0,31498950
21077,bevacizumab,gene,0.7056,31498950
21078,ranibizumab,gene,0.777,31498950
21079,PARTICIPANTS,species,0.6377,31498950
21080,patients,species,0.97,31498950
21081,macular oedema,disease,1.0,31498950
21082,bevacizumab,gene,0.834,31498950
21083,ranibizumab,gene,0.9473,31498950
21084,aflibercept,gene,0.972,31498950
21085,diabetic retinopathy,disease,1.0,31498950
21086,Patients,species,0.975,31498950
21087,bevacizumab,gene,0.9478,31498950
21088,ranibizumab,gene,0.948,31498950
21089,aflibercept,gene,0.884,31498950
21090,BRVO,disease,0.9976,31498950
21091,CRVO,disease,1.0,31498950
21092,BRVO,disease,0.9917,31498950
21093,CRVO,disease,0.999,31498950
21094,ranibizumab,gene,0.7876,31498950
21095,bevacizumab,gene,0.901,31498950
21096,aflibercept,gene,0.9844,31498950
21097,bevacizumab,gene,0.828,31498950
21098,ranibizumab,gene,0.674,31498950
21099,macular oedema,disease,1.0,31498950
21100,RVO,disease,1.0,31498950
21101,Choroidal Neovascularization,disease,1.0,31485363
21102,Optic Disc Melanocytoma,disease,1.0,31485363
21103,Aflibercept,gene,0.8623,31485363
21104,melanocytoma,disease,1.0,31485363
21105,choroidal neovascularization,disease,0.9966,31485363
21106,CNV,disease,1.0,31485363
21107,aflibercept,gene,0.969,31485363
21108,Optic disc melanocytoma,disease,1.0,31485363
21109,benign,cell_type,0.527,31485363
21110,benign melanocytic tumor,disease,0.9595,31485363
21111,disc melanocytoma,disease,0.999,31485363
21112,exudative age-related macular degeneration,disease,1.0,31482277
21113,neovascular age-related macular degeneration,disease,1.0,31482277
21114,AMD,disease,1.0,31482277
21115,VEGF,gene,0.9985,31482277
21116,patients,species,0.995,31482277
21117,tachyphylaxis,disease,0.6714,31482277
21118,VEGF,gene,0.975,31482277
21119,patients,species,0.9907,31482277
21120,tachyphylaxis,disease,0.624,31482277
21121,IVA,gene,0.84,31482277
21122,neovascular AMD,disease,1.0,31482277
21123,tachyphylaxis,disease,0.645,31482277
21124,patients,species,0.9814,31482277
21125,AMD,disease,0.9995,31482277
21126,aflibercept,gene,0.969,31482277
21127,tachyphylaxis,disease,0.9985,31482277
21128,polypoidal choroidal vasculopathy,disease,1.0,31482277
21129,AMD,disease,1.0,31482277
21130,tachyphylaxis,disease,0.96,31482277
21131,polypoidal choroidal vasculopathy,disease,1.0,31482277
21132,AMD,disease,1.0,31482277
21133,tachyphylaxis,disease,0.964,31482277
21134,polypoidal choroidal vasculopathy,disease,0.9995,31482277
21135,intraretinal edema,disease,1.0,31482277
21136,aflibercept,gene,0.9688,31482277
21137,ranibizumab,gene,0.6104,31482277
21138,patients,species,0.9673,31482277
21139,AMD,disease,1.0,31482277
21140,retinal,cell_type,0.4368,31482277
21141,intraretinal edema,disease,1.0,31482277
21142,AMD,disease,1.0,31482277
21143,Patients,species,0.958,31479024
21144,Unilateral Polypoidal SIGNIFICANCE,disease,0.9893,31479024
21145,patients,species,0.958,31479024
21146,unilateral polypoidal choroidal vasculopathy,disease,1.0,31479024
21147,patients,species,0.991,31479024
21148,patients,species,0.988,31479024
21149,visual deterioration,disease,0.747,31479024
21150,patients,species,0.93,31479024
21151,unilateral polypoidal,disease,0.804,31479024
21152,choroidal vasculopathy,disease,1.0,31479024
21153,patients,species,0.992,31479024
21154,unilateral polypoidal choroidal vasculopathy,disease,1.0,31479024
21155,vascular endothelial growth factor,gene,0.9136,31479024
21156,patients,species,0.952,31479024
21157,patients,species,0.9863,31479024
21158,visual deterioration,disease,0.983,31479024
21159,Patients,species,0.949,31479024
21160,retinal vein occlusion,disease,0.999,31479024
21161,posterior capsule opacification,disease,1.0,31479024
21162,patients,species,0.984,31479024
21163,patients,species,0.9673,31479024
21164,unilateral polypoidal choroidal vasculopathy,disease,1.0,31479024
21165,polypoidal choroidal vasculopathy,disease,1.0,31476891
21166,Ranibizumab,gene,0.8306,31476891
21167,ranibizumab,gene,0.7856,31476891
21168,aflibercept,gene,0.9854,31476891
21169,polypoidal choroidal vasculopathy,disease,1.0,31476891
21170,patients,species,0.974,31476891
21171,polypoidal choroidal vasculopathy,disease,1.0,31476891
21172,ranibizumab,gene,0.6787,31476891
21173,aflibercept,gene,0.9907,31476891
21174,ranibizumab,gene,0.8486,31476891
21175,aflibercept,gene,0.9766,31476891
21176,ranibizumab,gene,0.8286,31476891
21177,aflibercept,gene,0.9873,31476891
21178,ranibizumab,gene,0.4983,31476891
21179,aflibercept,gene,0.978,31476891
21180,ranibizumab,gene,0.707,31476891
21181,aflibercept,gene,0.983,31476891
21182,Diabetic Macular Edema,disease,1.0,31473172
21183,diabetic macular edema,disease,1.0,31473172
21184,DME,disease,1.0,31473172
21185,aflibercept,gene,0.972,31473172
21186,DME,disease,0.9985,31473172
21187,PARTICIPANTS,species,0.8696,31473172
21188,IAI,drug,0.8994,31473172
21189,IAI 2q4 arm,DNA,0.9062,31473172
21190,IAI 2q8 arm,DNA,0.897,31473172
21191,retinal pigment epithelium,cell_type,0.4702,31473172
21192,2q8,DNA,0.687,31473172
21193,2q8,DNA,0.7993,31473172
21194,aflibercept,gene,0.9844,31473172
21195,2q4,DNA,0.553,31473172
21196,Retinal Fractal,DNA,0.4692,31472160
21197,Diabetic Retinopathy,disease,1.0,31472160
21198,Fluorescein,drug,0.8477,31472160
21199,retinal nonperfusion,disease,0.6577,31472160
21200,diabetic retinopathy,disease,1.0,31472160
21201,DR,disease,1.0,31472160
21202,fluorescein,drug,0.995,31472160
21203,DR,disease,0.9976,31472160
21204,DR,disease,0.999,31472160
21205,FD,disease,0.8633,31472160
21206,DR,disease,1.0,31472160
21207,retinal nonperfusion,disease,0.999,31472160
21208,diabetic macular edema,disease,1.0,31471564
21209,BKT130,gene,0.599,31467935
21210,Monocyte,cell_type,0.6465,31467935
21211,Age-related macular degeneration,disease,1.0,31467935
21212,AMD,disease,1.0,31467935
21213,blindness,disease,0.9966,31467935
21214,visual loss,disease,0.8535,31467935
21215,choroidal neovascularization,disease,1.0,31467935
21216,CNV,disease,1.0,31467935
21217,Mononuclear phagocytes,cell_type,0.6978,31467935
21218,monocytes,cell_type,0.7314,31467935
21219,macrophages,cell_type,0.7437,31467935
21220,neovascular AMD,disease,1.0,31467935
21221,nvAMD,disease,1.0,31467935
21222,nvAMD,disease,1.0,31467935
21223,vascular endothelial growth factor,gene,0.998,31467935
21224,VEGF,gene,0.994,31467935
21225,mononuclear cell,cell_type,0.6636,31467935
21226,nvAMD,disease,1.0,31467935
21227,BKT130,drug,0.9985,31467935
21228,aflibercept,gene,0.9272,31467935
21229,BKT130,drug,0.999,31467935
21230,aflibercept,gene,0.9844,31467935
21231,choroidal neovascularization,disease,1.0,31467935
21232,LI-CNV,disease,0.99,31467935
21233,CD11b+ cell,cell_line,0.767,31467935
21234,CD11b,gene,0.8794,31467935
21235,CNV,disease,0.9995,31467935
21236,mRNA,RNA,0.905,31467935
21237,genes,DNA,0.4717,31467935
21238,CNV,disease,1.0,31467935
21239,BKT130,drug,0.9995,31467935
21240,CNV,DNA,0.8247,31467935
21241,CD11b+ cells,cell_line,0.775,31467935
21242,CD11b+,gene,0.862,31467935
21243,BKT130,gene,0.845,31467935
21244,macrophages,cell_type,0.777,31467935
21245,VEGFA,gene,0.996,31467935
21246,CCR2,gene,0.9814,31467935
21247,TNF,gene,0.989,31467935
21248,NOS1,gene,0.9907,31467935
21249,RPE,cell_type,0.5674,31467935
21250,LI-CNV,disease,0.998,31467935
21251,BKT130,drug,0.9985,31467935
21252,monocyte,cell_type,0.627,31467935
21253,CNV,disease,0.9985,31467935
21254,nvAMD,disease,1.0,31467935
21255,Ranibizumab,gene,0.943,31465100
21256,Aflibercept,gene,0.9707,31465100
21257,ranibizumab,gene,0.875,31465100
21258,aflibercept,gene,0.973,31465100
21259,bevacizumab,gene,0.7007,31465100
21260,macular edema,disease,1.0,31465100
21261,central retinal vein occlusion,disease,1.0,31465100
21262,CRVO,disease,1.0,31465100
21263,aflibercept,gene,0.9937,31465100
21264,bevacizumab,gene,0.637,31465100
21265,CRVO,disease,1.0,31465100
21266,PARTICIPANTS,species,0.739,31465100
21267,Vein Occlusion,disease,0.9995,31465100
21268,visual impairment,disease,1.0,31465100
21269,CRVO,disease,1.0,31465100
21270,macular edema,disease,0.9995,31465100
21271,Diabetic Retinopathy,disease,0.9995,31465100
21272,Participants,species,0.8926,31465100
21273,ranibizumab,gene,0.757,31465100
21274,aflibercept,gene,0.9897,31465100
21275,participants,species,0.984,31465100
21276,aflibercept,gene,0.9917,31465100
21277,bevacizumab,gene,0.88,31465100
21278,Aflibercept,gene,0.9766,31465100
21279,ranibizumab,gene,0.65,31465100
21280,Bevacizumab,gene,0.741,31465100
21281,ranibizumab,gene,0.5566,31465100
21282,aflibercept,gene,0.9937,31465100
21283,ranibizumab,gene,0.539,31465100
21284,macular edema,disease,1.0,31465100
21285,CRVO,disease,1.0,31465100
21286,aflibercept,gene,0.982,31465100
21287,ranibizumab,gene,0.5093,31465100
21288,bevacizumab,gene,0.7275,31465100
21289,ranibizumab,gene,0.637,31465100
21290,bevacizumab,gene,0.5405,31465100
21291,Aflibercept,gene,0.9287,31465088
21292,vascular endothelial growth factor,gene,0.9976,31465088
21293,VEGF,gene,0.9976,31465088
21294,rectal adenocarcinoma,disease,1.0,31465088
21295,VEGF,gene,0.9683,31465088
21296,aflibercept,gene,0.9937,31465088
21297,fluorouracil,drug,0.9995,31465088
21298,leucovorin,drug,0.9985,31465088
21299,oxaliplatin,drug,0.9995,31465088
21300,patients,species,0.961,31465088
21301,rectal adenocarcinoma,disease,1.0,31465088
21302,PARTICIPANTS,species,0.6343,31465088
21303,Cancer,disease,0.753,31465088
21304,patients,species,0.978,31465088
21305,rectal adenocarcinoma,disease,0.9946,31465088
21306,Patients,species,0.96,31465088
21307,Patients,species,0.9077,31465088
21308,aflibercept,gene,0.957,31465088
21309,patients,species,0.9863,31465088
21310,aflibercept,gene,0.976,31465088
21311,men,species,0.9116,31465088
21312,women,species,0.9917,31465088
21313,patients,species,0.9805,31465088
21314,men,species,0.9043,31465088
21315,women,species,0.9863,31465088
21316,hypertension,disease,0.991,31465088
21317,patients,species,0.986,31465088
21318,aflibercept,gene,0.9834,31465088
21319,patients,species,0.9614,31465088
21320,rectal adenocarcinoma,disease,1.0,31465088
21321,GEMCAD 1402,drug,0.99,31465088
21322,Aflibercept,gene,0.9253,31461723
21323,Macular Edema,disease,1.0,31461723
21324,Branch Retinal Vein Occlusion,disease,1.0,31461723
21325,aflibercept,gene,0.9385,31461723
21326,macular edema,disease,1.0,31461723
21327,branch retinal vein occlusion,disease,1.0,31461723
21328,BRVO,disease,1.0,31461723
21329,macular edema,disease,1.0,31461723
21330,BRVO,disease,0.9995,31461723
21331,aflibercept,gene,0.9624,31461723
21332,photoreceptor layer,cell_type,0.541,31461723
21333,PRLT,DNA,0.4863,31461723
21334,aflibercept,gene,0.9746,31461723
21335,macular edema,disease,1.0,31461723
21336,BRVO,disease,0.999,31461723
21337,posterior ocular structures,DNA,0.542,31461723
21338,diabetic macular edema,disease,1.0,31460612
21339,diabatic macular edema,disease,1.0,31460612
21340,bevacizumab,gene,0.7407,31460612
21341,ranibizumab,gene,0.881,31460612
21342,aflibercept,gene,0.9727,31460612
21343,bevacizumab,gene,0.9067,31460612
21344,ranibizumab,gene,0.6577,31460612
21345,bevacizumab,gene,0.74,31460612
21346,"BRL 349,319",drug,0.73,31460612
21347,BRL 543,drug,0.777,31460612
21348,aflibercept,gene,0.974,31460612
21349,Bevacizumab,gene,0.7314,31460612
21350,Aflibercept,gene,0.979,31456948
21351,Folfiri,drug,0.8643,31456948
21352,Bevacizumab,gene,0.8984,31456948
21353,RAS Mutated Metastatic Colorectal Cancer,disease,0.9077,31456948
21354,RAS,gene,0.541,31456948
21355,bevacizumab,gene,0.843,31456948
21356,aflibercept,gene,0.9814,31456948
21357,folfiri,drug,0.953,31456948
21358,RAS,gene,0.993,31456948
21359,RAS,gene,0.9893,31456948
21360,metastatic colorectal cancer,disease,1.0,31456948
21361,mCRC,disease,0.999,31456948
21362,folfox,drug,0.886,31456948
21363,bevacizumab,gene,0.692,31456948
21364,RAS,gene,0.985,31456948
21365,mCRC,disease,0.9937,31456948
21366,folfox,drug,0.914,31456948
21367,bevacizumab,gene,0.856,31456948
21368,folfiri,drug,0.988,31456948
21369,bevacizumab,gene,0.801,31456948
21370,aflibercept,gene,0.9937,31456948
21371,metastatic sites,DNA,0.4917,31456948
21372,pts,species,0.8823,31456948
21373,pts,species,0.8223,31456948
21374,pts,species,0.902,31456948
21375,arm,DNA,0.4788,31456948
21376,pts,species,0.9087,31456948
21377,pts,species,0.9155,31456948
21378,pts,species,0.899,31456948
21379,aflibercept,gene,0.9824,31456948
21380,bevacizumab,gene,0.7773,31456948
21381,fluorouracil,drug,0.9985,31456948
21382,folinic acid,drug,0.998,31456948
21383,Folfiri,drug,0.979,31456948
21384,bevacizumab,gene,0.976,31456948
21385,folfiri,drug,0.945,31456948
21386,aflibercept,gene,0.994,31456948
21387,RAS,gene,0.97,31456948
21388,mCRC,disease,0.7837,31456948
21389,folfiri,drug,0.826,31456948
21390,aflibercept,gene,0.9937,31456948
21391,anti-vascular endothelial growth factor,gene,0.9966,31451777
21392,anti-VEGF,gene,0.9956,31451777
21393,diabetic macular edema,disease,1.0,31451777
21394,DME,disease,1.0,31451777
21395,DME,disease,1.0,31451777
21396,ranibizumab,gene,0.7715,31451777
21397,DME,disease,1.0,31451777
21398,aflibercept,gene,0.972,31451777
21399,VIRMs,gene,0.86,31451777
21400,cardiac myoglobin,gene,0.9966,31451777
21401,cardiac troponin,gene,0.9897,31451777
21402,intercellular adhesion molecule,gene,0.996,31451777
21403,monocyte chemotactic protein-1,gene,0.997,31451777
21404,matrix metalloproteinase-8,gene,0.9927,31451777
21405,placental growth factor,gene,0.9966,31451777
21406,PlGF,gene,0.9243,31451777
21407,tenascin-C,gene,0.9863,31451777
21408,tissue inhibitor of metalloproteinase-1,gene,0.998,31451777
21409,thrombospondin-2,gene,0.996,31451777
21410,vascular cell adhesion molecule-1,gene,0.9956,31451777
21411,VEGF,gene,0.9907,31451777
21412,VEGF,gene,0.6763,31451777
21413,VEGF,gene,0.9697,31451777
21414,plasma,cell_type,0.5503,31451777
21415,anti-VEGF,gene,0.993,31451777
21416,DME,disease,1.0,31451777
21417,macular edema,disease,1.0,31448093
21418,Macular edema,disease,1.0,31448093
21419,ME,disease,1.0,31448093
21420,vascular and inflammatory retinal diseases,disease,0.9995,31448093
21421,visual impairment,disease,1.0,31448093
21422,ME,disease,1.0,31448093
21423,ME,disease,1.0,31448093
21424,ME,disease,1.0,31448093
21425,ME,disease,1.0,31448093
21426,diabetic retinopathy,disease,1.0,31448093
21427,DR,disease,1.0,31448093
21428,retinal vein occlusion,disease,1.0,31448093
21429,RVO,disease,1.0,31448093
21430,uveitis,disease,1.0,31448093
21431,ranibizumab,gene,0.9185,31448093
21432,aflibercept,gene,0.97,31448093
21433,dexamethasone,drug,0.9893,31448093
21434,ME,disease,0.999,31448093
21435,DR,disease,0.9995,31448093
21436,RVO,disease,0.9893,31448093
21437,ME,disease,1.0,31448093
21438,DR,disease,0.9995,31448093
21439,RVO,disease,1.0,31448093
21440,fluocinolone acetonide,drug,0.9985,31448093
21441,diabetic ME,disease,1.0,31448093
21442,RVO,disease,1.0,31448093
21443,brolucizumab,gene,0.5107,31448093
21444,abicipar pegol,drug,0.706,31448093
21445,diabetic ME,disease,1.0,31448093
21446,ME,disease,1.0,31448093
21447,uveitis,disease,1.0,31448093
21448,corticosteroids,drug,0.5327,31448093
21449,uveitic ME,disease,0.9956,31448093
21450,Aflibercept,gene,0.945,31446029
21451,Diabetic Macular Edema,disease,1.0,31446029
21452,aflibercept,gene,0.98,31446029
21453,microaneurysms,disease,0.778,31446029
21454,diabetic macular edema,disease,1.0,31446029
21455,DME,disease,1.0,31446029
21456,DME,disease,1.0,31446029
21457,Fluorescein,drug,0.9966,31446029
21458,IVA,drug,0.615,31446029
21459,microaneurysms,disease,0.7144,31446029
21460,NPA,disease,0.9917,31446029
21461,microaneurysms,disease,0.6475,31446029
21462,CRT,DNA,0.5273,31446029
21463,microaneurysms,disease,0.854,31446029
21464,CRT,DNA,0.4783,31446029
21465,microaneurysms,disease,0.981,31446029
21466,CRT,DNA,0.5513,31446029
21467,microaneurysms,disease,0.9507,31446029
21468,Glioma,disease,1.0,31440056
21469,radiation retinopathy,disease,0.9863,31440056
21470,aflibercept,gene,0.9443,31440056
21471,Radiation retinopathy,disease,1.0,31440056
21472,retinal microangiopathy,disease,1.0,31440056
21473,cancer,disease,1.0,31440056
21474,nasopharyngeal tumors,disease,1.0,31440056
21475,intraocular tumors,disease,1.0,31440056
21476,uveal melanoma,disease,1.0,31440056
21477,retinoblastoma,disease,1.0,31440056
21478,anti-VEGFs,gene,0.902,31440056
21479,argon,drug,0.606,31440056
21480,radiation retinopathy,disease,0.9834,31440056
21481,macular edema,disease,1.0,31440056
21482,glioma,disease,1.0,31440056
21483,aflibercept,gene,0.9517,31440056
21484,fluorescein,drug,0.982,31440056
21485,non-proliferative retinopathy,disease,1.0,31440056
21486,proliferative retinopathy,disease,1.0,31440056
21487,macular edema,disease,1.0,31440056
21488,radiation retinopathy,disease,1.0,31440056
21489,aflibercept,gene,0.9604,31440056
21490,macular edema,disease,1.0,31440056
21491,radiation retinopathy,disease,1.0,31440056
21492,aflibercept,gene,0.9883,31440056
21493,macular edema,disease,1.0,31440056
21494,radiation retinopathy,disease,0.9995,31440056
21495,glioma,disease,1.0,31440056
21496,radiation retinopathy,disease,0.9995,31440056
21497,nasopharyngeal tumors,disease,1.0,31440056
21498,meningiomas,disease,1.0,31440056
21499,melanomas,disease,1.0,31440056
21500,aflibercept,gene,0.9897,31438736
21501,dexamethasone,drug,0.994,31438736
21502,aflibercept,gene,0.9883,31438736
21503,dexamethasone,drug,0.9917,31438736
21504,diabetic macular edema,disease,1.0,31438736
21505,DME,disease,1.0,31438736
21506,serous retinal detachment,disease,1.0,31438736
21507,SRD,disease,1.0,31438736
21508,patients,species,0.983,31438736
21509,DME,disease,1.0,31438736
21510,SRD,disease,0.9907,31438736
21511,aflibercept,gene,0.8354,31438736
21512,dexamethasone,drug,0.983,31438736
21513,SRD,disease,0.999,31438736
21514,patients,species,0.98,31438736
21515,IVA,disease,0.9985,31438736
21516,patients,species,0.9736,31438736
21517,IDI,disease,0.9985,31438736
21518,patients,species,0.977,31438736
21519,HbA1c,gene,0.9956,31438736
21520,diabetes,disease,0.9995,31438736
21521,SRD,DNA,0.5503,31438736
21522,IDI,disease,0.6914,31438736
21523,IDI,disease,0.9863,31438736
21524,IVA,disease,0.876,31438736
21525,SRD,DNA,0.5654,31438736
21526,IDI,disease,0.8896,31438736
21527,SRD,DNA,0.6504,31438736
21528,IDI,disease,0.997,31438736
21529,IVA,disease,0.997,31438736
21530,SRD,disease,0.9995,31438736
21531,patients,species,0.961,31438736
21532,IDI,disease,0.9995,31438736
21533,IVA,disease,0.9995,31438736
21534,dexamethasone,drug,0.9976,31438736
21535,aflibercept,gene,0.927,31438736
21536,diabetic macular edema,disease,1.0,31438736
21537,DME,disease,1.0,31438736
21538,serous retinal detachment,disease,1.0,31438736
21539,SRD,DNA,0.638,31438736
21540,aflibercept,gene,0.99,31436224
21541,retinopathy of prematurity,disease,1.0,31436224
21542,Vascular endothelial growth factor,gene,0.998,31433611
21543,VEGF,gene,0.998,31433611
21544,capillary dropout,disease,0.9995,31433611
21545,vascular occlusion,disease,0.998,31433611
21546,branch retinal vein occlusion,disease,1.0,31433611
21547,BRVO,disease,1.0,31433611
21548,choroidal retinal vein occlusion,disease,1.0,31433611
21549,CRVO,disease,1.0,31433611
21550,VEGF,gene,0.9917,31433611
21551,retinal diseases,disease,1.0,31433611
21552,age-related macular degeneration,disease,1.0,31433611
21553,AMD,disease,1.0,31433611
21554,macular edema,disease,1.0,31433611
21555,vision loss,disease,0.999,31433611
21556,AMD,disease,1.0,31433611
21557,macular edema,disease,1.0,31433611
21558,VEGF,gene,0.813,31433611
21559,Steroids,drug,0.9946,31433611
21560,triamcinolone,drug,0.9995,31433611
21561,dexamethasone,drug,0.999,31433611
21562,DEX,drug,0.9985,31433611
21563,inflammation,disease,0.998,31433611
21564,edema,disease,0.9995,31433611
21565,VEGF,gene,0.985,31433611
21566,VEGF,gene,0.74,31433611
21567,aflibercept,gene,0.978,31433611
21568,bevacizumab,gene,0.906,31433611
21569,pegaptanib sodium,drug,0.996,31433611
21570,ranibizumab,gene,0.796,31433611
21571,Aflibercept,gene,0.9844,31433611
21572,115 kDa,RNA,0.6846,31433611
21573,bevacizumab,gene,0.8535,31433611
21574,149 kDa,RNA,0.65,31433611
21575,recombinant full-length humanized monoclonal immunoglobulin G1 antibody,gene,0.979,31433611
21576,humanized,species,0.7163,31433611
21577,pegaptanib sodium,drug,0.997,31433611
21578,ranibizumab,gene,0.5996,31433611
21579,recombinant humanized immunoglobulin G1 kappa isotype antibody fragment,gene,0.9595,31433611
21580,humanized,species,0.7856,31433611
21581,aflibercept,gene,0.966,31433611
21582,ranibizumab,gene,0.724,31433611
21583,bevacizumab,gene,0.8257,31433611
21584,pegaptanib sodium,drug,0.9985,31433611
21585,VEGF,gene,0.9575,31433611
21586,AMD,disease,1.0,31433611
21587,VEGF,gene,0.9736,31433611
21588,endophthalmitis,disease,1.0,31433611
21589,cataract,disease,1.0,31433611
21590,vitreous hemorrhage,disease,1.0,31433611
21591,retinal tears and detachments,disease,1.0,31433611
21592,vitreous floaters,disease,1.0,31433611
21593,inflammation,disease,0.9995,31433611
21594,Patients,species,0.9854,31433611
21595,hypertension,disease,1.0,31433611
21596,nasopharyngitis,disease,1.0,31433611
21597,headache,disease,1.0,31433611
21598,VEGF,gene,0.898,31433611
21599,carbonic,DNA,0.551,31433611
21600,carbonic anhydrase,gene,0.9976,31433611
21601,anti-VEGF,gene,0.7925,31433611
21602,retinal disease,disease,1.0,31433611
21603,aflibercept,gene,0.945,31421024
21604,wet age-related macular degeneration,disease,0.9287,31421024
21605,aflibercept,gene,0.9585,31421024
21606,wet age-related macular degeneration,disease,0.957,31421024
21607,wAMD,disease,1.0,31421024
21608,wAMD,disease,1.0,31421024
21609,aflibercept,gene,0.959,31421024
21610,aflibercept,gene,0.987,31421024
21611,dry macula,disease,0.9897,31421024
21612,T,disease,0.7563,31421024
21613,T,disease,0.577,31421024
21614,aflibercept,gene,0.9873,31421024
21615,vision-destroying diseases,disease,1.0,31419089
21616,age-related macular degeneration,disease,1.0,31419089
21617,AMD,disease,1.0,31419089
21618,vision loss,disease,0.999,31419089
21619,aflibercept,gene,0.986,31419089
21620,bevacizumab,gene,0.866,31419089
21621,pegaptanib,drug,0.8247,31419089
21622,vision,disease,0.978,31419089
21623,AMD,disease,1.0,31419089
21624,Colorectal Cancer,disease,1.0,31416205
21625,metastatic colorectal cancer,disease,1.0,31416205
21626,mCRC,disease,1.0,31416205
21627,epidermal growth factor receptor,gene,0.9976,31416205
21628,EGFR,gene,0.9907,31416205
21629,bevacizumab,gene,0.6133,31416205
21630,aflibercept,gene,0.984,31416205
21631,mCRC,disease,0.974,31416205
21632,colorectal cancer,disease,1.0,31416205
21633,tumor,disease,1.0,31416205
21634,mCRC,disease,0.999,31416205
21635,mCRC,disease,0.9995,31416205
21636,Bullous Serous Pigment Epithelial Detachment,disease,1.0,31415698
21637,bullous serous pigment epithelial detachment,disease,1.0,31415698
21638,PED,disease,1.0,31415698
21639,PATIENTS,species,0.913,31415698
21640,PED,disease,0.96,31415698
21641,choroidal neovascularization,disease,0.9985,31415698
21642,PED,disease,1.0,31415698
21643,nonhemorrhagic retinal pigment epithelial tear,disease,0.9995,31415698
21644,aflibercept,gene,0.9688,31415698
21645,Serous PED,disease,0.7715,31415698
21646,choroidal neovascularization,disease,1.0,31415698
21647,aflibercept,gene,0.9883,31415382
21648,ranibizumab,gene,0.825,31415382
21649,anti-vascular endothelial growth factor,gene,0.9277,31415382
21650,anti-VEGF,gene,0.9536,31415382
21651,aflibercept,gene,0.9697,31415382
21652,ranibizumab,gene,0.5913,31415382
21653,aflibercept,gene,0.972,31415382
21654,ranibizumab,gene,0.8306,31415382
21655,aflibercept,gene,0.9844,31415382
21656,ranibizumab,gene,0.6025,31415382
21657,aflibercept,gene,0.9785,31415382
21658,ranibizumab,gene,0.6304,31415382
21659,ranibizumab,gene,0.5957,31415382
21660,aflibercept,gene,0.92,31415382
21661,aflibercept,gene,0.952,31415382
21662,aflibercept,gene,0.974,31415382
21663,conjunctivitis,disease,1.0,31415382
21664,aflibercept,gene,0.9897,31415382
21665,ranibizumab,gene,0.8076,31415382
21666,Endophthalmitis,disease,1.0,31415382
21667,aflibercept,gene,0.9673,31415382
21668,aflibercept,gene,0.984,31415382
21669,retinal disorder,disease,1.0,31415382
21670,aflibercept,gene,0.977,31415382
21671,ranibizumab,gene,0.69,31415382
21672,Retinal Vein Occlusion,disease,1.0,31412332
21673,cardiovascular disease,disease,1.0,31412332
21674,retinal vascular disease,disease,1.0,31412332
21675,Retinal vein occlusions,disease,1.0,31412332
21676,disturbances,disease,0.944,31412332
21677,retinal hemorrhage and edema,disease,0.9976,31412332
21678,retinal thickening,disease,0.9985,31412332
21679,retinal ischemia,disease,0.9995,31412332
21680,fluorescein,drug,0.993,31412332
21681,VEGF,gene,0.872,31412332
21682,aflibercept,gene,0.992,31412332
21683,ranibizumab,gene,0.553,31412332
21684,bevacizumab,gene,0.7266,31412332
21685,retinal vein occlusion,disease,1.0,31412332
21686,retinal vein occlusion,disease,1.0,31412332
21687,Aflibercept,gene,0.959,31409968
21688,neovascular age-related macular degeneration,disease,0.9995,31409968
21689,neovascular macular degeneration,disease,1.0,31409968
21690,Aflibercept,gene,0.948,31409968
21691,AMD,disease,1.0,31409968
21692,age-related macular degeneration,disease,1.0,31409968
21693,Aflibercept,gene,0.936,31409968
21694,anti-VEGF,gene,0.891,31409968
21695,subretinal,disease,0.761,31409968
21696,pigment-epithelial detachment,disease,1.0,31409968
21697,Aflibercept,gene,0.982,31409968
21698,Aflibercept,gene,0.9175,31409968
21699,Aflibercept,gene,0.9785,31409968
21700,ranibizumab,gene,0.8633,31409963
21701,aflibercept,gene,0.971,31409963
21702,exudative age-related macular degeneration,disease,1.0,31409963
21703,VEGF,gene,0.941,31409963
21704,exudative age-related macular degeneration,disease,1.0,31409963
21705,AMD,disease,1.0,31409963
21706,choroidal neovascularization,disease,0.9995,31409963
21707,ranibizumab,gene,0.961,31409963
21708,aflibercept,gene,0.985,31409963
21709,AMD,disease,0.999,31409963
21710,aflibercept,gene,0.978,31409963
21711,aflibercept,gene,0.9644,31409963
21712,ranibizumab,gene,0.7993,31409963
21713,aflibercept,gene,0.965,31409963
21714,aflibercept,gene,0.985,31409963
21715,ranibizumab,gene,0.8955,31409963
21716,aflibercept,gene,0.971,31409963
21717,AMD,disease,1.0,31409963
21718,aflibercept,gene,0.967,31409963
21719,Anti-VEGF-Aptamer,gene,0.8657,31402576
21720,C,cell_line,0.4365,31402576
21721,Ocular Vascular Disorders,disease,0.999,31402576
21722,vascular endothelial growth factor,gene,0.999,31402576
21723,VEGF,gene,0.9946,31402576
21724,angiogenetic ocular diseases,disease,1.0,31402576
21725,VEGF,gene,0.9937,31402576
21726,Carbon,drug,0.9995,31402576
21727,VEGF,gene,0.56,31402576
21728,anti-VEGF,gene,0.87,31402576
21729,murine,species,0.9395,31402576
21730,VEGF,gene,0.9956,31402576
21731,choroidal blood vessels,cell_type,0.56,31402576
21732,VEGF,gene,0.595,31402576
21733,bevacizumab,gene,0.84,31402576
21734,aflibercept,gene,0.962,31402576
21735,age-related macular degeneration,disease,1.0,31402576
21736,diabetic retinopathy,disease,1.0,31402576
21737,vascular endothelial growth factor,gene,0.977,31388029
21738,polypoidal choroidal vasculopathy,disease,1.0,31388029
21739,anti-VEGF,gene,0.824,31388029
21740,polypoidal choroidal vasculopathy,disease,1.0,31388029
21741,PCV,disease,1.0,31388029
21742,PCV,disease,1.0,31388029
21743,ranibizumab,gene,0.9175,31388029
21744,aflibercept,gene,0.9644,31388029
21745,Wet macula,disease,1.0,31388029
21746,pachyvessels,disease,0.8696,31388029
21747,pachychoroid,disease,1.0,31388029
21748,pachyvessel,disease,0.588,31388029
21749,pachychoroid,disease,1.0,31388029
21750,CVD,DNA,0.516,31388029
21751,dry macula,disease,0.6606,31388029
21752,VEGF,gene,0.985,31388029
21753,pachyvessels,disease,1.0,31388029
21754,pachychoroid,disease,1.0,31388029
21755,VEGF,gene,0.9917,31388029
21756,VEGF,gene,0.9966,31388029
21757,aflibercept,gene,0.988,31383649
21758,ranibizumab,gene,0.789,31383649
21759,neovascular age-related macular degeneration,disease,1.0,31383649
21760,vascular endothelial growth factors,gene,0.9766,31383649
21761,neovascular age-related macular degeneration,disease,1.0,31383649
21762,nAMD,disease,1.0,31383649
21763,aflibercept,gene,0.987,31383649
21764,ranibizumab,gene,0.865,31383649
21765,ranibizumab,gene,0.873,31383649
21766,ranibizumab,gene,0.739,31383649
21767,Diabetic Retinopathy,disease,1.0,31383649
21768,aflibercept,gene,0.9854,31383649
21769,ranibizumab,gene,0.777,31383649
21770,nAMD,disease,1.0,31383649
21771,aflibercept,gene,0.985,31383649
21772,ranibizumab,gene,0.828,31383649
21773,Fluorescein,drug,0.7773,31383483
21774,Diabetic Retinopathy,disease,1.0,31383483
21775,Edema,disease,0.997,31383483
21776,Vascular Endothelial Growth Factor,gene,0.947,31383483
21777,vascular endothelial growth factor,gene,0.977,31383483
21778,VEGF,gene,0.9927,31383483
21779,diabetic macular edema,disease,1.0,31383483
21780,DME,disease,1.0,31383483
21781,fluorescein,drug,0.9873,31383483
21782,nonproliferative diabetic retinopathy,disease,0.9937,31383483
21783,NPDR,disease,0.9995,31383483
21784,proliferative DR,disease,0.998,31383483
21785,PDR,disease,1.0,31383483
21786,DME,disease,1.0,31383483
21787,anti-VEGF,gene,0.8496,31383483
21788,NP,disease,0.995,31383483
21789,DR,disease,0.9995,31383483
21790,NP area,DNA,0.4856,31383483
21791,NP,cell_line,0.5557,31383483
21792,capillaries,cell_type,0.5,31383483
21793,diabetic retinopathy,disease,1.0,31383483
21794,DR,disease,1.0,31383483
21795,microaneurysms,disease,1.0,31383483
21796,retinal hemorrhages,disease,1.0,31383483
21797,Retinal capillaries,cell_type,0.5815,31383483
21798,DR,disease,0.985,31383483
21799,anti-VEGF,gene,0.8086,31383483
21800,NP,disease,0.8657,31383483
21801,Drusen,disease,0.9414,31377285
21802,neovascular age-related macular degeneration,disease,1.0,31377285
21803,nAMD,disease,1.0,31377285
21804,nAMD,disease,0.53,31377285
21805,nAMD,disease,0.992,31377285
21806,nAMD,disease,1.0,31377285
21807,nAMD,disease,1.0,31377285
21808,drusen,disease,0.9746,31377285
21809,FE nAMD,disease,0.9956,31377285
21810,subretinal drusenoid deposits,disease,1.0,31377285
21811,SDD,disease,0.9985,31377285
21812,SDD,disease,1.0,31377285
21813,pachydrusen,disease,1.0,31377285
21814,drusen,disease,0.9824,31377285
21815,SDD,disease,0.9434,31377285
21816,soft drusen,disease,0.888,31377285
21817,SDD,disease,0.986,31377285
21818,Pachydrusen,disease,1.0,31377285
21819,drusen,disease,0.9365,31377285
21820,FE nAMD,disease,0.998,31377285
21821,Soft drusen,disease,0.9966,31377285
21822,SDD,disease,0.9976,31377285
21823,neovascular AMD,disease,1.0,31377285
21824,soft drusen,disease,0.995,31377285
21825,SDD,disease,0.9995,31377285
21826,age-related maculopathy,disease,0.9995,31376050
21827,age-related maculopathy susceptibility 2 gene variant,gene,0.779,31376050
21828,aflibercept,gene,0.953,31376050
21829,polypoidal choroidal vasculopathy,disease,1.0,31376050
21830,age-related maculopathy susceptibility 2 (ARMS2) gene polymorphisms,DNA,0.664,31376050
21831,age,RNA,0.4792,31376050
21832,age-related maculopathy,disease,1.0,31376050
21833,age-related maculopathy susceptibility 2,gene,0.9404,31376050
21834,ARMS2,gene,0.991,31376050
21835,aflibercept,gene,0.9487,31376050
21836,polypoidal choroidal vasculopathy,disease,1.0,31376050
21837,PCV,disease,1.0,31376050
21838,PCV,disease,1.0,31376050
21839,single nucleotide polymorphism,DNA,0.534,31376050
21840,rs10490924,gene,,31376050
21841,rs10490924,mutation,,31376050
21842,ARMS2 gene,gene,0.8003,31376050
21843,rs10490924,DNA,,31376050
21844,rs10490924,mutation,,31376050
21845,rs10490924,DNA,,31376050
21846,rs10490924,mutation,,31376050
21847,T allele,DNA,0.5083,31376050
21848,rs10490924,DNA,,31376050
21849,rs10490924,mutation,,31376050
21850,G allele,RNA,0.4858,31376050
21851,rs10490924,DNA,,31376050
21852,rs10490924,mutation,,31376050
21853,ARMS2 gene,gene,0.8706,31376050
21854,PCV,disease,1.0,31376050
21855,VEGF,gene,0.686,31370346
21856,Age-Related Macular Degeneration,disease,1.0,31370346
21857,anti-vascular endothelial growth factor,gene,0.9517,31370346
21858,VEGF,gene,0.8813,31370346
21859,Age-Related Macular Degeneration,disease,1.0,31370346
21860,bevacizumab,gene,0.7363,31370346
21861,ranibizumab,gene,0.72,31370346
21862,aflibercept,gene,0.9463,31370346
21863,VEGF,gene,0.9106,31370346
21864,vitrectomy,disease,0.5747,31370346
21865,lensectomy,disease,0.7363,31370346
21866,VEGF,gene,0.957,31370346
21867,anti-vascular endothelial growth factor,gene,0.903,31367847
21868,anti-vascular endothelial growth factor,gene,0.9834,31367847
21869,anti-VEGF,gene,0.993,31367847
21870,neovascular age-related macular degeneration,disease,1.0,31367847
21871,nAMD,disease,1.0,31367847
21872,patients,species,0.9897,31367847
21873,aflibercept,gene,0.981,31367847
21874,ranibizumab,gene,0.7773,31367847
21875,nAMD,disease,1.0,31367847
21876,anti-VEGF,gene,0.9326,31367847
21877,patients,species,0.9424,31367847
21878,nAMD,disease,1.0,31367847
21879,anti-VEGF,gene,0.9595,31367847
21880,nAMD,disease,1.0,31367847
21881,anti-VEGF,gene,0.7944,31367847
21882,exudative lesions,disease,0.991,31367847
21883,Diabetic macular edema,disease,1.0,31367468
21884,aflibercept,gene,0.987,31367468
21885,Diabetic macular edema,disease,1.0,31367468
21886,DME,disease,1.0,31367468
21887,vision loss,disease,0.9985,31367468
21888,DME,disease,1.0,31367468
21889,VEGF,gene,0.512,31367468
21890,patients,species,0.955,31367468
21891,DME,disease,1.0,31367468
21892,VEGF,gene,0.732,31367468
21893,aflibercept,gene,0.9473,31367468
21894,patients,species,0.9863,31367468
21895,DME,disease,1.0,31367468
21896,VEGF,gene,0.5713,31367468
21897,ranibizumab,gene,0.898,31367468
21898,bevacizumab,gene,0.773,31367468
21899,Patients,species,0.9644,31367468
21900,IAI,drug,0.712,31367468
21901,ETDRS,DNA,0.479,31367468
21902,non-proliferative diabetic retinopathy,disease,1.0,31367468
21903,Patients,species,0.9688,31367468
21904,Diabetic Macular Edema,disease,1.0,31367468
21905,Aflibercept,gene,0.9756,31367468
21906,Ranibizumab,gene,0.9,31367468
21907,Bevacizumab,gene,0.8677,31367468
21908,Apratoxin S4,drug,0.9985,31361305
21909,Abnormal blood vessel,disease,0.991,31361305
21910,blinding eye diseases,disease,0.999,31361305
21911,VEGF,gene,0.9956,31361305
21912,angiogenic diseases,disease,0.9976,31361305
21913,patients,species,0.9873,31361305
21914,VEGF,gene,0.661,31361305
21915,Apratoxin S4,drug,0.943,31361305
21916,Retinal vascular cell,cell_type,0.866,31361305
21917,Apratoxin S4,drug,0.991,31361305
21918,Apratoxin S4,drug,0.998,31361305
21919,mouse,species,0.9546,31361305
21920,oxygen-induced retinopathy,disease,0.9907,31361305
21921,oxygen,drug,0.9995,31361305
21922,OIR,disease,1.0,31361305
21923,CNV,disease,1.0,31361305
21924,rabbit,species,0.942,31361305
21925,persistent retinal neovascularization,disease,1.0,31361305
21926,PRNV,disease,1.0,31361305
21927,Apratoxin S4,drug,0.98,31361305
21928,Apratoxin S4,drug,0.905,31361305
21929,retinal vascular cell,cell_type,0.855,31361305
21930,VEGF-activated vascular cells,cell_line,0.7065,31361305
21931,VEGF,gene,0.587,31361305
21932,-activated vascular cells,cell_type,0.725,31361305
21933,Apratoxin S4,drug,0.899,31361305
21934,quiescent vascular cells,cell_type,0.628,31361305
21935,Apratoxin S4,gene,0.7085,31361305
21936,Apratoxin S4,drug,0.9517,31361305
21937,VEGF,gene,0.9766,31361305
21938,aflibercept,gene,0.7563,31361305
21939,Apratoxin S4,drug,0.997,31361305
21940,retinal endothelial cells,cell_type,0.9014,31361305
21941,pericytes,cell_type,0.8506,31361305
21942,Aflibercept,gene,0.983,31351870
21943,glucose,drug,0.995,31351870
21944,Diabetic retinopathy,disease,1.0,31351870
21945,DR,disease,1.0,31351870
21946,diabetes,disease,1.0,31351870
21947,DR,disease,,31351870
21948,blindness,disease,0.9985,31351870
21949,DR,disease,,31351870
21950,vision loss,disease,0.9556,31351870
21951,diabetic,disease,1.0,31351870
21952,patients,species,0.992,31351870
21953,diabetic macular edema,disease,1.0,31351870
21954,aflibercept,gene,0.9565,31351870
21955,anti-VEGF,gene,0.87,31351870
21956,diabetic macular edema,disease,1.0,31351870
21957,Aflibercept,gene,0.982,31351870
21958,vascular permeability factors,gene,0.6284,31351870
21959,"VEGF-A, B",gene,0.9976,31351870
21960,PlGF,gene,0.9917,31351870
21961,aflibercept,gene,0.987,31351870
21962,PlGF,gene,0.998,31351870
21963,PlGF,gene,0.9893,31351870
21964,DR,disease,,31351870
21965,primary human retinal endothelial cells,cell_line,0.8843,31351870
21966,human,species,0.85,31351870
21967,HRECs,cell_line,0.9087,31351870
21968,mouse retinal epithelial cells,cell_type,0.74,31351870
21969,mouse,species,0.981,31351870
21970,RPEs,cell_type,0.7197,31351870
21971,aflibercept,gene,0.933,31351870
21972,anti-PlGF antibody,gene,0.9937,31351870
21973,aflibercept,gene,0.9854,31351870
21974,PlGF,gene,0.997,31351870
21975,ERK,gene,0.982,31351870
21976,DR,disease,,31351870
21977,aflibercept,gene,0.981,31351870
21978,anti-PlGF antibody,gene,0.965,31351870
21979,retinal cells,cell_type,0.8164,31351870
21980,ERK,gene,0.9785,31351870
21981,aflibercept,gene,0.953,31351870
21982,TNF-,gene,0.9653,31351870
21983,DR,disease,,31351870
21984,PlGF,gene,0.991,31351870
21985,Diabetic Macular Edema,disease,1.0,31345726
21986,diabetic macular edema,disease,1.0,31345726
21987,DME,disease,1.0,31345726
21988,DME,disease,1.0,31345726
21989,DME,disease,1.0,31345726
21990,anti-vascular endothelial growth factor,gene,0.802,31345726
21991,VEGF,gene,0.9946,31345726
21992,DME,disease,1.0,31345726
21993,bevacizumab,gene,0.7593,31345726
21994,ranibizumab,gene,0.9365,31345726
21995,aflibercept,gene,0.983,31345726
21996,steroid,drug,0.7534,31345726
21997,bevacizumab,gene,0.5703,31345726
21998,ranibizumab,gene,0.8555,31345726
21999,aflibercept,gene,0.991,31345726
22000,ranibizumab,gene,0.7163,31345726
22001,aflibercept,gene,0.9453,31345726
22002,anti-VEGF,gene,0.8047,31345726
22003,bevacizumab,gene,0.7676,31345726
22004,DME,disease,1.0,31345726
22005,Acneiform eruption,disease,1.0,31332772
22006,aflibercept,gene,0.9575,31332772
22007,metastatic colorectal carcinoma,disease,0.999,31332772
22008,lncRNAs,RNA,0.6177,31327036
22009,RNCR2,gene,0.545,31327036
22010,NEAT2,gene,0.8013,31327036
22011,CDKN2B-AS1,gene,0.705,31327036
22012,PVT1,gene,0.8438,31327036
22013,anti-VEGF,gene,0.735,31327036
22014,diabetic retinopathy,disease,1.0,31327036
22015,long,DNA,0.506,31327036
22016,long non-coding RNAs,RNA,0.7705,31327036
22017,lncRNAs,RNA,0.6523,31327036
22018,diabetic retinopathy,disease,1.0,31327036
22019,DR,disease,1.0,31327036
22020,hyperglycemia,disease,0.9985,31327036
22021,RNCR2,gene,0.5347,31327036
22022,NEAT2,gene,0.866,31327036
22023,CDKN2B-AS1,gene,0.727,31327036
22024,PVT1,gene,0.8354,31327036
22025,type 2 diabetes,disease,1.0,31327036
22026,DR,disease,0.9556,31327036
22027,aflibercept,gene,0.9854,31327036
22028,macular edema,disease,1.0,31327036
22029,lncRNAs,RNA,0.559,31327036
22030,diabetes,disease,1.0,31327036
22031,DR,disease,0.5454,31327036
22032,aflibercept,gene,0.9893,31327036
22033,DR,disease,0.991,31327036
22034,lncRNAs,RNA,0.669,31327036
22035,DM,disease,1.0,31327036
22036,RNCR2,gene,0.619,31327036
22037,NEAT2,gene,0.9717,31327036
22038,DR,disease,0.9995,31327036
22039,lncRNAs,RNA,0.736,31327036
22040,retinopathy,disease,1.0,31327036
22041,lncRNAs,RNA,0.7334,31327036
22042,DR,disease,0.985,31327036
22043,aflibercept,gene,0.984,31327036
22044,DM,disease,1.0,31327036
22045,DR,disease,0.9634,31327036
22046,Aflibercept,gene,0.9673,31316822
22047,Choroidal Neovascular Membrane,disease,1.0,31316822
22048,patients,species,0.978,31316822
22049,nAMD,disease,1.0,31316822
22050,aflibercept,gene,0.955,31316822
22051,choroidal neovascular membrane,disease,1.0,31316822
22052,CNV,disease,1.0,31316822
22053,Patients,species,0.966,31316822
22054,CNV,DNA,0.6265,31316822
22055,nAMD,disease,1.0,31316822
22056,Diabetic Retinopathy,disease,0.9995,31316822
22057,patients,species,0.986,31316822
22058,CNV,disease,0.9995,31316822
22059,CRTSD,disease,0.5845,31316822
22060,CRT,DNA,0.5405,31316822
22061,aflibercept,gene,0.976,31316822
22062,nAMD,disease,1.0,31316822
22063,patients,species,0.9946,31316822
22064,CNV,DNA,0.525,31316822
22065,CNV,DNA,0.64,31316822
22066,Ziv-Aflibercept,gene,0.962,31314638
22067,Age-related macular degeneration,disease,1.0,31314638
22068,blindness,disease,0.997,31314638
22069,Neovascular age-related macular degeneration,disease,1.0,31314638
22070,nAMD,disease,1.0,31314638
22071,aflibercept,gene,0.9893,31314638
22072,bevacizumab,gene,0.6807,31314638
22073,ranibizumab,gene,0.5728,31314638
22074,Ziv-aflibercept,gene,0.9644,31314638
22075,aflibercept,gene,0.981,31314638
22076,ziv-aflibercept,gene,0.979,31314638
22077,ziv-aflibercept,gene,0.979,31314638
22078,neovascular disorders,disease,0.9995,31314638
22079,diabetic macular edema,disease,1.0,31314638
22080,DME,disease,1.0,31314638
22081,retinal vein occlusion,disease,1.0,31314638
22082,RVO,disease,1.0,31314638
22083,ziv-aflibercept,gene,0.9575,31314638
22084,nAMD,disease,1.0,31314638
22085,iris,disease,0.5713,31311970
22086,VEGF,gene,0.998,31311970
22087,INV,disease,1.0,31311970
22088,anterior,DNA,0.5444,31311970
22089,indocyanine green,drug,0.991,31311970
22090,VEGF,gene,0.5225,31311970
22091,INV,disease,0.9995,31311970
22092,VEGF,gene,0.858,31311970
22093,thromboembolic adverse,disease,0.9375,31309853
22094,VEGF,gene,0.752,31309853
22095,neovascular age-related macular degeneration,disease,1.0,31309853
22096,wet AMD,disease,0.9985,31309853
22097,thromboembolic events,disease,0.7617,31309853
22098,anti-VEGF,gene,0.83,31309853
22099,anti-VEGF,gene,0.9517,31309853
22100,anti-VEGF,gene,0.908,31309853
22101,aflibercept,gene,0.9844,31308680
22102,dexamethasone,drug,0.977,31308680
22103,retinal vein occlusions,disease,1.0,31308680
22104,anti-VEGF,gene,0.87,31308680
22105,dexamethasone,drug,0.896,31308680
22106,retinal vein occlusions,disease,1.0,31308680
22107,central retinal vein occlusion,disease,1.0,31308680
22108,CRVO,disease,1.0,31308680
22109,branch retinal vein occlusion,disease,1.0,31308680
22110,BRVO,disease,1.0,31308680
22111,CRA,DNA,0.523,31308680
22112,CRVO,disease,1.0,31308680
22113,CRA,DNA,0.5166,31308680
22114,CRA,DNA,0.648,31308680
22115,BRVO,disease,1.0,31308680
22116,CRA,DNA,0.4727,31308680
22117,anti-VEGF,gene,0.989,31308680
22118,dexamethasone,drug,0.9946,31308680
22119,CRVO,disease,1.0,31308680
22120,BRVO,disease,0.9985,31308680
22121,anti,gene,0.723,31308680
22122,dexamethasone,drug,0.9883,31308680
22123,retinal vein occlusion,disease,1.0,31308680
22124,Colorectal Cancer,disease,1.0,31298142
22125,anti-EGFR,gene,0.8354,31298142
22126,cetuximab,gene,0.9434,31298142
22127,panitumumab,gene,0.9116,31298142
22128,bevacizumab,gene,0.841,31298142
22129,regorafeninb,gene,0.712,31298142
22130,ramucirumab,gene,0.5776,31298142
22131,aflibercept,gene,0.957,31298142
22132,metastatic colorectal cancer,disease,0.877,31298142
22133,CRC,disease,1.0,31298142
22134,advanced CRC,disease,0.991,31298142
22135,tumor,disease,0.9995,31298142
22136,germ,DNA,0.786,31298142
22137,inflammation,disease,0.9897,31298142
22138,tumor,disease,1.0,31298142
22139,KRAS 3'UTR region,gene,0.888,31298142
22140,EGF,gene,0.809,31298142
22141,/ EGFR genes,DNA,0.6343,31298142
22142,EGFR,gene,0.996,31298142
22143,cetuximab,gene,0.6895,31298142
22144,EGFR,gene,0.742,31298142
22145,germ-line variants,DNA,0.642,31298142
22146,COX-2,gene,0.995,31298142
22147,LIFR,gene,0.995,31298142
22148,IGF1,gene,0.9873,31298142
22149,FCGRs,gene,0.9834,31298142
22150,IL-1RA,gene,0.995,31298142
22151,RAS,gene,0.989,31298142
22152,Hippo pathway related genes,DNA,0.763,31298142
22153,Hippo,gene,0.949,31298142
22154,Rassf,gene,0.695,31298142
22155,YAP,gene,0.9976,31298142
22156,TAZ,gene,0.995,31298142
22157,VEGF,gene,0.963,31298142
22158,EGF,gene,0.998,31298142
22159,IGF-1,gene,0.9985,31298142
22160,HIF1,gene,0.9976,31298142
22161,eNOS,gene,0.994,31298142
22162,iNOS,gene,0.9946,31298142
22163,EGFL7,gene,0.5576,31298142
22164,CXCR-1/2,gene,0.9937,31298142
22165,CXCR4,gene,0.9844,31298142
22166,CXCL12,gene,0.967,31298142
22167,TLRs,gene,0.937,31298142
22168,GADD34,gene,0.9956,31298142
22169,PPP1R15A,gene,0.742,31298142
22170,ANXA11,gene,0.677,31298142
22171,MKNK1,gene,0.928,31298142
22172,bevacizumab,gene,0.8706,31298142
22173,inhered variants,DNA,0.5215,31298142
22174,CRC,disease,0.999,31298142
22175,Choroidal Neovascularization,disease,1.0,31294771
22176,Patients,species,0.9595,31294771
22177,neovascular age-related macular degeneration,disease,1.0,31294771
22178,nAMD,disease,1.0,31294771
22179,patients,species,0.9927,31294771
22180,nAMD,disease,1.0,31294771
22181,vascular endothelial growth factor,gene,0.9785,31294771
22182,patients,species,0.9873,31294771
22183,aflibercept,gene,0.953,31294771
22184,nAMD,disease,1.0,31294771
22185,VEGF,gene,0.997,31294771
22186,Vascular Endothelial,gene,0.895,31294771
22187,AMD,disease,0.973,31294771
22188,PARTICIPANTS,species,0.683,31294771
22189,aflibercept,gene,0.903,31294771
22190,patients,species,0.983,31294771
22191,nAMD,disease,1.0,31294771
22192,participants,species,0.981,31294771
22193,nAMD,disease,1.0,31294771
22194,participants,species,0.979,31294771
22195,ranibizumab,gene,0.513,31294771
22196,aflibercept,gene,0.915,31294771
22197,aflibercept,gene,0.942,31294771
22198,aflibercept,gene,0.817,31294771
22199,Patients,species,0.9585,31294771
22200,nAMD,disease,1.0,31294771
22201,nAMD,disease,1.0,31294771
22202,patients,species,0.9834,31294771
22203,participants,species,0.988,31294771
22204,patients,species,0.9927,31294771
22205,neovascular disease,disease,1.0,31294771
22206,aflibercept,gene,0.9854,31294771
22207,aflibercept,gene,0.967,31294771
22208,aflibercept,gene,0.9214,31294771
22209,patient,species,0.9736,31294771
22210,patient,species,0.882,31294771
22211,intraretinal fluid,disease,0.928,31294771
22212,choroidal neovascularization,disease,1.0,31294771
22213,patients,species,0.9536,31294771
22214,nAMD,disease,1.0,31294771
22215,patients,species,0.986,31294771
22216,patients,species,0.9604,31286206
22217,diabetic retinopathy,disease,1.0,31286206
22218,patients,species,0.96,31286206
22219,diabetic retinopathy,disease,1.0,31286206
22220,DR,disease,1.0,31286206
22221,neovascular age-related macular degeneration,disease,1.0,31286206
22222,nAMD,disease,1.0,31286206
22223,patients,species,0.979,31286206
22224,anti-vascular endothelial growth factor,gene,0.934,31286206
22225,VEGF,gene,0.9966,31286206
22226,patients,species,0.989,31286206
22227,VEGF,gene,0.9043,31286206
22228,patients,species,0.977,31286206
22229,nAMD,disease,1.0,31286206
22230,patients,species,0.9707,31286206
22231,DR,disease,,31286206
22232,patients,species,0.9663,31286206
22233,DR,disease,,31286206
22234,nAMD,disease,1.0,31286206
22235,patients,species,0.9834,31286206
22236,patients,species,0.9795,31286206
22237,patients,species,0.9385,31286206
22238,patient,species,0.9746,31286206
22239,ranibizumab,gene,0.5894,31282617
22240,vascular endothelial growth factor,gene,0.999,31282617
22241,neovascular age-related macular degeneration,disease,1.0,31282617
22242,nAMD,disease,1.0,31282617
22243,ETDRS,DNA,0.4995,31282617
22244,patients,species,0.985,31282617
22245,BCVA,DNA,0.462,31282617
22246,BCVA,cell_type,0.43,31282617
22247,BCVA,cell_type,0.4065,31282617
22248,nAMD,disease,1.0,31282617
22249,patients,species,0.9526,31282617
22250,nAMD,disease,1.0,31282617
22251,BCVA,DNA,0.4792,31282617
22252,Choroidal Neovascularization,disease,1.0,31277802
22253,Aflibercept,gene,0.9224,31277797
22254,Radiation Maculopathy,disease,1.0,31277797
22255,vascular endothelial growth factor,gene,0.998,31277797
22256,radiation maculopathy,disease,1.0,31277797
22257,aflibercept,gene,0.952,31277797
22258,patients,species,0.9824,31277797
22259,aflibercept,gene,0.6284,31277797
22260,patients,species,0.989,31277797
22261,uveal melanoma,disease,1.0,31277797
22262,patients,species,0.9805,31277797
22263,radiation maculopathy,disease,1.0,31277797
22264,radiation maculopathy,disease,1.0,31277797
22265,patients,species,0.977,31277797
22266,BCVA,DNA,0.4795,31277797
22267,patients,species,0.98,31277797
22268,patients,species,0.982,31277797
22269,patient,species,0.9775,31277797
22270,aflibercept,gene,0.9893,31277797
22271,patient,species,0.9707,31277797
22272,patients,species,0.968,31277797
22273,endophthalmitis,disease,1.0,31277797
22274,metastatic disease,disease,0.9814,31277797
22275,Aflibercept,gene,0.9414,31277797
22276,vision,disease,0.9653,31277797
22277,radiation maculopathy,disease,1.0,31277797
22278,patients,species,0.988,31277797
22279,patients,species,0.9814,31277797
22280,BCVA,DNA,0.471,31277797
22281,Aflibercept,gene,0.959,31277797
22282,radiation maculopathy,disease,1.0,31277797
22283,Retinal Nonperfusion,disease,0.872,31277796
22284,retinal capillary nonperfusion,disease,0.9995,31277796
22285,RNP,disease,0.9917,31277796
22286,macular retinal capillary nonperfusion,disease,0.998,31277796
22287,MNP,disease,0.99,31277796
22288,PARTICIPANTS,species,0.8076,31277796
22289,patients,species,0.941,31277796
22290,macular edema,disease,1.0,31277796
22291,central retinal vein occlusion,disease,1.0,31277796
22292,patients,species,0.9824,31277796
22293,aflibercept,gene,0.966,31277796
22294,RNP,RNA,0.544,31277796
22295,patients,species,0.9917,31277796
22296,RNP,RNA,0.478,31277796
22297,MNP,disease,0.5605,31277796
22298,MNP,disease,0.9375,31277796
22299,RNP,RNA,0.4502,31277796
22300,MNP,disease,0.5747,31277796
22301,RNP,RNA,0.4949,31277796
22302,MNP,disease,0.7397,31277796
22303,patients,species,0.9854,31277796
22304,RNP,RNA,0.5806,31277796
22305,RNP,RNA,0.5273,31277796
22306,patients,species,0.9844,31277796
22307,aflibercept,gene,0.967,31277796
22308,RNP,RNA,0.658,31277796
22309,MNP,disease,0.7993,31277796
22310,aflibercept,gene,0.9077,31277796
22311,RNP,RNA,0.7056,31277796
22312,MNP,RNA,0.578,31277796
22313,aflibercept,gene,0.921,31277796
22314,aflibercept,gene,0.979,31277796
22315,RNP,RNA,0.6753,31277796
22316,RNP,gene,0.78,31277796
22317,MNP,disease,0.8135,31277796
22318,patients,species,0.991,31277796
22319,aflibercept,gene,0.9805,31277796
22320,aflibercept,gene,0.9565,31277796
22321,RNP,gene,0.7466,31277796
22322,Perifoveal Exudative Vascular Anomalous Complex,disease,1.0,31274742
22323,Patient,species,0.9526,31274742
22324,Perifoveal exudative vascular anomalous complex,disease,1.0,31274742
22325,PEVAC,disease,1.0,31274742
22326,vascular lesions,disease,0.9995,31274742
22327,retinal angiomatous proliferation,disease,1.0,31274742
22328,Perifoveal exudative vascular anomalous complex,disease,1.0,31274742
22329,vascular endothelial growth factor,gene,0.9463,31274742
22330,PEVAC,disease,0.999,31274742
22331,patient,species,0.9487,31274742
22332,diabetes mellitus,disease,1.0,31274742
22333,diabetic retinopathy,disease,1.0,31274742
22334,woman,species,0.836,31274742
22335,diabetes mellitus,disease,1.0,31274742
22336,Fluorescein,drug,0.997,31274742
22337,aflibercept,gene,0.988,31274742
22338,PEVAC lesion,DNA,0.493,31274742
22339,PEVAC,disease,0.9517,31274742
22340,Perifoveal exudative vascular anomalous complex,disease,1.0,31274742
22341,"perifoveal,",disease,1.0,31274742
22342,aneurysmal abnormality,disease,0.8994,31274742
22343,patients,species,0.985,31274742
22344,diabetes mellitus,disease,1.0,31274742
22345,retinopathy,disease,1.0,31274742
22346,macular vascular anomalies,disease,1.0,31274742
22347,PEVAC,disease,1.0,31274742
22348,vascular endothelial growth factor,gene,0.9746,31274742
22349,nurses,cell_type,0.4817,31267688
22350,nurses,cell_type,0.4868,31267688
22351,patients,species,0.9873,31267688
22352,age-related macular degeneration,disease,1.0,31267688
22353,retinal vein occlusion,disease,1.0,31267688
22354,diabetic macular oedema,disease,1.0,31267688
22355,participants,species,0.972,31267688
22356,anti-,gene,0.833,31267688
22357,vascular endothelial growth factor,gene,0.88,31267688
22358,nurse,cell_type,0.47,31267688
22359,patients,species,0.9688,31267688
22360,nurses,cell_type,0.473,31267688
22361,nurses,cell_type,0.5093,31267688
22362,choroidal neovascularization,disease,1.0,31267094
22363,choroidal neovascularization,disease,1.0,31267094
22364,CNV,disease,1.0,31267094
22365,CSC,disease,1.0,31267094
22366,patients,species,0.989,31267094
22367,chronic CSC,disease,0.9985,31267094
22368,CNV,disease,1.0,31267094
22369,patients,species,0.986,31267094
22370,aflibercept,gene,0.92,31267094
22371,aflibercept,gene,0.83,31267094
22372,CNV,disease,0.9995,31267094
22373,patients,species,0.898,31267094
22374,patients,species,0.9873,31267094
22375,patients,species,0.985,31267094
22376,aflibercept,gene,0.99,31267094
22377,aflibercept,gene,0.8374,31267094
22378,CNV,disease,1.0,31267094
22379,aflibercept,gene,0.9683,31267094
22380,patients,species,0.9893,31267094
22381,CNVs,DNA,0.4895,31267094
22382,CSC,disease,0.5234,31267094
22383,CNV,DNA,0.7134,31267094
22384,pachychoroid-related macular disorders,disease,0.966,31267094
22385,VEGF,gene,0.9927,31265210
22386,human,species,0.9814,31265210
22387,glucose,drug,0.998,31265210
22388,RPE,cell_type,0.4612,31265210
22389,diabetic,disease,1.0,31265210
22390,anti-vascular endothelial growth factor,gene,0.9834,31265210
22391,VEGF,gene,0.999,31265210
22392,Diabetic,disease,1.0,31265210
22393,ARPE-19 cell-line culture,cell_line,0.7373,31265210
22394,glucose,drug,0.9854,31265210
22395,hypoxia,disease,0.506,31265210
22396,cobalt chloride,drug,0.9985,31265210
22397,HIF-1a,gene,0.997,31265210
22398,VEGF-,gene,0.988,31265210
22399,VEGF,gene,0.9946,31265210
22400,pigment epithelium-derived factor,gene,0.9976,31265210
22401,PEDF,gene,0.9937,31265210
22402,bevacizumab,gene,0.6025,31265210
22403,ranibizumab,gene,0.6797,31265210
22404,aflibercept,gene,0.9614,31265210
22405,PEDF,gene,0.94,31265210
22406,Glucose,drug,0.999,31265210
22407,PEDF,gene,0.9844,31265210
22408,Brain-derived neurotrophic factor,gene,0.9976,31265210
22409,BDNF,gene,0.996,31265210
22410,glucose,drug,0.9985,31265210
22411,Placental growth factor,gene,0.997,31265210
22412,PlGF,gene,0.9897,31265210
22413,ARPE-19,cell_line,0.8555,31265210
22414,glucose,drug,0.9946,31265210
22415,VEGF,gene,0.993,31265210
22416,photoreceptor,cell_type,0.7354,31265210
22417,diabetic,disease,1.0,31265210
22418,VEGF,gene,0.9966,31265210
22419,anti-vascular endothelial growth factor,gene,0.9424,31264363
22420,anti-vascular endothelial growth factor,gene,0.916,31264363
22421,VEGF,gene,0.8447,31264363
22422,people,species,0.955,31264363
22423,Patient,species,0.993,31264363
22424,bevacizumab,gene,0.888,31264363
22425,aflibercept,gene,0.973,31264363
22426,patients,species,0.9927,31264363
22427,patients,species,0.9863,31264363
22428,macular degeneration,disease,1.0,31264363
22429,diabetic retinopathy,disease,1.0,31264363
22430,retinal vein occlusion,disease,1.0,31264363
22431,bevacizumab,gene,0.8823,31264363
22432,aflibercept,gene,0.99,31264363
22433,ranibizumab,gene,0.8613,31264363
22434,dexamethasone,drug,0.9795,31264363
22435,bevacizumab,gene,0.952,31264363
22436,aflibercept,gene,0.9946,31264363
22437,macular degeneration,disease,1.0,31264363
22438,diabetic retinopathy,disease,1.0,31264363
22439,retinal vein occlusion,disease,1.0,31264363
22440,patients,species,0.986,31264363
22441,Macular degeneration,disease,1.0,31264363
22442,bevacizumab,gene,0.925,31264363
22443,aflibercept,gene,0.969,31264363
22444,vascular endothelial growth factor,gene,0.9907,31259835
22445,age-related macular degeneration,disease,1.0,31259835
22446,Age-related macular degeneration,disease,1.0,31259835
22447,AMD,disease,1.0,31259835
22448,blindness,disease,0.9985,31259835
22449,anti-,gene,0.6885,31259835
22450,vascular endothelial growth factor,gene,0.916,31259835
22451,VEGF,gene,0.9927,31259835
22452,VEGF,gene,0.938,31259835
22453,wet AMD,disease,0.973,31259835
22454,choroidal neovascularization,disease,1.0,31259835
22455,AMD,disease,1.0,31259835
22456,VEGF,gene,0.8506,31259835
22457,retinal pigment epithelial detachment,disease,1.0,31259835
22458,hypertension,disease,1.0,31259835
22459,coronary artery disease,disease,1.0,31259835
22460,cerebral vascular accidents,disease,1.0,31259835
22461,VEGF,gene,0.718,31259835
22462,ranibizumab,gene,0.895,31259835
22463,aflibercept,gene,0.954,31259835
22464,aflibercept,gene,0.9893,31259835
22465,aflibercept,gene,0.9805,31259835
22466,ranibizumab,gene,0.917,31259835
22467,aflibercept,gene,0.9727,31259835
22468,PATIENTS,species,0.9546,31259813
22469,NEOVASCULARIZATION,disease,0.957,31259813
22470,aflibercept,gene,0.9585,31259813
22471,Type 3 neovascularization lesions,disease,0.998,31259813
22472,Stage I/II Type 3 neovascularization lesions,disease,0.9062,31259813
22473,Diabetic Retinopathy,disease,1.0,31259813
22474,Diabetic Retinopathy,disease,1.0,31259813
22475,intraretinal/subretinal fluid,disease,0.817,31259813
22476,endophthalmitis,disease,1.0,31259813
22477,palpitations,disease,0.9995,31259813
22478,nonfatal stroke,disease,0.9976,31259813
22479,aflibercept,gene,0.965,31259813
22480,retinal edema,disease,1.0,31259813
22481,Type 3 neovascularization,disease,0.863,31259813
22482,eye disorders,disease,0.998,31256417
22483,eye disorders,disease,0.9717,31256417
22484,ICSRs,disease,0.608,31256417
22485,Visual impairment,disease,1.0,31256417
22486,blindness,disease,1.0,31256417
22487,vascular endothelial growth factor,gene,0.976,31256417
22488,VEGF,gene,0.997,31256417
22489,bevacizumab,gene,0.793,31256417
22490,aflibercept,gene,0.964,31256417
22491,ranibizumab,gene,0.793,31256417
22492,Retinal haemorrhage,disease,1.0,31256417
22493,blindness,disease,1.0,31256417
22494,uveitis,disease,1.0,31256417
22495,aflibercept,gene,0.9727,31256417
22496,bevacizumab,gene,0.8794,31256417
22497,ranibizumab,gene,0.802,31256417
22498,retinal haemorrhage,disease,1.0,31256417
22499,uveitis,disease,1.0,31256417
22500,blindness,disease,1.0,31256417
22501,VEGF,gene,0.996,31256417
22502,proliferative eye disorders,disease,0.997,31256417
22503,ranibizumab,gene,0.776,31256237
22504,aflibercept,gene,0.982,31256237
22505,VEGF,gene,0.7017,31256237
22506,Patients,species,0.962,31256237
22507,age-related macular degeneration,disease,1.0,31256237
22508,ranibizumab,gene,0.6387,31256237
22509,aflibercept,gene,0.853,31256237
22510,patients,species,0.9824,31256237
22511,ranibizumab,drug,0.8525,31256237
22512,ranibizumab,drug,0.594,31256237
22513,aflibercept,gene,0.8306,31256237
22514,ranibizumab,gene,0.5654,31256237
22515,ranibizumab,gene,0.625,31256237
22516,ranibizumab,gene,0.6865,31256237
22517,aflibercept,gene,0.6997,31256237
22518,patients,species,0.9873,31256237
22519,ranibizumab,gene,0.671,31256237
22520,ranibizumab,gene,0.848,31256237
22521,the,gene,0.5635,31256237
22522,aflibercept,gene,0.856,31256237
22523,Ranibizumab,gene,0.516,31256237
22524,aflibercept,gene,0.9194,31256237
22525,Choroidal Neovascularization,disease,1.0,31254924
22526,(Pro)renin Receptor,gene,0.9966,31254924
22527,prorenin,gene,0.9844,31254924
22528,prorenin,gene,0.9927,31254924
22529,(pro)renin receptor,gene,0.998,31254924
22530,(P)RR,gene,0.9927,31254924
22531,renin,gene,0.9937,31254924
22532,ocular diseases,disease,0.959,31254924
22533,mouse (P)RR ((P)RR-proline-modified short hairpin,RNA,0.6,31254924
22534,mouse,species,0.9805,31254924
22535,(P)RR,DNA,0.568,31254924
22536,(P)RR-PshRNA,gene,0.783,31254924
22537,ocular inflammation,disease,0.9976,31254924
22538,(P)RR-,RNA,0.617,31254924
22539,PshRNA,gene,0.607,31254924
22540,choroidal neovascularization,disease,0.8433,31254924
22541,CNV,disease,1.0,31254924
22542,subretinal fibrosis,disease,1.0,31254924
22543,age-related macular degeneration,disease,1.0,31254924
22544,AMD,disease,1.0,31254924
22545,(P)RR-PshRNA,RNA,0.764,31254924
22546,mice,species,0.957,31254924
22547,macrophage,cell_type,0.7266,31254924
22548,(P)RR-PshRNA,RNA,0.6973,31254924
22549,PshRNA,gene,0.658,31254924
22550,subretinal fibrosis,disease,0.999,31254924
22551,SMAD2,gene,0.6475,31254924
22552,(P)RR-PshRNA,RNA,0.793,31254924
22553,PshRNA,gene,0.621,31254924
22554,aflibercept,gene,0.88,31254924
22555,anti-vascular endothelial growth factor,gene,0.924,31254924
22556,AMD,disease,1.0,31254924
22557,AMD,disease,1.0,31254924
22558,(P)RR,gene,0.9673,31254924
22559,ERK1/2,gene,0.901,31254924
22560,neovascular endothelial cells,cell_type,0.907,31254924
22561,retinal pigment epithelial cells,cell_type,0.88,31254924
22562,(,drug,0.9507,31254924
22563,(,drug,0.9146,31254924
22564,RR-,RNA,0.677,31254924
22565,PshRNA,gene,0.4695,31254924
22566,AMD,disease,1.0,31254924
22567,patients,species,0.9907,31254051
22568,anti-VEGF,gene,0.945,31254051
22569,retinal nerve fiber,cell_type,0.5312,31254051
22570,ONH,disease,1.0,31254051
22571,ONH,disease,0.9995,31254051
22572,VEGF,gene,0.626,31254051
22573,ONH,disease,1.0,31254051
22574,Diabetic Macular Edema,disease,1.0,31246237
22575,Aflibercept,gene,0.9883,31246237
22576,Bevacizumab,gene,0.8794,31246237
22577,Ranibizumab,gene,0.8823,31246237
22578,OCT,gene,0.4902,31246237
22579,diabetic macular edema,disease,1.0,31246237
22580,anti-,gene,0.698,31246237
22581,vascular endothelial growth factor,gene,0.892,31246237
22582,anti-VEGF,gene,0.822,31246237
22583,diabetic macular edema,disease,1.0,31246237
22584,aflibercept,gene,0.977,31246237
22585,bevacizumab,gene,0.9043,31246237
22586,ranibizumab,gene,0.6465,31246237
22587,diabetic macular edema,disease,1.0,31246237
22588,anti-VEGF,gene,0.9395,31246237
22589,aflibercept,gene,0.978,31246237
22590,bevacizumab,gene,0.765,31246237
22591,ranibizumab,gene,0.623,31246237
22592,OCT CST,DNA,0.547,31246237
22593,diabetic macular edema,disease,1.0,31246237
22594,VEGF,gene,0.725,31246237
22595,Ziv-aflibercept,gene,0.9404,31238424
22596,polypoidal choroidal vasculopathy,disease,1.0,31238424
22597,ziv-aflibercept,gene,0.992,31238423
22598,bevacizumab,gene,0.7695,31238423
22599,polypoidal choroidal vasculopathy,disease,1.0,31238423
22600,ziv-aflibercept,gene,0.991,31238423
22601,bevacizumab,gene,0.7324,31238423
22602,BVZ,gene,0.5547,31238423
22603,polypoidal choroidal vasculopathy,disease,1.0,31238423
22604,IVZ,drug,0.951,31238423
22605,BVZ,drug,0.9717,31238423
22606,PCV,disease,1.0,31238423
22607,IVZ,drug,0.73,31238423
22608,BVZ,drug,0.862,31238423
22609,BVZ,drug,0.855,31238423
22610,IVZ,drug,0.9766,31238423
22611,BVZ,drug,0.9863,31238423
22612,IVZ,drug,0.7334,31238423
22613,BVZ,drug,0.9087,31238423
22614,BVZ,drug,0.696,31238423
22615,PED,disease,0.9507,31238423
22616,PCV,disease,1.0,31238423
22617,IVZ,drug,0.882,31238423
22618,BVZ,drug,0.927,31238423
22619,IVZ,drug,0.934,31238423
22620,Bevacizumab,gene,0.7905,31238422
22621,ziv-aflibercept,gene,0.976,31238422
22622,branch retinal vein occlusion,disease,0.9966,31238422
22623,bevacizumab,gene,0.8145,31238422
22624,ziv-aflibercept,gene,0.97,31238422
22625,macular edema,disease,1.0,31238422
22626,ME,disease,0.9995,31238422
22627,branch retinal vein occlusion,disease,1.0,31238422
22628,BRVO,disease,1.0,31238422
22629,ME,disease,0.9995,31238422
22630,BRVO,disease,1.0,31238422
22631,IVZ,drug,0.966,31238422
22632,IVB,drug,0.963,31238422
22633,IVZ,drug,0.9043,31238422
22634,IVZ,drug,0.696,31238422
22635,Bilateral Choroidal Osteoma,disease,0.997,31233159
22636,Bilateral Choroidal Choroidal osteoma,disease,0.997,31233159
22637,unilateral tumor,disease,0.918,31233159
22638,choroidal neovascularization,disease,1.0,31233159
22639,CNV,disease,1.0,31233159
22640,choroidal osteoma,disease,0.987,31233159
22641,patient,species,0.9214,31233159
22642,CNV,disease,0.9995,31233159
22643,CNV OD,disease,1.0,31233159
22644,CNV,disease,0.9995,31233159
22645,patient,species,0.9834,31233159
22646,aflibercept,gene,0.9883,31233159
22647,CNV,disease,0.9634,31233159
22648,patients,species,0.929,31230012
22649,patients,species,0.9707,31230012
22650,neovascular age-related macular degeneration,disease,1.0,31230012
22651,AMD,disease,1.0,31230012
22652,vascular endothelial growth factor,gene,0.8794,31230012
22653,VEGF,gene,0.996,31230012
22654,AMD,disease,1.0,31230012
22655,AMD,disease,0.999,31230012
22656,PARTICIPANTS,species,0.871,31230012
22657,patient,species,0.9546,31230012
22658,patients,species,0.989,31230012
22659,aflibercept,gene,0.9565,31230012
22660,AMD,disease,1.0,31230012
22661,Diabetic Retinopathy,disease,1.0,31230012
22662,Patients,species,0.913,31230012
22663,AMD,disease,1.0,31230012
22664,AMD,disease,1.0,31230012
22665,Nephrotoxicity,disease,0.9873,31229276
22666,vascular endothelial growth factor,gene,0.9946,31229276
22667,Vascular endothelial growth factor,gene,0.999,31229276
22668,VEGF,gene,0.9966,31229276
22669,malignant neoplasms,disease,1.0,31229276
22670,ocular diseases,disease,0.9995,31229276
22671,VEGF,gene,0.994,31229276
22672,VEGF,gene,0.9233,31229276
22673,hypertension,disease,1.0,31229276
22674,proteinuria,disease,1.0,31229276
22675,glomerular disease,disease,1.0,31229276
22676,thrombotic microangiopathy,disease,1.0,31229276
22677,renal function,disease,0.7075,31229276
22678,VEGF,gene,0.661,31229276
22679,bevacizumab,gene,0.8228,31229276
22680,ranibizumab,gene,0.7993,31229276
22681,aflibercept,gene,0.9634,31229276
22682,VEGF,gene,0.9185,31229276
22683,Nepafenac,drug,0.999,31221565
22684,nepafenac,drug,0.9995,31221565
22685,PARTICIPANTS,species,0.517,31221565
22686,bevacizumab,gene,0.9414,31221565
22687,aflibercept,gene,0.989,31221565
22688,triamcinolone acetonide,drug,0.999,31221565
22689,nepafenac,drug,0.996,31221565
22690,nepafenac,drug,0.9995,31221565
22691,nepafenac,drug,0.9995,31221565
22692,Nepafenac,drug,0.999,31221565
22693,Aflibercept,gene,0.9316,31221542
22694,FOLFIRI,drug,0.971,31221542
22695,Metastatic Colorectal Cancer,disease,1.0,31221542
22696,Aflibercept,gene,0.8613,31221542
22697,ASQoP,DNA,0.4563,31221542
22698,aflibercept,gene,0.9897,31221542
22699,metastatic colorectal cancer,disease,1.0,31221542
22700,mCRC,disease,0.9995,31221542
22701,aflibercept,gene,0.9673,31221542
22702,PATIENTS,species,0.9624,31221542
22703,aflibercept,gene,0.9727,31221542
22704,FOLFIRI,drug,0.5107,31221542
22705,fluorouracil,drug,0.9995,31221542
22706,leucovorin,drug,0.999,31221542
22707,irinotecan,drug,0.9985,31221542
22708,QLQ,DNA,0.4773,31221542
22709,QLQ-CR29,DNA,0.4148,31221542
22710,mCRC,disease,0.998,31221542
22711,oxaliplatin,drug,0.9995,31221542
22712,oxaliplatin,drug,0.9995,31221542
22713,diarrhea,disease,1.0,31221542
22714,hypertension,disease,1.0,31221542
22715,nausea,disease,1.0,31221542
22716,hypertension,disease,1.0,31221542
22717,neutropenia,disease,1.0,31221542
22718,diarrhea,disease,1.0,31221542
22719,aflibercept,gene,0.982,31221542
22720,FOLFIRI,drug,0.9863,31221542
22721,mCRC,disease,0.9946,31221542
22722,oxaliplatin,drug,0.9995,31221542
22723,Anti-Vascular Endothelial Growth Factor,gene,0.8477,31219520
22724,anti-vascular endothelial growth factor,gene,0.872,31219520
22725,VEGF,gene,0.994,31219520
22726,bevacizumab,gene,0.7183,31219520
22727,ranibizumab,gene,0.7065,31219520
22728,aflibercept,gene,0.963,31219520
22729,anti-VEGF,gene,0.9243,31219520
22730,VEGF,gene,0.769,31219520
22731,anti-VEGF,gene,0.971,31219520
22732,ranibizumab,gene,0.7305,31219520
22733,aflibercept,gene,0.96,31219520
22734,bevacizumab,gene,0.5654,31219520
22735,aflibercept,gene,0.99,31219520
22736,ranibizumab,gene,0.7153,31219520
22737,bevacizumab,gene,0.644,31219520
22738,Ranibizumab,gene,0.922,31219520
22739,bevacizumab,gene,0.8647,31219520
22740,aflibercept,gene,0.981,31219520
22741,ranibizumab,gene,0.885,31219520
22742,ranibizumab,gene,0.53,31219520
22743,ophthalmologists,cell_type,0.4087,31219520
22744,aflibercept,gene,0.9746,31219520
22745,aflibercept,gene,0.986,31219520
22746,bevacizumab,gene,0.9062,31219520
22747,bevacizumab,gene,0.807,31219520
22748,aflibercept,gene,0.99,31219520
22749,ranibizumab,gene,0.942,31219520
22750,bevacizumab,gene,0.9365,31219520
22751,VEGF,gene,0.9927,31219520
22752,bevacizumab,gene,0.9307,31219520
22753,ranibizumab,gene,0.655,31219520
22754,aflibercept,gene,0.9907,31219520
22755,anti-,gene,0.75,31208350
22756,VEGF,gene,0.6606,31208350
22757,patients,species,0.9785,31208350
22758,VEGF,gene,0.8394,31208350
22759,age-related macular degeneration,disease,1.0,31208350
22760,AMD,disease,1.0,31208350
22761,diabetic macular edema,disease,1.0,31208350
22762,DME,disease,1.0,31208350
22763,retinal vein occlusion,disease,1.0,31208350
22764,RVO,disease,1.0,31208350
22765,macular edema,disease,1.0,31208350
22766,ME,disease,1.0,31208350
22767,Patients,species,0.986,31208350
22768,anti-VEGF,gene,0.973,31208350
22769,FOLFIRI,drug,0.993,31203498
22770,Aflibercept,gene,0.7993,31203498
22771,FOLFIRI,drug,0.997,31203498
22772,aflibercept,gene,0.987,31203498
22773,colorectal cancer,disease,0.98,31203498
22774,mCRC,disease,0.9956,31203498
22775,aflibercept,gene,0.993,31203498
22776,mCRC,disease,0.599,31203498
22777,PATIENTS,species,0.933,31203498
22778,aflibercept,gene,0.9956,31203498
22779,mCRC,disease,0.934,31203498
22780,CEACAM-positive circulating tumor cells,cell_type,0.8594,31203498
22781,CEACAM,gene,0.9805,31203498
22782,CTC,cell_type,0.8066,31203498
22783,patients,species,0.9775,31203498
22784,patients,species,0.981,31203498
22785,sepsis,disease,0.999,31203498
22786,neutropenia,disease,1.0,31203498
22787,diarrhea,disease,1.0,31203498
22788,hypertension,disease,1.0,31203498
22789,asthenia,disease,1.0,31203498
22790,proteinuria,disease,1.0,31203498
22791,bowel perforation,disease,1.0,31203498
22792,CTC,cell_type,0.5894,31203498
22793,CTCs,cell_type,0.7915,31203498
22794,FOLFIRI,drug,0.858,31203498
22795,aflibercept,gene,0.9907,31203498
22796,Endophthalmitis,disease,1.0,31201794
22797,Anti-vascular Endothelial Growth Factor,gene,0.972,31201794
22798,acute endophthalmitis,disease,1.0,31201794
22799,anti-vascular endothelial growth factor,gene,0.971,31201794
22800,VEGF,gene,0.995,31201794
22801,endophthalmitis,disease,1.0,31201794
22802,aflibercept,gene,0.971,31201794
22803,bevacizumab,gene,0.871,31201794
22804,ranibizumab,gene,0.7295,31201794
22805,endophthalmitis,disease,1.0,31201794
22806,anti-VEGF,gene,0.885,31201794
22807,endophthalmitis,disease,1.0,31201794
22808,endophthalmitis,disease,0.9995,31201794
22809,endophthalmitis,disease,1.0,31201794
22810,VEGF,gene,0.932,31201794
22811,aflibercept,gene,0.9497,31198888
22812,age-related macular degeneration,disease,1.0,31198888
22813,AMD,disease,1.0,31198888
22814,patients,species,0.973,31198888
22815,AMD,disease,1.0,31198888
22816,patients,species,0.9893,31198888
22817,type 1,disease,0.984,31198888
22818,choroidal neovascularization,disease,0.821,31198888
22819,CNV,disease,1.0,31198888
22820,polypoidal choroidal vasculopathy,disease,1.0,31198888
22821,CNV,DNA,0.6904,31198888
22822,CNV,DNA,0.7134,31198888
22823,CNV,disease,1.0,31198888
22824,CNV,disease,0.578,31198888
22825,feeder,cell_type,0.493,31198888
22826,CNV,disease,0.9995,31198888
22827,CNV,disease,0.9995,31198888
22828,CNV,DNA,0.556,31198888
22829,CNV,DNA,0.6875,31198888
22830,cytomegalovirus retinitis,disease,1.0,31198672
22831,diabetic macular edema,disease,1.0,31198672
22832,Cytomegalovirus (CMV) retinitis,disease,1.0,31198672
22833,diabetic retinopathy,disease,1.0,31198672
22834,CMV retinitis,disease,0.9146,31198672
22835,diabetic retinopathy,disease,1.0,31198672
22836,patient,species,0.966,31198672
22837,type-1 diabetes mellitus,disease,1.0,31198672
22838,blurred vision,disease,0.999,31198672
22839,diabetic macular edema,disease,1.0,31198672
22840,DME,disease,1.0,31198672
22841,intraocular inflammatory,disease,0.7935,31198672
22842,DME,disease,0.9995,31198672
22843,aflibercept,gene,0.9775,31198672
22844,bilateral panuveitis,disease,0.8574,31198672
22845,CMV retinitis,disease,1.0,31198672
22846,retinitis,disease,0.9995,31198672
22847,DME,disease,1.0,31198672
22848,aflibercept,gene,0.9844,31198672
22849,CMV retinitis,disease,1.0,31198672
22850,retinal diseases,disease,1.0,31198672
22851,diabetic retinopathy,disease,1.0,31198672
22852,aflibercept,gene,0.9526,31198295
22853,Aflibercept,gene,0.876,31198295
22854,neovascular age-related macular degeneration,disease,1.0,31198295
22855,nAMD,DNA,0.675,31198295
22856,patients,species,0.9917,31198295
22857,patients,species,0.9873,31198295
22858,aflibercept,gene,0.973,31198295
22859,Patients,species,0.9355,31198295
22860,patients,species,0.9673,31198295
22861,patients,species,0.988,31198295
22862,Aflibercept,gene,0.947,31198295
22863,nAMD,disease,1.0,31198295
22864,patients,species,0.9614,31182243
22865,aflibercept,gene,0.983,31182243
22866,aflibercept,gene,0.97,31182243
22867,patients,species,0.925,31182243
22868,neovascular age-related macular degeneration,disease,1.0,31182243
22869,patients,species,0.9946,31182243
22870,neovascular age-related macular degeneration,disease,1.0,31182243
22871,aflibercept,gene,0.9653,31182243
22872,Patients,species,0.977,31182243
22873,patients,species,0.982,31182243
22874,pigment epithelial detachment,disease,1.0,31182243
22875,PED,disease,1.0,31182243
22876,PED,disease,1.0,31182243
22877,Aflibercept,gene,0.9517,31182243
22878,Anti-vascular Endothelial Growth Factor,gene,0.9146,31179654
22879,Foveal Serous,disease,0.984,31179654
22880,anti-vascular endothelial growth factor,gene,0.947,31179654
22881,VEGF,gene,0.995,31179654
22882,serous retinal detachment,disease,1.0,31179654
22883,SRD,disease,1.0,31179654
22884,inferior staphyloma,disease,1.0,31179654
22885,VEGF,gene,0.536,31179654
22886,inferior staphyloma,disease,1.0,31179654
22887,anti-VEGF,gene,0.9727,31179654
22888,VEGF,gene,0.586,31179654
22889,patients,species,0.973,31179654
22890,SRF,DNA,0.483,31179654
22891,SRF,disease,0.744,31179654
22892,VEGF,gene,0.932,31179654
22893,SRD,disease,0.824,31179654
22894,inferior staphyloma,disease,0.9976,31179654
22895,aflibercept,gene,0.9873,31179386
22896,patients,species,0.9653,31179386
22897,patients,species,0.9707,31179386
22898,age-related macular degeneration,disease,1.0,31179386
22899,wet AMD,disease,0.8125,31179386
22900,aflibercept,gene,0.9834,31179386
22901,Aflibercept,gene,0.97,31179386
22902,Wet age-related macular degeneration,disease,0.9746,31179386
22903,AFL,drug,0.8555,31179386
22904,wet AMD,disease,0.999,31179386
22905,patients,species,0.9897,31179386
22906,patients,species,0.9697,31179386
22907,patients,species,0.9824,31179386
22908,patients,species,0.9834,31179386
22909,patients,species,0.9766,31179386
22910,patients,species,0.987,31179386
22911,AFL,gene,0.7456,31179386
22912,patients,species,0.992,31179386
22913,patients,species,0.959,31179386
22914,CRT,DNA,0.6196,31179386
22915,patients,species,0.9814,31179386
22916,AFL,disease,0.9917,31179386
22917,Aflibercept,gene,0.986,31176994
22918,Erlotinib,drug,0.997,31176994
22919,cancer,disease,1.0,31176994
22920,aflibercept,gene,0.9805,31176994
22921,VEGFR,gene,0.9873,31176994
22922,erlotinib,drug,0.9956,31176994
22923,tyrosine,drug,0.9985,31176994
22924,tyrosine-kinase,gene,0.997,31176994
22925,rats,species,0.987,31176994
22926,aflibercept,gene,0.9907,31176994
22927,erlotinib,drug,0.993,31176994
22928,aflibercept,gene,0.986,31176994
22929,aflibercept,gene,0.985,31176994
22930,erlotinib,drug,0.995,31176994
22931,erlotinib,drug,0.9917,31176994
22932,(1)H,drug,0.9995,31176994
22933,serum,cell_type,0.4646,31176994
22934,aflibercept,gene,0.995,31176994
22935,erlotinib,drug,0.997,31176994
22936,aflibercept,gene,0.9805,31176994
22937,choline,drug,0.9995,31176994
22938,amino acid,drug,0.999,31176994
22939,aflibercept,gene,0.9927,31176994
22940,erlotinib,drug,0.9946,31176994
22941,aflibercept,gene,0.9565,31176994
22942,aflibercept,gene,0.9814,31176994
22943,aflibercept,gene,0.983,31176994
22944,vascular endothelial growth factor,gene,0.9927,31174872
22945,retinopathy of Retinopathy of prematurity,disease,0.998,31174872
22946,vascular endothelial factor,gene,0.829,31174872
22947,VEGF,gene,0.9985,31174872
22948,VEGF,gene,0.907,31174872
22949,ROP,disease,0.9976,31174872
22950,infant,species,0.717,31174872
22951,anti-VEGF,gene,0.837,31174872
22952,VEGF,gene,0.988,31174872
22953,vascular endothelial,DNA,0.506,31174237
22954,vascular endothelial growth factor,gene,0.998,31174237
22955,tyrosine,drug,0.9805,31174237
22956,tyrosine kinase,gene,0.989,31174237
22957,patients,species,0.946,31174237
22958,thyroid cancer,disease,0.8267,31174237
22959,antitumor,disease,0.922,31174237
22960,Vascular endothelial growth factor (VEGF) Trap,gene,0.9224,31174237
22961,VT,gene,0.999,31174237
22962,human sequences,DNA,0.6416,31174237
22963,human,species,0.943,31174237
22964,VEGF receptors 1 and 2 extracellular domains,gene,0.984,31174237
22965,human immunoglobulin 1,gene,0.994,31174237
22966,human,species,0.98,31174237
22967,patients,species,0.9727,31174237
22968,thyroid cancer,disease,1.0,31174237
22969,VEGF,gene,0.9873,31174237
22970,patients,species,0.958,31174237
22971,patients,species,0.9795,31174237
22972,RAI,drug,0.995,31174237
22973,[(18) F]fludeoxyglucose,drug,0.9995,31174237
22974,"nonmedullary, nonanaplastic thyroid cancer",disease,1.0,31174237
22975,patients,species,0.992,31174237
22976,patients,species,0.9814,31174237
22977,papillary thyroid cancer,disease,1.0,31174237
22978,follicular thyroid cancer,disease,1.0,31174237
22979,Hurthle cell thyroid cancer,disease,1.0,31174237
22980,tumors,disease,1.0,31174237
22981,patients,species,0.991,31174237
22982,patients,species,0.9893,31174237
22983,patients,species,0.9917,31174237
22984,patients,species,0.974,31174237
22985,patients,species,0.9834,31174237
22986,thyroid cancer,disease,1.0,31174237
22987,Patient,species,0.9946,31169862
22988,vascular endothelial growth factor,gene,0.8696,31169862
22989,anti-VEGF,gene,0.9336,31169862
22990,macular edema,disease,1.0,31169862
22991,central retinal vein occlusion,disease,1.0,31169862
22992,CRVO,disease,1.0,31169862
22993,hemiretinal vein occlusion,disease,1.0,31169862
22994,HRVO,disease,1.0,31169862
22995,VEGF,gene,0.748,31169862
22996,patient,species,0.9946,31169862
22997,aflibercept,gene,0.9873,31169862
22998,bevacizumab,gene,0.65,31169862
22999,patient,species,0.923,31169862
23000,patients,species,0.9224,31169862
23001,macular edema,disease,1.0,31169862
23002,CRVO,disease,1.0,31169862
23003,HRVO,disease,1.0,31169862
23004,PARTICIPANTS,species,0.596,31169862
23005,Retinal Vein Occlusion,disease,1.0,31169862
23006,participants,species,0.9497,31169862
23007,Participants,species,0.925,31169862
23008,CRVO- or HRVO-,disease,0.8315,31169862
23009,bevacizumab,gene,0.7285,31169862
23010,aflibercept,gene,0.982,31169862
23011,participants,species,0.9814,31169862
23012,men,species,0.926,31169862
23013,NEI,DNA,0.56,31169862
23014,aflibercept,gene,0.9746,31169862
23015,bevacizumab,gene,0.4902,31169862
23016,NEI,DNA,0.513,31169862
23017,participants,species,0.9717,31169862
23018,aflibercept,gene,0.9844,31169862
23019,bevacizumab,gene,0.635,31169862
23020,NEI,DNA,0.473,31169862
23021,patient,species,0.978,31169862
23022,NEI,DNA,0.4915,31169862
23023,participants,species,0.952,31169862
23024,aflibercept,gene,0.9917,31169862
23025,bevacizumab,gene,0.7295,31169862
23026,macular edema,disease,1.0,31169862
23027,CRVO,disease,1.0,31169862
23028,HRVO,disease,1.0,31169862
23029,bevacizumab,gene,0.715,31169862
23030,aflibercept,gene,0.983,31169862
23031,Aflibercept,gene,0.9854,31163436
23032,Retinal Angiomatous Proliferation,disease,1.0,31163436
23033,Retinal angiomatous proliferation,disease,1.0,31163436
23034,RAP,disease,1.0,31163436
23035,neovascular age-related macular degeneration,disease,1.0,31163436
23036,nAMD,disease,1.0,31163436
23037,RAP lesions,disease,0.999,31163436
23038,anti-VEGF,gene,0.8945,31163436
23039,ranibizumab,gene,0.6177,31163436
23040,aflibercept,gene,0.9863,31163436
23041,nAMD,disease,1.0,31163436
23042,patients,species,0.9824,31163436
23043,RAP lesions,disease,0.9897,31163436
23044,aflibercept,gene,0.976,31163436
23045,nAMD,disease,0.9995,31163436
23046,patients,species,0.9917,31163436
23047,RAP lesions,disease,0.998,31163436
23048,patients,species,0.9897,31163436
23049,aflibercept,gene,0.9214,31163436
23050,patients,species,0.9556,31163436
23051,patients,species,0.977,31163436
23052,BCVA,cell_type,0.4094,31163436
23053,patients,species,0.9644,31163436
23054,patients,species,0.9614,31163436
23055,patients,species,0.982,31163436
23056,aflibercept,gene,0.968,31163436
23057,type 1 and 2 nAMD,disease,1.0,31163436
23058,VEGF,gene,0.8145,31158837
23059,Macular Oedema,disease,1.0,31158837
23060,macular oedema,disease,1.0,31158837
23061,branch retinal vein occlusion,disease,1.0,31158837
23062,BRVO,disease,1.0,31158837
23063,VEGF,gene,0.557,31158837
23064,BRVO,disease,0.9995,31158837
23065,aflibercept,gene,0.9824,31158837
23066,bevacizumab,gene,0.9385,31158837
23067,ranibizumab,gene,0.8438,31158837
23068,patient,species,0.9907,31158837
23069,VEGF,gene,0.7437,31158837
23070,BCVA,cell_type,0.392,31158837
23071,VEGF,gene,0.8877,31158837
23072,endophthalmitis,disease,1.0,31158837
23073,glaucoma,disease,1.0,31158837
23074,VEGF,gene,0.9795,31158837
23075,patients,species,0.939,31158837
23076,cystoid macular oedema,disease,1.0,31158837
23077,BRVO,disease,1.0,31158837
23078,VEGF,gene,0.9243,31158837
23079,BRVO,disease,0.9995,31158837
23080,Aflibercept,gene,0.9595,31153850
23081,Sterile Intraocular Inflammation,disease,1.0,31153850
23082,sterile intraocular inflammation,disease,1.0,31153850
23083,aflibercept,gene,0.981,31153850
23084,blurry vision,disease,1.0,31153850
23085,floaters,disease,0.783,31153850
23086,photophobia,disease,0.9746,31153850
23087,intraocular inflammation,disease,1.0,31153850
23088,vitritis,disease,1.0,31153850
23089,keratic,cell_type,0.5093,31153850
23090,corneal edema,disease,1.0,31153850
23091,conjunctival injection,disease,1.0,31153850
23092,chemosis,disease,1.0,31153850
23093,fibrin,gene,0.985,31153850
23094,steroids,drug,0.649,31153850
23095,vision loss,disease,0.87,31153850
23096,fibrin,gene,0.9956,31153850
23097,aflibercept,gene,0.9893,31153850
23098,aflibercept,gene,0.986,31153850
23099,sterile intraocular inflammation,disease,0.998,31153850
23100,intraocular inflammation,disease,1.0,31153850
23101,hypopyon,disease,0.9756,31153850
23102,fibrin,gene,0.8047,31153850
23103,Aflibercept,gene,0.9775,31147489
23104,Advanced Colorectal Cancer,disease,1.0,31147489
23105,aflibercept,gene,0.987,31147489
23106,FOLFIRI,drug,0.909,31147489
23107,fluorouracil,drug,0.9995,31147489
23108,leucovorin,drug,0.9985,31147489
23109,irinotecan,drug,0.999,31147489
23110,metastatic colorectal cancer,disease,1.0,31147489
23111,mCRC,disease,0.99,31147489
23112,mCRC,disease,0.9893,31147489
23113,aflibercept,gene,0.991,31147489
23114,irinotecan,drug,0.997,31147489
23115,carcinoembryonic antigen,gene,0.995,31147489
23116,colorectal cancer,disease,1.0,31147489
23117,FOLFIRI,drug,0.888,31147489
23118,aflibercept,gene,0.9727,31147489
23119,FOLFIRI,drug,0.5854,31147489
23120,aflibercept,gene,0.9897,31147489
23121,aflibercept,gene,0.974,31147489
23122,colon cancer,disease,1.0,31147489
23123,aflibercept,gene,0.95,31146962
23124,ranibizumab,gene,0.5356,31146962
23125,dexamethasone,drug,0.996,31146962
23126,aflibercept,gene,0.9873,31146962
23127,ranibizumab,gene,0.802,31146962
23128,cyclosporine,drug,0.9995,31146962
23129,difluprednate,drug,0.9985,31146962
23130,HUMANS,species,0.975,31145389
23131,NEOVASCULAR AGE-RELATED MACULAR DEGENERATION,disease,0.9995,31145389
23132,aflibercept,gene,0.9854,31145389
23133,neovascular age-related macular degeneration,disease,1.0,31145389
23134,neovascular age-related macular degeneration,disease,1.0,31145389
23135,vascular endothelial growth factor,gene,0.9785,31145389
23136,aflibercept,gene,0.8564,31145389
23137,blood,cell_type,0.4944,31145389
23138,blood,cell_type,0.4766,31145389
23139,plasma,cell_type,0.3955,31145389
23140,aflibercept,gene,0.9893,31145389
23141,aflibercept,gene,0.9805,31145389
23142,aflibercept,gene,0.9897,31145389
23143,plasma,cell_type,0.5957,31145389
23144,aflibercept,gene,0.9917,31145389
23145,aflibercept,gene,0.9673,31145389
23146,vascular endothelial growth factor,gene,0.997,31145389
23147,ranibizumab,gene,0.67,31144055
23148,aflibercept,gene,0.9663,31144055
23149,aflibercept,gene,0.9893,31144055
23150,ranibizumab,gene,0.6567,31144055
23151,neovascular age-related macular degeneration,disease,1.0,31144055
23152,PATIENTS,species,0.906,31144055
23153,patients,species,0.987,31144055
23154,neovascular age-related macular degeneration,disease,1.0,31144055
23155,ranibizumab,gene,0.8296,31144055
23156,aflibercept,gene,0.9673,31144055
23157,aflibercept,gene,0.991,31144055
23158,ranibizumab,gene,0.689,31144055
23159,aflibercept,gene,0.9795,31144055
23160,ranibizumab,drug,0.507,31144055
23161,aflibercept,gene,0.978,31144055
23162,aflibercept,gene,0.9746,31144055
23163,vascular endothelial growth factor,gene,0.9946,31142516
23164,retinal conditions,disease,0.9883,31142516
23165,bevacizumab,gene,0.9233,31142516
23166,ranibizumab,gene,0.888,31142516
23167,aflibercept,gene,0.9653,31142516
23168,choroidal neovascular age-related macular degeneration,disease,1.0,31142516
23169,cn-AMD,disease,1.0,31142516
23170,diabetic macular oedema,disease,1.0,31142516
23171,DMO,disease,1.0,31142516
23172,macular oedema,disease,1.0,31142516
23173,retinal vein occlusion,disease,0.999,31142516
23174,RVO-MO,disease,0.9985,31142516
23175,myopic choroidal neovascularisation,disease,1.0,31142516
23176,m-CNV,disease,1.0,31142516
23177,VEGF,gene,0.7495,31142516
23178,cn-AMD,disease,0.9985,31142516
23179,DMO,disease,1.0,31142516
23180,RVO-MO,disease,0.9995,31142516
23181,m-CNV,disease,0.9985,31142516
23182,cn-AMD,disease,1.0,31142516
23183,DMO,disease,1.0,31142516
23184,RVO-MO,disease,0.9995,31142516
23185,m-CNV,disease,0.9995,31142516
23186,bevacizumab,gene,0.7925,31142516
23187,cn-AMD,disease,0.9995,31142516
23188,aflibercept,gene,0.989,31142516
23189,ranibizumab,gene,0.821,31142516
23190,DMO,disease,1.0,31142516
23191,aflibercept,gene,0.982,31142516
23192,ranibizumab,gene,0.8457,31142516
23193,bevacizumab,gene,0.681,31142516
23194,VEGF,gene,0.857,31142516
23195,cn-AMD,disease,0.9976,31142516
23196,bevacizumab,gene,0.8296,31142516
23197,ranibizumab,gene,0.8975,31142516
23198,aflibercept,gene,0.9795,31142516
23199,cn-AMD,disease,1.0,31142516
23200,DMO,disease,1.0,31142516
23201,RVO-MO,disease,0.998,31142516
23202,m-CNV,disease,1.0,31142516
23203,DME,disease,1.0,31142516
23204,diabetic retinopathy,disease,0.999,31142516
23205,aflibercept,gene,0.9707,31142516
23206,bevacizumab,gene,0.5156,31142516
23207,VEGF,gene,0.6426,31142516
23208,retinal condition,disease,0.988,31142516
23209,Age-Related Macular Degeneration,disease,1.0,31132283
23210,(subretinal) neovascularization,disease,0.992,31132283
23211,neovascular age-related macular degeneration,disease,1.0,31132283
23212,AMD,disease,1.0,31132283
23213,vascular endothelial growth factor,gene,0.996,31132283
23214,VEGF,gene,0.997,31132283
23215,neovascular AMD,disease,1.0,31132283
23216,patients,species,0.9854,31132283
23217,patients,species,0.9863,31132283
23218,anti-VEGF,gene,0.813,31132283
23219,neovascular AMD,disease,1.0,31132283
23220,VEGF,gene,0.677,31132283
23221,Aflibercept,gene,0.974,31127381
23222,aflibercept,gene,0.988,31127381
23223,aflibercept,gene,0.9893,31127381
23224,diabetic macular edema,disease,1.0,31127381
23225,DME,disease,1.0,31127381
23226,patients,species,0.9746,31127381
23227,DME,disease,1.0,31127381
23228,Patients,species,0.959,31127381
23229,aflibercept,gene,0.9844,31127381
23230,aflibercept,gene,0.944,31127381
23231,Aflibercept,gene,0.9897,31127381
23232,patients,species,0.9897,31127381
23233,patients,species,0.967,31127381
23234,the,gene,0.924,31127381
23235,aflibercept,gene,0.576,31127381
23236,aflibercept,gene,0.9893,31124509
23237,retinopathy of prematurity,disease,1.0,31124509
23238,Aflibercept,gene,0.983,31124509
23239,anti,gene,0.565,31124509
23240,Vascular Endothelial Growth factor,gene,0.97,31124509
23241,anti-VEGF,gene,0.9805,31124509
23242,Retinopathy of Prematurity,disease,1.0,31124509
23243,ROP,disease,1.0,31124509
23244,Aflibercept,gene,0.9126,31124509
23245,ROP,disease,0.4216,31124509
23246,Posterior ROP,disease,0.985,31124509
23247,AP-ROP,disease,0.9985,31124509
23248,Aflibercept,gene,0.973,31124509
23249,ROP,disease,0.999,31124509
23250,ROP,disease,0.9976,31124509
23251,Aflibercept,gene,0.969,31124509
23252,ROP,disease,0.978,31124509
23253,ROP,disease,0.99,31124509
23254,I ROP,disease,0.838,31124509
23255,Aflibercept,gene,0.983,31124509
23256,ROP,disease,0.9995,31124509
23257,ROP,disease,0.9995,31124509
23258,Aflibercept,gene,0.9355,31124509
23259,ROP,disease,0.949,31124509
23260,Aflibercept,gene,0.9854,31121590
23261,Type 3 Neovascularization,disease,0.9995,31121590
23262,aflibercept,gene,0.982,31121590
23263,aflibercept,gene,0.986,31121590
23264,ETDRS,cell_type,0.4546,31121590
23265,RPE atrophy,disease,1.0,31121590
23266,serous pigment epithelium detachment,disease,0.8906,31121590
23267,fibrotic lesion,disease,0.9995,31121590
23268,aflibercept,gene,0.9404,31121590
23269,RPE atrophy,disease,1.0,31121590
23270,subretinal/intraretinal fibrosis,disease,1.0,31121590
23271,anti-VEGF,gene,0.8193,31119505
23272,patients,species,0.8667,31119505
23273,diabetic macular edema,disease,1.0,31119505
23274,DME,disease,1.0,31119505
23275,proliferative diabetic retinopathy,disease,0.999,31119505
23276,PDR,disease,1.0,31119505
23277,patients,species,0.9478,31119505
23278,DME,disease,1.0,31119505
23279,PDR,disease,0.991,31119505
23280,anti-VEGF,gene,0.962,31119505
23281,DCP,DNA,0.4646,31119505
23282,DME,disease,0.9995,31119505
23283,PDR,disease,0.9966,31119505
23284,anti-VEGF,gene,0.6367,31119505
23285,DME,disease,1.0,31119505
23286,macular,DNA,0.4683,31119505
23287,VEGF,gene,0.563,31119505
23288,anti-VEGF,gene,0.6875,31119505
23289,macular,DNA,0.4736,31119505
23290,diabetic macular edema,disease,1.0,31114146
23291,diabetic macular edema,disease,1.0,31114146
23292,DME,disease,1.0,31114146
23293,patients,species,0.993,31114146
23294,anti-VEGF,gene,0.9785,31114146
23295,patients,species,0.946,31114146
23296,DME,disease,1.0,31114146
23297,ziv-aflibercept,gene,0.977,31114146
23298,patients,species,0.989,31114146
23299,patients,species,0.9897,31114146
23300,anti-VEGF,gene,0.9697,31114146
23301,anti-VEGF,gene,0.9004,31114146
23302,DME,disease,1.0,31114146
23303,patients,species,0.9927,31114146
23304,Aflibercept,gene,0.9907,31112967
23305,Betamethasone,drug,0.9595,31112967
23306,Corneal Neovascularization,disease,1.0,31112967
23307,Rabbit,species,0.948,31112967
23308,aflibercept,gene,0.9893,31112967
23309,antivascular endothelial growth factor,gene,0.9062,31112967
23310,VEGF,gene,0.9966,31112967
23311,betamethasone,drug,0.9946,31112967
23312,Celestone,drug,0.9785,31112967
23313,corneal neovascularization,disease,1.0,31112967
23314,rabbit,species,0.962,31112967
23315,corneal,disease,0.877,31112967
23316,rabbits,species,0.9478,31112967
23317,rabbits,species,0.951,31112967
23318,aflibercept,gene,0.993,31112967
23319,betamethasone,drug,0.991,31112967
23320,aflibercept,gene,0.981,31112967
23321,betamethasone,drug,0.9883,31112967
23322,corneal neovascularization,disease,0.8584,31112967
23323,corneal neovascularization,disease,0.9883,31112967
23324,rabbits,species,0.92,31112967
23325,hematoxylin,drug,0.9995,31112967
23326,eosin,drug,0.9985,31112967
23327,VEGF,gene,0.9966,31112967
23328,rabbit,species,0.956,31112967
23329,corneal neovascularization,disease,0.9985,31112967
23330,chemical burn,disease,0.962,31112967
23331,aflibercept,gene,0.964,31112967
23332,betamethasone,drug,0.954,31112967
23333,anti-vascular endothelial growth factor,gene,0.939,31110222
23334,VEGF,gene,0.9956,31110222
23335,diabetic macular oedema,disease,1.0,31110222
23336,DME,disease,1.0,31110222
23337,patients,species,0.969,31110222
23338,DME,disease,1.0,31110222
23339,anti-VEGF,gene,0.943,31110222
23340,anti-VEGF,gene,0.964,31110222
23341,anti-VEGF,gene,0.768,31110222
23342,patients,species,0.992,31110222
23343,anti-VEGF,gene,0.84,31110222
23344,DME,disease,0.9976,31110222
23345,anti-VEGF,gene,0.945,31110222
23346,FDG,drug,0.997,31107745
23347,FOLFIRI,drug,0.8735,31107745
23348,Aflibercept,gene,0.9546,31107745
23349,Metastatic Colorectal Cancer,disease,1.0,31107745
23350,FOLFIRI,drug,0.737,31107745
23351,aflibercept,gene,0.996,31107745
23352,metastatic colorectal cancer,disease,1.0,31107745
23353,mCRC,disease,1.0,31107745
23354,FOLFOX,drug,0.9824,31107745
23355,bevacizumab,gene,0.9585,31107745
23356,FDG,drug,0.994,31107745
23357,mCRC,disease,0.9565,31107745
23358,aflibercept,gene,0.979,31107745
23359,FDG,drug,0.9966,31107745
23360,mCRC,disease,0.996,31107745
23361,DME,disease,0.6284,31103642
23362,DME,disease,0.547,31103642
23363,subretinal fluid,disease,0.9976,31103642
23364,SRF,disease,0.994,31103642
23365,aflibercept,gene,0.9824,31103642
23366,diabetic macular edema,disease,0.998,31103642
23367,DME,disease,1.0,31103642
23368,PARTICIPANTS,species,0.4844,31103642
23369,DME,disease,1.0,31103642
23370,IAI,drug,0.7964,31103642
23371,IAI,drug,0.626,31103642
23372,SRF,gene,0.5913,31103642
23373,Bevacizumab,gene,0.8647,31102206
23374,Ranibizumab,gene,0.903,31102206
23375,Aflibercept,gene,0.9863,31102206
23376,Age-Related Macular Degeneration,disease,1.0,31102206
23377,vascular endothelial growth factor,gene,0.9385,31102206
23378,neovascular age-related macular degeneration,disease,1.0,31102206
23379,nAMD,disease,1.0,31102206
23380,nAMD,disease,1.0,31102206
23381,anti-VEGF,gene,0.784,31102206
23382,bevacizumab,gene,0.8306,31102206
23383,nAMD,disease,1.0,31102206
23384,anti-VEGF,gene,0.9395,31102206
23385,ranibizumab,gene,0.751,31102206
23386,bevacizumab,gene,0.769,31102206
23387,aflibercept,gene,0.912,31102206
23388,aflibercept,gene,0.9062,31102206
23389,pigment,disease,0.6924,31102206
23390,VEGF,gene,0.671,31102206
23391,nAMD,disease,1.0,31102206
23392,Bevacizumab,gene,0.717,31100217
23393,Ranibizumab,gene,0.6914,31100217
23394,Wet,disease,0.872,31100217
23395,Age-Related Macular Degeneration,disease,0.9834,31100217
23396,Aflibercept,gene,0.984,31100217
23397,Age-related macular degeneration,disease,1.0,31100217
23398,aflibercept,gene,0.978,31100217
23399,bevacizumab,gene,0.765,31100217
23400,bevacizumab,gene,0.881,31100217
23401,aflibercept,gene,0.9893,31100217
23402,neovascular macular degeneration,disease,1.0,31100217
23403,anti-vascular endothelial growth factor,gene,0.864,31100217
23404,bevacizumab,gene,0.6753,31100217
23405,ranibizumab,gene,0.682,31100217
23406,ranibizumab,gene,0.7866,31100217
23407,ranibizumab,gene,0.524,31100217
23408,bevacizumab,gene,0.6973,31100217
23409,bevacizumab,gene,0.644,31100217
23410,bevacizumab,gene,0.784,31100217
23411,ranibizumab,gene,0.776,31100217
23412,aflibercept,gene,0.9844,31100217
23413,ranibizumab,gene,0.731,31100217
23414,aflibercept,gene,0.9834,31100217
23415,bevacizumab,gene,0.89,31100217
23416,aflibercept,gene,0.9956,31100217
23417,bevacizumab,gene,0.7773,31100217
23418,ranibizumab,drug,0.5977,31100217
23419,Aflibercept,gene,0.969,31100217
23420,bevacizumab,gene,0.4988,31100217
23421,Strokes,disease,0.9873,31100168
23422,Anti-Vascular Endothelial Growth Factor,gene,0.9346,31100168
23423,anti-vascular endothelial growth factor,gene,0.9854,31100168
23424,VEGF,gene,0.7817,31100168
23425,PATIENTS,species,0.9277,31100168
23426,anti-VEGF,gene,0.6445,31100168
23427,AMD,disease,1.0,31100168
23428,diabetic macular edema,disease,1.0,31100168
23429,DME,disease,1.0,31100168
23430,),disease,0.5283,31100168
23431,proliferative diabetic retinopathy,disease,1.0,31100168
23432,PDR,disease,1.0,31100168
23433,retinal vein occlusion,disease,1.0,31100168
23434,RVO,disease,1.0,31100168
23435,AMD,disease,1.0,31100168
23436,DME,disease,1.0,31100168
23437,PDR,disease,1.0,31100168
23438,RVO,disease,1.0,31100168
23439,stroke,disease,0.867,31100168
23440,strokes,disease,0.9995,31100168
23441,ischemic infarcts,disease,1.0,31100168
23442,hemorrhagic strokes,disease,1.0,31100168
23443,anti-VEGF,gene,0.9453,31100168
23444,Aflibercept,gene,0.963,31100159
23445,aflibercept,gene,0.928,31100159
23446,PATIENTS,species,0.8384,31100159
23447,aflibercept,gene,0.9604,31100159
23448,aflibercept-treated control,cell_line,0.635,31100159
23449,aflibercept,gene,0.652,31100159
23450,anterior uveitis,disease,1.0,31100159
23451,vitreous,cell_line,0.5957,31100159
23452,vitreous cells,cell_type,0.774,31100159
23453,inflammation,disease,0.994,31100159
23454,ganglion,cell_line,0.477,31099498
23455,ganglion cell layer,cell_type,0.6978,31099498
23456,diabetic macular oedema,disease,1.0,31099498
23457,anti-,gene,0.8057,31099498
23458,vascular endothelial growth factor,gene,0.8955,31099498
23459,ganglion cell layer cysts,disease,0.999,31099498
23460,GCLC,disease,0.9995,31099498
23461,diabetic macular oedema,disease,1.0,31099498
23462,DME,disease,1.0,31099498
23463,VEGF,gene,0.9966,31099498
23464,DME,disease,1.0,31099498
23465,anti-VEGF,gene,0.8174,31099498
23466,GCLC,disease,0.666,31099498
23467,DME,disease,1.0,31099498
23468,GCLC,gene,0.9863,31099498
23469,Diabetic-Retinopathy,disease,1.0,31099498
23470,GCLC,gene,0.9263,31099498
23471,GCLC,gene,0.996,31099498
23472,GCLC,gene,0.9946,31099498
23473,GCLC,gene,0.9927,31099498
23474,CRT,DNA,0.5376,31099498
23475,Ganglion cell layer cysts,disease,0.9995,31099498
23476,GCLC,disease,0.9995,31099498
23477,DME,disease,1.0,31099498
23478,vascular endothelial growth factor,gene,0.944,31092017
23479,corneal endothelial cell,cell_type,0.6035,31092017
23480,anti-vascular endothelial growth factor,gene,0.9883,31092017
23481,VEGF,gene,0.998,31092017
23482,patients,species,0.988,31092017
23483,Patients,species,0.9854,31092017
23484,anti-VEGF,gene,0.816,31092017
23485,bevacizumab,gene,0.88,31092017
23486,ranibizumab,gene,0.823,31092017
23487,aflibercept,gene,0.957,31092017
23488,phakic,disease,0.9985,31092017
23489,phakic,disease,0.9976,31092017
23490,pseudophakic,disease,0.9814,31092017
23491,phakic and pseudophakic,disease,0.861,31092017
23492,anti-VEGF,gene,0.815,31092017
23493,phakic,disease,0.865,31092017
23494,pseudophakic,disease,0.9976,31092017
23495,ACD,disease,0.962,31092017
23496,phakic,disease,0.955,31092017
23497,aflibercept,gene,0.9336,31088543
23498,aflibercept,gene,0.8613,31088543
23499,IVA,disease,0.8027,31088543
23500,polypoidal choroidal vasculopathy,disease,1.0,31088543
23501,PCV,disease,1.0,31088543
23502,patients,species,0.9756,31088543
23503,PCV,disease,1.0,31088543
23504,polyp,disease,0.998,31088543
23505,dry macula,disease,0.9995,31088543
23506,polypoidal,DNA,0.45,31088543
23507,polypoidal lesions,disease,1.0,31088543
23508,BCVA,cell_type,0.411,31088543
23509,patients,species,0.992,31088543
23510,polyp,disease,0.993,31088543
23511,PCV,disease,1.0,31088543
23512,patients,species,0.9927,31088543
23513,BCVA,cell_type,0.4558,31088543
23514,aflibercept,gene,0.972,31088111
23515,neovascular age-related macular degeneration,disease,1.0,31088111
23516,vascular endothelial growth factor-A,gene,0.9907,31088111
23517,aflibercept,gene,0.989,31088111
23518,neovascular age-related macular degeneration,disease,1.0,31088111
23519,aflibercept,gene,0.8315,31088111
23520,neovascular age-related macular degeneration,disease,1.0,31088111
23521,vascular endothelial growth factor A,gene,0.9814,31088111
23522,neovascular age-related macular degeneration,disease,0.9995,31088111
23523,ranibizumab,gene,0.8057,31088111
23524,bevacizumab,gene,0.5767,31088111
23525,Aflibercept,gene,0.985,31088111
23526,aflibercept,gene,0.9663,31088111
23527,noninfectious endophthalmitis,disease,0.99,31088111
23528,aflibercept,gene,0.9946,31081526
23529,radiation-induced macular edema,disease,0.96,31081526
23530,aflibercept,gene,0.989,31081526
23531,patients,species,0.951,31081526
23532,post-radiation macular edema,disease,1.0,31081526
23533,choroidal melanoma,disease,1.0,31081526
23534,patients,species,0.9395,31081526
23535,radiation maculopathy,disease,1.0,31081526
23536,RM,disease,1.0,31081526
23537,macular edema,disease,1.0,31081526
23538,ruthenium-106,drug,0.9473,31081526
23539,choroidal melanoma,disease,1.0,31081526
23540,aflibercept,gene,0.971,31081526
23541,RM,disease,,31081526
23542,patients,species,0.9785,31081526
23543,BCVA,cell_type,0.4226,31081526
23544,aflibercept,gene,0.964,31081526
23545,maculopathy,disease,1.0,31081526
23546,endophthalmitis,disease,1.0,31081526
23547,aflibercept,gene,0.9683,31081526
23548,patients,species,0.9814,31081526
23549,radiation-induced macular edema,disease,0.9966,31081526
23550,Diabetic Macular Edema,disease,1.0,31080168
23551,Aflibercept,gene,0.9023,31080168
23552,diabetic macular edema,disease,1.0,31080168
23553,DME,disease,1.0,31080168
23554,aflibercept,gene,0.9585,31080168
23555,PARTICIPANTS,species,0.5796,31080168
23556,type 1 or 2 diabetes mellitus,disease,1.0,31080168
23557,DME,disease,1.0,31080168
23558,aflibercept,gene,0.9263,31080168
23559,Diabetic Retinopathy,disease,1.0,31080168
23560,NEI,DNA,0.509,31080168
23561,NEI,DNA,0.4832,31080168
23562,NEI,DNA,0.519,31080168
23563,BSE,disease,1.0,31080168
23564,WSE,disease,0.9995,31080168
23565,CRT,DNA,0.505,31080168
23566,TEAE,disease,1.0,31080168
23567,endophthalmitis,disease,1.0,31080168
23568,aflibercept,gene,0.9497,31080168
23569,NEI,DNA,0.533,31080168
23570,DME,disease,1.0,31080168
23571,aflibercept,gene,0.982,31080168
23572,Eicosapentaenoic acid,drug,0.9995,31059084
23573,IL6,gene,0.987,31059084
23574,VEGF,gene,0.9907,31059084
23575,colon cancerassociated fibroblasts,cell_type,0.7236,31059084
23576,colon cancer,disease,0.7217,31059084
23577,Eicosapentaenoic acid,drug,0.9995,31059084
23578,EPA,drug,0.9995,31059084
23579,interleukin (IL,disease,0.9224,31059084
23580,interleukin (IL)6,gene,0.9907,31059084
23581,advanced cancer,disease,1.0,31059084
23582,anticancer,disease,0.8896,31059084
23583,EPA,drug,0.999,31059084
23584,cancer cells,cell_type,0.838,31059084
23585,cancer,disease,0.999,31059084
23586,tumor,disease,1.0,31059084
23587,EPA,drug,0.999,31059084
23588,cancer,disease,0.9966,31059084
23589,colon cancerassociated fibroblasts,cell_type,0.6367,31059084
23590,colon cancer,disease,0.5977,31059084
23591,CAFs,cell_type,0.8174,31059084
23592,human CAFs,cell_line,0.915,31059084
23593,normal fibroblasts,cell_type,0.7817,31059084
23594,NFs,cell_type,0.7046,31059084
23595,IL6,gene,0.993,31059084
23596,vascular endothelial growth factor,gene,0.9976,31059084
23597,VEGF,gene,0.9897,31059084
23598,EPA,drug,0.994,31059084
23599,mitogenactivated protein kinase,gene,0.9917,31059084
23600,ERK,gene,0.99,31059084
23601,CAFs,cell_type,0.8364,31059084
23602,EPA,drug,0.9966,31059084
23603,human umbilical vein endothelial cells,cell_line,0.948,31059084
23604,HUVECs,species,0.4717,31059084
23605,CAF,cell_type,0.4634,31059084
23606,EPA,drug,0.9995,31059084
23607,IL6,gene,0.989,31059084
23608,CAFs,cell_type,0.881,31059084
23609,NFs,cell_type,0.873,31059084
23610,IL6,gene,0.9907,31059084
23611,fibroblast types,cell_line,0.551,31059084
23612,fibroblasts,cell_type,0.9272,31059084
23613,VEGF,gene,0.9824,31059084
23614,EPA,drug,0.9995,31059084
23615,IL6,gene,0.9688,31059084
23616,VEGF,gene,0.983,31059084
23617,CAFs,cell_type,0.85,31059084
23618,EPA,drug,0.996,31059084
23619,ERK,gene,0.9907,31059084
23620,CAFs,gene,0.877,31059084
23621,CAF,cell_type,0.768,31059084
23622,EPA,drug,0.999,31059084
23623,HUVECs,cell_line,0.742,31059084
23624,ERK,gene,0.9927,31059084
23625,EPA,drug,0.998,31059084
23626,EPA,drug,0.9995,31059084
23627,cancer,disease,0.9976,31059084
23628,CAFs,cell_type,0.8486,31059084
23629,bevacizumab,gene,0.842,31059084
23630,aflibercept,gene,0.9595,31059084
23631,EPA,drug,0.9985,31059084
23632,EPA,drug,0.9995,31059084
23633,Diabetic Macular Edema,disease,1.0,31047609
23634,diabetic macular edema,disease,1.0,31047609
23635,DME,disease,1.0,31047609
23636,PARTICIPANTS,species,0.7793,31047609
23637,patients,species,0.991,31047609
23638,DME,disease,1.0,31047609
23639,aflibercept,gene,0.953,31047609
23640,DME,disease,1.0,31047609
23641,Aflibercept,gene,0.9478,31047606
23642,Patients,species,0.972,31047606
23643,Neovascular Age-Related Macular Degeneration,disease,1.0,31047606
23644,aflibercept,gene,0.9946,31047606
23645,nAMD,disease,1.0,31047606
23646,PARTICIPANTS,species,0.8135,31047606
23647,Patients,species,0.9775,31047606
23648,nAMD,disease,1.0,31047606
23649,Patients,species,0.987,31047606
23650,patients,species,0.9756,31047606
23651,patients,species,0.987,31047606
23652,patients,species,0.9854,31047606
23653,patients,species,0.987,31047606
23654,patients,species,0.9766,31047606
23655,patients,species,0.9946,31047606
23656,patients,species,0.9844,31047606
23657,patients,species,0.982,31047606
23658,patient,species,0.97,31047606
23659,patients,species,0.988,31047606
23660,patients,species,0.9844,31047606
23661,patients,species,0.9775,31047606
23662,endophthalmitis,disease,1.0,31047606
23663,IAI,drug,0.6885,31047606
23664,patients,species,0.9746,31047606
23665,patients,species,0.981,31047606
23666,VEGF,gene,0.9043,31047549
23667,Myopic Choroidal,disease,1.0,31047549
23668,VEGF,gene,0.998,31047549
23669,myopic choroidal neovascularization,disease,1.0,31047549
23670,mCNV,disease,1.0,31047549
23671,PARTICIPANTS,species,0.721,31047549
23672,mCNV,disease,1.0,31047549
23673,patients,species,0.965,31047549
23674,aflibercept,gene,0.8613,31047549
23675,mCNV,disease,1.0,31047549
23676,mCNV,disease,1.0,31047549
23677,anti-VEGF,gene,0.8506,31047549
23678,mCNV,DNA,0.661,31047549
23679,Vascular Endothelial Growth Factor,gene,0.9316,31047530
23680,vascular endothelial growth factor,gene,0.9937,31047530
23681,VEGF,gene,0.9985,31047530
23682,PARTICIPANTS,species,0.7993,31047530
23683,aflibercept,gene,0.9614,31047530
23684,Eylea,drug,0.9814,31047530
23685,VEGF,gene,0.8125,31047530
23686,ranibizumab,gene,0.833,31047530
23687,aflibercept,gene,0.979,31047530
23688,aflibercept,gene,0.95,31047530
23689,ranibizumab,gene,0.8906,31047530
23690,aflibercept,gene,0.9043,31047530
23691,anti-VEGF,gene,0.821,31047530
23692,Ranibizumab,gene,0.915,31047530
23693,aflibercept,gene,0.9785,31047530
23694,Bevacizumab,gene,0.8555,31047530
23695,Aflibercept,gene,0.978,31047501
23696,Diabetic Retinopathy,disease,1.0,31047501
23697,aflibercept,gene,0.9937,31047501
23698,diabetic retinopathy,disease,1.0,31047501
23699,DR,disease,1.0,31047501
23700,Aflibercept,gene,0.9863,31047501
23701,Vision Impairment,disease,1.0,31047501
23702,DME,disease,1.0,31047501
23703,DME,disease,0.999,31047501
23704,Aflibercept,gene,0.9736,31047501
23705,Patients,species,0.9307,31047501
23706,Diabetic Macular Edema,disease,1.0,31047501
23707,DME,disease,1.0,31047501
23708,PARTICIPANTS,species,0.5083,31047501
23709,patients,species,0.9844,31047501
23710,Diabetic Retinopathy,disease,1.0,31047501
23711,patients,species,0.9785,31047501
23712,proliferative DR,disease,0.9595,31047501
23713,DME,disease,0.972,31047501
23714,DME,disease,0.8657,31047501
23715,patients,species,0.9175,31047501
23716,diabetic macular edema,disease,1.0,31047501
23717,DME,disease,1.0,31047501
23718,aflibercept,gene,0.9834,31047501
23719,aflibercept,gene,0.9805,31047501
23720,patients,species,0.9834,31047501
23721,PDR,disease,0.9185,31047501
23722,patients,species,0.9634,31047501
23723,nonproliferative DR,disease,0.58,31047501
23724,patients,species,0.97,31047501
23725,patients,species,0.926,31047501
23726,PDR,disease,0.597,31047501
23727,DME,disease,0.997,31047501
23728,patients,species,0.9956,31047501
23729,PRP,cell_type,0.527,31047501
23730,DME,drug,0.9873,31047501
23731,cataract,disease,0.9995,31047501
23732,aflibercept,gene,0.6553,31047501
23733,patients,species,0.924,31047501
23734,patients,species,0.9854,31047501
23735,aflibercept,gene,0.975,31047501
23736,DR,disease,,31047501
23737,DME,disease,0.9736,31047501
23738,DR,disease,,31047501
23739,Aflibercept,gene,0.9062,31047376
23740,age-related macular degeneration,disease,1.0,31047376
23741,AMD,disease,1.0,31047376
23742,patient,species,0.967,31047376
23743,VEGF,gene,0.9927,31047376
23744,PARTICIPANTS,species,0.744,31047376
23745,patients,species,0.9517,31047376
23746,subfoveal choroidal neovascularization,disease,0.834,31047376
23747,CNV,disease,1.0,31047376
23748,AMD,disease,1.0,31047376
23749,BCVA,disease,0.9917,31047376
23750,Patients,species,0.9736,31047376
23751,CNV,disease,1.0,31047376
23752,vascular endothelial growth factor,gene,0.993,31047376
23753,CNV,disease,1.0,31047376
23754,wet AMD,disease,0.9995,31047376
23755,Aflibercept,gene,0.9546,31047326
23756,Neovascular Age-Related Macular PURPOSE,disease,0.9995,31047326
23757,aflibercept,gene,0.986,31047326
23758,neovascular age-related macular degeneration,disease,1.0,31047326
23759,AMD,disease,1.0,31047326
23760,macular atrophy,disease,1.0,31047326
23761,PARTICIPANTS,species,0.792,31047326
23762,neovascular AMD,disease,1.0,31047326
23763,AMD,disease,1.0,31047326
23764,choroidal neovascularization,disease,1.0,31047326
23765,CNV,disease,1.0,31047326
23766,AMD,disease,1.0,31047326
23767,CNV,disease,1.0,31047326
23768,polypoidal choroidal vasculopathy,disease,1.0,31047326
23769,retinal angiomatous proliferation,disease,1.0,31047326
23770,RAP,disease,1.0,31047326
23771,neovascular AMD,disease,1.0,31047326
23772,aflibercept,gene,0.9727,31047326
23773,macular atrophy,disease,1.0,31047326
23774,macular atrophy,disease,1.0,31047326
23775,macular atrophy,disease,1.0,31047326
23776,RAP,disease,0.924,31047326
23777,macular atrophy,disease,1.0,31047326
23778,RAP,disease,0.549,31047326
23779,RAP,disease,0.985,31047326
23780,BCVA,cell_type,0.407,31047326
23781,aflibercept,gene,0.9727,31047326
23782,neovascular AMD,disease,1.0,31047326
23783,RAP,drug,0.6904,31047326
23784,macular atrophy,disease,1.0,31047326
23785,Ziv-aflibercept,gene,0.9795,31047323
23786,ziv-aflibercept,gene,0.99,31047323
23787,bevacizumab,gene,0.7495,31047323
23788,diabetic macular edema,disease,1.0,31047323
23789,DME,disease,1.0,31047323
23790,PARTICIPANTS,species,0.863,31047323
23791,DME,disease,1.0,31047323
23792,DME,disease,1.0,31047323
23793,ziv-aflibercept,gene,0.98,31047323
23794,ziv-aflibercept,gene,0.9824,31047323
23795,ziv-aflibercept,gene,0.977,31047323
23796,patients,species,0.961,31047323
23797,ziv-aflibercept,gene,0.976,31047323
23798,ziv-aflibercept,gene,0.9565,31047323
23799,Diabetic,RNA,0.422,31047323
23800,Diabetic Retinopathy,disease,1.0,31047323
23801,IVZ,drug,0.8486,31047323
23802,IVB,drug,0.523,31047323
23803,IVZ,drug,0.9814,31047323
23804,ziv-aflibercept,gene,0.98,31047323
23805,ziv-aflibercept,gene,0.9556,31047323
23806,IVZ,drug,0.987,31047323
23807,IVZ,drug,0.9736,31047323
23808,DME,disease,1.0,31047323
23809,IVZ,drug,0.9854,31047323
23810,Triamcinolone Acetonide,drug,0.9985,31047241
23811,Retinal Vein Occlusion,disease,1.0,31047241
23812,triamcinolone acetonide,drug,0.9985,31047241
23813,aflibercept,gene,0.9497,31047241
23814,aflibercept,gene,0.945,31047241
23815,patients,species,0.9487,31047241
23816,macular edema,disease,1.0,31047241
23817,retinal vein occlusion,disease,1.0,31047241
23818,RVO,disease,1.0,31047241
23819,patients,species,0.947,31047241
23820,RVO,disease,1.0,31047241
23821,aflibercept,gene,0.9717,31047241
23822,aflibercept,gene,0.9844,31047241
23823,aflibercept,gene,0.9766,31047241
23824,aflibercept,gene,0.9604,31047241
23825,aflibercept,gene,0.9556,31047241
23826,participants,species,0.9736,31047241
23827,aflibercept,gene,0.79,31047241
23828,participants,species,0.9814,31047241
23829,BCVA,DNA,0.581,31047241
23830,aflibercept,gene,0.7725,31047241
23831,aflibercept,gene,0.98,31047241
23832,Edema,disease,0.995,31047241
23833,participants,species,0.977,31047241
23834,participants,species,0.9697,31047241
23835,aflibercept,gene,0.9863,31047241
23836,participant,species,0.976,31047241
23837,cataract,disease,1.0,31047241
23838,glaucoma,disease,1.0,31047241
23839,aflibercept,gene,0.971,31047241
23840,aflibercept,gene,0.533,31047241
23841,patients,species,0.9565,31047241
23842,RVO,disease,1.0,31047241
23843,edema,disease,0.992,31047241
23844,Vascular Endothelial Growth Factor,gene,0.9453,31047187
23845,Diabetic,disease,0.9766,31047187
23846,VEGF,gene,0.687,31047187
23847,diabetic macular edema,disease,1.0,31047187
23848,DME,disease,1.0,31047187
23849,patients,species,0.9863,31047187
23850,PARTICIPANTS,species,0.627,31047187
23851,DME,disease,1.0,31047187
23852,patient,species,0.993,31047187
23853,anti-VEGF,gene,0.9316,31047187
23854,VEGF,gene,0.7246,31047187
23855,aflibercept,gene,0.992,31047187
23856,bevacizumab,gene,0.9243,31047187
23857,ranibizumab,gene,0.7153,31047187
23858,DME,disease,1.0,31047187
23859,patient,species,0.996,31047187
23860,aflibercept,gene,0.9395,31047187
23861,aflibercept,gene,0.975,31047187
23862,bevacizumab,gene,0.8257,31047187
23863,VEGF,gene,0.618,31047187
23864,DME,disease,1.0,31047187
23865,VEGF,gene,0.7905,31047187
23866,anti-vascular endothelial growth factor,gene,0.977,31044732
23867,VEGF,gene,0.998,31044732
23868,diabetic retinopathy,disease,1.0,31044732
23869,DR,disease,1.0,31044732
23870,patients,species,0.989,31044732
23871,patients,species,0.991,31044732
23872,anti-VEGF,gene,0.8496,31044732
23873,patients,species,0.979,31044732
23874,diabetes,disease,1.0,31044732
23875,PARTICIPANTS,species,0.5317,31044732
23876,patients,species,0.958,31044732
23877,diabetes,disease,1.0,31044732
23878,diabetic,disease,1.0,31044732
23879,patients,species,0.9883,31044732
23880,anti-VEGF,gene,0.971,31044732
23881,anti-VEGF,gene,0.987,31044732
23882,anti-VEGF,gene,0.981,31044732
23883,DR,disease,,31044732
23884,kidney disease,disease,1.0,31044732
23885,Type 1 diabetes,disease,1.0,31044732
23886,hemoglobin A1c,gene,0.998,31044732
23887,VEGF,gene,0.7417,31044732
23888,patients,species,0.972,31044732
23889,diabetes,disease,1.0,31044732
23890,type 1 diabetes,disease,1.0,31044732
23891,DR,disease,,31044732
23892,Aflibercept,gene,0.981,31044729
23893,patients,species,0.8843,31044729
23894,neovascular age-related macular degeneration,disease,1.0,31044729
23895,nAMD,disease,1.0,31044729
23896,aflibercept,gene,0.9683,31044729
23897,PARTICIPANTS,species,0.804,31044729
23898,Patients,species,0.975,31044729
23899,nAMD,disease,1.0,31044729
23900,aflibercept,gene,0.874,31044729
23901,aflibercept,gene,0.9634,31044729
23902,patients,species,0.986,31044729
23903,patients,species,0.9873,31044729
23904,BCVA,cell_type,0.4578,31044729
23905,patients,species,0.9766,31044729
23906,patients,species,0.9536,31044729
23907,nAMD,disease,1.0,31044729
23908,Aflibercept,gene,0.963,31043958
23909,Choroidal Neovascularization,disease,1.0,31043958
23910,Punctate inner choroidopathy,disease,1.0,31043958
23911,PIC,disease,1.0,31043958
23912,inflammatory chorioretinopathy,disease,1.0,31043958
23913,women,species,0.772,31043958
23914,choroidal neovascularization,disease,1.0,31043958
23915,CNV,disease,1.0,31043958
23916,anti-,gene,0.651,31043958
23917,vascular endothelial growth factor,gene,0.8813,31043958
23918,VEGF,gene,0.9985,31043958
23919,ranibizumab,gene,0.9272,31043958
23920,bevacizumab,gene,0.555,31043958
23921,CNV,disease,0.996,31043958
23922,PIC,drug,0.998,31043958
23923,aflibercept,gene,0.9927,31043958
23924,anti-VEGF,gene,0.9185,31043958
23925,myopic,disease,0.998,31043958
23926,woman,species,0.914,31043958
23927,CNV,disease,0.9175,31043958
23928,PIC,disease,1.0,31043958
23929,aflibercept,gene,0.966,31043958
23930,prednisone,drug,0.942,31043958
23931,CNV,DNA,0.785,31043958
23932,Rhegmatogenous Retinal Detachment,disease,1.0,31042567
23933,rhegmatogenous retinal detachment,disease,1.0,31042567
23934,RRD,disease,1.0,31042567
23935,vascular endothelial growth factor,gene,0.8535,31042567
23936,PARTICIPANTS,species,0.671,31042567
23937,patients,species,0.9883,31042567
23938,ranibizumab,gene,0.6304,31042567
23939,bevacizumab,gene,0.6543,31042567
23940,aflibercept,gene,0.958,31042567
23941,neovascular age-related macular degeneration,disease,1.0,31042567
23942,retinal vein occlusion,disease,1.0,31042567
23943,Rhegmatogenous retinal detachment,disease,1.0,31042567
23944,patients,species,0.9917,31042567
23945,retinal detachment,disease,0.999,31042567
23946,patients,species,0.989,31042567
23947,RRD,disease,0.981,31042567
23948,patients,species,0.9897,31042567
23949,RRD,disease,0.9033,31042567
23950,RRD,disease,0.9937,31042567
23951,patients,species,0.984,31042567
23952,RRD,disease,0.998,31042567
23953,retinal tear,disease,1.0,31042567
23954,patients,species,0.988,31042567
23955,RRD,disease,1.0,31042567
23956,patients,species,0.994,31042567
23957,RRD,disease,0.9995,31042567
23958,patients,species,0.99,31042567
23959,patients,species,0.9873,31042567
23960,patients,species,0.977,31042567
23961,patients,species,0.9907,31042567
23962,proliferative,disease,0.854,31042567
23963,vitreoretinopathy,disease,0.58,31042567
23964,RRD,disease,1.0,31042567
23965,Retinal detachment,disease,0.9976,31042567
23966,RRD,disease,1.0,31042567
23967,Patients,species,0.9873,31037295
23968,Diabetic Macular Edema,disease,1.0,31037295
23969,Aflibercept,gene,0.9346,31037289
23970,diabetic macular edema,disease,1.0,31037289
23971,DME,disease,1.0,31037289
23972,DME,disease,1.0,31037289
23973,DME,disease,0.9863,31037289
23974,patients,species,0.9795,31037289
23975,CI-DME,disease,1.0,31037289
23976,aflibercept,gene,0.9736,31037289
23977,PARTICIPANTS,species,0.6226,31037289
23978,type 1 or type 2 diabetes,disease,1.0,31037289
23979,Participants,species,0.8853,31037289
23980,CI-DME,disease,1.0,31037289
23981,participant,species,0.9814,31037289
23982,aflibercept,gene,0.94,31037289
23983,Aflibercept,gene,0.935,31037289
23984,myocardial infarction,disease,1.0,31037289
23985,stroke,disease,1.0,31037289
23986,vascular or unknown death,disease,0.9736,31037289
23987,participants,species,0.982,31037289
23988,aflibercept,gene,0.9844,31037289
23989,aflibercept,gene,0.9854,31037289
23990,aflibercept,gene,0.951,31037289
23991,aflibercept,gene,0.9355,31037289
23992,participants,species,0.977,31037289
23993,aflibercept,gene,0.9824,31037289
23994,CI-DME,disease,0.9995,31037289
23995,aflibercept,gene,0.946,31037289
23996,aflibercept,gene,0.975,31037289
23997,CI-DME,disease,0.9976,31037289
23998,Diabetic Retinopathy,disease,1.0,31037285
23999,Bevacizumab,gene,0.908,31030198
24000,Aflibercept,gene,0.963,31030198
24001,Neuroendocrine carcinoma,disease,1.0,31030198
24002,NEC,disease,1.0,31030198
24003,tumor,disease,1.0,31030198
24004,patients,species,0.989,31030198
24005,vascular endothelial growth factor,gene,0.9956,31030198
24006,VEGF,gene,0.9985,31030198
24007,tumors,disease,1.0,31030198
24008,human cell line,cell_line,0.831,31030198
24009,human,species,0.991,31030198
24010,H460,cell_line,0.9478,31030198
24011,COLO320,cell_line,0.9243,31030198
24012,NEC,cell_line,0.8105,31030198
24013,aflibercept,gene,0.985,31030198
24014,bevacizumab,gene,0.7944,31030198
24015,tumor,disease,1.0,31030198
24016,tumors,disease,1.0,31030198
24017,aflibercept,gene,0.9907,31030198
24018,bevacizumab,gene,0.812,31030198
24019,H460 model,cell_line,0.8794,31030198
24020,aflibercept,gene,0.991,31030198
24021,tumor,disease,0.9653,31030198
24022,bevacizumab,gene,0.5986,31030198
24023,COLO320 model,cell_line,0.9106,31030198
24024,aflibercept,gene,0.993,31030198
24025,bevacizumab,gene,0.5513,31030198
24026,tumor,disease,1.0,31030198
24027,human,species,0.992,31030198
24028,tumor,disease,1.0,31030198
24029,aflibercept,gene,0.9956,31030198
24030,NEC,cell_line,0.573,31030198
24031,NEC,cell_type,0.4868,31030198
24032,NEC tumors,disease,0.9985,31030198
24033,bevacizumab,gene,0.863,31030198
24034,VEGF,gene,0.931,31030198
24035,aflibercept,gene,0.969,31030198
24036,NECs,disease,1.0,31030198
24037,Subretinal,disease,0.5034,31018677
24038,subretinal,disease,0.8774,31018677
24039,patient,species,0.96,31018677
24040,age-related macular degeneration,disease,1.0,31018677
24041,woman,species,0.8096,31018677
24042,age-related macular degeneration,disease,1.0,31018677
24043,type 1 macular neovascularization,disease,0.9995,31018677
24044,anti-vascular endothelial growth factor,gene,0.907,31018677
24045,ranibizumab,gene,0.884,31018677
24046,aflibercept,gene,0.9062,31018677
24047,anti-vascular endothelial growth factor,gene,0.983,31018677
24048,Subretinal,cell_type,0.492,31018677
24049,Subretinal pseudocysts,disease,0.98,31018677
24050,age-related macular degeneration,disease,1.0,31018677
24051,aflibercept,gene,0.9844,31016030
24052,chronic central retinal vein,disease,1.0,31016030
24053,aflibercept,gene,0.9595,31016030
24054,Eylea,gene,0.8105,31016030
24055,macular edema,disease,1.0,31016030
24056,patients,species,0.9775,31016030
24057,non-ischemic central retinal vein occlusions,disease,1.0,31016030
24058,CRVOs,disease,1.0,31016030
24059,ranibizumab,gene,0.6846,31016030
24060,Lucentis,gene,0.728,31016030
24061,bevacizumab,gene,0.5986,31016030
24062,Avastin,gene,0.6895,31016030
24063,patients,species,0.9565,31016030
24064,macular edema,disease,1.0,31016030
24065,non-ischemic CRVOs,disease,0.996,31016030
24066,ranibizumab,gene,0.77,31016030
24067,bevacizumab,gene,0.5234,31016030
24068,aflibercept,gene,0.99,31016030
24069,TAE,drug,0.555,31016030
24070,patients,species,0.9873,31016030
24071,macular edema,disease,1.0,31016030
24072,macular edema,disease,1.0,31016030
24073,patients,species,0.991,31016030
24074,CRVO,disease,1.0,31016030
24075,macular edema,disease,1.0,31016030
24076,aflibercept,gene,0.971,31016030
24077,macular edema,disease,1.0,31016030
24078,aflibercept,gene,0.9653,31016030
24079,macular edema,disease,1.0,31016030
24080,aflibercept,gene,0.938,31016030
24081,aflibercept,gene,0.9526,31016030
24082,patients,species,0.943,31016030
24083,patients,species,0.9766,31016030
24084,macular edema,disease,1.0,31016030
24085,non-ischemic CRVO,disease,0.9995,31016030
24086,polypoidal choroidal vasculopathy,disease,1.0,31014698
24087,PCV,disease,1.0,31014698
24088,vascular endothelial growth factor,gene,0.935,31014698
24089,VEGF,gene,0.9966,31014698
24090,PARTICIPANTS,species,0.777,31014698
24091,PCV,disease,1.0,31014698
24092,Retinal Blindness,disease,1.0,31014698
24093,neovascular age-related macular degeneration,disease,1.0,31014698
24094,VEGF,gene,0.6655,31014698
24095,VEGF,gene,0.68,31014698
24096,bevacizumab,gene,0.7876,31014698
24097,PCV,disease,1.0,31014698
24098,PCV,disease,0.9995,31014698
24099,Patients,species,0.99,31014689
24100,Diabetic Macular,disease,1.0,31014689
24101,diabetic macular edema,disease,1.0,31014689
24102,DME,disease,1.0,31014689
24103,patients,species,0.987,31014689
24104,Patients,species,0.976,31014689
24105,PARTICIPANTS,species,0.849,31014689
24106,patients,species,0.9927,31014689
24107,Patients,species,0.98,31014689
24108,DME,disease,1.0,31014689
24109,VEGF,gene,0.9946,31014689
24110,anti-VEGF,gene,0.936,31014689
24111,patient,species,0.9824,31014689
24112,anti-VEGF,gene,0.844,31014689
24113,anti-VEGF,gene,0.9644,31014689
24114,patient,species,0.982,31014689
24115,VEGF,gene,0.662,31014689
24116,Anti-VEGF,gene,0.897,31014689
24117,DME,disease,1.0,31014689
24118,patient,species,0.9756,31014689
24119,anti-VEGF,gene,0.9526,31014689
24120,patient,species,0.985,31014689
24121,aflibercept,gene,0.985,31014689
24122,bevacizumab,gene,0.7383,31014689
24123,patient,species,0.964,31014689
24124,VEGF,gene,0.4907,31014689
24125,VEGF,gene,0.8945,31014689
24126,DME,disease,1.0,31014689
24127,Diabetic Retinopathy,disease,1.0,31012025
24128,Diabetic retinopathy,disease,1.0,31012025
24129,DR,disease,1.0,31012025
24130,diabetes,disease,1.0,31012025
24131,DR,disease,0.9937,31012025
24132,proliferative DR,disease,0.9736,31012025
24133,ranibizumab,gene,0.6675,31012025
24134,bevacizumab,gene,0.761,31012025
24135,diabetic macular oedema,disease,1.0,31012025
24136,DMO,disease,1.0,31012025
24137,DMO,disease,1.0,31012025
24138,vascular endothelial growth factor,gene,0.9927,31012025
24139,VEGF,gene,0.9917,31012025
24140,IVB,drug,0.9824,31012025
24141,DMO,disease,1.0,31012025
24142,triamcinolone,drug,0.996,31012025
24143,triamcinolone,drug,0.998,31012025
24144,pseudophakic,disease,0.991,31012025
24145,fluocinolone,drug,0.999,31012025
24146,DMO,disease,1.0,31012025
24147,aflibercept,gene,0.9,31012025
24148,VEGF,gene,0.6196,31012025
24149,DMO,disease,0.911,31012025
24150,aflibercept,gene,0.9897,31010334
24151,aflibercept,gene,0.9863,31010334
24152,diabetic macular oedema,disease,1.0,31010334
24153,DME,disease,1.0,31010334
24154,patients,species,0.9897,31010334
24155,DME,disease,1.0,31010334
24156,aflibercept,gene,0.9854,31010334
24157,patients,species,0.991,31010334
24158,patient,species,0.994,31010334
24159,DME,disease,1.0,31010334
24160,CRAE,disease,0.802,31010334
24161,CRVE,disease,0.962,31010334
24162,AVR,disease,0.9536,31010334
24163,patients,species,0.978,31010334
24164,Patients,species,0.97,31010334
24165,retinal,DNA,0.5366,31010334
24166,Vascular Endothelial Growth Factor,gene,0.986,30999772
24167,macular ganglion cell layer,cell_type,0.591,30999772
24168,patients,species,0.9556,30999772
24169,vascular,DNA,0.745,30999772
24170,vascular endothelial growth factor,gene,0.952,30999772
24171,anti-VEGF,gene,0.9707,30999772
24172,exudative age-related macular degeneration,disease,0.966,30999772
24173,AMD,disease,1.0,30999772
24174,patients,species,0.9834,30999772
24175,AMD,disease,0.986,30999772
24176,ETDRS,DNA,0.526,30999772
24177,patients,species,0.967,30999772
24178,anti-VEGF,gene,0.924,30999772
24179,exudative AMD,disease,1.0,30999772
24180,anti-VEGF,gene,0.8726,30999772
24181,AMD,disease,0.948,30999772
24182,aflibercept,gene,0.964,30997397
24183,aflibercept,gene,0.961,30997397
24184,neovascular age-related macular degeneration,disease,1.0,30997397
24185,nAMD,disease,1.0,30997397
24186,diabetic macular oedema,disease,1.0,30997397
24187,DME,disease,1.0,30997397
24188,aflibercept,gene,0.993,30997397
24189,plasma,cell_type,0.554,30997397
24190,aflibercept,gene,0.9956,30997397
24191,aflibercept,gene,0.993,30997397
24192,aflibercept,gene,0.9927,30997397
24193,aflibercept,gene,0.9937,30997397
24194,patients,species,0.941,30997397
24195,nAMD,disease,1.0,30997397
24196,DME,disease,1.0,30997397
24197,anti-vascular endothelial growth factor,gene,0.959,30997397
24198,aflibercept,gene,0.984,30988797
24199,ranibizumab,gene,0.716,30988797
24200,wet age-associated macular degeneration,disease,0.9883,30988797
24201,Aflibercept,gene,0.9653,30988797
24202,ranibizumab,gene,0.749,30988797
24203,age-associated macular degeneration,disease,1.0,30988797
24204,AMD,disease,1.0,30988797
24205,aflibercept,gene,0.9937,30988797
24206,ranibizumab,gene,0.8564,30988797
24207,wet AMD,disease,0.9956,30988797
24208,AMD,disease,0.9995,30988797
24209,aflibercept,gene,0.988,30988797
24210,transforming growth factor-1,gene,0.9976,30988797
24211,TGF-1,gene,0.997,30988797
24212,monocyte chemoattractant protein 1,gene,0.995,30988797
24213,MCP-1,gene,0.996,30988797
24214,interleukin 6,gene,0.99,30988797
24215,IL-6,gene,0.9844,30988797
24216,aflibercept,gene,0.992,30988797
24217,ranibizumab,gene,0.6636,30988797
24218,aflibercept,gene,0.919,30988797
24219,ranibizumab,gene,0.8296,30988797
24220,aflibercept,gene,0.9927,30988797
24221,aflibercept,gene,0.9824,30988797
24222,ranibizumab,gene,0.7656,30988797
24223,aflibercept,gene,0.978,30988797
24224,aflibercept,gene,0.9907,30988797
24225,ranibizumab,gene,0.705,30988797
24226,TGF-1,gene,0.998,30988797
24227,IL-6,gene,0.971,30988797
24228,MCP-1,gene,0.985,30988797
24229,the,gene,0.8037,30988797
24230,aflibercept,gene,0.651,30988797
24231,TGF-1,gene,0.998,30988797
24232,MCP-1,gene,0.995,30988797
24233,IL-6,gene,0.9907,30988797
24234,aflibercept,gene,0.9775,30988797
24235,ranibizumab,gene,0.7246,30988797
24236,TGF-1,gene,0.9976,30988797
24237,MCP-1,gene,0.994,30988797
24238,IL-6,gene,0.988,30988797
24239,aflibercept,gene,0.9863,30988797
24240,AMD,disease,0.9995,30988797
24241,ranibizumab,gene,0.6,30988797
24242,aflibercept,gene,0.9844,30988797
24243,ranibizumab,gene,0.7964,30988797
24244,wet AMD,disease,0.992,30988797
24245,brolucizumab,gene,0.5283,30986442
24246,vascular endothelial growth factor-A,gene,0.998,30986442
24247,aflibercept,gene,0.9873,30986442
24248,neovascular age-related macular degeneration,disease,1.0,30986442
24249,nAMD,disease,1.0,30986442
24250,PARTICIPANTS,species,0.7803,30986442
24251,Patients,species,0.9863,30986442
24252,choroidal neovascularization,disease,1.0,30986442
24253,age-related macular degeneration,disease,1.0,30986442
24254,Patients,species,0.9717,30986442
24255,brolucizumab,gene,0.9287,30986442
24256,aflibercept,gene,0.774,30986442
24257,brolucizumab,gene,0.881,30986442
24258,aflibercept,gene,0.9204,30986442
24259,patients,species,0.986,30986442
24260,brolucizumab,gene,0.834,30986442
24261,aflibercept,gene,0.9634,30986442
24262,brolucizumab,gene,0.8516,30986442
24263,aflibercept,gene,0.973,30986442
24264,brolucizumab,gene,0.9414,30986442
24265,aflibercept,gene,0.9937,30986442
24266,brolucizumab,gene,0.8315,30986442
24267,brolucizumab,gene,0.8706,30986442
24268,aflibercept,gene,0.9346,30986442
24269,HAWK,disease,0.9897,30986442
24270,HARRIER,disease,0.842,30986442
24271,brolucizumab,gene,0.819,30986442
24272,aflibercept,gene,0.9707,30986442
24273,retinal fluid,disease,0.9365,30986442
24274,brolucizumab,gene,0.8013,30986442
24275,aflibercept,gene,0.9897,30986442
24276,brolucizumab,gene,0.9004,30986442
24277,aflibercept,gene,0.968,30986442
24278,Brolucizumab,gene,0.89,30986442
24279,aflibercept,gene,0.9727,30986442
24280,brolucizumab,gene,0.9224,30986442
24281,brolucizumab,gene,0.8096,30986442
24282,aflibercept,gene,0.988,30986442
24283,brolucizumab,gene,0.8047,30986442
24284,aflibercept,gene,0.945,30986442
24285,Ranibizumab,gene,0.9385,30983426
24286,Aflibercept,gene,0.9536,30983426
24287,Diabetic Macular Edema,disease,1.0,30983426
24288,Serous Retinal Detachment,disease,1.0,30983426
24289,Aflibercept,gene,0.9873,30983426
24290,Ranibizumab,gene,0.8936,30983426
24291,diabetic macular edema,disease,1.0,30983426
24292,DME,disease,1.0,30983426
24293,serous retinal detachment,disease,1.0,30983426
24294,SRD,disease,1.0,30983426
24295,DME,disease,1.0,30983426
24296,SRD,disease,0.988,30983426
24297,Ranibizumab,gene,0.9,30983426
24298,Aflibercept,gene,0.9873,30983426
24299,IVA,gene,0.601,30983426
24300,SRD,DNA,0.6206,30983426
24301,SRDH,DNA,0.4583,30983426
24302,BCVA,cell_type,0.405,30983426
24303,SRD,disease,1.0,30983426
24304,Aflibercept,gene,0.957,30983426
24305,SRD,disease,1.0,30983426
24306,DME,disease,1.0,30983426
24307,Ranibizumab,gene,0.8145,30983426
24308,aflibercept,gene,0.987,30979731
24309,aflibercept,gene,0.9824,30979731
24310,age-related macular degeneration,disease,1.0,30979731
24311,nAMD,disease,1.0,30979731
24312,patients,species,0.939,30979731
24313,nAMD,disease,1.0,30979731
24314,nAMD,disease,1.0,30979731
24315,aflibercept,gene,0.931,30979731
24316,nAMD,disease,1.0,30979731
24317,Aflibercept,gene,0.957,30977321
24318,Diabetic Macular Edema,disease,1.0,30977321
24319,vascular Endothelial Growth Factor,gene,0.9736,30977321
24320,aflibercept,gene,0.9775,30977321
24321,diabetic macular edema,disease,1.0,30977321
24322,DME,disease,1.0,30977321
24323,anti-vascular endothelial growth factor,gene,0.866,30977321
24324,VEGF,gene,0.9917,30977321
24325,DME,disease,1.0,30977321
24326,VEGF,gene,0.73,30977321
24327,aflibercept,gene,0.962,30977321
24328,aflibercept,gene,0.988,30977321
24329,aflibercept,gene,0.9785,30977321
24330,aflibercept,gene,0.9873,30977321
24331,aflibercept,gene,0.973,30977321
24332,DME,disease,1.0,30977321
24333,anti-VEGF,gene,0.8604,30977321
24334,proliferative diabetic retinopathy,disease,0.996,30973596
24335,PDR,disease,1.0,30973596
24336,severe nonproliferative diabetic retinopathy,disease,0.8394,30973596
24337,NPDR,disease,0.9985,30973596
24338,PDR,disease,0.9985,30973596
24339,neovascularization of the optic disc,disease,1.0,30973596
24340,NVD,disease,1.0,30973596
24341,retinal neovascularization elsewhere,disease,0.999,30973596
24342,NVE,disease,1.0,30973596
24343,PARTICIPANTS,species,0.5757,30973596
24344,Ranibizumab,gene,0.9683,30973596
24345,Diabetic Macular Edema,disease,1.0,30973596
24346,Aflibercept,gene,0.903,30973596
24347,Patients,species,0.962,30973596
24348,Proliferative Diabetic Retinopathy,disease,1.0,30973596
24349,NPDR,disease,0.9136,30973596
24350,PDR,disease,0.9766,30973596
24351,retinal nonperfusion,disease,0.9824,30973596
24352,retinal nonperfusion,disease,0.8564,30973596
24353,patients,species,0.9917,30973596
24354,PDR,disease,0.9883,30973596
24355,NPDR,disease,0.9995,30973596
24356,NVE,disease,0.9985,30973596
24357,NVD,disease,1.0,30973596
24358,NVE,disease,0.993,30973596
24359,retinal nonperfusion,disease,0.962,30973596
24360,NPDR,disease,1.0,30973596
24361,PDR,disease,0.9897,30973596
24362,NVD,disease,1.0,30973596
24363,NVE,drug,0.509,30973596
24364,NVD,disease,1.0,30973596
24365,retinal nonperfusion,disease,0.9985,30973596
24366,Patients,species,0.984,30969404
24367,aflibercept,gene,0.9365,30969404
24368,macular edema,disease,1.0,30969404
24369,central retinal vein occlusion,disease,1.0,30969404
24370,CRVO,disease,1.0,30969404
24371,patients,species,0.99,30969404
24372,CRVO,disease,1.0,30969404
24373,Patients,species,0.9727,30969404
24374,aflibercept,gene,0.95,30969404
24375,Diabetic Retinopathy,disease,1.0,30969404
24376,macular and peripheral ischemia,disease,0.9966,30969404
24377,patients,species,0.99,30969404
24378,patients,species,0.9805,30969404
24379,macula edema,disease,0.9995,30969404
24380,CRVO,disease,1.0,30969404
24381,patients,species,0.985,30969404
24382,aflibercept,gene,0.9697,30969404
24383,CRVO,disease,0.9995,30969404
24384,Peripapillary Choroidal Neovascular Membrane,disease,1.0,30951011
24385,Idiopathic Intracranial Hypertension,disease,1.0,30951011
24386,peripapillary choroidal neovascular membrane,disease,0.948,30951011
24387,CNVM,disease,1.0,30951011
24388,idiopathic intracranial hypertension,disease,1.0,30951011
24389,IIH,disease,1.0,30951011
24390,IIH,disease,1.0,30951011
24391,IIH,disease,1.0,30951011
24392,CNVM,disease,0.9995,30951011
24393,CNVM,disease,1.0,30951011
24394,IIH,disease,1.0,30951011
24395,CNVM,disease,1.0,30951011
24396,CNVM,disease,1.0,30951011
24397,acetazolamide,drug,0.9985,30951011
24398,IIH,disease,0.9995,30951011
24399,anti-vascular endothelial growth factor,gene,0.981,30951011
24400,anti-VEGF,gene,0.956,30951011
24401,ranibizumab,gene,0.517,30951011
24402,aflibercept,gene,0.926,30951011
24403,CNVMs,disease,1.0,30951011
24404,subretinal fibrosis,disease,0.9224,30951011
24405,Papilledema,disease,1.0,30951011
24406,papilledema,disease,1.0,30951011
24407,Peripapillary CNVM,disease,0.84,30951011
24408,IIH,disease,1.0,30951011
24409,IIH,disease,0.9995,30951011
24410,DEXAMETHASONE,drug,0.973,30950970
24411,AFLIBERCEPT,drug,0.961,30950970
24412,PATIENTS,species,0.99,30950970
24413,DIABETIC MACULAR EDEMA,disease,1.0,30950970
24414,SEROUS RETINAL DETACHMENT,disease,0.9976,30950970
24415,dexamethasone,drug,0.9917,30950970
24416,DEX,drug,0.9707,30950970
24417,aflibercept,gene,0.898,30950970
24418,diabetic macular edema,disease,1.0,30950970
24419,diabetic macular edema,disease,1.0,30950970
24420,serous retinal detachment,disease,1.0,30950970
24421,aflibercept,gene,0.982,30950970
24422,DEX,drug,0.742,30950970
24423,aflibercept,gene,0.9263,30950970
24424,anti-vascular endothelial growth factor,gene,0.986,30950970
24425,DEX,drug,0.911,30950970
24426,DEX,drug,0.979,30950970
24427,DEX,drug,0.6475,30950970
24428,the,gene,0.673,30950970
24429,aflibercept,gene,0.7627,30950970
24430,DEX,drug,0.9404,30950970
24431,aflibercept,gene,0.986,30950970
24432,DEX,drug,0.949,30950970
24433,Diabetic Retinopathy,disease,1.0,30950970
24434,DEX,drug,0.9165,30950970
24435,Diabetic Retinopathy,disease,1.0,30950970
24436,aflibercept,gene,0.9756,30950970
24437,aflibercept,gene,0.9746,30950970
24438,DEX,drug,0.893,30950970
24439,aflibercept,gene,0.9565,30950970
24440,Diabetic Retinopathy,disease,1.0,30950970
24441,DEX,drug,0.8574,30950970
24442,DEX,drug,0.841,30950970
24443,aflibercept,gene,0.971,30950970
24444,diabetic macular edema,disease,1.0,30950970
24445,DEX,drug,0.931,30950970
24446,aflibercept,gene,0.955,30950970
24447,pseudophakic,disease,0.9434,30950970
24448,aflibercept,gene,0.99,30950970
24449,Diabetic Macular Edema,disease,1.0,30946887
24450,Aflibercept,gene,0.888,30946887
24451,aflibercept,gene,0.99,30946887
24452,diabetic macular edema,disease,1.0,30946887
24453,PARTICIPANTS,species,0.682,30946887
24454,DME,disease,0.7427,30946887
24455,IAI,drug,0.559,30946887
24456,IAI,drug,0.8076,30946887
24457,fluorescein,drug,0.9976,30946887
24458,retinal nonperfusion,disease,0.989,30946887
24459,RNP,disease,0.988,30946887
24460,RNP,RNA,0.6743,30946887
24461,2q4,DNA,0.777,30946887
24462,2q8,DNA,0.7573,30946887
24463,RNP,RNA,0.5586,30946887
24464,DME,disease,1.0,30946887
24465,diabetic retinopathy,disease,1.0,30946887
24466,RNP,RNA,0.4878,30946887
24467,Anti-Vascular Endothelial Growth Factor,gene,0.9473,30935655
24468,anti-VEGF,gene,0.81,30935655
24469,VEGF,gene,0.961,30935655
24470,retinal diseases,disease,0.9995,30935655
24471,patient,species,0.983,30935655
24472,anti-VEGF,gene,0.9897,30935655
24473,bevacizumab,gene,0.4695,30935655
24474,ranibizumab,drug,0.608,30935655
24475,aflibercept,gene,0.4998,30935655
24476,pegaptanib,drug,0.9785,30935655
24477,conbercept,gene,0.8726,30935655
24478,VEGF,gene,0.65,30935655
24479,patient,species,0.976,30935655
24480,Bevacizumab,gene,0.824,30935655
24481,VEGF,gene,0.915,30935655
24482,aflibercept,gene,0.958,30935655
24483,ranibizumab,gene,0.9863,30935655
24484,aflibercept,gene,0.832,30935655
24485,VEGF,gene,0.952,30935655
24486,ziv-aflibercept,gene,0.7515,30935655
24487,ranibizumab,gene,0.987,30935655
24488,aflibercept,gene,0.9673,30935655
24489,Ranibizumab,gene,0.983,30935655
24490,Conbercept,gene,0.74,30935655
24491,VEGF,gene,0.5103,30935655
24492,VEGF,gene,0.537,30935655
24493,patient,species,0.959,30935655
24494,retinal diseases,disease,1.0,30935655
24495,patients,species,0.9897,30935224
24496,aflibercept,gene,0.97,30935224
24497,neovascular age-related macular degeneration,disease,0.997,30935224
24498,patients,species,0.992,30935224
24499,vascular endothelial growth factor,gene,0.9395,30935224
24500,patient,species,0.965,30935224
24501,aflibercept,gene,0.9644,30935224
24502,haemorrhage,disease,0.918,30935224
24503,patients,species,0.98,30935224
24504,haemorrhage,disease,0.9927,30935224
24505,Aflibercept,gene,0.9565,30935224
24506,neovascular age-related macular degeneration,disease,1.0,30935224
24507,anti-human vascular endothelial growth factor antibodies bevacizumab,gene,0.9424,30933891
24508,aflibercept,gene,0.9697,30933891
24509,"canine, feline, and equine vascular endothelial growth factor",gene,0.9673,30933891
24510,canine,species,0.9834,30933891
24511,feline,species,0.675,30933891
24512,equine,species,0.795,30933891
24513,vascular endothelial growth factor,gene,0.9976,30933891
24514,VEGF,gene,0.9956,30933891
24515,corneal neovascularization,disease,1.0,30933891
24516,anti-human VEGF antibodies,gene,0.9873,30933891
24517,bevacizumab,gene,0.7383,30933891
24518,Avastin,gene,0.4702,30933891
24519,aflibercept,gene,0.9863,30933891
24520,Zaltrap,gene,0.6646,30933891
24521,"canine, feline,",gene,0.759,30933891
24522,canine,species,0.978,30933891
24523,feline,species,0.909,30933891
24524,equine VEGF,gene,0.9043,30933891
24525,equine,species,0.9517,30933891
24526,"Human, equine, feline, and canine VEGF",gene,0.825,30933891
24527,equine,species,0.949,30933891
24528,feline,species,0.762,30933891
24529,canine,species,0.857,30933891
24530,canine,species,0.99,30933891
24531,feline,species,0.907,30933891
24532,equine VEGF,gene,0.863,30933891
24533,equine,species,0.965,30933891
24534,VEGF-A,gene,0.9927,30933891
24535,bevacizumab,gene,0.684,30933891
24536,canine,species,0.988,30933891
24537,feline VEGF,gene,0.7764,30933891
24538,feline,species,0.975,30933891
24539,equine VEGF,gene,0.914,30933891
24540,equine,species,0.996,30933891
24541,Aflibercept,gene,0.9307,30933891
24542,VEGF,gene,0.996,30933891
24543,bevacizumab,gene,0.927,30933891
24544,aflibercept,gene,0.988,30933891
24545,canine VEGF,gene,0.8535,30933891
24546,canine,species,0.992,30933891
24547,Feline VEGF,gene,0.9785,30933891
24548,Feline,species,0.9775,30933891
24549,bevacizumab,gene,0.968,30933891
24550,aflibercept,gene,0.9873,30933891
24551,bevacizumab,gene,0.9424,30933891
24552,equine VEGF,gene,0.9434,30933891
24553,equine,species,0.9937,30933891
24554,aflibercept,gene,0.991,30933891
24555,Bevacizumab,gene,0.806,30933891
24556,aflibercept,gene,0.992,30933891
24557,VEGF,gene,0.9956,30933891
24558,patients,species,0.9707,30931489
24559,type 3 PURPOSE,disease,0.9907,30931489
24560,patients,species,0.986,30931489
24561,anti-vascular endothelial growth factor,gene,0.9824,30931489
24562,VEGF,gene,0.998,30931489
24563,patients,species,0.99,30931489
24564,type 3 neovascularization with,disease,0.974,30931489
24565,dry macula,disease,0.9146,30931489
24566,anti-VEGF,gene,0.9673,30931489
24567,patients,species,0.9756,30931489
24568,anti-VEGF,gene,0.985,30931489
24569,patients,species,0.985,30931489
24570,women,species,0.9185,30931489
24571,patients,species,0.982,30931489
24572,patients,species,0.951,30931489
24573,anti-VEGF,gene,0.949,30931489
24574,patients,species,0.989,30931489
24575,Ranibizumab,gene,0.957,30929819
24576,Neovascular Age-Related Macular PURPOSE,disease,0.9194,30929819
24577,ranibizumab,gene,0.798,30929819
24578,aflibercept,gene,0.9707,30929819
24579,nAMD,disease,1.0,30929819
24580,PARTICIPANTS,species,0.696,30929819
24581,Patients,species,0.9785,30929819
24582,nAMD,disease,1.0,30929819
24583,ranibizumab,gene,0.872,30929819
24584,aflibercept,gene,0.9404,30929819
24585,Patient,species,0.972,30929819
24586,ranibizumab,gene,0.7026,30929819
24587,patient,species,0.9883,30929819
24588,patients,species,0.983,30929819
24589,ranibizumab,gene,0.5874,30929819
24590,aflibercept,gene,0.9795,30929819
24591,ranibizumab,gene,0.502,30929819
24592,Endophthalmitis,disease,1.0,30929813
24593,endophthalmitis,disease,1.0,30929813
24594,anti-vascular endothelial growth factor,gene,0.9287,30929813
24595,VEGF,gene,0.9976,30929813
24596,endophthalmitis,disease,1.0,30929813
24597,PARTICIPANTS,species,0.655,30929813
24598,patients,species,0.99,30929813
24599,VEGF,gene,0.9326,30929813
24600,anti-VEGF,gene,0.9507,30929813
24601,endophthalmitis,disease,1.0,30929813
24602,endophthalmitis,disease,1.0,30929813
24603,endophthalmitis,disease,1.0,30929813
24604,endophthalmitis,disease,1.0,30929813
24605,anti-VEGF,gene,0.954,30929813
24606,endophthalmitis,disease,1.0,30929813
24607,lidocaine,drug,0.9434,30929813
24608,endophthalmitis,disease,1.0,30929813
24609,povidone iodine,drug,0.9995,30929813
24610,lidocaine,drug,0.658,30929813
24611,endophthalmitis,disease,1.0,30929813
24612,endophthalmitis,disease,1.0,30929813
24613,VEGF,gene,0.6094,30929813
24614,bevacizumab,gene,0.977,30929813
24615,ranibizumab,gene,0.665,30929813
24616,ranibizumab,gene,0.511,30929813
24617,aflibercept,gene,0.971,30929813
24618,endophthalmitis,disease,1.0,30929813
24619,anti-VEGF,gene,0.7114,30929813
24620,lidocaine,drug,0.9937,30929813
24621,Tetravisc,drug,0.571,30929813
24622,endophthalmitis,disease,1.0,30929813
24623,Anti-Vascular Endothelial Growth Factor,gene,0.953,30928983
24624,anti-VEGF,gene,0.9717,30928983
24625,patients,species,0.986,30928983
24626,anti-VEGF,gene,0.8975,30928983
24627,patients,species,0.99,30928983
24628,bevacizumab,gene,0.6025,30928983
24629,ranibizumab,gene,0.657,30928983
24630,aflibercept,gene,0.923,30928983
24631,anti-VEGF,gene,0.831,30928983
24632,patients,species,0.986,30928983
24633,patient,species,0.9893,30928983
24634,Ranibizumab,gene,0.811,30928983
24635,VEGF,gene,0.605,30928983
24636,endophthalmitis,disease,1.0,30928983
24637,acute intraocular inflammation,disease,0.9995,30928983
24638,ranibizumab,gene,0.8843,30928983
24639,anti-VEGF,gene,0.823,30928983
24640,patients,species,0.9873,30928983
24641,patients,species,0.985,30928983
24642,FOLFIRI,drug,0.8965,30923702
24643,Ziv-aflibercept,gene,0.9775,30923702
24644,FOLFIRI,drug,0.7334,30923702
24645,patients,species,0.9487,30923702
24646,metastatic colorectal cancer,disease,1.0,30923702
24647,mCRC,disease,1.0,30923702
24648,ziv-aflibercept,gene,0.9897,30923702
24649,5-fluorouracil,drug,0.9995,30923702
24650,leucovorin,drug,0.9985,30923702
24651,irinotecan,drug,0.9985,30923702
24652,FOLFIRI,drug,0.756,30923702
24653,5-fluoruracil,drug,0.9995,30923702
24654,leucovorin,drug,0.9985,30923702
24655,oxaliplatin,drug,0.9995,30923702
24656,FOLFOX,drug,0.9116,30923702
24657,bevacizumab,gene,0.9185,30923702
24658,FOLFIRI,drug,0.9946,30923702
24659,bevacizumab,gene,0.906,30923702
24660,FOLFIRI,drug,0.997,30923702
24661,patients,species,0.9907,30923702
24662,advanced cancer,disease,1.0,30923702
24663,patients,species,0.986,30923702
24664,mCRC,disease,0.971,30923702
24665,Cancer,disease,0.533,30923702
24666,CEA,gene,0.97,30923702
24667,mCRC,disease,0.999,30923702
24668,bevacizumab,gene,0.842,30923702
24669,FOLFOX,drug,0.9893,30923702
24670,bevacizumab,gene,0.815,30923702
24671,FOLFIRI,drug,0.972,30923702
24672,mCRC,disease,1.0,30923702
24673,FCCC,cell_line,0.684,30923702
24674,mCRC,disease,0.9976,30923702
24675,patients,species,0.9907,30923702
24676,patient,species,0.982,30923702
24677,bevacizumab,gene,0.9106,30923702
24678,FOLFOX,drug,0.9277,30923702
24679,irinotecan,drug,0.9976,30923702
24680,FCCC,cell_line,0.528,30923702
24681,mCRC,disease,0.996,30923702
24682,patients,species,0.9863,30923702
24683,bevacizumab,gene,0.8467,30923702
24684,FOLFIRI,drug,0.9956,30923702
24685,mutant-KRAS,gene,0.9956,30923702
24686,WT-KRAS,gene,0.9956,30923702
24687,BRAF-V600E,gene,0.953,30923702
24688,V600E,mutation,,30923702
24689,patient,species,0.9497,30923702
24690,BRAF-V600E mutation,gene,0.9253,30923702
24691,V600E,mutation,,30923702
24692,BRAF,gene,0.9985,30923702
24693,patient,species,0.9775,30923702
24694,WT,gene,0.999,30923702
24695,mCRC,disease,0.664,30923702
24696,patients,species,0.9717,30923702
24697,mutated-KRAS,gene,0.98,30923702
24698,CEA,gene,0.987,30923702
24699,mCRC,disease,0.9966,30923702
24700,patients,species,0.985,30923702
24701,zFOLFIRI,drug,0.671,30923702
24702,bevacizumab,gene,0.772,30923702
24703,FOLFIRI,drug,0.995,30923702
24704,patients,species,0.9204,30923702
24705,mCRC,disease,0.993,30923702
24706,aflibercept,gene,0.988,30916896
24707,age-related maculopathy,disease,1.0,30916896
24708,anti-vascular endothelial growth factor,gene,0.9316,30916896
24709,anti-VEGF,gene,0.9385,30916896
24710,neovascular age-related macular degeneration,disease,1.0,30916896
24711,AMD,disease,1.0,30916896
24712,VEGF,gene,0.996,30916896
24713,neovascular AMD,disease,0.9897,30916896
24714,aflibercept,gene,0.9326,30916896
24715,aflibercept,gene,0.987,30916896
24716,ONH,disease,0.8916,30916896
24717,ONH,disease,0.9956,30916896
24718,aflibercept,gene,0.9863,30916896
24719,IVA,gene,0.8237,30916896
24720,Anti-Vascular Endothelial Growth Factor,gene,0.898,30916605
24721,Aflibercept,gene,0.978,30916605
24722,Aflibercept,gene,0.959,30916605
24723,Eylea,gene,0.6978,30916605
24724,polycarbonate,drug,0.999,30916605
24725,aflibercept,gene,0.988,30916605
24726,antivascular endothelial growth factor,gene,0.995,30916605
24727,anti-VEGF,gene,0.9927,30916605
24728,Aflibercept,gene,0.9873,30916605
24729,VEGF,gene,0.811,30916605
24730,aflibercept,gene,0.9937,30916605
24731,aflibercept,gene,0.9844,30916605
24732,anti-VEGF,gene,0.9043,30916605
24733,aflibercept,gene,0.9897,30916605
24734,anti-VEGF,gene,0.9326,30916605
24735,aflibercept,gene,0.9873,30916605
24736,polycarbonate,drug,0.999,30916605
24737,VEGF,gene,0.9565,30916605
24738,FOLFOX,drug,0.8506,30913304
24739,ziv-aflibercept,gene,0.9727,30913304
24740,esophagogastric,disease,0.672,30913304
24741,gastric and gastroesophageal junction adenocarcinoma,disease,1.0,30913304
24742,ziv-aflibercept,gene,0.978,30913304
24743,oxaliplatin,drug,1.0,30913304
24744,leucovorin,drug,0.999,30913304
24745,5- fluorouracil,drug,0.998,30913304
24746,metastatic esophagogastric adenocarcinoma,disease,0.9995,30913304
24747,Patients,species,0.973,30913304
24748,metastatic esophagogastric adenocarcinoma,disease,0.9995,30913304
24749,ziv-aflibercept,gene,0.97,30913304
24750,patients,species,0.9526,30913304
24751,ziv-aflibercept,gene,0.963,30913304
24752,patients,species,0.983,30913304
24753,patients,species,0.9844,30913304
24754,Patients,species,0.9688,30913304
24755,ziv-aflibercept,gene,0.9653,30913304
24756,oxaliplatin,drug,0.9995,30913304
24757,5-fluorouracil,drug,0.999,30913304
24758,ziv-aflibercept,gene,0.99,30913304
24759,cerebral hemorrhage,disease,1.0,30913304
24760,bowel perforation,disease,0.9995,30913304
24761,ziv-aflibercept,gene,0.9785,30913304
24762,Ziv-aflibercept,gene,0.983,30913304
24763,metastatic esophagogastric cancer,disease,1.0,30913304
24764,FOLFOX,drug,0.994,30913304
24765,ziv-aflibercept,gene,0.9863,30913304
24766,patients,species,0.9653,30913304
24767,metastatic esophagogastric adenocarcinoma,disease,0.9966,30913304
24768,Exudative Age-Related Macular Degeneration,disease,1.0,30905726
24769,patients,species,0.9844,30905726
24770,exudative age-related macular degeneration,disease,1.0,30905726
24771,AMD,disease,1.0,30905726
24772,antivascular endothelial growth factors,gene,0.9717,30905726
24773,VEGF,gene,0.9956,30905726
24774,patients,species,0.9766,30905726
24775,exudative AMD,disease,0.9614,30905726
24776,anti-VEGF,gene,0.8804,30905726
24777,Patients,species,0.9873,30905726
24778,patients,species,0.993,30905726
24779,patient,species,0.984,30905726
24780,patients,species,0.99,30905726
24781,patient,species,0.986,30905726
24782,patients,species,0.9854,30905726
24783,exudative AMD,disease,0.9995,30905726
24784,patients,species,0.976,30905726
24785,wet AMD,disease,0.9985,30905726
24786,Age-related macular degeneration,disease,1.0,30905169
24787,AMD,disease,1.0,30905169
24788,vision loss,disease,0.9985,30905169
24789,patients,species,0.994,30905169
24790,RTP,DNA,0.5264,30905169
24791,AMD,disease,1.0,30905169
24792,bevacizumab,gene,0.878,30905169
24793,aflibercept,gene,0.9766,30905169
24794,RTP,DNA,0.5435,30905169
24795,human and rat cell lines,cell_line,0.8774,30905169
24796,human,species,0.9854,30905169
24797,rat,species,0.954,30905169
24798,rats,species,0.968,30905169
24799,Bevacizumab,gene,0.858,30905169
24800,aflibercept,gene,0.986,30905169
24801,human,species,0.9893,30905169
24802,rat cells,cell_type,0.4783,30905169
24803,rat,species,0.98,30905169
24804,inflammation,disease,0.9863,30905169
24805,gliosis,disease,1.0,30905169
24806,RTP,DNA,0.568,30905169
24807,Ranibizumab,gene,0.832,30904595
24808,aflibercept,gene,0.9297,30904595
24809,vascular endothelial growth factor,gene,0.9336,30904595
24810,diabetic macular edema,disease,1.0,30904595
24811,VEGF,gene,0.647,30904595
24812,ranibizumab,gene,0.9785,30904595
24813,aflibercept,gene,0.987,30904595
24814,bevacizumab,gene,0.937,30904595
24815,ranibizumab,gene,0.899,30904595
24816,ranibizumab,gene,0.883,30904595
24817,healthcare,cell_type,0.4802,30904595
24818,ranibizumab,gene,0.796,30904595
24819,ranibizumab,gene,0.535,30904595
24820,ranibizumab,gene,0.615,30904595
24821,patients,species,0.9917,30904595
24822,ranibizumab,gene,0.8047,30904595
24823,patients,species,0.8853,30901385
24824,vascular endothelial growth factor,gene,0.878,30901385
24825,VEGF,gene,0.997,30901385
24826,neovascular age-related macular degeneration,disease,1.0,30901385
24827,nAMD,disease,1.0,30901385
24828,patients,species,0.9604,30901385
24829,nAMD,disease,1.0,30901385
24830,VEGF,gene,0.5273,30901385
24831,patients,species,0.985,30901385
24832,-VEGF,gene,0.7856,30901385
24833,nAMD,disease,1.0,30901385
24834,aflibercept,gene,0.96,30899849
24835,aflibercept,gene,0.9473,30899849
24836,AMD,disease,1.0,30899849
24837,patients,species,0.9854,30899849
24838,patients,species,0.9897,30899849
24839,aflibercept,gene,0.9727,30899849
24840,neovascular AMD,disease,1.0,30899849
24841,aflibercept,gene,0.988,30899849
24842,Aflibercept,gene,0.954,30899849
24843,patients,species,0.9746,30899849
24844,aflibercept,gene,0.9805,30899849
24845,Aflibercept,gene,0.9604,30899849
24846,neovascular AMD,disease,1.0,30899849
24847,EYLEA,drug,0.9214,30897067
24848,DIABETIC MACULAR EDEMA,disease,1.0,30897067
24849,aflibercept,gene,0.978,30897067
24850,Eylea,gene,0.8394,30897067
24851,macular edema,disease,1.0,30897067
24852,diabetic,disease,1.0,30897067
24853,patients,species,0.974,30897067
24854,macular edema,disease,1.0,30897067
24855,diabetes mellitus,disease,1.0,30897067
24856,patients,species,0.9927,30897067
24857,diabetic,disease,1.0,30897067
24858,patients,species,0.9917,30897067
24859,aflibercept,gene,0.935,30897067
24860,macular edema,disease,1.0,30897067
24861,aflibercept,gene,0.9917,30897067
24862,patients,species,0.98,30897067
24863,aflibercept,gene,0.9697,30897067
24864,patients,species,0.9766,30897067
24865,diabetic macular,disease,1.0,30897067
24866,edema,disease,0.9995,30897067
24867,patients,species,0.9893,30897067
24868,Aflibercept,gene,0.9355,30893450
24869,Diabetic Macular Edema,disease,1.0,30893450
24870,aflibercept,gene,0.98,30893450
24871,diabetic macular edema,disease,0.993,30893450
24872,DME,disease,0.9995,30893450
24873,PATIENTS,species,0.8403,30893450
24874,DME,disease,0.9995,30893450
24875,systemic disease,disease,0.6475,30893450
24876,glycosylated hemoglobin,gene,0.9326,30893450
24877,renal impairment,disease,1.0,30893450
24878,hypertension,disease,1.0,30893450
24879,cerebrovascular disease,disease,1.0,30893450
24880,ischemic heart disease,disease,1.0,30893450
24881,systemic disease,disease,0.9917,30893450
24882,Retinal Vein Occlusion,disease,1.0,30893449
24883,Anti-VEGF,gene,0.877,30893449
24884,retinal vein occlusion,disease,1.0,30893449
24885,RVO,disease,1.0,30893449
24886,anti-vascular endothelial growth factor,gene,0.98,30893449
24887,VEGF,gene,0.9966,30893449
24888,PATIENTS,species,0.961,30893449
24889,RVO,disease,1.0,30893449
24890,macular edema,disease,1.0,30893449
24891,RVO,disease,1.0,30893449
24892,branch retinal vein occlusion,disease,0.998,30893449
24893,RVO,disease,1.0,30893449
24894,vision,disease,0.9497,30893449
24895,Vascular Endothelial Growth Factor,gene,0.9175,30892159
24896,Neovascular Age-related Macular Degeneration,disease,1.0,30892159
24897,ganglion cell,cell_type,0.514,30892159
24898,macular degeneration,disease,1.0,30892159
24899,ranibizumab,gene,0.8164,30892159
24900,aflibercept,gene,0.9507,30892159
24901,aflibercept,gene,0.9795,30892159
24902,ranibizumab,gene,0.8066,30892159
24903,retinal nerve fiber layer,cell_type,0.4841,30892159
24904,ganglion cell,cell_type,0.54,30892159
24905,Diabetic Retinopathy,disease,1.0,30892159
24906,retinal nerve fiber layer,cell_type,0.6367,30892159
24907,Diabetic Retinopathy,disease,1.0,30892159
24908,aflibercept,gene,0.9893,30892159
24909,ranibizumab,gene,0.6143,30892159
24910,ganglion cell,cell_type,0.561,30892159
24911,aflibercept,gene,0.993,30892159
24912,aflibercept,gene,0.963,30892159
24913,ranibizumab,gene,0.574,30892159
24914,vascular endothelial growth factor,gene,0.9966,30892159
24915,anti-,gene,0.85,30892159
24916,vascular endothelial growth factor,gene,0.8755,30892159
24917,neuronal and retinal pigment epithelium cells,cell_type,0.8345,30892159
24918,vascular endothelial growth factor,gene,0.998,30892159
24919,retinal cells,cell_type,0.743,30892159
24920,VEGF,gene,0.96,30892063
24921,VEGF,gene,0.984,30892063
24922,VEGF,gene,0.8604,30892063
24923,VEGF,gene,0.5728,30892063
24924,VEGF,gene,0.9897,30892063
24925,VEGF,gene,0.877,30892063
24926,anti-VEGF165 mAb,gene,0.976,30892063
24927,VEGF165,gene,0.9985,30892063
24928,aflibercept,gene,0.994,30892063
24929,bevacizumab,gene,0.4824,30892063
24930,anti-VEGF165 mAb,gene,0.9966,30892063
24931,VEGF,gene,0.992,30892063
24932,aflibercept,gene,0.9893,30892063
24933,ranibizumab,gene,0.736,30892063
24934,bevacizumab,gene,0.766,30892063
24935,VEGF,gene,0.9937,30892063
24936,VEGF,gene,0.992,30892063
24937,ranibizumab,gene,0.9263,30892063
24938,bevacizumab,gene,0.8887,30892063
24939,aflibercept,gene,0.991,30892063
24940,VEGF,gene,0.998,30892063
24941,ranibizumab,gene,0.9146,30892063
24942,VEGF,gene,0.9956,30892063
24943,bevacizumab,gene,0.7783,30892063
24944,VEGF,gene,0.998,30892063
24945,aflibercept,gene,0.7554,30892063
24946,VEGF,gene,0.994,30892063
24947,VEGF,gene,0.995,30892063
24948,VEGF,gene,0.993,30892063
24949,VEGF,gene,0.9956,30891770
24950,neurotrophin,gene,0.9844,30891770
24951,caspase-3,gene,0.983,30891770
24952,rabbit retina,cell_type,0.4485,30891770
24953,rabbit,species,0.988,30891770
24954,vascular endothelial growth factor,gene,0.998,30891770
24955,VEGF,gene,0.9976,30891770
24956,nerve growth factor,gene,0.9966,30891770
24957,NGF,gene,0.9966,30891770
24958,BDNF,gene,0.9946,30891770
24959,rabbit retina,cell_type,0.4336,30891770
24960,rabbit,species,0.9897,30891770
24961,aflibercept,gene,0.8926,30891770
24962,ranibizumab,gene,0.7773,30891770
24963,VEGF,gene,0.9897,30891770
24964,neurotrophin,gene,0.988,30891770
24965,VEGF,gene,0.992,30891770
24966,proneurotrophin,gene,0.9814,30891770
24967,TrkA,gene,0.99,30891770
24968,TrkB,gene,0.9897,30891770
24969,pan-,gene,0.8994,30891770
24970,neurotrophin receptor,gene,0.744,30891770
24971,p75,gene,0.5586,30891770
24972,VEGF,gene,0.989,30891770
24973,cleaved caspase-3,gene,0.811,30891770
24974,beclin-1,gene,0.987,30891770
24975,LC3,gene,0.8184,30891770
24976,aflibercept,gene,0.9937,30891770
24977,ranibizumab,gene,0.825,30891770
24978,rabbits,species,0.9595,30891770
24979,VEGF,gene,0.997,30891770
24980,NGF,gene,0.995,30891770
24981,BDNF,gene,0.9775,30891770
24982,VEGF,gene,0.9463,30891770
24983,anti-VEGF,gene,0.9893,30891770
24984,neurotrophin,gene,0.9507,30891770
24985,ranibizumab,gene,0.8228,30880436
24986,aflibercept,gene,0.973,30880436
24987,choroidal neovascularization,disease,1.0,30880436
24988,ranibizumab,gene,0.862,30880436
24989,aflibercept,gene,0.989,30880436
24990,choroidal neovascularization,disease,1.0,30880436
24991,angioid streaks,disease,1.0,30880436
24992,Patients,species,0.9136,30880436
24993,ranibizumab,gene,0.825,30880436
24994,aflibercept,gene,0.9805,30880436
24995,aflibercept,gene,0.963,30880436
24996,choroidal neovascularization,disease,1.0,30880436
24997,Diabetic Retinopathy,disease,1.0,30880436
24998,fluorescein,drug,0.9966,30880436
24999,patients,species,0.97,30880436
25000,Fluorescein,drug,0.9917,30880436
25001,ranibizumab,gene,0.928,30880436
25002,aflibercept,gene,0.977,30880436
25003,patients,species,0.947,30880436
25004,choroidal neovascularization,disease,1.0,30880436
25005,angioid streaks,disease,1.0,30880436
25006,aflibercept,gene,0.9834,30858687
25007,corneal endothelial cells,cell_type,0.8853,30858687
25008,aflibercept,gene,0.991,30858687
25009,diabetic or cystoid macular edema,disease,1.0,30858687
25010,retinal vein occlusion,disease,0.9995,30858687
25011,aflibercept,gene,0.984,30858687
25012,endothelial cell,cell_type,0.78,30858687
25013,hexagonal cells,cell_type,0.8325,30858687
25014,Hex,drug,0.7905,30858687
25015,aflibercept,gene,0.99,30858687
25016,aflibercept,gene,0.981,30858687
25017,neovascular age-related macular degeneration,disease,1.0,30858684
25018,neovascular age-related macular degeneration,disease,1.0,30858684
25019,nAMD,disease,1.0,30858684
25020,aflibercept,gene,0.9907,30858684
25021,ranibizumab,gene,0.89,30858684
25022,bevacizumab,gene,0.566,30858684
25023,nAMD,disease,1.0,30858684
25024,aflibercept,gene,0.978,30858684
25025,ranibizumab,gene,0.691,30858684
25026,bevacizumab,gene,0.6406,30858684
25027,macular edema,disease,1.0,30858684
25028,edema,disease,0.9873,30858684
25029,edema,disease,0.9995,30858684
25030,nAMD,disease,1.0,30858684
25031,patients,species,0.978,30858565
25032,patients,species,0.9824,30858565
25033,age-related macular degeneration,disease,1.0,30858565
25034,AMD,disease,1.0,30858565
25035,vascular endothelial growth factor,gene,0.9883,30858565
25036,wet AMD,disease,1.0,30858565
25037,patients,species,0.9946,30858565
25038,wet AMD,disease,0.9995,30858565
25039,aflibercept,gene,0.954,30858565
25040,people,species,0.986,30858565
25041,wet AMD,disease,0.9976,30858565
25042,AMD,disease,1.0,30858565
25043,Aflibercept,gene,0.9717,30849345
25044,Polypoidal Choroidal Vasculopathy,disease,1.0,30849345
25045,Aflibercept,gene,0.942,30849345
25046,Polypoidal Choroidal Vasculopathy,disease,1.0,30849345
25047,aflibercept,gene,0.9854,30849345
25048,polypoidal choroidal vasculopathy,disease,1.0,30849345
25049,PCV,disease,1.0,30849345
25050,PCV,disease,1.0,30849345
25051,Diabetic Retinopathy,disease,0.998,30849345
25052,Diabetic Retinopathy,disease,1.0,30849345
25053,polyp,disease,1.0,30849345
25054,polyps,disease,1.0,30849345
25055,gastrointestinal malignancies,disease,1.0,30848108
25056,anticancer,disease,0.893,30848108
25057,cancer,disease,0.9736,30848108
25058,advanced gastrointestinal cancers,disease,0.999,30848108
25059,advanced GI malignancies,disease,0.812,30848108
25060,GI cancer,disease,0.9834,30848108
25061,monoclonal,gene,0.5874,30848108
25062,aflibercept,gene,0.9814,30848108
25063,gastrointestinal cancer,disease,0.9995,30848108
25064,CD11b+ Monocytes,cell_type,0.846,30844038
25065,Anti-Vascular Endothelial Growth Factor,gene,0.965,30844038
25066,CD11b+ immune cells,cell_type,0.801,30844038
25067,choroidal,disease,0.5947,30844038
25068,humans,species,0.99,30844038
25069,CD11b,cell_line,0.654,30844038
25070,CD11b+ circulating monocytes,cell_type,0.599,30844038
25071,CD11b+,gene,0.9336,30844038
25072,anti-vascular endothelial growth factor,gene,0.9976,30844038
25073,anti-VEGF,gene,0.9946,30844038
25074,neovascular age-related macular degeneration,disease,0.9966,30844038
25075,AMD,disease,1.0,30844038
25076,polypoidal choroidal vasculopathy,disease,1.0,30844038
25077,PCV,disease,1.0,30844038
25078,PARTICIPANTS,species,0.4917,30844038
25079,patients,species,0.9707,30844038
25080,neovascular AMD,disease,1.0,30844038
25081,PCV,disease,1.0,30844038
25082,aflibercept,gene,0.9775,30844038
25083,ranibizumab,gene,0.7827,30844038
25084,Patients,species,0.9766,30844038
25085,immune diseases,disease,1.0,30844038
25086,CD11b+ circulating monocytes,cell_line,0.72,30844038
25087,CD11b+,gene,0.9854,30844038
25088,anti-VEGF,gene,0.988,30844038
25089,CD11b,gene,0.805,30844038
25090,circulating monocytes,cell_type,0.71,30844038
25091,CD11b+ circulating monocytes,cell_type,0.7827,30844038
25092,CCR2,gene,0.5796,30844038
25093,patients,species,0.9707,30844038
25094,women,species,0.9033,30844038
25095,CD11b+ monocytes,cell_line,0.75,30844038
25096,CD11b+,gene,0.9126,30844038
25097,anti-VEGF,gene,0.978,30844038
25098,patients,species,0.993,30844038
25099,neovascular AMD,disease,1.0,30844038
25100,patients,species,0.989,30844038
25101,PCV,disease,0.862,30844038
25102,AMD,disease,1.0,30844038
25103,VEGF,gene,0.9956,30844038
25104,CD11b+ monocytes,cell_type,0.8853,30844038
25105,CCR2,gene,0.9863,30844038
25106,circulating CD11b+ monocytes,cell_type,0.8076,30844038
25107,CD11b+ monocytes,cell_line,0.6714,30844038
25108,CD11b+,gene,0.815,30844038
25109,anti-VEGF,gene,0.977,30844038
25110,patients,species,0.9893,30844038
25111,neovascular AMD,disease,0.9995,30844038
25112,PCV,disease,1.0,30844038
25113,Aflibercept,gene,0.869,30842468
25114,Neovascular Age-Related Macular Degeneration,disease,1.0,30842468
25115,vascular endothelial growth factor,gene,0.8916,30842468
25116,ranibizumab,gene,0.688,30842468
25117,aflibercept,gene,0.972,30842468
25118,neovascular age-related macular degeneration,disease,1.0,30842468
25119,AMD,disease,1.0,30842468
25120,AMD,disease,1.0,30842468
25121,patients,species,0.99,30842468
25122,patients,species,0.9897,30842468
25123,AMD,disease,1.0,30842468
25124,AMD,disease,0.9976,30842468
25125,polypoidal choroidal vasculopathy,disease,1.0,30842468
25126,retinal angiomatous proliferation,disease,1.0,30842468
25127,aflibercept,gene,0.9697,30842468
25128,ELM,cell_type,0.463,30842468
25129,patients,species,0.9707,30841748
25130,diabetic macular oedema,disease,1.0,30841748
25131,ziv-aflibercept,gene,0.9824,30841748
25132,patients,species,0.9727,30841748
25133,diabetic macular oedema,disease,1.0,30841748
25134,ziv-aflibercept,gene,0.977,30841748
25135,patients,species,0.9155,30841748
25136,diabetic macular oedema,disease,1.0,30841748
25137,patients,species,0.9004,30841748
25138,ziv-aflibercept,gene,0.9883,30841748
25139,Polypoidal choroidal vasculopathy,disease,1.0,30834360
25140,Polypoidal choroidal vasculopathy,disease,1.0,30834360
25141,serosanguineous,disease,0.801,30834360
25142,retinal pigment epithelial and neurosensory layer detachments,disease,0.992,30834360
25143,neovascular age-related macular degeneration,disease,1.0,30834360
25144,indocyanine,drug,0.9946,30834360
25145,FOLFIRI3,drug,0.88,30815374
25146,bevacizumab,gene,0.6807,30815374
25147,metastatic colorectal cancer,disease,1.0,30815374
25148,mCRC,disease,1.0,30815374
25149,irinotecan,drug,0.9927,30815374
25150,FOLFIRI3,drug,0.523,30815374
25151,bevacizumab,gene,0.9067,30815374
25152,aflibercept,gene,0.9736,30815374
25153,patients,species,0.958,30815374
25154,mCRC,disease,0.9937,30815374
25155,patients,species,0.9536,30815374
25156,bevacizumab,gene,0.9277,30815374
25157,aflibercept,gene,0.9727,30815374
25158,aflibercept,gene,0.9707,30815374
25159,diarrhoea,disease,1.0,30815374
25160,neutropenia,disease,1.0,30815374
25161,aflibercept,gene,0.9585,30815374
25162,aflibercept,gene,0.9883,30815374
25163,FOLFIRI,drug,0.7783,30815374
25164,mCRC,disease,0.986,30815374
25165,patients,species,0.9927,30815374
25166,aflibercept,gene,0.9873,30815374
25167,patients,species,0.987,30815371
25168,metastatic colorectal cancer,disease,0.9995,30815371
25169,patients,species,0.98,30815371
25170,bevacizumab,gene,0.8853,30815371
25171,bevacizumab,gene,0.825,30815371
25172,aflibercept,gene,0.984,30815371
25173,patient,species,0.9688,30815371
25174,tumor,disease,0.8203,30815371
25175,bevacizumab,gene,0.859,30815371
25176,Aflibercept,gene,0.9663,30813810
25177,vascular endothelial growth factor,gene,0.9966,30813810
25178,exudative age-related macular degeneration,disease,0.999,30813810
25179,VEGF,gene,0.8623,30813810
25180,wet age-related macular degeneration,disease,0.8896,30813810
25181,Aflibercept,gene,0.9595,30813810
25182,anti-VEGF,gene,0.968,30813810
25183,age-related macular degeneration,disease,1.0,30813810
25184,VEGF,gene,0.8677,30813810
25185,choroidal neovascularization,disease,1.0,30813810
25186,VEGF-A factor,gene,0.9907,30813810
25187,VEGF,gene,0.9937,30813810
25188,Aflibercept,gene,0.947,30813810
25189,exudative age-related macular degeneration,disease,0.9634,30813810
25190,VEGF,gene,0.5386,30813810
25191,neovascular age-related macular degeneration,disease,1.0,30813810
25192,Streptozotocin,drug,1.0,30811545
25193,Diabetic,disease,0.7764,30811545
25194,Mouse,species,0.917,30811545
25195,streptozotocin,drug,1.0,30811545
25196,STZ,drug,1.0,30811545
25197,diabetic retinopathy,disease,1.0,30811545
25198,DR,disease,1.0,30811545
25199,mouse,species,0.9775,30811545
25200,mouse,species,0.988,30811545
25201,STZ,drug,0.9995,30811545
25202,neurodegeneration,disease,1.0,30811545
25203,inflammation,disease,1.0,30811545
25204,gliosis,disease,1.0,30811545
25205,diabetes,disease,0.952,30811545
25206,Aflibercept,gene,0.9595,30811545
25207,triamcinolone acetonide,drug,0.999,30811545
25208,TAAC,drug,0.992,30811545
25209,retinal thinning,disease,0.807,30811545
25210,cholinergic amacrine cell,cell_type,0.846,30811545
25211,aflibercept,gene,0.9795,30811545
25212,adherent leukocytes,cell_type,0.595,30811545
25213,Aflibercept,gene,0.9863,30811545
25214,TAAC,DNA,0.4912,30811545
25215,inflammation,disease,0.9995,30811545
25216,gliosis,disease,1.0,30811545
25217,STZ,drug,1.0,30811545
25218,diabetic,disease,0.9907,30811545
25219,mice,species,0.923,30811545
25220,DR,disease,,30811545
25221,mouse,species,0.9756,30811545
25222,STZ,drug,0.999,30811545
25223,DR,disease,,30811545
25224,aflibercept,gene,0.9927,30808179
25225,diabetic macular oedema,disease,1.0,30808179
25226,aflibercept,gene,0.9883,30808179
25227,diabetic macular oedema,disease,1.0,30808179
25228,patients,species,0.987,30808179
25229,PARTICIPANTS,species,0.837,30808179
25230,diabetic,disease,1.0,30808179
25231,patients,species,0.9883,30808179
25232,vascular endothelial growth factor,gene,0.935,30808179
25233,aflibercept,gene,0.9517,30808179
25234,patient,species,0.9766,30808179
25235,Diabetic Retinopathy,disease,1.0,30808179
25236,Patients,species,0.988,30808179
25237,aflibercept,gene,0.9736,30808179
25238,aflibercept,gene,0.9795,30808179
25239,Diabetic,disease,0.9995,30808179
25240,Retinopathy,disease,0.957,30808179
25241,Diabetic,disease,0.9995,30808179
25242,Retinopathy,disease,0.9995,30808179
25243,Diabetic Retinopathy,disease,1.0,30808179
25244,aflibercept,gene,0.9526,30808179
25245,diabetic macular oedema,disease,1.0,30808179
25246,Anti-Fumarase Antibody,gene,0.9917,30807637
25247,VEGF,gene,0.7427,30807637
25248,anti-fumarase antibody,gene,0.9907,30807637
25249,VEGF,gene,0.9375,30807637
25250,diabetic macular edema,disease,1.0,30807637
25251,DME,disease,1.0,30807637
25252,DME,disease,1.0,30807637
25253,patients,species,0.994,30807637
25254,VEGF,gene,0.5005,30807637
25255,ranibizumab,gene,0.965,30807637
25256,aflibercept,gene,0.9546,30807637
25257,anti-fumarase antibody,gene,0.9453,30807637
25258,anti-fumarase antibody,gene,0.9688,30807637
25259,anti-fumarase IgG,gene,0.9897,30807637
25260,VEGF,gene,0.5747,30807637
25261,VEGF,gene,0.519,30807637
25262,Anti-fumarase antibody,gene,0.928,30807637
25263,VEGF,gene,0.556,30807637
25264,DME,disease,1.0,30807637
25265,Anti-Vascular Endothelial Growth Factor,gene,0.9653,30807236
25266,Pachychoroid,disease,1.0,30807236
25267,anti-vascular endothelial growth factor,gene,0.989,30807236
25268,anti-VEGF,gene,0.985,30807236
25269,pachychoroid neovasculopathy,disease,1.0,30807236
25270,neovascular age-related macular degeneration,disease,1.0,30807236
25271,AMD,disease,1.0,30807236
25272,pachychoroid neovasculopathy,disease,1.0,30807236
25273,neovascular AMD,disease,1.0,30807236
25274,patients,species,0.9766,30807236
25275,anti-VEGF,gene,0.9683,30807236
25276,pachychoroid neovasculopathy,disease,1.0,30807236
25277,neovascular AMD,disease,1.0,30807236
25278,pachychoroid neovasculopathy,disease,1.0,30807236
25279,patients,species,0.9766,30807236
25280,VEGF,gene,0.9556,30807236
25281,pachychoroid neovasculopathy,disease,1.0,30807236
25282,VEGF,gene,0.9062,30807236
25283,neovascular AMD,disease,1.0,30807236
25284,pachychoroid neovasculopathy,disease,1.0,30807236
25285,aflibercept,gene,0.979,30806775
25286,macular degeneration,disease,1.0,30806775
25287,aflibercept,gene,0.991,30806775
25288,aflibercept,gene,0.9893,30806775
25289,patients,species,0.99,30806775
25290,CNV,disease,0.9854,30806775
25291,AMD,disease,0.9995,30806775
25292,patients,species,0.9785,30806775
25293,bevacizumab,gene,0.8657,30806775
25294,ranibizumab,gene,0.7534,30806775
25295,aflibercept,gene,0.9795,30806775
25296,aflibercept,gene,0.992,30806775
25297,patients,species,0.9697,30806775
25298,aflibercept,gene,0.979,30806775
25299,Aflibercept,gene,0.9717,30806775
25300,Encephalopathy,disease,1.0,30804142
25301,Lactic Acidosis,disease,1.0,30804142
25302,Hyperammonaemia,disease,1.0,30804142
25303,FOLFIRI,drug,0.9355,30804142
25304,Aflibercept,gene,0.943,30804142
25305,liver metastases,disease,0.995,30804142
25306,PATIENTS,species,0.9507,30804142
25307,metastatic colorectal cancer,disease,1.0,30804142
25308,encephalopathy,disease,1.0,30804142
25309,lactic acidosis,disease,0.9995,30804142
25310,hyperammonaemia,disease,1.0,30804142
25311,5-fluorouracil,drug,0.999,30804142
25312,vitamin B1,drug,0.997,30804142
25313,metastatic colorectal cancer,disease,1.0,30804142
25314,5-fluorouracil,drug,0.999,30804142
25315,Aflibercept,gene,0.978,30795014
25316,Cystoid Macular Edema,disease,1.0,30795014
25317,aflibercept,gene,0.9927,30795014
25318,cystoid macular edema,disease,1.0,30795014
25319,CME,disease,1.0,30795014
25320,central retinal vein occlusion,disease,1.0,30795014
25321,CRVO,disease,1.0,30795014
25322,patients,species,0.948,30795014
25323,CME,disease,1.0,30795014
25324,CRVO,disease,1.0,30795014
25325,aflibercept,gene,0.9883,30795014
25326,BCVA,cell_type,0.4038,30795014
25327,CRT,DNA,0.5146,30795014
25328,aflibercept,gene,0.9873,30795014
25329,CME,disease,0.999,30795014
25330,CRVO,disease,1.0,30795014
25331,Aflibercept,gene,0.9683,30793798
25332,neovascular age-related macular degeneration,disease,1.0,30793798
25333,aflibercept,gene,0.9067,30793798
25334,neovascular age-related macular degeneration,disease,1.0,30793798
25335,NV-,disease,1.0,30793798
25336,patients,species,0.9834,30793798
25337,aflibercept,gene,0.9844,30793798
25338,patients,species,0.942,30793798
25339,NV-AMD,disease,1.0,30793798
25340,aflibercept,gene,0.9727,30793798
25341,patients,species,0.9854,30793798
25342,avascular retinal pigment epithelium detachments,disease,0.9785,30774304
25343,aflibercept,gene,0.991,30774304
25344,triamcinolone acetonide,drug,0.997,30774304
25345,avascular pigment epithelium detachments,disease,1.0,30774304
25346,aPEDs,disease,1.0,30774304
25347,PATIENTS,species,0.95,30774304
25348,Patients,species,0.9766,30774304
25349,aPEDs,DNA,0.589,30774304
25350,aflibercept,gene,0.9424,30774304
25351,aPED,disease,0.9966,30774304
25352,patients,species,0.985,30774304
25353,triamcinolone acetonide,drug,0.9165,30774304
25354,aflibercept,gene,0.967,30774304
25355,patients,species,0.969,30774304
25356,choroidal neovascularization,disease,1.0,30774304
25357,geographic atrophy,disease,1.0,30774304
25358,GA,disease,1.0,30774304
25359,patients,species,0.9834,30774304
25360,aPEDs,DNA,0.62,30774304
25361,patients,species,0.979,30774304
25362,aPED,disease,1.0,30774304
25363,patient,species,0.9717,30774304
25364,serous chorioretinopathy,disease,0.9824,30774304
25365,Choroidal neovascularization,disease,1.0,30774304
25366,retinal pigment epithelium tear,disease,0.9995,30774304
25367,patient,species,0.894,30774304
25368,patient,species,0.988,30774304
25369,patients,species,0.987,30774304
25370,outer retinal atrophy,disease,1.0,30774304
25371,outer retinal atrophy,disease,1.0,30774304
25372,drusenoid aPEDs,disease,0.8594,30774304
25373,Ziv-Aflibercept,gene,0.9204,30768575
25374,Pancreatic Neuroendocrine Tumors,disease,0.998,30768575
25375,pNETs,disease,1.0,30768575
25376,Ziv-aflibercept,gene,0.969,30768575
25377,vascular endothelial growth factor (VEGF) receptors 1 and 2,gene,0.9976,30768575
25378,Fc,gene,0.938,30768575
25379,immunoglobulin,gene,0.966,30768575
25380,VEGF,gene,0.996,30768575
25381,neuroendocrine tumors,disease,0.4712,30768575
25382,ziv-aflibercept,gene,0.9824,30768575
25383,pNETs,disease,0.977,30768575
25384,gastrointestinal hemorrhage,disease,0.9995,30768575
25385,proteinuria,disease,1.0,30768575
25386,ziv-aflibercept,gene,0.9844,30768575
25387,VEGF,gene,0.994,30768575
25388,pNET,disease,0.4941,30768575
25389,Indocyanine green,drug,0.996,30767090
25390,patients,species,0.977,30767090
25391,indocyanine green,drug,0.9976,30767090
25392,patients,species,0.9717,30767090
25393,neovascular age-related macular degeneration,disease,1.0,30767090
25394,nAMD,disease,1.0,30767090
25395,ranibizumab,gene,0.7646,30767090
25396,aflibercept,gene,0.967,30767090
25397,patients,species,0.982,30767090
25398,nAMD,disease,1.0,30767090
25399,ranibizumab,gene,0.8447,30767090
25400,aflibercept,gene,0.9434,30767090
25401,type I choroidal neovascularization,disease,0.9976,30767090
25402,CNV,disease,1.0,30767090
25403,polypoidal choroidal vasculopathy,disease,1.0,30767090
25404,PCV,disease,1.0,30767090
25405,aflibercept,gene,0.988,30767090
25406,aflibercept,gene,0.9937,30767090
25407,polyps,disease,0.794,30767090
25408,aflibercept,gene,0.992,30767090
25409,dry macula,disease,0.999,30767090
25410,CNV,disease,0.9985,30767090
25411,PCV,disease,1.0,30767090
25412,ranibizumab,gene,0.8633,30767090
25413,aflibercept,gene,0.9785,30767090
25414,aflibercept,gene,0.989,30767090
25415,dry macula,disease,0.7446,30767090
25416,polyps,disease,1.0,30767090
25417,patients,species,0.9453,30767090
25418,nAMD,disease,1.0,30767090
25419,ranibizumab,gene,0.8906,30767090
25420,aflibercept,gene,0.9917,30767090
25421,polyps,disease,0.9995,30767090
25422,patients,species,0.9854,30767090
25423,aflibercept,gene,0.9917,30765771
25424,pachychoroid neovasculopathy,disease,1.0,30765771
25425,ranibizumab,gene,0.913,30765771
25426,aflibercept,gene,0.9727,30765771
25427,patients,species,0.9604,30765771
25428,pachychoroid neovasculopathy,disease,1.0,30765771
25429,ranibizumab,gene,0.9453,30765771
25430,aflibercept,gene,0.965,30765771
25431,ranibizumab,gene,0.846,30765771
25432,aflibercept,gene,0.973,30765771
25433,aflibercept,gene,0.9697,30765771
25434,aflibercept,gene,0.996,30765771
25435,ranibizumab,gene,0.874,30765771
25436,aflibercept,gene,0.993,30765771
25437,ranibizumab,gene,0.6284,30765771
25438,ranibizumab,gene,0.928,30765771
25439,aflibercept,gene,0.981,30765771
25440,vascular endothelial growth factor,gene,0.9077,30765771
25441,Aflibercept,gene,0.968,30765771
25442,ranibizumab,gene,0.864,30765771
25443,pachychoroid neovasculopathy,disease,1.0,30763369
25444,Pachychoroid neovasculopathy,disease,1.0,30763369
25445,PNV,disease,1.0,30763369
25446,pachychoroid spectrum diseases,disease,1.0,30763369
25447,VEGF,gene,0.9976,30763369
25448,anti-VEGF,gene,0.883,30763369
25449,pachychoroid neovasculopathy,disease,1.0,30763369
25450,PNV,disease,1.0,30763369
25451,neovascular age,disease,0.986,30763369
25452,macular degeneration,disease,1.0,30763369
25453,PNV,disease,0.8784,30763369
25454,PNV,disease,1.0,30763369
25455,PNV,disease,0.999,30763369
25456,VEGF,gene,0.908,30763369
25457,Choroidal neovascularization,disease,1.0,30763369
25458,CNV,disease,1.0,30763369
25459,fluorescein,drug,0.998,30763369
25460,dry macula,disease,1.0,30763369
25461,CNV,disease,0.993,30763369
25462,VEGF,gene,0.876,30763369
25463,PNV,disease,1.0,30763369
25464,PNV,cell_type,0.4604,30763369
25465,CNV area,DNA,0.628,30763369
25466,aflibercept,gene,0.983,30763369
25467,ranibizumab,gene,0.6973,30763369
25468,PNV,disease,0.782,30763369
25469,CNV,disease,0.995,30763369
25470,aflibercept,gene,0.983,30763369
25471,ranibizumab,drug,0.5347,30763369
25472,PNV,disease,0.571,30763369
25473,anti-VEGF,gene,0.9478,30763369
25474,PNV,disease,0.9976,30763369
25475,anti-VEGF,gene,0.9565,30763369
25476,glaucoma,disease,1.0,30762649
25477,retinopathies,disease,0.9995,30762649
25478,bevacizumab,gene,0.614,30762649
25479,aflibercept,gene,0.963,30762649
25480,diabetic retinopathy,disease,1.0,30762649
25481,retinal vein occlusion,disease,1.0,30762649
25482,macular degeneration,disease,1.0,30762649
25483,retinal neovascularization,disease,1.0,30762649
25484,radiation retinopathy,disease,1.0,30762649
25485,glaucomatous damage,disease,1.0,30762649
25486,aflibercept,gene,0.9478,30762298
25487,wet,disease,0.61,30762298
25488,age-related macular degeneration,disease,0.999,30762298
25489,aflibercept,gene,0.988,30757913
25490,ranibizumab,gene,0.6523,30757913
25491,diabetic macular edema,disease,1.0,30757913
25492,ranibizumab,gene,0.6904,30757913
25493,aflibercept,gene,0.981,30757913
25494,diabetic macular edema,disease,1.0,30757913
25495,retinal detachment,disease,1.0,30757913
25496,diabetic macular edema,disease,1.0,30757913
25497,patients,species,0.992,30757913
25498,diabetic macular edema,disease,1.0,30757913
25499,subfoveal retinal detachment,disease,1.0,30757913
25500,aflibercept,gene,0.9624,30757913
25501,patients,species,0.9644,30757913
25502,subfoveal retinal detachment,disease,1.0,30757913
25503,patients,species,0.981,30757913
25504,aflibercept,gene,0.9966,30757913
25505,ranibizumab,gene,0.801,30757913
25506,subfoveal retinal detachment,disease,1.0,30757913
25507,aflibercept,gene,0.9785,30757913
25508,ranibizumab,gene,0.5464,30757913
25509,aflibercept,gene,0.987,30757913
25510,ranibizumab,gene,0.801,30757913
25511,diabetic macular edema,disease,1.0,30757913
25512,patients,species,0.9907,30757913
25513,subfoveal retinal detachment,disease,1.0,30757913
25514,aflibercept,gene,0.9956,30757913
25515,ranibizumab,gene,0.727,30757913
25516,subfoveal retinal detachment,disease,1.0,30757913
25517,patients,species,0.978,30746134
25518,vascular endothelial growth factor,gene,0.938,30746134
25519,Vascular endothelial growth factor,gene,0.997,30746134
25520,VEGF,gene,0.9976,30746134
25521,tumors,disease,1.0,30746134
25522,retinal diseases,disease,1.0,30746134
25523,malignancies,disease,1.0,30746134
25524,diminishing eyesight,disease,0.998,30746134
25525,retinopathy,disease,1.0,30746134
25526,Hypertension,disease,0.9995,30746134
25527,proteinuria,disease,1.0,30746134
25528,VEGF,gene,0.9937,30746134
25529,nephrotic-range proteinuria,disease,0.999,30746134
25530,glomerulopathies,disease,1.0,30746134
25531,anti-VEGF,gene,0.8374,30746134
25532,VEGF,gene,0.9956,30746134
25533,simian glomeruli,cell_type,0.472,30746134
25534,simian,species,0.9214,30746134
25535,patients,species,0.974,30746134
25536,bevacizumab,gene,0.725,30746134
25537,aflibercept,gene,0.9863,30746134
25538,hypertension,disease,1.0,30746134
25539,proteinuria,disease,1.0,30746134
25540,renal injury,disease,1.0,30746134
25541,VEGF,gene,0.9976,30746134
25542,VEGF,gene,0.9653,30746134
25543,patients,species,0.9883,30746134
25544,diabetes,disease,1.0,30746134
25545,hypertension,disease,1.0,30746134
25546,nephropathy,disease,1.0,30746134
25547,proteinuria,disease,1.0,30746134
25548,VEGF,gene,0.985,30746134
25549,anti-VEGF,gene,0.933,30741468
25550,dexamethasone,drug,0.9897,30741468
25551,aflibercept,gene,0.9805,30740921
25552,aflibercept,gene,0.9736,30740921
25553,neovascular,disease,0.9995,30740921
25554,age-related macular degeneration,disease,1.0,30740921
25555,nAMD,disease,1.0,30740921
25556,patients,species,0.983,30740921
25557,nAMD,disease,1.0,30740921
25558,aflibercept,gene,0.9766,30740921
25559,ranibizumab,gene,0.846,30740921
25560,bevacizumab,gene,0.698,30740921
25561,pigment epithelial detachment,disease,1.0,30740921
25562,PED,disease,0.9976,30740921
25563,geographic atrophy,disease,1.0,30740921
25564,patients,species,0.966,30740921
25565,patients,species,0.9897,30740921
25566,BCVA,cell_type,0.4219,30740921
25567,geographic atrophy,disease,1.0,30740921
25568,Aflibercept,gene,0.9175,30740921
25569,nAMD,disease,1.0,30740921
25570,nAMD,disease,0.9995,30740921
25571,patients,species,0.983,30740921
25572,Diabetic retinopathy,disease,1.0,30736075
25573,diabetes,disease,1.0,30736075
25574,diabetic retinopathy,disease,1.0,30736075
25575,patients,species,0.9897,30736075
25576,ranibizumab,gene,0.934,30736075
25577,aflibercept,gene,0.961,30736075
25578,patients,species,0.984,30736075
25579,PDR,disease,0.9854,30736075
25580,PDR,disease,0.999,30736075
25581,patients,species,0.9937,30736075
25582,ranibizumab,gene,0.776,30736075
25583,PDR,disease,0.995,30736075
25584,patients,species,0.993,30736075
25585,aflibercept,gene,0.922,30736075
25586,patients,species,0.9746,30736075
25587,epiretinal membranes,disease,0.9946,30736075
25588,macular oedema,disease,1.0,30736075
25589,Eylea,drug,0.983,30736075
25590,Eylea,drug,0.6006,30736075
25591,platelets,cell_type,0.8315,30736075
25592,erythrocytes,cell_type,0.851,30736075
25593,macrophages,cell_type,0.8115,30736075
25594,aflibercept,gene,0.957,30736075
25595,PDR,disease,0.997,30736075
25596,thrombotic microangiopathy,disease,1.0,30736075
25597,VEGF,gene,0.729,30736075
25598,macular oedema,disease,1.0,30736075
25599,VEGF,gene,0.9976,30736075
25600,placental growth factor,gene,0.9985,30736075
25601,DR,disease,,30736075
25602,Aflibercept,gene,0.989,30733512
25603,retinal vascular,DNA,0.55,30733512
25604,aflibercept,gene,0.9854,30733512
25605,diabetic macular,disease,1.0,30733512
25606,edema,disease,0.968,30733512
25607,DME,disease,1.0,30733512
25608,FAZ,disease,0.768,30733512
25609,patients,species,0.9644,30733512
25610,DME,disease,1.0,30733512
25611,aflibercept,gene,0.969,30733512
25612,retinal vascular,DNA,0.5684,30733512
25613,retinal vascular,DNA,0.5405,30733512
25614,DCP,DNA,0.552,30733512
25615,aflibercept,gene,0.6255,30733512
25616,MAs,disease,0.978,30733512
25617,MAs,disease,0.999,30733512
25618,MAs,disease,0.9976,30733512
25619,DME,disease,1.0,30733512
25620,aflibercept,gene,0.968,30733512
25621,Choroidal neovascularisation,disease,1.0,30733067
25622,serpiginous choroiditis,disease,1.0,30733067
25623,aflibercept,gene,0.978,30733067
25624,serpiginous choroiditis,disease,1.0,30733067
25625,SC,disease,1.0,30733067
25626,metamorphopsia,disease,1.0,30733067
25627,peripapillary haemorrhage,disease,0.992,30733067
25628,choroidal neovascularisation,disease,1.0,30733067
25629,CNV,disease,1.0,30733067
25630,aflibercept,gene,0.9854,30733067
25631,aflibercept,gene,0.9697,30733067
25632,Papillophlebitis,disease,1.0,30733066
25633,polyarteritis nodosa,disease,1.0,30733066
25634,polyarteritis nodosa,disease,1.0,30733066
25635,papillophlebitis,disease,1.0,30733066
25636,macular oedema,disease,1.0,30733066
25637,aflibercept,gene,0.961,30733066
25638,episcleritis,disease,1.0,30733066
25639,Papillophlebitis,disease,1.0,30733066
25640,non-ischaemic central retinal vein occlusion,disease,1.0,30733066
25641,Polyarteritis nodosa,disease,1.0,30733066
25642,systemic necrotising vasculitis,disease,0.9604,30733066
25643,inflammation,disease,0.937,30733066
25644,PGF,drug,0.6836,30732627
25645,VEGF,gene,0.9956,30732627
25646,mononuclear phagocytes,cell_type,0.8745,30732627
25647,murine,species,0.9683,30732627
25648,Age-related macular degeneration,disease,1.0,30732627
25649,AMD,disease,1.0,30732627
25650,visual impairment,disease,1.0,30732627
25651,AMD,disease,0.9995,30732627
25652,anti-,gene,0.4983,30732627
25653,vascular endothelial growth factor,gene,0.952,30732627
25654,VEGF,gene,0.9966,30732627
25655,Placental growth factor,gene,0.9917,30732627
25656,PGF,gene,0.996,30732627
25657,VEGF family,gene,0.996,30732627
25658,VEGF-A,gene,0.998,30732627
25659,PGF,drug,0.845,30732627
25660,mouse,species,0.9595,30732627
25661,choroidal neovascularization,disease,1.0,30732627
25662,CNV,disease,1.0,30732627
25663,retinal mononuclear phagocytes,cell_type,0.893,30732627
25664,CNV,disease,0.9985,30732627
25665,mice,species,0.9263,30732627
25666,YAG,drug,0.8765,30732627
25667,VEGF-A,gene,0.998,30732627
25668,aVEGF,gene,0.991,30732627
25669,anti-PGF,gene,0.9946,30732627
25670,aPGF,gene,0.99,30732627
25671,aVEGF,gene,0.9824,30732627
25672,aPGF,gene,0.991,30732627
25673,aflibercept,gene,0.9893,30732627
25674,IgG,gene,0.9727,30732627
25675,Lectin,gene,0.9414,30732627
25676,RPE,cell_type,0.4836,30732627
25677,CNV,disease,0.976,30732627
25678,mRNA,RNA,0.8594,30732627
25679,Iba1,gene,0.9873,30732627
25680,VEGF,gene,0.995,30732627
25681,PGF,gene,0.8335,30732627
25682,RPE,cell_type,0.608,30732627
25683,VEGF,gene,0.963,30732627
25684,PGF,drug,0.592,30732627
25685,IL-6,gene,0.927,30732627
25686,IL1-beta,gene,0.992,30732627
25687,TNF,gene,0.9404,30732627
25688,CNV,disease,0.9976,30732627
25689,PGF,drug,0.9746,30732627
25690,VEGF-A,gene,0.981,30732627
25691,aflibercept,gene,0.9663,30732627
25692,VEGF-A,gene,0.997,30732627
25693,PGF,drug,0.8,30732627
25694,aflibercept,gene,0.991,30732627
25695,reactive microglia,cell_line,0.668,30732627
25696,macrophages,cell_type,0.78,30732627
25697,mRNA,RNA,0.667,30732627
25698,VEGF-A,gene,0.9976,30732627
25699,PGF,drug,0.9746,30732627
25700,mononuclear phagocytes,cell_type,0.8496,30732627
25701,PGF,drug,0.983,30732627
25702,VEGF-A,gene,0.9927,30732627
25703,IL-6,gene,0.993,30732627
25704,IL1-beta,gene,0.994,30732627
25705,PGF,drug,0.998,30732627
25706,VEGF-A,gene,0.9956,30732627
25707,vascular leakage,disease,0.9604,30732627
25708,CNV,disease,1.0,30732627
25709,mononuclear phagocytes,cell_type,0.8438,30732627
25710,PGF,drug,0.9575,30732627
25711,wet AMD,disease,0.9985,30732627
25712,aflibercept,gene,0.991,30728380
25713,polypoidal choroidal vasculopathy,disease,1.0,30728380
25714,aflibercept,gene,0.9907,30728380
25715,polypoidal choroidal vasculopathy,disease,1.0,30728380
25716,PCV,disease,1.0,30728380
25717,polyps,disease,0.991,30728380
25718,patients,species,0.982,30728380
25719,PCV,disease,1.0,30728380
25720,polyps,disease,0.9727,30728380
25721,vascular endothelial growth factor,gene,0.996,30728380
25722,VEGF,gene,0.9976,30728380
25723,aflibercept,gene,0.9785,30728380
25724,Participants,species,0.924,30728380
25725,aflibercept,gene,0.9814,30728380
25726,indocyanine green,drug,0.9966,30728380
25727,inner retinal cyst,disease,0.999,30728380
25728,aflibercept,gene,0.988,30728380
25729,PCV,disease,1.0,30728380
25730,BVN,disease,0.9976,30728380
25731,aflibercept,gene,0.9917,30728380
25732,Choroidal Neovascularization,disease,1.0,30727875
25733,Choroidal neovascularization,disease,1.0,30727875
25734,CNV,disease,1.0,30727875
25735,neovascular age-related macular degeneration,disease,1.0,30727875
25736,AMD,disease,1.0,30727875
25737,pathologic myopia,disease,0.9995,30727875
25738,CNV,disease,1.0,30727875
25739,uveitis,disease,1.0,30727875
25740,central serous chorioretinopathy,disease,1.0,30727875
25741,angioid streaks,disease,1.0,30727875
25742,intraocular tumors,disease,1.0,30727875
25743,hereditary chorioretinal dystrophies,disease,1.0,30727875
25744,CNV,disease,0.9995,30727875
25745,visual loss,disease,0.7476,30727875
25746,retinal or subretinal hemorrhage,disease,1.0,30727875
25747,fibrosis involving,disease,0.93,30727875
25748,CNV,disease,1.0,30727875
25749,vascular endothelial growth factor,gene,0.998,30727875
25750,VEGF,gene,0.996,30727875
25751,VEGF,gene,0.9937,30727875
25752,CNV,disease,0.999,30727875
25753,VEGF,gene,0.968,30727875
25754,CNV,disease,1.0,30727875
25755,VEGF,gene,0.9917,30727875
25756,bevacizumab,gene,0.8735,30727875
25757,ranibizumab,gene,0.882,30727875
25758,aflibercept,gene,0.984,30727875
25759,ziv-aflibercept,gene,0.9697,30727875
25760,CNV,disease,0.691,30727875
25761,verteporfin,drug,0.9985,30727875
25762,CNV,disease,0.9995,30727875
25763,anti-VEGF,gene,0.8115,30727875
25764,CNV,disease,1.0,30727875
25765,Anti-VEGF,gene,0.97,30721208
25766,neovascular age-related macular degeneration,disease,1.0,30721208
25767,Neovascular Age-related,disease,0.9937,30721208
25768,Macular Degeneration,disease,1.0,30721208
25769,nAMD,disease,1.0,30721208
25770,VEGF,gene,0.943,30721208
25771,VEGF,gene,0.8936,30721208
25772,aflibercept,gene,0.962,30721208
25773,nAMD,disease,1.0,30721208
25774,VEGF,gene,0.607,30721208
25775,VEGF,gene,0.9883,30721208
25776,VEGF,gene,0.9478,30721202
25777,age-related macular degeneration,disease,1.0,30721202
25778,aflibercept,gene,0.9854,30721202
25779,neovascular age-related macular degeneration,disease,1.0,30721202
25780,nAMD,disease,1.0,30721202
25781,nAMD,disease,1.0,30721202
25782,nAMD,disease,1.0,30721202
25783,ranibizumab,gene,0.89,30721202
25784,aflibercept,gene,0.9683,30721202
25785,subretinal,disease,0.901,30721202
25786,SRF,disease,0.9673,30721202
25787,pigment epithelium detachment,disease,1.0,30721202
25788,PED,disease,1.0,30721202
25789,intraretinal fluid,disease,0.9453,30721202
25790,IRF,disease,0.825,30721202
25791,aflibercept,gene,0.985,30721202
25792,BCVA,DNA,0.5454,30721202
25793,Aflibercept,gene,0.7666,30721202
25794,nAMD,disease,1.0,30721202
25795,aflibercept,gene,0.9893,30720091
25796,fluoropyrimidine,drug,0.962,30720091
25797,metastatic colorectal cancer,disease,1.0,30720091
25798,Aflibercept,gene,0.9795,30720091
25799,5fluorouracil,drug,0.9995,30720091
25800,5FU,drug,0.999,30720091
25801,irinotecan,drug,0.9976,30720091
25802,metastatic colorectal cancer,disease,0.9995,30720091
25803,mCRC,disease,0.9985,30720091
25804,aflibercept,gene,0.986,30720091
25805,FOLFOX,drug,0.543,30720091
25806,fluoropyrimidine,drug,0.9863,30720091
25807,mCRC,disease,0.9805,30720091
25808,5FU,drug,0.9985,30720091
25809,folinic acid,drug,0.999,30720091
25810,oxaliplatin,drug,1.0,30720091
25811,aflibercept,gene,0.9746,30720091
25812,fluoropyrimidine,drug,0.989,30720091
25813,aflibercept,gene,0.917,30720091
25814,oxaliplatin,drug,0.9995,30720091
25815,hypertension,disease,1.0,30720091
25816,fatigue,disease,0.9995,30720091
25817,neutropenia,disease,1.0,30720091
25818,neuropathy,disease,1.0,30720091
25819,stomatitis,disease,1.0,30720091
25820,stroke,disease,1.0,30720091
25821,pulmonary embolism,disease,1.0,30720091
25822,neutropenic sepsis,disease,1.0,30720091
25823,aflibercept,gene,0.9805,30720091
25824,oxaliplatin,drug,0.9995,30720091
25825,mCRC,disease,0.9746,30720091
25826,hypertension,disease,0.9966,30720091
25827,Ziv-aflibercept,gene,0.986,30705040
25828,bevacizumab,gene,0.5967,30705040
25829,diabetic,disease,1.0,30705040
25830,ziv-aflibercept,gene,0.9946,30705040
25831,bevacizumab,gene,0.5103,30705040
25832,patients,species,0.988,30705040
25833,proliferative diabetic retinopathy,disease,0.9995,30705040
25834,PDR,disease,1.0,30705040
25835,patients,species,0.931,30705040
25836,PDR,disease,0.995,30705040
25837,tractional retinal detachment,disease,1.0,30705040
25838,TRD,disease,1.0,30705040
25839,vitreous haemorrhaging,disease,1.0,30705040
25840,TRD,disease,1.0,30705040
25841,vitreous haemorrhage,disease,1.0,30705040
25842,PDR,disease,0.996,30705040
25843,FOLFIRI,drug,0.946,30690930
25844,aflibercept,gene,0.9956,30690930
25845,metastatic PURPOSE,disease,0.9043,30690930
25846,FOLFIRI,drug,0.984,30690930
25847,aflibercept,gene,0.994,30690930
25848,patients,species,0.9487,30690930
25849,metastatic colorectal cancer,disease,1.0,30690930
25850,oxaliplatin,drug,0.9995,30690930
25851,bevacizumab,gene,0.77,30690930
25852,FOLFIRI,drug,0.8066,30690930
25853,aflibercept,gene,0.9966,30690930
25854,PATIENTS,species,0.9272,30690930
25855,patients,species,0.9688,30690930
25856,FOLFIRI,drug,0.6514,30690930
25857,aflibercept,gene,0.971,30690930
25858,Patients,species,0.99,30690930
25859,tumours,disease,1.0,30690930
25860,RAS,gene,0.998,30690930
25861,EGFR,gene,0.9746,30690930
25862,tumours,disease,0.79,30690930
25863,RAS,gene,0.9976,30690930
25864,tumour,disease,0.996,30690930
25865,neutropenia,disease,1.0,30690930
25866,asthenia,disease,1.0,30690930
25867,diarrhea,disease,1.0,30690930
25868,mucositis,disease,1.0,30690930
25869,Dysphonia,disease,1.0,30690930
25870,patients,species,0.9614,30690930
25871,grade,disease,0.784,30690930
25872,hypertension,disease,0.959,30690930
25873,hypertension,disease,0.9995,30690930
25874,FOLFIRI,drug,0.723,30690930
25875,aflibercept,gene,0.995,30690930
25876,primary,disease,0.993,30690930
25877,tumour,disease,0.6323,30690930
25878,RAS,DNA,0.584,30690930
25879,RAS-mutant,gene,0.875,30690930
25880,primary,disease,0.9053,30690930
25881,tumour,disease,0.663,30690930
25882,Hypertension,disease,0.999,30690930
25883,patient,species,0.955,30690930
25884,myopic macular degeneration,disease,1.0,30690902
25885,myopic macular degeneration,disease,1.0,30690902
25886,MMD,disease,1.0,30690902
25887,aflibercept,gene,0.9805,30690902
25888,patients,species,0.969,30690902
25889,myopic choroidal neovascularization,disease,1.0,30690902
25890,CNV,disease,1.0,30690902
25891,patients,species,0.9814,30690902
25892,myopic CNV,disease,1.0,30690902
25893,MMD,disease,0.999,30690902
25894,MMD,disease,1.0,30690902
25895,MMD,disease,1.0,30690902
25896,MMD,disease,1.0,30690902
25897,patients,species,0.9746,30690902
25898,MMD,disease,1.0,30690902
25899,MMD,disease,1.0,30690902
25900,MMD,disease,1.0,30690902
25901,patients,species,0.969,30690902
25902,MMD,disease,1.0,30690902
25903,metastatic colorectal cancer,disease,0.9863,30690295
25904,Metastatic colorectal cancer,disease,1.0,30690295
25905,mCRC,disease,1.0,30690295
25906,mCRC,disease,0.8745,30690295
25907,RAS,gene,0.996,30690295
25908,BRAF,DNA,0.858,30690295
25909,BRAF,gene,0.994,30690295
25910,bevacizumab,gene,0.7,30690295
25911,aflibercept,gene,0.94,30690295
25912,patients,species,0.9526,30690295
25913,epidermal growth factor receptor,gene,0.998,30690295
25914,EGFR,gene,0.9966,30690295
25915,RAS,gene,0.9897,30690295
25916,patients,species,0.976,30690295
25917,EGFR,gene,0.981,30690295
25918,cetuximab,gene,0.886,30690295
25919,panitumumab,gene,0.8135,30690295
25920,regorafenib,drug,0.9297,30690295
25921,trifluridine,drug,0.8716,30690295
25922,tipiracil,drug,0.9907,30690295
25923,patients,species,0.9746,30690295
25924,HER2,gene,0.9976,30690295
25925,neu,gene,0.9985,30690295
25926,CRC tumours,disease,1.0,30690295
25927,mCRC,disease,0.756,30690295
25928,tumour,disease,1.0,30690295
25929,vascular endothelial growth factor,gene,0.996,30689620
25930,neovascular,cell_type,0.463,30689620
25931,neovascular age-related macular degeneration,disease,0.9004,30689620
25932,neovascular age-related macular degeneration,disease,1.0,30689620
25933,aflibercept,gene,0.9526,30689620
25934,Diabetic Retinopathy,disease,1.0,30689620
25935,LOR,DNA,0.6016,30689620
25936,patients,species,0.9727,30689620
25937,neovascular age-related macular degeneration,disease,0.9976,30689620
25938,LOR,DNA,0.6084,30689620
25939,Nepafenac,drug,0.9966,30688558
25940,nepafenac,drug,0.999,30688558
25941,patients,species,0.9844,30688558
25942,Patients,species,0.974,30688558
25943,nepafenac,drug,0.9985,30688558
25944,nepafenac,drug,0.999,30688558
25945,patients,species,0.969,30688558
25946,nepafenac,drug,0.999,30688558
25947,nepafenac,drug,0.9995,30688558
25948,nepafenac,drug,0.9995,30688558
25949,nepafenac,drug,0.9985,30688558
25950,nepafenac,drug,0.9995,30688558
25951,nepafenac,drug,0.999,30688558
25952,exudative age-related macular degeneration,disease,0.9795,30680768
25953,aflibercept,gene,0.9766,30680768
25954,pranoprofen,drug,0.9917,30680768
25955,aflibercept,gene,0.899,30680768
25956,pranoprofen,drug,0.997,30680768
25957,choroidal neovascularization,disease,1.0,30680768
25958,CNV,disease,1.0,30680768
25959,age-related macular degeneration,disease,1.0,30680768
25960,CNV,disease,0.9985,30680768
25961,aflibercept,gene,0.9824,30680768
25962,aflibercept,gene,0.984,30680768
25963,pranoprofen,drug,0.992,30680768
25964,aflibercept,gene,0.956,30680768
25965,omega-3,drug,0.9927,30680768
25966,CRT,DNA,0.6045,30680768
25967,omega-3,drug,0.8574,30680768
25968,neovascular age-related macular degeneration,disease,1.0,30679743
25969,nAMD,disease,1.0,30679743
25970,vascular endothelial growth factor,gene,0.9673,30679743
25971,nAMD,disease,1.0,30679743
25972,ranibizumab,gene,0.8213,30679743
25973,aflibercept,gene,0.9614,30679743
25974,intraretinal cysts,disease,1.0,30679743
25975,IRCs,disease,1.0,30679743
25976,subretinal fluid,disease,0.9766,30679743
25977,SRF,disease,0.9814,30679743
25978,pigment epithelial detachment,disease,1.0,30679743
25979,PED,disease,1.0,30679743
25980,PED,disease,0.999,30679743
25981,IRCs,cell_type,0.6094,30679743
25982,PED,DNA,0.524,30679743
25983,IRCs,cell_type,0.7344,30679743
25984,IRCs,cell_type,0.698,30679743
25985,IRCs,cell_type,0.462,30679743
25986,PED,disease,0.984,30679743
25987,nAMD,disease,1.0,30679743
25988,IRCs,cell_type,0.8433,30679743
25989,SRF,cell_line,0.5996,30679743
25990,PED,disease,0.976,30679743
25991,VEGF,gene,0.876,30679743
25992,anti-,gene,0.8433,30676635
25993,VEGF,gene,0.7163,30676635
25994,diabetic macular edema,disease,1.0,30676635
25995,DME,disease,1.0,30676635
25996,DME,disease,1.0,30676635
25997,anti-VEGF,gene,0.838,30676635
25998,PARTICIPANTS,species,0.637,30676635
25999,Diabetic Retinopathy,disease,1.0,30676635
26000,participants,species,0.976,30676635
26001,DME,disease,1.0,30676635
26002,vision impairment,disease,1.0,30676635
26003,aflibercept,gene,0.989,30676635
26004,bevacizumab,gene,0.7505,30676635
26005,ranibizumab,gene,0.7695,30676635
26006,participants,species,0.9766,30676635
26007,anti-VEGF,gene,0.9214,30676635
26008,participant,species,0.883,30676635
26009,hemoglobin A1c,gene,0.9976,30676635
26010,nonproliferative diabetic retinopathy,disease,1.0,30676635
26011,PRP,cell_type,0.5923,30676635
26012,participants,species,0.963,30676635
26013,participants,species,0.977,30676635
26014,subretinal fluid,disease,0.9844,30676635
26015,predictive,DNA,0.4878,30676635
26016,hemoglobin A1c,gene,0.991,30676635
26017,VEGF,gene,0.7866,30676635
26018,persons,species,0.9224,30676635
26019,diabetes,disease,1.0,30676635
26020,patients,species,0.987,30676635
26021,PRP,cell_type,0.5874,30676635
26022,patients,species,0.992,30676635
26023,PRP,cell_type,0.6,30676635
26024,Ranibizumab,gene,0.9272,30676617
26025,Aflibercept,gene,0.978,30676617
26026,ranibizumab,gene,0.9126,30676617
26027,aflibercept,gene,0.9805,30676617
26028,neovascular age-related macular degeneration,disease,1.0,30676617
26029,nAMD,disease,1.0,30676617
26030,PARTICIPANTS,species,0.719,30676617
26031,Ranibizumab,gene,0.848,30676617
26032,Aflibercept,gene,0.9707,30676617
26033,Geographic Atrophy,disease,1.0,30676617
26034,(Wet) AMD,disease,0.9844,30676617
26035,Patients,species,0.9937,30676617
26036,participants,species,0.9775,30676617
26037,choroidal neovascularization,disease,1.0,30676617
26038,nAMD,disease,1.0,30676617
26039,Participants,species,0.925,30676617
26040,ranibizumab,gene,0.8555,30676617
26041,aflibercept,gene,0.9697,30676617
26042,participants,species,0.9707,30676617
26043,participants,species,0.9824,30676617
26044,women,species,0.899,30676617
26045,ranibizumab,gene,0.7837,30676617
26046,aflibercept,gene,0.9893,30676617
26047,ranibizumab,gene,0.5234,30676617
26048,participants,species,0.9883,30676617
26049,aflibercept,gene,0.9585,30676617
26050,participants,species,0.987,30676617
26051,BCVA,DNA,0.4868,30676617
26052,BCVA,DNA,0.5645,30676617
26053,ranibizumab,gene,0.544,30676617
26054,aflibercept,gene,0.9355,30676617
26055,ranibizumab,drug,0.7095,30676617
26056,aflibercept,gene,0.9785,30676617
26057,aflibercept,gene,0.9937,30676617
26058,ranibizumab,gene,0.8833,30676617
26059,nAMD,disease,1.0,30676617
26060,Myopic Choroidal Neovascularization,disease,1.0,30674251
26061,Myopic choroidal neovascularization,disease,1.0,30674251
26062,CNV,disease,1.0,30674251
26063,visual loss,disease,0.997,30674251
26064,high myopia,disease,0.9937,30674251
26065,CNV,disease,1.0,30674251
26066,myopic CNV,disease,1.0,30674251
26067,vascular,DNA,0.484,30674251
26068,vascular endothelial growth factor,gene,0.996,30674251
26069,VEGF,gene,0.6245,30674251
26070,VEGF,gene,0.923,30674251
26071,aflibercept,gene,0.9736,30674251
26072,bevacizumab,gene,0.9204,30674251
26073,ranibizumab,gene,0.697,30674251
26074,chorioretinal atrophy,disease,1.0,30674251
26075,VEGF,gene,0.5933,30674251
26076,myopic CNV,disease,1.0,30674251
26077,Aflibercept,gene,0.9546,30664844
26078,Ranibizumab,gene,0.8667,30664844
26079,Neovascular Age-Related Macular Degeneration,disease,1.0,30664844
26080,neovascular age-related macular degeneration,disease,1.0,30664844
26081,aflibercept,gene,0.992,30664844
26082,ranibizumab,gene,0.7695,30664844
26083,Rq4,DNA,0.88,30664844
26084,2q4,DNA,0.7803,30664844
26085,2q8,DNA,0.811,30664844
26086,choroidal neovascularization,disease,1.0,30664844
26087,CNV,disease,1.0,30664844
26088,CNV,disease,1.0,30664844
26089,ranibizumab,gene,0.687,30664844
26090,Mineralocorticoid receptor,gene,0.991,30664640
26091,neovascular age-related macular degeneration,disease,0.992,30664640
26092,Choroidal neovascularization,disease,1.0,30664640
26093,CNV,disease,1.0,30664640
26094,visual impairment,disease,0.9976,30664640
26095,age-related macular degeneration,disease,0.9995,30664640
26096,AMD,disease,1.0,30664640
26097,anti-VEGF,gene,0.8516,30664640
26098,mineralocorticoid receptor,gene,0.997,30664640
26099,MR,gene,0.9775,30664640
26100,spironolactone,drug,0.9907,30664640
26101,CNV,disease,0.9995,30664640
26102,anti-VEGF,gene,0.682,30664640
26103,wet AMD,disease,0.9995,30664640
26104,MR,gene,0.9766,30664640
26105,MR,gene,0.985,30664640
26106,VEGF,gene,0.9893,30664640
26107,decorin,gene,0.861,30664640
26108,spironolactone,drug,0.9995,30664640
26109,CNV,disease,0.9136,30664640
26110,MR,gene,0.988,30664640
26111,wet AMD,disease,0.9927,30664640
26112,VEGF,gene,0.9023,30664640
26113,DIABETIC RETINOPATHY,disease,1.0,30664126
26114,fluorescein,drug,0.9897,30664126
26115,diabetic retinopathy,disease,1.0,30664126
26116,anti-vascular endothelial growth factor,gene,0.9717,30664126
26117,patients,species,0.9834,30664126
26118,anti-VEGF,gene,0.8955,30664126
26119,microaneurysms,disease,1.0,30664126
26120,hemorrhages,disease,0.9985,30664126
26121,DR,disease,,30664126
26122,non,DNA,0.4639,30664126
26123,diabetic,disease,1.0,30664126
26124,patients,species,0.9814,30664126
26125,anti-vascular endothelial growth factor,gene,0.94,30664126
26126,fluorescein,drug,0.9956,30664126
26127,age-related macular degeneration,disease,1.0,30660630
26128,central vision loss,disease,0.984,30660630
26129,age-related macular degeneration,disease,1.0,30660630
26130,AMD,disease,1.0,30660630
26131,AMD,disease,0.999,30660630
26132,anti-VEGF antibody,gene,0.988,30660630
26133,ranibizumab,gene,0.6562,30660630
26134,aflibercept,gene,0.9683,30660630
26135,Eylea,gene,0.5093,30660630
26136,"poly(D,L-lactic co glycolic acid)",drug,0.998,30660630
26137,PLGA,drug,0.995,30660630
26138,AMD,disease,0.9995,30660630
26139,AMD,disease,0.9995,30660630
26140,aflibercept,gene,0.979,30657223
26141,FOLFIRI,drug,0.905,30657223
26142,metastatic colorectal cancer,disease,0.999,30657223
26143,Aflibercept,gene,0.9204,30657223
26144,vascular endothelial growth factor,gene,0.998,30657223
26145,aflibercept,gene,0.9814,30657223
26146,5-fluorouracil,drug,0.999,30657223
26147,levofolinate,drug,0.997,30657223
26148,irinotecan,drug,0.9985,30657223
26149,FOLFIRI,drug,0.8706,30657223
26150,metastatic colorectal cancer,disease,1.0,30657223
26151,mCRC,disease,1.0,30657223
26152,Aflibercept,gene,0.9404,30657223
26153,FOLFIRI,drug,0.7563,30657223
26154,mCRC,disease,0.973,30657223
26155,Tumors,disease,0.667,30657223
26156,aflibercept,gene,0.9814,30657223
26157,irinotecan,drug,0.997,30657223
26158,5-fluorouracil,drug,0.9995,30657223
26159,bevacizumab,gene,0.8677,30657223
26160,neutropenia,disease,1.0,30657223
26161,aflibercept,gene,0.992,30657223
26162,aflibercept,gene,0.9863,30657223
26163,vascular endothelial growth factor,gene,0.998,30657223
26164,Aflibercept,gene,0.9805,30657223
26165,irinotecan,drug,0.996,30657223
26166,5-fluorouracil,drug,0.999,30657223
26167,irinotecan,drug,0.9985,30657223
26168,5-fluorouracil,drug,0.9985,30657223
26169,aflibercept,gene,0.9907,30657223
26170,FOLFIRI,drug,0.9126,30657223
26171,mCRC,disease,0.973,30657223
26172,Diabetic Macular,disease,1.0,30654365
26173,Edema,disease,0.9995,30654365
26174,diabetic macular edema,disease,1.0,30654365
26175,DME,disease,1.0,30654365
26176,vascular endothelial growth factor,gene,0.875,30654365
26177,VEGF,gene,0.992,30654365
26178,ranibizumab,gene,0.867,30654365
26179,aflibercept,gene,0.9795,30654365
26180,anti-VEGF,gene,0.9336,30654365
26181,ranibizumab,gene,0.89,30654365
26182,aflibercept,gene,0.9497,30654365
26183,DME,disease,1.0,30654365
26184,VEGF,gene,0.526,30654365
26185,Cancer,disease,1.0,30649744
26186,Gastrointestinal Malignancies,disease,1.0,30649744
26187,tumor,disease,1.0,30649744
26188,tumors,disease,1.0,30649744
26189,metastatic,disease,0.914,30649744
26190,gastrointestinal cancers,disease,0.9517,30649744
26191,Bevacizumab,gene,0.9043,30649744
26192,aflibercept,gene,0.98,30649744
26193,regorafenib,drug,0.9673,30649744
26194,metastatic colorectal cancer,disease,0.9995,30649744
26195,apatinib,drug,0.977,30649744
26196,metastatic gastric cancer,disease,1.0,30649744
26197,subclonal populations,cell_line,0.554,30649744
26198,gastrointestinal cancers,disease,1.0,30649744
26199,secretogranin III,gene,0.9795,30644010
26200,oxygen,drug,1.0,30644010
26201,retinopathy,disease,0.8965,30644010
26202,Retinopathy of prematurity,disease,1.0,30644010
26203,ROP,disease,1.0,30644010
26204,blindness,disease,0.999,30644010
26205,children,species,0.9175,30644010
26206,ROP,disease,1.0,30644010
26207,ROP,disease,0.998,30644010
26208,Secretogranin III,gene,0.994,30644010
26209,Scg3,gene,0.9917,30644010
26210,Scg3-neutralizing monoclonal antibody,gene,0.922,30644010
26211,oxygen,drug,0.9995,30644010
26212,OIR,disease,1.0,30644010
26213,mice,species,0.9634,30644010
26214,ROP,disease,1.0,30644010
26215,anti-Scg3 mAb,gene,0.986,30644010
26216,OIR,disease,0.9995,30644010
26217,mice,species,0.9805,30644010
26218,mice,species,0.9614,30644010
26219,Scg3-neutralizing mAb,gene,0.965,30644010
26220,Scg3,gene,0.588,30644010
26221,mice,species,0.9834,30644010
26222,anti-Scg3 mAb,gene,0.9717,30644010
26223,anti-Scg3 mAb,gene,0.9766,30644010
26224,renal tubular injury,disease,0.9927,30644010
26225,abnormality in,disease,0.9907,30644010
26226,mice,species,0.9224,30644010
26227,vascular endothelial growth factor,gene,0.994,30644010
26228,aflibercept,gene,0.874,30644010
26229,mice,species,0.952,30644010
26230,anti-Scg3 mAb,gene,0.988,30644010
26231,ROP,disease,1.0,30644010
26232,aflibercept,gene,0.985,30643966
26233,ranibizumab,gene,0.912,30643966
26234,chorioretinal atrophy,disease,1.0,30643966
26235,CRA,disease,1.0,30643966
26236,myopic choroidal neovascularization,disease,1.0,30643966
26237,mCNV,disease,1.0,30643966
26238,ranibizumab,gene,0.7188,30643966
26239,aflibercept,gene,0.9663,30643966
26240,mCNV,disease,1.0,30643966
26241,patients,species,0.987,30643966
26242,mCNV,disease,1.0,30643966
26243,CRA,disease,1.0,30643966
26244,CRA,disease,1.0,30643966
26245,CRA,disease,1.0,30643966
26246,CRA,disease,1.0,30643966
26247,aflibercept,gene,0.9854,30643966
26248,ranibizumab,gene,0.652,30643966
26249,aflibercept,gene,0.9805,30643966
26250,ranibizumab,drug,0.5527,30643966
26251,CRA,disease,0.9995,30643966
26252,IVA,drug,0.732,30643966
26253,mCNV,disease,0.9995,30643966
26254,CRA,disease,0.999,30643966
26255,CRA,disease,1.0,30643966
26256,CNV,DNA,0.5767,30643966
26257,CRA,disease,1.0,30643966
26258,vascular endothelial growth factor,gene,0.918,30643966
26259,mCNV,disease,0.9976,30643966
26260,VEGF,gene,0.992,30642877
26261,Nephrotoxicities,disease,1.0,30642877
26262,vascular endothelial growth factor A,gene,0.9995,30642877
26263,VEGFA,gene,0.999,30642877
26264,vascular endothelial growth factor receptor 2,gene,0.9995,30642877
26265,VEGFR2,gene,0.998,30642877
26266,nephrotoxicities,disease,0.97,30642877
26267,VEGF,gene,0.9956,30642877
26268,MAPK,gene,0.9814,30642877
26269,ERK1/2,gene,0.995,30642877
26270,nitric,drug,0.9873,30642877
26271,oxide,drug,0.7017,30642877
26272,mammalian target of rapamycin,gene,0.98,30642877
26273,rapamycin,drug,0.9927,30642877
26274,mTOR,gene,0.9937,30642877
26275,VEGFA,gene,0.9966,30642877
26276,VEGF,gene,0.9937,30642877
26277,thrombotic microangiopathy,disease,0.998,30642877
26278,TMA,disease,1.0,30642877
26279,tyrosine,drug,0.8765,30642877
26280,tyrosine kinase,gene,0.9946,30642877
26281,VEGF receptors,gene,0.995,30642877
26282,glomerulopathies,disease,1.0,30642877
26283,minimal change disease,disease,1.0,30642877
26284,FSGS,disease,1.0,30642877
26285,RAF,gene,0.9985,30642877
26286,MAPK,gene,0.9834,30642877
26287,ERK,gene,0.9956,30642877
26288,tubulointerstitial injury,disease,1.0,30642877
26289,mTOR,gene,0.9854,30642877
26290,albuminuria,disease,0.9995,30642877
26291,podocyte,cell_type,0.5825,30642877
26292,renal-specific TMA,disease,0.9907,30642877
26293,VEGFA,gene,0.992,30642877
26294,VEGFR2,gene,0.998,30642877
26295,peripapillary choroidal neovascularisation,disease,1.0,30642868
26296,Peripapillary choroidal neovascularisation,disease,1.0,30642868
26297,PPCNV,disease,1.0,30642868
26298,optic disc drusen,disease,1.0,30642868
26299,vision impairment,disease,0.8965,30642868
26300,children,species,0.989,30642868
26301,PPCNV,disease,1.0,30642868
26302,optic disc drusen,disease,1.0,30642868
26303,aflibercept,gene,0.9653,30642868
26304,girl,species,0.8184,30642868
26305,reduced vision,disease,0.9834,30642868
26306,peripapillary pigmentary lesion,disease,0.9995,30642868
26307,optic,disease,0.8647,30642868
26308,PPCNV,disease,1.0,30642868
26309,fluorescein,drug,0.983,30642868
26310,child,species,0.7715,30642868
26311,aflibercept,gene,0.9844,30642868
26312,anti-vascular endothelial growth factors,gene,0.999,30642195
26313,anti-vascular endothelial growth factors,gene,0.999,30642195
26314,polypropylene,drug,0.998,30642195
26315,silicone,drug,0.634,30642195
26316,silicone,drug,0.9556,30642195
26317,bevacizumab,gene,0.8564,30642195
26318,insulin,gene,0.9976,30642195
26319,silicone,drug,0.584,30642195
26320,Silicone,drug,0.5044,30642195
26321,insulin,gene,0.993,30642195
26322,vascular endothelial growth factors,gene,0.9775,30642195
26323,insulin,gene,0.943,30642195
26324,anti-vascular endothelial growth factor,gene,0.8438,30642195
26325,cancer,disease,1.0,30636586
26326,cancers,disease,1.0,30636586
26327,VEGF,gene,0.996,30636586
26328,tumors,disease,1.0,30636586
26329,VEGF,gene,0.9937,30636586
26330,bevacizumab,gene,0.8784,30636586
26331,aflibercept,gene,0.9844,30636586
26332,sunitinib,drug,0.991,30636586
26333,tumors,disease,1.0,30636586
26334,VEGF,gene,0.9956,30636586
26335,tumor,disease,0.9995,30636586
26336,gastrointestinal cancers,disease,1.0,30636586
26337,Secretogranin III,gene,0.995,30633921
26338,choroidal Wet age-related macular degeneration,disease,1.0,30633921
26339,AMD,disease,1.0,30633921
26340,choroidal neovascularization,disease,1.0,30633921
26341,CNV,disease,1.0,30633921
26342,vision loss,disease,0.998,30633921
26343,vascular endothelial growth factor,gene,0.936,30633921
26344,VEGF,gene,0.997,30633921
26345,wet AMD,disease,0.833,30633921
26346,Secretogranin III,gene,0.994,30633921
26347,Scg3,gene,0.9946,30633921
26348,SgIII,gene,0.9893,30633921
26349,VEGF,gene,0.9976,30633921
26350,Scg3-neutralizing monoclonal antibody,gene,0.6533,30633921
26351,oxygen,drug,0.9995,30633921
26352,retinopathy,disease,0.8677,30633921
26353,mice,species,0.964,30633921
26354,retinal vascular leakage,disease,0.972,30633921
26355,diabetic,disease,1.0,30633921
26356,mice,species,0.9404,30633921
26357,Scg3,gene,0.9805,30633921
26358,CNV,disease,1.0,30633921
26359,mouse,species,0.864,30633921
26360,anti-Scg3 ML49,gene,0.981,30633921
26361,Scg3,gene,0.9883,30633921
26362,Src,gene,0.995,30633921
26363,human retinal microvascular endothelial cells,cell_line,0.9116,30633921
26364,human,species,0.9556,30633921
26365,Scg3-neutralizing polyclonal antibodies,gene,0.8955,30633921
26366,CNV,disease,0.8687,30633921
26367,Scg3,gene,0.9966,30633921
26368,CNV,disease,0.972,30633921
26369,anti-Scg3 pAb,gene,0.988,30633921
26370,VEGF,gene,0.9946,30633921
26371,aflibercept,gene,0.9526,30633921
26372,Scg3,gene,0.9956,30633921
26373,CNV,disease,0.9976,30633921
26374,anti-Scg3 mAb,gene,0.938,30633921
26375,CNV,disease,0.7427,30633921
26376,Adalimumab,gene,0.9272,30629105
26377,ranibizumab,gene,0.8213,30629105
26378,aflibercept,gene,0.965,30629105
26379,adalimumab,gene,0.933,30629105
26380,ranibizumab,gene,0.8687,30629105
26381,aflibercept,gene,0.9766,30629105
26382,PARTICIPANTS,species,0.5107,30629105
26383,human,species,0.9956,30629105
26384,participants,species,0.9688,30629105
26385,adalimumab,gene,0.9585,30629105
26386,ranibizumab,gene,0.9575,30629105
26387,aflibercept,gene,0.9863,30629105
26388,adalimumab,gene,0.877,30629105
26389,ranibizumab,gene,0.541,30629105
26390,aflibercept,gene,0.9736,30629105
26391,adalimumab,gene,0.8657,30629105
26392,ranibizumab,gene,0.643,30629105
26393,aflibercept,gene,0.965,30629105
26394,adalimumab,gene,0.88,30629105
26395,ranibizumab,gene,0.82,30629105
26396,aflibercept,gene,0.9775,30629105
26397,adalimumab,gene,0.964,30629105
26398,ranibizumab,gene,0.9043,30629105
26399,aflibercept,gene,0.956,30629105
26400,Colorectal Carcinoma,disease,1.0,30617958
26401,colorectal cancer,disease,1.0,30617958
26402,vascular endothelial growth factor family proteins,gene,0.9966,30617958
26403,endothelial cell,cell_type,0.8633,30617958
26404,colorectal cancer,disease,1.0,30617958
26405,Bevacizumab,gene,0.923,30617958
26406,aflibercept,gene,0.968,30617958
26407,bevacizumab,gene,0.842,30617958
26408,receptor tyrosine kinase,gene,0.976,30617958
26409,tyrosine,drug,0.9272,30617958
26410,miRNA,RNA,0.6733,30615884
26411,human retinal endothelial cells,cell_line,0.866,30615884
26412,Human retinal microvascular endothelial cells,cell_type,0.848,30615884
26413,HRMVECs,cell_line,0.7485,30615884
26414,retinopathy of prematurity,disease,1.0,30615884
26415,microRNA,RNA,0.765,30615884
26416,miRNA,RNA,0.5303,30615884
26417,HRMVECs,cell_line,0.637,30615884
26418,VEGF,gene,0.9927,30615884
26419,VEGF,gene,0.967,30615884
26420,miRNA,RNA,0.688,30615884
26421,HRMVECs,cell_line,0.6113,30615884
26422,VEGF,gene,0.9946,30615884
26423,aflibercept,gene,0.985,30615884
26424,bevacizumab,gene,0.736,30615884
26425,ranibizumab,gene,0.569,30615884
26426,small non-coding RNAs,RNA,0.7285,30615884
26427,miRNAs,RNA,0.596,30615884
26428,miRNAs,RNA,0.5327,30615884
26429,miRNAs,RNA,0.7124,30615884
26430,miRNAs,RNA,0.6636,30615884
26431,miR-139-5p/-3p,gene,0.545,30615884
26432,miR-335-5p/-3p,gene,0.5625,30615884
26433,miRNAs,RNA,0.776,30615884
26434,HRMVEC,cell_line,0.666,30615884
26435,miRNome,DNA,0.5146,30615884
26436,miRNome,DNA,0.5483,30615884
26437,miR,DNA,0.6216,30615884
26438,miR-21-,gene,0.975,30615884
26439,miR-29a-3p,gene,0.6094,30615884
26440,miR-100-5p,gene,0.5605,30615884
26441,miR-126-5p/-3p,gene,0.5884,30615884
26442,miRNAs,RNA,0.543,30615884
26443,miRNAs,RNA,0.669,30615884
26444,anti-VEGF,gene,0.788,30615884
26445,miRNA,RNA,0.574,30615884
26446,HRMVECs,cell_line,0.7324,30615884
26447,miRNAs,RNA,0.721,30615884
26448,angioproliferative retinal diseases,disease,1.0,30615884
26449,miRNA,RNA,0.4873,30615884
26450,diabetic retinopathy,disease,1.0,30615884
26451,retinopathy of prematurity,disease,1.0,30615884
26452,Ischaemic colitis,disease,1.0,30610744
26453,aflibercept,gene,0.9727,30610744
26454,age-related macular degeneration,disease,1.0,30610744
26455,AMD,disease,1.0,30610744
26456,antivascular endothelial growth factor,gene,0.9683,30610744
26457,choroidal neovascularization,disease,1.0,30610744
26458,ischaemic colitis,disease,1.0,30610744
26459,VEGF,gene,0.936,30610744
26460,aflibercept,gene,0.982,30610744
26461,VEGF,gene,0.856,30610744
26462,VEGF,gene,0.6626,30610744
26463,ischaemic colitis,disease,1.0,30610744
26464,aflibercept,gene,0.9893,30610744
26465,VEGF,gene,0.7827,30610744
26466,VEGF,gene,0.787,30610744
26467,AMD,disease,1.0,30610744
26468,VEGF,gene,0.9727,30610744
26469,perforating collagenosis,disease,1.0,30607312
26470,ranibizumab,gene,0.8784,30607312
26471,aflibercept,gene,0.977,30607312
26472,acquired reactive perforating collagenosis,disease,1.0,30607312
26473,ARPC,disease,1.0,30607312
26474,ranibizumab,gene,0.9175,30607312
26475,aflibercept,gene,0.9883,30607312
26476,AFL,gene,0.991,30607312
26477,choroidal neovascular membrane,disease,1.0,30607312
26478,ranibizumab,gene,0.7407,30607312
26479,ranibizumab,gene,0.7524,30607312
26480,excessively pruriginous eruption,disease,0.8105,30607312
26481,ARPC,disease,1.0,30607312
26482,AFL,drug,0.85,30607312
26483,AFL,drug,0.7,30607312
26484,perforating collagenosis,disease,0.997,30607312
26485,choroidal neovascular membrane,disease,0.865,30607312
26486,ARPC,disease,0.963,30607312
26487,ranibizumab,gene,0.7383,30607312
26488,skin lesions,disease,0.9995,30607312
26489,choroidal neovascular membrane,disease,0.9995,30607312
26490,AFL,drug,0.9736,30607312
26491,retinal diseases,disease,1.0,30598037
26492,age-related macular degeneration,disease,1.0,30598037
26493,anterior and posterior segments,DNA,0.491,30598037
26494,macular edema,disease,1.0,30593547
26495,vascular endothelial growth factor,gene,0.867,30593547
26496,VEGF,gene,0.9966,30593547
26497,macular oedema,disease,1.0,30593547
26498,ME,disease,1.0,30593547
26499,central retinal vein occlusion,disease,1.0,30593547
26500,CRVO,disease,1.0,30593547
26501,PARTICIPANTS,species,0.719,30593547
26502,Patients,species,0.9507,30593547
26503,anti-VEGF,gene,0.8975,30593547
26504,ME,disease,,30593547
26505,CRVO,disease,1.0,30593547
26506,patients,species,0.9883,30593547
26507,cataracts,disease,1.0,30593547
26508,vitreous haemorrhage,disease,1.0,30593547
26509,VH,disease,1.0,30593547
26510,retinal tear,disease,1.0,30593547
26511,ADDIS,DNA,0.4365,30593547
26512,patients,species,0.9697,30593547
26513,patients,species,0.987,30593547
26514,aflibercept,gene,0.9766,30593547
26515,patients,species,0.9854,30593547
26516,ranibizumab,drug,0.6914,30593547
26517,dexamethasone,drug,0.9624,30593547
26518,Aflibercept,gene,0.988,30593547
26519,bevacizumab,gene,0.8906,30593547
26520,ranibizumab,gene,0.6333,30593547
26521,ranibizumab,gene,0.4998,30593547
26522,dexamethasone,drug,0.954,30593547
26523,Dexamethasone,drug,0.997,30593547
26524,aflibercept,gene,0.9297,30593547
26525,ranibizumab,gene,0.5,30593547
26526,Ranibizumab,gene,0.831,30593547
26527,cataracts,disease,0.9995,30593547
26528,dexamethasone,drug,0.9946,30593547
26529,Aflibercept,gene,0.973,30593547
26530,VH,disease,,30593547
26531,retinal tear,disease,0.9995,30593547
26532,Aflibercept,gene,0.97,30593547
26533,VEGF,gene,0.97,30593547
26534,ME,disease,,30593547
26535,CRVO,disease,1.0,30593547
26536,Aflibercept,gene,0.968,30593547
26537,ranibizumab,gene,0.637,30593547
26538,Aflibercept,gene,0.9663,30593547
26539,ranibizumab,gene,0.6113,30593547
26540,patient,species,0.9917,30593547
26541,vascular growth factor,gene,0.8267,30591022
26542,VEGF,gene,0.9985,30591022
26543,patients,species,0.941,30591022
26544,diabetic macular edema,disease,1.0,30591022
26545,DME,disease,1.0,30591022
26546,patient,species,0.989,30591022
26547,IPD,DNA,0.785,30591022
26548,aflibercept,gene,0.9907,30591022
26549,ranibizumab,gene,0.6865,30591022
26550,Diabetic Retinopathy,disease,0.996,30591022
26551,patients,species,0.9824,30591022
26552,AFL 2q8,DNA,0.4595,30591022
26553,ranibizumab,gene,0.4846,30591022
26554,ETDRS,DNA,0.4617,30591022
26555,aflibercept,gene,0.982,30589922
26556,bevacizumab,gene,0.53,30589922
26557,macular edema,disease,1.0,30589922
26558,central retinal vein occlusion,disease,1.0,30589922
26559,CRVO,disease,1.0,30589922
26560,hemiretinal vein occlusion,disease,1.0,30589922
26561,HRVO,disease,1.0,30589922
26562,aflibercept,gene,0.981,30589922
26563,bevacizumab,gene,0.5923,30589922
26564,Retinal Vein Occlusion,disease,1.0,30589922
26565,PARTICIPANTS,species,0.618,30589922
26566,Retinal Vein Occlusion,disease,1.0,30589922
26567,Participants,species,0.82,30589922
26568,patients,species,0.982,30589922
26569,patient,species,0.9404,30589922
26570,CRVO- or HRVO-associated macular edema,disease,0.9985,30589922
26571,aflibercept,gene,0.945,30589922
26572,bevacizumab,gene,0.725,30589922
26573,aflibercept,gene,0.932,30589922
26574,dexamethasone,drug,0.972,30589922
26575,bevacizumab,gene,0.8477,30589922
26576,aflibercept,gene,0.955,30589922
26577,aflibercept,gene,0.94,30589922
26578,participants,species,0.9526,30589922
26579,aflibercept,gene,0.892,30589922
26580,women,species,0.967,30589922
26581,Bevacizumab,gene,0.8794,30589922
26582,patients,species,0.9873,30589922
26583,women,species,0.9272,30589922
26584,aflibercept,gene,0.9717,30589922
26585,dexamethasone,drug,0.9194,30589922
26586,bevacizumab,gene,0.8857,30589922
26587,aflibercept,gene,0.9756,30589922
26588,aflibercept,gene,0.958,30589922
26589,bevacizumab,gene,0.8555,30589922
26590,aflibercept,gene,0.9883,30589922
26591,dexamethasone,drug,0.843,30589922
26592,aflibercept,gene,0.989,30587915
26593,bevacizumab,gene,0.878,30587915
26594,wet,disease,0.8687,30587915
26595,age-related macular degeneration,disease,0.9556,30587915
26596,bevacizumab,gene,0.971,30587915
26597,aflibercept,gene,0.9824,30587915
26598,wet age-related macular degeneration,disease,1.0,30587915
26599,wAMD,disease,1.0,30587915
26600,wAMD,disease,0.9995,30587915
26601,bevacizumab,gene,0.814,30587915
26602,aflibercept,gene,0.982,30587915
26603,wAMD,disease,0.999,30587915
26604,bevacizumab,gene,0.958,30587915
26605,aflibercept,gene,0.994,30587915
26606,aflibercept,gene,0.9907,30587915
26607,aflibercept,gene,0.972,30587915
26608,aflibercept,gene,0.9854,30587915
26609,aflibercept,gene,0.9824,30587915
26610,BCVA,cell_type,0.4238,30587915
26611,aflibercept,gene,0.9688,30587915
26612,aflibercept,gene,0.9404,30587915
26613,Neovascular Age-related Macular Degeneration,disease,1.0,30585922
26614,anti-VEGFs,gene,0.74,30578008
26615,neovascular age-related macular degeneration,disease,0.9995,30578008
26616,vascular endothelial growth factor,gene,0.8843,30578008
26617,anti-VEGF,gene,0.8584,30578008
26618,neovascular age-related macular degeneration,disease,0.9995,30578008
26619,nAMD,disease,1.0,30578008
26620,nAMD,disease,1.0,30578008
26621,ranibizumab,gene,0.9487,30578008
26622,aflibercept,gene,0.9756,30578008
26623,fluorescein,drug,0.998,30578008
26624,aflibercept,gene,0.833,30578008
26625,choroidal neovascularization,disease,1.0,30578008
26626,CNV,disease,1.0,30578008
26627,pigment epithelial detachment,disease,1.0,30578008
26628,PED,disease,1.0,30578008
26629,CNV,DNA,0.741,30578008
26630,PED,DNA,0.4756,30578008
26631,VEGF,gene,0.5083,30578008
26632,nAMD,disease,1.0,30578008
26633,Aflibercept,gene,0.9517,30578008
26634,ranibizumab,gene,0.8335,30578008
26635,corneal neovascularization,disease,1.0,30574927
26636,aflibercept,gene,0.984,30574927
26637,boy,species,0.627,30574927
26638,corneal neovascularization,disease,1.0,30574927
26639,keratopathy,disease,0.664,30574927
26640,cerebellar astrocytoma,disease,1.0,30574927
26641,stromal haze,disease,0.9995,30574927
26642,corneal neovascularization,disease,1.0,30574927
26643,corneal neovascularization,disease,1.0,30574927
26644,aflibercept,gene,0.977,30574927
26645,exudative age-related macular degeneration,disease,0.997,30573498
26646,exudative age-related macular degeneration,disease,1.0,30573498
26647,AMD,disease,1.0,30573498
26648,ranibizumab,gene,0.6016,30573498
26649,aflibercept,gene,0.9644,30573498
26650,exudative AMD,disease,1.0,30573498
26651,ranibizumab,gene,0.9136,30573498
26652,aflibercept,gene,0.977,30573498
26653,exudative AMD,disease,0.9946,30573498
26654,exudative AMD,disease,0.9995,30573498
26655,ranibizumab,gene,0.7485,30573498
26656,aflibercept,gene,0.942,30573498
26657,exudative AMD,disease,0.996,30573498
26658,exudative AMD,disease,0.9946,30573498
26659,aflibercept,gene,0.983,30572850
26660,patients,species,0.963,30572850
26661,neovascular age-related macular degeneration,disease,0.994,30572850
26662,nAMD,disease,1.0,30572850
26663,aflibercept,gene,0.984,30572850
26664,patients,species,0.9785,30572850
26665,nAMD,disease,1.0,30572850
26666,aflibercept,gene,0.985,30572850
26667,patients,species,0.9766,30572850
26668,Diabetic Retinopathy,disease,1.0,30572850
26669,patients,species,0.9775,30572850
26670,patients,species,0.978,30572850
26671,aflibercept,gene,0.9253,30572850
26672,patients,species,0.957,30572850
26673,nAMD,disease,1.0,30572850
26674,aflibercept,gene,0.983,30572850
26675,CNV,disease,1.0,30566698
26676,Anti-VEGF,gene,0.804,30566698
26677,choroidal neovascularization,disease,1.0,30566698
26678,CNV,disease,1.0,30566698
26679,vascular endothelium growth factor,gene,0.9937,30566698
26680,VEGF,gene,0.9966,30566698
26681,PATIENTS,species,0.954,30566698
26682,CNV,disease,0.5977,30566698
26683,CNV,DNA,0.551,30566698
26684,CNV,DNA,0.5757,30566698
26685,CNV,DNA,0.759,30566698
26686,CNV,disease,0.6855,30566698
26687,CNV,disease,0.999,30566698
26688,CNV,disease,1.0,30566698
26689,CNV,DNA,0.803,30566698
26690,CNV,disease,0.9995,30566698
26691,anti-VEGF,gene,0.7505,30566698
26692,aflibercept,gene,0.972,30565585
26693,BRAF,gene,0.7397,30565585
26694,metastatic colon cancer,disease,0.997,30565585
26695,BRAF,gene,0.6074,30565585
26696,colon cancer,disease,0.9854,30565585
26697,nodes,DNA,0.4397,30565585
26698,bevacizumab,gene,0.9316,30565585
26699,aflibercept,gene,0.9727,30565585
26700,BRAF,gene,0.786,30565585
26701,FOLFIRI,drug,0.917,30565584
26702,aflibercept,gene,0.981,30565584
26703,RAS,gene,0.5776,30565584
26704,BRAF,gene,0.997,30565584
26705,left-sided colon cancer,disease,0.9995,30565584
26706,oxaliplatin,drug,0.999,30565584
26707,liver metastases,disease,0.999,30565584
26708,liver,disease,0.6626,30565584
26709,oxaliplatin,drug,1.0,30565584
26710,RAS,gene,0.9863,30565584
26711,BRAF,gene,0.9883,30565584
26712,aflibercept,gene,0.993,30565584
26713,cetuximab,gene,0.9644,30565584
26714,panitumumab,gene,0.9287,30565584
26715,cetuximab,gene,0.886,30565584
26716,FOLFIRI,drug,0.681,30565583
26717,aflibercept,gene,0.982,30565583
26718,RAS,gene,0.49,30565583
26719,BRAF,gene,0.4534,30565583
26720,right-sided colon cancer,disease,0.998,30565583
26721,liver metastases,disease,0.998,30565583
26722,RAS,gene,0.5293,30565583
26723,BRAF,gene,0.9907,30565583
26724,metastatic colorectal cancer,disease,0.8423,30565583
26725,bevacizumab,gene,0.8447,30565583
26726,FOLFIRI,drug,0.81,30565583
26727,aflibercept,gene,0.9688,30565583
26728,aflibercept,gene,0.973,30565583
26729,tumor,disease,0.9487,30565583
26730,metastatic colorectal cancer,disease,0.999,30565582
26731,metastatic colorectal cancer,disease,1.0,30565582
26732,aflibercept,gene,0.989,30565582
26733,FOLFIRI,drug,0.9585,30565582
26734,5-flourouracil,drug,0.999,30565582
26735,leucovorin,drug,0.9976,30565582
26736,irinotecan,drug,0.9985,30565582
26737,oxaliplatin,drug,0.9995,30565582
26738,bevacizumab,gene,0.6636,30565582
26739,aflibercept,gene,0.991,30565582
26740,bevacizumab,gene,0.832,30565582
26741,metastatic colorectal adenocarcinoma,disease,1.0,30565582
26742,RAS,gene,0.7075,30565582
26743,BRAF,gene,0.539,30565582
26744,aflibercept,gene,0.945,30565582
26745,oxaliplatin,drug,1.0,30565582
26746,anti-EGFR antibody,gene,0.8706,30565582
26747,Ziv-Aflibercept,gene,0.9424,30564512
26748,Rabbits,species,0.6763,30564512
26749,ziv-aflibercept,gene,0.9688,30564512
26750,colon cancer,disease,1.0,30564512
26751,ziv-aflibercept,gene,0.969,30564512
26752,rabbits,species,0.9004,30564512
26753,ziv-aflibercept,gene,0.9736,30564512
26754,Glial fibrillary acidic protein,gene,0.998,30564512
26755,GFAP,gene,0.995,30564512
26756,GFAP,gene,0.995,30564512
26757,retinal Mller cells,cell_type,0.868,30564512
26758,ziv-aflibercept,gene,0.985,30564512
26759,ziv-aflibercept,gene,0.995,30564512
26760,Ziv-aflibercept,gene,0.991,30564512
26761,rabbits,species,0.91,30564512
26762,GFAP,gene,0.9844,30564512
26763,ziv-aflibercept,gene,0.9663,30564512
26764,neovascularization,disease,0.904,30564512
26765,macular edema,disease,1.0,30564512
26766,aflibercept,gene,0.9824,30555967
26767,patients,species,0.97,30555967
26768,age-related macular PURPOSE,disease,0.997,30555967
26769,aflibercept,gene,0.9917,30555967
26770,patients,species,0.9263,30555967
26771,age-related macular degeneration,disease,1.0,30555967
26772,AMD,disease,1.0,30555967
26773,bevacizumab,gene,0.8433,30555967
26774,ranibizumab,gene,0.578,30555967
26775,patients,species,0.9834,30555967
26776,bevacizumab,gene,0.7476,30555967
26777,intraretinal and subretinal fluid,disease,0.8345,30555967
26778,IRF,disease,0.843,30555967
26779,SRF,disease,0.611,30555967
26780,bevacizumab,gene,0.8213,30555967
26781,ranibizumab,gene,0.848,30555967
26782,pigment epithelial detachment,disease,0.9995,30555967
26783,PED,disease,0.919,30555967
26784,aflibercept,gene,0.9663,30555967
26785,aflibercept,gene,0.9805,30555967
26786,aflibercept,gene,0.9917,30555967
26787,aflibercept,gene,0.9624,30555967
26788,aflibercept,gene,0.9834,30555967
26789,retinal,disease,0.92,30555967
26790,SRF,disease,0.999,30555967
26791,bevacizumab,gene,0.828,30555967
26792,ranibizumab,gene,0.571,30555967
26793,anti-vascular endothelial growth factor,gene,0.913,30550375
26794,anti-vascular endothelial growth factor,gene,0.8887,30550375
26795,VEGF,gene,0.998,30550375
26796,visual impairment,disease,1.0,30550375
26797,blindness,disease,1.0,30550375
26798,patients,species,0.98,30550375
26799,diabetic macular edema,disease,1.0,30550375
26800,DME,disease,1.0,30550375
26801,patient,species,0.9854,30550375
26802,VEGF,gene,0.86,30550375
26803,VEGF,gene,0.919,30550375
26804,DME,disease,1.0,30550375
26805,patients,species,0.9956,30550375
26806,Diabetic Retinopathy,disease,0.9404,30550375
26807,DME,disease,1.0,30550375
26808,aflibercept,gene,0.988,30550375
26809,ranibizumab,gene,0.7275,30550375
26810,triamcinolone acetonide,drug,0.997,30550375
26811,patients,species,0.9526,30550375
26812,DME,disease,1.0,30550375
26813,Patient,species,0.9893,30550375
26814,human,species,0.9688,30550375
26815,DME,disease,1.0,30550375
26816,patients,species,0.9956,30550375
26817,VEGF,gene,0.8716,30550375
26818,severe visual impairment,disease,0.871,30550375
26819,SVI,disease,1.0,30550375
26820,blindness,disease,1.0,30550375
26821,VEGF,gene,0.5337,30550375
26822,triamcinolone,drug,0.999,30550375
26823,VEGF,gene,0.9194,30550375
26824,SVI,disease,1.0,30550375
26825,legal blindness,disease,1.0,30550375
26826,patients,species,0.9385,30550375
26827,DME,disease,1.0,30550375
26828,patient,species,0.9863,30550375
26829,aflibercept,gene,0.9756,30549221
26830,age-related macular degeneration,disease,1.0,30549221
26831,nAMD,disease,1.0,30549221
26832,oxygen,drug,0.997,30549221
26833,aflibercept,gene,0.9346,30549221
26834,nAMD,disease,1.0,30549221
26835,nAMD,disease,1.0,30549221
26836,dry AMD,disease,1.0,30549221
26837,nAMD,disease,1.0,30549221
26838,aflibercept,gene,0.9805,30549221
26839,oxygen,drug,0.9995,30549221
26840,Patients,species,0.9688,30549221
26841,nAMD,disease,1.0,30549221
26842,dry AMD,disease,1.0,30549221
26843,oxygen,drug,0.9946,30549221
26844,nAMD,disease,1.0,30549221
26845,retinal,DNA,0.5146,30549221
26846,oxygen,drug,0.9995,30549221
26847,retinal,DNA,0.503,30549221
26848,oxygen,drug,0.9985,30549221
26849,oxygen,drug,0.9985,30549221
26850,nAMD,disease,1.0,30549221
26851,Ranibizumab,gene,0.9497,30542050
26852,Aflibercept,gene,0.868,30542050
26853,Dexamethasone,drug,0.975,30542050
26854,ranibizumab,gene,0.873,30542050
26855,aflibercept,gene,0.972,30542050
26856,dexamethasone,drug,0.996,30542050
26857,ranibizumab,gene,0.794,30542050
26858,aflibercept,gene,0.9497,30542050
26859,dexamethasone,drug,0.9404,30542050
26860,ranibizumab,gene,0.605,30542050
26861,aflibercept,gene,0.9854,30542050
26862,dexamethasone,drug,0.997,30542050
26863,AXL,DNA,0.4607,30542050
26864,ranibizumab,gene,0.9556,30542050
26865,aflibercept,gene,0.966,30542050
26866,Antivascular Endothelial Growth Factor,gene,0.913,30538852
26867,Neovascular Age-Related Macular Degeneration,disease,1.0,30538852
26868,VEGF,gene,0.793,30538852
26869,nAMD,disease,1.0,30538852
26870,VEGF,gene,0.995,30538852
26871,neovascular age-related macular degeneration,disease,1.0,30538852
26872,nAMD,disease,1.0,30538852
26873,nAMD,disease,1.0,30538852
26874,ranibizumab,gene,0.7964,30538852
26875,aflibercept,gene,0.9424,30538852
26876,CRT,DNA,0.5127,30538852
26877,atrophic retinal pigment epithelium,disease,0.9995,30538852
26878,nAMD,disease,1.0,30538852
26879,nAMD,disease,1.0,30538852
26880,VEGF,gene,0.5576,30538852
26881,nAMD,disease,1.0,30538852
26882,nAMD,disease,1.0,30538852
26883,ADVM-022,drug,0.7236,30528929
26884,Wet Age-Related Macular Degeneration,disease,1.0,30528929
26885,vascular endothelial growth factor,gene,0.9985,30528929
26886,choroidal,disease,0.833,30528929
26887,age-related macular degeneration,disease,0.9985,30528929
26888,aflibercept,gene,0.9624,30528929
26889,wet,disease,0.651,30528929
26890,macular degeneration,disease,0.9897,30528929
26891,vision impairment,disease,0.9995,30528929
26892,anti-vascular endothelial growth factor,gene,0.994,30528929
26893,ADVM,DNA,0.507,30528929
26894,adeno,DNA,0.494,30528929
26895,aflibercept,gene,0.988,30528929
26896,ADVM-022,gene,0.869,30528929
26897,aflibercept,gene,0.837,30528929
26898,choroidal neovascularization,disease,0.9707,30528929
26899,ADVM,drug,0.77,30528929
26900,aflibercept,gene,0.993,30528929
26901,ADVM,drug,0.8325,30528929
26902,choroidal neovascularization lesions,disease,1.0,30528929
26903,aflibercept,gene,0.9688,30528929
26904,ADVM-022,drug,0.8945,30528929
26905,wet macular degeneration,disease,0.999,30528929
26906,vascular endothelial growth factor,gene,0.897,30515606
26907,post-injection endophthalmitis,disease,0.933,30515606
26908,vascular endothelial growth factor,gene,0.881,30515606
26909,endophthalmitis,disease,0.9966,30515606
26910,patients,species,0.985,30515606
26911,bevacizumab,gene,0.8984,30515606
26912,aflibercept,gene,0.9736,30515606
26913,post-injection endophthalmitis,disease,0.998,30515606
26914,endophthalmitis,disease,1.0,30515606
26915,post-,disease,0.9937,30515606
26916,neovascular age-related macular degeneration,disease,0.9995,30511374
26917,nAMD,disease,1.0,30511374
26918,antivascular endothelial growth factor,gene,0.985,30511374
26919,anti-VEGF,gene,0.943,30511374
26920,Macula,disease,0.9316,30511374
26921,patient,species,0.9756,30511374
26922,Diabetic Retinopathy,disease,1.0,30511374
26923,ETDRS,DNA,0.805,30511374
26924,nAMD,disease,1.0,30511374
26925,aflibercept,gene,0.9893,30499545
26926,retinal pigment epithelial detachments,disease,0.999,30499545
26927,aflibercept,gene,0.989,30499545
26928,pigment epithelium detachment,disease,1.0,30499545
26929,PED,disease,1.0,30499545
26930,age-related macular degeneration,disease,1.0,30499545
26931,AMD,disease,1.0,30499545
26932,aflibercept,gene,0.9854,30499545
26933,neuroepithelium detachment,disease,0.7847,30499545
26934,NED,disease,0.8706,30499545
26935,PED,disease,1.0,30499545
26936,PED,disease,0.9956,30499545
26937,aflibercept,gene,0.983,30499545
26938,AMD,disease,1.0,30499545
26939,PED,DNA,0.4756,30499545
26940,PED,disease,0.7217,30499545
26941,NED,disease,0.9976,30499545
26942,BCVA,disease,1.0,30499545
26943,PEDs,DNA,0.438,30499545
26944,aflibercept,gene,0.917,30499545
26945,PEDs,cell_line,0.4194,30499545
26946,PED,DNA,0.5923,30499545
26947,VEGF,gene,0.963,30499531
26948,geographic atrophy,disease,1.0,30499531
26949,Age-related macular degeneration,disease,1.0,30499531
26950,AMD,disease,1.0,30499531
26951,retinal disease,disease,1.0,30499531
26952,deterioration of central vision,disease,0.9995,30499531
26953,Geographic atrophy,disease,1.0,30499531
26954,GA,disease,1.0,30499531
26955,AMD,disease,1.0,30499531
26956,GA,disease,1.0,30499531
26957,RPE,cell_type,0.563,30499531
26958,AMD,disease,1.0,30499531
26959,choroidal neovascularization,disease,1.0,30499531
26960,VEGF,gene,0.6587,30499531
26961,RPE detachment,disease,0.954,30499531
26962,RPE rupture,disease,0.831,30499531
26963,exudative AMD,disease,0.9995,30499531
26964,VEGF,gene,0.507,30499531
26965,Retinal disease,disease,0.9956,30498330
26966,anti-VEGF,gene,0.833,30498330
26967,ranibizumab,gene,0.8647,30498330
26968,aflibercept,gene,0.992,30498330
26969,bevacizumab,gene,0.879,30498330
26970,Avastin,gene,0.6455,30498330
26971,ranibizumab,gene,0.7686,30498330
26972,aflibercept,gene,0.9844,30498330
26973,Aflibercept,gene,0.955,30498330
26974,aflibercept,gene,0.977,30478752
26975,retinopathy of prematurity,disease,1.0,30478752
26976,aflibercept,gene,0.978,30478752
26977,type,disease,0.7046,30478752
26978,retinopathy of prematurity,disease,1.0,30478752
26979,ROP,disease,1.0,30478752
26980,aggressive posterior retinopathy of prematurity,disease,0.9956,30478752
26981,APROP,disease,1.0,30478752
26982,patients,species,0.978,30478752
26983,type 1 ROP,disease,0.999,30478752
26984,APROP,disease,1.0,30478752
26985,fluorescein,drug,0.999,30478752
26986,IVA,drug,0.7305,30478752
26987,unresponsiveness,disease,0.7407,30478752
26988,infant,species,0.818,30478752
26989,vascular abnormality,disease,1.0,30478752
26990,cystoid macular changes,disease,1.0,30478752
26991,infants,species,0.848,30478752
26992,foveal,DNA,0.595,30478752
26993,infants,species,0.8374,30478752
26994,infants,species,0.897,30478752
26995,aflibercept,gene,0.9854,30478752
26996,type I ROP,disease,0.9927,30478752
26997,APROP,disease,0.999,30478752
26998,Anti-Vascular Endothelial Growth Factor,gene,0.8965,30457641
26999,Retinal Vein Occlusion,disease,1.0,30457641
27000,vascular endothelial growth factor,gene,0.9873,30457641
27001,VEGF,gene,0.9927,30457641
27002,macular edema,disease,1.0,30457641
27003,ME,disease,1.0,30457641
27004,retinal vein occlusions,disease,1.0,30457641
27005,RVO,disease,1.0,30457641
27006,PATIENTS,species,0.948,30457641
27007,ME,disease,0.9985,30457641
27008,RVO,disease,1.0,30457641
27009,VEGF,gene,0.722,30457641
27010,WET AGE,disease,0.956,30441949
27011,MACULAR DEGENERATION,disease,0.8604,30441949
27012,aflibercept,gene,0.9707,30441949
27013,age-related macular degeneration,disease,1.0,30441949
27014,ARMD,disease,1.0,30441949
27015,aflibercept,gene,0.9746,30441949
27016,Kr,DNA,0.4275,30441949
27017,Diabetic Retinopathy,disease,0.9995,30441949
27018,aflibercept,gene,0.878,30441949
27019,ARMD,disease,1.0,30441949
27020,aflibercept,gene,0.991,30441949
27021,VEGF,gene,0.829,30441949
27022,ARMD,disease,1.0,30441949
27023,ranibizumab,gene,0.911,30428856
27024,aflibercept,gene,0.97,30428856
27025,neovascular age-related macular degeneration,disease,0.998,30428856
27026,AMD,disease,1.0,30428856
27027,anti-,gene,0.6294,30428856
27028,vascular endothelial growth factor,gene,0.9155,30428856
27029,aflibercept,gene,0.9644,30428856
27030,ranibizumab,gene,0.582,30428856
27031,ranibizumab,gene,0.836,30428856
27032,patients,species,0.987,30428856
27033,ranibizumab,gene,0.725,30428856
27034,aflibercept,gene,0.9805,30428856
27035,ORT,disease,0.999,30428856
27036,ranibizumab,gene,0.7617,30428856
27037,aflibercept,gene,0.8955,30428856
27038,ORT,disease,0.9976,30428856
27039,ranibizumab,gene,0.8096,30428856
27040,SHRM,disease,0.9966,30428856
27041,ORT,disease,1.0,30428856
27042,ranibizumab,gene,0.685,30428856
27043,aflibercept,gene,0.8525,30428856
27044,ORT,disease,0.989,30428856
27045,VEGF,gene,0.8276,30428856
27046,ORT,gene,0.8115,30428856
27047,aflibercept,gene,0.9897,30410308
27048,conbercept,gene,0.9165,30410308
27049,diabetic macular edema,disease,1.0,30410308
27050,Diabetic macular edema,disease,1.0,30410308
27051,DME,disease,1.0,30410308
27052,diabetic retinopathy blindness,disease,1.0,30410308
27053,cataracts,disease,1.0,30410308
27054,VEGF,gene,0.995,30410308
27055,DME,disease,1.0,30410308
27056,VEGF,gene,0.9463,30410308
27057,DME,disease,1.0,30410308
27058,macular edema,disease,1.0,30410308
27059,aflibercept,gene,0.966,30410308
27060,conbercept,gene,0.518,30410308
27061,VEGF,gene,0.992,30410308
27062,DME,disease,1.0,30410308
27063,VEGF,gene,0.593,30410308
27064,DME,disease,1.0,30410308
27065,aflibercept,gene,0.9824,30410092
27066,diabetic macular edema,disease,1.0,30410092
27067,DME,disease,1.0,30410092
27068,VEGF,gene,0.976,30410092
27069,IL-6,gene,0.9536,30410092
27070,IL-5,gene,0.9346,30410092
27071,IL-1,gene,0.9478,30410092
27072,Eotaxin,gene,0.853,30410092
27073,GRO,gene,0.8076,30410092
27074,IL-12p40,gene,0.9873,30410092
27075,IL-12p70,gene,0.9873,30410092
27076,IL-1RA,gene,0.982,30410092
27077,Flt-3L,gene,0.998,30410092
27078,IP-10,gene,0.9634,30410092
27079,Fraktalkine,gene,0.944,30410092
27080,GM-CSF,gene,0.997,30410092
27081,GRO,gene,0.962,30410092
27082,VEGF,gene,0.98,30410092
27083,Fraktalkine,gene,0.961,30410092
27084,IP-10,gene,0.979,30410092
27085,IL-12p70,gene,0.989,30410092
27086,Aflibercept,gene,0.916,30410092
27087,anti-VEGF,gene,0.788,30410092
27088,aflibercept,gene,0.9634,30410092
27089,edema,disease,0.992,30410092
27090,aflibercept,gene,0.993,30410092
27091,VEGF,gene,0.994,30409915
27092,aflibercept,gene,0.994,30409915
27093,bevacizumab,gene,0.8086,30409915
27094,ranibizumab,gene,0.8203,30409915
27095,neovascular age-related macular degeneration,disease,1.0,30409915
27096,NVAMD,disease,1.0,30409915
27097,diabetic macular oedema,disease,1.0,30409915
27098,DME,disease,1.0,30409915
27099,central or branch retinal vein occlusion,disease,0.981,30409915
27100,RVO,disease,1.0,30409915
27101,bevacizumab,gene,0.849,30409915
27102,ranibizumab,gene,0.623,30409915
27103,NVAMD,disease,1.0,30409915
27104,bevacizumab,gene,0.8003,30409915
27105,ranibizumab,gene,0.5483,30409915
27106,DME,disease,0.998,30409915
27107,aflibercept,gene,0.9897,30409915
27108,ranibizumab,gene,0.857,30409915
27109,NVAMD,disease,1.0,30409915
27110,aflibercept,gene,0.9897,30409915
27111,bevacizumab,gene,0.8906,30409915
27112,RVO,disease,1.0,30409915
27113,DME,disease,1.0,30409915
27114,bevacizumab,gene,0.893,30409915
27115,ranibizumab,gene,0.493,30409915
27116,RVO,disease,0.9995,30409915
27117,arterial thrombotic events,disease,0.956,30409915
27118,ranibizumab,gene,0.8755,30409915
27119,aflibercept,gene,0.9316,30409915
27120,Aflibercept,gene,0.973,30409915
27121,bevacizumab,gene,0.8906,30409915
27122,aflibercept,gene,0.984,30406511
27123,aflibercept,gene,0.9585,30406511
27124,verteporfin,drug,0.9956,30406511
27125,PCV,disease,1.0,30406511
27126,patients,species,0.9937,30406511
27127,polyp,disease,0.9995,30406511
27128,patients,species,0.981,30406511
27129,BCVA,cell_type,0.396,30406511
27130,polypoidal lesions,disease,1.0,30406511
27131,patients,species,0.9937,30406511
27132,PCV,disease,1.0,30406511
27133,patients,species,0.992,30406511
27134,Aflibercept,gene,0.8726,30405907
27135,aflibercept,gene,0.9087,30405907
27136,patients,species,0.981,30405907
27137,macular oedema,disease,1.0,30405907
27138,MO,disease,1.0,30405907
27139,central retinal vein occlusion,disease,1.0,30405907
27140,CRVO,disease,1.0,30405907
27141,PATIENTS,species,0.917,30405907
27142,patients,species,0.965,30405907
27143,MO,disease,,30405907
27144,CRVO,disease,1.0,30405907
27145,aflibercept,gene,0.9526,30405907
27146,BCVA,DNA,0.463,30405907
27147,patients,species,0.982,30405907
27148,patients,species,0.9717,30405907
27149,ETDRS,DNA,0.4722,30405907
27150,patients,species,0.9834,30405907
27151,MO,disease,,30405907
27152,patients,species,0.972,30405907
27153,aflibercept,gene,0.7627,30405907
27154,patients,species,0.9434,30405907
27155,MO,disease,,30405907
27156,CRVO,disease,0.9995,30405907
27157,ranibizumab,gene,0.629,30397793
27158,aflibercept,gene,0.9336,30397793
27159,ranibizumab,gene,0.6562,30397793
27160,aflibercept,gene,0.9443,30397793
27161,infants,species,0.7686,30397793
27162,retinopathy of prematurity,disease,1.0,30397793
27163,ROP,disease,0.961,30397793
27164,infants,species,0.886,30397793
27165,ROP,disease,0.9624,30397793
27166,Infants,species,0.794,30397793
27167,ranibizumab,gene,0.6665,30397793
27168,aflibercept,gene,0.9624,30397793
27169,patients,species,0.987,30397793
27170,infants,species,0.549,30397793
27171,ranibizumab,gene,0.725,30397793
27172,ranibizumab,gene,0.944,30397793
27173,infants,species,0.5405,30397793
27174,aflibercept,gene,0.954,30397793
27175,aflibercept,gene,0.9883,30397793
27176,ranibizumab,drug,0.5,30397793
27177,aflibercept,gene,0.9507,30397793
27178,ranibizumab,gene,0.8433,30397793
27179,aflibercept,gene,0.985,30397793
27180,ROP,disease,0.9995,30397793
27181,ranibizumab,gene,0.7725,30397793
27182,aflibercept,gene,0.963,30397793
27183,ROP,disease,0.978,30397793
27184,ranibizumab,gene,0.7544,30397793
27185,ROP,disease,0.9746,30397793
27186,Recombinant Chinese Hamster Ovary (rCHO) Cell,cell_type,0.8115,30394043
27187,Chinese Hamster Ovary,species,0.5376,30394043
27188,rCHO cell lines,cell_line,0.783,30394043
27189,CHO cells,cell_line,0.9585,30394043
27190,DMSO,drug,0.8574,30394043
27191,rCHO cells,cell_line,0.783,30394043
27192,aflibercept,gene,0.9844,30394043
27193,rCHO cells,cell_line,0.966,30394043
27194,aflibercept,gene,0.9873,30394043
27195,pembrolizumab,gene,0.8877,30394043
27196,single-cell derived rCHO clones,cell_line,0.9546,30394043
27197,rCHO cell clones,cell_line,0.889,30394043
27198,aflibercept,gene,0.9873,30394043
27199,pembrolizumab,gene,0.6987,30394043
27200,DMSO,drug,0.774,30394043
27201,rCHO cell lines,cell_line,0.9727,30394043
27202,rCHO cell lines,cell_line,0.9653,30394043
27203,polypoidal choroidal vasculopathy,disease,1.0,30390650
27204,ranibizumab,gene,0.6787,30390650
27205,Polypoidal choroidal vasculopathy,disease,1.0,30390650
27206,PCV,disease,1.0,30390650
27207,subretinal hemorrhage,disease,0.9614,30390650
27208,indocyanine green,drug,0.996,30390650
27209,vascular endothelial growth factor,gene,0.9653,30390650
27210,VEGF,gene,0.997,30390650
27211,polyp,disease,0.9995,30390650
27212,active polyps,disease,0.9023,30390650
27213,polyps,disease,1.0,30390650
27214,PCV,disease,1.0,30390650
27215,vision deterioration,disease,0.964,30390650
27216,subretinal,disease,0.5303,30390650
27217,ranibizumab,gene,0.8555,30390650
27218,polyp,disease,0.987,30390650
27219,BVN,disease,1.0,30390650
27220,BVN,disease,0.9995,30390650
27221,polyp,disease,1.0,30390650
27222,polyp,disease,1.0,30390650
27223,left vision deterioration,disease,0.9976,30390650
27224,PCV,disease,1.0,30390650
27225,aflibercept,gene,0.9717,30390650
27226,subretinal fluid,disease,0.8247,30390650
27227,BVN,disease,0.9966,30390650
27228,polyp,disease,0.997,30390650
27229,BVN,disease,0.955,30390650
27230,polyp,disease,0.9995,30390650
27231,BVN,disease,0.8477,30390650
27232,Anti-VEGF,gene,0.6777,30386955
27233,neovascular age-related macular degeneration,disease,1.0,30386955
27234,anti-VEGF,gene,0.681,30386955
27235,patients,species,0.985,30386955
27236,nAMD,disease,1.0,30386955
27237,bevacizumab,gene,0.9224,30386955
27238,aflibercept,gene,0.989,30386955
27239,ranibizumab,gene,0.5537,30386955
27240,aflibercept,gene,0.9863,30386955
27241,ranibizumab,gene,0.7617,30386955
27242,patients,species,0.987,30386955
27243,patients,species,0.991,30386955
27244,aflibercept,gene,0.948,30386955
27245,patients,species,0.9883,30386955
27246,ranibizumab,gene,0.5234,30386955
27247,patients,species,0.9863,30386955
27248,aflibercept,gene,0.956,30386955
27249,ranibizumab,gene,0.8022,30386955
27250,aflibercept,gene,0.987,30386955
27251,ranibizumab,gene,0.7314,30386955
27252,diabetic macular,disease,1.0,30386806
27253,diabetic macular edema,disease,1.0,30386806
27254,DME,disease,1.0,30386806
27255,patients,species,0.978,30386806
27256,DME,disease,1.0,30386806
27257,ranibizumab,gene,0.863,30386806
27258,aflibercept,gene,0.9756,30386806
27259,CRT,DNA,0.4958,30386806
27260,diabetes,disease,1.0,30386806
27261,HbA1c,gene,0.879,30386806
27262,hypertension,disease,0.9995,30386806
27263,subfoveal neuroretinal detachment,disease,1.0,30386806
27264,anti-VEGF,gene,0.9473,30386806
27265,SND,disease,0.81,30386806
27266,DME,disease,1.0,30386806
27267,aflibercept,gene,0.9966,30386633
27268,ziv-aflibercept,gene,0.9893,30386633
27269,aflibercept,gene,0.994,30386633
27270,ziv-aflibercept,gene,0.988,30386633
27271,vascular endothelial growth factor,gene,0.9956,30386633
27272,aflibercept,gene,0.98,30386633
27273,ziv-aflibercept,gene,0.944,30386633
27274,anti-VEGF,gene,0.98,30386633
27275,VEGF,gene,0.991,30386633
27276,aflibercept,gene,0.9937,30386633
27277,ziv-aflibercept,gene,0.983,30386633
27278,recombinant VEGF,gene,0.997,30386633
27279,anti-VEGF,gene,0.855,30386633
27280,aflibercept,gene,0.9326,30386633
27281,ziv-aflibercept,gene,0.9824,30386633
27282,Anti-Vascular Endothelial Growth Factor,gene,0.8687,30383436
27283,VEGF,gene,0.6616,30383436
27284,Diabetic Macular Edema,disease,1.0,30383436
27285,diabetic macular edema,disease,1.0,30383436
27286,DME,disease,1.0,30383436
27287,DME,disease,0.9966,30383436
27288,DME,disease,1.0,30383436
27289,VEGF,gene,0.807,30383436
27290,DME,disease,1.0,30383436
27291,Recurrent Colon Cancer,disease,0.983,30382071
27292,Peritoneal Dissemination,disease,0.714,30382071
27293,Aflibercept,gene,0.908,30382071
27294,colon cancer,disease,0.957,30382071
27295,5-fluorouracil,drug,0.999,30382071
27296,5-FU,drug,0.9985,30382071
27297,irinotecan,drug,0.9966,30382071
27298,Leucovorin,drug,0.9985,30382071
27299,FOLFIRI,drug,0.923,30382071
27300,aflibercept,gene,0.9785,30382071
27301,colon cancer,disease,1.0,30382071
27302,nodal enlargement,disease,0.9985,30382071
27303,liver metastases,disease,0.991,30382071
27304,bevacizumab,gene,0.733,30382071
27305,FOLFIRI,drug,0.847,30382071
27306,aflibercept,gene,0.982,30382071
27307,aflibercept,gene,0.9624,30382071
27308,leukopenia,disease,1.0,30382071
27309,neutropenia,disease,1.0,30382071
27310,thrombocytopenia,disease,1.0,30382071
27311,hypertension,disease,1.0,30382071
27312,sweating,disease,1.0,30382071
27313,Placentalderived growth factor,gene,0.9985,30382071
27314,PIGF,gene,0.9927,30382071
27315,macrophages,cell_type,0.855,30382071
27316,IL-6,gene,0.9795,30382071
27317,inflammation,disease,0.938,30382071
27318,cancer,disease,1.0,30382071
27319,neutrophil-,cell_type,0.7793,30382071
27320,NLR,cell_type,0.532,30382071
27321,aflibercept,gene,0.973,30382071
27322,NLR,cell_type,0.674,30382071
27323,aflibercept,gene,0.945,30382071
27324,dexamethasone,drug,0.9976,30381045
27325,dexamethasone,drug,0.996,30381045
27326,diabetic macular oedema,disease,1.0,30381045
27327,patients,species,0.926,30381045
27328,diabetic macular oedema,disease,1.0,30381045
27329,aflibercept,gene,0.9927,30381045
27330,ranibizumab,gene,0.945,30381045
27331,dexamethasone,drug,0.981,30381045
27332,diabetic macular oedema,disease,1.0,30381045
27333,Dexamethasone,drug,0.998,30381045
27334,patients,species,0.9854,30381045
27335,patient,species,0.9883,30381045
27336,cataracts,disease,1.0,30381045
27337,endophthalmitis,disease,1.0,30381045
27338,vitreous  haemorrhage,disease,1.0,30381045
27339,retinal detachment,disease,1.0,30381045
27340,dexamethasone,drug,0.989,30381045
27341,dexamethasone,drug,0.995,30381045
27342,patient,species,0.9414,30381045
27343,dexamethasone,drug,0.995,30381045
27344,diabetic macular oedema,disease,1.0,30381045
27345,vascular endothelial growth factor,gene,0.951,30374744
27346,ranibizumab,gene,0.7573,30374744
27347,aflibercept,gene,0.9497,30374744
27348,bevacizumab,gene,0.5347,30374744
27349,neovascular age-related macular degeneration,disease,1.0,30374744
27350,Aflibercept,gene,0.6665,30372756
27351,Proliferative Diabetic Retinopathy,disease,1.0,30372756
27352,aflibercept,gene,0.979,30372756
27353,retinal,cell_type,0.4973,30372756
27354,oxygen,drug,0.9956,30372756
27355,retinal nonperfusion,disease,0.932,30372756
27356,proliferative diabetic retinopathy,disease,0.992,30372756
27357,proliferative diabetic retinopathy,disease,0.9404,30372756
27358,aflibercept,gene,0.9595,30372756
27359,aflibercept,gene,0.978,30372756
27360,retinal nonperfusion,disease,0.989,30372756
27361,aflibercept,gene,0.9517,30372756
27362,aflibercept,gene,0.9863,30372756
27363,PRP,cell_type,0.5537,30372756
27364,aflibercept,gene,0.9746,30372756
27365,aflibercept,gene,0.9785,30372756
27366,proliferative diabetic retinopathy,disease,0.9995,30372756
27367,oxygen,drug,0.9985,30372756
27368,aflibercept,gene,0.953,30369094
27369,diabetic macular oedema,disease,1.0,30369094
27370,Fc fusion protein,gene,0.944,30367290
27371,aflibercept,gene,0.888,30367290
27372,retinal endothelial cells,cell_type,0.8643,30367290
27373,VEGF-binding protein,gene,0.9956,30367290
27374,aflibercept,gene,0.767,30367290
27375,immortalized bovine retinal endothelial cells,cell_line,0.6636,30367290
27376,bovine,species,0.6616,30367290
27377,iBREC,cell_line,0.9385,30367290
27378,aflibercept,gene,0.9766,30367290
27379,neonatal Fc receptor,gene,0.998,30367290
27380,FcRn,gene,0.9976,30367290
27381,Fc domain,gene,0.9146,30367290
27382,aflibercept,gene,0.9824,30367290
27383,FcRn,gene,0.99,30367290
27384,iBREC,cell_line,0.9375,30367290
27385,aflibercept,gene,0.9897,30367290
27386,aflibercept,gene,0.976,30367290
27387,IgG,gene,0.998,30367290
27388,FcRn,gene,0.993,30367290
27389,endosomal Rab4,gene,0.9746,30367290
27390,Rab11,gene,0.9897,30367290
27391,aflibercept,gene,0.9917,30367290
27392,Aflibercept,gene,0.526,30367290
27393,dynein,gene,0.9375,30367290
27394,anti-kinesin antibody,gene,0.9443,30367290
27395,aflibercept,gene,0.993,30367290
27396,microtubules,RNA,0.479,30367290
27397,-,gene,0.4812,30367290
27398,tubulin,gene,0.475,30367290
27399,Rab4,gene,0.9937,30367290
27400,Rab11,gene,0.9946,30367290
27401,aflibercept,gene,0.983,30367290
27402,Rab7,gene,0.997,30367290
27403,aflibercept,gene,0.9937,30367290
27404,IgG bevacizumab,gene,0.944,30367290
27405,cation-independent mannose 6-phosphate receptor,gene,0.995,30367290
27406,mannose,drug,0.9795,30367290
27407,6-phosphate,drug,0.8203,30367290
27408,multivesicular endosomes,cell_type,0.7534,30367290
27409,intracellular,gene,0.8545,30367290
27410,aflibercept,gene,0.7827,30367290
27411,MG-132,drug,0.764,30367290
27412,MG-101,drug,0.764,30367290
27413,Serum-deprived iBREC,cell_line,0.9697,30367290
27414,iBREC,cell_type,0.4846,30367290
27415,Rab11,gene,0.991,30367290
27416,dynein,gene,0.9897,30367290
27417,Rab4,gene,0.9937,30367290
27418,iBREC,cell_line,0.6196,30367290
27419,aflibercept,gene,0.9893,30367290
27420,FcRn,gene,0.9946,30367290
27421,aflibercept,gene,0.9824,30367290
27422,Rab11,gene,0.9907,30367290
27423,aflibercept,gene,0.985,30362070
27424,ranibizumab,gene,0.531,30362070
27425,aflibercept,gene,0.989,30362070
27426,aflibercept,gene,0.99,30362070
27427,aflibercept,gene,0.969,30362070
27428,Aflibercept,gene,0.955,30362070
27429,ranibizumab,gene,0.7656,30362070
27430,age-related macular degeneration,disease,1.0,30362070
27431,aflibercept,gene,0.9863,30362070
27432,Aflibercept,gene,0.8965,30362070
27433,ranibizumab,gene,0.727,30362070
27434,aflibercept,gene,0.9937,30362070
27435,thromboembolic events,disease,0.9995,30362070
27436,ranibizumab,gene,0.849,30362070
27437,aflibercept,gene,0.9365,30362070
27438,aflibercept,gene,0.979,30362070
27439,aflibercept,gene,0.8174,30362070
27440,Macula,disease,0.6636,30361178
27441,age-related macular degeneration,disease,1.0,30361178
27442,AMD,disease,1.0,30361178
27443,VEGF,gene,0.586,30361178
27444,exudative AMD,disease,0.9985,30361178
27445,VEGF,gene,0.9385,30361178
27446,wet-AMD,disease,0.9995,30361178
27447,aflibercept,gene,0.9746,30361176
27448,macular edema,disease,1.0,30361176
27449,central retinal vein occlusion,disease,1.0,30361176
27450,ranibizumab,gene,0.9155,30361176
27451,aflibercept,gene,0.9893,30361176
27452,macular edema,disease,1.0,30361176
27453,central retinal vein occlusion,disease,1.0,30361176
27454,CRVO,disease,1.0,30361176
27455,macular edema,disease,1.0,30361176
27456,CRVO,disease,1.0,30361176
27457,ranibizumab,gene,0.636,30361176
27458,aflibercept,gene,0.9863,30361176
27459,aflibercept,gene,0.956,30361176
27460,CRT,DNA,0.4805,30361176
27461,BCVA,cell_type,0.4058,30361176
27462,aflibercept,gene,0.9727,30361176
27463,aflibercept,gene,0.956,30361176
27464,macular edema,disease,1.0,30361176
27465,CRVO,disease,1.0,30361176
27466,ranibizumab,gene,0.5483,30361176
27467,aflibercept,gene,0.965,30353107
27468,vascular endothelial growth factor,gene,0.9985,30353107
27469,VEGF,gene,0.997,30353107
27470,placental growth factor,gene,0.9976,30353107
27471,PIGF,gene,0.9946,30353107
27472,myopic choroidal neovascularization,disease,1.0,30353107
27473,mCNV,disease,1.0,30353107
27474,aflibercept,gene,0.9346,30353107
27475,patients,species,0.979,30353107
27476,mCNV,disease,0.9995,30353107
27477,aflibercept,gene,0.9727,30353107
27478,fluorescein,drug,0.9985,30353107
27479,VEGF,gene,0.9976,30353107
27480,PlGF,gene,0.995,30353107
27481,cataract,disease,0.994,30353107
27482,patients,species,0.9873,30353107
27483,PIGF,gene,0.988,30353107
27484,VEGF,gene,0.9873,30353107
27485,PIGF,gene,0.997,30353107
27486,VEGF,gene,0.9956,30353107
27487,PlGF,gene,0.994,30353107
27488,PlGF,gene,0.992,30353107
27489,PlGF,gene,0.992,30353107
27490,mCNV,disease,1.0,30353107
27491,aflibercept,gene,0.945,30353107
27492,VEGF,gene,0.9966,30353107
27493,PIGF,gene,0.9927,30353107
27494,Epigenetic Pathway Genes,DNA,0.909,30339265
27495,acetylation genes,DNA,0.9336,30339265
27496,immortalized human retinal pigment epithelium cells,cell_line,0.944,30339265
27497,ARPE-19,cell_line,0.8267,30339265
27498,histone acetylation genes,gene,0.9424,30339265
27499,immortalized ARPE-19 cell cultures,cell_line,0.828,30339265
27500,ARPE,cell_type,0.4597,30339265
27501,ARPE-19 cells,cell_line,0.7095,30339265
27502,aflibercept,gene,0.9907,30339265
27503,Eylea;,gene,0.5327,30339265
27504,ranibizumab,drug,0.5376,30339265
27505,bevacizumab,gene,0.5312,30339265
27506,Avastin,gene,0.3997,30339265
27507,Untreated cells,cell_line,0.723,30339265
27508,RNA,RNA,0.6724,30339265
27509,genes,DNA,0.4812,30339265
27510,histone acetyltransferase 1,gene,0.9946,30339265
27511,HAT1,gene,0.984,30339265
27512,"histone deacetylases 1, 6, and 11",gene,0.997,30339265
27513,HDAC1,gene,0.9883,30339265
27514,HDAC6,gene,0.9873,30339265
27515,HDAC11,gene,0.985,30339265
27516,candidate genes,DNA,0.6436,30339265
27517,untreated cells,cell_type,0.9116,30339265
27518,ranibizumab-treated cells,cell_line,0.849,30339265
27519,ranibizumab,gene,0.4282,30339265
27520,-,cell_type,0.6533,30339265
27521,treated cells,cell_type,0.52,30339265
27522,HDAC6,gene,0.9893,30339265
27523,2 ranibizumab-treated cells,cell_line,0.8643,30339265
27524,ranibizumab,gene,0.591,30339265
27525,-treated cells,cell_type,0.611,30339265
27526,HDAC11,gene,0.9946,30339265
27527,Bevacizumab-treated (1) cells,cell_line,0.881,30339265
27528,Bevacizumab,gene,0.934,30339265
27529,-treated (1) cells,cell_type,0.499,30339265
27530,HDAC1,gene,0.992,30339265
27531,HDAC6,gene,0.991,30339265
27532,HDAC11,gene,0.9883,30339265
27533,bevacizumab,gene,0.8364,30339265
27534,HDAC11,gene,0.612,30339265
27535,Aflibercept-treated (1) cells,cell_line,0.9473,30339265
27536,Aflibercept,gene,0.526,30339265
27537,-treated (1) cells,cell_type,0.485,30339265
27538,HDAC1,gene,0.992,30339265
27539,HDAC6,gene,0.9893,30339265
27540,HDAC11,gene,0.9873,30339265
27541,HDAC11,gene,0.4993,30339265
27542,genes,DNA,0.6255,30339265
27543,histone,gene,0.982,30339265
27544,ARPE-19 cells,cell_line,0.674,30339265
27545,vascular endothelial growth factor,gene,0.9624,30339265
27546,VEGF,gene,0.7666,30337096
27547,macular oedema,disease,1.0,30337096
27548,acute retinal necrosis,disease,1.0,30337096
27549,patient,species,0.9595,30337096
27550,Acute Retinal Necrosis,disease,0.836,30337096
27551,ARN,disease,1.0,30337096
27552,macular oedema,disease,1.0,30337096
27553,MO,disease,1.0,30337096
27554,macular oedema,disease,1.0,30337096
27555,MO,disease,1.0,30337096
27556,anti-VEGF,gene,0.8477,30337096
27557,VEGF,gene,0.966,30337096
27558,MO,disease,,30337096
27559,ARN,disease,1.0,30337096
27560,MO,disease,,30337096
27561,panuveitis,disease,1.0,30337096
27562,vascular endothelial growth factor,gene,0.9966,30325017
27563,diabetic macular oedema,disease,1.0,30325017
27564,Diabetic macular oedema,disease,1.0,30325017
27565,DMO,disease,1.0,30325017
27566,diabetic retinopathy,disease,1.0,30325017
27567,vascular endothelial growth factor,gene,0.9517,30325017
27568,anti-VEGF,gene,0.901,30325017
27569,oedema,disease,0.9995,30325017
27570,visual loss,disease,0.9995,30325017
27571,DMO,disease,1.0,30325017
27572,VEGF,gene,0.9146,30325017
27573,DMO,disease,1.0,30325017
27574,VEGF,gene,0.698,30325017
27575,VEGF,gene,0.992,30325017
27576,VEGF,gene,0.813,30325017
27577,DMO,disease,1.0,30325017
27578,aflibercept,gene,0.9766,30325017
27579,ranibizumab,gene,0.679,30325017
27580,bevacizumab,gene,0.666,30325017
27581,Diabetic Retinopathy,disease,0.937,30325017
27582,arterial thromboembolic events,disease,1.0,30325017
27583,DMO,disease,1.0,30325017
27584,vision loss,disease,0.996,30325017
27585,aflibercept,gene,0.985,30325017
27586,bevacizumab,drug,0.561,30325017
27587,ranibizumab,gene,0.752,30325017
27588,pegaptanib,drug,0.998,30325017
27589,ranibizumab,drug,0.556,30325017
27590,ranibizumab,gene,0.817,30325017
27591,Aflibercept,gene,0.9766,30325017
27592,bevacizumab,gene,0.8784,30325017
27593,ranibizumab,gene,0.671,30325017
27594,aflibercept,gene,0.958,30325017
27595,bevacizumab,gene,0.689,30325017
27596,VEGF,gene,0.9937,30325017
27597,aflibercept,gene,0.924,30325017
27598,bevacizumab,gene,0.6294,30325017
27599,aflibercept,gene,0.9893,30325017
27600,ranibizumab,gene,0.793,30325017
27601,bevacizumab,gene,0.725,30325017
27602,ranibizumab,gene,0.8345,30325017
27603,aflibercept,gene,0.9253,30325017
27604,aflibercept,gene,0.982,30325017
27605,ranibizumab,gene,0.7275,30325017
27606,ranibizumab,gene,0.7427,30325017
27607,Ranibizumab,gene,0.8086,30325017
27608,bevacizumab,gene,0.6465,30325017
27609,aflibercept,gene,0.9907,30325017
27610,ranibizumab,gene,0.494,30325017
27611,aflibercept,gene,0.9956,30325017
27612,ranibizumab,gene,0.679,30325017
27613,bevacizumab,gene,0.586,30325017
27614,arterial thromboembolic,disease,0.983,30325017
27615,VEGF,gene,0.817,30325017
27616,DMO,disease,1.0,30325017
27617,Aflibercept,gene,0.9746,30325017
27618,DMO,disease,1.0,30325017
27619,DMO,disease,1.0,30325017
27620,ENDOPHTHALMITIS,disease,1.0,30312260
27621,BEVACIZUMAB,drug,0.9507,30312260
27622,vascular endothelial growth factor,gene,0.972,30312260
27623,vascular endothelial growth factor,gene,0.881,30312260
27624,patients,species,0.9863,30312260
27625,endophthalmitis,disease,1.0,30312260
27626,endophthalmitis,disease,1.0,30312260
27627,endophthalmitis,disease,1.0,30312260
27628,bevacizumab,gene,0.8774,30312260
27629,ranibizumab,gene,0.821,30312260
27630,aflibercept,gene,0.9785,30312260
27631,patients,species,0.983,30312260
27632,aflibercept,gene,0.9775,30312260
27633,endophthalmitis,disease,1.0,30312260
27634,bevacizumab,gene,0.5474,30312260
27635,aflibercept,gene,0.977,30312260
27636,endophthalmitis,disease,1.0,30312260
27637,patients,species,0.992,30312260
27638,patients,species,0.9863,30312260
27639,endophthalmitis,disease,1.0,30312260
27640,endophthalmitis,disease,1.0,30312260
27641,aflibercept,gene,0.974,30312260
27642,ranibizumab,gene,0.8784,30312260
27643,bevacizumab,gene,0.7803,30312260
27644,ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR,gene,0.8994,30312257
27645,anti-vascular endothelial growth factor,gene,0.995,30312257
27646,retinoblastoma,disease,1.0,30312257
27647,patients,species,0.9614,30312257
27648,anti-,gene,0.7246,30312257
27649,vascular endothelial growth factor,gene,0.8696,30312257
27650,ranibizumab,gene,0.947,30312257
27651,aflibercept,gene,0.9775,30312257
27652,new iris,disease,0.9688,30312257
27653,retinal neovascularization,disease,1.0,30312257
27654,retinal ischemia,disease,1.0,30312257
27655,retinal detachment,disease,1.0,30312257
27656,tumor,disease,0.9697,30312257
27657,intravitreal hemorrhage,disease,1.0,30312257
27658,glaucoma,disease,1.0,30312257
27659,anti-,gene,0.6875,30312257
27660,vascular endothelial growth factor,gene,0.884,30312257
27661,ranibizumab,gene,0.6924,30312257
27662,aflibercept,gene,0.875,30312257
27663,ischemic retina,disease,1.0,30312257
27664,tumor,disease,0.7666,30312257
27665,phthisic,disease,0.99,30312257
27666,tumor,disease,1.0,30312257
27667,patients,species,0.9697,30312257
27668,anti-vascular endothelial growth factor,gene,0.904,30312257
27669,Neovascular age-related macular degeneration,disease,1.0,30310267
27670,interleukin (IL)-6,gene,0.9897,30310267
27671,vascular endothelial growth factor-A,gene,0.995,30310267
27672,platelet-derived growth factor,gene,0.9995,30310267
27673,placental growth factor,gene,0.998,30310267
27674,PLGF,gene,0.9917,30310267
27675,patients,species,0.9756,30310267
27676,neovascular age-related macular degeneration,disease,1.0,30310267
27677,ranibizumab,gene,0.7075,30310267
27678,PATIENTS,species,0.9653,30310267
27679,patients,species,0.9795,30310267
27680,patients,species,0.9907,30310267
27681,ranibizumab,gene,0.803,30310267
27682,aflibercept,gene,0.9624,30310267
27683,AF,gene,0.9995,30310267
27684,patients,species,0.9946,30310267
27685,ranibizumab,gene,0.598,30310267
27686,patients,species,0.994,30310267
27687,ranibizumab,gene,0.5005,30310267
27688,AF,disease,,30310267
27689,vascular endothelial growth factor-C,gene,0.998,30310267
27690,IL-7,gene,0.983,30310267
27691,angiopoeitin-2,gene,0.9907,30310267
27692,intercellular adhesion molecule,gene,0.8726,30310267
27693,IL-17,gene,0.9824,30310267
27694,PLGF,gene,0.9937,30310267
27695,IL-7,gene,0.9863,30310267
27696,ranibizumab,gene,0.5615,30310267
27697,aflibercept,gene,0.97,30310267
27698,PLGF,gene,0.9927,30310267
27699,ranibizumab,gene,0.493,30310267
27700,Optic disk melanocytoma,disease,1.0,30309335
27701,polypoidal choroidal vasculopathy lesions,disease,1.0,30309335
27702,woman,species,0.778,30309335
27703,optic disk melanocytoma,disease,1.0,30309335
27704,ODMC,disease,1.0,30309335
27705,polypoidal choroidal vasculopathy,disease,1.0,30309335
27706,PCV,disease,1.0,30309335
27707,aflibercept,gene,0.9336,30309335
27708,woman,species,0.823,30309335
27709,visual decline,disease,0.991,30309335
27710,ODMC,disease,1.0,30309335
27711,PCV,disease,0.9907,30309335
27712,fluorescein,drug,0.998,30309335
27713,Indocyanine green,drug,0.999,30309335
27714,polypoidal lesions,disease,0.794,30309335
27715,retinal pigment epithelium detachment,disease,1.0,30309335
27716,RPE,disease,0.999,30309335
27717,polyps,disease,0.9995,30309335
27718,aflibercept,gene,0.98,30309335
27719,subretinal,disease,0.625,30309335
27720,RPE detachment,disease,0.9985,30309335
27721,PCV,disease,1.0,30309335
27722,ODMC,disease,1.0,30309335
27723,aflibercept,gene,0.983,30309335
27724,PCV,disease,1.0,30309335
27725,Retinal Pigment Epithelium Atrophy,disease,1.0,30304737
27726,VEGF,gene,0.654,30304737
27727,retinal pigment epithelium (RPE) atrophy,disease,0.999,30304737
27728,patients,species,0.9043,30304737
27729,neovascular age-related macular degeneration,disease,1.0,30304737
27730,nAMD,disease,1.0,30304737
27731,nAMD,disease,1.0,30304737
27732,patients,species,0.993,30304737
27733,RPE atrophy,disease,1.0,30304737
27734,vascular endothelial,DNA,0.652,30304737
27735,vascular endothelial growth factor,gene,0.997,30304737
27736,VEGF,gene,0.998,30304737
27737,RPE atrophy,disease,1.0,30304737
27738,VEGF,gene,0.9526,30304737
27739,C3d,gene,0.988,30304737
27740,C3,gene,0.9995,30304737
27741,atrophy,disease,1.0,30304737
27742,nAMD,disease,1.0,30304737
27743,Anti-VEGF,gene,0.939,30304737
27744,C3d,gene,0.98,30304737
27745,C3,gene,0.997,30304737
27746,intraocular,gene,0.763,30304737
27747,VEGF,gene,0.5093,30304737
27748,RPE atrophy,disease,1.0,30304737
27749,nAMD,disease,1.0,30304737
27750,RPE atrophy,disease,1.0,30304737
27751,nAMD,disease,1.0,30304737
27752,patients,species,0.9946,30304737
27753,NCI 8628,drug,0.856,30303516
27754,ziv-aflibercept,gene,0.955,30303516
27755,interleukin 2,gene,0.9023,30303516
27756,Interleukin 2,gene,0.9893,30303516
27757,IL-2,gene,0.995,30303516
27758,T,cell_line,0.561,30303516
27759,T and natural killer cells,cell_type,0.799,30303516
27760,patients,species,0.953,30303516
27761,melanoma,disease,1.0,30303516
27762,Vascular endothelial growth factor,gene,0.9985,30303516
27763,VEGF,gene,0.997,30303516
27764,VEGF,gene,0.996,30303516
27765,IL-2,gene,0.9834,30303516
27766,Ziv-aflibercept,gene,0.9565,30303516
27767,VEGF,gene,0.986,30303516
27768,T-cell,cell_type,0.749,30303516
27769,IL-2,gene,0.9634,30303516
27770,NCI,cell_line,0.5312,30303516
27771,ziv-aflibercept,gene,0.9756,30303516
27772,IL-2,gene,0.9863,30303516
27773,IL-2,gene,0.974,30303516
27774,patients,species,0.9785,30303516
27775,melanoma,disease,0.739,30303516
27776,patients,species,0.9844,30303516
27777,patients,species,0.99,30303516
27778,patients,species,0.989,30303516
27779,patients,species,0.9897,30303516
27780,patients,species,0.9907,30303516
27781,patients,species,0.9873,30303516
27782,patients,species,0.9897,30303516
27783,patients,species,0.976,30303516
27784,VEGF,gene,0.728,30303516
27785,VEGF receptor 2,gene,0.9956,30303516
27786,IL-2,gene,0.988,30303516
27787,ziv-aflibercept,gene,0.961,30303516
27788,Ziv-aflibercept,gene,0.9756,30303516
27789,IL-2,gene,0.9927,30303516
27790,IL-2,gene,0.9893,30303516
27791,VEGF,gene,0.995,30303516
27792,Age-related macular degeneration,disease,1.0,30303083
27793,Age-related macular degeneration,disease,1.0,30303083
27794,visual impairment,disease,1.0,30303083
27795,vision loss,disease,0.9976,30303083
27796,retinal pigmentary changes,disease,0.8843,30303083
27797,Age-related macular degeneration,disease,1.0,30303083
27798,multifactorial disorder,disease,0.996,30303083
27799,dysregulation in the complement,disease,0.839,30303083
27800,genetic susceptibility loci,DNA,0.7876,30303083
27801,CFH and ARMS2 genes,DNA,0.7866,30303083
27802,CFH,gene,0.9937,30303083
27803,ARMS2 genes,gene,0.991,30303083
27804,zinc,drug,1.0,30303083
27805,zinc,drug,1.0,30303083
27806,vascular endothelial growth factor,gene,0.921,30303083
27807,ranibizumab,gene,0.8306,30303083
27808,aflibercept,gene,0.946,30303083
27809,bevacizumab,gene,0.4998,30303083
27810,neovascular age-related macular degeneration,disease,1.0,30303083
27811,visual impairment,disease,1.0,30303083
27812,atrophic disease,disease,1.0,30303083
27813,vascular endothelial growth factor,gene,0.8916,30303083
27814,patients,species,0.9624,30303670
27815,proliferative diabetic retinopathy,disease,0.9995,30303670
27816,PDR,disease,1.0,30303670
27817,visual loss,disease,0.981,30303670
27818,PDR,disease,1.0,30303670
27819,aflibercept,gene,0.9688,30303670
27820,proliferative diabetic retinopathy,disease,0.9966,30303670
27821,aflibercept,gene,0.8677,30303670
27822,Eylea,gene,0.8057,30303670
27823,PDR,disease,0.9907,30303670
27824,aflibercept,gene,0.954,30303670
27825,PRP,cell_type,0.545,30303670
27826,participants,species,0.9785,30303670
27827,PARTICIPANTS,species,0.6025,30303670
27828,Patients,species,0.986,30303670
27829,PDR,disease,1.0,30303670
27830,retinal neovascularisation,disease,1.0,30303670
27831,NV,disease,1.0,30303670
27832,Diabetic Retinopathy,disease,0.958,30303670
27833,macular oedema,disease,1.0,30303670
27834,aflibercept,gene,0.9556,30303670
27835,patients,species,0.922,30303670
27836,retinal NV,disease,0.996,30303670
27837,PRP,cell_type,0.6006,30303670
27838,participants,species,0.9834,30303670
27839,participants,species,0.979,30303670
27840,participants,species,0.9766,30303670
27841,Aflibercept,gene,0.964,30303670
27842,PRP,cell_type,0.5664,30303670
27843,aflibercept,gene,0.9756,30303670
27844,patient,species,0.9897,30303670
27845,PRP,cell_type,0.499,30303670
27846,Patients,species,0.9854,30303670
27847,aflibercept,gene,0.926,30303670
27848,PRP,cell_type,0.5845,30303670
27849,aflibercept,gene,0.9536,30303670
27850,PDR,disease,0.988,30303670
27851,aflibercept,gene,0.9883,30303670
27852,PRP,cell_type,0.586,30303670
27853,vascular endothelial growth factor,gene,0.9766,30303670
27854,Aflibercept,gene,0.933,30303670
27855,neovascular eye diseases,disease,1.0,30295090
27856,anti-VEGFs,gene,0.914,30295090
27857,aflibercept,gene,0.989,30295090
27858,aflibercept,gene,0.987,30295090
27859,poly(lactic-co-glycolic acid),drug,0.9995,30295090
27860,poly(ethylene glycol)-co-(l-lactic acid) diacrylate,drug,0.9995,30295090
27861,N-isopropylacrylamide,drug,0.999,30295090
27862,PEG-PLLA-DA,drug,0.9995,30295090
27863,NIPAAm,drug,0.999,30295090
27864,iodine-125,drug,0.8203,30295090
27865,aflibercept,gene,0.986,30295090
27866,DDS,drug,0.966,30295090
27867,aflibercept,gene,0.99,30295090
27868,aflibercept,gene,0.987,30295090
27869,PEG-PLLA-DA,drug,0.9995,30295090
27870,DDS,DNA,0.455,30295090
27871,DDS,drug,0.9795,30295090
27872,aflibercept,gene,0.9907,30295090
27873,ocular neovascularization,disease,0.9946,30295090
27874,choroidal nevus,disease,0.9736,30289791
27875,pachychoroid neovasculopathy,disease,1.0,30289791
27876,choroidal nevi,disease,0.9985,30289791
27877,choroidal nevus,disease,1.0,30289791
27878,aflibercept,gene,0.98,30289791
27879,pigmented choroidal lesion,disease,0.9995,30289791
27880,abnormal pigmentation,disease,1.0,30289791
27881,choroidal nevus,disease,1.0,30289791
27882,occult malignancy,disease,0.85,30289791
27883,choroidal nevus,disease,1.0,30289791
27884,fundus abnormalities,disease,1.0,30289791
27885,choroidal nevus,disease,1.0,30289791
27886,benign,cell_type,0.587,30289791
27887,benign choroidal nevus,disease,0.9985,30289791
27888,neoplastic,disease,0.9556,30289791
27889,Ranibizumab,gene,0.9414,30288685
27890,Aflibercept,gene,0.9546,30288685
27891,Macular INTRODUCTION,disease,0.861,30288685
27892,ranibizumab,gene,0.857,30288685
27893,aflibercept,gene,0.938,30288685
27894,patients,species,0.944,30288685
27895,macular oedema,disease,1.0,30288685
27896,MO,disease,1.0,30288685
27897,branch retinal vein occlusion,disease,1.0,30288685
27898,BRVO,disease,1.0,30288685
27899,patients,species,0.9536,30288685
27900,MO,disease,,30288685
27901,BRVO,disease,1.0,30288685
27902,ranibizumab,gene,0.7754,30288685
27903,patients,species,0.988,30288685
27904,intraretinal,disease,0.522,30288685
27905,patients,species,0.9883,30288685
27906,aflibercept,gene,0.929,30288685
27907,BCVA,DNA,0.5015,30288685
27908,CRT,DNA,0.5845,30288685
27909,Participants,species,0.906,30288685
27910,patients,species,0.9785,30288685
27911,Patients,species,0.983,30288685
27912,ranibizumab,gene,0.8525,30288685
27913,BCVA,cell_type,0.4106,30288685
27914,aflibercept,gene,0.9834,30288685
27915,MO,disease,,30288685
27916,BRVO,disease,1.0,30288685
27917,aflibercept,gene,0.948,30288685
27918,ranibizumab,gene,0.8647,30288685
27919,patients,species,0.9863,30288685
27920,Disorganization of Retinal Inner Layers,disease,0.8853,30286219
27921,Disorganization of retinal inner layers,disease,0.9863,30286219
27922,DRIL,disease,0.9927,30286219
27923,diabetic macular edema,disease,1.0,30286219
27924,patients,species,0.96,30286219
27925,retinal vein occlusion,disease,1.0,30286219
27926,RVO,disease,1.0,30286219
27927,macular edema,disease,1.0,30286219
27928,DRIL,gene,0.85,30286219
27929,DRIL,gene,0.643,30286219
27930,RVO,disease,1.0,30286219
27931,PARTICIPANTS,species,0.5503,30286219
27932,patients,species,0.9897,30286219
27933,branch RVO,disease,0.994,30286219
27934,BRVO,disease,1.0,30286219
27935,RVO,disease,1.0,30286219
27936,CRVO,disease,1.0,30286219
27937,hemispheric RVO,disease,0.994,30286219
27938,HRVO,disease,1.0,30286219
27939,retinal or ocular disease,disease,0.999,30286219
27940,DRIL,gene,0.988,30286219
27941,Anti-vascular endothelial growth factor,gene,0.9473,30286219
27942,AVF,gene,0.988,30286219
27943,ranibizumab,gene,0.923,30286219
27944,aflibercept,gene,0.9688,30286219
27945,bevacizumab,gene,0.5684,30286219
27946,DRIL,DNA,0.4893,30286219
27947,DRIL,disease,0.9966,30286219
27948,patients,species,0.986,30286219
27949,DRIL,disease,0.998,30286219
27950,BRVO,disease,0.9995,30286219
27951,CRVO,disease,0.9995,30286219
27952,DRIL,gene,0.9814,30286219
27953,Diabetic Retinopathy,disease,0.9985,30286219
27954,DRIL,gene,0.9736,30286219
27955,DRIL,gene,0.9727,30286219
27956,CRVO,disease,1.0,30286219
27957,HRVO,disease,1.0,30286219
27958,DRIL,gene,0.964,30286219
27959,DRIL,gene,0.9355,30286219
27960,DRIL,gene,0.977,30286219
27961,DRIL,gene,0.9854,30286219
27962,DRIL,gene,0.928,30286219
27963,DRIL,gene,0.962,30286219
27964,CRVO,disease,0.9995,30286219
27965,HRVO,disease,1.0,30286219
27966,DRIL,gene,0.9775,30286219
27967,DRIL,gene,0.986,30286219
27968,DRIL,gene,0.992,30286219
27969,DRIL,gene,0.99,30286219
27970,DRIL,gene,0.9917,30286219
27971,DRIL,gene,0.9907,30286219
27972,DRIL,gene,0.9756,30286219
27973,macular edema,disease,1.0,30286219
27974,RVO,disease,1.0,30286219
27975,Glioblastoma Multiforme,disease,1.0,30283503
27976,Glioblastoma multiforme,disease,1.0,30283503
27977,GBM,disease,1.0,30283503
27978,solid tumors,disease,1.0,30283503
27979,tumor,disease,0.543,30283503
27980,GBM,disease,1.0,30283503
27981,malignant,disease,0.713,30283503
27982,tumors,disease,0.9517,30283503
27983,vascular endothelial growth factor,gene,0.9995,30283503
27984,VEGF,gene,0.998,30283503
27985,integrin,gene,0.937,30283503
27986,GBMs,disease,1.0,30283503
27987,bevacizumab,gene,0.55,30283503
27988,enzastaurin,drug,0.9844,30283503
27989,aflibercept,gene,0.973,30283503
27990,cediranib,drug,0.998,30283503
27991,cilengitide,drug,0.997,30283503
27992,VEGF,gene,0.9204,30283503
27993,integrin,gene,0.9844,30283503
27994,glioblastoma,disease,1.0,30283503
27995,integrin,gene,0.983,30283503
27996,glioblastomas,disease,1.0,30283503
27997,aflibercept,gene,0.994,30271222
27998,choroidal neovascularization,disease,1.0,30271222
27999,angioid,disease,1.0,30271222
28000,patient,species,0.9688,30271222
28001,ranibizumab,gene,0.8154,30271222
28002,aflibercept,gene,0.9736,30271222
28003,choroidal neovascularization,disease,1.0,30271222
28004,CNV,disease,1.0,30271222
28005,angioid streaks,disease,1.0,30271222
28006,AS,disease,1.0,30271222
28007,CNV,disease,0.999,30271222
28008,AS,disease,,30271222
28009,ranibizumab,gene,0.636,30271222
28010,aflibercept,gene,0.9414,30271222
28011,patient,species,0.9834,30271222
28012,age-related macular degeneration,disease,1.0,30271222
28013,aflibercept,gene,0.9814,30271222
28014,aflibercept,gene,0.969,30271222
28015,aflibercept,gene,0.994,30271222
28016,CNV,disease,0.9985,30271222
28017,AS,disease,,30271222
28018,aflibercept,gene,0.944,30271222
28019,Bevacizumab,gene,0.6694,30269186
28020,neovascular age-related macular degeneration,disease,1.0,30269186
28021,neovascular age-related macular degeneration,disease,0.999,30269186
28022,nAMD,disease,1.0,30269186
28023,nAMD,disease,1.0,30269186
28024,patients,species,0.9893,30269186
28025,anti-vascular endothelial growth factor,gene,0.9546,30269186
28026,VEGF,gene,0.997,30269186
28027,patients,species,0.9766,30269186
28028,bevacizumab,gene,0.949,30269186
28029,bevacizumab,gene,0.881,30269186
28030,aflibercept,gene,0.984,30269186
28031,Subretinal fluid,disease,0.993,30269186
28032,bevacizumab,gene,0.9087,30269186
28033,nAMD,disease,1.0,30269186
28034,aflibercept,gene,0.9946,30258077
28035,bevacizumab,gene,0.507,30258077
28036,myopic choroidal,disease,0.867,30258077
28037,aflibercept,gene,0.989,30258077
28038,patients,species,0.971,30258077
28039,choroidal neovascularization,disease,0.9995,30258077
28040,mCNV,disease,1.0,30258077
28041,patients,species,0.9844,30258077
28042,mCNV,disease,0.999,30258077
28043,bevacizumab,gene,0.6123,30258077
28044,patients,species,0.9185,30258077
28045,aflibercept,gene,0.978,30258077
28046,patients,species,0.9824,30258077
28047,bevacizumab,gene,0.855,30258077
28048,patients,species,0.986,30258077
28049,bevacizumab,gene,0.8467,30258077
28050,bevacizumab,gene,0.6577,30258077
28051,aflibercept,gene,0.9917,30258077
28052,patients,species,0.985,30258077
28053,aflibercept,gene,0.9487,30258077
28054,aflibercept,gene,0.957,30258077
28055,bevacizumab,gene,0.8843,30258077
28056,aflibercept,gene,0.9746,30258077
28057,aflibercept,gene,0.992,30258077
28058,bevacizumab,gene,0.745,30258077
28059,retinal detachment,disease,1.0,30258077
28060,infectious endophthalmitis,disease,1.0,30258077
28061,aflibercept,gene,0.988,30258077
28062,choroidal neovascularization,disease,1.0,30258077
28063,aflibercept,gene,0.9907,30258077
28064,bevacizumab,gene,0.5576,30258077
28065,mCNV,disease,0.9985,30258077
28066,Severe Proliferative Diabetic,disease,1.0,30255745
28067,patients,species,0.9604,30255745
28068,proliferative diabetic retinopathy,disease,1.0,30255745
28069,PDR,disease,1.0,30255745
28070,PATIENTS,species,0.93,30255745
28071,patients,species,0.9917,30255745
28072,Patients,species,0.932,30255745
28073,patients,species,0.98,30255745
28074,proliferative diabetic retinopathy,disease,1.0,30255745
28075,PDR,disease,1.0,30255745
28076,aflibercept,gene,0.988,30255745
28077,PDR,disease,1.0,30255745
28078,patients,species,0.9917,30255745
28079,aflibercept,gene,0.979,30255745
28080,patients,species,0.993,30255745
28081,diabetes mellitus,disease,1.0,30255745
28082,patients,species,0.9697,30255745
28083,IL-6,gene,0.9756,30255745
28084,IL-8,gene,0.958,30255745
28085,IL-12p70,gene,0.9956,30255745
28086,TNF,gene,0.989,30255745
28087,IL-10,gene,0.9863,30255745
28088,IL-1,gene,0.979,30255745
28089,patients,species,0.981,30255745
28090,Human,species,0.9976,30255745
28091,PDR,disease,0.9995,30255745
28092,patients,species,0.993,30255745
28093,aflibercept,gene,0.9478,30255745
28094,IL-12p70,gene,0.998,30255745
28095,TNF,gene,0.988,30255745
28096,IL-10,gene,0.98,30255745
28097,IL-1,gene,0.9526,30255745
28098,patients,species,0.9863,30255745
28099,aflibercept,gene,0.99,30255745
28100,IL-8,gene,0.9575,30255745
28101,IL-8,gene,0.95,30255745
28102,PDR,disease,0.997,30255745
28103,patients,species,0.996,30255745
28104,IL-8,gene,0.95,30255745
28105,PDR,disease,0.96,30255745
28106,Aflibercept,gene,0.985,30255745
28107,aflibercept,gene,0.9927,30254966
28108,metastatic colorectal cancer,disease,0.9995,30254966
28109,aflibercept,gene,0.9736,30254966
28110,metastatic colorectal cancer,disease,1.0,30254966
28111,aflibercept,gene,0.9424,30254966
28112,FOLFIRI3,drug,0.9585,30254966
28113,aflibercept,gene,0.924,30254966
28114,folinic acid,drug,0.99,30254966
28115,irinotecan,drug,0.998,30254966
28116,5-fluorouracil,drug,0.999,30254966
28117,irinotecan,drug,0.998,30254966
28118,metastatic colorectal cancer,disease,0.9795,30254966
28119,aflibercept,gene,0.976,30254966
28120,irinotecan,drug,0.9976,30254966
28121,irinotecan,drug,0.9995,30254966
28122,diarrhea,disease,1.0,30254966
28123,neutropenia,disease,1.0,30254966
28124,stomatitis,disease,1.0,30254966
28125,anemia,disease,1.0,30254966
28126,hypertension,disease,1.0,30254966
28127,irinotecan,drug,0.9995,30254966
28128,aflibercept,gene,0.9287,30254966
28129,irinotecan,drug,0.999,30254966
28130,FOLFIRI,drug,0.9004,30254966
28131,aflibercept,gene,0.9697,30254966
28132,FOLFIRI3,drug,0.9697,30254966
28133,aflibercept,gene,0.9766,30254966
28134,macular oedema,disease,1.0,30251325
28135,retinal vein occlusions,disease,1.0,30251325
28136,aflibercept,gene,0.9316,30251325
28137,bevacizumab,gene,0.883,30251325
28138,ranibizumab,gene,0.8174,30251325
28139,aflibercept,gene,0.9673,30251325
28140,macular oedema,disease,1.0,30251325
28141,retinal vein occlusions,disease,1.0,30251325
28142,aflibercept,gene,0.968,30251325
28143,macular oedema,disease,1.0,30251325
28144,branch and central RVO,disease,0.9604,30251325
28145,RVO,disease,0.998,30251325
28146,aflibercept,gene,0.942,30251325
28147,aflibercept,gene,0.9395,30251325
28148,bevacizumab,gene,0.935,30251325
28149,ranibizumab,gene,0.947,30251325
28150,aflibercept,gene,0.9844,30251325
28151,macular oedema,disease,1.0,30251325
28152,RVO,disease,1.0,30251325
28153,Acute Endophthalmitis,disease,1.0,30242325
28154,patients,species,0.9907,30242325
28155,retinal diseases,disease,0.9995,30242325
28156,endophthalmitis,disease,1.0,30242325
28157,acute endophthalmitis,disease,0.9946,30242325
28158,vascular endothelial growth factor,gene,0.9062,30242325
28159,VEGF,gene,0.7773,30242325
28160,PARTICIPANTS,species,0.564,30242325
28161,patients,species,0.975,30242325
28162,VEGF,gene,0.96,30242325
28163,acute endophthalmitis,disease,0.9976,30242325
28164,VEGF,gene,0.943,30242325
28165,patients,species,0.9907,30242325
28166,acute endophthalmitis,disease,1.0,30242325
28167,endophthalmitis,disease,1.0,30242325
28168,endophthalmitis,disease,1.0,30242325
28169,patients,species,0.9897,30242325
28170,VEGF,gene,0.9404,30242325
28171,VEGF,gene,0.794,30242325
28172,aflibercept,gene,0.9766,30242325
28173,acute endophthalmitis,disease,1.0,30242325
28174,VEGF,gene,0.938,30242325
28175,acute endophthalmitis,disease,0.998,30242325
28176,anti-VEGF,gene,0.733,30242325
28177,endophthalmitis,disease,1.0,30242325
28178,VEGF,gene,0.7803,30242325
28179,aflibercept,gene,0.976,30238648
28180,age-related macular degeneration,disease,0.989,30238648
28181,Macula,disease,1.0,30238648
28182,aflibercept,gene,0.9604,30238648
28183,Macula,disease,0.999,30238648
28184,age-related macular degeneration,disease,1.0,30238648
28185,aflibercept,gene,0.9385,30238648
28186,Diabetic Retinopathy,disease,1.0,30238648
28187,ranibizumab,gene,0.8726,30238189
28188,aflibercept,gene,0.9756,30238189
28189,aflibercept,gene,0.972,30238189
28190,ranibizumab,gene,0.728,30238189
28191,triamcinolone acetonide,drug,0.9976,30238189
28192,patients,species,0.962,30238189
28193,diabetic macular edema,disease,1.0,30238189
28194,DME,disease,1.0,30238189
28195,patients,species,0.987,30238189
28196,DME,disease,1.0,30238189
28197,Patients,species,0.972,30238189
28198,phakia,disease,1.0,30238189
28199,patients,species,0.976,30238189
28200,pseudophakia,disease,1.0,30238189
28201,patients,species,0.99,30238189
28202,phakia,disease,1.0,30238189
28203,patients,species,0.993,30238189
28204,pseudophakia,disease,1.0,30238189
28205,pseudophakic,disease,0.9985,30238189
28206,pseudophakic,disease,1.0,30238189
28207,CRT,DNA,0.5444,30238189
28208,DME,disease,0.923,30238189
28209,IVTA,drug,0.665,30238189
28210,IVA,drug,0.6973,30238189
28211,IVTA,drug,0.7983,30238189
28212,PATIENTS,species,0.992,30234855
28213,vascular endothelial growth factor,gene,0.931,30234855
28214,bevacizumab,gene,0.9116,30234855
28215,ranubizumab,gene,0.952,30234855
28216,aflibercept,gene,0.963,30234855
28217,glaucoma,disease,1.0,30234855
28218,AC,disease,0.8315,30234855
28219,glaucoma,disease,0.796,30234855
28220,anti-vascular endothelial growth factor,gene,0.933,30234855
28221,Endophthalmitis,disease,1.0,30214147
28222,anti-VEGF,gene,0.8154,30214147
28223,anti-,gene,0.5767,30214147
28224,vascular endothelial growth factor,gene,0.9126,30214147
28225,VEGF,gene,0.9976,30214147
28226,aflibercept,gene,0.9844,30214147
28227,bevacizumab,gene,0.871,30214147
28228,ranibizumab,gene,0.6655,30214147
28229,neovascular,disease,0.8833,30214147
28230,age-related macular degeneration,disease,1.0,30214147
28231,nAMD,disease,1.0,30214147
28232,ocular inflammation,disease,0.9956,30214147
28233,anti-VEGF,gene,0.988,30214147
28234,endophthalmitis,disease,1.0,30214147
28235,anti-VEGF,gene,0.994,30214147
28236,endophthalmitis,disease,1.0,30214147
28237,endophthalmitis,disease,1.0,30214147
28238,aflibercept,gene,0.989,30214147
28239,bevacizumab,gene,0.825,30214147
28240,ranibizumab,gene,0.7173,30214147
28241,nAMD,disease,1.0,30214147
28242,endophthalmitis,disease,1.0,30214147
28243,anti-VEGF,gene,0.9917,30214147
28244,Endophthalmitis,disease,1.0,30214147
28245,aflibercept,gene,0.98,30214147
28246,bevacizumab,gene,0.9014,30214147
28247,ranibizumab,gene,0.641,30214147
28248,endophthalmitis,disease,1.0,30214147
28249,nAMD,disease,1.0,30214147
28250,endophthalmitis,disease,1.0,30214147
28251,aflibercept,gene,0.994,30214147
28252,bevacizumab,gene,0.927,30214147
28253,ranibizumab,gene,0.803,30214147
28254,aflibercept,gene,0.991,30214147
28255,endophthalmitis,disease,1.0,30214147
28256,endophthalmitis,disease,1.0,30214147
28257,bevacizumab,gene,0.8843,30214147
28258,ranibizumab,gene,0.5483,30214147
28259,endophthalmitis,disease,1.0,30214147
28260,endophthalmitis,disease,1.0,30214147
28261,aflibercept,gene,0.9893,30214147
28262,bevacizumab,gene,0.818,30214147
28263,ranibizumab,gene,0.5317,30214147
28264,nAMD,disease,1.0,30214147
28265,aflibercept,gene,0.9746,30214143
28266,ranibizumab,gene,0.729,30214143
28267,age-related macular degeneration,disease,1.0,30214143
28268,polypoidal choroidal vasculopathy,disease,1.0,30214143
28269,aflibercept,gene,0.8843,30214143
28270,neovascular age-related macula degenelation,disease,1.0,30214143
28271,t-AMD,disease,0.999,30214143
28272,polypoidal choroidal vasculopathy,disease,1.0,30214143
28273,PCV,disease,1.0,30214143
28274,ranibizumab,gene,0.7295,30214143
28275,aflibercept,gene,0.968,30214143
28276,t-AMD,disease,0.999,30214143
28277,PCV,disease,1.0,30214143
28278,aflibercept,gene,0.987,30214143
28279,aflibercept,gene,0.982,30214143
28280,PCV,disease,1.0,30214143
28281,t-,disease,0.998,30214143
28282,AMD,disease,1.0,30214143
28283,PCV,disease,1.0,30214143
28284,ranibizumab,gene,0.841,30214143
28285,aflibercept,gene,0.9907,30214143
28286,PCV,disease,1.0,30214143
28287,t-AMD,disease,0.999,30214143
28288,branch retinal vein occlusion,disease,0.992,30213608
28289,Aflibercept,gene,0.949,30208574
28290,VEGF,gene,0.993,30208574
28291,Age-related macular degeneration,disease,1.0,30208574
28292,AMD,disease,1.0,30208574
28293,blindness,disease,0.9937,30208574
28294,AMD,disease,1.0,30208574
28295,vascular endothelial growth factor,gene,0.998,30208574
28296,VEGF,gene,0.9927,30208574
28297,aflibercept,gene,0.976,30208574
28298,VEGF,gene,0.9956,30208574
28299,retinal detachment,disease,1.0,30208574
28300,Aflibercept,gene,0.9873,30208574
28301,AFL,gene,0.996,30208574
28302,poly lactic-co-glycolic acid,drug,0.9995,30208574
28303,PLGA,drug,0.9995,30208574
28304,AFL,drug,0.9443,30208574
28305,aflibercept,gene,0.964,30208574
28306,AMD,disease,1.0,30208574
28307,vascular endothelial growth factor,gene,0.8984,30204303
28308,anti-,gene,0.7373,30204303
28309,vascular endothelial growth factor,gene,0.892,30204303
28310,VEGF,gene,0.995,30204303
28311,diabetic macular edema,disease,1.0,30204303
28312,DME,disease,1.0,30204303
28313,ophthalmologists,cell_type,0.4204,30204303
28314,anti-VEGF antibodies,gene,0.919,30204303
28315,VEGF,gene,0.5605,30204303
28316,VEGF,gene,0.888,30204303
28317,cerebral infarction,disease,1.0,30204303
28318,ranibizumab,gene,0.915,30204303
28319,aflibercept,gene,0.985,30204303
28320,VEGF,gene,0.908,30204303
28321,DME,disease,1.0,30204303
28322,Aflibercept,gene,0.9688,30202619
28323,Choroidal Choroidal neovascular membrane,disease,1.0,30202619
28324,CNV,disease,1.0,30202619
28325,patients,species,0.8823,30202619
28326,sympathetic ophthalmia,disease,1.0,30202619
28327,man,species,0.886,30202619
28328,type 2 CNV,disease,1.0,30202619
28329,aflibercept,gene,0.97,30202619
28330,vascular endothelial growth factor,gene,0.9907,30202619
28331,sympathetic ophthalmia,disease,1.0,30202619
28332,CNV,disease,0.943,30202619
28333,Vascular Endothelial Growth Factor,gene,0.8325,30202615
28334,anti-vascular endothelial growth factor,gene,0.813,30202615
28335,VEGF,gene,0.9985,30202615
28336,on,cell_line,,30202615
28337,retinal pigment epithelium cell culture,cell_line,0.886,30202615
28338,retinal pigment epithelium,cell_type,0.4834,30202615
28339,Aflibercept,gene,0.9795,30202615
28340,bevacizumab,gene,0.7764,30202615
28341,ranibizumab,gene,0.5015,30202615
28342,retinal pigment epithelium cell cultures,cell_line,0.958,30202615
28343,retinal pigment epithelium,cell_type,0.52,30202615
28344,rabbits,species,0.7705,30202615
28345,drug-treated cultures,cell_line,0.946,30202615
28346,aflibercept,gene,0.987,30202615
28347,control culture,cell_line,0.9165,30202615
28348,bevacizumab,gene,0.559,30202615
28349,bevacizumab,gene,0.836,30202615
28350,ranibizumab,gene,0.7446,30202615
28351,VEGF,gene,0.969,30202615
28352,retinal pigment epithelium cells,cell_type,0.857,30202615
28353,Aflibercept,gene,0.986,30202615
28354,retinal pigment epithelium culture,cell_line,0.971,30202615
28355,retinal pigment epithelium,cell_type,0.504,30202615
28356,retinal specialists,cell_type,0.4563,30188025
28357,age-related macular degeneration,disease,1.0,30188025
28358,ranibizumab,gene,0.8936,30188025
28359,bevacizumab,gene,0.6206,30188025
28360,polypoidal choroidal vasculopathy,disease,1.0,30188025
28361,verteporfin,drug,0.9985,30188025
28362,vascular endothelial growth factor,gene,0.956,30188025
28363,VEGF,gene,0.996,30188025
28364,aflibercept,gene,0.964,30188025
28365,VEGF,gene,0.964,30188025
28366,diabetic macular edema,disease,1.0,30188025
28367,DME,disease,1.0,30188025
28368,dexamethasone,drug,0.9746,30188025
28369,DME,disease,1.0,30188025
28370,anti-VEGF,gene,0.9644,30188025
28371,anti-vascular endothelial growth factor,gene,0.9688,30181760
28372,anti-VEGF,gene,0.9897,30181760
28373,Diabetes,disease,1.0,30181760
28374,visual impairment,disease,1.0,30181760
28375,diabetic retinopathy,disease,1.0,30181760
28376,vision loss,disease,0.9995,30181760
28377,proliferative diabetic retinopathy,disease,1.0,30181760
28378,PDR,disease,1.0,30181760
28379,Vascular endothelial growth factor,gene,0.998,30181760
28380,VEGF,gene,0.9966,30181760
28381,VEGF,gene,0.996,30181760
28382,VEGF,gene,0.603,30181760
28383,diabetic macular edema,disease,1.0,30181760
28384,DME,disease,1.0,30181760
28385,diabetic retinopathy,disease,1.0,30181760
28386,VEGF,gene,0.8516,30181760
28387,anti-VEGF,gene,0.8364,30181760
28388,PRP,cell_type,0.6567,30181760
28389,PDR,disease,0.998,30181760
28390,anti-VEGF,gene,0.9556,30181760
28391,vitreous hemorrhage,disease,0.9995,30181760
28392,PRP,cell_type,0.6094,30181760
28393,VEGF,gene,0.906,30181760
28394,PDR,disease,0.9995,30181760
28395,VEGF,gene,0.833,30181760
28396,patient,species,0.978,30181760
28397,VEGF,gene,0.8438,30181760
28398,PDR,disease,0.9995,30181760
28399,neovascular age-related macular degeneration,disease,1.0,30173338
28400,AMD,disease,1.0,30173338
28401,VEGF,gene,0.9966,30173338
28402,patients,species,0.972,30173338
28403,SHRM,disease,1.0,30173338
28404,exudative AMD,disease,0.998,30173338
28405,SHRM,disease,1.0,30173338
28406,fibrosis,disease,0.9937,30173338
28407,subretinal hyperreflective exudation,disease,1.0,30173338
28408,SHE,disease,1.0,30173338
28409,hemorrhage,disease,0.7744,30173338
28410,SHRM,cell_line,0.5776,30173338
28411,patients,species,0.9893,30173338
28412,fibrosis,disease,0.978,30173338
28413,type 2 NV,disease,0.9995,30173338
28414,SHE,disease,0.995,30173338
28415,SHE,disease,1.0,30173338
28416,type 2 NV,disease,1.0,30173338
28417,hemorrhage,disease,1.0,30173338
28418,SHRM,disease,0.9976,30173338
28419,patients,species,0.948,30173338
28420,AMD,disease,1.0,30173338
28421,vascular endothelial growth factor receptor-1,gene,0.998,30170190
28422,VEGFR-1,gene,0.9883,30170190
28423,cancer cells,cell_type,0.835,30170190
28424,cancer,disease,0.9976,30170190
28425,tumor,disease,0.959,30170190
28426,vascular endothelial growth factor receptor-1,gene,0.999,30170190
28427,VEGFR-1,gene,0.9966,30170190
28428,tyrosine,drug,0.977,30170190
28429,tyrosine kinase receptor,gene,0.9893,30170190
28430,VEGF-A,gene,0.999,30170190
28431,VEGF-B,gene,0.999,30170190
28432,PlGF,gene,0.9175,30170190
28433,endothelial,cell_line,0.612,30170190
28434,"endothelial, myelomonocytic and tumor cells",cell_type,0.81,30170190
28435,tumor,disease,0.906,30170190
28436,VEGF-B,gene,0.997,30170190
28437,PlGF,gene,0.9844,30170190
28438,VEGFR-1,gene,0.994,30170190
28439,VEGF-A,gene,0.997,30170190
28440,VEGFR-2,gene,0.9966,30170190
28441,VEGFR-2,gene,0.9946,30170190
28442,VEGFR-1,gene,0.9937,30170190
28443,tumor,disease,0.555,30170190
28444,VEGFR-1,gene,0.9966,30170190
28445,PlGF,gene,0.9907,30170190
28446,tumors,disease,1.0,30170190
28447,VEGF-A,gene,0.993,30170190
28448,solid tumors,disease,1.0,30170190
28449,VEGF-A,gene,0.996,30170190
28450,VEGFR-2,gene,0.9946,30170190
28451,VEGFR-1,gene,0.9907,30170190
28452,mAb,gene,0.675,30170190
28453,anti-VEGF-A,gene,0.959,30170190
28454,bevacizumab,gene,0.4507,30170190
28455,aflibercept,gene,0.9697,30170190
28456,tyrosine,drug,0.97,30170190
28457,tyrosine kinase,gene,0.9805,30170190
28458,VEGFR-2,gene,0.994,30170190
28459,mAb anti-VEGFR-2 ramucirumab,gene,0.893,30170190
28460,VEGF-A,gene,0.9985,30170190
28461,VEGFR-2,gene,0.9946,30170190
28462,tumor,disease,0.9863,30170190
28463,protumoral myeloid cells,cell_type,0.933,30170190
28464,VEGFR-1,gene,0.9883,30170190
28465,tumor,disease,0.989,30170190
28466,tumor,disease,0.9756,30170190
28467,myeloid progenitor,cell_line,0.796,30170190
28468,VEGFR,cell_line,0.776,30170190
28469,VEGFR-,cell_type,0.689,30170190
28470,VEGFR-1,gene,0.9927,30170190
28471,tumor,disease,1.0,30170190
28472,VEGFR,cell_line,0.885,30170190
28473,VEGFR-1 positive tumor cells,cell_type,0.6816,30170190
28474,VEGFR-1,gene,0.993,30170190
28475,VEGFR-1,gene,0.9897,30170190
28476,VEGF-A,gene,0.992,30170190
28477,VEGFR-1,gene,0.9927,30170190
28478,VEGFR-1,gene,0.992,30170190
28479,cancer,disease,1.0,30170190
28480,macular atrophy,disease,1.0,30166328
28481,neovascular age-related macular degeneration,disease,1.0,30166328
28482,ranibizumab,gene,0.758,30166328
28483,aflibercept,gene,0.7817,30166328
28484,macular atrophy,disease,1.0,30166328
28485,MA,disease,1.0,30166328
28486,neovascular age-related macular degeneration,disease,1.0,30166328
28487,ranibizumab,gene,0.815,30166328
28488,aflibercept,gene,0.8647,30166328
28489,ranibizumab,gene,0.6143,30166328
28490,aflibercept,gene,0.8887,30166328
28491,MA,disease,0.9316,30166328
28492,MA,disease,0.9736,30166328
28493,choroidal neovascularisation,disease,1.0,30166328
28494,CONCLUSION,cell_line,0.504,30166328
28495,neovascular age-related macular degeneration,disease,1.0,30166233
28496,nAMD,disease,1.0,30166233
28497,Aflibercept,gene,0.9634,30166233
28498,aflibercept,gene,0.995,30166233
28499,nAMD,disease,1.0,30166233
28500,PATIENTS,species,0.9546,30166233
28501,nAMD,disease,1.0,30166233
28502,aflibercept,gene,0.935,30166233
28503,neovascular,DNA,0.4429,30166233
28504,neovascular lesion,disease,0.996,30166233
28505,Aflibercept,gene,0.843,30166233
28506,neovascular AMD,disease,1.0,30166233
28507,AFLIBERCEPT,disease,0.7256,30161093
28508,MACULAR DEGENERATION,disease,0.7393,30161093
28509,aflibercept,gene,0.942,30161093
28510,age-related macular degeneration,disease,1.0,30161093
28511,aflibercept,gene,0.96,30161093
28512,Diabetic Retinopathy,disease,0.995,30161093
28513,Retinopathy,disease,0.9995,30161093
28514,Diabetic,RNA,0.4255,30161093
28515,Diabetic Retinopathy,disease,1.0,30161093
28516,Aflibercept,gene,0.4487,30161093
28517,exudative age-related macular degeneration,disease,1.0,30150279
28518,vascular endothelial growth factor,gene,0.9966,30150279
28519,VEGF,gene,0.992,30150279
28520,age-related macular degeneration,disease,1.0,30150279
28521,AMD,disease,1.0,30150279
28522,exudative AMD,disease,0.9995,30150279
28523,anti-VEGF,gene,0.8467,30150279
28524,intraretinal fluid,disease,0.8506,30150279
28525,SFCT,DNA,0.516,30150279
28526,exudative AMD,disease,0.9663,30150279
28527,aflibercept,gene,0.985,30150144
28528,photoreceptors,cell_type,0.711,30150144
28529,mice,species,0.977,30150144
28530,anti-placental growth factor,gene,0.9956,30150144
28531,PlGF,gene,0.9707,30150144
28532,retinal damage,disease,0.7397,30150144
28533,age-related macular degeneration,disease,0.993,30150144
28534,AMD,disease,1.0,30150144
28535,Aflibercept,gene,0.97,30150144
28536,vascular endothelial growth factor,gene,0.998,30150144
28537,VEGF,gene,0.9966,30150144
28538,PlGF,gene,0.991,30150144
28539,aflibercept,gene,0.983,30150144
28540,anti-VEGF antibody,gene,0.9336,30150144
28541,PlGF,gene,0.9917,30150144
28542,human retinal pigment epithelial cells,cell_type,0.8843,30150144
28543,aflibercept,gene,0.9873,30150144
28544,the,gene,0.8643,30150144
28545,aflibercept,gene,0.501,30150144
28546,non-exudative AMD,disease,0.999,30150144
28547,Bevacizumab,gene,0.897,30149985
28548,Metastatic Colorectal Cancer,disease,1.0,30149985
28549,metastatic colorectal cancer,disease,0.9995,30149985
28550,bevacizumab,gene,0.827,30149985
28551,aflibercept,gene,0.9146,30149985
28552,vascular endothelial growth factor (VEGF)-D,gene,0.991,30149985
28553,VEGF-D,gene,0.9985,30149985
28554,VEGF receptor,gene,0.9956,30149985
28555,VEGF-D,gene,0.9985,30149985
28556,bevacizumab,gene,0.677,30149985
28557,VEGF ligands,gene,0.8203,30149985
28558,RAISE,DNA,0.508,30149985
28559,Polyp,disease,0.5376,30140086
28560,Aflibercept,gene,0.871,30140086
28561,Polypoidal Choroidal Vasculopathy,disease,1.0,30140086
28562,aflibercept,gene,0.8564,30140086
28563,polypoidal choroidal vasculopathy,disease,1.0,30140086
28564,polyp,disease,0.957,30140086
28565,IVA,drug,0.9243,30140086
28566,polyp,disease,1.0,30140086
28567,polyp,disease,0.9966,30140086
28568,polyp,disease,0.625,30140086
28569,CRT,DNA,0.575,30140086
28570,polyp,disease,0.8843,30140086
28571,polyp,disease,1.0,30140086
28572,vascular endothelial growth factor Trap,gene,0.574,30136881
28573,glioma,disease,1.0,30136881
28574,vascular endothelial growth factor Trap,gene,0.995,30136881
28575,VEGF-Trap,gene,0.9863,30136881
28576,4T1,cell_line,0.849,30136881
28577,metastatic breast cancer,disease,0.9976,30136881
28578,VEGF-Trap,gene,0.8877,30136881
28579,glioma,disease,1.0,30136881
28580,glioma,disease,1.0,30136881
28581,rats,species,0.9893,30136881
28582,VEGF-Trap,gene,0.788,30136881
28583,bevacizumab,drug,0.756,30136881
28584,BEV,drug,0.9766,30136881
28585,temozolomide,drug,0.9985,30136881
28586,TMZ,drug,0.9976,30136881
28587,TMZ,drug,0.996,30136881
28588,VEGF-Trap,gene,0.93,30136881
28589,TMZ,drug,0.9927,30136881
28590,BEV,drug,0.991,30136881
28591,tumor,disease,0.9146,30136881
28592,terminal dexynucleotidyl transferase,gene,0.995,30136881
28593,TdT,gene,0.987,30136881
28594,dUTP,drug,0.9927,30136881
28595,tumor,disease,0.9863,30136881
28596,TMZ,drug,0.9365,30136881
28597,VEGF,gene,0.994,30136881
28598,BEV,drug,0.6753,30136881
28599,tumor,disease,0.9985,30136881
28600,VEGF,gene,0.9956,30136881
28601,Trap,gene,0.371,30136881
28602,TMZ,drug,0.974,30136881
28603,apoptotic tumor cells,cell_type,0.6772,30136881
28604,tumor,disease,0.8027,30136881
28605,TMZ,drug,0.98,30136881
28606,VEGF,gene,0.995,30136881
28607,Trap,gene,0.6123,30136881
28608,TMZ,drug,0.9814,30136881
28609,BEV,drug,0.9897,30136881
28610,Ki-67,gene,0.949,30136881
28611,CD31,gene,0.973,30136881
28612,VEGF,gene,0.993,30136881
28613,Trap,gene,0.4502,30136881
28614,glioma,disease,1.0,30136881
28615,BEV,cell_line,0.573,30136881
28616,VEGF,gene,0.995,30136881
28617,Trap,gene,0.396,30136881
28618,TMZ,drug,0.9375,30136881
28619,Colorectal Cancer,disease,1.0,30119079
28620,Colorectal carcinoma,disease,1.0,30119079
28621,cancer,disease,1.0,30119079
28622,colorectal cancer,disease,1.0,30119079
28623,colon cancer,disease,1.0,30119079
28624,metastatic cancer,disease,0.999,30119079
28625,metastatic colorectal cancer,disease,1.0,30119079
28626,colorectal carcinoma,disease,1.0,30119079
28627,metastatic colorectal cancer,disease,0.932,30119079
28628,Bevacizumab,gene,0.9277,30119079
28629,metastatic colorectal cancer,disease,0.9937,30119079
28630,ziv-aflibercept,gene,0.974,30119079
28631,regorafenib,drug,0.9585,30119079
28632,bevacizumab,gene,0.6426,30117450
28633,vascular endothelial growth factor,gene,0.998,30117450
28634,VEGF,gene,0.993,30117450
28635,cancers,disease,1.0,30117450
28636,ranibizumab,gene,0.9634,30117450
28637,aflibercept,gene,0.976,30117450
28638,ocular diseases,disease,0.9907,30117450
28639,Aflibercept,gene,0.95,30117334
28640,FOLFIRI,drug,0.4995,30117334
28641,metastatic colorectal cancer,disease,0.9995,30117334
28642,aflibercept,gene,0.99,30117334
28643,5-fluorouracil,drug,0.999,30117334
28644,folinic acid,drug,0.998,30117334
28645,irinotecan,drug,0.998,30117334
28646,oxaliplatin,drug,1.0,30117334
28647,metastatic colorectal cancer,disease,1.0,30117334
28648,aflibercept,gene,0.963,30117334
28649,aflibercept,gene,0.9863,30117334
28650,FOLFIRI,drug,0.9365,30117334
28651,aflibercept,gene,0.9785,30117334
28652,FOLFIRI,drug,0.9854,30117334
28653,metastatic colorectal cancer,disease,0.974,30117334
28654,Aflibercept,gene,0.944,30116636
28655,Pigment Epithelial Detachment,disease,1.0,30116636
28656,Neovascular Age-Related Macular Degeneration,disease,1.0,30116636
28657,nAMD,disease,1.0,30116636
28658,Ranibizumab,gene,0.85,30116636
28659,Ranibizumab,gene,0.966,30116635
28660,Aflibercept,gene,0.9727,30116635
28661,Macular Edema,disease,1.0,30116635
28662,Central Retinal Vein Occlusion,disease,1.0,30116635
28663,ranibizumab,gene,0.9443,30116635
28664,aflibercept,gene,0.939,30116635
28665,macular edema,disease,1.0,30116635
28666,ME,disease,1.0,30116635
28667,central retinal vein occlusion,disease,1.0,30116635
28668,CRVO,disease,1.0,30116635
28669,CRVO,disease,1.0,30116635
28670,ranibizumab,gene,0.8315,30116635
28671,aflibercept,gene,0.6953,30116635
28672,ranibizumab,gene,0.875,30116635
28673,aflibercept,gene,0.958,30116635
28674,ME,disease,0.9893,30116635
28675,CRVO,disease,0.999,30116635
28676,ranibizumab,gene,0.905,30116635
28677,aflibercept,gene,0.99,30116635
28678,ziv-aflibercept,gene,0.9873,30099379
28679,ziv-aflibercept,gene,0.99,30099379
28680,retinal conditions,disease,0.957,30099379
28681,IVZ,drug,0.9326,30099379
28682,IVZ,drug,0.979,30099379
28683,IVZ,drug,0.9478,30099379
28684,IVZ,drug,0.9307,30099379
28685,chorioretinal pathologies,disease,0.993,30099379
28686,endophthalmitis,disease,1.0,30099379
28687,intraocular inflammation,disease,1.0,30099379
28688,conjunctival thinning/necrosis,disease,0.9966,30099379
28689,scleral nodule,disease,1.0,30099379
28690,myocardial infarction,disease,1.0,30099379
28691,stroke,disease,1.0,30099379
28692,IVZ,drug,0.9795,30099379
28693,IVZ,drug,0.975,30099379
28694,vascular endothelial growth factor,gene,0.996,30099379
28695,IVZ,drug,0.9673,30099379
28696,retinal disorders,disease,0.9995,30099379
28697,neovascular age-related macular degeneration,disease,1.0,30097785
28698,VEGF,gene,0.803,30097785
28699,neovascular age-related macular degeneration,disease,1.0,30097785
28700,nAMD,disease,1.0,30097785
28701,nAMD,disease,1.0,30097785
28702,nAMD,disease,1.0,30097785
28703,nAMD,disease,1.0,30097785
28704,subretinal neovascular membrane,disease,0.9194,30097785
28705,nAMD,disease,1.0,30097785
28706,Ranibizumab,gene,0.8916,30091312
28707,Bevacizumab,gene,0.7886,30091312
28708,Aflibercept,gene,0.8936,30091312
28709,Senescent Retinal Pigment Epithelial Cells,cell_type,0.9263,30091312
28710,vascular endothelial growth factor,gene,0.9673,30091312
28711,VEGF,gene,0.9966,30091312
28712,retinal pigment epithelial (RPE) cells,cell_type,0.924,30091312
28713,VEGF,gene,0.987,30091312
28714,healthy RPE cells,cell_type,0.743,30091312
28715,VEGF,gene,0.6055,30091312
28716,ranibizumab,gene,0.8394,30091312
28717,bevacizumab,gene,0.891,30091312
28718,aflibercept,gene,0.9766,30091312
28719,senescent RPE cells,cell_type,0.896,30091312
28720,Senescent human induced pluripotent stem cell-derived RPE cells,cell_line,0.937,30091312
28721,Senescent,cell_type,0.54,30091312
28722,senescent RPE cells,cell_type,0.9014,30091312
28723,anti-VEGF,gene,0.901,30091312
28724,ranibizumab,gene,0.6763,30091312
28725,bevacizumab,gene,0.8657,30091312
28726,aflibercept,gene,0.963,30091312
28727,ranibizumab,gene,0.7266,30091312
28728,bevacizumab,gene,0.8535,30091312
28729,aflibercept,gene,0.978,30091312
28730,senescent RPE cells,cell_type,0.8823,30091312
28731,VEGF,gene,0.791,30091312
28732,zonula occludens-1,gene,0.993,30091312
28733,RPE65,gene,0.987,30091312
28734,senescent RPE cells,cell_type,0.903,30091312
28735,ranibizumab,gene,0.7476,30091312
28736,bevacizumab,gene,0.857,30091312
28737,aflibercept,gene,0.962,30091312
28738,senescent RPE cells,cell_type,0.8975,30091312
28739,Macular Edema,disease,1.0,30089307
28740,Branch Retinal Vein Occlusion,disease,1.0,30089307
28741,disorganization of the retinal inner layers,disease,0.8574,30089307
28742,DRIL,disease,0.9814,30089307
28743,anti-VEGF,gene,0.751,30089307
28744,macular edema,disease,1.0,30089307
28745,ME,disease,1.0,30089307
28746,branch retinal vein occlusion,disease,1.0,30089307
28747,BRVO,disease,1.0,30089307
28748,DRIL,disease,1.0,30089307
28749,DRIL,DNA,0.546,30089307
28750,ME,disease,0.999,30089307
28751,Vascular endothelial growth factor,gene,0.9985,30082848
28752,VEGF,gene,0.996,30082848
28753,choroidal neovascularization,disease,1.0,30082848
28754,CNV,disease,1.0,30082848
28755,patients,species,0.961,30082848
28756,age-related macular degeneration,disease,1.0,30082848
28757,AMD,disease,1.0,30082848
28758,VEGF,gene,0.892,30082848
28759,Aflibercept,gene,0.9727,30082848
28760,VEGF,gene,0.9917,30082848
28761,CNV,disease,0.9976,30082848
28762,anti-VEGF,gene,0.9404,30082848
28763,patient,species,0.9844,30082848
28764,patient,species,0.9785,30082848
28765,retinal and choroidal atrophy,disease,1.0,30082848
28766,patients,species,0.9316,30082848
28767,AMD,disease,1.0,30082848
28768,wet AMD,disease,0.9746,30082848
28769,CNV,disease,0.993,30082848
28770,Eylea,gene,0.994,30082848
28771,riboswitch elements,DNA,0.9185,30082848
28772,rAAV expression cassette,DNA,0.809,30082848
28773,tetracycline,drug,0.9995,30082848
28774,Eylea,drug,0.965,30082848
28775,CNV,disease,0.991,30082848
28776,mouse,species,0.9785,30082848
28777,wet AMD,disease,0.998,30082848
28778,wet AMD,disease,0.9917,30082848
28779,VEGF,gene,0.699,30082848
28780,polypoidal choroidal,disease,1.0,30077969
28781,Ranibizumab,gene,0.8374,30077969
28782,Polypoidal choroidal vasculopathy,disease,1.0,30077969
28783,ranibizumab,gene,0.8774,30077969
28784,patients,species,0.8677,30077969
28785,polypoidal choroidal vasculopathy,disease,1.0,30077969
28786,PCV,disease,1.0,30077969
28787,patientsrandomised,species,0.974,30077969
28788,LAPTOP,DNA,0.62,30077969
28789,dry macula,disease,0.999,30077969
28790,macular atrophy,disease,1.0,30077969
28791,patients,species,0.9854,30077969
28792,aflibercept,gene,0.971,30077969
28793,dry macula,disease,0.9995,30077969
28794,ranibizumab,gene,0.891,30077969
28795,macular atrophy,disease,1.0,30077969
28796,ranibizumab,drug,0.8564,30077969
28797,Vascular Endothelial Growth Factor,gene,0.9834,30077616
28798,Neovascular Age-Related Macular Degeneration,disease,1.0,30077616
28799,vascular endothelial growth factor,gene,0.997,30077616
28800,VEGF,gene,0.997,30077616
28801,neovascular age-related macular degeneration,disease,0.9995,30077616
28802,AMD,disease,1.0,30077616
28803,VEGF,gene,0.977,30077616
28804,neovascular AMD,disease,1.0,30077616
28805,ranibizumab,gene,0.8853,30077616
28806,aflibercept,gene,0.9756,30077616
28807,bevacizumab,gene,0.9004,30077616
28808,ranibizumab,gene,0.7974,30077616
28809,bevacizumab,gene,0.7363,30077616
28810,neovascular AMD,disease,1.0,30077616
28811,Proliferative Diabetic Retinopathy,disease,1.0,30077614
28812,Vascular Endothelial Growth Factor,gene,0.917,30077614
28813,proliferative diabetic retinopathy,disease,0.9995,30077614
28814,PDR,disease,1.0,30077614
28815,vascular endothelial growth factor,gene,0.986,30077614
28816,VEGF,gene,0.9917,30077614
28817,anti-VEGF,gene,0.933,30077614
28818,anti-VEGF,gene,0.973,30077614
28819,PRP,cell_type,0.583,30077614
28820,anti-VEGF,gene,0.886,30077614
28821,PRP,cell_type,0.5522,30077614
28822,tractional retinal detachment,disease,0.996,30077614
28823,PDR,disease,0.9995,30077614
28824,anti-VEGF,gene,0.8125,30077614
28825,PRP,cell_type,0.6733,30077614
28826,PDR,disease,0.999,30077614
28827,Anti-Vascular Endothelial Growth Factor,gene,0.836,30077569
28828,Diabetic Macular Edema,disease,1.0,30077569
28829,vascular endothelial growth factor,gene,0.9844,30077569
28830,diabetic macular edema,disease,1.0,30077569
28831,PATIENT,species,0.9805,30077569
28832,aflibercept,gene,0.9937,30077569
28833,bevacizumab,gene,0.9106,30077569
28834,ranibizumab,gene,0.7773,30077569
28835,aflibercept,gene,0.9785,30077569
28836,bevacizumab,gene,0.9155,30077569
28837,ranibizumab,gene,0.863,30077569
28838,aflibercept,gene,0.9927,30077569
28839,bevacizumab,gene,0.9023,30077569
28840,ranibizumab,gene,0.745,30077569
28841,NK1 and,gene,0.827,30076797
28842,Y2 receptor,gene,0.755,30076797
28843,CNVs,disease,0.995,30076797
28844,mice,species,0.957,30076797
28845,NK1 and Y2 receptors,gene,0.9863,30076797
28846,CNV,disease,0.9946,30076797
28847,choroidal neovascularization,disease,1.0,30076797
28848,mice,species,0.926,30076797
28849,CNV,disease,0.999,30076797
28850,CNV,disease,0.9956,30076797
28851,CNV,disease,0.5234,30076797
28852,CNV,disease,0.642,30076797
28853,NK1,gene,0.6694,30076797
28854,Y2,gene,0.7617,30076797
28855,mice,species,0.98,30076797
28856,CNV,disease,0.9937,30076797
28857,NK1,gene,0.93,30076797
28858,SR140333,drug,0.988,30076797
28859,BIIEO246,drug,0.955,30076797
28860,Eylea,drug,0.9927,30076797
28861,CNV,disease,0.9976,30076797
28862,CNV,disease,0.927,30076797
28863,mice,species,0.9697,30076797
28864,NK1 and Y2 KO,cell_line,0.5737,30076797
28865,NK1,gene,0.986,30076797
28866,Y2,gene,0.937,30076797
28867,mice,species,0.9766,30076797
28868,CNV,DNA,0.669,30076797
28869,Eylea,drug,0.9844,30076797
28870,CNV,disease,0.9995,30076797
28871,Eylea,drug,0.982,30076797
28872,CNV,DNA,0.8013,30076797
28873,Eylea,drug,0.984,30076797
28874,CNV,disease,0.9023,30076797
28875,CONCLUSION NK1 and Y2 receptors,gene,0.942,30076797
28876,CNVs,disease,0.989,30076797
28877,mice,species,0.981,30076797
28878,CNVs,disease,0.999,30076797
28879,VEGF,gene,0.9956,30076797
28880,VEGF receptor,gene,0.9966,30076797
28881,CNV,disease,0.998,30076797
28882,CNV,disease,1.0,30076797
28883,CNV,disease,0.999,30076797
28884,colorectal cancer,disease,1.0,30075835
28885,colorectal cancer,disease,1.0,30075835
28886,CRC,disease,1.0,30075835
28887,fluoropyrimidines,drug,0.9995,30075835
28888,irinotecan,drug,0.9985,30075835
28889,oxaliplatin,drug,0.9995,30075835
28890,CRC,disease,0.9995,30075835
28891,anti-EGFR,gene,0.7554,30075835
28892,cetuximab,gene,0.891,30075835
28893,panitumumab,gene,0.889,30075835
28894,bevacizumab,gene,0.574,30075835
28895,regorafenib,drug,0.97,30075835
28896,advanced CRC,disease,0.9937,30075835
28897,CRC,disease,0.998,30075835
28898,inhered,DNA,0.491,30075835
28899,ATP,drug,0.9976,30075835
28900,ATP-binding cassette,gene,0.9795,30075835
28901,ABC,gene,0.7905,30075835
28902,solute carrier,gene,0.8286,30075835
28903,SLC,gene,0.8906,30075835
28904,folate,drug,0.9995,30075835
28905,fluoropyrimidines,drug,0.999,30075835
28906,irinotecan,drug,0.997,30075835
28907,oxaliplatin,drug,0.9995,30075835
28908,peripheral neuropathy,disease,1.0,30075835
28909,host genetic markers,DNA,0.596,30075835
28910,irinotecan,drug,0.9966,30075835
28911,UGT1A1,DNA,0.512,30075835
28912,UGT1A1*28 genotype,gene,0.9214,30075835
28913,fluoropyrimidines,drug,0.999,30075835
28914,DPYD genetic variants,DNA,0.6265,30075835
28915,DPYD genetic,gene,0.745,30075835
28916,CRC,disease,0.999,30075835
28917,aflibercept,gene,0.9243,30075585
28918,aflibercept,gene,0.8955,30075585
28919,exudative age-related macular degeneration,disease,0.976,30075585
28920,age-related-macula-degeneration,disease,1.0,30075585
28921,patients,species,0.992,30075585
28922,participants,species,0.98,30075585
28923,IVA,drug,0.714,30075585
28924,macular atrophy,disease,1.0,30075585
28925,MA,disease,1.0,30075585
28926,BCVA,DNA,0.4717,30075585
28927,patients,species,0.99,30075585
28928,patients,species,0.993,30075585
28929,patients,species,0.995,30075585
28930,CRT,DNA,0.58,30075585
28931,MA,disease,,30075585
28932,dry macula,disease,0.939,30075585
28933,MA,disease,,30075585
28934,BCVA,cell_type,0.512,30075585
28935,PATIENT,species,0.992,30074571
28936,PERIPHERAL EXUDATIVE HEMORRHAGIC CHORIORETINOPATHY,disease,1.0,30074571
28937,vision loss,disease,0.998,30074571
28938,peripheral exudative hemorrhagic chorioretinopathy,disease,0.9985,30074571
28939,loss of,disease,0.7007,30074571
28940,vitreous hemorrhage,disease,1.0,30074571
28941,peripheral exudative hemorrhagic chorioretinopathy,disease,0.906,30074571
28942,vitreous hemorrhage,disease,0.9976,30074571
28943,subretinal,disease,0.9263,30074571
28944,aflibercept,gene,0.92,30074571
28945,Peripheral,disease,0.6855,30074571
28946,exudative hemorrhagic chorioretinopathy,disease,0.848,30074571
28947,mouse,species,0.99,30073769
28948,retinopathy of prematurity,disease,1.0,30073769
28949,vascular endothelial growth factor,gene,0.995,30073769
28950,VEGF,gene,0.995,30073769
28951,retinopathy of prematurity,disease,1.0,30073769
28952,ROP,disease,1.0,30073769
28953,placental growth factor,gene,0.996,30073769
28954,PlGF,gene,0.9844,30073769
28955,mice,species,0.92,30073769
28956,oxygen,drug,0.995,30073769
28957,Mice,species,0.9775,30073769
28958,oxygen,drug,0.999,30073769
28959,IgG,gene,0.991,30073769
28960,VEGF,gene,0.9956,30073769
28961,PlGF,gene,0.9966,30073769
28962,anti-VEGF,gene,0.997,30073769
28963,anti-PlGF,gene,0.996,30073769
28964,aflibercept,gene,0.9805,30073769
28965,sunitinib,drug,0.9946,30073769
28966,anti-VEGF,gene,0.9683,30073769
28967,PlGF,gene,0.994,30073769
28968,sunitinib,drug,0.99,30073769
28969,VEGF,gene,0.634,30073769
28970,mouse,species,0.9653,30073769
28971,ROP,disease,0.9995,30073769
28972,anti-VEGF,gene,0.8496,30073769
28973,anti-PlGF,gene,0.9673,30073769
28974,sunitinib,drug,0.9863,30073769
28975,ziv-aflibercept,gene,0.9824,30072436
28976,ziv-aflibercept,gene,0.9717,30072436
28977,macular diseases,disease,1.0,30072436
28978,ziv-aflibercept,gene,0.987,30072436
28979,macular diseases,disease,1.0,30072436
28980,ziv-aflibercept,gene,0.981,30072436
28981,neovascular age-related macular degeneration,disease,1.0,30072436
28982,nAMD,disease,1.0,30072436
28983,diabetic macular oedema,disease,1.0,30072436
28984,DMO,disease,1.0,30072436
28985,nAMD,disease,1.0,30072436
28986,DMO,disease,1.0,30072436
28987,ziv-aflibercept,gene,0.982,30072436
28988,retinal disease,disease,1.0,30072436
28989,Retinal,DNA,0.448,30071565
28990,Aflibercept,gene,0.9536,30071565
28991,Diabetic Macular Oedema,disease,1.0,30071565
28992,Diabetic retinopathy,disease,1.0,30071565
28993,retinal hyperperfusion,disease,0.75,30071565
28994,capillary drop out,disease,0.997,30071565
28995,peripheral,disease,0.7974,30071565
28996,ischemia,disease,0.578,30071565
28997,aflibercept,gene,0.9683,30071565
28998,diabetic macular oedema,disease,1.0,30071565
28999,diabetic macular oedema,disease,1.0,30071565
29000,aflibercept,gene,0.9736,30071565
29001,diabetic macular oedema,disease,1.0,30071565
29002,Macular oedema,disease,1.0,30071565
29003,aflibercept,gene,0.9785,30071565
29004,diabetic macular oedema,disease,1.0,30071565
29005,anti-VEGF,gene,0.948,30071565
29006,bevacizumab,gene,0.515,30071215
29007,ranibizumab,gene,0.571,30071215
29008,aflibercept,gene,0.972,30071215
29009,retina pigment epithelium (RPE) cells,cell_line,0.8213,30071215
29010,photoreceptor,cell_type,0.5713,30071215
29011,RPE cells,cell_type,0.877,30071215
29012,age-related macular degeneration,disease,1.0,30071215
29013,AMD,disease,0.9995,30071215
29014,transmitochondrial cybrid model,cell_line,0.897,30071215
29015,RPE cells,cell_type,0.9277,30071215
29016,AMD,disease,1.0,30071215
29017,vascular endothelial growth factor,gene,0.877,30071215
29018,VEGF,gene,0.9956,30071215
29019,bevacizumab,gene,0.7485,30071215
29020,ranibizumab,gene,0.7417,30071215
29021,aflibercept,gene,0.9355,30071215
29022,Cybrids,cell_line,0.749,30071215
29023,cell lines,cell_line,0.911,30071215
29024,mtDNA,DNA,0.5605,30071215
29025,ARPE-19cells,cell_line,0.878,30071215
29026,platelets,cell_type,0.4978,30071215
29027,AMD,disease,1.0,30071215
29028,patients,species,0.9536,30071215
29029,AMD,disease,1.0,30071215
29030,normal,cell_line,0.712,30071215
29031,cybrids,cell_line,0.631,30071215
29032,bevacizumab,gene,0.8154,30071215
29033,ranibizumab,gene,0.801,30071215
29034,aflibercept,gene,0.975,30071215
29035,VEGF,gene,0.615,30071215
29036,AMD,disease,1.0,30071215
29037,patients,species,0.99,30071215
29038,choroidal neovascularization,disease,1.0,30071215
29039,cybrids,cell_type,0.4858,30071215
29040,bevacizumab,gene,0.8545,30071215
29041,aflibercept,gene,0.951,30071215
29042,normal cybrids,cell_line,0.921,30071215
29043,bevacizumab,gene,0.8696,30071215
29044,ranibizumab,gene,0.8965,30071215
29045,aflibercept-treated AMD cybrids,cell_line,0.8135,30071215
29046,aflibercept,gene,0.922,30071215
29047,AMD,disease,0.998,30071215
29048,AMD cybrids,cell_line,0.83,30071215
29049,AMD,disease,0.9893,30071215
29050,bevacizumab,gene,0.8506,30071215
29051,ranibizumab,gene,0.728,30071215
29052,AMD cybrids,cell_line,0.7505,30071215
29053,AMD,disease,1.0,30071215
29054,age-matched normal cybrids,cell_line,0.95,30071215
29055,normal cybrids,cell_line,0.785,30071215
29056,aflibercept,gene,0.987,30071215
29057,VEGF,gene,0.968,30071215
29058,bevacizumab,gene,0.882,30071180
29059,ranibizumab,gene,0.6895,30071180
29060,aflibercept,gene,0.9067,30071180
29061,macular edema,disease,1.0,30071180
29062,retinal vein occlusion,disease,1.0,30071180
29063,vascular endothelial growth factor,gene,0.9946,30071180
29064,VEGF,gene,0.993,30071180
29065,macular edema,disease,1.0,30071180
29066,retinal vein occlusion,disease,1.0,30071180
29067,RVO,disease,1.0,30071180
29068,VEGF,gene,0.786,30071180
29069,bevacizumab,gene,0.911,30071180
29070,ranibizumab,gene,0.817,30071180
29071,aflibercept,gene,0.943,30071180
29072,macular edema,disease,1.0,30071180
29073,RVO,disease,1.0,30071180
29074,bevacizumab,gene,0.9043,30071180
29075,ranibizumab,gene,0.6484,30071180
29076,aflibercept,gene,0.949,30071180
29077,VEGF,gene,0.577,30071180
29078,VEGF,gene,0.8667,30071180
29079,ranibizumab,gene,0.639,30051312
29080,aflibercept,gene,0.9097,30051312
29081,aflibercept,gene,0.979,30051312
29082,ranibizumab,gene,0.783,30051312
29083,neovascular age-related macular degeneration,disease,1.0,30051312
29084,nAMD,disease,1.0,30051312
29085,Participants,species,0.9185,30051312
29086,nAMD,disease,1.0,30051312
29087,Retinal Blindness,disease,0.9995,30051312
29088,aflibercept,gene,0.9883,30051312
29089,ranibizumab,gene,0.829,30051312
29090,ranibizumab,gene,0.8496,30051312
29091,aflibercept,gene,0.965,30051312
29092,Ranibizumab,gene,0.909,30051312
29093,patients,species,0.983,30051312
29094,aflibercept,gene,0.9604,30051312
29095,patients,species,0.98,30051312
29096,aflibercept,gene,0.9873,30051312
29097,patients,species,0.9785,30051312
29098,ranibizumab,gene,0.5425,30051312
29099,patients,species,0.9805,30051312
29100,ranibizumab,gene,0.879,30051312
29101,aflibercept,gene,0.973,30051312
29102,ranibizumab,gene,0.505,30051312
29103,aflibercept,gene,0.9434,30051312
29104,aflibercept,gene,0.9795,30051312
29105,ranibizumab,gene,0.619,30051312
29106,ranibizumab,gene,0.76,30051312
29107,aflibercept,gene,0.972,30051312
29108,ranibizumab,gene,0.844,30051312
29109,aflibercept,gene,0.946,30051312
29110,Ranibizumab,gene,0.807,30051312
29111,patients,species,0.9873,30051312
29112,aflibercept,gene,0.977,30051312
29113,ziv-aflibercept,gene,0.9624,30050283
29114,ziv-aflibercept,gene,0.9673,30050283
29115,aflibercept,gene,0.991,30050283
29116,patients,species,0.9683,30050283
29117,CSC,disease,1.0,30050283
29118,PATIENTS,species,0.9385,30050283
29119,patients,species,0.9897,30050283
29120,CSC,disease,1.0,30050283
29121,sSRF,gene,0.953,30050283
29122,mSRF,gene,0.949,30050283
29123,ziv-aflibercept,gene,0.901,30050283
29124,aflibercept,gene,0.9595,30050283
29125,BCVA,disease,0.9927,30050283
29126,allergic reaction,disease,0.903,30050283
29127,fluorescein,drug,0.998,30050283
29128,ophthalmic migraine,disease,1.0,30050283
29129,ziv-aflibercept,gene,0.9907,30050283
29130,vision loss,disease,0.9854,30050283
29131,ziv-aflibercept,gene,0.915,30050283
29132,aflibercept,gene,0.978,30050283
29133,CSC,disease,0.9893,30050283
29134,CSC,cell_line,0.902,30050283
29135,vascular endothelial growth factor,gene,0.9844,30050283
29136,diabetic macular edema,disease,1.0,30039271
29137,DME,disease,1.0,30039271
29138,patients,species,0.9814,30039271
29139,DME,disease,1.0,30039271
29140,ranibizumab,gene,0.76,30039271
29141,aflibercept,gene,0.957,30039271
29142,SFCT,cell_type,0.4485,30039271
29143,DME,disease,1.0,30039271
29144,aflibercept,gene,0.968,30030923
29145,neovascular age-related macular degeneration,disease,1.0,30030923
29146,aflibercept,gene,0.9854,30030923
29147,age-related macular degeneration,disease,1.0,30030923
29148,AMD,disease,1.0,30030923
29149,aflibercept,gene,0.987,30030923
29150,aflibercept,gene,0.917,30030923
29151,wet AMD,disease,0.9976,30030923
29152,aflibercept,gene,0.9824,30030923
29153,VEGF,gene,0.6313,30030393
29154,neovascular age-related macular degeneration,disease,1.0,30030393
29155,Vascular endothelial growth factor,gene,0.993,30030393
29156,VEGF,gene,0.988,30030393
29157,neovascular age-related macular degeneration,disease,1.0,30030393
29158,nAMD,disease,1.0,30030393
29159,nAMD,disease,1.0,30030393
29160,ranibizumab,gene,0.809,30030393
29161,aflibercept,gene,0.9546,30030393
29162,nAMD,disease,1.0,30030393
29163,pigment,disease,0.9097,30030393
29164,PED,disease,0.9775,30030393
29165,anti-VEGF,gene,0.822,30030393
29166,PED,DNA,0.5547,30030393
29167,nAMD,disease,1.0,30030393
29168,depression,disease,0.9805,30030393
29169,VEGF,gene,0.9927,30030393
29170,Angioid Streaks,disease,1.0,30025095
29171,VEGF,gene,0.991,30025095
29172,subfoveal choroidal neovascularization,disease,0.99,30025095
29173,CNV,disease,1.0,30025095
29174,angioid streaks,disease,1.0,30025095
29175,AS,disease,1.0,30025095
29176,AS,disease,1.0,30025095
29177,CNV,disease,0.994,30025095
29178,AS,disease,1.0,30025095
29179,aflibercept,gene,0.983,30025095
29180,HF,cell_type,0.744,30025095
29181,CNV,disease,0.999,30025095
29182,HF,gene,0.511,30025095
29183,HF,disease,0.5376,30025095
29184,intraretinal,cell_type,0.506,30025095
29185,CNV,disease,0.9966,30025095
29186,CNV,disease,0.9985,30025095
29187,anti-VEGF,gene,0.9893,30025095
29188,DIABETIC MACULAR EDEMA,disease,1.0,30015767
29189,bevacizumab,gene,0.778,30015767
29190,aflibercept,gene,0.974,30015767
29191,diabetic macular edema,disease,1.0,30015767
29192,diabetic macular edema,disease,1.0,30015767
29193,bevacizumab,gene,0.8696,30015767
29194,aflibercept,gene,0.968,30015767
29195,anti-vascular endothelial growth factor,gene,0.984,30015767
29196,diabetic macular edema,disease,1.0,30015767
29197,bevacizumab,gene,0.7935,30015767
29198,aflibercept,gene,0.9033,30015767
29199,bevacizumab,gene,0.613,30015767
29200,patients,species,0.915,30002485
29201,polypoidal choroidal vasculopathy,disease,1.0,30002485
29202,patients,species,0.9263,30002485
29203,polypoidal choroidal vasculopathy,disease,1.0,30002485
29204,PCV,disease,1.0,30002485
29205,patients,species,0.929,30002485
29206,PCV,disease,1.0,30002485
29207,indocyanine green,drug,0.996,30002485
29208,verteporfin,drug,0.999,30002485
29209,vascular endothelial growth factor,gene,0.968,30002485
29210,VEGF,gene,0.9956,30002485
29211,anti-VEGF,gene,0.742,30002485
29212,Aflibercept,gene,0.977,30002485
29213,VEGF,gene,0.89,30002485
29214,retinal pigment epithelial detachment,disease,1.0,30002485
29215,patients,species,0.953,30002485
29216,PCV,disease,1.0,30002485
29217,VEGF,gene,0.575,30002485
29218,Patients,species,0.9688,30002400
29219,Pachychoroid,disease,1.0,30002400
29220,pachychoroid neovasculopathy,disease,1.0,30002400
29221,PNV,disease,1.0,30002400
29222,neovascular age-related macular degeneration,disease,1.0,30002400
29223,nAMD,disease,1.0,30002400
29224,PNV,disease,1.0,30002400
29225,nAMD,disease,1.0,30002400
29226,patients,species,0.968,30002400
29227,aflibercept,gene,0.985,30002400
29228,PNV,disease,1.0,30002400
29229,nAMD,disease,1.0,30002400
29230,PNV,disease,1.0,30002400
29231,vascular endothelial growth factor (VEGF)-A,gene,0.993,30002400
29232,nAMD,disease,0.9995,30002400
29233,nAMD,disease,1.0,30002400
29234,interleukin (IL)-6,gene,0.992,30002400
29235,IL-8,gene,0.956,30002400
29236,IL-6,gene,0.9614,30002400
29237,monocyte chemoattractant protein (MCP)-1,gene,0.9927,30002400
29238,MCP-1,gene,0.986,30002400
29239,nAMD,disease,1.0,30002400
29240,dry maculae,disease,1.0,30002400
29241,aflibercept,gene,0.9883,30002400
29242,VEGF-A,gene,0.998,30002400
29243,placental growth factor,gene,0.9985,30002400
29244,PlGF,gene,0.995,30002400
29245,wet maculae,disease,0.9863,30002400
29246,PNV,disease,1.0,30002400
29247,PNV,disease,1.0,30002400
29248,nAMD,disease,1.0,30002400
29249,Ziv-Aflibercept,gene,0.9507,29999888
29250,ziv-aflibercept,gene,0.9854,29999888
29251,cancer,disease,1.0,29999888
29252,ziv-aflibercept,gene,0.9795,29999888
29253,ziv-aflibercept,gene,0.994,29999888
29254,infant,species,0.9673,29999888
29255,ziv-aflibercept,gene,0.986,29999888
29256,aflibercept,gene,0.793,29999888
29257,vascular endothelial growth factor,gene,0.9976,29999888
29258,woman,species,0.681,29999888
29259,VEGF,gene,0.997,29999888
29260,human,species,0.979,29999888
29261,infants,species,0.872,29999888
29262,VEGF,gene,0.995,29999888
29263,infant,species,0.661,29999888
29264,VEGF,gene,0.996,29999888
29265,Aflibercept,gene,0.962,29999887
29266,aflibercept,gene,0.976,29999887
29267,Aflibercept,gene,0.955,29999887
29268,vascular endothelial growth factor,gene,0.9985,29999887
29269,VEGF,gene,0.9966,29999887
29270,Aflibercept,gene,0.976,29999887
29271,infant,species,0.839,29999887
29272,infants,species,0.8076,29999887
29273,aflibercept,gene,0.965,29999887
29274,aflibercept,gene,0.989,29999887
29275,VEGF,gene,0.9814,29999887
29276,VEGF,gene,0.994,29999887
29277,VEGF,gene,0.995,29999887
29278,human,species,0.9106,29999887
29279,VEGF,gene,0.997,29999887
29280,VEGF,gene,0.9966,29999887
29281,Ranibizumab,gene,0.8687,30001546
29282,Bevacizumab,gene,0.73,30001546
29283,Aflibercept,gene,0.934,30001546
29284,exudative age-related macular degeneration,disease,1.0,30001546
29285,vascular endothelial growth factor,gene,0.999,30001546
29286,VEGF,gene,0.9976,30001546
29287,ranibizumab,gene,0.512,30001546
29288,bevacizumab,gene,0.8296,30001546
29289,Avastin,gene,0.8174,30001546
29290,aflibercept,gene,0.9727,30001546
29291,Eylea,gene,0.7783,30001546
29292,primary human retinal pigment epithelial (hRPE) cells,cell_line,0.9214,30001546
29293,human,species,0.8926,30001546
29294,hRPE,species,0.8745,30001546
29295,hRPE cells,cell_line,0.927,30001546
29296,hRPE,species,0.6426,30001546
29297,Scleral fibroblasts,cell_type,0.719,30001546
29298,anti-VEGF molecules,gene,0.8535,30001546
29299,trypan blue,drug,0.994,30001546
29300,MTT,drug,0.996,30001546
29301,VEGF,gene,0.996,30001546
29302,RPE cells,cell_line,0.6694,30001546
29303,scleral fibroblasts,cell_type,0.792,30001546
29304,RPE cells,cell_type,0.869,30001546
29305,ranibizumab,gene,0.933,30001546
29306,bevacizumab,gene,0.8384,30001546
29307,aflibercept,gene,0.9834,30001546
29308,RPE cells,cell_type,0.862,30001546
29309,RPE cells,cell_type,0.826,30001546
29310,Dexamethasone,drug,0.989,29996128
29311,Aflibercept,gene,0.944,29996128
29312,Patients,species,0.965,29996128
29313,Diabetic,disease,0.9995,29996128
29314,aflibercept,gene,0.9766,29996128
29315,dexamethasone,drug,0.994,29996128
29316,aflibercept,gene,0.971,29996128
29317,patients,species,0.9634,29996128
29318,diabetic macular edema,disease,1.0,29996128
29319,DME,disease,1.0,29996128
29320,DME,disease,1.0,29996128
29321,patients,species,0.9956,29996128
29322,aflibercept,gene,0.9653,29996128
29323,dexamethasone,drug,0.9917,29996128
29324,aflibercept,gene,0.9766,29996128
29325,aflibercept,gene,0.963,29996128
29326,aflibercept,gene,0.965,29996128
29327,DME,disease,1.0,29996128
29328,dexamethasone,drug,0.9556,29996128
29329,aflibercept,gene,0.927,29996128
29330,aflibercept,gene,0.9775,29996128
29331,Reduced vision,disease,0.9614,29989226
29332,diabetic,disease,1.0,29989226
29333,patient,species,0.974,29989226
29334,leukaemic retinopathy,disease,1.0,29989226
29335,Aflibercept,gene,0.982,29984251
29336,Ranibizumab,gene,0.7812,29984251
29337,Exudative AMD,disease,0.999,29984251
29338,neovascular age-related macular degeneration,disease,1.0,29984251
29339,nAMD,disease,1.0,29984251
29340,AMD,disease,1.0,29984251
29341,nAMD,disease,1.0,29984251
29342,Aflibercept,gene,0.9624,29984251
29343,Ranibizumab,gene,0.7983,29984251
29344,Aflibercept,gene,0.983,29984251
29345,Ranibizumab,gene,0.8286,29984251
29346,BCVA,DNA,0.4585,29984251
29347,Aflibercept,gene,0.978,29984251
29348,nAMD,disease,1.0,29984251
29349,Aflibercept,gene,0.9463,29982914
29350,Neovascular Age-Related Macular INTRODUCTION,disease,0.969,29982914
29351,aflibercept,gene,0.9863,29982914
29352,neovascular age,disease,0.8174,29982914
29353,related,disease,0.722,29982914
29354,macular degeneration,disease,0.799,29982914
29355,nAMD,disease,1.0,29982914
29356,patients,species,0.9805,29982914
29357,nAMD,disease,1.0,29982914
29358,Diabetic Retinopathy,disease,0.9995,29982914
29359,patients,species,0.9707,29982914
29360,patients,species,0.9814,29982914
29361,aflibercept,gene,0.978,29982914
29362,nAMD,disease,1.0,29982914
29363,Endophthalmitis,disease,1.0,29981738
29364,Anti-Vascular Endothelial Growth Factor,gene,0.929,29981738
29365,anti-vascular endothelial growth factor,gene,0.988,29981738
29366,VEGF,gene,0.997,29981738
29367,endophthalmitis,disease,0.9995,29981738
29368,anti-VEGF,gene,0.906,29981738
29369,anti-VEGF,gene,0.823,29981738
29370,neovascular age-related macular degeneration,disease,1.0,29981738
29371,diabetic macular edema,disease,1.0,29981738
29372,retinal vein occlusion,disease,1.0,29981738
29373,endophthalmitis,disease,1.0,29981738
29374,anti-VEGF,gene,0.857,29981738
29375,neovascular age-related macular degeneration,disease,1.0,29981738
29376,diabetic macular edema,disease,1.0,29981738
29377,endophthalmitis,disease,1.0,29981738
29378,endophthalmitis,disease,0.9995,29981738
29379,endophthalmitis,disease,1.0,29981738
29380,anti-VEGF,gene,0.95,29981738
29381,bilateral endophthalmitis,disease,0.8984,29981738
29382,unilateral endophthalmitis,disease,0.919,29981738
29383,anti-VEGF,gene,0.8804,29981738
29384,FOLFIRI,drug,0.796,29980490
29385,Aflibercept,gene,0.877,29980490
29386,Aflibercept,gene,0.8945,29980490
29387,Metastatic Colorectal Cancer,disease,1.0,29980490
29388,FOLFIRI,drug,0.7607,29980490
29389,leucovorin,drug,0.9995,29980490
29390,5-fluorouracil,drug,0.9995,29980490
29391,irinotecan,drug,0.9995,29980490
29392,oxaliplatin,drug,0.9995,29980490
29393,aflibercept,gene,0.988,29980490
29394,metastatic colorectal cancer,disease,1.0,29980490
29395,mCRC,disease,1.0,29980490
29396,PATIENTS,species,0.9697,29980490
29397,mCRC,disease,0.9937,29980490
29398,FOLFIRI,drug,0.632,29980490
29399,aflibercept,gene,0.963,29980490
29400,aflibercept,gene,0.871,29980490
29401,irinotecan,drug,0.9966,29980490
29402,aflibercept,gene,0.978,29980490
29403,neutropenia,disease,1.0,29980490
29404,febrile neutropenia,disease,1.0,29980490
29405,diarrhea,disease,1.0,29980490
29406,hypertension,disease,1.0,29980490
29407,proteinuria,disease,1.0,29980490
29408,mucositis,disease,1.0,29980490
29409,toxic,disease,0.5796,29980490
29410,right,DNA,0.5303,29980490
29411,stromal core lymphocytes,cell_type,0.867,29980490
29412,FOLFIRI,drug,0.9355,29980490
29413,aflibercept,gene,0.9565,29980490
29414,mCRC,disease,0.98,29980490
29415,Aflibercept,gene,0.9404,29977815
29416,diabetic macular oedema,disease,1.0,29977815
29417,aflibercept,gene,0.9297,29977815
29418,diabetic macular oedema,disease,1.0,29977815
29419,DMO,disease,1.0,29977815
29420,anti-vascular endothelial growth factor,gene,0.9663,29977815
29421,anti-VEGF,gene,0.97,29977815
29422,thromboembolic events,disease,1.0,29977815
29423,aflibercept,gene,0.995,29977815
29424,bevacizumab,gene,0.8325,29977815
29425,ranibizumab,gene,0.6016,29977815
29426,aflibercept,gene,0.947,29977815
29427,Aflibercept,gene,0.818,29977815
29428,CMT at,DNA,0.5283,29977815
29429,CMT at 1 or 2y,gene,0.9785,29977815
29430,aflibercept,gene,0.9854,29977815
29431,VEGF,gene,0.712,29977815
29432,Eyelid Swelling,disease,1.0,29977647
29433,Rash,disease,1.0,29977647
29434,Macular Degeneration,disease,1.0,29977647
29435,macular degeneration,disease,1.0,29977647
29436,anti-VEGF,gene,0.8447,29977647
29437,urticaria,disease,1.0,29977647
29438,eyelid swelling,disease,1.0,29977647
29439,aflibercept,gene,0.9854,29977647
29440,ranibizumab,gene,0.832,29977647
29441,bevacizumab,gene,0.598,29977647
29442,hypersensitivity reactions,disease,0.9653,29977647
29443,anti-VEGF,gene,0.945,29977647
29444,macular degeneration,disease,1.0,29977647
29445,VEGF,gene,0.7036,29977647
29446,aflibercept,gene,0.991,29977647
29447,tetracaine,drug,0.996,29977647
29448,proparacaine hydrochloride,drug,0.9375,29977647
29449,povidine,drug,0.976,29977647
29450,VEGF,gene,0.7646,29977647
29451,ranibizumab,gene,0.809,29977647
29452,bevacizumab,gene,0.534,29977647
29453,aflibercept,gene,0.9663,29977647
29454,ranibizumab,gene,0.6157,29977647
29455,bevacizumab,gene,0.5444,29977647
29456,aflibercept,gene,0.9536,29977647
29457,ranibizumab,drug,0.661,29977647
29458,povidine,drug,0.9956,29977647
29459,tetracaine,drug,0.995,29977647
29460,proparacaine hydrochloride,drug,0.998,29977647
29461,aflibercept,gene,0.982,29977647
29462,ranibizumab,gene,0.7583,29977647
29463,bevacizumab,gene,0.7144,29977647
29464,ester,drug,0.9966,29977647
29465,amide,drug,0.9985,29977647
29466,lidocaine,drug,0.997,29977647
29467,lidocaine,drug,0.9927,29977647
29468,immunoglobulin E (,disease,0.8643,29977647
29469,immunoglobulin E,gene,0.998,29977647
29470,IgE,gene,0.994,29977647
29471,ester,drug,0.991,29977647
29472,VEGF,gene,0.807,29977647
29473,amide,drug,0.932,29977647
29474,hypersensitivity,disease,0.9995,29977647
29475,VEGF,gene,0.8413,29977647
29476,Eyelid swelling,disease,0.9995,29977647
29477,rash,disease,0.998,29977647
29478,macular degeneration,disease,1.0,29977647
29479,aflibercept,gene,0.969,29974277
29480,age-related macular degeneration,disease,1.0,29974277
29481,polypoidal choroidal vasculopathy,disease,1.0,29974277
29482,aflibercept,gene,0.987,29974277
29483,neovascular age-related macular degeneration,disease,1.0,29974277
29484,AMD,disease,1.0,29974277
29485,polypoidal choroidal vasculopathy,disease,1.0,29974277
29486,PCV,disease,1.0,29974277
29487,neovascular AMD,disease,1.0,29974277
29488,aflibercept,gene,0.9805,29974277
29489,neovascular AMD,disease,1.0,29974277
29490,PCV,disease,1.0,29974277
29491,pigment,disease,0.6777,29974277
29492,subretinal fluid,disease,0.6343,29974277
29493,neovascular AMD,disease,1.0,29974277
29494,choroidal vascular hyperpermeability,disease,1.0,29974277
29495,CVH,disease,1.0,29974277
29496,subretinal fluid,disease,0.7456,29974277
29497,PCV,disease,1.0,29974277
29498,aflibercept,gene,0.984,29974277
29499,neovascular AMD,disease,1.0,29974277
29500,pigment epithelial detachment,disease,1.0,29974277
29501,CVH,disease,0.999,29974277
29502,aflibercept,gene,0.9907,29970955
29503,exudative age-related macular degeneration,disease,1.0,29970955
29504,aflibercept,gene,0.979,29970955
29505,exudative age-related macular degeneration,disease,1.0,29970955
29506,AMD,disease,1.0,29970955
29507,AMD,disease,1.0,29970955
29508,AMD,disease,1.0,29970955
29509,typical AMD,disease,0.9995,29970955
29510,tAMD,disease,1.0,29970955
29511,"type 1, and type 2 polypoidal choroidal vasculopathy",disease,1.0,29970955
29512,tAMD,disease,1.0,29970955
29513,type 1 and type 2 PCV,disease,0.8774,29970955
29514,subretinal hemorrhage,disease,1.0,29970955
29515,SRH,disease,1.0,29970955
29516,BCVA,cell_type,0.4087,29970955
29517,tAMD,disease,1.0,29970955
29518,type 1 and 2 PCV,disease,0.9956,29970955
29519,AMD,disease,1.0,29970955
29520,Venous Thromboembolic Events,disease,0.999,29965804
29521,Cancer,disease,1.0,29965804
29522,Aflibercept,gene,0.8174,29965804
29523,Aflibercept,gene,0.9805,29952707
29524,Ranibizumab,gene,0.8804,29952707
29525,Wet,disease,0.825,29952707
29526,Age-Related Macular Degeneration,disease,0.955,29952707
29527,Age-related macular degeneration,disease,1.0,29952707
29528,AMD,disease,1.0,29952707
29529,vision loss,disease,0.9985,29952707
29530,vision,disease,0.9673,29952707
29531,neovascular AMD,disease,1.0,29952707
29532,wet AMD,disease,0.9995,29952707
29533,wAMD,disease,1.0,29952707
29534,antivascular endothelial growth factor,gene,0.9585,29952707
29535,VEGF,gene,0.996,29952707
29536,wAMD,disease,1.0,29952707
29537,ranibizumab,gene,0.585,29952707
29538,aflibercept,gene,0.9893,29952707
29539,ranibizumab,gene,0.5483,29952707
29540,aflibercept,gene,0.887,29952707
29541,wAMD,disease,0.9985,29952707
29542,wAMD,disease,1.0,29952707
29543,ranibizumab,gene,0.618,29952707
29544,blindness,disease,0.9995,29952707
29545,AMD,disease,0.929,29952707
29546,ranibizumab,gene,0.8525,29952707
29547,IAI,DNA,0.525,29952707
29548,Rq4,DNA,0.48,29952707
29549,ranibizumab,gene,0.571,29952707
29550,wAMD,disease,0.997,29952707
29551,aflibercept,gene,0.965,29952707
29552,pigment epithelial detachment,disease,0.9995,29929478
29553,pigment epithelial detachment,disease,1.0,29929478
29554,PED,disease,1.0,29929478
29555,neovascular age-related macular degeneration,disease,0.999,29929478
29556,nAMD,disease,1.0,29929478
29557,patients,species,0.994,29929478
29558,Ranibizumab,gene,0.9326,29929478
29559,Aflibercept,gene,0.9663,29929478
29560,nAMD,disease,1.0,29929478
29561,PED,disease,0.9473,29929478
29562,Ranibizumab,gene,0.958,29929478
29563,Aflibercept,gene,0.959,29929478
29564,PED,DNA,0.472,29929478
29565,Aflibercept,gene,0.9463,29929478
29566,BCVA,cell_type,0.4182,29929478
29567,PED,DNA,0.5073,29929478
29568,PED,DNA,0.468,29929478
29569,Aflibercept,gene,0.8867,29929478
29570,Aflibercept,gene,0.967,29929478
29571,PED,disease,0.9995,29929478
29572,colorectal cancer,disease,1.0,29928383
29573,colon cancer,disease,1.0,29928383
29574,colon cancer,disease,1.0,29928383
29575,metastatic colon cancer,disease,1.0,29928383
29576,vascular endothelial growth factor,gene,0.9976,29928383
29577,VEGF,gene,0.995,29928383
29578,bevacizumab,gene,0.5215,29928383
29579,ziv-aflibercept,gene,0.964,29928383
29580,regorafenib,drug,0.9653,29928383
29581,epithelial growth factor receptor,gene,0.9966,29928383
29582,EGFR,gene,0.994,29928383
29583,cetuximab,gene,0.8325,29928383
29584,panitumumab,gene,0.876,29928383
29585,VEGF,gene,0.9736,29928383
29586,cardiovascular and kidney problems,disease,0.979,29928383
29587,EGFR receptor,gene,0.9824,29928383
29588,rashes,disease,0.9985,29928383
29589,diarrhea,disease,1.0,29928383
29590,hypertension,disease,1.0,29928383
29591,Posterior segment diseases,disease,0.969,29916734
29592,blindness,disease,0.9995,29916734
29593,age-related macular degeneration,disease,1.0,29916734
29594,poly(ethylene glycol),drug,0.9995,29916734
29595,poly(lactic-co-glycolic acid),drug,0.9927,29916734
29596,silica,drug,0.9995,29916734
29597,poly(N-isopropylacrylamide),drug,0.9995,29916734
29598,ranibizumab,gene,0.906,29916734
29599,dexamethasone,drug,0.9966,29916734
29600,Avastin,gene,0.918,29916734
29601,bevacizumab,gene,0.977,29916734
29602,aflibercept,gene,0.989,29916734
29603,neovascular AMD,disease,1.0,29915918
29604,neovascular age-related macular degeneration,disease,1.0,29915918
29605,AMD,disease,1.0,29915918
29606,exudative AMD,disease,0.9893,29915918
29607,anti-VEGF,gene,0.828,29915918
29608,SRF,gene,0.9966,29915918
29609,IRF,gene,0.994,29915918
29610,IRF,gene,0.9253,29915918
29611,degenerative cysts,disease,0.8345,29915918
29612,SRF,gene,0.987,29915918
29613,IRF,gene,0.891,29915918
29614,AMD,disease,1.0,29915918
29615,degenerative cysts,disease,0.941,29915918
29616,Metastatic Colorectal Cancer,disease,1.0,29910669
29617,metastatic colorectal cancer,disease,0.994,29910669
29618,Fluorouracil,drug,0.999,29910669
29619,metastatic colorectal cancer,disease,1.0,29910669
29620,fluorouracil,drug,0.9995,29910669
29621,irinotecan,drug,0.999,29910669
29622,FOLFIRI,drug,0.998,29910669
29623,oxaliplatin,drug,0.9995,29910669
29624,FOLFOX,drug,0.9995,29910669
29625,capecitabine,drug,0.999,29910669
29626,CAPOX,drug,0.999,29910669
29627,XELOX,drug,0.9917,29910669
29628,bevacizumab,gene,0.8145,29910669
29629,aflibercept,gene,0.9805,29910669
29630,anti-vascular endothelial growth factor monoclonal antibody,gene,0.997,29910669
29631,anti-epidermal growth factor receptor monoclonal antibody,gene,0.9453,29910669
29632,patients,species,0.9663,29910669
29633,patients,species,0.947,29910669
29634,patient,species,0.994,29910669
29635,metastatic colorectal cancer,disease,1.0,29910669
29636,patients,species,0.995,29910669
29637,regorafenib,drug,0.986,29910669
29638,TAS,drug,0.944,29910669
29639,metastatic colorectal cancer,disease,1.0,29910669
29640,aflibercept,gene,0.972,29908884
29641,platelet,cell_type,0.7246,29908884
29642,Aflibercept,gene,0.966,29908884
29643,neovascular age-related macular degeneration,disease,1.0,29908884
29644,aflibercept,gene,0.9824,29908884
29645,platelets,cell_type,0.817,29908884
29646,arterial thromboembolic,disease,0.989,29908884
29647,aflibercept,gene,0.9907,29908884
29648,platelet,cell_type,0.4802,29908884
29649,platelets,cell_type,0.8164,29908884
29650,aflibercept,gene,0.9907,29908884
29651,IgG1 antibody,gene,0.9014,29908884
29652,GPIIb/IIIa,gene,0.9946,29908884
29653,P-selectin,gene,0.991,29908884
29654,platelet-bound stromal-cell-derived factor-1,gene,0.9756,29908884
29655,ATEs,gene,0.695,29908884
29656,activated platelets,cell_type,0.863,29908884
29657,Platelet,cell_type,0.7114,29908884
29658,aflibercept,gene,0.994,29908884
29659,platelets,cell_type,0.854,29908884
29660,aflibercept,gene,0.9956,29908884
29661,FITC,drug,0.999,29908884
29662,platelets,cell_type,0.818,29908884
29663,thrombin,gene,0.995,29908884
29664,PAR-4-AP,gene,0.9966,29908884
29665,aflibercept,gene,0.99,29908884
29666,fibrinogen receptor,gene,0.98,29908884
29667,GPIIb/IIIa,gene,0.98,29908884
29668,platelet-derived P-selectin,gene,0.981,29908884
29669,SDF-1,gene,0.9707,29908884
29670,aflibercept,gene,0.97,29908884
29671,thrombin,gene,0.9775,29908884
29672,CD62P,gene,0.9595,29908884
29673,aflibercept,gene,0.99,29908884
29674,aflibercept,gene,0.995,29908884
29675,SDF-1,gene,0.9897,29908884
29676,mL aflibercept,gene,0.835,29908884
29677,aflibercept,gene,0.9893,29908884
29678,aflibercept,gene,0.854,29908884
29679,FITC,drug,0.9995,29908884
29680,activated platelets,cell_type,0.8774,29908884
29681,platelet,cell_type,0.562,29908884
29682,aflibercept,gene,0.9814,29908884
29683,platelet,cell_type,0.823,29908884
29684,fibrinogen receptor,gene,0.9917,29908884
29685,GPIIb/IIIa,gene,0.9814,29908884
29686,aflibercept,gene,0.9897,29908884
29687,platelets,cell_type,0.84,29908884
29688,ATE,disease,0.9995,29908884
29689,patients,species,0.9775,29908884
29690,aflibercept,gene,0.9727,29908884
29691,FcRIIa,gene,0.9946,29908884
29692,integrin,gene,0.9463,29908884
29693,aflibercept,gene,0.9873,29908884
29694,platelets,cell_type,0.82,29908884
29695,Fc domain,gene,0.753,29908884
29696,aflibercept,gene,0.9907,29908884
29697,platelets,cell_type,0.804,29908884
29698,Fc,gene,,29908884
29699,aflibercept,gene,0.99,29908884
29700,platelets,cell_type,0.856,29908884
29701,patients,species,0.979,29907628
29702,neovascular age-related macular degeneration,disease,1.0,29907628
29703,patient,species,0.9785,29907628
29704,aflibercept,gene,0.936,29907628
29705,neovascular age-related macular degeneration,disease,1.0,29907628
29706,AMD,disease,1.0,29907628
29707,patients,species,0.965,29907628
29708,AMD,disease,0.9995,29907628
29709,aflibercept,gene,0.971,29907628
29710,intraretinal oedema,disease,1.0,29907628
29711,subretinal fluid,disease,0.9897,29907628
29712,pigment epithelial detachment,disease,1.0,29907628
29713,patients,species,0.9883,29907628
29714,aflibercept,gene,0.9688,29907628
29715,choroidal vascular hyperpermeability,disease,1.0,29907628
29716,indocyanine green,drug,0.997,29907628
29717,ranibizumab,gene,0.7295,29907628
29718,aflibercept,gene,0.94,29907628
29719,aflibercept,gene,0.9863,29907628
29720,AMD,disease,0.9995,29907628
29721,patients,species,0.955,29907628
29722,choroidal vascular hyperpermeability,disease,1.0,29907628
29723,FOLFIRI,drug,0.909,29905927
29724,regorafenib,drug,0.993,29905927
29725,Regorafenib,drug,0.9956,29905927
29726,patients,species,0.947,29905927
29727,colorectal cancer,disease,1.0,29905927
29728,regorafenib,drug,0.997,29905927
29729,folinic acid,drug,0.999,29905927
29730,fluorouracil,drug,0.9995,29905927
29731,irinotecan,drug,0.998,29905927
29732,FOLFIRI,drug,0.9917,29905927
29733,metastatic colorectal cancer,disease,0.9985,29905927
29734,Patients,species,0.9385,29905927
29735,metastatic colorectal cancer,disease,1.0,29905927
29736,oxaliplatin,drug,0.9995,29905927
29737,fluoropyrimidine,drug,0.998,29905927
29738,Patients,species,0.972,29905927
29739,bevacizumab,gene,0.881,29905927
29740,regorafenib,drug,0.991,29905927
29741,regorafenib,drug,0.9897,29905927
29742,patients,species,0.9883,29905927
29743,patients,species,0.954,29905927
29744,regorafenib,drug,0.9976,29905927
29745,FOLFIRI,drug,0.992,29905927
29746,FOLFIRI,drug,0.98,29905927
29747,bevacizumab,gene,0.775,29905927
29748,aflibercept,gene,0.985,29905927
29749,regorafenib,drug,0.999,29905927
29750,FOLFIRI,drug,0.9966,29905927
29751,FOLFIRI,drug,0.9966,29905927
29752,regorafenib,drug,0.9985,29905927
29753,FOLFIRI,drug,0.989,29905927
29754,FOLFIRI,drug,0.989,29905927
29755,regorafenib,drug,0.9976,29905927
29756,diarrhea,disease,1.0,29905927
29757,neutropenia,disease,1.0,29905927
29758,febrile neutropenia,disease,1.0,29905927
29759,hypophosphatemia,disease,1.0,29905927
29760,hypertension,disease,1.0,29905927
29761,regorafenib,drug,0.998,29905927
29762,FOLFIRI,drug,0.995,29905927
29763,metastatic colorectal cancer,disease,1.0,29905927
29764,FOLFIRI,drug,0.986,29905927
29765,Cancer,disease,0.8164,29905927
29766,Age-related Macular Degeneration,disease,1.0,29885297
29767,neovascular age-related macular degeneration,disease,1.0,29885297
29768,AMD,disease,1.0,29885297
29769,AMD,disease,0.9985,29885297
29770,ranibizumab,drug,0.577,29885297
29771,aflibercept,gene,0.9404,29885297
29772,ranibizumab,gene,0.7983,29885297
29773,aflibercept,gene,0.9937,29867156
29774,neovascular age-related macular degeneration,disease,1.0,29867156
29775,aflibercept,gene,0.9946,29867156
29776,neovascular age-related macular degeneration,disease,0.9995,29867156
29777,nAMD,disease,1.0,29867156
29778,patients,species,0.973,29867156
29779,patients,species,0.9663,29867156
29780,nAMD,disease,1.0,29867156
29781,aflibercept,gene,0.971,29867156
29782,EDTRS,DNA,0.7295,29867156
29783,patients,species,0.984,29867156
29784,patients,species,0.974,29867156
29785,nAMD,disease,1.0,29867156
29786,aflibercept,gene,0.975,29867156
29787,patients,species,0.986,29867156
29788,patients,species,0.984,29867156
29789,TOPICAL DORZOLAMIDE,drug,0.9956,29864044
29790,TIMOLOL,drug,0.9937,29864044
29791,RETINAL VEIN OCCLUSION,disease,1.0,29864044
29792,dorzolamide hydrochloride,drug,0.9976,29864044
29793,timolol maleate,drug,0.9976,29864044
29794,anti-vascular endothelial growth factor,gene,0.9795,29864044
29795,retinal vein occlusion,disease,1.0,29864044
29796,Retinal vein occlusion,disease,1.0,29864044
29797,macular edema,disease,1.0,29864044
29798,anti-vascular endothelial growth factor,gene,0.893,29864044
29799,dorzolamide,drug,0.996,29864044
29800,timolol,drug,0.9897,29864044
29801,vascular endothelial growth factor,gene,0.9175,29864044
29802,dorzolamide,drug,0.992,29864044
29803,timolol,drug,0.9937,29864044
29804,macular edema,disease,1.0,29864044
29805,retinal vein occlusion,disease,0.952,29864044
29806,neovascular age-related macular degeneration,disease,1.0,29862641
29807,nAMD,disease,1.0,29862641
29808,low-vision,disease,1.0,29862641
29809,bevacizumab,gene,0.5527,29862641
29810,bevacizumab,gene,0.6626,29862641
29811,aflibercept,gene,0.96,29862641
29812,ranibizumab,gene,0.513,29862641
29813,CEAs,disease,0.9907,29862641
29814,aflibercept,gene,0.986,29862641
29815,aflibercept,gene,0.987,29862641
29816,ranibizumab,gene,0.6704,29862641
29817,ranibizumab,gene,0.8394,29862641
29818,aflibercept,gene,0.9395,29862641
29819,ophthalmologists,cell_type,0.4282,29862641
29820,Retinal Vein Occlusion,disease,1.0,29860457
29821,macular edema,disease,1.0,29860457
29822,retinal vein occlusion,disease,1.0,29860457
29823,RVO,disease,1.0,29860457
29824,RVO,disease,1.0,29860457
29825,VEGF,gene,0.8486,29860457
29826,VEGF,gene,0.9194,29860457
29827,ranibizumab,gene,0.875,29860457
29828,aflibercept,gene,0.9307,29860457
29829,FAZ,DNA,0.527,29860457
29830,macular edema,disease,1.0,29860457
29831,VEGF,gene,0.629,29860457
29832,Anti-CD160,gene,0.9736,29860455
29833,Bevacizumab,gene,0.525,29860455
29834,Ocular Neovascularization,disease,0.9536,29860455
29835,Rabbit,species,0.877,29860455
29836,Monkey,species,0.544,29860455
29837,murine,species,0.922,29860455
29838,CL1-R2 monoclonal antibody,gene,0.823,29860455
29839,human CD160,gene,0.9277,29860455
29840,bevacizumab,gene,0.8125,29860455
29841,rabbit,species,0.9766,29860455
29842,corneal neovascularization,disease,0.998,29860455
29843,CNV,disease,0.9995,29860455
29844,ELB01101,drug,0.9883,29860455
29845,CL1-R2-derived humanized,cell_line,0.813,29860455
29846,humanized,species,0.816,29860455
29847,IgG4 mAb,gene,0.9907,29860455
29848,monkey,species,0.577,29860455
29849,choroidal neovascularization,disease,1.0,29860455
29850,ChNV,disease,1.0,29860455
29851,CL1-R2,gene,0.981,29860455
29852,bevacizumab,gene,0.8467,29860455
29853,aflibercept,gene,0.948,29860455
29854,IgG1,gene,0.9883,29860455
29855,VEGF,gene,0.996,29860455
29856,FGF2,gene,0.996,29860455
29857,rabbit,species,0.9863,29860455
29858,CNV,disease,0.5747,29860455
29859,bevacizumab,gene,0.749,29860455
29860,CL1,cell_line,0.6123,29860455
29861,ELB01101,drug,0.9937,29860455
29862,ChNV,disease,0.9995,29860455
29863,fluorescein,drug,0.9883,29860455
29864,rabbit,species,0.9604,29860455
29865,CNV,disease,1.0,29860455
29866,anti-VEGF,gene,0.9424,29860455
29867,bevacizumab,gene,0.6978,29860455
29868,CL1,DNA,0.5356,29860455
29869,CL1-R2,gene,0.8794,29860455
29870,ChNV,disease,1.0,29860455
29871,ELB01101,drug,0.9985,29860455
29872,anti-CD160,gene,0.9717,29860455
29873,CNV,disease,0.999,29860455
29874,ChNV,disease,0.729,29860455
29875,ELB01101,drug,0.996,29860455
29876,CD160,gene,0.991,29860455
29877,wet AMD,disease,0.9663,29860455
29878,corneal endothelium,cell_type,0.553,29856479
29879,rabbits,species,0.9316,29856479
29880,p75NTR,gene,0.998,29856479
29881,proNGF,gene,0.993,29856479
29882,antivascular endothelial growth factor,gene,0.969,29856479
29883,VEGF,gene,0.575,29856479
29884,retinal vascular diseases,disease,1.0,29856479
29885,VEGF,gene,0.6104,29856479
29886,neovascular glaucoma,disease,1.0,29856479
29887,VEGF,gene,0.9937,29856479
29888,nerve growth factor,gene,0.9966,29856479
29889,NGF,gene,0.996,29856479
29890,aflibercept,gene,0.987,29856479
29891,ranibizumab,gene,0.9185,29856479
29892,rabbit,species,0.9844,29856479
29893,NGF precursor,gene,0.9966,29856479
29894,proNGF,gene,0.995,29856479
29895,p75 neurotrophin receptor,gene,0.996,29856479
29896,p75NTR) receptor,gene,0.788,29856479
29897,corneal endothelial cell,cell_type,0.882,29856479
29898,trypan blue,drug,0.984,29856479
29899,cleaved-caspase 3,gene,0.985,29856479
29900,c-Casp3,gene,0.9966,29856479
29901,p75NTR,gene,0.9976,29856479
29902,RhoA,gene,0.995,29856479
29903,VEGF,gene,0.7896,29856479
29904,aflibercept,gene,0.9873,29856479
29905,Aflibercept,gene,0.9644,29856479
29906,proNGF,gene,0.9873,29856479
29907,VEGF,gene,0.6733,29856479
29908,endothelial cells,cell_type,0.9424,29856479
29909,c-,gene,0.5366,29856479
29910,Casp3,gene,0.836,29856479
29911,Bad,gene,0.994,29856479
29912,Ser,drug,0.997,29856479
29913,AKT,gene,0.996,29856479
29914,anti-VEGF,gene,0.9463,29856479
29915,rabbit,species,0.974,29856479
29916,endothelial cell,cell_type,0.9014,29856479
29917,NGF,gene,0.995,29856479
29918,aflibercept,gene,0.994,29855194
29919,ranibizumab,gene,0.857,29855194
29920,age-related macular degeneration,disease,1.0,29855194
29921,ranibizumab,gene,0.8276,29855194
29922,aflibercept,gene,0.9834,29855194
29923,age-related macular degeneration,disease,1.0,29855194
29924,AMD,disease,1.0,29855194
29925,AMD,disease,0.9995,29855194
29926,aflibercept,gene,0.9365,29855194
29927,AMD,disease,1.0,29855194
29928,ranibizumab,gene,0.598,29855194
29929,aflibercept,gene,0.9907,29855194
29930,ranibizumab,gene,0.7983,29855194
29931,aflibercept,gene,0.992,29855194
29932,aflibercept,gene,0.969,29855194
29933,diabetic macular edema,disease,1.0,29854429
29934,DME,drug,0.9385,29854429
29935,DME,disease,1.0,29854429
29936,VEGF,gene,0.9775,29854429
29937,ranibizumab,gene,0.9062,29854429
29938,bevacizumab,gene,0.72,29854429
29939,aflibercept,gene,0.9766,29854429
29940,triamcinolone acetonide,drug,0.997,29854429
29941,edema,disease,0.758,29854429
29942,abnormal vitreomacular attachment,disease,0.9604,29854429
29943,VMA,disease,0.999,29854429
29944,BCVA,DNA,0.4885,29854429
29945,DME,disease,1.0,29854429
29946,edema,disease,1.0,29854429
29947,DME,disease,1.0,29854429
29948,VMA,disease,1.0,29854429
29949,Ganetespib,drug,0.7715,29853657
29950,Ziv-Aflibercept,gene,0.9375,29853657
29951,Advanced Carcinomas,disease,0.9985,29853657
29952,Sarcomas,disease,0.9917,29853657
29953,ziv-aflibercept,gene,0.986,29853657
29954,heat shock protein 90,gene,0.9863,29853657
29955,ganetespib,drug,0.9106,29853657
29956,cancer,disease,1.0,29853657
29957,Heat shock protein 90,gene,0.997,29853657
29958,Hsp90,gene,0.9966,29853657
29959,Hsp90,gene,0.9976,29853657
29960,ziv-aflibercept,gene,0.972,29853657
29961,Hsp90,gene,0.997,29853657
29962,ganetespib,drug,0.4458,29853657
29963,gastrointestinal carcinomas,disease,1.0,29853657
29964,nonsquamous non-small cell lung carcinomas,disease,1.0,29853657
29965,urothelial carcinomas,disease,1.0,29853657
29966,sarcomas,disease,1.0,29853657
29967,Ziv-aflibercept,gene,0.9624,29853657
29968,ganetespib,gene,0.7295,29853657
29969,retinal neovascularization,disease,0.995,29852133
29970,VEGF,gene,0.6333,29852133
29971,vascular endothelial growth factor,gene,0.9966,29852133
29972,VEGF,gene,0.9956,29852133
29973,neovascular retinal diseases,disease,1.0,29852133
29974,age-related macular degeneration,disease,1.0,29852133
29975,diabetic,disease,1.0,29852133
29976,retinopathy,disease,0.932,29852133
29977,retinal vascular disease,disease,1.0,29852133
29978,rabbit,species,0.9897,29852133
29979,persistent retinal neovascularization,disease,1.0,29852133
29980,PRNV,disease,1.0,29852133
29981,Retinal Mller glial,cell_type,0.8164,29852133
29982,DL-alpha-aminoadipic acid,drug,0.9995,29852133
29983,DL-AAA,drug,0.9995,29852133
29984,retinal glial (Mller,cell_line,0.6426,29852133
29985,retinal glial (Mller) cell,cell_type,0.86,29852133
29986,VEGF,gene,0.9966,29852133
29987,VEGF,gene,0.996,29852133
29988,VEGF,gene,0.6724,29852133
29989,bevacizumab,gene,0.9014,29852133
29990,ranibizumab,gene,0.9214,29852133
29991,aflibercept,gene,0.9624,29852133
29992,VEGF,gene,0.6665,29852133
29993,PRNV,disease,0.999,29852133
29994,aflibercept,gene,0.9863,29852133
29995,Aflibercept,gene,0.99,29850202
29996,Ranibizumab,gene,0.9116,29850202
29997,patients,species,0.98,29850202
29998,diabetic macular edema,disease,1.0,29850202
29999,DME,disease,1.0,29850202
30000,ranibizumab,gene,0.527,29850202
30001,aflibercept,gene,0.9546,29850202
30002,ranibizumab,gene,0.516,29850202
30003,patients,species,0.989,29850202
30004,DME350m,disease,0.9985,29850202
30005,ranibizumab,gene,0.8394,29850202
30006,aflibercept,gene,0.9834,29850202
30007,ranibizumab,gene,0.781,29850202
30008,patients,species,0.973,29850202
30009,ranibizumab,gene,0.684,29850202
30010,ranibizumab,gene,0.6123,29850202
30011,aflibercept,gene,0.9883,29850202
30012,ranibizumab,gene,0.757,29850202
30013,patients,species,0.977,29850202
30014,DME,disease,1.0,29850202
30015,ranibizumab,gene,0.903,29850202
30016,aflibercept,gene,0.9194,29850202
30017,Aflibercept,gene,0.9717,29850003
30018,Vascular Abnormalization of the Choroidal,disease,1.0,29850003
30019,VEGF,gene,0.995,29850003
30020,patients,species,0.9736,29850003
30021,vascular age-related macular degeneration,disease,0.9985,29850003
30022,AMD,disease,1.0,29850003
30023,aflibercept,gene,0.893,29850003
30024,choroidal neovascularization,disease,1.0,29850003
30025,CNV,DNA,0.8413,29850003
30026,anti-VEGF,gene,0.922,29850003
30027,patients,species,0.9927,29850003
30028,CNV,DNA,0.6357,29850003
30029,anti-VEGF,gene,0.8896,29850003
30030,vascular abnormalization,disease,1.0,29850003
30031,vascular endothelial growth factor,gene,0.954,29843663
30032,neovascular age-related macular,disease,1.0,29843663
30033,anti-vascular endothelial growth factor,gene,0.962,29843663
30034,VEGF,gene,0.761,29843663
30035,neovascular age-related macular degeneration,disease,1.0,29843663
30036,AMD,disease,1.0,29843663
30037,VEGF,gene,0.7764,29843663
30038,patients,species,0.9907,29843663
30039,arteriothrombotic and venous thrombotic events,disease,1.0,29843663
30040,patients,species,0.9624,29843663
30041,pegaptanib,drug,0.9956,29843663
30042,ranibizumab,drug,0.509,29843663
30043,bevacizumab,gene,0.828,29843663
30044,ranibizumab,gene,0.724,29843663
30045,aflibercept,gene,0.984,29843663
30046,ranibizumab,gene,0.76,29843663
30047,bevacizumab,gene,0.799,29843663
30048,ranibizumab,gene,0.5024,29843663
30049,bevacizumab,gene,0.741,29843663
30050,Aflibercept,gene,0.9688,29843663
30051,ranibizumab,gene,0.5303,29843663
30052,Bevacizumab,gene,0.928,29843663
30053,BCVA,disease,0.9995,29843663
30054,Aflibercept,gene,0.9707,29843663
30055,ranibizumab,gene,0.614,29843663
30056,VEGF,gene,0.9614,29843663
30057,metastatic colorectal cancer,disease,1.0,29804191
30058,colorectal cancer,disease,1.0,29804191
30059,CRC,disease,1.0,29804191
30060,cancer,disease,1.0,29804191
30061,metastatic CRC,disease,1.0,29804191
30062,mCRC,disease,0.9995,29804191
30063,FOLFIRI,drug,0.9785,29804191
30064,aflibercept,gene,0.9814,29804191
30065,aflibercept,gene,0.9453,29804191
30066,FOLFIRI,drug,0.936,29804191
30067,mCRC,disease,0.978,29804191
30068,Aflibercept,gene,0.9443,29804123
30069,Polypoidal Choroidal Vasculopathy,disease,1.0,29804123
30070,Polypoidal choroidal vasculopathy,disease,1.0,29804123
30071,PCV,disease,1.0,29804123
30072,choroidal pathology,disease,1.0,29804123
30073,subretinal hemorrhages,disease,0.968,29804123
30074,ranibizumab,gene,0.9146,29804123
30075,bevacizumab,gene,0.5674,29804123
30076,aflibercept,gene,0.931,29804123
30077,PCV,disease,1.0,29804123
30078,PCV,disease,1.0,29804123
30079,PVC,disease,1.0,29804123
30080,aflibercept,gene,0.931,29804123
30081,polypoidal dilations,disease,1.0,29804123
30082,indocyanine green,drug,0.994,29804123
30083,aflibercept,gene,0.8545,29804123
30084,indocyanine green,drug,0.9883,29804123
30085,aflibercept,gene,0.9946,29804123
30086,polypoidal dilations,disease,1.0,29804123
30087,Aflibercept,gene,0.9736,29804123
30088,hemorrhagic,disease,0.5767,29804123
30089,atrophy,disease,0.9995,29804123
30090,Ranibizumab,gene,0.912,29804112
30091,Aflibercept,gene,0.922,29804112
30092,Central Retinal Vein Occlusion,disease,1.0,29804112
30093,Macular Edema,disease,1.0,29804112
30094,vascular endothelial growth factor,gene,0.998,29804112
30095,VEGF,gene,0.9976,29804112
30096,placental growth factor,gene,0.9985,29804112
30097,PlGF,gene,0.9917,29804112
30098,ranibizumab,gene,0.561,29804112
30099,aflibercept,gene,0.9863,29804112
30100,central retinal vein occlusion,disease,1.0,29804112
30101,CRVO,disease,1.0,29804112
30102,macular edema,disease,1.0,29804112
30103,CRVO,disease,1.0,29804112
30104,ranibizumab,gene,0.521,29804112
30105,aflibercept,gene,0.9585,29804112
30106,VEGF,gene,0.991,29804112
30107,PlGF,gene,0.964,29804112
30108,soluble intercellular adhesion molecule-1,gene,0.989,29804112
30109,monocyte chemotactic protein (MCP)-1,gene,0.9956,29804112
30110,CCL2,gene,0.97,29804112
30111,platelet-derived growth factor-AA,gene,0.8984,29804112
30112,interleukin (IL)-6,gene,0.9917,29804112
30113,IL-8,gene,0.97,29804112
30114,CXCL8,gene,0.9077,29804112
30115,IL-12(p70),gene,0.9395,29804112
30116,IL12B,gene,0.986,29804112
30117,IL,gene,0.8115,29804112
30118,VEGF,gene,0.9966,29804112
30119,PlGF,gene,0.989,29804112
30120,MCP-1,gene,0.987,29804112
30121,IL-6,gene,0.9614,29804112
30122,CRVO,disease,1.0,29804112
30123,ranibizumab,gene,0.8677,29804112
30124,aflibercept,gene,0.9546,29804112
30125,VEGF,gene,0.9897,29804112
30126,PlGF,gene,0.993,29804112
30127,MCP-1,gene,0.981,29804112
30128,IL-6,gene,0.9395,29804112
30129,Aflibercept,gene,0.927,29801084
30130,Aflibercept,gene,0.852,29801084
30131,Aflibercept,gene,0.9805,29801063
30132,Polypoidal Choroidal IMPORTANCE,disease,0.9995,29801063
30133,Polypoidal choroidal vasculopathy,disease,1.0,29801063
30134,PCV,disease,1.0,29801063
30135,aflibercept,gene,0.99,29801063
30136,participants,species,0.8354,29801063
30137,PCV,disease,1.0,29801063
30138,PARTICIPANTS,species,0.705,29801063
30139,PCV,disease,0.519,29801063
30140,Diabetic Retinopathy,disease,0.9995,29801063
30141,Participants,species,0.9434,29801063
30142,participants,species,0.9233,29801063
30143,Participants,species,0.9463,29801063
30144,IAI,drug,0.517,29801063
30145,participants,species,0.9766,29801063
30146,women,species,0.9663,29801063
30147,participants,species,0.9624,29801063
30148,Participants,species,0.9434,29801063
30149,participants,species,0.972,29801063
30150,polypoidal,DNA,0.4387,29801063
30151,polypoidal lesions,disease,1.0,29801063
30152,indocyanine green,drug,0.9966,29801063
30153,IAI,drug,0.811,29801063
30154,IAI,drug,0.7817,29801063
30155,polypoidal lesions,disease,1.0,29801063
30156,conjunctival hemorrhage,disease,1.0,29801063
30157,dry eye,disease,1.0,29801063
30158,participants,species,0.9683,29801063
30159,polypoidal lesions,disease,1.0,29801063
30160,patients,species,0.973,29785301
30161,diabetic macular edema,disease,1.0,29785301
30162,DME,disease,1.0,29785301
30163,DME,disease,1.0,29785301
30164,DME,disease,1.0,29785301
30165,DME,disease,1.0,29785301
30166,patients,species,0.996,29785301
30167,aflibercept,gene,0.9536,29785301
30168,aflibercept,gene,0.9614,29785301
30169,patients,species,0.9844,29785301
30170,CRT,DNA,0.5117,29785301
30171,aflibercept,gene,0.9556,29785301
30172,patients,species,0.951,29785301
30173,aflibercept,gene,0.93,29785301
30174,CRT,DNA,0.5347,29785301
30175,aflibercept,gene,0.8003,29785301
30176,DME,disease,0.9946,29785301
30177,DME,disease,0.998,29785301
30178,aflibercept,gene,0.9526,29785301
30179,DME,disease,1.0,29785301
30180,patients,species,0.9893,29785301
30181,bevacizumab,gene,0.872,29772018
30182,ranibizumab,gene,0.8555,29772018
30183,aflibercept,gene,0.9717,29772018
30184,bevacizumab,gene,0.834,29772018
30185,bevacizumab,gene,0.6387,29772018
30186,Bevacizumab,gene,0.851,29772018
30187,neovascular age-related macular degeneration,disease,1.0,29772018
30188,AMD,disease,1.0,29772018
30189,ranibizumab,gene,0.871,29772018
30190,aflibercept,gene,0.94,29772018
30191,AMD,disease,1.0,29772018
30192,ranibizumab,gene,0.54,29772018
30193,aflibercept,gene,0.973,29772018
30194,bevacizumab,gene,0.7227,29772018
30195,bevacizumab,gene,0.7573,29772018
30196,Bevacizumab,gene,0.9253,29772018
30197,aflibercept,gene,0.9854,29772018
30198,ranibizumab,gene,0.707,29772018
30199,bevacizumab,gene,0.783,29772018
30200,Aflibercept,gene,0.9585,29772018
30201,Aflibercept,gene,0.977,29772018
30202,aflibercept,gene,0.988,29772018
30203,AMD,disease,1.0,29772018
30204,aflibercept,gene,0.9736,29772018
30205,bevacizumab,gene,0.879,29772018
30206,Bevacizumab,gene,0.878,29772018
30207,AMD,disease,0.9995,29772018
30208,ranibizumab,gene,0.8193,29772018
30209,aflibercept,gene,0.969,29772018
30210,bevacizumab,gene,0.6167,29772018
30211,VEGF,gene,0.973,29771880
30212,diabetic macular edema,disease,1.0,29771880
30213,aflibercept,gene,0.9883,29771880
30214,patients,species,0.9526,29771880
30215,diabetic macular edema,disease,1.0,29771880
30216,DME,disease,1.0,29771880
30217,VEGF,gene,0.9966,29771880
30218,patients,species,0.993,29771880
30219,DME,disease,1.0,29771880
30220,patients,species,0.986,29771880
30221,patients,species,0.993,29771880
30222,macular edema,disease,1.0,29771880
30223,ranibizumab,gene,0.8755,29771880
30224,anti-VEGF,gene,0.947,29771880
30225,aflibercept,gene,0.991,29771880
30226,DME,drug,0.9526,29771880
30227,aflibercept,gene,0.9844,29771880
30228,patients,species,0.988,29771880
30229,patients,species,0.9927,29771880
30230,patients,species,0.982,29771880
30231,patients,species,0.9775,29771880
30232,aflibercept,gene,0.9785,29771880
30233,Aflibercept,gene,0.983,29771880
30234,DME,disease,1.0,29771880
30235,patients,species,0.9946,29771880
30236,ranibizumab,gene,0.8564,29771880
30237,Neovascular Age-Related Macular PURPOSE,disease,1.0,29768266
30238,age-related macular degeneration,disease,1.0,29768266
30239,AMD,disease,1.0,29768266
30240,patients,species,0.9253,29768266
30241,neovascular AMD,disease,1.0,29768266
30242,women,species,0.969,29768266
30243,men,species,0.98,29768266
30244,VEGF,gene,0.938,29768266
30245,Patients,species,0.9766,29768266
30246,AMD,disease,1.0,29768266
30247,polypoidal choroidal vasculopathy,disease,1.0,29768266
30248,PCV,disease,1.0,29768266
30249,retinal angiomatous proliferation,disease,1.0,29768266
30250,RAP,disease,1.0,29768266
30251,AMD,disease,1.0,29768266
30252,PCV,disease,1.0,29768266
30253,RAP,disease,1.0,29768266
30254,BCVA,cell_type,0.4033,29768266
30255,AMD,drug,0.991,29768266
30256,PCV,drug,0.999,29768266
30257,RAP,drug,0.9985,29768266
30258,RAP,gene,0.813,29768266
30259,PCV,disease,1.0,29768266
30260,RAP,disease,0.9995,29768266
30261,RAP,drug,0.7646,29768266
30262,anti-VEGF,gene,0.9585,29768266
30263,AMD,disease,1.0,29768266
30264,Neovascular Age-Related Macular Degeneration,disease,1.0,29765959
30265,anti-vascular endothelial growth factor,gene,0.951,29765959
30266,anti-VEGF,gene,0.986,29765959
30267,patients,species,0.959,29765959
30268,neovascular age-related macular degeneration,disease,1.0,29765959
30269,nAMD,disease,1.0,29765959
30270,patients,species,0.982,29765959
30271,anti-VEGF,gene,0.8755,29765959
30272,patients,species,0.988,29765959
30273,nAMD,disease,1.0,29765959
30274,VEGF,gene,0.709,29765959
30275,Patients,species,0.983,29765959
30276,Patients,species,0.965,29765959
30277,bevacizumab,gene,0.743,29765959
30278,ranibizumab,gene,0.6245,29765959
30279,choroidal neovascularization,disease,1.0,29765959
30280,CNV,disease,1.0,29765959
30281,CNV,disease,1.0,29765959
30282,CNV,disease,0.999,29765959
30283,patients,species,0.992,29765959
30284,aflibercept,gene,0.9644,29765959
30285,PARTICIPANTS,species,0.783,29765959
30286,patients,species,0.9907,29765959
30287,patients,species,0.99,29765959
30288,patients,species,0.991,29765959
30289,Patients,species,0.9507,29765959
30290,patients,species,0.975,29765959
30291,VEGF,gene,0.6846,29765959
30292,nAMD,disease,1.0,29765959
30293,patients,species,0.977,29765959
30294,CRISPR,gene,0.507,29748595
30295,LbCpf1,gene,0.9883,29748595
30296,choroidal neovascularization,disease,0.9272,29748595
30297,mouse,species,0.935,29748595
30298,age-related macular degeneration,disease,1.0,29748595
30299,LbCpf1,gene,0.9746,29748595
30300,CRISPR RNA-guided endonuclease,gene,0.835,29748595
30301,LbCpf1,gene,0.9863,29748595
30302,mouse,species,0.909,29748595
30303,age-related macular degeneration,disease,1.0,29748595
30304,AMD,disease,1.0,29748595
30305,LbCpf1,gene,0.976,29748595
30306,angiogenesis-associated genes,DNA,0.8604,29748595
30307,vascular endothelial growth factor A,gene,0.9985,29748595
30308,Vegfa,gene,0.997,29748595
30309,hypoxia inducing factor 1a,gene,0.9956,29748595
30310,Hif1a,gene,0.9966,29748595
30311,retinal pigment epithelium (RPE) cells,cell_type,0.901,29748595
30312,LbCpf1,gene,0.9834,29748595
30313,Vegfa,gene,0.617,29748595
30314,Hif1a,gene,0.53,29748595
30315,RPE cells,cell_type,0.9106,29748595
30316,choroidal neovascularization,disease,0.7017,29748595
30317,aflibercept,gene,0.987,29748595
30318,VEGF,gene,0.5796,29748595
30319,cone dysfunction,disease,0.995,29748595
30320,aflibercept,gene,0.987,29748595
30321,LbCpf1,gene,0.9834,29748595
30322,Vegfa,gene,0.9985,29748595
30323,Hif1a,gene,0.9985,29748595
30324,CNV,disease,0.993,29748595
30325,LbCpf1,gene,0.986,29748595
30326,AMD,disease,1.0,29748595
30327,neovascularization-associated diseases,disease,0.949,29748595
30328,aflibercept,gene,0.9907,29746511
30329,polypoidal choroidal vasculopathy,disease,1.0,29746511
30330,aflibercept,gene,0.984,29746511
30331,polypoidal choroidal vasculopathy,disease,1.0,29746511
30332,PCV,disease,1.0,29746511
30333,PCV,disease,1.0,29746511
30334,aflibercept,gene,0.9707,29746511
30335,BCVA,DNA,0.5454,29746511
30336,aflibercept,gene,0.9863,29746511
30337,PCV,disease,1.0,29746511
30338,retinal endothelial cells,cell_type,0.908,29743587
30339,REC,cell_line,0.916,29743587
30340,patients,species,0.931,29743587
30341,ocular disorders,disease,0.978,29743587
30342,VEGF,gene,0.9946,29743587
30343,aflibercept,gene,0.9277,29743587
30344,Human REC,cell_line,0.8687,29743587
30345,Human,species,0.923,29743587
30346,umbilical vein endothelial cells,cell_line,0.831,29743587
30347,HUVEC,cell_line,0.9175,29743587
30348,pericytes,cell_type,0.8677,29743587
30349,patients,species,0.9575,29743587
30350,cataract,disease,1.0,29743587
30351,glaucoma,disease,1.0,29743587
30352,proliferative diabetic retinopathy,disease,1.0,29743587
30353,PDR,disease,1.0,29743587
30354,REC-pericyte co-culture,cell_line,0.93,29743587
30355,pericyte,cell_type,0.45,29743587
30356,Aflibercept,gene,0.959,29743587
30357,co-culture,cell_line,0.9033,29743587
30358,PDR AH,cell_line,0.812,29743587
30359,GF,gene,,29743587
30360,REC,cell_line,0.802,29743587
30361,REC,cell_type,0.888,29743587
30362,HUVEC,cell_line,0.9487,29743587
30363,GF,gene,,29743587
30364,PDR,disease,1.0,29743587
30365,patient,species,0.9766,29743587
30366,REC,gene,0.969,29743587
30367,Aflibercept,gene,0.9575,29743587
30368,PDR,drug,0.589,29743587
30369,REC,cell_line,0.748,29743587
30370,REC,cell_type,0.5703,29743587
30371,Aflibercept,gene,0.9375,29739007
30372,choroidal neovascularization,disease,1.0,29739007
30373,CNV,disease,1.0,29739007
30374,vascular endothelial growth factor,gene,0.99,29739007
30375,VEGF,gene,0.992,29739007
30376,age-related macular degeneration,disease,1.0,29739007
30377,aflibercept,gene,0.977,29739007
30378,CNV,disease,1.0,29739007
30379,CNV,disease,0.975,29739007
30380,aflibercept,gene,0.99,29739007
30381,aflibercept,gene,0.9927,29735320
30382,chronic central serous chorioretihopathy,disease,0.9263,29735320
30383,aflibercept,gene,0.9927,29735320
30384,chronic central serous chorioretinopathy,disease,1.0,29735320
30385,CSCR,disease,1.0,29735320
30386,chronic CSCR,disease,0.997,29735320
30387,aflibercept,gene,0.9844,29735320
30388,aflibercept,gene,0.9795,29735320
30389,chronic CSCR,disease,0.9214,29735320
30390,anti-vascular epithelial growth factor,gene,0.982,29715501
30391,VEGF,gene,0.998,29715501
30392,fibroblast growth factor-2,gene,0.9966,29715501
30393,FGF-2,gene,0.9976,29715501
30394,RC28,gene,0.937,29715501
30395,IgG1,gene,0.9717,29715501
30396,Fc-fusion protein,gene,0.679,29715501
30397,VEGFA,gene,0.996,29715501
30398,FGF-2,gene,0.9927,29715501
30399,neovascular age-related macular degeneration,disease,0.9985,29715501
30400,choroidal neovascularization,disease,1.0,29715501
30401,CNV,disease,1.0,29715501
30402,VEGF,gene,0.9946,29715501
30403,endothelial cell,cell_type,0.912,29715501
30404,Bevacizumab,gene,0.868,29715501
30405,Ranibizumab,gene,0.8223,29715501
30406,Aflibercept,gene,0.975,29715501
30407,Ranibizumab,gene,0.891,29715501
30408,CNV,disease,0.9985,29715501
30409,VEGF,gene,0.997,29715501
30410,FGF-2,gene,0.9844,29715501
30411,CNV,disease,0.9995,29715501
30412,VEGF,gene,0.991,29715501
30413,CNV,disease,1.0,29715501
30414,CNV,disease,1.0,29715501
30415,RC28,DNA,0.4844,29715501
30416,(89)Zr,drug,0.999,29715501
30417,RC28,DNA,0.4543,29715501
30418,RC28,gene,0.971,29715501
30419,VEGF,gene,0.9976,29715501
30420,FGF-2,gene,0.9976,29715501
30421,CNV,disease,0.998,29715501
30422,VEGF,gene,0.9937,29715501
30423,RC28,drug,0.9097,29715501
30424,photoreceptor,cell_type,0.675,29713139
30425,aflibercept,gene,0.968,29713139
30426,age-related macular degeneration,disease,1.0,29713139
30427,photoreceptor,cell_type,0.642,29713139
30428,aflibercept,gene,0.9556,29713139
30429,neovascular age-related macular degeneration,disease,1.0,29713139
30430,AMD,disease,1.0,29713139
30431,AMD,disease,1.0,29713139
30432,photoreceptors,cell_type,0.7173,29713139
30433,foveal,DNA,0.5527,29713139
30434,foveal,DNA,0.5244,29713139
30435,neovascular AMD,disease,1.0,29713139
30436,Embolic stroke,disease,1.0,29710026
30437,aflibercept,gene,0.9814,29710026
30438,right upper limb monoplegia,disease,0.9663,29710026
30439,aflibercept,gene,0.983,29710026
30440,vascular endothelial growth factor,gene,0.9976,29710026
30441,ischemic lesions,disease,1.0,29710026
30442,hyperfibrinolysis,disease,1.0,29710026
30443,patent foramen ovale,disease,1.0,29710026
30444,deep vein thrombosis,disease,1.0,29710026
30445,cerebral emboli,disease,0.9927,29710026
30446,aflibercept,gene,0.991,29710026
30447,Eyelid allergic contact dermatitis,disease,0.9985,29708276
30448,anti-vascular endothelial growth factor,gene,0.9805,29708276
30449,tumor,disease,0.928,29700575
30450,tumor,disease,0.9863,29700575
30451,tumor,disease,0.998,29700575
30452,target lesions,DNA,0.496,29700575
30453,metastatic colorectal cancer,disease,1.0,29700575
30454,patients,species,0.966,29700575
30455,tumor,disease,0.996,29700575
30456,patient,species,0.932,29700575
30457,tumor,disease,0.998,29700575
30458,ILD,disease,0.991,29700575
30459,tumor,disease,0.8765,29700575
30460,tumor,disease,0.9976,29700575
30461,Wet,disease,0.978,29682574
30462,Age-Related Macular Degeneration,disease,0.9155,29682574
30463,Age-related macular degeneration,disease,1.0,29682574
30464,AMD,disease,1.0,29682574
30465,vision loss,disease,0.9946,29682574
30466,Wet AMD,disease,0.994,29682574
30467,wAMD,disease,1.0,29682574
30468,choroidal neovascularization,disease,1.0,29682574
30469,CNV,disease,1.0,29682574
30470,ranibizumab,gene,0.884,29682574
30471,aflibercept,gene,0.97,29682574
30472,wAMD,disease,1.0,29682574
30473,anti-VEGF,gene,0.974,29682574
30474,wAMD,disease,1.0,29682574
30475,CNV,disease,0.999,29682574
30476,anti-VEGF,gene,0.884,29682574
30477,genotype risk alleles,DNA,0.597,29682574
30478,wAMD,disease,1.0,29682574
30479,VA,disease,0.95,29682574
30480,VEGF,gene,0.715,29682574
30481,Aflibercept,gene,0.964,29681832
30482,Polypoidal Choroidal Vasculopathy,disease,1.0,29681832
30483,Ranibizumab,gene,0.7393,29681832
30484,Polypoidal choroidal vasculopathy,disease,1.0,29681832
30485,PCV,disease,1.0,29681832
30486,neovascular age-related macular degeneration,disease,1.0,29681832
30487,aneurysmal polypoidal choroidal vascular lesions,disease,1.0,29681832
30488,PCV,disease,1.0,29681832
30489,anti-vascular endothelial growth factor,gene,0.923,29681832
30490,PCV,disease,0.999,29681832
30491,Ranibizumab,gene,0.839,29681832
30492,anti-VEGF,gene,0.8545,29681832
30493,VEGF,gene,0.729,29681832
30494,VEGF,gene,0.9937,29681832
30495,polyp,disease,0.998,29681832
30496,PCV,disease,1.0,29681832
30497,VEGF,gene,0.7905,29681832
30498,ranibizumab,gene,0.5474,29681832
30499,Aflibercept,gene,0.9683,29681832
30500,choroidal neovascular lesions,disease,1.0,29681832
30501,PCV,disease,1.0,29681832
30502,indocyanine green,drug,0.995,29681832
30503,ranibizumab,gene,0.8423,29681832
30504,ranibizumab,gene,0.6333,29681832
30505,aflibercept,gene,0.9805,29681832
30506,Aflibercept,gene,0.958,29681832
30507,Mouse,species,0.993,29677368
30508,murine,species,0.986,29677368
30509,very-low-density lipoprotein receptor,gene,0.9985,29677368
30510,VLDLR,gene,0.9707,29677368
30511,mice,species,0.9565,29677368
30512,mice,species,0.9795,29677368
30513,vascular endothelial growth factor,gene,0.961,29677368
30514,VEGF,gene,0.998,29677368
30515,aflibercept,gene,0.9507,29677368
30516,retinal neovascularization,disease,0.9917,29677368
30517,pigmented,DNA,0.4827,29677368
30518,VEGF,gene,0.9536,29677368
30519,VLDLR-/- mouse retinas,cell_line,0.6104,29677368
30520,VLDLR,gene,0.994,29677368
30521,mouse,species,0.9146,29677368
30522,Wet Age-Related Macular Degeneration,disease,0.9995,29677356
30523,choroidal neovascularization,disease,1.0,29677356
30524,CNV,disease,1.0,29677356
30525,neovascular age-related macular degeneration,disease,1.0,29677356
30526,nAMD,disease,1.0,29677356
30527,VEGF,gene,0.7783,29677356
30528,nAMD,disease,1.0,29677356
30529,Bruch,cell_type,0.4683,29677356
30530,CNV,disease,1.0,29677356
30531,CNV,DNA,0.88,29677356
30532,CNV,DNA,0.4983,29677356
30533,CNV,disease,1.0,29677356
30534,CNV,disease,1.0,29677356
30535,Bruch,cell_type,0.4326,29677356
30536,CNV,DNA,0.658,29677356
30537,CNV,disease,0.6367,29677356
30538,CNV,disease,0.996,29677356
30539,CNV,disease,1.0,29677356
30540,CNV,DNA,0.731,29677356
30541,CNV,disease,0.9995,29677356
30542,CNV,DNA,0.556,29677356
30543,aflibercept,gene,0.989,29672933
30544,bevacizumab,gene,0.81,29672933
30545,primary oral squamous cell carcinoma cells,cell_line,0.593,29672933
30546,cancer,disease,1.0,29672933
30547,bevacizumab,gene,0.8584,29672933
30548,aflibercept,gene,0.984,29672933
30549,primary oral squamous cell carcinoma (OSCC) cells,cell_line,0.8574,29672933
30550,primary,cell_type,0.6255,29672933
30551,oral squamous cell carcinoma,disease,0.9995,29672933
30552,OSCC,disease,0.9727,29672933
30553,bevacizumab,gene,0.881,29672933
30554,aflibercept,gene,0.9287,29672933
30555,vascular endothelial growth factor,gene,0.999,29672933
30556,VEGF,gene,0.9937,29672933
30557,primary OSCC cells,cell_line,0.764,29672933
30558,OSCC cells,cell_type,0.665,29672933
30559,OSCC,disease,1.0,29672933
30560,MTT,drug,0.9956,29672933
30561,VEGF,gene,0.9946,29672933
30562,primary cancer cells,cell_line,0.7637,29672933
30563,primary cancer,disease,0.9434,29672933
30564,VEGF,gene,0.994,29672933
30565,aflibercept,gene,0.9497,29672933
30566,bevacizumab-treated cells,cell_line,0.859,29672933
30567,bevacizumab,gene,0.4563,29672933
30568,-,cell_type,0.583,29672933
30569,treated cells,cell_type,0.5737,29672933
30570,aflibercept,gene,0.992,29672933
30571,bevacizumab,gene,0.6875,29672933
30572,OSCC,disease,0.9995,29672933
30573,Cancer,disease,1.0,29670046
30574,VEGF,gene,0.6064,29670046
30575,solid cancers,disease,1.0,29670046
30576,Bevacizumab,gene,0.4963,29670046
30577,recombinant humanized monoclonal antibody of,gene,0.802,29670046
30578,vascular endothelial growth factor (VEGF) A,gene,0.9873,29670046
30579,metastatic colorectal cancer,disease,0.998,29670046
30580,CRC,disease,1.0,29670046
30581,VEGF,gene,0.4949,29670046
30582,tyrosine,drug,0.942,29670046
30583,tyrosine kinase,gene,0.9595,29670046
30584,sunitinib,drug,0.9985,29670046
30585,sorafenib,drug,0.999,29670046
30586,pazopanib,drug,0.999,29670046
30587,VEGF decoy receptor,gene,0.7607,29670046
30588,aflibercept,gene,0.982,29670046
30589,VEGF receptor 2,gene,0.9927,29670046
30590,VEGFR2,gene,0.986,29670046
30591,cancer,disease,1.0,29670046
30592,VEGF,gene,0.996,29670046
30593,cancer,disease,1.0,29670046
30594,VEGF,gene,0.828,29670046
30595,cancer,disease,1.0,29670046
30596,VEGF,gene,0.9976,29670046
30597,VEGF,gene,0.9707,29670046
30598,cancer,disease,1.0,29670046
30599,Ziv-Aflibercept,gene,0.973,29664981
30600,Diabetic Macular Edema,disease,1.0,29664981
30601,ziv-aflibercept,gene,0.988,29664981
30602,IVI-ZA,gene,0.9277,29664981
30603,diabetic macular edema,disease,1.0,29664981
30604,DME,disease,1.0,29664981
30605,PATIENTS,species,0.958,29664981
30606,DME,disease,1.0,29664981
30607,CRT,DNA,0.5894,29664981
30608,DME,disease,1.0,29664981
30609,VEGF,gene,0.914,29662298
30610,macular edema,disease,1.0,29662298
30611,retinal vein occlusion,disease,1.0,29662298
30612,vascular endothelial growth factor,gene,0.9985,29662298
30613,VEGF,gene,0.9976,29662298
30614,macular edema,disease,1.0,29662298
30615,RVO,disease,1.0,29662298
30616,RVO,disease,0.95,29662298
30617,RVO,disease,0.9897,29662298
30618,anti-VEGF,gene,0.8325,29662298
30619,anti-VEGF,gene,0.9106,29662298
30620,RVO,disease,1.0,29662298
30621,anti-VEGF,gene,0.9307,29662298
30622,ranibizumab,gene,0.588,29662298
30623,bevacizumab,gene,0.974,29662298
30624,aflibercept,gene,0.989,29662298
30625,anti-VEGF,gene,0.9653,29662298
30626,anti-VEGF,gene,0.9272,29662298
30627,CRT,DNA,0.521,29662298
30628,blurry or cloudy vision,disease,1.0,29662298
30629,VEGF,gene,0.9897,29662298
30630,VEGF,gene,0.952,29662298
30631,VEGF,gene,0.919,29662298
30632,anti-vascular endothelial growth factor,gene,0.9536,29659411
30633,bevacizumab,gene,0.7666,29659411
30634,ranibizumab,drug,0.512,29659411
30635,aflibercept,gene,0.9893,29659411
30636,vascular endothelial growth factor,gene,0.9766,29659411
30637,patients,species,0.97,29659183
30638,neovascular age-related macular,disease,1.0,29659183
30639,vascular endothelial growth factor,gene,0.962,29659183
30640,VEGF,gene,0.998,29659183
30641,patients,species,0.902,29659183
30642,neovascular (wet) age-related macular degeneration,disease,1.0,29659183
30643,nAMD,disease,1.0,29659183
30644,Patients,species,0.919,29659183
30645,aflibercept,gene,0.974,29659183
30646,IVT,drug,0.8276,29659183
30647,AFL,drug,0.9854,29659183
30648,IVT,drug,0.919,29659183
30649,AFL,drug,0.9824,29659183
30650,patients,species,0.988,29659183
30651,AFL,gene,0.78,29659183
30652,Diabetic Retinopathy,disease,1.0,29659183
30653,choroidal neovascularization,disease,1.0,29659183
30654,CNV,disease,1.0,29659183
30655,CNV,DNA,0.677,29659183
30656,classic CNV,disease,0.9995,29659183
30657,CNV,DNA,0.719,29659183
30658,dry retina,disease,0.9995,29659183
30659,CNV,disease,0.9985,29659183
30660,CNV,disease,0.9995,29659183
30661,Bevacizumab,gene,0.8154,29655642
30662,Exudative Age-related Macular Degeneration,disease,1.0,29655642
30663,bevacizumab,gene,0.8853,29655642
30664,exudative age-related macular degeneration,disease,0.9995,29655642
30665,AMD,disease,1.0,29655642
30666,bevacizumab,gene,0.9424,29655642
30667,ranibizumab,gene,0.881,29655642
30668,aflibercept,gene,0.952,29655642
30669,CPT),DNA,0.5713,29655642
30670,vascular endothelial growth factor,gene,0.9966,29655642
30671,bevacizumab,gene,0.8135,29655642
30672,bevacizumab,gene,0.924,29655642
30673,exudative AMD,disease,1.0,29655642
30674,bevacizumab,gene,0.613,29655642
30675,diabetic macular edema,disease,1.0,29655642
30676,retinal vein occlusion,disease,1.0,29655642
30677,Polypoidal Choroidal Vasculopathy,disease,1.0,29643788
30678,Optic Disc Coloboma,disease,1.0,29643788
30679,polypoidal choroidal vasculopathy,disease,1.0,29643788
30680,optic disc coloboma,disease,1.0,29643788
30681,disc coloboma,disease,0.9834,29643788
30682,retinochoroidal coloboma,disease,1.0,29643788
30683,subretinal hemorrhage,disease,1.0,29643788
30684,serous retinal detachment,disease,1.0,29643788
30685,SRD,disease,1.0,29643788
30686,SRD,disease,1.0,29643788
30687,retinal,cell_type,0.3992,29643788
30688,retinal epithelial detachment,disease,0.783,29643788
30689,choroidal cavitation,disease,0.8896,29643788
30690,optic coloboma,disease,1.0,29643788
30691,Fluorescein,drug,0.9966,29643788
30692,indocyanine green,drug,0.9946,29643788
30693,polypoidal lesions,disease,1.0,29643788
30694,polypoidal choroidal vasculopathy,disease,1.0,29643788
30695,PCV,disease,1.0,29643788
30696,PCV,disease,0.4714,29643788
30697,anti-vascular endothelial growth factor aflibercept,gene,0.9463,29643788
30698,aflibercept,gene,0.988,29643788
30699,SRD,disease,1.0,29643788
30700,PCV,disease,1.0,29643788
30701,optic disc coloboma,disease,1.0,29643788
30702,choroidal cavitation,disease,0.994,29643788
30703,choroidal excavation,disease,0.9966,29643788
30704,optic disc coloboma,disease,1.0,29643788
30705,PCV,disease,1.0,29643788
30706,Ranibizumab,gene,0.9263,29636594
30707,aflibercept,gene,0.979,29636594
30708,VEGF,gene,0.801,29636594
30709,ranibizumab,gene,0.8086,29636594
30710,ranibizumab,gene,0.8677,29636594
30711,aflibercept,gene,0.9805,29636594
30712,neovascular age-related macular degeneration,disease,1.0,29636594
30713,patients,species,0.9897,29636594
30714,ranibizumab,gene,0.7495,29636594
30715,aflibercept,gene,0.9634,29636594
30716,aflibercept,gene,0.96,29636594
30717,ranibizumab,drug,0.6646,29636594
30718,aflibercept,gene,0.9673,29636594
30719,patients,species,0.9624,29636594
30720,epithelium detachment,disease,0.993,29636594
30721,aflibercept,gene,0.971,29636594
30722,ranibizumab,gene,0.8354,29636594
30723,pigment epithelium detachment,disease,0.999,29636594
30724,aflibercept,gene,0.9907,29636594
30725,CRT,DNA,0.4702,29636594
30726,CRT,DNA,0.712,29636594
30727,Ranibizumab,gene,0.944,29636594
30728,aflibercept,gene,0.962,29636594
30729,Urine,RNA,0.4824,29625440
30730,Creatinine,drug,0.999,29625440
30731,creatinine,drug,0.9985,29625440
30732,participants,species,0.951,29625440
30733,aflibercept,gene,0.979,29625440
30734,bevacizumab,gene,0.923,29625440
30735,ranibizumab,gene,0.8887,29625440
30736,aflibercept,gene,0.9863,29625440
30737,bevacizumab,gene,0.9043,29625440
30738,ranibizumab,gene,0.636,29625440
30739,diabetic macular edema,disease,1.0,29625440
30740,DME,disease,1.0,29625440
30741,Diabetic Retinopathy,disease,1.0,29625440
30742,participants,species,0.972,29625440
30743,DME,disease,1.0,29625440
30744,aflibercept,gene,0.9927,29625440
30745,bevacizumab,gene,0.901,29625440
30746,ranibizumab,gene,0.7324,29625440
30747,albumin,gene,0.757,29625440
30748,creatinine,drug,0.9307,29625440
30749,participants,species,0.978,29625440
30750,aflibercept,gene,0.99,29625440
30751,bevacizumab,gene,0.832,29625440
30752,ranibizumab,drug,0.551,29625440
30753,participants,species,0.973,29625440
30754,microalbuminuria,disease,0.8994,29625440
30755,macroalbuminuria,disease,0.9585,29625440
30756,patients,species,0.9043,29625440
30757,DME,disease,1.0,29625440
30758,aflibercept,gene,0.979,29625440
30759,bevacizumab,gene,0.923,29625440
30760,ranibizumab,gene,0.8887,29625440
30761,AFLIBERCEPT,gene,0.7666,29624543
30762,RANIBIZUMAB,drug,0.987,29624543
30763,aflibercept,gene,0.9717,29624543
30764,ranibizumab,gene,0.729,29624543
30765,macular edema,disease,1.0,29624543
30766,central retinal vein occlusion,disease,1.0,29624543
30767,Patients,species,0.976,29624543
30768,central retinal vein occlusion,disease,1.0,29624543
30769,macular edema,disease,1.0,29624543
30770,aflibercept,gene,0.968,29624543
30771,macular edema,disease,1.0,29624543
30772,aflibercept,gene,0.9688,29624543
30773,aflibercept,gene,0.99,29624543
30774,ranibizumab,gene,0.761,29624543
30775,Patients,species,0.9414,29624543
30776,macular edema,disease,1.0,29624543
30777,central retinal vein occlusion,disease,1.0,29624543
30778,aflibercept,gene,0.962,29624543
30779,patients,species,0.9766,29624543
30780,miR,DNA,0.5156,29617404
30781,miR-20a,gene,0.934,29617404
30782,breast cancer,disease,1.0,29617404
30783,tumor,disease,1.0,29617404
30784,breast cancer,disease,1.0,29617404
30785,microRNA,RNA,0.698,29617404
30786,tumor,disease,0.9995,29617404
30787,miR-17,DNA,0.761,29617404
30788,miR-17-92,gene,0.9707,29617404
30789,miRNA cluster,DNA,0.748,29617404
30790,breast cancer,disease,1.0,29617404
30791,miR-20a,gene,0.9707,29617404
30792,miR-17-92 cluster,gene,0.9863,29617404
30793,tumor,disease,0.9985,29617404
30794,patients,species,0.9893,29617404
30795,invasive breast carcinoma,disease,1.0,29617404
30796,MCF7,cell_line,0.919,29617404
30797,MDA-MB-,cell_type,0.4397,29617404
30798,breast cancer,disease,0.9976,29617404
30799,miR,RNA,0.5806,29617404
30800,anti,DNA,0.5425,29617404
30801,anti-miR20a,gene,0.988,29617404
30802,breast cancer,disease,0.999,29617404
30803,patients,species,0.9824,29617404
30804,miR-17,DNA,0.578,29617404
30805,miR-17-92,gene,0.912,29617404
30806,endothelial cells,cell_type,0.9346,29617404
30807,breast cancer cell lines,cell_line,0.884,29617404
30808,breast cancer,disease,1.0,29617404
30809,anti,DNA,0.5166,29617404
30810,anti-miR20a,gene,0.986,29617404
30811,MDA-MB-231,cell_line,0.9263,29617404
30812,miR-20a,gene,0.946,29617404
30813,MCF7 cells,cell_line,0.9497,29617404
30814,MiR-20a,gene,0.9253,29617404
30815,aflibercept,gene,0.956,29617404
30816,VEGF,gene,0.9946,29617404
30817,mir,DNA,0.5825,29617404
30818,mir-20a,gene,0.9565,29617404
30819,tumors,cell_type,0.421,29617404
30820,tumors,disease,1.0,29617404
30821,estrogen,drug,0.998,29617404
30822,estrogen receptor,gene,0.9956,29617404
30823,miR-20a,gene,0.9746,29617404
30824,VEGFA,gene,0.996,29617404
30825,glomeruloid microvascular proliferations,cell_type,0.6533,29617404
30826,tumor subtype,cell_line,0.6245,29617404
30827,tumor,disease,1.0,29617404
30828,VEGFA,gene,0.995,29617404
30829,breast cancer cells,cell_line,0.8765,29617404
30830,breast cancer cells,cell_type,0.6753,29617404
30831,breast cancer,disease,0.9985,29617404
30832,miR-20a,gene,0.905,29617404
30833,miR,RNA,0.557,29617404
30834,miR-20a,gene,0.957,29617404
30835,breast invasive carcinomas,disease,1.0,29617404
30836,VEGFA,gene,0.997,29617404
30837,miR-20a,gene,0.922,29617404
30838,breast cancer,disease,1.0,29617404
30839,Aflibercept,gene,0.9336,29605592
30840,FOLFIRI,drug,0.5576,29605592
30841,Aflibercept,gene,0.9565,29605592
30842,Aflibercept,gene,0.9243,29605592
30843,FOLFIRI,drug,0.6187,29605592
30844,folinic acid,drug,0.999,29605592
30845,5-fluorouracil,drug,0.9995,29605592
30846,irinotecan,drug,0.998,29605592
30847,metastatic colorectal cancer,disease,1.0,29605592
30848,mCRC,disease,1.0,29605592
30849,FOLFIRI,drug,0.9263,29605592
30850,aflibercept,gene,0.984,29605592
30851,irinotecan,drug,0.998,29605592
30852,5-fluorouracil,drug,0.9985,29605592
30853,metastatic colorectal cancer,disease,0.9995,29605592
30854,oxaliplatin,drug,0.9995,29605592
30855,Aflibercept,gene,0.9053,29605592
30856,PATIENTS,species,0.97,29605592
30857,aflibercept,gene,0.961,29605592
30858,FOLFIRI,drug,0.8965,29605592
30859,mCRC,disease,0.997,29605592
30860,oxaliplatin,drug,0.9995,29605592
30861,bevacizumab,gene,0.5396,29605592
30862,Cancer,disease,0.9233,29605592
30863,ASQoP,disease,1.0,29605592
30864,aflibercept,gene,0.9766,29605592
30865,FOLFIRI,drug,0.6616,29605592
30866,Hypertension,disease,1.0,29605592
30867,neutropenia,disease,1.0,29605592
30868,asthenic conditions,disease,1.0,29605592
30869,diarrhea,disease,1.0,29605592
30870,stomatitis,disease,1.0,29605592
30871,sepsis,disease,1.0,29605592
30872,neutropenic complications,disease,0.8516,29605592
30873,Aflibercept,gene,0.6646,29605592
30874,FOLFIRI,drug,0.9575,29605592
30875,mCRC,disease,0.992,29605592
30876,Bevacizumab,gene,0.9233,29600470
30877,Ranibizumab,gene,0.941,29600470
30878,Aflibercept,gene,0.974,29600470
30879,bevacizumab,gene,0.5723,29600470
30880,ranibizumab,drug,0.6963,29600470
30881,aflibercept,gene,0.8916,29600470
30882,LED,DNA,0.4873,29600470
30883,anti-VEGF antibody,gene,0.9536,29600470
30884,Aflibercept,gene,0.839,29571831
30885,Proliferative Diabetic,disease,1.0,29571831
30886,type 1 CNV,disease,0.731,29567794
30887,exudative AMD,disease,0.966,29567794
30888,anti-VEGF,gene,0.6885,29567794
30889,type 1 choroidal neovascularisation,disease,0.994,29567794
30890,CNV,disease,1.0,29567794
30891,age-related macular degeneration,disease,1.0,29567794
30892,anti-,gene,0.8125,29567794
30893,vascular endothelial growth factor,gene,0.9014,29567794
30894,VEGF,gene,0.9976,29567794
30895,Patients,species,0.9624,29567794
30896,type 1 CNV,disease,0.9976,29567794
30897,anti-VEGF,gene,0.7173,29567794
30898,patients,species,0.983,29567794
30899,VEGF,gene,0.7393,29567794
30900,aflibercept,gene,0.973,29567794
30901,ranibizumab,gene,0.7856,29567794
30902,CNV,disease,1.0,29567794
30903,Cystoid macular oedema,disease,1.0,29567794
30904,Neuroretinal detachment,disease,1.0,29567794
30905,CNV,disease,1.0,29567794
30906,CNV,disease,1.0,29567794
30907,type 1 CNV,disease,1.0,29567794
30908,Choroidal perfusion impairment,disease,0.892,29567794
30909,CNV,disease,1.0,29567794
30910,anti-VEGF,gene,0.962,29567019
30911,anti-vascular endothelial growth factors,gene,0.9966,29567019
30912,anti-VEGFs,gene,0.9907,29567019
30913,cancer,disease,1.0,29567019
30914,hypertension,disease,1.0,29567019
30915,proteinuria,disease,1.0,29567019
30916,anti-VEGFs,gene,0.965,29567019
30917,anti-VEGFs,gene,0.9805,29567019
30918,anti-VEGFs,gene,0.7314,29567019
30919,Colorectal Cancer,disease,1.0,29562227
30920,cancer,disease,1.0,29562227
30921,vascular endothelial growth factor,gene,0.998,29562227
30922,VEGF,gene,0.9873,29562227
30923,VEGF,gene,0.995,29562227
30924,colorectal cancer,disease,1.0,29562227
30925,CRC,disease,1.0,29562227
30926,anti-VEGF antibody,gene,0.932,29562227
30927,metastatic CRC,disease,1.0,29562227
30928,mCRC,disease,1.0,29562227
30929,aflibercept,gene,0.954,29562227
30930,regorafenib,drug,0.9697,29562227
30931,tumor,disease,0.999,29562227
30932,tumor,disease,0.997,29562227
30933,tumor,disease,0.633,29562227
30934,immune cells,cell_type,0.821,29562227
30935,tumor,disease,0.999,29562227
30936,patients,species,0.9736,29562227
30937,mCRC,disease,0.9956,29562227
30938,patients,species,0.9956,29562227
30939,Aflibercept,gene,0.9863,29554385
30940,Wet,disease,0.9917,29554385
30941,Age-Related Macular Degeneration,disease,0.9023,29554385
30942,Ranibizumab,gene,0.881,29554385
30943,Bevacizumab,gene,0.7275,29554385
30944,neovascular age-related macular degeneration,disease,0.999,29554385
30945,vascular endothelial growth factor,gene,0.9795,29554385
30946,aflibercept,gene,0.605,29554385
30947,Eylea,drug,0.9624,29554385
30948,PATIENTS,species,0.959,29554385
30949,ZIV,drug,0.6436,29554051
30950,PATIENT,species,0.985,29554051
30951,MACULAR EDEMA,disease,1.0,29554051
30952,BRANCH RETINAL VEIN OCCLUSION,disease,1.0,29554051
30953,macular edema,disease,1.0,29554051
30954,branch retinal vein occlusion,disease,1.0,29554051
30955,ziv-aflibercept,gene,0.9795,29554051
30956,ziv-aflibercept,gene,0.976,29554051
30957,ziv-aflibercept,gene,0.9854,29554051
30958,macular edema,disease,1.0,29554051
30959,branch retinal vein occlusion,disease,0.9873,29554051
30960,ziv-aflibercept,gene,0.9795,29554051
30961,macular edema,disease,1.0,29554051
30962,branch retinal vein occlusion,disease,1.0,29554051
30963,ranibizumab,gene,0.8853,29550932
30964,aflibercept,gene,0.9785,29550932
30965,dexamethasone,drug,0.9565,29550932
30966,ranibizumab,gene,0.789,29550932
30967,aflibercept,gene,0.946,29550932
30968,dexamethasone,drug,0.984,29550932
30969,macular edema,disease,1.0,29550932
30970,ME,disease,1.0,29550932
30971,non-ischemic central retinal vein occlusion,disease,1.0,29550932
30972,CRVO,disease,1.0,29550932
30973,Patients,species,0.9883,29550932
30974,IDI,drug,0.983,29550932
30975,ME,disease,,29550932
30976,non-,disease,0.9517,29550932
30977,patients,species,0.993,29550932
30978,patients,species,0.994,29550932
30979,patients,species,0.994,29550932
30980,Cataract,disease,1.0,29550932
30981,ME,disease,,29550932
30982,IDI,drug,0.9595,29550932
30983,cataract,disease,1.0,29550932
30984,IDI,drug,0.9966,29550932
30985,ziv-aflibercept,gene,0.984,29548928
30986,ziv-aflibercept,gene,0.9873,29548928
30987,corneal neovascularization,disease,1.0,29548928
30988,NV,disease,1.0,29548928
30989,bevacizumab,gene,0.5996,29548928
30990,sulfur,drug,0.9985,29548928
30991,rabbit,species,0.9424,29548928
30992,SM burn,disease,0.9795,29548928
30993,rabbits,species,0.9067,29548928
30994,Ziv-aflibercept,gene,0.978,29548928
30995,neovascularized eyes,disease,0.9287,29548928
30996,bevacizumab,gene,0.5645,29548928
30997,blood vessels,cell_type,0.536,29548928
30998,NV,disease,,29548928
30999,conjunctival goblet cell,cell_type,0.766,29548928
31000,Corneal NV,disease,1.0,29548928
31001,ziv-aflibercept,gene,0.9766,29548928
31002,NV,disease,,29548928
31003,NV,disease,,29548928
31004,ziv-aflibercept,gene,0.9453,29548928
31005,Bevacizumab,gene,0.9175,29548928
31006,NV,disease,,29548928
31007,ziv-aflibercept,gene,0.984,29548928
31008,ziv-aflibercept,gene,0.982,29548928
31009,conjunctival goblet cells,cell_type,0.844,29548928
31010,ziv-aflibercept,gene,0.983,29548928
31011,corneal NV,disease,0.9995,29548928
31012,sulfur,drug,0.9985,29548928
31013,ziv-aflibercept,gene,0.988,29548928
31014,corneal,disease,0.7314,29548928
31015,Diabetic Retinopathy,disease,1.0,29528861
31016,Diabetic Retinopathy,disease,1.0,29528861
31017,diabetic macular edema,disease,1.0,29528861
31018,DME,disease,1.0,29528861
31019,proliferative diabetic retinopathy,disease,1.0,29528861
31020,PDR,disease,1.0,29528861
31021,DME,disease,1.0,29528861
31022,aflibercept,gene,0.935,29528861
31023,bevacizumab,gene,0.8555,29528861
31024,ranibizumab,gene,0.593,29528861
31025,Aflibercept,gene,0.9785,29528861
31026,diabetic retinopathy,disease,1.0,29528861
31027,PDR,disease,0.9995,29528861
31028,vision,disease,0.917,29528861
31029,DME,disease,0.9995,29528861
31030,bevacizumab,gene,0.755,29528861
31031,DME,disease,1.0,29528861
31032,antivascular endothelial growth factor,gene,0.9946,29528861
31033,anti-VEGF,gene,0.985,29528861
31034,ranibizumab,gene,0.5664,29528861
31035,dexamethasone,drug,0.913,29528861
31036,PDR,disease,0.999,29528861
31037,PDR,disease,0.991,29528861
31038,DME,disease,0.9995,29528861
31039,Ranibizumab,gene,0.734,29528861
31040,PDR,disease,0.996,29528861
31041,DME,disease,0.9995,29528861
31042,Aflibercept,gene,0.9116,29528861
31043,DME,disease,0.9995,29528861
31044,bevacizumab,gene,0.764,29528861
31045,DME,disease,1.0,29528861
31046,anti-VEGF,gene,0.9385,29528861
31047,Aflibercept,gene,0.774,29525840
31048,diabetic macular edema,disease,1.0,29525840
31049,Vascular Endothelial Growth Factor,gene,0.9165,29525602
31050,vascular endothelial growth factor (VEGF)-A,gene,0.9966,29525602
31051,aflibercept,gene,0.985,29525602
31052,ranibizumab,gene,0.7324,29525602
31053,participants,species,0.9604,29525602
31054,aflibercept,gene,0.9937,29525602
31055,bevacizumab,gene,0.8936,29525602
31056,ranibizumab,gene,0.631,29525602
31057,PARTICIPANTS,species,0.858,29525602
31058,Participants,species,0.9497,29525602
31059,plasma,cell_type,0.5576,29525602
31060,VEGF,gene,0.9478,29525602
31061,VEGF,gene,0.5547,29525602
31062,VEGF,gene,0.57,29525602
31063,VEGF,gene,0.9854,29525602
31064,VEGF,gene,0.982,29525602
31065,aflibercept,gene,0.992,29525602
31066,bevacizumab,gene,0.796,29525602
31067,aflibercept,gene,0.9697,29525602
31068,bevacizumab,gene,0.988,29525602
31069,aflibercept,gene,0.995,29525602
31070,ranibizumab,gene,0.9805,29525602
31071,bevacizumab,gene,0.978,29525602
31072,ranibizumab,gene,0.98,29525602
31073,VEGF,gene,0.991,29525602
31074,bevacizumab,gene,0.7866,29525602
31075,aflibercept,gene,0.9917,29525602
31076,ranibizumab,gene,0.704,29525602
31077,aflibercept,gene,0.9907,29525602
31078,bevacizumab,gene,0.76,29525602
31079,participants,species,0.9727,29525602
31080,plasma,cell_type,0.555,29525602
31081,Participants,species,0.9766,29525602
31082,heart attack,disease,1.0,29525602
31083,stroke,disease,1.0,29525602
31084,VEGF,gene,0.994,29525602
31085,-VEGF,gene,0.561,29525602
31086,aflibercept,gene,0.9844,29525602
31087,bevacizumab,gene,0.82,29525602
31088,bevacizumab,gene,0.929,29525602
31089,ranibizumab,gene,0.7627,29525602
31090,participants,species,0.9634,29525602
31091,VEGF,gene,0.994,29525602
31092,VEGF,gene,0.9937,29525602
31093,VEGF,gene,0.9966,29525602
31094,VEGF,gene,0.994,29525602
31095,Aflibercept,gene,0.973,29523991
31096,diabetic macular edema,disease,1.0,29523991
31097,bevacizumab,gene,0.6333,29523991
31098,anti-VEGF,gene,0.762,29522724
31099,Anti-Vascular Endothelial Growth Factor,gene,0.9697,29522724
31100,VEGF,gene,0.998,29522724
31101,patients,species,0.992,29522724
31102,age-related macular degeneration,disease,1.0,29522724
31103,VEGF,gene,0.4944,29522724
31104,retinal pigment epithelial (RPE) cells,cell_type,0.9155,29522724
31105,anti-VEGF,gene,0.774,29522724
31106,primary porcine RPE cells,cell_line,0.9634,29522724
31107,porcine,species,0.9395,29522724
31108,bevacizumab,gene,0.83,29522724
31109,ranibizumab,gene,0.7554,29522724
31110,aflibercept,gene,0.9795,29522724
31111,rituximab,gene,0.958,29522724
31112,"3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoli bromide tetrazolium",drug,0.98,29522724
31113,MTT,drug,0.9995,29522724
31114,trypan blue,drug,0.9985,29522724
31115,-galactosidase,gene,0.9297,29522724
31116,cathepsin D,gene,0.99,29522724
31117,rapamycin,drug,0.9985,29522724
31118,mTOR,gene,0.9917,29522724
31119,Pigment Epithelium Derived Factor,gene,0.997,29522724
31120,PEDF,gene,0.9897,29522724
31121,Transforming Growth Factor,gene,0.992,29522724
31122,TGF,gene,0.997,29522724
31123,autophagosomes,cell_type,0.542,29522724
31124,RPE cells,cell_type,0.848,29522724
31125,Ranibizumab,gene,0.6885,29522724
31126,-galactosidase,gene,0.7236,29522724
31127,ranibizumab,gene,0.5576,29522724
31128,untreated cells,cell_line,0.727,29522724
31129,untreated cells,cell_type,0.875,29522724
31130,Bevacizumab,gene,0.66,29522724
31131,the,gene,0.595,29522724
31132,-galactosidase,gene,0.8306,29522724
31133,Aflibercept,gene,0.889,29522724
31134,Rituximab,gene,0.8354,29522724
31135,-galactosidase,gene,0.7183,29522724
31136,mTOR,gene,0.996,29522724
31137,phospho,drug,0.62,29522724
31138,phospho-mTOR,gene,0.94,29522724
31139,cathepsin D,gene,0.9937,29522724
31140,RPE cells,cell_type,0.9097,29522724
31141,TGF-,gene,0.98,29522724
31142,Bevacizumab,drug,0.9033,29522724
31143,treated cells,cell_type,0.622,29522724
31144,TGF-,gene,0.984,29522724
31145,ranibizumab,drug,0.7983,29522724
31146,rituximab,gene,0.82,29522724
31147,PEDF,gene,0.9917,29522724
31148,mitochondria,cell_type,0.4934,29522724
31149,Autophagosomes,cell_type,0.5977,29522724
31150,anti-VEGF,gene,0.931,29522724
31151,bevacizumab,cell_line,0.505,29522724
31152,bevacizumab,gene,0.9575,29522724
31153,aflibercept treated cells,cell_line,0.6465,29522724
31154,aflibercept,gene,0.9893,29522724
31155,treated cells,cell_type,0.5347,29522724
31156,ranibizumab,gene,0.735,29522724
31157,rituximab treated cells,cell_line,0.723,29522724
31158,rituximab,cell_type,0.4585,29522724
31159,rituximab,gene,0.9604,29522724
31160,treated cells,cell_type,0.631,29522724
31161,VEGF,gene,0.989,29522724
31162,primary RPE cells,cell_line,0.955,29522724
31163,bevacizumab,gene,0.8833,29522724
31164,aflibercept,gene,0.977,29522724
31165,rituximab,gene,0.917,29522724
31166,ranibizumab,gene,0.585,29522724
31167,rituximab,gene,0.978,29522724
31168,VEGF,gene,0.6924,29522724
31169,Aflibercept,gene,0.869,29508370
31170,Diabetic Macular Oedema,disease,1.0,29508370
31171,diabetic macular oedema,disease,1.0,29508370
31172,DMO,disease,1.0,29508370
31173,patients,species,0.987,29508370
31174,aflibercept,gene,0.991,29508370
31175,bevacizumab,gene,0.8867,29508370
31176,ranibizumab,gene,0.93,29508370
31177,patients,species,0.986,29508370
31178,DMO,disease,1.0,29508370
31179,aflibercept,gene,0.9634,29508370
31180,bevacizumab,gene,0.625,29508370
31181,ranibizumab,gene,0.8984,29508370
31182,patients,species,0.9707,29508370
31183,bevacizumab,gene,0.9224,29508370
31184,ranibizumab,drug,0.8647,29508370
31185,aflibercept,gene,0.956,29508370
31186,DMO,disease,1.0,29508370
31187,retinal arteriolar macroaneurysm,disease,1.0,29505440
31188,RAM,disease,1.0,29505440
31189,anti-,gene,0.7017,29505440
31190,vascular endothelial growth factor,gene,0.859,29505440
31191,RAMs,disease,1.0,29505440
31192,RAM,DNA,0.617,29505440
31193,patients,species,0.989,29505440
31194,RAM,DNA,0.597,29505440
31195,Diabetic Retinopathy,disease,1.0,29505440
31196,vascular endothelial growth factor,gene,0.9956,29505440
31197,RAMs,disease,1.0,29505440
31198,vascular endothelial growth factor,gene,0.8975,29505440
31199,macular edema,disease,1.0,29505440
31200,Bevacizumab,gene,0.932,29492680
31201,Ranibizumab,gene,0.9136,29492680
31202,Aflibercept,gene,0.9834,29492680
31203,bevacizumab,gene,0.894,29492680
31204,mAb fragment,gene,0.823,29492680
31205,ranibizumab,gene,0.8438,29492680
31206,aflibercept,gene,0.9214,29492680
31207,anti-VEGF mAbs,gene,0.985,29492680
31208,bevacizumab,gene,0.934,29492680
31209,ranibizumab,gene,0.9004,29492680
31210,aflibercept,gene,0.966,29492680
31211,Avastin,drug,0.5215,29492680
31212,Lucentis,drug,0.653,29492680
31213,Eylea,drug,0.9023,29492680
31214,NaCl,drug,0.9995,29492680
31215,trehalose,drug,0.999,29492680
31216,arginine,drug,0.99,29492680
31217,Tween 80,drug,0.996,29492680
31218,mAbs,gene,0.651,29492680
31219,Anti-Vascular Endothelial Growth Factor,gene,0.98,29490349
31220,Pachychoroid Neovasculopathy,disease,1.0,29490349
31221,pachychoroid neovasculopathy,disease,1.0,29490349
31222,PNV,disease,1.0,29490349
31223,vascular endothelial growth factor,gene,0.964,29490349
31224,VEGF,gene,0.996,29490349
31225,PNV,disease,1.0,29490349
31226,Diabetic Retinopathy,disease,0.998,29490349
31227,SFCT,DNA,0.4868,29490349
31228,SFCT,DNA,0.4856,29490349
31229,PNV,disease,1.0,29490349
31230,PNV,species,0.775,29490349
31231,Ranibizumab,gene,0.9175,29486762
31232,Aflibercept,gene,0.9453,29486762
31233,macular disease,disease,1.0,29486762
31234,patients,species,0.9854,29486762
31235,macular disease,disease,1.0,29486762
31236,aflibercept,gene,0.9736,29486762
31237,ranibizumab,gene,0.8643,29486762
31238,patient,species,0.9844,29486762
31239,patients,species,0.982,29486762
31240,ranibizumab,gene,0.969,29486762
31241,aflibercept,gene,0.9766,29486762
31242,patients,species,0.985,29486762
31243,ranibizumab,gene,0.8438,29486762
31244,aflibercept,gene,0.9517,29486762
31245,patients,species,0.985,29486762
31246,CRT,DNA,0.5596,29486762
31247,patients,species,0.986,29486762
31248,ranibizumab,gene,0.802,29486762
31249,aflibercept,gene,0.9043,29486762
31250,ranibizumab,gene,0.7627,29486762
31251,aflibercept,gene,0.962,29486762
31252,aflibercept,gene,0.974,29486762
31253,ranibizumab,gene,0.5596,29486762
31254,aflibercept,gene,0.975,29486762
31255,aflibercept,gene,0.8564,29486762
31256,ranibizumab,gene,0.59,29486762
31257,aflibercept,gene,0.9507,29486762
31258,ranibizumab,gene,0.8403,29486762
31259,aflibercept,gene,0.964,29486762
31260,aflibercept,gene,0.9673,29486762
31261,Aflibercept,gene,0.7427,31047597
31262,Macular Edema,disease,1.0,31047597
31263,Choroidal Neovascularization,disease,1.0,31047590
31264,Neovascular Age-Related Macular PURPOSE,disease,0.9966,31047590
31265,patients,species,0.9805,31047590
31266,choroidal neovascularization,disease,1.0,31047590
31267,CNV,disease,1.0,31047590
31268,neovascular age-related macular degeneration,disease,1.0,31047590
31269,nAMD,disease,1.0,31047590
31270,PARTICIPANTS,species,0.648,31047590
31271,patients,species,0.966,31047590
31272,nAMD,disease,1.0,31047590
31273,patients,species,0.9556,31047590
31274,anti-vascular endothelial growth factor,gene,0.9507,31047590
31275,VEGF,gene,0.998,31047590
31276,CNV,disease,0.9917,31047590
31277,patients,species,0.9893,31047590
31278,patients,species,0.9946,31047590
31279,CNV,disease,1.0,31047590
31280,patients,species,0.9575,31047590
31281,CNV,DNA,0.7495,31047590
31282,patients,species,0.9907,31047590
31283,patients,species,0.9863,31047590
31284,CNV,disease,1.0,31047590
31285,Patients,species,0.9683,31047590
31286,Patients,species,0.97,31047590
31287,CNV,disease,0.646,31047590
31288,patient,species,0.9756,29480271
31289,diminished vision,disease,0.9976,29480271
31290,choroidal neovascular membrane,disease,0.9956,29480271
31291,CNVM,disease,1.0,29480271
31292,peripapillary subretinal hemorrhage,disease,0.9966,29480271
31293,angioid streaks,disease,1.0,29480271
31294,CNVM,disease,0.9995,29480271
31295,CNVM,disease,0.9995,29480271
31296,ziv-aflibercept,gene,0.978,29480271
31297,CNVM,disease,0.9995,29480271
31298,angioid streaks,disease,0.9995,29480271
31299,CNVM,disease,1.0,29480271
31300,Retinal pigment epithelium,cell_type,0.5103,29480261
31301,ziv-aflibercept,gene,0.9663,29480261
31302,Ziv-Aflibercept,gene,0.947,29479487
31303,Nave,disease,0.8877,29479487
31304,Ziv-Aflibercept,gene,0.9634,29479487
31305,Chronic Central Serous Chorioretinopathy,disease,1.0,29479487
31306,CSCR,disease,1.0,29479487
31307,Choroidal Neovascular Membrane,disease,1.0,29479487
31308,CNVM,disease,1.0,29479487
31309,patient,species,0.967,29479487
31310,IVZ,drug,0.9863,29479487
31311,CSCR,disease,0.997,29479487
31312,CNVM,disease,1.0,29479487
31313,fluorescein,drug,0.769,29479487
31314,Patients,species,0.989,29479487
31315,patient,species,0.9463,29479487
31316,CNVM,disease,1.0,29479487
31317,VEGF,gene,0.904,29479487
31318,CNVM,disease,1.0,29479487
31319,IVZ,drug,0.7256,29479487
31320,CSCR,disease,1.0,29479487
31321,CNVM,disease,1.0,29479487
31322,CSCR,disease,1.0,29479487
31323,CNVM,disease,1.0,29479487
31324,Endophthalmitis,disease,0.9995,29477689
31325,Vascular Endothelial Growth Factor,gene,0.997,29477689
31326,patients,species,0.9844,29477689
31327,endophthalmitis,disease,1.0,29477689
31328,vascular endothelial growth factor,gene,0.998,29477689
31329,VEGF,gene,0.9966,29477689
31330,PARTICIPANTS,species,0.6875,29477689
31331,Patients,species,0.9775,29477689
31332,endophthalmitis,disease,1.0,29477689
31333,VEGF,gene,0.8296,29477689
31334,patients,species,0.983,29477689
31335,endophthalmitis,disease,1.0,29477689
31336,patients,species,0.9946,29477689
31337,endophthalmitis,disease,0.9995,29477689
31338,patients,species,0.993,29477689
31339,patients,species,0.9946,29477689
31340,hypopyon,disease,0.9287,29477689
31341,coagulase,cell_line,0.52,29477689
31342,coagulase-negative,gene,0.7085,29477689
31343,Staphylococcus,species,0.3486,29477689
31344,Streptococcus,species,0.865,29477689
31345,patients,species,0.992,29477689
31346,Streptococcus,species,0.808,29477689
31347,coagulase,gene,0.978,29477689
31348,Staphylococcus,species,0.688,29477689
31349,hypopyon,disease,0.569,29477689
31350,BCVA,disease,1.0,29477689
31351,aflibercept,gene,0.9355,29476754
31352,ranibizumab,gene,0.5225,29476754
31353,aflibercept,gene,0.9395,29476754
31354,neovascular age-related macular degeneration,disease,0.974,29476754
31355,ranibizumab,gene,0.947,29476754
31356,aflibercept,gene,0.9824,29476754
31357,Macular IMPORTANCE,disease,0.954,29476687
31358,anti-VEGF,gene,0.801,29476687
31359,macular edema,disease,1.0,29476687
31360,central retinal vein occlusion,disease,1.0,29476687
31361,hemiretinal vein occlusion,disease,1.0,29476687
31362,participants,species,0.9014,29476687
31363,Retinal Vein Occlusion,disease,1.0,29476687
31364,aflibercept,gene,0.9824,29476687
31365,PARTICIPANTS,species,0.691,29476687
31366,participants,species,0.9614,29476687
31367,participants,species,0.9575,29476687
31368,macular edema,disease,1.0,29476687
31369,central retinal vein occlusion,disease,1.0,29476687
31370,hemiretinal vein occlusion,disease,1.0,29476687
31371,Participants,species,0.9595,29476687
31372,aflibercept,gene,0.987,29476687
31373,aflibercept,gene,0.9814,29476687
31374,participants,species,0.973,29476687
31375,bevacizumab,gene,0.7065,29476687
31376,bevacizumab,gene,0.648,29476687
31377,participant,species,0.982,29476687
31378,Diabetic Retinopathy,disease,1.0,29476687
31379,participants,species,0.978,29476687
31380,aflibercept,gene,0.9766,29476687
31381,aflibercept,gene,0.9785,29476687
31382,aflibercept,gene,0.967,29476687
31383,bevacizumab,gene,0.8115,29476687
31384,aflibercept,gene,0.9863,29476687
31385,bevacizumab,gene,0.8896,29476687
31386,aflibercept,gene,0.988,29476687
31387,bevacizumab,gene,0.8906,29476687
31388,central retinal or hemiretinal vein occlusion,disease,1.0,29476687
31389,AFLIBERCEPT,gene,0.91,29470308
31390,PATIENTS,species,0.9814,29470308
31391,aflibercept,gene,0.992,29470308
31392,patients,species,0.932,29470308
31393,diabetic macular edema,disease,1.0,29470308
31394,DME,disease,1.0,29470308
31395,DME,disease,0.9985,29470308
31396,patients,species,0.917,29470308
31397,DME,disease,1.0,29470308
31398,IAI,drug,0.8394,29470308
31399,patients,species,0.987,29470308
31400,patients,species,0.956,29470308
31401,patients,species,0.8984,29470308
31402,DME,disease,1.0,29470308
31403,2q8,DNA,0.758,29470308
31404,VIVID,DNA,0.542,29470308
31405,VIVID-DME,cell_line,0.841,29470308
31406,IAI 2q8,DNA,0.813,29470308
31407,IAI,gene,0.697,29470308
31408,aflibercept,gene,0.991,29470308
31409,IAI,drug,0.8467,29470308
31410,patients,species,0.9487,29470308
31411,DME,disease,1.0,29470308
31412,patient,species,0.9546,29470308
31413,vascular endothelial growth factors,gene,0.997,29468838
31414,wet age-related macular,disease,0.9946,29468838
31415,diabetic macular edema,disease,1.0,29452450
31416,VEGF,gene,0.845,29452450
31417,anti-VEGF,gene,0.744,29452450
31418,Fluocinolone acetonide,drug,0.999,29452450
31419,Dexamethasone,drug,0.9966,29452450
31420,anti-VEGF,gene,0.7334,29452450
31421,Ranibizumab,gene,0.8916,29452450
31422,Aflibercept,gene,0.9688,29452450
31423,Eylea,gene,0.7275,29452450
31424,Fluocinolone acetonide,drug,0.9995,29452450
31425,Iluvien,drug,0.999,29452450
31426,Dexamethasone,drug,0.999,29452450
31427,Ozurdex,drug,0.9976,29452450
31428,endophthalmitis,disease,1.0,29452450
31429,cataract,disease,1.0,29452450
31430,anti-VEGF,gene,0.7427,29452450
31431,Ranibizumab,gene,0.8354,29452450
31432,Aflibercept,gene,0.8623,29452450
31433,Fluocinolone acetonide,drug,0.999,29452450
31434,Dexamethasone,drug,0.99,29452450
31435,anti-VEGF,gene,0.747,29452450
31436,diabetic macular edema,disease,1.0,29452450
31437,Fluocinolone acetonide,drug,0.9995,29452450
31438,Aflibercept,gene,0.983,29451077
31439,Ranibizumab,gene,0.892,29451077
31440,Wet,disease,0.8945,29451077
31441,Age-Related Macular Degeneration,disease,0.9243,29451077
31442,Age-related macular degeneration,disease,1.0,29451077
31443,AMD,disease,1.0,29451077
31444,vision loss,disease,0.9985,29451077
31445,vision,disease,0.9673,29451077
31446,neovascular AMD,disease,1.0,29451077
31447,wet AMD,disease,0.9995,29451077
31448,wAMD,disease,1.0,29451077
31449,antivascular endothelial growth factor,gene,0.9585,29451077
31450,VEGF,gene,0.996,29451077
31451,wAMD,disease,1.0,29451077
31452,ranibizumab,gene,0.585,29451077
31453,aflibercept,gene,0.9893,29451077
31454,ranibizumab,gene,0.5483,29451077
31455,aflibercept,gene,0.887,29451077
31456,wAMD,disease,0.9985,29451077
31457,wAMD,disease,1.0,29451077
31458,ranibizumab,gene,0.618,29451077
31459,blindness,disease,0.9995,29451077
31460,AMD,disease,0.929,29451077
31461,ranibizumab,gene,0.8525,29451077
31462,IAI,DNA,0.525,29451077
31463,Rq4,DNA,0.48,29451077
31464,ranibizumab,gene,0.571,29451077
31465,wAMD,disease,0.997,29451077
31466,aflibercept,gene,0.965,29451077
31467,Aflibercept,gene,0.9536,29450547
31468,Rabbit,species,0.9644,29450547
31469,Chronic Retinal Neovascularization,disease,1.0,29450547
31470,chronic retinal neovascularization,disease,0.9062,29450547
31471,RNV,disease,1.0,29450547
31472,DL--aminoadipic acid,drug,0.9995,29450547
31473,AAA,drug,0.999,29450547
31474,rabbit,species,0.9517,29450547
31475,aflibercept,gene,0.98,29450547
31476,RNV,disease,0.603,29450547
31477,Rabbits,species,0.922,29450547
31478,fluorescein,drug,0.999,29450547
31479,aflibercept,gene,0.893,29450547
31480,RNV,drug,0.998,29450547
31481,neuronal degeneration,disease,1.0,29450547
31482,RNV,cell_line,0.568,29450547
31483,RNV,species,0.536,29450547
31484,aflibercept,gene,0.859,29450547
31485,RNV,species,0.6206,29450547
31486,aflibercept,gene,0.9785,29450547
31487,aflibercept,gene,0.9854,29450547
31488,aflibercept,gene,0.9766,29450547
31489,retinal vascular diseases,disease,1.0,29450547
31490,ocular hypertension,disease,1.0,29450400
31491,VEGF,gene,0.883,29450400
31492,neovascular AMD,disease,1.0,29450400
31493,ocular hypertension,disease,0.9995,29450400
31494,VEGF,gene,0.701,29450400
31495,neovascular AMD,disease,1.0,29450400
31496,neovascular age-related macular degeneration,disease,1.0,29450400
31497,VEGF,gene,0.6836,29450400
31498,bevacizumab,gene,0.8906,29450400
31499,aflibercept,gene,0.953,29450400
31500,VEGF,gene,0.5566,29450400
31501,glaucoma,disease,1.0,29450400
31502,VEGF,gene,0.7783,29450400
31503,VEGF,gene,0.65,29450400
31504,anti VEGF,gene,0.661,29450400
31505,bevacizumab,gene,0.9727,29450400
31506,aflibercept,gene,0.987,29450400
31507,VEGF,gene,0.7983,29450400
31508,Aflibercept,gene,0.989,29447089
31509,Bevacizumab,gene,0.8765,29447089
31510,Ranibizumab,gene,0.652,29447089
31511,Macular Edema,disease,1.0,29447089
31512,aflibercept,gene,0.996,29447089
31513,bevacizumab,gene,0.697,29447089
31514,patients,species,0.966,29447089
31515,macular edema,disease,1.0,29447089
31516,ME,disease,1.0,29447089
31517,central retinal vein occlusion,disease,1.0,29447089
31518,CRVO,disease,1.0,29447089
31519,patients,species,0.9893,29447089
31520,ME,disease,,29447089
31521,CRVO,disease,1.0,29447089
31522,Patients,species,0.9614,29447089
31523,ME,disease,,29447089
31524,aflibercept,gene,0.9834,29447089
31525,bevacizumab,gene,0.568,29447089
31526,patients,species,0.9766,29447089
31527,ME,disease,,29447089
31528,aflibercept,gene,0.967,29447089
31529,ranibizumab,gene,0.5996,29447089
31530,ME,disease,,29447089
31531,ME,disease,,29447089
31532,ME,disease,,29447089
31533,patients,species,0.98,29447089
31534,patients,species,0.9604,29447089
31535,ME,disease,,29447089
31536,CRVO,disease,1.0,29447089
31537,patients,species,0.674,29447089
31538,aflibercept,gene,0.9795,29447089
31539,Exudative Age-Related Macular Degeneration,disease,0.9995,29443357
31540,vascular endothelial growth factor,gene,0.987,29443357
31541,VEGF,gene,0.995,29443357
31542,age-related macular degeneration,disease,1.0,29443357
31543,AMD,disease,1.0,29443357
31544,PATIENTS,species,0.976,29443357
31545,wet AMD,disease,0.9976,29443357
31546,VEGF,gene,0.8735,29443357
31547,VEGF,gene,0.9585,29440946
31548,metastatic colorectal cancer,disease,0.9985,29440946
31549,Colorectal cancer,disease,1.0,29440946
31550,cancer,disease,1.0,29440946
31551,Vascular endothelial growth factor,gene,0.996,29440946
31552,VEGF,gene,0.9937,29440946
31553,tumor,disease,1.0,29440946
31554,metastatic colorectal cancer,disease,1.0,29440946
31555,mCRC,disease,1.0,29440946
31556,mCRC,disease,0.975,29440946
31557,Infections,disease,0.9473,29426804
31558,Infections,disease,0.9224,29426804
31559,cancer,disease,1.0,29426804
31560,patients,species,0.9883,29426804
31561,Vascular endothelial growth factor,gene,0.995,29426804
31562,VEGF,gene,0.9985,29426804
31563,bevacizumab,gene,0.9395,29426804
31564,aflibercept,gene,0.9766,29426804
31565,neutropaenia,disease,0.9995,29426804
31566,VEGF tyrosine kinase,gene,0.9097,29426804
31567,tyrosine,drug,0.6523,29426804
31568,sorafenib,drug,0.999,29426804
31569,sunitinib,drug,0.998,29426804
31570,Anti-,gene,0.886,29426804
31571,epidermal growth factor receptor,gene,0.888,29426804
31572,EGFR,gene,0.968,29426804
31573,cetuximab,gene,0.9136,29426804
31574,panitumumab,gene,0.8525,29426804
31575,neutropaenia,disease,1.0,29426804
31576,skin and soft tissue infection,disease,1.0,29426804
31577,papulopustular,disease,1.0,29426804
31578,rash,disease,0.833,29426804
31579,doxycycline,drug,0.9995,29426804
31580,minocycline,drug,0.998,29426804
31581,Pneumocystis,disease,0.9995,29426804
31582,ErbB2,gene,0.7026,29426804
31583,HER2,gene,0.9946,29426804
31584,trastuzumab,gene,0.9673,29426804
31585,pertuzumab,gene,0.9316,29426804
31586,ErbB receptor tyrosine kinase,gene,0.8965,29426804
31587,tyrosine,drug,0.9077,29426804
31588,EGFR,gene,0.9976,29426804
31589,ErbB2,gene,0.9985,29426804
31590,lapatinib,drug,0.9937,29426804
31591,neratinib,drug,0.98,29426804
31592,neutropaenia,disease,0.982,29426804
31593,VEGF,gene,0.995,29426804
31594,aflibercept,gene,0.99,29411259
31595,choroidal neovascularization,disease,1.0,29411259
31596,rubella retinopathy,disease,1.0,29411259
31597,choroidal neovascularization,disease,1.0,29411259
31598,CNV,disease,1.0,29411259
31599,rubella retinopathy,disease,1.0,29411259
31600,RR,disease,1.0,29411259
31601,aflibercept,gene,0.9697,29411259
31602,visual decrease,disease,0.984,29411259
31603,hearing decrease,disease,0.999,29411259
31604,patent ductus arteriosus,disease,1.0,29411259
31605,whitish subretinal lesion,disease,0.875,29411259
31606,retinal hemorrhages,disease,0.9995,29411259
31607,fluorescein,drug,0.936,29411259
31608,CNV,disease,0.8857,29411259
31609,aflibercept,gene,0.988,29411259
31610,aflibercept,gene,0.9146,29411259
31611,RR,disease,0.998,29411259
31612,CNV,DNA,0.6377,29411259
31613,aflibercept,gene,0.936,29411171
31614,pachychoroid neovasculopathy,disease,1.0,29411171
31615,Type 1 neovascular age-related macular degeneration,disease,1.0,29411171
31616,aflibercept,gene,0.982,29411171
31617,PNV,disease,1.0,29411171
31618,neovascular age-related macular degeneration,disease,0.9917,29411171
31619,AMD,disease,1.0,29411171
31620,PNV,disease,1.0,29411171
31621,Type 1 neovascular AMD,disease,0.9883,29411171
31622,PNV,disease,1.0,29411171
31623,AMD,disease,1.0,29411171
31624,PNV,disease,1.0,29411171
31625,AMD,disease,1.0,29411171
31626,PNV,disease,1.0,29411171
31627,AMD,disease,0.9917,29411171
31628,PNV,disease,1.0,29411171
31629,polypoidal lesions,disease,1.0,29411171
31630,PNV,disease,1.0,29411171
31631,polypoidal lesions,disease,0.9995,29411171
31632,PNV,disease,1.0,29411171
31633,AMD,disease,0.9854,29411171
31634,polypoidal lesions,disease,1.0,29411171
31635,aflibercept,gene,0.959,29411171
31636,PNV,disease,1.0,29411171
31637,Type 1 neovascular AMD,disease,1.0,29411171
31638,PNV,disease,1.0,29411171
31639,polypoidal lesions,disease,0.9707,29411171
31640,polypoidal lesions,disease,0.7847,29411171
31641,VEGF,gene,0.7876,29405046
31642,Arteriothrombotic Events,disease,1.0,29405046
31643,vascular endothelial growth factor,gene,0.9976,29405046
31644,VEGF,gene,0.9937,29405046
31645,VEGF,gene,0.9927,29405046
31646,tyrosine,drug,0.993,29405046
31647,tyrosine kinases,gene,0.9966,29405046
31648,VEGF,gene,0.993,29405046
31649,nitric oxide,drug,1.0,29405046
31650,NO,drug,1.0,29405046
31651,prostaglandin-I 2,drug,0.9995,29405046
31652,PG-I 2,drug,0.9995,29405046
31653,vascular endothelial cell,cell_type,0.8555,29405046
31654,VEGF,gene,0.9956,29405046
31655,cancer,disease,1.0,29405046
31656,hypertension,disease,0.9995,29405046
31657,thrombosis,disease,0.9995,29405046
31658,VEGF,gene,0.917,29405046
31659,diabetic macular edema,disease,1.0,29405046
31660,neovascular age-related macular degeneration,disease,1.0,29405046
31661,arteriothrombotic events,disease,0.998,29405046
31662,diabetic macular edema,disease,1.0,29405046
31663,aflibercept,gene,0.9937,29405046
31664,ranibizumab,gene,0.7197,29405046
31665,VEGF,gene,0.946,29405046
31666,VEGF,gene,0.9277,29405046
31667,aflibercept,gene,0.98,29405046
31668,bevacizumab,gene,0.6797,29405046
31669,Ranibizumab,gene,0.835,29404860
31670,aflibercept,gene,0.9766,29404860
31671,vascularized pigment epithelium detachment,disease,0.9688,29404860
31672,age-related macular degeneration,disease,1.0,29404860
31673,anti-vascular endothelial growth factor,gene,0.9785,29404860
31674,anti-VEGF,gene,0.712,29404860
31675,ranibizumab,gene,0.8936,29404860
31676,aflibercept,gene,0.973,29404860
31677,vascularized pigment epithelium detachment,disease,1.0,29404860
31678,vPED,disease,1.0,29404860
31679,age-related macular degeneration,disease,1.0,29404860
31680,AMD,disease,1.0,29404860
31681,vPED,disease,0.9995,29404860
31682,AMD,disease,1.0,29404860
31683,ranibizumab,gene,0.7915,29404860
31684,aflibercept,gene,0.984,29404860
31685,PED,disease,0.686,29404860
31686,subretinal fluid,disease,0.9756,29404860
31687,SRF,disease,0.982,29404860
31688,intraretinal fluid,disease,0.9766,29404860
31689,diffuse macular edema,disease,1.0,29404860
31690,DME,disease,1.0,29404860
31691,aflibercept,gene,0.967,29404860
31692,PED,DNA,0.4934,29404860
31693,aflibercept,gene,0.9766,29404860
31694,PED,disease,0.822,29404860
31695,vPED,disease,0.999,29404860
31696,AMD,disease,1.0,29404860
31697,diabetic macular edema,disease,1.0,29403260
31698,aflibercept,gene,0.95,29403260
31699,ranibizumab,gene,0.826,29403260
31700,diabetic macular edema,disease,1.0,29403260
31701,ranibizumab,gene,0.9067,29403260
31702,aflibercept,gene,0.964,29403260
31703,ranibizumab,gene,0.698,29403260
31704,aflibercept,gene,0.9272,29403260
31705,ranibizumab,gene,0.6406,29403260
31706,aflibercept,gene,0.8994,29403260
31707,BCVA,DNA,0.5703,29403260
31708,CRT,DNA,0.4912,29403260
31709,ranibizumab,gene,0.778,29403260
31710,aflibercept,gene,0.964,29403260
31711,diabetic macular edema,disease,1.0,29403260
31712,CRT,DNA,0.4778,29403260
31713,CRT,DNA,0.5234,29403260
31714,aflibercept,gene,0.968,29402496
31715,age-related macular degeneration,disease,1.0,29402496
31716,choroidal neovascularization,disease,0.9756,29402496
31717,retinal angiomatous proliferation,disease,1.0,29402496
31718,VEGF,gene,0.586,29398697
31719,VEGF,gene,0.807,29398697
31720,angiogenesis-driven eye diseases,disease,0.869,29398697
31721,diabetic macular edema,disease,1.0,29398697
31722,macular degeneration,disease,1.0,29398697
31723,Pegaptanib,drug,0.99,29398697
31724,ranibizumab,drug,0.4993,29398697
31725,aflibercept,gene,0.954,29398697
31726,bevacizumab,gene,0.7715,29398697
31727,eye diseases,disease,0.961,29398697
31728,VEGF,gene,0.995,29398697
31729,VEGF,gene,0.765,29398697
31730,VEGF,gene,0.741,29398697
31731,wet AMD,disease,0.999,29397436
31732,VEGF,gene,0.5986,29397436
31733,VEGF,gene,0.908,29397436
31734,wet age-related macular degeneration,disease,0.999,29397436
31735,wAMD,disease,1.0,29397436
31736,patients,species,0.983,29397436
31737,patients,species,0.984,29397436
31738,wAMD,disease,1.0,29397436
31739,patients,species,0.9907,29397436
31740,wAMD,disease,1.0,29397436
31741,patients,species,0.991,29397436
31742,patients,species,0.987,29397436
31743,BCVA,cell_type,0.464,29397436
31744,aflibercept,gene,0.94,29397436
31745,Choroidal osteoma,disease,1.0,29397245
31746,choroidal osteoma,disease,0.9805,29397245
31747,choroidal excavation,disease,0.6294,29397245
31748,neovascular membrane,disease,0.727,29397245
31749,aflibercept,gene,0.98,29397245
31750,osteoma,disease,1.0,29397245
31751,Vascular Endothelial Growth Factor,gene,0.9805,29392302
31752,Diabetic Macular Edema,disease,1.0,29392302
31753,Macular Thickening,disease,1.0,29392288
31754,Aflibercept,gene,0.987,29392288
31755,Bevacizumab,gene,0.7695,29392288
31756,diabetic macular edema,disease,1.0,29392288
31757,DME,disease,1.0,29392288
31758,vascular endothelial growth factor,gene,0.998,29392288
31759,DME,disease,0.9995,29392288
31760,aflibercept,gene,0.99,29392288
31761,bevacizumab,gene,0.9116,29392288
31762,ranibizumab,gene,0.7417,29392288
31763,PARTICIPANTS,species,0.74,29392288
31764,DRCR,DNA,0.4832,29392288
31765,participants,species,0.9575,29392288
31766,anti-vascular endothelial growth factor,gene,0.9478,29392288
31767,DME,disease,1.0,29392288
31768,DME,disease,1.0,29392288
31769,participants,species,0.977,29392288
31770,women,species,0.9097,29392288
31771,DME,disease,0.996,29392288
31772,bevacizumab,gene,0.5684,29392288
31773,aflibercept,gene,0.9717,29392288
31774,aflibercept,gene,0.9956,29392288
31775,bevacizumab,gene,0.835,29392288
31776,bevacizumab,gene,0.866,29392288
31777,aflibercept,gene,0.9854,29392288
31778,ranibizumab,gene,0.802,29392288
31779,DME,disease,0.9995,29392288
31780,DME,disease,0.999,29392288
31781,aflibercept,gene,0.9707,29392288
31782,aflibercept,gene,0.9946,29392288
31783,bevacizumab,gene,0.585,29392288
31784,aflibercept,gene,0.9946,29392288
31785,ranibizumab,gene,0.6025,29392288
31786,bevacizumab,gene,0.8296,29392288
31787,ranibizumab,gene,0.505,29392288
31788,DME,disease,1.0,29392288
31789,DME,disease,1.0,29392288
31790,aflibercept,gene,0.984,29392288
31791,bevacizumab,gene,0.773,29392288
31792,ranibizumab,gene,0.7476,29392288
31793,DME,disease,0.9995,29392288
31794,DME,disease,1.0,29392288
31795,bevacizumab,gene,0.8086,29392288
31796,aflibercept,gene,0.9453,29392288
31797,DME,disease,1.0,29392288
31798,bevacizumab,gene,0.9023,29392288
31799,DME,disease,1.0,29392288
31800,aflibercept,gene,0.977,29392288
31801,anti-vascular endothelial growth factor,gene,0.8486,29392288
31802,DME,disease,0.9995,29392288
31803,DME,disease,1.0,29392288
31804,aflibercept,gene,0.9785,29391560
31805,Macular edema,disease,1.0,29391560
31806,neovascular age-related macular degeneration,disease,1.0,29391560
31807,diabetes,disease,1.0,29391560
31808,retinal vein occlusion,disease,1.0,29391560
31809,central vision,disease,0.8467,29391560
31810,vascular endothelial growth factor,gene,0.9976,29391560
31811,VEGF,gene,0.9976,29391560
31812,macular edema,disease,1.0,29391560
31813,VEGF,gene,0.795,29391560
31814,VEGF,gene,0.71,29391560
31815,aflibercept,gene,0.984,29391560
31816,VEGF,gene,0.997,29391560
31817,neonatal Fc receptor,gene,0.997,29391560
31818,FcRn,gene,0.9976,29391560
31819,aflibercept,gene,0.986,29391560
31820,patient,species,0.99,29391560
31821,Bevacizumab,gene,0.7646,29389239
31822,Ranibizumab,gene,0.839,29389239
31823,Aflibercept,gene,0.944,29389239
31824,MicroRNA,RNA,0.776,29389239
31825,bevacizumab,gene,0.7744,29389239
31826,ranibizumab,gene,0.6357,29389239
31827,aflibercept,gene,0.976,29389239
31828,microRNA,RNA,0.762,29389239
31829,miRNA,RNA,0.7295,29389239
31830,human retinal pigment epithelium cell (ARPE-19) culture,cell_line,0.8657,29389239
31831,human,species,0.991,29389239
31832,Control cells,cell_line,0.8335,29389239
31833,hydrogen peroxide,drug,1.0,29389239
31834,H(2)O(2),drug,1.0,29389239
31835,H(2)O(2),drug,1.0,29389239
31836,ARPE-19 cells,cell_line,0.8223,29389239
31837,ARPE-19 cells,cell_type,0.5146,29389239
31838,H(2)O(2),drug,1.0,29389239
31839,bevacizumab,gene,0.806,29389239
31840,ranibizumab,gene,0.7666,29389239
31841,aflibercept,gene,0.974,29389239
31842,H(2)O(2),drug,1.0,29389239
31843,ARPE-19 cells,cell_line,0.8843,29389239
31844,H(2)O(2),drug,1.0,29389239
31845,vascular endothelial growth factor,gene,0.999,29389239
31846,VEGF,gene,0.9976,29389239
31847,MTT,drug,0.9995,29389239
31848,"3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazol bromide",drug,0.996,29389239
31849,1,RNA,0.48,29389239
31850,miRNAs,RNA,0.533,29389239
31851,H(2)O(2),drug,1.0,29389239
31852,VEGF,gene,0.693,29389239
31853,H(2)O(2),drug,1.0,29389239
31854,VEGF,gene,0.9844,29389239
31855,VEGF,gene,0.979,29389239
31856,H(2)O(2),drug,1.0,29389239
31857,VEGF,gene,0.9272,29389239
31858,miRNA,RNA,0.6587,29389239
31859,ARPE-19 cells,cell_line,0.8213,29389239
31860,ARPE-19 cells,cell_type,0.626,29389239
31861,bevacizumab,gene,0.7666,29389239
31862,ranibizumab,gene,0.885,29389239
31863,aflibercept,gene,0.9463,29389239
31864,H(2)O(2),drug,1.0,29389239
31865,miRNA,RNA,0.592,29389239
31866,VEGF,gene,0.9336,29389239
31867,miRNA,RNA,0.6685,29389239
31868,H(2)O(2),drug,1.0,29389239
31869,Aflibercept,gene,0.893,29386883
31870,diabetic macular edema,disease,1.0,29386883
31871,aflibercept,gene,0.991,29386883
31872,diabetic macular edema,disease,1.0,29386883
31873,DME,RNA,0.7007,29386883
31874,vascular endothelial growth factor,gene,0.9785,29386883
31875,patients,species,0.9385,29386883
31876,DME,disease,1.0,29386883
31877,aflibercept,gene,0.908,29386883
31878,Diabetic Retinopathy,disease,0.994,29386883
31879,ETDRS,DNA,0.5796,29386883
31880,BCVA,cell_type,0.3953,29386883
31881,aflibercept,gene,0.97,29386883
31882,ETDRS,DNA,0.5396,29386883
31883,Aflibercept,gene,0.879,29386883
31884,DME,disease,1.0,29386883
31885,patients,species,0.98,29386883
31886,aflibercept,gene,0.931,29386883
31887,DME,disease,1.0,29386883
31888,Aflibercept,gene,0.953,29384810
31889,Age-Related Macular Degeneration,disease,1.0,29384810
31890,aflibercept,gene,0.9697,29384810
31891,neovascular age-related macular degeneration,disease,0.9976,29384810
31892,endothelial cell,cell_type,0.8247,29384810
31893,hexagonal cells,cell_type,0.8745,29384810
31894,macular degeneration,disease,1.0,29384810
31895,Neovascular Age-Related Macular Degeneration,disease,1.0,29383980
31896,vascular endothelial growth factor,gene,0.9326,29383980
31897,VEGF,gene,0.626,29383980
31898,neovascular age-related macular degeneration,disease,1.0,29383980
31899,nAMD,DNA,0.567,29383980
31900,nAMD,disease,1.0,29383980
31901,nAMD,disease,1.0,29383980
31902,blindness,disease,0.999,29383980
31903,VEGF,gene,0.977,29383980
31904,nAMD,disease,1.0,29383980
31905,nAMD,disease,1.0,29383980
31906,VEGF,gene,0.8735,29383980
31907,nAMD,disease,1.0,29383980
31908,nAMD,disease,1.0,29383980
31909,aflibercept,gene,0.9883,29383980
31910,ranibizumab,gene,0.9087,29383980
31911,nAMD,disease,1.0,29383980
31912,bevacizumab,gene,0.9033,29383980
31913,nAMD,disease,1.0,29383980
31914,nAMD,disease,1.0,29383980
31915,nAMD,disease,1.0,29383980
31916,anti-VEGF,gene,0.9443,29383980
31917,nAMD,disease,1.0,29383980
31918,nAMD,disease,1.0,29383980
31919,nAMD,disease,1.0,29383980
31920,Phosphorus,drug,0.9814,29383980
31921,Vascular Endothelial Growth Factor,gene,0.9966,29382038
31922,Vascular endothelial growth factor,gene,0.998,29382038
31923,VEGF,gene,0.9907,29382038
31924,neovascularization,disease,0.5176,29382038
31925,edema,disease,0.7896,29382038
31926,chorioretinal vascular conditions,disease,1.0,29382038
31927,aflibercept,gene,0.9854,29382038
31928,bevacizumab,gene,0.933,29382038
31929,conbercept,gene,0.804,29382038
31930,pegaptanib,drug,0.9844,29382038
31931,ranibizumab,gene,0.6533,29382038
31932,VEGF receptors,gene,0.9956,29382038
31933,encapsulated cell,cell_type,0.6084,29382038
31934,Aflibercept,gene,0.8496,31047339
31935,Macular Edema,disease,1.0,31047339
31936,aflibercept,gene,0.9805,31047339
31937,Eylea;,gene,0.7646,31047339
31938,patients,species,0.984,31047339
31939,nonischemic central retinal vein occlusions,disease,1.0,31047339
31940,CRVOs,disease,1.0,31047339
31941,ranibizumab,gene,0.6963,31047339
31942,bevacizumab,gene,0.698,31047339
31943,PARTICIPANTS,species,0.773,31047339
31944,patients,species,0.9565,31047339
31945,chronic nonischemic CRVOs,disease,0.93,31047339
31946,Patients,species,0.9697,31047339
31947,nonischemic CRVOs,disease,0.9126,31047339
31948,ranibizumab,gene,0.8633,31047339
31949,bevacizumab,gene,0.7314,31047339
31950,aflibercept,gene,0.929,31047339
31951,edema,disease,0.9917,31047339
31952,ranibizumab,gene,0.916,31047339
31953,bevacizumab,gene,0.615,31047339
31954,aflibercept,gene,0.985,31047339
31955,Macular edema,disease,1.0,31047339
31956,patients,species,0.992,31047339
31957,CRVO,disease,1.0,31047339
31958,anti-VEGF,gene,0.9517,31047339
31959,patients,species,0.981,31047339
31960,ranibizumab,gene,0.7847,31047339
31961,bevacizumab,gene,0.576,31047339
31962,macular edema,disease,1.0,31047339
31963,nonischemic CRVO,disease,1.0,31047339
31964,patients,species,0.978,31047339
31965,macular edema,disease,1.0,31047339
31966,aflibercept,gene,0.9595,31047339
31967,macular edema,disease,1.0,31047339
31968,aflibercept,gene,0.8843,31047339
31969,macular edema,disease,1.0,31047339
31970,aflibercept,gene,0.9814,31047339
31971,Diabetic Retinopathy,disease,0.9985,31047339
31972,aflibercept,gene,0.9595,31047339
31973,patients,species,0.984,31047339
31974,ranibizumab,gene,0.868,31047339
31975,bevacizumab,gene,0.675,31047339
31976,macular edema,disease,1.0,31047339
31977,nonischemic CRVO,disease,0.999,31047339
31978,aflibercept,gene,0.9873,31047339
31979,macular edema,disease,1.0,31047339
31980,patients,species,0.9785,31047339
31981,macular edema,disease,1.0,31047339
31982,nonischemic CRVO,disease,0.998,31047339
31983,Aflibercept,gene,0.923,29380812
31984,polypoidal choroidal vasculopathy,disease,1.0,29380812
31985,Aflibercept,gene,0.934,29380810
31986,polypoidal choroidal,disease,1.0,29380810
31987,Coats' Disease,disease,1.0,29379657
31988,Macular Edema,disease,0.99,29379657
31989,Aflibercept,gene,0.824,29379657
31990,macular edema,disease,1.0,29379657
31991,Coats' disease,disease,1.0,29379657
31992,aflibercept,gene,0.9854,29379657
31993,decreased vision of,disease,0.926,29379657
31994,intraretinal hemorrhages,disease,0.995,29379657
31995,edema,disease,0.9536,29379657
31996,microaneurysms,disease,0.9946,29379657
31997,capillary dropout,disease,0.965,29379657
31998,Factor V Leiden,DNA,0.659,29379657
31999,Factor V Leiden mutation,gene,0.953,29379657
32000,Coats' disease,disease,1.0,29379657
32001,aflibercept,gene,0.9863,29379657
32002,macular edema,disease,1.0,29379657
32003,macular edema,disease,1.0,29379657
32004,aflibercept,gene,0.976,29379657
32005,bevacizumab,gene,0.566,29379657
32006,Coats' disease,disease,1.0,29379657
32007,aflibercept,gene,0.9736,29378528
32008,patients,species,0.9326,29378528
32009,RBZ,drug,0.8643,29378528
32010,to,gene,,29378528
32011,aflibercept,gene,0.5083,29378528
32012,AFL,gene,0.996,29378528
32013,neovascular age-related macular degeneration,disease,1.0,29378528
32014,nvAMD,disease,1.0,29378528
32015,patients,species,0.9873,29378528
32016,intra- and/or sub-retinal fluid,disease,0.9995,29378528
32017,RBZ,drug,0.9395,29378528
32018,BCVA,DNA,0.4958,29378528
32019,patients,species,0.971,29378528
32020,CRT,DNA,0.4634,29378528
32021,RBZ,drug,0.66,29378528
32022,RBZ,drug,0.9663,29378528
32023,AFL,drug,0.968,29378528
32024,BCVA,DNA,0.503,29378528
32025,CRT,DNA,0.53,29378528
32026,BCVA,DNA,0.4907,29378528
32027,BCVA,DNA,0.542,29378528
32028,CRT,DNA,0.5605,29378528
32029,AFL,drug,0.896,29378528
32030,RBZ,drug,0.9414,29378528
32031,Neovascular Age-Related Macular Degeneration,disease,1.0,31735869
32032,Aflibercept,gene,0.974,31735869
32033,neovascular age-related macular degeneration,disease,1.0,31735869
32034,nAMD,disease,1.0,31735869
32035,aflibercept,gene,0.966,31735869
32036,aflibercept,gene,0.977,31735869
32037,nAMD,disease,1.0,31735869
32038,SHRM,DNA,0.4626,31735869
32039,pigment epithelial detachment,disease,1.0,31735869
32040,PED,disease,1.0,31735869
32041,PED,disease,1.0,31735869
32042,SRF,disease,0.9805,31735869
32043,IRF,disease,0.997,31735869
32044,aflibercept,gene,0.9863,31735869
32045,morphological abnormalities,disease,0.969,31735869
32046,nAMD,disease,1.0,31735869
32047,Visual impairment,disease,1.0,29369569
32048,neovascular (wet) age-related macular degeneration,disease,1.0,29369569
32049,AMD,disease,1.0,29369569
32050,diabetic macular edema,disease,1.0,29369569
32051,DME,disease,1.0,29369569
32052,central or branch retinal vein occlusion,disease,1.0,29369569
32053,CRVO,disease,1.0,29369569
32054,BRVO,disease,0.999,29369569
32055,vascular endothelial growth factors,gene,0.9976,29369569
32056,VEGFs,gene,0.997,29369569
32057,VEGF,gene,0.649,29369569
32058,VEGF,gene,0.7515,29369569
32059,bevacizumab,gene,0.748,29369569
32060,ranibizumabhave,gene,0.523,29369569
32061,vision,disease,0.9497,29369569
32062,patients,species,0.9375,29369569
32063,AMD,disease,1.0,29369569
32064,MACULAR ATROPHY INCIDENCE,disease,0.9937,29370035
32065,ANTI-VASCULAR ENDOTHELIAL GROWTH,disease,1.0,29370035
32066,NEOVASCULAR AGE-RELATED MACULAR DEGENERATION,disease,0.978,29370035
32067,Ranibizumab,gene,0.7534,29370035
32068,Aflibercept,gene,0.6,29370035
32069,macular atrophy,disease,1.0,29370035
32070,MA,disease,1.0,29370035
32071,neovascular age-related macular degeneration,disease,1.0,29370035
32072,ranibizumab,gene,0.841,29370035
32073,aflibercept,gene,0.9194,29370035
32074,ranibizumab,gene,0.8916,29370035
32075,aflibercept,gene,0.9414,29370035
32076,atrophy,disease,0.8135,29370035
32077,MA,disease,0.9995,29370035
32078,aflibercept,gene,0.969,29370035
32079,ranibizumab,gene,0.839,29370035
32080,anti-vascular endothelial growth factors,gene,0.952,29370035
32081,depigmentation,disease,1.0,29370035
32082,reticular pseudodrusen,disease,1.0,29370035
32083,retinal angiomatous proliferation,disease,1.0,29370035
32084,MA,disease,0.9893,29370035
32085,MA,disease,0.9946,29370035
32086,MA,disease,0.9927,29370035
32087,aflibercept,gene,0.9824,29367644
32088,anti-VEGF,gene,0.957,29367644
32089,plasma von Willebrand factor,gene,0.815,29367644
32090,von Willebrand,disease,0.994,29367644
32091,age-related macular degeneration,disease,1.0,29367644
32092,von Willebrand,disease,1.0,29367644
32093,von Willebrand factor,gene,0.989,29367644
32094,VWF,gene,0.988,29367644
32095,exudative age-related macular degeneration,disease,0.985,29367644
32096,AMD,disease,1.0,29367644
32097,vascular endothelial growth factor,gene,0.999,29367644
32098,VEGF,gene,0.996,29367644
32099,AMD,disease,0.9995,29367644
32100,VWF antigen,gene,0.994,29367644
32101,VWF:Ag,gene,0.9727,29367644
32102,VWF multimers,gene,0.9956,29367644
32103,VWFMs,gene,0.9805,29367644
32104,aflibercept,gene,0.984,29367644
32105,anti-VEGF,gene,0.9365,29367644
32106,complement factor H,gene,0.994,29367644
32107,p.Y402H,mutation,,29367644
32108,Y402H,DNA,0.501,29367644
32109,p.I62V,mutation,,29367644
32110,I62V,DNA,0.4302,29367644
32111,AMD,disease,1.0,29367644
32112,p.,DNA,0.656,29367644
32113,p.I62V,mutation,,29367644
32114,I62V,DNA,0.3877,29367644
32115,p.,DNA,0.599,29367644
32116,p.Y402H,mutation,,29367644
32117,Y402H,DNA,0.4817,29367644
32118,AMD,disease,0.9995,29367644
32119,VWF:Ag,gene,0.7812,29367644
32120,AMD,disease,1.0,29367644
32121,VWFMs,disease,0.7563,29367644
32122,AMD,disease,1.0,29367644
32123,vitreous or subretinal hemorrhage,disease,0.999,29367644
32124,aflibercept,gene,0.984,29367644
32125,VWF:Ag,gene,0.8184,29367644
32126,VEGF-A,gene,0.998,29367644
32127,UL-VWFMs,disease,0.9995,29367644
32128,aflibercept,gene,0.992,29367644
32129,VWF:Ag,gene,0.8164,29367644
32130,AMD,disease,1.0,29367644
32131,aflibercept,gene,0.982,29367644
32132,VWF,gene,0.995,29367644
32133,AMD,disease,1.0,29367644
32134,aflibercept,gene,0.9707,29367644
32135,AMD,disease,0.998,29367644
32136,VWF,gene,0.9966,29367644
32137,VEGF-A,gene,0.9976,29367644
32138,Aflibercept,gene,0.974,29349082
32139,Diabetic Macular Edema,disease,1.0,29349082
32140,diabetic macular edema,disease,0.9766,29349082
32141,DME,disease,1.0,29349082
32142,aflibercept,gene,0.9287,29349082
32143,patients,species,0.9893,29349082
32144,DME,disease,1.0,29349082
32145,serous retinal detachment,disease,1.0,29349082
32146,SRD,disease,1.0,29349082
32147,SRD,disease,1.0,29349082
32148,photoreceptor outer segment,cell_type,0.564,29349082
32149,DME,disease,0.9995,29349082
32150,SRD,DNA,0.5405,29349082
32151,SRD,DNA,0.558,29349082
32152,PROS,DNA,0.5747,29349082
32153,DME,disease,0.9995,29349082
32154,patients,species,0.987,29348424
32155,AMD,disease,1.0,29348424
32156,blindness,disease,0.999,29348424
32157,people,species,0.98,29348424
32158,AMD,disease,0.999,29348424
32159,Aflibercept,gene,0.916,29348424
32160,anti-vascular endothelial growth factor,gene,0.998,29348424
32161,VEGF,gene,0.996,29348424
32162,aflibercept,gene,0.9844,29348424
32163,neovascular AMD,disease,1.0,29348424
32164,nAMD,disease,0.989,29348424
32165,nAMD,disease,1.0,29348424
32166,patients,species,0.989,29348424
32167,nAMD,disease,1.0,29348424
32168,patients,species,0.996,29348424
32169,IP-10,gene,0.9893,29348424
32170,IL-6,gene,0.9883,29348424
32171,cataract,disease,1.0,29348424
32172,patients,species,0.985,29348424
32173,IP-10,gene,0.991,29348424
32174,IL-6,gene,0.983,29348424
32175,nAMD,disease,1.0,29348424
32176,IP-10,gene,0.9907,29348424
32177,IP-10,gene,0.992,29348424
32178,VEGF,gene,0.9927,29348424
32179,IP-10,gene,0.989,29348424
32180,nAMD,disease,1.0,29348424
32181,IVA,disease,0.9185,29348424
32182,Aflibercept,gene,0.9883,29344488
32183,aflibercept,gene,0.993,29344488
32184,CME,disease,1.0,29344488
32185,bevacizumab,gene,0.6416,29344488
32186,CME,disease,0.9966,29344488
32187,aflibercept,gene,0.9688,29344488
32188,patients,species,0.972,29344488
32189,CME,drug,0.681,29344488
32190,aflibercept,gene,0.9497,29344488
32191,Aflibercept,gene,0.8994,29344488
32192,CME,disease,0.884,29344488
32193,patients,species,0.991,29343970
32194,patients,species,0.9937,29343970
32195,ipilimumab,gene,0.974,29343970
32196,Zaltrap,drug,0.8257,29343970
32197,ziv-aflibercept,gene,0.9565,29343970
32198,necitumumab,gene,0.9824,29343970
32199,brentuximab-vedotin,gene,0.9746,29343970
32200,blinatumomab,gene,0.9556,29343970
32201,CL,cell_type,,29343970
32202,brentuximab-vedotin,gene,0.9595,29343970
32203,necitumumab,gene,0.972,29343970
32204,blinatumomab,gene,0.8545,29343970
32205,blinatumomab,gene,0.7153,29343970
32206,anticancer,disease,0.9155,29343970
32207,patients,species,0.9883,29343970
32208,patients,species,0.9775,29343970
32209,tumor,disease,0.6104,29338550
32210,colorectal cancer,disease,1.0,29338550
32211,colorectal cancer,disease,1.0,29338550
32212,CRC,disease,0.9976,29338550
32213,VEGF,gene,0.998,29338550
32214,VEGFR,gene,0.9927,29338550
32215,metastatic CRC,disease,1.0,29338550
32216,mCRC,disease,1.0,29338550
32217,patients,species,0.9927,29338550
32218,VEGF,gene,0.997,29338550
32219,CRC,disease,0.999,29338550
32220,mCRC,disease,0.995,29338550
32221,patients,species,0.994,29338550
32222,tumor,disease,1.0,29338550
32223,Vascular Endothelial Growth Factor,gene,0.9805,29336897
32224,vascular endothelial growth factor,gene,0.9824,29336897
32225,VEGF,gene,0.999,29336897
32226,PARTICIPANTS,species,0.8594,29336897
32227,Patients,species,0.9893,29336897
32228,patients,species,0.994,29336897
32229,VEGF,gene,0.5957,29336897
32230,bevacizumab,gene,0.9478,29336897
32231,aflibercept,gene,0.972,29336897
32232,ranibizumab,gene,0.6675,29336897
32233,patients,species,0.992,29336897
32234,age-related macular degeneration,disease,1.0,29336897
32235,patients,species,0.9927,29336897
32236,patients,species,0.982,29336897
32237,bevacizumab,gene,0.6777,29336897
32238,aflibercept,gene,0.969,29336897
32239,ranibizumab,gene,0.7173,29336897
32240,aflibercept,gene,0.9775,29336897
32241,ranibizumab,gene,0.764,29336897
32242,bevacizumab,gene,0.8096,29336897
32243,bevacizumab,gene,0.877,29336897
32244,ranibizumab,drug,0.6377,29336897
32245,aflibercept,gene,0.9775,29336897
32246,anti-VEGF,gene,0.8086,29336897
32247,patients,species,0.988,29336897
32248,aflibercept,gene,0.9834,29336897
32249,Brentuximab vedotin,gene,0.9023,29326861
32250,Purtscher-like retinopathy,disease,0.929,29326861
32251,woman,species,0.834,29326861
32252,Hodgkin&#x27;s lymphoma,disease,0.9966,29326861
32253,sudden visual loss,disease,0.8154,29326861
32254,brentuximab,gene,0.777,29326861
32255,retinal arteriolar occlusion,disease,1.0,29326861
32256,serous macular retinal detachment,disease,0.9834,29326861
32257,aflibercept,gene,0.9863,29326861
32258,brentuximab,gene,0.921,29326861
32259,respiratory failure,disease,1.0,29326861
32260,Purtscher-like retinopathy,disease,1.0,29326861
32261,Age-related Macular Degeneration,disease,1.0,29326855
32262,Patient,species,0.991,29326855
32263,neovascular age-related macular degeneration,disease,1.0,29326855
32264,patient,species,0.992,29326855
32265,retinal angiomatous proliferation,disease,1.0,29326855
32266,RAP,disease,1.0,29326855
32267,polypoidal choroidal vasculopathy,disease,1.0,29326855
32268,PCV,disease,1.0,29326855
32269,woman,species,0.876,29326855
32270,decreased vision,disease,0.993,29326855
32271,fluorescein,drug,0.9985,29326855
32272,indocyanine green,drug,0.997,29326855
32273,RAP,disease,1.0,29326855
32274,PCV lesions,disease,0.994,29326855
32275,patient,species,0.9907,29326855
32276,ranibizumab,gene,0.8823,29326855
32277,tachyphylaxis,disease,0.918,29326855
32278,aflibercept,gene,0.989,29326855
32279,POLYPOIDAL CHOROIDAL VASCULOPATHY,disease,1.0,29324624
32280,polypoidal choroidal vasculopathy,disease,1.0,29324624
32281,morning glory syndrome,disease,1.0,29324624
32282,aflibercept,gene,0.802,29324624
32283,man,species,0.905,29324624
32284,diminished vision,disease,0.9985,29324624
32285,morning glory syndrome disk anomaly,disease,1.0,29324624
32286,lipid depositions,disease,0.997,29324624
32287,fluorescein,drug,0.998,29324624
32288,indocyanine,drug,0.8867,29324624
32289,juxtapapillary polypoidal,disease,0.948,29324624
32290,choroidal vasculopathy,disease,1.0,29324624
32291,intraretinal and subretinal fluid,disease,0.985,29324624
32292,Patient,species,0.9087,29324624
32293,aflibercept,gene,0.9707,29324624
32294,neovascular lesion,disease,0.997,29324624
32295,Polypoidal choroidal vasculopathy,disease,1.0,29324624
32296,morning glory syndrome,disease,1.0,29324624
32297,vascular endothelial growth factor,gene,0.8823,29324624
32298,aflibercept,gene,0.9644,29324624
32299,aflibercept,gene,0.913,29324593
32300,neovascular,disease,0.671,29324593
32301,age-related macular degeneration,disease,1.0,29324593
32302,retinal pigment epithelium tears,disease,0.8926,29324593
32303,patients,species,0.9766,29324593
32304,aflibercept,gene,0.9883,29324593
32305,ranibizumab,gene,0.8496,29324593
32306,age-related macular degeneration,disease,1.0,29324593
32307,ranibizumab,gene,0.892,29324593
32308,aflibercept,gene,0.976,29324593
32309,tears,disease,0.8687,29324593
32310,aflibercept,gene,0.9917,29324593
32311,ranibizumab,gene,0.754,29324593
32312,retinal pigment epithelium tears,disease,0.9775,29324593
32313,Diabetic Retinopathy,disease,0.994,29324593
32314,Diabetic Retinopathy,disease,1.0,29324593
32315,aflibercept,gene,0.988,29324593
32316,ranibizumab,gene,0.4932,29324593
32317,anti-vascular endothelial growth factors,gene,0.994,29324593
32318,anti-vascular endothelial growth factor,gene,0.9526,29324593
32319,ziv-aflibercept,gene,0.9824,29317400
32320,ziv-aflibercept,gene,0.9897,29317400
32321,macular diseases,disease,1.0,29317400
32322,macular diseases,disease,0.999,29317400
32323,IVZ,drug,0.9604,29317400
32324,IVZ,drug,0.5137,29317400
32325,neovascular macular degeneration,disease,1.0,29317400
32326,diabetic macular oedema,disease,1.0,29317400
32327,macular oedema,disease,1.0,29317400
32328,retinal vein occlusion,disease,1.0,29317400
32329,transient uveitis,disease,1.0,29317400
32330,central retinal artery occlusion,disease,0.9995,29317400
32331,IVZ,drug,0.957,29317400
32332,macular diseases,disease,1.0,29317400
32333,aflibercept,gene,0.9683,29311612
32334,age-related macular degeneration,disease,1.0,29311612
32335,patients,species,0.993,29311612
32336,age-related macular degeneration,disease,1.0,29311612
32337,AMD,disease,1.0,29311612
32338,patients,species,0.9834,29311612
32339,patients,species,0.9917,29311612
32340,aflibercept,gene,0.9536,29311612
32341,AMD,disease,0.9995,29311612
32342,patients,species,0.994,29311612
32343,AMD,disease,1.0,29311612
32344,patients,species,0.993,29311612
32345,IVA,drug,0.586,29311612
32346,patients,species,0.973,29311612
32347,Hyperpigmented spots,disease,0.954,29302789
32348,submacular hemorrhage,disease,0.998,29302789
32349,hyperpigmented spots,disease,0.998,29302789
32350,submacular hemorrhage,disease,0.999,29302789
32351,polypoidal choroidal vasculopathy,disease,1.0,29302789
32352,PCV,DNA,0.6675,29302789
32353,anti-vascular endothelial growth factor,gene,0.9336,29302789
32354,VEGF,gene,0.998,29302789
32355,submacular hemorrhage,disease,0.9995,29302789
32356,PCV,disease,1.0,29302789
32357,Patients,species,0.977,29302789
32358,pigmented lesions,disease,0.974,29302789
32359,hyperpigmented spots,disease,0.9995,29302789
32360,hyperpigmented spots,disease,0.9995,29302789
32361,hyperpigmented,disease,1.0,29302789
32362,hyperpigmented,disease,0.6914,29302789
32363,hyperpigmented spots,disease,0.9995,29302789
32364,hyperpigmented spots,disease,1.0,29302789
32365,anti-VEGF,gene,0.9263,29302789
32366,hyperpigmented spots,disease,0.9985,29302789
32367,submacular hemorrhage,disease,0.9946,29302789
32368,PCV,disease,1.0,29302789
32369,hyperpigmented spots,disease,0.9995,29302789
32370,Polypoidal Choroidal Vasculopathy,disease,1.0,29299080
32371,Myopic,disease,0.677,29299080
32372,myopia,disease,1.0,29299080
32373,polypoidal choroidal vasculopathy,disease,1.0,29299080
32374,PCV,drug,0.9927,29299080
32375,PCV,drug,0.9976,29299080
32376,myopic,disease,0.753,29299080
32377,PCV,disease,1.0,29299080
32378,myopic,disease,1.0,29299080
32379,PCV,disease,1.0,29299080
32380,myopia,disease,0.9995,29299080
32381,PCV,disease,1.0,29299080
32382,patients,species,0.99,29299080
32383,PCV,disease,1.0,29299080
32384,patients,species,0.991,29299080
32385,PCV,disease,1.0,29299080
32386,patients,species,0.9897,29299080
32387,PCV,disease,1.0,29299080
32388,myopia,disease,0.8857,29299080
32389,patients,species,0.9854,29299080
32390,PCV,disease,1.0,29299080
32391,myopia,disease,0.9897,29299080
32392,PCV,disease,1.0,29299080
32393,patients,species,0.9883,29299080
32394,PCV,disease,1.0,29299080
32395,indocyanine green,drug,0.9976,29299080
32396,PCV,disease,1.0,29299080
32397,High myopia,disease,0.9785,29299080
32398,PCV,disease,1.0,29299080
32399,choroidal neovascularization,disease,1.0,29299080
32400,vision loss,disease,0.992,29299080
32401,myopic macular degeneration,disease,1.0,29299080
32402,myopic,disease,1.0,29299080
32403,PCV,disease,1.0,29299080
32404,vascular endothelial growth factor,gene,0.9976,29290015
32405,VEGF,gene,0.9946,29290015
32406,patients,species,0.9688,29290015
32407,type 1 ROP,disease,0.9146,29290015
32408,aflibercept,gene,0.991,29290015
32409,Patients,species,0.983,29290015
32410,type 1 ROP,disease,0.955,29290015
32411,IVB,drug,0.9683,29290015
32412,IVA,drug,0.92,29290015
32413,VEGF,gene,0.7236,29290015
32414,platelet,cell_type,0.598,29290015
32415,VEGF,gene,0.9917,29290015
32416,VEGF,gene,0.9956,29290015
32417,platelet,cell_type,0.623,29290015
32418,VEGF,gene,0.9966,29290015
32419,VEGF,gene,0.588,29290015
32420,patients,species,0.983,29290015
32421,type 1 ROP,disease,0.9727,29290015
32422,patients,species,0.991,29290015
32423,patients,species,0.9907,29290015
32424,ROP,disease,0.9995,29290015
32425,serum VEGF,gene,0.867,29290015
32426,ROP,disease,0.999,29290015
32427,patients,species,0.9946,29290015
32428,serum VEGF,gene,0.7656,29290015
32429,serum VEGF,gene,0.899,29290015
32430,PLT,cell_type,0.74,29290015
32431,serum VEGF,gene,0.917,29290015
32432,VEGF,gene,0.8047,29290015
32433,VEGF,gene,0.9937,29290015
32434,Serum VEGF,gene,0.8057,29290015
32435,VEGF,gene,0.993,29290015
32436,PLT,cell_type,0.6836,29290015
32437,patients,species,0.9526,29290015
32438,type 1 ROP,disease,0.954,29290015
32439,VEGF,gene,0.986,29290015
32440,patients,species,0.985,29290015
32441,plasma vascular endothelial growth factor,gene,0.8906,29280940
32442,VEGF,gene,0.995,29280940
32443,diabetic retinopathy,disease,1.0,29280940
32444,DR,disease,1.0,29280940
32445,diabetic macular edema,disease,1.0,29280940
32446,DME,disease,1.0,29280940
32447,bevacizumab,gene,0.9253,29280940
32448,aflibercept,gene,0.9824,29280940
32449,ranibizumab,gene,0.854,29280940
32450,DME,disease,1.0,29280940
32451,VEGF,gene,0.5264,29280940
32452,patients,species,0.9697,29280940
32453,DR,disease,,29280940
32454,patients,species,0.981,29280940
32455,DME,disease,1.0,29280940
32456,bevacizumab,gene,0.8623,29280940
32457,aflibercept,gene,0.9824,29280940
32458,ranibizumab,gene,0.81,29280940
32459,VEGF,gene,0.684,29280940
32460,DME,disease,1.0,29280940
32461,DR,disease,,29280940
32462,VEGF,gene,0.863,29280940
32463,bevacizumab,gene,0.7085,29280940
32464,aflibercept,gene,0.9634,29280940
32465,VEGF,gene,0.834,29280940
32466,patients,species,0.993,29280940
32467,ranibizumab,gene,0.57,29280940
32468,VEGF,gene,0.558,29280940
32469,DR,disease,,29280940
32470,DME,disease,1.0,29280940
32471,bevacizumab,gene,0.919,29280940
32472,aflibercept,gene,0.98,29280940
32473,plasma VEGF,gene,0.627,29280940
32474,VEGF,gene,0.852,29280940
32475,DME,disease,1.0,29280940
32476,DR,disease,,29280940
32477,AFLIBERCEPT,gene,0.848,29280937
32478,PATIENTS,species,0.9614,29280937
32479,aflibercept,gene,0.9873,29280937
32480,patients,species,0.958,29280937
32481,macular degeneration,disease,1.0,29280937
32482,aflibercept,gene,0.9585,29280937
32483,patients,species,0.9688,29280937
32484,patients,species,0.989,29280937
32485,patients,species,0.97,29280937
32486,aflibercept,gene,0.9863,29280937
32487,aflibercept,gene,0.9795,29280937
32488,dry retinas,disease,0.9966,29280937
32489,aflibercept,gene,0.986,29280937
32490,patients,species,0.9824,29280937
32491,patients,species,0.9585,29280937
32492,neovascular age-related macular degeneration,disease,1.0,29280937
32493,aflibercept,gene,0.9565,29280937
32494,ranibizumab,gene,0.496,29280937
32495,patients,species,0.9893,29280937
32496,aflibercept,gene,0.9634,29274022
32497,ranibizumab,gene,0.6304,29274022
32498,macular edema,disease,1.0,29274022
32499,non-ischemic branch retinal vein occlusion,disease,1.0,29274022
32500,aflibercept,gene,0.984,29274022
32501,ranibizumab,gene,0.7275,29274022
32502,macular edema,disease,1.0,29274022
32503,branch retinal vein occlusion,disease,0.9966,29274022
32504,branch retinal vein occlusion,disease,0.998,29274022
32505,fluorescein,drug,0.9814,29274022
32506,aflibercept,gene,0.9834,29274022
32507,aflibercept,gene,0.9893,29274022
32508,ranibizumab,gene,0.593,29274022
32509,macular edema,disease,1.0,29274022
32510,non-ischemic BRVO,disease,0.9995,29274022
32511,aflibercept,gene,0.961,29274022
32512,ranibizumab,gene,0.855,29274022
32513,aflibercept,gene,0.9883,29274022
32514,ranibizumab,gene,0.4817,29274022
32515,macular edema,disease,1.0,29274022
32516,branch vein occlusion,disease,0.8022,29274022
32517,endophthalmitis,disease,1.0,29273773
32518,patients,species,0.9824,29273773
32519,VEGF,gene,0.9727,29273773
32520,Endophthalmitis,disease,1.0,29273773
32521,patients,species,0.9937,29273773
32522,anti-VEGF,gene,0.9053,29273773
32523,endophthalmitis,disease,1.0,29273773
32524,endophthalmitis,disease,1.0,29273773
32525,anti-VEGF,gene,0.9717,29273773
32526,endophthalmitis,disease,1.0,29273773
32527,patients,species,0.986,29273773
32528,exudative age-related macular degeneration,disease,0.958,29263460
32529,aflibercept,gene,0.968,29263460
32530,aflibercept,gene,0.945,29263460
32531,exudative age-related macular degeneration,disease,1.0,29263460
32532,aflibercept,gene,0.9688,29263460
32533,oedema,disease,0.9956,29263460
32534,The,gene,0.718,29263460
32535,aflibercept,gene,0.5503,29263460
32536,exudative age-related macular degeneration,disease,0.989,29263460
32537,ziv-aflibercept,gene,0.968,29260119
32538,macular edema,disease,1.0,29260119
32539,central retinal vein occlusion,disease,1.0,29260119
32540,ziv-aflibercept,gene,0.987,29260119
32541,macular edema,disease,1.0,29260119
32542,central retinal vein occlusion,disease,1.0,29260119
32543,CRVO,disease,1.0,29260119
32544,ziv-aflibercept,gene,0.9893,29260119
32545,macular edema,disease,1.0,29260119
32546,CRVO,disease,1.0,29260119
32547,fluorescein,drug,0.984,29260119
32548,intraretinal,disease,0.919,29260119
32549,uveitis,disease,1.0,29260119
32550,cataract,disease,1.0,29260119
32551,Ziv-aflibercept,gene,0.978,29260119
32552,macular edema,disease,1.0,29260119
32553,CRVO,disease,1.0,29260119
32554,ziv-aflibercept,gene,0.9834,29260119
32555,CRVO,disease,0.9995,29260119
32556,patient,species,0.9585,29252912
32557,aflibercept,gene,0.9805,29252912
32558,wet,disease,0.9385,29252912
32559,age-related macular degeneration,disease,0.9946,29252912
32560,patient,species,0.8896,29252912
32561,neovascular age-related macular degeneration,disease,1.0,29252912
32562,AMD,disease,1.0,29252912
32563,aflibercept,gene,0.987,29252912
32564,aflibercept,gene,0.996,29252912
32565,SRF,disease,0.998,29252912
32566,epiretinal membrane,disease,1.0,29252912
32567,ERM,disease,1.0,29252912
32568,indocyanine green,drug,0.9976,29252912
32569,ILM,disease,0.982,29252912
32570,sulfur hexafluoride,drug,0.9995,29252912
32571,SF6,drug,0.9995,29252912
32572,wet AMD,disease,1.0,29252912
32573,macular holes,disease,0.8535,29252912
32574,aflibercept,gene,0.9863,29252912
32575,Rothia dentocariosa endophthalmitis,disease,0.9614,29247280
32576,Rothia dentocariosa,species,0.829,29247280
32577,Rothia dentocariosa,species,0.9204,29247280
32578,diabetic,disease,0.9966,29247280
32579,redness,disease,0.562,29247280
32580,decreased vision,disease,0.8584,29247280
32581,aflibercept,gene,0.9756,29247280
32582,diabetic vitreous haemorrhage,disease,1.0,29247280
32583,macular oedema,disease,1.0,29247280
32584,proliferative diabetic retinopathy,disease,0.999,29247280
32585,ocular hypertension,disease,1.0,29247280
32586,anterior chamber inflammation,disease,1.0,29247280
32587,diabetic retinopathy,disease,1.0,29247280
32588,Rothia dentocariosa,species,0.972,29247280
32589,endophthalmitis,disease,1.0,29247280
32590,cephazolin,drug,0.9995,29247280
32591,vancomycin,drug,0.999,29247280
32592,ceftazidime,drug,0.999,29247280
32593,ciprofloxacin,drug,0.9985,29247280
32594,gentamicin,drug,0.998,29247280
32595,ciprofloxacin,drug,0.9985,29247280
32596,retinal necrosis,disease,1.0,29247280
32597,Rothia dentocariosa,disease,1.0,29247280
32598,endophthalmitis,disease,1.0,29247280
32599,Diabetic macular oedema,disease,1.0,29240306
32600,anti-vascular endothelial growth factor,gene,0.9043,29240306
32601,ranibizumab,gene,0.8745,29240306
32602,diabetic macular oedema,disease,1.0,29240306
32603,DME,disease,1.0,29240306
32604,DME,disease,1.0,29240306
32605,ranibizumab,gene,0.815,29240306
32606,aflibercept,gene,0.9595,29240306
32607,BCVA,DNA,0.4734,29240306
32608,DME,disease,0.7603,29240306
32609,Diabetic macular edema,disease,1.0,29240298
32610,Diabetic macular edema,disease,1.0,29240298
32611,DME,disease,1.0,29240298
32612,vision loss,disease,1.0,29240298
32613,blindness,disease,1.0,29240298
32614,Dexamethasone,drug,0.998,29240298
32615,Aflibercept,gene,0.9326,29240298
32616,Ranibizumab,gene,0.8794,29240298
32617,DEX,drug,0.9795,29240298
32618,DEX,drug,0.9546,29240298
32619,Aflibercept,gene,0.9824,29240298
32620,Ranibizumab,gene,0.8975,29240298
32621,Ranibizumab,gene,0.8853,29240298
32622,Dexamethasone,drug,0.9956,29240298
32623,Aflibercept,gene,0.5713,29240298
32624,DEX,drug,0.8857,29240298
32625,DME,disease,1.0,29240298
32626,Aflibercept,gene,0.9,29234221
32627,macular edema,disease,1.0,29234221
32628,retinal vein occlusion,disease,1.0,29234221
32629,aflibercept,gene,0.983,29234221
32630,patients,species,0.9546,29234221
32631,macular edema,disease,1.0,29234221
32632,ME,disease,1.0,29234221
32633,retinal vein occlusion,disease,1.0,29234221
32634,RVO,disease,1.0,29234221
32635,ME,disease,,29234221
32636,patients,species,0.9907,29234221
32637,RVO,disease,0.9995,29234221
32638,IVAfl,drug,0.506,29234221
32639,patients,species,0.986,29234221
32640,IVAfl,drug,0.8936,29234221
32641,patients,species,0.9937,29234221
32642,patients,species,0.993,29234221
32643,patients,species,0.9707,29234221
32644,patients,species,0.979,29234221
32645,RVO,disease,0.9995,29234221
32646,RVO,disease,0.9995,29234221
32647,CRT,DNA,0.5996,29234221
32648,patients,species,0.9663,29234221
32649,ME,disease,,29234221
32650,RVO,disease,0.9995,29234221
32651,Aflibercept,gene,0.97,29232758
32652,neovascular age-related macular degeneration,disease,1.0,29232758
32653,nvAMD,disease,1.0,29232758
32654,Patients,species,0.8906,29232758
32655,nvAMD,disease,1.0,29232758
32656,ranibizumab,gene,0.9443,29232758
32657,aflibercept,gene,0.983,29232758
32658,aflibercept,gene,0.9893,29232758
32659,ranibizumab,gene,0.871,29232758
32660,Patients,species,0.8276,29232756
32661,nvAMD,disease,1.0,29232756
32662,VEGF,gene,0.866,29232756
32663,VEGF,gene,0.647,29232756
32664,ZIV-AFLIBERCEPT,gene,0.9805,29232334
32665,NEOVASCULAR AGE-RELATED MACULAR DEGENERATION,disease,0.9976,29232334
32666,ziv-aflibercept,gene,0.9863,29232334
32667,patients,species,0.974,29232334
32668,neovascular age-related macular degeneration,disease,1.0,29232334
32669,patients,species,0.9834,29232334
32670,ziv-aflibercept,gene,0.9795,29232334
32671,patients,species,0.98,29232334
32672,patient,species,0.9727,29232334
32673,intraocular inflammation,disease,1.0,29232334
32674,ziv-aflibercept,gene,0.9873,29232334
32675,neovascular age-related macular degeneration,disease,1.0,29232334
32676,patients,species,0.9897,29232334
32677,ziv-aflibercept,gene,0.9863,29232334
32678,aflibercept,gene,0.9424,29220114
32679,aflibercept,gene,0.9463,29220114
32680,age-related macular degeneration,disease,0.9946,29220114
32681,AMD,disease,1.0,29220114
32682,patients,species,0.981,29220114
32683,patients,species,0.9756,29220114
32684,BCVA,DNA,0.4622,29220114
32685,CRT,DNA,0.508,29220114
32686,TAE,DNA,0.4875,29220114
32687,aflibercept,gene,0.9272,29220114
32688,endophthalmitis,disease,1.0,29217032
32689,endophthalmitis,disease,1.0,29217032
32690,bevacizumab,gene,0.744,29217032
32691,endophthalmitis,disease,1.0,29217032
32692,ranibizumab,gene,0.979,29217032
32693,aflibercept,gene,0.9883,29217032
32694,endophthalmitis,disease,1.0,29217032
32695,ranibizumab,gene,0.9565,29217032
32696,aflibercept,gene,0.978,29217032
32697,bevacizumab,gene,0.9097,29217032
32698,PARTICIPANTS,species,0.7695,29217032
32699,patients,species,0.989,29217032
32700,post,disease,0.903,29217032
32701,endophthalmitis,disease,1.0,29217032
32702,patients,species,0.991,29217032
32703,bevacizumab,gene,0.8706,29217032
32704,ranibizumab,gene,0.896,29217032
32705,aflibercept,gene,0.9526,29217032
32706,bevacizumab,gene,0.738,29217032
32707,ranibizumab,gene,0.707,29217032
32708,aflibercept,gene,0.9727,29217032
32709,endophthalmitis,disease,1.0,29217032
32710,bevacizumab,gene,0.7554,29217032
32711,aflibercept,gene,0.9727,29217032
32712,bevacizumab,gene,0.8423,29217032
32713,aflibercept,gene,0.9746,29217032
32714,endophthalmitis,disease,1.0,29217032
32715,endophthalmitis,disease,1.0,29217032
32716,endophthalmitis,disease,1.0,29217032
32717,ranibizumab,gene,0.958,29217032
32718,aflibercept,gene,0.989,29217032
32719,endophthalmitis,disease,1.0,29217032
32720,bevacizumab,gene,0.876,29217032
32721,VEGF,gene,0.9966,29204996
32722,AMD,disease,0.9985,29204996
32723,aflibercept,gene,0.989,29204996
32724,patients,species,0.87,29204996
32725,choroidal neovascularization,disease,1.0,29204996
32726,CNV,disease,1.0,29204996
32727,ranibizumab,gene,0.75,29204996
32728,patients,species,0.9795,29204996
32729,CNV,disease,0.9985,29204996
32730,ranibizumab,gene,0.8945,29204996
32731,aflibercept,gene,0.9653,29204996
32732,patients,species,0.9907,29204996
32733,aflibercept,gene,0.97,29204996
32734,aflibercept,gene,0.9326,29204996
32735,intraretinal fluid,disease,0.9644,29204996
32736,IRF,disease,0.9795,29204996
32737,subretinal fluid,disease,0.991,29204996
32738,SRF,disease,0.9966,29204996
32739,aflibercept,gene,0.981,29204996
32740,macular edema,disease,1.0,29204996
32741,VEGF,gene,0.8403,29204993
32742,Retinal Vein Occlusions,disease,1.0,29204993
32743,vascular endothelial growth factor,gene,0.913,29204993
32744,VEGF,gene,0.997,29204993
32745,cystoid macular edema,disease,1.0,29204993
32746,diabetic macular edema,disease,1.0,29204993
32747,choroidal neovascularization,disease,1.0,29204993
32748,proliferative retinopathies,disease,1.0,29204993
32749,choroidal neovascularization,disease,0.994,29204993
32750,neovascular age-related macular degeneration,disease,1.0,29204993
32751,Retinal vein occlusion,disease,1.0,29204993
32752,RVO,disease,1.0,29204993
32753,vision loss,disease,0.9907,29204993
32754,macular edema,disease,1.0,29204993
32755,macular ischemia,disease,1.0,29204993
32756,neovascularization in,disease,0.9067,29204993
32757,macular edema,disease,1.0,29204993
32758,patients,species,0.9663,29204993
32759,RVOs,disease,1.0,29204993
32760,VEGF,gene,0.52,29204993
32761,RVO,disease,1.0,29204993
32762,patients,species,0.9854,29204993
32763,anti-VEGF,gene,0.7725,29204993
32764,patients,species,0.939,29204993
32765,retinal vein occlusions,disease,1.0,29204993
32766,patients,species,0.9917,29202760
32767,aflibercept,gene,0.984,29202760
32768,anti-VEGF,gene,0.7173,29202760
32769,aflibercept,gene,0.9634,29202760
32770,Patients,species,0.985,29202760
32771,aflibercept,gene,0.9907,29202760
32772,ranibizumab,gene,0.6743,29202760
32773,patients,species,0.9873,29202760
32774,VEGF,gene,0.9463,29202760
32775,patient,species,0.9893,29202760
32776,ranibizumab,gene,0.908,29202760
32777,aflibercept,gene,0.9766,29202760
32778,patients,species,0.9814,29202760
32779,aflibercept,gene,0.9795,29202760
32780,ranibizumab,gene,0.8105,29202760
32781,patients,species,0.9785,29202760
32782,aflibercept,gene,0.971,29202760
32783,ranibizumab,gene,0.605,29202760
32784,aflibercept,gene,0.9917,29202760
32785,aflibercept,gene,0.992,29202760
32786,ranibizumab,gene,0.4927,29202760
32787,VEGF,gene,0.7666,29202760
32788,Aflibercept,gene,0.9863,29201458
32789,Neovascular AMD,disease,1.0,29201458
32790,bevacizumab,gene,0.8857,29201458
32791,ranibizumab,gene,0.807,29201458
32792,aflibercept,gene,0.9824,29201458
32793,AMD,disease,0.9995,29201458
32794,bevacizumab,gene,0.592,29201458
32795,ranibizumab,drug,0.6206,29201458
32796,ETDRS,DNA,0.475,29201458
32797,CRT,DNA,0.545,29201458
32798,Aflibercept,gene,0.961,29201458
32799,neovascular AMD,disease,1.0,29201458
32800,BCVA,DNA,0.4695,29201458
32801,VEGF,gene,0.998,29200818
32802,chronic central serous chorioretinopathy,disease,1.0,29200818
32803,CSC,disease,1.0,29200818
32804,patients,species,0.981,29200818
32805,chronic CSC,disease,0.9824,29200818
32806,VEGF,gene,0.668,29200818
32807,patients,species,0.9795,29200818
32808,fluorescein,drug,0.9907,29200818
32809,indocyanine,drug,0.9985,29200818
32810,anti-VEGF,gene,0.9155,29200818
32811,bevacizumab,gene,0.7935,29200818
32812,aflibercept,gene,0.981,29200818
32813,Patients,species,0.972,29200818
32814,patients,species,0.9775,29200818
32815,CSC,disease,0.9116,29200818
32816,patients,species,0.975,29200818
32817,choroidal neovascularization,disease,1.0,29200818
32818,CNV,disease,1.0,29200818
32819,patients,species,0.9614,29200818
32820,VEGF,gene,0.8066,29200818
32821,CSC,disease,0.834,29200818
32822,CNV,disease,0.9985,29200818
32823,inflammation,disease,0.8633,29200818
32824,patients,species,0.981,29200818
32825,Triamcinolone Acetonide,drug,0.999,29199012
32826,triamcinolone acetonide,drug,0.9995,29199012
32827,macular edema,disease,1.0,29199012
32828,retinal vein occlusion,disease,1.0,29199012
32829,RVO,disease,1.0,29199012
32830,patients,species,0.9756,29199012
32831,macular edema,disease,1.0,29199012
32832,RVO,disease,1.0,29199012
32833,Triamcinolone Acetonide,drug,0.995,29199012
32834,Aflibercept,gene,0.9727,29199012
32835,Macular Edema,disease,1.0,29199012
32836,Retinal Vein Occlusion,disease,0.9995,29199012
32837,aflibercept,gene,0.9883,29199012
32838,aflibercept,gene,0.9854,29199012
32839,aflibercept,gene,0.968,29199012
32840,macular edema,disease,1.0,29199012
32841,RVO,disease,1.0,29199012
32842,Ranibizumab,gene,0.8867,29196745
32843,Age-related macular degeneration,disease,1.0,29196745
32844,AMD,disease,1.0,29196745
32845,blindness,disease,0.9985,29196745
32846,neovascular AMD,disease,1.0,29196745
32847,VEGF,gene,0.85,29196745
32848,ranibizumab,gene,0.9204,29196745
32849,aflibercept,gene,0.98,29196745
32850,liposomes,cell_type,0.4458,29196745
32851,liposomes,cell_type,0.458,29196745
32852,ranibizumab,gene,0.656,29196745
32853,liposomes,cell_type,0.434,29196745
32854,DPPC,drug,0.999,29196745
32855,DPPG,drug,0.996,29196745
32856,DPPC,drug,0.99,29196745
32857,DPPG,drug,0.9927,29196745
32858,ranibizumab,gene,0.925,29196745
32859,RANIBIZUMAB,drug,0.968,29190241
32860,aflibercept,gene,0.977,29190241
32861,pigment epithelial detachment,disease,1.0,29190241
32862,PED,disease,0.9995,29190241
32863,patients,species,0.975,29190241
32864,ranibizumab,gene,0.839,29190241
32865,patients,species,0.981,29190241
32866,neovascular age-related macular degeneration,disease,1.0,29190241
32867,PED,disease,0.949,29190241
32868,Patients,species,0.9487,29190241
32869,ranibizumab,gene,0.7334,29190241
32870,Patients,species,0.9175,29190241
32871,ranibizumab,gene,0.563,29190241
32872,aflibercept,gene,0.922,29190241
32873,PED,DNA,0.5386,29190241
32874,patients,species,0.983,29190241
32875,ranibizumab,gene,0.6113,29190241
32876,PED,disease,0.9277,29190241
32877,Diabetic Retinopathy,disease,0.9995,29190241
32878,Aflibercept,gene,0.8535,29190241
32879,PED,disease,0.9985,29190241
32880,patients,species,0.9585,29190241
32881,ranibizumab,gene,0.8037,29190241
32882,submacular hemorrhage,disease,0.9976,29188462
32883,polypoidal choroidal vasculopathy,disease,1.0,29188462
32884,submacular hemorrhage,disease,0.997,29188462
32885,polypoidal choroidal vasculopathy,disease,1.0,29188462
32886,PCV,disease,1.0,29188462
32887,submacular hemorrhage,disease,1.0,29188462
32888,PCV,disease,1.0,29188462
32889,vascular endothelial growth factor,gene,0.964,29188462
32890,hemorrhage,disease,0.9937,29188462
32891,photoreceptor layer,cell_type,0.5645,29188462
32892,PRL,cell_type,0.4993,29188462
32893,submacular hemorrhage,disease,0.9985,29188462
32894,bevacizumab,gene,0.835,29187360
32895,Aflibercept,gene,0.9683,29184385
32896,neovascular AMD,disease,1.0,29184385
32897,aflibercept,gene,0.992,29184385
32898,neovascular age-related macular degeneration,disease,1.0,29184385
32899,nAMD,disease,1.0,29184385
32900,macular hemorrhage,disease,1.0,29184385
32901,choroidal neovascularization,disease,1.0,29184385
32902,nAMD,disease,1.0,29184385
32903,ranibizumab,gene,0.6333,29184088
32904,vascular endothelial growth factor,gene,0.8804,29184088
32905,VEGF,gene,0.9985,29184088
32906,polypoidal choroidal vasculopathy,disease,1.0,29184088
32907,PCV,disease,1.0,29184088
32908,VEGF,gene,0.8823,29184088
32909,PCV,disease,1.0,29184088
32910,ranibizumab,gene,0.488,29184088
32911,aflibercept,gene,0.831,29184088
32912,IVA,disease,0.992,29184088
32913,IVR,cell_line,0.504,29184088
32914,ARMS2,gene,0.9785,29184088
32915,A69S,mutation,,29184088
32916,AREDS,disease,0.9995,29177890
32917,aflibercept,gene,0.9883,29177890
32918,exudative age-related macular degeneration,disease,1.0,29177890
32919,AMD,disease,1.0,29177890
32920,patients,species,0.985,29177890
32921,neovascular AMD,disease,1.0,29177890
32922,Age-Related Eye Disease,disease,1.0,29177890
32923,AREDS,disease,0.558,29177890
32924,AREDS,disease,0.6636,29177890
32925,drusen,disease,0.6357,29177890
32926,AREDS,disease,0.798,29177890
32927,advanced AMD,disease,0.7925,29177890
32928,ARMS2,gene,0.9893,29177890
32929,A69S,mutation,,29177890
32930,CFH,gene,0.994,29177890
32931,I62V,DNA,0.4036,29177890
32932,I62V,mutation,,29177890
32933,Fellow-eye,disease,0.7446,29177890
32934,risk,DNA,0.5107,29177890
32935,ARMS2,gene,0.975,29177890
32936,A69S,DNA,0.635,29177890
32937,A69S,mutation,,29177890
32938,AMD,disease,0.9966,29177890
32939,Aflibercept,gene,0.9907,29172741
32940,Galectin-1,gene,0.9863,29172741
32941,Vascular,cell_type,0.484,29172741
32942,Vascular Endothelial Growth,gene,0.9595,29172741
32943,aflibercept,gene,0.9927,29172741
32944,galectin-1,gene,0.9927,29172741
32945,galectin-1,gene,0.9614,29172741
32946,vascular endothelial growth factor (VEGF)-A,gene,0.996,29172741
32947,aflibercept,gene,0.973,29172741
32948,patients,species,0.9575,29172741
32949,diabetic retinopathy,disease,1.0,29172741
32950,DR,disease,1.0,29172741
32951,galectin-1,gene,0.997,29172741
32952,aflibercept,gene,0.9863,29172741
32953,patients,species,0.957,29172741
32954,type 2 diabetes,disease,1.0,29172741
32955,diabetic macular edema,disease,1.0,29172741
32956,DME,disease,1.0,29172741
32957,aflibercept,gene,0.901,29172741
32958,galectin-1,gene,0.6133,29172741
32959,VEGF-A,gene,0.9956,29172741
32960,participants,species,0.9717,29172741
32961,galectin-1,gene,0.998,29172741
32962,galectin-1,gene,0.996,29172741
32963,aflibercept,gene,0.9893,29172741
32964,galectin-1,gene,0.987,29172741
32965,aflibercept,gene,0.956,29172741
32966,galectin-1,gene,0.995,29172741
32967,galectin-1,gene,0.6226,29172741
32968,VEGF-A,gene,0.992,29172741
32969,DME,disease,1.0,29172741
32970,patients,species,0.9956,29172741
32971,VEGF-A,gene,0.6035,29172741
32972,VEGF-A,gene,0.4998,29172741
32973,patients,species,0.9795,29172741
32974,aflibercept,gene,0.991,29172741
32975,galectin-1,gene,0.993,29172741
32976,galectin-1,gene,0.9917,29172741
32977,aflibercept,gene,0.9473,29172741
32978,DR,disease,,29172741
32979,Age-Related Macular Degeneration,disease,1.0,29169154
32980,AMD,disease,1.0,29169154
32981,Patients,species,0.9785,29169154
32982,neovascular age-related macular degeneration,disease,1.0,29169154
32983,nAMD,disease,1.0,29169154
32984,patients,species,0.9746,29169154
32985,nAMD,disease,1.0,29169154
32986,aflibercept,gene,0.985,29169154
32987,patients,species,0.972,29169154
32988,nAMD,disease,0.9995,29169154
32989,nAMD,disease,1.0,29169154
32990,patients,species,0.9824,29169154
32991,AMD,disease,0.995,29169154
32992,tAMD,disease,1.0,29169154
32993,polypoidal choroidal vasculopathy,disease,1.0,29169154
32994,PCV,disease,1.0,29169154
32995,retinal angiomatous proliferation,disease,1.0,29169154
32996,RAP,gene,0.759,29169154
32997,BCVA,cell_type,0.4504,29169154
32998,patients,species,0.987,29169154
32999,tAMD,disease,1.0,29169154
33000,PCV,disease,0.9995,29169154
33001,RAP,disease,1.0,29169154
33002,patients,species,0.976,29169154
33003,nAMD,disease,1.0,29169154
33004,tAMD,disease,1.0,29169154
33005,PCV,drug,0.9976,29169154
33006,RAP,drug,0.999,29169154
33007,Patients,species,0.8896,29169154
33008,RAP,disease,1.0,29169154
33009,nAMD,disease,1.0,29169154
33010,aflibercept,gene,0.9775,29169154
33011,nAMD,disease,1.0,29169154
33012,nAMD,disease,1.0,29166140
33013,ranibizumab,gene,0.863,29166140
33014,aflibercept,gene,0.968,29166140
33015,patients,species,0.968,29166140
33016,nAMD,disease,1.0,29166140
33017,ranibizumab,gene,0.6387,29166140
33018,aflibercept,gene,0.9253,29166140
33019,intraretinal fluid,disease,0.983,29166140
33020,subretinal,disease,0.615,29166140
33021,pigment epithelium detachment,disease,0.9985,29166140
33022,Patients,species,0.9355,29166140
33023,ranibizumab,gene,0.642,29166140
33024,aflibercept,gene,0.969,29166140
33025,aflibercept,gene,0.9785,29166140
33026,ranibizumab,drug,0.5664,29166140
33027,choroidal neovascularization,disease,1.0,29166140
33028,anti-,gene,0.7427,29166140
33029,vascular endothelial growth factor,gene,0.8696,29166140
33030,Choroidal thinning,disease,0.9995,29166140
33031,aflibercept,gene,0.985,29166140
33032,ranibizumab,gene,0.6226,29166140
33033,dry macula,disease,1.0,29166140
33034,aflibercept,gene,0.9795,29166140
33035,ranibizumab,gene,0.9023,29166140
33036,aflibercept,gene,0.9727,29166140
33037,dry macula,disease,0.999,29166140
33038,aflibercept,gene,0.984,29166140
33039,Ranibizumab,gene,0.8926,29164480
33040,Aflibercept,gene,0.903,29164480
33041,vascular endothelial growth factor,gene,0.994,29164480
33042,neovascular age,disease,0.9834,29164480
33043,nAMD,disease,1.0,29164480
33044,ranibizumab,gene,0.959,29164480
33045,aflibercept,gene,0.988,29164480
33046,ranibizumab,gene,0.595,29164480
33047,aflibercept,gene,0.846,29164480
33048,nAMD,disease,1.0,29164480
33049,patients,species,0.9946,29164480
33050,ranibizumab,gene,0.8594,29164480
33051,aflibercept,gene,0.9116,29164480
33052,ranibizumab,gene,0.84,29164480
33053,aflibercept,gene,0.9834,29164480
33054,patient,species,0.9937,29164480
33055,ranibizumab,gene,0.9087,29164480
33056,aflibercept,gene,0.9565,29164480
33057,patient,species,0.992,29164480
33058,ranibizumab,drug,0.6123,29164480
33059,aflibercept,gene,0.948,29164480
33060,Ranibizumab,gene,0.8887,29164480
33061,aflibercept,gene,0.96,29164480
33062,AFLIBERCEPT,gene,0.98,29160779
33063,aflibercept,gene,0.99,29160779
33064,pigment epithelial detachment,disease,1.0,29160779
33065,PED,disease,1.0,29160779
33066,subretinal,disease,0.9995,29160779
33067,patients,species,0.962,29160779
33068,neovascular age-related macular degeneration,disease,1.0,29160779
33069,patients,species,0.9805,29160779
33070,bevacizumab,gene,0.6772,29160779
33071,ranibizumab,gene,0.6416,29160779
33072,aflibercept,gene,0.9785,29160779
33073,Pigment epithelial detachment,disease,0.9707,29160779
33074,SRF,DNA,0.4846,29160779
33075,PED,DNA,0.4849,29160779
33076,PED,disease,0.9365,29160779
33077,SRF,cell_type,0.45,29160779
33078,SRF,DNA,0.5317,29160779
33079,intraretinal cysts,disease,1.0,29160779
33080,aflibercept,gene,0.984,29160779
33081,neovascular age-related macular degeneration,disease,1.0,29160779
33082,PED,DNA,0.4512,29160779
33083,PED,DNA,0.4536,29160779
33084,Age-Related Macular Degeneration,disease,1.0,29146306
33085,Patients,species,0.991,29146306
33086,patients,species,0.9473,29146306
33087,neovascular age-related macular degeneration,disease,1.0,29146306
33088,nAMD,disease,1.0,29146306
33089,anti-vascular endothelial growth factor,gene,0.929,29146306
33090,VEGF,gene,0.9976,29146306
33091,PARTICIPANTS,species,0.7974,29146306
33092,patients,species,0.983,29146306
33093,nAMD,disease,1.0,29146306
33094,bevacizumab,gene,0.7554,29146306
33095,ranibizumab,gene,0.612,29146306
33096,aflibercept,gene,0.8926,29146306
33097,Participants,species,0.906,29146306
33098,patients,species,0.969,29146306
33099,bevacizumab,gene,0.574,29146306
33100,ranibizumab,gene,0.561,29146306
33101,aflibercept,gene,0.9443,29146306
33102,aflibercept,gene,0.965,29146306
33103,bevacizumab,gene,0.6196,29146306
33104,ranibizumab,gene,0.6597,29146306
33105,aflibercept,gene,0.969,29146306
33106,diabetes,disease,1.0,29146306
33107,posterior vitreous detachment,disease,0.9624,29146306
33108,bevacizumab,gene,0.7275,29146306
33109,aflibercept,gene,0.838,29146306
33110,patients,species,0.978,29146306
33111,bevacizumab,gene,0.587,29146306
33112,aflibercept,gene,0.9766,29146306
33113,aflibercept,gene,0.994,29146306
33114,bevacizumab,gene,0.8447,29146306
33115,aflibercept,gene,0.97,29144703
33116,aflibercept,gene,0.9863,29144703
33117,myopic choroidal neovascularization,disease,1.0,29144703
33118,mCNV,disease,1.0,29144703
33119,patient,species,0.996,29144703
33120,aflibercept,gene,0.984,29143753
33121,proliferative diabetic retinopathy,disease,0.983,29143753
33122,aflibercept,gene,0.9873,29143752
33123,proliferative diabetic retinopathy,disease,0.873,29143752
33124,aflibercept,gene,0.984,29143751
33125,proliferative diabetic retinopathy,disease,0.983,29143751
33126,patients,species,0.9453,29137019
33127,diabetic retinopathy,disease,1.0,29137019
33128,patients,species,0.9478,29137019
33129,diabetic retinopathy,disease,1.0,29137019
33130,DR,disease,1.0,29137019
33131,anti-VEGF,gene,0.8975,29137019
33132,patients,species,0.9683,29137019
33133,DR,disease,,29137019
33134,patients,species,0.9893,29137019
33135,DR,disease,,29137019
33136,diabetic macular edema,disease,1.0,29137019
33137,Patients,species,0.959,29137019
33138,aflibercept,gene,0.99,29137019
33139,capillaries,cell_type,0.5435,29137019
33140,capillary dropout,disease,0.999,29137019
33141,microaneurysms,disease,0.9946,29137019
33142,cystoid edema cells,cell_line,0.714,29137019
33143,cystoid edema,disease,1.0,29137019
33144,aflibercept,gene,0.983,29137019
33145,patients,species,0.988,29137019
33146,diabetes,disease,1.0,29137019
33147,HbA1c,gene,0.997,29137019
33148,VEGF,gene,0.6636,29137019
33149,TREAT-AND-EXTEND REGIMEN,DNA,0.736,29135888
33150,neovascular age-related macular degeneration,disease,1.0,29135888
33151,neovascular age-related macular degeneration,disease,1.0,29135888
33152,anti-vascular endothelial growth factor,gene,0.9346,29135888
33153,anti-vascular endothelial growth factor,gene,0.9443,29135888
33154,serous pigment epithelial detachment,disease,0.833,29135888
33155,vitrectomized,disease,0.9004,29134820
33156,vascular endothelial growth factor,gene,0.9844,29134820
33157,VEGF,gene,0.5957,29134820
33158,anti-VEGF,gene,0.953,29134820
33159,pegaptanib,drug,0.978,29134820
33160,ranibizumab,drug,0.7407,29134820
33161,bevacizumab,gene,0.589,29134820
33162,aflibercept,gene,0.9824,29134820
33163,VEGF,gene,0.939,29134820
33164,vitrectomized,disease,0.6733,29134820
33165,steroid,drug,0.9575,29134820
33166,DME,disease,0.9995,29134820
33167,RVO,disease,0.9995,29134820
33168,brolucizumab,gene,0.646,29134820
33169,Neovascular Age-Related Macular Degeneration,disease,1.0,29131696
33170,neovascular age-related macular degeneration,disease,1.0,29131696
33171,nAMD,disease,1.0,29131696
33172,nAMD,disease,1.0,29131696
33173,ranibizumab,gene,0.811,29131696
33174,aflibercept,gene,0.959,29131696
33175,ranibizumab,gene,0.837,29131696
33176,VEGF,gene,0.782,29131696
33177,Aflibercept,gene,0.7827,29131696
33178,Age-related macular degeneration,disease,1.0,29130626
33179,neovascular age-related macular degeneration,disease,1.0,29130626
33180,AMD,disease,1.0,29130626
33181,age related macular degeneration,disease,1.0,29130626
33182,neovascular AMD,disease,1.0,29130626
33183,choroidal neovascular membrane,disease,1.0,29130626
33184,CNV,disease,1.0,29130626
33185,anti-vascular endothelial growth factor,gene,0.9927,29130626
33186,anti-VEGF,gene,0.991,29130626
33187,aflibercept,gene,0.988,29130626
33188,ranibizumab,drug,0.844,29130626
33189,bevacizumab,drug,0.7217,29130626
33190,wet AMD,disease,0.9995,29130626
33191,CNV,disease,0.9995,29130626
33192,subretinal fluid,disease,0.9995,29130626
33193,SRF,disease,0.9985,29130626
33194,retinal angiomatous proliferation,disease,1.0,29130626
33195,RAP,disease,1.0,29130626
33196,VEGF,gene,0.8403,29130626
33197,CNV,disease,1.0,29130626
33198,pigment epithelial detachment,disease,1.0,29130626
33199,PED,disease,1.0,29130626
33200,intraretinal cysts,disease,1.0,29130626
33201,IRC,disease,1.0,29130626
33202,vitreomacular adhesion,disease,1.0,29130626
33203,VMA,disease,0.999,29130626
33204,VMA,disease,1.0,29130626
33205,VMT,disease,1.0,29130626
33206,posterior vitreous detachment,disease,1.0,29130626
33207,PVD,disease,1.0,29130626
33208,SRF,disease,1.0,29130626
33209,PED,disease,1.0,29130626
33210,CNV,DNA,0.595,29130626
33211,PED,disease,1.0,29130626
33212,anti-VEGF,gene,0.7563,29130626
33213,bevacizumab,gene,0.98,29127751
33214,aflibercept,gene,0.991,29127751
33215,multiple angiomatosis,disease,1.0,29127751
33216,Angiomatosis,disease,1.0,29127751
33217,hemangiomas,disease,1.0,29127751
33218,angiodysplasia,disease,1.0,29127751
33219,hemangiomas,disease,1.0,29127751
33220,interferon ,gene,0.995,29127751
33221,fatigue,disease,1.0,29127751
33222,anorexia,disease,1.0,29127751
33223,interferon ,gene,0.9976,29127751
33224,interferon,gene,0.9937,29127751
33225,thalidomide,drug,0.9976,29127751
33226,lenalidomide,drug,0.9966,29127751
33227,cyclophosphamide,drug,0.9995,29127751
33228,propranolol,drug,0.986,29127751
33229,octreotide,drug,0.561,29127751
33230,Sandostatin,drug,0.8716,29127751
33231,bevacizumab,gene,0.81,29127751
33232,bevacizumab,gene,0.6226,29127751
33233,hemorrhagic pleural effusion,disease,1.0,29127751
33234,hemorrhagic effusion,disease,1.0,29127751
33235,aflibercept,gene,0.9854,29127751
33236,proteinuria,disease,0.9995,29127751
33237,aflibercept,gene,0.933,29127751
33238,aflibercept,gene,0.981,29127751
33239,aflibercept,gene,0.725,29127751
33240,multiple angiomatosis,disease,1.0,29127751
33241,Bevacizumab,gene,0.7515,29127751
33242,aflibercept,gene,0.98,29127751
33243,multiple angiomatosis,disease,1.0,29127751
33244,aflibercept,gene,0.991,29127751
33245,angiomatosis,disease,1.0,29127751
33246,angiodysplasia,disease,1.0,29127751
33247,bevacizumab,gene,0.6973,29127751
33248,hemangiomas,disease,1.0,29127751
33249,Radiation retinopathy,disease,0.9995,29127134
33250,aflibercept,gene,0.9575,29127134
33251,Aflibercept,gene,0.7827,29127134
33252,aflibercept,gene,0.987,29127134
33253,anti-,gene,0.5864,29127134
33254,vascular endothelial growth factor,gene,0.942,29127134
33255,age-related macular degeneration,disease,0.999,29127134
33256,macular oedema,disease,1.0,29127134
33257,retinal vein occlusion,disease,0.9995,29127134
33258,diabetic macular oedema,disease,1.0,29127134
33259,retinopathy,disease,1.0,29127134
33260,aflibercept,gene,0.9893,29127134
33261,cystoid macular oedema,disease,1.0,29127134
33262,radiation retinopathy,disease,1.0,29127134
33263,Diabetic Macular Edema,disease,1.0,29120156
33264,Diabetes,disease,1.0,29120156
33265,Diabetic macular edema,disease,1.0,29120156
33266,DME,disease,1.0,29120156
33267,vision loss,disease,0.9976,29120156
33268,diabetes,disease,1.0,29120156
33269,diabetes,disease,1.0,29120156
33270,DME,disease,1.0,29120156
33271,DME,disease,1.0,29120156
33272,anti-VEGF,gene,0.938,29120156
33273,DME,disease,1.0,29120156
33274,macular thickening,disease,0.8135,29120156
33275,DME,disease,1.0,29120156
33276,DME,disease,0.9995,29120156
33277,DME,disease,1.0,29120156
33278,DME,disease,0.999,29120156
33279,CI-DME,disease,1.0,29120156
33280,visual impairment,disease,0.9966,29120156
33281,CI-DME,disease,0.9995,29120156
33282,visual impairment,disease,0.9995,29120156
33283,DME,disease,1.0,29120156
33284,blindness,disease,0.998,29120156
33285,DME,disease,1.0,29120156
33286,impaired vision,disease,0.751,29120156
33287,vision loss,disease,0.969,29120156
33288,neovascular age-related macular degeneration,disease,1.0,29113742
33289,Ranibizumab,gene,0.9243,29113742
33290,aflibercept,gene,0.9565,29113742
33291,ranibizumab,gene,0.915,29113742
33292,aflibercept,gene,0.967,29113742
33293,neovascular age-related macular degeneration,disease,1.0,29113742
33294,nAMD,disease,1.0,29113742
33295,nAMD,disease,1.0,29113742
33296,ranibizumab,gene,0.69,29113742
33297,nAMD,disease,1.0,29113742
33298,aflibercept,gene,0.9507,29113742
33299,ranibizumab,gene,0.5186,29113742
33300,aflibercept,gene,0.9897,29113742
33301,ranibizumab,gene,0.659,29113742
33302,nAMD,disease,1.0,29113742
33303,ranibizumab,gene,0.92,29113742
33304,aflibercept,gene,0.9766,29113742
33305,neovascular lesion,disease,0.9907,29113742
33306,vascular endothelial growth factor,gene,0.9976,29108393
33307,unilateral acute,disease,0.8584,29108393
33308,unilateral acute idiopathic maculopathy,disease,1.0,29108393
33309,UAIM,disease,1.0,29108393
33310,aflibercept,gene,0.9834,29108393
33311,woman,species,0.9,29108393
33312,sudden visual impairment,disease,0.999,29108393
33313,central scotoma,disease,1.0,29108393
33314,UAIM,disease,0.997,29108393
33315,central scotoma,disease,0.9995,29108393
33316,patient,species,0.976,29108393
33317,aflibercept,gene,0.974,29108393
33318,aflibercept,gene,0.9795,29108393
33319,patients,species,0.9785,29108393
33320,UAIM,disease,1.0,29108393
33321,vascular endothelial growth,gene,0.945,29108104
33322,vascular endothelial growth factor,gene,0.9976,29108104
33323,patients,species,0.967,29108104
33324,diabetes,disease,1.0,29108104
33325,chronic kidney disease,disease,1.0,29108104
33326,vascular endothelial growth factor,gene,0.9985,29108104
33327,aflibercept,gene,0.9907,29108104
33328,bevacizumab,gene,0.8823,29108104
33329,ranibizumab,gene,0.5645,29108104
33330,patients,species,0.951,29108104
33331,diabetes,disease,1.0,29108104
33332,acute kidney injury,disease,1.0,29108104
33333,vascular endothelial growth factor,gene,0.9985,29108104
33334,patients,species,0.9814,29108104
33335,patient,species,0.986,29108104
33336,acute kidney injury,disease,1.0,29108104
33337,vascular endothelial growth factor,gene,0.998,29108104
33338,patients,species,0.811,29108104
33339,diabetes,disease,1.0,29108104
33340,chronic kidney disease,disease,1.0,29108104
33341,patients,species,0.985,29103187
33342,patients,species,0.961,29103187
33343,metastatic colorectal cancer,disease,1.0,29103187
33344,mCRC,disease,1.0,29103187
33345,ziv-aflibercept,gene,0.951,29103187
33346,patients,species,0.9727,29103187
33347,mCRC,disease,0.974,29103187
33348,oxaliplatin,drug,0.999,29103187
33349,ziv-aflibercept,gene,0.9736,29103187
33350,ziv-aflibercept,gene,0.931,29103187
33351,patients,species,0.973,29103187
33352,bevacizumab,gene,0.859,29103187
33353,ziv-aflibercept,gene,0.9805,29103187
33354,ziv-aflibercept,gene,0.978,29103187
33355,FOLFIRI,drug,0.9487,29103187
33356,irinotecan,drug,0.9985,29103187
33357,irinotecan,drug,0.9966,29103187
33358,patients,species,0.984,29103187
33359,ziv-aflibercept,gene,0.971,29103187
33360,ziv-aflibercept,gene,0.9775,29103187
33361,patients,species,0.981,29103187
33362,ziv-aflibercept,gene,0.9883,29103187
33363,gastrointestinal disorders,disease,1.0,29103187
33364,asthenia,disease,1.0,29103187
33365,fatigue,disease,0.9824,29103187
33366,ziv-aflibercept,gene,0.9766,29103187
33367,patients,species,0.9897,29103187
33368,ziv-aflibercept,gene,0.9834,29103187
33369,patients,species,0.9546,29103187
33370,ziv-,gene,0.812,29103187
33371,aflibercept,gene,0.955,29103187
33372,neovascular age-related macular degeneration,disease,1.0,29095879
33373,AMD,disease,1.0,29095879
33374,aflibercept,gene,0.979,29095879
33375,neovascular AMD,disease,1.0,29095879
33376,AMD,disease,0.999,29095879
33377,RPE,cell_type,0.476,29095879
33378,AMD,disease,0.9966,29095879
33379,AMD,disease,1.0,29095879
33380,neovascular AMD,disease,1.0,29095879
33381,I-124,drug,0.9307,29094168
33382,bevacizumab,gene,0.889,29094168
33383,ranibizumab,gene,0.5874,29094168
33384,aflibercept,gene,0.98,29094168
33385,owl monkeys,species,0.7725,29094168
33386,bevacizumab,gene,0.755,29094168
33387,I-124 ranibizumab,gene,0.84,29094168
33388,I-124,gene,0.887,29094168
33389,aflibercept,gene,0.896,29094168
33390,28,DNA,,29094168
33391,I-124,drug,0.904,29094168
33392,I-124,drug,0.936,29094168
33393,I-124 aflibercept,gene,0.959,29094168
33394,bevacizumab,gene,0.6875,29094168
33395,ranibizumab,gene,0.8384,29094168
33396,aflibercept,gene,0.9546,29094168
33397,mononuclear phagocyte systems,cell_type,0.4773,29094168
33398,bevacizumab,gene,0.8237,29094168
33399,distal femur bones,DNA,0.4702,29094168
33400,bevacizumab,gene,0.692,29094168
33401,aflibercept,gene,0.918,29094168
33402,bevacizumab,gene,0.83,29094168
33403,Aflibercept,gene,0.91,29094167
33404,Neovascular Age-Related Macular Degeneration,disease,1.0,29094167
33405,aflibercept,gene,0.987,29094167
33406,anti-vascular endothelial growth factor,gene,0.957,29094167
33407,neovascular age-related macular degeneration,disease,1.0,29094167
33408,nAMD,disease,1.0,29094167
33409,aflibercept,gene,0.9746,29094167
33410,Aflibercept,gene,0.958,29094167
33411,aflibercept,gene,0.981,29094167
33412,ranibizumab,gene,0.584,29094167
33413,aflibercept,gene,0.9683,29094167
33414,patients,species,0.988,29094167
33415,aflibercept,gene,0.9927,29094167
33416,aflibercept,gene,0.988,29094167
33417,Aflibercept,gene,0.961,29094167
33418,ranibizumab,gene,0.898,29094167
33419,nAMD,disease,1.0,29094167
33420,patients,species,0.9814,29094167
33421,Aflibercept,gene,0.9697,29093970
33422,Patients,species,0.9727,29093970
33423,Pigment Epithelial Detachment,disease,1.0,29093970
33424,aflibercept,gene,0.9937,29093970
33425,DEP,disease,0.9634,29093970
33426,nAMD,disease,1.0,29093970
33427,ranibizumab,gene,0.863,29093970
33428,PATIENTS,species,0.9517,29093970
33429,patients,species,0.985,29093970
33430,anti-VEGF,gene,0.898,29093970
33431,Aflibercept,gene,0.9404,29093970
33432,patients,species,0.964,29093970
33433,fibrovascular DEP,disease,0.998,29093970
33434,nAMD,disease,1.0,29093970
33435,Aflibercept,gene,0.8213,29082448
33436,diabetic macular edema,disease,1.0,29082448
33437,bevacizumab,gene,0.7827,29082448
33438,aflibercept,gene,0.9756,29082448
33439,patients,species,0.9067,29082448
33440,diabetic macular edema,disease,1.0,29082448
33441,DME,disease,1.0,29082448
33442,bevacizumab,gene,0.814,29082448
33443,patients,species,0.953,29082448
33444,DME,disease,1.0,29082448
33445,bevacizumab,gene,0.8545,29082448
33446,aflibercept,gene,0.8843,29082448
33447,patients,species,0.983,29082448
33448,bevacizumab,gene,0.771,29082448
33449,macular edema,disease,1.0,29082448
33450,aflibercept,gene,0.9707,29082448
33451,bevacizumab,gene,0.8906,29082448
33452,aflibercept,gene,0.9873,29082448
33453,aflibercept,gene,0.9517,29082448
33454,aflibercept,gene,0.9946,29082448
33455,DME,disease,0.9995,29082448
33456,bevacizumab,gene,0.9062,29082448
33457,aflibercept,gene,0.9595,29082448
33458,Aflibercept,gene,0.939,29077188
33459,Diabetic Macular Edema,disease,1.0,29077188
33460,aflibercept,gene,0.988,29077188
33461,diabetic,disease,1.0,29077188
33462,macular edema,disease,0.853,29077188
33463,DME,disease,1.0,29077188
33464,vascular endothelial growth factor,gene,0.998,29077188
33465,VEGF,gene,0.9976,29077188
33466,placental growth factor,gene,0.997,29077188
33467,DME,disease,1.0,29077188
33468,aflibercept,gene,0.9946,29077188
33469,anti-VEGF,gene,0.912,29077188
33470,Aflibercept,gene,0.9565,29077188
33471,Diabetic macular edema,disease,1.0,29077188
33472,aflibercept,gene,0.94,29077188
33473,aflibercept,gene,0.9688,29077188
33474,patients,species,0.954,29077188
33475,DME,disease,1.0,29077188
33476,aflibercept,gene,0.95,29077188
33477,Patients,species,0.925,29074161
33478,Macular Edema,disease,1.0,29074161
33479,patients,species,0.9326,29074161
33480,macular edema,disease,1.0,29074161
33481,central retinal vein occlusion,disease,1.0,29074161
33482,CRVO,disease,1.0,29074161
33483,hemiretinal vein occlusion,disease,1.0,29074161
33484,HRVO,disease,1.0,29074161
33485,REtinal Vein Occlusion,disease,1.0,29074161
33486,NEI,DNA,0.4814,29074161
33487,participants,species,0.967,29074161
33488,patients,species,0.991,29074161
33489,retinal vein occlusion,disease,1.0,29074161
33490,bevacizumab,gene,0.814,29074161
33491,aflibercept,gene,0.992,29074161
33492,decreased vision,disease,0.9883,29074161
33493,macular edema,disease,1.0,29074161
33494,CRVO,disease,1.0,29074161
33495,HRVO,disease,1.0,29074161
33496,participants,species,0.964,29074161
33497,CRVO,disease,0.9995,29074161
33498,HRVO,disease,0.999,29074161
33499,NEI VFQ,DNA,0.5293,29074161
33500,participants,species,0.987,29074161
33501,NEI,DNA,0.5557,29074161
33502,patients,species,0.9937,29074161
33503,retinal vein occlusion,disease,1.0,29074161
33504,CRVO,disease,1.0,29074161
33505,HRVO,disease,1.0,29074161
33506,patients,species,0.9893,29074161
33507,patient,species,0.883,29074161
33508,participants,species,0.949,29073892
33509,metastatic colorectal cancer,disease,1.0,29073892
33510,mCRC,disease,1.0,29073892
33511,patients,species,0.981,29073892
33512,cetuximab,gene,0.965,29073892
33513,panitumumab,gene,0.9575,29073892
33514,aflibercept,gene,0.9404,29073892
33515,Cetuximab,gene,0.912,29073892
33516,panitumumab,gene,0.9067,29073892
33517,aflibercept,gene,0.983,29073892
33518,FOLFIRI,drug,0.668,29073892
33519,participants,species,0.9404,29073892
33520,mCRC,disease,0.9995,29073892
33521,participants,species,0.974,29073892
33522,participants,species,0.95,29073892
33523,PATIENTS,species,0.9937,29068914
33524,DIABETIC MACULAR EDEMA,disease,1.0,29068914
33525,patients,species,0.9854,29068914
33526,patients,species,0.992,29068914
33527,diabetic macular edema,disease,1.0,29068914
33528,DME,disease,1.0,29068914
33529,patients,species,0.9883,29068914
33530,age-related macular degeneration,disease,1.0,29068914
33531,AMD,disease,1.0,29068914
33532,patients,species,0.9917,29068914
33533,DME,disease,1.0,29068914
33534,women,species,0.927,29068914
33535,patients,species,0.979,29068914
33536,AMD,disease,0.9995,29068914
33537,women,species,0.9287,29068914
33538,patients,species,0.988,29068914
33539,patients,species,0.9927,29068914
33540,DME,disease,1.0,29068914
33541,patients,species,0.9917,29068914
33542,AMD,disease,1.0,29068914
33543,patients,species,0.9893,29068914
33544,DME,disease,1.0,29068914
33545,patients,species,0.9854,29068914
33546,AMD,disease,1.0,29068914
33547,patients,species,0.9727,29068914
33548,DME,disease,1.0,29068914
33549,DME,disease,1.0,29068914
33550,AMD,disease,1.0,29068914
33551,AMD,disease,1.0,29068914
33552,DME,disease,1.0,29068914
33553,patients,species,0.95,29068914
33554,AMD,disease,1.0,29068914
33555,DME,disease,1.0,29068914
33556,patients,species,0.979,29068914
33557,DME,disease,1.0,29068914
33558,aflibercept,gene,0.9907,29068524
33559,ranibizumab,gene,0.6553,29068524
33560,antivascular endothelial growth factor,gene,0.949,29061629
33561,eye disorders,disease,0.9834,29061629
33562,patients,species,0.9917,29061629
33563,Patients,species,0.992,29061629
33564,anti-VEGF,gene,0.7046,29061629
33565,age-related macular degeneration,disease,1.0,29061629
33566,diabetic macular oedema,disease,1.0,29061629
33567,eye disorders,disease,0.9595,29061629
33568,ranibizumab,gene,0.9824,29061629
33569,aflibercept,gene,0.985,29061629
33570,bevacizumab,gene,0.971,29061629
33571,eye disorders,disease,0.9907,29061629
33572,ranibizumab,gene,0.9077,29061629
33573,aflibercept,gene,0.976,29061629
33574,ranibizumab,gene,0.877,29061629
33575,aflibercept,gene,0.974,29061629
33576,CCG,DNA,0.497,29061629
33577,CCG,cell_line,0.479,29061629
33578,patient,species,0.9907,29061629
33579,patients,species,0.991,29061629
33580,ranibizumab,gene,0.903,29061629
33581,aflibercept,gene,0.9893,29061629
33582,bevacizumab,gene,0.7656,29061629
33583,patients,species,0.9946,29061629
33584,patients,species,0.959,29052610
33585,Diabetic Retinopathy,disease,1.0,29051325
33586,aflibercept,gene,0.98,29051325
33587,patients,species,0.981,29051325
33588,Diabetic Retinopathy,disease,1.0,29051325
33589,Patients,species,0.9346,29051325
33590,diabetic macular oedema,disease,1.0,29051325
33591,aflibercept,gene,0.956,29051325
33592,aflibercept,gene,0.9287,29051325
33593,patients,species,0.9863,29051325
33594,patients,species,0.992,29051325
33595,aflibercept,gene,0.922,29051325
33596,patients,species,0.986,29051325
33597,aflibercept,gene,0.9746,29051325
33598,aflibercept,gene,0.9897,29051325
33599,patients,species,0.986,29051325
33600,retinopathy,disease,0.9995,29051325
33601,patients,species,0.984,29044979
33602,patients,species,0.972,29044979
33603,nAMD,disease,1.0,29044979
33604,aflibercept,gene,0.973,29044979
33605,nAMD,disease,1.0,29044979
33606,aflibercept,gene,0.976,29044979
33607,patients,species,0.9785,29044979
33608,PARTICIPANTS,species,0.714,29044979
33609,patients,species,0.9795,29044979
33610,Retinal Blindness,disease,1.0,29044979
33611,aflibercept,gene,0.846,29044979
33612,aflibercept,gene,0.975,29044979
33613,patients,species,0.992,29044979
33614,Patients,species,0.9526,29044979
33615,aflibercept,gene,0.9805,29044979
33616,nAMD,disease,1.0,29044979
33617,patients,species,0.9907,29044979
33618,aflibercept,gene,0.97,29027065
33619,neovascular age-related macular degeneration,disease,1.0,29027065
33620,aflibercept,gene,0.978,29027065
33621,neovascular age-related macular degeneration,disease,1.0,29027065
33622,AMD,disease,1.0,29027065
33623,neovascular AMD,disease,0.9946,29027065
33624,Prothrombin,gene,0.99,29027065
33625,thromboplastin,gene,0.9956,29027065
33626,neovascular AMD,disease,1.0,29027065
33627,vascular endothelial growth factor,gene,0.997,29026284
33628,myopic choroidal neovascularization,disease,1.0,29026284
33629,Myopic choroidal neovascularization,disease,1.0,29026284
33630,CNV,disease,1.0,29026284
33631,myopia,disease,0.999,29026284
33632,pathologic myopia,disease,0.9863,29026284
33633,CNV,disease,0.9995,29026284
33634,CNV,disease,1.0,29026284
33635,scarring,disease,0.841,29026284
33636,chorioretinal atrophy,disease,1.0,29026284
33637,myopic CNV,disease,1.0,29026284
33638,vascular endothelial growth factor,gene,0.983,29026284
33639,VEGF,gene,0.987,29026284
33640,VEGF,gene,0.764,29026284
33641,myopic CNV,disease,1.0,29026284
33642,RADIANCE,DNA,0.482,29026284
33643,myopic CNV,disease,1.0,29026284
33644,ranibizumab,gene,0.6455,29026284
33645,ranibizumab,gene,0.806,29026284
33646,aflibercept,gene,0.966,29026284
33647,myopic CNV,disease,1.0,29026284
33648,myopic CNV,disease,1.0,29026284
33649,VEGF,gene,0.7715,29026284
33650,aflibercept,gene,0.9766,29026187
33651,neovascular age-related macular degeneration,disease,1.0,29026187
33652,Neovascular Age-related Macular Degeneration,disease,1.0,29025176
33653,neovascular age-related macular degeneration,disease,0.9956,29025176
33654,AMD,disease,1.0,29025176
33655,vascular endothelial growth factor,gene,0.997,29025176
33656,Metastatic Colorectal Cancer,disease,1.0,29022151
33657,Metastatic colorectal cancer,disease,1.0,29022151
33658,mCRC,disease,1.0,29022151
33659,mCRC,disease,0.9995,29022151
33660,PATIENTS,species,0.973,29022151
33661,aflibercept,gene,0.989,29022151
33662,bevacizumab,gene,0.8745,29022151
33663,cetuximab,gene,0.8853,29022151
33664,panitumumab,gene,0.914,29022151
33665,regorafenib,drug,0.9897,29022151
33666,CRC,disease,0.9995,29022151
33667,anticancer,disease,0.8896,29022151
33668,ICSRs,disease,0.999,29022151
33669,ICSRs,disease,0.8364,29022151
33670,Neutropenia,disease,1.0,29022151
33671,diarrhea,disease,1.0,29022151
33672,panitumumab,gene,0.8125,29022151
33673,Cardiac disorders,disease,1.0,29022151
33674,heart failure,disease,1.0,29022151
33675,bevacizumab,gene,0.866,29022151
33676,cetuximab,gene,0.7373,29022151
33677,regorafenib,drug,0.99,29022151
33678,mediastinal disorders,disease,1.0,29022151
33679,encephalopathies,disease,1.0,29022151
33680,bevacizumab,gene,0.8613,29022151
33681,mCRC,disease,0.994,29022151
33682,small bowel perforation,disease,0.9937,29021501
33683,aflibercept,gene,0.9834,29021501
33684,malignancy,disease,1.0,29021501
33685,aflibercept,gene,0.9854,29021501
33686,gastrointestinal perforation,disease,0.9995,29021501
33687,small bowel perforation,disease,0.994,29021501
33688,aflibercept,gene,0.956,29021501
33689,metachronous colorectal,disease,1.0,29021501
33690,liver metastases,disease,0.997,29021501
33691,small bowel perforation,disease,0.972,29021501
33692,anastomotic dehiscence,disease,0.977,29021501
33693,aflibercept,gene,0.992,29021501
33694,malignancy,disease,0.999,29021501
33695,gastrointestinal perforation,disease,0.9595,29021501
33696,Metastatic Colorectal Cancer,disease,0.9995,29021377
33697,metastatic colorectal cancer,disease,1.0,29021377
33698,mCRC,disease,1.0,29021377
33699,mCRC,disease,0.9976,29021377
33700,irinotecan,drug,0.9995,29021377
33701,oxaliplatin,drug,0.9995,29021377
33702,5-fluorouracil,drug,0.9995,29021377
33703,capecitabine,drug,0.9995,29021377
33704,TAS-102,drug,0.9985,29021377
33705,mCRC,disease,0.9277,29021377
33706,rat sarcoma viral oncogene homolog,gene,0.644,29021377
33707,rat,species,0.8984,29021377
33708,RAS,gene,0.9927,29021377
33709,mCRC,disease,0.9917,29021377
33710,anti-epidermal growth factor receptor antibodies cetuximab,gene,0.8965,29021377
33711,panitumumab,gene,0.8057,29021377
33712,bevacizumab,gene,0.6724,29021377
33713,ziv-aflibercept,gene,0.985,29021377
33714,RAS,gene,0.4995,29021377
33715,mCRC,disease,0.988,29021377
33716,Regorafenib,drug,0.9976,29021377
33717,RAS,gene,0.797,29021377
33718,mCRC,disease,0.999,29021377
33719,mCRC,disease,0.995,29021377
33720,metastatic colorectal cancer,disease,1.0,29021377
33721,mCRC,disease,1.0,29021377
33722,mCRC,disease,0.9946,29021377
33723,Acute Exudative Polymorphous Paraneoplastic Vitelliform Maculopathy,disease,0.997,29020430
33724,Aflibercept,gene,0.949,29020430
33725,acute exudative polymorphous paraneoplastic vitelliform maculopathy,disease,0.9995,29020430
33726,AEPPVM,disease,1.0,29020430
33727,aflibercept,gene,0.9805,29020430
33728,Eylea,gene,0.719,29020430
33729,breast carcinoma,disease,1.0,29020430
33730,colon carcinoma,disease,1.0,29020430
33731,macular vitelliform lesion,disease,0.9995,29020430
33732,atrophic retinal pigment epithelial,disease,1.0,29020430
33733,RPE,disease,0.7227,29020430
33734,vitelliform lesion,disease,1.0,29020430
33735,sensorineural retinal detachment,disease,1.0,29020430
33736,ellipsoid loss,disease,0.8735,29020430
33737,photoreceptor,cell_type,0.7324,29020430
33738,vitelliform macular lesion,disease,1.0,29020430
33739,aflibercept,gene,0.9556,29020430
33740,intraretinal edema,disease,1.0,29020430
33741,aflibercept,gene,0.9736,29020430
33742,APPVME,disease,1.0,29020430
33743,RPE,cell_type,0.653,29020430
33744,Aflibercept,gene,0.9604,29020426
33745,Serous Foveal Detachment,disease,1.0,29020426
33746,Dome-Shaped Macula,disease,0.982,29020426
33747,aflibercept,gene,0.9917,29020426
33748,Eylea,gene,0.7764,29020426
33749,serous foveal detachment,disease,1.0,29020426
33750,SFD,disease,1.0,29020426
33751,PATIENTS,species,0.942,29020426
33752,aflibercept,gene,0.983,29020426
33753,Diabetic Retinopathy,disease,1.0,29020426
33754,SFD,disease,1.0,29020426
33755,SRF,disease,0.8135,29020426
33756,aflibercept,gene,0.989,29020426
33757,SFD,disease,0.9873,29020426
33758,DSM,disease,1.0,29020426
33759,anti-vascular endothelial growth factor,gene,0.946,29019795
33760,submacular hemorrhages,disease,0.999,29019795
33761,vascular endothelial growth factor,gene,0.9946,29019795
33762,macular edema,disease,1.0,29018760
33763,central retinal vein occlusion,disease,1.0,29018760
33764,aflibercept,gene,0.9717,29018760
33765,Central retinal vein occlusion,disease,1.0,29018760
33766,CRVO,disease,1.0,29018760
33767,vision loss,disease,0.9995,29018760
33768,CRVO,disease,1.0,29018760
33769,Vision loss,disease,0.9785,29018760
33770,CRVO,disease,1.0,29018760
33771,macular edema,disease,1.0,29018760
33772,macular edema,disease,1.0,29018760
33773,vascular endothelial growth factor,gene,0.9976,29018760
33774,VEGF,gene,0.995,29018760
33775,aflibercept,gene,0.9883,29018760
33776,bevacizumab,gene,0.8896,29018760
33777,ranibizumab,gene,0.781,29018760
33778,VEGF,gene,0.994,29018760
33779,macular edema,disease,1.0,29018760
33780,aflibercept,gene,0.98,29018760
33781,AFLIBERCEPT,gene,0.8447,28984737
33782,RANIBIZUMAB,drug,0.6724,28984737
33783,aflibercept,gene,0.9795,28984737
33784,patients,species,0.971,28984737
33785,patients,species,0.985,28984737
33786,aflibercept,gene,0.99,28984737
33787,patients,species,0.9873,28984737
33788,aflibercept,gene,0.9756,28984737
33789,ranibizumab,gene,0.71,28984737
33790,aflibercept,gene,0.994,28984737
33791,ranibizumab,gene,0.7344,28984737
33792,geographic atrophy,disease,1.0,28984737
33793,aflibercept,gene,0.9937,28984737
33794,ranibizumab,gene,0.85,28984737
33795,the aflibercept,gene,0.6826,28984737
33796,ranibizumab,gene,0.722,28984737
33797,patients,species,0.978,28984737
33798,geographic atrophy,disease,1.0,28984737
33799,aflibercept,gene,0.9873,28984737
33800,VEGF,gene,0.9556,28980574
33801,neovascular age-related macular degeneration,disease,1.0,28980574
33802,age-related macular degeneration,disease,1.0,28980574
33803,AMD,disease,1.0,28980574
33804,blindness,disease,1.0,28980574
33805,AMD,disease,0.983,28980574
33806,exudative AMD,disease,0.9985,28980574
33807,pegaptanib,drug,0.9644,28980574
33808,ranibizumab,gene,0.54,28980574
33809,bevacizumab,gene,0.8804,28980574
33810,aflibercept,gene,0.972,28980574
33811,conbercept,gene,0.6455,28980574
33812,neovascular AMD,disease,1.0,28980574
33813,patients,species,0.9775,28980574
33814,Placenta Growth Factor,gene,0.995,28979997
33815,mononuclear phagocytes,cell_type,0.775,28979997
33816,MPs,cell_type,0.776,28979997
33817,choroidal neovascularization,disease,1.0,28979997
33818,CNV,disease,1.0,28979997
33819,anti-vascular endothelial growth factor-A,gene,0.971,28979997
33820,VEGF-A,gene,0.998,28979997
33821,aflibercept,gene,0.9062,28979997
33822,anti-VEGF-A,gene,0.7485,28979997
33823,placenta growth factor,gene,0.87,28979997
33824,PlGF,gene,0.9946,28979997
33825,patients,species,0.9927,28979997
33826,anti-VEGF-,gene,0.9644,28979997
33827,MPs,cell_type,0.694,28979997
33828,VEGFR1,gene,0.982,28979997
33829,P1GF,gene,0.9976,28979997
33830,vascular endothelial growth factor receptor 1,gene,0.997,28979997
33831,VEGFR1,gene,0.9946,28979997
33832,immune cells,cell_type,0.8657,28979997
33833,CNV,DNA,0.4282,28979997
33834,CNV,disease,0.999,28979997
33835,immune cells,cell_type,0.882,28979997
33836,macrophage,cell_type,0.542,28979997
33837,aflibercept,gene,0.9766,28979997
33838,anti-PlGF,gene,0.9673,28979997
33839,Plgf,gene,0.9883,28979997
33840,Vegfa,gene,0.9966,28979997
33841,VEGF-A,gene,0.992,28979997
33842,PlGF,gene,0.9897,28979997
33843,CNV,disease,0.996,28979997
33844,aflibercept,gene,0.967,28979997
33845,anti-PlGF,gene,0.8374,28979997
33846,subretinal MPs,cell_type,0.773,28979997
33847,PlGF,gene,0.9897,28979997
33848,CNV,DNA,0.857,28979997
33849,Aflibercept,gene,0.9487,28979997
33850,PlGF,gene,0.9985,28979997
33851,VEGFR1,gene,0.997,28979997
33852,MPs,cell_type,0.6685,28979997
33853,CNV,disease,0.9976,28979997
33854,VEGF-A,gene,0.998,28979997
33855,PlGF,gene,0.9956,28979997
33856,PlGF,gene,0.788,28979997
33857,subretinal MP,cell_type,0.6245,28979997
33858,Patients,species,0.9897,28973328
33859,diabetic macular edema,disease,1.0,28973328
33860,DME,disease,1.0,28973328
33861,aflibercept,gene,0.891,28973328
33862,glycated hemoglobin,gene,0.9717,28973328
33863,diabetes,disease,1.0,28973328
33864,patients,species,0.9536,28973328
33865,DME,disease,1.0,28973328
33866,UI,DNA,0.628,28973328
33867,BSE,DNA,0.473,28973328
33868,DME,disease,0.9995,28973328
33869,Ziv-Aflibercept,gene,0.9785,28971631
33870,vascular endothelial growth factor,gene,0.997,28971631
33871,VEGF,gene,0.997,28971631
33872,chorioretinal vascular conditions,disease,1.0,28971631
33873,ziv-aflibercept,gene,0.9854,28971631
33874,Zaltrap,gene,0.8403,28971631
33875,ziv-aflibercept,gene,0.9893,28971631
33876,aflibercept,gene,0.9785,28971631
33877,VEGF,gene,0.995,28971631
33878,Eylea,drug,0.766,28971631
33879,ziv-aflibercept,gene,0.9917,28971631
33880,anti-VEGFresistant,gene,0.982,28971631
33881,neovascular age-related macular degeneration,disease,1.0,28971631
33882,nAMD,disease,1.0,28971631
33883,diabetic macular edema,disease,1.0,28971631
33884,DME,disease,1.0,28971631
33885,retinal vein occlusion,disease,1.0,28971631
33886,RVO,disease,1.0,28971631
33887,choroidal neovascular membrane,disease,1.0,28971631
33888,CNVM,disease,1.0,28971631
33889,ziv-aflibercept,gene,0.986,28971631
33890,aflibercept,gene,0.988,28971631
33891,ziv-aflibercept,gene,0.986,28971631
33892,ziv-aflibercept,gene,0.982,28971631
33893,bevacizumab,gene,0.609,28971631
33894,Aflibercept,gene,0.9556,28967076
33895,acute retinal necrosis syndrome,disease,1.0,28967076
33896,Acute retinal necrosis,disease,1.0,28967076
33897,ARN,disease,1.0,28967076
33898,panuveitis syndrome,disease,1.0,28967076
33899,cystoid macular edema,disease,1.0,28967076
33900,CME,disease,1.0,28967076
33901,CME,disease,1.0,28967076
33902,ARN,disease,0.9995,28967076
33903,aflibercept,gene,0.949,28967076
33904,woman,species,0.899,28967076
33905,varicella-zoster virus,disease,1.0,28967076
33906,ARN,disease,0.9946,28967076
33907,epiretinal membrane,disease,1.0,28967076
33908,ERM,disease,1.0,28967076
33909,CME,disease,0.9995,28967076
33910,aflibercept,gene,0.964,28967076
33911,Cystoid macular edema,disease,1.0,28967076
33912,ARN,disease,1.0,28967076
33913,CME,disease,1.0,28967076
33914,ARN,disease,1.0,28967076
33915,pegaptanib,drug,0.988,28967076
33916,interferon--2,gene,0.9937,28967076
33917,interferon--2a,gene,0.998,28967076
33918,aflibercept,gene,0.981,28967076
33919,placental growth factor,gene,0.999,28967076
33920,vascular endothelial growth factor,gene,0.997,28967076
33921,VEGF,gene,0.9956,28967076
33922,VEGF-A,gene,0.996,28967076
33923,bevacizumab,gene,0.737,28967076
33924,pegaptanib,drug,0.866,28967076
33925,aflibercept,gene,0.9756,28967076
33926,CME,disease,0.994,28967076
33927,ARN,disease,0.9995,28967076
33928,placental growth factor,gene,0.9966,28965804
33929,diabetic retinopathy,disease,1.0,28965804
33930,DR,disease,1.0,28965804
33931,VEGF,gene,0.999,28965804
33932,placental growth factor,gene,0.998,28965804
33933,PlGF,gene,0.993,28965804
33934,DR,disease,,28965804
33935,anti-PlGF antibody,gene,0.9556,28965804
33936,PL5D11D4,gene,0.7114,28965804
33937,DR,disease,,28965804
33938,inflammation,disease,0.996,28965804
33939,neurodegeneration,disease,1.0,28965804
33940,vascular,disease,0.796,28965804
33941,fibrosis,disease,0.9976,28965804
33942,diabetic,disease,0.998,28965804
33943,streptozotocin,drug,1.0,28965804
33944,STZ,drug,1.0,28965804
33945,Akimba,disease,0.79,28965804
33946,choroidal neovascularization,disease,1.0,28965804
33947,CNV,disease,1.0,28965804
33948,mouse,species,0.963,28965804
33949,anti-PlGF antibody,gene,0.9927,28965804
33950,anti-VEGFR-2 antibody,gene,0.9917,28965804
33951,DC101,gene,0.911,28965804
33952,anti-VEGF antibody,gene,0.989,28965804
33953,B20,gene,0.8335,28965804
33954,VEGF-Trap,gene,0.9614,28965804
33955,aflibercept,gene,0.9966,28965804
33956,triamcinolone acetonide,drug,0.9985,28965804
33957,TAAC,drug,0.9946,28965804
33958,mouse,species,0.9883,28965804
33959,STZ,drug,0.9995,28965804
33960,fluorescein isothiocyanate,drug,0.9995,28965804
33961,bovine serum albumin,gene,0.991,28965804
33962,bovine,species,0.555,28965804
33963,FITC,drug,1.0,28965804
33964,FITC-BSA,gene,0.664,28965804
33965,Akimba,disease,0.9995,28965804
33966,fluorescein,drug,0.9995,28965804
33967,anti-PlGF antibody,gene,0.914,28965804
33968,VEGFR-2,gene,0.9873,28965804
33969,mouse,species,0.9893,28965804
33970,STZ,drug,0.999,28965804
33971,PL5D11D4,gene,0.872,28965804
33972,retinal ganglion cell,cell_type,0.662,28965804
33973,RGC,cell_type,0.7476,28965804
33974,Brn3a,gene,0.986,28965804
33975,RGC,cell_type,0.77,28965804
33976,CD45,gene,0.9844,28965804
33977,F4/,cell_line,0.7534,28965804
33978,F4,cell_type,,28965804
33979,fibrosis,disease,0.946,28965804
33980,collagen type 1a,gene,0.9956,28965804
33981,CNV,disease,1.0,28965804
33982,PL5D11D4,gene,0.889,28965804
33983,anti-PlGF antibody,gene,0.9937,28965804
33984,aflibercept,gene,0.979,28965804
33985,TAAC,drug,0.8237,28965804
33986,leukocyte,cell_type,0.846,28965804
33987,macrophage,cell_type,0.5327,28965804
33988,mouse,species,0.9824,28965804
33989,STZ,drug,0.9995,28965804
33990,microglia,cell_type,0.757,28965804
33991,macrophages,cell_type,0.694,28965804
33992,PL5D11D4,gene,0.898,28965804
33993,aflibercept,gene,0.987,28965804
33994,anti-PlGF antibody,gene,0.8574,28965804
33995,VEGF,gene,0.9976,28965804
33996,inflammation,disease,0.999,28965804
33997,fibrosis,disease,1.0,28965804
33998,neurodegenerative,disease,0.999,28965804
33999,Neovascular Age-Related Macular Degeneration,disease,1.0,28950272
34000,VEGF,gene,0.6836,28950272
34001,neovascular age-related macular degeneration,disease,1.0,28950272
34002,nAMD,disease,1.0,28950272
34003,choroidal neovascularization,disease,0.999,28950272
34004,nAMD,disease,1.0,28950272
34005,bevacizumab,gene,0.751,28950272
34006,ranibizumab,gene,0.49,28950272
34007,aflibercept,gene,0.922,28950272
34008,ziv-aflibercept,gene,0.974,28926212
34009,polypoidal choroidal vasculopathy,disease,1.0,28926212
34010,vascular endothelial growth factor,gene,0.9863,28926190
34011,neovascular age-related macular degeneration,disease,0.9976,28926190
34012,vascular endothelial growth factor,gene,0.995,28926190
34013,VEGF,gene,0.9976,28926190
34014,neovascular age-related macular degeneration,disease,1.0,28926190
34015,nAMD,disease,1.0,28926190
34016,bevacizumab,gene,0.746,28926190
34017,nAMD,disease,1.0,28926190
34018,Diabetic Retinopathy,disease,0.9824,28926190
34019,BCVA,cell_type,0.4358,28926190
34020,macular atrophy,disease,1.0,28926190
34021,neovascular lesions,disease,0.5327,28926190
34022,nAMD,disease,1.0,28926190
34023,macular atrophic,disease,0.9966,28926190
34024,metastatic colorectal cancer,disease,1.0,28923209
34025,metastatic colorectal cancer,disease,1.0,28923209
34026,mCRC,disease,1.0,28923209
34027,mCRC,disease,0.8613,28923209
34028,Sickle cell retinopathy,disease,1.0,28919773
34029,Sickle cell retinopathy,disease,1.0,28919773
34030,SCR,disease,1.0,28919773
34031,sickle cell disease,disease,1.0,28919773
34032,SCD,disease,1.0,28919773
34033,hemoglobinopathy,disease,1.0,28919773
34034,SCR,disease,1.0,28919773
34035,vision loss,disease,0.9893,28919773
34036,SCR,disease,0.994,28919773
34037,retinopathy,disease,0.9883,28919773
34038,SCD,disease,1.0,28919773
34039,anti-,gene,0.7856,28919773
34040,vascular endothelial growth factor,gene,0.91,28919773
34041,Lucentis,gene,0.564,28919773
34042,ranibizumab,gene,0.9644,28919773
34043,aflibercept,gene,0.986,28919773
34044,SCR,disease,0.718,28919773
34045,SCR,disease,0.979,28919773
34046,hemorrhage,disease,0.9995,28919773
34047,sight loss,disease,0.9985,28919773
34048,SCR,disease,0.998,28919773
34049,SCR,disease,0.9995,28919773
34050,ziv-aflibercept,gene,0.9873,28913517
34051,choroidal,disease,0.5693,28913517
34052,ziv-aflibercept,gene,0.9907,28913517
34053,choroidal and retinal vascular diseases,disease,1.0,28913517
34054,patients,species,0.976,28913517
34055,age-related macular degeneration,disease,1.0,28913517
34056,AMD,disease,1.0,28913517
34057,diabetic retinopathy,disease,1.0,28913517
34058,retinal vein occlusion,disease,1.0,28913517
34059,RVO,disease,1.0,28913517
34060,ziv-aflibercept,gene,0.9834,28913517
34061,patients,species,0.9795,28913517
34062,ziv-aflibercept,gene,0.9893,28913517
34063,patients,species,0.963,28913517
34064,intraocular vascular,disease,0.767,28913517
34065,VEGF,gene,0.9443,28902336
34066,Diabetic Macular Edema,disease,1.0,28902336
34067,vascular endothelial growth factor,gene,0.931,28902336
34068,VEGF,gene,0.998,28902336
34069,diabetic macular edema,disease,0.8833,28902336
34070,DME,disease,1.0,28902336
34071,VEGF,gene,0.971,28902336
34072,VEGF,gene,0.785,28902336
34073,DME,disease,1.0,28902336
34074,VEGF,gene,0.8926,28902336
34075,DME,disease,1.0,28902336
34076,anti-VEGFs,gene,0.981,28902336
34077,DME,disease,1.0,28902336
34078,CENTRAL RETINAL VEIN OCCLUSION,disease,1.0,28902097
34079,aflibercept,gene,0.9917,28902097
34080,central retinal vein occlusion,disease,1.0,28902097
34081,central retinal vein occlusion,disease,1.0,28902097
34082,macular edema,disease,1.0,28902097
34083,macular edema,disease,1.0,28902097
34084,aflibercept,gene,0.981,28902097
34085,aflibercept,gene,0.986,28902097
34086,retinal vascular,DNA,0.598,28902097
34087,DCP,DNA,0.5366,28902097
34088,DCP,DNA,0.561,28902097
34089,DCP,DNA,0.4827,28902097
34090,macular edema,disease,1.0,28902097
34091,ischemia,disease,0.9717,28902097
34092,fluorescein,drug,0.9766,28902097
34093,photoreceptor,cell_type,0.6523,28902097
34094,aflibercept,gene,0.8564,28902097
34095,central retinal vein occlusion,disease,1.0,28902097
34096,Aflibercept,gene,0.98,28900543
34097,Diabetic Macular Edema,disease,1.0,28900543
34098,Ranibizumab,gene,0.9175,28900543
34099,diabetic macular edema,disease,1.0,28900543
34100,DME,disease,1.0,28900543
34101,ranibizumab,gene,0.908,28900543
34102,dexamethasone,drug,0.989,28900543
34103,aflibercept,gene,0.919,28900543
34104,DME,disease,1.0,28900543
34105,ranibizumab,gene,0.7817,28900543
34106,dexamethasone,drug,0.996,28900543
34107,aflibercept,gene,0.9785,28900543
34108,ranibizumab,gene,0.671,28900543
34109,dexamethasone,drug,0.983,28900543
34110,dexamethasone,drug,0.995,28900543
34111,preswitch,DNA,0.5444,28900543
34112,aflibercept,gene,0.9614,28900543
34113,DME,disease,1.0,28900543
34114,Aflibercept,gene,0.8857,28898873
34115,Age-Related Macular Degeneration,disease,1.0,28898873
34116,aflibercept,gene,0.965,28898873
34117,age-related macular degeneration,disease,1.0,28898873
34118,tAMD,disease,0.999,28898873
34119,tAMD,disease,1.0,28898873
34120,choroidal neovascularization,disease,0.9937,28898873
34121,CNV,disease,1.0,28898873
34122,CNV,disease,0.707,28898873
34123,subfoveal fibrosis,disease,1.0,28898873
34124,classic CNV,disease,0.999,28898873
34125,tAMD,disease,1.0,28898873
34126,CNV,disease,0.9937,28898873
34127,CNV,disease,0.9746,28898873
34128,aflibercept,gene,0.99,28894355
34129,choroidal neovascularization,disease,1.0,28894355
34130,aflibercept,gene,0.9785,28883712
34131,macular edema,disease,1.0,28883712
34132,central retinal vein occlusion,disease,1.0,28883712
34133,CRVO,disease,1.0,28883712
34134,PATIENTS,species,0.911,28883712
34135,aflibercept,gene,0.9688,28883712
34136,aflibercept,gene,0.9756,28883712
34137,aflibercept,gene,0.804,28883712
34138,aflibercept,gene,0.9824,28883712
34139,aflibercept,gene,0.969,28883712
34140,aflibercept,gene,0.9556,28883712
34141,aflibercept,gene,0.957,28883712
34142,macular edema,disease,1.0,28883712
34143,CRVO,disease,0.9995,28883712
34144,aflibercept,gene,0.97,28879555
34145,triamcinolone,drug,0.5557,28879555
34146,aflibercept,disease,0.897,28879555
34147,polypoidal choroidal vasculopathy,disease,1.0,28879555
34148,neovascular age related macular,disease,1.0,28865938
34149,patients,species,0.983,28865938
34150,neovascular age- related macular degeneration,disease,1.0,28865938
34151,nARMD,disease,1.0,28865938
34152,anti-VEGF,gene,0.868,28865938
34153,PATIENTS,species,0.94,28865938
34154,patients,species,0.9893,28865938
34155,anti-VEGF,gene,0.855,28865938
34156,patients,species,0.99,28865938
34157,Patients,species,0.9688,28865938
34158,ETDRS,DNA,0.5195,28865938
34159,patient,species,0.9883,28865938
34160,patients,species,0.9937,28865938
34161,patients,species,0.994,28865938
34162,patients,species,0.9863,28865938
34163,patients,species,0.9863,28865938
34164,nARMD,disease,0.9995,28865938
34165,patients,species,0.995,28865938
34166,BLEB,cell_line,0.499,28858192
34167,BLEB-RELATED ENDOPHTHALMITIS,disease,0.9766,28858192
34168,patient,species,0.977,28858192
34169,bleb-related endophthalmitis,disease,0.9214,28858192
34170,endophthalmitis,disease,0.647,28858192
34171,bleb,disease,0.564,28858192
34172,blepharitis,disease,1.0,28858192
34173,hypotony,disease,1.0,28858192
34174,nasolacrimal duct obstruction,disease,1.0,28858192
34175,patient,species,0.948,28858192
34176,bleb-related endophthalmitis,disease,0.9917,28858192
34177,patients,species,0.9834,28858192
34178,glaucoma,disease,0.9985,28858192
34179,anti-VEGF,gene,0.9707,28852904
34180,anti-VEGF,gene,0.9683,28852904
34181,nAMD,disease,1.0,28852904
34182,anti-VEGF,gene,0.786,28852904
34183,anti-VEGF,gene,0.9487,28852904
34184,nAMD,disease,1.0,28852904
34185,bevacizumab,gene,0.886,28852904
34186,ranibizumab,gene,0.566,28852904
34187,bevacizumab,gene,0.7173,28852904
34188,aflibercept,gene,0.973,28852904
34189,VEGF,gene,0.802,28852904
34190,bevacizumab,gene,0.8613,28852904
34191,bevacizumab,gene,0.9277,28852904
34192,aflibercept,gene,0.987,28852904
34193,aflibercept,gene,0.915,28851779
34194,verteporfin,drug,0.996,28851779
34195,polypoidal choroidal vasculopathy,disease,1.0,28851779
34196,PCV,disease,1.0,28851779
34197,indocyanine green,drug,0.9956,28851779
34198,patients,species,0.9775,28851779
34199,PCV,disease,1.0,28851779
34200,patients,species,0.9814,28851779
34201,IVA,drug,0.6157,28851779
34202,patients,species,0.9707,28851779
34203,polyps,disease,0.7793,28851779
34204,polyp,disease,0.9976,28851779
34205,Fc,gene,0.8403,28850637
34206,VEGF,gene,0.9204,28850637
34207,VEGF-Trap,gene,0.979,28850637
34208,Fc region,gene,0.8086,28850637
34209,FcfVEGF-Trap,gene,0.991,28850637
34210,Fc region,gene,0.8,28850637
34211,VEGF-Trap,gene,0.934,28850637
34212,145,RNA,0.4077,28850637
34213,rabbits,species,0.943,28850637
34214,VEGF-Trap,gene,0.9717,28850637
34215,VEGF-Trap,gene,0.9834,28850637
34216,FcfVEGF-Trap,gene,0.878,28850637
34217,FcfVEGF-Trap,gene,0.909,28850637
34218,VEGF-Trap,gene,0.9673,28850637
34219,VEGF-Trap,gene,0.8916,28850637
34220,VEGF-Trap,gene,0.9863,28850637
34221,FcfVEGF-Trap,gene,0.9556,28850637
34222,VEGF-Trap,gene,0.9834,28850637
34223,Fc,gene,0.9673,28850637
34224,VEGF,gene,0.767,28850637
34225,Fc,gene,0.9497,28850637
34226,VEGF-Trap,gene,0.9688,28850637
34227,VEGF-Trap,gene,0.9785,28850637
34228,metastatic colorectal cancer,disease,0.999,28844343
34229,metastatic colorectal cancer,disease,1.0,28844343
34230,mCRC,disease,1.0,28844343
34231,Colorectal cancer,disease,1.0,28844343
34232,CRC,disease,1.0,28844343
34233,mCRC,disease,0.9985,28844343
34234,bevacizumab,gene,0.927,28844343
34235,cetuximab,gene,0.8413,28844343
34236,panitumumab,gene,0.7524,28844343
34237,regorafenib,drug,0.988,28844343
34238,aflibercept,gene,0.9272,28844343
34239,mCRC,disease,0.995,28844343
34240,hypertension,disease,1.0,28844343
34241,heart failure,disease,1.0,28844343
34242,creatinine,drug,0.9985,28844343
34243,mCRC,disease,0.9883,28844343
34244,mCRC,disease,0.9966,28844343
34245,aflibercept,gene,0.9443,28842751
34246,polypoidal choroidal vasculopathy,disease,1.0,28842751
34247,ANTI-VEGF,gene,0.988,28841584
34248,antivascular endothelial growth factor,gene,0.899,28841584
34249,VEGF,gene,0.995,28841584
34250,ranibizumab,drug,0.7227,28841584
34251,aflibercept,gene,0.9863,28841584
34252,bevacizumab,gene,0.928,28841584
34253,bevacizumab,gene,0.864,28841584
34254,bevacizumab,gene,0.9,28841584
34255,silicone,drug,0.5,28841584
34256,Ranibizumab,gene,0.908,28841584
34257,bevacizumab,gene,0.951,28841584
34258,Aflibercept,gene,0.9717,28837425
34259,bevacizumab,gene,0.888,28837425
34260,ranibizumab,gene,0.5767,28837425
34261,diabetic macular oedema,disease,1.0,28837425
34262,aflibercept,gene,0.719,28837425
34263,bevacizumab,gene,0.8594,28837425
34264,ranibizumab,gene,0.599,28837425
34265,diabetic macular oedema,disease,1.0,28837425
34266,DME,disease,1.0,28837425
34267,VEGF,gene,0.765,28837425
34268,aflibercept,gene,0.9834,28837425
34269,aflibercept,gene,0.9917,28837425
34270,bevacizumab,gene,0.7856,28837425
34271,ranibizumab,gene,0.539,28837425
34272,aflibercept,gene,0.995,28837425
34273,bevacizumab,gene,0.776,28837425
34274,aflibercept,gene,0.9937,28837425
34275,bevacizumab,gene,0.8516,28837425
34276,aflibercept,gene,0.9893,28837425
34277,bevacizumab,gene,0.9277,28837425
34278,ranibizumab,gene,0.7227,28837425
34279,DME,disease,1.0,28837425
34280,aflibercept,gene,0.975,28837425
34281,anti-,gene,0.7354,28831613
34282,vascular endothelial growth factor,gene,0.891,28831613
34283,diabetic macular edema,disease,1.0,28831613
34284,anti-VEGF,gene,0.9043,28831613
34285,diabetic macular edema,disease,1.0,28831613
34286,DME,disease,1.0,28831613
34287,glaucoma,disease,1.0,28831613
34288,anti-VEGF,gene,0.722,28831613
34289,DME,disease,1.0,28831613
34290,HbA1c,gene,0.9976,28831613
34291,DME,disease,1.0,28831613
34292,glaucoma,disease,1.0,28831613
34293,anti-VEGF,gene,0.831,28831613
34294,Neovascular Age-Related Macular Degeneration Disease,disease,1.0,28829220
34295,patients,species,0.975,28829220
34296,neovascular age-related macular degeneration,disease,1.0,28829220
34297,AMD,disease,1.0,28829220
34298,vascular endothelial growth factor,gene,0.989,28829220
34299,bevacizumab,gene,0.886,28829220
34300,ranibizumab,gene,0.908,28829220
34301,aflibercept,gene,0.9785,28829220
34302,patients,species,0.9814,28829220
34303,AMD,disease,1.0,28829220
34304,patients,species,0.9893,28829220
34305,patients,species,0.992,28829220
34306,patients,species,0.977,28829220
34307,Vascular Endothelial Growth Factor,gene,0.9883,28828763
34308,Retinal Arterial Macroaneurysm,disease,1.0,28828763
34309,vascular endothelial growth factor,gene,0.976,28828763
34310,VEGF,gene,0.6626,28828763
34311,retinal arterial macroaneurysm,disease,1.0,28828763
34312,RAM,disease,1.0,28828763
34313,RAM,disease,0.981,28828763
34314,Nd:YAG,drug,0.9077,28828763
34315,subinternal limiting membrane (sub-ILM) hemorrhage,disease,0.984,28828763
34316,VEGF,gene,0.7744,28828763
34317,macular exudation,disease,1.0,28828763
34318,RAM,disease,1.0,28828763
34319,macroaneurysms,disease,0.9307,28828763
34320,sub-ILM hemorrhage,disease,0.958,28828763
34321,Nd:YAG,drug,0.806,28828763
34322,preretinal hemorrhage,disease,0.9863,28828763
34323,Exudative RAM,disease,0.9966,28828763
34324,cystoid macular edema,disease,1.0,28828763
34325,VEGF,gene,0.9214,28828763
34326,RAM,disease,0.8574,28828763
34327,RAM,DNA,0.507,28828763
34328,VEGF,gene,0.696,28828763
34329,macular exudation,disease,0.9995,28828763
34330,RAM,drug,0.9946,28828763
34331,Nd:YAG,drug,0.8457,28828763
34332,RAM,drug,0.8086,28828763
34333,aflibercept,gene,0.9585,28828522
34334,polypoidal choroidal vasculopathy,disease,1.0,28828522
34335,Retinal conditions,disease,0.999,28825785
34336,age related macular degeneration,disease,1.0,28825785
34337,AMD,disease,1.0,28825785
34338,diabetic macular edema,disease,1.0,28825785
34339,DME,disease,1.0,28825785
34340,retinal vein occlusion,disease,1.0,28825785
34341,RVO,disease,1.0,28825785
34342,choroidal neovascularization,disease,1.0,28825785
34343,pathologic myopia,disease,0.9985,28825785
34344,CNV,disease,0.9995,28825785
34345,PM,disease,,28825785
34346,patients,species,0.959,28825785
34347,loss of vision,disease,1.0,28825785
34348,Anti-vascular endothelial growth factor,gene,0.955,28825785
34349,Anti-VEGF,gene,0.99,28825785
34350,ranibizumab,gene,0.7666,28825785
34351,aflibercept,gene,0.97,28825785
34352,Bevacizumab,gene,0.9106,28825785
34353,anti-cancer,disease,0.815,28825785
34354,ranibizumab,gene,0.5806,28825785
34355,bevacizumab,gene,0.7954,28825785
34356,retinal conditions,disease,0.8857,28825785
34357,Bevacizumab,gene,0.891,28825785
34358,bevacizumab,gene,0.911,28825785
34359,bevacizumab,gene,0.91,28825785
34360,bevacizumab,gene,0.9165,28825785
34361,cancer,disease,1.0,28825785
34362,patients,species,0.9937,28825785
34363,thromboembolic events,disease,0.848,28825785
34364,stroke,disease,0.9995,28825785
34365,Retinal Conditions,disease,0.973,28825785
34366,bevacizumab,gene,0.52,28825785
34367,ranibizumab,gene,0.692,28825785
34368,aflibercept,gene,0.8804,28825785
34369,bevacizumab,gene,0.7627,28825785
34370,bevacizumab,gene,0.5537,28825785
34371,bevacizumab,drug,0.772,28825785
34372,retinal conditions,disease,0.982,28825785
34373,bevacizumab,gene,0.594,28825785
34374,ranibizumab,gene,0.5757,28825785
34375,aflibercept,gene,0.7427,28825785
34376,retinal conditions,disease,0.9985,28825785
34377,PATIENTS,species,0.991,28820850
34378,exudative age-related macular degeneration,disease,0.9893,28820850
34379,patients,species,0.942,28820850
34380,age-related macular degeneration,disease,1.0,28820850
34381,patients,species,0.9917,28820850
34382,age-related macular degeneration,disease,1.0,28820850
34383,anti-vascular endothelial growth factor,gene,0.9707,28820850
34384,ranibizumab,gene,0.909,28820850
34385,aflibercept,gene,0.985,28820850
34386,patients,species,0.9863,28820850
34387,anti-vascular endothelial growth factor,gene,0.974,28820850
34388,vitreous detachment,disease,0.7534,28820850
34389,anti-vascular endothelial growth factor,gene,0.995,28820850
34390,RANIBIZUMAB,drug,0.9927,28820848
34391,AFLIBERCEPT,drug,0.6304,28820848
34392,PIGMENT EPITHELIAL DETACHMENT,disease,0.979,28820848
34393,ranibizumab,gene,0.6865,28820848
34394,aflibercept,gene,0.9443,28820848
34395,retinal pigment epithelial detachment,disease,1.0,28820848
34396,RPED,disease,1.0,28820848
34397,patients,species,0.9473,28820848
34398,neovascular age-related macular degeneration,disease,1.0,28820848
34399,neovascular age-related macular degeneration,disease,1.0,28820848
34400,RPED,disease,0.999,28820848
34401,aflibercept,gene,0.9873,28820848
34402,ranibizumab,gene,0.809,28820848
34403,RPED,DNA,0.621,28820848
34404,RPED,disease,1.0,28820848
34405,neovascular age-related macular degeneration,disease,1.0,28820848
34406,RPED,disease,1.0,28820848
34407,anti-vascular endothelial growth factor,gene,0.9604,28820848
34408,ranibizumab,gene,0.9185,28820848
34409,aflibercept,gene,0.938,28820848
34410,Aflibercept,gene,0.922,28820169
34411,polypoidal choroidal vasculopathy,disease,1.0,28820169
34412,polypoidal choroidal vasculopathy,disease,1.0,28820169
34413,PCV,disease,1.0,28820169
34414,PCV,disease,1.0,28820169
34415,anti-vascular endothelial growth factor,gene,0.951,28820169
34416,aflibercept,gene,0.979,28820169
34417,PCV,disease,1.0,28820169
34418,aflibercept,gene,0.97,28820169
34419,PCV,disease,1.0,28820169
34420,bevacizumab,gene,0.6436,28820169
34421,ranibizumab,gene,0.8247,28820169
34422,aflibercept,gene,0.943,28820169
34423,cardiotoxicity,disease,0.983,28818671
34424,cancer,disease,1.0,28818671
34425,patients,species,0.993,28818671
34426,Cardiotoxicityis,disease,0.963,28818671
34427,cardiotoxicity,disease,0.8955,28818671
34428,patients,species,0.958,28818671
34429,tumors,disease,1.0,28818671
34430,cardiotoxicity,disease,0.8174,28818671
34431,patients,species,0.984,28818671
34432,patients,species,0.9795,28818671
34433,breast cancer,disease,0.9995,28818671
34434,prostate cancer,disease,1.0,28818671
34435,malignancies,disease,1.0,28818671
34436,Vandetanib,drug,0.999,28818671
34437,Ramucirumab,gene,0.514,28818671
34438,Aflibercept,gene,0.964,28818671
34439,cardiotoxicity,disease,0.766,28818671
34440,VEGFR,gene,0.8115,28818671
34441,anti-VEGF mAbs,gene,0.974,28818671
34442,VEGF,gene,0.996,28818671
34443,tumor,disease,1.0,28818671
34444,cardiotoxicity,disease,0.997,28818671
34445,thyroid cancer,disease,1.0,28818671
34446,gastric cancer,disease,1.0,28818671
34447,cancer,disease,1.0,28818671
34448,patients,species,0.992,28818671
34449,cardiotoxicity,disease,0.5244,28818671
34450,AFLIBERCEPT,gene,0.869,28816730
34451,PATIENTS,species,0.9746,28816730
34452,POLYPOIDAL CHOROIDAL,disease,1.0,28816730
34453,aflibercept,gene,0.9673,28816730
34454,polypoidal choroidal vasculopathy,disease,1.0,28816730
34455,patients,species,0.9746,28816730
34456,polypoidal choroidal vasculopathy,disease,1.0,28816730
34457,aflibercept,gene,0.9497,28816730
34458,aflibercept,gene,0.981,28816730
34459,FD,disease,,28816730
34460,aflibercept,gene,0.7734,28816730
34461,aflibercept,gene,0.976,28816730
34462,patients,species,0.947,28816730
34463,polypoidal choroidal vasculopathy,disease,1.0,28816730
34464,aflibercept,gene,0.974,28814412
34465,diabetic macular oedema,disease,1.0,28814412
34466,aflibercept,gene,0.976,28814412
34467,diabetic macular oedema,disease,1.0,28814412
34468,DME,disease,1.0,28814412
34469,patients,species,0.9736,28814412
34470,Aflibercept,gene,0.8403,28814412
34471,Patients,species,0.932,28814412
34472,Diabetic Macular Edema,disease,1.0,28814412
34473,Aflibercept,gene,0.961,28814412
34474,DME,disease,1.0,28814412
34475,DME,disease,0.9204,28814412
34476,patients,species,0.9863,28814412
34477,aflibercept,gene,0.931,28814412
34478,DME,disease,0.9927,28814412
34479,aflibercept,gene,0.9927,28814412
34480,aflibercept,gene,0.988,28814412
34481,patients,species,0.9907,28814412
34482,patients,species,0.9775,28814412
34483,patients,species,0.986,28814412
34484,aflibercept,gene,0.949,28814412
34485,diabetic retinopathy,disease,1.0,28814412
34486,patients,species,0.9927,28814412
34487,diabetic retinopathy,disease,0.999,28814412
34488,PDR,disease,0.995,28814412
34489,patients,species,0.992,28814412
34490,PDR,disease,1.0,28814412
34491,aflibercept,gene,0.9644,28814412
34492,aflibercept,gene,0.9487,28814412
34493,aflibercept,gene,0.9414,28814412
34494,DME,disease,1.0,28814412
34495,DME,disease,0.9976,28814412
34496,diabetic retinopathy,disease,1.0,28814412
34497,PDR,disease,0.8755,28814412
34498,Aflibercept,gene,0.9834,28810842
34499,retinal angiomatous proliferation,disease,1.0,28810842
34500,aflibercept,gene,0.9854,28807738
34501,metastatic colorectal cancer,disease,1.0,28807738
34502,Aflibercept,gene,0.953,28807738
34503,ziv-aflibercept,gene,0.981,28807738
34504,5-fluorouracil,drug,0.999,28807738
34505,leucovorin,drug,0.999,28807738
34506,irinotecan,drug,0.999,28807738
34507,FOLFIRI,drug,0.993,28807738
34508,FOLFIRI,drug,0.991,28807738
34509,metastatic colorectal cancer,disease,1.0,28807738
34510,oxaliplatin,drug,1.0,28807738
34511,aflibercept,gene,0.986,28807738
34512,FOLFIRI,drug,0.991,28807738
34513,FOLFIRI,drug,0.992,28807738
34514,aflibercept,gene,0.9194,28807738
34515,aflibercept,gene,0.97,28807738
34516,FOLFIRI,drug,0.7915,28807738
34517,aflibercept,gene,0.972,28807738
34518,aflibercept,gene,0.877,28807738
34519,aflibercept,gene,0.9907,28807738
34520,FOLFIRI,drug,0.909,28807738
34521,aflibercept,gene,0.988,28803666
34522,idiopathic macular telangiectasia type 2,disease,1.0,28803666
34523,Idiopathic macular telangectasia type 2,disease,1.0,28803666
34524,bilateral macular capillary telangiectasia,disease,0.976,28803666
34525,alterations,disease,0.7173,28803666
34526,intraretinal cysts,disease,1.0,28803666
34527,macular edema,disease,1.0,28803666
34528,aflibercept,gene,0.9795,28803666
34529,aflibercept,gene,0.9824,28803666
34530,macular telangectasia type 2,disease,1.0,28803666
34531,cystoid macular edema,disease,1.0,28803666
34532,anti-VEGF,gene,0.8916,28803666
34533,VEGFs,gene,0.554,28803666
34534,MacTel 2 intraretinal cysts,disease,0.9185,28803666
34535,Infectious and Noninfectious Endophthalmitis,disease,1.0,28801117
34536,infectious and noninfectious endophthalmitis,disease,1.0,28801117
34537,vascular endothelial growth factor,gene,0.903,28801117
34538,VEGF,gene,0.998,28801117
34539,PARTICIPANTS,species,0.912,28801117
34540,neovascular age-related macular degeneration,disease,1.0,28801117
34541,nAMD,disease,1.0,28801117
34542,Retinal Blindness,disease,0.9937,28801117
34543,VEGF,gene,0.6514,28801117
34544,endophthalmitis,disease,1.0,28801117
34545,endophthalmitis,disease,1.0,28801117
34546,endophthalmitis,disease,1.0,28801117
34547,Infectious endophthalmitis,disease,1.0,28801117
34548,VEGF,gene,0.8286,28801117
34549,infectious endophthalmitis,disease,1.0,28801117
34550,patient,species,0.9497,28801117
34551,infectious endophthalmitis,disease,1.0,28801117
34552,Noninfectious endophthalmitis,disease,1.0,28801117
34553,noninfectious endophthalmitis,disease,1.0,28801117
34554,patient,species,0.959,28801117
34555,noninfectious endophthalmitis,disease,1.0,28801117
34556,bevacizumab,gene,0.5176,28801117
34557,ranibizumab,gene,0.536,28801117
34558,aflibercept,gene,0.9727,28801117
34559,aflibercept,gene,0.915,28801117
34560,infectious and noninfectious endophthalmitis,disease,0.9893,28801117
34561,endophthalmitis,disease,1.0,28801117
34562,infectious and noninfectious endophthalmitis,disease,0.9326,28801117
34563,noninfectious endophthalmitis,disease,0.9995,28801117
34564,bevacizumab,gene,0.7656,28801117
34565,ranibizumab,gene,0.88,28801117
34566,aflibercept,gene,0.97,28801117
34567,noninfectious endophthalmitis,disease,0.996,28801117
34568,endophthalmitis,disease,1.0,28801117
34569,Aflibercept,gene,0.858,28800905
34570,Neovascular Age-Related Macular Degeneration,disease,1.0,28800905
34571,MACULAR DYSTROPHIES,disease,1.0,28800018
34572,macular dystrophies,disease,1.0,28800018
34573,choroidal neovascularization,disease,1.0,28800018
34574,CNV,disease,1.0,28800018
34575,fluorescein,drug,0.996,28800018
34576,macular dystrophy,disease,1.0,28800018
34577,FCE,disease,1.0,28800018
34578,Best vitelliform dystrophy,disease,1.0,28800018
34579,pattern dystrophy,disease,1.0,28800018
34580,pseudoxanthoma elasticum,disease,1.0,28800018
34581,Stargardt disease,disease,1.0,28800018
34582,FCE,disease,1.0,28800018
34583,macular dystrophy,disease,1.0,28800018
34584,FCE,disease,0.9995,28800018
34585,subfoveal CNV,disease,0.9985,28800018
34586,CNV,disease,0.9766,28800018
34587,anti-vascular endothelial growth factor,gene,0.975,28800018
34588,CNV,disease,0.9443,28800018
34589,macular dystrophies,disease,1.0,28800018
34590,CNV,DNA,0.5723,28800018
34591,FCE,disease,0.9985,28800018
34592,vascular endothelial growth factor,gene,0.987,28800018
34593,FCE,disease,0.9995,28800018
34594,neovascular age-related macular degeneration,disease,1.0,28798980
34595,Aflibercept,gene,0.943,28798980
34596,Aflibercept,gene,0.9556,28798980
34597,neovascular age-related macular degeneration,disease,1.0,28798980
34598,nAMD,disease,1.0,28798980
34599,Aflibercept,gene,0.9346,28798980
34600,nAMD,disease,1.0,28798980
34601,nAMD,disease,0.9985,28798980
34602,Ranibizumab,gene,0.8535,28796997
34603,Aflibercept,gene,0.875,28796997
34604,Age-Related Macular Degeneration,disease,1.0,28796997
34605,ranibizumab,gene,0.8223,28796997
34606,aflibercept,gene,0.5957,28796997
34607,exudative age-related macular degeneration,disease,0.9937,28796997
34608,AMD,disease,1.0,28796997
34609,AMD,disease,1.0,28796997
34610,IRI,disease,0.996,28796997
34611,IAI,disease,0.997,28796997
34612,humor,disease,0.995,28796997
34613,VEGF,gene,0.9966,28796997
34614,monocyte chemoattractant protein 1,gene,0.9956,28796997
34615,MCP-1,gene,0.9966,28796997
34616,platelet-derived growth factor (PDGF,gene,0.8955,28796997
34617,interleukin,gene,0.9033,28796997
34618,IL,gene,0.581,28796997
34619,IL-8,gene,0.977,28796997
34620,AMD,disease,1.0,28796997
34621,cataract,disease,1.0,28796997
34622,MCP-1,gene,0.995,28796997
34623,PDGF-AA,gene,0.9946,28796997
34624,IL-6,gene,0.981,28796997
34625,IL-8,gene,0.9683,28796997
34626,VEGF,gene,0.993,28796997
34627,MCP-1,gene,0.9966,28796997
34628,PDGF-AA,gene,0.9937,28796997
34629,AMD,disease,1.0,28796997
34630,IAI,disease,0.9707,28796997
34631,5-Fluorouracil,drug,0.999,28792245
34632,5-FU,drug,0.999,28792245
34633,Ziv-Aflibercept,gene,0.9424,28792245
34634,II/III Rectal Cancer,disease,0.9233,28792245
34635,aflibercept,gene,0.9805,28792245
34636,stage II/III rectal cancer,disease,0.891,28792245
34637,aflibercept,gene,0.9917,28792245
34638,5-FU,drug,0.9966,28792245
34639,aflibercept,gene,0.6455,28792245
34640,aflibercept,gene,0.9844,28792245
34641,aflibercept,gene,0.9727,28792245
34642,diarrhea,disease,1.0,28792245
34643,fatigue,disease,0.9995,28792245
34644,mucositis,disease,1.0,28792245
34645,5-FU,drug,0.996,28792245
34646,rectal cancer,disease,0.9966,28792245
34647,ophthalmologists,cell_type,0.4688,28784553
34648,Ranibizumab,gene,0.9067,28784553
34649,aflibercept,gene,0.9688,28784553
34650,ophthalmologists,cell_type,0.4207,28784553
34651,anti-vascular endothelial growth factor,gene,0.9707,28784553
34652,anti-VEGF,gene,0.9624,28784553
34653,ophthalmologists,cell_type,0.4294,28784553
34654,VEGF,gene,0.6704,28784553
34655,ranibizumab,gene,0.842,28784553
34656,aflibercept,gene,0.95,28784553
34657,aflibercept,gene,0.992,28780686
34658,neovascular age-related macular degeneration,disease,1.0,28780686
34659,aflibercept,gene,0.988,28772268
34660,neovascular age-related macular degeneration,disease,1.0,28772268
34661,patients,species,0.98,28772268
34662,ranibizumab,gene,0.645,28772268
34663,intraretinal,disease,0.896,28772268
34664,patients,species,0.9785,28772268
34665,subretinal fluid,disease,0.987,28772268
34666,SRF,disease,0.9937,28772268
34667,SRF,disease,0.94,28772268
34668,IRF,gene,0.6104,28772268
34669,IRF,gene,0.5386,28772268
34670,hyperreflective,DNA,0.528,28772268
34671,HRF,DNA,0.7554,28772268
34672,HRF,cell_type,0.4697,28772268
34673,ranibizumab,gene,0.69,28772268
34674,aflibercept,gene,0.883,28772268
34675,aflibercept,gene,0.9937,28769551
34676,choroidal neovascularization,disease,1.0,28769551
34677,aflibercept,gene,0.991,28769551
34678,choroidal neovascularization,disease,1.0,28769551
34679,CNV,disease,0.999,28769551
34680,chorioretinitis,disease,1.0,28769551
34681,patients,species,0.9805,28769551
34682,CNV,disease,1.0,28769551
34683,ocular toxoplasmosis,disease,1.0,28769551
34684,aflibercept,gene,0.9424,28769551
34685,aflibercept,gene,0.9688,28769551
34686,BCVA,cell_type,0.4153,28769551
34687,endophthalmitis,disease,1.0,28769551
34688,uveitis,disease,1.0,28769551
34689,stroke,disease,1.0,28769551
34690,retinal detachment,disease,1.0,28769551
34691,patient,species,0.9526,28769551
34692,aflibercept,gene,0.9805,28769551
34693,CNV,disease,0.9995,28769551
34694,chorioretinitis,disease,1.0,28769551
34695,CNV,disease,1.0,28769551
34696,chorioretinitis,disease,1.0,28769551
34697,Necrotising fasciitis,disease,1.0,28768426
34698,patient,species,0.985,28768426
34699,aflibercept,gene,0.9946,28768426
34700,colorectal,disease,0.9956,28768426
34701,tumours,disease,1.0,28768426
34702,"ovarian, breast, lung and colorectal cancer",disease,1.0,28768426
34703,Necrotising fasciitis,disease,1.0,28768426
34704,bevacizumab,gene,0.6924,28768426
34705,aflibercept,gene,0.9814,28768426
34706,regorafenib,drug,0.976,28768426
34707,patients,species,0.89,28768426
34708,colorectal cancer,disease,1.0,28768426
34709,Necrotising fasciitis,disease,1.0,28768426
34710,bevacizumab,gene,0.822,28768426
34711,man,species,0.8574,28768426
34712,stage IV,disease,0.998,28768426
34713,rectosigmoid cancer,disease,0.838,28768426
34714,folinic acid,drug,0.9995,28768426
34715,fluorouracil,drug,0.999,28768426
34716,irinotecan,drug,0.997,28768426
34717,FOLFIRI,drug,0.9834,28768426
34718,aflibercept,DNA,0.6187,28768426
34719,Fournier&#39;s gangrene,disease,0.9946,28768426
34720,aflibercept,gene,0.9863,28767552
34721,bevacizumab,gene,0.629,28767552
34722,macular edema,disease,1.0,28767552
34723,central retinal vein occlusion,disease,1.0,28767552
34724,PATIENTS,species,0.9487,28767552
34725,macular edema,disease,1.0,28767552
34726,central retinal vein occlusion,disease,1.0,28767552
34727,aflibercept,gene,0.978,28767552
34728,bevacizumab,gene,0.6973,28767552
34729,macular edema,disease,1.0,28767552
34730,central retinal vein occlusion,disease,1.0,28767552
34731,macular ischemia,disease,1.0,28767552
34732,diabetes,disease,1.0,28767552
34733,hypertensive or renal retinopathy,disease,1.0,28767552
34734,retinal disease,disease,1.0,28767552
34735,anti-vascular endothelial growth factor,gene,0.842,28767552
34736,retinal nonperfusion,disease,0.9165,28767552
34737,patients,species,0.99,28767552
34738,Retinal nonperfusion,disease,0.993,28767552
34739,aflibercept,gene,0.989,28767552
34740,bevacizumab,gene,0.8315,28767552
34741,macular edema,disease,1.0,28767552
34742,central retinal vein occlusion,disease,1.0,28767552
34743,aflibercept,gene,0.99,28767552
34744,anti-vascular endothelial growth factor,gene,0.972,28767550
34745,patients,species,0.9487,28767550
34746,diabetic macular edema,disease,1.0,28767550
34747,diabetic macular edema,disease,1.0,28767550
34748,anti-vascular endothelial growth factor,gene,0.9375,28767550
34749,aflibercept,gene,0.9873,28767550
34750,ranibizumab,gene,0.771,28767550
34751,disruption,disease,0.8623,28767550
34752,retinal atrophy,disease,1.0,28767550
34753,Henle fiber layer,cell_type,0.565,28767550
34754,anti-vascular endothelial growth factor,gene,0.994,28767550
34755,disorganization,disease,0.9873,28767550
34756,retinal atrophy,disease,1.0,28767550
34757,ranibizumab,gene,0.9326,28767550
34758,aflibercept,gene,0.9854,28767550
34759,Diabetic Retinopathy,disease,1.0,28764888
34760,Diabetic Retinopathy,disease,1.0,28764888
34761,PARTICIPANTS,species,0.877,28764888
34762,patients,species,0.9697,28764888
34763,diabetic macular edema,disease,1.0,28764888
34764,DME,disease,1.0,28764888
34765,DME,disease,1.0,28764888
34766,patients,species,0.978,28764888
34767,aflibercept,gene,0.976,28764888
34768,patients,species,0.9897,28764888
34769,patients,species,0.9746,28764888
34770,diabetes,disease,1.0,28764888
34771,hemoglobin A1c,gene,0.9956,28764888
34772,HbA1c,gene,0.992,28764888
34773,patients,species,0.9863,28764888
34774,DRSS,DNA,0.4692,28764888
34775,diabetes,disease,1.0,28764888
34776,HbA1c,gene,0.87,28764888
34777,patients,species,0.9834,28764888
34778,DME,disease,1.0,28764888
34779,patients,species,0.9907,28764888
34780,patients,species,0.993,28761750
34781,aflibercept,gene,0.9873,28761750
34782,Zaltrap,drug,0.998,28761750
34783,irinotecan,drug,0.9985,28761750
34784,5-fluorouracil,drug,0.9995,28761750
34785,folinic acid,drug,0.9995,28761750
34786,metastatic colorectal cancer,disease,1.0,28761750
34787,oxaliplatin,drug,0.9995,28761750
34788,Aflibercept,gene,0.9736,28761750
34789,vascular endothelial growth factor (VEGF) receptors,gene,0.9487,28761750
34790,endothelial cells,cell_type,0.942,28761750
34791,VEGF-A,gene,0.998,28761750
34792,placental growth factor,gene,0.997,28761750
34793,VEGF-B,gene,0.9976,28761750
34794,aflibercept,gene,0.9897,28761750
34795,patients,species,0.9214,28761750
34796,metastatic colorectal cancer,disease,1.0,28761750
34797,mCRC,disease,1.0,28761750
34798,oxaliplatin,drug,0.9995,28761750
34799,bevacizumab,gene,0.709,28761750
34800,Aflibercept,gene,0.9253,28761750
34801,FOLFIRI,drug,0.6377,28761750
34802,fluorouracil,drug,0.993,28761750
34803,leucovorin,drug,0.997,28761750
34804,irinotecan,drug,0.9976,28761750
34805,aflibercept,gene,0.964,28761750
34806,aflibercept,gene,0.983,28761750
34807,VEGF,gene,0.868,28761750
34808,aflibercept,gene,0.971,28761750
34809,Aflibercept,gene,0.9844,28758110
34810,Ranibizumab,gene,0.915,28758110
34811,aflibercept,gene,0.9937,28758110
34812,ranibizumab,gene,0.7583,28758110
34813,diabetic macular edema,disease,1.0,28758110
34814,DME,disease,1.0,28758110
34815,patients,species,0.993,28758110
34816,DME,disease,1.0,28758110
34817,patients,species,0.99,28758110
34818,serous retinal detachment,disease,1.0,28758110
34819,SRD,disease,1.0,28758110
34820,SRD,DNA,0.555,28758110
34821,SRD,DNA,0.596,28758110
34822,IVR,drug,0.5977,28758110
34823,IVA,drug,0.5728,28758110
34824,SRD,DNA,0.6787,28758110
34825,IRB,DNA,0.7114,28758110
34826,IRB#,cell_line,0.758,28758110
34827,Anti-Vascular Endothelial Growth Factors,gene,0.8794,28743128
34828,Retinal Pigment Epithelium Cells,cell_type,0.8696,28743128
34829,Nitric Oxide,drug,0.9995,28743128
34830,vascular endothelial growth factors,gene,0.96,28743128
34831,VEGF,gene,0.99,28743128
34832,Aflibercept,gene,0.963,28743128
34833,Ranibizumab,gene,0.8604,28743128
34834,macular degeneration,disease,1.0,28743128
34835,nitric oxide,drug,0.9995,28743128
34836,NO,drug,1.0,28743128
34837,human retinal pigment epithelium cells,cell_type,0.9106,28743128
34838,RPE,cell_type,0.4915,28743128
34839,RPE,cell_line,0.765,28743128
34840,Ranibizumab,gene,0.96,28743128
34841,Aflibercept,gene,0.977,28743128
34842,NO,drug,1.0,28743128
34843,NO synthase,gene,0.96,28743128
34844,NOS,gene,0.985,28743128
34845,rapamicyn,drug,0.999,28743128
34846,3-methyladenine,drug,0.9995,28743128
34847,NO,drug,0.9995,28743128
34848,oxygen,drug,0.9995,28743128
34849,RPE,cell_type,0.8716,28743128
34850,Aflibercept,gene,0.995,28743128
34851,Ranibizumab,gene,0.9854,28743128
34852,NO,drug,0.995,28743128
34853,RPE,cell_line,0.827,28743128
34854,hydrogen peroxide,drug,0.9995,28743128
34855,NOS,gene,0.989,28743128
34856,3-methyladenine,drug,0.9995,28743128
34857,rapamycin,drug,0.9995,28743128
34858,Aflibercept,gene,0.965,28743128
34859,Ranibizumab,gene,0.538,28743128
34860,NOS,gene,0.99,28743128
34861,Phosphatidylinositol,drug,0.9814,28743128
34862,Phosphatidylinositol-3-Kinase,gene,0.9956,28743128
34863,Protein Kinase B,gene,0.993,28743128
34864,Extracellular signal-,gene,0.5586,28743128
34865,CONCLUSION Aflibercept,gene,0.4985,28743128
34866,Ranibizumab,gene,0.838,28743128
34867,RPE,cell_type,0.76,28743128
34868,NO,drug,0.999,28743128
34869,Dovitinib,drug,0.998,28736761
34870,Vascular Endothelial Growth Factor,gene,0.96,28736761
34871,fibroblast growth factor,gene,0.999,28736761
34872,FGF,gene,0.997,28736761
34873,vascular endothelial growth factor,gene,0.9673,28736761
34874,VEGF,gene,0.9956,28736761
34875,dovitinib,drug,0.997,28736761
34876,FGF,gene,0.9976,28736761
34877,VEGF receptors,gene,0.975,28736761
34878,VEGF,gene,0.9634,28736761
34879,advanced colorectal or non-small cell lung cancer,disease,0.994,28736761
34880,VEGF,gene,0.6777,28736761
34881,dovitinib,drug,0.9985,28736761
34882,tumor,disease,0.949,28736761
34883,Intratumor,RNA,0.538,28736761
34884,mRNA,RNA,0.7363,28736761
34885,bevacizumab,gene,0.9287,28736761
34886,ziv-aflibercept,gene,0.9673,28736761
34887,dovitinib,drug,0.9985,28736761
34888,"gastrointestinal, metabolic, and biochemical derangements",disease,0.935,28736761
34889,fatigue,disease,0.997,28736761
34890,GGT,gene,0.8228,28736761
34891,lymphopenia,disease,1.0,28736761
34892,tumors,disease,1.0,28736761
34893,VEGF,gene,0.59,28736761
34894,FGFR1,gene,0.9976,28736761
34895,VEGFA,gene,0.997,28736761
34896,dovitinib,drug,0.9985,28736761
34897,VEGF,gene,0.6445,28736761
34898,tumors,disease,1.0,28736761
34899,VEGF,gene,0.75,28736761
34900,FGF,gene,0.983,28736761
34901,gastrointestinal cancers,disease,1.0,28736636
34902,malignant cells,cell_type,0.8745,28736636
34903,malignant,disease,0.828,28736636
34904,malignancies,disease,1.0,28736636
34905,gastrointestinal (GI) malignancies,disease,1.0,28736636
34906,vascular endothelial growth factor,gene,0.999,28736636
34907,VEGF,gene,0.9966,28736636
34908,human epidermal growth factor receptor 2,gene,0.9976,28736636
34909,Her2,gene,0.997,28736636
34910,Neu,gene,0.995,28736636
34911,epidermal growth factor receptor,gene,0.9966,28736636
34912,EGFR,gene,0.993,28736636
34913,VEGF,gene,0.852,28736636
34914,bevacizumab,gene,0.8877,28736636
34915,aflibercept,gene,0.984,28736636
34916,renal and vascular complications,disease,0.977,28736636
34917,hypertension,disease,1.0,28736636
34918,arterial thrombotic events,disease,1.0,28736636
34919,ATE,disease,0.9995,28736636
34920,proteinuria,disease,1.0,28736636
34921,GI perforations,disease,0.98,28736636
34922,EGFR,gene,0.824,28736636
34923,hypomagnesemia,disease,1.0,28736636
34924,Trastuzumab,gene,0.9146,28736636
34925,Her2,gene,0.9966,28736636
34926,Neu,gene,0.9956,28736636
34927,cardiotoxicity,disease,0.937,28736636
34928,anthracyclines,drug,0.999,28736636
34929,nivolumab,gene,0.533,28736636
34930,GI cancers,disease,1.0,28736636
34931,Vascular Endothelial Growth Factor,gene,0.9956,28736316
34932,Vascular Endothelial Growth Factor Receptor,gene,0.9517,28736316
34933,Angiogenic Blood Vessels,cell_type,0.6084,28736316
34934,Tumors,disease,0.9946,28736316
34935,vascular endothelial growth factor (VEGF)-A,gene,0.9946,28736316
34936,VEGF,gene,0.997,28736316
34937,VEGF receptor,gene,0.996,28736316
34938,VEGFR,gene,0.9956,28736316
34939,cancer,disease,1.0,28736316
34940,VEGF-A,gene,0.9976,28736316
34941,VEGF-A164,gene,0.9614,28736316
34942,tumor,disease,0.9985,28736316
34943,mice,species,0.964,28736316
34944,tumor cells,cell_type,0.8965,28736316
34945,tumor,disease,0.949,28736316
34946,Mother vessels,cell_type,0.7163,28736316
34947,MV,cell_type,0.569,28736316
34948,angiogenic vessel type,cell_type,0.567,28736316
34949,tumors,disease,1.0,28736316
34950,VEGF,DNA,0.441,28736316
34951,VEGF-A164,gene,0.9824,28736316
34952,VEGF,gene,0.998,28736316
34953,MV,cell_type,0.513,28736316
34954,normal microvessels,cell_type,0.505,28736316
34955,VEGF,gene,0.7466,28736316
34956,MV,cell_type,0.592,28736316
34957,glomeruloid microvascular,disease,0.6743,28736316
34958,endothelial cell,cell_type,0.8555,28736316
34959,GMP,gene,0.736,28736316
34960,cancers,disease,1.0,28736316
34961,normal microvessels,cell_type,0.514,28736316
34962,combretastatin CA4,drug,0.9976,28736316
34963,MV,cell_type,0.4558,28736316
34964,tumors,disease,1.0,28736316
34965,VEGF,DNA,0.4822,28736316
34966,VEGF-A164,gene,0.9883,28736316
34967,endothelial nitric oxide synthase,gene,0.9897,28736316
34968,nitric oxide,drug,0.994,28736316
34969,eNOS,gene,0.9927,28736316
34970,eNOS,gene,0.9863,28736316
34971,N(G)-Nitro-l-arginine methyl ester,drug,0.9995,28736316
34972,VEGF,gene,0.9897,28736316
34973,VEGFR,gene,0.996,28736316
34974,GMP,drug,0.9883,28736316
34975,eNOS,gene,0.9897,28736316
34976,nitric oxide,drug,0.9995,28736316
34977,arterial contraction,disease,0.8857,28736316
34978,mice,species,0.9805,28736316
34979,VEGF,gene,0.9854,28736316
34980,VEGFR,gene,0.995,28736316
34981,hypertension,disease,0.999,28736316
34982,VEGF,gene,0.978,28736316
34983,VEGFR,gene,0.9946,28736316
34984,eNOS,gene,0.9756,28736316
34985,GMP,drug,0.9805,28736316
34986,GMP,drug,0.986,28736316
34987,microvessels,cell_type,0.3757,28736316
34988,ranibizumab,gene,0.836,28731052
34989,aflibercept,gene,0.98,28731052
34990,neovascular AMD,disease,1.0,28731052
34991,neovascular age-related macular degeneration,disease,1.0,28731052
34992,nAMD,disease,1.0,28731052
34993,PED,disease,1.0,28731052
34994,ranibizumab,gene,0.6313,28731052
34995,aflibercept,gene,0.951,28731052
34996,ranibizumab,gene,0.5366,28731052
34997,aflibercept,gene,0.9385,28731052
34998,nAMD,disease,1.0,28731052
34999,ranibizumab,gene,0.7676,28731052
35000,aflibercept,gene,0.974,28731052
35001,ranibizumab,gene,0.6157,28731052
35002,aflibercept,gene,0.949,28731052
35003,ranibizumab,gene,0.548,28731052
35004,aflibercept,gene,0.981,28731052
35005,ranibizumab,gene,0.607,28731052
35006,aflibercept,gene,0.8774,28731052
35007,ranibizumab,gene,0.6997,28731052
35008,ranibizumab,gene,0.945,28731052
35009,aflibercept,gene,0.984,28731052
35010,PED,disease,0.9995,28731052
35011,aflibercept,gene,0.9585,28731052
35012,ranibizumab,gene,0.4856,28731052
35013,aflibercept,gene,0.9854,28731052
35014,aflibercept,gene,0.9604,28731052
35015,nAMD,disease,1.0,28731052
35016,PED,disease,0.9985,28731052
35017,Choroidal Neovascularization,disease,1.0,28728186
35018,Geographic Atrophy,disease,1.0,28728186
35019,Large Colloid Drusen,disease,0.9956,28728186
35020,large colloid drusen,disease,1.0,28728186
35021,LCD,disease,1.0,28728186
35022,choroidal neovascularization,disease,1.0,28728186
35023,CNV,disease,1.0,28728186
35024,geographic atrophy,disease,1.0,28728186
35025,GA,disease,1.0,28728186
35026,retinal drusen,disease,1.0,28728186
35027,LCD,disease,1.0,28728186
35028,GA,disease,0.999,28728186
35029,CNV,disease,1.0,28728186
35030,aflibercept,gene,0.9863,28728186
35031,Eylea;,gene,0.716,28728186
35032,GA,disease,0.9937,28728186
35033,CNV,DNA,0.56,28728186
35034,LCD,disease,1.0,28728186
35035,aflibercept,gene,0.9756,28728186
35036,CNV,disease,0.987,28728186
35037,Aflibercept,gene,0.944,28728178
35038,Diabetic Macular Edema,disease,1.0,28728178
35039,Ranibizumab,gene,0.809,28728178
35040,age-related macular degeneration,disease,1.0,28726562
35041,neovascular age related macular degeneration,disease,1.0,28726562
35042,nAMD,disease,1.0,28726562
35043,anti-vascular endothelial growth factor,gene,0.9966,28726562
35044,VEGF,gene,0.977,28726562
35045,AMD,disease,1.0,28726562
35046,factor gene,DNA,0.7905,28726562
35047,nAMD,disease,1.0,28726562
35048,AMD,disease,1.0,28726562
35049,soluble fms-like tyrosine kinase-1,gene,0.997,28726562
35050,tyrosine,drug,0.928,28726562
35051,sFLT-1,gene,0.9946,28726562
35052,VEGF,gene,0.998,28726562
35053,VEGF-A,gene,0.9976,28726562
35054,ranibizumab,gene,0.814,28726562
35055,aflibercept,gene,0.979,28726562
35056,angiostatin,gene,0.989,28726562
35057,endostatin,gene,0.874,28726562
35058,geographic atrophy,disease,1.0,28726562
35059,non-neovascular AMD,disease,1.0,28726562
35060,AMD,disease,1.0,28726562
35061,promoter,DNA,0.6035,28726562
35062,MACULAR ATROPHY,disease,0.9834,28723848
35063,NEOVASCULARIZATION,disease,0.7314,28723848
35064,MACULAR DEGENERATION,disease,0.9956,28723848
35065,macular atrophy,disease,1.0,28723848
35066,Type-1 neovascularization,disease,1.0,28723848
35067,NV,disease,1.0,28723848
35068,age-related macular degeneration,disease,1.0,28723848
35069,vascular endothelial growth factor,gene,0.989,28723848
35070,Type-1 NV,disease,1.0,28723848
35071,retinal pigment epithelial detachment,disease,1.0,28723848
35072,PED,disease,1.0,28723848
35073,macular atrophy,disease,1.0,28723848
35074,macular atrophy,disease,1.0,28723848
35075,Type-1 NV,disease,1.0,28723848
35076,atrophy,disease,0.964,28723848
35077,atrophy,disease,0.9995,28723848
35078,PED,DNA,0.616,28723848
35079,PED,DNA,0.5947,28723848
35080,atrophy,disease,0.9937,28723848
35081,fibrovascular PED,disease,0.994,28723848
35082,atrophy,disease,0.6104,28723848
35083,Type,cell_line,0.5205,28723848
35084,Type-1 NV,disease,1.0,28723848
35085,atrophy,disease,0.9766,28723848
35086,Type-1 NV,disease,0.8833,28723848
35087,age-related macular degeneration,disease,1.0,28723848
35088,macular atrophy,disease,1.0,28723848
35089,vascular endothelial growth factor,gene,0.998,28723848
35090,Type-1 NV,disease,1.0,28723848
35091,retinal pigment epithelium,cell_type,0.542,28723848
35092,Metastatic Colorectal Cancer,disease,1.0,28712102
35093,PART 2,gene,0.981,28712102
35094,metastatic colorectal cancer,disease,0.9995,28712102
35095,vascular endothelial growth factor,gene,0.9985,28712102
35096,VEGF,gene,0.994,28712102
35097,ziv-aflibercept,gene,0.9824,28712102
35098,bevacizumab,gene,0.8174,28712102
35099,Tumor RAS,gene,0.618,28712102
35100,RAS,DNA,0.495,28712102
35101,epidermal growth factor receptor,gene,0.998,28712102
35102,EGFR,gene,0.998,28712102
35103,BRAF,gene,0.744,28712102
35104,HER2,gene,0.5327,28712102
35105,mismatch repair deficiency,disease,1.0,28712102
35106,malignancies,disease,1.0,28712102
35107,mismatch repair-proficient tumors,disease,0.959,28712102
35108,metastatic colorectal cancer,disease,0.975,28712102
35109,Metastatic Colorectal Cancer,disease,1.0,28712098
35110,PART 1,gene,0.9487,28712098
35111,Epidermal Growth Factor Receptor,gene,0.9985,28712098
35112,Vascular Endothelial Growth Factor,gene,0.9976,28712098
35113,metastatic colorectal cancer,disease,1.0,28712098
35114,metastatic colorectal cancer,disease,0.8223,28712098
35115,fluoropyrimidine,drug,0.998,28712098
35116,oxaliplatin,drug,0.9995,28712098
35117,irinotecan,drug,0.9985,28712098
35118,epidermal growth factor receptor,gene,0.9976,28712098
35119,EGFR,gene,0.994,28712098
35120,cetuximab,gene,0.84,28712098
35121,panitumumab,gene,0.9116,28712098
35122,vascular endothelial growth factor,gene,0.998,28712098
35123,VEGF,gene,0.997,28712098
35124,bevacizumab,gene,0.7256,28712098
35125,ziv-aflibercept,gene,0.9634,28712098
35126,regorafenib,drug,0.9683,28712098
35127,Bevacizumab,gene,0.884,28712098
35128,VEGF,gene,0.9966,28712098
35129,EGFR,gene,0.987,28712098
35130,RAS,gene,0.992,28712098
35131,BRAF wild-type tumors,disease,0.829,28712098
35132,BRAF,gene,0.988,28712098
35133,Tumor,disease,0.8535,28712098
35134,tumor,disease,0.977,28712098
35135,left-sided primary tumors,disease,0.943,28712098
35136,EGFR,gene,0.994,28712098
35137,right-sided primary tumors,disease,0.946,28712098
35138,EGFR,gene,0.9946,28712098
35139,VEGF,gene,0.994,28712098
35140,Colorectal Cancer,disease,1.0,28708103
35141,metastatic colorectal cancer,disease,0.988,28708103
35142,CRC,disease,1.0,28708103
35143,epidermal growth factor receptor,gene,0.9624,28708103
35144,anti-EGFR,gene,0.7627,28708103
35145,cetuximab,gene,0.898,28708103
35146,panitumumab,gene,0.907,28708103
35147,bevacizumab,gene,0.7427,28708103
35148,regorafeninb,gene,0.711,28708103
35149,aflibercept,gene,0.9683,28708103
35150,CRC,disease,0.9995,28708103
35151,MAPK,gene,0.9976,28708103
35152,mitogen-activated protein kinase,gene,0.9985,28708103
35153,PI3K,gene,0.998,28708103
35154,AKT,gene,0.994,28708103
35155,phosphatidylinositol,drug,0.9995,28708103
35156,3-kinase,gene,0.987,28708103
35157,AKT serine/threonine kinase,gene,0.9453,28708103
35158,serine,drug,0.775,28708103
35159,threonine,drug,0.867,28708103
35160,mTOR,gene,0.9946,28708103
35161,mammalian target of rapamycin,gene,0.9473,28708103
35162,rapamycin,drug,0.9893,28708103
35163,HER-2 and 3,gene,0.9985,28708103
35164,human epidermal growth factor receptor-2 and -3,gene,0.9927,28708103
35165,BRAF,gene,0.897,28708103
35166,tumor,disease,1.0,28708103
35167,tumor,disease,0.9907,28708103
35168,RAS,gene,0.995,28708103
35169,RAF,gene,0.997,28708103
35170,EGFR,gene,0.9443,28708103
35171,EGFR pathway genes,gene,0.844,28708103
35172,tumor,disease,1.0,28708103
35173,circulating tumor DNA,DNA,0.818,28708103
35174,tumor,disease,0.9995,28708103
35175,ocriplasmin,gene,0.881,28699051
35176,idebenone,drug,0.999,28699051
35177,aflibercept,gene,0.9663,28699051
35178,bromfenac,drug,0.998,28699051
35179,nepafenac,drug,0.999,28699051
35180,tafluprost,drug,0.9976,28699051
35181,timolol,drug,0.9946,28699051
35182,bromfenac,drug,0.998,28699051
35183,nepafenac,drug,0.999,28699051
35184,aflibercept,gene,0.9883,28697703
35185,aflibercept,gene,0.9326,28697703
35186,patients,species,0.9814,28697703
35187,neovascular age-related macular degeneration,disease,0.992,28697703
35188,AMD,disease,1.0,28697703
35189,PARTICIPANTS,species,0.516,28697703
35190,patients,species,0.975,28697703
35191,neovascular AMD,disease,1.0,28697703
35192,BCVA,cell_type,0.4263,28697703
35193,choroidal thinning,disease,0.999,28697703
35194,Aflibercept,gene,0.898,28697497
35195,Polypoidal Choroidal Vasculopathy,disease,1.0,28697497
35196,aflibercept,gene,0.981,28697497
35197,polypoidal choroidal vasculopathy,disease,1.0,28697497
35198,PCV,disease,1.0,28697497
35199,PCV,disease,1.0,28697497
35200,IVA,drug,0.8604,28697497
35201,PCV,disease,1.0,28697497
35202,aflibercept,gene,0.956,28697497
35203,polypoidal lesions,disease,1.0,28697497
35204,PCV,disease,1.0,28697497
35205,AFLIBERCEPT,disease,0.9985,28691937
35206,NEOVASCULAR AGE-RELATED,disease,0.9087,28691937
35207,MACULAR DEGENERATION,disease,0.852,28691937
35208,macular atrophy,disease,1.0,28691937
35209,aflibercept,gene,0.9863,28691937
35210,neovascular age-related macular degeneration,disease,1.0,28691937
35211,aflibercept,gene,0.977,28691937
35212,retinal pigment epithelial atrophy,disease,1.0,28691937
35213,macular atrophy,disease,1.0,28691937
35214,macular atrophy,disease,1.0,28691937
35215,aflibercept,gene,0.955,28691937
35216,macular atrophy,disease,1.0,28691937
35217,intraretinal fluid,disease,0.9937,28691937
35218,macular atrophy,disease,1.0,28691937
35219,aflibercept,gene,0.957,28691937
35220,Macular atrophy,disease,1.0,28691937
35221,neovascular age-related macular degeneration,disease,1.0,28691937
35222,aflibercept,gene,0.9634,28691937
35223,Intraretinal,disease,0.657,28691937
35224,macular atrophy,disease,1.0,28691937
35225,vascular endothelial growth factor,gene,0.94,28691937
35226,VEGF,gene,0.9927,28691937
35227,aflibercept,gene,0.992,28687872
35228,neovascular age-related macular degeneration,disease,1.0,28687872
35229,age-related macular degeneration,disease,1.0,28686003
35230,Age-related macular degeneration,disease,1.0,28686003
35231,AMD,disease,1.0,28686003
35232,visual impairment,disease,1.0,28686003
35233,AMD,disease,1.0,28686003
35234,wAMD,disease,0.999,28686003
35235,wAMD,disease,1.0,28686003
35236,Tumour,disease,0.999,28682829
35237,tumour,disease,1.0,28682829
35238,Vascular endothelial growth factor,gene,0.9985,28682829
35239,bevacizumab,gene,0.605,28682829
35240,metastatic colorectal carcinoma,disease,0.9697,28682829
35241,metastatic colorectal cancer,disease,1.0,28682829
35242,tumour,disease,0.9985,28682829
35243,aflibercept,gene,0.9834,28682829
35244,tumour,disease,0.9927,28682829
35245,mice,species,0.9453,28682829
35246,metastatic colorectal cancer,disease,1.0,28682829
35247,bevacizumab,gene,0.703,28682829
35248,Solid Tumours,disease,0.996,28682829
35249,liver disease,disease,1.0,28682829
35250,Solid Tumours,disease,0.982,28682829
35251,MACULAR ISCHEMIA,disease,1.0,28671896
35252,CENTRAL RETINAL VEIN OCCLUSION,disease,1.0,28671896
35253,aflibercept,gene,0.99,28671896
35254,central retinal vein occlusion,disease,1.0,28671896
35255,macular edema,disease,1.0,28671896
35256,central retinal vein occlusion,disease,1.0,28671896
35257,aflibercept,gene,0.98,28671896
35258,macular edema,disease,1.0,28671896
35259,NPA,disease,0.9995,28671896
35260,NPA,disease,0.9146,28671896
35261,NPA,disease,0.9956,28671896
35262,foveal,DNA,0.4849,28671896
35263,NPA,disease,0.9976,28671896
35264,NPA,disease,0.9995,28671896
35265,NPA,disease,1.0,28671896
35266,central retinal vein occlusion,disease,1.0,28671896
35267,aflibercept,gene,0.9336,28671896
35268,retinal vein occlusion,disease,1.0,28671896
35269,macular edema,disease,1.0,28671896
35270,aflibercept,gene,0.9785,28669776
35271,neovascular age-related macular degeneration,disease,1.0,28669776
35272,nAMD,disease,1.0,28669776
35273,patients,species,0.9717,28669776
35274,nAMD,disease,1.0,28669776
35275,SHRM,disease,0.8813,28669776
35276,patients,species,0.983,28669776
35277,aflibercept,gene,0.9834,28669776
35278,SHRM,disease,1.0,28669776
35279,SHRM,disease,1.0,28669776
35280,SHRM,disease,1.0,28669776
35281,SHRM,disease,1.0,28669776
35282,SHRM,disease,0.9946,28669776
35283,SHRM,disease,0.7666,28669776
35284,SHRM,disease,1.0,28669776
35285,classic choroidal neovascularization,disease,0.977,28669776
35286,CNV,disease,1.0,28669776
35287,intraretinal,disease,0.7603,28669776
35288,aflibercept,gene,0.9883,28669776
35289,SHRM,disease,1.0,28669776
35290,SHRM,disease,1.0,28669776
35291,SHRM,disease,0.9155,28669776
35292,polypoidal lesion,disease,1.0,28669776
35293,SHRM,disease,1.0,28669776
35294,intraretinal,disease,0.912,28669776
35295,Dry macula,disease,0.9614,28669776
35296,nAMD,disease,1.0,28669776
35297,SHRM,disease,0.998,28669776
35298,SHRM,disease,0.9937,28669776
35299,SHRM,disease,0.996,28669776
35300,VEGF,gene,0.714,28669776
35301,aflibercept,gene,0.9585,28669041
35302,polypoidal choroidal vasculopathy,disease,1.0,28669041
35303,aflibercept,gene,0.986,28669041
35304,polypoidal choroidal vasculopathy,disease,0.9995,28669041
35305,PCV,disease,1.0,28669041
35306,PCV,disease,1.0,28669041
35307,Polypoidal lesions,disease,1.0,28669041
35308,indocyanine green,drug,0.997,28669041
35309,polypoidal,DNA,0.4268,28669041
35310,polypoidal lesions,disease,1.0,28669041
35311,polypoidal lesions,disease,1.0,28669041
35312,aflibercept,gene,0.9883,28669041
35313,PCV,disease,1.0,28669041
35314,polypoidal lesions,disease,1.0,28669041
35315,aflibercept,gene,0.9844,28669041
35316,aflibercept,gene,0.981,28665474
35317,aflibercept,gene,0.984,28665474
35318,aflibercept,gene,0.9673,28665474
35319,aflibercept,gene,0.982,28665474
35320,diabetes mellitus,disease,1.0,28665474
35321,hypertension,disease,1.0,28665474
35322,diabetic macular edema,disease,1.0,28665474
35323,macular edema,disease,1.0,28665474
35324,central retinal vein occlusion,disease,1.0,28665474
35325,neovascular age-related macular degeneration,disease,1.0,28665474
35326,aflibercept,gene,0.961,28665474
35327,aflibercept,gene,0.984,28665474
35328,Posterior Reversible Encephalopathy Syndrome,disease,1.0,28660523
35329,Aflibercept,gene,0.954,28660523
35330,5-Fluorouracil,drug,0.999,28660523
35331,Leucovorin,drug,0.9985,28660523
35332,Irinotecan,drug,0.9946,28660523
35333,Metastatic Colorectal Cancer,disease,1.0,28660523
35334,Neovascular Age-Related Macular Degeneration,disease,1.0,28660080
35335,neovascular age-related macular degeneration,disease,1.0,28660080
35336,AMD,disease,1.0,28660080
35337,VEGF,gene,0.996,28660080
35338,Ranibizumab,gene,0.9165,28660080
35339,Aflibercept,gene,0.962,28660080
35340,neovascular AMD,disease,1.0,28660080
35341,Aflibercept,gene,0.965,28660080
35342,Ranibizumab,gene,0.913,28660080
35343,Aflibercept,gene,0.9805,28660080
35344,Ranibizumab,gene,0.904,28660080
35345,neovascular AMD,disease,1.0,28660080
35346,VEGF,gene,0.8286,28660080
35347,Aflibercept,gene,0.9844,28655307
35348,retinal angiomatous proliferation,disease,1.0,28655307
35349,aflibercept,gene,0.974,28655307
35350,retinal angiomatous proliferation,disease,1.0,28655307
35351,RAP,disease,1.0,28655307
35352,RAP,disease,0.9995,28655307
35353,bevacizumab,gene,0.865,28655307
35354,aflibercept,gene,0.9736,28655307
35355,IVA,drug,0.8945,28655307
35356,fibrovascular pigment epithelial detachment,disease,0.983,28655307
35357,PED,disease,1.0,28655307
35358,fibrovascular PED,disease,0.9863,28655307
35359,retinal edema,disease,1.0,28655307
35360,RAP,disease,1.0,28655307
35361,fibrovascular PED,disease,0.997,28655307
35362,fibrovascular PED,disease,0.999,28655307
35363,VEGF,gene,0.867,28652928
35364,bevacizumab,gene,0.8555,28652928
35365,ranibizumab,gene,0.941,28652928
35366,aflibercept,gene,0.992,28652928
35367,ziv-aflibercept,gene,0.9604,28652928
35368,epiretinal gliosis,disease,1.0,28652928
35369,bevacizumab,gene,0.9097,28652928
35370,ranibizumab,gene,0.825,28652928
35371,aflibercept,gene,0.991,28652928
35372,ziv-aflibercept,gene,0.968,28652928
35373,NaCl,drug,0.9897,28652928
35374,Rituximab,gene,0.8564,28652928
35375,intraocular lymphoma,disease,1.0,28652928
35376,IgG1 antibody,gene,0.983,28652928
35377,bevacizumab,gene,0.7417,28652928
35378,aflibercept,gene,0.932,28652928
35379,ziv,drug,0.707,28652928
35380,ziv-aflibercept,gene,0.8467,28652928
35381,rituximab,gene,0.886,28652928
35382,rituximab,gene,0.951,28652928
35383,aflibercept,gene,0.987,28652928
35384,bevacizumab,gene,0.9336,28652928
35385,ranibizumab,gene,0.953,28652928
35386,ziv-aflibercept,gene,0.9785,28652928
35387,ranibizumab,gene,0.949,28652928
35388,ranibizumab,gene,0.817,28652928
35389,rituximab,gene,0.9,28652928
35390,anti-VEGF,gene,0.6816,28652928
35391,ranibizumab,gene,0.9565,28652928
35392,bevacizumab,gene,0.9243,28652928
35393,aflibercept,gene,0.9897,28652928
35394,ziv-aflibercept,gene,0.9863,28652928
35395,Sulodexide,drug,0.9985,28651842
35396,PLA2,gene,0.985,28651842
35397,COX-2,gene,0.9976,28651842
35398,VEGF,gene,0.996,28651842
35399,human retinal endothelial cells,cell_line,0.846,28651842
35400,AGE,gene,0.9155,28651842
35401,RAGE,gene,0.9863,28651842
35402,Diabetic retinopathy,disease,1.0,28651842
35403,sulodexide,drug,0.9995,28651842
35404,SDX,drug,0.7866,28651842
35405,human retinal endothelial cells,cell_type,0.6313,28651842
35406,HREC,cell_line,0.6187,28651842
35407,glucose,drug,0.9966,28651842
35408,ERK,gene,0.988,28651842
35409,cPLA2,gene,0.993,28651842
35410,COX-2,gene,0.998,28651842
35411,PGE2,drug,0.998,28651842
35412,HREC,cell_line,0.753,28651842
35413,glycated-BSA,gene,0.8853,28651842
35414,SDX,drug,0.5547,28651842
35415,aflibercept,gene,0.991,28651842
35416,AFL,gene,0.9883,28651842
35417,VEGF,gene,0.998,28651842
35418,HREC,cell_line,0.6724,28651842
35419,MTT,drug,0.9995,28651842
35420,LDH,gene,0.9766,28651842
35421,claudin,DNA,0.5396,28651842
35422,claudin-5,gene,0.9893,28651842
35423,VE-cadherin,gene,0.996,28651842
35424,occludin,gene,0.9893,28651842
35425,phosphoERK,gene,0.951,28651842
35426,phospho,drug,0.704,28651842
35427,phospho-cPLA2,gene,0.9224,28651842
35428,SDX,drug,0.991,28651842
35429,AFL,drug,0.9834,28651842
35430,VEGF,gene,0.9746,28651842
35431,PGE2,drug,0.986,28651842
35432,VEGF,gene,0.9907,28651842
35433,NFB,gene,0.9893,28651842
35434,p65,gene,0.9883,28651842
35435,AFL,gene,0.599,28651842
35436,SDX,drug,0.652,28651842
35437,AFL,drug,0.9507,28651842
35438,SDX,drug,0.558,28651842
35439,AFL,drug,0.983,28651842
35440,HREC,cell_line,0.739,28651842
35441,HREC,cell_line,0.75,28651842
35442,ERK,gene,0.9863,28651842
35443,cPLA2,gene,0.9946,28651842
35444,COX-2,gene,0.9976,28651842
35445,PGE2,drug,0.999,28651842
35446,NFB,gene,0.9917,28651842
35447,VEGF,gene,0.992,28651842
35448,juxtapapillary retinal capillary haemangioma,disease,0.877,28651811
35449,aflibercept,gene,0.966,28651811
35450,adrenal phaeochromocytoma,disease,1.0,28651811
35451,subretinal juxtapapillary haemorrhage,disease,1.0,28651811
35452,vascular tumour,disease,0.9956,28651811
35453,bilateral retinal capillary haemangioma,disease,0.9976,28651811
35454,von Hippel Lindau disease,disease,1.0,28651811
35455,aflibercept,gene,0.9683,28651811
35456,juxtapapillary retinal capillary haemangioma,disease,1.0,28651811
35457,aflibercept,gene,0.9854,28651811
35458,nintedanib,drug,0.9995,28649871
35459,colorectal cancer,disease,1.0,28649871
35460,solid tumors,disease,0.9995,28649871
35461,metastatic colorectal cancer,disease,1.0,28649871
35462,mCRC,disease,1.0,28649871
35463,vascular endothelial growth factors,gene,0.997,28649871
35464,VEGF,gene,0.994,28649871
35465,VEGFR,gene,0.9883,28649871
35466,mCRC,disease,0.9814,28649871
35467,bevacizumab,gene,0.881,28649871
35468,aflibercept,gene,0.978,28649871
35469,regorafenib,drug,0.9814,28649871
35470,Nintedanib,drug,0.999,28649871
35471,VEGFR,gene,0.9966,28649871
35472,platelet-derived growth factor receptor,gene,0.9985,28649871
35473,PDGFR,gene,0.991,28649871
35474,fibroblast,cell_type,0.873,28649871
35475,growth factor receptor,gene,0.978,28649871
35476,FGFR,gene,0.9985,28649871
35477,patients,species,0.9927,28649871
35478,nintedanib,drug,0.9985,28649871
35479,nintedanib,drug,0.999,28649871
35480,bevacizumab,gene,0.7085,28649871
35481,mCRC,disease,0.99,28649871
35482,patients,species,0.9893,28649871
35483,nintedanib,drug,0.9985,28649871
35484,mCRC,disease,0.9995,28649871
35485,nintedanib,drug,0.998,28649871
35486,VEGF,gene,0.9937,28649871
35487,macular edema,disease,1.0,28646440
35488,ranibizumab,gene,0.554,28646440
35489,dexamethasone,drug,0.996,28646440
35490,aflibercept,gene,0.891,28646440
35491,macular edema,disease,1.0,28646440
35492,ME,disease,1.0,28646440
35493,branch retinal vein occlusion,disease,1.0,28646440
35494,BRVO,disease,1.0,28646440
35495,patients,species,0.982,28646440
35496,BRVO,disease,1.0,28646440
35497,ME,disease,,28646440
35498,Patients,species,0.9673,28646440
35499,ranibizumab,gene,0.785,28646440
35500,dexamethasone,drug,0.959,28646440
35501,aflibercept,gene,0.9736,28646440
35502,dexamethasone,drug,0.975,28646440
35503,serous retinal detachment,disease,1.0,28646440
35504,SRD,disease,1.0,28646440
35505,ME,disease,,28646440
35506,SRD,DNA,0.567,28646440
35507,SRD,DNA,0.5986,28646440
35508,ME,disease,,28646440
35509,BRVO,disease,1.0,28646440
35510,dexamethasone,drug,0.9863,28646440
35511,SRD,DNA,0.5366,28646440
35512,VEGF,gene,0.916,28646440
35513,dexamethasone,drug,0.994,28646440
35514,BRVO,disease,1.0,28646440
35515,Aflibercept,gene,0.974,28643799
35516,neovascular age-related macular degeneration,disease,1.0,28643799
35517,nAMD,disease,1.0,28643799
35518,Patients,species,0.9297,28643799
35519,patients,species,0.9844,28643799
35520,aflibercept,gene,0.9565,28643799
35521,nAMD,disease,1.0,28643799
35522,ranibizumab,gene,0.9214,28643528
35523,aflibercept,gene,0.9893,28643528
35524,anti-VEGF protein,gene,0.875,28643528
35525,ranibizumab,gene,0.9395,28643528
35526,aflibercept,gene,0.972,28643528
35527,tryptophan,drug,0.99,28643528
35528,VEGF,gene,0.994,28643528
35529,ranibizumab,gene,0.8926,28643528
35530,aflibercept,gene,0.969,28643528
35531,ocular diseases,disease,0.966,28643528
35532,AMD,disease,1.0,28643528
35533,DME,disease,1.0,28643528
35534,corneal neovascularization,disease,1.0,28643528
35535,vascular endothelial growth factor,gene,0.994,28639415
35536,diabetic macular oedema,disease,1.0,28639415
35537,Diabetic macular oedema,disease,1.0,28639415
35538,DMO,disease,1.0,28639415
35539,diabetic retinopathy,disease,1.0,28639415
35540,vascular endothelial growth factor,gene,0.9546,28639415
35541,VEGF,gene,0.615,28639415
35542,oedema,disease,0.9995,28639415
35543,visual loss,disease,0.9985,28639415
35544,people,species,0.976,28639415
35545,DMO,disease,1.0,28639415
35546,VEGF,gene,0.9673,28639415
35547,DMO,disease,1.0,28639415
35548,VEGF,gene,0.636,28639415
35549,VEGF,gene,0.938,28639415
35550,VEGF,gene,0.995,28639415
35551,people,species,0.9854,28639415
35552,DMO,disease,1.0,28639415
35553,aflibercept,gene,0.9766,28639415
35554,ranibizumab,gene,0.6797,28639415
35555,bevacizumab,gene,0.667,28639415
35556,Diabetic Retinopathy,disease,0.938,28639415
35557,arterial thromboembolic events,disease,1.0,28639415
35558,participants,species,0.97,28639415
35559,DMO,disease,1.0,28639415
35560,vision loss,disease,0.9976,28639415
35561,participants,species,0.9775,28639415
35562,participants,species,0.9897,28639415
35563,aflibercept,gene,0.985,28639415
35564,bevacizumab,drug,0.564,28639415
35565,ranibizumab,gene,0.752,28639415
35566,pegaptanib,drug,0.998,28639415
35567,ranibizumab,drug,0.558,28639415
35568,ranibizumab,gene,0.8164,28639415
35569,Aflibercept,gene,0.988,28639415
35570,bevacizumab,gene,0.878,28639415
35571,ranibizumab,gene,0.6704,28639415
35572,people,species,0.987,28639415
35573,people,species,0.975,28639415
35574,aflibercept,gene,0.958,28639415
35575,bevacizumab,gene,0.69,28639415
35576,VEGF,gene,0.9966,28639415
35577,aflibercept,gene,0.924,28639415
35578,bevacizumab,gene,0.6294,28639415
35579,aflibercept,gene,0.9893,28639415
35580,ranibizumab,gene,0.7925,28639415
35581,bevacizumab,gene,0.7256,28639415
35582,People,species,0.8896,28639415
35583,ranibizumab,gene,0.8345,28639415
35584,aflibercept,gene,0.925,28639415
35585,people,species,0.9873,28639415
35586,aflibercept,gene,0.982,28639415
35587,ranibizumab,gene,0.7285,28639415
35588,people,species,0.99,28639415
35589,ranibizumab,gene,0.7427,28639415
35590,Ranibizumab,gene,0.8086,28639415
35591,bevacizumab,gene,0.6465,28639415
35592,aflibercept,gene,0.99,28639415
35593,ranibizumab,gene,0.536,28639415
35594,aflibercept,gene,0.9956,28639415
35595,ranibizumab,gene,0.679,28639415
35596,bevacizumab,gene,0.586,28639415
35597,arterial thromboembolic,disease,0.983,28639415
35598,VEGF,gene,0.9404,28639415
35599,people,species,0.9653,28639415
35600,DMO,disease,1.0,28639415
35601,people,species,0.9624,28639415
35602,aflibercept,gene,0.987,28639415
35603,ranibizumab,gene,0.493,28639415
35604,bevacizumab,gene,0.553,28639415
35605,people,species,0.9644,28639415
35606,DMO,disease,1.0,28639415
35607,VEGF,gene,0.8394,28639415
35608,people,species,0.9834,28639415
35609,DMO,disease,1.0,28639415
35610,Anti-,gene,0.9087,28638337
35611,Vascular Endothelial Growth Factor,gene,0.865,28638337
35612,Macular Edema,disease,1.0,28638337
35613,retinal arterial macroaneurysms,disease,1.0,28638337
35614,RAM,disease,1.0,28638337
35615,hemorrhage,disease,0.6616,28638337
35616,VEGF,gene,0.527,28638337
35617,ranibizumab,gene,0.7583,28638337
35618,aflibercept,gene,0.9795,28638337
35619,macular edema,disease,1.0,28638337
35620,RAM,disease,1.0,28638337
35621,patients,species,0.985,28638337
35622,macular edema,disease,0.9897,28638337
35623,RAM,drug,0.6606,28638337
35624,ranibizumab,gene,0.758,28638337
35625,patient,species,0.985,28638337
35626,intraretinal exudation,disease,1.0,28638337
35627,patient,species,0.9854,28638337
35628,aflibercept,gene,0.9883,28638337
35629,sub- and intraretinal edema,disease,1.0,28638337
35630,patients,species,0.9897,28638337
35631,fluorescein,drug,0.995,28638337
35632,Patients,species,0.929,28638337
35633,Patients,species,0.946,28638337
35634,VEGF,gene,0.8315,28638337
35635,ranibizumab,gene,0.9683,28638337
35636,aflibercept,gene,0.975,28638337
35637,macular edema,disease,1.0,28638337
35638,RAM,disease,1.0,28638337
35639,macular edema,disease,1.0,28638337
35640,RAM,disease,1.0,28638337
35641,Aflibercept,gene,0.955,28638337
35642,ranibizumab,gene,0.848,28638337
35643,VEGF,gene,0.72,28638337
35644,RAM,disease,1.0,28638337
35645,patient,species,0.987,28638337
35646,aflibercept,gene,0.9766,28636275
35647,polypoidal choroidal vasculopathy,disease,1.0,28636275
35648,Aflibercept,gene,0.9814,28630787
35649,Bevacizumab,gene,0.954,28630787
35650,Ranibizumab,gene,0.951,28630787
35651,Wet Age-related Macular Degeneration,disease,1.0,28630787
35652,bevacizumab,gene,0.8853,28630787
35653,ranibizumab,gene,0.769,28630787
35654,aflibercept,gene,0.9717,28630787
35655,wet (neovascular) age-related macular degeneration,disease,0.998,28630787
35656,bevacizumab,gene,0.785,28630787
35657,pigment epithelial detachment,disease,1.0,28630787
35658,PED,DNA,0.606,28630787
35659,aflibercept,gene,0.9434,28630787
35660,bevacizumab,gene,0.762,28630787
35661,ranibizumab,gene,0.5913,28630787
35662,aflibercept,gene,0.875,28630787
35663,serous PED,disease,0.9766,28630787
35664,fibrovascular PED,disease,0.997,28630787
35665,fibrovascular PEDs,disease,0.95,28630787
35666,aflibercept,gene,0.979,28630787
35667,PED,disease,0.947,28630787
35668,Aflibercept,gene,0.867,28624325
35669,Neovascular Age-related Macular Degeneration,disease,1.0,28624325
35670,aflibercept,gene,0.968,28624325
35671,neovascular age-related macular degeneration,disease,1.0,28624325
35672,NVAMD,disease,1.0,28624325
35673,NVAMD,disease,1.0,28624325
35674,aflibercept,gene,0.911,28624325
35675,aflibercept,gene,0.987,28624325
35676,NVAMD,disease,1.0,28624325
35677,TAE,disease,0.6836,28624325
35678,aflibercept,gene,0.9517,28624325
35679,nAMD,disease,1.0,28622328
35680,aflibercept,gene,0.976,28622328
35681,Aflibercept,gene,0.66,28622328
35682,aflibercept,gene,0.975,28622328
35683,neovascular macular degeneration,disease,1.0,28622328
35684,nAMD,disease,1.0,28622328
35685,nAMD,disease,1.0,28622328
35686,aflibercept,gene,0.9365,28622328
35687,ranibizumab,gene,0.8193,28622326
35688,aflibercept,gene,0.935,28622326
35689,diabetic macular oedema,disease,1.0,28622326
35690,Colorectal Cancer,disease,1.0,28622036
35691,colorectal cancer,disease,1.0,28622036
35692,tumor,disease,1.0,28622036
35693,tumors,disease,1.0,28622036
35694,colorectal cancer,disease,1.0,28622036
35695,metastatic colorectal cancer,disease,1.0,28622036
35696,mCRC,disease,1.0,28622036
35697,bevacizumab,gene,0.863,28622036
35698,aflibercept,gene,0.972,28622036
35699,regorafenib,drug,0.9517,28622036
35700,cetuximab,gene,0.877,28622036
35701,panitumumab,gene,0.9126,28622036
35702,mCRC,disease,0.9956,28622036
35703,programmed death (PD)-1,gene,0.9214,28622036
35704,L1,gene,0.8755,28622036
35705,MEK,gene,0.9946,28622036
35706,MET,gene,0.4495,28622036
35707,RAS,gene,0.9956,28622036
35708,RAF,gene,0.998,28622036
35709,PD-1,gene,0.9893,28622036
35710,mCRC,disease,0.9927,28622036
35711,vascular endothelial growth factor,gene,0.9443,28621038
35712,aflibercept,gene,0.9897,28621038
35713,aflibercept,gene,0.981,28621038
35714,age-related macular degeneration,disease,1.0,28621038
35715,aflibercept,gene,0.984,28621038
35716,age-related macular degeneration,disease,1.0,28621038
35717,vascular endothelial growth factor,gene,0.9536,28621038
35718,aflibercept,gene,0.946,28621038
35719,aflibercept,gene,0.966,28621038
35720,age-related macular degeneration,disease,1.0,28621038
35721,PARTICIPANTS,species,0.7676,28621038
35722,exudative age-related macular degeneration,disease,0.9995,28621038
35723,aflibercept,gene,0.9604,28621038
35724,vascular endothelial growth factor,gene,0.999,28621038
35725,aflibercept,gene,0.9927,28621038
35726,vascular endothelial growth factor,gene,0.9395,28621038
35727,aflibercept,gene,0.979,28621038
35728,growth factor,gene,0.927,28621038
35729,aflibercept,gene,0.995,28621038
35730,aflibercept,gene,0.9756,28621038
35731,age-related macular degeneration,disease,1.0,28621038
35732,Inflamed Pterygia,disease,1.0,28614154
35733,Ziv-Aflibercept,gene,0.962,28614154
35734,vascular endothelial growth factor,gene,0.9966,28614154
35735,pterygia,disease,0.9517,28614154
35736,ziv-aflibercept,gene,0.989,28614154
35737,pterygia,disease,0.9673,28614154
35738,ziv-aflibercept,gene,0.9766,28614154
35739,pterygium,DNA,0.5386,28614154
35740,ziv-aflibercept,gene,0.989,28614154
35741,inflamed pterygia,disease,0.9624,28614154
35742,Aflibercept,gene,0.9585,28609081
35743,aflibercept,gene,0.9844,28609081
35744,ranibizumab,gene,0.7935,28609081
35745,aflibercept,gene,0.983,28609067
35746,patients,species,0.9507,28609067
35747,visual impairment,disease,1.0,28609067
35748,diabetic macular oedema,disease,1.0,28609067
35749,DMO,disease,1.0,28609067
35750,patient,species,0.9766,28609067
35751,patient,species,0.9756,28609067
35752,patients,species,0.984,28609067
35753,visual impairment,disease,1.0,28609067
35754,DMO,disease,1.0,28609067
35755,ranibizumab,gene,0.6187,28609067
35756,patients,species,0.978,28609067
35757,visual impairment,disease,1.0,28609067
35758,DMO,disease,1.0,28609067
35759,macular oedema,disease,1.0,28609067
35760,Diabetic Retinopathy,disease,0.9976,28609067
35761,patients,species,0.9873,28609067
35762,visual impairment,disease,1.0,28609067
35763,DMO,disease,1.0,28609067
35764,patient,species,0.9937,28609067
35765,aflibercept,gene,0.968,28604541
35766,neovascular age-related macular degeneration,disease,1.0,28604541
35767,wet age-related macular degeneration,disease,1.0,28604541
35768,patients,species,0.98,28604541
35769,age-related macular degeneration,disease,1.0,28604541
35770,patients,species,0.973,28604541
35771,ranibizumab,gene,0.837,28604541
35772,bevacizumab,gene,0.9624,28604541
35773,aflibercept,gene,0.9863,28604541
35774,aflibercept,gene,0.9653,28604541
35775,aflibercept,gene,0.9614,28604541
35776,patients,species,0.9727,28604541
35777,aflibercept,gene,0.896,28604541
35778,intraretinal or subretinal fluid,disease,0.843,28604541
35779,aflibercept,gene,0.9194,28604541
35780,intraretinal,disease,0.68,28604541
35781,retinal pigment detachment,disease,1.0,28604541
35782,aflibercept,gene,0.9907,28604541
35783,geographic atrophy,disease,1.0,28604541
35784,aflibercept,gene,0.985,28604541
35785,patients,species,0.9795,28604541
35786,wet age-related macular degeneration,disease,0.9946,28604541
35787,aflibercept,gene,0.965,28601912
35788,aflibercept,gene,0.929,28601912
35789,triamcinolone acetonide,drug,0.998,28601912
35790,polypoidal choroidal vasculopathy,disease,1.0,28601912
35791,PCV,disease,1.0,28601912
35792,patients,species,0.9736,28601912
35793,PCV,disease,1.0,28601912
35794,IVA,drug,0.9697,28601912
35795,patients,species,0.9805,28601912
35796,pigment epithelial detachment,disease,1.0,28601912
35797,PED,disease,0.9956,28601912
35798,patients,species,0.9897,28601912
35799,PED,DNA,0.55,28601912
35800,patient,species,0.972,28601912
35801,patients,species,0.942,28601912
35802,PCV,disease,1.0,28601912
35803,retinal fluid,disease,0.849,28601912
35804,PED,disease,0.9976,28601912
35805,ziv-aflibercept,gene,0.9917,28596286
35806,ziv-aflibercept,gene,0.99,28596286
35807,neovascular age-related macular degeneration,disease,1.0,28596286
35808,nAMD,disease,1.0,28596286
35809,bevacizumab,gene,0.8755,28596286
35810,ranibizumab,gene,0.5107,28596286
35811,patients,species,0.9834,28596286
35812,nAMD,disease,1.0,28596286
35813,bevacizumab,gene,0.825,28596286
35814,IVZ,drug,0.957,28596286
35815,retinal pigment epithelial detachment,disease,1.0,28596286
35816,RPED,disease,1.0,28596286
35817,BCVA,DNA,0.4814,28596286
35818,IVZ,drug,0.876,28596286
35819,antivascular endothelial growth factors,gene,0.994,28596286
35820,VEGFs,gene,0.9966,28596286
35821,IVZ,drug,0.9653,28596286
35822,IVZ,drug,0.9766,28596286
35823,IVZ,drug,0.9736,28596286
35824,BCVA,DNA,0.4646,28596286
35825,RPED,DNA,0.55,28596286
35826,IRF,gene,0.8833,28596286
35827,SRF,gene,0.894,28596286
35828,choroidal neovascularization,disease,0.9995,28590316
35829,CNV,disease,0.999,28590316
35830,age-related macular degeneration,disease,1.0,28590316
35831,AMD,disease,1.0,28590316
35832,aflibercept,gene,0.9697,28590316
35833,Age-related macular degeneration,disease,1.0,28590316
35834,aflibercept,gene,0.98,28590316
35835,aflibercept,gene,0.9897,28590316
35836,exudative AMD,disease,0.982,28590316
35837,AMD,disease,1.0,28590316
35838,polyps,disease,0.9985,28590316
35839,pigment epithelial detachment,disease,1.0,28590316
35840,PED,disease,1.0,28590316
35841,polypoidal choroidal vasculopathy,disease,1.0,28590316
35842,PCV,disease,1.0,28590316
35843,AMD,disease,1.0,28590316
35844,polyps,disease,0.99,28590316
35845,pigment epithelial detachment,disease,1.0,28590316
35846,polypoidal,disease,0.9995,28590316
35847,choroidal vasculopathy,disease,1.0,28590316
35848,AMD,disease,1.0,28590316
35849,polypoidal choroidal vasculopathy,disease,1.0,28590316
35850,ranibizumab,gene,0.9194,28576208
35851,aflibercept,gene,0.9863,28576208
35852,ranibizumab,gene,0.928,28576208
35853,aflibercept,gene,0.9946,28576208
35854,Ranibizumab,gene,0.953,28576208
35855,aflibercept,gene,0.993,28576208
35856,ranibizumab,gene,0.874,28576208
35857,aflibercept,gene,0.993,28576208
35858,ranibizumab,gene,0.8643,28576208
35859,aflibercept,gene,0.9873,28576208
35860,Aflibercept,gene,0.9414,28575913
35861,Ranibizumab,gene,0.836,28575913
35862,Patients,species,0.969,28575913
35863,aflibercept,gene,0.968,28575913
35864,ranibizumab,gene,0.5137,28575913
35865,patients,species,0.9604,28575913
35866,exudative age-related macular degeneration,disease,1.0,28575913
35867,patients,species,0.988,28575913
35868,ranibizumab,gene,0.5474,28575913
35869,aflibercept,gene,0.963,28575913
35870,patients,species,0.992,28575913
35871,patients,species,0.994,28575913
35872,patients,species,0.9785,28575913
35873,patients,species,0.991,28575913
35874,patients,species,0.981,28575913
35875,aflibercept,gene,0.9937,28575913
35876,ranibizumab,gene,0.8174,28575913
35877,patients,species,0.9634,28575913
35878,exudative age-related macular degeneration,disease,1.0,28575913
35879,Diabetic Retinopathy,disease,1.0,28570735
35880,diabetic retinopathy,disease,1.0,28570735
35881,diabetic retinopathy,disease,1.0,28570735
35882,PARTICIPANTS,species,0.65,28570735
35883,patients,species,0.9907,28570735
35884,diabetic retinopathy,disease,1.0,28570735
35885,patient,species,0.994,28570735
35886,patients,species,0.9907,28570735
35887,patients,species,0.989,28570735
35888,type 1 diabetes,disease,1.0,28570735
35889,hemoglobin A1C,gene,0.996,28570735
35890,A1,mutation,,28570735
35891,ranibizumab,gene,0.6104,28570735
35892,bevacizumab,drug,0.7305,28570735
35893,fluorescein,drug,0.996,28570735
35894,aflibercept,gene,0.9854,28570735
35895,triamcinolone,drug,0.9995,28570735
35896,dexamethasone,drug,0.999,28570735
35897,patients,species,0.9814,28570735
35898,diabetic retinopathy,disease,1.0,28570735
35899,Aflibercept,gene,0.666,28570733
35900,Proliferative Diabetic Retinopathy,disease,1.0,28570733
35901,anti-vascular endothelial growth factor,gene,0.903,28559722
35902,anti-VEGF,gene,0.9917,28559722
35903,Ranibizumab,gene,0.9424,28559722
35904,Bevacizumab,gene,0.93,28559722
35905,Aflibercept,gene,0.9766,28559722
35906,corneal neovascularization,disease,1.0,28559722
35907,NV,disease,1.0,28559722
35908,anti-VEGF,gene,0.923,28559722
35909,corneal NV,disease,1.0,28559722
35910,Corneal NV,disease,1.0,28559722
35911,corneal NV,disease,1.0,28559722
35912,VEGF,gene,0.953,28559722
35913,corneal NV,disease,1.0,28559722
35914,VEGF,gene,0.9927,28559722
35915,VEGF,gene,0.9946,28559722
35916,corneal NV,disease,1.0,28559722
35917,VEGF,gene,0.933,28559722
35918,corneal NV,disease,0.997,28559722
35919,VEGF,gene,0.9893,28559722
35920,Bevacizumab,gene,0.7646,28559722
35921,neo-vascular ocular diseases,disease,0.9995,28559722
35922,corneal NV,disease,0.9907,28559722
35923,bevacizumab,gene,0.944,28559722
35924,age-related macular degeneration,disease,0.9834,28559722
35925,ranibizumab,gene,0.581,28559722
35926,diabetic macular edema,disease,1.0,28559722
35927,aflibercept,gene,0.9707,28559722
35928,VEGF,gene,0.981,28559722
35929,Bevacizumab,gene,0.9346,28559722
35930,Ranibizumab,gene,0.8774,28559722
35931,Aflibercept,gene,0.9653,28559722
35932,corneal NV,disease,1.0,28559722
35933,bevacizumab,gene,0.8384,28559722
35934,corneal NV,disease,0.9995,28559722
35935,ranibizumab,gene,0.856,28559722
35936,corneal NV,disease,0.9995,28559722
35937,VEGF,gene,0.989,28559722
35938,NV,disease,,28559722
35939,Aflibercept,gene,0.954,28558181
35940,Macular Diseases,disease,1.0,28558181
35941,Aflibercept,gene,0.977,28557667
35942,Ranibizumab,gene,0.801,28557667
35943,Aflibercept,gene,0.966,28557667
35944,Ranibizumab,gene,0.8057,28557667
35945,neovascular age-related macular degeneration,disease,1.0,28557667
35946,nAMD,disease,1.0,28557667
35947,patients,species,0.9824,28557667
35948,nAMD,disease,1.0,28557667
35949,vascular endothelial growth factor,gene,0.908,28557667
35950,VEGF,gene,0.9976,28557667
35951,Aflibercept,gene,0.989,28557667
35952,Afl,gene,0.991,28557667
35953,Ranibizumab,gene,0.767,28557667
35954,Ran,gene,0.961,28557667
35955,Ran,drug,0.994,28557667
35956,Afl,drug,0.9844,28557667
35957,Patients,species,0.9556,28557667
35958,patients,species,0.952,28557667
35959,intraretinal fluid,disease,0.9023,28557667
35960,Afl,drug,0.6733,28557667
35961,Ran,drug,0.7583,28557667
35962,Ran,drug,0.9995,28557667
35963,Afl,drug,0.997,28557667
35964,Ran,drug,0.999,28557667
35965,Afl,drug,0.9995,28557667
35966,nAMD,disease,1.0,28557667
35967,Afl,drug,0.999,28557667
35968,Ran,drug,0.993,28557667
35969,anti-vascular endothelial growth factor,gene,0.996,28557571
35970,anti-VEGF,gene,0.995,28557571
35971,rat,species,0.932,28557571
35972,choroidal neovascularization,disease,1.0,28557571
35973,CNV,disease,1.0,28557571
35974,Anti-VEGF,gene,0.9844,28557571
35975,ranibizumab,gene,0.982,28557571
35976,aflibercept,gene,0.9805,28557571
35977,poly(lactic-co-glycolic acid),drug,0.999,28557571
35978,poly(N-isopropylacrylamide),drug,0.9995,28557571
35979,anti-VEGF,gene,0.9316,28557571
35980,CNV,disease,0.999,28557571
35981,VEGF,gene,0.675,28557571
35982,anti-VEGF,gene,0.971,28557571
35983,CNV,disease,1.0,28557571
35984,fluorescein,drug,0.993,28557571
35985,anti-VEGF,gene,0.933,28557571
35986,CNV,disease,1.0,28557571
35987,CNV lesions,disease,0.9053,28557571
35988,aflibercept,gene,0.985,28556485
35989,exudative age-related macular degeneration,disease,1.0,28556485
35990,AMD,disease,1.0,28556485
35991,exudative AMD,disease,1.0,28556485
35992,ranibizumab,gene,0.919,28556485
35993,bevacizumab,gene,0.761,28556485
35994,aflibercept,gene,0.9395,28556485
35995,patients,species,0.9727,28556485
35996,aflibercept,gene,0.9854,28556485
35997,CRT,DNA,0.4792,28556485
35998,aflibercept,gene,0.9893,28556485
35999,CRT,DNA,0.495,28556485
36000,dry macula,disease,0.8535,28556485
36001,BCVA,DNA,0.4597,28556485
36002,aflibercept,gene,0.9727,28556485
36003,aflibercept,gene,0.974,28556485
36004,Brolucizumab,gene,0.923,28551167
36005,Aflibercept,gene,0.9707,28551167
36006,Participants,species,0.9688,28551167
36007,Neovascular Age-Related Macular,disease,1.0,28551167
36008,brolucizumab,gene,0.9497,28551167
36009,aflibercept,gene,0.968,28551167
36010,neovascular age-related macular degeneration,disease,1.0,28551167
36011,AMD,disease,1.0,28551167
36012,PARTICIPANTS,species,0.8086,28551167
36013,participants,species,0.978,28551167
36014,choroidal neovascularization,disease,1.0,28551167
36015,AMD,disease,1.0,28551167
36016,participants,species,0.958,28551167
36017,brolucizumab,gene,0.966,28551167
36018,aflibercept,gene,0.9595,28551167
36019,brolucizumab,gene,0.8086,28551167
36020,participants,species,0.9297,28551167
36021,aflibercept,gene,0.531,28551167
36022,brolucizumab,gene,0.916,28551167
36023,aflibercept,gene,0.9824,28551167
36024,brolucizumab,gene,0.767,28551167
36025,aflibercept,gene,0.973,28551167
36026,brolucizumab,gene,0.8774,28551167
36027,participants,species,0.9863,28551167
36028,aflibercept,gene,0.9194,28551167
36029,brolucizumab,gene,0.973,28551167
36030,intraretinal and subretinal,disease,0.7456,28551167
36031,aflibercept,gene,0.9795,28551167
36032,brolucizumab,gene,0.8374,28551167
36033,BCVA,DNA,0.482,28551167
36034,Brolucizumab,gene,0.9014,28551167
36035,aflibercept,gene,0.989,28551167
36036,brolucizumab,gene,0.9326,28551167
36037,aflibercept,gene,0.9585,28551167
36038,brolucizumab,gene,0.864,28551167
36039,aflibercept,gene,0.9717,28551167
36040,brolucizumab,gene,0.739,28551167
36041,Macular Edema,disease,1.0,28551163
36042,Branch Retinal Vein Occlusion,disease,1.0,28551163
36043,macular edema,disease,1.0,28551163
36044,ME,disease,1.0,28551163
36045,branch retinal vein occlusion,disease,1.0,28551163
36046,BRVO,disease,1.0,28551163
36047,vascular endothelial growth factor,gene,0.9233,28551163
36048,VEGF,gene,0.999,28551163
36049,ME,disease,,28551163
36050,aflibercept,gene,0.951,28551163
36051,ranibizumab,gene,0.6704,28551163
36052,triamcinolone,drug,0.9995,28551163
36053,dexamethasone,drug,0.999,28551163
36054,VEGF,gene,0.915,28551163
36055,ME,disease,,28551163
36056,BRVO,disease,1.0,28551163
36057,ME,disease,,28551163
36058,BRVO,disease,1.0,28551163
36059,corticosteroids,drug,0.946,28551163
36060,cataracts,disease,1.0,28551163
36061,VEGF,gene,0.8877,28551163
36062,Aflibercept,gene,0.98,28548650
36063,age-related macular degeneration,disease,1.0,28548650
36064,aflibercept,gene,0.9697,28548650
36065,age related macular degeneration,disease,1.0,28548650
36066,AMD,disease,1.0,28548650
36067,ranibizumab,gene,0.7554,28548650
36068,aflibercept,gene,0.9775,28548650
36069,wet AMD,disease,0.9985,28548650
36070,patients,species,0.9604,28548650
36071,bevacizumab,gene,0.625,28548650
36072,ranibizumab,gene,0.8745,28548650
36073,bevacizumab,gene,0.7207,28548650
36074,aflibercept,gene,0.9883,28548650
36075,aflibercept,gene,0.9897,28548650
36076,VEGF,gene,0.7153,28548650
36077,aflibercept,gene,0.9883,28548650
36078,ziv-aflibercept,gene,0.956,28548650
36079,wet AMD,disease,0.998,28548650
36080,aflibercept,gene,0.987,28548650
36081,VEGF,gene,0.6514,28548650
36082,patients,species,0.9907,28548650
36083,aflibercept,gene,0.9507,28548650
36084,Aflibercept,gene,0.9893,28545998
36085,VEGF,gene,0.9985,28545998
36086,aflibercept,gene,0.9907,28545998
36087,clear-cell renal cell carcinoma,disease,1.0,28545998
36088,ccRCC,disease,1.0,28545998
36089,patients,species,0.9863,28545998
36090,pts,species,0.9707,28545998
36091,PATIENTS,species,0.977,28545998
36092,pts,species,0.968,28545998
36093,advanced or metastatic ccRCC,disease,0.9863,28545998
36094,VEGF receptor,gene,0.929,28545998
36095,tyrosine,drug,0.91,28545998
36096,tyrosine kinase,gene,0.801,28545998
36097,Pts,species,0.964,28545998
36098,aflibercept,gene,0.908,28545998
36099,Pts,species,0.5444,28545998
36100,pts,species,0.9717,28545998
36101,pts,species,0.9697,28545998
36102,sunitinib,drug,0.992,28545998
36103,pts,species,0.9785,28545998
36104,hypertension,disease,1.0,28545998
36105,proteinuria,disease,1.0,28545998
36106,fatigue,disease,1.0,28545998
36107,pts,species,0.977,28545998
36108,pts,species,0.969,28545998
36109,Aflibercept,gene,0.9683,28545998
36110,ccRCC,disease,0.9995,28545998
36111,VEGF,gene,0.9126,28539808
36112,vascular endothelial growth factor,gene,0.9155,28539808
36113,VEGF,gene,0.5435,28539808
36114,retinopathy of prematurity,disease,1.0,28539808
36115,ROP,disease,1.0,28539808
36116,VEGF,gene,0.566,28539808
36117,bevacizumab,gene,0.926,28539808
36118,ranibizumab,gene,0.8477,28539808
36119,aflibercept,gene,0.908,28539808
36120,high myopia,disease,0.9155,28539808
36121,ROP,disease,0.9995,28539808
36122,myopia,disease,0.998,28539808
36123,anti-VEGF,gene,0.774,28539808
36124,Maculopapular rash,disease,1.0,28538392
36125,Aflibercept,gene,0.96,28538392
36126,anti-vascular endothelial growth factor,gene,0.944,28538392
36127,VEGF,gene,0.998,28538392
36128,colon cancer,disease,1.0,28538392
36129,retinal diseases,disease,1.0,28538392
36130,age-related macular degeneration,disease,1.0,28538392
36131,AMD,disease,1.0,28538392
36132,AMD,disease,1.0,28538392
36133,vascular suppression,disease,0.9995,28538392
36134,aflibercept,gene,0.9634,28538392
36135,PATIENT,species,0.9214,28538392
36136,man,species,0.858,28538392
36137,polypoidal choroidal vasculopathy,disease,1.0,28538392
36138,PCV,disease,1.0,28538392
36139,wet AMD,disease,0.9995,28538392
36140,VEGF,gene,0.98,28538392
36141,systemic erythema,disease,0.9546,28538392
36142,itching,disease,0.828,28538392
36143,erythema,disease,0.905,28538392
36144,papules,disease,0.9644,28538392
36145,redness of the pharynx,disease,0.9976,28538392
36146,patient,species,0.943,28538392
36147,maculopapular-type drug eruption,disease,0.8965,28538392
36148,erythematous skin,disease,0.9976,28538392
36149,lymphocyte infiltration,disease,0.9395,28538392
36150,telangiectasia,disease,1.0,28538392
36151,patient,species,0.991,28538392
36152,pharyngeal lesion,disease,1.0,28538392
36153,itching,disease,0.9688,28538392
36154,maculopapular rash,disease,1.0,28538392
36155,aflibercept,gene,0.9697,28538392
36156,anti-VEGF,gene,0.7466,28538392
36157,retinal diseases,disease,1.0,28538392
36158,drug allergy,disease,0.9976,28538392
36159,aflibercept,gene,0.9814,28535756
36160,ranibizumab,gene,0.662,28535756
36161,bevacizumab,gene,0.891,28535756
36162,patients,species,0.939,28535756
36163,age-related macular degeneration,disease,1.0,28535756
36164,AMD,disease,1.0,28535756
36165,bevacizumab,gene,0.9097,28535756
36166,aflibercept,gene,0.97,28535756
36167,ranibizumab,gene,0.658,28535756
36168,bevacizumab,gene,0.674,28535756
36169,bevacizumab,gene,0.83,28535756
36170,aflibercept,gene,0.9487,28535756
36171,ranibizumab,gene,0.682,28535756
36172,bevacizumab,gene,0.6445,28535756
36173,aflibercept,gene,0.99,28535756
36174,bevacizumab,gene,0.7925,28535756
36175,BCVA,cell_type,0.4172,28535756
36176,bevacizumab,gene,0.9194,28535756
36177,aflibercept,gene,0.972,28535756
36178,ranibizumab,gene,0.729,28535756
36179,neovascular AMD,disease,1.0,28535756
36180,aflibercept,gene,0.9937,28535756
36181,Ranibizumab,gene,0.9834,28535531
36182,Aflibercept,gene,0.916,28535531
36183,Dexamethasone,drug,0.976,28535531
36184,macular edema,disease,1.0,28535531
36185,retinal vein occlusion,disease,0.9995,28535531
36186,bevacizumab,gene,0.9224,28535531
36187,ranibizumab,gene,0.847,28535531
36188,aflibercept,gene,0.9644,28535531
36189,dexamethasone,drug,0.993,28535531
36190,ranibizumab,drug,0.5337,28535531
36191,aflibercept,gene,0.919,28535531
36192,dexamethasone,drug,0.954,28535531
36193,dexamethasone,drug,0.99,28535531
36194,aflibercept,gene,0.989,28535531
36195,ranibizumab,gene,0.4788,28535531
36196,bevacizumab,gene,0.883,28535531
36197,VEGF,gene,0.8047,28527040
36198,vascular endothelial growth factor,gene,0.868,28527040
36199,VEGF,gene,0.998,28527040
36200,retinal disorders,disease,0.999,28527040
36201,patients,species,0.989,28527040
36202,VEGF,gene,0.5137,28527040
36203,retinal diseases,disease,1.0,28527040
36204,patients,species,0.976,28527040
36205,patients,species,0.993,28527040
36206,patient,species,0.979,28527040
36207,patient,species,0.986,28527040
36208,aflibercept,gene,0.99,28527039
36209,Neovascular age-related macular degeneration,disease,1.0,28520639
36210,nAMD,disease,1.0,28520639
36211,vascularized pigment epithelial detachment,disease,0.999,28520639
36212,v,DNA,0.9575,28520639
36213,v-PED,gene,0.92,28520639
36214,v-PED,disease,1.0,28520639
36215,wrinkled PED,disease,1.0,28520639
36216,w-PED,disease,0.9897,28520639
36217,w-PED,disease,0.9985,28520639
36218,w-PED,disease,0.9956,28520639
36219,patients,species,0.9824,28520639
36220,neovascular age-related macular degeneration,disease,1.0,28520639
36221,w-PED,disease,0.997,28520639
36222,anti-vascular endothelial growth factor,gene,0.984,28520639
36223,anti-VEGF,gene,0.9146,28520639
36224,anti-,gene,0.5977,28520639
36225,vascular endothelial growth factor,gene,0.885,28520639
36226,PED,disease,0.683,28520639
36227,Patients,species,0.9736,28520639
36228,patients,species,0.994,28520639
36229,PED,disease,1.0,28520639
36230,PED,disease,0.985,28520639
36231,patients,species,0.982,28520639
36232,anti-vascular endothelial growth factor,gene,0.952,28520639
36233,ranibizumab,gene,0.5283,28520639
36234,aflibercept,gene,0.8843,28520639
36235,patients,species,0.987,28520639
36236,w-PED,disease,1.0,28520639
36237,patients,species,0.99,28520639
36238,w-PED,disease,0.9976,28520639
36239,patients,species,0.991,28520639
36240,w,disease,0.9087,28520639
36241,w-PED,disease,0.915,28520639
36242,PED,disease,0.7695,28520639
36243,v-PED,disease,1.0,28520639
36244,anti-vascular endothelial growth factor,gene,0.9683,28520639
36245,w,disease,0.8345,28520639
36246,Polypoidal Choroidal Vasculopathy,disease,1.0,28512425
36247,Angioid,disease,0.999,28512425
36248,Angioid streaks,disease,0.9277,28512425
36249,systemic illnesses,disease,0.997,28512425
36250,Polypoidal choroidal vasculopathy,disease,1.0,28512425
36251,PCV,disease,1.0,28512425
36252,exudative chorioretinopathy,disease,1.0,28512425
36253,serosanguineous detachments,disease,0.985,28512425
36254,VEGF,gene,0.52,28512425
36255,ranibizumab,gene,0.7764,28512425
36256,aflibercept,gene,0.975,28512425
36257,PCV,disease,0.9995,28512425
36258,AS,disease,,28512425
36259,patients,species,0.9644,28512425
36260,PCV,disease,1.0,28512425
36261,AS,disease,,28512425
36262,PCV,disease,1.0,28512425
36263,AS,disease,,28512425
36264,patients,species,0.972,28512425
36265,VEGF,gene,0.6226,28512425
36266,patients,species,0.982,28512425
36267,AS,disease,,28512425
36268,PCV,disease,0.9995,28512425
36269,patients,species,0.9873,28512425
36270,fluorescein,drug,0.9985,28512425
36271,indocyanine green,drug,0.997,28512425
36272,patients,species,0.9683,28512425
36273,patient,species,0.979,28512425
36274,anti-VEGF,gene,0.756,28512425
36275,patients,species,0.9814,28512425
36276,PCV,disease,1.0,28512425
36277,aflibercept,gene,0.9854,28512425
36278,ranibizumab,gene,0.6987,28512425
36279,PCV,disease,0.9995,28512425
36280,AS,disease,,28512425
36281,Diclofenac,drug,0.9946,28508561
36282,diclofenac,drug,0.9966,28508561
36283,patients,species,0.972,28508561
36284,IVI,disease,0.8706,28508561
36285,PARTICIPANTS,species,0.815,28508561
36286,patients,species,0.9634,28508561
36287,diclofenac,drug,0.9985,28508561
36288,diclofenac,drug,0.998,28508561
36289,diclofenac,drug,0.996,28508561
36290,patients,species,0.978,28508561
36291,patients,species,0.965,28508561
36292,diclofenac,drug,0.999,28508561
36293,patients,species,0.977,28508561
36294,patients,species,0.9873,28508561
36295,patients,species,0.982,28508561
36296,diclofenac,drug,0.996,28508561
36297,diclofenac,drug,0.9976,28508561
36298,patients,species,0.973,28508561
36299,Sterile Intraocular Inflammation,disease,0.9995,28499055
36300,patients,species,0.9814,28499055
36301,cystoid macular edema,disease,1.0,28499055
36302,CME,disease,1.0,28499055
36303,central retinal vein occlusion,disease,0.977,28499055
36304,CRVO,disease,1.0,28499055
36305,aflibercept,gene,0.9766,28499055
36306,Eylea; Regeneron,gene,0.7344,28499055
36307,Lucentis,drug,0.9243,28499055
36308,CME,disease,1.0,28499055
36309,CRVO,disease,1.0,28499055
36310,aflibercept,gene,0.9966,28499055
36311,ranibizumab,gene,0.8115,28499055
36312,patients,species,0.9736,28499055
36313,steroids,drug,0.999,28499055
36314,ranibizumab,gene,0.7734,28499055
36315,aflibercept,gene,0.946,28499055
36316,Sterile intraocular inflammation,disease,1.0,28499055
36317,aflibercept,gene,0.9854,28499055
36318,ranibizumab,gene,0.9546,28499055
36319,patient,species,0.945,28499055
36320,Ziv-Aflibercept,gene,0.974,28499051
36321,Diabetic,disease,0.997,28499051
36322,ziv-aflibercept,gene,0.9893,28499051
36323,Zaltrap,gene,0.798,28499051
36324,diabetic macular edema,disease,1.0,28499051
36325,DME,disease,1.0,28499051
36326,PATIENTS,species,0.948,28499051
36327,ziv-aflibercept,gene,0.975,28499051
36328,patients,species,0.9688,28499051
36329,DME,disease,1.0,28499051
36330,anti-vascular endothelial growth factor,gene,0.8857,28499051
36331,VEGF,gene,0.997,28499051
36332,patients,species,0.9717,28499051
36333,ziv-aflibercept,gene,0.9785,28499051
36334,Ziv-aflibercept,gene,0.955,28499051
36335,patients,species,0.9785,28499051
36336,DME,disease,1.0,28499051
36337,VEGF,gene,0.788,28499051
36338,patients,species,0.976,28496301
36339,branch retinal vein occlusion,disease,1.0,28496301
36340,patients,species,0.983,28496301
36341,aflibercept,gene,0.977,28496301
36342,ranibizumab,gene,0.494,28496301
36343,macular edema,disease,1.0,28496301
36344,ME,disease,1.0,28496301
36345,branch retinal vein occlusion,disease,1.0,28496301
36346,BRVO,disease,1.0,28496301
36347,PATIENTS,species,0.9556,28496301
36348,Patients,species,0.9478,28496301
36349,ME,disease,,28496301
36350,BRVO,disease,1.0,28496301
36351,Patients,species,0.978,28496301
36352,ME,disease,,28496301
36353,Patient,species,0.9956,28496301
36354,patients,species,0.984,28496301
36355,epiretinal membrane,disease,1.0,28496301
36356,ME,disease,,28496301
36357,BRVO,disease,1.0,28496301
36358,age-related macular degeneration,disease,1.0,28496299
36359,VEGF,gene,0.915,28496299
36360,aflibercept,gene,0.974,28496299
36361,ranibizumab,gene,0.74,28496299
36362,patients,species,0.9873,28496299
36363,age-related macular degeneration,disease,1.0,28496299
36364,AMD,disease,1.0,28496299
36365,AMD,disease,1.0,28496299
36366,patients,species,0.9956,28496299
36367,aflibercept,gene,0.98,28496299
36368,ranibizumab,gene,0.9136,28496299
36369,aflibercept,gene,0.9795,28496299
36370,aflibercept,gene,0.98,28496299
36371,aflibercept,gene,0.9844,28496299
36372,ranibizumab,drug,0.5396,28496299
36373,aflibercept,gene,0.9707,28496299
36374,aflibercept,gene,0.9854,28496299
36375,patients,species,0.9893,28496299
36376,vascular endothelial growth factor,gene,0.993,28496299
36377,AMD,disease,0.9995,28496299
36378,Proliferative diabetic retinopathy,disease,0.9644,28494921
36379,aflibercept,gene,0.9595,28494920
36380,Proliferative diabetic retinopathy,disease,0.9995,28494920
36381,sight impairment,disease,0.9937,28494920
36382,people,species,0.907,28494920
36383,diabetes,disease,1.0,28494920
36384,Proliferative diabetic retinopathy,disease,0.999,28494920
36385,aflibercept,gene,0.9785,28494920
36386,diabetes,disease,0.992,28494920
36387,proliferative,disease,0.5303,28494920
36388,diabetic retinopathy,disease,0.9995,28494920
36389,Patients,species,0.914,28494920
36390,aflibercept,gene,0.958,28494920
36391,patients,species,0.986,28494920
36392,aflibercept,gene,0.9507,28494920
36393,PRP,cell_type,0.5796,28494920
36394,patients,species,0.9795,28494920
36395,PRP,cell_type,0.585,28494920
36396,participants,species,0.959,28494920
36397,vitreous haemorrhage,disease,0.999,28494920
36398,participants,species,0.948,28494920
36399,Diabetic Retinopathy,disease,1.0,28494920
36400,participants,species,0.9736,28494920
36401,participants,species,0.982,28494920
36402,participants,species,0.975,28494920
36403,aflibercept,gene,0.9395,28494920
36404,participants,species,0.977,28494920
36405,aflibercept,gene,0.982,28494920
36406,PRP,cell_type,0.459,28494920
36407,Aflibercept,gene,0.977,28494920
36408,PRP,cell_type,0.528,28494920
36409,Patients,species,0.9507,28494920
36410,proliferative diabetic retinopathy,disease,0.999,28494920
36411,aflibercept,gene,0.96,28494920
36412,Osteonecrosis of the Jaw,disease,1.0,28494743
36413,Serous Osteonecrosis of the jaw,disease,0.994,28494743
36414,ONJ,disease,1.0,28494743
36415,metastatic bone cancer,disease,1.0,28494743
36416,patient,species,0.9937,28494743
36417,bisphosphonates,drug,0.997,28494743
36418,ONJ,disease,0.9995,28494743
36419,ONJ,disease,0.9995,28494743
36420,ONJ,disease,0.9976,28494743
36421,oncologic,disease,0.8926,28494743
36422,patients,species,0.9688,28494743
36423,BPs,drug,0.6553,28494743
36424,bone metastatic cancers,disease,1.0,28494743
36425,ONJ,disease,0.9995,28494743
36426,cancer,disease,1.0,28494743
36427,cancer,disease,1.0,28494743
36428,patients,species,0.9907,28494743
36429,ONJ,disease,0.998,28494743
36430,cancer,disease,1.0,28494743
36431,patient,species,0.987,28494743
36432,Bevacizumab,gene,0.8213,28492910
36433,Aflibercept,gene,0.9575,28492910
36434,Patients,species,0.9746,28492910
36435,Macular IMPORTANCE,disease,1.0,28492910
36436,aflibercept,gene,0.986,28492910
36437,macular edema,disease,1.0,28492910
36438,central retinal vein occlusion,disease,1.0,28492910
36439,Bevacizumab,gene,0.881,28492910
36440,bevacizumab,gene,0.714,28492910
36441,aflibercept,gene,0.9673,28492910
36442,macular edema,disease,1.0,28492910
36443,central retinal or hemiretinal vein occlusion,disease,1.0,28492910
36444,PARTICIPANTS,species,0.586,28492910
36445,patients,species,0.9395,28492910
36446,macular edema,disease,1.0,28492910
36447,central retinal or hemiretinal vein occlusion,disease,1.0,28492910
36448,aflibercept,gene,0.963,28492910
36449,bevacizumab,gene,0.7446,28492910
36450,participant,species,0.979,28492910
36451,bevacizumab,gene,0.604,28492910
36452,aflibercept,gene,0.9614,28492910
36453,Diabetic Retinopathy,disease,1.0,28492910
36454,participants,species,0.985,28492910
36455,women,species,0.9507,28492910
36456,bevacizumab,gene,0.9385,28492910
36457,aflibercept,gene,0.9624,28492910
36458,aflibercept,gene,0.981,28492910
36459,participants,species,0.983,28492910
36460,bevacizumab,gene,0.825,28492910
36461,participant,species,0.976,28492910
36462,endophthalmitis,disease,1.0,28492910
36463,angle-closure glaucoma,disease,1.0,28492910
36464,patients,species,0.9277,28492910
36465,macular edema,disease,1.0,28492910
36466,central retinal or hemiretinal vein occlusion,disease,1.0,28492910
36467,bevacizumab,gene,0.568,28492910
36468,aflibercept,gene,0.938,28492910
36469,Macular edema,disease,1.0,28492860
36470,ME,disease,1.0,28492860
36471,retinal vein occlusion,disease,1.0,28492860
36472,RVO,disease,1.0,28492860
36473,RVO,disease,1.0,28492860
36474,vascular endothelial growth factor,gene,0.8677,28492860
36475,VEGF,gene,0.9985,28492860
36476,patients,species,0.99,28492860
36477,participants,species,0.8687,28492860
36478,Vein,disease,0.973,28492860
36479,PARTICIPANTS,species,0.6,28492860
36480,patients,species,0.985,28492860
36481,RVO,disease,0.9297,28492860
36482,hemi-RVO,disease,1.0,28492860
36483,bevacizumab,gene,0.7656,28492860
36484,aflibercept,gene,0.954,28492860
36485,participants,species,0.972,28492860
36486,participants,species,0.98,28492860
36487,bevacizumab,gene,0.729,28492860
36488,aflibercept,gene,0.98,28492860
36489,patients,species,0.976,28492860
36490,women,species,0.9067,28492860
36491,patient,species,0.9272,28492860
36492,bevacizumab,gene,0.933,28492860
36493,aflibercept,gene,0.989,28492860
36494,ME,disease,,28492860
36495,Macular edema,disease,1.0,28492860
36496,bevacizumab,gene,0.8765,28492860
36497,aflibercept,gene,0.9873,28492860
36498,Aflibercept,gene,0.9585,28492860
36499,ME,disease,,28492860
36500,CRVO,disease,1.0,28492860
36501,HRVO,disease,0.9995,28492860
36502,aflibercept,gene,0.988,28490861
36503,patients,species,0.9165,28490861
36504,aflibercept,gene,0.989,28490861
36505,patients,species,0.934,28490861
36506,polypoidal choroidal vasculopathy,disease,1.0,28490861
36507,Diabetic Retinopathy,disease,0.9956,28490861
36508,Patients,species,0.929,28490861
36509,PCV,disease,1.0,28490861
36510,aflibercept,gene,0.961,28490861
36511,indocyanine green,drug,0.995,28490861
36512,patients,species,0.9893,28490861
36513,ETDRS,DNA,0.4888,28490861
36514,patients,species,0.9834,28490861
36515,patients,species,0.985,28490861
36516,patients,species,0.988,28490861
36517,ETDRS,DNA,0.4592,28490861
36518,ETDRS,DNA,0.5034,28490861
36519,polyps,cell_type,0.473,28490861
36520,polyps,disease,0.998,28490861
36521,patients,species,0.982,28490861
36522,Cataract,disease,1.0,28490861
36523,patients,species,0.9624,28490861
36524,PCV,disease,1.0,28490861
36525,aflibercept,gene,0.9595,28490861
36526,ETDRS,DNA,0.5176,28490861
36527,polyp,disease,0.999,28490861
36528,corneal neovascularization,disease,1.0,28489275
36529,Corneal neovascularization,disease,1.0,28489275
36530,CNV,disease,1.0,28489275
36531,ocular surface diseases,disease,0.9985,28489275
36532,CNV,DNA,0.726,28489275
36533,CNV,DNA,0.739,28489275
36534,aflibercept,gene,0.9863,28489275
36535,netrins,gene,0.96,28489275
36536,CNV,disease,1.0,28489275
36537,CNV,DNA,0.768,28489275
36538,CNV,disease,1.0,28489275
36539,Ranibizumab,gene,0.727,28484833
36540,aflibercept,gene,0.906,28484833
36541,macular edema,disease,1.0,28484833
36542,central retinal vein occlusion,disease,1.0,28484833
36543,aflibercept,gene,0.9707,28478396
36544,ranibizumab,gene,0.913,28478396
36545,neovascular age-related macular degeneration,disease,1.0,28478396
36546,nAMD,disease,1.0,28478396
36547,nAMD,disease,1.0,28478396
36548,ranibizumab,gene,0.887,28478396
36549,aflibercept,gene,0.9014,28478396
36550,patients,species,0.9478,28478396
36551,ranibizumab,gene,0.7407,28478396
36552,Diabetic Retinopathy,disease,0.9937,28478396
36553,patients,species,0.9824,28478396
36554,aflibercept,gene,0.888,28478396
36555,aflibercept,gene,0.878,28478396
36556,ranibizumab,gene,0.894,28478396
36557,aflibercept,gene,0.978,28478396
36558,ranibizumab,gene,0.8545,28478396
36559,ranibizumab,gene,0.8555,28478396
36560,aflibercept,gene,0.9634,28478396
36561,ranibizumab,gene,0.644,28478396
36562,Aflibercept,gene,0.967,28478396
36563,aflibercept,gene,0.9717,28478396
36564,ranibizumab,gene,0.8887,28478396
36565,cancer,disease,0.9995,28472195
36566,cancer,disease,1.0,28472195
36567,gastrointestinal (GI) perforation,disease,0.9956,28472195
36568,cancer,disease,1.0,28472195
36569,cancer,disease,1.0,28472195
36570,cancer,disease,1.0,28472195
36571,cancer,disease,1.0,28472195
36572,cancer,disease,1.0,28472195
36573,AAs,disease,0.8237,28472195
36574,esophageal perforation,disease,0.9995,28472195
36575,pancreatitis,disease,1.0,28472195
36576,gastrostomy,DNA,0.4622,28472195
36577,terminal cancer,disease,1.0,28472195
36578,hepatic decompensation,disease,1.0,28472195
36579,sepsis,disease,1.0,28472195
36580,cancer,disease,1.0,28472195
36581,Ranibizumab,gene,0.7593,28470435
36582,aflibercept,gene,0.9277,28470435
36583,macular edema,disease,1.0,28470435
36584,central retinal vein occlusion,disease,1.0,28470435
36585,Oxygen,drug,0.995,28470332
36586,Central Retinal Vein Occlusion,disease,1.0,28470332
36587,Occlusion of the central retinal vein,disease,0.992,28470332
36588,CRVO,disease,1.0,28470332
36589,visual loss,disease,0.9995,28470332
36590,oxygen,drug,0.999,28470332
36591,anti-VEGF,gene,0.786,28470332
36592,CRVO,disease,1.0,28470332
36593,CRVO,disease,1.0,28470332
36594,oxygen,drug,1.0,28470332
36595,oxygen,drug,1.0,28470332
36596,VEGF,gene,0.7246,28470332
36597,oxygen,drug,0.9985,28470332
36598,oxygen,drug,1.0,28470332
36599,oxygen,drug,0.998,28470332
36600,VEGF,gene,0.9937,28470332
36601,oxygen,drug,0.9956,28470332
36602,CRVO,disease,1.0,28470332
36603,CRVO,disease,1.0,28470332
36604,anti-VEGF,gene,0.958,28470332
36605,aflibercept,gene,0.977,28467427
36606,polypoidal choroidal vasculopathy,disease,1.0,28467427
36607,Polypoidal choroidal vasculopathy,disease,1.0,28467427
36608,PCV,disease,1.0,28467427
36609,polyp-like choroidal neovascularization,disease,0.8677,28467427
36610,aflibercept,gene,0.991,28467427
36611,PCV,disease,1.0,28467427
36612,PCV,disease,0.997,28467427
36613,CRT,DNA,0.53,28467427
36614,neovascular age-related macular degeneration,disease,1.0,28458510
36615,aflibercept,gene,0.971,28458510
36616,ranibizumab,gene,0.756,28458510
36617,AMD,disease,1.0,28458510
36618,aflibercept,gene,0.989,28458510
36619,Eylea,gene,0.7393,28458510
36620,ranibizumab,gene,0.661,28458510
36621,ranibizumab,gene,0.705,28458510
36622,aflibercept,gene,0.8906,28458510
36623,NEI,DNA,0.556,28458510
36624,Ranibizumab,gene,0.9224,28458510
36625,NEI,DNA,0.5195,28458510
36626,CRT,DNA,0.577,28458510
36627,aflibercept,gene,0.988,28458510
36628,ranibizumab,gene,0.678,28458510
36629,neovascular AMD,disease,1.0,28458510
36630,Diabetic Retinopathy,disease,1.0,28448655
36631,vascular endothelial growth factor,gene,0.883,28448655
36632,diabetic macular edema,disease,1.0,28448655
36633,DME,disease,1.0,28448655
36634,diabetic retinopathy,disease,1.0,28448655
36635,DR,disease,1.0,28448655
36636,VEGF,gene,0.857,28448655
36637,DR,disease,,28448655
36638,aflibercept,gene,0.9775,28448655
36639,bevacizumab,gene,0.8125,28448655
36640,ranibizumab,gene,0.7056,28448655
36641,DME,disease,1.0,28448655
36642,PARTICIPANTS,species,0.6436,28448655
36643,DME,disease,0.994,28448655
36644,participants,species,0.9746,28448655
36645,aflibercept,gene,0.8857,28448655
36646,bevacizumab,gene,0.7983,28448655
36647,ranibizumab,gene,0.6704,28448655
36648,Retinopathy,disease,1.0,28448655
36649,Participants,species,0.9424,28448655
36650,aflibercept,gene,0.9937,28448655
36651,bevacizumab,gene,0.865,28448655
36652,ranibizumab,gene,0.686,28448655
36653,retinopathy,disease,1.0,28448655
36654,retinopathy,disease,1.0,28448655
36655,participants,species,0.975,28448655
36656,DR,disease,,28448655
36657,DR,disease,,28448655
36658,PDR,disease,0.9736,28448655
36659,women,species,0.9727,28448655
36660,NPDR,disease,0.9995,28448655
36661,aflibercept,gene,0.9663,28448655
36662,bevacizumab,gene,0.7637,28448655
36663,ranibizumab,gene,0.8237,28448655
36664,DR,disease,,28448655
36665,aflibercept,gene,0.976,28448655
36666,bevacizumab,gene,0.85,28448655
36667,ranibizumab,gene,0.8076,28448655
36668,bevacizumab,gene,0.7485,28448655
36669,aflibercept,gene,0.9546,28448655
36670,ranibizumab,gene,0.9106,28448655
36671,aflibercept,gene,0.995,28448655
36672,bevacizumab,gene,0.9526,28448655
36673,ranibizumab,gene,0.714,28448655
36674,PDR,disease,0.996,28448655
36675,aflibercept,gene,0.9883,28448655
36676,bevacizumab,gene,0.879,28448655
36677,aflibercept,gene,0.98,28448655
36678,bevacizumab,gene,0.8345,28448655
36679,ranibizumab,gene,0.701,28448655
36680,bevacizumab,gene,0.691,28448655
36681,aflibercept,gene,0.9775,28448655
36682,ranibizumab,gene,0.797,28448655
36683,retinopathy,disease,0.9995,28448655
36684,anti-VEGF,gene,0.987,28448655
36685,PDR,disease,0.9727,28448655
36686,NPDR,disease,0.9976,28448655
36687,VEGF,gene,0.712,28448655
36688,DME,disease,0.9995,28448655
36689,DR,disease,,28448655
36690,bevacizumab,gene,0.797,28448655
36691,aflibercept,gene,0.926,28448655
36692,ranibizumab,gene,0.559,28448655
36693,Aflibercept,gene,0.9556,28448655
36694,participants,species,0.9736,28448655
36695,PDR,disease,0.9746,28448655
36696,VEGF,gene,0.708,28448655
36697,DME,disease,1.0,28448655
36698,Antivascular Endothelial Growth Factor,gene,0.9863,28445077
36699,antivascular endothelial growth factor,gene,0.8955,28445077
36700,VEGF,gene,0.996,28445077
36701,neovascular age-related macular degeneration,disease,1.0,28445077
36702,nAMD,disease,1.0,28445077
36703,nAMD,disease,1.0,28445077
36704,patients,species,0.985,28445077
36705,ranibizumab,gene,0.9224,28445077
36706,aflibercept,gene,0.987,28445077
36707,ERMs,disease,0.9873,28445077
36708,ERMs,disease,0.96,28445077
36709,nAMD,disease,1.0,28445077
36710,ERMs,cell_type,0.4907,28445077
36711,ERM,disease,1.0,28445077
36712,nAMD,disease,1.0,28445077
36713,anti-VEGF,gene,0.7026,28445077
36714,nAMD,disease,1.0,28445077
36715,ERMs,disease,0.9966,28445077
36716,nAMD,disease,1.0,28445077
36717,Aflibercept,gene,0.983,28436640
36718,Diabetic Macular Edema,disease,1.0,28436640
36719,Bevacizumab,gene,0.8447,28436640
36720,Ranibizumab,gene,0.8345,28436640
36721,Aflibercept,gene,0.984,28436640
36722,aflibercept,gene,0.995,28436640
36723,diabetic macular edema,disease,1.0,28436640
36724,DME,disease,1.0,28436640
36725,ranibizumab,gene,0.5337,28436640
36726,bevacizumab,gene,0.858,28436640
36727,DME,disease,1.0,28436640
36728,bevacizumab,gene,0.794,28436640
36729,ranibizumab,gene,0.6353,28436640
36730,aflibercept,gene,0.9653,28436640
36731,aflibercept,gene,0.983,28436640
36732,aflibercept,gene,0.9673,28436640
36733,aflibercept,gene,0.9624,28436640
36734,aflibercept,gene,0.982,28436640
36735,aflibercept,gene,0.9863,28436640
36736,glycosylated hemoglobin,gene,0.7725,28436640
36737,creatinine,drug,0.998,28436640
36738,cholesterol,drug,0.999,28436640
36739,diabetic retinopathy,disease,1.0,28436640
36740,BCVA,DNA,0.4614,28436640
36741,aflibercept,gene,0.9683,28436640
36742,aflibercept,gene,0.9824,28436640
36743,DME,disease,1.0,28436640
36744,bevacizumab,gene,0.6577,28436640
36745,Vitrectomized,disease,0.998,28436640
36746,aflibercept,gene,0.94,28436640
36747,aflibercept,gene,0.983,28436565
36748,ranibizumab,drug,0.613,28436565
36749,ranibizumab,gene,0.9307,28435211
36750,aflibercept,gene,0.963,28435211
36751,macular edema,disease,1.0,28435211
36752,branch retinal vein occlusion,disease,1.0,28435211
36753,aflibercept,gene,0.982,28430321
36754,neovascular age-related macular degeneration,disease,1.0,28430321
36755,Proliferative Diabetic Retinopathy,disease,1.0,28427072
36756,proliferative diabetic retinopathy,disease,1.0,28427072
36757,PDR,disease,1.0,28427072
36758,VEGF,gene,0.9976,28427072
36759,PDR,disease,1.0,28427072
36760,diabetic macular edema,disease,1.0,28427072
36761,DME,disease,1.0,28427072
36762,VEGF,gene,0.8765,28427072
36763,ranibizumab,gene,0.6,28427072
36764,DME,disease,1.0,28427072
36765,PDR,disease,0.9946,28427072
36766,has,gene,0.6025,28427072
36767,aflibercept,gene,0.5703,28427072
36768,PDR,disease,0.996,28427072
36769,PRP,cell_type,0.587,28427072
36770,DME,disease,0.9995,28427072
36771,PDR,disease,0.98,28427072
36772,DME,disease,0.9834,28427072
36773,ranibizumab,gene,0.707,28427072
36774,PRP,cell_type,0.606,28427072
36775,DME,disease,1.0,28427072
36776,PRP,cell_type,0.5723,28427072
36777,ranibizumab,gene,0.857,28427072
36778,VEGF,gene,0.884,28427072
36779,endophthalmitis,disease,1.0,28427072
36780,VEGF,gene,0.9326,28427072
36781,PRP,cell_type,0.655,28427072
36782,cerebrovascular accident,disease,1.0,28427072
36783,myocardial infarction,disease,1.0,28427072
36784,Diabetic Macular Edema,disease,1.0,28427070
36785,Diabetic Retinopathy,disease,1.0,28427070
36786,aflibercept,gene,0.9814,28427070
36787,bevacizumab,gene,0.858,28427070
36788,ranibizumab,drug,0.523,28427070
36789,diabetic macular edema,disease,1.0,28427070
36790,DME,disease,1.0,28427070
36791,aflibercept,gene,0.9854,28427070
36792,type II diabetes,disease,1.0,28427070
36793,aflibercept,gene,0.9907,28427070
36794,ranibizumab,gene,0.7637,28427070
36795,bevacizumab,gene,0.6865,28427070
36796,aflibercept,gene,0.9805,28427070
36797,bevacizumab,gene,0.6934,28427070
36798,aflibercept,gene,0.9893,28427070
36799,ranibizumab,gene,0.826,28427070
36800,Bevacizumab,gene,0.8657,28427070
36801,bevacizumab,gene,0.884,28427070
36802,aflibercept,gene,0.974,28427070
36803,ranibizumab,gene,0.4995,28427070
36804,bevacizumab,gene,0.783,28427070
36805,myocardial infarction,disease,1.0,28427070
36806,stroke,disease,0.9995,28427070
36807,Aflibercept,gene,0.947,28427070
36808,bevacizumab,gene,0.8276,28427070
36809,ranibizumab,gene,0.754,28427070
36810,DME,disease,1.0,28427070
36811,Bevacizumab,gene,0.8696,28427070
36812,aflibercept,gene,0.9727,28427070
36813,ranibizumab,gene,0.649,28427070
36814,Aflibercept,gene,0.9507,28427067
36815,Diabetic Macular Edema,disease,1.0,28427067
36816,diabetic macular edema,disease,1.0,28427067
36817,DME,disease,1.0,28427067
36818,vascular endothelial growth factor,gene,0.9863,28427067
36819,VEGF,gene,0.9927,28427067
36820,DME,drug,0.619,28427067
36821,VEGF,gene,0.9937,28427067
36822,DME,disease,1.0,28427067
36823,VEGF,gene,0.9883,28427067
36824,DME,disease,0.996,28427067
36825,DME,disease,0.9995,28427067
36826,VA,disease,0.638,28427067
36827,aflibercept,gene,0.989,28427067
36828,ranibizumab,gene,0.589,28427067
36829,anti-VEGF,gene,0.8145,28427067
36830,DME,disease,1.0,28427067
36831,Aflibercerpt,gene,0.777,28427067
36832,VEGF binding domains,gene,0.9795,28427067
36833,human VEGF receptors-1 and -2,gene,0.992,28427067
36834,Fc,gene,0.9746,28427067
36835,immunoglobulin-G1,gene,0.9937,28427067
36836,placental growth factors 1 and 2,gene,0.999,28427067
36837,aflibercept,gene,0.944,28427067
36838,VEGF,gene,0.8184,28427067
36839,aflibercept,gene,0.98,28427067
36840,DME,disease,1.0,28427067
36841,DME,disease,1.0,28427067
36842,aflibercept,gene,0.979,28427067
36843,Ischemic Central Retinal Vein Occlusion,disease,1.0,28427057
36844,Vascular Endothelial Growth Factor,gene,0.9355,28427057
36845,ischemic central retinal vein occlusion,disease,1.0,28427057
36846,CRVO,disease,1.0,28427057
36847,anti-,gene,0.6177,28427057
36848,vascular endothelial growth factor,gene,0.9004,28427057
36849,VEGF,gene,0.992,28427057
36850,ischemic CRVO,disease,1.0,28427057
36851,macular edema,disease,1.0,28427057
36852,ranibizumab,gene,0.924,28427057
36853,aflibercept,gene,0.9136,28427057
36854,retinal ischemia,disease,1.0,28427057
36855,ischemic CRVO,disease,0.9995,28427057
36856,macular ischemia,disease,1.0,28427057
36857,macular ischemia,disease,0.998,28427057
36858,macular ischemia,disease,1.0,28427057
36859,VEGF,gene,0.7773,28427057
36860,ischemic CRVO,disease,1.0,28427057
36861,macular edema,disease,1.0,28427057
36862,peripheral ischemia,disease,0.9995,28427057
36863,macular ischemia,disease,1.0,28427057
36864,macular ischemia,disease,1.0,28427057
36865,VEGF,gene,0.8467,28427057
36866,aflibercept,gene,0.9907,28421399
36867,Eylea,gene,0.6157,28421399
36868,neovascular age-related macular degeneration,disease,1.0,28421399
36869,aflibercept,gene,0.984,28421399
36870,neovascular age-related macular degeneration,disease,1.0,28421399
36871,nAMD,disease,1.0,28421399
36872,nAMD,disease,1.0,28421399
36873,aflibercept,gene,0.9766,28421399
36874,Eylea,gene,0.582,28421399
36875,PCA,drug,0.892,28421399
36876,CRA,DNA,0.7007,28421399
36877,PCA,DNA,0.6035,28421399
36878,aflibercept,gene,0.9824,28421399
36879,Aflibercept,gene,0.976,28419391
36880,Diabetic Macular Edema,disease,1.0,28419391
36881,Ranibizumab,gene,0.7944,28419391
36882,Bevacizumab,gene,0.639,28419391
36883,Aflibercept,gene,0.9478,28413405
36884,Radiation Maculopathy,disease,0.987,28413405
36885,Nasopharyngeal Cancer,disease,1.0,28413405
36886,aflibercept,gene,0.9897,28413405
36887,radiation maculopathy,disease,1.0,28413405
36888,nasopharyngeal cancer,disease,1.0,28413405
36889,nasopharyngeal cancer,disease,1.0,28413405
36890,bevacizumab,gene,0.87,28413405
36891,bevacizumab,gene,0.78,28413405
36892,aflibercept,gene,0.9595,28413405
36893,aflibercept,gene,0.973,28413405
36894,hemorrhages,disease,0.999,28413405
36895,microaneurysms,disease,1.0,28413405
36896,aflibercept,gene,0.9805,28413405
36897,aflibercept,gene,0.99,28413405
36898,macular edema,disease,0.9985,28413405
36899,radiation maculopathy,disease,1.0,28413405
36900,RANIBIZUMAB,drug,0.9985,28406859
36901,AFLIBERCEPT,drug,0.983,28406859
36902,aflibercept,gene,0.9756,28406859
36903,ranibizumab,gene,0.6294,28406859
36904,neovascular age-related macular degeneration,disease,1.0,28406859
36905,ranibizumab,gene,0.8804,28406859
36906,aflibercept,gene,0.9688,28406859
36907,ranibizumab,gene,0.7407,28406859
36908,aflibercept,gene,0.93,28406859
36909,Diabetic Retinopathy,disease,1.0,28406859
36910,ranibizumab,gene,0.797,28406859
36911,aflibercept,gene,0.9614,28405787
36912,macular oedema,disease,1.0,28405787
36913,central retinal vein occlusion,disease,1.0,28405787
36914,ranibizumab,gene,0.6235,28405787
36915,ranibizumab,gene,0.926,28405787
36916,aflibercept,gene,0.942,28405787
36917,macular oedema,disease,1.0,28405787
36918,central retinal vein occlusion,disease,1.0,28405787
36919,CRVO,disease,1.0,28405787
36920,CRVO,disease,1.0,28405787
36921,macular oedema,disease,1.0,28405787
36922,ranibizumab,gene,0.642,28405787
36923,intraretinal fluid,disease,0.976,28405787
36924,aflibercept,gene,0.9497,28405787
36925,macular oedema,disease,1.0,28405787
36926,CRVO,disease,1.0,28405787
36927,ranibizumab,gene,0.8984,28405787
36928,intraretinal fluid,disease,0.601,28405787
36929,aflibercept,gene,0.7983,28405787
36930,aflibercept,gene,0.9844,28405787
36931,oedema,disease,0.542,28405787
36932,Aflibercept,gene,0.6514,28405787
36933,macular oedema,disease,1.0,28405787
36934,CRVO,disease,1.0,28405787
36935,ranibizumab,gene,0.75,28405787
36936,Aflibercept,gene,0.8594,28402983
36937,Neovascular Age-Related Macular Degeneration,disease,1.0,28402983
36938,aflibercept,gene,0.9546,28402983
36939,neovascular age-related macular degeneration,disease,1.0,28402983
36940,tAMD,disease,1.0,28402983
36941,tAMD,disease,1.0,28402983
36942,pigment epithelial detachment,disease,1.0,28402983
36943,aflibercept,gene,0.9863,28393046
36944,ruptured retinal arterial macroaneurysm,disease,0.885,28393046
36945,aflibercept,gene,0.9893,28393034
36946,neovascular age-related macular degeneration,disease,1.0,28393034
36947,aflibercept,gene,0.954,28393034
36948,patients,species,0.9736,28393034
36949,neovascular age-related macular degeneration,disease,1.0,28393034
36950,nAMD,disease,1.0,28393034
36951,ranibizumab,gene,0.809,28393034
36952,patients,species,0.986,28393034
36953,nAMD,disease,1.0,28393034
36954,ranibizumab,gene,0.5806,28393034
36955,Patients,species,0.9688,28393034
36956,aflibercept,gene,0.977,28393034
36957,patients,species,0.966,28393034
36958,aflibercept,gene,0.958,28393034
36959,aflibercept,gene,0.969,28393034
36960,BCVA,disease,1.0,28393034
36961,aflibercept,gene,0.9844,28393034
36962,infectious endophthalmitis,disease,1.0,28393034
36963,aflibercept,gene,0.9883,28393034
36964,patients,species,0.9106,28393034
36965,nAMD,disease,1.0,28393034
36966,ranibizumab,gene,0.866,28393034
36967,bevacizumab,gene,0.9346,28391371
36968,aflibercept,gene,0.9727,28391371
36969,diabetic macular edema,disease,1.0,28391371
36970,bevacizumab,gene,0.8887,28389701
36971,aflibercept,gene,0.957,28389701
36972,diabetic macular edema,disease,1.0,28389701
36973,Sterile Inflammation,disease,1.0,28386497
36974,Hypopyon,disease,0.991,28386497
36975,diabetic,disease,1.0,28386497
36976,patient,species,0.964,28386497
36977,cataract,disease,0.999,28386497
36978,rubeosis,disease,1.0,28386497
36979,ocular ischemic syndrome,disease,1.0,28386497
36980,aflibercept,gene,0.9907,28386497
36981,triamcinolone acetonide,drug,0.997,28386497
36982,cataract,disease,0.9976,28386497
36983,sterile anterior segment inflammation,disease,0.9995,28386497
36984,hypopyon,disease,0.9717,28386497
36985,sterile inflammation,disease,1.0,28386497
36986,sterile inflammation,disease,1.0,28386497
36987,cataract,disease,1.0,28386497
36988,prednisolone acetate,drug,0.994,28386497
36989,ocular ischemic syndrome,disease,1.0,28386497
36990,sterile inflammation,disease,0.994,28386497
36991,Neovascular Age-Related Macular,disease,1.0,28384009
36992,patients,species,0.988,28384009
36993,ranibizumab,gene,0.6475,28384009
36994,aflibercept,gene,0.969,28384009
36995,neovascular age-related macular degeneration,disease,1.0,28384009
36996,AMD,disease,1.0,28384009
36997,patients,species,0.9927,28384009
36998,neovascular AMD,disease,1.0,28384009
36999,polypoidal choroidal vasculopathy,disease,1.0,28384009
37000,PCV,disease,1.0,28384009
37001,ranibizumab,gene,0.813,28384009
37002,aflibercept,gene,0.945,28384009
37003,patients,species,0.984,28384009
37004,ranibizumab,gene,0.552,28384009
37005,patients,species,0.969,28384009
37006,neovascular AMD,disease,1.0,28384009
37007,patients,species,0.9834,28384009
37008,ranibizumab,gene,0.901,28384009
37009,aflibercept,gene,0.9863,28384009
37010,PCV,disease,0.9995,28384009
37011,patients,species,0.9854,28384009
37012,ranibizumab,gene,0.6943,28384009
37013,aflibercept,gene,0.9863,28384009
37014,patients,species,0.976,28384009
37015,ranibizumab,gene,0.656,28384009
37016,Aflibercept,gene,0.9526,28379655
37017,Neovascular Age-Related Macular Degeneration,disease,1.0,28379655
37018,aflibercept,gene,0.9805,28379655
37019,neovascular age-related macular degeneration,disease,1.0,28379655
37020,nAMD,disease,1.0,28379655
37021,vascular endothelial growth factor,gene,0.9966,28379655
37022,nAMD,disease,1.0,28379655
37023,blindness,disease,1.0,28379655
37024,visual impairment,disease,1.0,28379655
37025,aflibercept,gene,0.973,28379655
37026,nAMD,disease,1.0,28379655
37027,Retinal Vein Occlusion,disease,0.9995,28376554
37028,macular oedema,disease,1.0,28376554
37029,retinal vein occlusion,disease,1.0,28376554
37030,aflibercept,gene,0.9863,28376554
37031,bevacizumab,gene,0.827,28376554
37032,ranibizumab,gene,0.784,28376554
37033,anti-VEGF,gene,0.9834,28376554
37034,cataract,disease,1.0,28376554
37035,dexamethasone,drug,0.992,28376554
37036,macular oedema,disease,1.0,28376554
37037,fluorescein,drug,0.998,28376554
37038,ischemic retina,disease,0.983,28376554
37039,oedema,disease,0.9995,28376554
37040,retinal ischemia,disease,0.999,28376554
37041,rubeosis iridis,disease,1.0,28376554
37042,glaucoma,disease,0.9995,28376554
37043,Diabetic retinopathy,disease,1.0,28376510
37044,diabetic macular edema,disease,1.0,28376510
37045,DME,disease,1.0,28376510
37046,diabetic retinopathy,disease,1.0,28376510
37047,ranibizumab,gene,0.9053,28376510
37048,aflibercept,gene,0.925,28376510
37049,fluocinolone acetonide,drug,0.9985,28376510
37050,DME,disease,1.0,28376510
37051,diabetic retinopathy,disease,1.0,28376510
37052,proliferative,disease,0.973,28376510
37053,diabetic retinopathy,disease,0.8247,28376510
37054,diabetic retinopathy,disease,1.0,28376510
37055,retinal nonperfusion,disease,0.997,28376510
37056,diabetic retinopathy,disease,1.0,28376510
37057,diabetic retinopathy,disease,1.0,28376510
37058,visual loss,disease,0.9995,28376510
37059,DME,disease,1.0,28376510
37060,proliferative diabetic retinopathy,disease,0.8677,28376510
37061,diabetic retinopathy,disease,1.0,28376510
37062,vascular endothelial growth factor,gene,0.998,28376510
37063,diabetic retinopathy,disease,1.0,28376510
37064,retinal,DNA,0.5073,28376510
37065,aflibercept,gene,0.9785,28373914
37066,diabetic macular edema,disease,0.9995,28373914
37067,VEGF,gene,0.939,28373914
37068,diabetic macular edema,disease,0.962,28373914
37069,chronic DME,disease,0.9985,28373914
37070,bevacizumab,gene,0.891,28373914
37071,ranibizumab,gene,0.7705,28373914
37072,aflibercept,gene,0.9805,28373914
37073,diabetic macular edema,disease,1.0,28373914
37074,DME,disease,1.0,28373914
37075,aflibercept,gene,0.97,28373914
37076,DME,disease,1.0,28373914
37077,aflibercept,gene,0.95,28373914
37078,DME,disease,1.0,28373914
37079,DME,disease,1.0,28373914
37080,CRT,DNA,0.56,28373914
37081,aflibercept,gene,0.982,28373914
37082,aflibercept,gene,0.969,28373914
37083,diabetic macular edema,disease,1.0,28373914
37084,aflibercept,gene,0.975,28373914
37085,aflibercept,gene,0.986,28373914
37086,ziv-aflibercept,gene,0.9653,28371171
37087,macular oedema,disease,0.9834,28371171
37088,branch retinal vein occlusion,disease,1.0,28371171
37089,patients,species,0.963,28368974
37090,neovascular age-related macular degeneration,disease,1.0,28368974
37091,vascular endothelial growth factor,gene,0.8887,28368974
37092,patients,species,0.969,28368974
37093,neovascular age-related macular degeneration,disease,1.0,28368974
37094,PED,disease,0.996,28368974
37095,aflibercept,gene,0.9775,28368974
37096,Diabetic Retinopathy,disease,1.0,28368974
37097,neovascular age-related macular degeneration,disease,1.0,28368974
37098,PED,disease,0.999,28368974
37099,ranibizumab,gene,0.825,28368974
37100,aflibercept,gene,0.8936,28368974
37101,aflibercept,gene,0.9526,28368974
37102,Aflibercept,gene,0.956,28365905
37103,Macular Oedema,disease,1.0,28365905
37104,Branch Retinal Vein Occlusion,disease,1.0,28365905
37105,Aflibercept,gene,0.9766,28365905
37106,Eylea,gene,0.7534,28365905
37107,human,species,0.992,28365905
37108,macular oedema,disease,1.0,28365905
37109,branch retinal vein occlusion,disease,1.0,28365905
37110,BRVO,disease,1.0,28365905
37111,Aflibercept,gene,0.98,28365905
37112,vascular endothelial growth factor (VEGF)-A,gene,0.9985,28365905
37113,placental growth factor,gene,0.9985,28365905
37114,PIGF,gene,0.993,28365905
37115,cognate,DNA,0.568,28365905
37116,patient,species,0.7285,28365905
37117,aflibercept,gene,0.9717,28365905
37118,Diabetic Retinopathy,disease,1.0,28365905
37119,aflibercept,gene,0.9795,28365905
37120,aflibercept,gene,0.9883,28365905
37121,aflibercept,gene,0.9946,28365905
37122,Aflibercept,gene,0.9795,28365905
37123,aflibercept,gene,0.969,28365905
37124,macular oedema,disease,1.0,28365905
37125,BRVO,disease,1.0,28365905
37126,posterior reversible encephalopathy syndrome,disease,1.0,30730661
37127,Posterior reversible encephalopathy syndrome,disease,1.0,30730661
37128,PRES,disease,1.0,30730661
37129,neurological disorder,disease,1.0,30730661
37130,headache,disease,1.0,30730661
37131,visual disturbances,disease,0.9995,30730661
37132,seizures,disease,0.9995,30730661
37133,impaired consciousness,disease,0.9995,30730661
37134,cerebral oedema,disease,1.0,30730661
37135,cerebral haemorrhage,disease,1.0,30730661
37136,ischaemia,disease,1.0,30730661
37137,PRES,disease,1.0,30730661
37138,hypertension,disease,1.0,30730661
37139,pre-eclampsia,disease,1.0,30730661
37140,eclampsia,disease,1.0,30730661
37141,acute kid- ney injury,disease,1.0,30730661
37142,VEGF,gene,0.995,30730661
37143,fluid and sodium retention,disease,0.98,30730661
37144,sodium,drug,0.988,30730661
37145,STENOTROPHOMONAS MALTOPHILIA ENDOPHTHALMITIS,disease,0.959,28358745
37146,Endophthalmitis,disease,1.0,28358745
37147,Stenotrophomonas maltophilia,species,0.9595,28358745
37148,cataract,disease,0.679,28358745
37149,open globe injuries,disease,0.9595,28358745
37150,endophthalmitis,disease,0.999,28358745
37151,aflibercept,gene,0.9907,28358745
37152,anti-,disease,0.9985,28358745
37153,vascular endothelial growth factor,gene,0.9976,28358745
37154,diabetic macular edema,disease,1.0,28358745
37155,aflibercept,gene,0.9863,28358745
37156,endophthalmitis,disease,1.0,28358745
37157,conjunctival congestion,disease,0.9966,28358745
37158,anterior chamber,cell_type,0.4663,28358745
37159,hypopyon,disease,0.999,28358745
37160,dense,disease,0.6084,28358745
37161,vitritis,disease,0.823,28358745
37162,S. maltophilia,species,0.9624,28358745
37163,ceftazidime,drug,0.996,28358745
37164,vitritis,disease,0.999,28358745
37165,hypopyon,disease,0.995,28358745
37166,Stenotrophomonas maltophilia,disease,1.0,28358745
37167,aflibercept,gene,0.9893,28356711
37168,ranibizumab,gene,0.803,28356711
37169,diabetic macular edema,disease,1.0,28356711
37170,aflibercept,gene,0.992,28356711
37171,ranibizumab,gene,0.7373,28356711
37172,diabetic macular edema,disease,1.0,28356711
37173,DME,disease,1.0,28356711
37174,visual loss,disease,1.0,28356711
37175,PATIENTS,species,0.937,28356711
37176,DME,disease,0.9976,28356711
37177,aflibercept,gene,0.98,28356711
37178,ranibizumab,gene,0.8613,28356711
37179,aflibercept,gene,0.9917,28356711
37180,ranibizumab,gene,0.6553,28356711
37181,Aflibercept,gene,0.8726,28356711
37182,ranibizumab,gene,0.8345,28356711
37183,DME,disease,0.9995,28356711
37184,visual loss,disease,0.992,28356711
37185,aflibercept,gene,0.9814,28356711
37186,Tspan12,gene,0.967,28356444
37187,Vasoproliferative Retinopathy,disease,1.0,28356444
37188,-Catenin,gene,0.992,28356444
37189,vasoproliferative diseases,disease,1.0,28356444
37190,Tspan12,gene,0.4995,28356444
37191,neovascular disease,disease,1.0,28356444
37192,vasoproliferative diseases,disease,1.0,28356444
37193,retinal neovascular disease,disease,1.0,28356444
37194,mouse,species,0.9663,28356444
37195,oxygen,drug,0.9995,28356444
37196,very low density lipoprotein receptor,gene,0.997,28356444
37197,mouse,species,0.9775,28356444
37198,Tspan,gene,0.9937,28356444
37199,-catenin,gene,0.9966,28356444
37200,human combinatorial antibody (Ab) library,DNA,0.8667,28356444
37201,Tspan12,gene,0.4858,28356444
37202,vascular endothelial cells,cell_type,0.863,28356444
37203,oxygen,drug,0.9995,28356444
37204,retinopathy,disease,0.99,28356444
37205,very low density lipoprotein receptor,gene,0.998,28356444
37206,mouse,species,0.9673,28356444
37207,anti-Tspan12 Ab,gene,0.988,28356444
37208,endothelial cell,cell_type,0.9126,28356444
37209,Tspan12,gene,0.9844,28356444
37210,Frizzled-4,gene,0.9917,28356444
37211,-catenin,gene,0.9927,28356444
37212,target genes,DNA,0.8506,28356444
37213,vascular endothelial cells,cell_type,0.92,28356444
37214,Tspan12,gene,0.5386,28356444
37215,-catenin,gene,0.9956,28356444
37216,oxygen,drug,0.9995,28356444
37217,retinopathy,disease,0.891,28356444
37218,very low,disease,0.6377,28356444
37219,very low density lipoprotein receptor,gene,0.995,28356444
37220,mouse,species,0.9717,28356444
37221,proliferative retinopathy,disease,0.9897,28356444
37222,vascular endothelial growth factor,gene,0.999,28356444
37223,Aflibercept,gene,0.9595,28356444
37224,Tspan12,gene,0.9883,28356444
37225,anti-vascular endothelial growth factor,gene,0.9634,28356444
37226,Tspan12,gene,0.511,28356444
37227,-catenin,gene,0.9956,28356444
37228,vasoproliferative disease,disease,1.0,28356444
37229,anti-Tspan12 antibody,gene,0.974,28356444
37230,vasoproliferative retinopathy,disease,1.0,28356444
37231,anti- vascular endothelial growth factor,gene,0.955,28356444
37232,Retinal Vein Occlusions,disease,0.9995,28351046
37233,Retinal vein occlusions,disease,1.0,28351046
37234,RVOs,disease,1.0,28351046
37235,retinal vascular disorders,disease,1.0,28351046
37236,dilatation,disease,0.8306,28351046
37237,retinal and subretinal hemorrhages,disease,1.0,28351046
37238,macular edema,disease,1.0,28351046
37239,retinal ischemia,disease,1.0,28351046
37240,fluorescein,drug,0.9995,28351046
37241,indocyanine green,drug,0.999,28351046
37242,ICG,drug,0.9946,28351046
37243,RVOs,disease,0.9995,28351046
37244,RVOs,disease,1.0,28351046
37245,RVOs,disease,1.0,28351046
37246,fluorescein,drug,0.999,28351046
37247,ICG,drug,0.9653,28351046
37248,cystoid macular edema,disease,1.0,28351046
37249,ischemia,disease,0.9746,28351046
37250,photoreceptors,cell_type,0.745,28351046
37251,RVO,disease,1.0,28351046
37252,RVOs,disease,0.773,28351046
37253,macular edema,disease,1.0,28351046
37254,triamcinolone,drug,0.9995,28351046
37255,fluocinolone,drug,0.999,28351046
37256,dexamethasone,drug,0.998,28351046
37257,VEGF,gene,0.9814,28351046
37258,vascular endothelial growth factor,gene,0.9985,28351046
37259,bevacizumab,gene,0.9043,28351046
37260,ranibizumab,gene,0.9497,28351046
37261,aflibercept,gene,0.976,28351046
37262,steroids,drug,0.8525,28351046
37263,cataract,disease,1.0,28351046
37264,ocular hypertension,disease,1.0,28351046
37265,Aflibercept,gene,0.9575,28348885
37266,Diabetic Macular Edema,disease,1.0,28348885
37267,Patients,species,0.9927,28348885
37268,aflibercept,gene,0.9756,28348885
37269,patients,species,0.9673,28348885
37270,diabetic macular edema,disease,1.0,28348885
37271,DME,disease,1.0,28348885
37272,VEGF,gene,0.5703,28348885
37273,DME,disease,1.0,28348885
37274,anti-VEGF,gene,0.9688,28348885
37275,aflibercept,gene,0.974,28348885
37276,patients,species,0.9746,28348885
37277,anti-VEGF,gene,0.9805,28348885
37278,aflibercept,gene,0.987,28348885
37279,CRT,DNA,0.5586,28348885
37280,BCVA,DNA,0.448,28348885
37281,patients,species,0.967,28348885
37282,patients,species,0.982,28348885
37283,DME,disease,1.0,28348885
37284,patients,species,0.993,28348885
37285,ranibizumab,gene,0.92,28348885
37286,aflibercept,gene,0.9663,28348885
37287,VEGF,gene,0.6797,28348882
37288,Diabetic Macular Edema,disease,1.0,28348882
37289,Diabetic macular edema,disease,1.0,28348882
37290,DME,disease,1.0,28348882
37291,vision loss,disease,0.9966,28348882
37292,diabetic,disease,1.0,28348882
37293,Diabetic Retinopathy,disease,1.0,28348882
37294,vision,disease,0.9727,28348882
37295,DME,disease,1.0,28348882
37296,DME,disease,1.0,28348882
37297,bevacizumab,gene,0.9214,28348882
37298,ranibizumab,gene,0.9224,28348882
37299,aflibercept,gene,0.9585,28348882
37300,aflibercept,gene,0.947,28341388
37301,exudative age-related macular degeneration,disease,1.0,28341388
37302,VEGF,gene,0.9688,28341388
37303,neovascular age-related macular degeneration,disease,0.999,28341388
37304,AMD,disease,1.0,28341388
37305,aflibercept,gene,0.8784,28341388
37306,exudative AMD,disease,1.0,28341388
37307,aflibercept,gene,0.9204,28341388
37308,BCVA,cell_type,0.3918,28341388
37309,CONCLUSION,gene,0.5757,28341388
37310,Aflibercept,gene,0.617,28341388
37311,aflibercept,gene,0.9697,28336285
37312,patients,species,0.9536,28336285
37313,fibrovascular pigment,disease,0.9365,28336285
37314,Aflibercept,gene,0.9478,28335948
37315,Bevacizumab,gene,0.8613,28335948
37316,Ranibizumab,gene,0.8447,28335948
37317,diabetic macular,disease,1.0,28335948
37318,AFLIBERCEPT,gene,0.8813,28333879
37319,aflibercept,gene,0.9917,28333879
37320,patients,species,0.94,28333879
37321,ocular histoplasmosis syndrome,disease,0.928,28333879
37322,choroidal neovascularization,disease,1.0,28333879
37323,patients,species,0.96,28333879
37324,ocular histoplasmosis syndrome,disease,1.0,28333879
37325,choroidal neovascularization,disease,0.9995,28333879
37326,patients,species,0.975,28333879
37327,participants,species,0.978,28333879
37328,men,species,0.9673,28333879
37329,women,species,0.9834,28333879
37330,participants,species,0.9844,28333879
37331,endophthalmitis,disease,1.0,28333879
37332,retinal tears,disease,1.0,28333879
37333,detachments,disease,0.884,28333879
37334,vitreous hemorrhage,disease,1.0,28333879
37335,aflibercept,gene,0.9805,28333879
37336,ocular diseases,disease,0.9497,28332616
37337,vascular endothelial growth factor,gene,0.998,28332616
37338,VEGF,gene,0.9966,28332616
37339,aflibercept,gene,0.9634,28332616
37340,ranibizumab,gene,0.78,28332616
37341,patients,species,0.958,28332616
37342,retinal vascular diseases,disease,1.0,28332616
37343,amino-acid,drug,0.9795,28332616
37344,human,species,0.9907,28332616
37345,rabbit,species,0.984,28332616
37346,monkey,species,0.8887,28332616
37347,VEGF,gene,0.6206,28332616
37348,VEGF,gene,0.995,28332616
37349,retinal disease,disease,1.0,28332616
37350,retinal disease,disease,1.0,28332616
37351,Ranibizumab,gene,0.924,28318715
37352,macular edema,disease,1.0,28318715
37353,Retinal Pigment Epithelium,cell_type,0.455,28316836
37354,Patients,species,0.99,28316836
37355,RPE,cell_type,0.7153,28316836
37356,neovascular age-related macular degeneration,disease,1.0,28316836
37357,nAMD,disease,1.0,28316836
37358,RPE,cell_type,0.67,28316836
37359,patients,species,0.9785,28316836
37360,ranibizumab,gene,0.935,28316836
37361,patients,species,0.9766,28316836
37362,aflibercept,gene,0.9604,28316836
37363,aflibercept,gene,0.9478,28316836
37364,RPE,cell_type,0.639,28316836
37365,patients,species,0.9863,28316836
37366,RPE,cell_type,0.647,28316836
37367,patients,species,0.9824,28316836
37368,ranibizumab,gene,0.8315,28316836
37369,RPE,cell_type,0.4739,28316836
37370,patients,species,0.9424,28316836
37371,ranibizumab,gene,0.678,28316836
37372,RPE,cell_type,0.458,28316836
37373,aflibercept,gene,0.9775,28316836
37374,patients,species,0.9785,28316836
37375,RPE,cell_type,0.5645,28316836
37376,patients,species,0.973,28316836
37377,ranibizumab,gene,0.7803,28316836
37378,patients,species,0.8057,28316836
37379,aflibercept,gene,0.985,28316836
37380,aflibercept,gene,0.9546,28316836
37381,VEGF,gene,0.871,28315512
37382,ranibizumab,gene,0.8667,28315512
37383,aflibercept,gene,0.9697,28315512
37384,age-related choroidal neovascularization,disease,1.0,28315512
37385,VEGF,gene,0.8228,28306392
37386,VEGF,gene,0.645,28306392
37387,tuberculin,gene,0.9907,28306392
37388,bevacizumab,gene,0.8345,28306392
37389,ranibizumab,gene,0.7773,28306392
37390,aflibercept,gene,0.9395,28306392
37391,tuberculin,gene,0.992,28306392
37392,VEGF,gene,0.537,28306392
37393,tuberculin,gene,0.838,28306392
37394,Vascular Endothelial Growth Factor,gene,0.9663,28301850
37395,Neovascular Age-Related Macular Degeneration,disease,1.0,28301850
37396,neovascular age-related macular degeneration,disease,1.0,28301850
37397,AMD,disease,1.0,28301850
37398,neovascular AMD,disease,1.0,28301850
37399,vascular endothelial growth factor,gene,0.967,28301850
37400,VEGF,gene,0.8115,28301850
37401,VMA,drug,0.882,28301850
37402,VMA,drug,0.646,28301850
37403,VMA,disease,0.999,28301850
37404,VMA,drug,0.996,28301850
37405,VMA,drug,0.994,28301850
37406,BCVA,DNA,0.4717,28301850
37407,VMA,drug,0.9985,28301850
37408,neovascular AMD,disease,1.0,28301850
37409,VEGF,gene,0.7725,28301850
37410,ALLERGIC REACTION,disease,0.999,28301410
37411,vascular endothelial growth factor,gene,0.996,28301410
37412,bevacizumab,gene,0.583,28301410
37413,choroidal neovascularization,disease,1.0,28301410
37414,hypersensitivity,disease,1.0,28301410
37415,bevacizumab,gene,0.6113,28301410
37416,pegaptanib,drug,0.928,28301410
37417,aflibercept,gene,0.905,28301410
37418,murine,species,0.962,28301410
37419,pegaptanib,drug,0.9937,28301410
37420,aflibercept,gene,0.985,28301410
37421,pegaptanib,drug,0.9946,28301410
37422,aflibercept,gene,0.9546,28301410
37423,bevacizumab,gene,0.7886,28301410
37424,Ranibizumab,gene,0.907,28297035
37425,Aflibercept,gene,0.9614,28297035
37426,Diabetic Macular Edema,disease,1.0,28297035
37427,Bevacizumab,gene,0.898,28297035
37428,ranibizumab,gene,0.622,28297035
37429,Lucentis,gene,0.4883,28297035
37430,aflibercept,gene,0.963,28297035
37431,Eylea,gene,0.6685,28297035
37432,diabetic macular edema,disease,1.0,28297035
37433,DME,disease,1.0,28297035
37434,bevacizumab,gene,0.717,28297035
37435,PATIENTS,species,0.921,28297035
37436,DME,disease,1.0,28297035
37437,bevacizumab,gene,0.7476,28297035
37438,ranibizumab,gene,0.6665,28297035
37439,aflibercept,gene,0.7964,28297035
37440,aflibercept,gene,0.974,28297035
37441,aflibercept,gene,0.9927,28297035
37442,ranibizumab,drug,0.743,28297035
37443,ranibizumab,drug,0.6357,28297035
37444,ranibizumab,gene,0.6846,28297035
37445,aflibercept,gene,0.982,28297035
37446,aflibercept,gene,0.993,28297035
37447,ranibizumab,gene,0.7305,28297035
37448,Aflibercept,gene,0.692,28297035
37449,bevacizumab,gene,0.8716,28297035
37450,Aflibercept,gene,0.977,28285714
37451,Osteonecrosis of the jaw,disease,1.0,28280634
37452,ziv-aflibercept,gene,0.966,28280634
37453,aflibercept,gene,0.9854,28279730
37454,human VEGF,gene,0.989,28279730
37455,tumors,disease,1.0,28279730
37456,ophthalmological diseases,disease,0.998,28279730
37457,age-related macular degeneration,disease,0.817,28279730
37458,AMD,disease,1.0,28279730
37459,diabetic retinopathy,disease,1.0,28279730
37460,AMD,disease,1.0,28279730
37461,aflibercept,gene,0.9854,28279730
37462,Aflibercept,gene,0.976,28279730
37463,vascular endothelial growth factor (VEGF) receptors,gene,0.961,28279730
37464,VEGF,gene,0.9937,28279730
37465,VEGF,gene,0.9946,28279730
37466,aflibercept,gene,0.98,28279730
37467,macular degeneration,disease,1.0,28279730
37468,AMD,disease,1.0,28279730
37469,VEGF,gene,0.993,28279730
37470,aflibercept,gene,0.9917,28279730
37471,VEGF,gene,0.993,28279730
37472,human umbilical vein endothelial cells,cell_type,0.8667,28279730
37473,HUVEC,cell_line,0.753,28279730
37474,aflibercept,gene,0.9897,28279730
37475,human VEGF,gene,0.9937,28279730
37476,aflibercept,gene,0.987,28279730
37477,VEGF,gene,0.994,28279730
37478,HUVEC,cell_line,0.795,28279730
37479,aflibercept,gene,0.992,28279730
37480,ziv-aflibercept,gene,0.9697,28270485
37481,retinal diseases,disease,1.0,28270485
37482,ziv-aflibercept,gene,0.99,28270485
37483,ziv-aflibercept,gene,0.99,28270485
37484,aflibercept,gene,0.9873,28270485
37485,patients,species,0.9746,28270485
37486,retinal disease,disease,0.9995,28270485
37487,ziv-aflibercept,gene,0.9775,28270485
37488,ocular inflammation,disease,1.0,28270485
37489,lens opacities,disease,1.0,28270485
37490,patients,species,0.9673,28270485
37491,BCVA,cell_type,0.4194,28270485
37492,iritis,disease,1.0,28270485
37493,lens opacity,disease,1.0,28270485
37494,endophthalmitis,disease,1.0,28270485
37495,ziv-aflibercept,gene,0.98,28270485
37496,retinal disease,disease,1.0,28270485
37497,aflibercept,gene,0.977,28266609
37498,vascular endothelial growth factor,gene,0.996,28266609
37499,AMD,disease,1.0,28266609
37500,neovascular AMD,disease,1.0,28266609
37501,polypoidal choroidal vasculopathy,disease,1.0,28266609
37502,PCV,disease,1.0,28266609
37503,aflibercept,gene,0.962,28266609
37504,exudative AMD,disease,0.998,28266609
37505,T,DNA,0.5273,28266609
37506,ARMS2,DNA,0.734,28266609
37507,ARMS2 A69S,gene,0.7896,28266609
37508,A69S (rs10490924) variants,DNA,0.6187,28266609
37509,A69,mutation,,28266609
37510,rs10490924,gene,0.768,28266609
37511,rs1049092,mutation,,28266609
37512,T,DNA,0.6416,28266609
37513,T-allele,RNA,0.4768,28266609
37514,ARMS2 gene,gene,0.992,28266609
37515,ARMS2,DNA,0.783,28266609
37516,ARMS2 genotypes,gene,0.935,28266609
37517,exudative AMD,disease,0.9795,28266609
37518,ranibizumab,gene,0.932,28260852
37519,aflibercept,gene,0.9707,28260852
37520,macular edema,disease,1.0,28260852
37521,branch retinal vein occlusion,disease,1.0,28260852
37522,ranibizumab,gene,0.881,28260852
37523,aflibercept,gene,0.966,28260852
37524,macular edema,disease,1.0,28260852
37525,ME,disease,1.0,28260852
37526,BRVO,disease,1.0,28260852
37527,ME,disease,0.9985,28260852
37528,BRVO,disease,1.0,28260852
37529,ranibizumab,gene,0.6973,28260852
37530,aflibercept,gene,0.9585,28260852
37531,ranibizumab,gene,0.891,28260852
37532,aflibercept,gene,0.98,28260852
37533,aflibercept,gene,0.99,28260852
37534,aflibercept,gene,0.977,28260852
37535,aflibercept,gene,0.9736,28260852
37536,aflibercept,gene,0.9805,28260852
37537,aflibercept,gene,0.828,28260852
37538,ranibizumab,gene,0.934,28260852
37539,aflibercept,gene,0.966,28260852
37540,ME,disease,0.998,28260852
37541,BRVO,disease,1.0,28260852
37542,VEGF,gene,0.944,28260851
37543,diabetic macular edema,disease,1.0,28260851
37544,vascular endothelial growth factor,gene,0.9985,28260851
37545,VEGF,gene,0.997,28260851
37546,diabetic,disease,1.0,28260851
37547,macular edema,disease,1.0,28260851
37548,anti-VEGF,gene,0.972,28260851
37549,bevacizumab,gene,0.752,28260851
37550,ranibizumab,gene,0.979,28260851
37551,aflibercept,gene,0.9937,28260851
37552,ranibizumab,gene,0.53,28260851
37553,Aflibercept,gene,0.9067,28259869
37554,Exudative Age-Related Macular Degeneration,disease,1.0,28259869
37555,aflibercept,gene,0.961,28259869
37556,exudative age-related macular degeneration,disease,0.9985,28259869
37557,AMD,disease,1.0,28259869
37558,aflibercept,gene,0.986,28259869
37559,pigment epithelial detachment,disease,0.909,28259869
37560,aflibercept,gene,0.9814,28259869
37561,exudative AMD,disease,0.9917,28259869
37562,colorectal cancer,disease,1.0,28259285
37563,Colorectal cancer,disease,1.0,28259285
37564,CRC,disease,1.0,28259285
37565,cancers,disease,1.0,28259285
37566,cancer,disease,1.0,28259285
37567,patients,species,0.976,28259285
37568,metastatic CRC,disease,0.955,28259285
37569,irinotecan,drug,0.9995,28259285
37570,oxaliplatin,drug,0.9995,28259285
37571,bevacizumab,gene,0.927,28259285
37572,cetuximab,gene,0.9697,28259285
37573,panitumab,gene,0.8745,28259285
37574,aflibercept,gene,0.959,28259285
37575,regorafenib,drug,0.9697,28259285
37576,CRC disease,disease,0.9966,28259285
37577,CRCs,disease,0.932,28259285
37578,patients,species,0.9927,28259285
37579,tumors,disease,1.0,28259285
37580,colorectal cancer,disease,1.0,28259285
37581,Ranibizumab,gene,0.861,28257068
37582,Aflibercept,gene,0.9546,28257068
37583,Human Mller Cells,cell_type,0.828,28257068
37584,Human,species,0.9946,28257068
37585,Photoreceptors,cell_type,0.5786,28257068
37586,vascular endothelial growth factor,gene,0.9546,28257068
37587,VEGF,gene,0.998,28257068
37588,retinal vascular diseases,disease,1.0,28257068
37589,VEGF,gene,0.995,28257068
37590,retinal nonvascular cells,cell_line,0.547,28257068
37591,retinal nonvascular cells,cell_type,0.901,28257068
37592,aflibercept,gene,0.983,28257068
37593,ranibizumab,gene,0.552,28257068
37594,human Mller cells,cell_line,0.94,28257068
37595,human,species,0.9893,28257068
37596,photoreceptors,cell_type,0.6494,28257068
37597,glucose,drug,0.983,28257068
37598,CoCl2-,drug,0.9995,28257068
37599,calcein-AM,drug,0.995,28257068
37600,heat shock proteins,gene,0.9956,28257068
37601,Hsp,gene,0.9946,28257068
37602,thioredoxin 1 and 2,gene,0.927,28257068
37603,TRX1,gene,0.9956,28257068
37604,TRX2,gene,0.9946,28257068
37605,Mller cells,cell_line,0.9487,28257068
37606,interphotoreceptor retinoid-binding protein,gene,0.997,28257068
37607,retinoid,drug,0.719,28257068
37608,IRBP,gene,0.9893,28257068
37609,photoreceptors,cell_type,0.6504,28257068
37610,Aflibercept,gene,0.9805,28257068
37611,ranibizumab,gene,0.642,28257068
37612,aflibercept,gene,0.981,28257068
37613,Hsp60,gene,0.9946,28257068
37614,Hsp90,gene,0.993,28257068
37615,Mller cells,cell_line,0.956,28257068
37616,aflibercept,gene,0.9844,28257068
37617,Hsp60,gene,0.988,28257068
37618,Hsp9,gene,0.9927,28257068
37619,TRX1,gene,0.994,28257068
37620,TRX2,gene,0.992,28257068
37621,photoreceptors,cell_type,0.8086,28257068
37622,Aflibercept,gene,0.945,28257068
37623,IRBP,gene,0.9844,28257068
37624,photoreceptors,cell_type,0.7866,28257068
37625,aflibercept,gene,0.989,28257068
37626,ranibizumab,gene,0.5786,28257068
37627,aflibercept,gene,0.9634,28257068
37628,ranibizumab,gene,0.6187,28257068
37629,photoreceptors,cell_type,0.695,28257068
37630,Gemcitabine,drug,0.9995,28256961
37631,gemcitabine,drug,0.999,28256961
37632,advanced pancreatic cancer,disease,1.0,28256961
37633,advanced tumors,disease,0.99,28256961
37634,gemcitabine,drug,0.998,28256961
37635,gemcitabine,drug,0.9995,28256961
37636,gemcitabine,drug,0.999,28256961
37637,advanced pancreatic cancer,disease,1.0,28256961
37638,gemcitabine,drug,0.9995,28256961
37639,patients,species,0.9795,28256961
37640,erlotinib,drug,0.999,28256961
37641,cetuximab,gene,0.82,28256961
37642,rigosertib,drug,0.9966,28256961
37643,bevacizumab,gene,0.7056,28256961
37644,aflibercept,gene,0.9663,28256961
37645,axitinib,drug,0.9966,28256961
37646,masitinib,drug,0.996,28256961
37647,anti-EGFR,gene,0.8066,28256961
37648,advanced pancreatic cancer,disease,1.0,28256961
37649,pancreatic cancer,disease,1.0,28256961
37650,vascular endothelial growth factor,gene,0.9614,28251077
37651,human retinal pigment epithelial cells,cell_type,0.8726,28251077
37652,glucose,drug,0.9985,28251077
37653,glucose,drug,0.9995,28251077
37654,vascular endothelial growth factor,gene,0.9443,28251077
37655,VEGF,gene,0.9985,28251077
37656,bevacizumab,gene,0.8936,28251077
37657,ranibizumab,gene,0.9116,28251077
37658,aflibercept,gene,0.9663,28251077
37659,ARPE-19 cells,cell_line,0.931,28251077
37660,glucose,drug,0.9976,28251077
37661,MTT,drug,0.9995,28251077
37662,D-glucose,drug,0.999,28251077
37663,EdU,drug,0.839,28251077
37664,VEGF,gene,0.7417,28251077
37665,glucose,drug,0.9985,28251077
37666,ARPE-19 cells,cell_line,0.602,28251077
37667,glucose,drug,0.863,28251077
37668,TUNEL-positive cells,cell_line,0.6626,28251077
37669,glucose,drug,0.9873,28251077
37670,glucose,drug,0.979,28251077
37671,glucose,drug,0.9907,28251077
37672,anti-VEGF,gene,0.7085,28251077
37673,anti-VEGF,gene,0.8623,28251077
37674,glucose,drug,0.9995,28251077
37675,RPE cells,cell_type,0.675,28251077
37676,VEGF,gene,0.919,28251077
37677,RPE cells,cell_type,0.8755,28251077
37678,glucose,drug,0.966,28251077
37679,bevacizumab,gene,0.9014,28238195
37680,aflibercept,gene,0.9116,28238195
37681,bevacizumab,gene,0.8438,28238195
37682,aflibercept,gene,0.927,28238195
37683,patients,species,0.9326,28238195
37684,diabetic macular edema,disease,1.0,28238195
37685,DME,disease,1.0,28238195
37686,Patients,species,0.936,28238195
37687,DME,disease,1.0,28238195
37688,bevacizumab,gene,0.681,28238195
37689,aflibercept,gene,0.973,28238195
37690,participants,species,0.982,28238195
37691,Diabetic Retinopathy,disease,1.0,28238195
37692,patients,species,0.9834,28238195
37693,anti-VEGF,gene,0.907,28238195
37694,BCVA,cell_type,0.4143,28238195
37695,aflibercept,gene,0.9873,28238195
37696,patients,species,0.967,28238195
37697,aflibercept,gene,0.962,28237141
37698,macular edema,disease,1.0,28237141
37699,Aflibercept,gene,0.895,28237140
37700,Refractory Macular Edema,disease,0.999,28237140
37701,aflibercept,gene,0.9883,28231566
37702,age-related macular degeneration,disease,1.0,28231566
37703,AMD,disease,1.0,28231566
37704,AMD,disease,0.9976,28231566
37705,AMD,disease,0.992,28231566
37706,Aflibercept,gene,0.9062,28231566
37707,NEOVASCULAR AGE-RELATED MACULAR DEGENERATION,disease,0.9995,28221254
37708,patients,species,0.989,28221254
37709,neovascular age-related macular degeneration,disease,0.9976,28221254
37710,intraretinal,disease,0.8516,28221254
37711,hemorrhage,disease,0.9927,28221254
37712,fluorescein,drug,0.9946,28221254
37713,patients,species,0.985,28221254
37714,LTR,disease,0.9995,28221254
37715,patients,species,0.9937,28221254
37716,patients,species,0.978,28221254
37717,choroidal neovascular membrane,disease,0.9976,28221254
37718,retinal angiomatous proliferation,disease,1.0,28221254
37719,choroidal neovascular membrane,disease,0.9985,28221254
37720,patients,species,0.97,28221254
37721,retinal angiomatous proliferation,disease,1.0,28221254
37722,retinal angiomatous proliferation,disease,1.0,28221254
37723,patients,species,0.96,28221254
37724,age-related macular degeneration,disease,1.0,28221254
37725,Aflibercept,gene,0.9478,28219508
37726,Bevacizumab,gene,0.8613,28219508
37727,Ranibizumab,gene,0.8447,28219508
37728,diabetic macular,disease,1.0,28219508
37729,Aflibercept,gene,0.9795,28218369
37730,infants,species,0.9146,28218369
37731,aflibercept,gene,0.956,28218369
37732,type 1 retinopathy of prematurity,disease,1.0,28218369
37733,ROP,disease,1.0,28218369
37734,Patients,species,0.944,28218369
37735,type 1 ROP,disease,0.994,28218369
37736,central retinal,DNA,0.469,28218369
37737,infants,species,0.8447,28218369
37738,ROP,disease,0.991,28218369
37739,IVA,drug,0.947,28218369
37740,type 1 ROP,disease,0.9297,28218369
37741,vascular endothelial growth factor,gene,0.9253,28218369
37742,infants,species,0.829,28218369
37743,ROP,disease,0.9873,28218369
37744,VEGF,gene,0.7007,28218367
37745,diabetic retinopathy,disease,1.0,28215618
37746,Ranibizumab,gene,0.864,28214955
37747,aflibercept,gene,0.9653,28214955
37748,macular edema,disease,1.0,28214955
37749,central retinal vein,disease,0.9717,28214955
37750,ranibizumab,gene,0.664,28214955
37751,aflibercept,gene,0.954,28214955
37752,macular edema,disease,1.0,28214955
37753,central retinal vein occlusion,disease,1.0,28214955
37754,CRVO,disease,1.0,28214955
37755,Participants,species,0.809,28214955
37756,patients,species,0.968,28214955
37757,CRVO,disease,1.0,28214955
37758,ranibizumab,gene,0.8706,28214955
37759,aflibercept,gene,0.935,28214955
37760,ranibizumab,gene,0.654,28214955
37761,aflibercept,gene,0.9272,28214955
37762,patients,species,0.972,28214955
37763,ranibizumab,gene,0.8926,28214955
37764,aflibercept,gene,0.9805,28214955
37765,macular edema,disease,1.0,28214955
37766,Ranibizumab,gene,0.798,28214955
37767,aflibercept,gene,0.9478,28214955
37768,patients,species,0.9507,28214955
37769,macular edema,disease,1.0,28214955
37770,CRVO,disease,1.0,28214955
37771,Aflibercept,gene,0.9194,28211882
37772,Neovascular Age Related Macular,disease,0.998,28211882
37773,aflibecept,gene,0.913,28211882
37774,neovascular age,disease,0.9946,28211882
37775,nvAMD,disease,1.0,28211882
37776,bevacizumab,gene,0.9204,28211882
37777,Aflibercept,gene,0.992,28211882
37778,Neovascular Age Related Macular,disease,1.0,28211882
37779,nvAMD,disease,1.0,28211882
37780,bevacizumab,gene,0.8936,28211882
37781,aflibercept,gene,0.965,28211882
37782,patients,species,0.985,28211882
37783,bevacizumab,gene,0.9194,28211882
37784,bevacizumab,gene,0.7705,28211882
37785,aflibercept,gene,0.9814,28211882
37786,aflibercept,gene,0.975,28211882
37787,bevacizumab,gene,0.6304,28211882
37788,vascular endothelial growth factor,gene,0.974,28203056
37789,macular diseases,disease,1.0,28203056
37790,Ranibizumab,gene,0.9106,28203056
37791,aflibercept,gene,0.9688,28203056
37792,endophthalmitis,disease,1.0,28203056
37793,retinal detachment,disease,1.0,28203056
37794,endophthalmitis,disease,1.0,28203056
37795,acute intraocular inflammations,disease,0.9917,28203056
37796,acute intraocular inflammations,disease,0.9985,28203056
37797,endophthalmitis,disease,0.9995,28203056
37798,acute intraocular inflammation,disease,0.999,28203056
37799,endophthalmitis,disease,1.0,28203056
37800,endophthalmitis,disease,0.9995,28203056
37801,acute intraocular inflammation,disease,1.0,28203056
37802,Metastatic Colorectal Cancer,disease,0.9995,28197947
37803,Metastatic colorectal cancer,disease,1.0,28197947
37804,mCRC,disease,1.0,28197947
37805,cancer,disease,1.0,28197947
37806,colorectal tumours,disease,1.0,28197947
37807,mCRC,disease,0.99,28197947
37808,Diabetic Macular Edema,disease,1.0,28195620
37809,Aflibercept,gene,0.974,28195620
37810,diabetic macular edema,disease,0.985,28195620
37811,DME,disease,1.0,28195620
37812,aflibercept,gene,0.9873,28195620
37813,Eylea; Regeneron,gene,0.619,28195620
37814,Ranibizumab,gene,0.6533,28188433
37815,nAMD,disease,1.0,28188433
37816,Neovascular age-related macular degeneration,disease,1.0,28188433
37817,nAMD,disease,1.0,28188433
37818,chronic eye condition,disease,0.886,28188433
37819,deterioration of vision,disease,1.0,28188433
37820,blindness,disease,1.0,28188433
37821,vascular endothelial growth factor,gene,0.998,28188433
37822,nAMD,disease,1.0,28188433
37823,ranibizumab,gene,0.708,28188433
37824,aflibercept,gene,0.913,28188433
37825,ranibizumab,gene,0.754,28188433
37826,ranibizumab,gene,0.826,28188433
37827,nAMD,disease,1.0,28188433
37828,ranibizumab,gene,0.57,28188433
37829,ranibizumab,gene,0.8086,28188433
37830,aflibercept,gene,0.9717,28188433
37831,nAMD,disease,1.0,28188433
37832,Diabetic Retinopathy,disease,0.9946,28188433
37833,ranibizumab,gene,0.587,28188433
37834,aflibercept,gene,0.995,28188433
37835,ranibizumab,gene,0.668,28188433
37836,ranibizumab,gene,0.8726,28188433
37837,aflibercept,gene,0.9653,28188433
37838,ranibizumab,gene,0.842,28188433
37839,ranibizumab,gene,0.899,28188433
37840,aflibercept,gene,0.97,28188433
37841,nAMD,disease,1.0,28188433
37842,patients,species,0.956,28186507
37843,aflibercept,gene,0.9917,28186507
37844,aflibercept,gene,0.9775,28186507
37845,neovascular age-related macular degeneration,disease,0.997,28186507
37846,nAMD,disease,1.0,28186507
37847,patients,species,0.9575,28186507
37848,nAMD,disease,1.0,28186507
37849,aflibercept,gene,0.967,28186507
37850,BCVA,DNA,0.4714,28186507
37851,macular haemorrhage,disease,1.0,28186507
37852,subretinal,disease,0.667,28186507
37853,Uveitic Macular Edema,disease,1.0,28165851
37854,Uveitic (or inflammatory) macular edema,disease,1.0,28165851
37855,UME,disease,1.0,28165851
37856,visual impairment,disease,0.999,28165851
37857,uveitis,disease,1.0,28165851
37858,uveitis,disease,0.999,28165851
37859,macular edema,disease,1.0,28165851
37860,inflammation,disease,0.9375,28165851
37861,edema,disease,1.0,28165851
37862,retinovascular diseases,disease,0.9995,28165851
37863,UME,disease,0.4475,28165851
37864,NEOVASCULAR AGE,disease,0.9946,28145976
37865,MACULAR DEGENERATION,disease,0.783,28145976
37866,aflibercept,gene,0.978,28145976
37867,neovascular age-related macular degeneration,disease,1.0,28145976
37868,neovascular age-related macular degeneration,disease,1.0,28145976
37869,Retinal Blindness,disease,0.9985,28145976
37870,aflibercept,gene,0.971,28145976
37871,aflibercept,gene,0.9766,28145976
37872,ranibizumab,drug,0.5073,28145976
37873,aflibercept,gene,0.937,28145976
37874,neovascular age-related macular degeneration,disease,1.0,28139082
37875,neovascular age-related macular degeneration,disease,1.0,28139082
37876,AMD,disease,1.0,28139082
37877,bevacizumab,gene,0.74,28139082
37878,ranibizumab,gene,0.7544,28139082
37879,aflibercept,gene,0.945,28139082
37880,AMD,disease,0.9995,28139082
37881,small-cell lung cancer,disease,1.0,28138259
37882,Small-cell lung cancer,disease,1.0,28138259
37883,SCLC,disease,1.0,28138259
37884,poorly,disease,0.6206,28138259
37885,SCLC,disease,0.9995,28138259
37886,non-small-cell lung cancer,disease,1.0,28138259
37887,NSCLC,disease,1.0,28138259
37888,SCLC,cell_line,0.6875,28138259
37889,SCLC,disease,0.992,28138259
37890,bevacizumab,gene,0.9077,28138259
37891,paclitaxel,drug,0.999,28138259
37892,SCLC,disease,0.9985,28138259
37893,cisplatin,drug,1.0,28138259
37894,etoposide,drug,0.9985,28138259
37895,bevacizumab,gene,0.8135,28138259
37896,Ziv-aflibercept,gene,0.976,28138259
37897,topotecan,drug,0.9575,28138259
37898,platinum-,disease,0.895,28138259
37899,platinum,drug,0.9995,28138259
37900,SCLC,disease,0.884,28138259
37901,thalidomide,drug,0.993,28138259
37902,sunitinib,drug,0.995,28138259
37903,patients,species,0.986,28138259
37904,platinum,drug,0.9995,28138259
37905,etoposide,drug,0.997,28138259
37906,Serum angiopoietin-2,gene,0.6855,28138259
37907,vascular endothelial growth factor,gene,0.999,28138259
37908,Bevacizumab,gene,0.9272,28138259
37909,ziv-aflibercept,gene,0.9854,28138259
37910,sunitinib,drug,0.997,28138259
37911,Thalidomide,drug,0.9995,28138259
37912,sorafenib,drug,0.9995,28138259
37913,pomalidomide,drug,0.998,28138259
37914,cediranib,drug,0.999,28138259
37915,SCLC,cell_line,0.756,28138259
37916,SCLC,cell_type,0.548,28138259
37917,SCLC,disease,0.9966,28138259
37918,Vascular Toxicity,disease,0.6914,28137223
37919,Thromboembolism,disease,1.0,28137223
37920,Solid Cancer,disease,1.0,28137223
37921,cancer,disease,1.0,28137223
37922,Vascular Endothelial Growth Factor,gene,0.9985,28137223
37923,VEGF,gene,0.994,28137223
37924,VEGF,gene,0.91,28137223
37925,VEGF,gene,0.987,28137223
37926,endothelial dysfunction,disease,1.0,28137223
37927,venous thromboembolism,disease,1.0,28137223
37928,VEGF,gene,0.9937,28137223
37929,VEGF,gene,0.996,28137223
37930,VEGF genetic variants,gene,0.83,28137223
37931,cancer,disease,1.0,28137223
37932,patients,species,0.991,28137223
37933,solid cancer,disease,1.0,28137223
37934,thromboembolic complications,disease,0.725,28137223
37935,cancer,disease,1.0,28137223
37936,patients,species,0.9937,28137223
37937,VEGF gene,DNA,0.8516,28137223
37938,VEGF gene,gene,0.99,28137223
37939,glaucoma,disease,1.0,28127658
37940,patients,species,0.9824,28127658
37941,anti-VEGF,gene,0.7314,28127658
37942,anti-VEGF,gene,0.7783,28127658
37943,retinal ganglion cell,cell_type,0.5522,28127658
37944,patients,species,0.952,28127658
37945,neovascular AMD,disease,1.0,28127658
37946,glaucoma,disease,1.0,28127658
37947,patients,species,0.992,28127658
37948,anti-VEGF,gene,0.7437,28127658
37949,ETDRS,DNA,0.5205,28127658
37950,patients,species,0.986,28127658
37951,anti-VEGF,gene,0.8716,28127658
37952,RGCL,DNA,0.502,28127658
37953,Patients,species,0.939,28127658
37954,glaucoma,disease,1.0,28127658
37955,RGLC,disease,0.9985,28127658
37956,patients,species,0.991,28127658
37957,anti-VEGF,gene,0.899,28127658
37958,glaucoma,disease,1.0,28127658
37959,glaucoma,disease,1.0,28127658
37960,patients,species,0.991,28127658
37961,aflibercept,gene,0.976,28123287
37962,patients,species,0.97,28123287
37963,bevacizumab,gene,0.9517,28123287
37964,ranibizumab,gene,0.9673,28123287
37965,aflibercept,gene,0.912,28123287
37966,patients,species,0.944,28123287
37967,neovascular age-related macular degeneration,disease,1.0,28123287
37968,nAMD,disease,1.0,28123287
37969,patients,species,0.9688,28123287
37970,nAMD,disease,1.0,28123287
37971,vascular,DNA,0.7104,28123287
37972,vascular endothelial growth factor,gene,0.998,28123287
37973,VEGF,gene,0.999,28123287
37974,bevacizumab,gene,0.8784,28123287
37975,ranibizumab,gene,0.5806,28123287
37976,aflibercept,gene,0.9795,28123287
37977,CRT,DNA,0.547,28123287
37978,VEGF,gene,0.563,28123287
37979,patients,species,0.975,28123287
37980,aflibercept,gene,0.9614,28123287
37981,patients,species,0.989,28123287
37982,ziv-aflibercept,gene,0.9907,28119292
37983,choroidal neovascularisation,disease,1.0,28119292
37984,choroidal neovascularisation,disease,1.0,28119292
37985,CNV,disease,1.0,28119292
37986,age-related macular degeneration,disease,1.0,28119292
37987,AMD,disease,1.0,28119292
37988,ziv-aflibercept,gene,0.988,28119292
37989,AMD,disease,1.0,28119292
37990,CNV,disease,0.919,28119292
37991,IVZ,drug,0.665,28119292
37992,patients,species,0.9717,28119292
37993,CNV,disease,1.0,28119292
37994,high myopia,disease,1.0,28119292
37995,macular telangiectasia,disease,1.0,28119292
37996,central serous chorioretinopathy,disease,0.886,28119292
37997,choroidal osteoma,disease,1.0,28119292
37998,choroiditis,disease,1.0,28119292
37999,Best&#39;s disease,disease,0.979,28119292
38000,BCVA,cell_type,0.4412,28119292
38001,patients,species,0.97,28119292
38002,CNV,disease,0.9985,28119292
38003,AMD,disease,1.0,28119292
38004,aflibercept,gene,0.9844,28116649
38005,VEGF trap,gene,0.9155,28116649
38006,vascular endothelial growth factor,gene,0.8804,28116649
38007,VEGF,gene,0.9985,28116649
38008,high-grade gliomas,disease,1.0,28116649
38009,HGG,disease,1.0,28116649
38010,Aflibercept,gene,0.9707,28116649
38011,human,species,0.6777,28116649
38012,VEGF-A,gene,0.9985,28116649
38013,VEGF-B,gene,0.998,28116649
38014,placental growth factor,gene,0.9985,28116649
38015,Adult Brain Tumor,disease,0.8496,28116649
38016,aflibercept,gene,0.991,28116649
38017,temozolomide,drug,0.9985,28116649
38018,TMZ,drug,0.9976,28116649
38019,patients,species,0.966,28116649
38020,HGG,disease,1.0,28116649
38021,aflibercept,gene,0.9883,28116649
38022,temozolomide,drug,0.996,28116649
38023,temozolomide,drug,0.9976,28116649
38024,temozolomide,drug,0.997,28116649
38025,patients,species,0.98,28116649
38026,aflibercept,gene,0.9673,28116649
38027,patients,species,0.9863,28116649
38028,patients,species,0.9775,28116649
38029,deep vein thrombosis,disease,1.0,28116649
38030,neutropenia,disease,1.0,28116649
38031,patients,species,0.9854,28116649
38032,thrombotic microangiopathy,disease,1.0,28116649
38033,rash,disease,1.0,28116649
38034,thrombocytopenia,disease,1.0,28116649
38035,aflibercept,gene,0.941,28116649
38036,patients,species,0.969,28116649
38037,patients,species,0.983,28116649
38038,aflibercept,gene,0.986,28116649
38039,temozolomide,drug,0.9854,28116649
38040,Anti-VEGF,gene,0.917,28114697
38041,VEGF,gene,0.8584,28114697
38042,bevacizumab,gene,0.94,28114697
38043,ranibizumab,gene,0.9224,28114697
38044,aflibercept,gene,0.9526,28114697
38045,patients,species,0.98,28114697
38046,retinal diseases,disease,1.0,28114697
38047,neovascular AMD,disease,1.0,28114697
38048,diabetic macular oedema,disease,1.0,28114697
38049,macular oedema,disease,1.0,28114697
38050,retinal vein occlusion,disease,0.973,28114697
38051,Vascular Endothelial Growth Factor,gene,0.9736,28114590
38052,Pachychoroid,disease,1.0,28114590
38053,intraocular vascular endothelial growth factor,gene,0.8647,28114590
38054,VEGF,gene,0.9956,28114590
38055,pachychoroid neovasculopathy,disease,1.0,28114590
38056,neovascular age-related macular degeneration,disease,0.9995,28114590
38057,nAMD,disease,1.0,28114590
38058,anti-VEGF,gene,0.883,28114590
38059,pachychoroid neovasculopathy,disease,1.0,28114590
38060,nAMD,disease,1.0,28114590
38061,anti-VEGF,gene,0.7803,28114590
38062,VEGF,gene,0.993,28114590
38063,VEGF,gene,0.725,28114590
38064,VEGF,gene,0.996,28114590
38065,pachychoroid neovasculopathy,disease,1.0,28114590
38066,nAMD,disease,1.0,28114590
38067,VEGF,gene,0.9937,28114590
38068,drusen,disease,0.795,28114590
38069,VEGF,gene,0.91,28114590
38070,pachychoroid neovasculopathy,disease,1.0,28114590
38071,Dry macula,disease,1.0,28114590
38072,VEGF,gene,0.996,28114590
38073,pachychoroid neovasculopathy,disease,1.0,28114590
38074,nAMD,disease,0.9155,28114590
38075,VEGF,gene,0.9956,28114590
38076,pachychoroid neovasculopathy,disease,1.0,28114590
38077,nAMD,disease,1.0,28114590
38078,VEGF,gene,0.9917,28114590
38079,pachychoroid neovasculopathy,disease,1.0,28114590
38080,nAMD,disease,1.0,28114590
38081,aflibercept,gene,0.9854,28106709
38082,bevacizumab,gene,0.761,28106709
38083,ranibizumab,gene,0.664,28106709
38084,patients,species,0.9507,28106709
38085,neovascular age-related macular degeneration,disease,1.0,28106709
38086,AMD,disease,1.0,28106709
38087,diabetic macular edema,disease,1.0,28106709
38088,DME,disease,1.0,28106709
38089,retinal vein occlusion,disease,1.0,28106709
38090,RVO,disease,1.0,28106709
38091,patients,species,0.98,28106709
38092,AMD,disease,1.0,28106709
38093,DME,disease,1.0,28106709
38094,RVO,disease,1.0,28106709
38095,antivascular endothelial growth factor,gene,0.985,28106709
38096,VEGF,gene,0.998,28106709
38097,anti-VEGF,gene,0.8813,28106709
38098,Patients,species,0.961,28106709
38099,aflibercept,gene,0.9873,28106709
38100,bevacizumab,gene,0.8477,28106709
38101,AMD,disease,1.0,28106709
38102,RVO,disease,1.0,28106709
38103,DME,drug,0.7925,28106709
38104,-,gene,0.4304,28106709
38105,VEGF,gene,0.5137,28106709
38106,patients,species,0.989,28106709
38107,AMD,disease,1.0,28106709
38108,DME,disease,1.0,28106709
38109,RVO,disease,1.0,28106709
38110,bevacizumab,gene,0.9326,28106709
38111,aflibercept,gene,0.989,28106709
38112,ranibizumab,gene,0.771,28106709
38113,Ranibizumab,gene,0.812,28106709
38114,bevacizumab,gene,0.8574,28106709
38115,aflibercept,gene,0.993,28106709
38116,Aflibercept,gene,0.94,28106709
38117,VEGF,gene,0.579,28106709
38118,VEGF,gene,0.7227,28106709
38119,VEGF,gene,0.9766,28106709
38120,VEGF,gene,0.87,28106709
38121,aflibercept,gene,0.977,28106709
38122,ranibizumab,gene,0.887,28106709
38123,malignancy,disease,1.0,28104567
38124,vascular endothelial growth factor,gene,0.998,28104567
38125,VEGF,gene,0.999,28104567
38126,anti-VEGF antibodies,gene,0.9937,28104567
38127,hypertension,disease,1.0,28104567
38128,hypertension,disease,0.9976,28104567
38129,cardiac dysfunction,disease,1.0,28104567
38130,congestive heart failure,disease,1.0,28104567
38131,cardiac ischemia,disease,1.0,28104567
38132,arterial thromboembolism,disease,1.0,28104567
38133,venous thromboembolism,disease,1.0,28104567
38134,hypertension,disease,0.9883,28104567
38135,hypertension,disease,0.9995,28104567
38136,cardiac ischemia,disease,1.0,28104567
38137,cardiac dysfunction,disease,1.0,28104567
38138,NNH,cell_line,0.5186,28104567
38139,VEGF,gene,0.9746,28104567
38140,arterial thromboembolism,disease,1.0,28104567
38141,hypertension,disease,1.0,28104567
38142,arterial thromboembolism,disease,1.0,28104567
38143,cardiac ischemia,disease,1.0,28104567
38144,cardiac dysfunction,disease,1.0,28104567
38145,VEGF,gene,0.995,28104567
38146,FOLFIRI,drug,0.9795,28102464
38147,tumor,disease,0.9927,28102464
38148,of,gene,,28102464
38149,aflibercept,gene,0.6357,28102464
38150,5-fluorouracil,drug,0.999,28102464
38151,leucovorin,drug,0.9985,28102464
38152,irinotecan,drug,0.9985,28102464
38153,FOLFIRI,drug,0.9653,28102464
38154,patients,species,0.972,28102464
38155,advanced solid malignancies,disease,0.9995,28102464
38156,Patients,species,0.69,28102464
38157,patients,species,0.975,28102464
38158,solid malignancies,disease,1.0,28102464
38159,Patients,species,0.9795,28102464
38160,aflibercept,gene,0.9463,28102464
38161,patients,species,0.959,28102464
38162,colorectal cancer,disease,1.0,28102464
38163,CRC,disease,1.0,28102464
38164,patients,species,0.9897,28102464
38165,neutropenia,disease,1.0,28102464
38166,hypertension,disease,1.0,28102464
38167,stomatitis,disease,1.0,28102464
38168,proteinuria,disease,1.0,28102464
38169,anti-aflibercept antibodies,gene,0.9937,28102464
38170,patients,species,0.9126,28102464
38171,patients,species,0.953,28102464
38172,CRC,disease,0.992,28102464
38173,aflibercept,gene,0.985,28102464
38174,VEGF,gene,0.992,28102464
38175,aflibercept,gene,0.8223,28102464
38176,aflibercept,gene,0.949,28102464
38177,patients,species,0.935,28102464
38178,aflibercept,gene,0.9917,28102464
38179,patients,species,0.974,28102464
38180,advanced solid malignancies,disease,0.9995,28102464
38181,aflibercept,gene,0.9717,28102464
38182,FOLFIRI,drug,0.773,28102464
38183,tumor,disease,0.975,28102464
38184,patients,species,0.935,28102464
38185,Disseminated Mycobacterial Infection,disease,1.0,28101043
38186,Age-Related Macular Degeneration,disease,1.0,28101043
38187,patient,species,0.9683,28101043
38188,blurry vision,disease,1.0,28101043
38189,nonexudative age-related macular degeneration,disease,0.99,28101043
38190,pulmonary mycobacterial infection,disease,1.0,28101043
38191,autoimmune pancreatitis,disease,1.0,28101043
38192,patient,species,0.9688,28101043
38193,exudative age-related macular degeneration,disease,0.999,28101043
38194,choroiditis,disease,1.0,28101043
38195,choroiditis,disease,1.0,28101043
38196,Mycobacterium chelonae infection,disease,0.927,28101043
38197,Mycobacterium chelonae,species,0.9604,28101043
38198,chronic inflammatory,disease,0.9854,28101043
38199,patient,species,0.977,28101043
38200,aflibercept,gene,0.9756,28101043
38201,patient,species,0.9854,28101043
38202,retinal lesions,disease,0.999,28101043
38203,aflibercept,gene,0.9756,28101043
38204,Tyrosine,drug,0.9395,28100839
38205,Tyrosine kinase,gene,0.8296,28100839
38206,collagen IV,RNA,0.552,28100839
38207,collagen IV-derived peptide,gene,0.952,28100839
38208,Vascular endothelial growth factor,gene,0.999,28100839
38209,VEGF,gene,0.995,28100839
38210,retinal and choroidal vascular diseases,disease,1.0,28100839
38211,patients,species,0.9883,28100839
38212,collagen IV,gene,0.991,28100839
38213,AXT107,drug,0.5615,28100839
38214,subretinal neovascularization,disease,0.914,28100839
38215,mouse,species,0.882,28100839
38216,neovascular age-related macular degeneration,disease,1.0,28100839
38217,NVAMD,disease,1.0,28100839
38218,ischemic retinopathies,disease,1.0,28100839
38219,aflibercept,gene,0.925,28100839
38220,subretinal,disease,0.7295,28100839
38221,AXT107,drug,0.995,28100839
38222,choroidal NV,disease,1.0,28100839
38223,VEGF,gene,0.996,28100839
38224,macular edema,disease,1.0,28100839
38225,ischemic retinopathies,disease,1.0,28100839
38226,NVAMD,disease,1.0,28100839
38227,rabbit,species,0.9707,28100839
38228,human,species,0.994,28100839
38229,VEGF,gene,0.9966,28100839
38230,aflibercept,gene,0.971,28100839
38231,AXT107,drug,0.818,28100839
38232,AXT107,drug,0.9756,28100839
38233,VEGFR2,gene,0.995,28100839
38234,c-Met,gene,0.9966,28100839
38235,PDGFR,gene,0.9937,28100839
38236,(3) integrin,gene,0.994,28100839
38237,AXT107,gene,0.9297,28100839
38238,(v)(3),gene,0.9946,28100839
38239,VEGFR2,gene,0.9937,28100839
38240,VEGF-neutralizing proteins,gene,0.932,28100839
38241,ENDOPHTHALMITIS,disease,0.75,28099318
38242,endophthalmitis,disease,1.0,28099318
38243,EO,disease,1.0,28099318
38244,anti-VEGF,gene,0.984,28099318
38245,anti-,gene,0.762,28099318
38246,vascular endothelial growth factor,gene,0.861,28099318
38247,endophthalmitis,disease,1.0,28099318
38248,endophthalmitis,disease,1.0,28099318
38249,endophthalmitis,disease,1.0,28099318
38250,ANTI-VASCULAR ENDOTHELIAL GROWTH,disease,0.99,28085772
38251,retinal pigment epithelial,cell_type,0.5986,28085772
38252,RPE,cell_type,0.7427,28085772
38253,vascular endothelial growth factor,gene,0.9087,28085772
38254,anti-VEGF,gene,0.856,28085772
38255,retinal angiomatous proliferation,disease,1.0,28085772
38256,retinal angiomatous proliferation,disease,1.0,28085772
38257,patients,species,0.9897,28085772
38258,ranibizumab,gene,0.8228,28085772
38259,aflibercept,gene,0.9326,28085772
38260,RPE atrophy,disease,1.0,28085772
38261,ARMS2,gene,0.987,28085772
38262,A69,mutation,,28085772
38263,CFH,DNA,0.501,28085772
38264,CFH,gene,0.9937,28085772
38265,I62,mutation,,28085772
38266,RPE atrophy,disease,1.0,28085772
38267,ranibizumab,gene,0.7666,28085772
38268,RPE atrophy,disease,1.0,28085772
38269,RPE atrophy,disease,1.0,28085772
38270,aflibercept,gene,0.984,28085772
38271,RPE atrophy,disease,1.0,28085772
38272,RPE atrophy,disease,1.0,28085772
38273,RPE atrophy,disease,1.0,28085772
38274,RPE atrophy,disease,1.0,28085772
38275,RPE atrophy,disease,1.0,28085772
38276,Retinal pigment epithelial atrophy,disease,1.0,28085772
38277,anti-VEGF,gene,0.6963,28085772
38278,retinal angiomatous proliferation,disease,1.0,28085772
38279,RPE atrophy,disease,1.0,28085772
38280,bevacizumab,gene,0.9204,28084003
38281,ziv-aflibercept,gene,0.981,28084003
38282,neovascularization,disease,0.6846,28079756
38283,exudative age-related macular degeneration,disease,1.0,28079756
38284,vascular endothelial growth factor,gene,0.992,28079756
38285,patients,species,0.982,28079756
38286,patients,species,0.9585,28079756
38287,fluorescein,drug,0.9995,28079756
38288,indocyanine green,drug,0.999,28079756
38289,vascular endothelial growth factor,gene,0.8906,28079756
38290,patients,species,0.9688,28079756
38291,vascular endothelial growth factor,gene,0.9014,28079756
38292,aflibercept,gene,0.9736,28079756
38293,deep capillary plexus abnormalities,disease,1.0,28079756
38294,choriocapillaris atrophy,disease,1.0,28079756
38295,sub-,disease,0.765,28079756
38296,tuft,cell_line,0.4846,28079756
38297,abnormal outer retinal lesion,disease,0.9053,28079756
38298,vascular endothelial growth factor,gene,0.8916,28079756
38299,Osteonecrosis of the jaw,disease,1.0,28078129
38300,ziv-aflibercept,gene,0.9717,28078129
38301,Medication-related osteonecrosis of the jaw,disease,1.0,28078129
38302,MRONJ,disease,1.0,28078129
38303,bisphosphonates,drug,0.998,28078129
38304,denosumab,gene,0.7583,28078129
38305,bevacizumab,gene,0.541,28078129
38306,sunitinib,drug,0.997,28078129
38307,Ziv-aflibercept,gene,0.967,28078129
38308,recombinant human vascular endothelial growth factor (VEGF) receptor,gene,0.9854,28078129
38309,human,species,0.7593,28078129
38310,patients,species,0.9814,28078129
38311,advanced solid tumors,disease,0.999,28078129
38312,patients,species,0.9663,28078129
38313,MRONJ,disease,1.0,28078129
38314,jaw osteonecrosis,disease,1.0,28078129
38315,MRONJ,disease,1.0,28078129
38316,ziv-aflibercept,gene,0.9634,28078129
38317,patients,species,0.988,28078129
38318,metastatic gastrointestinal cancer,disease,1.0,28078129
38319,ziv-aflibercept,gene,0.9653,28078129
38320,MRONJ,disease,0.9985,28078129
38321,patients,species,0.99,28078129
38322,MRONJ,disease,1.0,28078129
38323,Patients,species,0.9575,28078129
38324,Patients,species,0.967,28078129
38325,ziv-aflibercept,gene,0.965,28078129
38326,necrotic bone,disease,0.979,28078129
38327,patients,species,0.974,28078129
38328,mandibular involvement,disease,0.9995,28078129
38329,Patients,species,0.8438,28078129
38330,patients,species,0.9927,28078129
38331,patient,species,0.9897,28078129
38332,patients,species,0.9883,28078129
38333,ziv-aflibercept,gene,0.9624,28078129
38334,MRONJ,disease,0.9995,28078129
38335,ziv-aflibercept,gene,0.982,28078129
38336,MRONJ,disease,0.9995,28078129
38337,VEGF,gene,0.6914,28078129
38338,bevacizumab,gene,0.598,28078129
38339,sunitinib,drug,0.977,28078129
38340,aflibercept,gene,0.9746,28076566
38341,exudative age-related macular degeneration,disease,1.0,28076566
38342,patients,species,0.976,28076566
38343,aflibercept,gene,0.978,28076566
38344,neovascular age-related macular degeneration,disease,1.0,28076566
38345,NV-AMD,disease,1.0,28076566
38346,patients,species,0.9346,28076566
38347,ranibizumab,gene,0.9155,28076566
38348,neovascular age-related macular degeneration,disease,1.0,28076566
38349,patients,species,0.9917,28076566
38350,patients,species,0.9897,28076566
38351,macular dryness,disease,0.998,28076566
38352,aflibercept,gene,0.986,28076566
38353,ranibizumab,gene,0.8096,28076566
38354,PED,disease,1.0,28076566
38355,aflibercept,gene,0.978,28076566
38356,aflibercept,gene,0.968,28076566
38357,Aflibercept,gene,0.9844,28060392
38358,Neovascular Polypoidal Choroidal Vasculopathy,disease,1.0,28060392
38359,aflibercept,gene,0.9956,28060392
38360,Eylea,gene,0.8047,28060392
38361,neovascular polypoidal choroidal vasculopathy,disease,1.0,28060392
38362,PCV,disease,1.0,28060392
38363,PATIENTS,species,0.957,28060392
38364,Patients,species,0.963,28060392
38365,neovascular,cell_type,0.453,28060392
38366,neovascular PCV,disease,0.9985,28060392
38367,ziv-aflibercept,gene,0.9893,28060148
38368,choroidal neovascular membranes,disease,1.0,28060148
38369,CNVM,disease,1.0,28060148
38370,choroidal neovascular membranes,disease,1.0,28060148
38371,ziv-aflibercept,gene,0.978,28060148
38372,electroretinographic abnormalities,disease,0.938,28060148
38373,patients,species,0.9863,28060148
38374,choroidal neovascular membranes,disease,0.9995,28060148
38375,age-related macular degeneration,disease,1.0,28060148
38376,polypoidal choroidal vasculopathy,disease,1.0,28060148
38377,PCV,disease,1.0,28060148
38378,myopia,disease,1.0,28060148
38379,idiopathic juxtafoveal telangiectasia,disease,1.0,28060148
38380,patients,species,0.987,28060148
38381,intraocular inflammation,disease,1.0,28060148
38382,ziv-aflibercept,gene,0.9766,28060148
38383,Choroidal neovascularization,disease,1.0,29503964
38384,tuberculosis,disease,0.999,29503964
38385,choroidal neovascularization,disease,1.0,29503964
38386,CNV,disease,1.0,29503964
38387,tuberculosis,disease,1.0,29503964
38388,CNV,disease,0.9985,29503964
38389,tuberculous chorioretinitis,disease,1.0,29503964
38390,patients,species,0.9873,29503964
38391,tuberculous chorioretinitis,disease,1.0,29503964
38392,CNV,disease,1.0,29503964
38393,patients,species,0.9883,29503964
38394,intraocular inflammation,disease,0.9937,29503964
38395,macular CNV,disease,0.9995,29503964
38396,patient,species,0.949,29503964
38397,chorioretinal scars,disease,0.9536,29503964
38398,posterior uveitis,disease,1.0,29503964
38399,macular CNV membranes,disease,0.9683,29503964
38400,patients,species,0.99,29503964
38401,tuberculosis,disease,0.7896,29503964
38402,anti-vascular endothelial growth factor,gene,0.822,29503964
38403,VEGF,gene,0.9946,29503964
38404,CNV,DNA,0.777,29503964
38405,patients,species,0.9785,29503964
38406,intraocular inflammation,disease,0.9995,29503964
38407,CNV,disease,1.0,29503964
38408,patients,species,0.9834,29503964
38409,CNV,disease,0.9927,29503964
38410,tuberculous chorioretinitis,disease,1.0,29503964
38411,loss of vision,disease,0.9873,29503964
38412,anti-,disease,0.9766,29503964
38413,tuberculosis,disease,0.902,29503964
38414,anti-VEGF,gene,0.817,29503964
38415,Coats&#39; disease,disease,0.999,28038924
38416,macular oedema,disease,1.0,28038924
38417,aflibercept,gene,0.97,28038924
38418,argon,drug,0.871,28038924
38419,boy,species,0.6284,28038924
38420,Coats&#39; disease,disease,1.0,28038924
38421,macular oedema,disease,1.0,28038924
38422,peripheral telangiectasias,disease,0.998,28038924
38423,ranibizumab,gene,0.8965,28038924
38424,argon,drug,0.8447,28038924
38425,macular oedema,disease,1.0,28038924
38426,aflibercept,gene,0.99,28038924
38427,foveal,DNA,0.6035,28038924
38428,aflibercept,gene,0.9893,28038924
38429,argon,drug,0.71,28038924
38430,patient,species,0.926,28038924
38431,Coats&#39; disease,disease,0.9795,28038924
38432,macular oedema,disease,1.0,28038924
38433,ranibizumab,gene,0.7373,28038924
38434,Diabetic Macular Edema,disease,1.0,31047565
38435,Patients,species,0.9893,31047565
38436,Hemoglobin A1c,gene,0.995,31047565
38437,diabetic macular edema,disease,1.0,31047565
38438,DME,disease,1.0,31047565
38439,PARTICIPANTS,species,0.811,31047565
38440,Patients,species,0.9614,31047565
38441,DME,disease,1.0,31047565
38442,aflibercept,gene,0.992,31047565
38443,DME,disease,1.0,31047565
38444,VISTA,DNA,0.4878,31047565
38445,hemoglobin A1c,gene,0.9976,31047565
38446,HbA1c,gene,0.9976,31047565
38447,HbA1c,gene,0.9956,31047565
38448,HbA1c,gene,0.998,31047565
38449,HbA1c,gene,0.9985,31047565
38450,HbA1c,gene,0.996,31047565
38451,HbA1c,gene,0.994,31047565
38452,HbA1c,gene,0.9976,31047565
38453,HbA1c,gene,0.997,31047565
38454,HbA1c,gene,0.997,31047565
38455,HbA1c,gene,0.9917,31047565
38456,patients,species,0.969,31047565
38457,DME,disease,1.0,31047565
38458,Ranibizumab,gene,0.762,31047523
38459,Aflibercept,gene,0.9263,31047523
38460,Macular Edema,disease,1.0,31047523
38461,Central Retinal Vein Occlusion,disease,1.0,31047523
38462,Aflibercept,gene,0.9873,31047516
38463,patients,species,0.982,31047516
38464,aflibercept,gene,0.987,31047516
38465,neovascular age-related macular degeneration,disease,1.0,31047516
38466,PARTICIPANTS,species,0.7524,31047516
38467,patients,species,0.961,31047516
38468,patients,species,0.9854,31047516
38469,ranibizumab,gene,0.8125,31047516
38470,vascular endothelial growth factor,gene,0.8555,31047516
38471,patients,species,0.952,31047516
38472,patients,species,0.9688,31047516
38473,Patients,species,0.896,31047516
38474,patients,species,0.974,31047516
38475,patients,species,0.9863,31047516
38476,endophthalmitis,disease,1.0,31047516
38477,arterial thromboembolic events,disease,0.9717,31047516
38478,vascular endothelial growth factor,gene,0.9756,31047516
38479,Anti-vascular endothelial growth factor,gene,0.8843,31047516
38480,IAI,disease,0.989,31047516
38481,Ranibizumab,gene,0.8833,31047422
38482,ranibizumab,gene,0.9634,31047422
38483,aflibercept,gene,0.9756,31047422
38484,ranibizumab,drug,0.4988,31047422
38485,aflibercept,gene,0.82,31047422
38486,PARTICIPANTS,species,0.757,31047422
38487,Patients,species,0.992,31047422
38488,neovascular age-related macular degeneration,disease,1.0,31047422
38489,ranibizumab,gene,0.862,31047422
38490,aflibercept,gene,0.939,31047422
38491,ranibizumab,gene,0.8184,31047422
38492,intraretinal fluid,disease,1.0,31047422
38493,Patients,species,0.982,31047422
38494,ranibizumab,gene,0.9067,31047422
38495,aflibercept,gene,0.967,31047422
38496,ranibizumab,gene,0.973,31047422
38497,aflibercept,gene,0.981,31047422
38498,ranibizumab,gene,0.8164,31047422
38499,aflibercept,gene,0.9844,31047422
38500,ranibizumab,gene,0.9463,31047422
38501,aflibercept,gene,0.9614,31047422
38502,aflibercept,gene,0.937,31047422
38503,Anti-vascular Endothelial Growth Factor,gene,0.996,31047391
38504,anti-vascular endothelial growth factor,gene,0.996,31047391
38505,VEGF,gene,0.997,31047391
38506,ophthalmologists,cell_type,0.4248,31047391
38507,VEGF,gene,0.551,31047391
38508,PARTICIPANTS,species,0.682,31047391
38509,VEGF,gene,0.7354,31047391
38510,VEGF,gene,0.643,31047391
38511,anti-VEGF,gene,0.824,31047391
38512,VEGF,gene,0.855,31047391
38513,VEGF,gene,0.768,31047391
38514,anti-VEGF,gene,0.96,31047391
38515,aflibercept,gene,0.9707,31047391
38516,aflibercept,gene,0.9526,31047391
38517,bevacizumab,gene,0.6,31047391
38518,ranibizumab,gene,0.9,31047391
38519,aflibercept,gene,0.9634,31047391
38520,bevacizumab,gene,0.8267,31047391
38521,Aflibercept,gene,0.9316,31047267
38522,Wet,disease,0.5806,31047267
38523,Age-Related Macular Degeneration,disease,0.9995,31047267
38524,patients,species,0.9873,31047267
38525,aflibercept,gene,0.9443,31047267
38526,exudative age-related macular degeneration,disease,1.0,31047267
38527,AMD,disease,1.0,31047267
38528,PARTICIPANTS,species,0.799,31047267
38529,patients,species,0.982,31047267
38530,Patients,species,0.97,31047267
38531,fluorescein,drug,0.9966,31047267
38532,Diabetic Retinopathy,disease,1.0,31047267
38533,bevacizumab,gene,0.8486,31047267
38534,ranibizumab,gene,0.791,31047267
38535,retinal edema,disease,1.0,31047267
38536,subretinal fluid,disease,0.9385,31047267
38537,anti-vascular endothelial growth factor,gene,0.875,31047267
38538,Patients,species,0.9585,31047267
38539,aflibercept,gene,0.972,31047267
38540,AMD,disease,1.0,31047267
38541,patients,species,0.9414,31047267
38542,exudative AMD,disease,0.823,31047267
38543,aflibercept,gene,0.9624,31047267
38544,patients,species,0.9194,31047267
38545,vascular endothelial growth factor,gene,0.8667,31047267
38546,Patients,species,0.9814,31047267
38547,Ziv-Aflibercept,gene,0.9917,31047266
38548,Bevacizumab,gene,0.6675,31047266
38549,ziv-aflibercept,gene,0.989,31047266
38550,bevacizumab,gene,0.769,31047266
38551,diabetic macular edema,disease,1.0,31047266
38552,DME,disease,1.0,31047266
38553,PARTICIPANTS,species,0.858,31047266
38554,DME,disease,1.0,31047266
38555,DME,disease,1.0,31047266
38556,IVZ,drug,0.9805,31047266
38557,IVZ,drug,0.973,31047266
38558,ziv-aflibercept,gene,0.982,31047266
38559,ziv-aflibercept,gene,0.972,31047266
38560,ziv-aflibercept,gene,0.983,31047266
38561,ziv-aflibercept,gene,0.984,31047266
38562,ziv-aflibercept,gene,0.9785,31047266
38563,IVZ,drug,0.99,31047266
38564,IVB,drug,0.9946,31047266
38565,DME,disease,1.0,31047266
38566,Sema3C Mutant,gene,0.9893,28036336
38567,Furin,gene,0.989,28036336
38568,FR-Sema3C,gene,0.9927,28036336
38569,age-related macular degeneration,disease,0.997,28036336
38570,AMD,disease,1.0,28036336
38571,abnormal sub retinal choroidal neovascularization,disease,0.9756,28036336
38572,CNV,DNA,0.7456,28036336
38573,blindness,disease,1.0,28036336
38574,FR-sema3C,gene,0.9873,28036336
38575,semaphorin-3C,gene,0.9956,28036336
38576,furin like pro-protein convertases,gene,0.998,28036336
38577,FPPC,gene,0.9883,28036336
38578,FR,gene,,28036336
38579,sema3C,gene,0.937,28036336
38580,FR,gene,,28036336
38581,sema3C,gene,0.83,28036336
38582,CNV,disease,1.0,28036336
38583,FR,gene,,28036336
38584,sema3C,gene,0.7905,28036336
38585,VEGF,gene,0.9883,28036336
38586,PDGF-BB,gene,0.987,28036336
38587,endothelial cells,cell_type,0.936,28036336
38588,bFGF,gene,0.978,28036336
38589,VEGF,gene,0.9927,28036336
38590,AMD,disease,1.0,28036336
38591,CNV,disease,0.9995,28036336
38592,C57 black,cell_line,0.4712,28036336
38593,mice,species,0.837,28036336
38594,FR,gene,,28036336
38595,Sema3C,gene,0.7134,28036336
38596,aflibercept,gene,0.986,28036336
38597,VEGF,gene,0.9976,28036336
38598,CNV,disease,0.979,28036336
38599,FITC,drug,1.0,28036336
38600,blood vessels,cell_type,0.4395,28036336
38601,FR-Sema3C,gene,0.7686,28036336
38602,aflibercept,gene,0.8564,28036336
38603,FR,gene,,28036336
38604,mice,species,0.977,28036336
38605,FR,gene,,28036336
38606,sema3C,gene,0.8794,28036336
38607,FR,gene,,28036336
38608,sema3C,gene,0.951,28036336
38609,AMD,disease,0.9995,28036336
38610,patients,species,0.984,28036336
38611,VEGF,gene,0.9937,28036336
38612,neovascular age-related macular degeneration,disease,1.0,28033280
38613,neovascular age-related macular degeneration,disease,1.0,28033280
38614,nAMD,DNA,0.675,28033280
38615,nAMD,disease,1.0,28033280
38616,Patients,species,0.9785,28033280
38617,patients,species,0.987,28033280
38618,patients,species,0.9795,28033280
38619,aflibercept,gene,0.982,28033280
38620,ranibizumab,gene,0.601,28033280
38621,patient,species,0.9546,28033280
38622,nAMD,disease,1.0,28033280
38623,patients,species,0.9937,28033280
38624,visual loss,disease,0.9434,28033280
38625,IVI,disease,0.9985,28033280
38626,CHOROIDAL NEOVASCULARIZATION,disease,0.8647,28002284
38627,vascular endothelial growth factor,gene,0.939,28002284
38628,VEGF,gene,0.9976,28002284
38629,choroidal neovascularization,disease,1.0,28002284
38630,CNV,disease,1.0,28002284
38631,patients,species,0.9824,28002284
38632,CNV,disease,1.0,28002284
38633,vascular endothelial growth factor,gene,0.91,28002284
38634,CNV,DNA,0.8345,28002284
38635,patients,species,0.97,28002284
38636,macular hole,disease,0.9556,28002284
38637,epiretinal membrane,disease,1.0,28002284
38638,ERM,disease,1.0,28002284
38639,drusen,disease,0.999,28002284
38640,CNV,disease,1.0,28002284
38641,patients,species,0.98,28002284
38642,anti-vascular endothelial growth factor,gene,0.9834,28002284
38643,CNV,disease,0.9995,28002284
38644,vascular endothelial growth factor,gene,0.934,28002284
38645,CNV,disease,0.9546,28002284
38646,Choroidal neovascularization,disease,1.0,28002284
38647,vascular endothelial growth factor,gene,0.908,28002284
38648,AFLIBERCEPT,gene,0.9326,28002269
38649,MACULAR TELANGIECTASIA TYPE 1,disease,0.931,28002269
38650,aflibercept,gene,0.9727,28002269
38651,macular telangiectasia Type 1,disease,1.0,28002269
38652,MacTel 1,disease,0.9995,28002269
38653,patients,species,0.979,28002269
38654,MacTel 1,disease,1.0,28002269
38655,bevacizumab,gene,0.837,28002269
38656,ranibizumab,gene,0.744,28002269
38657,aflibercept,gene,0.94,28002269
38658,patients,species,0.9814,28002269
38659,cataract,disease,0.9995,28002269
38660,patients,species,0.9517,28002269
38661,aflibercept,gene,0.9404,28002269
38662,aflibercept,gene,0.976,28002269
38663,patients,species,0.98,28002269
38664,Diabetic Retinopathy,disease,1.0,28002269
38665,MacTel 1,disease,1.0,28002269
38666,vascular endothelial growth factor-A,gene,0.9985,28002269
38667,placental growth factor,gene,0.97,28002269
38668,soluble,gene,0.6304,28002269
38669,vascular endothelial growth factor receptor-1,gene,0.9224,28002269
38670,sFlt-1,gene,0.9946,28002269
38671,vascular endothelial growth factor-D,gene,0.998,28002269
38672,Tie-2,gene,0.9907,28002269
38673,Placental growth factor,gene,0.9927,28002269
38674,aflibercept,gene,0.946,28002269
38675,MacTel 1,cell_line,0.7197,28002269
38676,placental growth factor,gene,0.986,28002269
38677,Flt-1,gene,0.972,28002269
38678,MacTel 1,gene,0.954,28002269
38679,CHOROIDAL THICKNESS,disease,1.0,28002268
38680,ranibizumab,gene,0.927,28002268
38681,aflibercept,gene,0.9805,28002268
38682,polypoidal choroidal vasculopathy,disease,1.0,28002268
38683,polypoidal choroidal vasculopathy,disease,1.0,28002268
38684,ranibizumab,gene,0.9185,28002268
38685,aflibercept,gene,0.9863,28002268
38686,polypoidal choroidal vasculopathy,disease,1.0,28002268
38687,ranibizumab,gene,0.516,28002268
38688,aflibercept,gene,0.8564,28002268
38689,VEGF,gene,0.972,28000166
38690,Glaucoma,disease,1.0,28000166
38691,anti-,gene,0.5864,28000166
38692,vascular endothelial growth factor,gene,0.945,28000166
38693,VEGF,gene,0.998,28000166
38694,neovascular age-related macular degeneration,disease,1.0,28000166
38695,retinal diseases,disease,0.9946,28000166
38696,VEGF,gene,0.994,28000166
38697,VEGF,gene,0.957,28000166
38698,neovascular glaucoma,disease,1.0,28000166
38699,NVG,disease,1.0,28000166
38700,anti-VEGFs,gene,0.901,28000166
38701,glaucoma,disease,1.0,28000166
38702,GFS,disease,0.993,28000166
38703,NVG,disease,0.9995,28000166
38704,VEGF,gene,0.7524,28000166
38705,Aflibercept,gene,0.9287,28000147
38706,Aflibercept,gene,0.952,27997921
38707,Age-Related Macular Degeneration,disease,1.0,27997921
38708,Choroidal Neovascularization,disease,1.0,27997921
38709,Retinal Angiomatous Proliferation,disease,1.0,27997921
38710,aflibercept,gene,0.9478,27997921
38711,choroidal neovascularization,disease,1.0,27997921
38712,CNV,disease,1.0,27997921
38713,retinal angiomatous,disease,1.0,27997921
38714,exudative age-related macular degeneration,disease,1.0,27997921
38715,AMD,disease,1.0,27997921
38716,aflibercept,gene,0.985,27997921
38717,fluorescein,drug,0.999,27997921
38718,RAP,DNA,0.5483,27997921
38719,CNV,disease,1.0,27997921
38720,Aflibercept,gene,0.961,27997921
38721,CNV,DNA,0.7944,27997921
38722,Primary Human Pigment Epithelium Cells,cell_type,0.8867,27997919
38723,Muller-Glia Cells,cell_type,0.8213,27997919
38724,Ziv-Aflibercept,gene,0.9917,27997919
38725,Aflibercept,gene,0.971,27997919
38726,vascular endothelial growth factor,gene,0.993,27997919
38727,ziv-aflibercept,gene,0.9917,27997919
38728,aflibercept,gene,0.9824,27997919
38729,retinal pigment epithelium cells,cell_type,0.753,27997919
38730,Muller-Glia cells,cell_type,0.785,27997919
38731,Primary human retinal pigment epithelium cells,cell_type,0.715,27997919
38732,pRPE,cell_type,0.502,27997919
38733,),cell_type,0.597,27997919
38734,Muller-Glia cells,cell_line,0.726,27997919
38735,Mio-M1,cell_line,0.8623,27997919
38736,ziv-aflibercept,gene,0.8467,27997919
38737,aflibercept,gene,0.975,27997919
38738,NaCl,drug,0.9995,27997919
38739,cells,cell_type,0.4949,27997919
38740,pRPE,cell_type,0.7686,27997919
38741,Mio-M1,cell_line,0.957,27997919
38742,tetrazolium,drug,0.9946,27997919
38743,pRPE,cell_type,0.762,27997919
38744,Mio-M1,cell_line,0.8423,27997919
38745,M1,cell_type,0.3662,27997919
38746,ziv,drug,0.9844,27997919
38747,ziv-aflibercept,gene,0.802,27997919
38748,aflibercept,gene,0.97,27997919
38749,NaCl,drug,0.9995,27997919
38750,dimethyl sulfoxide,drug,0.999,27997919
38751,neither,drug,0.7534,27997919
38752,ziv,drug,0.5273,27997919
38753,aflibercept,gene,0.9517,27997919
38754,aflibercept,gene,0.9844,27997919
38755,NaCl,drug,0.999,27997919
38756,neovascular age-related macular degeneration,disease,1.0,27997361
38757,neovascular age-related macular degeneration,disease,1.0,27997361
38758,n-AMD,disease,1.0,27997361
38759,anti-vascular endothelial growth factor,gene,0.9985,27997361
38760,VEGF,gene,0.9956,27997361
38761,anti-VEGF,gene,0.852,27997361
38762,n-AMD,disease,0.999,27997361
38763,AMD,disease,0.9995,27997361
38764,anti-VEGF,gene,0.845,27997361
38765,n-AMD,disease,1.0,27997361
38766,AMD,disease,0.9746,27997361
38767,-,disease,0.855,27997361
38768,AMD,disease,0.918,27997361
38769,n-AMD,disease,0.998,27997361
38770,n-AMD,disease,1.0,27997361
38771,Aflibercept,gene,0.967,27997008
38772,Aflibercept,gene,0.9683,27997008
38773,FOLFIRI,drug,0.9307,27997008
38774,metastatic colorectal cancer,disease,0.9976,27997008
38775,Aflibercept,gene,0.917,27993278
38776,bevacizumab,gene,0.865,27993278
38777,ranibizumab,gene,0.691,27993278
38778,diabetic macular,disease,1.0,27993278
38779,vascular endothelial growth factor-A,gene,0.998,27990354
38780,dry eye,disease,0.9995,27990354
38781,vascular endothelial growth factor A,gene,0.999,27990354
38782,VEGF-,gene,0.9976,27990354
38783,dry eye corneas,disease,0.9995,27990354
38784,murine,species,0.7744,27990354
38785,inflammation,disease,0.956,27990354
38786,neovascularization,disease,0.894,27990354
38787,aflibercept,gene,0.9834,27990354
38788,dexamethasone,drug,0.9966,27990354
38789,CD11b+ cell,cell_type,0.6587,27990354
38790,CD11b+,gene,0.978,27990354
38791,VEGF-A,gene,0.997,27990354
38792,VEGF-A,gene,0.995,27990354
38793,aflibercept,gene,0.99,27990354
38794,dexamethasone,drug,0.953,27990354
38795,dry eye,disease,0.9995,27990354
38796,VEGF-A,gene,0.996,27990354
38797,dexamethasone,drug,0.9346,27990354
38798,dry eye,disease,1.0,27990354
38799,RNA,RNA,0.831,27990354
38800,VEGF-A,gene,0.9966,27990354
38801,TNF-alpha,gene,0.995,27990354
38802,IL-6,gene,0.9844,27990354
38803,aflibercept,gene,0.993,27990354
38804,dry eye,disease,1.0,27990354
38805,dry eye,disease,0.931,27990354
38806,dry eye corneas,disease,0.955,27990354
38807,VEGF-A,gene,0.9966,27990354
38808,dry eye corneas,disease,0.994,27990354
38809,Neovascular Age-Related Macular Degeneration,disease,1.0,27981904
38810,neovascular age-related macular degeneration,disease,0.9995,27981904
38811,AMD,disease,1.0,27981904
38812,vascular endothelial growth factor,gene,0.983,27981904
38813,VEGF,gene,0.987,27981904
38814,neovascular AMD,disease,1.0,27981904
38815,neovascular AMD,disease,1.0,27981904
38816,VEGF,gene,0.5645,27981904
38817,choroidal neovascularization,disease,1.0,27981904
38818,neovascular AMD,disease,1.0,27981904
38819,aflibercept,gene,0.9927,27974321
38820,polypoidal AIMS,disease,1.0,27974321
38821,aflibercept,gene,0.8823,27974321
38822,polypoidal choroidal vasculopathy,disease,1.0,27974321
38823,PCV,disease,1.0,27974321
38824,patients,species,0.9697,27974321
38825,PCV,disease,1.0,27974321
38826,luminal,DNA,0.651,27974321
38827,Pachychoroid,disease,0.926,27974321
38828,IVA,disease,0.8003,27974321
38829,Non-Small Cell Lung Cancer,disease,1.0,27940520
38830,VEGF-A,gene,0.997,27940520
38831,advanced non-squamous non-small cell lung cancer,disease,0.9995,27940520
38832,NSCLC,disease,1.0,27940520
38833,NSCLC,disease,1.0,27940520
38834,NSCLC,disease,0.9956,27940520
38835,VEGF receptor-2,gene,0.995,27940520
38836,VEGFR-2,gene,0.991,27940520
38837,squamous,cell_line,0.6,27940520
38838,non-squamous NSCLC,disease,0.997,27940520
38839,nintedanib,drug,0.9976,27940520
38840,anti-,gene,0.746,27940520
38841,VEGFR-1/2/3,gene,0.961,27940520
38842,platelet-derived growth factor receptor-,gene,0.9985,27940520
38843,fibroblast growth factor receptor-1/2/3 angiokinase,gene,0.996,27940520
38844,adenocarcinoma of the lung,disease,1.0,27940520
38845,NSCLC,disease,0.999,27940520
38846,aflibercept,gene,0.981,27940520
38847,sunitinib,drug,0.998,27940520
38848,sorafenib,drug,0.9985,27940520
38849,cediranib,drug,0.9985,27940520
38850,vandetanib,drug,0.9976,27940520
38851,NSCLC,disease,0.9995,27940520
38852,VEGF-A isoforms,gene,0.9077,27940520
38853,neuropilin-1,gene,0.993,27940520
38854,VEGFR-1,gene,0.991,27940520
38855,tumors,disease,1.0,27940520
38856,plasma,cell_type,0.4265,27940520
38857,VEGF-A,gene,0.9985,27940520
38858,VEGFR,gene,0.9897,27940520
38859,tumor,disease,0.9985,27940520
38860,tumor protein p53,gene,0.9316,27940520
38861,VEGF-A transcripts,gene,0.797,27940520
38862,NSCLC,disease,0.999,27940520
38863,Ranibizumab,gene,0.6123,27931718
38864,ABBV642,gene,0.7505,27929753
38865,dual variable domain immunoglobulin,gene,0.618,27929753
38866,Exudative age-related macular degeneration,disease,0.9995,27929753
38867,AMD,disease,1.0,27929753
38868,vision,disease,0.8994,27929753
38869,vascular endothelial growth factor,gene,0.999,27929753
38870,VEGF,gene,0.9966,27929753
38871,VEGF-A,gene,0.9937,27929753
38872,patients,species,0.977,27929753
38873,subretinal fibrosis,disease,0.9995,27929753
38874,VEGF,gene,0.998,27929753
38875,platelet-derived growth factor-BB,gene,0.999,27929753
38876,PDGF-BB,gene,0.9976,27929753
38877,VEGF,gene,0.9937,27929753
38878,subretinal fibrosis,disease,1.0,27929753
38879,variable domain immunoglobulin molecule,gene,0.572,27929753
38880,ABBV642,gene,0.609,27929753
38881,VEGF,gene,0.9976,27929753
38882,PDGF-BB,gene,0.9976,27929753
38883,ABBV642,drug,0.999,27929753
38884,exudative AMD,disease,0.8022,27929753
38885,VEGF-A isoforms,gene,0.9976,27929753
38886,PDGF-BB,gene,0.989,27929753
38887,wild type Fc region,gene,0.9717,27929753
38888,FcRn,gene,0.9976,27929753
38889,ABBV642,drug,0.9946,27929753
38890,mouse,species,0.829,27929753
38891,exudative AMD,disease,0.999,27929753
38892,ABBV642,drug,0.9995,27929753
38893,aflibercept,gene,0.967,27929753
38894,ABBV642,drug,0.9956,27929753
38895,patients,species,0.9434,27929753
38896,exudative AMD,disease,0.9165,27929753
38897,patients,species,0.975,27929753
38898,aflibercept,gene,0.9844,27928695
38899,aflibercept,gene,0.9805,27928695
38900,polypoidal choroidal vasculopathy,disease,1.0,27928695
38901,PCV,disease,1.0,27928695
38902,PCV,disease,1.0,27928695
38903,patients,species,0.9854,27928695
38904,CRT,DNA,0.4717,27928695
38905,polypoidal lesions,disease,1.0,27928695
38906,patients,species,0.987,27928695
38907,PCV,disease,1.0,27928695
38908,osteonecrosis of the jaw,disease,0.999,27923511
38909,aflibercept,gene,0.9756,27923511
38910,VEGF,gene,0.9375,27913442
38911,fibrovascular pigment epithelial,cell_type,0.5044,27913442
38912,antivascular endothelial growth factor,gene,0.991,27913442
38913,VEGF,gene,0.993,27913442
38914,bevacizumab,gene,0.9497,27913442
38915,aflibercept,gene,0.974,27913442
38916,ranibizumab,gene,0.789,27913442
38917,fibrovascular,cell_type,0.4673,27913442
38918,fibrovascular pigment epithelial detachments,disease,0.995,27913442
38919,fvPEDs,disease,0.9946,27913442
38920,age-related macular degeneration,disease,1.0,27913442
38921,AMD,disease,1.0,27913442
38922,fvPEDs,disease,0.9424,27913442
38923,neovascular AMD,disease,1.0,27913442
38924,VEGF,gene,0.5415,27913442
38925,fluorescein,drug,0.997,27913442
38926,serous/drusenoid PEDs,disease,0.7554,27913442
38927,patients,species,0.9873,27913442
38928,anti-VEGF,gene,0.979,27913442
38929,patients,species,0.9883,27913442
38930,bevacizumab,gene,0.8647,27913442
38931,aflibercept,gene,0.9766,27913442
38932,ranibizumab,gene,0.7197,27913442
38933,patients,species,0.989,27913442
38934,subretinal fluid,disease,0.9917,27913442
38935,intraretinal fluid,disease,0.999,27913442
38936,PED,disease,0.8784,27913442
38937,patients,species,0.99,27913442
38938,aflibercept,gene,0.986,27913442
38939,patients,species,0.992,27913442
38940,bevacizumab,gene,0.796,27913442
38941,Aflibercept,gene,0.9556,27913442
38942,PED,disease,0.9565,27913442
38943,bevacizumab,gene,0.6816,27913442
38944,aflibercept,gene,0.9863,27913442
38945,bevacizumab,gene,0.863,27913442
38946,aflibercept,gene,0.89,27913442
38947,Aflibercept,gene,0.8677,27907924
38948,Neovascular Age-Related Macular Degeneration,disease,1.0,27907924
38949,neovascular age-related macular degeneration,disease,1.0,27907924
38950,AMD,disease,1.0,27907924
38951,aflibercept,gene,0.9673,27907924
38952,CRT,DNA,0.4805,27907924
38953,aflibercept,gene,0.9233,27907924
38954,AMD,disease,0.9995,27907924
38955,CYSTOID MACULAR EDEMA,disease,1.0,27902539
38956,CYSTOID MACULAR DEGENERATION,disease,1.0,27902539
38957,CENTRAL SEROUS CHORIORETINOPATHY,disease,1.0,27902539
38958,cystoid macular edema,disease,1.0,27902539
38959,cystoid macular degeneration,disease,1.0,27902539
38960,chronic central serous chorioretinopathy,disease,1.0,27902539
38961,CSC,disease,1.0,27902539
38962,fluorescein,drug,0.988,27902539
38963,cystoid macular edema,disease,1.0,27902539
38964,chronic CSC,disease,0.963,27902539
38965,chronic CSC,disease,0.9927,27902539
38966,visual decline,disease,0.9805,27902539
38967,retinal pigment epithelial changes,disease,0.9355,27902539
38968,macular edema,disease,1.0,27902539
38969,vitreomacular traction,disease,1.0,27902539
38970,attenuated retinal pigment epithelial,disease,0.973,27902539
38971,aflibercept,gene,0.984,27902539
38972,microaneurysms,disease,1.0,27902539
38973,intraretinal cysts,disease,0.997,27902539
38974,chronic CSC,disease,0.698,27902539
38975,cystoid macular edema,disease,1.0,27902539
38976,cystoid macular degeneration,disease,1.0,27902539
38977,vascular endothelial growth factor,gene,0.995,27902539
38978,cystoid macular edema,disease,1.0,27902539
38979,CSC,disease,0.7266,27902539
38980,aflibercept,gene,0.982,27899972
38981,metastatic colorectal cancer,disease,1.0,27899972
38982,bevacizumab,gene,0.8667,27899972
38983,Aflibercept,gene,0.9707,27899972
38984,tumoural,disease,0.9497,27899972
38985,aflibercept,gene,0.9575,27899972
38986,metastatic colorectal cancer,disease,1.0,27899972
38987,mCRC,disease,1.0,27899972
38988,oxaliplatin,drug,0.9966,27899972
38989,mCRC,disease,0.989,27899972
38990,aflibercept,gene,0.9688,27899972
38991,KRAS mutation,gene,0.7183,27899972
38992,fluoropyrimidine,drug,0.999,27899972
38993,oxaliplatin,drug,0.9995,27899972
38994,bevacizumab,gene,0.708,27899972
38995,irinotecan,drug,0.999,27899972
38996,aflibercept,gene,0.982,27899972
38997,aflibercept,gene,0.7734,27899972
38998,diarrhoea,disease,1.0,27899972
38999,neutropenia,disease,1.0,27899972
39000,fatigue,disease,1.0,27899972
39001,proteinuria,disease,1.0,27899972
39002,hypertension,disease,1.0,27899972
39003,bevacizumab,gene,0.8726,27899972
39004,aflibercept,gene,0.982,27899972
39005,bevacizumab,gene,0.796,27899972
39006,aflibercept,gene,0.991,27905791
39007,ranibizumab,gene,0.7495,27905791
39008,patients,species,0.903,27905791
39009,visual impairment,disease,1.0,27905791
39010,macular oedema,disease,1.0,27905791
39011,branch retinal vein occlusion,disease,1.0,27905791
39012,BRVO,disease,1.0,27905791
39013,ranibizumab,gene,0.597,27905791
39014,patient,species,0.996,27905791
39015,aflibercept,gene,0.9824,27905764
39016,visual impairment,disease,1.0,27905764
39017,macular oedema,disease,1.0,27905764
39018,central retinal vein occlusion,disease,1.0,27905764
39019,CRVO,disease,1.0,27905764
39020,ranibizumab,gene,0.759,27905764
39021,patient,species,0.994,27905764
39022,aflibercept,gene,0.99,27905753
39023,irinotecan,drug,0.9985,27905753
39024,5-fluorouracil,drug,0.9995,27905753
39025,folinic acid,drug,0.9985,27905753
39026,FOLFIRI,drug,0.77,27905753
39027,FOLFIRI,drug,0.985,27905753
39028,patients,species,0.9785,27905753
39029,metastatic colorectal cancer,disease,1.0,27905753
39030,mCRC,disease,1.0,27905753
39031,oxaliplatin,drug,0.998,27905753
39032,patient,species,0.9937,27905753
39033,aflibercept,gene,0.9897,27905747
39034,ranibizumab,gene,0.6084,27905747
39035,patients,species,0.941,27905747
39036,AMD,disease,1.0,27905747
39037,patient,species,0.9937,27905747
39038,aflibercept,gene,0.99,27905747
39039,ranibizumab,gene,0.576,27905747
39040,ranibizumab,gene,0.566,27905747
39041,Anti-Vascular Endothelial Growth Factor,gene,0.9224,27890437
39042,anti-vascular endothelial growth factor,gene,0.962,27890437
39043,VEGF,gene,0.9966,27890437
39044,ophthalmic disease,disease,0.996,27890437
39045,bevacizumab,gene,0.865,27890437
39046,ranibizumab,gene,0.93,27890437
39047,aflibercept,gene,0.9414,27890437
39048,patients,species,0.99,27890437
39049,patients,species,0.985,27890437
39050,anti-VEGF,gene,0.911,27890437
39051,patients,species,0.9834,27890437
39052,ophthalmic disease,disease,0.9966,27890437
39053,anti-VEGF,gene,0.9473,27890437
39054,patients,species,0.9893,27890437
39055,bevacizumab,gene,0.887,27890437
39056,ranibizumab,gene,0.823,27890437
39057,aflibercept,gene,0.9673,27890437
39058,age-related macular degeneration,disease,1.0,27890437
39059,AMD,disease,1.0,27890437
39060,diabetic retinal diseases,disease,1.0,27890437
39061,proliferative diabetic retinopathy,disease,0.9985,27890437
39062,retinal vein occlusions,disease,1.0,27890437
39063,bevacizumab,gene,0.9326,27890437
39064,ranibizumab,gene,0.631,27890437
39065,AMD,disease,0.9995,27890437
39066,AMD,disease,1.0,27890437
39067,patients,species,0.9966,27890437
39068,aflibercept,gene,0.972,27890437
39069,AMD,disease,0.9995,27890437
39070,patients,species,0.9956,27890437
39071,Bevacizumab,gene,0.9014,27890437
39072,diabetic retinal disease,disease,1.0,27890437
39073,patients,species,0.992,27890437
39074,diabetic retinal disease,disease,1.0,27890437
39075,Aflibercept,gene,0.9634,27890437
39076,patients,species,0.9785,27890437
39077,diabetic retinal diseases,disease,1.0,27890437
39078,retinal vein occlusions,disease,1.0,27890437
39079,retinal vein occlusion,disease,1.0,27890437
39080,patients,species,0.9907,27890437
39081,VEGF,gene,0.9077,27890437
39082,Bevacizumab,gene,0.9053,27890437
39083,ophthalmic disease,disease,1.0,27890437
39084,AMD,disease,1.0,27890437
39085,Ranibizumab,gene,0.9355,27890437
39086,bevacizumab,gene,0.9277,27890437
39087,aflibercept,gene,0.989,27890437
39088,ziv-aflibercept,gene,0.9907,27888621
39089,ascites,disease,1.0,27888621
39090,colorectal cancer,disease,1.0,27888621
39091,Ascites,disease,0.996,27888621
39092,metastatic colorectal cancer,disease,1.0,27888621
39093,mCRC,disease,1.0,27888621
39094,ascites,disease,0.992,27888621
39095,ziv-aflibercept,gene,0.9956,27888621
39096,ascites,disease,0.993,27888621
39097,mCRC,disease,0.9985,27888621
39098,ziv-aflibercept,gene,0.98,27888621
39099,ascites,disease,0.993,27888621
39100,ziv-aflibercept,gene,0.976,27888621
39101,serum ascites albumin,gene,0.7344,27888621
39102,ziv-aflibercept,gene,0.9863,27888621
39103,ascites,disease,0.9976,27888621
39104,mCRC,disease,1.0,27888621
39105,placental growth factor,gene,0.9976,27886182
39106,diabetic retinopathy,disease,0.994,27886182
39107,PlGF,gene,0.9683,27886182
39108,VEGF,DNA,0.703,27886182
39109,VEGF family,gene,0.997,27886182
39110,diabetic retinopathy,disease,1.0,27886182
39111,PlGF,gene,0.9927,27886182
39112,proliferative diabetic retinopathy,disease,1.0,27886182
39113,PDR,disease,1.0,27886182
39114,VEGF,gene,0.9946,27886182
39115,PDR,disease,1.0,27886182
39116,PlGF receptor,gene,0.9863,27886182
39117,FLT1,gene,0.981,27886182
39118,endothelial cells,cell_type,0.9346,27886182
39119,PDR,disease,0.9995,27886182
39120,bevacizumab,gene,0.824,27886182
39121,PDR,disease,0.9995,27886182
39122,bevacizumab,gene,0.7827,27886182
39123,PDR,disease,0.9995,27886182
39124,PlGF,gene,0.994,27886182
39125,VEGF,gene,0.9927,27886182
39126,FLT1,gene,0.9893,27886182
39127,PDR,disease,1.0,27886182
39128,vitreous,gene,0.4912,27886182
39129,PlGF,gene,0.618,27886182
39130,PDR,disease,1.0,27886182
39131,PlGF,gene,0.993,27886182
39132,PDR,disease,0.998,27886182
39133,PDR,disease,0.9995,27886182
39134,PlGF,gene,0.9927,27886182
39135,PDR,disease,1.0,27886182
39136,PlGF,gene,0.995,27886182
39137,VEGF,gene,0.9907,27886182
39138,PDR,disease,0.9995,27886182
39139,VEGFR1,gene,0.992,27886182
39140,endothelial cells,cell_type,0.8887,27886182
39141,PDR,disease,0.998,27886182
39142,PlGF,gene,0.985,27886182
39143,PDR,disease,0.9995,27886182
39144,FLT1,gene,0.9873,27886182
39145,PDR,disease,0.996,27886182
39146,PlGF,gene,0.993,27886182
39147,diabetic retinopathy,disease,0.9976,27886182
39148,PlGF,gene,0.9897,27886182
39149,aflibercept,gene,0.944,27886182
39150,Age-Related macular degeneration,disease,1.0,27881184
39151,neovascular age-related macular degeneration,disease,1.0,27881184
39152,nAMD,disease,1.0,27881184
39153,vascular endothelial growth factor,gene,0.998,27881184
39154,VEGF,gene,0.4568,27881184
39155,ranibizumab,gene,0.5967,27881184
39156,bevacizumab,gene,0.897,27881184
39157,aflibercept,gene,0.961,27881184
39158,anti-VEGF,gene,0.961,27881184
39159,nAMD,disease,1.0,27881184
39160,nAMD,disease,1.0,27881184
39161,nAMD,disease,1.0,27881184
39162,ranibizumab,gene,0.783,27881184
39163,ranibizumab,gene,0.8345,27881184
39164,radiation retinopathy,disease,0.9995,27881184
39165,ranibizumab,gene,0.4917,27881184
39166,aflibercept,gene,0.9946,27878592
39167,neovascular age-related macular,disease,0.982,27878592
39168,aflibercept,gene,0.9917,27878592
39169,neovascular age-related macular degeneration,disease,1.0,27878592
39170,nAMD,disease,1.0,27878592
39171,patients,species,0.9883,27878592
39172,bevacizumab,gene,0.895,27878592
39173,ranibizumab,gene,0.7407,27878592
39174,aflibercept,gene,0.96,27878592
39175,patients,species,0.9736,27878592
39176,nAMD,disease,1.0,27878592
39177,bevacizumab,gene,0.812,27878592
39178,ranibizumab,gene,0.582,27878592
39179,aflibercept,gene,0.9746,27878592
39180,Patients,species,0.9785,27878592
39181,aflibercept,gene,0.9316,27878592
39182,pigment epithelial detachment,disease,0.9136,27878592
39183,aflibercept,gene,0.984,27878592
39184,PED,DNA,0.5913,27878592
39185,atrophy,disease,0.8,27878592
39186,aflibercept,gene,0.895,27878592
39187,participants,species,0.974,27863843
39188,REtinal Vein Occlusion,disease,0.999,27863843
39189,retinal vein occlusion,disease,0.9995,27863843
39190,bevacizumab,gene,0.8145,27863843
39191,aflibercept,gene,0.985,27863843
39192,decreased vision,disease,0.9907,27863843
39193,central retinal vein occlusion,disease,1.0,27863843
39194,CRVO,disease,1.0,27863843
39195,hemiretinal vein occlusion,disease,1.0,27863843
39196,HRVO,disease,1.0,27863843
39197,PARTICIPANTS,species,0.892,27863843
39198,participants,species,0.9746,27863843
39199,CRVO,disease,1.0,27863843
39200,HRVO,disease,0.9995,27863843
39201,CRVO,disease,1.0,27863843
39202,HRVO,disease,0.9995,27863843
39203,participants,species,0.9746,27863843
39204,hypertension,disease,1.0,27863843
39205,diabetes mellitus,disease,1.0,27863843
39206,coronary artery disease,disease,1.0,27863843
39207,participants,species,0.9805,27863843
39208,participants,species,0.9824,27863843
39209,HRVO,disease,1.0,27863843
39210,patients,species,0.9937,27863843
39211,CRVO,disease,1.0,27863843
39212,patients,species,0.996,27863843
39213,hypertension,disease,1.0,27863843
39214,diabetes mellitus,disease,1.0,27863843
39215,coronary artery disease,disease,1.0,27863843
39216,macular edema,disease,1.0,27863843
39217,participants,species,0.9854,27863843
39218,anti-,gene,0.544,27863843
39219,vascular endothelial growth factor,gene,0.898,27863843
39220,participants,species,0.9746,27863843
39221,anti-VEGF,gene,0.8193,27863843
39222,macular edema,disease,1.0,27863843
39223,anti-VEGF,gene,0.703,27863843
39224,CRVO,disease,1.0,27863843
39225,HRVO,disease,1.0,27863843
39226,anti-VEGF,gene,0.862,27863843
39227,CRVO,disease,1.0,27863843
39228,HRVO,disease,1.0,27863843
39229,patients,species,0.986,27863843
39230,macular edema,disease,1.0,27863843
39231,CRVO,disease,0.9995,27863843
39232,superior vena cava syndrome,disease,0.915,27855459
39233,patient,species,0.8965,27855459
39234,man,species,0.8374,27855459
39235,metastasized rectum cancer,disease,1.0,27855459
39236,cyanosis of,disease,0.993,27855459
39237,patient,species,0.9863,27855459
39238,Cyanosis,disease,1.0,27855459
39239,folinic acid,drug,0.9995,27855459
39240,5-fluoruracil,drug,0.9995,27855459
39241,irinotecan,drug,0.9937,27855459
39242,aflibercept,gene,0.7686,27855459
39243,superior vena cava syndrome,disease,1.0,27855459
39244,SCVS,disease,1.0,27855459
39245,acute pulmonary embolism,disease,0.9395,27855459
39246,thoracic aortic aneurysm,disease,1.0,27855459
39247,cyanosis,disease,0.9985,27855459
39248,Cyanosis,disease,1.0,27855459
39249,patient,species,0.989,27855459
39250,SCVS,disease,0.9985,27855459
39251,port-catheter associated thrombosis,disease,0.912,27855459
39252,tumor,disease,1.0,27855459
39253,patients,species,0.9663,27855459
39254,tumor,disease,1.0,27855459
39255,patients,species,0.982,27855459
39256,tumor,disease,1.0,27855459
39257,aflibercept,gene,0.992,27853350
39258,choroidal neovascularization,disease,1.0,27853350
39259,pathologic myopia,disease,0.992,27853350
39260,aflibercept,gene,0.989,27853350
39261,choroidal neovascularization,disease,1.0,27853350
39262,CNV,disease,1.0,27853350
39263,pathologic myopia,disease,0.9976,27853350
39264,CNV,disease,0.9956,27853350
39265,pathologic myopia,disease,0.977,27853350
39266,aflibercept,gene,0.8994,27853350
39267,fluorescein,drug,0.987,27853350
39268,aflibercept,gene,0.9917,27853350
39269,aflibercept,gene,0.974,27853350
39270,BCVA,cell_type,0.4097,27853350
39271,CRT,DNA,0.5117,27853350
39272,endophthalmitis,disease,1.0,27853350
39273,uveitis,disease,1.0,27853350
39274,stroke,disease,1.0,27853350
39275,retinal detachment,disease,1.0,27853350
39276,aflibercept,gene,0.949,27853350
39277,myopic CNV,disease,1.0,27853350
39278,anti-vascular endothelial growth factor,gene,0.884,27853011
39279,anti-vascular endothelial growth factor,gene,0.941,27853011
39280,VEGF,gene,0.9946,27853011
39281,age-related macular degeneration,disease,1.0,27853011
39282,AMD,disease,1.0,27853011
39283,diabetic macular edema,disease,1.0,27853011
39284,DME,disease,1.0,27853011
39285,anti-VEGF,gene,0.805,27853011
39286,AMD,disease,1.0,27853011
39287,DME,disease,1.0,27853011
39288,DME,disease,1.0,27853011
39289,AMD,disease,1.0,27853011
39290,AMD,disease,1.0,27853011
39291,DME,disease,1.0,27853011
39292,polypoidal choroidal vasculopathy,disease,1.0,27848983
39293,aflibercept,gene,0.9414,27848983
39294,Polypoidal choroidal vasculopathy,disease,1.0,27848983
39295,degenerative macular disease,disease,1.0,27848983
39296,aflibercept,gene,0.9683,27848983
39297,patients,species,0.899,27848983
39298,polypoidal choroidal vasculopathy,disease,1.0,27848983
39299,patients,species,0.9644,27848983
39300,polypoidal choroidal vasculoapathy,disease,1.0,27848983
39301,aflibercept,gene,0.9595,27848983
39302,aflibercept,gene,0.9683,27848983
39303,polypoidal choroidal vasculopathy,disease,1.0,27848983
39304,Aflibercept,gene,0.903,27847638
39305,branch retinal vein occlusion,disease,1.0,27847638
39306,aflibercept,gene,0.9795,27847638
39307,patients,species,0.942,27847638
39308,chronic macular edema,disease,1.0,27847638
39309,branch retinal vein occlusion,disease,1.0,27847638
39310,BRVO,disease,1.0,27847638
39311,bevacizumab,gene,0.798,27847638
39312,ranibizumab,gene,0.5537,27847638
39313,patients,species,0.9844,27847638
39314,chronic macular edema,disease,1.0,27847638
39315,BRVO,disease,1.0,27847638
39316,patients,species,0.987,27847638
39317,aflibercept,gene,0.9434,27847638
39318,ranibizumab,gene,0.707,27847638
39319,aflibercept,gene,0.9844,27847638
39320,aflibercept,gene,0.9873,27847638
39321,patients,species,0.9746,27847638
39322,patients,species,0.987,27847638
39323,ranibizumab,gene,0.831,27847638
39324,bevacizumab,gene,0.754,27847638
39325,to aflibercept,gene,0.4456,27847638
39326,aflibercept,gene,0.8955,27847638
39327,CRV,DNA,0.4646,27847638
39328,aflibercept,gene,0.9585,27847638
39329,aflibercept,gene,0.973,27847638
39330,aflibercept,gene,0.965,27847638
39331,patients,species,0.9263,27847638
39332,chronic macular edema,disease,1.0,27847638
39333,BRVO,disease,1.0,27847638
39334,aflibercept,gene,0.983,27847634
39335,patients,species,0.9717,27847634
39336,Diabetic macular edema,disease,1.0,27847634
39337,DME,disease,1.0,27847634
39338,vascular endothelial growth factor,gene,0.9966,27847634
39339,VEGF,gene,0.996,27847634
39340,VEGF,gene,0.9663,27847634
39341,DME,drug,0.9644,27847634
39342,aflibercept,gene,0.97,27847634
39343,aflibercept,gene,0.976,27847634
39344,DME,disease,0.8047,27847634
39345,CRT,DNA,0.446,27847634
39346,BCVA,DNA,0.4968,27847634
39347,BCVA,disease,0.885,27847634
39348,patients,species,0.9727,27847634
39349,CRT,DNA,0.4915,27847634
39350,VIVID,DNA,0.4663,27847634
39351,DME,disease,0.994,27847634
39352,DME,disease,0.999,27847634
39353,retinal diseases,disease,0.9966,27847621
39354,aflibercept,gene,0.993,27847621
39355,ziv-aflibercept,gene,0.9897,27847621
39356,retinal neovascular,disease,0.9966,27847621
39357,aflibercept,gene,0.988,27847621
39358,ziv-aflibercept,gene,0.972,27847621
39359,conbercept,gene,0.6816,27847621
39360,ocular diseases,disease,0.9927,27847621
39361,ophthalmic diseases,disease,0.9946,27847621
39362,Aflibercept,gene,0.9805,27847621
39363,VEGF Trap Eye,gene,0.8647,27847621
39364,VEGF receptors 1 and 2,gene,0.9917,27847621
39365,retinal diseases,disease,0.9995,27847621
39366,ranibizumab,gene,0.8555,27847621
39367,bevacizumab,gene,0.7407,27847621
39368,neovascular AMD,disease,0.9956,27847621
39369,DME,disease,0.9307,27847621
39370,Ziv-aflibercept,gene,0.9756,27847621
39371,metastatic colorectal cancer,disease,1.0,27847621
39372,human,species,0.9736,27847621
39373,VEGF-A,gene,0.998,27847621
39374,VEGF-B,gene,0.9985,27847621
39375,VEGF-C,gene,0.9985,27847621
39376,PlGF,gene,0.9946,27847621
39377,VEGF,gene,0.997,27847621
39378,aflibercept,gene,0.9946,27847621
39379,ziv-aflibercept,gene,0.9893,27847621
39380,conbercept,gene,0.968,27847621
39381,retinal diseases,disease,0.9995,27847621
39382,bevacizumab,gene,0.6445,27847620
39383,Neovascular age-related macular degeneration,disease,1.0,27847620
39384,VEGF,gene,0.9,27847620
39385,patients,species,0.965,27847620
39386,patients,species,0.9844,27847620
39387,bevacizumab,gene,0.846,27847620
39388,ranibizumab,gene,0.8457,27847620
39389,aflibercept,gene,0.9673,27847620
39390,patients,species,0.978,27847620
39391,bevacizumab,gene,0.8877,27847620
39392,ranibizumab,gene,0.5474,27847620
39393,aflibercept,gene,0.977,27847620
39394,bevacizumab,gene,0.7866,27847620
39395,bevacizumab,gene,0.73,27847620
39396,ranibizumab,drug,0.609,27847620
39397,aflibercept,gene,0.977,27847620
39398,aflibercept,gene,0.977,27847620
39399,aflibercept,gene,0.9814,27847620
39400,bevacizumab,gene,0.7417,27847620
39401,ranibizumab,gene,0.6567,27847620
39402,pigment epithelial detachments,cell_type,0.6445,27847620
39403,bevacizumab,gene,0.748,27847620
39404,aflibercept,gene,0.8984,27847620
39405,aflibercept,gene,0.9785,27847620
39406,bevacizumab,gene,0.7417,27847620
39407,aflibercept,gene,0.9795,27847620
39408,patients,species,0.9746,27847620
39409,aflibercept,gene,0.9834,27847620
39410,bevacizumab,gene,0.7983,27847620
39411,VEGF,gene,0.937,27847620
39412,Aflibercept,gene,0.869,27842696
39413,Aflibercept,gene,0.9844,27841282
39414,Ang1,gene,0.9937,27841282
39415,VEGF-A,gene,0.998,27841282
39416,VEGF family members,gene,0.982,27841282
39417,Angiopoietin,gene,0.997,27841282
39418,Tie2,gene,0.969,27841282
39419,mouse,species,0.8125,27841282
39420,triple-negative breast cancer,disease,1.0,27841282
39421,TNBC,disease,1.0,27841282
39422,MDA-MB-231 human TNBC cell line,cell_line,0.9697,27841282
39423,human,species,0.9355,27841282
39424,TNBC,disease,0.7446,27841282
39425,LM2-4,cell_line,0.9116,27841282
39426,tumor,disease,0.93,27841282
39427,Aflibercept,gene,0.9824,27841282
39428,VEGF Trap,gene,0.9575,27841282
39429,VEGF-A,gene,0.999,27841282
39430,VEGF-B,gene,0.9985,27841282
39431,PlGF,gene,0.9966,27841282
39432,anti-Ang2 antibody,gene,0.9897,27841282
39433,Ang1,gene,0.997,27841282
39434,Ang2,gene,0.997,27841282
39435,antagonistic anti-Tie2 antibody,gene,0.8687,27841282
39436,Ang2,gene,0.998,27841282
39437,BowAng1,gene,0.9775,27841282
39438,recombinant Ang1,gene,0.8965,27841282
39439,VEGF,gene,0.994,27841282
39440,Ang,gene,0.9937,27841282
39441,Tie2,gene,0.9854,27841282
39442,anti-Ang2,gene,0.986,27841282
39443,anti-Ang2,gene,0.9487,27841282
39444,Ang1,gene,0.9844,27841282
39445,Tie2,gene,0.54,27841282
39446,TNBC,disease,0.99,27841282
39447,Ang1,gene,0.996,27841282
39448,TNBC,cell_line,0.738,27841282
39449,TNBC,cell_type,0.6875,27841282
39450,TNBC,disease,0.995,27841282
39451,Neonatal Fc receptor,gene,0.9946,27836572
39452,FcRn,gene,0.763,27836572
39453,Fc,gene,,27836572
39454,Retinal endothelial cells,cell_type,0.872,27836572
39455,REC,cell_line,0.847,27836572
39456,IgG,gene,0.996,27836572
39457,Fc fusion protein,gene,0.9414,27836572
39458,aflibercept,gene,0.8984,27836572
39459,immortalized bovine REC,cell_line,0.954,27836572
39460,bovine,species,0.8696,27836572
39461,iBREC,cell_line,0.9146,27836572
39462,IgG,gene,0.996,27836572
39463,Fc fusion proteins,gene,0.9624,27836572
39464,aflibercept,gene,0.9736,27836572
39465,endothelial cells,cell_type,0.8965,27836572
39466,neonatal Fc receptor,gene,0.998,27836572
39467,FcRn,gene,0.997,27836572
39468,iBREC,cell_type,0.8853,27836572
39469,aflibercept,gene,0.982,27836572
39470,FcRn,gene,0.993,27836572
39471,aflibercept,gene,0.9917,27836572
39472,aflibercept,gene,0.974,27836572
39473,FcRn,gene,0.996,27836572
39474,aflibercept,gene,0.994,27836572
39475,aflibercept,gene,0.9844,27836572
39476,iBREC monolayer,cell_line,0.9375,27836572
39477,aflibercept,gene,0.992,27836572
39478,aflibercept,gene,0.956,27836572
39479,phosphatidylinositol,drug,0.997,27836572
39480,phosphatidylinositol 3-kinase,gene,0.9883,27836572
39481,LY294002,drug,0.996,27836572
39482,FcRn,gene,0.995,27836572
39483,IgG,gene,0.997,27836572
39484,aflibercept,gene,0.966,27836572
39485,IgG-binding proteins,gene,0.9927,27836572
39486,protein A,gene,0.9927,27836572
39487,protein G,gene,0.995,27836572
39488,FcRn,gene,0.9946,27836572
39489,aflibercept,gene,0.993,27836572
39490,aflibercept,gene,0.9287,27836572
39491,FcRn,gene,0.9946,27836572
39492,protein A,gene,0.988,27836572
39493,protein G,gene,0.9937,27836572
39494,inhibitory FcRn-specific monoclonal antibody 1G3,gene,0.8237,27836572
39495,aflibercept,gene,0.754,27836572
39496,FcRn,gene,0.993,27836572
39497,aflibercept,gene,0.941,27836572
39498,REC,cell_line,0.884,27836572
39499,REC,cell_type,0.825,27836572
39500,vascular endothelial growth factor,gene,0.9697,27833450
39501,VEGF,gene,0.9985,27833450
39502,vascular endothelial growth factor,gene,0.9985,27833450
39503,VEGF,gene,0.993,27833450
39504,VEGFR,gene,0.9917,27833450
39505,cancer,disease,1.0,27833450
39506,VEGF,gene,0.9956,27833450
39507,VEGFR,gene,0.993,27833450
39508,VEGF,gene,0.9546,27833450
39509,rheumatological disorders,disease,1.0,27833450
39510,tumour,disease,1.0,27833450
39511,bevacizumab,gene,0.86,27833450
39512,ranibizumab,gene,0.8745,27833450
39513,aflibercept,gene,0.952,27833450
39514,pegaptanib,drug,0.993,27833450
39515,related macular degeneration,disease,0.9375,27833450
39516,AMD,disease,1.0,27833450
39517,macular oedema,disease,1.0,27833450
39518,proliferative retinopathies,disease,1.0,27833450
39519,iris neovascularisation,disease,1.0,27833450
39520,corneal pathologies,disease,0.989,27833450
39521,glaucoma,disease,0.978,27833450
39522,Bevacizumab,gene,0.865,27827554
39523,Ranibizumab,gene,0.9136,27827554
39524,Aflibercept,gene,0.982,27827554
39525,antivascular endothelial growth factor,gene,0.9243,27827554
39526,VEGF,gene,0.9985,27827554
39527,bevacizumab,gene,0.906,27827554
39528,ranibizumab,gene,0.869,27827554
39529,aflibercept,gene,0.9805,27827554
39530,human corneal epithelial cells,cell_type,0.893,27827554
39531,human,species,0.9775,27827554
39532,HCECs,cell_line,0.892,27827554
39533,VEGF,gene,0.824,27827554
39534,HCECs,cell_type,0.853,27827554
39535,HCEC,cell_type,0.67,27827554
39536,HCECs,cell_line,0.837,27827554
39537,HCECs,cell_type,0.8823,27827554
39538,VEGF,gene,0.561,27827554
39539,extracellular signal-regulated kinase,gene,0.991,27827554
39540,VEGF,gene,0.704,27827554
39541,p38 mitogen-activated protein kinase,gene,0.938,27827554
39542,aflibercept,gene,0.9917,27827554
39543,bevacizumab,gene,0.8677,27827554
39544,ranibizumab,gene,0.616,27827554
39545,HCEC,cell_line,0.9233,27827554
39546,anti-VEGF,gene,0.913,27827554
39547,Bevacizumab,gene,0.746,27827554
39548,HCEC,cell_line,0.895,27827554
39549,HCEC,cell_type,0.864,27827554
39550,bevacizumab,gene,0.574,27827554
39551,p38,gene,0.84,27827554
39552,Bevacizumab,gene,0.703,27827554
39553,anti-VEGF,gene,0.858,27827554
39554,epithelial cell,cell_type,0.8594,27827554
39555,VEGF,gene,0.937,27827554
39556,bevacizumab,drug,0.576,27827554
39557,corneal neovascularization,disease,1.0,27827554
39558,epithelial defects,disease,1.0,27827554
39559,bevacizumab,gene,0.928,27826933
39560,ranibizumab,gene,0.8916,27826933
39561,aflibercept,gene,0.9453,27826933
39562,neovascular age-related macular degeneration,disease,1.0,27826933
39563,bevacizumab,gene,0.8955,27826933
39564,ranibizumab,gene,0.89,27826933
39565,aflibercept,gene,0.967,27826933
39566,neovascular age-related macular degeneration,disease,1.0,27826933
39567,nAMD,disease,1.0,27826933
39568,anti-vascular endothelial growth factor,gene,0.9907,27826933
39569,VEGF,gene,0.996,27826933
39570,nAMD,disease,1.0,27826933
39571,nAMD,disease,1.0,27826933
39572,pigment,cell_type,0.5083,27826933
39573,VEGF,gene,0.6865,27826933
39574,bevacizumab,gene,0.912,27826933
39575,ranibizumab,gene,0.6997,27826933
39576,aflibercept,gene,0.929,27826933
39577,aflibercept,gene,0.9917,27826933
39578,PED,disease,0.9297,27826933
39579,bevacizumab,gene,0.8286,27826933
39580,Bevacizumab,gene,0.524,27826933
39581,ranibizumab,gene,0.6685,27826933
39582,aflibercept,gene,0.9795,27826933
39583,nAMD,disease,1.0,27826933
39584,aflibercept,gene,0.9893,27826933
39585,aflibercept,gene,0.9893,27826933
39586,VEGF,gene,0.714,27826933
39587,PED,disease,0.9946,27826933
39588,aflibercept,gene,0.945,27816486
39589,age-related choroidal neovascularisation,disease,1.0,27816486
39590,aflibercept,gene,0.9824,27816486
39591,neovascularizations,disease,1.0,27816486
39592,CNV,disease,1.0,27816486
39593,AMD,disease,1.0,27816486
39594,aflibercept,gene,0.8604,27816486
39595,fluorescein,drug,0.9985,27816486
39596,AMD,disease,1.0,27816486
39597,CNV,disease,0.84,27816486
39598,type 3 CNV,disease,0.997,27816486
39599,retinal angiomatous proliferation,disease,1.0,27816486
39600,RAP,disease,1.0,27816486
39601,RAP,gene,0.6724,27816486
39602,CNV,disease,0.9995,27816486
39603,Aflibercept,gene,0.965,27816486
39604,exudative-AMD,disease,0.986,27816486
39605,CNV,disease,0.5767,27816486
39606,VEGF,gene,0.9663,27815675
39607,VEGF,gene,0.855,27815675
39608,macular diseases,disease,1.0,27815675
39609,macular edema,disease,1.0,27815675
39610,IVOM,disease,1.0,27815675
39611,VEGF,gene,0.9927,27815675
39612,diabetic retinopathy,disease,1.0,27815675
39613,edema,disease,0.9873,27815675
39614,macular edema,disease,1.0,27815675
39615,Choroidal neovascularization,disease,1.0,27815675
39616,CNV,disease,1.0,27815675
39617,age-related macular degeneration,disease,1.0,27815675
39618,AMD,disease,1.0,27815675
39619,diabetic macular edema,disease,1.0,27815675
39620,DME,disease,1.0,27815675
39621,branch vein thrombosis,disease,1.0,27815675
39622,AVT,disease,1.0,27815675
39623,CVT,disease,1.0,27815675
39624,macular edema,disease,1.0,27815675
39625,myopic CNV,disease,1.0,27815675
39626,mCNV,disease,1.0,27815675
39627,EDTRS,DNA,0.4756,27815675
39628,AMD,drug,0.827,27815675
39629,mCNV,DNA,0.542,27815675
39630,macular edema,disease,1.0,27815675
39631,aflibercept,gene,0.9746,27814771
39632,retinoblastoma,disease,1.0,27814771
39633,aflibercept,gene,0.9746,27814771
39634,retinoblastoma,disease,1.0,27814771
39635,mouse,species,0.9604,27814771
39636,Y-79 cells,cell_line,0.944,27814771
39637,retinoblastoma,disease,1.0,27814771
39638,aflibercept,gene,0.9893,27814771
39639,Y-79,cell_line,0.89,27814771
39640,WERI-Rb-1 cells,cell_line,0.938,27814771
39641,human umbilical vein endothelial cells,cell_type,0.8906,27814771
39642,human,species,0.8555,27814771
39643,HUVECs,cell_type,0.792,27814771
39644,aflibercept,gene,0.9727,27814771
39645,Y-79,cell_line,0.8916,27814771
39646,aflibercept,gene,0.9824,27814771
39647,tumor,disease,0.8975,27814771
39648,mice,species,0.942,27814771
39649,Tumors,disease,0.9795,27814771
39650,aflibercept,gene,0.9854,27814771
39651,mice,species,0.9746,27814771
39652,apoptotic cells,cell_type,0.9067,27814771
39653,tumor cells,cell_type,0.831,27814771
39654,tumor,disease,0.978,27814771
39655,aflibercept,gene,0.968,27814771
39656,aflibercept,gene,0.989,27814771
39657,HUVECs,cell_type,0.865,27814771
39658,"Y-79, WERI-Rb-1 cells",cell_line,0.9126,27814771
39659,HUVEC,cell_type,0.8105,27814771
39660,Aflibercept,gene,0.934,27814771
39661,retinoblastoma,disease,1.0,27814771
39662,tumor,disease,0.9937,27814771
39663,aflibercept,gene,0.994,27814771
39664,retinoblastoma,disease,1.0,27814771
39665,Aflibercept,gene,0.961,27813522
39666,diabetic macular edema,disease,1.0,27813522
39667,Aflibercept,gene,0.961,27813521
39668,diabetic macular edema,disease,1.0,27813521
39669,aflibercept,gene,0.9863,27812769
39670,murine,species,0.906,27812769
39671,colorectal cancer,disease,1.0,27812769
39672,CRC,disease,1.0,27812769
39673,tumor,disease,0.9995,27812769
39674,liver metastases,disease,0.9834,27812769
39675,CRC cell lines,cell_line,0.8936,27812769
39676,CRC,disease,1.0,27812769
39677,HT29,cell_line,0.799,27812769
39678,HCT116,cell_line,0.859,27812769
39679,mice,species,0.896,27812769
39680,aflibercept,gene,0.958,27812769
39681,Aflibercept,gene,0.954,27812769
39682,HCT116,cell_line,0.9663,27812769
39683,HT29,cell_line,0.9526,27812769
39684,tumor,disease,1.0,27812769
39685,aflibercept,gene,0.944,27812769
39686,aflibercept,gene,0.964,27812769
39687,human,species,0.997,27812769
39688,tumor,disease,0.996,27812769
39689,liver metastasis,disease,0.9873,27812769
39690,anti-VEGF,gene,0.9893,27810558
39691,CNV,disease,0.988,27810558
39692,anti-vascular endothelial growth factor,gene,0.989,27810558
39693,VEGF,gene,0.9946,27810558
39694,age-related macular degeneration,disease,1.0,27810558
39695,AMD,disease,0.9946,27810558
39696,anti-VEGF molecule,gene,0.9897,27810558
39697,anti-VEGF domain antibodies,gene,0.9966,27810558
39698,human IgG1 Fc region,gene,0.972,27810558
39699,VEGF,gene,0.993,27810558
39700,VEGF,gene,0.9946,27810558
39701,aflibercept,gene,0.98,27810558
39702,VEGF receptor,gene,0.9834,27810558
39703,rabbit,species,0.984,27810558
39704,primate,species,0.898,27810558
39705,Cynomolgus,species,0.911,27810558
39706,choroidal neovascularisation,disease,0.9995,27810558
39707,CNV,disease,1.0,27810558
39708,anti-VEGF molecule,gene,0.8276,27810558
39709,wet AMD,disease,0.984,27810558
39710,AFLIBERCEPT,disease,1.0,27787445
39711,NEOVASCULAR AGE-RELATED MACULAR DEGENERATION,disease,0.9917,27787445
39712,age-related macular degeneration,disease,1.0,27787445
39713,AMD,disease,1.0,27787445
39714,vision loss,disease,0.987,27787445
39715,aflibercept,gene,0.9585,27787445
39716,AMD,disease,0.9995,27787445
39717,aflibercept,gene,0.93,27787445
39718,Vision loss,disease,0.9985,27787445
39719,vision loss,disease,0.8228,27787445
39720,Vision loss,disease,0.9937,27787445
39721,vision loss,disease,0.992,27787445
39722,vision,disease,0.8965,27787445
39723,aflibercept,gene,0.955,27787445
39724,MACULAR DEGENERATION,disease,0.757,27798520
39725,ziv-aflibercept,gene,0.9824,27798520
39726,exudative age-related macular degeneration,disease,0.9976,27798520
39727,exudative,disease,0.641,27798520
39728,age-related macular degeneration,disease,0.9395,27798520
39729,ziv-aflibercept,gene,0.9644,27798520
39730,ziv-aflibercept,gene,0.9785,27798520
39731,retinal toxicity,disease,0.9,27798520
39732,Aflibercept,gene,0.9873,30730125
39733,osteonecrosis of the jaw,disease,1.0,30730125
39734,Vascular endothelial growth factor,gene,0.996,27045225
39735,diabetic macular edema,disease,1.0,27045225
39736,Diabetes mellitus,disease,1.0,27045225
39737,diabetic macular edema,disease,1.0,27045225
39738,vision loss,disease,0.998,27045225
39739,microaneurysms,disease,0.98,27045225
39740,thickened,disease,0.8726,27045225
39741,diabetic macular edema,disease,1.0,27045225
39742,glucose,drug,0.9814,27045225
39743,vascular endothelial growth factor,gene,0.9976,27045225
39744,VEGF,gene,0.992,27045225
39745,anti-,gene,0.607,27045225
39746,vascular endothelial growth factor,gene,0.9287,27045225
39747,ranibizumab,gene,0.771,27045225
39748,bevacizumab,gene,0.899,27045225
39749,aflibercept,gene,0.9707,27045225
39750,diabetic macular edema,disease,1.0,27045225
39751,ranibizumab,gene,0.8574,27045225
39752,bevacizumab,gene,0.8726,27045225
39753,aflibercept,gene,0.9937,27045225
39754,bevacizumab,gene,0.721,27045225
39755,diabetic edema,disease,1.0,27045225
39756,aflibercept,gene,0.967,27045225
39757,anti-VEGF,gene,0.651,27045225
39758,VEGF,gene,0.8447,27045225
39759,aflibercept,gene,0.9834,27791249
39760,vascularized pigment epithelium detachment,disease,0.994,27791249
39761,neovascular AMD,disease,1.0,27791249
39762,aflibercept,gene,0.98,27791249
39763,neovascular age-related macular degeneration,disease,1.0,27791249
39764,nAMD,disease,1.0,27791249
39765,pigment epithelial detachment,disease,1.0,27791249
39766,PED,disease,1.0,27791249
39767,nAMD,disease,1.0,27791249
39768,PED,disease,0.998,27791249
39769,ranibizumab,gene,0.8555,27791249
39770,aflibercept,gene,0.9756,27791249
39771,PED,disease,0.68,27791249
39772,aflibercept,gene,0.9883,27791249
39773,PED,DNA,0.5864,27791249
39774,Aflibercept,gene,0.832,27791249
39775,ranibizumab,drug,0.5444,27791249
39776,nAMD,disease,1.0,27791249
39777,PED,disease,0.9927,27791249
39778,PED,DNA,0.63,27791249
39779,aflibercept,gene,0.9854,27791249
39780,Retinal Artery Macroaneurysms,disease,1.0,27790133
39781,Aflibercept,gene,0.9756,27790133
39782,aflibercept,gene,0.994,27790133
39783,retinal artery macroaneurysms,disease,1.0,27790133
39784,RAM,disease,1.0,27790133
39785,RAM,disease,1.0,27790133
39786,macular edema,disease,1.0,27790133
39787,ME,disease,1.0,27790133
39788,submacular hemorrhage,disease,1.0,27790133
39789,SMH,disease,0.9995,27790133
39790,vitreous hemorrhage,disease,1.0,27790133
39791,VH,disease,0.9995,27790133
39792,SMH,disease,0.999,27790133
39793,ME,disease,0.999,27790133
39794,ME,disease,0.9995,27790133
39795,VH,disease,1.0,27790133
39796,SMH,disease,1.0,27790133
39797,macular scar,disease,0.997,27790133
39798,Thrombosis of RAM,disease,1.0,27790133
39799,ME,disease,0.997,27790133
39800,VH,disease,0.9995,27790133
39801,RAM,disease,0.4478,27790133
39802,SMH,disease,0.9707,27790133
39803,thrombosis of,disease,0.7783,27790133
39804,RAM,disease,0.6963,27790133
39805,age-related macular degeneration,disease,1.0,27789040
39806,aflibercept,gene,0.9805,27789040
39807,Aflibercept,gene,0.9395,27789040
39808,age-related macular degeneration,disease,0.9883,27789040
39809,wAMD,disease,1.0,27789040
39810,wAMD,disease,0.9995,27789040
39811,aflibercept,gene,0.9614,27789040
39812,aflibercept,gene,0.8496,27789040
39813,aflibercept,gene,0.9766,27789040
39814,VEGF,gene,0.9487,27739561
39815,ranibizumab,gene,0.825,27739561
39816,aflibercept,gene,0.976,27739561
39817,age-related choroidal neovascularization,disease,1.0,27739561
39818,ranibizumab,gene,0.806,27739561
39819,aflibercept,gene,0.9595,27739561
39820,neovascular age-related macular degeneration,disease,1.0,27739561
39821,nAMD,disease,1.0,27739561
39822,ranibizumab,gene,0.742,27739561
39823,nAMD,disease,1.0,27739561
39824,aflibercept,gene,0.984,27739561
39825,CRT,DNA,0.584,27739561
39826,aflibercept,gene,0.971,27739561
39827,nAMD,disease,1.0,27739561
39828,ranibizumab,gene,0.972,27739561
39829,aflibercept,gene,0.9277,27739561
39830,Ranibizumab,gene,0.8794,27787744
39831,Aflibercept,gene,0.937,27787744
39832,Wet,disease,0.956,27787744
39833,Age-Related Macular Degeneration,disease,0.994,27787744
39834,wet age-related macular degeneration,disease,0.9995,27787744
39835,wAMD,disease,1.0,27787744
39836,ranibizumab,gene,0.6523,27787744
39837,aflibercept,gene,0.9766,27787744
39838,wAMD,disease,0.9995,27787744
39839,BCVA,DNA,0.4788,27787744
39840,ranibizumab,gene,0.849,27787744
39841,aflibercept,gene,0.956,27787744
39842,wAMD,disease,1.0,27787744
39843,Markov structure,DNA,0.5024,27787744
39844,Aflibercept,gene,0.9805,27784074
39845,Neovascular Age-Related Macular Degeneration,disease,1.0,27784074
39846,aflibercept,gene,0.988,27784074
39847,BMO,disease,0.998,27784074
39848,prelaminar tissue thinning,disease,0.994,27784074
39849,neovascular AMD,disease,1.0,27784074
39850,advanced gastric cancer,disease,1.0,27781258
39851,gastric cancer,disease,1.0,27781258
39852,gastric cancer,disease,1.0,27781258
39853,human epidermal growth factor receptor,gene,0.9985,27781258
39854,HER,gene,0.988,27781258
39855,vascular endothelial,cell_type,0.5205,27781258
39856,VEGF,gene,0.99,27781258
39857,phosphatidylinositol,drug,0.983,27781258
39858,phosphatidylinositol 3-kinase-protein kinase,gene,0.9937,27781258
39859,mammalian target of,gene,0.9595,27781258
39860,rapamycin,drug,0.997,27781258
39861,PI3K,gene,0.994,27781258
39862,mTOR,gene,0.991,27781258
39863,NF-B,gene,0.9907,27781258
39864,HER,DNA,0.4863,27781258
39865,HER family,gene,0.9863,27781258
39866,Cetuximab,gene,0.922,27781258
39867,Nimotuzumab,gene,0.8774,27781258
39868,Matuzumab,gene,0.8584,27781258
39869,Panitumumab,gene,0.9087,27781258
39870,Erlotinib,drug,0.992,27781258
39871,HER-1,gene,0.994,27781258
39872,Trastuzumab,gene,0.9717,27781258
39873,Pertuzumab,gene,0.897,27781258
39874,trastuzumab emtansine,gene,0.9155,27781258
39875,HER-2,gene,0.9927,27781258
39876,Lapatinib,drug,0.997,27781258
39877,Afatinib,drug,0.991,27781258
39878,HER,gene,0.9893,27781258
39879,VEGF,gene,0.994,27781258
39880,anti-VEGF monoclonal antibody,gene,0.9824,27781258
39881,Bevacizumab,gene,0.77,27781258
39882,VEGFR,gene,0.8696,27781258
39883,Apatinib,drug,0.9707,27781258
39884,Sorafenib,drug,0.992,27781258
39885,Sunitinib,drug,0.999,27781258
39886,cediranib,drug,0.9976,27781258
39887,Aflibercept,gene,0.989,27781258
39888,LY294002,drug,0.998,27781258
39889,BEZ235,drug,0.9927,27781258
39890,Everolimus,drug,0.9976,27781258
39891,PI3K,gene,0.998,27781258
39892,mTOR,gene,0.9844,27781258
39893,Bortezomib,drug,0.9995,27781258
39894,NF-B,gene,0.993,27781258
39895,Trastuzumab,gene,0.9883,27781258
39896,Ramucirumab,gene,0.5884,27781258
39897,Apatinib,drug,0.993,27781258
39898,gastric cancer,disease,1.0,27781258
39899,aflibercept,gene,0.9272,27230919
39900,aflibercept,gene,0.9062,27230919
39901,neovascular age-related macular degeneration,disease,1.0,27230919
39902,AMD,disease,1.0,27230919
39903,patients,species,0.989,27230919
39904,neovascular AMD,disease,1.0,27230919
39905,ranibizumab,gene,0.7812,27230919
39906,aflibercept,gene,0.9224,27230919
39907,aflibercept,gene,0.9175,27230919
39908,Patients,species,0.972,27230919
39909,ranibizumab,gene,0.6304,27230919
39910,aflibercept,gene,0.9756,27230919
39911,ranibizumab,gene,0.888,27230919
39912,aflibercept,gene,0.975,27230919
39913,ranibizumab,gene,0.9663,27230919
39914,aflibercept,gene,0.9873,27230919
39915,dome-shaped macula,disease,0.998,27780183
39916,DSM,disease,0.9727,27780183
39917,serous macular detachment,disease,1.0,27780183
39918,DSM,disease,1.0,27780183
39919,serous macular detachment,disease,1.0,27780183
39920,DSM,disease,1.0,27780183
39921,serous macular detachment,disease,0.9995,27780183
39922,serous macular detachment,disease,1.0,27780183
39923,Subretinal fluid,disease,0.9497,27780183
39924,aflibercept,gene,0.9883,27780183
39925,DSM,disease,0.999,27780183
39926,myopic,disease,0.968,27780183
39927,aflibercept,gene,0.988,27780183
39928,serous macular detachment,disease,1.0,27780183
39929,DSM,disease,1.0,27780183
39930,Aflibercept,gene,0.9785,27651226
39931,Diabetic Macular Edema,disease,1.0,27651226
39932,aflibercept,gene,0.9897,27651226
39933,diabetic macular edema,disease,1.0,27651226
39934,DME,disease,1.0,27651226
39935,PARTICIPANTS,species,0.6147,27651226
39936,DME,disease,1.0,27651226
39937,IAI,disease,0.9995,27651226
39938,Diabetic Retinopathy,disease,1.0,27651226
39939,DRSS,DNA,0.4949,27651226
39940,IAI 2q4,DNA,0.7124,27651226
39941,IAI 2q8,DNA,0.6445,27651226
39942,VIVID,disease,1.0,27651226
39943,cataract,disease,0.9995,27651226
39944,IAI,drug,0.663,27651226
39945,DME,disease,1.0,27613201
39946,VEGF,gene,0.659,27613201
39947,diabetic macular edema,disease,1.0,27613201
39948,DME,disease,1.0,27613201
39949,vascular endothelial growth factor,gene,0.96,27613201
39950,VEGF,gene,0.9907,27613201
39951,DME,disease,1.0,27613201
39952,VEGF,gene,0.6475,27613201
39953,DME,disease,1.0,27613201
39954,DME,disease,1.0,27613201
39955,anti-VEGF,gene,0.79,27613201
39956,anti-VEGF,gene,0.914,27613201
39957,foveal,DNA,0.483,27613201
39958,microaneurysms,disease,0.984,27613201
39959,DME,disease,0.9985,27613201
39960,DME,disease,1.0,27613201
39961,microaneurysms,disease,0.678,27613201
39962,anti-VEGF,gene,0.981,27613201
39963,microaneurysms,disease,1.0,27613201
39964,DME,disease,1.0,27613201
39965,anti-VEGF,gene,0.783,27613201
39966,DME,disease,1.0,27613201
39967,anti-VEGF,gene,0.761,27613201
39968,RANIBIZUMAB,drug,0.9985,27258669
39969,POLYPOIDAL CHOROIDAL VASCULOPATHY,disease,0.996,27258669
39970,ranibizumab,drug,0.9634,27258669
39971,polypoidal choroidal vasculopathy,disease,1.0,27258669
39972,aflibercept,gene,0.979,27258669
39973,patients,species,0.938,27258669
39974,polypoidal choroidal vasculopathy,disease,1.0,27258669
39975,men,species,0.941,27258669
39976,women,species,0.9673,27258669
39977,aflibercept,gene,0.9834,27258669
39978,patients,species,0.9814,27258669
39979,aflibercept,gene,0.9,27258669
39980,polypoidal choroidal vasculopathy,disease,1.0,27258669
39981,ranibizumab,gene,0.5293,27258669
39982,aflibercept,gene,0.9814,27258669
39983,ranibizumab,drug,0.5044,27258669
39984,patients,species,0.9546,27258669
39985,aflibercept,gene,0.9673,27769324
39986,macular edema,disease,1.0,27769324
39987,central retinal vein occlusion,disease,1.0,27769324
39988,aflibercept,gene,0.8657,27769324
39989,macular edema,disease,1.0,27769324
39990,central retinal vein occlusion,disease,1.0,27769324
39991,CRVO,disease,1.0,27769324
39992,macular edema,disease,1.0,27769324
39993,CRVO,disease,1.0,27769324
39994,intraretinal edema,disease,1.0,27769324
39995,aflibercept,gene,0.7725,27769324
39996,anti-VEGF,gene,0.7637,27769324
39997,macular edema,disease,1.0,27769324
39998,CFT,disease,0.5444,27769324
39999,CRVO,disease,1.0,27769324
40000,aflibercept,gene,0.984,27769324
40001,anti-VEGF,gene,0.87,27769324
40002,aflibercept,gene,0.9443,27769324
40003,aflibercept,gene,0.9736,27769324
40004,aflibercept,gene,0.995,27769324
40005,macular edema,disease,1.0,27769324
40006,Aflibercept,gene,0.89,27769324
40007,macular edema,disease,1.0,27769324
40008,CRVO,disease,0.9995,27769324
40009,bevacizumab,gene,0.8496,27769324
40010,ranibizumab,gene,0.537,27769324
40011,Vascular Endothelial Growth Factor,gene,0.998,27766582
40012,Diabetic Retinopathy,disease,1.0,27766582
40013,diabetes,disease,1.0,27766582
40014,Diabetic retinopathy,disease,1.0,27766582
40015,blindness,disease,0.9995,27766582
40016,diabetic retinopathy,disease,1.0,27766582
40017,vision,disease,0.8203,27766582
40018,diabetic edema,disease,1.0,27766582
40019,proliferative diabetic retinopathy,disease,0.998,27766582
40020,anti-vascular endothelial growth factor,gene,0.8545,27766582
40021,diabetic macular edema,disease,1.0,27766582
40022,retinopathy,disease,0.9985,27766582
40023,anti-vascular endothelial growth factor,gene,0.9766,26856706
40024,anti-vascular endothelial growth factor,gene,0.981,26856706
40025,VEGF),gene,0.956,26856706
40026,mesenchymal stem cells,cell_type,0.881,26856706
40027,CB-MSC,cell_line,0.6494,26856706
40028,LMSC,cell_line,0.857,26856706
40029,CB-MSCs,cell_type,0.669,26856706
40030,LMSCs,cell_type,0.612,26856706
40031,rats,species,0.829,26856706
40032,aflibercept,gene,0.979,26856706
40033,bevacizumab,gene,0.836,26856706
40034,ranibizumab,gene,0.499,26856706
40035,CB-MSCs,cell_type,0.784,26856706
40036,LMSCs,cell_line,0.7207,26856706
40037,Methylthiazoltetrazoli,drug,0.9995,26856706
40038,MTT,drug,0.999,26856706
40039,CB-,cell_line,0.6187,26856706
40040,MSCs,cell_type,0.866,26856706
40041,LMSCs,cell_type,0.794,26856706
40042,anti-VEGF,gene,0.987,26856706
40043,CB-MSCs,cell_type,0.789,26856706
40044,LMSCs,cell_type,0.707,26856706
40045,VEGF,gene,0.8315,26856706
40046,CB-MSCs,cell_type,0.825,26856706
40047,LMSCs,cell_type,0.809,26856706
40048,WET,disease,0.985,27755376
40049,MACULAR DEGENERATION,disease,0.8726,27755376
40050,pigment epithelial detachment,disease,1.0,27755376
40051,PED,disease,0.999,27755376
40052,wet age-related macular,disease,0.9526,27755376
40053,PED,disease,0.9995,27755376
40054,wet age-related macular degeneration,disease,1.0,27755376
40055,PED,disease,0.99,27755376
40056,aflibercept,gene,0.9624,27755376
40057,Pigment epithelial detachment,disease,0.8857,27755376
40058,aflibercept,gene,0.9727,27755376
40059,aflibercept,gene,0.949,27755376
40060,aflibercept,gene,0.974,27755376
40061,aflibercept,gene,0.9585,27755376
40062,Pigment epithelial detachments,cell_type,0.638,27755376
40063,aflibercept,gene,0.95,27755376
40064,Hepatic malignancies,disease,1.0,27643516
40065,tumor,disease,0.999,27643516
40066,hepatic tumor,disease,1.0,27643516
40067,Mice,species,0.8535,27643516
40068,Lewis lung carcinoma (LLC) cells,cell_line,0.8506,27643516
40069,Lewis,cell_type,0.554,27643516
40070,Lewis lung carcinoma,disease,1.0,27643516
40071,LLC,disease,1.0,27643516
40072,vascular endothelial growth factor,gene,0.9966,27643516
40073,VEGF,gene,0.815,27643516
40074,bovine serum albumin,gene,0.9956,27643516
40075,bovine,species,0.949,27643516
40076,LLC-,cell_line,0.7817,27643516
40077,mice,species,0.9,27643516
40078,tumor,disease,0.9824,27643516
40079,LLC-,cell_line,0.78,27643516
40080,LLC,disease,0.991,27643516
40081,mice,species,0.919,27643516
40082,VEGF-Trap,gene,0.952,27643516
40083,tumors,disease,1.0,27643516
40084,hepatic tumor,disease,0.815,27643516
40085,hepatic tumors,disease,1.0,27643516
40086,age-related macular degeneration,disease,1.0,27481048
40087,Wet age-related macular degeneration,disease,0.999,27481048
40088,AMD,disease,1.0,27481048
40089,blindness,disease,0.9985,27481048
40090,VEGF,gene,0.995,27481048
40091,aflibercept,gene,0.9917,27481048
40092,ranibizumab,gene,0.79,27481048
40093,bevacizumab,gene,0.8813,27481048
40094,aflibercept,gene,0.982,27481048
40095,bevacizumab,gene,0.733,27481048
40096,wet AMD,disease,0.9756,27481048
40097,bevacizumab,gene,0.9,27481048
40098,ranibizumab,gene,0.504,27481048
40099,ziv-aflibercept,gene,0.976,27227354
40100,diabetic macular oedema,disease,1.0,27227354
40101,Anti-Vascular Endothelial Growth Factor,gene,0.9663,27749445
40102,vascular endothelial growth factor,gene,0.8994,27749445
40103,anti-VEGF,gene,0.951,27749445
40104,VEGF,gene,0.8394,27749445
40105,macular degeneration,disease,1.0,27749445
40106,ranibizumab,gene,0.6523,27749445
40107,aflibercept,gene,0.9683,27749445
40108,aflibercept,gene,0.961,27749445
40109,oxygen,drug,0.9985,27749445
40110,aflibercept,gene,0.989,27749445
40111,aflibercept,gene,0.8022,27749445
40112,VEGF,gene,0.992,27749445
40113,VEGF,gene,0.9507,27749445
40114,Aflibercept,gene,0.9155,27746298
40115,Neovascular Age-Related Macular Degeneration,disease,1.0,27746298
40116,aflibercept,gene,0.968,27746298
40117,neovascular age-related macular degeneration,disease,1.0,27746298
40118,nAMD,disease,1.0,27746298
40119,nAMD,disease,1.0,27746298
40120,aflibercept,gene,0.9634,27746298
40121,Diabetic Retinopathy,disease,1.0,27746298
40122,aflibercept,gene,0.99,27746298
40123,nAMD,disease,1.0,27746298
40124,aflibercept,gene,0.946,27743159
40125,patients,species,0.9575,27743159
40126,aflibercept,gene,0.982,27743159
40127,patients,species,0.9336,27743159
40128,neovascular age-related macular degeneration,disease,1.0,27743159
40129,AMD,disease,1.0,27743159
40130,patients,species,0.982,27743159
40131,patients,species,0.968,27743159
40132,patients,species,0.972,27743159
40133,neovascular AMD,disease,1.0,27743159
40134,Aflibercept,gene,0.9775,27729757
40135,Submacular Hemorrhage,disease,1.0,27729757
40136,Wet Age-related Macular Degeneration,disease,1.0,27729757
40137,aflibercept,gene,0.992,27729757
40138,submacular hemorrhage,disease,1.0,27729757
40139,SMH,disease,1.0,27729757
40140,age-related macular degeneration,disease,1.0,27729757
40141,AMD,disease,1.0,27729757
40142,SMH,disease,1.0,27729757
40143,wet-AMD,disease,1.0,27729757
40144,aflibercept,gene,0.9653,27729757
40145,SMH,disease,0.998,27729757
40146,SMH,disease,0.998,27729757
40147,SMH,disease,0.93,27729757
40148,aflibercept,gene,0.98,27729757
40149,SMH,disease,0.999,27729757
40150,wet-AMD,disease,1.0,27729757
40151,SMH,disease,0.9995,27729757
40152,Retinitis Pigmentosa-Associated Cystoid Macular Oedema,disease,0.9644,27721789
40153,Aflibercept,gene,0.973,27721789
40154,Eylea,gene,0.6567,27721789
40155,Ranibizumab,gene,0.875,27721789
40156,Lucentis,gene,0.511,27721789
40157,retinitis pigmentosa,disease,1.0,27721789
40158,RP,disease,1.0,27721789
40159,cystoid macular oedema,disease,1.0,27721789
40160,aflibercept,gene,0.9673,27721789
40161,ranibizumab,gene,0.7407,27721789
40162,aflibercept,gene,0.953,27721789
40163,RP,disease,1.0,27721789
40164,RP-associated cystoid macular oedema,disease,0.887,27721789
40165,dorzolamide,drug,0.9966,27721789
40166,acetazolamide,drug,0.9966,27721789
40167,ranibizumab,gene,0.9614,27721789
40168,cystoid macular oedema,disease,1.0,27721789
40169,aflibercept,gene,0.9326,27721789
40170,ranibizumab,gene,0.69,27721789
40171,aflibercept,gene,0.9907,27721789
40172,aflibercept,gene,0.961,27721789
40173,RP,disease,0.999,27721789
40174,CMO,disease,0.999,27721789
40175,aflibercept,gene,0.9727,27721789
40176,ranibizumab,gene,0.7495,27721789
40177,Aflibercept,gene,0.95,27721789
40178,VEGF,gene,0.774,27721789
40179,115 kDa,RNA,0.4966,27721789
40180,aflibercept,gene,0.972,27721789
40181,Chlorhexidine,drug,0.9995,27720552
40182,endophthalmitis,disease,1.0,27720552
40183,chlorhexidine,drug,0.999,27720552
40184,chlorhexidine,drug,0.998,27720552
40185,PARTICIPANTS,species,0.873,27720552
40186,patients,species,0.99,27720552
40187,chlorhexidine,drug,0.994,27720552
40188,infective endophthalmitis,disease,1.0,27720552
40189,endophthalmitis,disease,1.0,27720552
40190,chlorhexidine,drug,0.999,27720552
40191,endophthalmitis,disease,1.0,27720552
40192,Chlorhexidine,drug,0.9995,27720552
40193,patient,species,0.9893,27720552
40194,endophthalmitis,disease,1.0,27720552
40195,endophthalmitis,disease,1.0,27720552
40196,povidone-iodine,drug,0.945,27720552
40197,chlorhexidine,drug,0.999,27720552
40198,postinjection endophthalmitis,disease,0.955,27720552
40199,patients,species,0.975,27720552
40200,aflibercept,gene,0.9526,27718155
40201,metastatic colorectal cancer,disease,1.0,27718155
40202,aflibercept,gene,0.9873,27718155
40203,FOLFIRI,drug,0.815,27718155
40204,metastatic colorectal cancer,disease,1.0,27718155
40205,mCRC,disease,0.9995,27718155
40206,oxaliplatin,drug,0.9995,27718155
40207,aflibercept,gene,0.9805,27718155
40208,aflibercept,gene,0.967,27718155
40209,mCRC,disease,0.994,27718155
40210,FOLFIRI,drug,0.988,27718155
40211,aflibercept,gene,0.976,27718155
40212,NPP,disease,1.0,27718155
40213,K-RAS mutation,gene,0.68,27718155
40214,mCRC,disease,0.999,27718155
40215,NPP,disease,1.0,27718155
40216,K-RAS,DNA,0.6553,27718155
40217,K-RAS mutation,gene,0.9575,27718155
40218,lactate,drug,0.981,27718155
40219,lactate dehydrogenase,gene,0.994,27718155
40220,LDH,gene,0.9834,27718155
40221,LDH,gene,0.9873,27718155
40222,Aflibercept,gene,0.961,27718155
40223,aflibercept,gene,0.967,27718155
40224,FOLFIRI,drug,0.8247,27718155
40225,Aflibercept,gene,0.9756,27716748
40226,neovascular AMD,disease,1.0,27716748
40227,Aflibercept,gene,0.9756,27716747
40228,neovascular AMD,disease,1.0,27716747
40229,Vascular Endothelial Growth Factor,gene,0.861,27711918
40230,Diabetic,disease,0.9995,27711918
40231,Diabetic Retinopathy,disease,1.0,27711918
40232,aflibercept,gene,0.961,27711918
40233,bevacizumab,gene,0.6987,27711918
40234,diabetic macular edema,disease,1.0,27711918
40235,DME,disease,1.0,27711918
40236,vascular endothelial growth factor,gene,0.872,27711918
40237,VEGF,gene,0.9985,27711918
40238,DME,disease,0.9995,27711918
40239,PARTICIPANTS,species,0.5825,27711918
40240,participants,species,0.9775,27711918
40241,anti-VEGF,gene,0.921,27711918
40242,DME,disease,1.0,27711918
40243,vision impairment,disease,0.9995,27711918
40244,aflibercept,gene,0.9673,27711918
40245,bevacizumab,gene,0.787,27711918
40246,DME,disease,1.0,27711918
40247,DME,disease,0.9995,27711918
40248,participants,species,0.9824,27711918
40249,aflibercept,gene,0.987,27711918
40250,bevacizumab,gene,0.8467,27711918
40251,aflibercept,gene,0.976,27711918
40252,bevacizumab,gene,0.776,27711918
40253,DME,disease,1.0,27711918
40254,participants,species,0.9634,27711918
40255,bevacizumab,gene,0.596,27711918
40256,aflibercept,gene,0.9785,27711918
40257,bevacizumab,gene,0.7046,27711918
40258,polypoidal choroidal vasculopathy,disease,1.0,27709394
40259,aflibercept,gene,0.9795,27709394
40260,Ranibizumab,gene,0.7,27707549
40261,Aflibercept,gene,0.9453,27707549
40262,Neovascular Age-Related Macular Degeneration,disease,1.0,27707549
40263,ranibizumab,gene,0.809,27707549
40264,aflibercept,gene,0.975,27707549
40265,neovascular age-related macular degeneration,disease,1.0,27707549
40266,nAMD,disease,1.0,27707549
40267,PARTICIPANTS,species,0.5425,27707549
40268,nAMD,disease,1.0,27707549
40269,Retinal Blindness,disease,0.999,27707549
40270,endothelial growth factor,gene,0.9883,27707549
40271,aflibercept,gene,0.906,27707549
40272,choroidal neovascular membrane,disease,1.0,27707549
40273,CNV,disease,1.0,27707549
40274,inactive CNV,DNA,0.8105,27707549
40275,ranibizumab,gene,0.8496,27707549
40276,aflibercept,gene,0.932,27707549
40277,ranibizumab,gene,0.6514,27707549
40278,aflibercept,gene,0.967,27707549
40279,CNV lesion,disease,0.9346,27707549
40280,ranibizumab,gene,0.852,27707549
40281,aflibercept,gene,0.956,27707549
40282,ranibizumab,gene,0.7925,27707549
40283,aflibercept,gene,0.952,27707549
40284,nAMD,disease,1.0,27707549
40285,ziv-aflibercept,gene,0.9844,27703326
40286,macular edema,disease,1.0,27703326
40287,retinal vein occlusion,disease,0.9995,27703326
40288,ziv-aflibercept,gene,0.986,27703326
40289,macular edema,disease,1.0,27703326
40290,retinal vein occlusions,disease,1.0,27703326
40291,RVOs,disease,1.0,27703326
40292,macular edema,disease,1.0,27703326
40293,RVO,disease,1.0,27703326
40294,ziv-aflibercept,gene,0.9746,27703326
40295,intraretinal edema,disease,1.0,27703326
40296,subretinal fluid,disease,0.999,27703326
40297,RVOs,disease,0.999,27703326
40298,BCVA,cell_type,0.402,27703326
40299,ziv-aflibercept,gene,0.9873,27703326
40300,macular edema,disease,1.0,27703326
40301,ziv-aflibercept,gene,0.955,27703326
40302,Aflibercept,gene,0.953,27702624
40303,aflibercept,gene,0.9634,27702624
40304,diabetic macular edema,disease,1.0,27702624
40305,DME,disease,1.0,27702624
40306,DME,disease,1.0,27702624
40307,IAIs,disease,0.8564,27702624
40308,IAI,disease,0.9946,27702624
40309,aflibercept,gene,0.9814,27701921
40310,aflibercept,gene,0.9546,27701921
40311,wet,disease,0.9824,27701921
40312,age-related macular degeneration,disease,0.992,27701921
40313,wAMD,disease,1.0,27701921
40314,pegaptanib sodium,drug,0.994,27701921
40315,verteporfin,drug,0.999,27701921
40316,blindness,disease,0.999,27701921
40317,ranibizumab,gene,0.834,27701921
40318,ranibizumab,drug,0.577,27701921
40319,pegaptanib sodium,drug,0.9873,27701921
40320,wAMD,disease,0.9995,27701921
40321,Ophthalmologists,cell_type,0.392,27697472
40322,anti-vascular endothelial growth factor,gene,0.8325,27697472
40323,anti-VEGF,gene,0.7534,27697472
40324,Ranibizumab,gene,0.8823,27697472
40325,aflibercept,gene,0.8867,27697472
40326,ranibizumab,gene,0.825,27697472
40327,aflibercept,gene,0.9766,27697472
40328,ophthalmologists,cell_type,0.4795,27697472
40329,VEGF,gene,0.6587,27697472
40330,ranibizumab,gene,0.8535,27697472
40331,aflibercept,gene,0.9736,27697472
40332,Providers,cell_type,0.45,27697472
40333,ranibizumab,drug,0.8926,27697472
40334,ranibizumab,drug,0.866,27697472
40335,aflibercept,gene,0.939,27697472
40336,aflibercept,gene,0.993,27697472
40337,bevacizumab,gene,0.969,27697472
40338,anti-VEGF,gene,0.981,27697472
40339,Ophthalmologists,cell_type,0.4924,27697472
40340,aflibercept,gene,0.95,27697472
40341,ranibizumab,drug,0.5483,27697472
40342,VEGF,gene,0.5747,27697472
40343,ranibizumab,gene,0.9224,27697472
40344,aflibercept,gene,0.966,27697472
40345,bevacizumab,gene,0.6445,27697472
40346,aflibercept,gene,0.973,27664916
40347,macular edema,disease,1.0,27664916
40348,branch retinal vein occlusion,disease,1.0,27664916
40349,aflibercept,gene,0.979,27660164
40350,exudative age-related macular degeneration,disease,1.0,27660164
40351,aflibercept,gene,0.986,27660164
40352,exudative age-related macular degeneration,disease,0.904,27660164
40353,AMD,disease,1.0,27660164
40354,AMD,disease,1.0,27660164
40355,aflibercept,gene,0.95,27660164
40356,geography atrophy,disease,1.0,27660164
40357,GA,disease,0.9995,27660164
40358,dry macula,disease,1.0,27660164
40359,AMD,disease,1.0,27660164
40360,polypoidal choroidal vasculopathy,disease,1.0,27660164
40361,PCV,disease,1.0,27660164
40362,AMD,disease,1.0,27660164
40363,PCV,disease,1.0,27660164
40364,dry macula,disease,0.88,27660164
40365,AMD,disease,1.0,27660164
40366,PCV,disease,1.0,27660164
40367,GA,disease,0.995,27660164
40368,AMD,disease,1.0,27660164
40369,PCV,disease,1.0,27660164
40370,aflibercept,gene,0.966,27660164
40371,AMD,disease,0.9995,27660164
40372,PCV,disease,1.0,27660164
40373,GA,disease,0.998,27660164
40374,ranibizumab,gene,0.641,27660163
40375,aflibercept,gene,0.914,27660163
40376,macular edema,disease,1.0,27660163
40377,central retinal vein occlusion,disease,1.0,27660163
40378,ranibizumab,gene,0.64,27660163
40379,aflibercept,gene,0.9673,27660163
40380,macular edema,disease,1.0,27660163
40381,ME,disease,1.0,27660163
40382,central retinal vein occlusion,disease,1.0,27660163
40383,CRVO,disease,1.0,27660163
40384,PATIENTS,species,0.9697,27660163
40385,ME,disease,1.0,27660163
40386,CRVO,disease,1.0,27660163
40387,ranibizumab,gene,0.6904,27660163
40388,aflibercept,gene,0.9907,27660163
40389,ranibizumab,gene,0.7466,27660163
40390,aflibercept,gene,0.975,27660163
40391,aqueous vascular endothelial growth factor,gene,0.9604,27660163
40392,VEGF,gene,0.9907,27660163
40393,ranibizumab,gene,0.537,27660163
40394,aflibercept,gene,0.9556,27660163
40395,ranibizumab,gene,0.5776,27660163
40396,aflibercept,gene,0.9575,27660163
40397,ranibizumab,gene,0.5864,27660163
40398,aflibercept,gene,0.947,27660163
40399,VEGF,gene,0.9937,27660163
40400,ranibizumab,gene,0.6562,27660163
40401,Aflibercept,gene,0.94,27654888
40402,poor vision,disease,0.9937,27654888
40403,neovascular age-related macular degeneration,disease,1.0,27654888
40404,Bevacizumab,gene,0.4712,27654424
40405,Human Tenon Fibroblasts,cell_type,0.8027,27654424
40406,Vascular Endothelial Growth Factor,gene,0.998,27654424
40407,Vascular endothelial growth factor,gene,0.9985,27654424
40408,human tenon fibroblasts,cell_type,0.8604,27654424
40409,hTFs,cell_type,0.7144,27654424
40410,glaucoma filtration,disease,0.7573,27654424
40411,anti-VEGF antibody,gene,0.9727,27654424
40412,bevacizumab,gene,0.4268,27654424
40413,BVC,drug,0.9805,27654424
40414,VEGF,gene,0.991,27654424
40415,Human tenon fibroblast primary cultures,cell_line,0.954,27654424
40416,tenon fibroblast,cell_type,0.458,27654424
40417,strabismus,disease,1.0,27654424
40418,BVC,drug,0.9644,27654424
40419,RNB,drug,0.7544,27654424
40420,aflibercept,gene,0.9863,27654424
40421,AFB,drug,0.9937,27654424
40422,rituximab,gene,0.929,27654424
40423,RTX,gene,0.899,27654424
40424,dead,cell_type,0.7104,27654424
40425,proliferating (5-bromo-2-deoxy-uridine-positive) cells,cell_line,0.7886,27654424
40426,proliferating (5,cell_type,0.781,27654424
40427,5-bromo-2-deoxy-uridine,drug,0.9976,27654424
40428,VEGF-A,gene,0.997,27654424
40429,cell culture,cell_line,0.5664,27654424
40430,IgG,gene,0.9937,27654424
40431,quiescent hTF culture,cell_line,0.778,27654424
40432,BVC,drug,0.999,27654424
40433,proliferating cells,cell_type,0.929,27654424
40434,BVC,drug,0.9946,27654424
40435,AFB,drug,0.9937,27654424
40436,RNB,drug,0.993,27654424
40437,VEGF-A,gene,0.998,27654424
40438,CD20 antibody,gene,0.909,27654424
40439,RTX,gene,0.684,27654424
40440,VEGF,gene,0.9883,27654424
40441,hTF,cell_type,0.7153,27654424
40442,Bevacizumab,gene,0.9404,27654424
40443,AFB,drug,0.995,27654424
40444,RTX,drug,0.995,27654424
40445,VEGF,gene,0.9893,27654424
40446,VEGF,gene,0.9893,27654424
40447,hTF,cell_type,0.7295,27654424
40448,AFLIBERCEPT,disease,0.8203,27652915
40449,NEOVASCULAR AGE,disease,0.728,27652915
40450,MACULAR DEGENERATION,disease,0.9297,27652915
40451,RANIBIZUMAB,drug,0.9976,27652915
40452,aflibercept,gene,0.984,27652915
40453,neovascular age-related macular degeneration,disease,1.0,27652915
40454,ranibizumab,gene,0.679,27652915
40455,neovascular age-related macular degeneration,disease,0.999,27652915
40456,ranibizumab,gene,0.699,27652915
40457,aflibercept,gene,0.923,27652915
40458,ranibizumab,gene,0.9785,27652915
40459,aflibercept,gene,0.9756,27652915
40460,choroidal neovascularization,disease,1.0,27652915
40461,vascular endothelial growth factor,gene,0.698,27650362
40462,Aflibercept,gene,0.9287,27650362
40463,NSC 724770,drug,0.998,27650362
40464,myelodysplastic syndrome,disease,1.0,27650362
40465,Cancer,disease,0.6074,27650362
40466,Aflibercept,gene,0.955,27631479
40467,Diabetic Macular Edema,disease,1.0,27631479
40468,Ranibizumab,gene,0.86,27631479
40469,aflibercept,gene,0.9834,27631479
40470,Eylea,gene,0.6064,27631479
40471,diabetic macular edema,disease,1.0,27631479
40472,DME,disease,1.0,27631479
40473,ranibizumab,gene,0.6655,27631479
40474,Lucentis,gene,0.4326,27631479
40475,Avastin,gene,0.441,27631479
40476,PATIENTS,species,0.8325,27631479
40477,DME,disease,1.0,27631479
40478,ranibizumab,gene,0.649,27631479
40479,bevacizumab,gene,0.7295,27631479
40480,aflibercept,gene,0.9473,27631479
40481,anti-vascular endothelial growth factor,gene,0.9976,27631479
40482,VEGF,gene,0.9966,27631479
40483,aflibercept,gene,0.9243,27631479
40484,aflibercept,gene,0.9917,27631479
40485,aflibercept,gene,0.9785,27631479
40486,DME,disease,1.0,27631479
40487,ranibizumab,gene,0.8076,27631479
40488,bevacizumab,gene,0.639,27631479
40489,aflibercept,gene,0.975,27631479
40490,PATIENTS,species,0.9697,27628926
40491,WET AGE,disease,0.7563,27628926
40492,MACULAR DEGENERATION,disease,0.935,27628926
40493,aflibercept,gene,0.99,27628926
40494,exudative age-related macular degeneration,disease,1.0,27628926
40495,age-related macular degeneration,disease,0.965,27628926
40496,Type 1 choroidal neovascularization,disease,0.964,27628926
40497,aflibercept,gene,0.972,27628926
40498,Foveal,DNA,0.573,27628926
40499,Parafoveal,DNA,0.4783,27628926
40500,Choroidal neovascularization lesion,disease,0.8477,27628926
40501,aflibercept,gene,0.978,27628926
40502,choroidal neovascularization,disease,0.971,27628926
40503,aflibercept,gene,0.994,27628062
40504,polypoidal choroidal vasculopathy,disease,1.0,27628062
40505,aflibercept,gene,0.9883,27628062
40506,polypoidal choroidal vasculopathy,disease,1.0,27628062
40507,PCV,disease,1.0,27628062
40508,PCV,disease,1.0,27628062
40509,patients,species,0.9907,27628062
40510,aflibercept,gene,0.98,27628062
40511,Fluorescein,drug,0.9966,27628062
40512,indocyanine green,drug,0.998,27628062
40513,patients,species,0.977,27628062
40514,polypoidal,DNA,0.4705,27628062
40515,polypoidal lesion,disease,1.0,27628062
40516,patients,species,0.9873,27628062
40517,polyp,disease,0.9985,27628062
40518,aflibercept,gene,0.994,27628062
40519,PCV,disease,1.0,27628062
40520,patients,species,0.9917,27628062
40521,patients,species,0.9893,27628062
40522,patients,species,0.9883,27628062
40523,diabetic retinopathy,disease,1.0,27625747
40524,Diabetic retinopathy,disease,1.0,27625747
40525,DR,disease,1.0,27625747
40526,blindness,disease,0.9985,27625747
40527,DR,disease,,27625747
40528,diabetes,disease,1.0,27625747
40529,blindness,disease,0.9995,27625747
40530,patients,species,0.987,27625747
40531,vascular endothelial growth factor,gene,0.9985,27625747
40532,VEGF,gene,0.997,27625747
40533,DR,disease,,27625747
40534,VEGF,gene,0.569,27625747
40535,patients,species,0.966,27625747
40536,diabetic macular edema,disease,1.0,27625747
40537,DME,disease,1.0,27625747
40538,patients,species,0.987,27625747
40539,VEGF,gene,0.748,27625747
40540,patient,species,0.984,27625747
40541,VEGF,gene,0.9873,27625747
40542,proliferative diabetic retinopathy,disease,0.9814,27625747
40543,DME,disease,1.0,27625747
40544,patients,species,0.9585,27625747
40545,ranibizumab,gene,0.62,27621587
40546,ranibizumab,gene,0.8853,27621587
40547,dexamethasone,drug,0.9854,27621587
40548,DEX,drug,0.9897,27621587
40549,diabetic macular edema,disease,1.0,27621587
40550,DME,disease,1.0,27621587
40551,patients,species,0.8325,27621587
40552,DME,disease,0.999,27621587
40553,RZB,drug,0.927,27621587
40554,DEX,drug,0.9136,27621587
40555,RZB,drug,0.818,27621587
40556,patients,species,0.984,27621587
40557,DEX,drug,0.942,27621587
40558,DME,disease,0.9995,27621587
40559,patients,species,0.9844,27621587
40560,DEX,drug,0.7017,27621587
40561,Aflibercept,gene,0.944,27600470
40562,Patient,species,0.9404,27600470
40563,Colorectal Cancer,disease,1.0,27600470
40564,Ranibizumab,gene,0.9097,27599047
40565,Bevacizumab,gene,0.825,27599047
40566,aflibercept,gene,0.9834,27597740
40567,aflibercept,gene,0.968,27597740
40568,polypoidal choroidal vasculopathy,disease,1.0,27597740
40569,PCV,disease,1.0,27597740
40570,indocyanine green,drug,0.997,27597740
40571,patients,species,0.9844,27597740
40572,polypoidal choroidal neovascularisation,disease,1.0,27597740
40573,CNV,disease,1.0,27597740
40574,idiopathic PCV,disease,1.0,27597740
40575,aflibercept,gene,0.9854,27597740
40576,polyp,disease,1.0,27597740
40577,polyp,disease,1.0,27597740
40578,patients,species,0.9873,27597740
40579,patients,species,0.9854,27597740
40580,patients,species,0.988,27597740
40581,patients,species,0.9883,27597740
40582,patients,species,0.99,27597740
40583,aflibercept,gene,0.9443,27597740
40584,PCV,disease,0.9956,27597740
40585,polypoidal CNV,disease,1.0,27597740
40586,polyp,disease,0.942,27597740
40587,idiopathic PCV,disease,0.9985,27597740
40588,Aflibercept,gene,0.869,27594519
40589,aflibercept,gene,0.991,27588271
40590,neovascular age-related macular degeneration,disease,1.0,27588271
40591,neovascular age related macular degeneration,disease,1.0,27588271
40592,nvAMD,disease,1.0,27588271
40593,aflibercept,gene,0.982,27588271
40594,nvAMD,disease,1.0,27588271
40595,aflibercept,gene,0.9243,27588271
40596,ranibizumab,gene,0.869,27588271
40597,bevacizumab,gene,0.871,27588271
40598,aflibercept,gene,0.969,27588271
40599,nave aflibercept,gene,0.844,27588271
40600,ranibizumab,drug,0.5083,27588271
40601,bevacizumab,gene,0.724,27588271
40602,ranibizumab,gene,0.7466,27588271
40603,bevacizumab,gene,0.8086,27588271
40604,aflibercept,gene,0.9927,27588271
40605,aflibercept,gene,0.987,27588271
40606,nvAMD,disease,1.0,27588271
40607,VEGF,gene,0.995,27576699
40608,Glioblastoma,disease,1.0,27576699
40609,GBM,disease,1.0,27576699
40610,brain tumor,disease,1.0,27576699
40611,VEGF Trap,gene,0.9395,27576699
40612,patients,species,0.974,27576699
40613,temozolomide,drug,0.999,27576699
40614,GBM,disease,0.9604,27576699
40615,[(18)F]Fluorodeoxyglucose,drug,0.9995,27576699
40616,FDG,drug,0.9976,27576699
40617,participants,species,0.963,27576699
40618,FDG,drug,0.9995,27576699
40619,VEGF Trap,gene,0.9004,27576699
40620,tumor,disease,0.942,27576699
40621,FDG,drug,0.998,27576699
40622,participants,species,0.9746,27576699
40623,FDG,DNA,0.4656,27576699
40624,FDG,drug,0.9956,27576699
40625,VEGF Trap,gene,0.8887,27576699
40626,tumor,disease,0.999,27576699
40627,FDG,drug,0.9995,27576699
40628,patient,species,0.9478,27576699
40629,diabetic macular edema,disease,1.0,29727116
40630,Diabetic macular edema,disease,1.0,29727116
40631,vision impairment,disease,0.9985,29727116
40632,diabetic,disease,1.0,29727116
40633,vascular endothelial growth factor,gene,0.999,29727116
40634,diabetic macular edema,disease,1.0,29727116
40635,vascular endothelial growth factor,gene,0.998,29727116
40636,VEGF,gene,0.882,29727116
40637,diabetic macular edema,disease,1.0,29727116
40638,anti-VEGF,gene,0.76,29727116
40639,aflibercept,gene,0.9834,29727116
40640,ranibizumab,gene,0.746,29727116
40641,patients,species,0.983,29727116
40642,patients,species,0.969,29727116
40643,diabetic macular edema,disease,1.0,29727116
40644,aflibercept,gene,0.994,29727106
40645,patients,species,0.9844,29727106
40646,aflibercept,gene,0.9917,29727106
40647,patients,species,0.962,29727106
40648,patients,species,0.988,29727106
40649,exudative age-related macular degeneration,disease,0.979,29727106
40650,fluorescein,drug,0.999,29727106
40651,patients,species,0.986,29727106
40652,aflibercept,gene,0.959,29727106
40653,patients,species,0.9897,29727106
40654,aflibercept,gene,0.9834,29727106
40655,aflibercept,gene,0.982,29727106
40656,patients,species,0.9614,29727106
40657,exudative age-related macular degeneration,disease,1.0,29727106
40658,aflibercept,gene,0.7603,27572301
40659,patients,species,0.8853,27572301
40660,patients,species,0.9707,27572301
40661,neovascular age-related macular degeneration,disease,0.9995,27572301
40662,nAMD,disease,1.0,27572301
40663,aflibercept,gene,0.976,27572301
40664,patients,species,0.9663,27572301
40665,nAMD,disease,1.0,27572301
40666,vascular endothelial growth factor,gene,0.8867,27572301
40667,aflibercept,gene,0.9116,27572301
40668,Patients,species,0.962,27572301
40669,NEI VFQ,DNA,0.514,27572301
40670,NEI VFQ,DNA,0.5146,27572301
40671,NEI,DNA,0.524,27572301
40672,aflibercept,gene,0.951,27572301
40673,Aflibercept,gene,0.919,27564719
40674,diabetic macular edema,disease,1.0,27564719
40675,aflibercept,gene,0.983,27564719
40676,diabetic macular edema,disease,0.9995,27564719
40677,patients,species,0.989,27564719
40678,aflibercept,gene,0.987,27564719
40679,bevacizumab,gene,0.521,27564719
40680,patients,species,0.9854,27564719
40681,ranibizumab,gene,0.7583,27564719
40682,aflibercept,gene,0.9233,27564719
40683,aflibercept,gene,0.984,27564719
40684,aflibercept,gene,0.984,27564719
40685,diabetic macular edema,disease,1.0,27564719
40686,PlGF,gene,0.995,27556218
40687,MMC,drug,0.9404,27556218
40688,Scarring,disease,0.621,27556218
40689,mitomycin-C,drug,0.997,27556218
40690,MMC,drug,0.9995,27556218
40691,placental growth factor,gene,0.9985,27556218
40692,PlGF,gene,0.9966,27556218
40693,MMC,drug,0.9844,27556218
40694,aflibercept,gene,0.983,27556218
40695,PlGF,gene,0.994,27556218
40696,glaucoma,disease,1.0,27556218
40697,patients,species,0.972,27556218
40698,trabeculectomy,disease,0.9907,27556218
40699,mouse,species,0.9673,27556218
40700,PlGF,gene,0.996,27556218
40701,MMC,drug,0.994,27556218
40702,aflibercept,gene,0.9644,27556218
40703,Sirius Red,drug,0.9395,27556218
40704,PlGF,gene,0.993,27556218
40705,mice,species,0.958,27556218
40706,latanoprost,drug,0.8306,27556218
40707,MMC,drug,0.9946,27556218
40708,5D11D4,drug,0.519,27556218
40709,MMC,drug,0.9985,27556218
40710,5D11D4,drug,0.7217,27556218
40711,MMC,drug,0.9937,27556218
40712,aflibercept,gene,0.9897,27556218
40713,MMC,drug,0.9966,27556218
40714,5D11D4,gene,0.6255,27556218
40715,mice,species,0.9536,27556218
40716,PlGF,gene,0.988,27556218
40717,mice,species,0.9907,27556218
40718,latanoprost,drug,0.8203,27556218
40719,MMC,drug,0.9917,27556218
40720,PlGF,gene,0.9907,27556218
40721,MMC,drug,0.9956,27556218
40722,aflibercept,gene,0.987,27556218
40723,PlGF,gene,0.9946,27556218
40724,glaucoma,disease,1.0,27556218
40725,patients,species,0.9736,27556218
40726,PlGF,gene,0.9307,27556218
40727,Colorectal Cancer,disease,1.0,27551256
40728,colorectal cancer,disease,1.0,27551256
40729,Bevacizumab,gene,0.7754,27551256
40730,vascular endothelial growth factor,gene,0.9087,27551256
40731,metastatic colorectal cancer,disease,0.9995,27551256
40732,vascular endothelial growth factor receptor,gene,0.9897,27551256
40733,aflibercept,gene,0.873,27551256
40734,5-fluorouracil,drug,0.9995,27551256
40735,leucovorin,drug,0.999,27551256
40736,irinotecan,drug,0.9985,27551256
40737,metastatic colorectal cancer,disease,1.0,27551256
40738,patients,species,0.9883,27551256
40739,oxaliplatin,drug,0.9995,27551256
40740,regorafenib,drug,0.9946,27551256
40741,colorectal cancer,disease,1.0,27551256
40742,anti-,gene,0.853,27551256
40743,vascular endothelial growth factor receptor 2,gene,0.9043,27551256
40744,5-fluorouracil,drug,0.9995,27551256
40745,leucovorin,drug,0.9995,27551256
40746,irinotecan,drug,0.9917,27551256
40747,bevacizumab,gene,0.783,27551256
40748,oxaliplatin,drug,0.9995,27551256
40749,fluoropyrimidine,drug,0.997,27551256
40750,aflibercept,gene,0.968,27550436
40751,aflibercept,gene,0.9595,27550436
40752,patients,species,0.9756,27550436
40753,ranibizumab,gene,0.732,27550436
40754,bevacizumab,gene,0.8037,27550436
40755,patients,species,0.9624,27550436
40756,choroidal neovascularization,disease,1.0,27550436
40757,CNV,disease,1.0,27550436
40758,ranibizumab,gene,0.933,27550436
40759,bevacizumab,gene,0.8003,27550436
40760,to aflibercept,gene,0.4456,27550436
40761,intraretinal,disease,0.5767,27550436
40762,aflibercept,gene,0.98,27550436
40763,aflibercept,gene,0.981,27550436
40764,aflibercept,gene,0.989,27550436
40765,ranibizumab,gene,0.8755,27550436
40766,anti-vascular endothelial growth factor,gene,0.9062,27550436
40767,VEGF,gene,0.998,27550436
40768,aflibercept,gene,0.9604,27550436
40769,patients,species,0.9917,27550436
40770,aflibercept,gene,0.975,27550436
40771,Aflibercept,gene,0.972,27550436
40772,ranibizumab,gene,0.654,27550436
40773,aflibercept,gene,0.9805,27538907
40774,aflibercept,gene,0.983,27538907
40775,polypoidal choroidal vasculopathy,disease,1.0,27538907
40776,PCV,disease,1.0,27538907
40777,patients,species,0.982,27538907
40778,PCV,disease,0.999,27538907
40779,patients,species,0.9854,27538907
40780,nave,disease,0.8823,27538907
40781,PCV,disease,0.789,27538907
40782,IAI,disease,0.998,27538907
40783,CRT,DNA,0.56,27538907
40784,Neovascular age-related macular degeneration,disease,1.0,27535819
40785,ranibizumab,gene,0.8916,27535819
40786,aflibercept,gene,0.9634,27535819
40787,neovascular age-related macular degeneration,disease,1.0,27535819
40788,nAMD,disease,1.0,27535819
40789,ranibizumab,gene,0.9517,27535819
40790,aflibercept,gene,0.975,27535819
40791,ranibizumab,gene,0.9424,27535819
40792,aflibercept,gene,0.975,27535819
40793,ranibizumab,gene,0.849,27535819
40794,aflibercept,gene,0.9375,27535819
40795,ranibizumab,gene,0.8037,27535819
40796,aflibercept,gene,0.9736,27535819
40797,ranibizumab,gene,0.7563,27535819
40798,aflibercept,gene,0.9443,27535819
40799,ranibizumab,gene,0.66,27535819
40800,aflibercept,gene,0.877,27535819
40801,nAMD,disease,1.0,27535819
40802,aflibercept,gene,0.9805,27535819
40803,aflibercept,gene,0.956,27534663
40804,polypoidal choroidal vasculopathy,disease,1.0,27534663
40805,PCV,disease,1.0,27534663
40806,patients,species,0.983,27534663
40807,PCV,disease,1.0,27534663
40808,aflibercept,gene,0.9824,27534663
40809,polypoidal,DNA,0.5137,27534663
40810,polypoidal vascular lesions,disease,1.0,27534663
40811,PCV,disease,1.0,27534663
40812,type 3 neovascularisation,disease,0.899,27503396
40813,AMD,disease,1.0,27503396
40814,antivascular endothelial growth factor,gene,0.8833,27503396
40815,anti-VEGF,gene,0.9062,27503396
40816,patients,species,0.9834,27503396
40817,AMD,disease,0.9995,27503396
40818,fluorescein,drug,0.9727,27503396
40819,anti-VEGF,gene,0.9634,27503396
40820,patients,species,0.967,27503396
40821,VEGF,gene,0.6904,27503396
40822,Cystoid macular oedema,disease,1.0,27503396
40823,subretinal fluid,disease,0.7153,27503396
40824,AMD,disease,1.0,27503396
40825,anti-VEGF,gene,0.847,27503396
40826,anti-VEGF,gene,0.967,27503396
40827,VEGF,gene,0.7173,27494692
40828,anti-vascular-endothelial-growth-factor,gene,0.9785,27494692
40829,VEGF,gene,0.9985,27494692
40830,patients,species,0.9805,27494692
40831,neovascular age-related macular degeneration,disease,1.0,27494692
40832,nAMD,disease,1.0,27494692
40833,diabetic macular edema,disease,1.0,27494692
40834,DME,disease,1.0,27494692
40835,retinal vein occlusion,disease,1.0,27494692
40836,RVO,disease,1.0,27494692
40837,Patient,species,0.945,27494692
40838,VEGF,gene,0.5396,27494692
40839,nAMD,disease,1.0,27494692
40840,patients,species,0.9956,27494692
40841,aflibercept,gene,0.983,27494692
40842,aflibercept,gene,0.969,27494692
40843,nAMD,disease,1.0,27494692
40844,DME,disease,1.0,27494692
40845,RVO,disease,1.0,27494692
40846,patients,species,0.99,27494692
40847,Patients,species,0.9697,27494692
40848,nAMD,disease,1.0,27494692
40849,Patients,species,0.95,27494692
40850,nAMD,disease,1.0,27494692
40851,patients,species,0.9966,27494692
40852,anti-VEGF,gene,0.929,27494692
40853,DME,disease,1.0,27494692
40854,patients,species,0.995,27494692
40855,RVO,disease,1.0,27494692
40856,patients,species,0.993,27494692
40857,nAMD,disease,1.0,27494692
40858,patients,species,0.996,27494692
40859,aflibercept,gene,0.9688,27494692
40860,nAMD,disease,1.0,27494692
40861,patients,species,0.988,27494692
40862,aflibercept,gene,0.8667,27465570
40863,age-related macular degeneration,disease,1.0,27465570
40864,patients,species,0.979,27465570
40865,age-related macular degeneration,disease,1.0,27465570
40866,IVA,disease,0.5576,27465570
40867,aflibercept,gene,0.9863,27465105
40868,PolypoIdal,disease,1.0,27465105
40869,Polypoidal choroidal vasculopathy,disease,1.0,27465105
40870,choroidal neovascularization,disease,1.0,27465105
40871,neovascular age related macular degeneration,disease,1.0,27465105
40872,vision loss,disease,0.9985,27465105
40873,neovascular age related macular degeneration,disease,1.0,27465105
40874,polypoidal choroidal vasculopathy,disease,1.0,27465105
40875,polypoidal choroidal vasculopathy,disease,1.0,27465105
40876,vascular endothelial growth factor,gene,0.9863,27465105
40877,aflibercept,gene,0.761,27465105
40878,polypoidal choroidal vasculopathy,disease,1.0,27465105
40879,aflibercept,gene,0.9795,27465105
40880,polypoidal choroidal vasculopathy,disease,1.0,27465105
40881,aflibercept,gene,0.9653,27465105
40882,polypoidal choroidal vasculopathy,disease,1.0,27465105
40883,subretinal hemorrhage,disease,0.987,27465105
40884,serous detachment,disease,0.9985,27465105
40885,retinal pigment epithelial detachment,disease,1.0,27465105
40886,polypoidal complexes,disease,1.0,27465105
40887,indocyanine green,drug,0.997,27465105
40888,Diabetic,disease,0.9995,27465105
40889,Retinopathy,disease,1.0,27465105
40890,Diabetic Retinopathy,disease,1.0,27465105
40891,patient,species,0.948,27465105
40892,vision loss,disease,0.8657,27465105
40893,subretinal hemorrhage,disease,1.0,27465105
40894,polyps,disease,1.0,27465105
40895,retinal pigment epithelial detachment,disease,1.0,27465105
40896,patients,species,0.9863,27465105
40897,aflibercept,gene,0.984,27465105
40898,polyps,disease,0.996,27465105
40899,polypoidal choroidal vasculopathy,disease,1.0,27465105
40900,polypoidal choroidal vasculopathy,disease,1.0,27465105
40901,ranibizumab,gene,0.8096,27465105
40902,bevacizumab,gene,0.603,27465105
40903,retinal pigment epithelial detachments,disease,0.9995,27465105
40904,polyps,disease,0.999,27465105
40905,aflibercept,gene,0.9814,27465105
40906,vascular endothelial growth factor,gene,0.8994,27462248
40907,VEGF,gene,0.998,27462248
40908,neovascular age-related macular degeneration,disease,0.943,27462248
40909,nAMD,disease,1.0,27462248
40910,VEGF,gene,0.723,27462248
40911,ranibizumab,gene,0.935,27462248
40912,aflibercept,gene,0.983,27462248
40913,man,species,0.8813,27462248
40914,glaucoma,disease,1.0,27462248
40915,ranibizumab,gene,0.8623,27462248
40916,nAMD,disease,1.0,27462248
40917,ranibizumab,gene,0.6816,27462248
40918,ranibizumab,gene,0.7896,27462248
40919,aflibercept,gene,0.9756,27462248
40920,glaucoma,disease,1.0,27462248
40921,aflibercept,gene,0.995,27462248
40922,glaucoma,disease,1.0,27462248
40923,aflibercept,gene,0.9575,27462248
40924,glaucoma,disease,0.9995,27462248
40925,patient,species,0.9844,27462248
40926,patients,species,0.986,27462248
40927,VEGF,gene,0.9453,27462248
40928,ocular hypertension,disease,1.0,27462248
40929,Ranibizumab,gene,0.823,27457470
40930,Aflibercept,gene,0.9395,27457470
40931,Wet age-related macular degeneration,disease,1.0,27457470
40932,AMD,disease,1.0,27457470
40933,chronic eye condition,disease,0.9824,27457470
40934,deterioration of vision,disease,1.0,27457470
40935,blindness,disease,1.0,27457470
40936,wet AMD,disease,0.997,27457470
40937,vascular endothelial growth factor,gene,0.9985,27457470
40938,ranibizumab,gene,0.6885,27457470
40939,aflibercept,gene,0.937,27457470
40940,wet AMD,disease,1.0,27457470
40941,wet AMD,disease,1.0,27457470
40942,ranibizumab,gene,0.7554,27457470
40943,ranibizumab,gene,0.589,27457470
40944,aflibercept,gene,0.938,27457470
40945,Ranibizumab,gene,0.6914,27457470
40946,aflibercept,gene,0.8516,27457470
40947,ranibizumab,drug,0.4993,27457470
40948,aflibercept,gene,0.939,27457470
40949,ranibizumab,gene,0.5938,27457470
40950,aflibercept,gene,0.852,27457470
40951,ranibizumab,gene,0.573,27457470
40952,aflibercept,gene,0.9663,27457470
40953,wet AMD,disease,0.9966,27457470
40954,Central Retinal Vein Occlusion,disease,1.0,27450625
40955,central retinal vein occlusion,disease,1.0,27450625
40956,CRVO,disease,1.0,27450625
40957,macular edema,disease,1.0,27450625
40958,REtinal Vein Occlusion,disease,1.0,27450625
40959,REtinal Vein Occlusion,disease,1.0,27450625
40960,CRVO,disease,1.0,27450625
40961,macular edema,disease,0.999,27450625
40962,Neovascular Age-Related Macular Degeneration,disease,1.0,27449643
40963,neovascular age-related macular degeneration,disease,1.0,27449643
40964,nAMD,disease,1.0,27449643
40965,nAMD,disease,1.0,27449643
40966,aflibercept,gene,0.9824,27449643
40967,choroidal neovascularization,disease,1.0,27449643
40968,CNV,disease,1.0,27449643
40969,AMD,disease,0.9995,27449643
40970,AMD,disease,1.0,27449643
40971,CNV,disease,0.5933,27449643
40972,aflibercept,gene,0.99,27444307
40973,pigment epithelial detachment,disease,1.0,27444307
40974,ranibizumab,gene,0.924,27444307
40975,aflibercept,gene,0.9683,27444307
40976,retinal pigment epithelial detachment,disease,1.0,27444307
40977,PED,disease,1.0,27444307
40978,patients,species,0.982,27444307
40979,aflibercept,gene,0.945,27444307
40980,PED,DNA,0.622,27444307
40981,PED,DNA,0.502,27444307
40982,PED,disease,0.9995,27444307
40983,patients,species,0.9907,27444307
40984,BCVA,cell_type,0.4094,27444307
40985,aflibercept,gene,0.989,27444307
40986,PED,disease,1.0,27444307
40987,Eylea,drug,0.5947,27440854
40988,Aflibercept,gene,0.981,27435924
40989,Soluble,gene,0.87,27435924
40990,VEGF Receptor-1 and -2,gene,0.9365,27435924
40991,Mouse,species,0.97,27435924
40992,Hepatocellular Carcinoma,disease,1.0,27435924
40993,Aflibercept,gene,0.7734,27435924
40994,ziv-aflibercept,gene,0.972,27435924
40995,vascular endothelial growth factor (VEGF) receptor-1 and -2,gene,0.946,27435924
40996,VEGF,gene,0.9937,27435924
40997,placental growth factor,gene,0.9985,27435924
40998,PlGF,gene,0.9805,27435924
40999,VEGF receptor-1 and -2,gene,0.9976,27435924
41000,aflibercept,gene,0.9897,27435924
41001,mouse,species,0.9785,27435924
41002,hepatoma,disease,1.0,27435924
41003,aflibercept,gene,0.9897,27435924
41004,human umbilical vein cell,cell_line,0.633,27435924
41005,HUVEC,cell_line,0.7207,27435924
41006,bone,cell_type,0.451,27435924
41007,endothelial progenitor cells,cell_type,0.9434,27435924
41008,EPCs,cell_type,0.801,27435924
41009,aflibercept,gene,0.9893,27435924
41010,hepatoma cell,disease,0.665,27435924
41011,mice,species,0.8975,27435924
41012,tumor,disease,0.9995,27435924
41013,BM cell,cell_type,0.4922,27435924
41014,tumor,disease,0.9985,27435924
41015,Aflibercept,gene,0.8916,27435924
41016,VEGF receptor-1 and -2,gene,0.998,27435924
41017,HUVEC,cell_line,0.815,27435924
41018,VEGF,gene,0.995,27435924
41019,HUVEC,cell_type,0.7314,27435924
41020,BM cells,cell_type,0.8857,27435924
41021,EPCs,cell_type,0.89,27435924
41022,BM cells,cell_type,0.8545,27435924
41023,tumor,disease,1.0,27435924
41024,tumor,disease,1.0,27435924
41025,tumor,disease,0.9995,27435924
41026,mice,species,0.878,27435924
41027,tumor,disease,1.0,27435924
41028,aflibercept,gene,0.9497,27435924
41029,hypoxia inducible factor1-,gene,0.9976,27435924
41030,VEGF,gene,0.997,27435924
41031,PlGF,gene,0.99,27435924
41032,fibroblast growth factor-2,gene,0.9985,27435924
41033,platelet derived growth factor-,gene,0.998,27435924
41034,transforming growth factor-,gene,0.9966,27435924
41035,aflibercept,gene,0.9824,27435924
41036,mouse,species,0.9443,27435924
41037,hepatocellular carcinoma,disease,1.0,27435924
41038,endothelial cell,cell_type,0.819,27435924
41039,EPC,cell_type,0.916,27435924
41040,tumor,disease,0.9995,27435924
41041,Diabetic Macular Edema,disease,1.0,27434498
41042,diabetic macular edema,disease,1.0,27434498
41043,DME,disease,1.0,27434498
41044,DME,disease,1.0,27434498
41045,ranibizumab,gene,0.774,27434498
41046,aflibercept,gene,0.9688,27434498
41047,triamcinolone,drug,0.969,27434498
41048,aflibercept,gene,0.9697,27434498
41049,vascular endothelial growth factor,gene,0.996,27434498
41050,aflibercept,gene,0.95,27434498
41051,DME,disease,0.9995,27434498
41052,Vascular endothelial growth factor,gene,0.997,27434498
41053,DME,disease,1.0,27434498
41054,triamcinolone,drug,0.977,27434498
41055,NEOVASCULAR AGE,disease,0.9673,27429385
41056,MACULAR DEGENERATION,disease,0.8022,27429385
41057,ADVANCED VISUAL LOSS,disease,0.99,27429385
41058,neovascular age-related macular degeneration,disease,0.9976,27429385
41059,visual loss,disease,0.9995,27429385
41060,vascular endothelial growth factor,gene,0.9937,27429385
41061,neovascular age-related macular degeneration,disease,0.992,27429385
41062,visually limiting eye disease,disease,0.9985,27429385
41063,Diabetic Retinopathy,disease,0.9883,27429385
41064,retinal hemorrhage,disease,1.0,27429385
41065,subretinal fluid,disease,0.7344,27429385
41066,retinal pigment epithelial detachment,disease,1.0,27429385
41067,intraretinal fluid,disease,0.978,27429385
41068,vascular endothelial growth factor,gene,0.99,27429385
41069,age-related macular degeneration,disease,0.998,27429385
41070,anti-vascular endothelial growth factor,gene,0.9136,27429385
41071,Macular atrophy,disease,1.0,27417506
41072,neovascular age-related macular degeneration,disease,1.0,27417506
41073,macular atrophy,disease,1.0,27417506
41074,MA,disease,1.0,27417506
41075,neovascular age-related macular degeneration,disease,1.0,27417506
41076,AMD,disease,1.0,27417506
41077,vascular endothelial growth factor,gene,0.9985,27417506
41078,VEGF,gene,0.9976,27417506
41079,neovascular AMD,disease,1.0,27417506
41080,anti-VEGF,gene,0.704,27417506
41081,Macular atrophy,disease,1.0,27417506
41082,MA,disease,1.0,27417506
41083,anti-VEGF,gene,0.883,27417506
41084,aflibercept,gene,0.9834,27417506
41085,MA,disease,0.997,27417506
41086,choroidal neovascularization,disease,1.0,27417506
41087,CNV,disease,1.0,27417506
41088,CNV,DNA,0.78,27417506
41089,posterior vitreous detachment,disease,1.0,27417506
41090,PVD,disease,1.0,27417506
41091,intraretinal cysts,disease,1.0,27417506
41092,IRCs,disease,1.0,27417506
41093,Macular atrophy,disease,1.0,27417506
41094,MA,disease,1.0,27417506
41095,CNV,disease,1.0,27417506
41096,VEGF,gene,0.548,27417506
41097,Reticular pseudodrusen,disease,1.0,27417506
41098,RPD,disease,0.9995,27417506
41099,IRC,disease,0.9946,27417506
41100,PVD,disease,1.0,27417506
41101,Aflibercept,gene,0.9663,27412031
41102,Metastatic Colorectal Cancer,disease,1.0,27412031
41103,mCRC,disease,1.0,27412031
41104,Colorectal cancer,disease,1.0,27412031
41105,CRC,disease,1.0,27412031
41106,tumour,disease,1.0,27412031
41107,fluoropyrimides,drug,0.9995,27412031
41108,oxaliplatin,drug,0.9995,27412031
41109,irinotecan,drug,0.9995,27412031
41110,mCRC,disease,0.9976,27412031
41111,mCRC,disease,0.9766,27412031
41112,aflibercept,gene,0.987,27412031
41113,aflibercept,gene,0.9766,27412031
41114,"VEGF-A, -B",gene,0.984,27412031
41115,PlGF,gene,0.9717,27412031
41116,tumour,disease,1.0,27412031
41117,bevacizumab,gene,0.834,27412031
41118,aflibercept,gene,0.983,27412031
41119,FOLFIRI,drug,0.5557,27412031
41120,mCRC,disease,0.9585,27412031
41121,RAS,gene,0.869,27412031
41122,bevacizumab,gene,0.8755,27412031
41123,aflibercept,gene,0.988,27412031
41124,Aflibercept,gene,0.971,27412031
41125,mCRC,disease,0.9614,27412031
41126,Central Retinal Vein Occlusion,disease,1.0,27409478
41127,Foveal,DNA,0.4695,27409478
41128,central retinal vein occlusion,disease,1.0,27409478
41129,CRVO,disease,0.9995,27409478
41130,CRVO,disease,1.0,27409478
41131,aflibercept,gene,0.979,27409478
41132,macular edema,disease,1.0,27409478
41133,CRVO,disease,1.0,27409478
41134,FAZ,disease,0.5063,27409478
41135,CRVO,disease,1.0,27409478
41136,macular edema,disease,1.0,27409478
41137,Aflibercept,gene,0.956,27409826
41138,aflibercept,gene,0.875,27409826
41139,aflibercept,gene,0.985,27409826
41140,iridocorneal angle,DNA,0.4814,27409826
41141,Aflibercept,gene,0.9585,27409826
41142,iridocorneal angle closure,disease,1.0,27409826
41143,bevacizumab,gene,0.7075,27405285
41144,aflibercept,gene,0.9746,27405285
41145,bevacizumab,gene,0.644,27405283
41146,aflibercept,gene,0.991,27403807
41147,neovascular age-related macular degeneration,disease,1.0,27403807
41148,AMD,disease,1.0,27403807
41149,vascular endothelial growth factor,gene,0.9985,27403807
41150,aflibercept,gene,0.9224,27403807
41151,patients,species,0.986,27403807
41152,IVA,drug,0.912,27403807
41153,AMD,disease,1.0,27403807
41154,patients,species,0.9927,27403807
41155,patients,species,0.982,27403807
41156,BCVA,DNA,0.4668,27403807
41157,serous pigment epithelial detachment,disease,0.9995,27403807
41158,PED,disease,1.0,27403807
41159,AMD,disease,1.0,27403807
41160,patients,species,0.996,27403807
41161,Dome shaped macula,disease,0.7744,27402451
41162,myopic retinochoroidosis,disease,1.0,27402451
41163,spironolactone,drug,0.9995,27402451
41164,bilateral myopic retinochoroidosis,disease,0.7354,27402451
41165,decreased visual acuity,disease,0.947,27402451
41166,bilateral and unilateral,disease,0.949,27402451
41167,myopic maculopathy,disease,0.7837,27402451
41168,neurosensory detachment,disease,1.0,27402451
41169,spironolactone,drug,0.9985,27402451
41170,spironolactone,drug,0.998,27402451
41171,neovascular age-related macular degeneration,disease,1.0,27397583
41172,AMD,disease,1.0,27397583
41173,ranibizumab,gene,0.9146,27397583
41174,aflibercept,gene,0.984,27397583
41175,neovascular AMD,disease,1.0,27397583
41176,ranibizumab,gene,0.9263,27397583
41177,aflibercept,gene,0.934,27397583
41178,ranibizumab,gene,0.9434,27397583
41179,aflibercept,gene,0.976,27397583
41180,ORTs,DNA,0.4812,27397583
41181,patient,species,0.899,27397583
41182,fluorescein,drug,0.999,27397583
41183,indocyanine green,drug,0.998,27397583
41184,PED,disease,0.8296,27397583
41185,intraretinal cysts,disease,0.9976,27397583
41186,subretinal,disease,0.7188,27397583
41187,SRF,disease,0.833,27397583
41188,patients,species,0.9766,27397583
41189,neovascular AMD,disease,1.0,27397583
41190,ranibizumab,gene,0.752,27397583
41191,aflibercept,gene,0.951,27397583
41192,aflibercept,gene,0.978,27397583
41193,patients,species,0.9814,27397583
41194,aflibercept,gene,0.9575,27397583
41195,PED,disease,0.9956,27397583
41196,intraretinal cysts,disease,0.9995,27397583
41197,SRF,gene,0.926,27397583
41198,ranibizumab,gene,0.9106,27397583
41199,aflibercept,gene,0.968,27397583
41200,intraretinal cysts,disease,0.9995,27397583
41201,VEGFA,gene,0.9946,27375487
41202,retinal diseases,disease,0.9995,27375487
41203,Age-Related Macular Degeneration,disease,1.0,27369111
41204,aflibercept,gene,0.994,27369111
41205,ranibizumab,gene,0.696,27369111
41206,neovascular age-related macular degeneration,disease,1.0,27369111
41207,NVAMD,disease,1.0,27369111
41208,retinal fluid,disease,0.787,27369111
41209,PARTICIPANTS,species,0.794,27369111
41210,NVAMD,disease,1.0,27369111
41211,aflibercept,gene,0.985,27369111
41212,IAI,drug,0.806,27369111
41213,cystic intraretinal or subretinal fluid,disease,0.763,27369111
41214,Rq4,DNA,0.8784,27369111
41215,2q4,DNA,0.666,27369111
41216,2q8 groups,DNA,0.658,27369111
41217,Rq4,DNA,0.8604,27369111
41218,2q8,DNA,0.7817,27369111
41219,2q4,DNA,0.8706,27369111
41220,Rq4,DNA,0.88,27369111
41221,2q8,DNA,0.827,27369111
41222,Rq4,DNA,0.6885,27369111
41223,patients,species,0.898,27366049
41224,vascular endothelial growth factor,gene,0.8716,27366049
41225,VEGF,gene,0.9956,27366049
41226,diabetic macular edema,disease,1.0,27366049
41227,diabetic macular edema,disease,1.0,27366049
41228,patients,species,0.9863,27366049
41229,VEGF,gene,0.5645,27366049
41230,ranibizumab,gene,0.5605,27366049
41231,aflibercept,gene,0.927,27366049
41232,Diabetic Retinopathy,disease,0.9844,27366049
41233,ETDRS,DNA,0.6084,27366049
41234,Histone,gene,0.907,27362259
41235,Lewis Lung Tumor cells,cell_line,0.803,27362259
41236,Lewis Lung Tumor,disease,1.0,27362259
41237,anti-VEGF,gene,0.9688,27362259
41238,vascular endothelial growth factor,gene,0.9976,27362259
41239,VEGF,gene,0.9976,27362259
41240,VEGF-Trap,gene,0.9917,27362259
41241,tumor,disease,1.0,27362259
41242,angiogenesis-related genes,DNA,0.784,27362259
41243,Histone,gene,0.9604,27362259
41244,histone,gene,0.8613,27362259
41245,tumor,disease,1.0,27362259
41246,mouse Lewis lung carcinoma (LLC) cell line,cell_line,0.9736,27362259
41247,mouse,species,0.9907,27362259
41248,Lewis lung carcinoma,disease,0.9556,27362259
41249,genome,DNA,0.4744,27362259
41250,histone,gene,0.8843,27362259
41251,tumor,disease,1.0,27362259
41252,LLC-NR,cell_line,0.9185,27362259
41253,tumor,disease,0.997,27362259
41254,LLC-R,cell_line,0.953,27362259
41255,VEGF-Trap,gene,0.9624,27362259
41256,histone,gene,0.989,27362259
41257,histone,gene,0.984,27362259
41258,promoters,DNA,0.772,27362259
41259,histone,gene,0.991,27362259
41260,LLC-NR,cell_line,0.953,27362259
41261,LLC-R cell lines,cell_line,0.9316,27362259
41262,Histone,gene,0.9907,27362259
41263,LLC-NR,cell_line,0.936,27362259
41264,LLC-R cell lines,cell_line,0.8794,27362259
41265,CpG-rich and CpG-poor promoters,DNA,0.9136,27362259
41266,CpG,drug,0.553,27362259
41267,genes,DNA,0.6626,27362259
41268,CpG,drug,0.7725,27362259
41269,histone,gene,0.9907,27362259
41270,promoters,DNA,0.893,27362259
41271,angiogenesis-related genes,DNA,0.7065,27362259
41272,histone,gene,0.9873,27362259
41273,promoters,DNA,0.753,27362259
41274,tumor,disease,1.0,27362259
41275,Bevacizumab,gene,0.814,29450339
41276,acute central/hemicentral retinal vein occlusions,disease,0.994,29450339
41277,bevacizumab,gene,0.845,29450339
41278,retinal vein occlusion,disease,1.0,29450339
41279,macular edema,disease,1.0,29450339
41280,venous occlusion,disease,0.9995,29450339
41281,Central/ hemicentral retinal vein occlusion,disease,1.0,29450339
41282,ophthalmic,disease,0.853,29450339
41283,central/ hemicentral retinal vein occlusion,disease,1.0,29450339
41284,ocular hypertension,disease,1.0,29450339
41285,primary open angle glaucoma,disease,1.0,29450339
41286,primary angle closure,disease,0.994,29450339
41287,primary angle closure glaucoma,disease,1.0,29450339
41288,vascular endothelial growth factor,gene,0.95,29450339
41289,bevacizumab,gene,0.8867,29450339
41290,ranibizumab,gene,0.9136,29450339
41291,aflibercept,gene,0.984,29450339
41292,central/ hemicentral retinal vein occlusion,disease,0.9497,29450339
41293,Vascular Endothelial Growth Factor,gene,0.9395,27356110
41294,physicians,cell_type,0.577,27356110
41295,anti-vascular endothelial growth factor,gene,0.947,27356110
41296,VEGF,gene,0.998,27356110
41297,PARTICIPANTS,species,0.569,27356110
41298,anti-VEGF,gene,0.9727,27356110
41299,anti-VEGF,gene,0.9272,27356110
41300,physicians,cell_type,0.4932,27356110
41301,ranibizumab,gene,0.8735,27356110
41302,aflibercept,gene,0.9316,27356110
41303,aflibercept,gene,0.9893,27356110
41304,ranibizumab,gene,0.798,27356110
41305,aflibercept,gene,0.9897,27356110
41306,ranibizumab,drug,0.508,27356110
41307,bevacizumab,gene,0.7754,27356110
41308,physicians,cell_type,0.5093,27356110
41309,aflibercept,gene,0.9834,27356110
41310,ranibizumab,gene,0.891,27356110
41311,ophthalmologists,cell_type,0.4265,27356110
41312,VEGF,gene,0.874,27356110
41313,aflibercept,gene,0.972,27356110
41314,ranibizumab,gene,0.6875,27356110
41315,aflibercept,gene,0.9727,27354759
41316,Antivascular endothelial growth factor,gene,0.881,27354759
41317,neovascular age-related macular degeneration,disease,1.0,27354759
41318,AMD,disease,1.0,27354759
41319,ranibizumab,gene,0.9062,27354759
41320,aflibercept,gene,0.9556,27354759
41321,patients,species,0.992,27354759
41322,neovascular AMD,disease,1.0,27354759
41323,ranibizumab,gene,0.9243,27354759
41324,aflibercept,gene,0.9673,27354759
41325,neovascular AMD,disease,1.0,27354759
41326,ranibizumab,gene,0.654,27354759
41327,aflibercept,gene,0.947,27354759
41328,ranibizumab,gene,0.876,27354759
41329,aflibercept,gene,0.9673,27354759
41330,patients,species,0.982,27354759
41331,ranibizumab,gene,0.6777,27354759
41332,aflibercept,gene,0.985,27354759
41333,patients,species,0.985,27354759
41334,aflibercept,gene,0.991,27354759
41335,ranibizumab,gene,0.8457,27354759
41336,ranibizumab,gene,0.8916,27354759
41337,aflibercept,gene,0.9707,27354759
41338,neovascular AMD,disease,1.0,27354759
41339,patients,species,0.9917,27354759
41340,aflibercept,gene,0.9697,27350361
41341,patients,species,0.95,27350361
41342,neovascular age-related macular,disease,1.0,27350361
41343,VEGF,gene,0.944,27348433
41344,Diabetic Macular Edema,disease,1.0,27348433
41345,Diabetic retinopathy,disease,1.0,27348433
41346,DR,disease,1.0,27348433
41347,blindness,disease,0.998,27348433
41348,DR,disease,,27348433
41349,diabetic macular edema,disease,1.0,27348433
41350,DME,disease,1.0,27348433
41351,patient,species,0.986,27348433
41352,vision loss,disease,0.9985,27348433
41353,DME,disease,1.0,27348433
41354,vascular endothelial growth factor,gene,0.998,27348433
41355,VEGF,gene,0.9927,27348433
41356,DME,disease,1.0,27348433
41357,VEGF,gene,0.994,27348433
41358,patients,species,0.9766,27348433
41359,DME,disease,1.0,27348433
41360,VEGF,gene,0.918,27348433
41361,DME,disease,1.0,27348433
41362,ranibizumab,gene,0.718,27348433
41363,Lucentis,gene,0.7344,27348433
41364,aflibercept,gene,0.978,27348433
41365,Eylea,gene,0.758,27348433
41366,Bevacizumab,gene,0.9106,27348433
41367,Avastin,gene,0.7803,27348433
41368,cancer,disease,1.0,27348433
41369,DME,disease,1.0,27348433
41370,VEGF,gene,0.967,27348433
41371,vision loss,disease,0.947,27348433
41372,DME,disease,1.0,27348433
41373,VEGF,gene,0.547,27348433
41374,Aflibercept,gene,0.9663,27348231
41375,Patients,species,0.9814,27348231
41376,Neovascular,disease,0.8633,27348231
41377,aflibercept,gene,0.985,27348231
41378,patients,species,0.9624,27348231
41379,neovascular age-related macular degeneration,disease,1.0,27348231
41380,nvAMD,disease,1.0,27348231
41381,patients,species,0.961,27348231
41382,nvAMD,disease,1.0,27348231
41383,Patients,species,0.966,27348231
41384,aflibercept,gene,0.9775,27348231
41385,Eylea,gene,0.7817,27348231
41386,patients,species,0.973,27348231
41387,ETDRS,DNA,0.556,27348231
41388,pigment epithelial detachment,disease,1.0,27348231
41389,PED,disease,1.0,27348231
41390,PED,disease,1.0,27348231
41391,Aflibercept,gene,0.935,27348231
41392,nvAMD,disease,0.9995,27348231
41393,patients,species,0.99,27348231
41394,aflibercept,gene,0.984,27336229
41395,retinal angiomatous proliferation,disease,1.0,27336229
41396,RAP,disease,1.0,27336229
41397,retinal pigment epithelium (RPE) atrophy,disease,1.0,27336229
41398,RAP,drug,0.998,27336229
41399,RPE atrophy,disease,1.0,27336229
41400,RAP,drug,0.7373,27336229
41401,RPE atrophy,disease,1.0,27336229
41402,RPE atrophy,disease,1.0,27336229
41403,aflibercept,gene,0.9893,27336229
41404,RAP,disease,1.0,27336229
41405,RPE atrophy,disease,1.0,27336229
41406,Macular Telangiectasia Type 1,disease,1.0,27327292
41407,Aflibercept,gene,0.879,27327292
41408,macular telangiectasia type 1,disease,1.0,27327292
41409,MacTel 1,disease,1.0,27327292
41410,aflibercept,gene,0.979,27327292
41411,Eylea,gene,0.6074,27327292
41412,aflibercept,gene,0.9814,27327292
41413,macular edema,disease,1.0,27327292
41414,MacTel 1,disease,1.0,27327292
41415,MacTel,gene,0.5127,27327292
41416,chronic macular edema,disease,0.9995,27327292
41417,photoreceptor,cell_type,0.554,27327292
41418,VEGF,gene,0.988,27327285
41419,Bevacizumab,gene,0.914,27327285
41420,Ranibizumab,gene,0.849,27327285
41421,Aflibercept,gene,0.9478,27327285
41422,vascular endothelial growth factor,gene,0.9985,27327285
41423,VEGF,gene,0.9976,27327285
41424,PATIENTS,species,0.924,27327285
41425,bevacizumab,gene,0.7275,27327285
41426,Avastin,gene,0.3525,27327285
41427,aflibercept,gene,0.9863,27327285
41428,Eylea,gene,0.5103,27327285
41429,VEGF,gene,0.9897,27327285
41430,bevacizumab,gene,0.5127,27327285
41431,bevacizumab,gene,0.7153,27327285
41432,Ranibizumab,gene,0.844,27327285
41433,bevacizumab,gene,0.6895,27327285
41434,bevacizumab,gene,0.5483,27327285
41435,ophthalmologists,cell_type,0.425,27327285
41436,VEGF,gene,0.9956,27327285
41437,bevacizumab,gene,0.5854,27327285
41438,Diabetic Macular Edema,disease,1.0,27327284
41439,age-related macular degeneration,disease,1.0,27327284
41440,diabetic macular edema,disease,1.0,27327284
41441,DME,disease,1.0,27327284
41442,PATIENTS,species,0.974,27327284
41443,DME,disease,1.0,27327284
41444,bevacizumab,gene,0.6777,27327284
41445,Avastin;,gene,0.4485,27327284
41446,aflibercept,gene,0.981,27327284
41447,Eylea; Regeneron,gene,0.646,27327284
41448,aflibercept,gene,0.939,27327284
41449,aflibercept,gene,0.976,27327284
41450,aflibercept,gene,0.9727,27327284
41451,bevacizumab,gene,0.9434,27327284
41452,Ranibizumab,gene,0.906,27320059
41453,Aflibercept,gene,0.953,27320059
41454,Age-Related Macular Degeneration,disease,1.0,27320059
41455,neovascular age-related macular degeneration,disease,1.0,27320059
41456,AMD,disease,1.0,27320059
41457,aflibercept,gene,0.97,27320059
41458,neovascular AMD,disease,1.0,27320059
41459,ranibizumab,gene,0.9243,27320059
41460,aflibercept,gene,0.977,27320059
41461,intraretinal edema,disease,1.0,27320059
41462,subretinal fluid,disease,0.9937,27320059
41463,IVR,disease,1.0,27320059
41464,IVA,disease,1.0,27320059
41465,AMD,disease,0.9995,27320059
41466,ranibizumab,gene,0.8457,27320059
41467,aflibercept,gene,0.974,27320059
41468,Anti-Vascular Endothelial Growth Factor,gene,0.9585,27320058
41469,anti-vascular endothelial growth factor,gene,0.96,27320058
41470,VEGF,gene,0.996,27320058
41471,bevacizumab,drug,0.5264,27320058
41472,ranibizumab,drug,0.681,27320058
41473,pegaptanib,drug,0.9893,27320058
41474,aflibercept,gene,0.864,27320058
41475,VEGF,gene,0.812,27320058
41476,eye disease,disease,0.9233,27320058
41477,bevacizumab,gene,0.798,27320058
41478,ranibizumab,gene,0.575,27320058
41479,pegaptanib,drug,0.9966,27320058
41480,aflibercept,gene,0.9697,27320058
41481,VEGF,gene,0.7397,27316276
41482,vascular endothelial growth factor,gene,0.998,27314606
41483,VEGF,gene,0.9985,27314606
41484,aflibercept,gene,0.973,27314606
41485,bevacizumab,gene,0.7593,27314606
41486,ranibizumab,gene,0.6396,27314606
41487,rabbits,species,0.9346,27314606
41488,rabbits,species,0.821,27314606
41489,ranibizumab,gene,0.7695,27314606
41490,bevacizumab,gene,0.526,27314606
41491,bevacizumab,gene,0.729,27314606
41492,aflibercept,gene,0.921,27314606
41493,VEGF,gene,0.758,27314606
41494,caspase-3,gene,0.994,27314606
41495,retinal abnormality,disease,1.0,27314606
41496,apoptotic cell,cell_type,0.7036,27314606
41497,caspase-3,gene,0.9927,27314606
41498,caspase-3,gene,0.9917,27314606
41499,VEGF,gene,0.643,27314606
41500,caspase-3,gene,0.9907,27314606
41501,Serum VEGF,gene,0.691,27314606
41502,rabbits,species,0.8325,27314606
41503,VEGF,gene,0.925,27314606
41504,VEGF,gene,0.8594,27314606
41505,VEGF,gene,0.8555,27314606
41506,ranibizumab,gene,0.4812,27314606
41507,VEGF,gene,0.7583,27314606
41508,VEGF,gene,0.732,27314606
41509,retinopathy of,disease,1.0,27314606
41510,prematurity,disease,0.9976,27314606
41511,aflibercept,gene,0.99,27307700
41512,age-related macular degeneration,disease,1.0,27307700
41513,aflibercept,gene,0.9873,27307700
41514,age-related macular degeneration,disease,1.0,27307700
41515,AMD,disease,1.0,27307700
41516,ranibizumab,gene,0.8975,27307700
41517,PARTICIPANTS,species,0.53,27307700
41518,AMD,disease,0.9995,27307700
41519,ranibizumab,gene,0.8433,27307700
41520,AMD,disease,1.0,27307700
41521,choroidal neovascularization,disease,0.9966,27307700
41522,CNV,disease,1.0,27307700
41523,polypoidal choroidal vasculopathy,disease,1.0,27307700
41524,PCV,disease,1.0,27307700
41525,aflibercept,gene,0.757,27307700
41526,CNV,disease,0.6445,27307700
41527,PCV,disease,1.0,27307700
41528,PCV,disease,0.997,27307700
41529,pigment,disease,0.5967,27307700
41530,PCV,disease,1.0,27307700
41531,CNV,disease,0.9946,27307700
41532,AMD,disease,0.9995,27307700
41533,ranibizumab,gene,0.7925,27307700
41534,AMD,disease,1.0,27307700
41535,PI3K,gene,0.9946,27304845
41536,mTOR,gene,0.989,27304845
41537,Choroidal Neovascularization,disease,0.8926,27304845
41538,VEGF-A,gene,0.995,27304845
41539,Choroidal neovascularization,disease,1.0,27304845
41540,CNV,disease,1.0,27304845
41541,visual loss,disease,0.995,27304845
41542,age-related macular degeneration,disease,1.0,27304845
41543,AMD,disease,1.0,27304845
41544,phosphatidyl-inositol,drug,0.986,27304845
41545,phosphatidyl-inositol-3-kinase,gene,0.994,27304845
41546,PI3K,gene,0.9854,27304845
41547,mammalian target,gene,0.649,27304845
41548,rapamycin,drug,0.9995,27304845
41549,mTOR,gene,0.988,27304845
41550,VEGF-A,gene,0.997,27304845
41551,platelet-derived growth factor,gene,0.9985,27304845
41552,PDGF,gene,0.9917,27304845
41553,CNV,disease,0.9917,27304845
41554,mice,species,0.974,27304845
41555,Choroidal neovascularization lesions,disease,0.9985,27304845
41556,mice,species,0.9795,27304845
41557,mice,species,0.9644,27304845
41558,GSK2126458,drug,0.999,27304845
41559,GSK2126458,drug,0.999,27304845
41560,aflibercept,gene,0.9863,27304845
41561,fluorescein,drug,0.997,27304845
41562,FITC,drug,0.9995,27304845
41563,ED1,gene,0.9683,27304845
41564,isolectin B4,gene,0.9644,27304845
41565,IB4,gene,0.908,27304845
41566,GSK2126458,drug,0.999,27304845
41567,CNV lesions,disease,0.768,27304845
41568,Fluorescein isothiocyanate,drug,0.9995,27304845
41569,CNV,disease,0.9995,27304845
41570,GSK2126458,drug,0.9976,27304845
41571,GSK2126458,drug,0.998,27304845
41572,Aflibercept,gene,0.9307,27304845
41573,Phosphatidyl-inositol,drug,0.989,27304845
41574,Phosphatidyl-inositol-3-kinase,gene,0.9854,27304845
41575,mTOR,gene,0.989,27304845
41576,CNV,disease,0.6777,27304845
41577,GSK2126458,drug,0.9976,27304845
41578,CNV,DNA,0.7485,27304845
41579,Choroidal neovascularization,disease,1.0,27304845
41580,GSK2126458,drug,0.9966,27304845
41581,PI3K,gene,0.9966,27304845
41582,mTOR,gene,0.982,27304845
41583,diabetic,disease,0.998,27293138
41584,vascular endothelial growth factor,gene,0.9985,27293138
41585,VEGF,gene,0.998,27293138
41586,diabetic retinopathy,disease,1.0,27293138
41587,DR,disease,1.0,27293138
41588,patients,species,0.9824,27293138
41589,chronic diabetic macular edema,disease,0.994,27293138
41590,DR,disease,,27293138
41591,VEGF,gene,0.6763,27293138
41592,aflibercept,gene,0.989,27293138
41593,corticosteroids,drug,0.7246,27293138
41594,dexamethasone,drug,0.9995,27293138
41595,fluocinolone,drug,0.998,27293138
41596,anti-VEGF,gene,0.746,27293138
41597,encapsulated cell,cell_type,0.7173,27293138
41598,danazol,drug,0.999,27293138
41599,minocycline,drug,0.999,27293138
41600,loteprednol,drug,0.9995,27293138
41601,Patients,species,0.9717,27289179
41602,Neovascular Age-Related Macular Degeneration,disease,1.0,27289179
41603,patients,species,0.974,27289179
41604,neovascular age-related macular degeneration,disease,1.0,27289179
41605,nAMD,disease,1.0,27289179
41606,ranibizumab,gene,0.7354,27289179
41607,aflibercept,gene,0.961,27289179
41608,PARTICIPANTS,species,0.612,27289179
41609,patients,species,0.9385,27289179
41610,nAMD,disease,1.0,27289179
41611,ranibizumab,gene,0.8813,27289179
41612,aflibercept,gene,0.942,27289179
41613,patients,species,0.9937,27289179
41614,intraretinal fluid,disease,0.9443,27289179
41615,pigment epithelial detachment,disease,1.0,27289179
41616,subfoveal thickening,disease,1.0,27289179
41617,Patients,species,0.979,27289179
41618,ranibizumab,gene,0.918,27289179
41619,retinal dehydration,disease,0.9814,27289179
41620,aflibercept,gene,0.9497,27289179
41621,aflibercept,gene,0.988,27286893
41622,myopic choroidal neovascularization,disease,1.0,27286893
41623,aflibercept,gene,0.9863,27286893
41624,subfoveal myopic choroidal neovascularization,disease,0.997,27286893
41625,CNV,disease,1.0,27286893
41626,patients,species,0.9785,27286893
41627,myopic subfoveal CNV,disease,1.0,27286893
41628,patients,species,0.987,27286893
41629,aflibercept,gene,0.9766,27286893
41630,aflibercept,gene,0.9863,27286893
41631,aflibercept,gene,0.984,27286893
41632,patients,species,0.992,27286893
41633,patients,species,0.9795,27286893
41634,aflibercept,gene,0.9814,27286893
41635,myopic CNV,disease,1.0,27286893
41636,diabetic macular edema,disease,1.0,27283845
41637,aflibercept,gene,0.989,27282873
41638,ranibizumab,gene,0.562,27282873
41639,neovascular age-related macular degeneration,disease,1.0,27282873
41640,Aflibercept,gene,0.9487,27280850
41641,Bevacizumab,gene,0.797,27280850
41642,Ranibizumab,gene,0.8296,27280850
41643,Diabetic,disease,0.9956,27280850
41644,vascular endothelial growth factor,gene,0.991,27280850
41645,VEGF,gene,0.9976,27280850
41646,diabetic macular edema,disease,1.0,27280850
41647,DME,drug,0.9854,27280850
41648,VEGF,gene,0.6167,27280850
41649,patients,species,0.9604,27280850
41650,DME,disease,1.0,27280850
41651,aflibercept,gene,0.931,27280850
41652,bevacizumab,gene,0.8364,27280850
41653,ranibizumab,gene,0.7266,27280850
41654,aflibercept,gene,0.9717,27280850
41655,aflibercept,gene,0.9907,27280850
41656,ranibizumab,gene,0.513,27280850
41657,bevacizumab,gene,0.825,27280850
41658,aflibercept,gene,0.993,27280850
41659,bevacizumab,gene,0.911,27280850
41660,ranibizumab,gene,0.7793,27280850
41661,DME,disease,1.0,27280850
41662,PARTICIPANTS,species,0.543,27280850
41663,Diabetic Retinopathy,disease,1.0,27280850
41664,Patients,species,0.9526,27280850
41665,participants,species,0.9824,27280850
41666,participants,species,0.985,27280850
41667,aflibercept,gene,0.988,27280850
41668,bevacizumab,gene,0.931,27280850
41669,ranibizumab,gene,0.879,27280850
41670,participants,species,0.969,27280850
41671,aflibercept,gene,0.99,27280850
41672,ranibizumab,gene,0.8613,27280850
41673,bevacizumab,gene,0.813,27280850
41674,aflibercept,gene,0.9653,27280850
41675,aflibercept,gene,0.988,27280850
41676,ranibizumab,gene,0.5645,27280850
41677,bevacizumab,gene,0.781,27280850
41678,DME,disease,1.0,27280850
41679,aflibercept,gene,0.9785,27280850
41680,ranibizumab,gene,0.6274,27280850
41681,Aflibercept,gene,0.962,27280850
41682,ranibizumab,gene,0.7056,27280850
41683,bevacizumab,gene,0.856,27280850
41684,DME,drug,0.737,27280850
41685,patients,species,0.972,27280850
41686,ACTINOMYCES NEUII ENDOPHTHALMITIS,disease,0.9995,27280342
41687,acute endophthalmitis,disease,0.9995,27280342
41688,Actinomyces neuii,species,0.9395,27280342
41689,anti-vascular endothelial growth factor,gene,0.988,27280342
41690,age-related macular degeneration,disease,0.9985,27280342
41691,endophthalmitis,disease,1.0,27280342
41692,A,disease,0.8945,27280342
41693,A. neuii,species,0.9355,27280342
41694,anti-vascular endothelial growth factor,gene,0.9673,27280342
41695,A. neuii,species,0.947,27280342
41696,vancomycin,drug,0.998,27280342
41697,ceftazidime,drug,0.9966,27280342
41698,endophthalmitis,disease,1.0,27280342
41699,A. neuii,species,0.926,27280342
41700,Aflibercept,gene,0.9907,27270364
41701,Diabetic,disease,1.0,27270364
41702,Aflibercept,gene,0.946,27262619
41703,Aflibercept,gene,0.99,27258433
41704,Eylea,gene,0.8604,27258433
41705,Rabbit,species,0.924,27258433
41706,aflibercept,gene,0.995,27258433
41707,Eylea,gene,0.87,27258433
41708,rabbit,species,0.848,27258433
41709,Aflibercept,gene,0.9614,27258433
41710,rabbits,species,0.929,27258433
41711,aflibercept,gene,0.99,27258433
41712,aflibercept,gene,0.987,27258433
41713,aflibercept,gene,0.986,27258433
41714,rabbits,species,0.937,27258433
41715,aflibercept,gene,0.982,27258433
41716,bevacizumab,gene,0.8096,27258433
41717,ranibizumab,gene,0.8726,27258433
41718,VEGF-Trap,gene,0.871,27258433
41719,Cataract,disease,0.993,27255691
41720,patients,species,0.944,27255691
41721,neovascular age-related macular degeneration,disease,1.0,27255691
41722,patients,species,0.953,27255691
41723,neovascular age-related macular degeneration,disease,1.0,27255691
41724,AMD,disease,1.0,27255691
41725,anti,gene,0.703,27255691
41726,vascular endothelial growth factor,gene,0.8696,27255691
41727,VEGF,gene,0.9966,27255691
41728,patients,species,0.9937,27255691
41729,anti-VEGF,gene,0.911,27255691
41730,cataract,disease,0.9995,27255691
41731,Diabetic Retinopathy,disease,1.0,27255691
41732,anti-VEGF,gene,0.9175,27255691
41733,cataract,disease,0.9478,27255691
41734,patients,species,0.9834,27255691
41735,cataract,disease,0.9995,27255691
41736,anti-VEGF,gene,0.839,27255691
41737,neovascular AMD,disease,0.955,27255691
41738,ETDRS,DNA,0.5117,27255691
41739,cataract,disease,1.0,27255691
41740,cataract,disease,0.999,27255691
41741,patients,species,0.979,27255691
41742,cataract,disease,0.9893,27255691
41743,Cataract,disease,0.9985,27255691
41744,patients,species,0.98,27255691
41745,neovascular AMD,disease,1.0,27255691
41746,Cataract,disease,1.0,27255691
41747,patients,species,0.986,27255691
41748,patients,species,0.9785,27255691
41749,cataract,disease,0.9995,27255691
41750,aflibercept,gene,0.9854,27251193
41751,ranibizumab,gene,0.7495,27251193
41752,anti-vascular endothelial growth factor,gene,0.916,27236451
41753,ocular neovascular diseases,disease,0.9937,27236451
41754,anti-VEGF,gene,0.9243,27236451
41755,VEGF,gene,0.761,27236451
41756,bevacizumab,gene,0.818,27236451
41757,ranibizumab,gene,0.852,27236451
41758,aflibercept,gene,0.974,27236451
41759,fatal thromboembolic events,disease,0.9297,27236451
41760,thromboembolic events,disease,0.9956,27236451
41761,serious non-ocular hemorrhage,disease,0.8135,27236451
41762,endophthalmitis,disease,1.0,27236451
41763,traumatic cataracts,disease,0.9834,27236451
41764,retinal detachment,disease,1.0,27236451
41765,thromboembolic events,disease,1.0,27236451
41766,ranibizumab,gene,0.587,27236451
41767,lucentis,gene,0.582,27236451
41768,bevacizumab,gene,0.8447,27236451
41769,avastin,gene,0.704,27236451
41770,aflibercept,gene,0.9644,27236451
41771,Eylea,gene,0.66,27236451
41772,Aflibercept,gene,0.983,27234973
41773,VEGF,gene,0.9966,27234973
41774,bevacizumab,gene,0.9634,27234973
41775,vascular endothelial growth factor,gene,0.9907,27234973
41776,VEGF,gene,0.9966,27234973
41777,cancers,disease,1.0,27234973
41778,retinal vascular diseases,disease,1.0,27234973
41779,VEGF,gene,0.8516,27234973
41780,pegaptanib,drug,0.9575,27234973
41781,ranibizumab,gene,0.6235,27234973
41782,aflibercept,gene,0.953,27234973
41783,bevacizumab,gene,0.6597,27234973
41784,renal cancers,disease,1.0,27234973
41785,ocular vascular diseases,disease,0.9814,27234973
41786,bevacizumab,gene,0.9136,27234973
41787,ranibizumab,gene,0.7773,27234973
41788,neovascular age-related macular degeneration,disease,1.0,27234973
41789,bevacizumab,gene,0.5977,27234973
41790,VEGF165,gene,0.8726,27234973
41791,Fc,gene,0.9624,27234973
41792,platelet,cell_type,0.729,27234973
41793,Fc receptor,gene,0.995,27234973
41794,epithelial and endothelial cells,cell_type,0.925,27234973
41795,bevacizumab,gene,0.863,27234973
41796,aflibercept,gene,0.989,27234973
41797,VEGF,gene,0.995,27234973
41798,bevacizumab,gene,0.892,27234973
41799,aflibercept,gene,0.987,27234973
41800,VEGF dimer,gene,0.546,27234973
41801,bevacizumab,gene,0.996,27234973
41802,VEGF,gene,0.9546,27234973
41803,aflibercept,gene,0.986,27234973
41804,VEGF,gene,0.9907,27234973
41805,low-affinity Fc receptors,gene,0.9604,27234973
41806,platelets,cell_type,0.7856,27234973
41807,epithelial or endothelial cells,cell_type,0.8745,27234973
41808,aflibercept,gene,0.9956,27234973
41809,Fc,gene,0.9785,27234973
41810,aflibercept,gene,0.985,27234973
41811,VEGF,gene,0.9946,27234973
41812,amino acids,drug,0.9863,27234973
41813,VEGFR1,gene,0.998,27234973
41814,R2,gene,0.9653,27234973
41815,VEGF165,gene,0.995,27234973
41816,Aflibercept,gene,0.9336,27229701
41817,neovascular AMD,disease,1.0,27229701
41818,aflibercept,gene,0.961,27229701
41819,patients,species,0.947,27229701
41820,neovascular AMD,disease,1.0,27229701
41821,intraretinal/subretinal fluid,disease,0.8438,27229701
41822,IRF,disease,0.984,27229701
41823,SRF,disease,0.8965,27229701
41824,ranibizumab,gene,0.895,27229701
41825,aflibercept,gene,0.9824,27229701
41826,patient,species,0.9536,27229701
41827,fluorescein,drug,0.998,27229701
41828,indocyanine green,drug,0.997,27229701
41829,IRF,gene,0.5674,27229701
41830,aflibercept,gene,0.802,27229701
41831,vision,disease,0.567,27229701
41832,nAMD,disease,0.9795,27229701
41833,Ranibizumab,gene,0.9263,27225494
41834,Aflibercept,gene,0.9624,27225494
41835,Bevacizumab,gene,0.722,27225494
41836,anti-VEGF,gene,0.5933,27225494
41837,ranibizumab,gene,0.848,27225494
41838,aflibercept,gene,0.9497,27225494
41839,bevacizumab,gene,0.634,27225494
41840,Ruthenium,drug,0.9995,27225494
41841,Ru(bpy)2(mcbpy-O-Su-ester)(PF6)2,drug,0.9995,27225494
41842,Ru(bpy)2(mcbpy-O-Su-ester)(PF6)2,drug,0.9995,27225494
41843,glycerol,drug,0.9966,27225494
41844,ranibizumab,gene,0.9004,27225494
41845,aflibercept,gene,0.9697,27225494
41846,bevacizumab,gene,0.79,27225494
41847,Wet age related macular degeneration,disease,1.0,27220225
41848,Age-related macular degeneration,disease,1.0,27220225
41849,AMD,disease,1.0,27220225
41850,irreversible,disease,0.742,27220225
41851,visual loss,disease,0.98,27220225
41852,AMD,disease,0.9976,27220225
41853,subretinal choroidal neovascularization,disease,0.999,27220225
41854,visual loss,disease,0.9995,27220225
41855,vascular endothelial growth factor,gene,0.999,27220225
41856,VEGF,gene,0.994,27220225
41857,neovascular AMD,disease,1.0,27220225
41858,wet AMD,disease,0.993,27220225
41859,retinal thickening,disease,0.994,27220225
41860,bevacizumab,gene,0.631,27220225
41861,ranibizumab,gene,0.681,27220225
41862,aflibercept,gene,0.957,27220225
41863,retinopathy of prematurity,disease,1.0,27216852
41864,ROP,disease,1.0,27216852
41865,infants,species,0.8223,27216852
41866,ROP,disease,0.97,27216852
41867,patients,species,0.988,27216852
41868,babies,species,0.722,27216852
41869,ranibizumab,gene,0.6875,27216852
41870,babies,species,0.743,27216852
41871,aflibercept,gene,0.971,27216852
41872,babies,species,0.755,27216852
41873,infants,species,0.8384,27216852
41874,ranibizumab,gene,0.8843,27216852
41875,intraocular sterile,disease,0.5464,27216852
41876,patients,species,0.9897,27215744
41877,vascular endothelial growth factor,gene,0.9707,27215744
41878,VEGF,gene,0.998,27215744
41879,patients,species,0.988,27215744
41880,age-related macular degeneration,disease,1.0,27215744
41881,AMD,disease,1.0,27215744
41882,diabetic macular oedema,disease,1.0,27215744
41883,DME,disease,1.0,27215744
41884,retinal vein occlusion,disease,1.0,27215744
41885,RVO,disease,1.0,27215744
41886,myopic choroidal neovascularisation,disease,1.0,27215744
41887,CNV,disease,1.0,27215744
41888,AMD,disease,1.0,27215744
41889,DME,disease,0.9995,27215744
41890,RVO,disease,0.998,27215744
41891,myopic CNV,DNA,0.524,27215744
41892,patients,species,0.9272,27215744
41893,AMD,disease,1.0,27215744
41894,patients,species,0.9453,27215744
41895,AMD,disease,1.0,27215744
41896,DME,disease,1.0,27215744
41897,RVO,disease,1.0,27215744
41898,DME,disease,0.9995,27215744
41899,patients,species,0.9155,27215744
41900,RVO,disease,1.0,27215744
41901,AMD,disease,0.9995,27215744
41902,DME,disease,1.0,27215744
41903,RVO,disease,0.997,27215744
41904,AMD,disease,1.0,27215744
41905,patient,species,0.9463,27215744
41906,AMD,disease,1.0,27215744
41907,DME,disease,0.9995,27215744
41908,RVO,disease,1.0,27215744
41909,myopic CNV,disease,1.0,27215744
41910,patients,species,0.9854,27215744
41911,aflibercept,gene,0.98,27215012
41912,rubeosis iridis,disease,1.0,27215012
41913,proliferative diabetic retinopathy,disease,0.9995,27215012
41914,rubeosis iridis,disease,1.0,27215012
41915,aflibercept,gene,0.971,27215012
41916,iris neovascularization,disease,0.8374,27215012
41917,vitreous hemorrhage,disease,0.9985,27215012
41918,proliferative diabetic retinopathy,disease,0.9907,27215012
41919,aflibercept,gene,0.9785,27215012
41920,Rubeosis iridis,disease,1.0,27215012
41921,Aflibercept,gene,0.9736,27215012
41922,anti-vascular endothelial growth factor,gene,0.9956,27215012
41923,anti-VEGF,gene,0.989,27215012
41924,rubeosis iridis,disease,1.0,27215012
41925,myopic choroidal neovascularization,disease,1.0,27215011
41926,ranibizumab,gene,0.799,27215011
41927,aflibercept,gene,0.9673,27215011
41928,Myopic choroidal neovascularization,disease,1.0,27215011
41929,mCNV,disease,1.0,27215011
41930,visual impairment,disease,0.9995,27215011
41931,mCNV,disease,0.9995,27215011
41932,ranibizumab,gene,0.9233,27215011
41933,aflibercept,gene,0.9487,27215011
41934,vascular endothelial growth factor,gene,0.999,27215011
41935,VEGF,gene,0.9937,27215011
41936,verteporfin,drug,0.988,27215011
41937,ranibizumab,gene,0.685,27215011
41938,aflibercept,gene,0.8604,27215011
41939,mCNV,disease,1.0,27215011
41940,diabetic macular edema,disease,1.0,27215008
41941,Diabetic macular edema,disease,1.0,27215008
41942,DME,disease,1.0,27215008
41943,diabetic,disease,1.0,27215008
41944,DME,disease,1.0,27215008
41945,dexamethasone,drug,0.999,27215008
41946,fluocinolone acetonide,drug,0.999,27215008
41947,VEGF,gene,0.996,27215008
41948,ranibizumab,gene,0.962,27215008
41949,aflibercept,gene,0.9863,27215008
41950,VEGF,gene,0.9507,27215008
41951,glaucoma,disease,1.0,27215008
41952,cataract,disease,1.0,27215008
41953,Aflibercept,gene,0.979,27213222
41954,ranibizumab,gene,0.668,27213222
41955,neovascular age-related macular degeneration,disease,0.9917,27213222
41956,AMD,disease,1.0,27213222
41957,aflibercept,gene,0.989,27213222
41958,neovascular AMD,disease,1.0,27213222
41959,patients,species,0.982,27213222
41960,neovascular AMD,disease,1.0,27213222
41961,patients,species,0.966,27213222
41962,reticular pseudodrusen,disease,1.0,27213222
41963,RPD,disease,1.0,27213222
41964,patients,species,0.9766,27213222
41965,RPD,disease,1.0,27213222
41966,RPD,disease,1.0,27213222
41967,RPD,disease,1.0,27213222
41968,RPD,disease,1.0,27213222
41969,neovascular AMD,disease,1.0,27213222
41970,patients,species,0.91,27213222
41971,RPD,disease,1.0,27213222
41972,patients,species,0.9487,27213222
41973,RPD,disease,1.0,27213222
41974,Diabetic retinopathy,disease,1.0,27209895
41975,diabetic retinopathy,disease,1.0,27209895
41976,diabetic macular edema,disease,1.0,27209895
41977,diabetic retinopathy,disease,1.0,27209895
41978,extrafoveolar edema,disease,1.0,27209895
41979,cystoid edema,disease,1.0,27209895
41980,cystoid macular edema,disease,1.0,27209895
41981,VEGF,gene,0.995,27209895
41982,Vascular endothelial growth factor,gene,0.9966,27209895
41983,diabetic macular edema,disease,1.0,27209895
41984,patients,species,0.994,27209895
41985,VEGF,gene,0.9966,27209895
41986,ranibizumab,gene,0.799,27209895
41987,aflibercept,gene,0.9663,27209895
41988,bevacizumab,gene,0.8457,27209895
41989,dexamethasone,drug,0.9956,27209895
41990,fluocinolone,drug,0.998,27209895
41991,triamcinolone,drug,0.999,27209895
41992,Aflibercept,gene,0.9927,27190640
41993,Bevacizumab,gene,0.5293,27190640
41994,patients,species,0.975,27190640
41995,macular edema,disease,1.0,27190640
41996,perfused branch retinal vein occlusion,disease,1.0,27190640
41997,aflibercept,gene,0.984,27190640
41998,aflibercept,gene,0.9937,27190640
41999,bevacizumab,gene,0.5713,27190640
42000,participants,species,0.9727,27190640
42001,macular edema,disease,1.0,27190640
42002,branch retinal vein occlusion,disease,1.0,27190640
42003,ziv-aflibercept,gene,0.99,27190127
42004,diabetic macular PURPOSE,disease,0.8584,27190127
42005,ziv-aflibercept,gene,0.9897,27190127
42006,patients,species,0.918,27190127
42007,diabetic macular oedema,disease,1.0,27190127
42008,DME,disease,1.0,27190127
42009,patients,species,0.9585,27190127
42010,DME,disease,1.0,27190127
42011,ziv-aflibercept,gene,0.9834,27190127
42012,intraocular inflammation,disease,0.9995,27190127
42013,cataract,disease,1.0,27190127
42014,participants,species,0.956,27190127
42015,men,species,0.969,27190127
42016,women,species,0.982,27190127
42017,ziv-aflibercept,gene,0.9893,27190127
42018,DME,disease,1.0,27190127
42019,aflibercept,gene,0.9497,27190127
42020,Vitreomacular Traction,disease,0.968,27183554
42021,Aflibercept,gene,0.98,27183554
42022,diabetic macular edema,disease,1.0,27183554
42023,DME,disease,1.0,27183554
42024,vitreomacular traction,disease,1.0,27183554
42025,VMT,disease,0.9995,27183554
42026,aflibercept,gene,0.97,27183554
42027,Eylea,gene,0.599,27183554
42028,VMT,drug,0.9937,27183554
42029,aflibercept,gene,0.988,27183554
42030,DME,disease,1.0,27183554
42031,vascular endothelial growth factor,gene,0.9927,27183554
42032,Diabetic Macular Edema,disease,1.0,27183553
42033,Aflibercept,gene,0.9644,27183553
42034,diabetic macular edema,disease,1.0,27183553
42035,aflibercept,gene,0.9893,27183553
42036,Eylea;,gene,0.674,27183553
42037,diabetic macular edema,disease,1.0,27183553
42038,aflibercept,gene,0.9653,27183553
42039,Aflibercept,gene,0.979,27183550
42040,Ranibizumab,gene,0.8633,27183550
42041,Bevacizumab,gene,0.731,27183550
42042,Neovascular Age-related Macular Degeneration,disease,1.0,27183550
42043,age-related macular degeneration,disease,1.0,27183550
42044,aflibercept,gene,0.904,27183550
42045,Eylea;,gene,0.4075,27183550
42046,ranibizumab,gene,0.6816,27183550
42047,Lucentis,gene,0.4248,27183550
42048,bevacizumab,gene,0.5996,27183550
42049,Avastin,gene,0.4587,27183550
42050,PATIENTS,species,0.943,27183550
42051,aflibercept,gene,0.985,27183550
42052,aflibercept,gene,0.974,27183550
42053,geographic atrophy,disease,0.992,27183550
42054,aflibercept,gene,0.9614,27183550
42055,ranibizumab,gene,0.526,27183550
42056,bevacizumab,gene,0.5186,27183550
42057,anti-VEGF,gene,0.969,27170968
42058,vascular endothelial growth,gene,0.996,27170968
42059,retinal conditions,disease,0.6084,27170968
42060,aflibercept,gene,0.993,27170968
42061,VEGF,gene,0.6216,27170968
42062,retinal conditions,disease,0.882,27170968
42063,VEGF,gene,0.94,27170968
42064,Aflibercept,gene,0.9717,27166390
42065,Diabetic Eye Complications,disease,0.9956,27166390
42066,Aflibercept,gene,0.935,27166390
42067,vascular endothelial growth factor,gene,0.999,27166390
42068,anti-VEGF,gene,0.979,27166390
42069,diabetic macular edema,disease,1.0,27166390
42070,diabetic retinopathy,disease,1.0,27166390
42071,aflibercept,gene,0.976,27166390
42072,diabetic eye,disease,0.96,27166390
42073,VEGF,gene,0.9307,27166390
42074,Aflibercept,gene,0.977,27166390
42075,bevacizumab,gene,0.762,27166390
42076,ranibizumab,gene,0.7065,27166390
42077,diabetic macular edema,disease,1.0,27166390
42078,aflibercept,gene,0.98,27166390
42079,VEGF,gene,0.7324,27166390
42080,aflibercept,gene,0.9717,27166390
42081,bevacizumab,gene,0.7637,27166390
42082,aflibercept,gene,0.9883,27166390
42083,ranibizumab,drug,0.619,27166390
42084,aflibercept,gene,0.992,27166390
42085,VEGF,gene,0.8975,27166390
42086,Blinding Polypoidal Choroidal Vasculopathy,disease,0.941,27162459
42087,Eplerenone,drug,0.9937,27162459
42088,serous retinal detachment,disease,1.0,27162459
42089,retinal pigment epithelium detachment,disease,0.9995,27162459
42090,atrophy of the neurosensory retina,disease,1.0,27162459
42091,Fluorescein,drug,0.957,27162459
42092,polypoidal choroidal vasculopathy,disease,1.0,27162459
42093,PCV,disease,1.0,27162459
42094,PCV,disease,1.0,27162459
42095,aflibercept,gene,0.9707,27162459
42096,PCV,disease,1.0,27162459
42097,stroke,disease,0.9995,27162459
42098,hypertension,disease,1.0,27162459
42099,atrial fibrillation,disease,1.0,27162459
42100,eplerenone,drug,0.998,27162459
42101,retinal reattachment,disease,0.9976,27162459
42102,ganglion cell,cell_type,0.713,27162459
42103,eplerenone,drug,0.9956,27162459
42104,PCV,disease,1.0,27162459
42105,Aflibercept,gene,0.984,27157149
42106,Ranibizumab,gene,0.9155,27157149
42107,Neovascular Age-Related Macular Degeneration,disease,1.0,27157149
42108,aflibercept,gene,0.9946,27157149
42109,ranibizumab,gene,0.5234,27157149
42110,neovascular age-related macular degeneration,disease,1.0,27157149
42111,nAMD,disease,1.0,27157149
42112,ranibizumab,gene,0.6396,27157149
42113,aflibercept,gene,0.988,27157149
42114,aflibercept,gene,0.9824,27157149
42115,intraretinal cystoid,disease,0.708,27157149
42116,IRC,disease,0.928,27157149
42117,subretinal fluid,disease,0.8335,27157149
42118,SRF,disease,0.5205,27157149
42119,pigment epithelial detachment,disease,1.0,27157149
42120,PED,disease,1.0,27157149
42121,PED,disease,0.975,27157149
42122,IRC,disease,0.9995,27157149
42123,SRF,disease,0.9985,27157149
42124,PED,disease,0.9995,27157149
42125,aflibercept,gene,0.9824,27157149
42126,ranibizumab,gene,0.692,27157149
42127,IRC,disease,0.9985,27157149
42128,aflibercept,gene,0.995,27157149
42129,ranibizumab,gene,0.677,27157149
42130,PED,disease,0.9976,27157149
42131,aflibercept,gene,0.975,27157149
42132,ranibizumab,drug,0.6587,27157149
42133,IRC,disease,0.971,27157149
42134,aflibercept,gene,0.9897,27157149
42135,aflibercept,gene,0.981,27157149
42136,ranibizumab,gene,0.779,27157149
42137,SRF,disease,0.9985,27157149
42138,aflibercept,gene,0.989,27157149
42139,ranibizumab,gene,0.817,27157149
42140,PED,disease,0.999,27157149
42141,aflibercept,gene,0.982,27157149
42142,aflibercept,gene,0.9707,27157149
42143,ranibizumab,gene,0.8374,27157149
42144,aflibercept,gene,0.932,27157149
42145,IRC,disease,0.9746,27157149
42146,aflibercept,gene,0.897,27157149
42147,aflibercept,gene,0.943,27157149
42148,aflibercept,gene,0.9775,27157149
42149,ranibizumab,gene,0.6733,27157149
42150,Cancer,disease,0.9995,27153824
42151,afatinib,drug,0.9897,27153824
42152,aflibercept,gene,0.919,27153824
42153,bevacizumab,gene,0.57,27153824
42154,dabrafenib,drug,0.995,27153824
42155,ipilimumab,drug,0.761,27153824
42156,afatinib,drug,0.9956,27153824
42157,bevacizumab,gene,0.912,27153824
42158,dabrafenib,drug,0.991,27153824
42159,cancer,disease,0.9995,27153824
42160,Y402H,DNA,,27151934
42161,Y402H,mutation,,27151934
42162,CFH gene,gene,0.912,27151934
42163,VEGF,gene,0.885,27151934
42164,age-related macular degeneration,disease,1.0,27151934
42165,complement factor H (,DNA,0.5435,27151934
42166,complement factor H,gene,0.997,27151934
42167,CFH,gene,0.997,27151934
42168,rs1061170,gene,,27151934
42169,rs1061170,mutation,,27151934
42170,Y402H,mutation,,27151934
42171,VEGF,gene,0.993,27151934
42172,AMD,disease,1.0,27151934
42173,rs1061170,gene,,27151934
42174,rs1061170,mutation,,27151934
42175,Y402H,mutation,,27151934
42176,CFH gene,gene,0.8984,27151934
42177,VEGF,gene,0.926,27151934
42178,AMD,disease,1.0,27151934
42179,AMD,disease,1.0,27151934
42180,AMD,disease,1.0,27151934
42181,rs1061170,DNA,,27151934
42182,rs1061170,mutation,,27151934
42183,Y402H,mutation,,27151934
42184,rs1061170,DNA,,27151934
42185,rs1061170,mutation,,27151934
42186,Y402H,mutation,,27151934
42187,VEGF,gene,0.7183,27151934
42188,AMD,disease,1.0,27151934
42189,aflibercept,gene,0.9746,27140945
42190,colorectal cancer,disease,1.0,27140945
42191,intestinal perforations,disease,0.999,27140945
42192,colorectal neoplasm,disease,1.0,27140945
42193,subocclusive rectal cancer,disease,1.0,27140945
42194,intestinal perforation,disease,0.9995,27140945
42195,haemorrhage,disease,0.9995,27140945
42196,intestinal leak,disease,0.9976,27140945
42197,MACULAR,disease,0.8857,27135213
42198,PATIENTS,species,0.993,27135213
42199,NEOVASCULAR AGE,disease,0.998,27135213
42200,macular atrophy,disease,1.0,27135213
42201,MA,disease,1.0,27135213
42202,neovascular age-related macular degeneration,disease,1.0,27135213
42203,age-related macular degeneration,disease,1.0,27135213
42204,atrophy,disease,0.98,27135213
42205,antivascular endothelial growth factor,gene,0.957,27135213
42206,Macular atrophy,disease,1.0,27135213
42207,MA,disease,0.999,27135213
42208,MA,disease,0.999,27135213
42209,atrophy,disease,0.946,27135213
42210,MA,disease,0.996,27135213
42211,Macular atrophy,disease,1.0,27135213
42212,age-related macular degeneration,disease,1.0,27135213
42213,atrophy,disease,0.954,27135213
42214,HARBOR,drug,0.7285,27135213
42215,MA,disease,0.993,27135213
42216,atrophy,disease,0.997,27135213
42217,choroidal neovascularization,disease,1.0,27135213
42218,Aflibercept,gene,0.9077,27130974
42219,patients,species,0.9756,27130974
42220,neovascular age-related macular degeneration,disease,0.9985,27130974
42221,nAMD,disease,1.0,27130974
42222,aflibercept,gene,0.962,27130974
42223,ranibizumab,gene,0.522,27130974
42224,nAMD,disease,1.0,27130974
42225,ranibizumab,gene,0.847,27130974
42226,macular oedema,disease,1.0,27130974
42227,patients,species,0.988,27130974
42228,aflibercept,gene,0.9883,27130974
42229,Patients,species,0.9854,27130974
42230,pigment epithelial detachment,disease,1.0,27130974
42231,aflibercept,gene,0.992,27130974
42232,ranibizumab,gene,0.8525,27130974
42233,patients,species,0.9717,27130974
42234,aflibercept,gene,0.996,27130974
42235,ranibizumab,gene,0.773,27130974
42236,ranibizumab,gene,0.6523,27130974
42237,aflibercept,gene,0.9917,27130974
42238,PED,disease,0.623,27130974
42239,aflibercept,gene,0.9966,27130974
42240,ranibizumab,drug,0.557,27130974
42241,PED,DNA,0.525,27130974
42242,aflibercept,gene,0.4885,27130974
42243,ranibizumab,gene,0.9883,27130974
42244,CRT,DNA,0.5444,27130974
42245,PED,DNA,0.57,27130974
42246,PED,DNA,0.6045,27130974
42247,Aflibercept,gene,0.8525,27130974
42248,ranibizumab,gene,0.9375,27130974
42249,patients,species,0.972,27130974
42250,nAMD,disease,1.0,27130974
42251,vascular endothelial growth factor,gene,0.963,27128510
42252,anti-VEGF,gene,0.69,27128510
42253,ranibizumab,gene,0.898,27128510
42254,aflibercept,gene,0.9766,27128510
42255,bevacizumab,gene,0.6553,27128510
42256,retinal diseases,disease,1.0,27128510
42257,exudative age-related macular degeneration,disease,0.9995,27128510
42258,AMD,disease,1.0,27128510
42259,diabetic macular edema,disease,1.0,27128510
42260,DME,disease,1.0,27128510
42261,macular edema,disease,1.0,27128510
42262,ME,disease,1.0,27128510
42263,RVO,disease,1.0,27128510
42264,AMD,disease,1.0,27128510
42265,retinal vascular diseases,disease,1.0,27128510
42266,VEGF,gene,0.892,27128510
42267,ranibizumab,gene,0.738,27128510
42268,aflibercept,gene,0.969,27128510
42269,bevacizumab,gene,0.843,27128510
42270,retinal diseases,disease,1.0,27128510
42271,VEGF,gene,0.7285,27128510
42272,VEGF,gene,0.735,27128510
42273,Fc,gene,0.975,27127811
42274,Fc,drug,0.4956,27127811
42275,RpR,DNA,0.5054,27127811
42276,disulfide,drug,0.999,27127811
42277,PEG,drug,0.999,27127811
42278,Fc,drug,0.4294,27127811
42279,VEGF,gene,0.995,27127811
42280,aflibercept,gene,0.982,27127811
42281,RpRs,DNA,0.621,27127811
42282,Aflibercept,gene,0.99,27124775
42283,Bevacizumab,gene,0.66,27124775
42284,aflibercept,gene,0.994,27124775
42285,vascular endothelial growth factor,gene,0.9985,27124775
42286,corneal neovascularization,disease,1.0,27124775
42287,rat,species,0.952,27124775
42288,Sprague-Dawley rats,species,0.812,27124775
42289,aflibercept,gene,0.9937,27124775
42290,bevacizumab,drug,0.606,27124775
42291,Corneal neovascularization,disease,0.998,27124775
42292,rats,species,0.973,27124775
42293,rats,species,0.9824,27124775
42294,aflibercept,gene,0.5166,27124775
42295,hematoxylin,drug,0.9995,27124775
42296,eosin,drug,0.997,27124775
42297,blood,cell_type,0.4473,27124775
42298,bevacizumab,gene,0.986,27124775
42299,aflibercept,gene,0.732,27124775
42300,endothelial,DNA,0.4814,27124775
42301,aflibercept,gene,0.992,27124775
42302,Aflibercept,gene,0.989,27124775
42303,rat,species,0.9653,27124775
42304,humans,species,0.974,27124775
42305,Ranibizumab,gene,0.9297,27123887
42306,Bevacizumab,gene,0.8257,27123887
42307,Aflibercept,gene,0.9854,27123887
42308,ranibizumab,gene,0.719,27123887
42309,aflibercept,gene,0.806,27123887
42310,neovascular age-related macular degeneration,disease,1.0,27123887
42311,patients,species,0.9907,27123887
42312,ranibizumab,gene,0.795,27123887
42313,bevacizumab,gene,0.76,27123887
42314,PATIENTS,species,0.942,27123887
42315,neovascular age-related macular degeneration,disease,0.999,27123887
42316,AMD,disease,1.0,27123887
42317,ranibizumab,gene,0.9136,27123887
42318,bevacizumab,gene,0.7017,27123887
42319,intra- and/or subretinal fluid,disease,0.9453,27123887
42320,pigment epithelial,cell_type,0.4836,27123887
42321,pigment epithelial detachments,disease,0.994,27123887
42322,PED,disease,0.995,27123887
42323,patients,species,0.9785,27123887
42324,aflibercept,gene,0.9517,27123887
42325,PEDs,DNA,0.473,27123887
42326,CRT,DNA,0.493,27123887
42327,aflibercept,gene,0.9287,27123887
42328,PEDs,DNA,0.558,27123887
42329,aflibercept,gene,0.9375,27123887
42330,ETDRS,DNA,0.5,27123887
42331,patients,species,0.963,27123887
42332,neovascular AMD,disease,1.0,27123887
42333,ranibizumab,gene,0.927,27123887
42334,bevacizumab,gene,0.7207,27123887
42335,aflibercept,gene,0.973,27123887
42336,NONINFECTIOUS VITRITIS,disease,1.0,27115856
42337,bevacizumab,gene,0.834,27115856
42338,Avastin,gene,0.7944,27115856
42339,ranibizumab,gene,0.5796,27115856
42340,aflibercept,gene,0.9736,27115856
42341,Eylea,gene,0.7866,27115856
42342,endophthalmitis,disease,1.0,27115856
42343,noninfectious vitritis,disease,0.9995,27115856
42344,bevacizumab,gene,0.8384,27115856
42345,ranibizumab,gene,0.839,27115856
42346,aflibercept,gene,0.9805,27115856
42347,noninfectious vitritis,disease,1.0,27115856
42348,bevacizumab,gene,0.73,27115856
42349,ranibizumab,gene,0.643,27115856
42350,aflibercept,gene,0.9814,27115856
42351,patients,species,0.991,27115856
42352,patients,species,0.997,27115856
42353,blurred vision,disease,1.0,27115856
42354,Bevacizumab,gene,0.83,27115856
42355,aflibercept,gene,0.9805,27115856
42356,noninfectious vitritis,disease,1.0,27115856
42357,CHOROIDAL NEOVASCULARIZATION,disease,0.977,27115855
42358,choroidal neovascularization,disease,1.0,27115855
42359,CNV,disease,1.0,27115855
42360,serous chorioretinopathy,disease,0.99,27115855
42361,patients,species,0.9785,27115855
42362,CNV,disease,0.999,27115855
42363,serous chorioretinopathy,disease,0.9785,27115855
42364,CNV,DNA,0.8345,27115855
42365,CNV,disease,1.0,27115855
42366,men,species,0.9595,27115855
42367,women,species,0.9805,27115855
42368,CNV,disease,1.0,27115855
42369,CNV,disease,0.9995,27115855
42370,CNV,disease,0.994,27115855
42371,fluorescein,drug,0.994,27115855
42372,extrafoveal CNV,disease,0.998,27115855
42373,juxtafoveal CNV,disease,0.9995,27115855
42374,CNV,disease,0.9995,27115855
42375,patient,species,0.9824,27115855
42376,CNV,disease,0.999,27115855
42377,patients,species,0.9863,27115855
42378,CNV,disease,0.9956,27115855
42379,CNVs,disease,1.0,27115855
42380,Choroidal neovascularizations,disease,1.0,27115855
42381,vascular endothelial growth factor,gene,0.886,27115852
42382,ranibizumab,gene,0.776,27115852
42383,aflibercept,gene,0.9478,27115852
42384,neovascular age-related macular degeneration,disease,1.0,27115852
42385,patients,species,0.9756,27115852
42386,neovascular age-related macular degeneration,disease,1.0,27115852
42387,intraretinal or subretinal fluid,disease,0.9795,27115852
42388,ranibizumab,gene,0.9,27115852
42389,PED,disease,0.999,27115852
42390,aflibercept,gene,0.928,27115852
42391,patients,species,0.9717,27115852
42392,PED,disease,0.997,27115852
42393,PED,disease,0.9834,27115852
42394,ranibizumab,gene,0.8906,27115852
42395,aflibercept,gene,0.957,27115852
42396,aflibercept,gene,0.974,27115852
42397,intraretinal or subretinal fluid,disease,0.953,27115852
42398,PED,DNA,0.4736,27115852
42399,vascular endothelial growth factor,gene,0.887,27115852
42400,ranibizumab,gene,0.8057,27115852
42401,aflibercept,gene,0.9546,27115852
42402,aflibercept,gene,0.9834,27111455
42403,choroidal neovascularization,disease,1.0,27111455
42404,choroidal neovascularization,disease,1.0,27111455
42405,CNV,disease,1.0,27111455
42406,patients,species,0.978,27111455
42407,neovascular age-related macular degeneration,disease,1.0,27111455
42408,AMD,disease,1.0,27111455
42409,ranibizumab,gene,0.871,27111455
42410,aflibercept,gene,0.951,27111455
42411,patients,species,0.9824,27111455
42412,neovascular AMD,disease,1.0,27111455
42413,neovascular AMD,disease,1.0,27111455
42414,choriodal neovascularization,disease,0.9995,27111455
42415,AMD,disease,1.0,27111455
42416,intraretinal fluid,disease,0.8384,27111455
42417,ranibizumab,gene,0.917,27111455
42418,aflibercept,gene,0.979,27111455
42419,CNV,disease,1.0,27111455
42420,CNV,disease,1.0,27111455
42421,CNV,disease,1.0,27111455
42422,fluorescein,drug,0.9927,27111455
42423,ranibizumab,gene,0.85,27111455
42424,CNV,disease,1.0,27111455
42425,CNV,DNA,0.537,27111455
42426,ETDRS,DNA,0.4656,27111455
42427,CNV,disease,1.0,27111455
42428,CNV,disease,1.0,27111455
42429,edema,disease,0.962,27111455
42430,aflibercept,gene,0.9854,27111455
42431,CNV,disease,0.9995,27111455
42432,patients,species,0.9595,27111455
42433,neovascular AMD,disease,1.0,27111455
42434,VEGF-A,gene,0.996,27106625
42435,aflibercept,gene,0.977,27106625
42436,ranibizumab,gene,0.6274,27106625
42437,ranibizumab,gene,0.703,27106625
42438,aflibercept,gene,0.9775,27106625
42439,cynomolgus monkeys,species,0.951,27106625
42440,ciliary,cell_type,0.475,27106625
42441,blood vessels,cell_type,0.4373,27106625
42442,aflibercept,gene,0.9824,27106625
42443,ranibizumab,gene,0.804,27106625
42444,aflibercept,gene,0.9834,27106625
42445,ranibizumab,gene,0.7524,27106625
42446,VEGF,gene,0.9946,27106625
42447,aflibercept,gene,0.988,27106625
42448,Ranibizumab,gene,0.904,27106625
42449,Aflibercept,gene,0.9795,27106625
42450,ranibizumab,gene,0.8623,27106625
42451,aflibercept,gene,0.9937,27106625
42452,ranibizumab,gene,0.862,27106625
42453,aflibercept,gene,0.995,27106625
42454,ranibizumab,gene,0.525,27106625
42455,aflibercept,gene,0.9917,27106625
42456,ranibizumab,gene,0.8667,27106625
42457,Aflibercept,gene,0.949,27106625
42458,VEGF,gene,0.9937,27106625
42459,aflibercept,gene,0.9854,27100568
42460,patients,species,0.9834,27100568
42461,diabetic retinopathy,disease,0.9985,27100568
42462,proliferative diabetic retinopathy,disease,0.9995,27100568
42463,tractional retinal detachment,disease,0.9863,27100568
42464,aflibercept,gene,0.982,27100568
42465,epiretinal,disease,0.525,27100568
42466,epiretinal membranes,disease,1.0,27100568
42467,epiretinal membranes,disease,0.9985,27100568
42468,epiretinal,disease,0.682,27100568
42469,endothelial cells,cell_type,0.8696,27100568
42470,blood cells,cell_type,0.7944,27100568
42471,Capillaries,cell_type,0.5254,27100568
42472,aflibercept,gene,0.9893,27100568
42473,epiretinal membranes,disease,1.0,27100568
42474,endothelial cells,cell_type,0.8257,27100568
42475,blood cells,cell_type,0.817,27100568
42476,hypertension,disease,1.0,27093330
42477,metastatic colorectal cancer,disease,1.0,27093330
42478,patients,species,0.976,27093330
42479,Oxaliplatin,drug,0.9995,27091810
42480,5-FU,drug,0.9995,27091810
42481,folinic acid,drug,0.999,27091810
42482,aflibercept,gene,0.9673,27091810
42483,aflibercept,gene,0.982,27091810
42484,FOLFIRI,drug,0.9233,27091810
42485,patients,species,0.964,27091810
42486,metastatic colorectal cancer,disease,1.0,27091810
42487,mCRC,disease,1.0,27091810
42488,oxaliplatin,drug,0.9995,27091810
42489,aflibercept,gene,0.9907,27091810
42490,oxaliplatin,drug,0.9995,27091810
42491,patients,species,0.9653,27091810
42492,mCRC,disease,0.923,27091810
42493,PATIENTS,species,0.9404,27091810
42494,Patients,species,0.9287,27091810
42495,mCRC,disease,0.9604,27091810
42496,aflibercept,gene,0.9634,27091810
42497,patients,species,0.9883,27091810
42498,patients,species,0.9897,27091810
42499,aflibercept,gene,0.994,27091810
42500,aflibercept,gene,0.9175,27091810
42501,aflibercept,gene,0.98,27091810
42502,patients,species,0.9927,27091810
42503,aflibercept,gene,0.9536,27091810
42504,laboratory,disease,0.8213,27091810
42505,aflibercept,gene,0.952,27091810
42506,neuropathy,disease,0.9995,27091810
42507,diarrhea,disease,1.0,27091810
42508,Neutropenia,disease,1.0,27091810
42509,vascular endothelial growth factor,gene,0.995,27091810
42510,aflibercept,gene,0.974,27091810
42511,hypertension,disease,0.9746,27091810
42512,proteinuria,disease,1.0,27091810
42513,deep vein thrombosis,disease,1.0,27091810
42514,pulmonary embolism,disease,1.0,27091810
42515,aflibercept,gene,0.9893,27091810
42516,CNV,disease,1.0,27085265
42517,ocular histoplasmosis,disease,1.0,27085265
42518,aflibercept,gene,0.983,27085265
42519,CNV,disease,1.0,27085265
42520,POHS,disease,1.0,27085265
42521,aflibercept,gene,0.98,27085265
42522,CNV,disease,0.9995,27085265
42523,ocular histoplasmosis syndrome,disease,1.0,27085265
42524,aflibercept,gene,0.98,27085265
42525,aflibercept,gene,0.9824,27085265
42526,CNV,disease,1.0,27085265
42527,ocular histoplasmosis syndrome,disease,0.9995,27085265
42528,aflibercept,gene,0.99,27084563
42529,neovascular age-related macular degeneration,disease,1.0,27084563
42530,nAMD,disease,1.0,27084563
42531,macular edema following,disease,0.982,27084563
42532,central retinal vein occlusion,disease,0.944,27084563
42533,MEfCRVO,disease,1.0,27084563
42534,macular edema following branch retinal vein occlusion,disease,1.0,27084563
42535,MEfBRVO,disease,1.0,27084563
42536,diabetic macular edema,disease,1.0,27084563
42537,DME,disease,1.0,27084563
42538,retinal diseases,disease,0.9995,27084563
42539,PARTICIPANTS,species,0.8545,27084563
42540,Patients,species,0.9736,27084563
42541,nAMD,disease,1.0,27084563
42542,VIBRANT,drug,0.99,27084563
42543,DME,disease,0.999,27084563
42544,DA,drug,1.0,27084563
42545,VIVID,drug,0.592,27084563
42546,VISTA,drug,0.958,27084563
42547,person,species,0.9644,27084563
42548,intraocular inflammation,disease,1.0,27084563
42549,endophthalmitis,disease,1.0,27084563
42550,hypertension,disease,1.0,27084563
42551,HTN,disease,1.0,27084563
42552,arterial thromboembolic events,disease,0.9946,27084563
42553,ATEs,disease,0.9956,27084563
42554,nonfatal myocardial infarction,disease,0.9995,27084563
42555,nonfatal stroke,disease,0.999,27084563
42556,vascular death,disease,1.0,27084563
42557,patients,species,0.9883,27084563
42558,IAI,disease,0.9966,27084563
42559,intraocular inflammation,disease,1.0,27084563
42560,IAI,disease,0.9995,27084563
42561,endophthalmitis,disease,1.0,27084563
42562,HTN,disease,1.0,27084563
42563,HTN,drug,0.913,27084563
42564,ATEs,disease,0.663,27084563
42565,IAI,disease,0.6777,27084563
42566,aflibercept,gene,0.991,27084563
42567,patients,species,0.9775,27084563
42568,Retinal Ganglion Cell,cell_type,0.5386,27084000
42569,Patients,species,0.954,27084000
42570,retinal ganglion,cell_type,0.4546,27084000
42571,patients,species,0.8765,27084000
42572,neovascular age-related macular degeneration,disease,1.0,27084000
42573,AMD,disease,1.0,27084000
42574,anti-,gene,0.6978,27084000
42575,vascular endothelial growth factor,gene,0.883,27084000
42576,VEGF,gene,0.998,27084000
42577,Patients,species,0.942,27084000
42578,anti-VEGF,gene,0.928,27084000
42579,subfoveal and juxtafoveal neovascular AMD,disease,1.0,27084000
42580,retinal,cell_type,0.505,27084000
42581,ETDRS grid,DNA,0.543,27084000
42582,ETDRS grid,DNA,0.524,27084000
42583,anti-VEGF,gene,0.9604,27084000
42584,patients,species,0.9785,27084000
42585,retinal pigment epithelium (RPE) atrophy,disease,0.9985,27084000
42586,patients,species,0.9897,27084000
42587,anti-VEGF,gene,0.9287,27084000
42588,RPE atrophy,disease,1.0,27084000
42589,VEGF,gene,0.6694,27084000
42590,RGCL,DNA,0.4768,27084000
42591,patients,species,0.937,27084000
42592,neovascular AMD,disease,1.0,27084000
42593,Arteriosclerotic,disease,0.9995,27082736
42594,anti-vascular endothelial growth factor,gene,0.9375,27082736
42595,VEGF,gene,0.977,27082736
42596,age-related macular degeneration,disease,1.0,27082736
42597,AMD,disease,1.0,27082736
42598,systemic arteriosclerosis,disease,0.998,27082736
42599,AMD,disease,1.0,27082736
42600,patients,species,0.9917,27082736
42601,ranibizumab,gene,0.9814,27082736
42602,aflibercept,gene,0.9854,27082736
42603,VEGF,gene,0.7744,27082736
42604,serum cystatin C,gene,0.908,27082736
42605,aflibercept,gene,0.972,27082736
42606,CAVI,disease,0.998,27082736
42607,VEGF,gene,0.649,27082736
42608,VEGF,gene,0.591,27082736
42609,AMD,disease,1.0,27082736
42610,Patients,species,0.9844,27082298
42611,macular degeneration,disease,1.0,27082298
42612,AMD,disease,1.0,27082298
42613,patients,species,0.9644,27082298
42614,late AMD,disease,0.9995,27082298
42615,exudative AMD,disease,1.0,27082298
42616,AMD,disease,0.897,27082298
42617,nonexudative AMD,disease,1.0,27082298
42618,neovascular AMD,disease,1.0,27082298
42619,ranibizumab,gene,0.899,27082298
42620,aflibercept,gene,0.9697,27082298
42621,bevacizumab,gene,0.7744,27082298
42622,RPE,cell_type,0.4324,27082298
42623,geographic atrophy,disease,1.0,27082298
42624,GA,disease,1.0,27082298
42625,macular neovascularization,disease,1.0,27082298
42626,MNV,disease,1.0,27082298
42627,patients,species,0.9814,27082298
42628,neovascular AMD,disease,1.0,27082298
42629,MNV,disease,0.9995,27082298
42630,participants,species,0.9814,27082298
42631,MNV,disease,1.0,27082298
42632,GA,disease,,27082298
42633,MNV,disease,0.9995,27082298
42634,GA,disease,,27082298
42635,MNV,disease,1.0,27082298
42636,AMD,disease,0.9863,27082298
42637,Patients,species,0.98,27082298
42638,AMD,disease,0.8965,27082298
42639,drusen,disease,0.5474,27082298
42640,AMD,disease,0.891,27082298
42641,MNV,disease,0.924,27082298
42642,late AMD,disease,0.619,27082298
42643,ranibizumab,gene,0.527,27081372
42644,aflibercept,gene,0.968,27081372
42645,patients,species,0.9844,27081372
42646,ranibizumab,gene,0.5073,27081372
42647,aflibercept,gene,0.9604,27081372
42648,patients,species,0.982,27081372
42649,visual impairment,disease,1.0,27081372
42650,diabetic macular edema,disease,1.0,27081372
42651,DME,disease,1.0,27081372
42652,ranibizumab,gene,0.7314,27081372
42653,aflibercept,gene,0.6714,27081372
42654,DME,disease,0.9976,27081372
42655,Patients,species,0.9775,27081372
42656,DME,disease,0.997,27081372
42657,aflibercept,gene,0.801,27081372
42658,visual impairment,disease,1.0,27081372
42659,aflibercept,gene,0.9824,27081372
42660,ranibizumab,gene,0.641,27081372
42661,aflibercept,gene,0.901,27081372
42662,DME,disease,1.0,27081372
42663,ranibizumab,gene,0.87,27081372
42664,visual impairment,disease,1.0,27081372
42665,DME,disease,1.0,27081372
42666,VEGF-A,gene,0.729,27079208
42667,retinal pigment epithelial cells,cell_type,0.913,27079208
42668,age-related macular degeneration,disease,1.0,27079208
42669,VEGF,gene,0.993,27079208
42670,VEGF,gene,0.7144,27079208
42671,neovascular diseases of the eyes,disease,0.9946,27079208
42672,VEGF-A,gene,0.5396,27079208
42673,ranibizumab,gene,0.849,27079208
42674,aflibercept,gene,0.979,27079208
42675,VEGF,DNA,0.4856,27079208
42676,VEGF family members,gene,0.9756,27079208
42677,retinal pigment epithelial cells,cell_type,0.91,27079208
42678,RPE,cell_line,0.8516,27079208
42679,ARPE-19 cells,cell_line,0.848,27079208
42680,ranibizumab,gene,0.8003,27079208
42681,aflibercept,gene,0.963,27079208
42682,VEGF-A,gene,0.998,27079208
42683,VEGF-B,gene,0.998,27079208
42684,VEGF-C,gene,0.9985,27079208
42685,placental growth factor,gene,0.9976,27079208
42686,PlGF,gene,0.993,27079208
42687,Ranibizumab,gene,0.915,27079208
42688,aflibercept,gene,0.9746,27079208
42689,ARPE-19,cell_line,0.848,27079208
42690,ARPE,cell_type,0.822,27079208
42691,Ranibizumab,gene,0.835,27079208
42692,VEGF-A,gene,0.9976,27079208
42693,PlGF,gene,0.986,27079208
42694,VEGF-C,gene,0.997,27079208
42695,PlGF,gene,0.9907,27079208
42696,Aflibercept,gene,0.9756,27079208
42697,VEGF-A,gene,0.997,27079208
42698,PlGF,gene,0.994,27079208
42699,VEGF-C,gene,0.998,27079208
42700,VEGF-B,gene,0.9937,27079208
42701,Ranibizumab,gene,0.8384,27079208
42702,aflibercept,gene,0.97,27079208
42703,VEGF,gene,0.995,27079208
42704,VEGF-A,gene,0.9956,27079208
42705,RPE cells,cell_type,0.4875,27079208
42706,VEGF-A,gene,0.9917,27079208
42707,bevacizumab,gene,0.75,27079204
42708,aflibercept,gene,0.984,27079204
42709,patients,species,0.9663,27079204
42710,neovascular age-related macular degeneration,disease,1.0,27079204
42711,AMD,disease,1.0,27079204
42712,aflibercept,gene,0.9844,27079204
42713,VEGF Trap-Eye,gene,0.968,27079204
42714,bevacizumab,gene,0.7544,27079204
42715,bevacizumab,gene,0.7944,27079204
42716,aflibercept,gene,0.7812,27079204
42717,aflibercept,gene,0.954,27079204
42718,bevacizumab,gene,0.865,27079204
42719,aflibercept,gene,0.987,27079204
42720,bevacizumab,gene,0.604,27079204
42721,aflibercept,gene,0.9688,27079204
42722,bevacizumab,gene,0.749,27079204
42723,aflibercept,gene,0.9834,27079204
42724,bevacizumab,gene,0.7305,27079204
42725,neovascular AMD,disease,1.0,27079204
42726,bevacizumab,gene,0.8237,27079204
42727,aflibercept,gene,0.9688,27079204
42728,bevacizumab,gene,0.8115,27079204
42729,aflibercept,gene,0.9907,27079204
42730,RETINAL PIGMENT EPITHELIAL DETACHMENT,disease,0.9937,27078613
42731,retinal pigment epithelial detachment,disease,1.0,27078613
42732,PED,disease,1.0,27078613
42733,neovascular age-related macular degeneration,disease,1.0,27078613
42734,ziv-aflibercept,gene,0.9927,27078613
42735,Zaltrap,gene,0.8115,27078613
42736,woman,species,0.9033,27078613
42737,neovascular age-related macular degeneration,disease,1.0,27078613
42738,PED,disease,0.9966,27078613
42739,bevacizumab,gene,0.812,27078613
42740,ranibizumab,gene,0.566,27078613
42741,verteporfin,drug,0.9985,27078613
42742,ziv-aflibercept,gene,0.987,27078613
42743,patient,species,0.9717,27078613
42744,bevacizumab,gene,0.773,27078613
42745,ranibizumab,gene,0.532,27078613
42746,PED,DNA,0.5156,27078613
42747,ziv-aflibercept,gene,0.984,27078613
42748,PED,disease,0.8105,27078613
42749,ziv-aflibercept,gene,0.9873,27078613
42750,PED,disease,0.999,27078613
42751,ziv-aflibercept,gene,0.988,27078613
42752,neovascular age-related macular degeneration,disease,1.0,27078613
42753,aflibercept,gene,0.951,27078613
42754,Eylea,gene,0.8203,27078613
42755,aflibercept,gene,0.9854,27075236
42756,fluorouracil,drug,1.0,27075236
42757,leucovorin,drug,0.9985,27075236
42758,fluorouracil,drug,0.9995,27075236
42759,leucovorin,drug,0.999,27075236
42760,irinotecan,drug,0.9976,27075236
42761,FOLFIRI,drug,0.856,27075236
42762,aflibercept,gene,0.973,27075236
42763,patients,species,0.9565,27075236
42764,metastatic colorectal cancer,disease,1.0,27075236
42765,mCRC,disease,1.0,27075236
42766,oxaliplatin,drug,1.0,27075236
42767,mCRC,disease,0.999,27075236
42768,patients,species,0.9897,27075236
42769,aflibercept,gene,0.9365,27075236
42770,Patient,species,0.978,27075236
42771,patients,species,0.974,27075236
42772,patients,species,0.9775,27075236
42773,patients,species,0.9937,27075236
42774,patients,species,0.995,27075236
42775,leucopenia,disease,1.0,27075236
42776,anemia,disease,0.9995,27075236
42777,fatigue,disease,0.9976,27075236
42778,neutropenia,disease,1.0,27075236
42779,neutropenic complications,disease,1.0,27075236
42780,FOLFIRI,drug,0.9404,27075236
42781,aflibercept,gene,0.993,27075236
42782,patients,species,0.939,27075236
42783,mCRC,disease,0.985,27075236
42784,FOLFIRI,drug,0.9834,27075236
42785,aflibercept,gene,0.9897,27075236
42786,patients,species,0.927,27075236
42787,mCRC,disease,0.933,27075236
42788,oxaliplatin,drug,0.9995,27075236
42789,Osteonecrosis of jaw,disease,1.0,27074901
42790,Osteonecrosis of the jaw,disease,1.0,27074901
42791,ONJ,disease,1.0,27074901
42792,cancer,disease,1.0,27074901
42793,patients,species,0.989,27074901
42794,ONJ,disease,1.0,27074901
42795,Bisphosphonate,drug,0.9995,27074901
42796,Bisphosphonate-Related Osteonecrosis of the Jaw,disease,1.0,27074901
42797,Bisphosphonate,drug,0.923,27074901
42798,BRONJ,disease,1.0,27074901
42799,ONJ,disease,1.0,27074901
42800,Medication-Related Osteonecrosis of the Jaw,disease,1.0,27074901
42801,MRONJ,disease,1.0,27074901
42802,ONJ,disease,1.0,27074901
42803,BRONJ,disease,1.0,27074901
42804,BRONJ,disease,1.0,27074901
42805,ONJ,disease,1.0,27074901
42806,ONJ,disease,0.998,27074901
42807,Diabetic Macular,disease,0.9995,27065368
42808,Aflibercept,gene,0.9424,27061020
42809,Ranibizumab,gene,0.888,27061020
42810,ranibizumab,gene,0.673,27061020
42811,RBZ,drug,0.922,27061020
42812,patients,species,0.986,27061020
42813,neovascular (&,disease,0.9995,27061020
42814,wAMD,disease,1.0,27061020
42815,RBZ,drug,0.941,27061020
42816,aflibercept,gene,0.73,27061020
42817,AFL,gene,0.98,27061020
42818,RBZ,drug,0.9653,27061020
42819,RBZ,drug,0.9893,27061020
42820,wAMD,disease,0.9995,27061020
42821,RBZ q4,DNA,0.602,27061020
42822,RBZ,drug,0.5493,27061020
42823,RBZ PRN,DNA,0.4714,27061020
42824,RBZ q4,DNA,0.626,27061020
42825,RBZ PRN,drug,0.893,27061020
42826,RBZ,DNA,0.5117,27061020
42827,RBZ,drug,0.919,27061020
42828,RBZ,drug,0.8105,27061020
42829,AFL,drug,0.8237,27061020
42830,RBZ,drug,0.8984,27061020
42831,AFL,drug,0.994,27061020
42832,RBZ PRN,drug,0.937,27061020
42833,metastatic Colorectal cancer,disease,0.9976,27057810
42834,cancer,disease,1.0,27057810
42835,patients,species,0.9873,27057810
42836,patients,species,0.994,27057810
42837,tumors,disease,0.9995,27057810
42838,metastatic colorectal cancer,disease,0.9995,27057810
42839,mCRC,disease,1.0,27057810
42840,5-fluorouracil,drug,0.999,27057810
42841,5-FU,drug,0.999,27057810
42842,patients,species,0.95,27057810
42843,mCRC,disease,0.9907,27057810
42844,irinotecan,drug,0.9995,27057810
42845,oxaliplatin,drug,0.9995,27057810
42846,capecitabine,drug,0.9995,27057810
42847,humanized,species,0.58,27057810
42848,vascular endothelial growth factor,gene,0.997,27057810
42849,bevacizumab,gene,0.797,27057810
42850,aflibercept,gene,0.926,27057810
42851,epidermal growth factor receptor,gene,0.996,27057810
42852,cetuximab,gene,0.9336,27057810
42853,panitumumab,gene,0.8813,27057810
42854,regorafenib,drug,0.936,27057810
42855,trifluridine,drug,0.996,27057810
42856,tipiracil,drug,0.9966,27057810
42857,mCRC,disease,0.9463,27057810
42858,oxaliplatin,drug,0.9995,27057810
42859,irinotecan,drug,0.9985,27057810
42860,5-FU,drug,0.996,27057810
42861,patient,species,0.9795,27057810
42862,mCRC,disease,0.998,27057810
42863,mCRC,disease,0.967,27057810
42864,patients,species,0.979,27057810
42865,mCRC,disease,0.979,27057810
42866,Metastatic Colorectal Cancer,disease,0.9995,27057668
42867,Colorectal cancer,disease,1.0,27057668
42868,CRC,disease,1.0,27057668
42869,patients,species,0.986,27057668
42870,CRC,disease,0.9985,27057668
42871,patients,species,0.965,27057668
42872,metastatic CRC,disease,0.9995,27057668
42873,mCRC,disease,1.0,27057668
42874,mCRC,disease,0.916,27057668
42875,irinotecan,drug,0.9927,27057668
42876,oxaliplatin,drug,1.0,27057668
42877,capecitabine,drug,0.9995,27057668
42878,fluoropyrimidine,drug,0.9995,27057668
42879,5-fluorouracil,drug,0.9995,27057668
42880,capecitabine,drug,0.999,27057668
42881,oxaliplatin,drug,0.9995,27057668
42882,irinotecan,drug,0.999,27057668
42883,mCRC,disease,0.722,27057668
42884,mCRC,disease,0.7227,27057668
42885,vascular endothelial growth factor receptor,gene,0.998,27057668
42886,bevacizumab,gene,0.8105,27057668
42887,ziv-aflibercept,gene,0.968,27057668
42888,epidermal growth factor receptor,gene,0.997,27057668
42889,cetuximab,gene,0.9297,27057668
42890,panitumumab,gene,0.8657,27057668
42891,mCRC,disease,0.6353,27057668
42892,Aflibercept,gene,0.9424,27049000
42893,Neovascular Age-Related Macular Degeneration,disease,1.0,27049000
42894,aflibercept,gene,0.978,27049000
42895,neovascular macular degeneration,disease,1.0,27049000
42896,intraretinal or subretinal fluid,disease,0.9985,27049000
42897,aflibercept,gene,0.9854,27049000
42898,aflibercept,gene,0.9805,27049000
42899,pigment epithelial detachment,disease,0.7456,27049000
42900,aflibercept,gene,0.9863,27049000
42901,Aflibercept,gene,0.922,27049000
42902,bevacizumab,gene,0.7114,27049000
42903,choroidal neovascular membrane,disease,1.0,27049000
42904,Pigment,cell_line,0.4631,27048998
42905,Pigment Epithelial Detachment,disease,0.9985,27048998
42906,Vascular Endothelial Growth Factor,gene,0.9336,27048998
42907,Age-Related Macular Degeneration,disease,1.0,27048998
42908,pigment epithelial detachment,disease,0.997,27048998
42909,PED,disease,0.9976,27048998
42910,vascular endothelial growth factor,gene,0.9937,27048998
42911,VEGF,gene,0.992,27048998
42912,neovascular age-related macular degeneration,disease,0.9995,27048998
42913,nAMD,disease,1.0,27048998
42914,PED,disease,1.0,27048998
42915,nAMD,disease,1.0,27048998
42916,PED,disease,0.993,27048998
42917,ranibizumab,gene,0.8745,27048998
42918,aflibercept,gene,0.969,27048998
42919,PED,disease,1.0,27048998
42920,PED,disease,0.4746,27048998
42921,PED,disease,0.963,27048998
42922,polypoidal choroidal vasculopathy,disease,1.0,27048998
42923,retinal angiomatous proliferation,disease,1.0,27048998
42924,nAMD,disease,1.0,27048998
42925,serous PED,disease,0.991,27048998
42926,fibrovascular PED,disease,0.969,27048998
42927,aflibercept,gene,0.993,27048998
42928,ranibizumab,gene,0.8726,27048998
42929,PEDs,disease,0.9985,27048998
42930,nAMD,disease,1.0,27048998
42931,anti-VEGF,gene,0.948,27048998
42932,VEGF,gene,0.7964,27048998
42933,PED,disease,0.9995,27048998
42934,PED,disease,1.0,27048998
42935,nAMD,disease,1.0,27048998
42936,PED,disease,0.981,27048998
42937,VEGF,gene,0.7437,27048998
42938,PED,disease,0.9995,27048998
42939,VEGF,gene,0.7295,27046391
42940,Age-Related Macular Degeneration,disease,1.0,27046391
42941,vascular endothelial growth factor,gene,0.9824,27046391
42942,VEGF,gene,0.9956,27046391
42943,neovascular age-related macular degeneration,disease,1.0,27046391
42944,AMD,disease,1.0,27046391
42945,VEGF,gene,0.937,27046391
42946,ocular hypertension,disease,0.9985,27046391
42947,OHT,disease,1.0,27046391
42948,OHT,drug,0.5796,27046391
42949,anti-VEGF,gene,0.959,27046391
42950,OHT,disease,1.0,27046391
42951,Neovascular Age-Related Macular Degeneration,disease,1.0,27042342
42952,Aflibercept,gene,0.932,27042342
42953,aflibercept,gene,0.9927,27042342
42954,neovascular age-related macular degeneration,disease,1.0,27042342
42955,AMD,disease,1.0,27042342
42956,ranibizumab,gene,0.8906,27042342
42957,bevacizumab,gene,0.6816,27042342
42958,aflibercept,gene,0.946,27042342
42959,neovascular AMD,disease,1.0,27042342
42960,aflibercept,gene,0.971,27042342
42961,aflibercept,gene,0.9395,27042342
42962,aflibercept,gene,0.9595,27042342
42963,aflibercept,gene,0.7583,27042342
42964,Aflibercept,gene,0.9717,27039822
42965,Fluorouracil,drug,0.999,27039822
42966,Leucovorin,drug,0.999,27039822
42967,Irinotecan,drug,0.9688,27039822
42968,Metastatic Colorectal Cancer,disease,1.0,27039822
42969,metastatic colorectal cancer,disease,1.0,27039822
42970,mCRC,disease,1.0,27039822
42971,aflibercept,gene,0.917,27039822
42972,Aflibercept,gene,0.645,27039822
42973,aflibercept,gene,0.891,27039822
42974,FOLFIRI,drug,0.976,27039822
42975,gastrointestinal toxicity,disease,0.8975,27039822
42976,diarrhea,disease,1.0,27039822
42977,mucositis,disease,1.0,27039822
42978,nausea,disease,0.9976,27039822
42979,Neutropenia,disease,1.0,27039822
42980,febrile neutropenia,disease,1.0,27039822
42981,Aflibercept,gene,0.9517,27039822
42982,Aflibercept,gene,0.9395,27039822
42983,FOLFIRI,drug,0.9785,27039822
42984,mCRC,disease,0.995,27039822
42985,vascular endo-thelial growth factor,gene,0.995,27034182
42986,ranibizumab,drug,0.878,27034182
42987,ranibizumab,drug,0.893,27034182
42988,aflibercept,gene,0.8193,27034182
42989,aflibercept,gene,0.959,27034182
42990,ranibizumab,gene,0.9834,27034182
42991,ophthalmologists,cell_type,0.5186,27034182
42992,Diabetic retinopathy,disease,1.0,27031563
42993,vascular endothelial growth factor,gene,0.9976,27031563
42994,diabetic macular oedema,disease,1.0,27031563
42995,Diabetic retinopathy,disease,1.0,27031563
42996,diabetes,disease,1.0,27031563
42997,blindness,disease,0.999,27031563
42998,diabetes,disease,1.0,27031563
42999,hypertension,disease,1.0,27031563
43000,hyperlipidaemia,disease,1.0,27031563
43001,Diabetic macular oedema,disease,1.0,27031563
43002,diabetic retinopathy,disease,1.0,27031563
43003,vascular endothelial growth factor,gene,0.9985,27031563
43004,VEGF,gene,0.995,27031563
43005,diabetes,disease,1.0,27031563
43006,vision loss,disease,0.9575,27031563
43007,diabetic macular oedema,disease,1.0,27031563
43008,VEGF,gene,0.9927,27031563
43009,diabetic macular oedema,disease,1.0,27031563
43010,VEGF,gene,0.9927,27031563
43011,VEGF,gene,0.9946,27031563
43012,diabetic macular oedema,disease,1.0,27031563
43013,VEGF,gene,0.994,27031563
43014,aflibercept,gene,0.9634,27031563
43015,bevacizumab,gene,0.857,27031563
43016,ranibizumab,gene,0.8315,27031563
43017,VEGF,gene,0.995,27031563
43018,ziv-aflibercept,gene,0.9785,27030277
43019,exudative age-related macular PURPOSE,disease,0.975,27030277
43020,epithelium cells,cell_type,0.698,27030277
43021,ziv-aflibercept,gene,0.983,27030277
43022,age-related macular degeneration,disease,1.0,27030277
43023,AMD,disease,1.0,27030277
43024,ziv-aflibercept,gene,0.9893,27030277
43025,patients,species,0.955,27030277
43026,wet AMD,disease,0.997,27030277
43027,ziv-aflibercept,gene,0.9844,27030277
43028,intraocular inflammation,disease,0.999,27030277
43029,cataract,disease,1.0,27030277
43030,men,species,0.9785,27030277
43031,women,species,0.9814,27030277
43032,intraocular inflammation,disease,1.0,27030277
43033,ziv-aflibercept,gene,0.9717,27030277
43034,aflibercept,gene,0.988,27030277
43035,aflibercept,gene,0.9907,27030277
43036,Eylea,gene,0.7725,27030277
43037,Aflibercept,gene,0.891,29450330
43038,choroidal neovascularization,disease,1.0,29450330
43039,aflibercept,gene,0.9873,29450330
43040,choroidal neovascularization,disease,1.0,29450330
43041,CNV,disease,1.0,29450330
43042,bevacizumab,gene,0.637,29450330
43043,AVASTIN,gene,0.4265,29450330
43044,CNVs,disease,1.0,29450330
43045,bevacizumab,gene,0.8267,29450330
43046,aflibercept,gene,0.984,29450330
43047,CNVs,disease,1.0,29450330
43048,bevacizumab,gene,0.683,29450330
43049,AVASTIN,gene,0.4343,29450330
43050,aflibercept,gene,0.982,29450330
43051,CNV,disease,0.9907,29450330
43052,age related macular degeneration,disease,1.0,29450330
43053,angioid streaks,disease,1.0,29450330
43054,bevacizumab,gene,0.816,29450330
43055,AVASTIN,gene,0.4963,29450330
43056,bevacizumab,gene,0.7676,29450330
43057,aflibercept,gene,0.9893,29450330
43058,aflibercept,gene,0.9385,29450330
43059,CNV,disease,1.0,29450330
43060,VEGF,gene,0.568,29450330
43061,aflibercept,gene,0.971,29450330
43062,Ranibizumab,gene,0.9233,27027523
43063,Aflibercept,gene,0.9316,27027523
43064,Age-Related Macular Degeneration,disease,1.0,27027523
43065,aflibercept,gene,0.986,27027523
43066,ranibizumab,gene,0.518,27027523
43067,age-related macular degeneration,disease,1.0,27027523
43068,AMD,disease,1.0,27027523
43069,neovascular AMD,disease,1.0,27027523
43070,AMD,disease,1.0,27027523
43071,ranibizumab,gene,0.766,27027523
43072,ranibizumab,gene,0.9033,27027523
43073,aflibercept,gene,0.926,27027523
43074,ranibizumab,gene,0.919,27027523
43075,aflibercept,gene,0.9663,27027523
43076,intraocular inflammation,disease,0.993,27027523
43077,aflibercept,gene,0.985,27027523
43078,ranibizumab,gene,0.7295,27027523
43079,neovascular AMD,disease,1.0,27027523
43080,aflibercept,gene,0.9893,27027523
43081,Fc portion,gene,0.748,27027523
43082,inflammation,disease,0.9927,27027523
43083,Dll4,gene,0.9946,27009216
43084,Aflibercept,gene,0.9595,27009216
43085,Ovarian Tumor,disease,1.0,27009216
43086,Delta-like ligand 4,gene,0.9985,27009216
43087,Dll4,gene,0.998,27009216
43088,Notch ligands,gene,0.973,27009216
43089,ovarian cancer,disease,1.0,27009216
43090,tumors,disease,1.0,27009216
43091,VEGF,gene,0.9146,27009216
43092,VEGF,gene,0.7876,27009216
43093,ovarian cancer,disease,1.0,27009216
43094,Dll4,gene,0.9985,27009216
43095,Fc,gene,0.844,27009216
43096,anti-Dll4 antibodies,gene,0.9663,27009216
43097,murine,species,0.9927,27009216
43098,REGN1035,gene,0.4343,27009216
43099,human,species,0.999,27009216
43100,Dll4,gene,0.9956,27009216
43101,aflibercept,gene,0.9688,27009216
43102,mouse,species,0.9595,27009216
43103,ovarian cancer,disease,1.0,27009216
43104,Dll4,gene,0.997,27009216
43105,VEGF,gene,0.9966,27009216
43106,tumor,disease,1.0,27009216
43107,Dll4,gene,0.993,27009216
43108,VEGF,gene,0.998,27009216
43109,Dll4,gene,0.9956,27009216
43110,murine,species,0.9355,27009216
43111,REGN1035,drug,0.835,27009216
43112,ovarian cancer,disease,1.0,27009216
43113,A2780 model,cell_line,0.8276,27009216
43114,REGN1035,drug,0.999,27009216
43115,murine Dll4,gene,0.974,27009216
43116,murine,species,0.997,27009216
43117,REGN421,drug,0.997,27009216
43118,human Dll4,gene,0.9814,27009216
43119,human,species,0.999,27009216
43120,aflibercept,gene,0.9463,27009216
43121,Dll4,gene,0.995,27009216
43122,REGN1035,drug,0.997,27009216
43123,aflibercept,gene,0.973,27009216
43124,docetaxel,drug,0.9966,27009216
43125,aflibercept,gene,0.6206,27009216
43126,REGN1035,drug,0.999,27009216
43127,aflibercept,gene,0.9644,27009216
43128,tumor cells,cell_type,0.8413,27009216
43129,tumor,disease,0.9995,27009216
43130,GATA3,gene,0.9937,27009216
43131,tumor stroma,cell_type,0.4988,27009216
43132,tumor,disease,0.998,27009216
43133,mice,species,0.9277,27009216
43134,REGN1035,drug,0.999,27009216
43135,docetaxel,drug,0.999,27009216
43136,aflibercept,gene,0.97,27009216
43137,tumor,disease,1.0,27009216
43138,Dll4,gene,0.9946,27009216
43139,VEGF,gene,0.9956,27009216
43140,Colorectal cancer,disease,1.0,27002945
43141,solid tumors,disease,1.0,27002945
43142,patients,species,0.97,27002945
43143,patients,species,0.993,27002945
43144,oxaliplatin,drug,0.9995,27002945
43145,FOLFOX,drug,0.8867,27002945
43146,CapOx,drug,0.991,27002945
43147,FOLFOXIRI,drug,0.7935,27002945
43148,oxaliplatin,drug,1.0,27002945
43149,bevacizumab,gene,0.9204,27002945
43150,metastatic colorectal,disease,0.9976,27002945
43151,cetuximab,gene,0.75,27002945
43152,ziv-aflibercept,gene,0.9824,27002945
43153,regorafenib,drug,0.941,27002945
43154,patient,species,0.9634,27002945
43155,tumor,disease,0.8564,27002945
43156,metastatic colorectal cancer,disease,1.0,27002945
43157,RAS,gene,0.996,27002945
43158,BRAF,gene,0.999,27002945
43159,aflibercept,gene,0.9556,26995074
43160,AMD,disease,1.0,26995074
43161,age-related macular degeneration,disease,1.0,26995074
43162,legal blindness,disease,1.0,26995074
43163,VEGF,gene,0.926,26995074
43164,neovascular AMD,disease,1.0,26995074
43165,Ranibizumab,gene,0.9146,26995074
43166,aflibercept,gene,0.9824,26995074
43167,aflibercept,gene,0.976,26995074
43168,AMD,disease,1.0,26995074
43169,patients,species,0.952,26995074
43170,neovascular AMD,disease,1.0,26995074
43171,aflibercept,gene,0.9805,26995074
43172,patients,species,0.9805,26995074
43173,patients,species,0.9844,26995074
43174,patients,species,0.987,26995074
43175,patients,species,0.9893,26995074
43176,ranibizumab,gene,0.6875,26995074
43177,patients,species,0.958,26995074
43178,ETDRS,DNA,0.519,26995074
43179,aflibercept,gene,0.9224,26995074
43180,ranibizumab,gene,0.8477,26994110
43181,aflibercept,gene,0.975,26994110
43182,ranibizumab,gene,0.655,26994110
43183,aflibercept,gene,0.95,26994110
43184,neovascular age-related macular degeneration,disease,0.993,26994110
43185,nAMD,disease,1.0,26994110
43186,nAMD,disease,1.0,26994110
43187,Retinal Blindness,disease,1.0,26994110
43188,ranibizumab,gene,0.544,26994110
43189,aflibercept,gene,0.9453,26994110
43190,ranibizumab,gene,0.6816,26994110
43191,aflibercept,gene,0.9404,26994110
43192,choroidal neovascular membrane,disease,1.0,26994110
43193,ranibizumab,gene,0.5327,26994110
43194,ranibizumab,gene,0.9307,26994110
43195,aflibercept,gene,0.9746,26994110
43196,ZIV,drug,0.8345,26991646
43197,DIABETIC MACULAR EDEMA,disease,1.0,26991646
43198,Diabetic macular edema,disease,1.0,26991646
43199,blindness,disease,0.998,26991646
43200,vascular endothelial growth factor,gene,0.9937,26991646
43201,ziv-aflibercept,gene,0.9795,26991646
43202,diabetic macular edema,disease,1.0,26991646
43203,diabetic,disease,1.0,26991646
43204,macular edema,disease,1.0,26991646
43205,ziv-aflibercept,gene,0.9575,26991646
43206,ziv-aflibercept,gene,0.966,26991646
43207,ziv-aflibercept,gene,0.985,26991646
43208,ziv-aflibercept,gene,0.99,26991646
43209,diabetic macular edema,disease,1.0,26991646
43210,Vascular endothelial growth factor,gene,0.997,26985834
43211,Myopic choroidal neovascularization,disease,1.0,26985834
43212,CNV,disease,1.0,26985834
43213,CNV,disease,1.0,26985834
43214,visual loss,disease,0.992,26985834
43215,myopia,disease,0.887,26985834
43216,vascular endothelial growth factor,gene,0.9976,26985834
43217,VEGF,gene,0.997,26985834
43218,myopia,disease,1.0,26985834
43219,high myopia,disease,1.0,26985834
43220,myopic CNV,disease,1.0,26985834
43221,VEGF,gene,0.5903,26985834
43222,ranibizumab,gene,0.9204,26985834
43223,aflibercept,gene,0.9653,26985834
43224,myopic CNV,disease,1.0,26985834
43225,myopic CNV,disease,1.0,26985834
43226,VEGF,gene,0.9927,26985834
43227,ranibizumab,gene,0.9287,26985834
43228,aflibercept,gene,0.956,26985834
43229,myopic CNV,disease,1.0,26985834
43230,age-related macular degeneration,disease,1.0,26985834
43231,myopic CNV,disease,1.0,26985834
43232,visual loss,disease,0.9385,26985834
43233,chorioretinal atrophy,disease,1.0,26985834
43234,Aflibercept,gene,0.901,26985798
43235,Exudative Age-Related Macular,disease,0.999,26985798
43236,aflibercept,gene,0.983,26985798
43237,Eylea; Regeneron,gene,0.6523,26985798
43238,patients,species,0.9717,26985798
43239,exudative age-related macular degeneration,disease,1.0,26985798
43240,AMD,disease,1.0,26985798
43241,PATIENTS,species,0.967,26985798
43242,patients,species,0.9707,26985798
43243,bevacizumab,gene,0.747,26985798
43244,Avastin,gene,0.7754,26985798
43245,Lucentis,gene,0.727,26985798
43246,pigment epithelial detachment,disease,1.0,26985798
43247,PED,disease,0.9995,26985798
43248,aflibercept,gene,0.962,26985798
43249,aflibercept,gene,0.9497,26985798
43250,exudative AMD,disease,0.959,26985798
43251,vascular endothelial growth factor,gene,0.9126,26985798
43252,patients,species,0.9805,26985797
43253,neovascular age-related macular degeneration,disease,0.9995,26985797
43254,PATIENTS,species,0.97,26985797
43255,aflibercept,gene,0.9795,26985797
43256,Eylea;,gene,0.821,26985797
43257,Rq4,DNA,0.9136,26985797
43258,2q4,DNA,0.8604,26985797
43259,2q8,DNA,0.8667,26985797
43260,2q4,DNA,0.8193,26985797
43261,2q8,DNA,0.7905,26985797
43262,Rq4,DNA,0.8525,26985797
43263,Aflibercept,gene,0.9863,26982640
43264,age-related macular degeneration,disease,1.0,26982640
43265,neovascular age-related macular degeneration,disease,1.0,26982640
43266,NV-AMD,disease,1.0,26982640
43267,NV-AMD,disease,0.9995,26982640
43268,Aflibercept,gene,0.987,26982640
43269,AFL,gene,0.9956,26982640
43270,VEGF,gene,0.667,26982640
43271,NV-AMD,disease,1.0,26982640
43272,AFL,drug,0.895,26982640
43273,AFL,drug,0.7393,26982640
43274,NV-AMD,disease,0.9995,26982640
43275,VEGF,gene,0.7935,26982640
43276,AFL,drug,0.962,26982640
43277,anti-VEGF,gene,0.8945,26982640
43278,AFL,drug,0.9595,26982640
43279,NV-AMD,disease,0.9995,26982640
43280,ranibizumab,gene,0.7363,26982640
43281,RBZ,gene,0.838,26982640
43282,AFL,drug,0.99,26982640
43283,patients,species,0.9507,26982640
43284,NV-AMD,disease,1.0,26982640
43285,RBZ,drug,0.9385,26982640
43286,bevacizumab,gene,0.8145,26982640
43287,AFL,drug,0.9907,26982640
43288,Anti-Vascular Endothelial Growth Factor,gene,0.968,26976701
43289,vascular endothelial growth factor,gene,0.9053,26976701
43290,VEGF,gene,0.9976,26976701
43291,PARTICIPANTS,species,0.4927,26976701
43292,Medicare,species,0.495,26976701
43293,beneficiaries,species,0.542,26976701
43294,VEGF,gene,0.58,26976701
43295,anti-VEGF,gene,0.797,26976701
43296,VEGF,gene,0.684,26976701
43297,VEGF,gene,0.8623,26976701
43298,anti-VEGF,gene,0.9097,26976701
43299,anti-VEGF,gene,0.893,26976701
43300,VEGF,gene,0.6567,26976701
43301,Ulcerations,disease,0.989,26970060
43302,abdominal wound scar,disease,0.7773,26970060
43303,aflibercept,gene,0.9697,26970060
43304,ranibizumab,gene,0.8843,26967930
43305,aflibercept,gene,0.9683,26967930
43306,aflibercept,gene,0.9683,26967930
43307,ranibizumab,gene,0.6035,26967930
43308,diabetic macular edema,disease,1.0,26967930
43309,aflibercept,gene,0.8804,26967930
43310,aflibercept,gene,0.971,26967930
43311,Age-related macular degeneration,disease,1.0,26962608
43312,AMD,disease,1.0,26962608
43313,degenerative disease of the macula,disease,1.0,26962608
43314,people,species,0.9844,26962608
43315,AMD,disease,1.0,26962608
43316,AMD,disease,0.9995,26962608
43317,AMD,disease,1.0,26962608
43318,visual impairment,disease,1.0,26962608
43319,blindness,disease,0.999,26962608
43320,AMD,disease,1.0,26962608
43321,AMD,disease,1.0,26962608
43322,dry AMD,disease,1.0,26962608
43323,neovascular (wet) AMD,disease,1.0,26962608
43324,wAMD,disease,1.0,26962608
43325,wAMD,disease,1.0,26962608
43326,people,species,0.946,26962608
43327,dry AMD,disease,1.0,26962608
43328,vision loss,disease,0.9946,26962608
43329,wAMD,disease,1.0,26962608
43330,choroidal neovascularization,disease,0.998,26962608
43331,vascular endothelial growth factor,gene,0.9985,26962608
43332,VEGF,gene,0.997,26962608
43333,wAMD,disease,0.9995,26962608
43334,disability,disease,0.5776,26962608
43335,wAMD,disease,1.0,26962608
43336,ranibizumab,gene,0.8184,26962608
43337,VEGF,gene,0.991,26962608
43338,Pegaptanib,drug,0.9956,26962608
43339,verteporfin,drug,0.996,26962608
43340,wAMD,disease,0.986,26962608
43341,patients,species,0.98,26962608
43342,wAMD,disease,0.9995,26962608
43343,Bevacizumab,gene,0.8037,26962608
43344,ranibizumab,gene,0.821,26962608
43345,wAMD,disease,1.0,26962608
43346,wAMD,disease,1.0,26962608
43347,patients,species,0.9927,26962608
43348,ranibizumab,gene,0.894,26962608
43349,Aflibercept,gene,0.972,26962608
43350,Eylea,gene,0.782,26962608
43351,VEGF,gene,0.9976,26962608
43352,patients,species,0.967,26962608
43353,wAMD,disease,1.0,26962608
43354,Aflibercept,gene,0.979,26962608
43355,aflibercept,gene,0.9795,26962608
43356,wAMD,disease,0.9985,26962608
43357,Vascular Endothelial Growth Factor,gene,0.998,26959822
43358,Ranibizumab,gene,0.666,26959822
43359,Aflibercept,gene,0.862,26959822
43360,Vascular Endothelial Cells,cell_type,0.906,26959822
43361,VEGF,gene,0.997,26959822
43362,Ranibizumab,gene,0.9175,26959822
43363,Aflibercept,gene,0.9673,26959822
43364,cardiovascular,disease,0.8223,26959822
43365,atheroma,disease,1.0,26959822
43366,atherosclerotic plaque,disease,1.0,26959822
43367,endothelial cells,cell_type,0.946,26959822
43368,Human coronary artery endothelial cells,cell_line,0.751,26959822
43369,Ranibizumab,gene,0.8516,26959822
43370,Aflibercept,gene,0.9644,26959822
43371,CCL2,gene,0.9053,26959822
43372,CCL5,gene,0.9805,26959822
43373,CXC3L1,gene,0.979,26959822
43374,VCAM-1,gene,0.9785,26959822
43375,ICAM-1,gene,0.9893,26959822
43376,NF-b,gene,0.9883,26959822
43377,p65,gene,0.7134,26959822
43378,VEGF-A protein,gene,0.984,26959822
43379,cell adhesion molecule,gene,0.846,26959822
43380,CAM,gene,0.907,26959822
43381,p65,gene,0.957,26959822
43382,VEGF-,gene,0.996,26959822
43383,Aflibercept,gene,0.98,26959822
43384,Ranibizumab,gene,0.877,26959822
43385,VEGF-A,gene,0.9985,26959822
43386,VEGF-A receptor,gene,0.9976,26959822
43387,VEGF-A gene,gene,0.923,26959822
43388,VEGF-A,gene,0.9966,26959822
43389,Toll-like receptor 4,gene,0.995,26959822
43390,Toll-like receptor 4,gene,0.9907,26959822
43391,endothelial cell,cell_type,0.8633,26959822
43392,VEGF-A,gene,0.9966,26959822
43393,Central Retinal Vein Occlusion,disease,1.0,26957838
43394,central retinal vein occlusion,disease,1.0,26957838
43395,CRVO,disease,1.0,26957838
43396,macular edema,disease,1.0,26957838
43397,neovascularization,disease,0.9043,26957838
43398,CRVO,disease,1.0,26957838
43399,CRVO,disease,1.0,26957838
43400,CRVO,disease,1.0,26957838
43401,CRVO,disease,1.0,26957838
43402,CRVO,disease,1.0,26957838
43403,Branch Retinal Vein Occlusion,disease,1.0,26957837
43404,Branch retinal vein occlusion,disease,1.0,26957837
43405,BRVO,disease,1.0,26957837
43406,retinal vascular disorder,disease,1.0,26957837
43407,macular edema,disease,1.0,26957837
43408,anti-,gene,0.5054,26957837
43409,vascular endothelial growth factors,gene,0.953,26957837
43410,VEGF,gene,0.9946,26957837
43411,ranibizumab,gene,0.8804,26957837
43412,bevacizumab,gene,0.8955,26957837
43413,aflibercept,gene,0.9697,26957837
43414,VEGF,gene,0.808,26957837
43415,macular edema,disease,1.0,26957837
43416,BRVO,disease,1.0,26957837
43417,VEGF,gene,0.914,26957837
43418,Neovascular Age-related Macular Degeneration,disease,1.0,26957836
43419,neovascular age-related macular degeneration,disease,1.0,26957836
43420,AMD,disease,0.97,26957836
43421,neovascular AMD,disease,0.999,26957836
43422,AMD,disease,1.0,26957836
43423,visual loss,disease,0.9985,26957836
43424,vascular endothelial growth factor,gene,0.9727,26957836
43425,neovascular AMD,disease,1.0,26957836
43426,AMD,disease,0.9995,26957836
43427,AMD,disease,1.0,26957836
43428,AMD,disease,1.0,26957836
43429,Diabetic Macular Edema,disease,1.0,26957834
43430,diabetic macular edema,disease,1.0,26957834
43431,DME,disease,1.0,26957834
43432,vascular endothelial growth factors,gene,0.9263,26957834
43433,DME,cell_line,0.479,26957834
43434,diabetic retinopathy,disease,1.0,26957834
43435,vision loss,disease,0.8125,26957834
43436,DME,disease,1.0,26957834
43437,DME,disease,1.0,26957834
43438,DME,disease,1.0,26957834
43439,Vascularized Pigment Epithelial Detachment,disease,1.0,26955349
43440,VEGF,gene,0.889,26955349
43441,VEGF,gene,0.7354,26955349
43442,massive vascularized retinal pigment epithelial detachment,disease,0.9624,26955349
43443,PED,disease,1.0,26955349
43444,PED,disease,0.9824,26955349
43445,bevacizumab,gene,0.79,26955349
43446,aflibercept,gene,0.9917,26955349
43447,PED,disease,0.538,26955349
43448,PED,disease,1.0,26955349
43449,age-related macular degeneration,disease,1.0,26955349
43450,patients,species,0.767,26951770
43451,neovascular age-related macular degeneration,disease,1.0,26951770
43452,AMD,disease,1.0,26951770
43453,patients,species,0.9795,26951770
43454,ranibizumab,gene,0.5376,26951770
43455,aflibercept,gene,0.95,26951770
43456,patients,species,0.9873,26951770
43457,neovascular AMD,disease,1.0,26951770
43458,ranibizumab,gene,0.809,26951770
43459,ranibizumab,gene,0.929,26951770
43460,aflibercept,gene,0.9634,26951770
43461,aflibercept,gene,0.989,26951770
43462,neovascular AMD,disease,1.0,26951770
43463,polypoidal choroidal vasculopathy,disease,1.0,26951770
43464,PCV,disease,1.0,26951770
43465,retinal angiomatous proliferation,disease,1.0,26951770
43466,RAP,disease,1.0,26951770
43467,ranibizumab,gene,0.7793,26951770
43468,aflibercept,gene,0.9917,26951770
43469,aflibercept,gene,0.989,26951770
43470,aflibercept,gene,0.9917,26951770
43471,neovascular AMD,disease,1.0,26951770
43472,RAP,disease,0.9995,26951770
43473,aflibercept,gene,0.9863,26951770
43474,ranibizumab,gene,0.675,26951770
43475,PCV,disease,1.0,26951770
43476,neovascular AMD,disease,1.0,26951770
43477,Visual Impairment,disease,1.0,26951552
43478,Diabetic Macular Edema,disease,1.0,26951552
43479,diabetic macular edema,disease,1.0,26951552
43480,vascular endothelial growth factor,gene,0.995,26951552
43481,Diabetic Retinopathy,disease,1.0,26951552
43482,ranibizumab,gene,0.6016,26951552
43483,VISTA,DNA,0.4253,26951552
43484,aflibercept,gene,0.92,26951552
43485,aflibercept,gene,0.969,26951552
43486,aflibercept,gene,0.9814,26951552
43487,ranibizumab,gene,0.7173,26951552
43488,aflibercept,gene,0.964,26951552
43489,age-related macular,disease,1.0,26951250
43490,vascular endothelial growth factor,gene,0.95,26951250
43491,VEGF,gene,0.997,26951250
43492,VEGF,gene,0.8735,26951250
43493,age-related macular degeneration,disease,1.0,26951250
43494,AMD,disease,1.0,26951250
43495,vitreomacular traction,disease,0.9995,26951250
43496,VMT,disease,1.0,26951250
43497,epiretinal membrane,disease,1.0,26951250
43498,ERM,disease,1.0,26951250
43499,patients,species,0.9697,26951250
43500,AMD,disease,0.9985,26951250
43501,VMT,disease,1.0,26951250
43502,ERM,disease,1.0,26951250
43503,patients,species,0.9717,26951250
43504,AMD,disease,1.0,26951250
43505,patients,species,0.985,26951250
43506,VEGF,gene,0.5527,26951250
43507,patient,species,0.982,26951250
43508,patients,species,0.9775,26951250
43509,VEGF,gene,0.6694,26951250
43510,BCVA,cell_type,0.41,26951250
43511,VEGF,gene,0.7954,26951250
43512,AMD,disease,0.999,26951250
43513,VMT,disease,0.996,26951250
43514,ERM,disease,0.9985,26951250
43515,Endophthalmitis,disease,1.0,26944277
43516,Bevacizumab,gene,0.9155,26944277
43517,Ranibizumab,gene,0.951,26944277
43518,Aflibercept,gene,0.972,26944277
43519,endophthalmitis,disease,1.0,26944277
43520,bevacizumab,gene,0.9087,26944277
43521,ranibizumab,gene,0.879,26944277
43522,aflibercept,gene,0.9194,26944277
43523,bevacizumab,gene,0.4983,26944277
43524,ranibizumab,gene,0.693,26944277
43525,aflibercept,gene,0.9316,26944277
43526,anti-vascular endothelial growth factor,gene,0.9766,26944277
43527,VEGF,gene,0.9976,26944277
43528,endophthalmitis,disease,1.0,26944277
43529,endophthalmitis,disease,1.0,26944277
43530,endophthalmitis,disease,1.0,26944277
43531,anti-VEGF,gene,0.86,26944277
43532,anti-VEGF,gene,0.9795,26944277
43533,endophthalmitis,disease,1.0,26944277
43534,endophthalmitis,disease,1.0,26944277
43535,bevacizumab,gene,0.8926,26944277
43536,ranibizumab,gene,0.8022,26944277
43537,aflibercept,gene,0.9756,26944277
43538,ranibizumab,gene,0.919,26944277
43539,aflibercept,gene,0.9854,26944277
43540,bevacizumab,gene,0.948,26944277
43541,ranibizumab,gene,0.9365,26944277
43542,aflibercept,gene,0.9927,26944277
43543,ranibizumab,drug,0.6157,26944277
43544,aflibercept,gene,0.991,26944277
43545,Endophthalmitis,disease,1.0,26944277
43546,bevacizumab,gene,0.8486,26944277
43547,ranibizumab,gene,0.728,26944277
43548,aflibercept,gene,0.9844,26944277
43549,VEGF,gene,0.6187,26944277
43550,aflibercept,gene,0.9883,26939557
43551,choroidal neovascularisation,disease,1.0,26939557
43552,angioid streaks,disease,1.0,26939557
43553,aflibercept,gene,0.987,26939555
43554,choroidal neovascularization,disease,1.0,26939555
43555,angioid streaks,disease,1.0,26939555
43556,colorectal cancer,disease,1.0,26938715
43557,metastatic CRC,disease,0.985,26938715
43558,Bevacizumab,gene,0.901,26938715
43559,aflibercept,gene,0.9814,26938715
43560,regorafenib,drug,0.941,26938715
43561,bevacizumab,gene,0.898,26938715
43562,VEGF,gene,0.767,26938715
43563,VEGF,gene,0.995,26938715
43564,fruquintinib,drug,0.999,26938715
43565,famitinib,drug,0.997,26938715
43566,nintedanib,drug,0.999,26938715
43567,VEGF-C,gene,0.9976,26938715
43568,VEGFR-2,gene,0.9946,26938715
43569,VEGFR-3,gene,0.995,26938715
43570,VEGFR-2,gene,0.997,26938715
43571,vanucizumab,gene,0.7393,26938715
43572,VEGF-A,gene,0.992,26938715
43573,Angiopoietin-2,gene,0.9907,26938715
43574,anterior chamber,disease,0.938,26938579
43575,vitreous inflammation,disease,0.9746,26938579
43576,ranibizumab,gene,0.889,26938579
43577,aflibercept,gene,0.978,26938579
43578,patients,species,0.913,26938579
43579,choroidal neovascularization,disease,1.0,26938579
43580,age-related macular degeneration,disease,1.0,26938579
43581,aflibercept,gene,0.983,26938579
43582,vitreous inflammation,disease,0.998,26938579
43583,Uveitis,disease,0.995,26938579
43584,patient,species,0.9595,26938579
43585,aflibercept,gene,0.568,26938579
43586,patient,species,0.991,26938579
43587,aflibercept,gene,0.988,26938579
43588,anterior chamber inflammation,disease,1.0,26938579
43589,patient,species,0.9585,26938579
43590,ranibizumab,gene,0.858,26938579
43591,Aflibercept,gene,0.953,26938579
43592,anterior chamber inflammation,disease,0.9976,26938579
43593,endophthalmitis,disease,1.0,26938579
43594,Aflibercept,gene,0.986,26935357
43595,Bevacizumab,gene,0.8794,26935357
43596,Ranibizumab,gene,0.7773,26935357
43597,Diabetic Macular Edema,disease,1.0,26935357
43598,vascular endothelial growth factor,gene,0.9917,26935357
43599,VEGF,gene,0.9966,26935357
43600,diabetic macular edema,disease,1.0,26935357
43601,DME,disease,1.0,26935357
43602,DME,disease,1.0,26935357
43603,aflibercept,gene,0.9873,26935357
43604,bevacizumab,gene,0.8447,26935357
43605,ranibizumab,gene,0.475,26935357
43606,DME,disease,1.0,26935357
43607,aflibercept,gene,0.9893,26935357
43608,bevacizumab,gene,0.8594,26935357
43609,ranibizumab,drug,0.621,26935357
43610,aflibercept,gene,0.9907,26935357
43611,bevacizumab,gene,0.801,26935357
43612,aflibercept,gene,0.9893,26935357
43613,ranibizumab,gene,0.5215,26935357
43614,bevacizumab,gene,0.8647,26935357
43615,ranibizumab,gene,0.572,26935357
43616,aflibercept,gene,0.9897,26935357
43617,bevacizumab,gene,0.539,26935357
43618,aflibercept,gene,0.987,26935357
43619,ranibizumab,drug,0.512,26935357
43620,ranibizumab,drug,0.7983,26935357
43621,bevacizumab,gene,0.6167,26935357
43622,aflibercept,gene,0.989,26935357
43623,bevacizumab,gene,0.717,26935357
43624,ranibizumab,gene,0.6445,26935357
43625,aflibercept,gene,0.9873,26935357
43626,bevacizumab,gene,0.5776,26935357
43627,aflibercept,gene,0.985,26935357
43628,ranibizumab,drug,0.599,26935357
43629,ranibizumab,drug,0.5757,26935357
43630,bevacizumab,gene,0.8013,26935357
43631,anti-VEGF,gene,0.7925,26935357
43632,aflibercept,gene,0.991,26935357
43633,bevacizumab,gene,0.7974,26935357
43634,aflibercept,gene,0.986,26935357
43635,APTC,disease,1.0,26935357
43636,ranibizumab,gene,0.552,26935357
43637,Aflibercept,gene,0.9717,26929279
43638,diabetic macular oedema,disease,1.0,26929279
43639,Aflibercept,gene,0.9604,26921806
43640,Ranibizumab,gene,0.9263,26921806
43641,Polypoidal Choroidal Vasculopathy,disease,1.0,26921806
43642,aflibercept,gene,0.985,26921806
43643,ranibizumab,gene,0.7607,26921806
43644,polypoidal choroidal vasculopathy,disease,1.0,26921806
43645,PCV,disease,1.0,26921806
43646,PCV,disease,0.9995,26921806
43647,aflibercept,gene,0.99,26921806
43648,aflibercept,gene,0.9854,26921806
43649,ranibizumab,gene,0.7104,26921806
43650,aflibercept,gene,0.992,26921806
43651,Polyp,disease,0.9985,26921806
43652,aflibercept,gene,0.9937,26921806
43653,ranibizumab,gene,0.8716,26921806
43654,PCV,disease,1.0,26921806
43655,aflibercept,gene,0.936,26921806
43656,aflibercept,gene,0.9844,26921806
43657,polyp,disease,0.9976,26921806
43658,ranibizumab,gene,0.8438,26921806
43659,VEGF,gene,0.9414,26921327
43660,IL6,gene,0.9883,26921327
43661,STAT3,gene,0.9883,26921327
43662,IL6,gene,0.9634,26921327
43663,VEGF,gene,0.959,26921327
43664,cancer,disease,1.0,26921327
43665,cell lines,cell_line,0.9395,26921327
43666,anti-VEGF,gene,0.933,26921327
43667,tumor,disease,0.9966,26921327
43668,tumor cells,cell_type,0.822,26921327
43669,tumor,disease,0.999,26921327
43670,A431 (A431-V) epidermoid carcinoma cells,cell_line,0.9443,26921327
43671,epidermoid carcinoma,disease,0.9966,26921327
43672,VEGF,gene,0.9976,26921327
43673,aflibercept,gene,0.9263,26921327
43674,parental tumors,disease,0.998,26921327
43675,A431-V tumors,cell_line,0.91,26921327
43676,IL6,gene,0.972,26921327
43677,phospho-STAT3,gene,0.95,26921327
43678,IL6 receptor,gene,0.9976,26921327
43679,IL6R,gene,0.998,26921327
43680,VEGF,gene,0.994,26921327
43681,A431-V tumors,cell_line,0.912,26921327
43682,A431,disease,0.5244,26921327
43683,IL6R,gene,0.997,26921327
43684,aflibercept,gene,0.926,26921327
43685,DU145 prostate tumor cells,cell_line,0.8354,26921327
43686,IL6R,gene,0.994,26921327
43687,aflibercept,gene,0.7896,26921327
43688,ovarian cancer,disease,1.0,26921327
43689,IL6,gene,0.992,26921327
43690,IL6,gene,0.992,26921327
43691,STAT3,gene,0.973,26921327
43692,tumor cells,cell_type,0.867,26921327
43693,tumor,disease,0.9917,26921327
43694,anti-VEGF,gene,0.642,26921327
43695,neovascular age-related macular degeneration,disease,1.0,26920612
43696,neovascular age-related macular degeneration,disease,1.0,26920612
43697,nAMD,disease,1.0,26920612
43698,vascular endothelial growth factor,gene,0.9565,26920612
43699,VEGF,gene,0.997,26920612
43700,ranibizumab,gene,0.798,26920612
43701,geographic atrophy,disease,1.0,26920612
43702,GA,disease,1.0,26920612
43703,anti-VEGF,gene,0.8887,26920612
43704,bevacizumab,gene,0.743,26920612
43705,pegaptanib,drug,0.8213,26920612
43706,ranibizumab,gene,0.7407,26920612
43707,aflibercept,gene,0.882,26920612
43708,geographic atrophy,disease,1.0,26920612
43709,patients,species,0.977,26920612
43710,nAMD,disease,1.0,26920612
43711,dry AMD,disease,0.9907,26920612
43712,IBI302,drug,0.924,26919788
43713,AMD,disease,1.0,26919788
43714,VEGF,gene,0.997,26919788
43715,rhesus monkeys,species,0.9497,26919788
43716,vascular endothelial growth factor,gene,0.9985,26919788
43717,VEGF,gene,0.99,26919788
43718,age-related macular degeneration,disease,1.0,26919788
43719,AMD,disease,1.0,26919788
43720,AMD,disease,1.0,26919788
43721,AMD,disease,1.0,26919788
43722,VEGF,gene,0.9966,26919788
43723,Fc,gene,0.9756,26919788
43724,human immunoglobulin,gene,0.9937,26919788
43725,VEGF isoforms,gene,0.993,26919788
43726,complement proteins,gene,0.56,26919788
43727,VEGF,gene,0.847,26919788
43728,aflibercept,gene,0.974,26919788
43729,bevacizumab,gene,0.814,26919788
43730,complement receptor 1,gene,0.9614,26919788
43731,IBI302,drug,0.519,26919788
43732,VEGF isoforms,gene,0.997,26919788
43733,IBI302,drug,0.99,26919788
43734,IBI302,drug,0.9526,26919788
43735,human primary umbilical vein endothelial cell,cell_line,0.809,26919788
43736,IBI302,drug,0.9946,26919788
43737,rhesus monkeys,species,0.878,26919788
43738,IBI302,drug,0.9326,26919788
43739,vitreous humor,disease,0.9883,26919788
43740,IBI302,drug,0.9917,26919788
43741,rhesus monkeys,species,0.858,26919788
43742,IBI302,drug,0.996,26919788
43743,AMD,disease,1.0,26919788
43744,Dorzolamide,drug,0.999,26914218
43745,Timolol,drug,0.9985,26914218
43746,Vascular Endothelial Growth,gene,0.8184,26914218
43747,neovascular age-related macular degeneration,disease,1.0,26914218
43748,AMD,disease,1.0,26914218
43749,anti-vascular endothelial growth factor,gene,0.9766,26914218
43750,VEGF,gene,0.998,26914218
43751,dorzolamide hydrochloride,drug,0.997,26914218
43752,timolol maleate,drug,0.9956,26914218
43753,neovascular AMD,disease,1.0,26914218
43754,PARTICIPANTS,species,0.7344,26914218
43755,Patients,species,0.9204,26914218
43756,neovascular AMD,disease,1.0,26914218
43757,macular edema,disease,1.0,26914218
43758,Patients,species,0.9595,26914218
43759,pigment,cell_type,0.4536,26914218
43760,dorzolamide,drug,0.9966,26914218
43761,timolol,drug,0.9946,26914218
43762,VEGF,gene,0.5874,26914218
43763,pigment,cell_type,0.5103,26914218
43764,patients,species,0.99,26914218
43765,patients,species,0.986,26914218
43766,aflibercept,gene,0.9805,26914218
43767,ranibizumab,gene,0.7485,26914218
43768,dorzolamide,drug,0.995,26914218
43769,timolol,drug,0.997,26914218
43770,anti-VEGF,gene,0.783,26914218
43771,neovascular AMD,disease,1.0,26914218
43772,diabetic retinopathy,disease,1.0,26913740
43773,Diabetic Retinopathy,disease,1.0,26913740
43774,Diabetic retinopathy,disease,1.0,26913740
43775,diabetic macular edema,disease,1.0,26913740
43776,DME,disease,1.0,26913740
43777,eye diseases,disease,0.9976,26913740
43778,vision loss,disease,0.9985,26913740
43779,Diabetic Retinopathy,disease,1.0,26913740
43780,Digestive and Kidney Diseases,disease,0.9995,26913740
43781,diabetic eye disease,disease,1.0,26913740
43782,bevacizumab,gene,0.8584,26913740
43783,ranibizumab,gene,0.622,26913740
43784,aflibercept,gene,0.916,26913740
43785,DME,disease,1.0,26913740
43786,aflibercept,gene,0.964,26913740
43787,ranibizumab,gene,0.6797,26913740
43788,proliferative diabetic retinopathy,disease,1.0,26913740
43789,PDR,disease,1.0,26913740
43790,ranibizumab,gene,0.8364,26913740
43791,PDR,disease,0.954,26913740
43792,DME,disease,1.0,26913740
43793,PDR,disease,0.9995,26913740
43794,Age-related macular degeneration,disease,1.0,26909890
43795,vascular endothelial growth factor,gene,0.9907,26909890
43796,age-related macular degeneration,disease,1.0,26909890
43797,AMD,disease,1.0,26909890
43798,drusen,disease,0.999,26909890
43799,age-related macular degeneration,disease,0.991,26909890
43800,aflibercept,gene,0.992,26909890
43801,bevazicumab,gene,0.6465,26909890
43802,ranibizumab,gene,0.539,26909890
43803,verteporfin,drug,0.9585,26909890
43804,Aflibercept,gene,0.9355,26907516
43805,diabetic macular edema,disease,1.0,26907516
43806,Diabetic macular edema,disease,1.0,26907516
43807,DME,disease,1.0,26907516
43808,diabetic vascular damage,disease,0.999,26907516
43809,DME,disease,1.0,26907516
43810,diabetes,disease,1.0,26907516
43811,blindness,disease,0.9976,26907516
43812,VEGF,gene,0.525,26907516
43813,DME,disease,1.0,26907516
43814,Aflibercept,gene,0.962,26907516
43815,VEGF,gene,0.574,26907516
43816,VEGF receptors 1 and 2 extracellular domains,gene,0.9937,26907516
43817,Fc-,gene,0.979,26907516
43818,human-IgG1,gene,0.9976,26907516
43819,VEGF isoforms A and B,gene,0.9985,26907516
43820,placental growth factor,gene,0.998,26907516
43821,aflibercept,gene,0.9736,26907516
43822,DME,disease,1.0,26907516
43823,metastatic colorectal cancer,disease,1.0,26907512
43824,tumour,disease,0.999,26907512
43825,metastatic colorectal cancer,disease,1.0,26907512
43826,bevacizumab,gene,0.8965,26907512
43827,aflibercept,gene,0.9844,26907512
43828,colorectal cancer,disease,1.0,26907512
43829,bevacizumab,gene,0.9385,26907512
43830,aflibercept,gene,0.9907,26907512
43831,Aflibercept,gene,0.9663,26902063
43832,Macular Edema,disease,1.0,26902063
43833,Branch Retinal Vein Occlusion,disease,1.0,26902063
43834,aflibercept,gene,0.9736,26902063
43835,macular edema,disease,1.0,26902063
43836,BRVO,disease,1.0,26902063
43837,macular edema,disease,1.0,26902063
43838,BRVO,disease,1.0,26902063
43839,aflibercept,gene,0.968,26902063
43840,retinal detachment,disease,1.0,26902063
43841,infectious endophthalmitis,disease,1.0,26902063
43842,aflibercept,gene,0.972,26902063
43843,macular edema,disease,1.0,26902063
43844,BRVO,disease,1.0,26902063
43845,VEGF,gene,0.513,26899882
43846,retinal pigment epithelium tear,disease,0.995,26899882
43847,aflibercept,gene,0.982,26899882
43848,retinal pigment epithelium detachment,disease,0.975,26899882
43849,PED,disease,0.9995,26899882
43850,age-related macular degeneration,disease,1.0,26899882
43851,AMD,disease,1.0,26899882
43852,retinal pigment epithelium (RPE) tear,disease,1.0,26899882
43853,aflibercept,gene,0.9854,26899882
43854,RPE tear,disease,0.9976,26899882
43855,VEGF,gene,0.7114,26899882
43856,PED,disease,0.9995,26899882
43857,Colorectal cancer,disease,1.0,26895445
43858,cancer,disease,1.0,26895445
43859,colorectal cancer,disease,1.0,26895445
43860,patients,species,0.9907,26895445
43861,VEGF,gene,0.9966,26895445
43862,colorectal cancer,disease,1.0,26895445
43863,human,species,0.9644,26895445
43864,vascular endothelial growth factor receptor-2,gene,0.998,26895445
43865,VEGFR-2,gene,0.9976,26895445
43866,metastatic colorectal cancer,disease,1.0,26895445
43867,Ramucirumab,gene,0.569,26895445
43868,advanced colorectal cancer,disease,1.0,26895445
43869,patients,species,0.9873,26895445
43870,bevacizumab,gene,0.898,26895445
43871,bevacizumab,gene,0.954,26895445
43872,ziv-aflibercept,gene,0.978,26895445
43873,ranibizumab,gene,0.607,26888975
43874,aflibercept,gene,0.982,26888975
43875,vascular endothelial growth factor A,gene,0.9097,26888975
43876,VEGF-A,gene,0.9966,26888975
43877,neovascular age-related macular degeneration,disease,1.0,26888975
43878,nAMD,disease,1.0,26888975
43879,ranibizumab,gene,0.763,26888975
43880,aflibercept,gene,0.9644,26888975
43881,Eylea,gene,0.7583,26888975
43882,nAMD,disease,1.0,26888975
43883,choroidal neovascular membrane,disease,1.0,26888975
43884,CNV,disease,1.0,26888975
43885,ranibizumab,gene,0.7188,26888975
43886,aflibercept,gene,0.9336,26888975
43887,patients,species,0.9507,26888975
43888,VEGF-A,gene,0.9966,26888975
43889,VEGF-A,gene,0.913,26888975
43890,CNV,disease,0.998,26888975
43891,VEGF-A,gene,0.9966,26888975
43892,ranibizumab,gene,0.745,26888975
43893,aflibercept,gene,0.961,26888975
43894,aflibercept,gene,0.9907,26888975
43895,ranibizumab,gene,0.9297,26888975
43896,aflibercept,gene,0.9917,26888975
43897,aflibercept,gene,0.9907,26888975
43898,ranibizumab,gene,0.806,26888975
43899,Metastatic Colorectal,disease,1.0,26887105
43900,Bevacizumab,gene,0.8906,26875003
43901,Ranibizumab,gene,0.8213,26875003
43902,Diabetic Macular Edema,disease,1.0,26875003
43903,bevacizumab,gene,0.842,26875003
43904,Avastin,gene,0.56,26875003
43905,Lucentis,gene,0.4895,26875003
43906,diabetic macular,disease,1.0,26875003
43907,DME,disease,1.0,26875003
43908,bevacizumab,gene,0.9097,26875003
43909,bevacizumab,gene,0.529,26875003
43910,bevacizumab,gene,0.723,26875003
43911,bevacizumab,gene,0.705,26875003
43912,bevacizumab,gene,0.877,26875003
43913,ranibizumab,gene,0.8135,26875003
43914,bevacizumab,gene,0.7046,26875003
43915,Diabetic Retinopathy,disease,1.0,26875003
43916,bevacizumab,gene,0.7944,26875003
43917,ranibizumab,gene,0.739,26875003
43918,aflibercept,gene,0.898,26875003
43919,DME,disease,0.9995,26875003
43920,DME,disease,1.0,26875003
43921,Fc Receptor,gene,0.9854,26871551
43922,Human RPE Cells,cell_line,0.7466,26871551
43923,Bevacizumab,gene,0.6904,26871551
43924,Aflibercept,gene,0.9727,26871551
43925,VEGF-A,gene,0.98,26871551
43926,retinal pigment epithelial,cell_type,0.781,26871551
43927,RPE,cell_type,0.6606,26871551
43928,vascular endothelial growth factor,gene,0.9946,26871551
43929,VEGF,gene,0.998,26871551
43930,aflibercept,gene,0.9614,26871551
43931,bevacizumab,gene,0.742,26871551
43932,neovascular age-related macular degeneration,disease,0.9956,26871551
43933,AMD,disease,1.0,26871551
43934,Fc receptor,gene,0.991,26871551
43935,FcR,gene,0.9863,26871551
43936,VEGF,gene,0.993,26871551
43937,ARPE-19 (human RPE) cells,cell_line,0.9346,26871551
43938,aflibercept,gene,0.984,26871551
43939,bevacizumab,gene,0.6343,26871551
43940,H2O2,drug,0.9995,26871551
43941,VEGF-A,gene,0.997,26871551
43942,oxygen,drug,0.9995,26871551
43943,FcR,gene,0.989,26871551
43944,VEGF-A,gene,0.998,26871551
43945,RPE,cell_type,0.832,26871551
43946,VEGF-A,gene,0.9966,26871551
43947,FcR,gene,0.9917,26871551
43948,bevacizumab,gene,0.71,26871551
43949,aflibercept,gene,0.989,26871551
43950,RPE cells,cell_type,0.9087,26871551
43951,aflibercept,gene,0.9907,26871551
43952,bevacizumab,drug,0.5684,26871551
43953,RPE cells,cell_type,0.9175,26871551
43954,VEGF-A,gene,0.998,26871551
43955,FcR,gene,0.9854,26871551
43956,bevacizumab,gene,0.7944,26871551
43957,aflibercept,gene,0.9907,26871551
43958,RPE cell,cell_type,0.87,26871551
43959,FcR,gene,0.9897,26871551
43960,inflammatory retinal disorders,disease,1.0,26871551
43961,Central retinal vein occlusion,disease,1.0,26869163
43962,Central retinal vein occlusion,disease,1.0,26869163
43963,CRVO,disease,1.0,26869163
43964,retinal vascular disorder,disease,1.0,26869163
43965,VEGFs,gene,0.6875,26869163
43966,CRVO,disease,1.0,26869163
43967,HORIZON,drug,0.8755,26869163
43968,anti-VEGFs,gene,0.5957,26869163
43969,VEGFs,gene,0.7524,26869163
43970,CRVO,disease,1.0,26869163
43971,ranibizumab,gene,0.7925,26869163
43972,aflibercept,gene,0.981,26869163
43973,GENEVA,DNA,0.4727,26869163
43974,steroids,drug,0.8916,26869163
43975,VEGF,gene,0.7065,26869163
43976,CRVO,disease,1.0,26869163
43977,aflibercept,gene,0.9893,26869160
43978,macular oedema,disease,1.0,26869160
43979,central retinal vein occlusion,disease,1.0,26869160
43980,bevacizumab,gene,0.7505,26869160
43981,aflibercept,gene,0.9814,26869157
43982,macular oedema,disease,1.0,26869157
43983,central retinal vein occlusion,disease,1.0,26869157
43984,bevacizumab,gene,0.7017,26869157
43985,ranibizmab,gene,0.587,26869157
43986,Vascular Endothelial Growth Factor,gene,0.9985,26868748
43987,VEGF,gene,0.9956,26868748
43988,VEGF,gene,0.9395,26868748
43989,vascular endothelial growth factor,gene,0.9985,26868748
43990,VEGF,gene,0.995,26868748
43991,macular degeneration,disease,1.0,26868748
43992,VEGF,gene,0.7593,26868748
43993,bevacizumab,gene,0.6436,26868748
43994,pegaptanib,drug,0.9937,26868748
43995,ranibizumab,gene,0.5083,26868748
43996,aflibercept,gene,0.982,26868748
43997,Vascular endothelial growth factor,gene,0.9985,26868748
43998,VEGF,gene,0.989,26868748
43999,VEGF,gene,0.9077,26868748
44000,mouse immunoglobulin G,gene,0.9253,26868748
44001,mouse,species,0.9985,26868748
44002,IgG,gene,0.9897,26868748
44003,monocyte chemotactic protein-1,gene,0.998,26868748
44004,MCP-1,gene,0.9956,26868748
44005,VEGF,gene,0.997,26868748
44006,aflibercept,gene,0.9844,26868748
44007,bevacizumab,gene,0.7974,26868748
44008,pegaptanib,drug,0.9224,26868748
44009,ranibizumab,gene,0.6914,26868748
44010,VEGF,gene,0.995,26868748
44011,VEGF,gene,0.9487,26868748
44012,pegaptanib,drug,0.983,26868748
44013,VEGF,gene,0.9927,26868748
44014,Vascular endothelial growth factor,gene,0.9956,26868748
44015,aflibercept,gene,0.9746,26868748
44016,bevacizumab,gene,0.758,26868748
44017,ranibizumab,gene,0.688,26868748
44018,VEGF,gene,0.996,26868748
44019,aflibercept,gene,0.9673,26868748
44020,bevacizumab,gene,0.73,26868748
44021,ranibizumab,gene,0.7217,26868748
44022,mouse,species,0.999,26868748
44023,VEGF,gene,0.9937,26868748
44024,Ranibizumab,gene,0.6064,26868748
44025,MCP-1,gene,0.9795,26868748
44026,VEGF,gene,0.9907,26868748
44027,VEGF,gene,0.8994,26868748
44028,aflibercept,gene,0.983,26868007
44029,neovascular age-related macular degeneration,disease,1.0,26868007
44030,aflibercept,gene,0.99,26868007
44031,neovascular age-related macular degeneration,disease,1.0,26868007
44032,aflibercept,gene,0.935,26868007
44033,choroidal neovascularization,disease,1.0,26868007
44034,CNV,disease,1.0,26868007
44035,CNV,disease,0.54,26868007
44036,Diabetic Retinopathy,disease,1.0,26868007
44037,CNV,disease,0.5483,26868007
44038,aflibercept,gene,0.9824,26868007
44039,aflibercept,gene,0.9907,26868005
44040,choroidal neovascularization,disease,1.0,26868005
44041,ocular sarcoidosis,disease,1.0,26868005
44042,choroidal neovascularization,disease,1.0,26868005
44043,CNV,disease,1.0,26868005
44044,ocular sarcoidosis,disease,1.0,26868005
44045,aflibercept,gene,0.964,26868005
44046,optic disk swelling,disease,0.976,26868005
44047,yellowish,disease,0.9854,26868005
44048,chorioretinal lesions,disease,0.964,26868005
44049,peripapillary neovascular complex,disease,1.0,26868005
44050,ocular sarcoidosis,disease,0.963,26868005
44051,Fluorescein,drug,0.9976,26868005
44052,indocyanine green,drug,0.9946,26868005
44053,peripapillary type 2 (classic) CNV,disease,0.9995,26868005
44054,peripapillary CNV,disease,1.0,26868005
44055,aflibercept,gene,0.951,26868005
44056,LE,DNA,0.505,26868005
44057,retinal atrophy,disease,0.967,26868005
44058,CNV,disease,1.0,26868005
44059,ocular sarcoidosis,disease,1.0,26868005
44060,aflibercept,gene,0.8564,26868005
44061,aflibercept,gene,0.991,26868005
44062,sarcoid-related peripapillary CNV,disease,1.0,26868005
44063,PATIENTS,species,0.994,26866528
44064,AGE,disease,0.647,26866528
44065,MACULAR DEGENERATION,disease,0.994,26866528
44066,AFLIBERCEPT,drug,0.8135,26866528
44067,aflibercept,gene,0.966,26866528
44068,age-related macular degeneration,disease,1.0,26866528
44069,aflibercept,gene,0.9707,26866528
44070,age-related macular degeneration,disease,1.0,26866528
44071,Aflibercept,gene,0.9546,26857947
44072,neovascular age-related macular degeneration,disease,1.0,26857947
44073,Central vision loss,disease,0.9785,26857947
44074,age-related macular degeneration,disease,1.0,26857947
44075,AMD,disease,1.0,26857947
44076,blindness,disease,0.999,26857947
44077,Neovascular AMD,disease,1.0,26857947
44078,choroidal neovascularization,disease,1.0,26857947
44079,CNV,disease,1.0,26857947
44080,neovascular AMD,disease,1.0,26857947
44081,vascular endothelial growth factor A,gene,0.9985,26857947
44082,VEGF-,gene,0.9956,26857947
44083,VEGF,gene,0.813,26857947
44084,ranibizumab,gene,0.687,26857947
44085,bevacizumab,gene,0.888,26857947
44086,aflibercept,gene,0.9844,26857947
44087,aflibercept,gene,0.985,26857947
44088,ranibizumab,gene,0.6216,26857947
44089,bevacizumab,gene,0.7554,26857947
44090,neovascular AMD,disease,1.0,26857947
44091,aflibercept,gene,0.974,26857947
44092,ranibizumab,gene,0.4849,26857947
44093,bevacizumab,gene,0.805,26857947
44094,neovascular AMD,disease,1.0,26857947
44095,neovascular AMD,disease,1.0,26857947
44096,subfoveal choroidal neovascular lesions,disease,0.999,26857947
44097,aflibercept,gene,0.9756,26857947
44098,aflibercept,gene,0.9595,26857947
44099,aflibercept,gene,0.989,26857947
44100,aflibercept,gene,0.9844,26857947
44101,ranibizumab,drug,0.658,26857947
44102,aflibercept,gene,0.942,26857947
44103,ranibizumab,gene,0.6616,26857947
44104,Early Treatment Diabetic Retinopathy,disease,0.9316,26857947
44105,aflibercept,gene,0.9897,26857947
44106,ranibizumab,gene,0.5205,26857947
44107,aflibercept,gene,0.98,26857947
44108,ranibizumab,gene,0.551,26857947
44109,aflibercept,gene,0.988,26857947
44110,ranibizumab,gene,0.542,26857947
44111,aflibercept,gene,0.9805,26857947
44112,ranibizumab,gene,0.8096,26857947
44113,CNV,disease,0.9453,26857947
44114,dry retina,disease,0.985,26857947
44115,aflibercept,gene,0.9854,26857947
44116,ranibizumab,drug,0.518,26857947
44117,cystic intraretinal fluid,disease,0.9185,26857947
44118,subretinal fluid,disease,0.8667,26857947
44119,CNV,disease,0.9775,26857947
44120,aflibercept,gene,0.9966,26857947
44121,ranibizumab,gene,0.8613,26857947
44122,fluorescein,drug,0.994,26857947
44123,aflibercept,gene,0.9927,26857947
44124,ranibizumab,gene,0.8755,26857947
44125,aflibercept,gene,0.9844,26857947
44126,ranibizumab,gene,0.903,26857947
44127,aflibercept,gene,0.989,26857947
44128,ranibizumab,gene,0.681,26857947
44129,neovascular AMD,disease,1.0,26857947
44130,aflibercept,gene,0.984,26857947
44131,ranibizumab,gene,0.826,26857947
44132,aflibercept,gene,0.8857,26857947
44133,Ocular Inflammation,disease,0.999,26855278
44134,Ranibizumab,gene,0.926,26855278
44135,Aflibercept,gene,0.8726,26855278
44136,Age-Related Macular Degeneration,disease,1.0,26855278
44137,anti-,gene,0.6,26855278
44138,vascular endothelial growth factor,gene,0.911,26855278
44139,VEGF,gene,0.995,26855278
44140,ranibizumab,gene,0.7617,26855278
44141,aflibercept,gene,0.9385,26855278
44142,ocular disorders,disease,0.994,26855278
44143,neovascular age-related macular degeneration,disease,1.0,26855278
44144,nAMD,disease,1.0,26855278
44145,ocular inflammation,disease,0.9985,26855278
44146,severe ocular inflammation,disease,0.8335,26855278
44147,ranibizumab,gene,0.727,26855278
44148,aflibercept,gene,0.927,26855278
44149,ocular inflammation,disease,0.806,26855278
44150,ranibizumab,gene,0.7944,26855278
44151,aflibercept,gene,0.9673,26855278
44152,ocular inflammation,disease,1.0,26855278
44153,aflibercept,gene,0.97,26855278
44154,glaucoma,disease,1.0,26855278
44155,cataract,disease,0.995,26855278
44156,antibiotic-associated endophthalmitis,disease,0.995,26855278
44157,antibiotic-associated endophthalmitis,disease,0.8813,26855278
44158,ocular inflammation,disease,0.9956,26855278
44159,anti-VEGF,gene,0.8936,26855278
44160,ranibizumab,gene,0.6675,26855278
44161,ocular inflammation,disease,0.889,26855278
44162,aflibercept,gene,0.9907,26855278
44163,ranibizumab,gene,0.736,26855278
44164,nAMD,disease,1.0,26855278
44165,aflibercept,gene,0.988,26851951
44166,myopic choroidal neovascularization,disease,1.0,26851951
44167,Ranibizumab,gene,0.8022,34860956
44168,Diabetic Retinopathy,disease,1.0,34860956
44169,ranibizumab,gene,0.672,34860956
44170,vascular endothelial growth factor,gene,0.998,34860956
44171,VEGF,gene,0.9956,34860956
44172,diabetic retinopathy,disease,1.0,34860956
44173,DR,disease,1.0,34860956
44174,patients,species,0.9043,34860956
44175,diabetic macular edema,disease,1.0,34860956
44176,DME,disease,1.0,34860956
44177,ranibizumab,gene,0.5835,34860956
44178,DR,disease,,34860956
44179,DME,disease,0.9995,34860956
44180,anti-VEGF,gene,0.93,34860956
44181,DR,disease,,34860956
44182,ranibizumab,gene,0.7183,34860956
44183,ranibizumab,gene,0.6777,34860956
44184,ranibizumab,gene,0.6743,34860956
44185,VEGF,gene,0.572,34860956
44186,Ranibizumab,gene,0.845,34860956
44187,patients,species,0.968,34860956
44188,DME,disease,1.0,34860956
44189,ranibizumab,gene,0.4998,34860956
44190,Ranibizumab,gene,0.707,34860956
44191,Patients,species,0.916,34860956
44192,ranibizumab,gene,0.7065,34860956
44193,VEGF,gene,0.572,34860956
44194,aflibercept,gene,0.9917,34860956
44195,pegaptanib,drug,0.9854,34860956
44196,bevacizumab,gene,0.8125,34860956
44197,Ranibizumab,gene,0.808,34860956
44198,DR,disease,,34860956
44199,patients,species,0.9414,34860956
44200,DME,disease,1.0,34860956
44201,Aflibercept,gene,0.973,26817131
44202,Ranibizumab,gene,0.885,26817131
44203,Age-related Macular Degeneration,disease,1.0,26817131
44204,aflibercept,gene,0.9897,26817131
44205,ranibizumab,gene,0.5947,26817131
44206,macular degeneration,disease,0.9126,26817131
44207,AMD,disease,1.0,26817131
44208,IVA,drug,0.586,26817131
44209,VA,disease,0.519,26817131
44210,polypoidal choroidal vasculopathy,disease,1.0,26817131
44211,VEGF,gene,0.8057,26817131
44212,AMD,disease,1.0,26817131
44213,aflibercept,gene,0.9824,26802719
44214,patients,species,0.9565,26802719
44215,myopic,disease,0.9883,26802719
44216,aflibercept,gene,0.9707,26802716
44217,polypoidal,disease,0.989,26802716
44218,Cotton,species,0.5977,26800210
44219,Vascular Endothelial Growth Factor,gene,0.962,26800210
44220,Macular Edema,disease,1.0,26800210
44221,Central Retinal Vein Occlusion,disease,1.0,26800210
44222,anti-vascular endothelial growth factor,gene,0.9873,26800210
44223,macular edema,disease,1.0,26800210
44224,central retinal vein occlusion,disease,1.0,26800210
44225,CRVO,disease,1.0,26800210
44226,aflibercept,gene,0.971,26800210
44227,ranibizumab,gene,0.7974,26800210
44228,CWS,disease,0.999,26800210
44229,systemic diseases,disease,0.9985,26800210
44230,hypertension,disease,1.0,26800210
44231,diabetes mellitus,disease,1.0,26800210
44232,retinopathy,disease,0.9995,26800210
44233,dyslipidemia,disease,1.0,26800210
44234,chronic renal failure,disease,1.0,26800210
44235,macular edema,disease,1.0,26800210
44236,CRVO,disease,1.0,26800210
44237,macular edema,disease,0.9995,26800210
44238,macular edema,disease,1.0,26800210
44239,retinal hemorrhage,disease,1.0,26800210
44240,aflibercept,gene,0.979,26795418
44241,choroidal neovascularization,disease,0.816,26795418
44242,angioid streaks,disease,1.0,26795418
44243,aflibercept,gene,0.9883,26795411
44244,choroidal neovascularisation,disease,1.0,26795411
44245,angioid streaks,disease,1.0,26795411
44246,bevacizumab,gene,0.7383,26793998
44247,ranibizumab,gene,0.845,26793998
44248,aflibercept,gene,0.985,26793998
44249,ARPE-19 cells,cell_line,0.527,26793998
44250,bevacizumab,gene,0.7417,26793998
44251,ranibizumab,gene,0.857,26793998
44252,aflibercept,gene,0.9854,26793998
44253,ARPE-19,cell_line,0.815,26793998
44254,ARPE-19 cells,cell_type,0.5386,26793998
44255,MTT,drug,0.9985,26793998
44256,BrdU,drug,0.8223,26793998
44257,VEGF,gene,0.9717,26793998
44258,Caspase-3,gene,0.9834,26793998
44259,anti-VEGFs,gene,0.9224,26793998
44260,RPE,cell_type,0.464,26793998
44261,RPE cell,cell_type,0.8296,26793998
44262,VEGF,gene,0.8525,26793998
44263,H2O2,drug,0.9995,26793998
44264,anti-VEGF,gene,0.9233,26793998
44265,caspase-3,gene,0.9927,26793998
44266,anti-VEGFs,gene,0.9263,26793998
44267,H2O2,drug,0.9995,26793998
44268,VEGF,gene,0.994,26793998
44269,anti-VEGFs,gene,0.696,26793998
44270,RPE barrier,cell_type,0.528,26793998
44271,VEGF Agent,gene,0.787,26783500
44272,Aflibercept,gene,0.933,26783500
44273,Cancer,disease,1.0,26783500
44274,vascular endothelial growth factor,gene,0.936,26783500
44275,VEGF,gene,0.9985,26783500
44276,cancer,disease,0.999,26783500
44277,aflibercept,gene,0.9775,26783500
44278,aflibercept,gene,0.9614,26783500
44279,VEGF,gene,0.9824,26783500
44280,aflibercept,gene,0.755,26783500
44281,Aflibercept,gene,0.945,26782727
44282,Diabetic Macular Edema,disease,1.0,26782727
44283,Diabetic retinopathy,disease,1.0,26782727
44284,diabetic macular edema,disease,1.0,26782727
44285,vision loss,disease,0.9976,26782727
44286,diabetic microvascular abnormality,disease,1.0,26782727
44287,Aflibercept,gene,0.916,26782727
44288,diabetic macular edema,disease,1.0,26782727
44289,"VEGF A, B",gene,0.998,26782727
44290,P1GF,gene,0.858,26782727
44291,aflibercept,gene,0.983,26782727
44292,ranibizumab,gene,0.8677,26782727
44293,bevacizumab,gene,0.6875,26782727
44294,diabetic macular edema,disease,1.0,26782727
44295,aflibercept,gene,0.9873,26782727
44296,aflibercept,gene,0.981,26782727
44297,aflibercept,gene,0.996,26781585
44298,ranibizumab,drug,0.5864,26781585
44299,aflibercept,gene,0.9883,26781585
44300,ranibizumab,drug,0.602,26781585
44301,neovascular age-related macular degeneration,disease,1.0,26781585
44302,AMD,disease,1.0,26781585
44303,patients,species,0.989,26781585
44304,neovascular AMD,disease,1.0,26781585
44305,aflibercept,gene,0.9736,26781585
44306,ranibizumab,drug,0.7935,26781585
44307,aflibercept,gene,0.929,26781585
44308,aflibercept,gene,0.996,26781585
44309,ranibizumab,gene,0.8604,26781585
44310,aflibercept,gene,0.888,26781585
44311,ranibizumab,gene,0.7915,26781585
44312,aflibercept,gene,0.9907,26781585
44313,Choroidal thinning,disease,1.0,26781585
44314,aflibercept,gene,0.9917,26781585
44315,aflibercept,gene,0.97,26780597
44316,choroidal neovascularization,disease,1.0,26780597
44317,serpiginous choroiditis,disease,1.0,26780597
44318,anti-EFGR,gene,0.9434,26780078
44319,aflibercept,gene,0.9956,26780078
44320,cetuximab,gene,0.8813,26780078
44321,colon adenocarcinoma,disease,1.0,26780078
44322,cetuximab,gene,0.921,26780078
44323,aflibercept,gene,0.99,26780078
44324,Neovascular Age-Related Macular Degeneration,disease,1.0,26778346
44325,neovascular age-related macular degeneration,disease,1.0,26778346
44326,nAMD,disease,1.0,26778346
44327,vascular endothelial growth factor,gene,0.9897,26778346
44328,VEGF,gene,0.9956,26778346
44329,PARTICIPANTS,species,0.577,26778346
44330,nAMD,disease,1.0,26778346
44331,nAMD,disease,1.0,26778346
44332,nAMD,disease,1.0,26778346
44333,Fc-receptors,gene,0.9946,26773870
44334,Fc,gene,0.9556,26773870
44335,Fc,gene,0.8467,26773870
44336,RPE cells,cell_type,0.907,26773870
44337,Fc-receptors,gene,0.991,26773870
44338,Fc-receptors,gene,0.9985,26773870
44339,neonatal Fc-receptor,gene,0.998,26773870
44340,FcRn,gene,0.996,26773870
44341,VEGF,gene,0.9854,26773870
44342,bevacizumab,gene,0.61,26773870
44343,aflibercept,gene,0.9897,26773870
44344,anti-CD20 antibody rituximab,gene,0.9565,26773870
44345,primary porcine RPE cells,cell_type,0.8315,26773870
44346,porcine,species,0.6616,26773870
44347,ARPE-19 cells,cell_line,0.853,26773870
44348,porcine,species,0.819,26773870
44349,Fc-receptors,gene,0.996,26773870
44350,primary porcine RPE cells,cell_line,0.715,26773870
44351,porcine,species,0.9106,26773870
44352,Fc-receptors I and II,gene,0.998,26773870
44353,FcRn,gene,0.987,26773870
44354,bevacizumab,gene,0.91,26773870
44355,rituximab,gene,0.984,26773870
44356,aflibercept,gene,0.987,26773870
44357,Fc-receptors,gene,0.9946,26773870
44358,genistein,drug,0.9985,26773870
44359,R406,drug,0.9873,26773870
44360,FcRn,gene,0.9927,26773870
44361,IgG,gene,0.866,26773870
44362,porcine RPE cells,cell_type,0.839,26773870
44363,porcine,species,0.8335,26773870
44364,rituximab,gene,0.9717,26773870
44365,ARPE-19 cells,cell_line,0.97,26773870
44366,bevacizumab,gene,0.9336,26773870
44367,rituximab,gene,0.9736,26773870
44368,myosin7a,gene,0.988,26773870
44369,FcRn,gene,0.994,26773870
44370,FcRn,gene,0.9956,26773870
44371,myosin7a,gene,0.9766,26773870
44372,myosin7a,gene,0.989,26773870
44373,FcRn,gene,0.992,26773870
44374,Fc,drug,0.4497,26773870
44375,FcRn,gene,0.991,26773870
44376,Fc,gene,0.9775,26773870
44377,IgG,gene,0.988,26773870
44378,RPE,cell_type,0.521,26773870
44379,RPE/choroid explants,cell_line,0.544,26773870
44380,FcRn,gene,0.9917,26773870
44381,bevacizumab,gene,0.705,26773870
44382,FcRn,gene,0.9917,26773870
44383,bevacizumab,gene,0.8633,26773870
44384,FcRn,gene,0.995,26773870
44385,Fc-receptors,gene,0.997,26773870
44386,Fc,gene,0.986,26773870
44387,RPE,cell_type,0.8438,26773870
44388,FcRn,gene,0.994,26773870
44389,VEGF-A,gene,0.837,26771090
44390,endothelial cells,cell_type,0.951,26771090
44391,VEGF-A,gene,0.8403,26771090
44392,Ranibizumab,gene,0.902,26771090
44393,Aflibercept,gene,0.9683,26771090
44394,VEGFs,DNA,0.511,26771090
44395,VEGFs family members,gene,0.984,26771090
44396,endothelial cells,cell_type,0.9473,26771090
44397,HECV,cell_line,0.881,26771090
44398,HECV cells,cell_line,0.658,26771090
44399,Ranibizumab,gene,0.8315,26771090
44400,Aflibercept,gene,0.9062,26771090
44401,Ranibizumab,gene,0.895,26771090
44402,Aflibercept,gene,0.9805,26771090
44403,VEGF-A,gene,0.999,26771090
44404,VEGF-B,gene,0.999,26771090
44405,VEGF-C,gene,0.9995,26771090
44406,PlGF,gene,0.9956,26771090
44407,VEGF-A,gene,0.998,26771090
44408,VEGF-C,gene,0.9985,26771090
44409,VEGFR2,gene,0.9946,26771090
44410,vegf,gene,0.5605,26771090
44411,Ranibizumab,gene,0.844,26771090
44412,Aflibercept,gene,0.972,26771090
44413,HECV,cell_line,0.4924,26771090
44414,Ranibizumab,gene,0.6475,26771090
44415,mRNA,RNA,0.8247,26771090
44416,VEGF-A,gene,0.997,26771090
44417,VEGF-C,gene,0.9966,26771090
44418,VEGFR2,gene,0.994,26771090
44419,VEGF-A,gene,0.9966,26771090
44420,HECV cells,cell_line,0.58,26771090
44421,Aflibercept,gene,0.94,26771090
44422,mRNA,RNA,0.829,26771090
44423,"VEGF-A, -B",gene,0.997,26771090
44424,PlGF,gene,0.949,26771090
44425,phVEGFR2,gene,0.966,26771090
44426,VEGF-A,gene,0.998,26771090
44427,VEGF-C,gene,0.9976,26771090
44428,VEGF-B,gene,0.998,26771090
44429,Aflibercept,gene,0.968,26771090
44430,anti-VEGFs,gene,0.917,26771090
44431,VEGF-A,gene,0.998,26771090
44432,VEGF-B,gene,0.9976,26771090
44433,VEGF-C mRNA,gene,0.848,26771090
44434,VEGFR2,gene,0.9917,26771090
44435,Ranibizumab,gene,0.963,26771090
44436,Aflibercept,gene,0.985,26771090
44437,endothelial cells,cell_type,0.9316,26771090
44438,Ranibizumab,gene,0.7163,26771090
44439,Aflibercept,gene,0.97,26771090
44440,endothelial cells,cell_type,0.936,26771090
44441,Aflibercept,gene,0.985,26748058
44442,Diabetic,disease,0.684,26748058
44443,patients,species,0.9688,26748058
44444,diabetic macular edema,disease,0.9995,26748058
44445,DME,disease,1.0,26748058
44446,bevacizumab,gene,0.6943,26748058
44447,ranibizumab,gene,0.663,26748058
44448,aflibercept,gene,0.973,26748058
44449,ranibizumab,drug,0.8335,26748058
44450,aflibercept,gene,0.993,26748058
44451,patient,species,0.99,26748058
44452,patients,species,0.9717,26748058
44453,bevacizumab,drug,0.5557,26748058
44454,ranibizumab,drug,0.877,26748058
44455,aflibercept,gene,0.9814,26748058
44456,aflibercept,gene,0.9893,26748058
44457,aflibercept,gene,0.9707,26748058
44458,DME,disease,1.0,26748058
44459,Ranibizumab,gene,0.8926,26747252
44460,Aflibercept,gene,0.9526,26747252
44461,Macular Edema,disease,1.0,26747252
44462,Ranibizumab,gene,0.7983,26747252
44463,aflibercept,gene,0.964,26747252
44464,vascular endothelial growth factor,gene,0.934,26747252
44465,macular edema,disease,1.0,26747252
44466,branch retinal vein occlusion,disease,1.0,26747252
44467,BRVO,disease,1.0,26747252
44468,ranibizumab,gene,0.723,26747252
44469,aflibercept,gene,0.9595,26747252
44470,BRVO,disease,1.0,26747252
44471,Patient,species,0.983,26747252
44472,ranibizumab,gene,0.854,26747252
44473,aflibercept,gene,0.9824,26747252
44474,ranibizumab,gene,0.5854,26747252
44475,aflibercept,gene,0.964,26747252
44476,Patients,species,0.99,26747252
44477,patient,species,0.9897,26747252
44478,ranibizumab,gene,0.848,26747252
44479,aflibercept,gene,0.9478,26747252
44480,Ranibizumab,gene,0.854,26747252
44481,aflibercept,gene,0.9795,26747252
44482,ranibizumab,gene,0.79,26747252
44483,Ranibizumab,gene,0.9,26747252
44484,aflibercept,gene,0.962,26747252
44485,visual impairment,disease,1.0,26747252
44486,macular edema,disease,1.0,26747252
44487,BRVO,disease,1.0,26747252
44488,Ranibizumab,gene,0.7163,26747252
44489,advanced colorectal cancer,disease,0.997,26730280
44490,metastatic colorectal cancer,disease,0.93,26730280
44491,Aflibercept,gene,0.967,26730280
44492,human vascular endothelial growth factor receptors (VEGFR) 1 and 2,gene,0.997,26730280
44493,human,species,0.8394,26730280
44494,Fc,gene,,26730280
44495,human,species,0.9697,26730280
44496,immunoglobulin G1,gene,0.9917,26730280
44497,IgG1,gene,0.997,26730280
44498,folfiri,drug,0.949,26730280
44499,patients,species,0.9917,26730280
44500,folfox,drug,0.9395,26730280
44501,bevacizumab,gene,0.9497,26730280
44502,human IgG1 monoclonal antibody,gene,0.942,26730280
44503,human,species,0.908,26730280
44504,VEGFR-2,gene,0.9917,26730280
44505,Tas-102,drug,0.969,26730280
44506,fluoropyrimidine,drug,0.988,26730280
44507,regorafenib,drug,0.9893,26730280
44508,tyrosine,drug,0.9805,26730280
44509,tyrosine kinase,gene,0.9824,26730280
44510,patients,species,0.9937,26730280
44511,regorafenib,drug,0.9844,26730280
44512,Tas-,drug,0.8916,26730280
44513,patients,species,0.9775,26730280
44514,Human,species,0.9087,26728464
44515,VEGF,gene,0.9956,26728464
44516,VEGF dual dAb,gene,0.9453,26728464
44517,VEGF,gene,0.9946,26728464
44518,VEGF,gene,0.994,26728464
44519,anti-VEGF,gene,0.881,26728464
44520,VEGF,gene,0.993,26728464
44521,bevacizumab,gene,0.666,26728464
44522,VEGF,gene,0.9897,26728464
44523,VEGF,gene,0.991,26728464
44524,VEGF,gene,0.996,26728464
44525,aflibercept,gene,0.9863,26728464
44526,VEGF dual dAb,gene,0.94,26728464
44527,anti-VEGF domain antibodies,gene,0.991,26728464
44528,human IgG1 Fc domain,gene,0.9478,26728464
44529,human,species,0.9473,26728464
44530,VEGF dual dAb,gene,0.8447,26728464
44531,VEGF,gene,0.9937,26728464
44532,Bevacizumab,gene,0.8896,26720459
44533,Aflibercept,gene,0.9536,26720459
44534,Platelets,cell_type,0.792,26720459
44535,FcRIIa,gene,0.9873,26720459
44536,VEGF,gene,0.9946,26720459
44537,platelets,cell_type,0.8564,26720459
44538,AMD,disease,1.0,26720459
44539,patients,species,0.987,26720459
44540,Platelets,cell_type,0.7505,26720459
44541,platelet,cell_type,0.6226,26720459
44542,HEPES,drug,0.585,26720459
44543,Platelet,cell_type,0.732,26720459
44544,VEGF,gene,0.997,26720459
44545,bevacizumab,gene,0.7524,26720459
44546,VEGF-A,gene,0.9976,26720459
44547,bevacizumab,gene,0.753,26720459
44548,VEGF-A,gene,0.5776,26720459
44549,ranibizumab,gene,0.9106,26720459
44550,VEGF-A,gene,0.998,26720459
44551,bevacizumab,gene,0.702,26720459
44552,AMD,disease,1.0,26720459
44553,patient,species,0.9863,26720459
44554,VEGF-B,gene,0.9966,26720459
44555,aflibercept,gene,0.9893,26720459
44556,placental growth factor,gene,0.997,26720459
44557,PlGF,gene,0.9897,26720459
44558,aflibercept,gene,0.9927,26720459
44559,FcRIIa antibody,gene,0.943,26720459
44560,bevacizumab,gene,0.898,26720459
44561,aflibercept,gene,0.9785,26720459
44562,platelets,cell_type,0.8613,26720459
44563,FcRIIa,gene,0.991,26720459
44564,Aflibercept,gene,0.9697,26719668
44565,choroidal neovascularization,disease,1.0,26719668
44566,Choroidal neovascularization,disease,1.0,26719668
44567,CNV,disease,1.0,26719668
44568,age-related macular degeneration,disease,1.0,26719668
44569,AMD,disease,1.0,26719668
44570,neovascular AMD,disease,0.9966,26719668
44571,CNV,disease,0.998,26719668
44572,Vascular endothelial growth factor,gene,0.998,26719668
44573,VEGF,gene,0.9956,26719668
44574,neovascular AMD,disease,1.0,26719668
44575,Aflibercept,gene,0.9844,26719668
44576,VEGF,gene,0.9814,26719668
44577,anti-VEGF,gene,0.808,26719668
44578,neovascular AMD,disease,0.9985,26719668
44579,aflibercept,gene,0.9927,26719668
44580,VEGF,gene,0.992,26719668
44581,VEGF,gene,0.6553,26719668
44582,VEGF,gene,0.993,26719668
44583,CNV,DNA,0.731,26719668
44584,aflibercept,gene,0.9756,26719668
44585,CNV,disease,1.0,26719668
44586,aflibercept,gene,0.9175,26719668
44587,CNV,disease,0.9985,26719668
44588,CNV,disease,0.9834,26719668
44589,CNV,disease,1.0,26719668
44590,polypoidal choroidal vasculopathy,disease,1.0,26719668
44591,patient,species,0.9854,26719668
44592,aflibercept,gene,0.9824,26719668
44593,aflibercept,gene,0.9893,26719668
44594,neovascular AMD,disease,1.0,26719668
44595,cystoid macular oedema,disease,1.0,26719492
44596,retinal vein,disease,0.8784,26719492
44597,cystoid macular oedema,disease,1.0,26719492
44598,CMO,disease,1.0,26719492
44599,retinal vein occlusion,disease,1.0,26719492
44600,RVO,disease,1.0,26719492
44601,antivascular endothelial growth factor,gene,0.973,26719492
44602,aflibercept,gene,0.9927,26719492
44603,bevacizumab,gene,0.9214,26719492
44604,ranibizumab,gene,0.9214,26719492
44605,CMO,disease,1.0,26719492
44606,RVO,disease,1.0,26719492
44607,patients,species,0.9854,26719492
44608,CMO,disease,1.0,26719492
44609,branch RVO,disease,0.9634,26719492
44610,BRVO,disease,0.9995,26719492
44611,CMO,disease,1.0,26719492
44612,patient,species,0.9854,26719492
44613,VEGF,gene,0.8984,26719492
44614,patients,species,0.979,26719492
44615,BRVO,disease,1.0,26719492
44616,bevacizumab,gene,0.6206,26719492
44617,aflibercept,gene,0.9727,26719492
44618,physicians,cell_type,0.4524,26719492
44619,ranibizumab,gene,0.5,26719492
44620,bevacizumab,gene,0.646,26719492
44621,aflibercept,gene,0.86,26719492
44622,patients,species,0.9683,26719492
44623,CRVO,disease,1.0,26719492
44624,bevacizumab,gene,0.673,26719492
44625,aflibercept,gene,0.984,26719492
44626,aflibercept,gene,0.9707,26719492
44627,bevacizumab,gene,0.767,26719492
44628,ranibizumab,drug,0.599,26719492
44629,patients,species,0.986,26719492
44630,RETINAL VEIN OCCLUSIONS,disease,1.0,26716954
44631,retinal vein occlusions,disease,1.0,26716954
44632,RVOs,disease,1.0,26716954
44633,RVO,disease,1.0,26716954
44634,Retinal vein occlusions,disease,1.0,26716954
44635,RVO,disease,1.0,26716954
44636,RVO,disease,0.9785,26716954
44637,RVO,disease,0.99,26716954
44638,RVOs,disease,1.0,26716954
44639,RVO,disease,0.55,26716954
44640,Retinal vein occlusion,disease,1.0,26716954
44641,blindness,disease,0.999,26716954
44642,RVO,disease,1.0,26716954
44643,bevacizumab,gene,0.9487,26716954
44644,ranibizumab,gene,0.9546,26716954
44645,aflibercept,gene,0.985,26716954
44646,triamcinolone,drug,0.9995,26716954
44647,dexamethasone,drug,0.999,26716954
44648,RVO,disease,1.0,26716954
44649,visual loss,disease,0.9995,26716954
44650,Bevacizumab,gene,0.8325,26714801
44651,Colorectal Brain Metastasis,disease,1.0,26714801
44652,Brain metastases,disease,0.8887,26714801
44653,patients,species,0.9375,26714801
44654,colorectal cancer,disease,1.0,26714801
44655,intracranial hemorrhage,disease,0.9985,26714801
44656,patients,species,0.9717,26714801
44657,colorectal brain metastases,disease,1.0,26714801
44658,bevacizumab,gene,0.918,26714801
44659,aflibercept,gene,0.979,26714801
44660,PATIENTS,species,0.8647,26714801
44661,patients,species,0.974,26714801
44662,colorectal brain metastases,disease,0.9985,26714801
44663,bevacizumab,gene,0.7466,26714801
44664,patients,species,0.9893,26714801
44665,brain metastases,disease,0.9385,26714801
44666,brain metastases,disease,0.9526,26714801
44667,patients,species,0.981,26714801
44668,hypertension,disease,1.0,26714801
44669,diarrhea,disease,1.0,26714801
44670,fatigue,disease,0.9995,26714801
44671,intracranial hemorrhage,disease,1.0,26714801
44672,Bevacizumab,gene,0.9087,26714801
44673,patients,species,0.9663,26714801
44674,colorectal brain metastasis,disease,1.0,26714801
44675,POLYPOIDAL CHOROIDAL VASCULOPATHY,disease,1.0,26710307
44676,patients,species,0.9263,26710307
44677,polypoidal choroidal vasculopathy,disease,1.0,26710307
44678,aflibercept,gene,0.9756,26710307
44679,patients,species,0.9736,26710307
44680,polypoidal choroidal vasculopathy,disease,1.0,26710307
44681,patients,species,0.9897,26710307
44682,polyps,disease,0.9995,26710307
44683,indocyanine-green,drug,0.9946,26710307
44684,polyp,disease,0.995,26710307
44685,patients,species,0.9487,26710307
44686,polypoidal choroidal vasculopathy,disease,1.0,26710307
44687,Aflibercept,gene,0.9604,26706237
44688,FOLFIRI,drug,0.8496,26706237
44689,FOLFIRI,drug,0.9556,26706237
44690,aflibercept,gene,0.9927,26706237
44691,5-fluorouracil,drug,0.999,26706237
44692,5-FU,drug,0.9995,26706237
44693,leucovorin,drug,0.999,26706237
44694,irinotecan,drug,0.9985,26706237
44695,FOLFIRI,drug,0.9785,26706237
44696,patients,species,0.8555,26706237
44697,metastatic colorectal cancer,disease,1.0,26706237
44698,mCRC,disease,0.994,26706237
44699,oxaliplatin,drug,0.999,26706237
44700,oxaliplatin,drug,0.9995,26706237
44701,patients,species,0.991,26706237
44702,bevacizumab,gene,0.59,26706237
44703,VELOUR,cell_line,0.561,26706237
44704,aflibercept,gene,0.978,26706237
44705,FOLFIRI,drug,0.921,26706237
44706,FOLFIRI,drug,0.965,26706237
44707,patients,species,0.9917,26706237
44708,bevacizumab,gene,0.895,26706237
44709,aflibercept,gene,0.9873,26706237
44710,FOLFIRI,drug,0.92,26706237
44711,FOLFIRI,drug,0.9214,26706237
44712,aflibercept,gene,0.928,26706237
44713,bevacizumab,gene,0.599,26706237
44714,patients,species,0.983,26706237
44715,aflibercept,gene,0.9937,26706237
44716,patients,species,0.9644,26706237
44717,mCRC,disease,0.9795,26706237
44718,Macular Edema,disease,1.0,26692257
44719,macular edema,disease,1.0,26692257
44720,retinal vein occlusion,disease,1.0,26692257
44721,RVO,disease,1.0,26692257
44722,dexamethasone,drug,0.999,26692257
44723,ranibizumab,gene,0.724,26692257
44724,aflibercept,gene,0.983,26692257
44725,aflibercept,gene,0.9897,26692257
44726,ranibizumab,gene,0.7075,26692257
44727,vascular endothelial growth factor,gene,0.998,26692257
44728,macular edema,disease,1.0,26692257
44729,RVO,disease,1.0,26692257
44730,dexamethasone,drug,0.994,26692257
44731,cataract,disease,1.0,26692257
44732,dexamethasone,drug,0.9907,26692257
44733,dexamethasone,drug,0.9966,26692257
44734,ranibizumab,gene,0.888,26692257
44735,macular edema,disease,1.0,26692257
44736,retinal ischemia,disease,0.9688,26692257
44737,patients,species,0.919,26692257
44738,RVO,disease,1.0,26692257
44739,Aflibercept,gene,0.9663,26686967
44740,aflibercept,gene,0.9834,26686967
44741,neovascular age-related macular degeneration,disease,0.9995,26686967
44742,AMD,disease,1.0,26686967
44743,PARTICIPANTS,species,0.776,26686967
44744,patients,species,0.974,26686967
44745,neovascular AMD,disease,1.0,26686967
44746,patients,species,0.984,26686967
44747,neovascular AMD,disease,1.0,26686967
44748,polypoidal choroidal vasculopathy,disease,1.0,26686967
44749,PCV,disease,1.0,26686967
44750,PCV,disease,1.0,26686967
44751,neovascular AMD,disease,1.0,26686967
44752,retinal fluid,disease,0.997,26686967
44753,retinal fluid,disease,0.9985,26686967
44754,neovascular AMD,disease,1.0,26686967
44755,PCV,disease,1.0,26686967
44756,neovascular AMD,disease,1.0,26686967
44757,Ziv-aflibercept,gene,0.9585,26682842
44758,polypoidal choroidal Polypoidal choroidal vasculopathy,disease,1.0,26682842
44759,PCV,disease,1.0,26682842
44760,exudative maculopathy,disease,1.0,26682842
44761,ranibizumab,gene,0.78,26682842
44762,bevacizumab,gene,0.727,26682842
44763,intra-retinal fluid,disease,0.998,26682842
44764,aflibercept,gene,0.9873,26682842
44765,Ziv-aflibercept,gene,0.917,26682842
44766,Zaltrap,gene,0.7485,26682842
44767,aflibercept,gene,0.983,26682842
44768,macular oedema,disease,1.0,26682842
44769,PCV,disease,1.0,26682842
44770,ranibizumab,gene,0.612,26682842
44771,ziv-aflibercept,gene,0.988,26682842
44772,Fluocinolone acetonide,drug,0.9985,26681198
44773,diabetic macular edema,disease,1.0,26681198
44774,VEGF,gene,0.9917,26681198
44775,ranibizumab,gene,0.801,26681198
44776,aflibercept,gene,0.9214,26681198
44777,bevacizumab,gene,0.8296,26681198
44778,steroids,drug,0.745,26681198
44779,DME,disease,1.0,26681198
44780,DME,disease,1.0,26681198
44781,dexamethasone,drug,0.9985,26681198
44782,fluocinolone acetat,drug,0.9985,26681198
44783,Iluvien,drug,0.9927,26681198
44784,patients,species,0.978,26681198
44785,DME,disease,0.9995,26681198
44786,cataract,disease,0.999,26681198
44787,phakic,disease,0.986,26681198
44788,patients,species,0.9795,26681198
44789,patients,species,0.9893,26681198
44790,Diabetic Retinopathy,disease,1.0,26676668
44791,Diabetic retinopathy,disease,1.0,26676668
44792,diabetes mellitus,disease,1.0,26676668
44793,visual loss,disease,0.9995,26676668
44794,diabetic macular edema,disease,1.0,26676668
44795,DME,disease,1.0,26676668
44796,vascular endothelial growth factor,gene,0.9126,26676668
44797,VEGF,gene,0.653,26676668
44798,VEGF,gene,0.8726,26676668
44799,DME,disease,1.0,26676668
44800,aflibercept,gene,0.984,26676668
44801,patients,species,0.9937,26676668
44802,proliferative diabetic retinopathy,disease,1.0,26676668
44803,PDR,disease,1.0,26676668
44804,ranibizumab,gene,0.9365,26676668
44805,aflibercept,gene,0.9766,26676668
44806,diabetic retinopathy,disease,1.0,26676668
44807,DME,disease,1.0,26676668
44808,PDR,disease,0.998,26676668
44809,small interfering RNAs,RNA,0.7974,26676668
44810,kallikrein,gene,0.7812,26676668
44811,kinin,gene,0.9814,26676668
44812,diabetic retinopathy,disease,1.0,26676668
44813,DME,disease,1.0,26676668
44814,diabetic retinopathy,disease,1.0,26676668
44815,diabetic macular edema,disease,1.0,26674182
44816,VEGF,gene,0.7515,26674182
44817,diabetic macular edema,disease,1.0,26674182
44818,DME,disease,1.0,26674182
44819,VEGF,gene,0.997,26674182
44820,DME,disease,1.0,26674182
44821,anti-VEGF,gene,0.854,26674182
44822,anti-VEGF,gene,0.892,26674182
44823,DME,disease,1.0,26674182
44824,DME,disease,1.0,26674182
44825,anti-VEGF,gene,0.948,26674182
44826,DME,disease,1.0,26674182
44827,aflibercept,gene,0.991,26674182
44828,bevacizumab,gene,0.9097,26674182
44829,ranibizumab,gene,0.8413,26674182
44830,refractory,disease,0.5957,26674182
44831,macular edema,disease,0.9907,26674182
44832,VEGF,gene,0.9946,26674182
44833,DME,disease,1.0,26674182
44834,patients,species,0.964,26674182
44835,DME,disease,1.0,26674182
44836,vision loss,disease,0.973,26674182
44837,bevacizumab,gene,0.6924,26674182
44838,aflibercept,gene,0.9775,26674182
44839,patients,species,0.987,26674182
44840,visual loss,disease,0.9985,26674182
44841,bevacizumab,gene,0.8057,26674182
44842,aflibercept,gene,0.8516,26674182
44843,pseudophakic,disease,0.994,26674182
44844,patients,species,0.9785,26674182
44845,VEGF,gene,0.6035,26674182
44846,DME,disease,1.0,26674182
44847,aflibercept,gene,0.99,26669334
44848,exudative age-related macular BACKGROUND,disease,0.9272,26669334
44849,exudative age-related macular degeneration,disease,1.0,26669334
44850,aflibercept,gene,0.968,26669334
44851,ranibizumab,gene,0.8022,26669334
44852,ranibizumab,gene,0.7812,26669334
44853,ranibizumab,gene,0.7075,26669334
44854,ranibizumab,gene,0.6763,26669334
44855,aflibercept,gene,0.9756,26669334
44856,ranibizumab,gene,0.613,26669334
44857,aflibercept,gene,0.986,26669334
44858,ranibizumab,gene,0.878,26669334
44859,ranibizumab,gene,0.685,26669334
44860,aflibercept,gene,0.969,26669334
44861,intraretinal macular fluid,disease,1.0,26669334
44862,aflibercept,gene,0.971,26669334
44863,aflibercept,gene,0.976,26669334
44864,intraretinal macular fluid,disease,1.0,26669334
44865,ranibizumab,gene,0.9624,26669334
44866,aflibercept,gene,0.9595,26669334
44867,neovascular age-related macular degeneration,disease,1.0,26661463
44868,intraretinal cystoid fluid,disease,0.958,26661463
44869,IRC,disease,0.813,26661463
44870,BCVA,DNA,0.748,26661463
44871,neovascular age-related macular degeneration,disease,0.9995,26661463
44872,PARTICIPANTS,species,0.536,26661463
44873,patients,species,0.989,26661463
44874,subfoveal choroidal neovascularization,disease,1.0,26661463
44875,ranibizumab,gene,0.6465,26661463
44876,aflibercept,gene,0.9165,26661463
44877,IRC,disease,1.0,26661463
44878,SRF,disease,1.0,26661463
44879,annotation,DNA,0.5977,26661463
44880,BCVA,DNA,0.4658,26661463
44881,SRF,DNA,0.5117,26661463
44882,patients,species,0.973,26661463
44883,Diabetic Retinopathy,disease,0.9927,26661463
44884,foveal,DNA,0.58,26661463
44885,IRC,DNA,0.4944,26661463
44886,neurosensory,disease,0.7085,26661463
44887,ziv-aflibercept,gene,0.9917,26655620
44888,Zaltrap,gene,0.821,26655620
44889,choroidal neovascularization,disease,1.0,26655620
44890,age-related macular degeneration,disease,1.0,26655620
44891,choroidal neovascularization,disease,1.0,26655620
44892,age-related macular degeneration,disease,1.0,26655620
44893,ziv-aflibercept,gene,0.9756,26655620
44894,patients,species,0.984,26655620
44895,patients,species,0.976,26655620
44896,blurred vision,disease,0.9995,26655620
44897,ocular pain,disease,0.985,26655620
44898,bulbar injection,disease,1.0,26655620
44899,intraocular inflammation,disease,1.0,26655620
44900,patients,species,0.982,26655620
44901,ziv-aflibercept,gene,0.972,26655620
44902,neovascular age-related macular degeneration,disease,1.0,26655620
44903,Ziv-aflibercept,gene,0.974,26655620
44904,macular diseases,disease,1.0,26655620
44905,aflibercept,gene,0.8965,26655620
44906,Eylea,gene,0.735,26655620
44907,Aflibercept,gene,0.9775,26648523
44908,Galectin-1,gene,0.986,26648523
44909,Vascular endothelial growth factor,gene,0.931,26648523
44910,VEGF)-A,gene,0.762,26648523
44911,cancer,disease,1.0,26648523
44912,proliferative diabetic retinopathy,disease,1.0,26648523
44913,PDR,disease,1.0,26648523
44914,VEGF-A,gene,0.995,26648523
44915,aflibercept,gene,0.9453,26648523
44916,VEGFR1,gene,0.9966,26648523
44917,VEGFR2,gene,0.9985,26648523
44918,Fc,gene,,26648523
44919,IgG1,gene,0.947,26648523
44920,VEGFR1,gene,0.998,26648523
44921,VEGFR2,gene,0.9985,26648523
44922,Fc,gene,0.982,26648523
44923,aflibercept,gene,0.989,26648523
44924,VEGF family members,gene,0.99,26648523
44925,galectin-1,gene,0.9966,26648523
44926,aflibercept,gene,0.989,26648523
44927,aflibercept,gene,0.9634,26648523
44928,galectin-1,gene,0.995,26648523
44929,VEGFR1-Fc,gene,0.981,26648523
44930,VEGFR2-Fc,gene,0.987,26648523
44931,aflibercept,gene,0.9917,26648523
44932,N,drug,1.0,26648523
44933,N-glycosidase F,gene,0.9805,26648523
44934,LGALS1/Galectin-1 mRNA,RNA,0.706,26648523
44935,LGALS1,gene,0.9917,26648523
44936,Galectin-1,gene,0.9956,26648523
44937,diabetes,disease,1.0,26648523
44938,Galectin-1,gene,0.987,26648523
44939,VEGFR2,gene,0.9863,26648523
44940,neovascular tissues,cell_type,0.536,26648523
44941,human,species,0.982,26648523
44942,PDR,disease,1.0,26648523
44943,galectin-1 protein,gene,0.8867,26648523
44944,PDR,disease,0.999,26648523
44945,VEGF-A,gene,0.9956,26648523
44946,VEGF-A,gene,0.9463,26648523
44947,VEGF-A,gene,0.9976,26648523
44948,galectin-1,gene,0.992,26648523
44949,Galectin-1,gene,0.9746,26648523
44950,human retinal microvascular endothelial cells,cell_line,0.922,26648523
44951,human,species,0.9736,26648523
44952,VEGFR2,gene,0.9893,26648523
44953,aflibercept,gene,0.9624,26648523
44954,aflibercept,gene,0.9634,26648523
44955,galectin-1,gene,0.994,26648523
44956,PDR,disease,0.9995,26648523
44957,VEGF-A,gene,0.9985,26648523
44958,Aflibercept,gene,0.9927,26637166
44959,Neovascular Age-Related Macular,disease,1.0,26637166
44960,aflibercept,gene,0.995,26637166
44961,neovascular age-related macular degeneration,disease,0.911,26637166
44962,nAMD,disease,1.0,26637166
44963,patients,species,0.978,26637166
44964,nAMD,disease,1.0,26637166
44965,aflibercept,gene,0.9473,26637166
44966,nAMD,disease,1.0,26637166
44967,fluorescein,drug,0.9985,26637166
44968,bevacizumab,gene,0.852,26637166
44969,Patients,species,0.9565,26637166
44970,Retinal pigment epithelium atrophy,disease,1.0,26637166
44971,RPEA,disease,1.0,26637166
44972,BCVA,cell_type,0.424,26637166
44973,CRT,DNA,0.4927,26637166
44974,RPEA,DNA,0.6904,26637166
44975,arterial thromboembolic event,disease,0.9995,26637166
44976,submacular haemorrhage,disease,1.0,26637166
44977,nAMD,disease,1.0,26637166
44978,patients,species,0.9946,26637166
44979,aflibercept,gene,0.971,26637166
44980,ziv-aflibercept,gene,0.985,26632138
44981,macular edema,disease,1.0,26632138
44982,central retinal venous occlusion,disease,1.0,26632138
44983,GL261 Glioma,disease,0.866,26620211
44984,glioblastoma,disease,1.0,26620211
44985,tumor,disease,1.0,26620211
44986,tumors,disease,1.0,26620211
44987,GL261 glioma mouse model,cell_line,0.6997,26620211
44988,GL261 glioma,disease,0.89,26620211
44989,mouse,species,0.9746,26620211
44990,aflibercept,gene,0.9873,26620211
44991,vascular endothelial growth factor,gene,0.998,26620211
44992,tumor,disease,0.6216,26620211
44993,tumor,disease,0.999,26620211
44994,aflibercept,gene,0.9736,26620211
44995,tumor,disease,0.994,26620211
44996,tumors,disease,1.0,26620211
44997,vascular endothelial growth factor,gene,0.9985,26620211
44998,tumor,disease,0.97,26620211
44999,Aflibercept,gene,0.9727,26620211
45000,tumor,disease,0.999,26620211
45001,tumor,disease,0.9985,26620211
45002,gliomas,disease,1.0,26620211
45003,Mller glia,cell_type,0.5146,26607807
45004,VEGF,gene,0.985,26607807
45005,rat primary retinal cultures,cell_line,0.954,26607807
45006,rat,species,0.976,26607807
45007,Vascular Endothelial Growth Factor,gene,0.97,26607807
45008,VEGF,gene,0.9976,26607807
45009,ranibizumab,gene,0.7905,26607807
45010,aflibercept,gene,0.955,26607807
45011,Mller glia,cell_type,0.787,26607807
45012,primary mixed cultures,cell_line,0.69,26607807
45013,rat,species,0.9595,26607807
45014,neonatal,cell_type,0.5034,26607807
45015,Mller glia,cell_line,0.819,26607807
45016,Glial Fibrillary Acidic Protein,gene,0.998,26607807
45017,Extracellular-Regulated Kinase 1/2,gene,0.994,26607807
45018,ERK 1/2,gene,0.99,26607807
45019,activated Mller glia,cell_line,0.887,26607807
45020,activated,cell_type,0.4697,26607807
45021,Mller glia,cell_type,0.757,26607807
45022,aflibercept,gene,0.9785,26607807
45023,K(+),drug,1.0,26607807
45024,K,gene,0.7134,26607807
45025,Aquaporin 4,gene,0.9985,26607807
45026,AQP4,gene,0.9917,26607807
45027,VEGF,gene,0.991,26607807
45028,Mller cells,cell_type,0.807,26607807
45029,primary retinal cultures,cell_line,0.927,26607807
45030,Kir4,gene,0.676,26607807
45031,AQP4,gene,0.9595,26607807
45032,Mller glia,cell_type,0.705,26607807
45033,VEGF,gene,0.93,26607807
45034,gliotic,disease,0.657,26607807
45035,macular edema,disease,1.0,26607807
45036,diabetic macular edema,disease,1.0,26605836
45037,vascular endothelial growth factor,gene,0.964,26605836
45038,diabetic macular edema,disease,1.0,26605836
45039,PARTICIPANTS,species,0.601,26605836
45040,diabetic macular edema,disease,1.0,26605836
45041,aflibercept,gene,0.9717,26605836
45042,bevacizumab,gene,0.64,26605836
45043,ranibizumab,gene,0.6167,26605836
45044,aflibercept,gene,0.993,26605836
45045,bevacizumab,gene,0.829,26605836
45046,ranibizumab,gene,0.5737,26605836
45047,aflibercept,gene,0.9946,26605836
45048,bevacizumab,gene,0.772,26605836
45049,ranibizumab,drug,0.7046,26605836
45050,bevacizumab,gene,0.8965,26605836
45051,aflibercept,gene,0.9897,26605836
45052,bevacizumab,gene,0.7593,26605836
45053,ranibizumab,drug,0.5854,26605836
45054,aflibercept,gene,0.989,26605836
45055,bevacizumab,gene,0.8677,26605836
45056,bevacizumab,gene,0.7207,26605836
45057,aflibercept,gene,0.986,26605836
45058,ranibizumab,gene,0.592,26605836
45059,aflibercept,gene,0.9824,26605836
45060,ranibizumab,gene,0.7866,26605836
45061,patients,species,0.9824,26605836
45062,vascular endothelial growth factor,gene,0.9854,26604674
45063,choroidal neovascularization,disease,1.0,26604674
45064,age-related macular degeneration,disease,1.0,26604674
45065,aflibercept,gene,0.982,26604674
45066,ranibizumab,gene,0.637,26604674
45067,choroidal neovascularization,disease,1.0,26604674
45068,CNV,disease,1.0,26604674
45069,age-related macular degeneration,disease,1.0,26604674
45070,AMD,disease,1.0,26604674
45071,neovascular AMD,disease,1.0,26604674
45072,CNV,disease,0.9995,26604674
45073,ranibizumab,gene,0.5273,26604674
45074,ranibizumab,gene,0.514,26604674
45075,aflibercept,gene,0.9756,26604674
45076,aflibercept,gene,0.9707,26604674
45077,serous retinal detachments,disease,1.0,26604674
45078,retinal pigment epithelial elevation,disease,0.9995,26604674
45079,IAI,disease,0.9097,26604674
45080,aflibercept,gene,0.9854,26604674
45081,ranibizumab,gene,0.862,26604674
45082,aflibercept,gene,0.98,26604674
45083,VEGF,gene,0.8115,26604674
45084,CNV,disease,1.0,26604674
45085,neovascular AMD,disease,1.0,26604674
45086,PATIENTS,species,0.9126,26599245
45087,patients,species,0.981,26599245
45088,endophthalmitis,disease,1.0,26599245
45089,endophthalmitis,disease,0.998,26599245
45090,post,disease,0.869,26599245
45091,Aflibercept,gene,0.981,26599244
45092,Neovascular AMD,disease,1.0,26599244
45093,aflibercept,gene,0.9937,26599244
45094,neovascular age-related macular degeneration,disease,1.0,26599244
45095,nAMD,disease,1.0,26599244
45096,PATIENTS,species,0.9385,26599244
45097,patients,species,0.954,26599244
45098,nAMD,disease,1.0,26599244
45099,patients,species,0.9736,26599244
45100,glaucoma,disease,1.0,26595845
45101,vascular occlusive disease,disease,1.0,26595845
45102,glaucomas,disease,1.0,26595845
45103,vascular occlusive disease,disease,1.0,26595845
45104,Retinal ischemia,disease,0.9917,26595845
45105,neovascular glaucoma,disease,1.0,26595845
45106,VEGF,gene,0.9985,26595845
45107,bevacizumab,gene,0.859,26595845
45108,aflibercept,gene,0.9946,26595845
45109,VEGF,gene,0.7866,26595845
45110,glaucoma,disease,0.9985,26595845
45111,vascular occlusive disease,disease,1.0,26595845
45112,glaucoma,disease,1.0,26595845
45113,Aflibercept,gene,0.964,26595845
45114,glaucomas,disease,1.0,26595845
45115,vascular occlusive disease,disease,1.0,26595845
45116,VEGF,gene,0.5903,26595845
45117,aflibercept,gene,0.986,26595845
45118,endophthalmitis,disease,0.5044,26584579
45119,endophthalmitis,disease,1.0,26584579
45120,antivascular endothelial growth factor,gene,0.874,26584579
45121,VEGF,gene,0.996,26584579
45122,diabetic eye disease,disease,1.0,26584579
45123,neovascular age-related macular degeneration,disease,1.0,26584579
45124,AMD,disease,1.0,26584579
45125,retinal vein occlusion,disease,1.0,26584579
45126,RVO,disease,1.0,26584579
45127,patients,species,0.985,26584579
45128,bevacizumab,gene,0.8735,26584579
45129,ranibizumab,gene,0.9116,26584579
45130,aflibercept,gene,0.9644,26584579
45131,diabetic eye disease,disease,1.0,26584579
45132,neovascular AMD,disease,1.0,26584579
45133,RVO,disease,1.0,26584579
45134,anti-VEGF,gene,0.983,26584579
45135,Endophthalmitis,disease,1.0,26584579
45136,endophthalmitis,disease,1.0,26584579
45137,Patient,species,0.904,26584579
45138,endophthalmitis,disease,1.0,26584579
45139,anti-VEGF,gene,0.8647,26584579
45140,anti-VEGF,gene,0.741,26584579
45141,infectious endophthalmitis,disease,0.9985,26584579
45142,neovascular AMD,disease,1.0,26584579
45143,diabetic,disease,0.9995,26584579
45144,RVO,disease,0.9995,26584579
45145,endophthalmitis,disease,1.0,26584579
45146,diabetic eye disease,disease,1.0,26584579
45147,RVO,disease,1.0,26584579
45148,neovascular AMD,disease,1.0,26584579
45149,RVO,disease,1.0,26584579
45150,diabetic eye disease,disease,1.0,26584579
45151,neovascular AMD,disease,1.0,26584579
45152,neovascular AMD,disease,1.0,26584579
45153,patient,species,0.994,26584579
45154,diabetic eye disease,disease,1.0,26584579
45155,RVO,disease,0.8784,26584579
45156,Endophthalmitis,disease,1.0,26584579
45157,RVO,disease,1.0,26584579
45158,diabetic eye disease,disease,1.0,26584579
45159,neovascular AMD,disease,1.0,26584579
45160,diabetics,disease,0.998,26584579
45161,AMD,disease,1.0,26584579
45162,VEGFA,gene,0.9946,26578958
45163,retinal neovascular degenerative diseases,disease,1.0,26578958
45164,vascular endothelial growth factor A,gene,0.998,26578958
45165,VEGFA,gene,0.9976,26578958
45166,retinal diseases,disease,1.0,26578958
45167,ranibizumab,gene,0.5625,26578958
45168,bevacizumab,gene,0.9233,26578958
45169,aflibercept,gene,0.964,26578958
45170,anti-VEGF,gene,0.9946,26578958
45171,VEGFA,gene,0.998,26578958
45172,aflibercept,gene,0.9976,26578958
45173,VEGFA,gene,0.998,26578958
45174,ranibizumab,gene,0.898,26578958
45175,bevacizumab,gene,0.91,26578958
45176,aflibercept,gene,0.98,26578958
45177,VEGFA,gene,0.9976,26578958
45178,ranibizumab,gene,0.6675,26578958
45179,ranibizumab,gene,0.924,26578958
45180,VEGFA,gene,0.985,26578958
45181,hydrogen,drug,0.9976,26578958
45182,bevacizumab,gene,0.9346,26578958
45183,aflibercept,gene,0.987,26578958
45184,Aflibercept,gene,0.9634,26578446
45185,Aflibercept,gene,0.918,26578446
45186,patients,species,0.9497,26578446
45187,neovascular macular degeneration,disease,1.0,26578446
45188,nAMD,disease,1.0,26578446
45189,VEGF,gene,0.9956,26578446
45190,Wet AMD,disease,0.7764,26578446
45191,PARTICIPANTS,species,0.784,26578446
45192,patients,species,0.9873,26578446
45193,aflibercept,gene,0.9688,26578446
45194,nAMD,disease,1.0,26578446
45195,women,species,0.956,26578446
45196,aflibercept,gene,0.954,26578446
45197,patients,species,0.9834,26578446
45198,patients,species,0.994,26578446
45199,neovascular macular degeneration,disease,1.0,26568279
45200,vascular endothelial growth factor,gene,0.999,26568279
45201,VEGF,gene,0.996,26568279
45202,neovascular age-dependent macular degeneration,disease,1.0,26568279
45203,nAMD,disease,1.0,26568279
45204,cancer,disease,0.9995,26568279
45205,VEGF,gene,0.9907,26568279
45206,cancer,disease,0.9946,26568279
45207,nAMD,disease,1.0,26568279
45208,VEGF-inactivating proteins,gene,0.844,26568279
45209,loss of vision,disease,0.9873,26568279
45210,VEGF,gene,0.883,26568279
45211,nAMD,disease,1.0,26568279
45212,bevacizumab,gene,0.879,26568279
45213,Aflibercept,gene,0.984,26562136
45214,Patients,species,0.9937,26562136
45215,age related macular degeneration,disease,1.0,26562136
45216,ranibizumab,gene,0.6934,26562136
45217,patients,species,0.9883,26562136
45218,aflibercept,gene,0.6084,26562136
45219,patients,species,0.9854,26562136
45220,ranibizumab,gene,0.8037,26562136
45221,aflibercept,gene,0.965,26562136
45222,patients,species,0.9893,26562136
45223,ranibizumab,gene,0.8804,26562136
45224,aflibercept,gene,0.969,26562136
45225,ranibizumab,gene,0.724,26562136
45226,aflibercept,gene,0.9526,26562136
45227,Patients,species,0.9697,26562136
45228,choroidal neovascular,disease,0.8115,26562136
45229,aflibercept,gene,0.991,26562136
45230,aflibercept,gene,0.991,26562136
45231,aflibercept,gene,0.994,26562136
45232,aflibercept,gene,0.9814,26562136
45233,aflibercept,gene,0.9863,26562136
45234,choroidal neovascularisation,disease,1.0,26562136
45235,patients,species,0.989,26562136
45236,ranibizumab,gene,0.814,26562136
45237,endometrial cancer,disease,1.0,26560489
45238,Endometrial carcinoma,disease,1.0,26560489
45239,gynecologic tumor,disease,1.0,26560489
45240,low,cell_type,0.5073,26560489
45241,low-grade tumors,disease,0.998,26560489
45242,endometrial cancer,disease,1.0,26560489
45243,cancer,disease,1.0,26560489
45244,endometrial cancer,disease,1.0,26560489
45245,endometrial cancer,disease,1.0,26560489
45246,endometrial cancer,disease,1.0,26560489
45247,anti-,gene,0.6646,26560489
45248,vascular endothelial growth factor,gene,0.8774,26560489
45249,VEGF,gene,0.9946,26560489
45250,aflibercept,gene,0.9326,26560489
45251,mammalian target of rapamycin,gene,0.8276,26560489
45252,rapamycin,drug,0.997,26560489
45253,mTORi,gene,0.966,26560489
45254,everolimus,drug,0.999,26560489
45255,temsirolimus,drug,0.999,26560489
45256,ridaforolimus,drug,0.999,26560489
45257,PI3 K,gene,0.9966,26560489
45258,BKM120,drug,0.997,26560489
45259,tyrosine,drug,0.9824,26560489
45260,tyrosine kinase,gene,0.9927,26560489
45261,brivanib,drug,0.9995,26560489
45262,sunitinib,drug,0.9995,26560489
45263,dovitinib,drug,0.998,26560489
45264,nintedanib,drug,0.999,26560489
45265,thalidomide,drug,0.998,26560489
45266,endometrial cancer,disease,1.0,26560489
45267,metastatic colorectal cancer,disease,0.9907,26549053
45268,Colorectal cancer,disease,1.0,26549053
45269,CRC,disease,1.0,26549053
45270,cancer,disease,1.0,26549053
45271,vascular endothelial growth factor,gene,0.9976,26549053
45272,epidermal growth factor receptor,gene,0.9927,26549053
45273,EGFR,gene,0.995,26549053
45274,CRC,disease,0.998,26549053
45275,fluoropyrimidines,drug,0.9995,26549053
45276,irinotecan,drug,0.997,26549053
45277,oxaliplatin,drug,0.9995,26549053
45278,CRC,disease,0.9985,26549053
45279,bevacizumab,gene,0.828,26549053
45280,aflibercept,gene,0.9844,26549053
45281,metastatic CRC,disease,0.9185,26549053
45282,EGFR,gene,0.98,26549053
45283,cetuximab,gene,0.6777,26549053
45284,panitumumab,gene,0.6436,26549053
45285,wild,cell_line,0.596,26549053
45286,wild-type RAS tumors,disease,0.7856,26549053
45287,wild-type RAS,gene,0.9424,26549053
45288,regorafenib,drug,0.985,26549053
45289,TAS-102,drug,0.997,26549053
45290,colorectal cancer,disease,1.0,26549053
45291,CRC,disease,0.9995,26549053
45292,Bevacizumab,gene,0.834,26540671
45293,bevacizumab,gene,0.863,26540671
45294,PARTICIPANTS,species,0.54,26540671
45295,bevacizumab,gene,0.83,26540671
45296,ranibizumab,gene,0.6963,26540671
45297,aflibercept,gene,0.9717,26540671
45298,age-related macular degeneration,disease,1.0,26540671
45299,diabetic macular edema,disease,1.0,26540671
45300,bevacizumab,gene,0.8433,26540671
45301,bevacizumab,gene,0.8633,26540671
45302,bevacizumab,gene,0.8545,26540671
45303,physicians,cell_type,0.4539,26540671
45304,Bevacizumab,gene,0.9087,26540671
45305,ranibizumab,gene,0.8296,26540671
45306,ranibizumab,gene,0.728,26540671
45307,aflibercept,gene,0.98,26540671
45308,bevacizumab,gene,0.919,26540671
45309,bevacizumab,gene,0.8896,26540671
45310,Pigment Epithelial Detachment,disease,0.9985,26540259
45311,Aflibercept,gene,0.8735,26540259
45312,Neovascular Age-Related Macular Degeneration,disease,1.0,26540259
45313,aflibercept,gene,0.9863,26540259
45314,retinal fluid,disease,0.924,26540259
45315,pigment epithelial detachment,disease,1.0,26540259
45316,PED,disease,1.0,26540259
45317,AMD,disease,1.0,26540259
45318,choroidal neovascularisation,disease,1.0,26540259
45319,AMD,disease,1.0,26540259
45320,aflibercept,gene,0.9766,26540259
45321,intraretinal fluid,disease,0.827,26540259
45322,IRF,disease,0.786,26540259
45323,subretinal fluid,disease,0.8354,26540259
45324,aflibercept,gene,0.9824,26540259
45325,IRF,disease,1.0,26540259
45326,SRF,disease,1.0,26540259
45327,retinal pigment epithelium (RPE) atrophy,disease,1.0,26540259
45328,RPE atrophy,disease,1.0,26540259
45329,aflibercept,gene,0.9,26540259
45330,RETINOPATHY AND,disease,0.9995,26536012
45331,MACULAR EDEMA,disease,1.0,26536012
45332,patient,species,0.967,26536012
45333,retinal complications,disease,0.994,26536012
45334,fistula,disease,0.4426,26536012
45335,patient,species,0.937,26536012
45336,head trauma,disease,0.995,26536012
45337,venous stasis retinopathy,disease,1.0,26536012
45338,cystoid macular edema,disease,1.0,26536012
45339,edema,disease,0.9897,26536012
45340,aflibercept,gene,0.987,26536012
45341,bevacizumab,gene,0.7456,26536012
45342,patient,species,0.9805,26536012
45343,venous stasis retinopathy,disease,1.0,26536012
45344,carotid-cavernous fistula,disease,1.0,26536012
45345,Aflibercept,gene,0.98,26522708
45346,Macular Edema,disease,1.0,26522708
45347,macular edema,disease,1.0,26522708
45348,branch retinal vein occlusion,disease,0.9966,26522708
45349,BRVO,disease,1.0,26522708
45350,aflibercept,gene,0.9795,26522708
45351,PARTICIPANTS,species,0.8765,26522708
45352,BCVA,DNA,0.5854,26522708
45353,Traumatic cataract,disease,0.9976,26522708
45354,macular edema,disease,1.0,26522708
45355,Aflibercept,gene,0.943,26515015
45356,exudative age related macular degeneration,disease,0.997,26515015
45357,aflibercept,gene,0.9863,26515015
45358,age-related macular degeneration,disease,1.0,26515015
45359,ARMD,disease,1.0,26515015
45360,ranibizumab,gene,0.6855,26515015
45361,patients,species,0.9883,26515015
45362,ARMD,disease,0.9946,26515015
45363,ranibizumab,gene,0.8013,26515015
45364,aflibercept,gene,0.9644,26515015
45365,the,gene,0.573,26515015
45366,aflibercept,gene,0.8535,26515015
45367,aflibercept,gene,0.9727,26515015
45368,patients,species,0.982,26515015
45369,Aflibercept,gene,0.9463,26515015
45370,patients,species,0.99,26515015
45371,ranibizumab,gene,0.4968,26515015
45372,ranibizumab,gene,0.861,26515015
45373,Aflibercept,gene,0.9717,26514244
45374,myopic choroidal neovascularisation,disease,1.0,26514244
45375,aflibercept,gene,0.982,26514244
45376,subfoveal/juxtafoveal myopic choroidal neovascularisation,disease,1.0,26514244
45377,CNV,disease,1.0,26514244
45378,patients,species,0.9585,26514244
45379,subfoveal/juxtafoveal myopic,disease,1.0,26514244
45380,CNV,disease,0.998,26514244
45381,aflibercept,gene,0.983,26514244
45382,Aflibercept,gene,0.9463,26514244
45383,CNV,disease,1.0,26514244
45384,patient,species,0.9824,26514244
45385,patient,species,0.969,26514244
45386,aflibercept,gene,0.986,26514244
45387,Patients,species,0.934,26514244
45388,myopic CNV,disease,1.0,26514244
45389,aflibercept,gene,0.9893,26514244
45390,myopic CNV,disease,0.843,26514244
45391,CNV,disease,1.0,26514244
45392,myopic,disease,0.9995,26514244
45393,CNV,disease,0.508,26514244
45394,aflibercept,gene,0.9683,26514244
45395,myopic CNV,disease,1.0,26514244
45396,myopic CNV,disease,0.99,26514244
45397,aflibercept,gene,0.9907,26514244
45398,myopic CNV,disease,1.0,26514244
45399,aflibercept,gene,0.9795,26514244
45400,neovascular age-related macular degeneration,disease,1.0,26514244
45401,Anti-Vascular Endothelial Growth Factor,gene,0.863,26513684
45402,vascular endothelial growth factor,gene,0.892,26513684
45403,VEGF,gene,0.998,26513684
45404,retinal conditions,disease,0.9985,26513684
45405,anti-VEGF,gene,0.9414,26513684
45406,patients,species,0.929,26513684
45407,diabetic macular edema,disease,1.0,26513684
45408,DME,disease,1.0,26513684
45409,patients,species,0.9897,26513684
45410,anti-VEGF,gene,0.8105,26513684
45411,anti-VEGF,gene,0.97,26513684
45412,DME,disease,1.0,26513684
45413,cerebrovascular accidents,disease,1.0,26513684
45414,arteriothrombotic events,disease,1.0,26513684
45415,cerebrovascular accidents,disease,1.0,26513684
45416,myocardial infarctions,disease,1.0,26513684
45417,arteriothrombotic events,disease,1.0,26513684
45418,vascular-related death,disease,0.9976,26513684
45419,aflibercept,gene,0.986,26513684
45420,ranibizumab,gene,0.685,26513684
45421,patients,species,0.989,26513684
45422,patients,species,0.9253,26513684
45423,aflibercept,gene,0.99,26513684
45424,ranibizumab,gene,0.5957,26513684
45425,aflibercept,gene,0.992,26513684
45426,ranibizumab,gene,0.626,26513684
45427,cerebrovascular accidents,disease,1.0,26513684
45428,vascular death,disease,1.0,26513684
45429,myocardial infarctions,disease,1.0,26513684
45430,arteriothrombotic events,disease,1.0,26513684
45431,VEGF,gene,0.8364,26513684
45432,patients,species,0.9824,26513684
45433,DME,disease,1.0,26513684
45434,patients,species,0.985,26513684
45435,DME,disease,1.0,26513684
45436,cerebrovascular accidents,disease,1.0,26513684
45437,VEGF,gene,0.7905,26513684
45438,vascular disease,disease,1.0,26513684
45439,Aflibercept,gene,0.987,26512939
45440,Bevacizumab,gene,0.8804,26512939
45441,Ranibizumab,gene,0.777,26512939
45442,Diabetic,disease,0.983,26512939
45443,Diabetic Retinopathy,disease,1.0,26512939
45444,anti-vascular endothelial growth factor,gene,0.847,26512939
45445,aflibercept,gene,0.9883,26512939
45446,bevacizumab,gene,0.8696,26512939
45447,ranibizumab,gene,0.7866,26512939
45448,diabetic macular edema,disease,1.0,26512939
45449,DME,disease,1.0,26512939
45450,DME,disease,1.0,26512939
45451,DME,disease,1.0,26512939
45452,aflibercept,gene,0.9473,26512939
45453,bevacizumab,gene,0.5405,26512939
45454,aflibercept,gene,0.9844,26512939
45455,bevacizumab,gene,0.828,26512939
45456,ranibizumab,drug,0.559,26512939
45457,bevacizumab,gene,0.6665,26512939
45458,patients,species,0.9854,26512939
45459,DME,disease,1.0,26512939
45460,VEGF,gene,0.877,26512939
45461,VEGF,gene,0.608,26512939
45462,DME,disease,1.0,26512939
45463,aflibercept,gene,0.9927,26512939
45464,bevacizumab,gene,0.877,26512939
45465,ranibizumab,drug,0.5024,26512939
45466,bevacizumab,gene,0.5625,26512939
45467,bevacizumab,gene,0.573,26512939
45468,bevacizumab,gene,0.7974,26512939
45469,aflibercept,gene,0.9873,26512939
45470,colorectal cancer,disease,1.0,26508880
45471,regorafenib,drug,0.993,26508880
45472,Metastatic colorectal cancer,disease,1.0,26508880
45473,mCRC,disease,1.0,26508880
45474,anti-EGFR antibodies,gene,0.963,26508880
45475,cetuximab,gene,0.8643,26508880
45476,panitumumab,gene,0.8755,26508880
45477,VEGF,gene,0.9883,26508880
45478,bevacizumab,gene,0.771,26508880
45479,aflibercept,gene,0.923,26508880
45480,patients,species,0.992,26508880
45481,RAS mutation,gene,0.949,26508880
45482,EGFR antibodies,gene,0.899,26508880
45483,Regorafenib,drug,0.9966,26508880
45484,mCRC,disease,0.957,26508880
45485,regorafenib,drug,0.995,26508880
45486,mCRC,disease,0.9995,26508880
45487,RAS,gene,0.995,26508880
45488,BRAF,gene,0.9844,26508880
45489,regorafenib,drug,0.992,26508880
45490,Aflibercept,gene,0.9917,26501481
45491,VEGF Trap-Eye,gene,0.871,26501481
45492,Vascular endothelial growth factor,gene,0.9985,26501481
45493,VEGF,gene,0.995,26501481
45494,eye diseases,disease,0.906,26501481
45495,VEGF,gene,0.996,26501481
45496,retinal diseases,disease,0.9995,26501481
45497,VEGF Trap,gene,0.96,26501481
45498,human IgG,gene,0.9873,26501481
45499,Aflibercept,gene,0.9824,26501481
45500,VEGF Trap-Eye,gene,0.938,26501481
45501,VEGF receptor,gene,0.99,26501481
45502,VEGFR,gene,0.9893,26501481
45503,VEGFR-2,gene,0.995,26501481
45504,Fc,gene,0.7905,26501481
45505,IgG,gene,0.8975,26501481
45506,human amino-acid sequences,DNA,0.6216,26501481
45507,amino-acid,drug,0.999,26501481
45508,aflibercept,gene,0.9907,26501481
45509,aflibercept,gene,0.989,26501481
45510,retinal vascular diseases,disease,0.999,26501481
45511,age-related macular degeneration,disease,1.0,26501481
45512,diabetic retinopathy,disease,1.0,26501481
45513,macular edema,disease,1.0,26501481
45514,retinal vein occlusion,disease,1.0,26501481
45515,Retinal Vein Occlusion,disease,0.9995,26501219
45516,macular edema,disease,1.0,26501219
45517,retinal vein occlusion,disease,1.0,26501219
45518,RVO,disease,1.0,26501219
45519,CRVO,disease,0.9946,26501219
45520,BRVO,disease,1.0,26501219
45521,anti-,gene,0.648,26501219
45522,vascular endothelial growth factor,gene,0.9717,26501219
45523,VEGF,gene,0.9966,26501219
45524,VEGF,gene,0.975,26501219
45525,ranibizumab,gene,0.4973,26501219
45526,aflibercept,gene,0.9272,26501219
45527,macular edema,disease,1.0,26501219
45528,CRVO,disease,1.0,26501219
45529,CRVO,disease,1.0,26501219
45530,cataract,disease,1.0,26501219
45531,VEGF,gene,0.905,26501219
45532,ranibizumab,gene,0.623,26501219
45533,macular edema,disease,1.0,26501219
45534,BRVO,disease,1.0,26501219
45535,triamcinolone,drug,0.992,26501219
45536,BRVO,disease,1.0,26501219
45537,cataract,disease,0.9995,26501219
45538,triamcinolone,drug,0.999,26501219
45539,CRVO,disease,1.0,26501219
45540,BRVO,disease,1.0,26501219
45541,VEGF,gene,0.702,26501219
45542,Neovascular Age-Related Macular Degeneration,disease,1.0,26501146
45543,Age-related macular degeneration,disease,1.0,26501146
45544,AMD,disease,1.0,26501146
45545,vision loss,disease,0.9966,26501146
45546,Choroidal neovascularization,disease,1.0,26501146
45547,CNV,disease,1.0,26501146
45548,severe vision,disease,0.675,26501146
45549,AMD,disease,1.0,26501146
45550,Vascular endothelial growth factor,gene,0.9966,26501146
45551,VEGF,gene,0.99,26501146
45552,wet AMD,disease,0.9976,26501146
45553,ranibizumab,gene,0.834,26501146
45554,VEGF,gene,0.991,26501146
45555,wet AMD,disease,0.9995,26501146
45556,Ranibizumab,gene,0.8457,26501146
45557,bevacizumab,gene,0.8813,26501146
45558,aflibercept,gene,0.9414,26501146
45559,VEGF,gene,0.7837,26501146
45560,wet AMD,disease,0.9985,26501146
45561,AMD,disease,1.0,26501146
45562,Bevacizumab,gene,0.946,26500886
45563,Ovarian Cancer,disease,1.0,26500886
45564,vascular endothelial growth factor,gene,0.9795,26500886
45565,VEGF,gene,0.9023,26500886
45566,bevacizumab,gene,0.3882,26500886
45567,ovarian cancer,disease,1.0,26500886
45568,aflibercept,gene,0.6606,26500886
45569,trebananib,drug,0.972,26500886
45570,pazopanib,drug,0.9985,26500886
45571,nintedanib,drug,0.9985,26500886
45572,cediranib,drug,0.999,26500886
45573,sunitinib,drug,0.9995,26500886
45574,sorafenib,drug,0.9995,26500886
45575,VEGF receptors,gene,0.9976,26500886
45576,Nintedanib,drug,0.999,26500886
45577,pazopanib,drug,0.997,26500886
45578,trebananib,drug,0.9985,26500886
45579,cediranib,drug,0.9966,26500886
45580,bevacizumab,gene,0.9375,26500886
45581,Platinum,drug,0.9995,26498504
45582,Extensive Stage Small-Cell Lung Cancer,disease,0.9683,26498504
45583,platinum,drug,1.0,26498504
45584,extensive stage (ES) small-cell lung cancer,disease,0.8506,26498504
45585,SCLC,disease,0.416,26498504
45586,ES-SCLC,disease,0.8794,26498504
45587,ES-SCLC,disease,0.9995,26498504
45588,lactate,drug,0.9927,26498504
45589,lactate dehydrogenase,gene,0.9917,26498504
45590,ES-SCLC,disease,0.9917,26498504
45591,ES,cell_line,0.4863,26498504
45592,ES-SCLC,disease,0.9937,26498504
45593,Aflibercept,gene,0.969,26492090
45594,aflibercept,gene,0.9146,26492090
45595,vascular endothelial growth factor decoy receptor protein,gene,0.9907,26492090
45596,VEGF Trap,gene,0.9927,26492090
45597,docetaxel,drug,0.998,26492090
45598,cisplatin,drug,0.9995,26492090
45599,5-fluorouracil,drug,0.999,26492090
45600,patients,species,0.98,26492090
45601,advanced solid,disease,0.992,26492090
45602,tumors,disease,0.575,26492090
45603,PATIENTS,species,0.9556,26492090
45604,Patients,species,0.969,26492090
45605,aflibercept,gene,0.983,26492090
45606,docetaxel,drug,0.9985,26492090
45607,cisplatin,drug,0.9995,26492090
45608,5-fluorouracil,drug,0.998,26492090
45609,antitumor,disease,0.927,26492090
45610,patients,species,0.9775,26492090
45611,patients,species,0.9907,26492090
45612,patients,species,0.984,26492090
45613,febrile neutropenia,disease,1.0,26492090
45614,patients,species,0.9907,26492090
45615,aflibercept,gene,0.926,26492090
45616,granulocyte colony-stimulating factor,gene,0.9976,26492090
45617,ciprofloxacin,drug,0.996,26492090
45618,febrile neutropenia,disease,1.0,26492090
45619,pulmonary embolism,disease,0.9946,26492090
45620,VEGF,gene,0.995,26492090
45621,aflibercept,gene,0.887,26492090
45622,neutropenia,disease,1.0,26492090
45623,lymphopenia,disease,1.0,26492090
45624,stomatitis,disease,0.9976,26492090
45625,VEGF,gene,0.9946,26492090
45626,epistaxis,disease,1.0,26492090
45627,dysphonia,disease,1.0,26492090
45628,hypertension,disease,0.9995,26492090
45629,proteinuria,disease,1.0,26492090
45630,patients,species,0.9756,26492090
45631,gastroesophageal cancers,disease,1.0,26492090
45632,patients,species,0.983,26492090
45633,Aflibercept,gene,0.9556,26492090
45634,docetaxel,drug,0.9985,26492090
45635,cisplatin,drug,0.9995,26492090
45636,5- fluorouracil,drug,0.9995,26492090
45637,antitumor,disease,0.711,26492090
45638,Ranibizumab,gene,0.6006,26491557
45639,Choroidal neovascularization,disease,1.0,26491557
45640,CNV,disease,1.0,26491557
45641,retinal diseases,disease,1.0,26491557
45642,vascular endothelial growth factor,gene,0.998,26491557
45643,VEGF,gene,0.9966,26491557
45644,anti-VEGFs,gene,0.7866,26491557
45645,ranibizumab,gene,0.932,26491557
45646,bevacizumab,gene,0.7725,26491557
45647,pegaptanib,drug,0.907,26491557
45648,aflibercept,gene,0.97,26491557
45649,CNV,disease,0.993,26491557
45650,VEGF,gene,0.8545,26491557
45651,fibroblasts,cell_type,0.88,26491557
45652,CNVs,disease,0.9995,26491557
45653,anti-VEGFs,gene,0.9824,26491557
45654,L929 fibroblasts,cell_line,0.9355,26491557
45655,anti-VEGFs,gene,0.9287,26491557
45656,fibroblasts,cell_type,0.751,26491557
45657,anti-VEGFs,gene,0.991,26491557
45658,anti-VEGFs,gene,0.985,26491557
45659,fibroblasts,cell_type,0.8877,26491557
45660,CNV,disease,1.0,26491557
45661,CNV,DNA,0.518,26491557
45662,Fluorouracil,drug,0.9995,26490656
45663,leucovorin,drug,0.9995,26490656
45664,irinotecan,drug,0.9995,26490656
45665,aflibercept,gene,0.9736,26490656
45666,Aflibercept,gene,0.969,26490656
45667,vascular endothelial growth factor,gene,0.9966,26490656
45668,VEGF,gene,0.9966,26490656
45669,VEGF-A,gene,0.9946,26490656
45670,VEGF-B,gene,0.998,26490656
45671,placental growth factor,gene,0.9985,26490656
45672,Aflibercept,gene,0.963,26490656
45673,metastatic colorectal cancer,disease,1.0,26490656
45674,mCRC,disease,1.0,26490656
45675,irinotecan,drug,0.995,26490656
45676,aflibercept,gene,0.9897,26490656
45677,irinotecan,drug,0.999,26490656
45678,diarrhea,disease,0.984,26490656
45679,patients,species,0.9585,26490656
45680,diarrhea,disease,0.998,26490656
45681,fluorouracil,drug,1.0,26490656
45682,leucovorin,drug,0.9995,26490656
45683,irinotecan,drug,0.999,26490656
45684,aflibercept,gene,0.9727,26490656
45685,mCRC,disease,0.9995,26490656
45686,patient,species,0.9873,26490656
45687,diarrhea,disease,0.9995,26490656
45688,patients,species,0.9907,26490656
45689,patients,species,0.9834,26490656
45690,budesonide,drug,0.984,26490656
45691,mesalazine,drug,0.9976,26490656
45692,patients,species,0.9736,26490656
45693,diarrhea,disease,0.9985,26490656
45694,mesalazine,drug,0.9985,26490656
45695,budesonide,drug,0.9966,26490656
45696,aflibercept,gene,0.992,26490656
45697,colitis,disease,0.9253,26490656
45698,digestive adverse events,disease,0.9473,26490656
45699,PARTICIPANTS,species,0.733,26477840
45700,neovascular age-related macular degeneration,disease,0.9995,26477840
45701,AMD,disease,1.0,26477840
45702,ranibizumab,gene,0.8984,26477840
45703,aflibercept,gene,0.976,26477840
45704,aflibercept,gene,0.9795,26477840
45705,Diabetic Retinopathy,disease,0.9893,26477840
45706,ETDRS,DNA,0.4824,26477840
45707,arterial thromboembolic events,disease,0.994,26477840
45708,AMD,disease,1.0,26477840
45709,choroidal neovascularization,disease,1.0,26469535
45710,CNV,disease,1.0,26469535
45711,CNV,disease,0.989,26469535
45712,CNV,disease,0.9917,26469535
45713,CNV,DNA,0.4893,26469535
45714,CNV channels,DNA,0.8555,26469535
45715,CNV,disease,1.0,26469535
45716,Aflibercept,gene,0.941,26469235
45717,Diabetic Macular Edema,disease,1.0,26469235
45718,Patients,species,0.986,26469235
45719,Aflibercept,gene,0.9473,26469235
45720,vascular endothelial growth factor,gene,0.9966,26469235
45721,VEGF,gene,0.9985,26469235
45722,diabetic macular edema,disease,1.0,26469235
45723,DME,disease,1.0,26469235
45724,aflibercept,gene,0.9917,26469235
45725,VEGF,gene,0.6157,26469235
45726,DME,disease,1.0,26469235
45727,PATIENTS,species,0.916,26469235
45728,DME,disease,1.0,26469235
45729,patients,species,0.9946,26469235
45730,ranibizumab,gene,0.7114,26469235
45731,bevacizumab,gene,0.8604,26469235
45732,aflibercept,gene,0.99,26469235
45733,edema,disease,0.7817,26469235
45734,aflibercept,gene,0.9814,26469235
45735,patients,species,0.9517,26469235
45736,DME,disease,1.0,26469235
45737,ranibizumab,gene,0.8013,26469235
45738,bevacizumab,gene,0.769,26469235
45739,aflibercept,gene,0.9536,26469235
45740,aflibercept,gene,0.985,26458482
45741,subfoveal choroidal neovascularization,disease,0.9536,26458482
45742,angioid streaks,disease,1.0,26458482
45743,ranibizumab,gene,0.8696,26458482
45744,aflibercept,gene,0.968,26458482
45745,choroidal neovascularization,disease,1.0,26458482
45746,CNV,disease,1.0,26458482
45747,angioid streaks,disease,1.0,26458482
45748,AS,disease,0.9434,26458482
45749,CNV,disease,0.9995,26458482
45750,AS,disease,1.0,26458482
45751,ranibizumab,gene,0.9346,26458482
45752,aflibercept,gene,0.957,26458482
45753,aflibercept,gene,0.9844,26458482
45754,aflibercept,gene,0.997,26458482
45755,intraretinal,disease,0.528,26458482
45756,aflibercept,gene,0.9844,26458482
45757,CNV,disease,0.9995,26458482
45758,AS,disease,1.0,26458482
45759,ranibizumab,gene,0.845,26458482
45760,Sterile Inflammation,disease,1.0,26457038
45761,Aflibercept,gene,0.9683,26457038
45762,sterile inflammation,disease,0.9995,26457038
45763,aflibercept,gene,0.989,26457038
45764,aflibercept,gene,0.9614,26457038
45765,sterile inflammation,disease,0.765,26457038
45766,aflibercept,gene,0.9683,26457038
45767,aflibercept,gene,0.9707,26457038
45768,inflammatory cells,cell_type,0.891,26457038
45769,vitritis,disease,1.0,26457038
45770,sterile inflammation,disease,1.0,26457038
45771,aflibercept,gene,0.9824,26457038
45772,Sterile inflammation,disease,1.0,26457038
45773,aflibercept,gene,0.981,26457038
45774,Aflibercept,gene,0.9727,26455973
45775,neovascular age-related macular degeneration,disease,1.0,26455973
45776,aflibercept,gene,0.9893,26455973
45777,pigment,disease,0.5234,26455973
45778,PED,disease,0.8633,26455973
45779,neovascular age-related macular degeneration,disease,1.0,26455973
45780,AMD,disease,1.0,26455973
45781,PED,disease,0.989,26455973
45782,aflibercept,gene,0.973,26455973
45783,bevacizumab,gene,0.763,26455973
45784,ranibizumab,gene,0.59,26455973
45785,PED,DNA,0.5103,26455973
45786,aflibercept,gene,0.7476,26455973
45787,aflibercept,gene,0.9746,26455973
45788,aflibercept,gene,0.94,26455973
45789,neovascular AMD,disease,1.0,26455973
45790,colorectal cancer,disease,1.0,26452184
45791,anti-VEGF,gene,0.79,26451092
45792,wet,disease,0.7524,26451092
45793,age-related macular degeneration,disease,0.9673,26451092
45794,Age-related macular degeneration,disease,1.0,26451092
45795,AMD,disease,1.0,26451092
45796,blindness,disease,0.9995,26451092
45797,vascular endothelial growth factor,gene,0.994,26451092
45798,wet AMD,disease,0.997,26451092
45799,vascular endothelial growth factor,gene,0.9946,26451092
45800,wet AMD,disease,0.996,26451092
45801,ranibizumab,gene,0.853,26451092
45802,aflibercept,gene,0.953,26451092
45803,bevacizumab,gene,0.8687,26451092
45804,neovascular AMD,disease,1.0,26451092
45805,aflibercept,gene,0.9805,26451092
45806,aflibercept,gene,0.989,26449196
45807,macular oedema,disease,1.0,26449196
45808,macular oedema,disease,1.0,26449196
45809,MO,disease,1.0,26449196
45810,CRVO,disease,1.0,26449196
45811,bevacizumab,gene,0.835,26449196
45812,ranibizumab,gene,0.615,26449196
45813,aflibercept,gene,0.9863,26449196
45814,MO,disease,,26449196
45815,CRVO,disease,1.0,26449196
45816,bevacizumab,gene,0.832,26449196
45817,ranibizumab,gene,0.6924,26449196
45818,aflibercept,gene,0.971,26449196
45819,MO,disease,,26449196
45820,bevacizumab,gene,0.8896,26449196
45821,ranibizumab,gene,0.7944,26449196
45822,patients,species,0.987,26449196
45823,aflibercept,gene,0.969,26449196
45824,aflibercept,gene,0.9204,26449196
45825,MO,disease,,26449196
45826,CRVO,disease,1.0,26449196
45827,aflibercept,gene,0.985,26449196
45828,aflibercept,gene,0.957,26449194
45829,neovascular age-related macular degeneration,disease,1.0,26449194
45830,aflibercept,gene,0.9673,26449193
45831,neovascular age-related macular degeneration,disease,1.0,26449193
45832,Ranibizumab,gene,0.732,26447985
45833,Aflibercept,gene,0.9556,26447985
45834,VEGF,gene,0.569,26447985
45835,Macaque,species,0.769,26447985
45836,ranibizumab,gene,0.924,26447985
45837,aflibercept,gene,0.979,26447985
45838,VEGF,gene,0.9956,26447985
45839,macaque,species,0.675,26447985
45840,ranibizumab,gene,0.506,26447985
45841,aflibercept,gene,0.909,26447985
45842,macaques,species,0.661,26447985
45843,macaques,species,0.658,26447985
45844,ranibizumab,gene,0.964,26447985
45845,aflibercept,gene,0.9946,26447985
45846,VEGF,gene,0.9937,26447985
45847,vitrectomized,disease,0.8965,26447985
45848,ranibizumab,gene,0.789,26447985
45849,aflibercept,gene,0.896,26447985
45850,VEGF,gene,0.9966,26447985
45851,vitrectomized,disease,0.559,26447985
45852,vitrectomized,disease,0.901,26447985
45853,ranibizumab,gene,0.9785,26447985
45854,aflibercept,gene,0.9785,26447985
45855,VEGF,gene,0.9976,26447985
45856,ranibizumab,gene,0.948,26447985
45857,aflibercept,gene,0.987,26447985
45858,vitrectomized,disease,0.5586,26447985
45859,VEGF,gene,0.992,26447985
45860,aflibercept,gene,0.94,26445522
45861,exudative age-related macular degeneration,disease,1.0,26445522
45862,ranibizumab,gene,0.759,26445522
45863,bevacizumab,gene,0.5586,26445522
45864,exudative,disease,0.805,26445522
45865,age-related macular degeneration,disease,0.908,26445522
45866,aflibercept,gene,0.9785,26445522
45867,neovascular age-related macular degeneration,disease,1.0,26445522
45868,AMD,disease,1.0,26445522
45869,aflibercept,gene,0.9927,26445522
45870,ranibizumab,gene,0.719,26445522
45871,bevacizumab,gene,0.5283,26445522
45872,IAI,drug,0.6655,26445522
45873,diabetic retinopathy,disease,1.0,26445522
45874,ETDRS,DNA,0.6343,26445522
45875,exudative AMD,disease,0.9165,26445522
45876,neovascular age-related macular degeneration,disease,0.999,26444725
45877,AMD,disease,1.0,26444725
45878,patients,species,0.965,26444725
45879,neovascular AMD,disease,1.0,26444725
45880,aflibercept,gene,0.9844,26444725
45881,choroidal neovascularization,disease,1.0,26444725
45882,CNV,disease,1.0,26444725
45883,HF,cell_type,,26444725
45884,HF,cell_type,,26444725
45885,CNV,disease,1.0,26444725
45886,ranibizumab,gene,0.923,26444725
45887,aflibercept,gene,0.974,26444725
45888,aflibercept,gene,0.987,26444725
45889,Exudative Age-related Macular Degeneration,disease,1.0,26442858
45890,Aflibercept,gene,0.975,26442858
45891,aflibercept,gene,0.9917,26442858
45892,patients,species,0.971,26442858
45893,exudative age-related macular degeneration,disease,1.0,26442858
45894,AMD,disease,1.0,26442858
45895,Aflibercept,gene,0.9727,26442858
45896,Vascular endothelial growth factor (VEGF)-A,gene,0.9966,26442858
45897,anti-VEGF antibodies,gene,0.8745,26442858
45898,VEGF-A isoforms,gene,0.998,26442858
45899,aflibercept,gene,0.9834,26442858
45900,VEGF-B,gene,0.9985,26442858
45901,placental growth factor,gene,0.998,26442858
45902,patients,species,0.9854,26442858
45903,exudative AMD,disease,0.994,26442858
45904,ranibizumab,gene,0.9077,26442858
45905,patients,species,0.9785,26442858
45906,patients,species,0.992,26442858
45907,patients,species,0.976,26442858
45908,polypoidal choroidopathy,disease,1.0,26442858
45909,retinal angiomatous proliferation,disease,1.0,26442858
45910,aflibercept,gene,0.9775,26442858
45911,aflibercept,gene,0.982,26442858
45912,aflibercept,gene,0.973,26425104
45913,diabetic macular edema,disease,1.0,26425104
45914,diabetic macular edema,disease,1.0,26425104
45915,DME,disease,1.0,26425104
45916,vascular endothelial growth factor,gene,0.997,26425104
45917,VEGF,gene,0.9946,26425104
45918,VEGF,gene,0.698,26425104
45919,aflibercept,gene,0.9175,26425104
45920,DME,disease,1.0,26425104
45921,diabetic retinopathy,disease,1.0,26425104
45922,DME,disease,1.0,26425104
45923,aflibercept,gene,0.944,26425104
45924,Diabetic Retinopathy,disease,1.0,26425104
45925,anti-VEGF,gene,0.947,26425104
45926,VEGF,gene,0.996,26425104
45927,aflibercept,gene,0.9766,26425104
45928,bevacizumab,gene,0.8423,26425104
45929,aflibercept,gene,0.997,26425104
45930,bevacizumab,gene,0.806,26425104
45931,aflibercept,gene,0.99,26425104
45932,aflibercept,gene,0.976,26425104
45933,bevacizumab,gene,0.749,26425104
45934,aflibercept,gene,0.989,26425104
45935,bevacizumab,gene,0.8125,26425104
45936,ranibizumab,gene,0.6626,26425104
45937,diabetic,disease,1.0,26425104
45938,patients,species,0.9917,26425104
45939,aflibercept,gene,0.9893,26425104
45940,VEGF,gene,0.996,26425104
45941,VEGF,gene,0.972,26424177
45942,Subretinal neovascularization,disease,0.988,26424177
45943,impairment of central vision,disease,0.9673,26424177
45944,vascular endothelial growth factor,gene,0.9683,26424177
45945,VEGF,gene,0.7,26424177
45946,patients,species,0.954,26424177
45947,age-related macular degeneration,disease,1.0,26424177
45948,diabetic retinopathy,disease,1.0,26424177
45949,ocular diseases,disease,0.887,26424177
45950,neovascularization,disease,0.977,26424177
45951,edema,disease,0.9995,26424177
45952,VEGF,gene,0.8105,26424177
45953,VEGF,gene,0.615,26424177
45954,ocular neovascularization,disease,0.9976,26424177
45955,pegaptanib,drug,0.983,26424177
45956,ranibizumab,gene,0.5356,26424177
45957,aflibercept,gene,0.937,26424177
45958,bevacizumab,gene,0.5303,26424177
45959,VEGF,gene,0.925,26424177
45960,neovascularization,disease,0.876,26424177
45961,VEGF,gene,0.994,26424177
45962,retinal and choroidal endothelial cells,cell_type,0.92,26424177
45963,VEGF,gene,0.9956,26424177
45964,thinning and atrophy of the choriocapillaris,disease,0.9756,26424177
45965,degeneration of photoreceptors,disease,0.9995,26424177
45966,cones,cell_type,0.609,26424177
45967,VEGF,gene,0.993,26424177
45968,VEGF,gene,0.9766,26424177
45969,serum VEGF,gene,0.7197,26424177
45970,VEGF,gene,0.9985,26424177
45971,VEGF,gene,0.692,26424177
45972,thromboembolic adverse events,disease,0.9844,26424177
45973,heart attack,disease,1.0,26424177
45974,stroke,disease,1.0,26424177
45975,VEGF,gene,0.9233,26424177
45976,VEGF,gene,0.7427,26424177
45977,Diabetic maculopathy,disease,1.0,26420681
45978,Diabetic maculopathy,disease,1.0,26420681
45979,diabetes mellitus,disease,1.0,26420681
45980,ischemic maculopathy,disease,1.0,26420681
45981,diabetic,disease,1.0,26420681
45982,macular edema,disease,1.0,26420681
45983,Diabetic macular edema,disease,1.0,26420681
45984,blindness,disease,0.998,26420681
45985,people,species,0.9805,26420681
45986,fovea-involving macular edema,disease,0.9204,26420681
45987,vascular endothelial growth factor,gene,0.9985,26420681
45988,VEGF,gene,0.9985,26420681
45989,ranibizumab,gene,0.6714,26420681
45990,aflibercept,gene,0.9014,26420681
45991,Steroids,drug,0.783,26420681
45992,dexamethasone,drug,0.9985,26420681
45993,fluocinolone,drug,0.999,26420681
45994,flucinolone,drug,0.9966,26420681
45995,VEGF,gene,0.983,26420681
45996,macular edema,disease,1.0,26420681
45997,retinal ischemic areas,disease,0.974,26420681
45998,macular edema,disease,1.0,26420681
45999,vascular endothelial growth factor,gene,0.996,29450313
46000,anti-,gene,0.635,29450313
46001,vascular endothelial growth factor,gene,0.918,29450313
46002,anti-VEGF,gene,0.8643,29450313
46003,ocular diseases,disease,0.836,29450313
46004,anti-VEGF,gene,0.9414,29450313
46005,retinal or anterior segment diseases,disease,0.9985,29450313
46006,VEGF,gene,0.852,29450313
46007,age-related macular degeneration,disease,1.0,29450313
46008,retinal vein occlusion,disease,1.0,29450313
46009,diabetic retinopathy,disease,1.0,29450313
46010,abnormal neovascularization,disease,0.8115,29450313
46011,ocular angiogenesis,disease,0.996,29450313
46012,macular edema,disease,1.0,29450313
46013,VEGF,gene,0.5254,29450313
46014,Aflibercept,gene,0.974,26417628
46015,Eylea,gene,0.758,26417628
46016,diabetic macular oedema,disease,1.0,26417628
46017,VEGF,gene,0.9927,26417628
46018,VEGF,gene,0.9907,26417628
46019,aflibercept,gene,0.9883,26417628
46020,ranibizumab,gene,0.862,26417628
46021,bevacizumab,gene,0.733,26417628
46022,patients,species,0.984,26417628
46023,metastatic colorectal,disease,0.9546,26414575
46024,Colorectal cancer,disease,1.0,26414575
46025,CRC,disease,1.0,26414575
46026,patients,species,0.964,26414575
46027,metastatic CRC,disease,0.9985,26414575
46028,bevacizumab,gene,0.7437,26414575
46029,Avastin,gene,0.7734,26414575
46030,ziv-aflibercept,gene,0.9624,26414575
46031,Zaltrap,drug,0.9585,26414575
46032,regorafenib,drug,0.994,26414575
46033,Stivarga,drug,0.998,26414575
46034,patients,species,0.9897,26414575
46035,Regorafenib,drug,0.9985,26414575
46036,ziv-aflibercept,gene,0.964,26414575
46037,nurses,cell_type,0.4875,26414575
46038,patients,species,0.9883,26414575
46039,ranibizumab,gene,0.727,26413794
46040,bevacizumab,gene,0.7017,26413794
46041,macular edema,disease,1.0,26413794
46042,central retinal vein occlusion,disease,1.0,26413794
46043,CRVO,disease,1.0,26413794
46044,patients,species,0.991,26413794
46045,ranibizumab,gene,0.917,26413794
46046,bevacizumab,gene,0.962,26413794
46047,aflibercept,gene,0.9824,26413794
46048,vascular endothelial growth factor-A,gene,0.999,26413794
46049,VEGF-A,gene,0.9995,26413794
46050,VEGF-B,gene,0.9976,26413794
46051,patients,species,0.987,26413794
46052,CRVO,disease,1.0,26413794
46053,ranibizumab,gene,0.703,26413794
46054,bevacizumab,gene,0.933,26413794
46055,CRVO,disease,1.0,26413794
46056,patients,species,0.995,26413794
46057,ranibizumab,gene,0.8657,26413794
46058,bevacizumab,gene,0.6963,26413794
46059,patients,species,0.9844,26413794
46060,aflibercept,gene,0.8433,26413794
46061,aflibercept,gene,0.9707,26413794
46062,aflibercept,gene,0.977,26413794
46063,aflibercept,gene,0.963,26413794
46064,ranibizumab,gene,0.878,26413794
46065,bevacizumab,gene,0.954,26413794
46066,aflibercept,gene,0.9824,26413794
46067,macular edema,disease,1.0,26413794
46068,CRVO,disease,1.0,26413794
46069,Aflibercept,gene,0.9526,26401896
46070,vascular,DNA,0.6636,26401896
46071,vascular endothelial growth factor,gene,0.983,26401896
46072,vitrectomized,disease,0.974,26401896
46073,RETINAL PIGMENT EPITHELIAL DETACHMENTS,disease,1.0,26398694
46074,pigment epithelial detachments,disease,1.0,26398694
46075,PEDs,disease,1.0,26398694
46076,exudative age-related macular degeneration,disease,1.0,26398694
46077,bevacizumab,gene,0.876,26398694
46078,PEDs,disease,0.9995,26398694
46079,ranibizumab,gene,0.7646,26398694
46080,bevacizumab,gene,0.6245,26398694
46081,aflibercept,gene,0.9707,26398694
46082,aflibercept,gene,0.9595,26398694
46083,PEDs,DNA,0.557,26398694
46084,aflibercept,gene,0.9917,26398694
46085,ranibizumab,gene,0.77,26398694
46086,PED,disease,0.6855,26398694
46087,CHOROIDAL NEOVASCULARIZATION,disease,0.8574,26398691
46088,aflibercept,gene,0.975,26398691
46089,choroidal neovascularization,disease,1.0,26398691
46090,macular degeneration,disease,1.0,26398691
46091,ranibizumab,gene,0.678,26398691
46092,aflibercept,gene,0.988,26398691
46093,ranibizumab,gene,0.876,26398691
46094,subretinal and/or intraretinal fluid,disease,0.9985,26398691
46095,Diabetic Retinopathy,disease,0.9995,26398691
46096,fluorescein,drug,0.9995,26398691
46097,indocyanine green,drug,0.998,26398691
46098,Patients,species,0.938,26398691
46099,Diabetic Retinopathy,disease,1.0,26398691
46100,Patients,species,0.983,26398691
46101,aflibercept,gene,0.975,26398691
46102,patients,species,0.951,26398691
46103,neovascular age-related macular degeneration,disease,1.0,26398691
46104,ranibizumab,gene,0.769,26398691
46105,aflibercept,gene,0.9917,26396494
46106,diabetic macular edema,disease,1.0,26396494
46107,ranibizumab,gene,0.896,26396494
46108,diabetic macular edema,disease,1.0,26396494
46109,DME,disease,1.0,26396494
46110,ranibizumab,gene,0.72,26396494
46111,bevacizumab,gene,0.648,26396494
46112,aflibercept,gene,0.9883,26396494
46113,DME,disease,1.0,26396494
46114,ranibizumab,gene,0.862,26396494
46115,bevacizumab,gene,0.7773,26396494
46116,aflibercept,gene,0.9585,26396494
46117,ranibizumab,gene,0.701,26396494
46118,bevacizumab,gene,0.722,26396494
46119,aflibercept,gene,0.9917,26396494
46120,aflibercept,gene,0.99,26396494
46121,intraretinal,cell_type,0.4722,26396494
46122,intraretinal cysts,disease,0.99,26396494
46123,CFT,cell_type,0.478,26396494
46124,aflibercept,gene,0.9854,26396494
46125,DME,disease,1.0,26396494
46126,ranibizumab,gene,0.9136,26396494
46127,bevacizumab,gene,0.959,26396494
46128,aflibercept,gene,0.9834,26396494
46129,MACULAR DEGENERATION,disease,0.9917,26383711
46130,PURE RETICULAR PSEUDODRUSEN,disease,0.9863,26383711
46131,NV,disease,0.994,26383711
46132,age-related macular degeneration,disease,1.0,26383711
46133,reticular pseudodrusen,disease,1.0,26383711
46134,neovascular age-related macular degeneration,disease,1.0,26383711
46135,type 2 NV,disease,0.9985,26383711
46136,neovascular age-related macular degeneration,disease,1.0,26383711
46137,NV,disease,0.999,26383711
46138,type 2 NV,disease,0.994,26383711
46139,age,disease,0.754,26383711
46140,macular degeneration,disease,0.998,26383711
46141,reticular pseudodrusen,disease,1.0,26383711
46142,POLYPOIDAL CHOROIDAL VASCULOPATHY,disease,1.0,26383709
46143,aflibercept,gene,0.985,26383709
46144,polypoidal choroidal vasculopathy,disease,1.0,26383709
46145,indocyanine green,drug,0.987,26383709
46146,polypoidal choroidal vasculopathy,disease,1.0,26383709
46147,aflibercept,gene,0.9863,26383709
46148,polypoidal,DNA,0.4834,26383709
46149,polypoidal lesions,disease,1.0,26383709
46150,indocyanine green,drug,0.9976,26383709
46151,polypoidal lesions,disease,1.0,26383709
46152,polypoidal lesions,disease,1.0,26383709
46153,polypoidal lesions,disease,1.0,26383709
46154,polypoidal lesions,disease,1.0,26383709
46155,polypoidal lesions,disease,1.0,26383709
46156,Aflibercept,gene,0.726,26383709
46157,polypoidal choroidal vasculopathy,disease,1.0,26383709
46158,polypoidal lesions,disease,1.0,26383709
46159,polypoidal lesion,disease,1.0,26383709
46160,polyps,disease,1.0,26383709
46161,neovascular age-related macular degeneration,disease,1.0,26381099
46162,age-related macular degeneration,disease,1.0,26381099
46163,ARMD,disease,1.0,26381099
46164,visual disability,disease,1.0,26381099
46165,endothelial growth factors,gene,0.8223,26381099
46166,ARMD,disease,1.0,26381099
46167,ARMD,disease,1.0,26381099
46168,neovascular ARMD,disease,0.976,26381099
46169,vascular endothelial growth factor,gene,0.98,26381099
46170,neovascular ARMD,disease,0.9985,26381099
46171,neovascular ARMD,disease,1.0,26381099
46172,neovascular ARMD,disease,1.0,26381099
46173,aflibercept,gene,0.978,26369798
46174,Proliferative diabetic retinopathy,disease,0.9995,26369798
46175,PDR,disease,1.0,26369798
46176,visual loss,disease,0.999,26369798
46177,people,species,0.8745,26369798
46178,diabetes mellitus,disease,1.0,26369798
46179,vascular endothelial growth factor,gene,0.999,26369798
46180,VEGF,gene,0.997,26369798
46181,retinal neovascularisation,disease,0.9995,26369798
46182,aflibercept,gene,0.967,26369798
46183,VEGF-A,gene,0.997,26369798
46184,VEGF-,gene,0.993,26369798
46185,placental growth factor,gene,0.9976,26369798
46186,PLGF,gene,0.993,26369798
46187,PDR,disease,0.9995,26369798
46188,aflibercept,gene,0.9453,26369798
46189,PDR,disease,0.9985,26369798
46190,participants,species,0.9673,26369798
46191,retinal neovascularisation,disease,1.0,26369798
46192,aflibercept,gene,0.972,26369798
46193,PRP,cell_type,0.6567,26369798
46194,human,species,0.994,26369798
46195,aflibercept,gene,0.975,26369798
46196,PDR,disease,0.999,26369798
46197,Age-related macular degeneration,disease,1.0,26364363
46198,Age-related macular degeneration,disease,1.0,26364363
46199,AMD,disease,1.0,26364363
46200,legal blindness of the,disease,0.993,26364363
46201,geographic atrophy,disease,1.0,26364363
46202,exsudative (wet) AMD,disease,1.0,26364363
46203,photoreceptor,cell_type,0.5996,26364363
46204,photoreceptors,cell_type,0.5806,26364363
46205,AMD,disease,0.999,26364363
46206,AMD,disease,1.0,26364363
46207,AMD,disease,1.0,26364363
46208,geographic atrophy,disease,1.0,26364363
46209,vascular endothelial growth factor,gene,0.9976,26364363
46210,VEGF,gene,0.9927,26364363
46211,ranibizumab,gene,0.944,26364363
46212,aflibercept,gene,0.983,26364363
46213,bevacizumab,gene,0.9077,26364363
46214,retinal pigment epithelial cells,cell_type,0.918,26364363
46215,vascular endothelial growth,gene,0.659,26358547
46216,retinal vein occlusion,disease,1.0,26358547
46217,Retinal vein occlusion,disease,1.0,26358547
46218,RVO,disease,1.0,26358547
46219,retinal vascular disorder,disease,1.0,26358547
46220,Macular edema,disease,1.0,26358547
46221,ME,disease,1.0,26358547
46222,retinal ischemia,disease,0.999,26358547
46223,visual impairment,disease,0.999,26358547
46224,RVO,disease,1.0,26358547
46225,ME,disease,0.9995,26358547
46226,RVO,disease,1.0,26358547
46227,VEGF,gene,0.8804,26358547
46228,ME,disease,0.9995,26358547
46229,RVO,disease,1.0,26358547
46230,VEGF,gene,0.8887,26358547
46231,ME,disease,1.0,26358547
46232,RVO,disease,0.9995,26358547
46233,VEGF,gene,0.6724,26358547
46234,RVO,disease,1.0,26358547
46235,retinal ischemia,disease,1.0,26358547
46236,metastatic colorectal cancer,disease,1.0,26355232
46237,aflibercept,gene,0.968,26355232
46238,Aflibercept,gene,0.9297,26355232
46239,ziv-aflibercept,gene,0.9844,26355232
46240,FOLFIRI,drug,0.8633,26355232
46241,metastatic colorectal cancer,disease,1.0,26355232
46242,mCRC,disease,0.9995,26355232
46243,oxaliplatin,drug,0.9995,26355232
46244,aflibercept,gene,0.9604,26355232
46245,aflibercept,gene,0.976,26355232
46246,mCRC,disease,0.899,26355232
46247,mCRC,disease,1.0,26355232
46248,single-nucleotide polymorphisms,DNA,0.655,26355232
46249,vascular endothelial growth factor (VEGF) pathway genes,DNA,0.8247,26355232
46250,vascular endothelial growth factor,gene,0.9985,26355232
46251,VEGF,gene,0.9956,26355232
46252,KRAS,gene,0.8765,26355232
46253,BRAF,gene,0.817,26355232
46254,NRAS,gene,0.805,26355232
46255,PIK3CA,gene,0.719,26355232
46256,PIK3R1,gene,0.5625,26355232
46257,SNPs,DNA,0.5347,26355232
46258,VEGFB,gene,0.8525,26355232
46259,IL8,gene,0.975,26355232
46260,IL8,gene,0.957,26355232
46261,mCRC,disease,0.991,26355232
46262,aflibercept,gene,0.9546,26355232
46263,IL8,gene,0.9893,26355232
46264,IL8,gene,0.962,26355232
46265,IL8,gene,0.977,26355232
46266,aflibercept,gene,0.6978,26355232
46267,aflibercept,gene,0.965,26331893
46268,cancer,disease,0.9995,26331893
46269,Aflibercept,gene,0.8613,26331893
46270,humanized,species,0.4963,26331893
46271,vascular endothelial growth factor,gene,0.889,26331893
46272,VEGF,gene,0.9995,26331893
46273,aflibercept,gene,0.9443,26331893
46274,aflibercept,gene,0.9927,26331893
46275,cancer,disease,1.0,26331893
46276,patients,species,0.991,26331893
46277,aflibercept,gene,0.9673,26331893
46278,aflibercept,gene,0.926,26331893
46279,cancer,disease,1.0,26331893
46280,patients,species,0.993,26331893
46281,patients,species,0.9917,26331893
46282,solid tumours,disease,1.0,26331893
46283,aflibercept,gene,0.98,26331893
46284,patients,species,0.986,26331893
46285,aflibercept,gene,0.9624,26331893
46286,aflibercept,gene,0.985,26331893
46287,bevacizumab,gene,0.9,26331893
46288,Aflibercept,gene,0.923,26331893
46289,patients,species,0.955,26331893
46290,solid tumours,disease,1.0,26331893
46291,aflibercept,gene,0.954,26331893
46292,VEGF,gene,0.9976,26323572
46293,Semaphorin3A,gene,0.992,26323572
46294,VEGF,gene,0.998,26323572
46295,VEGF,gene,0.9956,26323572
46296,nascent,cell_type,0.536,26323572
46297,transduced myoblasts,cell_line,0.779,26323572
46298,transduced,cell_type,0.511,26323572
46299,myoblasts,cell_type,0.4976,26323572
46300,VEGF,gene,0.9937,26323572
46301,mouse,species,0.8994,26323572
46302,VEGF,gene,0.985,26323572
46303,Aflibercept,gene,0.9507,26323572
46304,VEGF,gene,0.996,26323572
46305,pericyte,cell_type,0.8696,26323572
46306,VEGF,gene,0.994,26323572
46307,Semaphorin3A,gene,0.7603,26323572
46308,Neuropilin,cell_line,0.5825,26323572
46309,Neuropilin-1-expressing monocytes,cell_type,0.6484,26323572
46310,Neuropilin-1,gene,0.983,26323572
46311,NEM,cell_line,0.794,26323572
46312,TGF-1,gene,0.9956,26323572
46313,endothelial,cell_type,0.7197,26323572
46314,SMAD2/3,gene,0.9844,26323572
46315,TGF-1,gene,0.991,26323572
46316,endothelial,cell_type,0.6494,26323572
46317,Semaphorin3A,gene,0.9507,26323572
46318,NEM,gene,0.9883,26323572
46319,endogenous Semaphorin3A,gene,0.9424,26323572
46320,TGF-1,gene,0.9956,26323572
46321,Semaphorin3A,gene,0.9956,26323572
46322,NEM,gene,0.976,26323572
46323,Semaphorin3A,gene,0.9604,26323572
46324,VEGF,gene,0.991,26323572
46325,VEGF,gene,0.997,26323572
46326,Semaphorin3A,gene,0.9966,26323572
46327,NEM,gene,0.9995,26323572
46328,TGF-1,gene,0.999,26323572
46329,Semaphorin3A,gene,0.982,26323572
46330,VEGF,gene,0.9966,26323572
46331,age-related macular degeneration,disease,1.0,26314897
46332,aflibercept,gene,0.9546,26314897
46333,AMD,disease,1.0,26314897
46334,patients,species,0.986,26314897
46335,neovascular AMD,disease,1.0,26314897
46336,AMD,disease,0.9995,26314897
46337,patient,species,0.989,26314897
46338,aflibercept,gene,0.9746,26314897
46339,Ovarian Cancer,disease,1.0,28465743
46340,tumor,disease,1.0,28465743
46341,cancer,disease,1.0,28465743
46342,tumors,disease,1.0,28465743
46343,oxygen,drug,0.967,28465743
46344,Vascular endothelial growth factor,gene,0.999,28465743
46345,VEGF,gene,0.9976,28465743
46346,VEGF,gene,0.988,28465743
46347,bevacizumab,gene,0.8936,28465743
46348,BEV,gene,0.7886,28465743
46349,aflibercept,gene,0.981,28465743
46350,VEGF receptor,gene,0.996,28465743
46351,pazopanib,drug,0.9976,28465743
46352,nintedanib,drug,0.999,28465743
46353,cediranib,drug,0.999,28465743
46354,sunitinib,drug,0.999,28465743
46355,sorafenib,drug,0.9995,28465743
46356,ovarian tumors,disease,1.0,28465743
46357,VEGF ligand,gene,0.962,28465743
46358,ascites,disease,0.999,28465743
46359,ovarian cancer,disease,1.0,28465743
46360,ovarian carcinoma,disease,1.0,28465743
46361,Aflibercept,gene,0.9805,26305529
46362,aflibercept,gene,0.989,26305529
46363,VEGF-A,gene,0.995,26305529
46364,patients,species,0.862,26305529
46365,neovascular age-related macular degeneration,disease,1.0,26305529
46366,nAMD,disease,0.9946,26305529
46367,patients,species,0.9873,26305529
46368,macular edema,disease,1.0,26305529
46369,nAMD,disease,1.0,26305529
46370,aflibercept,gene,0.9736,26305529
46371,Patients,species,0.9746,26305529
46372,aflibercept,gene,0.9834,26305529
46373,humor,disease,0.997,26305529
46374,VEGF-A,gene,0.9976,26305529
46375,aflibercept,gene,0.9956,26305529
46376,AMD,disease,0.602,26305529
46377,aflibercept,gene,0.994,26305529
46378,aflibercept,gene,0.9897,26305529
46379,VEGF-A,gene,0.991,26305529
46380,aflibercept,gene,0.9976,26305529
46381,VEGF-A,gene,0.997,26305529
46382,aflibercept,gene,0.977,26305529
46383,aflibercept,gene,0.9844,26305529
46384,Anti-VEGF,gene,0.9526,26302032
46385,antivascular endothelial growth factor,gene,0.9956,26302032
46386,anti-VEGF,gene,0.9775,26302032
46387,women,species,0.9424,26302032
46388,women,species,0.952,26302032
46389,women,species,0.9014,26302032
46390,bevacizumab,gene,0.7554,26302032
46391,anti-VEGF,gene,0.663,26302032
46392,patients,species,0.9824,26302032
46393,women,species,0.909,26302032
46394,Infants,species,0.8364,26302032
46395,pegaptanib,drug,0.998,26302032
46396,bevacizumab,gene,0.888,26302032
46397,ranibizumab,gene,0.875,26302032
46398,aflibercept,gene,0.992,26302032
46399,anti-VEGF,gene,0.994,26302032
46400,abortion,disease,0.7754,26302032
46401,miscarriage,disease,0.999,26302032
46402,preeclampsia,disease,1.0,26302032
46403,embryo-fetal toxicity,disease,0.9976,26302032
46404,fetal malformations,disease,1.0,26302032
46405,maternofetal complications,disease,1.0,26302032
46406,anti-VEGF,gene,0.877,26302032
46407,woman,species,0.8096,26302032
46408,patients,species,0.981,26302032
46409,Ranibizumab,gene,0.8755,26296050
46410,aflibercept,gene,0.976,26296050
46411,age-related macular degeneration,disease,1.0,26296050
46412,aflibercept,gene,0.9873,26296050
46413,AMD,disease,1.0,26296050
46414,aflibercept,gene,0.9644,26296050
46415,vascular endothelial growth factor,gene,0.9985,26296050
46416,wet AMD,disease,0.9844,26296050
46417,aflibercept,gene,0.989,26296050
46418,ETDRS,DNA,0.5146,26296050
46419,aflibercept,gene,0.9917,26296050
46420,ranibizumab,gene,0.6196,26296050
46421,aflibercept,gene,0.987,26296050
46422,ranibizumab,gene,0.664,26296050
46423,aflibercept,gene,0.985,26296050
46424,ranibizumab,gene,0.9688,26296050
46425,aflibercept,gene,0.976,26296050
46426,wet AMD,disease,0.9985,26296050
46427,aflibercept,gene,0.9937,26296050
46428,aflibercept,gene,0.9893,26296050
46429,ranibizumab,gene,0.8887,26296050
46430,wet AMD,disease,0.992,26296050
46431,Ranibizumab,gene,0.8354,26295570
46432,Aflibercept,gene,0.9634,26295570
46433,Neovascular Age-Related Macular Degeneration,disease,1.0,26295570
46434,Diabetic Macular Edema,disease,1.0,26294336
46435,Diabetic macular edema,disease,1.0,26294336
46436,DME,disease,1.0,26294336
46437,diabetic retinopathy,disease,1.0,26294336
46438,DR,disease,1.0,26294336
46439,visual loss,disease,0.996,26294336
46440,DME,disease,1.0,26294336
46441,anti-vascular endothelial growth factor,gene,0.9746,26294336
46442,anti-VEGF,gene,0.9824,26294336
46443,DME,disease,1.0,26294336
46444,VEGF,gene,0.6113,26294336
46445,ranibizumab,gene,0.7686,26294336
46446,bevacizumab,gene,0.906,26294336
46447,aflibercept,gene,0.933,26294336
46448,DME,disease,1.0,26294336
46449,VEGF,gene,0.9956,26294336
46450,DME,disease,1.0,26294336
46451,VEGF,gene,0.5913,26294336
46452,DME,drug,0.663,26294336
46453,patients,species,0.967,26289356
46454,Ranibizumab,gene,0.925,26289356
46455,Aflibercept,gene,0.956,26289356
46456,patients,species,0.9727,26289356
46457,neovascular age-related macular degeneration,disease,0.9565,26289356
46458,nvAMD,disease,1.0,26289356
46459,patients,species,0.984,26289356
46460,Aflibercept,gene,0.9365,26289356
46461,Ranibizumab,gene,0.568,26289356
46462,Aflibercept,gene,0.9834,26289356
46463,Ranibizumab,gene,0.907,26289356
46464,Ranibizumab,gene,0.953,26289356
46465,Aflibercept,gene,0.962,26289356
46466,Conbercept,drug,0.983,26289225
46467,KH-902,drug,0.993,26289225
46468,neovascular age-related macular degeneration,disease,0.999,26289225
46469,Age-related macular degeneration,disease,1.0,26289225
46470,AMD,disease,1.0,26289225
46471,degenerative disease of the retina,disease,1.0,26289225
46472,visual impairment,disease,1.0,26289225
46473,VEGF,gene,0.993,26289225
46474,neovascular AMD,disease,0.9995,26289225
46475,VEGF,gene,0.993,26289225
46476,neovascular AMD,disease,1.0,26289225
46477,subfoveal neovascular lesions,disease,0.9946,26289225
46478,VEGF,gene,0.819,26289225
46479,neovascular AMD,disease,1.0,26289225
46480,pegaptanib,drug,0.998,26289225
46481,Macugen,drug,0.9917,26289225
46482,ranibizumab,gene,0.656,26289225
46483,bevacizumab,gene,0.6113,26289225
46484,VEGF receptor,gene,0.9937,26289225
46485,aflibercept,gene,0.954,26289225
46486,Eylea,gene,0.5254,26289225
46487,neovascular AMD,disease,0.9995,26289225
46488,VEGF,gene,0.6777,26289225
46489,neovascular AMD,disease,1.0,26289225
46490,MACULAR TELANGIECTASIA,disease,0.983,26288110
46491,macular telangiectasia Type 2,disease,1.0,26288110
46492,subretinal neovascularization,disease,0.9995,26288110
46493,macular telangiectasia Type 2,disease,1.0,26288110
46494,subretinal neovascularization,disease,0.9985,26288110
46495,aflibercept,gene,0.9795,26288110
46496,subretinal neovascularization,disease,1.0,26288110
46497,macular telangiectasia Type 2,disease,1.0,26288110
46498,vitamins,drug,0.9243,26265643
46499,zinc,drug,1.0,26265643
46500,age-related macular degeneration,disease,1.0,26265643
46501,vitamins,drug,0.919,26265643
46502,zinc,drug,0.9995,26265643
46503,age-related eye disease,disease,1.0,26265643
46504,AMD,disease,1.0,26265643
46505,wet AMD,disease,0.879,26265643
46506,AMD,disease,1.0,26265643
46507,wet AMD,disease,0.9556,26265643
46508,AREDS,DNA,0.447,26265643
46509,ranibizumab,gene,0.762,26265643
46510,wet AMD,disease,0.9976,26265643
46511,AREDS,DNA,0.4814,26265643
46512,bevacizumab,gene,0.7183,26265643
46513,wet AMD,disease,0.999,26265643
46514,AREDS,DNA,0.4724,26265643
46515,aflibercept,gene,0.984,26265643
46516,wet AMD,disease,0.9907,26265643
46517,AREDS,DNA,0.5405,26265643
46518,ranibizumab,gene,0.941,26265643
46519,aflibercept,gene,0.9956,26265643
46520,bevacizumab,gene,0.7695,26265643
46521,bevacizumab,gene,0.6685,26265643
46522,ranibizumab,gene,0.7207,26265643
46523,wet AMD,disease,0.998,26265643
46524,AMD,disease,0.998,26265643
46525,Diabetic Macular Edema,disease,1.0,26242766
46526,Diabetes mellitus,disease,1.0,26242766
46527,DM,disease,1.0,26242766
46528,chronic disease,disease,0.992,26242766
46529,people,species,0.968,26242766
46530,Diabetic retinopathy,disease,1.0,26242766
46531,DR,disease,1.0,26242766
46532,DM,disease,,26242766
46533,blindness,disease,0.9995,26242766
46534,Diabetic macular edema,disease,1.0,26242766
46535,DME,disease,1.0,26242766
46536,DR,disease,,26242766
46537,DR,disease,,26242766
46538,vision loss,disease,0.8745,26242766
46539,ranibizumab,gene,0.713,26242766
46540,antivascular endothelial growth factor,gene,0.98,26242766
46541,anti-VEGF,gene,0.929,26242766
46542,DME,disease,1.0,26242766
46543,ranibizumab,gene,0.803,26242766
46544,DME,disease,0.9995,26242766
46545,patients,species,0.9204,26242766
46546,DME,disease,1.0,26242766
46547,aflibercept,gene,0.9893,26242766
46548,bevacizumab,gene,0.592,26242766
46549,dexamethasone,drug,0.9995,26242766
46550,fluocinolone acetonide,drug,0.995,26242766
46551,DME,disease,1.0,26242766
46552,VEGF,gene,0.995,26242766
46553,patients,species,0.9644,26242766
46554,macular edema,disease,1.0,26242766
46555,DM,disease,,26242766
46556,DME,disease,1.0,26242766
46557,Ranibizumab,gene,0.911,26241852
46558,Aflibercept,gene,0.951,26241852
46559,VEGF,gene,0.717,26241852
46560,patients,species,0.9873,26241852
46561,PATIENTS,species,0.962,26241852
46562,patients,species,0.988,26241852
46563,age-related macular degeneration,disease,1.0,26241852
46564,diabetic macula edema,disease,1.0,26241852
46565,retinal vein occlusion,disease,1.0,26241852
46566,Patients,species,0.9795,26241852
46567,patients,species,0.9966,26241852
46568,Patients,species,0.98,26241852
46569,AMD,disease,1.0,26241852
46570,patients,species,0.9663,26241852
46571,DME,disease,1.0,26241852
46572,RVO,disease,0.995,26241852
46573,Patients,species,0.9683,26241852
46574,DME,disease,1.0,26241852
46575,AMD,disease,1.0,26241852
46576,RVO,disease,1.0,26241852
46577,patients,species,0.99,26241852
46578,Aflibercept,gene,0.952,26240506
46579,Neovascular Age-related Macular Degeneration,disease,1.0,26240506
46580,vascular endothelial growth factor,gene,0.999,26240506
46581,VEGF,gene,0.9985,26240506
46582,aflibercept,gene,0.9956,26240506
46583,neovascular age-related macular degeneration,disease,1.0,26240506
46584,AMD,disease,1.0,26240506
46585,polypoidal choroidal vasculopathy,disease,1.0,26240506
46586,PCV,disease,1.0,26240506
46587,anti-VEGF,gene,0.8726,26240506
46588,ranibizumab,gene,0.915,26240506
46589,bevacizumab,gene,0.8076,26240506
46590,patients,species,0.989,26240506
46591,neovascular AMD,disease,1.0,26240506
46592,PCV,disease,1.0,26240506
46593,aflibercept,gene,0.9473,26240506
46594,aflibercept,gene,0.979,26240506
46595,aflibercept,gene,0.985,26240506
46596,bevacizumab,gene,0.6685,26240506
46597,aflibercept,gene,0.9956,26240506
46598,neovascular AMD,disease,1.0,26240506
46599,PCV,disease,1.0,26240506
46600,Aflibercept,gene,0.975,26240506
46601,neovascular AMD,disease,1.0,26240506
46602,PCV,disease,1.0,26240506
46603,anti-VEGF,gene,0.6714,26240506
46604,aflibercept,gene,0.9937,26240506
46605,bevacizumab,gene,0.741,26240506
46606,Neovascular Age-Related Macular Degeneration,disease,1.0,26239466
46607,vascular endothelial growth factor,gene,0.9985,26239466
46608,VEGF,gene,0.997,26239466
46609,neovascular age-related macular degeneration,disease,0.9995,26239466
46610,AMD,disease,1.0,26239466
46611,ranibizumab,gene,0.8926,26239466
46612,aflibercept,gene,0.9795,26239466
46613,macular edema,disease,1.0,26239466
46614,patients,species,0.9814,26239466
46615,patients,species,0.976,26239466
46616,patients,species,0.987,26239466
46617,patients,species,0.985,26239466
46618,anti-VEGF,gene,0.835,26239466
46619,patients,species,0.984,26239466
46620,patients,species,0.989,26239466
46621,anti-VEGF,gene,0.9155,26239466
46622,anti-,gene,0.5215,26237136
46623,vascular endothelial growth factor,gene,0.911,26237136
46624,patient,species,0.9385,26237136
46625,giant pigment epithelial detachments,disease,1.0,26237136
46626,woman,species,0.8804,26237136
46627,neovascular age-related macular degeneration,disease,0.999,26237136
46628,pigment epithelial detachments,disease,1.0,26237136
46629,aflibercept,gene,0.9854,26237136
46630,aflibercept,gene,0.989,26237136
46631,anti-vascular endothelial growth factor,gene,0.8447,26237136
46632,giant pigment epithelial detachment,disease,1.0,26237136
46633,vascular endothelial growth factor,gene,0.895,26237136
46634,pigment epithelial detachments,disease,1.0,26237136
46635,pigment epithelium tear,disease,0.986,26237136
46636,metastatic colorectal cancer,disease,1.0,26232849
46637,bevacizumab,gene,0.622,26232849
46638,colorectal cancer,disease,1.0,26232849
46639,patients,species,0.992,26232849
46640,patients,species,0.987,26232849
46641,anti-VEGF,gene,0.8716,26232849
46642,VEGFA,gene,0.9976,26232849
46643,metastatic colorectal cancer,disease,1.0,26232849
46644,patients,species,0.9883,26232849
46645,irinotecan,drug,0.9995,26232849
46646,oxaliplatin,drug,0.9995,26232849
46647,5-fluorouracil,drug,0.999,26232849
46648,tyrosine,drug,0.981,26232849
46649,tyrosine kinase,gene,0.9893,26232849
46650,VEGFA,gene,0.87,26232849
46651,colon cancer,disease,1.0,26232849
46652,patient,species,0.9873,26232849
46653,patients,species,0.987,26232849
46654,bevacizumab,gene,0.8057,26232849
46655,colorectal cancers,disease,1.0,26232849
46656,metastatic colorectal cancers,disease,0.994,26232849
46657,aflibercept,gene,0.991,26229424
46658,aflibercept,gene,0.9863,26229424
46659,neovascular age-related macular degeneration,disease,1.0,26229424
46660,patients,species,0.9595,26229424
46661,Patients,species,0.9863,26229424
46662,aflibercept,gene,0.908,26229424
46663,Diabetic Retinopathy,disease,0.9907,26229424
46664,aflibercept,gene,0.9756,26229424
46665,patients,species,0.996,26229424
46666,subretinal fluid,disease,0.997,26229424
46667,SRF,disease,0.997,26229424
46668,intraretinal fluid,disease,0.829,26229424
46669,IRF,disease,0.904,26229424
46670,PED,disease,0.9995,26229424
46671,patients,species,0.9927,26229424
46672,VA,disease,,26229424
46673,patients,species,0.9937,26229424
46674,SRF,disease,1.0,26229424
46675,IRF,disease,1.0,26229424
46676,PED,disease,1.0,26229424
46677,patient,species,0.991,26229424
46678,patients,species,0.988,26229424
46679,IRF,gene,0.935,26229424
46680,patients,species,0.9937,26229424
46681,patients,species,0.99,26229424
46682,patients,species,0.989,26229424
46683,neovascular age-related macular degeneration,disease,0.9995,26229424
46684,aflibercept,gene,0.995,26228865
46685,metastatic colorectal cancer,disease,1.0,26228865
46686,FOLFOX,drug,0.6855,26228865
46687,bevacizumab,gene,0.9795,26228865
46688,adenocarcinoma of the rectum,disease,1.0,26228865
46689,RAS,DNA,0.7334,26228865
46690,RAS wild,gene,0.7676,26228865
46691,liver metastases,disease,0.85,26228865
46692,FOLFOX,drug,0.8213,26228865
46693,bevacizumab,gene,0.705,26228865
46694,18FDG,drug,0.984,26228865
46695,bone metastases,disease,0.7656,26228865
46696,aflibercept,gene,0.9424,26228865
46697,Aflibercept,gene,0.973,26224565
46698,cancer,disease,1.0,26224565
46699,solid tumors,disease,0.999,26224565
46700,Vascular endothelial growth factor,gene,0.9985,26224565
46701,VEGF,gene,0.997,26224565
46702,tumor,disease,1.0,26224565
46703,tumor,disease,0.999,26224565
46704,Aflibercept,gene,0.9683,26224565
46705,VEGF receptor (VEGFR)1,gene,0.979,26224565
46706,VEGFR2 extracellular domains,gene,0.974,26224565
46707,VEGF-A,gene,0.997,26224565
46708,VEGF-B,gene,0.997,26224565
46709,Aflibercept,gene,0.944,26224565
46710,tumor,disease,1.0,26224565
46711,tumor,disease,0.599,26224565
46712,aflibercept,gene,0.988,26224565
46713,tumor,disease,0.989,26224565
46714,solid tumors,disease,1.0,26224565
46715,aflibercept,gene,0.981,26224565
46716,tumor,disease,0.9995,26222085
46717,patients,species,0.986,26222085
46718,patients,species,0.992,26222085
46719,Aflibercept,gene,0.9697,26220913
46720,Metastatic Colorectal Cancer,disease,1.0,26220913
46721,Aflibercept,gene,0.964,26220913
46722,vascular endothelial growth factor,gene,0.9966,26220913
46723,VEGF,gene,0.9976,26220913
46724,VEGF-A,gene,0.9966,26220913
46725,VEGF-B,gene,0.9976,26220913
46726,placental growth factor,gene,0.9985,26220913
46727,aflibercept,gene,0.9863,26220913
46728,leucovorin,drug,0.9995,26220913
46729,fluorouracil,drug,0.9995,26220913
46730,irinotecan,drug,0.9985,26220913
46731,FOLFIRI,drug,0.9688,26220913
46732,patients,species,0.994,26220913
46733,metastatic colorectal cancer,disease,0.994,26220913
46734,oxaliplatin,drug,0.9995,26220913
46735,aflibercept,gene,0.973,26220913
46736,aflibercept,gene,0.783,26220913
46737,FOLFIRI,drug,0.934,26220913
46738,FOLFIRI,drug,0.9785,26220913
46739,aflibercept,gene,0.99,26220913
46740,FOLFIRI,drug,0.9634,26220913
46741,aflibercept,gene,0.985,26220913
46742,FOLFIRI,drug,0.969,26220913
46743,FOLFIRI,drug,0.972,26220913
46744,aflibercept,gene,0.988,26220913
46745,FOLFIRI,drug,0.7354,26220913
46746,neutropenia,disease,1.0,26220913
46747,diarrhoea,disease,1.0,26220913
46748,hypertension,disease,0.9995,26220913
46749,aflibercept,gene,0.99,26220913
46750,patients,species,0.9404,26220913
46751,metastatic colorectal cancer,disease,1.0,26220913
46752,oxaliplatin,drug,0.9995,26220913
46753,bevacizumab,gene,0.774,26220913
46754,metastatic colorectal cancer,disease,1.0,26215324
46755,bevacizumab,gene,0.967,26215324
46756,ziv-aflibercept,gene,0.9863,26215324
46757,metastatic colorectal cancer,disease,1.0,26215324
46758,Ranibizumab,gene,0.949,26208030
46759,Aflibercept,gene,0.977,26208030
46760,ranibizumab,gene,0.8433,26208030
46761,aflibercept,gene,0.9844,26208030
46762,neovascular age-related macular degeneration,disease,1.0,26208030
46763,nAMD,disease,1.0,26208030
46764,patients,species,0.988,26208030
46765,nAMD,disease,1.0,26208030
46766,ranibizumab,gene,0.7827,26208030
46767,aflibercept,gene,0.903,26208030
46768,Patients,species,0.9683,26208030
46769,ranibizumab,gene,0.953,26208030
46770,aflibercept,gene,0.957,26208030
46771,Patient,species,0.986,26208030
46772,ranibizumab,gene,0.7617,26208030
46773,aflibercept,gene,0.925,26208030
46774,patients,species,0.988,26208030
46775,ranibizumab,gene,0.8223,26208030
46776,aflibercept,gene,0.934,26208030
46777,ranibizumab,gene,0.907,26208030
46778,aflibercept,gene,0.978,26208030
46779,patients,species,0.985,26208030
46780,ranibizumab,gene,0.6562,26208030
46781,aflibercept,gene,0.956,26208030
46782,aflibercept,gene,0.9604,26208030
46783,nAMD,disease,1.0,26208030
46784,patients,species,0.9756,26208030
46785,ranibizumab,gene,0.9375,26208030
46786,aflibercept,gene,0.9683,26208030
46787,AMD,disease,1.0,26201877
46788,patient,species,0.942,26201877
46789,CNV,disease,1.0,26201877
46790,vascular endothelial growth factor,gene,0.961,26201877
46791,VEGF,gene,0.992,26201877
46792,fluorescein,drug,0.9995,26201877
46793,indocyanine green,drug,0.998,26201877
46794,type I and type II CNV,DNA,0.7124,26201877
46795,VEGF,gene,0.988,26201877
46796,type I-II CNV,disease,0.995,26201877
46797,VEGF,gene,0.991,26201877
46798,patients,species,0.8994,26201877
46799,CNV,disease,0.997,26201877
46800,Aflibercept,gene,0.981,26198808
46801,Diabetic Macular Edema,disease,1.0,26198808
46802,aflibercept,gene,0.9805,26198808
46803,diabetic macular edema,disease,1.0,26198808
46804,DME,disease,1.0,26198808
46805,DME,drug,0.882,26198808
46806,DME,drug,0.803,26198808
46807,PARTICIPANTS,species,0.6724,26198808
46808,Patients,species,0.987,26198808
46809,type 1 or 2 diabetes mellitus,disease,1.0,26198808
46810,DME,disease,1.0,26198808
46811,Diabetic Retinopathy,disease,1.0,26198808
46812,VIVID,cell_line,0.6113,26198808
46813,cataract,disease,1.0,26198808
46814,2q4,DNA,0.852,26198808
46815,2q8,DNA,0.7896,26198808
46816,2q4,DNA,0.5815,26198808
46817,2q8,DNA,0.4724,26198808
46818,IAI,drug,0.87,26198808
46819,VEGF,gene,0.9536,26170626
46820,myopic choroid neovascularization,disease,1.0,26170626
46821,Choroidal neovascularization,disease,1.0,26170626
46822,CNV,disease,1.0,26170626
46823,myopia,disease,0.847,26170626
46824,central vision loss,disease,0.838,26170626
46825,patients,species,0.948,26170626
46826,pathologic myopia,disease,0.979,26170626
46827,CNV,disease,0.9985,26170626
46828,pathologic myopia,disease,0.962,26170626
46829,verteporfin,drug,0.9907,26170626
46830,bevacizumab,gene,0.8794,26170626
46831,ranibizumab,gene,0.8296,26170626
46832,pegaptanib,drug,0.811,26170626
46833,aflibercept,gene,0.957,26170626
46834,conbercept,gene,0.6094,26170626
46835,VEGF,gene,0.7256,26170626
46836,VEGF,gene,0.903,26170626
46837,CNV,disease,1.0,26170626
46838,pathologic myopia,disease,0.9673,26170626
46839,myopic CNV,disease,1.0,26170626
46840,VEGF,gene,0.9478,26170626
46841,CNV,disease,1.0,26170626
46842,myopia,disease,0.8213,26170626
46843,RANIBIZUMAB,drug,0.9883,26166797
46844,aflibercept,gene,0.9873,26166797
46845,ranibizumab,gene,0.7964,26166797
46846,Patients,species,0.9595,26166797
46847,patients,species,0.993,26166797
46848,neovascular age-related macular degeneration,disease,1.0,26166797
46849,ranibizumab,gene,0.7065,26166797
46850,Patients,species,0.96,26166797
46851,ranibizumab,gene,0.735,26166797
46852,aflibercept,gene,0.973,26166797
46853,patients,species,0.992,26166797
46854,aflibercept,gene,0.9785,26166797
46855,neovascular age-related macular degeneration,disease,1.0,26166797
46856,ranibizumab,gene,0.703,26166797
46857,ranibizumab,gene,0.6206,26166797
46858,aflibercept,gene,0.9253,26166797
46859,5-Fluorouracil,drug,0.9985,26165922
46860,5-Fluorouracil,drug,0.9995,26165922
46861,5-FU,drug,0.9995,26165922
46862,gastrointestinal solid tumors,disease,1.0,26165922
46863,5-FU,drug,0.998,26165922
46864,siRNA,RNA,0.4321,26165922
46865,5-FU,drug,0.9976,26165922
46866,antitumor,disease,0.534,26165922
46867,5-FU,drug,0.9976,26165922
46868,tumor,disease,1.0,26165922
46869,candidate genes,DNA,0.609,26165922
46870,microRNAs,RNA,0.7964,26165922
46871,5-FU,drug,0.9985,26165922
46872,5-FU,drug,0.9995,26165922
46873,5-FU,drug,0.999,26165922
46874,patients,species,0.984,26165922
46875,age-related macular degeneration,disease,1.0,26165696
46876,neovascular age-related macular degeneration,disease,1.0,26165696
46877,AMD,disease,1.0,26165696
46878,irreversible central blindness,disease,0.9575,26165696
46879,AMD,disease,1.0,26165696
46880,VEGF,gene,0.928,26165696
46881,neovascular AMD,disease,1.0,26165696
46882,VEGF,gene,0.6694,26165696
46883,VEGF,gene,0.902,26165696
46884,neovascular AMD,disease,1.0,26165696
46885,AMD,disease,1.0,26165696
46886,patients,species,0.9883,26165696
46887,choroidal neovascularization,disease,1.0,26165696
46888,patient,species,0.991,26165696
46889,age-related macular degeneration,disease,1.0,26164826
46890,AMD,disease,1.0,26164826
46891,vascular endothelial growth factor,gene,0.9175,26164826
46892,VEGF,gene,0.999,26164826
46893,patients,species,0.9727,26164826
46894,feeder vessel,DNA,0.6104,26164826
46895,anti-vascular endothelial growth factor,gene,0.891,26164826
46896,VEGF,gene,0.995,26164826
46897,VEGF,gene,0.666,26164826
46898,AMD,disease,1.0,26164826
46899,neovascular AMD,disease,1.0,26164826
46900,Aflibercept,gene,0.9517,26156564
46901,wet AMD,disease,0.999,26156564
46902,aflibercept,gene,0.9893,26156564
46903,age-related macular degeneration,disease,1.0,26156564
46904,AMD,disease,1.0,26156564
46905,Neovascular Age-Related Macular Degeneration,disease,0.9956,26147016
46906,Indocyanine Green,drug,0.9976,26147016
46907,indocyanine green,drug,0.9985,26147016
46908,ICG,drug,0.995,26147016
46909,neovascular age-related macular degeneration,disease,0.9995,26147016
46910,nAMD,disease,1.0,26147016
46911,nAMD,disease,1.0,26147016
46912,anti-vascular endothelial growth factor,gene,0.8447,26147016
46913,anti-VEGF,gene,0.8037,26147016
46914,retinal edema,disease,1.0,26147016
46915,anti-VEGF,gene,0.8794,26147016
46916,retinal edema,disease,1.0,26147016
46917,choroidal neovascularization,disease,1.0,26147016
46918,CNV,disease,1.0,26147016
46919,CNV,disease,0.998,26147016
46920,ICG,drug,0.7646,26147016
46921,anti-VEGF,gene,0.981,26147016
46922,CNV,DNA,0.5874,26147016
46923,CNV,disease,0.994,26147016
46924,nAMD,disease,1.0,26147016
46925,retinal edema,disease,1.0,26147016
46926,anti-VEGF,gene,0.8086,26147016
46927,Age-Related Macular Degeneration,disease,1.0,26144701
46928,ranibizumab,gene,0.9526,26144701
46929,aflibercept,gene,0.9785,26144701
46930,nave pigment epithelial detachment,disease,0.954,26144701
46931,PED,disease,1.0,26144701
46932,neovascular age-related macular degeneration,disease,1.0,26144701
46933,neovascular AMD,disease,1.0,26144701
46934,neovascular AMD,disease,1.0,26144701
46935,PED,disease,0.984,26144701
46936,ranibizumab,gene,0.599,26144701
46937,aflibercept,gene,0.92,26144701
46938,PED,DNA,0.4883,26144701
46939,subretinal fluid,disease,0.9937,26144701
46940,retinal angiomatous proliferation,disease,1.0,26144701
46941,PED,disease,0.985,26144701
46942,aflibercept,gene,0.8877,26144701
46943,neovascular AMD,disease,1.0,26144701
46944,PED,disease,1.0,26144701
46945,anti-VEGF,gene,0.8086,26144701
46946,subretinal fluid,disease,0.808,26144701
46947,retinal angiomatous proliferation,disease,1.0,26144701
46948,BCVA,DNA,0.4631,26144701
46949,STRATEGIC,DNA,0.509,26141683
46950,GERCOR,DNA,0.501,26141683
46951,wild-type,disease,0.8276,26141683
46952,wild-type RAS,gene,0.9595,26141683
46953,metastatic colorectal cancer,disease,0.9976,26141683
46954,metastatic colorectal cancer,disease,0.9995,26141683
46955,mCRC,disease,1.0,26141683
46956,fluoropyrimidine,drug,0.9995,26141683
46957,oxaliplatin,drug,1.0,26141683
46958,irinotecan,drug,0.9995,26141683
46959,bevacizumab,gene,0.8843,26141683
46960,aflibercept,gene,0.9756,26141683
46961,regorafenib,drug,0.976,26141683
46962,epidermal growth factor receptor,gene,0.9985,26141683
46963,cetuximab,gene,0.7803,26141683
46964,panitumumab,gene,0.8555,26141683
46965,STRATEGIC,DNA,0.682,26141683
46966,RAS,DNA,0.565,26141683
46967,RAS wild,gene,0.8833,26141683
46968,mCRC,disease,0.964,26141683
46969,cetuximab,gene,0.9023,26141683
46970,oxaliplatin,drug,0.9995,26141683
46971,bevacizumab,gene,0.647,26141683
46972,bevacizumab,gene,0.7188,26141683
46973,irinotecan,drug,0.9985,26141683
46974,bevacizumab,gene,0.6636,26141683
46975,anti-,gene,0.7036,26141683
46976,epidermal growth factor receptor,gene,0.9204,26141683
46977,irinotecan,drug,0.9917,26141683
46978,STRATEGIC,DNA,0.5283,26141683
46979,RAS,gene,0.5454,26141683
46980,mCRC,disease,0.967,26141683
46981,STRATEGIC,DNA,0.55,26141683
46982,STRATEGIC,DNA,0.6655,26141683
46983,ziv-aflibercept,gene,0.984,26139820
46984,macular edema,disease,1.0,26139820
46985,central retinal venous occlusion,disease,1.0,26139820
46986,neovascular age-related macular degeneration,disease,1.0,26133059
46987,nAMD,disease,1.0,26133059
46988,ranibizumab,gene,0.9243,26133059
46989,aflibercept,gene,0.9297,26133059
46990,patients,species,0.9854,26133059
46991,nAMD,disease,1.0,26133059
46992,ranibizumab,gene,0.667,26133059
46993,aflibercept,gene,0.9736,26133059
46994,aflibercept,gene,0.9897,26133059
46995,ranibizumab,gene,0.9126,26133059
46996,aflibercept,gene,0.989,26133059
46997,ranibizumab,gene,0.723,26133059
46998,antivascular endothelial growth factor,gene,0.985,26133059
46999,nAMD,disease,1.0,26133059
47000,aflibercept,gene,0.923,26133059
47001,ranibizumab,drug,0.597,26133059
47002,gynecological cancer,disease,1.0,26126494
47003,Vascular endothelial growth factor,gene,0.998,26126494
47004,VEGF,gene,0.995,26126494
47005,VEGF,gene,0.9844,26126494
47006,bevacizumab,gene,0.6357,26126494
47007,aflibercept,gene,0.9424,26126494
47008,VEGF receptor,gene,0.9966,26126494
47009,pazopanib,drug,0.9995,26126494
47010,nintedanib,drug,0.9985,26126494
47011,cediranid,drug,0.998,26126494
47012,sunitinib,drug,0.999,26126494
47013,sorafenib,drug,0.999,26126494
47014,trebananib,drug,0.998,26126494
47015,angiopoietin [Ang]-1,gene,0.997,26126494
47016,Ang-2,gene,0.997,26126494
47017,Tie2 receptor,gene,0.979,26126494
47018,BEV,drug,0.971,26126494
47019,ovarian carcinoma,disease,1.0,26126494
47020,ovarian carcinoma,disease,1.0,26126494
47021,tumors,disease,0.4497,26126494
47022,BEV,drug,0.9785,26126494
47023,cervical or endometrial cancer,disease,0.997,26126494
47024,malignancies,disease,1.0,26126494
47025,aflibercept,gene,0.974,29018684
47026,neovascular age-related macular degeneration,disease,1.0,29018684
47027,aflibercept,gene,0.9795,29018684
47028,neovascular age-related macular degeneration,disease,1.0,29018684
47029,AMD,disease,1.0,29018684
47030,neovascular AMD,disease,1.0,29018684
47031,triamcinolone,drug,0.932,29018684
47032,ranibizumab,gene,0.811,29018684
47033,aflibercept,gene,0.966,29018684
47034,neovascular AMD,disease,1.0,29018684
47035,aflibercept,gene,0.9414,29018684
47036,aflibercept,gene,0.978,29018684
47037,aflibercept,gene,0.986,29018684
47038,aflibercept,gene,0.968,29018684
47039,neovascular AMD,disease,1.0,29018684
47040,Infectious Endophthalmitis,disease,1.0,26114845
47041,infectious endophthalmitis,disease,1.0,26114845
47042,anti-VEGF,gene,0.8813,26114845
47043,PATIENTS,species,0.926,26114845
47044,Patient,species,0.987,26114845
47045,endophthalmitis,disease,1.0,26114845
47046,endophthalmitis,disease,1.0,26114845
47047,BPEI,disease,0.9375,26114845
47048,bevacizumab,gene,0.6514,26114845
47049,ranibizumab,gene,0.7827,26114845
47050,aflibercept,gene,0.9897,26114845
47051,BPEI,disease,1.0,26114845
47052,Streptococcus species,species,0.694,26114845
47053,coagulase,gene,0.884,26114845
47054,Endophthalmitis,disease,1.0,26114845
47055,anti-VEGF,gene,0.862,26114845
47056,Pigment Epithelial Detachment,disease,0.9966,26114844
47057,pigment epithelial detachment,disease,0.9995,26114844
47058,PED,disease,0.999,26114844
47059,aflibercept,gene,0.9126,26114844
47060,patients,species,0.9214,26114844
47061,neovascular age-related macular degeneration,disease,1.0,26114844
47062,AMD,disease,1.0,26114844
47063,PED,disease,1.0,26114844
47064,bevacizumab,gene,0.7485,26114844
47065,PATIENTS,species,0.951,26114844
47066,patients,species,0.9663,26114844
47067,neovascular AMD,disease,1.0,26114844
47068,fibrovascular,disease,0.604,26114844
47069,PED,disease,0.945,26114844
47070,PED,disease,0.857,26114844
47071,patients,species,0.987,26114844
47072,bevacizumab,gene,0.5806,26114844
47073,PED,disease,0.6753,26114844
47074,aflibercept,gene,0.9736,26114844
47075,aflibercept,gene,0.964,26114844
47076,PED,disease,0.9995,26114844
47077,neovascular AMD,disease,1.0,26114844
47078,Aflibercept,gene,0.982,26114826
47079,Corneal Neovascularization,disease,0.998,26114826
47080,Rabbits,species,0.8887,26114826
47081,aflibercept,gene,0.9893,26114826
47082,vascular endothelial growth factor,gene,0.997,26114826
47083,VEGF,gene,0.9927,26114826
47084,corneal neovascularization,disease,0.9995,26114826
47085,NV,disease,1.0,26114826
47086,rabbits,species,0.955,26114826
47087,Corneal NV,disease,1.0,26114826
47088,rabbits,species,0.9624,26114826
47089,rabbits,species,0.909,26114826
47090,aflibercept,gene,0.961,26114826
47091,bevacizumab,gene,0.8833,26114826
47092,VEGF,gene,0.9976,26114826
47093,placental growth factor (PIGF) messenger RNA,gene,0.8833,26114826
47094,reverse transcriptase,gene,0.995,26114826
47095,NV,disease,,26114826
47096,VEGF mRNA,RNA,0.8735,26114826
47097,VEGF mRNA,gene,0.991,26114826
47098,aflibercept,gene,0.9854,26114826
47099,aflibercept,gene,0.9854,26114826
47100,bevacizumab,gene,0.591,26114826
47101,VEGF,gene,0.9937,26114826
47102,aflibercept,gene,0.9956,26114826
47103,aflibercept,gene,0.995,26114826
47104,bevacizumab,gene,0.9346,26114826
47105,aflibercept,gene,0.993,26114826
47106,bevacizumab,gene,0.9424,26114826
47107,PIGF mRNA,gene,0.9897,26114826
47108,aflibercept,gene,0.982,26114826
47109,aflibercept,gene,0.985,26114826
47110,bevacizumab,gene,0.5205,26114826
47111,PIGF mRNA,RNA,0.9116,26114826
47112,PIGF mRNA,gene,0.9883,26114826
47113,aflibercept,gene,0.986,26114826
47114,aflibercept,gene,0.981,26114826
47115,aflibercept,gene,0.978,26114826
47116,corneal NV,disease,0.987,26114826
47117,rabbits,species,0.9355,26114826
47118,Aflibercept,gene,0.947,26114491
47119,Exudative AMD,disease,1.0,26114491
47120,aflibercept,gene,0.9854,26114491
47121,exudative age-related macular degeneration,disease,1.0,26114491
47122,eAMD,disease,1.0,26114491
47123,patients,species,0.986,26114491
47124,subretinal hyper-reflective exudation,disease,0.9985,26114491
47125,SHE,disease,0.992,26114491
47126,cystoid,disease,0.7114,26114491
47127,subretinal fluid,disease,0.8716,26114491
47128,pigmented epithelium detachment,disease,1.0,26114491
47129,BCVA,disease,0.998,26114491
47130,Swelling of the EZ,disease,0.9995,26114491
47131,Aflibercept,gene,0.928,26114491
47132,exudative AMD,disease,0.999,26114491
47133,BCVA,DNA,0.5044,26114491
47134,photoreceptor,cell_type,0.6914,26114491
47135,diabetic macular oedema,disease,1.0,26113500
47136,Diabetic macular oedema,disease,1.0,26113500
47137,DMO,disease,1.0,26113500
47138,visual impairment,disease,0.999,26113500
47139,diabetic,disease,1.0,26113500
47140,patients,species,0.984,26113500
47141,DMO,disease,1.0,26113500
47142,endothelial cell,cell_type,0.794,26113500
47143,EC,cell_type,0.889,26113500
47144,pericyte,cell_type,0.4993,26113500
47145,glial cells,cell_type,0.859,26113500
47146,EC,cell_type,,26113500
47147,oxygen,drug,1.0,26113500
47148,intracellular adhesion molecule-1,gene,0.962,26113500
47149,DMO,disease,1.0,26113500
47150,vascular endothelial growth factor,gene,0.9976,26113500
47151,VEGF,gene,0.9985,26113500
47152,VEGF,gene,0.996,26113500
47153,anti-VEGFs,gene,0.758,26113500
47154,ranibizumab,gene,0.9673,26113500
47155,aflibercept,gene,0.9795,26113500
47156,bevacizumab,gene,0.785,26113500
47157,steroids,drug,0.5405,26113500
47158,fluocinolone,drug,0.999,26113500
47159,dexamethasone,drug,0.9985,26113500
47160,triamcinolone,drug,0.9995,26113500
47161,DMO,disease,0.999,26113500
47162,DMO,disease,1.0,26113500
47163,macular oedema,disease,1.0,26113500
47164,patients,species,0.9844,26113500
47165,DMO,disease,1.0,26113500
47166,DMO,disease,0.7915,26113500
47167,metastatic,disease,0.843,26113053
47168,colorectal cancer,disease,0.8594,26113053
47169,patients,species,0.984,26113053
47170,metastatic colorectal cancer,disease,1.0,26113053
47171,mCRC,disease,1.0,26113053
47172,patient,species,0.9873,26113053
47173,tumor,disease,1.0,26113053
47174,cetuximab,gene,0.566,26113053
47175,panitumumab,gene,0.584,26113053
47176,anti-EGFR monoclonal antibody,gene,0.8486,26113053
47177,patients,species,0.964,26113053
47178,RAS wild,cell_line,0.5166,26113053
47179,RAS wild-type tumors,disease,0.991,26113053
47180,RAS,gene,0.9897,26113053
47181,bevacizumab,gene,0.882,26113053
47182,patients,species,0.864,26113053
47183,CRC,disease,0.997,26113053
47184,mCRC,disease,0.9805,26113053
47185,bevacizumab,gene,0.882,26113053
47186,patients,species,0.9785,26113053
47187,mCRC,disease,0.9976,26113053
47188,aflibercept,gene,0.9854,26113053
47189,regorafenib,drug,0.961,26113053
47190,patients,species,0.971,26113053
47191,patients,species,0.969,26113053
47192,mCRC,disease,0.948,26113053
47193,patients,species,0.951,26110596
47194,age,disease,1.0,26110596
47195,vascular endothelial growth factor,gene,0.9883,26110596
47196,patients,species,0.9805,26110596
47197,VMA,disease,1.0,26110596
47198,VMA,disease,1.0,26110596
47199,VMA,disease,0.977,26110596
47200,VMA,drug,0.798,26110596
47201,VMA,disease,0.996,26110596
47202,VMA,disease,0.983,26110596
47203,VMA,drug,0.9614,26110596
47204,VMA,cell_line,0.7124,26110596
47205,VMA,cell_line,0.6284,26110596
47206,VMA,cell_type,0.4753,26110596
47207,anti-vascular endothelial growth factor,gene,0.8994,26110596
47208,VMA,disease,0.9985,26110596
47209,aflibercept,gene,0.986,26092633
47210,aflibercept,gene,0.984,26092633
47211,patients,species,0.9663,26092633
47212,neovascular age-related macular degeneration,disease,1.0,26092633
47213,nAMD,disease,1.0,26092633
47214,ranibizumab,gene,0.8906,26092633
47215,aflibercept,gene,0.9517,26092633
47216,patients,species,0.9814,26092633
47217,nAMD,disease,1.0,26092633
47218,aflibercept,gene,0.9443,26092633
47219,Diabetic Retinopathy,disease,0.9995,26092633
47220,patients,species,0.988,26092633
47221,patients,species,0.984,26092633
47222,aflibercept,gene,0.9746,26092633
47223,ranibizumab,gene,0.5317,26092633
47224,CFT,cell_type,0.501,26092633
47225,aflibercept,gene,0.9736,26092633
47226,patients,species,0.965,26092633
47227,nAMD,disease,1.0,26092633
47228,Aflibercept,gene,0.9556,26088619
47229,Polypoidal Choroidal Vasculopathy,disease,1.0,26088619
47230,aflibercept,gene,0.97,26088619
47231,polypoidal choroidal vasculopathy,disease,1.0,26088619
47232,PCV,disease,1.0,26088619
47233,PARTICIPANTS,species,0.565,26088619
47234,PCV,disease,1.0,26088619
47235,PCV,disease,1.0,26088619
47236,aflibercept,gene,0.9844,26088619
47237,dry macula,disease,1.0,26088619
47238,indocyanine green,drug,0.996,26088619
47239,polypoidal lesions,disease,1.0,26088619
47240,aflibercept,gene,0.8667,26088619
47241,PCV,disease,1.0,26088619
47242,Diabetic Macular Edema,disease,1.0,26087135
47243,Diabetic Retinopathy,disease,1.0,26087135
47244,VEGF,gene,0.842,26081237
47245,neovascular glaucoma,disease,1.0,26081237
47246,Neovascular glaucoma,disease,1.0,26081237
47247,NVG,disease,1.0,26081237
47248,glaucoma,disease,0.866,26081237
47249,anoxia,disease,0.9995,26081237
47250,ischemia to the retina,disease,0.9185,26081237
47251,vascular endothelial growth factor,gene,0.9966,26081237
47252,VEGF,gene,0.995,26081237
47253,VEGF,gene,0.8467,26081237
47254,NVG,disease,1.0,26081237
47255,glaucoma,disease,1.0,26081237
47256,NVG,disease,0.9966,26081237
47257,VEGF,gene,0.7305,26081237
47258,Bevacizumab,gene,0.8345,26081237
47259,Ranibizumab,gene,0.7734,26081237
47260,Pegaptanib,drug,0.9976,26081237
47261,Aflibercept,gene,0.984,26081237
47262,NVG,disease,0.5674,26081237
47263,scarring,disease,0.7314,26081237
47264,NVG,disease,1.0,26081237
47265,Aflibercept,gene,0.956,26076885
47266,metastatic colorectal cancer,disease,1.0,26076885
47267,Aflibercept,gene,0.974,26076885
47268,metastatic colorectal cancer,disease,1.0,26076885
47269,mCRC,disease,1.0,26076885
47270,FOLFIRI,drug,0.958,26076885
47271,oxaliplatin,drug,0.999,26076885
47272,aflibercept,gene,0.975,26076885
47273,aflibercept,gene,0.954,26076885
47274,mCRC,disease,0.679,26076885
47275,aflibercept,gene,0.892,26076885
47276,FOLFIRI,drug,0.967,26076885
47277,mCRC,disease,0.997,26076885
47278,bevacizumab,gene,0.5977,26076885
47279,EGFR,gene,0.638,26076885
47280,FOLFIRI,drug,0.963,26076885
47281,aflibercept,gene,0.9634,26076885
47282,neutropenia,disease,1.0,26076885
47283,diarrhea,disease,1.0,26076885
47284,hypertension,disease,1.0,26076885
47285,aflibercept,gene,0.974,26076885
47286,FOLFIRI,drug,0.975,26076885
47287,Ranibizumab,gene,0.857,26076760
47288,aflibercept,gene,0.9546,26076760
47289,age-related macular degeneration,disease,1.0,26076760
47290,Wet,disease,0.9336,26076760
47291,age-related macular degeneration,disease,0.988,26076760
47292,AMD,disease,1.0,26076760
47293,blinding eye disease,disease,0.9473,26076760
47294,vision loss,disease,0.9946,26076760
47295,wet AMD,disease,0.9546,26076760
47296,choroidal neovascularization,disease,1.0,26076760
47297,CNV,disease,1.0,26076760
47298,ranibizumab,gene,0.789,26076760
47299,aflibercept,gene,0.9727,26076760
47300,anti-VEGF,gene,0.6616,26076760
47301,wet AMD,disease,0.999,26076760
47302,ranibizumab,gene,0.9316,26076760
47303,aflibercept,gene,0.9785,26076760
47304,wet AMD,disease,0.9995,26076760
47305,AMD,disease,0.9263,26076760
47306,anti-vascular endothelial growth factors,gene,0.9976,26076760
47307,anti-VEGF,gene,0.994,26076760
47308,age-related macular degeneration,disease,1.0,26076760
47309,AMD,disease,1.0,26076760
47310,aflibercept,gene,0.982,26076760
47311,ranibizumab,gene,0.5728,26076760
47312,ranibizumab,drug,0.6484,26076760
47313,ranibizumab,drug,0.534,26076760
47314,aflibercept,gene,0.9585,26076760
47315,aflibercept,gene,0.9834,26076760
47316,ranibizumab,gene,0.783,26076760
47317,wet AMD,disease,0.999,26076760
47318,Ranibizumab,gene,0.864,26076760
47319,aflibercept,gene,0.9736,26076760
47320,wet AMD,disease,1.0,26076760
47321,retinal angiomatous proliferation,disease,1.0,26076760
47322,RAP,disease,1.0,26076760
47323,CNV,disease,1.0,26076760
47324,VEGF,gene,0.7334,26076760
47325,ranibizumab,gene,0.667,26076760
47326,CNV,disease,1.0,26076760
47327,VEGF,gene,0.733,26076760
47328,VEGF,gene,0.6807,26076215
47329,RETINAL DISEASES,disease,1.0,26076215
47330,vascular endothelial growth factor,gene,0.981,26076215
47331,retinal diseases,disease,0.9985,26076215
47332,vascular endothelial growth factor,gene,0.99,26076215
47333,retinal diseases,disease,1.0,26076215
47334,anti-vascular endothelial growth factor,gene,0.8745,26076215
47335,retinal diseases,disease,0.9995,26076215
47336,VEGF,gene,0.964,26073857
47337,Retinal Vein Occlusions,disease,1.0,26073857
47338,Retinal vein occlusion,disease,1.0,26073857
47339,RVO,disease,1.0,26073857
47340,visual loss,disease,0.9995,26073857
47341,RVO,disease,1.0,26073857
47342,RVO,disease,0.9497,26073857
47343,BRVO,disease,0.996,26073857
47344,RVO,disease,0.986,26073857
47345,CRVO,disease,0.9976,26073857
47346,RVO,disease,1.0,26073857
47347,hypertension,disease,1.0,26073857
47348,hyperlipidemia,disease,1.0,26073857
47349,diabetes,disease,1.0,26073857
47350,thrombophilia,disease,1.0,26073857
47351,capillaries,cell_type,0.4758,26073857
47352,hemorrhages,disease,0.9995,26073857
47353,vascular endothelial growth factor,gene,0.9985,26073857
47354,VEGF,gene,0.997,26073857
47355,retinal oedema,disease,1.0,26073857
47356,VEGF,gene,0.994,26073857
47357,RVO,disease,1.0,26073857
47358,VEGF,gene,0.772,26073857
47359,patients,species,0.9883,26073857
47360,VEGF,gene,0.55,26073857
47361,ranimizumab,gene,0.9785,26073857
47362,aflibercept,gene,0.9805,26073857
47363,RVO,disease,1.0,26073857
47364,VEGF,gene,0.9966,26073857
47365,bevacizumab,gene,0.7734,26073857
47366,retinal vein occlusion,disease,1.0,26073857
47367,ranibizumab,drug,0.811,26073857
47368,bevacizumab,gene,0.6455,26073857
47369,aflibercept,gene,0.977,26073857
47370,vascular endothelial growth factor,gene,0.998,26073857
47371,macular oedema,disease,1.0,26073857
47372,retinal disease,disease,0.999,26065505
47373,diabetic macular edema,disease,1.0,26065505
47374,aflibercept,gene,0.9688,26065505
47375,dexamethasone,drug,0.9272,26065505
47376,age-related macular degeneration,disease,1.0,26065505
47377,AMD,disease,1.0,26065505
47378,zinc,drug,1.0,26065505
47379,vitamin C,drug,0.9995,26065505
47380,vitamin E,drug,1.0,26065505
47381,lutein,drug,0.9995,26065505
47382,zeaxanthin,drug,0.999,26065505
47383,Age-Related Eye Disease,disease,1.0,26065505
47384,choroideremia,disease,1.0,26065505
47385,squalamine,drug,0.999,26065505
47386,ranibizumab,gene,0.941,26065505
47387,AMD,disease,0.9995,26065505
47388,stem cell,cell_type,0.752,26065505
47389,retinal pigment epithelium,cell_type,0.6,26065505
47390,atrophic AMD,disease,1.0,26065505
47391,Stargardt macular dystrophy,disease,1.0,26065505
47392,vascular endothelial growth factor,gene,0.997,26065505
47393,retinal degenerative diseases,disease,1.0,26065505
47394,diabetic macular edema,disease,1.0,26065505
47395,AMD,disease,1.0,26065505
47396,Age-Related Eye Disease,disease,0.999,26065505
47397,AMD,disease,1.0,26065505
47398,retinal diseases,disease,1.0,26065226
47399,VEGF,gene,0.9395,26065226
47400,VEGF protein,gene,0.996,26065226
47401,Vascular Endothelial Growth Factor,gene,0.996,26065226
47402,retinal,cell_type,0.459,26065226
47403,edema,disease,0.999,26065226
47404,blindness,disease,0.9995,26065226
47405,diseases of the macula,disease,0.9995,26065226
47406,AMD,disease,0.9995,26065226
47407,Age,disease,0.991,26065226
47408,Macular Degeneration,disease,1.0,26065226
47409,diabetes,disease,1.0,26065226
47410,retinal vascular occlusions,disease,1.0,26065226
47411,VEGF,gene,0.6045,26065226
47412,Bevacizumab,gene,0.952,26065226
47413,Lucentis,gene,0.4827,26065226
47414,Ranibizumab,gene,0.9614,26065226
47415,Aflibercept,gene,0.986,26065226
47416,blindness,disease,1.0,26065226
47417,patients,species,0.992,26065226
47418,anti-VEGF,gene,0.778,26065226
47419,Aflibercept,gene,0.953,26057757
47420,Neovascular Age-Related Macular Degeneration,disease,1.0,26057757
47421,exudative age- related macular degeneration,disease,0.9995,26057757
47422,AMD,disease,1.0,26057757
47423,aflibercept,gene,0.982,26057757
47424,PATIENTS,species,0.89,26057757
47425,aflibercept,gene,0.989,26057757
47426,exudative AMD,disease,0.999,26057757
47427,aflibercept,gene,0.991,26057757
47428,bevacizumab,gene,0.704,26057757
47429,aflibercept,gene,0.9624,26057757
47430,aflibercept,gene,0.946,26057757
47431,Aflibercept,gene,0.958,26056075
47432,bevacizumab,gene,0.5522,26056075
47433,glucose,drug,0.999,26056075
47434,human retinal pericytes,cell_type,0.9004,26056075
47435,PLA2,gene,0.9683,26056075
47436,COX-2,gene,0.998,26056075
47437,VEGF-A,gene,0.9976,26056075
47438,Diabetic retinopathy,disease,1.0,26056075
47439,vision loss,disease,0.999,26056075
47440,VEGF,gene,0.922,26056075
47441,glucose,drug,0.999,26056075
47442,retinal pericytes,cell_type,0.8516,26056075
47443,endothelial cells,cell_type,0.8867,26056075
47444,VEGF,gene,0.9927,26056075
47445,anti-VEGFs,gene,0.962,26056075
47446,PLA2,gene,0.9917,26056075
47447,COX-2,gene,0.9966,26056075
47448,glucose,drug,0.999,26056075
47449,VEGF,gene,0.995,26056075
47450,endothelial cells,cell_type,0.943,26056075
47451,Human retinal pericytes,cell_type,0.8447,26056075
47452,glucose,drug,0.991,26056075
47453,anti-VEGFs,gene,0.8823,26056075
47454,aflibercept,gene,0.977,26056075
47455,bevacizumab,gene,0.877,26056075
47456,ranibizumab,gene,0.8315,26056075
47457,anti-VEGFs,gene,0.937,26056075
47458,glucose,drug,0.9985,26056075
47459,LDH,gene,0.9893,26056075
47460,MTT,drug,0.996,26056075
47461,glucose,drug,0.9995,26056075
47462,VEGF-A,gene,0.997,26056075
47463,mRNA,RNA,0.908,26056075
47464,VEGFR1,gene,0.9907,26056075
47465,VEGFR2,gene,0.9907,26056075
47466,glucose,drug,0.999,26056075
47467,PLA2,gene,0.9897,26056075
47468,COX-2,gene,0.9946,26056075
47469,cPLA2,gene,0.9795,26056075
47470,COX-2,gene,0.993,26056075
47471,PGE2,drug,0.996,26056075
47472,cPLA2,gene,0.986,26056075
47473,AACOCF3,drug,0.995,26056075
47474,COX-2,gene,0.9927,26056075
47475,NS-392,drug,0.981,26056075
47476,VEGF-A,gene,0.9897,26056075
47477,glucose,drug,0.999,26056075
47478,VEGF-A,gene,0.7837,26056075
47479,VEGF-A,gene,0.9966,26056075
47480,anti-VEGFs,gene,0.84,26056075
47481,VEGF-A,gene,0.995,26056075
47482,glucose,drug,0.9985,26056075
47483,VEGF-A,gene,0.9404,26056075
47484,glucose,drug,0.9985,26056075
47485,pericytes,cell_type,0.8496,26056075
47486,PLA2,gene,0.988,26056075
47487,COX-2,gene,0.9976,26056075
47488,VEGF-A,gene,0.996,26056075
47489,cPLA2,gene,0.992,26056075
47490,COX-2,gene,0.9976,26056075
47491,VEGF,gene,0.99,26056075
47492,anti-VEGFs,gene,0.9155,26056075
47493,pericytes,cell_type,0.8516,26056075
47494,glucose,drug,0.997,26056075
47495,Aflibercept,gene,0.9146,26056030
47496,Diabetic Macular Oedema,disease,1.0,26056030
47497,Aflibercept,gene,0.974,26056030
47498,Eylea,gene,0.5645,26056030
47499,anti-,gene,0.6846,26056030
47500,vascular endothelial growth factor,gene,0.919,26056030
47501,diabetic macular oedema,disease,1.0,26056030
47502,diabetic macular oedema,disease,1.0,26056030
47503,aflibercept,gene,0.8857,26056030
47504,DME,disease,0.989,26056030
47505,DME,disease,0.978,26056030
47506,bevacizumab,gene,0.7715,26056030
47507,ranibizumab,gene,0.833,26056030
47508,Diabetic Retinopathy,disease,1.0,26056030
47509,aflibercept,gene,0.9697,26056030
47510,diabetic macular oedema,disease,1.0,26056030
47511,aflibercept,gene,0.9756,26056030
47512,diabetic macular oedema,disease,1.0,26056030
47513,Aflibercept,gene,0.964,26054473
47514,Neovascular Age-Related Macular Degeneration,disease,1.0,26054473
47515,macular oedema,disease,1.0,26048209
47516,branch retinal vein occlusion,disease,1.0,26048209
47517,macular oedema,disease,1.0,26048209
47518,branch retinal vein occlusion,disease,1.0,26048209
47519,BRVO,disease,1.0,26048209
47520,macular oedema,disease,1.0,26048209
47521,BRVO,disease,1.0,26048209
47522,macular oedema,disease,1.0,26048209
47523,BRVO,disease,1.0,26048209
47524,Ranibizumab,gene,0.89,26048209
47525,aflibercept,gene,0.887,26048209
47526,dexamethasone,drug,0.988,26048209
47527,ranibizumab,drug,0.567,26048209
47528,Bevacizumab,gene,0.937,26048209
47529,triamcinolone,drug,0.9995,26048209
47530,Diabetic Retinopathy,disease,1.0,26048209
47531,ocular hypertension,disease,1.0,26048209
47532,OH,disease,1.0,26048209
47533,ranibizumab,gene,0.862,26048209
47534,aflibercept,gene,0.8433,26048209
47535,ranibizumab,drug,0.713,26048209
47536,dexamethasone,drug,0.9946,26048209
47537,aflibercept,gene,0.988,26048209
47538,ranibizumab,gene,0.565,26048209
47539,dexamethasone,drug,0.9946,26048209
47540,aflibercept,gene,0.9795,26048209
47541,aflibercept,gene,0.9653,26048209
47542,Dexamethasone,drug,0.9937,26048209
47543,ranibizumab,gene,0.8647,26048209
47544,aflibercept,gene,0.9736,26048209
47545,aflibercept,gene,0.9697,26043678
47546,age-related macular degeneration,disease,1.0,26043678
47547,aflibercept,gene,0.9604,26043678
47548,exudative age-related macular degeneration,disease,1.0,26043678
47549,AMD,drug,0.549,26043678
47550,AMD,disease,0.903,26043678
47551,tAMD,disease,1.0,26043678
47552,polypoidal choroidal vasculopathy,disease,1.0,26043678
47553,PCV,disease,1.0,26043678
47554,IVA,drug,0.932,26043678
47555,exudative AMD,disease,0.967,26043678
47556,AMD,disease,1.0,26043678
47557,cystoid macular edema,disease,1.0,26043678
47558,serous retinal detachment,disease,1.0,26043678
47559,pigment epithelium detachment,disease,1.0,26043678
47560,PVD,disease,1.0,26043678
47561,AMD,disease,1.0,26043678
47562,tAMD,disease,0.9995,26043678
47563,PVD,disease,0.9995,26043678
47564,AMD,disease,1.0,26043678
47565,PVD,disease,1.0,26043678
47566,tAMD,disease,1.0,26043678
47567,AMD,disease,1.0,26043678
47568,tAMD,disease,1.0,26043678
47569,PVD,disease,1.0,26043678
47570,Hypersensitivity reaction,disease,1.0,26042586
47571,folinic acid,drug,0.999,26042586
47572,5-Fluorouracil,drug,0.9995,26042586
47573,5-FU,drug,0.9995,26042586
47574,folinic acid,drug,0.999,26042586
47575,colon cancer,disease,1.0,26042586
47576,Folinic acid,drug,0.9995,26042586
47577,hypersensitivity reactions,disease,0.9995,26042586
47578,FA hypersensitivity,disease,0.978,26042586
47579,patient,species,0.977,26042586
47580,oxaliplatin,drug,0.9995,26042586
47581,patient,species,0.926,26042586
47582,colon cancer,disease,1.0,26042586
47583,FOLFOX6,drug,0.875,26042586
47584,oxaliplatin,drug,1.0,26042586
47585,patient,species,0.9717,26042586
47586,pruritus,disease,0.9937,26042586
47587,abdominal pain,disease,0.9897,26042586
47588,erythema,disease,0.999,26042586
47589,oedema,disease,1.0,26042586
47590,FOLFIRI,drug,0.964,26042586
47591,aflibercept,gene,0.98,26042586
47592,patient,species,0.9893,26042586
47593,irinotecan,drug,0.9966,26042586
47594,5-FU,drug,0.998,26042586
47595,hypersensitivity reaction,disease,0.9995,26042586
47596,oxaliplatin,drug,0.9985,26042586
47597,hypersensitivity reaction,disease,0.997,26042586
47598,hypersensitivity reaction,disease,0.9414,26042586
47599,oxaliplatin,drug,0.9995,26042586
47600,hypersensitivity reactions,disease,0.9985,26042586
47601,hypersensitivity reactions,disease,1.0,26042586
47602,patient,species,0.9897,26042586
47603,Anti-Vascular Endothelial Growth Factor,gene,0.973,26038338
47604,Neovascular Age-Related Macular Degeneration,disease,1.0,26038338
47605,posterior vitreous detachment,disease,1.0,26038338
47606,PVD,disease,1.0,26038338
47607,VEGF,gene,0.996,26038338
47608,neovascular age-related macular degeneration,disease,1.0,26038338
47609,AMD,disease,1.0,26038338
47610,neovascular AMD,disease,1.0,26038338
47611,neovascular AMD,disease,1.0,26038338
47612,VMA,disease,0.9795,26038338
47613,VMA,disease,1.0,26038338
47614,macular surface,DNA,0.5156,26038338
47615,VEGF,gene,0.8716,26038338
47616,PVD,disease,0.999,26038338
47617,Posterior vitreous detachment,disease,0.9976,26038338
47618,VEGF,gene,0.6543,26038338
47619,ranibizumab,gene,0.89,26038338
47620,bevacizumab,gene,0.8354,26038338
47621,aflibercept,gene,0.9653,26038338
47622,PVD,disease,0.9995,26038338
47623,bevacizumab,gene,0.912,26038338
47624,ranibizumab,gene,0.74,26038338
47625,ranibizumab,drug,0.913,26038338
47626,bevacizumab,gene,0.6455,26038338
47627,ranibizumab,drug,0.84,26038338
47628,aflibercept,gene,0.9897,26038338
47629,VMA,disease,1.0,26038338
47630,PVD,disease,1.0,26038338
47631,VMA,disease,1.0,26038338
47632,VEGF,gene,0.687,26038338
47633,PVD,disease,1.0,26038338
47634,neovascular AMD,disease,1.0,26038338
47635,VMA,disease,1.0,26038338
47636,PVD,disease,1.0,26038338
47637,VMA,disease,1.0,26038338
47638,colorectal cancer,disease,1.0,26027741
47639,Colorectal cancer,disease,1.0,26027741
47640,CRC,disease,1.0,26027741
47641,malignancies,disease,1.0,26027741
47642,cancer,disease,1.0,26027741
47643,patient,species,0.9854,26027741
47644,anti-EGFR,gene,0.8633,26027741
47645,cetuximab,gene,0.8564,26027741
47646,panitumumab,gene,0.95,26027741
47647,bevacizumab,gene,0.875,26027741
47648,aflibercept,gene,0.9824,26027741
47649,regorafenib,drug,0.9473,26027741
47650,fluoropyrimidines,drug,0.9985,26027741
47651,genetic variants,DNA,0.5586,26027741
47652,CRC,disease,0.9985,26027741
47653,tumor,disease,0.819,26027741
47654,RAS,gene,0.9985,26027741
47655,RAF,gene,0.999,26027741
47656,MAPK,gene,0.9946,26027741
47657,PI3K,gene,0.994,26027741
47658,PTEN,gene,0.9956,26027741
47659,AKT,gene,0.998,26027741
47660,CRC,disease,0.999,26027741
47661,CRC,disease,0.999,26027741
47662,KRAS exon 2,gene,0.9893,26027741
47663,BRAF,gene,0.998,26027741
47664,p.V600,mutation,,26027741
47665,PI3KCA,DNA,0.636,26027741
47666,PI3KCA-,gene,0.9976,26027741
47667,-exon 9,DNA,0.5083,26027741
47668,PTEN,gene,0.9946,26027741
47669,EGFR,gene,0.747,26027741
47670,germline,DNA,0.6953,26027741
47671,ABC,gene,0.569,26027741
47672,SLC,gene,0.754,26027741
47673,CYP450,gene,0.9927,26027741
47674,GST,gene,0.995,26027741
47675,UGT,gene,0.994,26027741
47676,folate,drug,0.9995,26027741
47677,EGF,gene,0.9976,26027741
47678,VEGF,gene,0.9917,26027741
47679,tumor,disease,0.968,26027741
47680,CRC,disease,0.999,26027741
47681,patients,species,0.9883,26027741
47682,fluoropyrimidines,drug,0.998,26027741
47683,irinotecan,drug,0.9995,26027741
47684,oxaliplatin,drug,0.9995,26027741
47685,multiple host polymorphisms,DNA,0.4707,26027741
47686,tumor,disease,1.0,26027741
47687,CRC,disease,0.998,26027741
47688,CRC,disease,0.999,26027741
47689,Neovascular Age-Related Macular Degeneration,disease,1.0,26025097
47690,Aflibercept,gene,0.944,26025097
47691,Ranibizumab,gene,0.7124,26025097
47692,neovascular age-related macular degeneration,disease,1.0,26025097
47693,NVAMD,disease,1.0,26025097
47694,aflibercept,gene,0.9893,26025097
47695,ranibizumab,gene,0.7617,26025097
47696,VEGF,gene,0.9834,26025097
47697,PARTICIPANTS,species,0.732,26025097
47698,NVAMD,disease,1.0,26025097
47699,Rq4,DNA,0.8877,26025097
47700,2q4,DNA,0.808,26025097
47701,2q8,DNA,0.7974,26025097
47702,0.5q4,DNA,0.823,26025097
47703,2q4,DNA,0.8677,26025097
47704,2q8,DNA,0.8447,26025097
47705,0.5q4,DNA,0.8804,26025097
47706,NVAMD,disease,1.0,26025097
47707,ranibizumab,gene,0.63,26025097
47708,placental growth factor,gene,0.9985,26024110
47709,aflibercept,gene,0.974,26024110
47710,Placental growth factor,gene,0.9907,26024110
47711,PlGF,gene,0.9814,26024110
47712,VEGF,gene,0.8374,26024110
47713,PlGF,gene,0.9956,26024110
47714,VEGF-A,gene,0.999,26024110
47715,VEGF-B,gene,0.999,26024110
47716,AMD,disease,1.0,26024110
47717,aflibercept,gene,0.9805,26024110
47718,ranibizumab,gene,0.747,26024110
47719,bevacizumab,gene,0.6455,26024110
47720,aflibercept,gene,0.989,26024110
47721,ranibizumab,gene,0.691,26024110
47722,bevacizumab,gene,0.7896,26024110
47723,PlGF,gene,0.9966,26024110
47724,anti-VEGF,gene,0.9614,26024110
47725,aflibercept,gene,0.989,26024110
47726,PlGF,gene,0.956,26024110
47727,plasma PlGF,gene,0.59,26024110
47728,ranibizumab,gene,0.507,26024110
47729,VEGF-A,gene,0.978,26024110
47730,aflibercept,gene,0.9263,26024110
47731,bevacizumab,gene,0.716,26024110
47732,VEGF-B,gene,0.994,26024110
47733,PlGF,gene,0.75,26024110
47734,aflibercept,gene,0.9683,26024110
47735,polypoidal choroidal vasculopathy,disease,1.0,26024101
47736,polypoidal,DNA,0.445,26024101
47737,polypoidal lesions,disease,1.0,26024101
47738,polypoidal choroidal vasculopathy,disease,1.0,26024101
47739,PCV,disease,1.0,26024101
47740,PCV,disease,1.0,26024101
47741,PCV,disease,1.0,26024101
47742,indocyanine green,drug,0.997,26024101
47743,aflibercept,gene,0.969,26024101
47744,polypoidal,DNA,0.4653,26024101
47745,polypoidal lesions,disease,1.0,26024101
47746,polypoidal lesions,disease,1.0,26024101
47747,polypoidal lesions,disease,1.0,26024101
47748,Polypoidal lesions,disease,1.0,26024101
47749,retinal pigment epithelial detachment,disease,1.0,26024101
47750,retinal pigment epithelial detachment,disease,1.0,26024101
47751,aflibercept,gene,0.9927,26024101
47752,polypoidal,DNA,0.4592,26024101
47753,polypoidal lesions,disease,1.0,26024101
47754,polypoidal,DNA,0.4375,26024101
47755,polypoidal lesions,disease,1.0,26024101
47756,PCV,disease,1.0,26024101
47757,PCV,disease,1.0,26024101
47758,aflibercept,gene,0.951,26021870
47759,neovascular age-related macular degeneration,disease,1.0,26021870
47760,neovascular age-related macular degeneration,disease,1.0,26021870
47761,nAMD,disease,1.0,26021870
47762,aflibercept,gene,0.8213,26021870
47763,nAMD,disease,1.0,26021870
47764,aflibercept,gene,0.948,26021870
47765,aflibercept,gene,0.9883,26021870
47766,ranibizumab,gene,0.732,26021870
47767,bevacizumab,gene,0.725,26021870
47768,aflibercept,gene,0.9736,26021870
47769,aflibercept,gene,0.9844,26021870
47770,ranibizumab,gene,0.8276,26021870
47771,bevacizumab,gene,0.7256,26021870
47772,aflibercept,gene,0.9497,26021870
47773,aflibercept,gene,0.9883,26021869
47774,choroidal neovascularisation,disease,1.0,26021869
47775,angioid streaks,disease,1.0,26021869
47776,Aflibercept,gene,0.9546,26016631
47777,neovascular glaucoma,disease,1.0,26016631
47778,Neovascular glaucoma,disease,1.0,26016631
47779,NVG,disease,1.0,26016631
47780,ocular ischaemia,disease,1.0,26016631
47781,vascular endothelial growth factor,gene,0.992,26016631
47782,NVG,disease,1.0,26016631
47783,NVG,disease,1.0,26016631
47784,aflibercept,gene,0.9795,26016631
47785,PARTICIPANTS,species,0.8022,26016631
47786,neovascular glaucoma,disease,1.0,26016631
47787,NVG,disease,1.0,26016631
47788,aflibercept,gene,0.9785,26016631
47789,neovascularization of the iris,disease,0.997,26016631
47790,aflibercept,gene,0.9653,26016631
47791,NVI,disease,1.0,26016631
47792,NVA,disease,1.0,26016631
47793,aflibercept,gene,0.963,26016631
47794,NVG,drug,0.8022,26016631
47795,NVI,disease,1.0,26016631
47796,NVA,disease,0.9995,26016631
47797,aflibercept,gene,0.982,26008915
47798,diabetic macular edema,disease,1.0,26008915
47799,ovarian cancer,disease,1.0,26001052
47800,Patients,species,0.977,26001052
47801,epithelial ovarian cancer,disease,1.0,26001052
47802,EOC,disease,1.0,26001052
47803,VEGFs,gene,0.9956,26001052
47804,tyrosine,drug,0.941,26001052
47805,tyrosine kinase,gene,0.924,26001052
47806,ascites,disease,0.725,26001052
47807,EOC,disease,0.9995,26001052
47808,EOC,disease,0.9966,26001052
47809,aflibercept,gene,0.9883,26001052
47810,bevacizumab,gene,0.844,26001052
47811,cediranib,drug,0.999,26001052
47812,fosbretabulin,drug,0.9814,26001052
47813,imatinib,drug,0.998,26001052
47814,nintedanib,drug,0.999,26001052
47815,pazopanib,drug,0.9995,26001052
47816,saracatinib,drug,0.9995,26001052
47817,sorafenib,drug,0.9995,26001052
47818,sunitinib,drug,0.999,26001052
47819,trebananib,drug,0.9946,26001052
47820,EOC,disease,0.9854,26001052
47821,EOC,disease,0.568,26001052
47822,patients,species,0.993,26001052
47823,aflibercept,gene,0.9575,25999748
47824,visual impairment,disease,1.0,25999748
47825,diabetic macular edema,disease,1.0,25999748
47826,Ranibizumab,gene,0.792,25999748
47827,aflibercept,gene,0.9224,25999748
47828,vascular endothelial growth factor,gene,0.9253,25999748
47829,visual impairment,disease,1.0,25999748
47830,VI,disease,0.9976,25999748
47831,diabetic macular edema,disease,1.0,25999748
47832,DME,disease,1.0,25999748
47833,aflibercept,gene,0.906,25999748
47834,VI,disease,0.961,25999748
47835,DME,disease,0.993,25999748
47836,DME,disease,1.0,25999748
47837,ranibizumab,gene,0.6694,25999748
47838,ranibizumab,drug,0.597,25999748
47839,aflibercept,gene,0.971,25999748
47840,DME,disease,1.0,25999748
47841,ranibizumab,gene,0.665,25999748
47842,aflibercept,gene,0.9165,25999748
47843,Ranibizumab,gene,0.8716,25999748
47844,aflibercept,gene,0.9775,25999748
47845,aflibercept,gene,0.9414,25999748
47846,Ranibizumab,gene,0.6743,25999748
47847,aflibercept,gene,0.9707,25999748
47848,ranibizumab,gene,0.687,25999748
47849,ranibizumab,gene,0.6113,25999748
47850,aflibercept,gene,0.893,25999748
47851,VI,disease,0.9956,25999748
47852,DME,disease,1.0,25999748
47853,anti-VEGF,gene,0.9634,25997681
47854,exudative AMD,disease,0.9985,25997681
47855,neovascular age-related macular degeneration,disease,1.0,25997681
47856,AMD,disease,1.0,25997681
47857,AMD,disease,0.999,25997681
47858,ranibizumab,gene,0.8374,25997681
47859,aflibercept,gene,0.9277,25997681
47860,IVT,disease,0.9287,25997681
47861,serous retinal detachment,disease,1.0,25997681
47862,retinal edema,disease,1.0,25997681
47863,metastatic colorectal cancer,disease,1.0,25994542
47864,aflibercept,gene,0.98,25994542
47865,adenocarcinoma of the ascending colon,disease,1.0,25994542
47866,liver metastases,disease,0.8384,25994542
47867,folfox,drug,0.985,25994542
47868,bevacizumab,gene,0.561,25994542
47869,aflibercept,gene,0.966,25994542
47870,tumour,disease,1.0,25994542
47871,Aflibercept,gene,0.9697,25989873
47872,ranibizumab,gene,0.736,25989873
47873,diabetic macular oedema,disease,1.0,25989873
47874,aflibercept,gene,0.992,25989873
47875,diabetic macular oedema,disease,1.0,25989873
47876,DME,disease,1.0,25989873
47877,DME,disease,1.0,25989873
47878,ranibizumab,gene,0.7954,25989873
47879,ranibizumab,gene,0.776,25989873
47880,aflibercept,gene,0.974,25989873
47881,ranibizumab,gene,0.908,25989873
47882,aflibercept,gene,0.9805,25989873
47883,ETDRS,DNA,0.4768,25989873
47884,aflibercept,gene,0.9756,25989873
47885,ranibizumab,gene,0.809,25989873
47886,aflibercept,gene,0.995,25989873
47887,aflibercept,gene,0.9946,25989873
47888,aflibercept,gene,0.946,25989873
47889,aflibercept,gene,0.96,25988772
47890,colorectal cancer,disease,1.0,25988772
47891,Colorectal cancer,disease,1.0,25988772
47892,CRC,disease,1.0,25988772
47893,tumors,disease,1.0,25988772
47894,tumor,disease,1.0,25988772
47895,Aflibercept,gene,0.973,25988772
47896,VEGF receptors 1 and 2,gene,0.997,25988772
47897,VEGF,gene,0.9966,25988772
47898,VEGFs,gene,0.995,25988772
47899,aflibercept,gene,0.9805,25988772
47900,cell lines,cell_line,0.962,25988772
47901,tumor,disease,1.0,25988772
47902,Aflibercept,gene,0.9424,25988772
47903,solid tumor,disease,1.0,25988772
47904,metastatic CRC,disease,1.0,25988772
47905,mCRC,disease,0.9907,25988772
47906,aflibercept,gene,0.971,25988772
47907,aflibercept,gene,0.981,25988772
47908,oxaliplatin,drug,1.0,25988772
47909,mCRC,disease,0.9883,25988772
47910,irinotecan,drug,0.998,25988772
47911,5-,drug,0.996,25988772
47912,fluorouracil,drug,0.4805,25988772
47913,aflibercept,gene,0.99,25983109
47914,ranibizumab,drug,0.9736,25983109
47915,exudative age-related macular degeneration,disease,0.998,25983109
47916,choroidal vascular hyperpermeability,disease,1.0,25983109
47917,exudative age-related macular degeneration,disease,0.9487,25983109
47918,AMD,disease,1.0,25983109
47919,choroidal vascular hyperpermeability,disease,1.0,25983109
47920,CVH,disease,1.0,25983109
47921,ranibizumab,gene,0.856,25983109
47922,aflibercept,gene,0.9746,25983109
47923,PARTICIPANTS,species,0.51,25983109
47924,ranibizumab,gene,0.8774,25983109
47925,aflibercept,gene,0.9844,25983109
47926,aflibercept,gene,0.9746,25983109
47927,CVH,disease,0.9937,25983109
47928,indocyanine green,drug,0.9907,25983109
47929,CVH,disease,0.887,25983109
47930,AMD,disease,0.9946,25983109
47931,AMD,disease,0.992,25983109
47932,AMD,disease,0.983,25983109
47933,AMD,disease,0.989,25983109
47934,CVH,drug,0.884,25983109
47935,intraretinal or subretinal fluid,disease,0.823,25983109
47936,hemorrhage,disease,0.9966,25983109
47937,CVH,disease,0.9995,25983109
47938,AMD,disease,1.0,25983109
47939,CVH,disease,1.0,25983109
47940,AMD,disease,1.0,25983109
47941,AMD,disease,1.0,25983109
47942,CVH,disease,0.9995,25983109
47943,AMD,disease,1.0,25983109
47944,CVH,disease,0.9995,25983109
47945,aflibercept,gene,0.9854,25983109
47946,ranibizumab,gene,0.6694,25976643
47947,aflibercept,gene,0.9644,25976643
47948,central retinal vein occlusion,disease,1.0,25976643
47949,ranibizumab,gene,0.8867,25976640
47950,aflibercept,gene,0.97,25976640
47951,central retinal vein occlusion,disease,1.0,25976640
47952,aflibercept,gene,0.972,25975823
47953,diabetic macular edema,disease,1.0,25975823
47954,DME,disease,1.0,25975823
47955,aflibercept,gene,0.9766,25975823
47956,IVT-AFL,gene,0.9194,25975823
47957,diabetic macular edema,disease,1.0,25975823
47958,DME,disease,1.0,25975823
47959,AFL,drug,0.512,25975823
47960,dexamethasone,drug,0.969,25975823
47961,Diabetic Retinopathy,disease,1.0,25975823
47962,dexamethasone,drug,0.95,25975823
47963,IVT,drug,0.696,25975823
47964,AFL,drug,0.507,25975823
47965,dexamethasone,drug,0.973,25975823
47966,IVR,drug,0.7534,25975823
47967,dexamethasone,drug,0.982,25975823
47968,bevacizumab,gene,0.861,25975662
47969,ranibizumab,gene,0.776,25975662
47970,aflibercept,gene,0.9756,25975662
47971,vascular endothelial growth factor,gene,0.9985,25975662
47972,bevacizumab,gene,0.661,25975662
47973,ranibizumab,gene,0.844,25975662
47974,aflibercept,gene,0.97,25975662
47975,acrolein,drug,0.9985,25975662
47976,human adult retinal pigment epithelial (ARPE)-19 cells,cell_line,0.9863,25975662
47977,human,species,0.989,25975662
47978,ARPE-19 cells,cell_line,0.92,25975662
47979,ARPE-19 cells,cell_type,0.6426,25975662
47980,"3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide",drug,0.999,25975662
47981,oxygen,drug,1.0,25975662
47982,ARPE-19 cells,cell_line,0.8438,25975662
47983,acrolein,drug,0.9995,25975662
47984,Bevacizumab,gene,0.7563,25975662
47985,ranibizumab,gene,0.786,25975662
47986,aflibercept,gene,0.9785,25975662
47987,ARPE-19 cells,cell_line,0.9253,25975662
47988,ARPE-19 cells,cell_type,0.664,25975662
47989,acrolein,drug,0.9985,25975662
47990,ranibizumab,gene,0.7153,25975662
47991,aflibercept,gene,0.983,25975662
47992,bevacizumab,gene,0.821,25975662
47993,acrolein,drug,0.9985,25975662
47994,mitogen-activated protein kinases,gene,0.992,25975662
47995,ARPE-19 cells,cell_line,0.9067,25975662
47996,Bevacizumab,gene,0.556,25975662
47997,ranibizumab,gene,0.786,25975662
47998,aflibercept,gene,0.9766,25975662
47999,Ranibizumab,gene,0.8228,25975662
48000,aflibercept,gene,0.975,25975662
48001,acrolein,drug,0.9985,25975662
48002,human ARPE-19 cells,cell_line,0.906,25975662
48003,human,species,0.9927,25975662
48004,plasma vascular endothelial growth factor,gene,0.9897,25966740
48005,plasma vascular endothelial growth factor,gene,0.9897,25966740
48006,VEGF,gene,0.9966,25966740
48007,aflibercept,gene,0.764,25966740
48008,patients,species,0.9834,25966740
48009,neovascular age-related macular degeneration,disease,1.0,25966740
48010,nAMD,disease,1.0,25966740
48011,patients,species,0.9644,25966740
48012,nAMD,disease,1.0,25966740
48013,aflibercept,gene,0.991,25966740
48014,VEGF,gene,0.994,25966740
48015,VEGF,gene,0.86,25966740
48016,Aflibercept,gene,0.828,25966740
48017,VEGF,gene,0.762,25966740
48018,VEGF,gene,0.9937,25966740
48019,VEGF,gene,0.7476,25966740
48020,aflibercept,gene,0.8877,25966740
48021,VEGF,gene,0.821,25966740
48022,VEGF,gene,0.812,25966740
48023,Aflibercept,gene,0.985,25962423
48024,aflibercept,gene,0.976,25962423
48025,age related macular degeneration,disease,1.0,25962423
48026,subretinal neovascular membranes,disease,1.0,25962423
48027,VEGF,gene,0.9966,25960682
48028,patients,species,0.9873,25960682
48029,age-related macular degeneration,disease,1.0,25960682
48030,diabetic retinopathy,disease,1.0,25960682
48031,retinal vein occlusion,disease,1.0,25960682
48032,anti-VEGF,gene,0.944,25960682
48033,patients,species,0.973,25960682
48034,ranibizumab,gene,0.4949,25960682
48035,aflibercept,gene,0.9614,25960682
48036,patients,species,0.9854,25960682
48037,Patients,species,0.974,25960682
48038,ranibizumab,gene,0.784,25960682
48039,aflibercept,gene,0.977,25960682
48040,aflibercept,gene,0.9805,25960682
48041,patients,species,0.9854,25960682
48042,patient,species,0.981,25960682
48043,ranibizumab,gene,0.857,25960682
48044,aflibercept,gene,0.95,25960682
48045,patients,species,0.982,25960682
48046,ranibizumab,gene,0.8877,25960682
48047,aflibercept,gene,0.9556,25960682
48048,patients,species,0.994,25960682
48049,patient,species,0.982,25960682
48050,aflibercept,gene,0.9834,25960682
48051,ranibizumab,gene,0.716,25960682
48052,VEGF,gene,0.793,25960682
48053,non-small-cell lung cancer,disease,1.0,25947099
48054,vascular endothelial growth factor,gene,0.999,25947099
48055,VEGF,gene,0.997,25947099
48056,VEGF,gene,0.9946,25947099
48057,VEGF receptor,gene,0.991,25947099
48058,VEGFR,gene,0.996,25947099
48059,non-small-cell lung cancer,disease,1.0,25947099
48060,NSCLC,disease,1.0,25947099
48061,VEGF,gene,0.994,25947099
48062,bevacizumab,gene,0.973,25947099
48063,aflibercept,gene,0.9824,25947099
48064,VEGFR-2,gene,0.9937,25947099
48065,ramucirumab,gene,0.755,25947099
48066,tyrosine,drug,0.9966,25947099
48067,tyrosine kinase,gene,0.9775,25947099
48068,VEGFRs,gene,0.997,25947099
48069,Bevacizumab,gene,0.8936,25947099
48070,advanced NSCLC,disease,0.979,25947099
48071,bevacizumab,gene,0.7983,25947099
48072,carboplatin,drug,0.9995,25947099
48073,paclitaxel,drug,1.0,25947099
48074,docetaxel,drug,0.998,25947099
48075,VEGFR-2,gene,0.9956,25947099
48076,NSCLC,disease,0.997,25947099
48077,VEGF,gene,0.9956,25947099
48078,NSCLC,disease,1.0,25947099
48079,endophthalmitis,disease,1.0,25940556
48080,vascular endothelial growth factor,gene,0.9233,25940556
48081,VEGF,gene,0.999,25940556
48082,endophthalmitis,disease,1.0,25940556
48083,bevacizumab,gene,0.669,25940556
48084,aflibercept,gene,0.9614,25940556
48085,Patients,species,0.9727,25940556
48086,anti-VEGF,gene,0.7886,25940556
48087,infectious endophthalmitis,disease,1.0,25940556
48088,endophthalmitis,disease,1.0,25940556
48089,endophthalmitis,disease,1.0,25940556
48090,vascular endothelial growth factors and receptors family,gene,0.9717,25936669
48091,blood vessels,cell_type,0.5425,25936669
48092,VEGF family,gene,0.9976,25936669
48093,VEGF-A,gene,0.997,25936669
48094,VEGF-B,gene,0.9966,25936669
48095,placental growth factor,gene,0.9985,25936669
48096,PlGF,gene,0.992,25936669
48097,VEGFR-1,gene,0.989,25936669
48098,VEGFR-2,gene,0.9907,25936669
48099,bevacizumab,gene,0.492,25936669
48100,VEGF-A,gene,0.998,25936669
48101,aflibercept,gene,0.9883,25936669
48102,VEGF-A,gene,0.997,25936669
48103,VEGF-B,gene,0.995,25936669
48104,PlGF,gene,0.9746,25936669
48105,tyrosine,drug,0.9663,25936669
48106,tyrosine kinase,gene,0.992,25936669
48107,VEGFR-1,gene,0.994,25936669
48108,VEGFR-2,gene,0.9854,25936669
48109,aflibercept,gene,0.9746,25932561
48110,neovascular age,disease,1.0,25932561
48111,macular degeneration,disease,1.0,25932561
48112,neovascular age-related macular degeneration,disease,1.0,25932561
48113,aflibercept,gene,0.9253,25932561
48114,posterior vitreous detachment,disease,0.995,25932561
48115,PVD,disease,1.0,25932561
48116,PVD,disease,1.0,25932561
48117,PVD,disease,1.0,25932561
48118,PVD,disease,1.0,25932561
48119,PVD,disease,1.0,25932561
48120,aflibercept,gene,0.9565,25932561
48121,neovascular age-related macular degeneration,disease,1.0,25932561
48122,Ischaemic stroke,disease,1.0,25930164
48123,aflibercept,gene,0.988,25930164
48124,vitamin K,drug,0.9985,25930164
48125,Vascular endothelial growth factor,gene,0.9985,25930164
48126,VEGF,gene,0.9976,25930164
48127,malignancies,disease,1.0,25930164
48128,exudative neo-vascular age-related macular degeneration,disease,1.0,25930164
48129,ischemic stroke,disease,1.0,25930164
48130,woman,species,0.868,25930164
48131,aflibercept,gene,0.9873,25930164
48132,anti-VEGF,gene,0.9136,25930164
48133,AMD,disease,1.0,25930164
48134,ranibizumab,gene,0.542,25930164
48135,ranibizumab,gene,0.855,25930164
48136,aflibercept,gene,0.9746,25930164
48137,stroke,disease,0.9956,25930164
48138,aflibercept,gene,0.991,25930164
48139,aflibercept,gene,0.987,25930164
48140,ischaemic stroke,disease,1.0,25930164
48141,aflibercept,gene,0.962,25930164
48142,aflibercept,gene,0.986,25925748
48143,Eylea,gene,0.7446,25925748
48144,cystoid macular edema,disease,1.0,25925748
48145,Cystoid macular edema,disease,1.0,25925748
48146,CME,disease,1.0,25925748
48147,retinitis pigmentosa,disease,1.0,25925748
48148,RP,disease,1.0,25925748
48149,aflibercept,gene,0.98,25925748
48150,patient,species,0.9473,25925748
48151,RP,disease,,25925748
48152,CME,disease,1.0,25925748
48153,man,species,0.892,25925748
48154,blurred vision,disease,0.9995,25925748
48155,RP,disease,,25925748
48156,CME,disease,0.9995,25925748
48157,patient,species,0.984,25925748
48158,aflibercept,gene,0.991,25925748
48159,eccentral vision,disease,0.7324,25925748
48160,aflibercept,gene,0.985,25925748
48161,CME,disease,0.999,25925748
48162,RP,disease,,25925748
48163,aflibercept,gene,0.9795,25925049
48164,Aflibercept,gene,0.958,25925049
48165,vegf,gene,0.7383,25925049
48166,ranibizumab,gene,0.799,25925049
48167,bevacizumab,gene,0.6187,25925049
48168,vegf-A,gene,0.9985,25925049
48169,placental growth factor,gene,0.9985,25925049
48170,human VEGF-A165,gene,0.9897,25925049
48171,human,species,0.9937,25925049
48172,endogenous vegf receptors,gene,0.7134,25925049
48173,Aflibercept,gene,0.9478,25925049
48174,neovascular (exudative) age-related macular degeneration,disease,0.993,25925049
48175,ARMD,disease,1.0,25925049
48176,visual alteration,disease,1.0,25925049
48177,macular edema,disease,1.0,25925049
48178,CRVO,disease,1.0,25925049
48179,visual alteration,disease,1.0,25925049
48180,diabetic macular edema,disease,1.0,25925049
48181,DME,disease,1.0,25925049
48182,aflibercept,gene,0.982,25925049
48183,diabetic macular edema,disease,1.0,25925048
48184,Aflibercept,gene,0.9683,25925048
48185,aflibercept,gene,0.9795,25925048
48186,diabetic macular edema,disease,1.0,25925048
48187,DME,disease,1.0,25925048
48188,patients,species,0.921,25925048
48189,DME,disease,1.0,25925048
48190,aflibercept,gene,0.773,25925048
48191,aflibercept,gene,0.9717,25925048
48192,patients,species,0.9917,25925048
48193,Diabetic Retinopathy,disease,1.0,25925048
48194,patients,species,0.991,25925048
48195,patients,species,0.9946,25925048
48196,diabetic retinopathy,disease,1.0,25925048
48197,aflibercept,gene,0.9526,25925048
48198,central retinal vein occlusion,disease,1.0,25925047
48199,aflibercept,gene,0.972,25925047
48200,macular edema,disease,1.0,25925047
48201,central retinal vein occlusion,disease,1.0,25925047
48202,patients,species,0.955,25925047
48203,galileo,DNA,0.4268,25925047
48204,patients,species,0.9434,25925047
48205,patients,species,0.972,25925047
48206,aflibercept,gene,0.9854,25925047
48207,Patients,species,0.9443,25925047
48208,afliberceptin,gene,0.962,25925047
48209,age-related macular degeneration,disease,1.0,25925046
48210,aflibercept,gene,0.986,25925046
48211,age-related macular degeneration,disease,1.0,25925046
48212,patients,species,0.989,25925046
48213,Aflibercept,gene,0.974,25925046
48214,patients,species,0.9873,25925046
48215,aflibercept,gene,0.978,25925046
48216,patients,species,0.987,25925046
48217,Aflibercept,gene,0.9062,25925045
48218,Aflibercept,gene,0.978,25925045
48219,IgG,gene,0.992,25925045
48220,VEGF receptors,gene,0.9946,25925045
48221,VEGF,gene,0.997,25925045
48222,placental growth factor,gene,0.9985,25925045
48223,PIGF,gene,0.9907,25925045
48224,ranibizumab,gene,0.9487,25925045
48225,bevacizumab,gene,0.88,25925045
48226,plasma,cell_type,0.5195,25925045
48227,arterial hypertension,disease,1.0,25925045
48228,VEGF,gene,0.9937,25925044
48229,cancer,disease,1.0,25925044
48230,exudative ageassociated macular degeneration,disease,0.999,25925044
48231,ARMD,disease,1.0,25925044
48232,vascular endothelial growth factor,gene,0.9985,25925044
48233,VEGF,gene,0.9966,25925044
48234,VEGF-A,gene,0.9985,25925044
48235,endothelial cells,cell_type,0.932,25925044
48236,VEGF,gene,0.9937,25925044
48237,retinal diseases,disease,0.9917,25925044
48238,diabetic macular edema,disease,1.0,25925044
48239,macular edema,disease,1.0,25925044
48240,retinal vein occlusion,disease,0.999,25925044
48241,placental growth factor,gene,0.999,25925044
48242,PIGF,gene,0.995,25925044
48243,VEGF,gene,0.9966,25925044
48244,VEGF,gene,0.668,25925044
48245,aflibercept,gene,0.967,25925044
48246,ranibizumab,gene,0.893,25925044
48247,bevacizumab,gene,0.8213,25925044
48248,cancer,disease,0.9995,25922090
48249,vascular endothelial growth factor,gene,0.8755,25922090
48250,VEGF,gene,0.998,25922090
48251,aflibercept,gene,0.99,25922090
48252,VEGF trap,gene,0.9316,25922090
48253,anti-VEGF receptor,gene,0.988,25922090
48254,VEGFR,gene,0.994,25922090
48255,tyrosine,drug,0.9507,25922090
48256,tyrosine kinase,gene,0.8887,25922090
48257,hypertension,disease,1.0,25922090
48258,proteinuria,disease,1.0,25922090
48259,human epidermal growth factor receptor,gene,0.9985,25922090
48260,human,species,0.7515,25922090
48261,HER,gene,0.99,25922090
48262,cetuximab,gene,0.6133,25922090
48263,panitumumab,gene,0.7153,25922090
48264,hypomagnesemia,disease,1.0,25922090
48265,hypokalemia,disease,1.0,25922090
48266,renal,cell_type,0.4731,25922090
48267,Cetuximab,gene,0.883,25922090
48268,renal tubular acidosis,disease,1.0,25922090
48269,imatinib,drug,0.9985,25922090
48270,dasatinib,drug,0.9966,25922090
48271,renal failure,disease,0.8657,25922090
48272,Rituximab,gene,0.694,25922090
48273,anti-CD20 monoclonal antibody,gene,0.9697,25922090
48274,acute,disease,0.7935,25922090
48275,renal failure,disease,0.767,25922090
48276,acute,disease,0.9663,25922090
48277,tumor lysis syndrome,disease,0.8804,25922090
48278,Everolimus,drug,0.999,25922090
48279,mammalian target,DNA,0.545,25922090
48280,mammalian target of rapamycin,gene,0.978,25922090
48281,rapamycin,drug,0.995,25922090
48282,mTOR,gene,0.999,25922090
48283,proteinuria,disease,1.0,25922090
48284,renal disease,disease,1.0,25922090
48285,aflibercept,gene,0.9927,25902122
48286,ranibizumab,gene,0.855,25902122
48287,aflibercept,gene,0.984,25902122
48288,exsudative age-related macular degeneration,disease,1.0,25902122
48289,AMD,disease,1.0,25902122
48290,ranibizumab,gene,0.838,25902122
48291,PATIENTS,species,0.884,25902122
48292,patients,species,0.9883,25902122
48293,aflibercept,gene,0.993,25902122
48294,patients,species,0.987,25902122
48295,aflibercept,gene,0.9795,25902122
48296,aflibercept,gene,0.988,25902122
48297,aflibercept,gene,0.987,25902122
48298,ranibizumab,gene,0.956,25902122
48299,aflibercept,gene,0.9814,25902122
48300,patients,species,0.9746,25902122
48301,macular degeneration,disease,1.0,25902122
48302,ranibizumab,gene,0.8887,25902122
48303,ranibizumab,gene,0.513,25902119
48304,aflibercept,gene,0.956,25902119
48305,macular BACKGROUND,disease,0.9995,25902119
48306,Macular edema,disease,1.0,25902119
48307,central retinal vein occlusion,disease,1.0,25902119
48308,patients,species,0.9893,25902119
48309,macular edema,disease,1.0,25902119
48310,ischemic central retinal vein occlusion,disease,1.0,25902119
48311,patients,species,0.888,25902119
48312,ranibizumab,gene,0.5664,25902119
48313,aflibercept,gene,0.9297,25902119
48314,PATIENTS,species,0.9487,25902119
48315,patients,species,0.992,25902119
48316,macular edema,disease,1.0,25902119
48317,ischemic central,disease,0.866,25902119
48318,retinal vein occlusion,disease,0.9995,25902119
48319,aflibercept,gene,0.964,25902119
48320,macular edema,disease,1.0,25902119
48321,patients,species,0.993,25902119
48322,patients,species,0.987,25902119
48323,aflibercept,gene,0.988,25902119
48324,macular edema,disease,1.0,25902119
48325,ranibizumab,gene,0.618,25902119
48326,ischemic central retinal vein occlusion,disease,1.0,25902119
48327,Aflibercept,gene,0.9766,25896317
48328,Neovascular AMD,disease,1.0,25896317
48329,aflibercept,gene,0.987,25896317
48330,neovascular age-related macular degeneration,disease,1.0,25896317
48331,AMD,disease,1.0,25896317
48332,bevacizumab,gene,0.767,25896317
48333,neovascular AMD,disease,1.0,25896317
48334,aflibercept,gene,0.9863,25896317
48335,bevacizumab,gene,0.8525,25896317
48336,ranibizumab,gene,0.526,25896317
48337,Aflibercept,gene,0.972,25896317
48338,bevacizumab,gene,0.812,25896317
48339,ranibizumab,gene,0.587,25896317
48340,aflibercept,gene,0.9746,25896317
48341,Aflibercept,gene,0.682,25896317
48342,vascular endothelial growth factor,gene,0.9214,25896317
48343,VEGF,gene,0.8223,25885684
48344,wet AMD,disease,1.0,25885684
48345,aflibercept,gene,0.9917,25885684
48346,age-related macular degeneration,disease,1.0,25885684
48347,AMD,disease,1.0,25885684
48348,wet AMD,disease,0.9985,25885684
48349,aflibercept,gene,0.989,25885684
48350,intraretinal/subretinal fluid,disease,0.9746,25885684
48351,pigment epithelial detachment,disease,1.0,25885684
48352,PED,disease,1.0,25885684
48353,ranibizumab,gene,0.6914,25885684
48354,aflibercept,gene,0.9883,25885684
48355,aflibercept,gene,0.9834,25885684
48356,PED,disease,0.976,25885684
48357,aflibercept,gene,0.978,25885684
48358,aflibercept,gene,0.9907,25885684
48359,aflibercept,gene,0.985,25885684
48360,aflibercept,gene,0.9907,25885684
48361,aflibercept,gene,0.9873,25885684
48362,aflibercept,gene,0.988,25885684
48363,aflibercept,gene,0.934,25885684
48364,AMD,disease,1.0,25885684
48365,ranibizumab,gene,0.829,25885684
48366,PED,disease,0.965,25885684
48367,aflibercept,gene,0.9917,25885684
48368,macular hole,disease,0.781,25881212
48369,aflibercept,gene,0.975,25881212
48370,macular hole,disease,1.0,25881212
48371,macular hole,disease,0.968,25881212
48372,aflibercept,gene,0.9893,25881212
48373,age-related macular degeneration,disease,1.0,25881212
48374,AMD,disease,1.0,25881212
48375,RPE,cell_type,0.704,25881212
48376,fibrovascular pigment epithelial detachment,disease,1.0,25881212
48377,PED,disease,1.0,25881212
48378,man,species,0.892,25881212
48379,neovascular AMD,disease,1.0,25881212
48380,fibrovascular PED,disease,0.9995,25881212
48381,vision loss,disease,0.9683,25881212
48382,RPE tear,disease,1.0,25881212
48383,aflibercept,gene,0.994,25881212
48384,neovascular AMD,disease,1.0,25881212
48385,aflibercept,gene,0.987,25881212
48386,contracted,cell_line,0.509,25881212
48387,RPE,cell_type,0.716,25881212
48388,macular hole,disease,0.8325,25881212
48389,VEGF,gene,0.6616,25881212
48390,neovascular AMD,disease,1.0,25881212
48391,aflibercept,gene,0.9844,25877895
48392,aflibercept,gene,0.9873,25877895
48393,neovascular age,disease,0.9697,25877895
48394,macular degeneration,disease,1.0,25877895
48395,aflibercept,gene,0.9604,25877895
48396,aflibercept,gene,0.9424,25877895
48397,Aflibercept,gene,0.9443,25877895
48398,neovascular age-related macular degeneration,disease,1.0,25877895
48399,aflibercept,gene,0.973,25877895
48400,aflibercept,gene,0.9785,25871873
48401,bevacizumab,drug,0.724,25871873
48402,neovascular age-related macular degeneration,disease,1.0,25871873
48403,aflibercept,gene,0.9824,25871873
48404,bevacizumab,gene,0.603,25871873
48405,bilateral iritis,disease,0.962,25871873
48406,woman,species,0.865,25871873
48407,nongranulomatous iritis,disease,1.0,25871873
48408,rheumatoid arthritis,disease,1.0,25871873
48409,bevacizumab,gene,0.7905,25871873
48410,neovascular age-related macular degeneration,disease,1.0,25871873
48411,bevacizumab,gene,0.825,25871873
48412,nongranulomatous iritis,disease,1.0,25871873
48413,aflibercept,gene,0.974,25871873
48414,iritis,disease,1.0,25871873
48415,bevacizumab,gene,0.633,25871873
48416,anterior uveitis,disease,1.0,25871873
48417,aflibercept,gene,0.9927,25871873
48418,neovascular age-related macular degeneration,disease,1.0,25871873
48419,aflibercept,gene,0.98,25867595
48420,neovascular,disease,0.9995,25867595
48421,Yttrium 90,drug,0.99,25866690
48422,metastatic colorectal cancer,disease,1.0,25866690
48423,isolated liver metastases,disease,0.9946,25866690
48424,yttrium 90,drug,0.9966,25866690
48425,Y90,drug,0.975,25866690
48426,patient,species,0.984,25866690
48427,colorectal cancer,disease,1.0,25866690
48428,Y90,drug,0.896,25866690
48429,aflibercept,gene,0.9575,25866690
48430,FOLFIRI,drug,0.8687,25866690
48431,bilateral breast cancer,disease,0.9995,25866690
48432,metastatic colon cancer,disease,1.0,25866690
48433,liver metastasis,disease,0.816,25866690
48434,aflibercept,gene,0.9756,25866690
48435,FOLFIRI,drug,0.7593,25866690
48436,Y90,drug,0.763,25866690
48437,left,DNA,0.54,25866690
48438,tumor,disease,0.6987,25866690
48439,tumor,disease,0.701,25866690
48440,liver metastases,disease,0.8525,25866690
48441,patient,species,0.992,25866690
48442,CEA,gene,0.9766,25866690
48443,patient,species,0.958,25866690
48444,Y90,drug,0.638,25866690
48445,aflibercept,gene,0.9688,25866690
48446,VEGF,gene,0.5845,25866690
48447,FOLFIRI,drug,0.8228,25866690
48448,Y90,drug,0.8423,25866690
48449,ranibizumab,gene,0.7993,25856827
48450,aflibercept,gene,0.9746,25856827
48451,woman,species,0.8843,25856827
48452,blurred vision,disease,0.999,25856827
48453,tilted disc syndrome,disease,0.9995,25856827
48454,staphyloma,disease,0.813,25856827
48455,ranibizumab,gene,0.9272,25856827
48456,aflibercept,gene,0.9917,25856827
48457,ranibizumab,gene,0.8306,25856827
48458,VEGF,gene,0.9985,25846847
48459,neovascular age-related macular degeneration,disease,1.0,25846847
48460,nAMD,disease,1.0,25846847
48461,PARTICIPANTS,species,0.8706,25846847
48462,ranibizumab,gene,0.5093,25846847
48463,nAMD,disease,1.0,25846847
48464,Retinal Blindness,disease,1.0,25846847
48465,Retinal Blindness,disease,0.9995,25846847
48466,patients,species,0.949,25846847
48467,nAMD,disease,1.0,25846847
48468,choroidal neovascular membrane,disease,1.0,25840618
48469,aflibercept,gene,0.9707,25840618
48470,patient,species,0.9526,25840618
48471,aflibercept,gene,0.995,25835307
48472,bevacizumab,gene,0.8867,25835307
48473,ranibizumab,gene,0.6377,25835307
48474,DME,disease,0.9995,25835307
48475,human,species,0.9946,25832756
48476,etanercept,gene,0.9688,25832756
48477,belatacept,gene,0.5654,25832756
48478,aflibercept,gene,0.9653,25832756
48479,denileukin,drug,0.5103,25832756
48480,Fc,gene,,25832756
48481,human IgG1,gene,0.996,25832756
48482,human,species,0.9805,25832756
48483,salvage neonatal FcRn receptor,gene,0.956,25832756
48484,IgG1 Fc,gene,0.9985,25832756
48485,modified diphtheria toxin effector peptide,gene,0.8457,25832756
48486,interleukin-2,gene,0.9976,25832756
48487,Fc fusion proteins,gene,0.987,25832756
48488,N,drug,0.9805,25832756
48489,Fc piece,gene,0.962,25832756
48490,thrombopoietin-,gene,0.996,25832756
48491,C,drug,0.996,25832756
48492,type I and IV hypersensitivities,disease,0.9004,25832756
48493,anaphylaxis,disease,1.0,25832756
48494,cytokine release syndrome,disease,0.9893,25832756
48495,cytokine,gene,0.5337,25832756
48496,"type II, III, or IV hypersensitivities",disease,1.0,25832756
48497,arthritis,disease,0.9805,25832756
48498,psoriasis,disease,0.9243,25832756
48499,etanercept,gene,0.8555,25832756
48500,hypersensitivity,disease,0.9976,25832756
48501,etanercept,gene,0.922,25832756
48502,aflibercept,gene,0.994,25821619
48503,patient,species,0.9634,25821619
48504,aflibercept,gene,0.985,25821619
48505,fundus flavimaculatus,disease,1.0,25821619
48506,FFM,disease,1.0,25821619
48507,unilateral subretinal neovascular membrane,disease,0.9873,25821619
48508,SRNM,disease,1.0,25821619
48509,man,species,0.896,25821619
48510,FFM,disease,1.0,25821619
48511,SRNM,disease,0.987,25821619
48512,ranibizumab,gene,0.881,25821619
48513,aflibercept,gene,0.9927,25821619
48514,aflibercept,gene,0.994,25821619
48515,aflibercept,gene,0.99,25821619
48516,submacular exudation,disease,0.9976,25821619
48517,SRNM,disease,0.999,25821619
48518,FFM,disease,1.0,25821619
48519,VEGF,gene,0.9863,25813037
48520,metastatic Metastatic cancer,disease,0.9272,25813037
48521,VEGF,gene,0.9434,25813037
48522,Bevacizumab,gene,0.8213,25813037
48523,mCRC,disease,0.966,25813037
48524,patients,species,0.9893,25813037
48525,RAS,gene,0.997,25813037
48526,bevacizumab,gene,0.768,25813037
48527,RAS,gene,0.9893,25813037
48528,EGFR,gene,0.673,25813037
48529,bevacizumab,gene,0.9497,25813037
48530,fluoropyrimidines,drug,0.9985,25813037
48531,bevacizumab,gene,0.9014,25813037
48532,patients,species,0.9873,25813037
48533,bevacizumab,gene,0.7866,25813037
48534,Patients,species,0.975,25813037
48535,oxaliplatin,drug,0.9995,25813037
48536,bevacizumab,gene,0.901,25813037
48537,aflibercept,gene,0.9863,25813037
48538,irinotecan,drug,0.9995,25813037
48539,regorafenib,drug,0.994,25813037
48540,anti-VEGF,gene,0.701,25813037
48541,EGFR,gene,0.72,25813037
48542,Colorectal Cancer,disease,1.0,25808652
48543,Colorectal cancer,disease,1.0,25808652
48544,CRC,disease,1.0,25808652
48545,cancers,disease,1.0,25808652
48546,cancer,disease,1.0,25808652
48547,metastatic CRC,disease,0.9985,25808652
48548,mCRC,disease,1.0,25808652
48549,mCRC,disease,0.9873,25808652
48550,vascular endothelial growth factor,gene,0.9985,25808652
48551,VEGF,gene,0.998,25808652
48552,aflibercept,gene,0.9443,25808652
48553,regorafenib,drug,0.9805,25808652
48554,patient,species,0.974,25808652
48555,aflibercept,gene,0.9893,25808652
48556,regorafenib,drug,0.9478,25808652
48557,bevacizumab,gene,0.612,25808652
48558,patients,species,0.983,25808652
48559,mCRC,disease,0.969,25808652
48560,aflibercept,gene,0.982,25808652
48561,regorafenib,drug,0.9595,25808652
48562,Peripapillary Choroidal Neovascularization,disease,1.0,25802505
48563,Optic Nerve Head,disease,0.9414,25802505
48564,Optic nerve head drusen,disease,0.999,25802505
48565,peripapillary choroidal neovascularization,disease,1.0,25802505
48566,visual loss,disease,0.9766,25802505
48567,VEGF,gene,0.782,25802505
48568,patient,species,0.9937,25802505
48569,patients,species,0.9683,25802505
48570,macular degeneration,disease,1.0,25802505
48571,peripapillary choroidal neovascularization,disease,0.992,25802505
48572,optic nerve head drusen,disease,0.9995,25802505
48573,retinopathy of prematurity,disease,1.0,25798707
48574,vascular endothelial growth factor,gene,0.9443,25798707
48575,VEGF,gene,0.998,25798707
48576,retinopathy of prematurity,disease,1.0,25798707
48577,ROP,disease,1.0,25798707
48578,VEGF,gene,0.739,25798707
48579,ROP,disease,0.9736,25798707
48580,VEGF,gene,0.75,25798707
48581,ROP,disease,0.993,25798707
48582,anti-VEGF,gene,0.791,25798707
48583,ROP,disease,0.9893,25798707
48584,Aflibercept,gene,0.966,25777816
48585,polypoidal choroidal vasculopathy,disease,1.0,25777816
48586,aflibercept,gene,0.99,25777816
48587,polypoidal choroidal vasculopathy,disease,1.0,25777816
48588,PCV,disease,1.0,25777816
48589,patients,species,0.969,25777816
48590,PCV,disease,1.0,25777816
48591,dry macula,disease,0.999,25777816
48592,subretinal haemorrhage,disease,1.0,25777816
48593,polyp,disease,0.604,25777816
48594,indocyanine green,drug,0.9966,25777816
48595,polyps,disease,1.0,25777816
48596,PCV,disease,1.0,25777816
48597,aflibercept,gene,0.984,25761547
48598,choroidal neovascularization,disease,1.0,25761547
48599,aflibercept,gene,0.9795,25761547
48600,choroidal neovascularization,disease,1.0,25761547
48601,CNV,disease,1.0,25761547
48602,choroidal osteoma,disease,1.0,25761547
48603,CO,disease,1.0,25761547
48604,ranibizumab,gene,0.786,25761547
48605,bevacizumab,gene,0.649,25761547
48606,CO-related,disease,0.7827,25761547
48607,CO,drug,,25761547
48608,CNV,disease,0.8037,25761547
48609,bevacizumab,gene,0.5474,25761547
48610,ranibizumab,gene,0.9307,25761547
48611,aflibercept,gene,0.988,25761547
48612,aflibercept,gene,0.9893,25761547
48613,retinal hemorrhage,disease,1.0,25761547
48614,choroidal osteoma,disease,1.0,25761547
48615,aflibercept,gene,0.9917,25761547
48616,CNV,disease,1.0,25761547
48617,ranibizumab,gene,0.8496,25761547
48618,bevacizumab,gene,0.6016,25761547
48619,patients,species,0.9883,25752908
48620,colorectal liver,disease,1.0,25752908
48621,patients,species,0.972,25752908
48622,colorectal cancer,disease,1.0,25752908
48623,liver metastases,disease,0.9463,25752908
48624,patients,species,0.9497,25752908
48625,colorectal liver metastases,disease,1.0,25752908
48626,CRLM,disease,1.0,25752908
48627,bevacizumab,gene,0.668,25752908
48628,aflibercept,gene,0.9854,25752908
48629,regorafenib,drug,0.949,25752908
48630,patients,species,0.9844,25752908
48631,patients,species,0.9927,25752908
48632,vascular endothelial growth factor,gene,0.9976,25752908
48633,VEGF,gene,0.9976,25752908
48634,patients,species,0.9673,25752908
48635,CRLM,disease,1.0,25752908
48636,5-fluorouracil,drug,0.9995,25752908
48637,leucovorin,drug,0.9995,25752908
48638,oxaliplatin,drug,0.9995,25752908
48639,FOLFOX,drug,0.928,25752908
48640,bevacizumab,gene,0.7383,25752908
48641,patients,species,0.978,25752908
48642,CRLM,disease,1.0,25752908
48643,bevacizumab,gene,0.8735,25752908
48644,liver metastasis,disease,0.992,25752908
48645,bevacizumab,gene,0.7314,25752908
48646,CRLM,disease,0.9995,25752908
48647,patients,species,0.9824,25752908
48648,Aflibercept,gene,0.986,25745875
48649,Patients,species,0.9585,25745875
48650,Myopic Choroidal PURPOSE,disease,0.9834,25745875
48651,aflibercept,gene,0.9917,25745875
48652,patients,species,0.935,25745875
48653,myopic choroidal neovascularization,disease,1.0,25745875
48654,CNV,disease,1.0,25745875
48655,PARTICIPANTS,species,0.5815,25745875
48656,Patients,species,0.9727,25745875
48657,high myopia,disease,0.931,25745875
48658,myopic CNV,disease,1.0,25745875
48659,Diabetic Retinopathy,disease,0.9995,25745875
48660,Patients,species,0.957,25745875
48661,aflibercept,gene,0.9756,25745875
48662,aflibercept,gene,0.9873,25745875
48663,patients,species,0.9707,25745875
48664,CNV,disease,0.979,25745875
48665,patients,species,0.9595,25745875
48666,patients,species,0.98,25745875
48667,aflibercept,gene,0.903,25745875
48668,patients,species,0.9644,25745875
48669,aflibercept,gene,0.9775,25745875
48670,patients,species,0.971,25745875
48671,aflibercept,gene,0.9766,25745875
48672,patients,species,0.9766,25745875
48673,aflibercept,gene,0.971,25745875
48674,aflibercept,gene,0.756,25745875
48675,Patients,species,0.8555,25745875
48676,aflibercept,gene,0.986,25745875
48677,Patients,species,0.944,25745875
48678,aflibercept,gene,0.9214,25745875
48679,aflibercept,gene,0.9185,25745875
48680,aflibercept,gene,0.9854,25745875
48681,myopic CNV,disease,0.9995,25745875
48682,aflibercept,gene,0.9688,25745875
48683,myopic CNV,disease,1.0,25745875
48684,recombinant tissue plasminogen activator,gene,0.999,25740806
48685,rtPA,gene,0.995,25740806
48686,aflibercept,gene,0.976,25740806
48687,recombinant tissue plasminogen activator,gene,0.999,25740806
48688,rtPA,gene,0.9956,25740806
48689,vascular endothelial growth factor,gene,0.9976,25740806
48690,VEGF,gene,0.9326,25740806
48691,age-related macular degeneration,disease,1.0,25740806
48692,submacular haemorrhage,disease,0.9995,25740806
48693,rtPA,gene,0.9907,25740806
48694,aflibercept,gene,0.9736,25740806
48695,rtPA,gene,0.9917,25740806
48696,rtPA,gene,0.996,25740806
48697,plasmin,gene,0.9937,25740806
48698,aflibercept,gene,0.9497,25740806
48699,Aflibercept,gene,0.95,25740806
48700,ranibizumab,gene,0.6357,25740806
48701,rtPA,gene,0.9854,25740806
48702,plasmin,gene,0.995,25740806
48703,silver,drug,0.9683,25740806
48704,VEGF,gene,0.991,25740806
48705,VEGF,gene,0.987,25740806
48706,primary porcine retinal pigment epithelium cell cultures,cell_line,0.9824,25740806
48707,porcine,species,0.693,25740806
48708,rtPA,gene,0.983,25740806
48709,plasmin,gene,0.9907,25740806
48710,VEGF,gene,0.9956,25740806
48711,rtPA,gene,0.9907,25740806
48712,blood,cell_type,0.5127,25740806
48713,plasmin,gene,0.9897,25740806
48714,rtPA,gene,0.992,25740806
48715,aflibercept,gene,0.988,25740806
48716,aflibercept,gene,0.988,25740806
48717,plasmin,gene,0.9956,25740806
48718,30kDa,RNA,0.6987,25740806
48719,27kDa,RNA,0.511,25740806
48720,19kDa,RNA,0.4824,25740806
48721,15kDa,RNA,0.577,25740806
48722,silver,drug,0.9473,25740806
48723,31kDa,RNA,0.7837,25740806
48724,26kDa,RNA,0.5386,25740806
48725,21kDa,RNA,0.4697,25740806
48726,19kDa,RNA,0.4624,25740806
48727,15kDa,RNA,0.56,25740806
48728,VEGF,gene,0.997,25740806
48729,aflibercept,gene,0.9727,25740806
48730,plasmin,gene,0.9883,25740806
48731,VEGF,gene,0.9824,25740806
48732,aflibercept,gene,0.977,25740806
48733,Ranibizumab,gene,0.9023,25740806
48734,rtPA,gene,0.9844,25740806
48735,plasmin,gene,0.982,25740806
48736,Aflibercept,gene,0.977,25740806
48737,VEGF,gene,0.989,25740806
48738,plasmin,gene,0.991,25740806
48739,rtPA,gene,0.986,25740806
48740,ranibizumab,gene,0.5864,25740806
48741,neovascular age-related macular degeneration,disease,1.0,25740806
48742,submacular haemorrhage,disease,1.0,25740806
48743,aflibercept,gene,0.982,25740806
48744,rtPA,gene,0.9907,25740806
48745,plasmin,gene,0.996,25740806
48746,VEGF,gene,0.9834,25739373
48747,neovascular age-related macular degeneration,disease,1.0,25739373
48748,age-related macular degeneration,disease,1.0,25733802
48749,AMD,disease,1.0,25733802
48750,ranibizumab,gene,0.903,25733802
48751,bevacizumab,gene,0.8804,25733802
48752,aflibercept,gene,0.9805,25733802
48753,legal blindness,disease,1.0,25733802
48754,AMD,disease,1.0,25733802
48755,visual impairment,disease,1.0,25733802
48756,blindness,disease,0.9995,25733802
48757,patients,species,0.946,25733802
48758,neovascular AMD,disease,1.0,25733802
48759,neovascular AMD,disease,1.0,25733802
48760,choroidal neovascularization,disease,0.998,25733802
48761,patient,species,0.9805,25733802
48762,AMD,disease,0.997,25733802
48763,choroidal neovascularization,disease,0.981,25733802
48764,aflibercept,gene,0.9854,25712826
48765,patients,species,0.984,25712826
48766,aflibercept,gene,0.982,25712826
48767,polypoidal choroidal vasculopathy,disease,1.0,25712826
48768,PCV,DNA,0.6675,25712826
48769,patients,species,0.958,25712826
48770,PCV,disease,1.0,25712826
48771,aflibercept,gene,0.9785,25712826
48772,patients,species,0.9736,25712826
48773,fluorescein,drug,0.9995,25712826
48774,indocyanine green,drug,0.999,25712826
48775,polypoidal,cell_type,0.448,25712826
48776,polypoidal lesions,disease,1.0,25712826
48777,aflibercept,gene,0.9956,25712826
48778,polypoidal,DNA,0.4622,25712826
48779,polypoidal lesions,disease,1.0,25712826
48780,retinal exudative,disease,0.751,25712826
48781,CRT,DNA,0.504,25712826
48782,aflibercept,gene,0.98,25712826
48783,polyps,disease,0.9976,25712826
48784,retinal exudation,disease,0.999,25712826
48785,patients,species,0.931,25712826
48786,PCV,disease,1.0,25712826
48787,Scleral thinning,disease,0.908,25711641
48788,anti-vascular endothelial growth factor,gene,0.9746,25711641
48789,anti-VEGF,gene,0.943,25711641
48790,patients,species,0.9805,25711641
48791,ranibizumab,gene,0.916,25711641
48792,aflibercept,gene,0.9336,25711641
48793,limbus,DNA,0.4636,25711641
48794,patients,species,0.9844,25711641
48795,exudative AMD,disease,0.7197,25708506
48796,choroidal neovascularization,disease,1.0,25707044
48797,bevacizumab,gene,0.9175,25707044
48798,ranibizumab,gene,0.854,25707044
48799,aflibercept,gene,0.968,25707044
48800,neovascular age-related macular degeneration,disease,1.0,25707044
48801,AMD,disease,1.0,25707044
48802,PATIENTS,species,0.9653,25707044
48803,patients,species,0.987,25707044
48804,neovascular AMD,disease,1.0,25707044
48805,bevacizumab,gene,0.749,25707044
48806,aflibercept,gene,0.9087,25707044
48807,aflibercept,gene,0.9834,25707044
48808,bevacizumab,gene,0.899,25707044
48809,ranibizumab,gene,0.6743,25707044
48810,pigment epithelial detachment,disease,1.0,25707044
48811,aflibercept,gene,0.9854,25707044
48812,bevacizumab,gene,0.76,25707044
48813,aflibercept,gene,0.98,25702661
48814,ovarian cancer,disease,1.0,25702661
48815,VEGF,gene,0.9956,25702661
48816,ovarian cancer,disease,1.0,25702661
48817,bevacizumab,gene,0.682,25702661
48818,Aflibercept,gene,0.979,25702661
48819,VEGF,gene,0.9927,25702661
48820,ovarian cancer,disease,1.0,25702661
48821,aflibercept,gene,0.986,25702661
48822,malignant ascites,disease,0.9995,25702661
48823,patient,species,0.98,25702661
48824,relapsed,disease,0.944,25702661
48825,ovarian cancer,disease,0.8057,25702661
48826,aflibercept,gene,0.9727,25702661
48827,aflibercept,gene,0.991,25702661
48828,carboplatin,drug,1.0,25702661
48829,paclitaxel,drug,0.9995,25702661
48830,ascites,disease,0.99,25702661
48831,ovarian cancer,disease,1.0,25702661
48832,patients,species,0.9795,25702661
48833,Aflibercept,gene,0.9546,25692915
48834,bevacizumab,gene,0.8706,25692915
48835,ranibizumab,gene,0.6895,25692915
48836,diabetic macular edema,disease,1.0,25692915
48837,aflibercept,gene,0.993,25692915
48838,bevacizumab,gene,0.8823,25692915
48839,ranibizumab,gene,0.6533,25692915
48840,diabetic macular edema,disease,1.0,25692915
48841,diabetic macular edema,disease,1.0,25692915
48842,aflibercept,gene,0.9927,25692915
48843,participants,species,0.9756,25692915
48844,bevacizumab,gene,0.8784,25692915
48845,participants,species,0.977,25692915
48846,ranibizumab,gene,0.844,25692915
48847,participants,species,0.97,25692915
48848,aflibercept,gene,0.9844,25692915
48849,bevacizumab,gene,0.8228,25692915
48850,ranibizumab,gene,0.814,25692915
48851,aflibercept,gene,0.991,25692915
48852,aflibercept,gene,0.9683,25692915
48853,bevacizumab,gene,0.9243,25692915
48854,aflibercept,gene,0.986,25692915
48855,ranibizumab,gene,0.915,25692915
48856,participants,species,0.9395,25692915
48857,aflibercept,gene,0.9854,25692915
48858,bevacizumab,gene,0.835,25692915
48859,ranibizumab,gene,0.5327,25692915
48860,aflibercept,gene,0.978,25692915
48861,bevacizumab,gene,0.5903,25692915
48862,ranibizumab,gene,0.5835,25692915
48863,aflibercept,gene,0.972,25692915
48864,bevacizumab,gene,0.769,25692915
48865,aflibercept,gene,0.982,25692915
48866,ranibizumab,gene,0.8423,25692915
48867,ranibizumab,gene,0.8867,25692915
48868,bevacizumab,gene,0.904,25692915
48869,cardiovascular,disease,0.9697,25692915
48870,aflibercept,gene,0.9917,25692915
48871,bevacizumab,gene,0.6064,25692915
48872,ranibizumab,gene,0.512,25692915
48873,diabetic macular edema,disease,1.0,25692915
48874,aflibercept,gene,0.9595,25692915
48875,diabetic macular edema,disease,1.0,25692914
48876,aflibercept,gene,0.987,25681022
48877,macular edema,disease,1.0,25681022
48878,central retinal vein occlusion,disease,1.0,25681022
48879,Ziv-aflibercept,gene,0.9414,25677668
48880,macular disease,disease,1.0,25677668
48881,Aflibercept,gene,0.8877,25677668
48882,neovascular age-related macular degeneration,disease,1.0,25677668
48883,AMD,disease,1.0,25677668
48884,diabetic macular oedema,disease,1.0,25677668
48885,DME,disease,1.0,25677668
48886,retinal pigment epithelium cells,cell_type,0.746,25677668
48887,cancer,disease,0.9653,25677668
48888,ziv-aflibercept,gene,0.9893,25677668
48889,ziv-aflibercept,gene,0.979,25677668
48890,AMD,disease,1.0,25677668
48891,DME,disease,1.0,25677668
48892,ziv-aflibercept,gene,0.9893,25677668
48893,patients,species,0.9785,25677668
48894,AMD,disease,1.0,25677668
48895,DME,disease,1.0,25677668
48896,poor vision,disease,0.996,25677668
48897,ziv-aflibercept,gene,0.9907,25677668
48898,intraocular inflammation,disease,0.9844,25677668
48899,cataract,disease,1.0,25677668
48900,Ziv-aflibercept,gene,0.9653,25677668
48901,vascular endothelial growth factor,gene,0.998,25677668
48902,retinal,disease,0.747,25677668
48903,intraocular inflammation,disease,1.0,25677668
48904,AMD,disease,1.0,25677668
48905,DME,disease,1.0,25677668
48906,patients,species,0.9683,25677668
48907,Ziv-aflibercept,gene,0.9805,25677668
48908,anti-VEGF,gene,0.8604,25677668
48909,polycarbonate,drug,0.9844,25677668
48910,bevacizumab,gene,0.919,25677668
48911,ziv,drug,0.9106,25677668
48912,ziv-aflibercept,gene,0.974,25677668
48913,aflibercept,gene,0.9854,25677668
48914,ranibizumab,gene,0.692,25677668
48915,ziv-aflibercept,gene,0.916,25677668
48916,aflibercept,gene,0.981,25677668
48917,Cancer,disease,0.998,25669849
48918,Cancer,disease,0.998,25669849
48919,eribulin,gene,0.541,25669849
48920,ziv-aflibercept,gene,0.972,25669849
48921,VEGF-A,gene,0.998,25663437
48922,VEGF-B,gene,0.9976,25663437
48923,VEGF-A,gene,0.998,25663437
48924,retinal endothelial cells,cell_line,0.911,25663437
48925,vascular endothelial growth factor,gene,0.9985,25663437
48926,VEGF,gene,0.991,25663437
48927,diabetes,disease,0.9995,25663437
48928,VEGF-A,gene,0.999,25663437
48929,ranibizumab,gene,0.9844,25663437
48930,aflibercept,gene,0.976,25663437
48931,VEGF,DNA,0.6436,25663437
48932,VEGF family,gene,0.9985,25663437
48933,VEGF-B,gene,0.9985,25663437
48934,VEGF-B variants,gene,0.993,25663437
48935,VEGF-A165,gene,0.9985,25663437
48936,retinal endothelial cells,cell_line,0.7744,25663437
48937,REC,cell_line,0.8438,25663437
48938,REC,cell_line,0.774,25663437
48939,VEGF,gene,0.995,25663437
48940,VEGF-B,gene,0.9946,25663437
48941,immortalized bovine REC,cell_line,0.949,25663437
48942,bovine,species,0.878,25663437
48943,iBREC,cell_line,0.609,25663437
48944,VEGF-B variants,gene,0.9956,25663437
48945,VEGF-A165,gene,0.9985,25663437
48946,VEGF-binding proteins,gene,0.9966,25663437
48947,iBREC,cell_line,0.776,25663437
48948,claudin-1,gene,0.9023,25663437
48949,VEGF-B167,gene,0.998,25663437
48950,VEGF-B186,gene,0.9556,25663437
48951,iBREC,cell_line,0.7476,25663437
48952,VEGF-A,gene,0.9985,25663437
48953,VEGF-B,gene,0.999,25663437
48954,VEGF-B variants,gene,0.978,25663437
48955,claudin-1,gene,0.99,25663437
48956,glucose,drug,0.996,25663437
48957,VEGF-A,gene,0.999,25663437
48958,claudin-1,gene,0.984,25663437
48959,VEGF-B,gene,0.9985,25663437
48960,REC,gene,0.4844,25663437
48961,VEGF-B variant,gene,0.9585,25663437
48962,VEGF-A,gene,0.9976,25663437
48963,growth factor-disturbed cells,cell_line,0.8184,25663437
48964,vascular endothelial growth factor,gene,0.98,25650712
48965,vascular endothelial growth factor,gene,0.9663,25650712
48966,NEOVASCULAR AGE-RELATED MACULAR DEGENERATION,disease,0.9937,25650711
48967,neovascular age-related macular degeneration,disease,1.0,25650711
48968,retinal disorders,disease,0.9556,25650711
48969,vascular endothelial growth factor,gene,0.984,25650711
48970,vascular endothelial growth factor,gene,0.9575,25650711
48971,aflibercept,gene,0.988,25650711
48972,aflibercept,gene,0.9385,25650711
48973,anti-vascular endothelial growth factor,gene,0.9414,25650711
48974,aflibercept,gene,0.978,25650711
48975,macular exudation,disease,1.0,25650711
48976,neovascular age-related macular degeneration,disease,1.0,25650711
48977,bevacizumab,gene,0.8384,25646034
48978,ranibizumab,gene,0.7637,25646034
48979,aflibercept,gene,0.989,25646034
48980,neovascular age-related macular degeneration,disease,1.0,25646034
48981,nAMD,disease,1.0,25646034
48982,bevacizumab,gene,0.8306,25646034
48983,ranibizumab,gene,0.7476,25646034
48984,aflibercept,gene,0.9775,25646034
48985,aflibercept,gene,0.9707,25646034
48986,ranibizumab,gene,0.802,25646034
48987,bevacizumab,gene,0.874,25646034
48988,nAMD,disease,0.9995,25646034
48989,subretinal fluid,disease,0.972,25646034
48990,SRF,disease,0.975,25646034
48991,cystoid macular edema,disease,1.0,25646034
48992,CME,disease,1.0,25646034
48993,pigment epithelial detachment,disease,1.0,25646034
48994,PED,disease,1.0,25646034
48995,3,DNA,0.4883,25646034
48996,patients,species,0.9805,25646034
48997,bevacizumab,gene,0.8677,25646034
48998,ranibizumab,drug,0.8564,25646034
48999,aflibercept,gene,0.937,25646034
49000,PED,DNA,0.4915,25646034
49001,bevacizumab,gene,0.974,25646034
49002,ranibizumab,gene,0.9,25646034
49003,SRF,disease,0.955,25646034
49004,CME,disease,0.9956,25646034
49005,PED,disease,0.9907,25646034
49006,bevacizumab,gene,0.8794,25646034
49007,ranibizumab,gene,0.9175,25646034
49008,retinal pigment epithelial tear,disease,1.0,25646034
49009,bevacizumab,gene,0.755,25646034
49010,ranibizumab,gene,0.5366,25646034
49011,aflibercept,gene,0.9756,25634529
49012,age-related macular degeneration,disease,1.0,25634529
49013,aflibercept,gene,0.985,25634529
49014,age-related macular degeneration,disease,1.0,25634529
49015,AMD,disease,1.0,25634529
49016,AMD,disease,0.9995,25634529
49017,aflibercept,gene,0.9287,25634529
49018,polypoidal choroidal vasculopathy,disease,1.0,25634529
49019,PCV,disease,1.0,25634529
49020,retinal angiomatous proliferation,disease,1.0,25634529
49021,RAP,disease,1.0,25634529
49022,AMD,disease,1.0,25634529
49023,polypoidal lesions,disease,1.0,25634529
49024,AMD,disease,0.988,25634529
49025,PCV,disease,1.0,25634529
49026,RAP,disease,1.0,25634529
49027,AMD,disease,0.998,25634529
49028,PCV,disease,1.0,25634529
49029,PCV,disease,1.0,25634529
49030,PCV,disease,1.0,25634529
49031,polyps,disease,0.4644,25634529
49032,polypoidal lesion,disease,1.0,25634529
49033,aflibercept,gene,0.9746,25634529
49034,PCV,disease,0.9995,25634529
49035,AMD,disease,1.0,25634529
49036,polypoidal lesion,disease,1.0,25634529
49037,aflibercept,gene,0.989,25632361
49038,Acute nonarteritic ischemic optic neuropathy,disease,1.0,25632361
49039,ANAION,disease,1.0,25632361
49040,optic neuropathy,disease,1.0,25632361
49041,man,species,0.902,25632361
49042,visual loss,disease,0.971,25632361
49043,ANAION,disease,0.999,25632361
49044,aflibercept,gene,0.9883,25632361
49045,OS,disease,,25632361
49046,retinal nerve fiber layer,cell_type,0.585,25632361
49047,ANAION,disease,1.0,25632361
49048,aflibercept,gene,0.98,25632361
49049,anti-VEGF,gene,0.9785,25632361
49050,neovascular age-related macular degeneration,disease,0.906,25627089
49051,Neovascular,cell_type,0.4492,25627089
49052,Neovascular lesions,disease,1.0,25627089
49053,fluorescein,drug,0.998,25627089
49054,NV,disease,1.0,25627089
49055,central geographic atrophy,disease,0.9614,25627089
49056,drusen,disease,0.5586,25627089
49057,cuticular drusen,disease,0.998,25627089
49058,neovascular,disease,0.8237,25627089
49059,age-related macular degeneration,disease,1.0,25627089
49060,Type 3 NV,disease,0.887,25627089
49061,reticular pseudodrusen,disease,0.8857,25627089
49062,central geographic atrophy,disease,0.998,25627089
49063,Type 1 NV,disease,1.0,25627089
49064,reticular pseudodrusen,disease,0.987,25627089
49065,age-related macular degeneration,disease,0.9707,25627089
49066,NV,disease,1.0,25627089
49067,fluorescein,drug,0.99,25627089
49068,Type 3 NV,disease,0.9297,25627089
49069,Type 1 NV,disease,0.9854,25627089
49070,Type 3 NV,disease,1.0,25627089
49071,geographic atrophy,disease,0.975,25627089
49072,pigment epithelial detachments,cell_type,0.737,25627086
49073,aflibercept,gene,0.927,25627086
49074,neovascular age-related macular degeneration,disease,1.0,25627086
49075,aflibercept,gene,0.984,25627086
49076,pigment epithelial detachment,disease,1.0,25627086
49077,PED,disease,1.0,25627086
49078,neovascular age-related macular degeneration,disease,1.0,25627086
49079,PEDs,disease,0.995,25627086
49080,neovascular age-related macular degeneration,disease,1.0,25627086
49081,aflibercept,gene,0.958,25627086
49082,PED,DNA,0.552,25627086
49083,Aflibercept,gene,0.9663,25627086
49084,PED,DNA,0.5664,25627086
49085,PEDs,DNA,0.4243,25627086
49086,PEDs,DNA,0.4253,25627086
49087,Aflibercept,gene,0.522,25627086
49088,PED,DNA,0.5845,25627086
49089,PEDs,DNA,0.499,25627086
49090,PED,DNA,0.6123,25627086
49091,diabetic macular edema,disease,1.0,25621943
49092,aflibercept,gene,0.968,25621943
49093,diabetic macular edema,disease,1.0,25621943
49094,aflibercept,gene,0.983,25621943
49095,VINCI,cell_line,0.501,25621943
49096,IAI,drug,0.572,25621943
49097,IAI,drug,0.5083,25621943
49098,aflibercept,gene,0.986,25621943
49099,Aflibercept,gene,0.9844,25616671
49100,Irinotecan,drug,0.99,25616671
49101,Fluorouracil,drug,0.9985,25616671
49102,Metastatic Colorectal Cancer,disease,1.0,25616671
49103,Oxaliplatin,drug,0.9995,25616671
49104,aflibercept,gene,0.9727,25616671
49105,aflibercept,gene,0.9487,25616671
49106,irinotecan,drug,0.999,25616671
49107,fluorouracil,drug,0.9995,25616671
49108,irinotecan,drug,0.9995,25616671
49109,5-fluorouracil,drug,0.9995,25616671
49110,folinic acid,drug,0.999,25616671
49111,FOLFIRI,drug,0.983,25616671
49112,metastatic colorectal cancer,disease,1.0,25616671
49113,oxaliplatin,drug,0.9995,25616671
49114,aflibercept,gene,0.9326,25616671
49115,FOLFIRI,drug,0.9175,25616671
49116,FOLFIRI,drug,0.9785,25616671
49117,aflibercept,gene,0.992,25616671
49118,aflibercept,gene,0.983,25616671
49119,aflibercept,gene,0.992,25616671
49120,aflibercept,gene,0.9854,25616671
49121,aflibercept,gene,0.9272,25616671
49122,aflibercept,gene,0.926,25616671
49123,irinotecan,drug,0.9985,25616671
49124,fluorouracil,drug,0.999,25616671
49125,metastatic colorectal cancer,disease,1.0,25616671
49126,oxaliplatin,drug,0.999,25616671
49127,Aflibercept,gene,0.978,25616671
49128,irinotecan,drug,0.9985,25616671
49129,fluorouracil,drug,0.9985,25616671
49130,metastatic colorectal cancer,disease,1.0,25616671
49131,oxaliplatin,drug,0.999,25616671
49132,VEGF,gene,0.996,25606789
49133,aflibercept,gene,0.96,25606789
49134,lymphatic,cell_type,0.4983,25606789
49135,vascular endothelial growth factor,gene,0.967,25606789
49136,VEGF,gene,0.9927,25606789
49137,anti-VEGF-C,gene,0.926,25606789
49138,sVEGFR-3,gene,0.981,25606789
49139,Th1 cells,cell_line,0.9517,25606789
49140,Th1,gene,0.587,25606789
49141,graft-infiltrating immune cells,cell_type,0.8525,25606789
49142,VEGF,gene,0.9927,25606789
49143,graft-infiltrating immune cells,cell_type,0.8022,25606789
49144,Anti-VEGF-C,gene,0.8286,25606789
49145,sVEGFR3,gene,0.9507,25606789
49146,lymphoid Th1 cell,cell_line,0.758,25606789
49147,VEGF,gene,0.9917,25606789
49148,anti-VEGF-C,gene,0.9385,25606789
49149,sVEGFR-3,gene,0.9873,25606789
49150,VEGF-,gene,0.994,25606789
49151,anti-VEGF-C,gene,0.98,25606789
49152,sVEGFR-3,gene,0.9854,25606789
49153,VEGF,gene,0.993,25606789
49154,anti-VEGF-C,gene,0.986,25606789
49155,sVEGFR-3,gene,0.983,25606789
49156,Choroidal,cell_line,0.4841,25606040
49157,Choroidal nevus,disease,1.0,25606040
49158,polypoidal choroidal vasculopathy,disease,1.0,25606040
49159,polypoidal choroidal vasculopathy,disease,1.0,25606040
49160,PCV,disease,1.0,25606040
49161,choroidal nevus,disease,1.0,25606040
49162,woman,species,0.9253,25606040
49163,macular tumor,disease,1.0,25606040
49164,distorted vision,disease,0.999,25606040
49165,patient,species,0.9883,25606040
49166,juxtafoveal,disease,0.7744,25606040
49167,chorioretinal lesion,disease,0.8125,25606040
49168,polyp-like reddish-orange lesions,disease,0.9995,25606040
49169,juxtafoveal choroidal lesion,disease,0.994,25606040
49170,choroidal neovascularization,disease,1.0,25606040
49171,CNV,disease,1.0,25606040
49172,CNV,disease,1.0,25606040
49173,pigment epithelial detachment,disease,1.0,25606040
49174,PED,disease,1.0,25606040
49175,Fluorescein,drug,0.942,25606040
49176,CNV,disease,0.999,25606040
49177,Indocyanine green,drug,0.998,25606040
49178,polypoidal lesions,disease,1.0,25606040
49179,CNV,DNA,0.894,25606040
49180,patient,species,0.982,25606040
49181,PCV,disease,1.0,25606040
49182,Aflibercept,gene,0.9336,25606040
49183,PED,disease,0.9995,25606040
49184,PED,disease,0.9863,25606040
49185,PCV,disease,0.9995,25606040
49186,posterior pole,DNA,0.5503,25606040
49187,aflibercept,gene,0.99,25606040
49188,PED,disease,0.993,25606040
49189,CNV,disease,0.9995,25606040
49190,vascular endothelial growth factor,gene,0.993,25596618
49191,age-related macular degeneration,disease,0.9995,25596618
49192,anti-vascular endothelial growth factor,gene,0.8154,25596618
49193,VEGF,gene,0.995,25596618
49194,age-related macular degeneration,disease,1.0,25596618
49195,AMD,disease,1.0,25596618
49196,PARTICIPANTS,species,0.5537,25596618
49197,exudative AMD,disease,1.0,25596618
49198,VEGF,gene,0.9233,25596618
49199,ranibizumab,gene,0.8364,25596618
49200,bevacizumab,gene,0.8857,25596618
49201,aflibercept,gene,0.9683,25596618
49202,VEGF,gene,0.53,25596618
49203,exudative AMD,disease,1.0,25596618
49204,aflibercept,gene,0.9893,25595177
49205,aflibercept,gene,0.976,25595177
49206,central,disease,0.5796,25595177
49207,serous chorioretinopathy,disease,0.8853,25595177
49208,CSCR,disease,1.0,25595177
49209,patients,species,0.964,25595177
49210,chronic CSCR,disease,0.9556,25595177
49211,aflibercept,gene,0.972,25595177
49212,Patients,species,0.8594,25595177
49213,Diabetic Retinopathy,disease,0.9995,25595177
49214,patients,species,0.9814,25595177
49215,men,species,0.952,25595177
49216,patients,species,0.903,25595177
49217,ETDRS letters,DNA,0.5146,25595177
49218,patients,species,0.99,25595177
49219,patients,species,0.991,25595177
49220,patients,species,0.9873,25595177
49221,ETDRS,DNA,0.515,25595177
49222,patients,species,0.9854,25595177
49223,ETDRS,DNA,0.532,25595177
49224,patients,species,0.9824,25595177
49225,aflibercept,gene,0.979,25595177
49226,CSCR,disease,0.946,25595177
49227,vascular endothelial growth factor,gene,0.9917,25592118
49228,vascular endothelial growth factor,gene,0.9966,25592118
49229,VEGF,gene,0.9917,25592118
49230,rabbit,species,0.9824,25592118
49231,VEGF-Trap,gene,0.802,25592118
49232,rabbit,species,0.978,25592118
49233,VEGF-Trap,gene,0.9453,25592118
49234,VEGF,gene,0.9927,25592118
49235,VEGF-Trap,gene,0.876,25592118
49236,VEGF-Trap,gene,0.937,25592118
49237,VEGF-Trap,gene,0.747,25592118
49238,bevacizumab,gene,0.853,25592118
49239,ranibizumab,gene,0.663,25592118
49240,VEGF,gene,0.994,25592118
49241,aflibercept,gene,0.9424,25590968
49242,sterile intraocular inflammation,disease,0.9995,25590968
49243,Aflibercept,gene,0.8486,25590968
49244,sterile inflammation,disease,0.9995,25590968
49245,aflibercept,gene,0.977,25590968
49246,sterile inflammation,disease,1.0,25590968
49247,PARTICIPANTS,species,0.495,25590968
49248,sterile inflammation,disease,1.0,25590968
49249,aflibercept,gene,0.988,25590968
49250,TSC,disease,0.867,25590968
49251,aflibercept,gene,0.977,25590968
49252,sterile inflammation,disease,0.9995,25590968
49253,sterile inflammation,disease,1.0,25590968
49254,loss of vision,disease,1.0,25590968
49255,intraocular inflammation,disease,1.0,25590968
49256,hypopyon,disease,0.9985,25590968
49257,vision loss,disease,0.955,25590968
49258,sterile inflammation,disease,1.0,25590968
49259,aflibercept,gene,0.9834,25590968
49260,sterile inflammation,disease,0.994,25590968
49261,sterile inflammation,disease,0.9946,25590968
49262,infectious endophthalmitis,disease,1.0,25590968
49263,physicians,cell_type,0.4788,25590968
49264,Aflibercept,gene,0.9795,25588083
49265,vascular endothelial growth factor,gene,0.9976,25588083
49266,VEGF,gene,0.996,25588083
49267,pegaptanib,drug,0.9414,25588083
49268,bevacizumab,gene,0.625,25588083
49269,retinal vascular diseases,disease,1.0,25588083
49270,age-related macular degeneration,disease,1.0,25588083
49271,AMD,disease,1.0,25588083
49272,diabetic macula edema,disease,1.0,25588083
49273,DME,disease,1.0,25588083
49274,retinal vein occlusion,disease,1.0,25588083
49275,aflibercept,gene,0.9526,25588083
49276,VEGF,gene,0.7524,25588083
49277,VEGF,gene,0.995,25588083
49278,placenta growth factor,gene,0.9976,25588083
49279,Aflibercept,gene,0.9756,25588083
49280,ranibizumab,gene,0.806,25588083
49281,neovascular AMD,disease,1.0,25588083
49282,aflibercept,gene,0.9956,25588083
49283,ranibizumab,gene,0.812,25588083
49284,bevacizumab,gene,0.612,25588083
49285,DME,disease,1.0,25588083
49286,RVO,disease,0.9995,25588083
49287,colorectal cancer,disease,1.0,25580262
49288,Colorectal cancer,disease,1.0,25580262
49289,solid tumors,disease,1.0,25580262
49290,patient,species,0.983,25580262
49291,tumor,disease,0.9995,25580262
49292,tumors,disease,1.0,25580262
49293,rectal cancer,disease,1.0,25580262
49294,colon cancer,disease,1.0,25580262
49295,colorectal cancer,disease,1.0,25580262
49296,5-fluorouracil,drug,0.9995,25580262
49297,5-FU,drug,0.9995,25580262
49298,5-FU,drug,0.9995,25580262
49299,oxaliplatin,drug,0.9995,25580262
49300,irinotecan,drug,0.998,25580262
49301,anti-vascular endothelial growth factor-A,gene,0.9883,25580262
49302,anti-VEGF-A,gene,0.8857,25580262
49303,bevacizumab,gene,0.4504,25580262
49304,epidermal growth factor receptor,gene,0.997,25580262
49305,anti-EGFR,gene,0.944,25580262
49306,cetuximab,gene,0.4797,25580262
49307,panitumumab,gene,0.8374,25580262
49308,regorafenib,drug,0.9365,25580262
49309,aflibercept,gene,0.96,25580262
49310,Anti-,gene,0.682,25580262
49311,EGFR antibodies,gene,0.8057,25580262
49312,tumors,disease,1.0,25580262
49313,KRAS,gene,0.9834,25580262
49314,"NRAS exon 2, 3, 4",DNA,0.8877,25580262
49315,anti-EGFR,gene,0.8394,25580262
49316,VEGF,gene,0.6943,25580262
49317,patient,species,0.973,25580262
49318,Right-sided sporadic colon cancers,disease,0.9985,25580262
49319,microsatellite instability (MSI-H) tumors,disease,0.947,25580262
49320,hereditary non-polyposis colorectal cancer,disease,1.0,25580262
49321,colorectal cancer,disease,1.0,25580262
49322,patients,species,0.985,25579664
49323,metastatic colorectal cancer,disease,0.9927,25579664
49324,patients,species,0.9805,25579664
49325,colorectal cancer,disease,1.0,25579664
49326,mCRC,disease,0.997,25579664
49327,VEGF,gene,0.6006,25579664
49328,bevacizumab,gene,0.9717,25579664
49329,aflibercept,gene,0.9946,25579664
49330,anti-EGFR antibodies,gene,0.9053,25579664
49331,panitumumab,gene,0.9526,25579664
49332,cetuximab,gene,0.9634,25579664
49333,regorafenib,drug,0.9854,25579664
49334,patients,species,0.973,25579664
49335,mCRC,disease,0.9907,25579664
49336,mCRC,disease,0.993,25579664
49337,Pigment epithelial detachment,disease,1.0,25578255
49338,retinal cystoid degeneration,disease,1.0,25578255
49339,neovascular age-related macular degeneration,disease,1.0,25578255
49340,AMD,disease,1.0,25578255
49341,PARTICIPANTS,species,0.833,25578255
49342,patients,species,0.9565,25578255
49343,neovascular AMD,disease,1.0,25578255
49344,Participants,species,0.967,25578255
49345,ranibizumab,gene,0.7197,25578255
49346,aflibercept,gene,0.8994,25578255
49347,intraretinal cysts,disease,1.0,25578255
49348,IRCs,disease,1.0,25578255
49349,subretinal fluid,disease,0.999,25578255
49350,SRF,disease,0.999,25578255
49351,pigment epithelial detachment,disease,1.0,25578255
49352,PED,disease,1.0,25578255
49353,neovascular AMD,disease,1.0,25578255
49354,Intraretinal,cell_type,0.476,25578255
49355,Intraretinal cysts,disease,0.9897,25578255
49356,visual loss,disease,0.9634,25578255
49357,PED,disease,0.9136,25578255
49358,IRC,cell_line,0.5566,25578255
49359,PED,disease,1.0,25578255
49360,cystoid degeneration,disease,1.0,25578255
49361,PED,disease,0.999,25578255
49362,vision loss,disease,0.9995,25578255
49363,macular edema,disease,1.0,25576994
49364,central retinal vein occlusion,disease,1.0,25576994
49365,macular edema,disease,1.0,25576994
49366,ME,disease,1.0,25576994
49367,central retinal vein occlusion,disease,1.0,25576994
49368,CRVO,disease,1.0,25576994
49369,vascular endothelial growth factor,gene,0.9126,25576994
49370,VEGF,gene,0.999,25576994
49371,ME,disease,,25576994
49372,CRVO,disease,1.0,25576994
49373,ranibizumab,gene,0.8174,25576994
49374,aflibercept,gene,0.977,25576994
49375,dexamethasone,drug,0.999,25576994
49376,triamcinolone,drug,0.9995,25576994
49377,cataract,disease,1.0,25576994
49378,glaucoma,disease,1.0,25576994
49379,ranibizumab,gene,0.8633,25576994
49380,anti-VEGF,gene,0.9404,25576994
49381,VEGF,gene,0.845,25576994
49382,ME,disease,,25576994
49383,CRVO,disease,1.0,25576994
49384,ranibizumab,gene,0.674,25572584
49385,aflibercept,gene,0.9316,25572584
49386,central retinal vein occlusion,disease,1.0,25572584
49387,anti-,gene,0.858,25572584
49388,vascular endothelial growth factor,gene,0.9336,25572584
49389,ranibizumab,gene,0.639,25572584
49390,aflibercept,gene,0.938,25572584
49391,central retinal vein occlusion,disease,1.0,25572584
49392,CRVO,disease,1.0,25572584
49393,patients,species,0.986,25572584
49394,CRVO,disease,1.0,25572584
49395,ranibizumab,gene,0.733,25572584
49396,aflibercept,gene,0.859,25572584
49397,Patients,species,0.9614,25572584
49398,anti-VEGF,gene,0.9014,25572584
49399,patients,species,0.994,25572584
49400,Patient,species,0.9824,25572584
49401,patients,species,0.951,25572584
49402,aflibercept,gene,0.8857,25572584
49403,patients,species,0.9844,25572584
49404,ranibizumab,gene,0.931,25572584
49405,aflibercept,gene,0.9766,25572584
49406,patient,species,0.994,25572584
49407,patients,species,0.986,25572584
49408,ranibizumab,gene,0.8716,25572584
49409,aflibercept,gene,0.9854,25572584
49410,patients,species,0.976,25572584
49411,ranibizumab,gene,0.9443,25572584
49412,aflibercept,gene,0.969,25572584
49413,CRVO,disease,1.0,25572584
49414,ziv-aflibercept,gene,0.984,25559518
49415,age-related macular degeneration,disease,1.0,25559518
49416,exudative age-related macular degeneration,disease,1.0,25559518
49417,ziv-aflibercept,gene,0.9697,25559518
49418,Zaltrap,gene,0.538,25559518
49419,fluorescein,drug,0.997,25559518
49420,Ziv-aflibercept,gene,0.972,25559518
49421,neovascular macular degeneration,disease,1.0,25559518
49422,Retinal,cell_type,0.4675,25559517
49423,Retinal pigment epithelial tear,disease,0.971,25559517
49424,aflibercept,gene,0.98,25559517
49425,neovascular age-related macular degeneration,disease,1.0,25559517
49426,neovascular age-related macular degeneration,disease,1.0,25559517
49427,ranibizumab,gene,0.938,25559517
49428,bevacizumab,gene,0.514,25559517
49429,tears,disease,0.988,25559517
49430,aflibercept,gene,0.987,25559517
49431,vascular endothelial growth factor,gene,0.998,25559517
49432,RPE,cell_type,0.593,25559517
49433,fibrovascular RPE detachment,disease,0.9253,25559517
49434,fibrovascular tissue,cell_type,0.636,25559517
49435,aflibercept,gene,0.9834,25559517
49436,tears,disease,0.972,25559517
49437,connective tissue growth factor,gene,0.997,25559517
49438,endothelial growth factor,gene,0.989,25559517
49439,aflibercept,gene,0.9727,25559511
49440,bevacizumab,gene,0.8296,25559511
49441,age-related macular degeneration,disease,0.9995,25559511
49442,aflibercept,gene,0.956,25559511
49443,bevacizumab,gene,0.6895,25559511
49444,age-related macular degeneration,disease,1.0,25559511
49445,AMD,disease,1.0,25559511
49446,PATIENTS,species,0.954,25559511
49447,ranibizumab,gene,0.564,25559511
49448,wet AMD,disease,0.999,25559511
49449,IVB,drug,0.8535,25559511
49450,IVR,drug,0.6504,25559511
49451,IVA,drug,0.927,25559511
49452,Aflibercept,gene,0.8945,25559511
49453,wet AMD,disease,0.9985,25559511
49454,aflibercept,gene,0.9746,25555799
49455,neovascular age-related macular degeneration,disease,1.0,25555799
49456,aflibercept,gene,0.983,25555799
49457,neovascular age-related macular degeneration,disease,1.0,25555799
49458,AMD,disease,1.0,25555799
49459,neovascular AMD,disease,1.0,25555799
49460,aflibercept,gene,0.972,25555799
49461,neovascular AMD,disease,1.0,25555799
49462,polypoidal choroidal vasculopathy,disease,1.0,25555799
49463,aflibercept,gene,0.987,25555799
49464,neovascular AMD,disease,1.0,25555799
49465,aflibercept,gene,0.985,25555799
49466,neovascular AMD,disease,1.0,25555799
49467,aflibercept,gene,0.9917,26999944
49468,polypoidal choroidal,disease,1.0,26999944
49469,woman,species,0.8022,26999944
49470,sudden vision impairment,disease,1.0,26999944
49471,polypoidal choroidal vasculopathy,disease,1.0,26999944
49472,Polypoidal choroidal vasculopathy,disease,1.0,26999944
49473,choroidal neovascularisation,disease,1.0,26999944
49474,age-related macular degeneration,disease,1.0,26999944
49475,vascular endothelial growth factor,gene,0.9683,26999944
49476,aflibercept,gene,0.9424,26999944
49477,Retinal vein occlusion,disease,1.0,26977728
49478,Macular edema,disease,1.0,26977728
49479,Macular edema,disease,1.0,26977728
49480,ME,disease,1.0,26977728
49481,ischemic and nonischemic retinal vein occlusion,disease,1.0,26977728
49482,RVO,disease,1.0,26977728
49483,ME,disease,0.9995,26977728
49484,Central Vein Occlusion,disease,0.998,26977728
49485,RVO,disease,1.0,26977728
49486,ME,disease,1.0,26977728
49487,ME,disease,0.994,26977728
49488,CRVO,disease,0.9995,26977728
49489,ME,disease,1.0,26977728
49490,cystic ME,disease,0.9937,26977728
49491,Ischemic maculopathy,disease,1.0,26977728
49492,macular edema,disease,1.0,26977728
49493,Ozurdex,drug,0.5347,26977728
49494,anti-VEGF,gene,0.6,26977728
49495,ranibizumab,gene,0.932,26977728
49496,aflibercept,gene,0.9775,26977728
49497,ME,disease,0.998,26977728
49498,CRVO,disease,1.0,26977728
49499,ME,disease,0.999,26977728
49500,VEGF,gene,0.757,26977728
49501,BRVO,disease,1.0,26977728
49502,edemas,disease,1.0,26977728
49503,aflibercept,gene,0.992,25547617
49504,choroidal neovascularisation,disease,1.0,25547617
49505,aflibercept,gene,0.994,25531046
49506,docetaxel,drug,0.998,25531046
49507,nasopharyngeal carcinoma,disease,1.0,25531046
49508,solid tumors,disease,1.0,25531046
49509,the,gene,0.8765,25531046
49510,aflibercept,gene,0.814,25531046
49511,docetaxel,drug,0.994,25531046
49512,TCD6120,drug,0.9307,25531046
49513,nasopharyngeal carcinoma,disease,1.0,25531046
49514,NPC,disease,1.0,25531046
49515,solid tumors,disease,1.0,25531046
49516,aflibercept,gene,0.9644,25531046
49517,docetaxel,drug,0.999,25531046
49518,NPC,disease,1.0,25531046
49519,lung cancer,disease,1.0,25531046
49520,aflibercept,gene,0.9907,25531046
49521,neutropenic infection,disease,1.0,25531046
49522,stomatitis,disease,1.0,25531046
49523,alopecia,disease,1.0,25531046
49524,oropharyngeal pain,disease,0.9995,25531046
49525,stomatitis,disease,1.0,25531046
49526,neutropenic infection,disease,1.0,25531046
49527,docetaxel,drug,0.9995,25531046
49528,aflibercept,gene,0.9907,25531046
49529,NPC,disease,0.999,25531046
49530,endophthalmitis,disease,1.0,25526099
49531,endophthalmitis,disease,1.0,25526099
49532,age-related macular degeneration,disease,0.904,25526099
49533,diabetic macular edema,disease,1.0,25526099
49534,cystoid macular edema,disease,1.0,25526099
49535,retinal vein occlusions,disease,1.0,25526099
49536,cytomegalovirus retinitis,disease,1.0,25526099
49537,severe uveitis,disease,0.751,25526099
49538,povidone-iodine,drug,0.9556,25526099
49539,proparacaine,drug,0.9966,25526099
49540,tetracaine,drug,0.996,25526099
49541,bevacizumab,gene,0.59,25526099
49542,triamcinolone acetonide,drug,0.9995,25526099
49543,Kenalog-40,drug,0.9897,25526099
49544,pegaptanib sodium,drug,0.9985,25526099
49545,aflibercept,gene,0.8853,25526099
49546,148,RNA,0.4053,25526099
49547,dexamethasone,drug,0.9985,25526099
49548,triamcinolone acetonide,drug,0.9995,25526099
49549,dexamethasone,drug,0.9995,25526099
49550,ganciclovir,drug,0.999,25526099
49551,postinjection endophthalmitis,disease,0.91,25526099
49552,endophthalmitis,disease,1.0,25526099
49553,endophthalmitis,disease,1.0,25526099
49554,ranibizumab,gene,0.9185,25523611
49555,aflibercept,gene,0.985,25523611
49556,exudative age-related macular degeneration,disease,1.0,25523611
49557,vascular endothelial growth factor,gene,0.91,25523611
49558,VEGF,gene,0.9917,25523611
49559,exudative age-related macular degeneration,disease,1.0,25523611
49560,AMD,disease,0.9985,25523611
49561,ranibizumab,gene,0.968,25523611
49562,aflibercept,gene,0.9756,25523611
49563,PATIENTS,species,0.9595,25523611
49564,AMD,disease,1.0,25523611
49565,aflibercept,gene,0.928,25523611
49566,ranibizumab,gene,0.5664,25523611
49567,pigment epithelial detachment,disease,1.0,25523611
49568,PED,disease,1.0,25523611
49569,photoreceptors,cell_type,0.614,25523611
49570,exudative,disease,0.6797,25523611
49571,AMD,disease,0.576,25523611
49572,ranibizumab,gene,0.9272,25523611
49573,aflibercept,gene,0.9355,25523611
49574,intraretinal edema,disease,1.0,25523611
49575,photoreceptor,DNA,0.479,25523611
49576,Aflibercept,gene,0.927,25505976
49577,Patients,species,0.985,25505976
49578,Persistent Macular Exudate,disease,0.9043,25505976
49579,aflibercept,gene,0.9946,25505976
49580,bevacizumab,gene,0.849,25505976
49581,patients,species,0.983,25505976
49582,neovascular age-related macular degeneration,disease,1.0,25505976
49583,patients,species,0.9824,25505976
49584,aflibercept,gene,0.9883,25505976
49585,ranibizumab,gene,0.7104,25505976
49586,bevacizumab,gene,0.582,25505976
49587,aflibercept,gene,0.9854,25505976
49588,patients,species,0.9766,25505976
49589,VEGF,gene,0.958,25505976
49590,retinal fluid,disease,0.8027,25505976
49591,ranibizumab,gene,0.5166,25505976
49592,bevacizumab,gene,0.623,25505976
49593,patients,species,0.9834,25505976
49594,aflibercept,gene,0.989,25505976
49595,neovascular age-related macular degeneration,disease,1.0,25503456
49596,aflibercept,gene,0.972,25503456
49597,aflibercept,gene,0.9595,25503456
49598,neovascular AMD,disease,1.0,25503456
49599,nAMD,disease,1.0,25503456
49600,nAMD,disease,1.0,25503456
49601,aflibercept,gene,0.985,25503456
49602,intraretinal fluid,disease,0.865,25503456
49603,IRF,disease,0.886,25503456
49604,intraretinal cystoid space,disease,0.853,25503456
49605,IRC,disease,0.564,25503456
49606,serous pigment epithelium detachment,disease,1.0,25503456
49607,sPED,disease,0.9995,25503456
49608,fibrovascular pigment epithelium detachment,disease,1.0,25503456
49609,fPED,disease,1.0,25503456
49610,NVC,DNA,0.5474,25503456
49611,IRC,DNA,0.4934,25503456
49612,IRF,DNA,0.531,25503456
49613,sPED,DNA,0.4783,25503456
49614,SRF,DNA,0.6465,25503456
49615,aflibercept,gene,0.976,25503456
49616,SRF,disease,0.999,25503456
49617,sPED,disease,0.9995,25503456
49618,intraretinal,disease,0.712,25503456
49619,intraretinal cysts,disease,1.0,25503456
49620,ZIv-aflibercept,gene,0.8257,25493238
49621,colorectal cancer,disease,1.0,25493238
49622,Ziv-afilbercept,gene,0.735,25493238
49623,vascular endothelial growth factor,gene,0.997,25493238
49624,VEGF,gene,0.9927,25493238
49625,human VEGF receptors,gene,0.905,25493238
49626,human,species,0.9814,25493238
49627,Fc,gene,,25493238
49628,human immunoglobulin IgG1,gene,0.988,25493238
49629,human,species,0.9946,25493238
49630,5-fluorouracil,drug,0.9995,25493238
49631,leucovorin,drug,0.999,25493238
49632,irinotecan,drug,0.999,25493238
49633,FOLFIRI,drug,0.995,25493238
49634,Ziv,drug,0.9536,25493238
49635,FOLFIRI,drug,0.951,25493238
49636,patients,species,0.9863,25493238
49637,oxaliplatin,drug,0.9995,25493238
49638,metastatic colon cancer,disease,1.0,25493238
49639,mCRC,disease,1.0,25493238
49640,Patients,species,0.983,25493238
49641,bevacizumab,gene,0.606,25493238
49642,Ziv,drug,0.993,25493238
49643,ziv,drug,0.921,25493238
49644,Ziv,drug,0.9785,25493238
49645,Ziv,drug,0.994,25493238
49646,FOLFIRI,drug,0.988,25493238
49647,FOLFIRI,drug,0.994,25493238
49648,Ziv,drug,0.996,25493238
49649,FOLFIRI,drug,0.994,25493238
49650,metastatic colon cancer,disease,1.0,25493238
49651,patients,species,0.984,25493238
49652,oxaliplatin,drug,0.9995,25493238
49653,diarrhea,disease,1.0,25493238
49654,stomatitis,disease,1.0,25493238
49655,fatigue,disease,1.0,25493238
49656,hypertension,disease,1.0,25493238
49657,weight loss,disease,0.995,25493238
49658,loss of appetite,disease,0.9985,25493238
49659,abdominal pain,disease,0.9995,25493238
49660,headache,disease,1.0,25493238
49661,Ziv,drug,0.9966,25493238
49662,Ziv,drug,0.984,25493238
49663,mCRC,disease,0.962,25493238
49664,platinum,drug,1.0,25490004
49665,small-cell lung cancer,disease,0.996,25490004
49666,SCLC,disease,1.0,25490004
49667,patients,species,0.984,25490004
49668,platinum,drug,1.0,25490004
49669,platinum,drug,0.9995,25490004
49670,platinum,drug,1.0,25490004
49671,patients,species,0.9917,25490004
49672,platinum,drug,1.0,25490004
49673,platinum,drug,0.9995,25490004
49674,patient,species,0.977,25490004
49675,SCLC,disease,0.6724,25490004
49676,platinum,drug,1.0,25490004
49677,patients,species,0.983,25490004
49678,platinum,drug,0.9995,25490004
49679,serum lactate dehydrogenase,gene,0.9043,25490004
49680,lactate,drug,0.982,25490004
49681,Platinum,drug,0.9995,25490004
49682,patients,species,0.989,25490004
49683,Platinum,drug,0.9995,25490004
49684,prognostic,DNA,0.49,25490004
49685,SCLC,disease,1.0,25490004
49686,VEGF,gene,0.9873,25489638
49687,VEGF,gene,0.992,25489638
49688,VEGF,gene,0.993,25489638
49689,neovascular age-related macular degeneration,disease,1.0,25489638
49690,nAMD,disease,1.0,25489638
49691,Ranibizumab,gene,0.8027,25489638
49692,aflibercept,gene,0.926,25489638
49693,VEGF,gene,0.996,25489638
49694,nAMD,disease,1.0,25489638
49695,Bevacizumab,gene,0.888,25489638
49696,nAMD,disease,0.9736,25489638
49697,arteriothrombotic events,disease,1.0,25489638
49698,ATEs,disease,1.0,25489638
49699,gastrointestinal,disease,0.9575,25489638
49700,ranibizumab,gene,0.882,25489638
49701,bevacizumab,gene,0.872,25489638
49702,aflibercept,gene,0.983,25489638
49703,VEGF,gene,0.6943,25489638
49704,ATE,disease,0.995,25489638
49705,VEGF,gene,0.9854,25489638
49706,patients,species,0.9946,25489638
49707,vascular endothelial growth factor,gene,0.9966,25488124
49708,vascular endothelial growth factor,gene,0.9985,25488124
49709,VEGF,gene,0.997,25488124
49710,aflibercept,gene,0.9106,25488124
49711,ranibizumab,gene,0.7715,25488124
49712,patients,species,0.977,25488124
49713,exudative age-related macular degeneration,disease,0.9995,25488124
49714,AMD,disease,1.0,25488124
49715,patients,species,0.9683,25488124
49716,exudative AMD,disease,0.986,25488124
49717,patients,species,0.9683,25488124
49718,aflibercept,gene,0.9883,25488124
49719,ranibizumab,gene,0.93,25488124
49720,VEGF,gene,0.9956,25488124
49721,patients,species,0.972,25488124
49722,chorioretinal diseases,disease,1.0,25488124
49723,plasma,RNA,0.4785,25488124
49724,plasma VEGF,gene,0.5635,25488124
49725,aflibercept,gene,0.962,25488124
49726,ranibizumab,gene,0.675,25488124
49727,aflibercept,gene,0.982,25488124
49728,patients,species,0.9854,25488124
49729,VEGF,gene,0.9966,25488124
49730,patients,species,0.9937,25488124
49731,patients,species,0.9795,25488124
49732,ranibizumab,gene,0.6196,25488124
49733,VEGF,gene,0.9976,25488124
49734,aflibercept,gene,0.9824,25488124
49735,VEGF,gene,0.9746,25488124
49736,ranibizumab,gene,0.9453,25488124
49737,plasma VEGF,gene,0.6694,25488124
49738,Aflibercept,gene,0.9087,25487369
49739,nasal septum perforation,disease,0.9424,25487369
49740,Hypertension,disease,1.0,25487369
49741,cytopenia,disease,1.0,25487369
49742,diarrhea,disease,1.0,25487369
49743,aflibercept,gene,0.9663,25487369
49744,thromboembolism,disease,1.0,25487369
49745,hemorrhage,disease,1.0,25487369
49746,fistulization,disease,0.999,25487369
49747,reversible posterior leukoencephalopathy,disease,1.0,25487369
49748,patient,species,0.986,25487369
49749,nasal septum perforation,disease,0.9575,25487369
49750,aflibercept,gene,0.9766,25487369
49751,hypotony,disease,1.0,25474585
49752,glaucoma,disease,0.998,25474585
49753,aflibercept,gene,0.9946,25471087
49754,aflibercept,gene,0.9824,25471087
49755,patients,species,0.9775,25471087
49756,type 1 retinopathy of prematurity,disease,0.9956,25471087
49757,ROP,disease,1.0,25471087
49758,PATIENTS,species,0.9424,25471087
49759,aflibercept,gene,0.971,25471087
49760,patients,species,0.979,25471087
49761,type 1 ROP,disease,0.9004,25471087
49762,ROP,disease,0.984,25471087
49763,retinopathy,disease,0.9795,25471087
49764,aflibercept,gene,0.9854,25471087
49765,type 1 ROP,disease,0.9746,25471087
49766,aflibercept,gene,0.9824,25466509
49767,FOLFIRI,drug,0.9907,25466509
49768,Patients,species,0.938,25466509
49769,metastatic colorectal cancer,disease,1.0,25466509
49770,mCRC,disease,1.0,25466509
49771,oxaliplatin,drug,0.9995,25466509
49772,aflibercept,gene,0.9834,25466509
49773,FOLFIRI,drug,0.9507,25466509
49774,PATIENTS,species,0.9536,25466509
49775,VEGF,gene,0.997,25466509
49776,aflibercept,gene,0.9976,25466509
49777,irinotecan,drug,0.9976,25466509
49778,colorectal cancer,disease,1.0,25466509
49779,oxaliplatin,drug,0.9995,25466509
49780,patients,species,0.9883,25466509
49781,FOLFIRI,drug,0.734,25466509
49782,aflibercept,gene,0.953,25466509
49783,Cancer,disease,0.5117,25466509
49784,aflibercept,gene,0.962,25466509
49785,VEGF,gene,0.9106,25466509
49786,aflibercept,gene,0.989,25466509
49787,FOLFIRI,drug,0.7837,25466509
49788,patients,species,0.9087,25466509
49789,mCRC,disease,0.9937,25466509
49790,aflibercept,gene,0.94,25466509
49791,aflibercept,gene,0.9795,25461263
49792,neovascular age,disease,0.988,25461263
49793,aflibercept,gene,0.956,25461263
49794,patients,species,0.9624,25461263
49795,neovascular age-related macular degeneration,disease,1.0,25461263
49796,AMD,disease,1.0,25461263
49797,patients,species,0.981,25461263
49798,ranibizumab,gene,0.6846,25461263
49799,bevacizumab,gene,0.6255,25461263
49800,Q8W aflibercept,gene,0.9253,25461263
49801,patients,species,0.982,25461263
49802,anti-VEGF,gene,0.9688,25461263
49803,aflibercept,gene,0.9814,25461263
49804,ETDRS,DNA,0.513,25461263
49805,ETDRS,DNA,0.499,25461263
49806,AMD,disease,0.9995,25461263
49807,ranibizumab,gene,0.89,25461263
49808,bevacizumab,gene,0.8403,25461263
49809,aflibercept,gene,0.982,25461263
49810,aflibercept,gene,0.9517,25461263
49811,aflibercept,gene,0.9463,25461263
49812,patients,species,0.9897,25461263
49813,ranibizumab,gene,0.91,25461263
49814,bevacizumab,gene,0.874,25461263
49815,advanced colorectal cancer,disease,0.987,25458604
49816,Colorectal cancer,disease,1.0,25458604
49817,CRC,disease,1.0,25458604
49818,cancer,disease,1.0,25458604
49819,advanced CRC,disease,0.9995,25458604
49820,aCRC,disease,0.999,25458604
49821,aCRC,disease,0.996,25458604
49822,VEGF,gene,0.9966,25458604
49823,bevacizumab,gene,0.638,25458604
49824,aflibercept,gene,0.976,25458604
49825,VEGFR,gene,0.898,25458604
49826,regorafenib,drug,0.9766,25458604
49827,EGFR,gene,0.9873,25458604
49828,cetuximab,gene,0.612,25458604
49829,panitumumab,gene,0.6133,25458604
49830,patients,species,0.973,25458604
49831,aCRC,disease,0.991,25458604
49832,CNV,disease,0.995,25449645
49833,patients,species,0.9785,25449645
49834,ranibizumab,gene,0.6504,25449645
49835,choroidal neovascular membrane,disease,1.0,25449645
49836,CNV,disease,1.0,25449645
49837,patients,species,0.9756,25449645
49838,CNV,disease,1.0,25449645
49839,Patients,species,0.9727,25449645
49840,patients,species,0.9834,25449645
49841,patients,species,0.9937,25449645
49842,OCT,drug,0.5903,25449645
49843,patients,species,0.9897,25449645
49844,aflibercept,gene,0.965,25449645
49845,vascular endothelial growth factor,gene,0.997,25449645
49846,insulin,gene,0.9746,25444681
49847,diabetic macular edema,disease,1.0,25444681
49848,type 2 diabetes,disease,1.0,25444681
49849,insulin,gene,0.872,25444681
49850,diabetic macular edema,disease,1.0,25444681
49851,DME,disease,1.0,25444681
49852,vascular endothelial growth factor,gene,0.9985,25444681
49853,VEGF,gene,0.9976,25444681
49854,people,species,0.9614,25444681
49855,type 2 diabetes,disease,1.0,25444681
49856,patients,species,0.972,25444681
49857,type 2 diabetes,disease,1.0,25444681
49858,DME,disease,1.0,25444681
49859,VEGF,gene,0.937,25444681
49860,patients,species,0.992,25444681
49861,patients,species,0.987,25444681
49862,insulin,gene,0.9565,25444681
49863,glycated hemoglobin,gene,0.7505,25444681
49864,A1C,gene,0.9165,25444681
49865,A1,mutation,,25444681
49866,creatinine,drug,0.9976,25444681
49867,insulin,gene,0.975,25444681
49868,insulin,gene,0.993,25444681
49869,A1C,gene,0.8633,25444681
49870,A1,mutation,,25444681
49871,VEGF,gene,0.9863,25444681
49872,DME,disease,1.0,25444681
49873,insulin,gene,0.985,25444681
49874,DME,disease,0.973,25444681
49875,aflibercept,gene,0.9927,25439429
49876,aflibercept,gene,0.9927,25439429
49877,macular degeneration,disease,1.0,25439429
49878,AMD,disease,1.0,25439429
49879,VEGF,gene,0.994,25439429
49880,Wet AMD,disease,0.9194,25439429
49881,PARTICIPANTS,species,0.8247,25439429
49882,Patients,species,0.981,25439429
49883,exudative AMD,disease,0.8184,25439429
49884,patients,species,0.964,25439429
49885,aflibercept,gene,0.9834,25439429
49886,Patients,species,0.9175,25439429
49887,aflibercept,gene,0.9595,25439429
49888,aflibercept,gene,0.961,25439429
49889,aflibercept,gene,0.961,25439429
49890,ranibizumab,gene,0.7856,25439429
49891,Patients,species,0.9146,25439429
49892,aflibercept,gene,0.958,25439429
49893,36,DNA,,25439429
49894,52,DNA,,25439429
49895,NEI,DNA,0.5527,25439429
49896,aflibercept,gene,0.9883,25439429
49897,NEI,DNA,0.585,25439429
49898,NEI VFQ,DNA,0.556,25439429
49899,ranibizumab,drug,0.529,25439429
49900,aflibercept,gene,0.9556,25439429
49901,NEI,DNA,0.545,25439429
49902,patients,species,0.9775,25439429
49903,Diabetic Retinopathy,disease,1.0,25439429
49904,aflibercept,gene,0.9893,25439429
49905,NEI,DNA,0.4824,25439429
49906,aflibercept,gene,0.9863,25439429
49907,ziv-aflibercept,gene,0.978,25423640
49908,ziv-aflibercept,gene,0.9917,25423640
49909,rabbits,species,0.94,25423640
49910,rabbits,species,0.946,25423640
49911,ziv-aflibercept,gene,0.971,25423640
49912,aflibercept,gene,0.993,25423640
49913,ziv-aflibercept,gene,0.9688,25423640
49914,human retinal cultured cells,cell_line,0.8984,25423640
49915,human,species,0.9946,25423640
49916,ARPE-19,cell_line,0.8525,25423640
49917,MTT,drug,0.999,25423640
49918,ARPE-19 cells,cell_line,0.882,25423640
49919,ziv-aflibercept,gene,0.9644,25423640
49920,ziv-aflibercept,gene,0.9917,25423640
49921,rabbit,species,0.9893,25423640
49922,aflibercept,gene,0.987,25423632
49923,bevacizumab,gene,0.6704,25423632
49924,aflibercept,gene,0.9854,25423632
49925,AMD,disease,1.0,25423632
49926,bevacizumab,gene,0.753,25423632
49927,ranibizumab,gene,0.598,25423632
49928,PATIENTS,species,0.941,25423632
49929,patients,species,0.966,25423632
49930,neovascular AMD,disease,1.0,25423632
49931,aflibercept,gene,0.859,25423632
49932,bevacizumab,gene,0.8516,25423632
49933,ranibizumab,gene,0.694,25423632
49934,patients,species,0.99,25423632
49935,anti-VEGF,gene,0.959,25423632
49936,retinal pigment epithelial detachments,disease,0.941,25423632
49937,PEDs,disease,1.0,25423632
49938,PED,DNA,0.523,25423632
49939,PED,disease,0.816,25423632
49940,aflibercept,gene,0.9746,25423632
49941,uterine,cell_type,0.4478,25418060
49942,uterine leiomyosarcomas,disease,1.0,25418060
49943,uterine leiomyosarcoma,disease,1.0,25418060
49944,LMS,disease,1.0,25418060
49945,uterine LMS,disease,0.9883,25418060
49946,Doxorubicin,drug,1.0,25418060
49947,DOX,drug,1.0,25418060
49948,ifosfamide,drug,0.9985,25418060
49949,dacarbazine,drug,0.9995,25418060
49950,malignancy,disease,0.997,25418060
49951,gemcitabine,drug,0.9995,25418060
49952,docetaxel,drug,0.9995,25418060
49953,trabectedin,drug,0.9995,25418060
49954,pazopanib,drug,0.9995,25418060
49955,aromatase,gene,0.9766,25418060
49956,eribulin,gene,0.8184,25418060
49957,bevacizumab,gene,0.8022,25418060
49958,aflibercept,gene,0.9907,25418060
49959,mammalian target,DNA,0.7095,25418060
49960,rapamycin,drug,0.999,25418060
49961,DOX,drug,0.9995,25418060
49962,gemcitabine,drug,0.9995,25418060
49963,DOX,drug,0.9995,25418060
49964,dacarbazine,drug,0.9995,25418060
49965,gemcitabine,drug,0.9995,25418060
49966,docetaxel,drug,0.998,25418060
49967,Trabectedin,drug,0.997,25418060
49968,LMS,disease,0.9785,25418060
49969,Pazopanib,drug,0.998,25418060
49970,aromatase,gene,0.967,25418060
49971,patients,species,0.95,25418060
49972,steroid,drug,0.956,25418060
49973,steroid receptor,gene,0.9453,25418060
49974,tumors,disease,0.885,25418060
49975,women,species,0.829,25418060
49976,uterine LMS,disease,0.883,25418060
49977,aflibercept,gene,0.9863,25415380
49978,ranibizumab,gene,0.74,25415380
49979,endothelial cells,cell_type,0.923,25415380
49980,VEGF,gene,0.9956,25415380
49981,VEGF,gene,0.9946,25415380
49982,glomerular podocytes,cell_type,0.9023,25415380
49983,aflibercept,gene,0.9927,25415380
49984,ranibizumab,gene,0.8467,25415380
49985,cynomolgus monkeys,species,0.8716,25415380
49986,aflibercept,gene,0.9863,25415380
49987,ranibizumab,gene,0.646,25415380
49988,aflibercept,gene,0.9946,25415380
49989,VEGF,gene,0.9956,25415380
49990,anti-Fc- or anti-F(ab)-fragment,gene,0.9517,25415380
49991,anti-VEGF antibodies,gene,0.9937,25415380
49992,Glomerular endothelial cell,cell_type,0.8955,25415380
49993,anti-VEGF,gene,0.9917,25415380
49994,ranibizumab,gene,0.631,25415380
49995,aflibercept,gene,0.858,25415380
49996,monkeys,species,0.4978,25415380
49997,aflibercept,gene,0.9917,25415380
49998,ranibizumab,drug,0.609,25415380
49999,aflibercept,gene,0.9463,25415380
50000,ranibizumab,drug,0.5835,25415380
50001,glomerular endothelial cells,cell_type,0.8984,25415380
50002,aflibercept,gene,0.99,25415380
50003,capillaries,cell_type,0.556,25415380
50004,aflibercept,gene,0.9746,25415380
50005,VEGF,gene,0.9937,25415380
50006,podocytes,cell_type,0.882,25415380
50007,Ranibizumab,gene,0.797,25415380
50008,s VEGF,gene,0.9844,25415380
50009,aflibercept&#,gene,0.988,25415380
50010,VEGF,gene,0.995,25415380
50011,ranibizumab,gene,0.6245,25415380
50012,aflibercept,gene,0.9873,25395483
50013,neovascular age-related macular,disease,0.9956,25395483
50014,aflibercept,gene,0.9863,25395483
50015,neovascular age-related macular degeneration,disease,1.0,25395483
50016,AMD,disease,0.9995,25395483
50017,choroidal vascular hyperpermeability,disease,1.0,25395483
50018,CVH,disease,1.0,25395483
50019,patients,species,0.9756,25395483
50020,exudative AMD,disease,0.996,25395483
50021,aflibercept,gene,0.9478,25395483
50022,CVH,disease,1.0,25395483
50023,pigment epithelial detachment,disease,1.0,25395483
50024,PED,disease,0.9966,25395483
50025,aflibercept,gene,0.979,25395483
50026,dry macula,disease,0.9995,25395483
50027,ranibizumab,gene,0.8906,25395483
50028,CVH,disease,1.0,25395483
50029,CVH,disease,1.0,25395483
50030,aflibercept,gene,0.978,25395483
50031,CVH,disease,0.9956,25395483
50032,aflibercept,gene,0.9565,25395483
50033,CVH,disease,1.0,25395483
50034,dry macula,disease,0.992,25395483
50035,ranibizumab,gene,0.6523,25395483
50036,CVH,disease,0.9995,25395483
50037,aflibercept,gene,0.981,25395483
50038,AMD,disease,1.0,25395483
50039,CVH,disease,1.0,25395483
50040,PED,disease,0.999,25395483
50041,ranibizumab,gene,0.8755,25395483
50042,CVH,disease,0.9165,25395483
50043,intraocular inflammation,disease,0.9995,25394166
50044,aflibercept,gene,0.985,25394166
50045,intraocular inflammation,disease,0.9995,25394166
50046,aflibercept,gene,0.982,25394166
50047,patients,species,0.9893,25394166
50048,aflibercept,gene,0.9727,25394166
50049,intraocular inflammation,disease,1.0,25394166
50050,aflibercept,gene,0.9785,25394166
50051,patients,species,0.9766,25394166
50052,aflibercept,gene,0.973,25394166
50053,Dll4,gene,0.99,25393540
50054,tumor,disease,0.841,25393540
50055,VEGF,gene,0.9927,25393540
50056,renal cell BACKGROUND,cell_line,0.509,25393540
50057,renal cell,cell_type,0.518,25393540
50058,renal,disease,0.828,25393540
50059,Notch ligand,gene,0.924,25393540
50060,Delta-like 4,gene,0.8438,25393540
50061,Dll4,gene,0.9976,25393540
50062,tumor,disease,1.0,25393540
50063,Dll4,gene,0.9985,25393540
50064,Notch,gene,0.9893,25393540
50065,cancer,disease,1.0,25393540
50066,tumor,disease,0.9995,25393540
50067,vascular endothelial growth factor,gene,0.9985,25393540
50068,VEGF,gene,0.998,25393540
50069,Delta,gene,0.963,25393540
50070,Notch,gene,0.991,25393540
50071,tumor,disease,0.999,25393540
50072,Dll4,gene,0.9863,25393540
50073,REGN1035,drug,0.874,25393540
50074,VEGF,gene,0.9834,25393540
50075,renal cell carcinoma,disease,1.0,25393540
50076,RCC,disease,1.0,25393540
50077,mice,species,0.8276,25393540
50078,patient-,cell_line,0.5576,25393540
50079,patient,species,0.9307,25393540
50080,clear cell,cell_type,0.4668,25393540
50081,RCC,disease,0.989,25393540
50082,REGN1035,drug,0.997,25393540
50083,tyrosine,drug,0.7827,25393540
50084,tyrosine kinase,gene,0.9683,25393540
50085,sunitinib,drug,0.997,25393540
50086,VEGF,gene,0.9966,25393540
50087,ziv-aflibercept,gene,0.9785,25393540
50088,REGN1035,drug,0.9937,25393540
50089,tumor,disease,0.9517,25393540
50090,anti-,disease,0.885,25393540
50091,tumor,disease,0.5664,25393540
50092,VEGF,gene,0.9907,25393540
50093,sunitinib,drug,0.9897,25393540
50094,ziv-aflibercept,gene,0.9805,25393540
50095,REGN1035,drug,0.9985,25393540
50096,VEGF,gene,0.9907,25393540
50097,tumor,disease,0.761,25393540
50098,tumor,disease,0.9966,25393540
50099,tumor,disease,0.934,25393540
50100,REGN1035,drug,0.999,25393540
50101,ziv-aflibercept,gene,0.98,25393540
50102,sunitinib,drug,0.9995,25393540
50103,ccRCC,disease,0.9995,25393540
50104,tumor,disease,0.7153,25393540
50105,Dll4,gene,0.9956,25393540
50106,RCC,disease,1.0,25393540
50107,patient,species,0.9844,25393540
50108,tumors,disease,0.999,25393540
50109,Dll4,gene,0.9985,25393540
50110,VEGF,gene,0.995,25393540
50111,RCC,cell_type,0.4758,25393540
50112,RCC,disease,0.9995,25393540
50113,VEGF,gene,0.991,25393440
50114,aflibercept,gene,0.9697,25393440
50115,Patients,species,0.953,25393440
50116,retinal diseases,disease,1.0,25393440
50117,vascular endothelial growth factor,gene,0.9976,25393440
50118,VEGF,gene,0.7983,25393440
50119,Aflibercept,gene,0.9824,25393440
50120,Eylea,gene,0.7515,25393440
50121,VEGF-binding protein,gene,0.995,25393440
50122,bevacizumab,gene,0.7603,25393440
50123,Avastin,gene,0.8105,25393440
50124,ranibizumab,gene,0.8926,25393440
50125,Aflibercept,gene,0.984,25393440
50126,VEGF,gene,0.9966,25393440
50127,placenta growth factor,gene,0.9976,25393440
50128,PlGF,gene,0.9917,25393440
50129,retinal,cell_type,0.5396,25393440
50130,endothelial cells,cell_type,0.9277,25393440
50131,Aflibercept,gene,0.9717,25393440
50132,VEGF,gene,0.9976,25393440
50133,PlGF,gene,0.9937,25393440
50134,aflibercept,gene,0.9873,25393440
50135,VEGF-binding proteins,gene,0.998,25393440
50136,VEGF,gene,0.994,25393440
50137,aflibercept,gene,0.9893,25393440
50138,VEGF,gene,0.9946,25393440
50139,retinal cells,cell_type,0.8145,25393440
50140,aflibercept,gene,0.9907,25393440
50141,endothelial cells,cell_type,0.94,25393440
50142,pigment epithelial cells,cell_line,0.854,25393440
50143,pigment epithelial cells,cell_type,0.9053,25393440
50144,Fc,gene,,25393440
50145,aflibercept,gene,0.989,25393440
50146,bevacizumab,gene,0.9185,25393440
50147,ranibizumab,gene,0.6406,25393440
50148,ocular cells,cell_type,0.8013,25393440
50149,patients,species,0.994,25393440
50150,VEGF-binding proteins,gene,0.9966,25393440
50151,aflibercept,gene,0.9897,25391986
50152,ranibizumab,drug,0.9287,25391986
50153,neovascular age-related macular,disease,0.986,25391986
50154,patients,species,0.9707,25391986
50155,neovascular age-related macular degeneration,disease,1.0,25391986
50156,AMD,disease,1.0,25391986
50157,polypoidal choroidal vasculopathy,disease,1.0,25391986
50158,PCV,disease,1.0,25391986
50159,patients,species,0.9814,25391986
50160,AMD,disease,1.0,25391986
50161,PCV,disease,1.0,25391986
50162,ranibizumab,gene,0.8394,25391986
50163,aflibercept,gene,0.904,25391986
50164,AMD,drug,0.9985,25391986
50165,PCV,drug,0.9995,25391986
50166,patient,species,0.961,25391986
50167,ARMS2,gene,0.9956,25391986
50168,A69S,DNA,0.4873,25391986
50169,A69,mutation,,25391986
50170,CFH,DNA,0.6934,25391986
50171,CFH Y402H,gene,0.864,25391986
50172,Y402H,DNA,0.4648,25391986
50173,Y402,mutation,,25391986
50174,I62V alleles,DNA,0.642,25391986
50175,I62,mutation,,25391986
50176,participants,species,0.9814,25391986
50177,patients,species,0.9907,25391986
50178,AMD,disease,1.0,25391986
50179,patients,species,0.9917,25391986
50180,PCV,disease,1.0,25391986
50181,PCV,disease,1.0,25391986
50182,patients,species,0.99,25391986
50183,AMD,disease,0.9995,25391986
50184,patients,species,0.9766,25391986
50185,CRT,DNA,0.5747,25391986
50186,dry retina,disease,0.998,25391986
50187,PCV,disease,1.0,25391986
50188,patients,species,0.9937,25391986
50189,patients,species,0.9863,25391986
50190,risk,DNA,0.4958,25391986
50191,non,DNA,0.504,25391986
50192,risk alleles,DNA,0.4993,25391986
50193,ARMS2,gene,0.994,25391986
50194,A69S,DNA,0.431,25391986
50195,A69,mutation,,25391986
50196,CFH,gene,0.994,25391986
50197,Y402H,DNA,0.486,25391986
50198,Y402,mutation,,25391986
50199,I62,mutation,,25391986
50200,AMD,disease,0.9995,25391986
50201,PCV,disease,1.0,25391986
50202,patients,species,0.983,25391986
50203,ranibizumab,gene,0.901,25391986
50204,aflibercept,gene,0.9844,25391986
50205,patient,species,0.9595,25391986
50206,PCV,disease,1.0,25391986
50207,patients,species,0.992,25391986
50208,AMD,disease,1.0,25391986
50209,patients,species,0.995,25391986
50210,Geographic atrophy,disease,1.0,25387047
50211,patients,species,0.986,25387047
50212,anti-vascular endothelial growth factor,gene,0.836,25387047
50213,geographic atrophy,disease,1.0,25387047
50214,GA,disease,1.0,25387047
50215,neovascular age-related macular degeneration,disease,1.0,25387047
50216,vascular endothelial growth factor,gene,0.875,25387047
50217,GA,disease,,25387047
50218,Neovascular lesion,disease,0.9985,25387047
50219,fluorescein,drug,0.997,25387047
50220,occult choroidal neovascularization,disease,0.797,25387047
50221,classic choroidal neovascularization,disease,0.993,25387047
50222,retinal angiomatous proliferation,disease,1.0,25387047
50223,patients,species,0.98,25387047
50224,GA,disease,,25387047
50225,neovascular age-related macular degeneration,disease,0.9897,25387047
50226,neovascular lesion,disease,0.9995,25387047
50227,neovascular age-related macular degeneration,disease,1.0,25387047
50228,GA,disease,,25387047
50229,GA,disease,,25387047
50230,neovascular age-related macular degeneration,disease,1.0,25378900
50231,anti-,gene,0.6367,25378900
50232,vascular endothelial growth factor,gene,0.8975,25378900
50233,VEGF,gene,0.998,25378900
50234,Aflibercept,gene,0.9834,25378900
50235,bevacizumab,gene,0.8438,25378900
50236,ranibizumab,gene,0.665,25378900
50237,choroidal neovascularization,disease,1.0,25378900
50238,neovascular age,disease,0.8174,25378900
50239,macular degeneration,disease,0.99,25378900
50240,aflibercept,gene,0.991,25378900
50241,bevacizumab,gene,0.8755,25378900
50242,aflibercept,gene,0.9946,25378900
50243,vitrectomized,disease,0.952,25378900
50244,VEGF,gene,0.953,25378900
50245,Vascular endothelial growth factor,gene,0.9976,25378873
50246,Aflibercept,gene,0.9893,25378873
50247,Anti-vascular endothelial growth factor,gene,0.997,25378873
50248,VEGF,gene,0.997,25378873
50249,eye diseases,disease,0.988,25378873
50250,monoclonal antibodies,gene,0.653,25378873
50251,VEGF,gene,0.996,25378873
50252,retinal diseases,disease,0.9995,25378873
50253,human immunoglobulin G,gene,0.996,25378873
50254,human,species,0.993,25378873
50255,IgG,gene,0.9976,25378873
50256,Aflibercept,gene,0.9927,25378873
50257,VEGF trap-eye,gene,0.899,25378873
50258,VTE,gene,0.9897,25378873
50259,VEGF receptors 1 and 2,gene,0.7944,25378873
50260,Fc,gene,,25378873
50261,IgG,gene,0.8877,25378873
50262,human amino acid sequences,DNA,0.7056,25378873
50263,human,species,0.99,25378873
50264,amino acid,drug,0.996,25378873
50265,human,species,0.9937,25378873
50266,patients,species,0.9834,25378873
50267,VTE,disease,0.9814,25378873
50268,VTE,disease,0.9956,25378873
50269,VTE,disease,0.9976,25378873
50270,aflibercept,gene,0.9805,25368290
50271,FOLFIRI,drug,0.8843,25368290
50272,patients,species,0.9697,25368290
50273,metastatic colorectal cancer,disease,1.0,25368290
50274,mCRC,disease,1.0,25368290
50275,isolated liver metastasis,disease,0.9263,25368290
50276,tumor,disease,0.7295,25368290
50277,vascular endothelial growth factor,gene,0.9976,25368290
50278,VEGF,gene,0.9956,25368290
50279,bevacuzimab,gene,0.705,25368290
50280,mCRC,disease,0.9067,25368290
50281,patient,species,0.9614,25368290
50282,colorectal cancer,disease,0.95,25368290
50283,aflibercept,gene,0.9644,25368290
50284,VEGF,gene,0.996,25368290
50285,aflibercept,gene,0.9893,25368290
50286,stage IV,disease,0.999,25368290
50287,rectal cancer,disease,0.8257,25368290
50288,hepatic metastases,disease,0.806,25368290
50289,tumor,disease,0.8887,25368290
50290,hepatic lesions,DNA,0.4773,25368290
50291,hepatic,disease,0.6304,25368290
50292,5-fluorouracil,drug,0.9995,25368290
50293,5-FU,drug,0.9995,25368290
50294,oxaliplatin,drug,0.9995,25368290
50295,capecitabine,drug,0.9985,25368290
50296,liver lesions,disease,0.9136,25368290
50297,liver,disease,0.5996,25368290
50298,aflibercept,gene,0.9414,25368290
50299,FOLFIRI,drug,0.892,25368290
50300,patient,species,0.9746,25368290
50301,aflibercept,gene,0.985,25368290
50302,VEGF,gene,0.6294,25368290
50303,FOLFIRI,drug,0.98,25368290
50304,mCRC,disease,0.934,25368290
50305,proteinuria,disease,0.9995,25365378
50306,aflibercept,gene,0.986,25365378
50307,cancer,disease,1.0,25365378
50308,patients,species,0.993,25365378
50309,Aflibercept,gene,0.9775,25365378
50310,human,species,0.8613,25365378
50311,vascular endothelial growth factor A,gene,0.998,25365378
50312,Proteinuria,disease,1.0,25365378
50313,proteinuria,disease,1.0,25365378
50314,proteinuria,disease,1.0,25365378
50315,cancer,disease,1.0,25365378
50316,patients,species,0.9927,25365378
50317,aflibercept,gene,0.9736,25365378
50318,cancer,disease,1.0,25365378
50319,patients,species,0.9927,25365378
50320,aflibercept,gene,0.97,25365378
50321,proteinuria,disease,1.0,25365378
50322,patients,species,0.9873,25365378
50323,solid tumors,disease,1.0,25365378
50324,proteinuria,disease,0.998,25365378
50325,cancer,disease,1.0,25365378
50326,patients,species,0.99,25365378
50327,proteinuria,disease,1.0,25365378
50328,aflibercept,gene,0.9497,25365378
50329,proteinuria,disease,1.0,25365378
50330,proteinuria,disease,0.9995,25365378
50331,aflibercept,gene,0.9897,25365378
50332,bevacizumab,gene,0.729,25365378
50333,Aflibercept,gene,0.9604,25365378
50334,proteinuria,disease,1.0,25365378
50335,aflibercept,gene,0.9775,25365378
50336,cancer,disease,1.0,25365378
50337,patients,species,0.9956,25365378
50338,Aflibercept,gene,0.9404,27202185
50339,Metastatic Colorectal Cancer,disease,1.0,27202185
50340,MCRC,disease,1.0,27202185
50341,Ranibizumab,gene,0.922,27202123
50342,Aflibercept,gene,0.9766,27202123
50343,Visual Impairment,disease,1.0,27202123
50344,Diabetic Macular Oedema,disease,1.0,27202123
50345,Dmo,disease,1.0,27202123
50346,Aflibercept,gene,0.9307,27202114
50347,Macular Oedema,disease,1.0,27202114
50348,Central Retinal Vein Occlusion,disease,1.0,27202114
50349,Ranibizumab,gene,0.7856,27202113
50350,Visual Impairment,disease,1.0,27202113
50351,Myopic Choroidal Neovascularization,disease,1.0,27202113
50352,Aflibercept,gene,0.986,27202113
50353,Macular oedema,disease,1.0,25349755
50354,idiopathic macular telangiectasia type 1,disease,1.0,25349755
50355,aflibercept,gene,0.928,25349755
50356,patient,species,0.927,25349755
50357,macular oedema,disease,1.0,25349755
50358,type 1 macular telangiectasia,disease,1.0,25349755
50359,aflibercept,gene,0.9604,25349755
50360,man,species,0.89,25349755
50361,type,disease,0.7734,25349755
50362,idiopathic macular telangiectasia,disease,0.8784,25349755
50363,IMT,disease,1.0,25349755
50364,macular oedema,disease,1.0,25349755
50365,bevacizumab,gene,0.6836,25349755
50366,argon,drug,0.5884,25349755
50367,patient,species,0.966,25349755
50368,aflibercept,gene,0.9814,25349755
50369,macular oedema,disease,1.0,25349755
50370,aflibercept,gene,0.992,25349755
50371,macular oedema,disease,1.0,25349755
50372,type 1 IMT,disease,1.0,25349755
50373,vascular endothelial growth factor,gene,0.996,25342124
50374,diabetic macular oedema,disease,1.0,25342124
50375,Diabetic macular oedema,disease,1.0,25342124
50376,DMO,disease,1.0,25342124
50377,diabetic retinopathy,disease,1.0,25342124
50378,DMO,disease,1.0,25342124
50379,macular oedema,disease,0.999,25342124
50380,CSMO,disease,0.9917,25342124
50381,vascular endothelial growth factor,gene,0.891,25342124
50382,VEGF,gene,0.6694,25342124
50383,people,species,0.946,25342124
50384,DMO,disease,1.0,25342124
50385,VEGF,gene,0.937,25342124
50386,DMO,disease,1.0,25342124
50387,VEGF,gene,0.969,25342124
50388,people,species,0.9897,25342124
50389,DMO,disease,1.0,25342124
50390,Participants,species,0.9565,25342124
50391,DMO,disease,1.0,25342124
50392,vision loss,disease,0.9995,25342124
50393,people,species,0.9873,25342124
50394,bevacizumab,gene,0.875,25342124
50395,ranibizumab,gene,0.7305,25342124
50396,aflibercept,gene,0.937,25342124
50397,participants,species,0.9497,25342124
50398,DMO,disease,1.0,25342124
50399,participants,species,0.956,25342124
50400,people,species,0.992,25342124
50401,People,species,0.8945,25342124
50402,participants,species,0.978,25342124
50403,participants,species,0.921,25342124
50404,endophthalmitis,disease,1.0,25342124
50405,participants,species,0.9614,25342124
50406,arterial thromboembolic events,disease,0.9985,25342124
50407,participants,species,0.9805,25342124
50408,participants,species,0.985,25342124
50409,participants,species,0.9717,25342124
50410,cardiovascular,disease,0.9385,25342124
50411,DMO,disease,1.0,25342124
50412,colorectal cancer,disease,1.0,25341011
50413,Metastatic colorectal cancer,disease,1.0,25341011
50414,FOLFOXIRI,drug,0.7637,25341011
50415,patient,species,0.993,25341011
50416,tumor,disease,1.0,25341011
50417,metastatic colorectal cancer,disease,1.0,25341011
50418,KRAS,gene,0.9775,25341011
50419,NRAS,DNA,0.8086,25341011
50420,NRAS,gene,0.9766,25341011
50421,BRAF,gene,0.9927,25341011
50422,PIK3CA,DNA,0.6567,25341011
50423,PIK3CA,gene,0.9956,25341011
50424,tumor,disease,1.0,25341011
50425,Cancer,disease,0.9946,25341011
50426,metastatic colorectal cancer,disease,0.867,25341011
50427,anti-programmed cell death receptor antibody,gene,0.939,25341011
50428,cancer,disease,0.997,25341011
50429,BRAF,gene,0.971,25341011
50430,PI3K,gene,0.986,25341011
50431,RAS,gene,0.9014,25341011
50432,aflibercept,gene,0.9917,25338279
50433,retinal angiomatous proliferation,disease,1.0,25338279
50434,metastatic colorectal cancer,disease,0.996,25326159
50435,metastatic colorectal cancer,disease,1.0,25326159
50436,mCRC,disease,1.0,25326159
50437,vascular endothelial growth factor,gene,0.9966,25326159
50438,VEGF,gene,0.995,25326159
50439,epidermal growth factor receptor,gene,0.998,25326159
50440,EGFR,gene,0.994,25326159
50441,aflibercept,gene,0.98,25326159
50442,regorafenib,drug,0.9683,25326159
50443,mCRC,disease,0.9404,25326159
50444,bevacizumab,gene,0.866,25326159
50445,fluoropyrimidine,drug,0.991,25326159
50446,VEGF,gene,0.9937,25326159
50447,aflibercept,gene,0.969,25326159
50448,regorafenib,drug,0.9487,25326159
50449,Cetuximab,gene,0.893,25326159
50450,fluoropyrimidine,drug,0.9985,25326159
50451,leucovorin,drug,0.999,25326159
50452,irinotecan,drug,0.9985,25326159
50453,FOLFIRI,drug,0.8955,25326159
50454,panitumumab,gene,0.8564,25326159
50455,oxaliplatin,drug,1.0,25326159
50456,fluoropyrimidine,drug,0.997,25326159
50457,anti-,gene,0.6294,25326159
50458,EGFR antibodies,gene,0.879,25326159
50459,tumors,disease,1.0,25326159
50460,Kirsten rat sarcoma,disease,1.0,25326159
50461,neuroblastoma,disease,0.505,25326159
50462,RAS,gene,0.4604,25326159
50463,anti-VEGF,gene,0.984,25326159
50464,anti- EGFR,gene,0.779,25326159
50465,diabetes,disease,1.0,25325853
50466,retinal disorders,disease,1.0,25325853
50467,intraocular infection,disease,1.0,25325853
50468,vascular endothelial growth factor,gene,0.9243,25325853
50469,diabetic macular edema,disease,1.0,25325853
50470,diabetic vascular pathology,disease,1.0,25325853
50471,Diabetic,disease,1.0,25325853
50472,diabetic,disease,0.9995,25325853
50473,cardiovascular and renal disease,disease,1.0,25325853
50474,fibrovascular proliferation,disease,0.9966,25325853
50475,endophthalmitis,disease,1.0,25325853
50476,diabetes,disease,1.0,25325853
50477,diabetic,disease,1.0,25325853
50478,diabetic,disease,0.9995,25325853
50479,diabetes,disease,1.0,25325853
50480,endophthalmitis,disease,1.0,25325851
50481,vascular endothelial growth factor,gene,0.9897,25325851
50482,vascular endothelial growth factor,gene,0.998,25325851
50483,VEGF,gene,0.9937,25325851
50484,age-related macular degeneration,disease,1.0,25325851
50485,AMD,disease,1.0,25325851
50486,retinal diseases,disease,1.0,25325851
50487,post-injection endophthalmitis,disease,0.8906,25325851
50488,vision loss,disease,0.987,25325851
50489,endophthalmitis,disease,1.0,25325851
50490,VEGF,gene,0.68,25325851
50491,Aflibercept,gene,0.962,25325116
50492,Metastatic colorectal cancer,disease,0.999,25325116
50493,bevacizumab,gene,0.8296,25325116
50494,metastatic colorectal cancer,disease,1.0,25325116
50495,bevacizumab,gene,0.729,25325116
50496,VEGF,gene,0.997,25325116
50497,Aflibercept,gene,0.9756,25325116
50498,Zaltrap,gene,0.7324,25325116
50499,VEGF,gene,0.997,25325116
50500,colorectal cancer,disease,1.0,25325116
50501,oxaliplatin,drug,0.999,25325116
50502,Folfox,drug,0.8486,25325116
50503,Aflibercept,gene,0.985,25325116
50504,bevacizumab,gene,0.577,25325116
50505,aflibercept,gene,0.973,25325116
50506,aflibercept,gene,0.9756,25325116
50507,Aflibercept,gene,0.967,25325116
50508,VEGF,gene,0.996,25325116
50509,arterial hypertension,disease,1.0,25325116
50510,arterial thrombosis,disease,1.0,25325116
50511,pulmonary embolism,disease,1.0,25325116
50512,bleeding,disease,0.8706,25325116
50513,fistulae,disease,0.9995,25325116
50514,bowel perforation,disease,0.9985,25325116
50515,leukoencephalopathy,disease,1.0,25325116
50516,wound,disease,0.6826,25325116
50517,aflibercept,gene,0.988,25325116
50518,diarrhoea,disease,1.0,25325116
50519,dehydration,disease,1.0,25325116
50520,mucositis,disease,1.0,25325116
50521,palmoplantar erythrodysesthesia,disease,1.0,25325116
50522,aflibercept,gene,0.961,25325116
50523,metastatic colorectal cancer,disease,1.0,25325116
50524,aflibercept,gene,0.9917,25325116
50525,bevacizumab,gene,0.8267,25325116
50526,Ocular Hypertension,disease,1.0,25318578
50527,Antivascular Endothelial Growth Factor,gene,0.907,25318578
50528,Nitric Oxide,drug,0.999,25318578
50529,ocular hypertension,disease,0.9995,25318578
50530,ocular hypertension,disease,1.0,25318578
50531,glaucoma,disease,1.0,25318578
50532,ocular hypertension,disease,1.0,25318578
50533,pegaptanib,drug,0.9976,25318578
50534,bevacizumab,drug,0.5903,25318578
50535,ranibizumab,gene,0.7393,25318578
50536,aflibercept,gene,0.986,25318578
50537,anti-vascular endothelial growth factor,gene,0.9976,25318578
50538,ocular hypertension,disease,1.0,25318578
50539,Ocular hypertension,disease,1.0,25318578
50540,pegaptanib,drug,0.931,25318578
50541,bevacizumab,gene,0.614,25318578
50542,ranibizumab,gene,0.673,25318578
50543,aflibercept,gene,0.95,25318578
50544,vascular endothelial growth factor,gene,0.9985,25318578
50545,nitric oxide,drug,0.9966,25318578
50546,(NO,drug,0.881,25318578
50547,(NO) synthase,gene,0.9834,25318578
50548,NO,drug,0.9995,25318578
50549,glaucomatous,disease,0.999,25318578
50550,ocular hypertension,disease,0.9995,25318578
50551,NO,drug,0.9976,25318578
50552,ocular hypertension,disease,0.9995,25318578
50553,NO,drug,0.9995,25318578
50554,VEGF,gene,0.9736,25318182
50555,diabetic macular edema,disease,1.0,25318182
50556,aflibercept,gene,0.9844,25315663
50557,macular edema,disease,1.0,25315663
50558,branch retinal vein occlusion,disease,1.0,25315663
50559,aflibercept,gene,0.989,25315663
50560,macular edema,disease,1.0,25315663
50561,branch retinal vein occlusion,disease,0.9976,25315663
50562,PARTICIPANTS,species,0.7417,25315663
50563,macular edema,disease,1.0,25315663
50564,BRVO,disease,1.0,25315663
50565,Diabetic Retinopathy,disease,0.911,25315663
50566,IAI,disease,1.0,25315663
50567,intraocular inflammation,disease,1.0,25315663
50568,endophthalmitis,disease,1.0,25315663
50569,nonfatal stroke,disease,0.998,25315663
50570,pneumonia,disease,1.0,25315663
50571,macular edema,disease,1.0,25315663
50572,BRVO,disease,0.9995,25315663
50573,aflibercept,gene,0.989,25284099
50574,bevacizumab,gene,0.8804,25284099
50575,AMD,disease,1.0,25284099
50576,aflibercept,gene,0.9917,25284099
50577,bevacizumab,gene,0.8145,25284099
50578,PARTICIPANTS,species,0.652,25284099
50579,intraretinal or subretinal fluid,disease,0.999,25284099
50580,bevacizumab,gene,0.763,25284099
50581,aflibercept,gene,0.9863,25284099
50582,bevacizumab,gene,0.726,25284099
50583,photoreceptor,cell_type,0.6455,25284099
50584,aflibercept,gene,0.99,25284099
50585,aflibercept,gene,0.974,25284099
50586,Diabetic Retinopathy,disease,0.9883,25284099
50587,intraretinal and subretinal fluid,disease,0.9775,25284099
50588,bevacizumab,gene,0.946,25284099
50589,aflibercept,gene,0.988,25284099
50590,age-related macular degeneration,disease,1.0,25280900
50591,Age-related macular degeneration,disease,1.0,25280900
50592,AMD,disease,1.0,25280900
50593,multifactorial degeneration of photoreceptors and retinal pigment epithelium,disease,0.9985,25280900
50594,AMD,disease,1.0,25280900
50595,AMD,disease,0.9995,25280900
50596,aflibercept,gene,0.9937,25271911
50597,bevacizumab,gene,0.59,25271911
50598,ranibizumab,gene,0.541,25271911
50599,bevacizumab,gene,0.681,25271911
50600,aflibercept,gene,0.9863,25271911
50601,age-related macular degeneration,disease,1.0,25271911
50602,AMD,disease,1.0,25271911
50603,AMD,disease,1.0,25271911
50604,antivascular endothelial growth factor,gene,0.938,25271911
50605,anti-VEGF,gene,0.828,25271911
50606,vascular,disease,0.948,25271911
50607,stroke,disease,1.0,25271911
50608,myocardial infarction,disease,1.0,25271911
50609,transient ischaemic attack,disease,1.0,25271911
50610,thrombotic events,disease,0.9956,25271911
50611,patients,species,0.977,25271911
50612,anti-VEGF,gene,0.87,25271911
50613,ranibizumab,gene,0.64,25271911
50614,bevacizumab,gene,0.523,25271911
50615,aflibercept,gene,0.961,25271911
50616,aflibercept,gene,0.9214,25271911
50617,ranibizumab,gene,0.7324,25271911
50618,bevacizumab,gene,0.501,25271911
50619,aflibercept,gene,0.9204,25271911
50620,aflibercept,gene,0.917,25271911
50621,systemic thrombotic events,disease,0.717,25271911
50622,aflibercept,gene,0.9673,25271911
50623,ranibizumab,gene,0.6807,25271911
50624,Vascular endothelial growth factor,gene,0.995,25261788
50625,platelet-derived growth factor receptor ,gene,0.9985,25261788
50626,vitreoretinopathy,disease,0.7188,25261788
50627,Proliferative vitreoretinopathy,disease,1.0,25261788
50628,PVR,disease,1.0,25261788
50629,rhegmatogenous retinal detachments,disease,1.0,25261788
50630,PVR,disease,0.9985,25261788
50631,PVR,disease,0.995,25261788
50632,PVR,disease,1.0,25261788
50633,vascular endothelial growth factor (VEGF) A,gene,0.964,25261788
50634,PVR,disease,0.9424,25261788
50635,PVR,disease,0.9995,25261788
50636,VEGF,gene,0.994,25261788
50637,aflibercept,gene,0.994,25261788
50638,VEGF Trap-Eye,gene,0.828,25261788
50639,rabbits,species,0.956,25261788
50640,PVR,disease,1.0,25261788
50641,aflibercept,gene,0.981,25261788
50642,PVR,disease,1.0,25261788
50643,VEGF,gene,0.9956,25261788
50644,PVR,gene,0.9946,25261788
50645,VEGF receptors,gene,0.996,25261788
50646,retinal pigment epithelial cells,cell_type,0.911,25261788
50647,VEGF,gene,0.9883,25261788
50648,platelet-derived growth factor receptor ,gene,0.9976,25261788
50649,VEGF,gene,0.9966,25261788
50650,PVR,gene,0.8975,25261788
50651,platelet-derived growth factor receptor ,gene,0.998,25261788
50652,VEGF,gene,0.9946,25261788
50653,nonangiogenic diseases,disease,0.956,25261788
50654,VEGF,gene,0.977,25261788
50655,Vascular endothelial growth factor,gene,0.9976,25230786
50656,VEGF,gene,0.9966,25230786
50657,neuroendocrine neoplasms,disease,1.0,25230786
50658,Neuroendocrine neoplasms,disease,1.0,25230786
50659,NENs,disease,1.0,25230786
50660,epithelial tumors,disease,0.9985,25230786
50661,vascular endothelial growth factor,gene,0.9985,25230786
50662,VEGF,gene,0.9966,25230786
50663,VEGF,gene,0.9966,25230786
50664,NENs,disease,1.0,25230786
50665,VEGF,gene,0.9956,25230786
50666,NENs,cell_line,0.553,25230786
50667,NENs,cell_type,0.4434,25230786
50668,NENs,disease,1.0,25230786
50669,Bevacizumab,gene,0.949,25230786
50670,sorafenib,drug,0.999,25230786
50671,NENs,disease,1.0,25230786
50672,gastroenteropancreatic (GEP)-NENs,disease,0.998,25230786
50673,sunitinib,drug,0.9985,25230786
50674,sunitinib,drug,0.9976,25230786
50675,VEGF,gene,0.9976,25230786
50676,aflibercept,gene,0.9526,25230786
50677,VEGFR,gene,0.9595,25230786
50678,patients,species,0.977,25230786
50679,VEGF,gene,0.9946,25230786
50680,VEGF,gene,0.994,25230786
50681,NENs,disease,0.991,25230786
50682,VEGF,gene,0.996,25230786
50683,aflibercept,gene,0.92,25230402
50684,patients,species,0.965,25230402
50685,patients,species,0.9756,25230402
50686,aflibercept,gene,0.9023,25230402
50687,VEGF,gene,0.9956,25230402
50688,bevacizumab,gene,0.7275,25230402
50689,PATIENTS,species,0.954,25230402
50690,Aflibercept,gene,0.929,25230402
50691,patients,species,0.9863,25230402
50692,aflibercept,gene,0.9595,25230402
50693,ranibizumab,gene,0.6846,25230402
50694,bevacizumab,gene,0.5923,25230402
50695,aflibercept,gene,0.9927,25230402
50696,Aflibercept,gene,0.974,25230402
50697,patients,species,0.986,25230402
50698,MicroRNAs,RNA,0.6924,25206276
50699,colorectal cancer,disease,1.0,25206276
50700,Colorectal cancer,disease,1.0,25206276
50701,CRC,disease,1.0,25206276
50702,cancer,disease,1.0,25206276
50703,CRC,disease,0.9985,25206276
50704,cancer,disease,1.0,25206276
50705,5-fluorouracil,drug,0.999,25206276
50706,metastatic CRC,disease,0.9995,25206276
50707,mCRC,disease,0.9995,25206276
50708,oxaliplatin,drug,0.9995,25206276
50709,irinotecan,drug,0.999,25206276
50710,cetuximab,gene,0.79,25206276
50711,panitumumab,gene,0.9346,25206276
50712,bevacizumab,gene,0.8086,25206276
50713,bevacizumab,gene,0.629,25206276
50714,cetuximab,gene,0.9546,25206276
50715,panitumumab,gene,0.9663,25206276
50716,aflibercept,gene,0.9556,25206276
50717,regorafenib,drug,0.9907,25206276
50718,CRC,disease,0.998,25206276
50719,microRNAs,RNA,0.7227,25206276
50720,miRNAs,RNA,0.6455,25206276
50721,cancer,disease,1.0,25206276
50722,CRC,disease,0.997,25206276
50723,miRNAs,RNA,0.604,25206276
50724,CRCs,disease,0.5,25206276
50725,tumor,disease,1.0,25206276
50726,cancer,disease,0.986,25206276
50727,CRC,disease,0.999,25206276
50728,miRNAs,RNA,0.492,25206276
50729,CRC,disease,0.999,25206276
50730,macular edema,disease,1.0,25200895
50731,retinal vascular diseases,disease,1.0,25200895
50732,exudative age-related macular degeneration,disease,1.0,25195354
50733,Age-related macular degeneration,disease,1.0,25195354
50734,AMD,disease,1.0,25195354
50735,vision damage,disease,0.99,25195354
50736,AMD,disease,1.0,25195354
50737,vascular endothelial growth factor,gene,0.9976,25195354
50738,VEGF,gene,0.994,25195354
50739,exudative AMD,disease,0.999,25195354
50740,VEGF,gene,0.5615,25195354
50741,VEGF,gene,0.7827,25195354
50742,exudative AMD,disease,0.9966,25195354
50743,AMD,disease,0.9995,25195354
50744,CNV,disease,0.9995,25195354
50745,exudative AMD,disease,0.9287,25195354
50746,exudative AMD,disease,0.9937,25195354
50747,exudative AMD,disease,0.9937,25195354
50748,CNV,DNA,0.59,25195354
50749,age related macular degeneration,disease,1.0,25190312
50750,Age related macular degeneration,disease,1.0,25190312
50751,AMD,disease,1.0,25190312
50752,geographic atrophy of the retina,disease,1.0,25190312
50753,choroidal neovascularization,disease,1.0,25190312
50754,VEGF,gene,0.9956,25190312
50755,vascular endothelial growth factor,gene,0.998,25190312
50756,VEGF family,gene,0.9976,25190312
50757,"VEGF-A, B, C, D, F",gene,0.999,25190312
50758,PlGF,gene,0.985,25190312
50759,placental growth factor,gene,0.9966,25190312
50760,VEGFR1,gene,0.9937,25190312
50761,VEGFR2,gene,0.971,25190312
50762,VEGFR3 receptors,gene,0.9727,25190312
50763,endothelial cells,cell_type,0.947,25190312
50764,AMD,disease,0.678,25190312
50765,VEGF-A,gene,0.9985,25190312
50766,VEGF-R2,gene,0.9966,25190312
50767,VEGF,gene,0.8657,25190312
50768,ranibizumab,gene,0.793,25190312
50769,bevacizumab,gene,0.8022,25190312
50770,aflibercept,gene,0.9443,25190312
50771,geographic atrophy,disease,1.0,25190312
50772,vascular accidents,disease,1.0,25190312
50773,anti-VEGF,gene,0.9585,25190312
50774,vascular endothelial growth factor A,gene,0.998,25162961
50775,vascular endothelial growth factor A,gene,0.9985,25162961
50776,VEGF,gene,0.9946,25162961
50777,neovascular,disease,0.726,25162961
50778,age-related macular degeneration,disease,1.0,25162961
50779,Ranibizumab,gene,0.7783,25162961
50780,fragment,gene,0.7593,25162961
50781,Fc,gene,0.7603,25162961
50782,Aflibercept,gene,0.979,25162961
50783,bevacizumab,gene,0.734,25162961
50784,Fc,gene,0.967,25162961
50785,ranibizumab,gene,0.797,25162961
50786,aflibercept,gene,0.9795,25162961
50787,VEGF,gene,0.996,25162961
50788,bovine retinal microvascular endothelial cell,cell_line,0.7354,25162961
50789,bovine,species,0.9385,25162961
50790,BREC,cell_line,0.517,25162961
50791,aflibercept,gene,0.9907,25162961
50792,recombinant VEGF,gene,0.9976,25162961
50793,rhVEGF,gene,0.9956,25162961
50794,ranibizumab,gene,0.626,25162961
50795,VEGF,gene,0.9946,25162961
50796,aflibercept,gene,0.989,25162961
50797,aflibercept,gene,0.9946,25162961
50798,VEGF,gene,0.9976,25162961
50799,aflibercept,gene,0.9907,25162961
50800,ranibizumab,gene,0.72,25162961
50801,ranibizumab,gene,0.9287,25162961
50802,VEGF,gene,0.996,25162961
50803,Ranibizumab,gene,0.8794,25162961
50804,aflibercept,gene,0.9795,25162961
50805,bevacizumab,gene,0.817,25162961
50806,BREC,cell_type,0.8525,25162961
50807,VEGF,gene,0.993,25162961
50808,VEGF,gene,0.987,25162961
50809,aflibercept,gene,0.991,25162961
50810,VEGF,gene,0.997,25162961
50811,VEGF,gene,0.9863,25162961
50812,vascular endothelial growth factor,gene,0.947,25158942
50813,vascular endothelial growth factor,gene,0.902,25158942
50814,bevacizumab,gene,0.766,25158942
50815,aflibercept,gene,0.9683,25158942
50816,vascular endothelial growth factor,gene,0.994,25158942
50817,exudative age-related macular degeneration,disease,1.0,25158942
50818,diabetic macular edema,disease,1.0,25158942
50819,retinal vein occlusion,disease,0.9995,25158942
50820,bevacizumab,gene,0.7153,25158942
50821,aflibercept,gene,0.9893,25158942
50822,bevacizumab,gene,0.682,25158942
50823,aflibercept,gene,0.985,25158942
50824,ranibizumab,gene,0.9473,25158942
50825,bevacizumab,gene,0.825,25158942
50826,ranibizumab,gene,0.5693,25158942
50827,aflibercept,gene,0.99,25158942
50828,bevacizumab,gene,0.803,25158942
50829,bevacizumab,gene,0.8467,25158942
50830,ranibizumab,gene,0.5317,25158942
50831,aflibercept,gene,0.9897,25158942
50832,aflibercept,gene,0.99,25158942
50833,age-related macular degeneration,disease,1.0,25154202
50834,age-related macular degeneration,disease,0.9995,25154202
50835,AMD,disease,1.0,25154202
50836,vascular endothelial growth factor,gene,0.999,25154202
50837,VEGF,gene,0.9966,25154202
50838,ranibizumab,gene,0.8447,25154202
50839,aflibercept,gene,0.9023,25154202
50840,bevacizumab,gene,0.8228,25154202
50841,AMD,disease,1.0,25154202
50842,blindness,disease,0.7954,25154202
50843,VEGF,gene,0.7637,25154202
50844,bevacizumab,gene,0.876,25154202
50845,anti-VEGF,gene,0.972,25154202
50846,aflibercept,gene,0.99,25154202
50847,aflibercept,gene,0.983,25152076
50848,metastatic colorectal cancer,disease,0.9873,25152076
50849,Colorectal cancer,disease,1.0,25152076
50850,CRC,disease,1.0,25152076
50851,cancer,disease,1.0,25152076
50852,tumor,disease,0.9966,25152076
50853,colon cancer,disease,1.0,25152076
50854,fluoropyrimidine,drug,0.9966,25152076
50855,oxaliplatin,drug,0.9995,25152076
50856,irinotecan,drug,0.998,25152076
50857,anti-vascular endothelial growth factor (,gene,0.9766,25152076
50858,VEGF) monoclonal,gene,0.517,25152076
50859,Aflibercept,gene,0.966,25152076
50860,VEGF receptor-2,gene,0.998,25152076
50861,Fc,gene,0.746,25152076
50862,IgG1,gene,0.981,25152076
50863,aflibercept,gene,0.967,25152076
50864,Aflibercept,gene,0.934,25152076
50865,irinotecan,drug,0.9995,25152076
50866,metastatic CRC,disease,0.899,25152076
50867,oxaliplatin,drug,0.9995,25152076
50868,aflibercept,gene,0.9897,25152076
50869,aflibercept,gene,0.968,25152076
50870,aflibercept,gene,0.975,25152076
50871,VEGF,gene,0.9907,25151950
50872,ovarian hyperstimulation syndrome,disease,1.0,25151950
50873,human chorionic gonadotropin,gene,0.989,25151950
50874,ovarian hyperstimulation syndrome,disease,1.0,25151950
50875,OHSS,disease,1.0,25151950
50876,vascular endothelial growth factor A,gene,0.9976,25151950
50877,VEGF,gene,0.99,25151950
50878,VEGF,gene,0.991,25151950
50879,endothelial,DNA,0.455,25151950
50880,endothelial cell,cell_type,0.658,25151950
50881,VEGF receptors,gene,0.9966,25151950
50882,KDR,gene,0.988,25151950
50883,Flt-1,gene,0.9946,25151950
50884,claudin-5,gene,0.99,25151950
50885,occludin,gene,0.9307,25151950
50886,OHSS,disease,1.0,25151950
50887,rat,species,0.922,25151950
50888,VEGF,gene,0.9917,25151950
50889,VEGF receptor-1,gene,0.9673,25151950
50890,FLT-1,gene,0.9756,25151950
50891,Fc,gene,0.799,25151950
50892,progesterone,drug,0.9966,25151950
50893,estradiol,drug,0.9985,25151950
50894,CL,cell_type,0.7407,25151950
50895,OHSS,disease,1.0,25151950
50896,rats,species,0.98,25151950
50897,CL,cell_type,0.8086,25151950
50898,Endothelial cell,cell_type,0.7783,25151950
50899,CL,cell_type,0.5493,25151950
50900,KDR,gene,0.9927,25151950
50901,claudin-5,gene,0.9844,25151950
50902,occludin,gene,0.9336,25151950
50903,OHSS,disease,1.0,25151950
50904,TRAP,drug,0.7524,25151950
50905,VEGF,gene,0.994,25151950
50906,OHSS,disease,1.0,25151950
50907,rats,species,0.984,25151950
50908,PI3K,gene,0.999,25144531
50909,AKT,gene,0.996,25144531
50910,mTOR,gene,0.996,25144531
50911,Ocular neovascularization,disease,0.976,25144531
50912,age-related macular degeneration,disease,1.0,25144531
50913,proliferative diabetic retinopathy,disease,0.9995,25144531
50914,Blindness,disease,1.0,25144531
50915,disabilities,disease,0.9946,25144531
50916,ocular neovascularisation,disease,0.9995,25144531
50917,VEGF,gene,0.919,25144531
50918,Ranibizumab,gene,0.9365,25144531
50919,Aflibercept,gene,0.9575,25144531
50920,Eylea,gene,0.433,25144531
50921,phosphatidylinositol,drug,0.999,25144531
50922,phosphatidylinositol-3-kinase,gene,0.993,25144531
50923,PI3K,gene,0.9976,25144531
50924,PI3K,gene,0.9985,25144531
50925,AKT,gene,0.9976,25144531
50926,mTOR,gene,0.995,25144531
50927,PI3K target genes,DNA,0.776,25144531
50928,PI3K,gene,0.998,25144531
50929,pik3ca,gene,0.8843,25144531
50930,pik3r1,gene,0.8184,25144531
50931,mtor,gene,0.6987,25144531
50932,akt1,gene,0.7637,25144531
50933,zebrafish,species,0.933,25144531
50934,zebrafish,species,0.976,25144531
50935,PI3K,gene,0.999,25144531
50936,Akt,gene,0.996,25144531
50937,mTOR,gene,0.9883,25144531
50938,NVP-,drug,0.991,25144531
50939,PI3K,gene,0.999,25144531
50940,mTOR,gene,0.9976,25144531
50941,PI-103,drug,0.997,25144531
50942,PI3K,gene,0.999,25144531
50943,mTOR,gene,0.997,25144531
50944,LY-294002,drug,0.999,25144531
50945,PI3K,gene,0.985,25144531
50946,NVP-BEZ235,drug,0.981,25144531
50947,NVP-BEZ235,drug,0.9883,25144531
50948,rapamycin,drug,0.9985,25144531
50949,mTOR,gene,0.996,25144531
50950,LY-294002,drug,0.9995,25144531
50951,rapamycin,drug,0.9995,25144531
50952,NVP-BEZ235,drug,0.877,25144531
50953,PI-103,drug,0.9956,25144531
50954,human ARPE19 retinal pigment epithelium cells,cell_line,0.9463,25144531
50955,PI3K,gene,0.998,25144531
50956,AKT,gene,0.998,25144531
50957,mTOR,gene,0.994,25144531
50958,FOLFIRI,drug,0.781,25142418
50959,aflibercept,gene,0.992,25142418
50960,FOLFIRI,drug,0.805,25142418
50961,metastatic colorectal cancer,disease,1.0,25142418
50962,mCRC,disease,1.0,25142418
50963,patients,species,0.9805,25142418
50964,oxaliplatin,drug,0.9995,25142418
50965,patients,species,0.9883,25142418
50966,oxaliplatin,drug,0.9995,25142418
50967,patients,species,0.981,25142418
50968,aflibercept,gene,0.9927,25142418
50969,patients,species,0.981,25142418
50970,PS,gene,,25142418
50971,aflibercept,gene,0.776,25142418
50972,aflibercept,gene,0.9966,25142418
50973,patients,species,0.9844,25142418
50974,aflibercept,gene,0.9795,25142418
50975,FOLFIRI,drug,0.553,25142418
50976,aflibercept,gene,0.9966,25142418
50977,FOLFIRI,drug,0.54,25142418
50978,patients,species,0.9805,25142418
50979,FOLFIRI,drug,0.832,25142418
50980,aflibercept,gene,0.9917,25142418
50981,mCRC,disease,0.9937,25142418
50982,patients,species,0.994,25142418
50983,diabetic macular edema,disease,1.0,25141904
50984,Diabetic macular edema,disease,1.0,25141904
50985,DME,disease,1.0,25141904
50986,visual impairment,disease,1.0,25141904
50987,diabetic retinopathy,disease,1.0,25141904
50988,DME,disease,1.0,25141904
50989,DME,disease,1.0,25141904
50990,VEGF,gene,0.817,25141904
50991,DME,disease,1.0,25141904
50992,DME,disease,1.0,25141904
50993,VEGF,gene,0.9937,25141904
50994,fluocinolone,drug,0.9995,25141904
50995,DME,disease,1.0,25141904
50996,retinal diseases,disease,0.9917,25141904
50997,aflibercept,gene,0.947,25141904
50998,dexamethasone,drug,0.9805,25141904
50999,DME,disease,1.0,25141904
51000,DME,disease,1.0,25141904
51001,edema,disease,0.9917,25141904
51002,DME,disease,1.0,25141904
51003,VEGF,gene,0.8315,25141904
51004,metastatic colorectal cancer,disease,0.9995,25138900
51005,metastatic colorectal cancer,disease,0.9995,25138900
51006,bevacizumab,gene,0.822,25138900
51007,aflibercept,gene,0.982,25138900
51008,cetuximab,gene,0.954,25138900
51009,panitumumab,gene,0.949,25138900
51010,regorafenib,drug,0.978,25138900
51011,metastatic colorectal cancer,disease,0.997,25138900
51012,RAS,gene,0.968,25138900
51013,patients,species,0.992,25138900
51014,colorectal cancer,disease,1.0,25138900
51015,aflibercept,gene,0.9854,25137165
51016,FOLFIRI,drug,0.9473,25137165
51017,aflibercept,gene,0.9795,25137165
51018,FOLFIRI,drug,0.9863,25137165
51019,metastatic colorectal cancer,disease,1.0,25137165
51020,mCRC,disease,1.0,25137165
51021,patients,species,0.969,25137165
51022,oxaliplatin,drug,0.9995,25137165
51023,aflibercept,gene,0.9805,25137165
51024,FOLFIRI,drug,0.9756,25137165
51025,aflibercept,gene,0.977,25137165
51026,FOLFIRI,drug,0.9814,25137165
51027,FOLFIRI,drug,0.979,25137165
51028,aflibercept,gene,0.9893,25137165
51029,FOLFIRI,drug,0.752,25137165
51030,FOLFIRI,drug,0.7217,25137165
51031,aflibercept,gene,0.975,25137165
51032,FOLFIRI,drug,0.934,25137165
51033,FOLFIRI,drug,0.933,25137165
51034,Aflibercept,gene,0.971,25137165
51035,FOLFIRI,drug,0.899,25137165
51036,FOLFIRI,drug,0.581,25137165
51037,patients,species,0.969,25137165
51038,mCRC,disease,0.9927,25137165
51039,Aflibercept,gene,0.969,25137165
51040,FOLFIRI,drug,0.9404,25137165
51041,mCRC,disease,0.9883,25137165
51042,metastatic colorectal cancer,disease,1.0,25136356
51043,metastatic colorectal cancer,disease,1.0,25136356
51044,mCRC,disease,1.0,25136356
51045,mCRC,disease,0.997,25136356
51046,colorectal cancer,disease,1.0,25136356
51047,mCRC,disease,0.999,25136356
51048,bevacizumab,gene,0.839,25136356
51049,regorafenib,drug,0.98,25136356
51050,aflibercept,gene,0.986,25136356
51051,mCRC,disease,0.9473,25136356
51052,tumor,disease,1.0,25136356
51053,tumor cells,cell_type,0.871,25136356
51054,tumor,disease,0.946,25136356
51055,tumor,disease,0.976,25136356
51056,aflibercept,gene,0.9897,25136356
51057,FOLFIRI,drug,0.7812,25136356
51058,mCRC,disease,0.827,25136356
51059,placental growth factor,gene,0.9985,25136356
51060,PlGF,gene,0.998,25136356
51061,vascular endothelial growth factor receptor 1,gene,0.9985,25136356
51062,VEGFR1,gene,0.999,25136356
51063,inflammatory cells,cell_type,0.924,25136356
51064,Aflibercept,gene,0.9917,25136356
51065,tumor,disease,0.9995,25136356
51066,Aflibercept,gene,0.9546,25135809
51067,age-related macular degeneration,disease,1.0,25135809
51068,Aflibercept,gene,0.9785,25135809
51069,vascular endothelial growth factor (VEGF) receptor (R) 1,gene,0.9985,25135809
51070,VEGFR2 extracellular domains,gene,0.9473,25135809
51071,Fc,gene,,25135809
51072,human immunoglobulin G1,gene,0.9883,25135809
51073,human,species,0.9927,25135809
51074,VEGF-A/-B,gene,0.996,25135809
51075,VEGF isoforms,gene,0.997,25135809
51076,VEGF-B and -C,gene,0.9956,25135809
51077,placental growth factor,gene,0.9976,25135809
51078,aflibercept,gene,0.9897,25135809
51079,patients,species,0.9395,25135809
51080,choroidal neovascularization due to,disease,0.937,25135809
51081,age-related macular degeneration,disease,1.0,25135809
51082,AMD,disease,1.0,25135809
51083,ranibizumab,gene,0.749,25135809
51084,patients,species,0.965,25135809
51085,wet AMD,disease,0.994,25135809
51086,aflibercept,gene,0.9893,25135809
51087,ranibizumab,gene,0.884,25135809
51088,Aflibercept,gene,0.9443,25135809
51089,arterial thromboembolic events,disease,1.0,25135809
51090,ATEs,disease,1.0,25135809
51091,non-fatal strokes,disease,0.98,25135809
51092,non-fatal myocardial infarction,disease,0.9956,25135809
51093,vascular,disease,0.889,25135809
51094,aflibercept,gene,0.9766,25135809
51095,patients,species,0.96,25135809
51096,wet AMD,disease,0.995,25135809
51097,vascular endothelial growth factor,gene,0.8623,25131244
51098,aflibercept,gene,0.9927,25107900
51099,wet age-related macular,disease,0.9805,25107900
51100,aflibercept,gene,0.9927,25107900
51101,AFL,gene,0.946,25107900
51102,patients,species,0.971,25107900
51103,wet age-related macular degeneration,disease,0.9976,25107900
51104,wAMD,disease,1.0,25107900
51105,patients,species,0.986,25107900
51106,IVT,drug,0.99,25107900
51107,AFL,drug,0.9893,25107900
51108,IVT,drug,0.9175,25107900
51109,AFL,gene,0.6274,25107900
51110,ranibizumab,gene,0.7363,25107900
51111,patients,species,0.9575,25107900
51112,patients,species,0.976,25107900
51113,ranibizumab,gene,0.8438,25107900
51114,patients,species,0.954,25107900
51115,BCVA,DNA,0.4634,25107900
51116,Rq4,DNA,0.5264,25107900
51117,BCVA,cell_type,0.416,25107900
51118,choroidal neovascularisation,disease,0.9995,25107900
51119,AFL,disease,0.7896,25107900
51120,patients,species,0.969,25107900
51121,ranibizumab,gene,0.8174,25091039
51122,age-related macular INTRODUCTION,disease,1.0,25091039
51123,ranibizumab,gene,0.792,25091039
51124,patients,species,0.9834,25091039
51125,age related macular degeneration,disease,1.0,25091039
51126,AMD,disease,1.0,25091039
51127,blindness,disease,0.999,25091039
51128,patients,species,0.98,25091039
51129,wet AMD,disease,0.9976,25091039
51130,ranibizumab,gene,0.754,25091039
51131,visual loss,disease,0.8403,25091039
51132,ranibizumab,gene,0.9155,25091039
51133,wet AMD,disease,0.997,25091039
51134,wet AMD,disease,0.9995,25091039
51135,bevacizumab,gene,0.938,25091039
51136,aflibercept,gene,0.976,25091039
51137,ranibizumab,gene,0.8335,25091039
51138,ranibizumab,gene,0.9536,25091039
51139,patients,species,0.9556,25091039
51140,wet AMD,disease,0.999,25091039
51141,retinal thinning,disease,1.0,25091039
51142,ranibizumab,gene,0.93,25091039
51143,advanced colorectal cancer,disease,1.0,25083064
51144,advanced colorectal cancer,disease,0.999,25083064
51145,patient,species,0.988,25083064
51146,patient,species,0.9937,25083064
51147,patients,species,0.9766,25083064
51148,patients,species,0.9756,25083064
51149,epidermal growth factor receptor antibodies,gene,0.993,25083064
51150,cetuximab,gene,0.943,25083064
51151,panitumumab,gene,0.928,25083064
51152,vascular endothelial growth factor,gene,0.99,25083064
51153,bevacizumab,gene,0.9688,25083064
51154,aflibercept,gene,0.99,25083064
51155,bevacizumab,gene,0.7817,25083064
51156,advanced colorectal cancer,disease,0.9966,25083064
51157,aflibercept,gene,0.994,25077530
51158,polypoidal choroidal PURPOSE,disease,0.9834,25077530
51159,aflibercept,gene,0.9907,25077530
51160,polypoidal choroidal vasculopathy,disease,1.0,25077530
51161,patients,species,0.9844,25077530
51162,polypoidal choroidal vasculopathy,disease,1.0,25077530
51163,aflibercept,gene,0.9336,25077530
51164,ranibizumab,gene,0.8867,25077530
51165,patients,species,0.981,25077530
51166,patients,species,0.989,25077530
51167,ranibizumab,gene,0.8755,25077530
51168,ranibizumab,gene,0.759,25077530
51169,ranibizumab,gene,0.769,25077530
51170,aflibercept,gene,0.9434,25077530
51171,polypoidal lesions,disease,1.0,25077530
51172,polypoidal lesions,disease,1.0,25077530
51173,aflibercept,gene,0.994,25077530
51174,patients,species,0.949,25077530
51175,polypoidal choroidal vasculopathy,disease,1.0,25077530
51176,ranibizumab,gene,0.8867,25077530
51177,polypoidal lesions,disease,0.9917,25077530
51178,Pegaptanib,drug,0.983,25073069
51179,ranibizumab,gene,0.6997,25073069
51180,aflibercept,gene,0.8716,25073069
51181,retinal pigmented epithelium tears,disease,0.9995,25073069
51182,thromboembolic events,disease,0.9995,25073069
51183,thromboembolic events,disease,1.0,25073069
51184,patients,species,0.9473,25072648
51185,neovascular age-related macular degeneration,disease,1.0,25072648
51186,neovascular age-related macular degeneration,disease,1.0,25072648
51187,patients,species,0.9746,25072648
51188,aflibercept,gene,0.967,25072648
51189,patients,species,0.994,25072648
51190,aflibercept,gene,0.979,25072648
51191,bevacizumab,gene,0.7646,25072648
51192,patient,species,0.9834,25072648
51193,anti-vascular endothelial growth factor,gene,0.9814,25072648
51194,aflibercept,gene,0.978,25072648
51195,person,species,0.975,25072648
51196,aflibercept,gene,0.9336,25072648
51197,bevacizumab,gene,0.884,25072648
51198,ranibizumab,gene,0.649,25072648
51199,aflibercept,gene,0.993,25072648
51200,patients,species,0.995,25072648
51201,ranibizumab,gene,0.6387,25072648
51202,aflibercept,gene,0.9805,25072648
51203,patients,species,0.9927,25072648
51204,ranibizumab,gene,0.55,25072648
51205,bevacizumab,gene,0.6807,25072648
51206,aflibercept,gene,0.962,25072648
51207,aflibercept,gene,0.979,25072648
51208,aflibercept,gene,0.987,25072648
51209,aflibercept,gene,0.982,25072648
51210,aflibercept,gene,0.971,25072648
51211,aflibercept,gene,0.976,25072648
51212,patients,species,0.9478,25072648
51213,aflibercept,gene,0.953,25072648
51214,ranibizumab,gene,0.786,25072648
51215,bevacizumab,gene,0.5586,25072648
51216,Aflibercept,gene,0.982,25072648
51217,patients,species,0.9854,25072648
51218,vascular endothelial growth factor,gene,0.8735,25072648
51219,aflibercept,gene,0.988,25072060
51220,gastrointestinal perforation,disease,0.995,25070487
51221,cancer,disease,1.0,25070487
51222,patients,species,0.994,25070487
51223,aflibercept,gene,0.9854,25070487
51224,Gastrointestinal (GI) perforation,disease,0.998,25070487
51225,aflibercept,gene,0.982,25070487
51226,VEGF,gene,0.999,25070487
51227,metastatic colorectal cancer,disease,1.0,25070487
51228,GI perforation,disease,0.931,25070487
51229,aflibercept,gene,0.9873,25070487
51230,GI perforation,disease,0.9336,25070487
51231,aflibercept,gene,0.976,25070487
51232,aflibercept,gene,0.9673,25070487
51233,cancer,disease,1.0,25070487
51234,patients,species,0.995,25070487
51235,patients,species,0.989,25070487
51236,solid tumors,disease,1.0,25070487
51237,GI perforation,disease,0.871,25070487
51238,aflibercept,gene,0.981,25070487
51239,patients,species,0.977,25070487
51240,aflibercept,gene,0.959,25070487
51241,patients,species,0.9893,25070487
51242,aflibercept,gene,0.985,25070487
51243,GI perforation,disease,0.71,25070487
51244,aflibercept,gene,0.9917,25068637
51245,macular edema,disease,1.0,25068637
51246,central retinal vein,disease,0.9873,25068637
51247,aflibercept,gene,0.985,25068637
51248,macular edema,disease,1.0,25068637
51249,central retinal vein occlusion,disease,1.0,25068637
51250,CRVO,disease,1.0,25068637
51251,patients,species,0.947,25068637
51252,macular edema,disease,1.0,25068637
51253,CRVO,disease,1.0,25068637
51254,aflibercept,gene,0.9414,25068637
51255,patients,species,0.927,25068637
51256,aflibercept,gene,0.956,25068637
51257,patients,species,0.9565,25068637
51258,aflibercept,gene,0.9243,25068637
51259,patients,species,0.9785,25068637
51260,patients,species,0.976,25068637
51261,aflibercept,gene,0.9873,25068637
51262,patients,species,0.978,25068637
51263,aflibercept,gene,0.9824,25068637
51264,macular edema,disease,1.0,25068637
51265,Patients,species,0.9136,25068637
51266,macular edema,disease,1.0,25068637
51267,CRVO,disease,0.9995,25068637
51268,aflibercept,gene,0.9214,25068637
51269,metastatic colorectal cancers,disease,0.9746,25065664
51270,metastatic colorectal cancer,disease,0.8247,25065664
51271,tyrosine,drug,0.9956,25065664
51272,tyrosine kinase,gene,0.9893,25065664
51273,EGF-receptor,gene,0.996,25065664
51274,cetuximab,gene,0.9253,25065664
51275,panitumumab,gene,0.905,25065664
51276,cutaneous toxicity,disease,0.9634,25065664
51277,bevacizumab,gene,0.9404,25065664
51278,aflibercept,gene,0.97,25065664
51279,regorafenib,drug,0.9814,25065664
51280,hypertension,disease,1.0,25065664
51281,gastrointestinal cancers,disease,1.0,25065664
51282,macular oedema,disease,1.0,25056974
51283,central retinal vein occlusion,disease,1.0,25056974
51284,aflibercept,gene,0.978,25056974
51285,bevacizumab,gene,0.782,25056974
51286,dexamethasone,drug,0.995,25056974
51287,ranibizumab,gene,0.6895,25056974
51288,triamcinolone,drug,0.997,25056974
51289,macular oedema,disease,1.0,25056974
51290,central retinal vein occlusion,disease,1.0,25056974
51291,CDSR,DNA,0.4695,25056974
51292,DARE,DNA,0.483,25056974
51293,patients,species,0.9775,25056974
51294,macular oedema,disease,1.0,25056974
51295,central retinal vein occlusion,disease,1.0,25056974
51296,patients,species,0.9917,25056974
51297,patients,species,0.9907,25056974
51298,triamcinolone,drug,0.9985,25056974
51299,ranibizumab,gene,0.796,25056974
51300,bevacizumab,gene,0.8765,25056974
51301,aflibercept,gene,0.9443,25056974
51302,dexamethasone,drug,0.9976,25056974
51303,patients,species,0.9907,25056974
51304,triamcinolone,drug,0.9985,25056974
51305,ranibizumab,gene,0.8896,25056974
51306,aflibercept,gene,0.947,25056974
51307,Patients,species,0.925,25056974
51308,triamcinolone,drug,0.998,25056974
51309,ranibizumab,gene,0.8535,25056974
51310,bevacizumab,gene,0.9214,25056974
51311,aflibercept,gene,0.9746,25056974
51312,ranibizumab,gene,0.789,25056974
51313,aflibercept,gene,0.9727,25056974
51314,bevacizumab,gene,0.817,25056974
51315,triamcinolone,drug,0.9956,25056974
51316,antivascular endothelial growth factors,gene,0.9956,25056974
51317,VEGFs,gene,0.996,25056974
51318,cataract,disease,0.98,25056974
51319,Aflibercept,gene,0.973,25056974
51320,aflibercept,gene,0.953,25055958
51321,cancer,disease,1.0,25055958
51322,patients,species,0.992,25055958
51323,aflibercept,gene,0.982,25047874
51324,ranibizumab,gene,0.658,25047874
51325,bevacizumab,gene,0.554,25047874
51326,VEGF,gene,0.987,25047874
51327,age-related macular degeneration,disease,1.0,25047874
51328,diabetic macular edema,disease,1.0,25047874
51329,retinal vein occlusion,disease,1.0,25047874
51330,aflibercept,gene,0.9775,25047874
51331,aflibercept,gene,0.982,25047874
51332,VEGF,gene,0.9907,25047874
51333,ranibizumab,gene,0.755,25047874
51334,bevacizumab,gene,0.587,25047874
51335,RPE/choroid organ cultures,cell_line,0.7783,25047874
51336,RPE/choroid organ cultures,cell_line,0.7983,25047874
51337,RPE,cell_type,0.487,25047874
51338,pigs,species,0.878,25047874
51339,Organ cultures,cell_line,0.775,25047874
51340,aflibercept,gene,0.97,25047874
51341,ranibizumab,gene,0.8213,25047874
51342,bevacizumab,gene,0.6987,25047874
51343,VEGF,gene,0.994,25047874
51344,VEGF,gene,0.992,25047874
51345,organ cultures,cell_line,0.881,25047874
51346,Aflibercept,gene,0.904,25047874
51347,VEGF,gene,0.9946,25047874
51348,bevacizumab,gene,0.767,25047874
51349,ranibizumab,gene,0.556,25047874
51350,VEGF,gene,0.994,25047874
51351,aflibercept,gene,0.9766,25047874
51352,ranibizumab,gene,0.7397,25047874
51353,bevacizumab,gene,0.855,25047874
51354,VEGF,gene,0.993,25047874
51355,aflibercept,gene,0.9893,25047874
51356,VEGF,gene,0.9824,25047874
51357,VEGF,gene,0.9956,25047874
51358,ranibizumab,gene,0.815,25047874
51359,VEGF,gene,0.997,25047874
51360,bevacizumab,gene,0.8438,25047874
51361,aflibercept,gene,0.99,25047874
51362,VEGF,gene,0.995,25047874
51363,bevacizumab,gene,0.9043,25047778
51364,ziv-aflibercept,gene,0.9814,25047778
51365,regorafenib,drug,0.9707,25047778
51366,patients,species,0.9663,25047778
51367,colorectal cancer,disease,1.0,25047778
51368,tumor,disease,0.9526,25047778
51369,aflibercept,gene,0.9854,25046397
51370,patients,species,0.9424,25046397
51371,patients,species,0.947,25046397
51372,polypoidal choroidal vasculopathy,disease,1.0,25046397
51373,aflibercept,gene,0.9854,25046397
51374,patients,species,0.9756,25046397
51375,polypoidal choroidal vasculopathy,disease,1.0,25046397
51376,aflibercept,gene,0.8774,25046397
51377,fibrin,gene,0.904,25046397
51378,pigment epithelial detachment,disease,1.0,25046397
51379,subretinal hemorrhage,disease,1.0,25046397
51380,polyps,disease,1.0,25046397
51381,indocyanine green,drug,0.9946,25046397
51382,patients,species,0.9907,25046397
51383,subretinal fluid,disease,0.855,25046397
51384,fibrin,gene,0.9805,25046397
51385,subretinal hemorrhage,disease,1.0,25046397
51386,pigment epithelial detachment,disease,0.9976,25046397
51387,polyp,disease,0.9985,25046397
51388,aflibercept,gene,0.986,25046397
51389,patients,species,0.944,25046397
51390,polypoidal choroidal vasculopathy,disease,1.0,25046397
51391,aflibercept,gene,0.9766,25046397
51392,polyps,cell_type,0.4287,25046397
51393,polyps,disease,0.996,25046397
51394,metastatic colorectal cancer,disease,0.8916,25045279
51395,Metastatic colorectal cancer,disease,0.9985,25045279
51396,patient,species,0.976,25045279
51397,epidermal growth factor receptor,gene,0.996,25045279
51398,panitumumab,gene,0.941,25045279
51399,cetuximab,gene,0.76,25045279
51400,cetuximab,gene,0.662,25045279
51401,cetuximab,gene,0.933,25045279
51402,bevacizumab,gene,0.5903,25045279
51403,KRAS exon 2,gene,0.983,25045279
51404,codons 12 and 13,DNA,0.6484,25045279
51405,vascular endothelial growth factor,gene,0.995,25045279
51406,bevacizumab,gene,0.501,25045279
51407,bevacizumab,gene,0.5283,25045279
51408,bevacizumab,gene,0.8604,25045279
51409,capecitabine,drug,0.999,25045279
51410,erlotinib,drug,0.996,25045279
51411,aflibercept,gene,0.9927,25045279
51412,regorafenib,drug,0.966,25045279
51413,metastatic colorectal cancer,disease,1.0,25045279
51414,patients,species,0.972,25045279
51415,metastatic colorectal cancer,disease,0.9985,25045279
51416,bevacizumab,gene,0.904,25037009
51417,aflibercept,gene,0.9805,25037009
51418,age-related macular degeneration,disease,0.9995,25037009
51419,AMD,disease,1.0,25037009
51420,bevacizumab,gene,0.651,25037009
51421,aflibercept,gene,0.988,25037009
51422,PATIENTS,species,0.897,25037009
51423,CRT,DNA,0.57,25037009
51424,BCVA,DNA,0.4927,25037009
51425,patients,species,0.958,25037009
51426,bevacizumab,gene,0.5127,25037009
51427,aflibercept,gene,0.986,25037009
51428,exudative AMD,disease,0.9985,25037009
51429,bevacizumab,gene,0.856,25037009
51430,aflibercept,gene,0.9595,25037009
51431,Aflibercept,gene,0.9727,25037009
51432,CRT,DNA,0.4883,25037009
51433,bevacizumab,gene,0.923,25037009
51434,aflibercept,gene,0.9897,25037009
51435,bevacizumab,gene,0.774,25037009
51436,BCVA,cell_type,0.4214,25037009
51437,aflibercept,gene,0.9673,25037009
51438,bevacizumab,gene,0.616,25037009
51439,aflibercept,gene,0.9536,25037009
51440,patients,species,0.9863,25037009
51441,bevacizumab,gene,0.7188,25037009
51442,aflibercept,gene,0.9277,25037009
51443,patients,species,0.9824,25037009
51444,bevacizumab,gene,0.9136,25037009
51445,aflibercept,gene,0.9873,25037009
51446,exudative AMD,disease,0.9976,25037009
51447,aflibercept,gene,0.9766,25034050
51448,primary RPE cells,cell_line,0.914,25034050
51449,VEGF,gene,0.9653,25034050
51450,diabetic macular oedema,disease,1.0,25034050
51451,retinal vein occlusion,disease,1.0,25034050
51452,aflibercept,gene,0.989,25034050
51453,aflibercept,gene,0.9785,25034050
51454,primary RPE cells,cell_line,0.922,25034050
51455,primary RPE cells,cell_type,0.8003,25034050
51456,Primary RPE cells,cell_line,0.961,25034050
51457,pigs,species,0.8735,25034050
51458,aflibercept,gene,0.9893,25034050
51459,MTT,drug,0.9985,25034050
51460,trypan blue,drug,0.9897,25034050
51461,aflibercept,gene,0.9883,25034050
51462,aflibercept,gene,0.99,25034050
51463,Aflibercept,gene,0.964,25034050
51464,RPE cells,cell_type,0.898,25034050
51465,RPE cells,cell_line,0.807,25034050
51466,RPE cells,cell_type,0.906,25034050
51467,aflibercept,gene,0.983,25034050
51468,RPE cells,cell_type,0.9204,25034050
51469,Aflibercept,gene,0.9634,25034050
51470,RPE cells,cell_type,0.874,25034050
51471,RPE cells,cell_type,0.898,25034050
51472,RPE cells,cell_line,0.8447,25034050
51473,RPE cells,cell_type,0.907,25034050
51474,RPE cells,cell_type,0.9126,25034050
51475,Ziv-aflibercept,gene,0.9062,25032013
51476,metastatic colorectal cancer,disease,1.0,25032013
51477,plasma,gene,0.5435,25030237
51478,vascular endothelial growth factor,gene,0.9053,25030237
51479,plasma vascular endothelial growth factor,gene,0.9297,25030237
51480,VEGF,gene,0.9976,25030237
51481,aflibercept,gene,0.975,25030237
51482,ranibizumab,gene,0.7827,25030237
51483,patients,species,0.9683,25030237
51484,exudative age-related macular degeneration,disease,1.0,25030237
51485,AMD,disease,1.0,25030237
51486,exudative AMD,disease,1.0,25030237
51487,polypoidal choroidal vasculopathy,disease,1.0,25030237
51488,retinal angiomatous proliferation,disease,1.0,25030237
51489,patients,species,0.993,25030237
51490,aflibercept,gene,0.9834,25030237
51491,patients,species,0.991,25030237
51492,ranibizumab,gene,0.852,25030237
51493,VEGF,gene,0.8965,25030237
51494,ranibizumab,gene,0.7837,25030237
51495,VEGF,gene,0.5957,25030237
51496,patients,species,0.979,25030237
51497,ranibizumab,gene,0.5337,25030237
51498,aflibercept,gene,0.992,25030237
51499,VEGF,gene,0.6978,25030237
51500,aflibercept,gene,0.9917,25030237
51501,VEGF,gene,0.6157,25030237
51502,ranibizumab,gene,0.9175,25030237
51503,VEGF,gene,0.852,25030237
51504,ranibizumab,gene,0.5933,25029255
51505,aflibercept,gene,0.9688,25029255
51506,diabetic macular edema,disease,1.0,25029255
51507,DME,disease,1.0,25029255
51508,ranibizumab,gene,0.6943,25029255
51509,aflibercept,gene,0.953,25029255
51510,patients,species,0.9814,25029255
51511,Diabetic Retinopathy,disease,1.0,25029255
51512,DME,disease,0.999,25029255
51513,patients,species,0.98,25029255
51514,ranibizumab,gene,0.8438,25029255
51515,aflibercept,gene,0.983,25029255
51516,Ranibizumab,gene,0.8687,25029255
51517,aflibercept,gene,0.965,25029255
51518,ranibizumab,gene,0.79,25029255
51519,aflibercept,gene,0.983,25029255
51520,ranibizumab,gene,0.726,25029255
51521,Ranibizumab,gene,0.863,25029255
51522,aflibercept,gene,0.9785,25029255
51523,VEGF,gene,0.631,25029255
51524,aflibercept,gene,0.9946,25028532
51525,age-related macular degeneration,disease,1.0,25028532
51526,aflibercept,gene,0.994,25028532
51527,AMD,disease,1.0,25028532
51528,retinal pigment epithelial (RPE) tear,disease,0.999,25028532
51529,ranibizumab,gene,0.7183,25028532
51530,AMD,disease,0.9995,25028532
51531,patients,species,0.9946,25028532
51532,RPE tears,disease,0.916,25028532
51533,ranibizumab,gene,0.7036,25028532
51534,aflibercept,gene,0.98,25028532
51535,patients,species,0.988,25028532
51536,AMD,disease,1.0,25028532
51537,RPE tear,disease,1.0,25028532
51538,aflibercept,gene,0.9893,25028532
51539,patients,species,0.982,25028532
51540,aflibercept,gene,0.9746,25028532
51541,AMD,disease,1.0,25028532
51542,RPE,cell_type,0.4758,25028532
51543,RPE tear,disease,0.975,25028532
51544,metastatic colon cancer,disease,0.993,25024813
51545,metastatic colon cancer,disease,0.992,25024813
51546,epidermal growth factor receptor,gene,0.997,25024813
51547,aflibercept,gene,0.972,25023147
51548,patients,species,0.9575,25023147
51549,aflibercept,gene,0.9717,25023147
51550,patients,species,0.9375,25023147
51551,polypoidal choroidal vasculopathy,disease,1.0,25023147
51552,PCV,disease,1.0,25023147
51553,PCV,disease,1.0,25023147
51554,patients,species,0.9907,25023147
51555,men,species,0.9785,25023147
51556,women,species,0.98,25023147
51557,aflibercept,gene,0.9634,25023147
51558,indocyanine green,drug,0.9956,25023147
51559,Polypoidal lesions,disease,1.0,25023147
51560,polypoidal lesions,disease,1.0,25023147
51561,polypoidal,DNA,0.451,25023147
51562,polypoidal lesions,disease,1.0,25023147
51563,aflibercept,gene,0.983,25023147
51564,patients,species,0.9404,25023147
51565,PCV,disease,1.0,25023147
51566,aflibercept,gene,0.986,25012934
51567,diabetic macular edema,disease,1.0,25012934
51568,vascular endothelial growth factor,gene,0.9976,25012934
51569,diabetic macular edema,disease,1.0,25012934
51570,DME,disease,1.0,25012934
51571,PARTICIPANTS,species,0.761,25012934
51572,patients,species,0.9937,25012934
51573,type 1 or 2 diabetes mellitus,disease,1.0,25012934
51574,DME,disease,1.0,25012934
51575,aflibercept,gene,0.9746,25012934
51576,Diabetic Retinopathy,disease,1.0,25012934
51577,arterial thromboembolic events,disease,0.9976,25012934
51578,vascular deaths,disease,0.9956,25012934
51579,topotecan,drug,0.8716,25002722
51580,small-cell lung cancer,disease,1.0,25002722
51581,SCLC,disease,1.0,25002722
51582,topotecan,drug,0.9497,25002722
51583,ziv-aflibercept,gene,0.9814,25002722
51584,VEGF,gene,0.998,25002722
51585,PATIENTS,species,0.9263,25002722
51586,Patients,species,0.9717,25002722
51587,SCLC,disease,0.996,25002722
51588,platinum,drug,0.9995,25002722
51589,brain metastases,disease,0.9995,25002722
51590,bleeding diatheses,disease,0.9995,25002722
51591,patients,species,0.962,25002722
51592,platinum,drug,0.9995,25002722
51593,platinum,drug,0.9995,25002722
51594,topotecan,drug,0.5376,25002722
51595,ziv-aflibercept,gene,0.9424,25002722
51596,patients,species,0.983,25002722
51597,ziv-aflibercept,gene,0.9834,25002722
51598,patients,species,0.9854,25002722
51599,platinum,drug,0.9995,25002722
51600,patients,species,0.9756,25002722
51601,platinum,drug,0.999,25002722
51602,topotecan,drug,0.96,25002722
51603,patients,species,0.976,25002722
51604,platinum,drug,0.999,25002722
51605,platinum-,disease,0.6,25002722
51606,platinum,drug,0.9995,25002722
51607,ziv-aflibercept,gene,0.974,25002722
51608,Ziv-aflibercept,gene,0.956,25002722
51609,patients,species,0.9814,25002722
51610,platinum-,disease,0.7227,25002722
51611,platinum,drug,0.9995,25002722
51612,SCLC,disease,0.905,25002722
51613,ziv-aflibercept,gene,0.984,25002722
51614,topotecan,drug,0.972,25002722
51615,topotecan,drug,0.938,25002722
51616,vascular endothelial growth factor,gene,0.998,25001321
51617,VEGF,gene,0.996,25001321
51618,ranibizumab,gene,0.691,25001321
51619,bevacizumab,gene,0.658,25001321
51620,aflibercept,gene,0.97,25001321
51621,patients,species,0.9595,25001321
51622,wet,disease,0.9453,25001321
51623,age-related macular degeneration,disease,0.9966,25001321
51624,ranibizumab,gene,0.888,25001321
51625,bevacizumab,gene,0.569,25001321
51626,aflibercept,gene,0.95,25001321
51627,VEGF,gene,0.9956,25001321
51628,aflibercept,gene,0.99,25001321
51629,ranibizumab,gene,0.8906,25001321
51630,bevacizumab,gene,0.7812,25001321
51631,ranibizumab,gene,0.565,25001321
51632,bevacizumab,gene,0.9478,25001321
51633,aflibercept,gene,0.9893,25001321
51634,ranibizumab,gene,0.894,25001321
51635,Aflibercept,gene,0.9326,25001321
51636,VEGF,gene,0.9844,25001321
51637,VEGF,gene,0.9946,25001321
51638,VEGF,gene,0.604,25001321
51639,ranibizumab,gene,0.752,25001321
51640,bevacizumab,gene,0.947,25001321
51641,aflibercept,gene,0.974,25001321
51642,VEGF,gene,0.9854,25001321
51643,aflibercept,gene,0.958,24999721
51644,patients,species,0.977,24999721
51645,macular edema,disease,1.0,24999721
51646,steroid,drug,0.529,24999721
51647,vascular endothelial growth factor,gene,0.95,24999721
51648,central retinal vein occlusion,disease,0.9995,24999721
51649,aflibercept,gene,0.9688,24999721
51650,macular edema,disease,1.0,24999721
51651,bevacizumab,gene,0.88,24999721
51652,ranibizumab,gene,0.733,24999721
51653,central retinal vein occlusion,disease,1.0,24999721
51654,macular edema,disease,1.0,24999721
51655,anti-vascular endothelial growth factor,gene,0.837,24999721
51656,aflibercept,gene,0.965,24999721
51657,patients,species,0.9297,24999721
51658,macular edema,disease,1.0,24999721
51659,aflibercept,gene,0.987,24999721
51660,edema,disease,0.938,24999721
51661,patients,species,0.9756,24999721
51662,patients,species,0.9883,24999721
51663,aflibercept,gene,0.9463,24999721
51664,Noninfectious inflammation,disease,0.9966,24983791
51665,aflibercept,gene,0.969,24983791
51666,patients,species,0.966,24983791
51667,noninfectious inflammation,disease,0.9995,24983791
51668,aflibercept,gene,0.953,24983791
51669,patients,species,0.99,24983791
51670,noninfectious inflammation,disease,0.9966,24983791
51671,aflibercept,gene,0.9883,24983791
51672,aflibercept,gene,0.962,24983791
51673,patients,species,0.977,24983791
51674,aflibercept,gene,0.9814,24983791
51675,conjunctival injection,disease,1.0,24983791
51676,patient,species,0.9634,24983791
51677,anterior chamber cell,cell_type,0.4958,24983791
51678,vitritis,disease,1.0,24983791
51679,Patients,species,0.984,24983791
51680,aflibercept,gene,0.968,24983791
51681,patient,species,0.9824,24983791
51682,patients,species,0.98,24983791
51683,patient,species,0.981,24983791
51684,patients,species,0.971,24983791
51685,aflibercept,gene,0.9526,24983791
51686,aflibercept,gene,0.936,24983791
51687,aflibercept,gene,0.9863,24983791
51688,patients,species,0.9854,24983791
51689,Noninfectious inflammation,disease,1.0,24983791
51690,aflibercept,gene,0.9736,24983791
51691,conjunctival injection,disease,0.9995,24983791
51692,hypopyon,disease,0.9985,24983791
51693,plasma,gene,0.6836,24973606
51694,vascular endothelial growth factor,gene,0.9067,24973606
51695,plasma,gene,0.59,24973606
51696,vascular endothelial growth factor,gene,0.915,24973606
51697,VEGF,gene,0.997,24973606
51698,macular degeneration,disease,0.9995,24973606
51699,patients,species,0.984,24973606
51700,aflibercept,gene,0.981,24973606
51701,ranibizumab,gene,0.8086,24973606
51702,patients,species,0.9907,24973606
51703,aflibercept,gene,0.946,24973606
51704,aflibercept,gene,0.9644,24973606
51705,patients,species,0.989,24973606
51706,ranibizumab,gene,0.915,24973606
51707,ranibizumab,gene,0.8613,24973606
51708,patients,species,0.977,24973606
51709,cataract,disease,1.0,24973606
51710,VEGF,gene,0.8887,24973606
51711,serum VEGF,gene,0.899,24973606
51712,aflibercept,gene,0.985,24973606
51713,ranibizumab,gene,0.73,24973606
51714,plasma,RNA,0.4927,24973606
51715,plasma VEGF,gene,0.6016,24973606
51716,aflibercept,gene,0.985,24973606
51717,ranibizumab,gene,0.73,24973606
51718,Aflibercept,gene,0.9106,24973606
51719,VEGF,gene,0.8335,24973606
51720,ranibizumab,gene,0.5737,24973606
51721,VEGF,gene,0.774,24973606
51722,Hemorrhagic events,disease,0.818,24957040
51723,cancer,disease,1.0,24957040
51724,patients,species,0.9893,24957040
51725,aflibercept,gene,0.951,24957040
51726,Aflibercept,gene,0.974,24957040
51727,Ziv-aflibercept,gene,0.9785,24957040
51728,VEGF Trap,gene,0.9883,24957040
51729,AVE005,gene,0.81,24957040
51730,vascular endothelial growth factor A,gene,0.998,24957040
51731,VEGF,gene,0.998,24957040
51732,Hemorrhagic events,disease,0.944,24957040
51733,epistaxis,disease,1.0,24957040
51734,gastrointestinal bleeding,disease,0.985,24957040
51735,pulmonary bleeding,disease,0.9717,24957040
51736,cancer,disease,1.0,24957040
51737,patients,species,0.992,24957040
51738,aflibercept,gene,0.986,24957040
51739,cancer,disease,1.0,24957040
51740,patients,species,0.9907,24957040
51741,aflibercept,gene,0.978,24957040
51742,hemorrhagic events,disease,0.5967,24957040
51743,patients,species,0.9863,24957040
51744,solid tumors,disease,1.0,24957040
51745,cancer,disease,1.0,24957040
51746,patients,species,0.987,24957040
51747,hemorrhagic,disease,0.764,24957040
51748,aflibercept,gene,0.98,24957040
51749,aflibercept,gene,0.986,24957040
51750,bevacizumab,gene,0.7563,24957040
51751,Aflibercept,gene,0.9224,24957040
51752,hemorrhagic events,disease,0.6733,24957040
51753,patients,species,0.9688,24957040
51754,solid tumors,disease,1.0,24957040
51755,Zaltrap,drug,0.9976,24941681
51756,melanoma,disease,1.0,24928310
51757,melanoma,disease,1.0,24928310
51758,BRAF,gene,0.9985,24928310
51759,V-RAF murine sarcoma viral oncogene homolog B,gene,0.9976,24928310
51760,vemurafenib,drug,0.999,24928310
51761,dabrafenib,drug,0.9956,24928310
51762,MEK,gene,0.9946,24928310
51763,mitogen-,gene,0.995,24928310
51764,protein kinase,gene,0.514,24928310
51765,trametinib,drug,0.9985,24928310
51766,bcr,gene,0.9946,24928310
51767,abl,gene,0.767,24928310
51768,c-kit,gene,0.997,24928310
51769,PDGF-R,gene,0.9995,24928310
51770,imatinib,drug,0.9966,24928310
51771,bevacizumab,gene,0.841,24928310
51772,aflibercept,gene,0.9175,24928310
51773,anti-CTLA-4,gene,0.975,24928310
51774,anti-cytotoxic T-lymphocyte antigen-4,gene,0.9883,24928310
51775,anti-PD,gene,0.954,24928310
51776,lambrolizumab,gene,0.5894,24928310
51777,anti-PD-L,gene,0.992,24928310
51778,anti-programmed death ligand,gene,0.997,24928310
51779,GM-CSF,gene,0.999,24928310
51780,granulocyte-macrophage colony-stimulating factor,gene,0.999,24928310
51781,T-VEC,gene,0.8003,24928310
51782,talimogene,DNA,0.788,24928310
51783,talimogene laherparepvec,gene,0.9883,24928310
51784,Melanoma,disease,1.0,24928310
51785,dacarbazine,drug,0.9985,24928310
51786,melanoma,disease,0.9604,24928310
51787,patients,species,0.994,24928310
51788,melanoma,disease,1.0,24928310
51789,advanced melanoma,disease,0.9995,24928310
51790,patients,species,0.9946,24928310
51791,panuveitis,disease,1.0,24920511
51792,aflibercept,gene,0.9893,24920511
51793,Aflibercept,gene,0.9473,24920511
51794,neovascular age-related macular degeneration,disease,1.0,24920511
51795,panuveitis,disease,1.0,24920511
51796,anterior and posterior uveitis,disease,1.0,24920511
51797,aflibercept,gene,0.9873,24920511
51798,patients,species,0.993,24920511
51799,vascular endothelial growth factor,gene,0.999,24920511
51800,aflibercept,gene,0.977,24920511
51801,sterile endophthalmitis,disease,1.0,24920511
51802,patients,species,0.9873,24920511
51803,VEGF,gene,0.978,24919750
51804,diabetic macular edema,disease,1.0,24919750
51805,Vascular endothelial growth factor,gene,0.997,24919750
51806,VEGF,gene,0.9946,24919750
51807,diabetic macular edema,disease,1.0,24919750
51808,DME,disease,1.0,24919750
51809,vision loss,disease,0.999,24919750
51810,VEGF,gene,0.996,24919750
51811,macular edema,disease,1.0,24919750
51812,patients,species,0.969,24919750
51813,DME,disease,1.0,24919750
51814,pegaptanib,drug,0.9873,24919750
51815,ranibizumab,gene,0.758,24919750
51816,bevacizumab,gene,0.9023,24919750
51817,aflibercept,gene,0.927,24919750
51818,DME,disease,1.0,24919750
51819,ranibizumab,gene,0.532,24919750
51820,bevacizumab,gene,0.869,24919750
51821,aflibercept,gene,0.986,24919750
51822,aflibercept,gene,0.9683,24895562
51823,patients,species,0.971,24895562
51824,subretinal and/or intraretinal fluid,disease,0.8994,24895562
51825,aflibercept,gene,0.987,24895562
51826,aflibercept,gene,0.9663,24895562
51827,pigment epithelial detachment,disease,0.993,24895562
51828,patients,species,0.981,24895562
51829,aflibercept,gene,0.988,24895562
51830,aflibercept,gene,0.9883,24895562
51831,PED,DNA,0.5366,24895562
51832,aflibercept,gene,0.9844,24895562
51833,choroidal thinning,disease,1.0,24895562
51834,intraocular vascular endothelial growth factor,gene,0.8755,24879948
51835,aflibercept,gene,0.831,24879948
51836,age-related macular degeneration,disease,1.0,24879948
51837,vascular endothelial growth factor,gene,0.9985,24879948
51838,VEGF,gene,0.9946,24879948
51839,neovascular age-related macular degeneration,disease,1.0,24879948
51840,AMD,disease,1.0,24879948
51841,aflibercept,gene,0.98,24879948
51842,neovascular AMD,disease,1.0,24879948
51843,aflibercept,gene,0.973,24879948
51844,aflibercept,gene,0.9756,24879948
51845,VEGF-A,gene,0.998,24879948
51846,aqueous humor VEGF,gene,0.7656,24879948
51847,aflibercept,gene,0.9873,24879948
51848,VEGF,gene,0.834,24879948
51849,VEGF,gene,0.9937,24879948
51850,VEGF,gene,0.9966,24879948
51851,aflibercept,gene,0.96,24879948
51852,VEGF,gene,0.9736,24879948
51853,VEGF,gene,0.993,24879948
51854,aflibercept,gene,0.985,24879948
51855,VEGF,gene,0.995,24879948
51856,aflibercept,gene,0.9736,24879948
51857,metastatic,disease,0.9897,30190967
51858,colorectal cancer,disease,0.76,30190967
51859,cetuximab,gene,0.9526,30190967
51860,panitumumab,gene,0.958,30190967
51861,bevacizumab,gene,0.898,30190967
51862,aflibercept,gene,0.969,30190967
51863,regorafenib,drug,0.925,30190967
51864,metastatic colorectal cancer,disease,1.0,30190967
51865,patient,species,0.956,30190967
51866,metastatic colorectal cancer,disease,0.999,30190967
51867,Bevacizumab,gene,0.928,24864163
51868,advanced ovarian cancer,disease,1.0,24864163
51869,ovarian cancer,disease,1.0,24864163
51870,Bevacizumab,gene,0.589,24864163
51871,vascular endothelial growth factor,gene,0.998,24864163
51872,advanced epithelial ovarian cancer,disease,1.0,24864163
51873,fallopian tube cancer,disease,1.0,24864163
51874,primary peritoneal cancer,disease,1.0,24864163
51875,carboplatin,drug,0.999,24864163
51876,paclitaxel,drug,0.992,24864163
51877,platinum-sensitive ovarian cancer,disease,0.9976,24864163
51878,platinum,drug,0.9995,24864163
51879,carboplatin,drug,0.9995,24864163
51880,gemcitabine,drug,0.9995,24864163
51881,bevacizumab,gene,0.8657,24864163
51882,ovarian cancer,disease,1.0,24864163
51883,ovarian cancer,disease,1.0,24864163
51884,bevacizumab,gene,0.723,24864163
51885,trebananib,drug,0.9985,24864163
51886,aflibercept,gene,0.952,24864163
51887,nintedanib,drug,0.9985,24864163
51888,cediranib,drug,0.999,24864163
51889,imatinib,drug,0.999,24864163
51890,pazopanib,drug,0.9985,24864163
51891,sorafenib,drug,0.999,24864163
51892,sunitinib,drug,0.9985,24864163
51893,bevacizumab,gene,0.8726,24864163
51894,bevacizumab,gene,0.7397,24864163
51895,advanced ovarian cancer,disease,0.998,24864163
51896,bevacizumab,gene,0.811,24864163
51897,ovarian cancer,disease,1.0,24864163
51898,macular degeneration,disease,1.0,24860863
51899,age-related macular degeneration,disease,1.0,24859475
51900,exudative age-related macular degeneration,disease,1.0,24859475
51901,anti-vascular endothelial growth factor,gene,0.8823,24859475
51902,aflibercept,gene,0.9824,24859475
51903,bevacizumab,gene,0.808,24859475
51904,ranibizumab,gene,0.628,24859475
51905,exudative age-related macular degeneration,disease,1.0,24859475
51906,exudative age-related macular degeneration,disease,1.0,24859475
51907,bevacizumab,gene,0.539,24859475
51908,exudative age-related macular degeneration,disease,1.0,24859475
51909,patients,species,0.983,24838864
51910,neovascular age-related macular degeneration,disease,1.0,24838864
51911,neovascular age-related macular degeneration,disease,1.0,24838864
51912,NVAMD,disease,1.0,24838864
51913,vascular endothelial growth factor,gene,0.9985,24838864
51914,ranibizumab,gene,0.9214,24838864
51915,ranibizumab,gene,0.8525,24838864
51916,aflibercept,gene,0.9844,24838864
51917,bevacizumab,gene,0.839,24838864
51918,patients,species,0.9653,24838864
51919,NVAMD,disease,1.0,24838864
51920,NVAMD,disease,1.0,24838864
51921,loss of vision,disease,0.999,24838864
51922,blindness,disease,0.9995,24838864
51923,aflibercept,gene,0.9917,24836866
51924,ranibizumab,gene,0.9,24836866
51925,bevacizumab,gene,0.6714,24836866
51926,exudative age-related macular degeneration,disease,0.991,24836866
51927,AMD,disease,1.0,24836866
51928,Patients,species,0.984,24836866
51929,Patients,species,0.9453,24836866
51930,exudative AMD,disease,0.9233,24836866
51931,ranibizumab,gene,0.91,24836866
51932,bevacizumab,gene,0.865,24836866
51933,ETDRS,DNA,0.6064,24836866
51934,patients,species,0.9873,24836866
51935,patient,species,0.9897,24836866
51936,exudative AMD,disease,0.976,24836866
51937,anti-VEGF,gene,0.9404,24836866
51938,VEGF,gene,0.8916,24836865
51939,bevacizumab,gene,0.838,24836865
51940,ranibizumab,gene,0.894,24836865
51941,aflibercept,gene,0.962,24836865
51942,antivascular endothelial growth factor,gene,0.9004,24836865
51943,VEGF,gene,0.9985,24836865
51944,bevacizumab,gene,0.7646,24836865
51945,aflibercept,gene,0.986,24836865
51946,ziv-aflibercept,gene,0.9614,24836865
51947,retinal pigment epithelium cells,cell_type,0.8916,24836865
51948,Human retinal pigment epithelium cells,cell_type,0.803,24836865
51949,Human,species,0.996,24836865
51950,ARPE-19,cell_line,0.9146,24836865
51951,bevacizumab,gene,0.4883,24836865
51952,aflibercept,gene,0.941,24836865
51953,ziv-aflibercept,gene,0.978,24836865
51954,ranibizumab-treated cells,cell_line,0.8374,24836865
51955,ranibizumab,disease,0.5933,24836865
51956,-,cell_type,0.61,24836865
51957,treated cells,cell_type,0.5854,24836865
51958,ranibizumab-treated cells,cell_line,0.8706,24836865
51959,ranibizumab,gene,0.974,24836865
51960,-,cell_type,0.6206,24836865
51961,treated cells,cell_type,0.6294,24836865
51962,aflibercept,gene,0.992,24836865
51963,treated cells,cell_line,0.738,24836865
51964,bevacizumab,gene,0.5093,24836865
51965,ziv-aflibercept,gene,0.971,24836865
51966,ranibizumab,gene,0.9424,24836865
51967,aflibercept,gene,0.9736,24836865
51968,bevacizumab,gene,0.9395,24836865
51969,ziv-aflibercept,gene,0.9854,24836865
51970,pigment epithelial detachment,disease,0.989,24833182
51971,polypoidal,disease,0.927,24833182
51972,aflibercept,gene,0.991,24833178
51973,aflibercept,gene,0.9893,24833178
51974,patients,species,0.956,24833178
51975,neovascular age-related macular degeneration,disease,1.0,24833178
51976,AMD,disease,1.0,24833178
51977,bevacizumab,gene,0.8413,24833178
51978,ranibizumab,gene,0.647,24833178
51979,AMD,disease,1.0,24833178
51980,patients,species,0.9844,24833178
51981,intraretinal fluid,disease,0.8823,24833178
51982,ranibizumab,gene,0.9165,24833178
51983,bevacizumab,gene,0.571,24833178
51984,aflibercept,gene,0.808,24833178
51985,aflibercept,gene,0.941,24833178
51986,PED,disease,1.0,24833178
51987,PED,disease,0.9526,24833178
51988,patients,species,0.9634,24833178
51989,AMD,disease,0.7646,24833178
51990,aflibercept,gene,0.967,24833178
51991,SRF,disease,0.999,24833178
51992,PED,disease,0.999,24833178
51993,patient,species,0.991,24815986
51994,Infectious endophthalmitis,disease,1.0,24815986
51995,visual loss,disease,1.0,24815986
51996,patients,species,0.9805,24815986
51997,infectious endophthalmitis,disease,1.0,24815986
51998,anti-vascular endothelial growth factor,gene,0.994,24814167
51999,VEGF,gene,0.9976,24814167
52000,patients,species,0.9604,24814167
52001,VEGF,gene,0.6484,24814167
52002,neovascular,disease,0.945,24814167
52003,age-related macular degeneration,disease,1.0,24814167
52004,AMD,disease,1.0,24814167
52005,anti-VEGF,gene,0.9604,24814167
52006,anti-VEGF,gene,0.9663,24814167
52007,VEGF,gene,0.8906,24814167
52008,VEGF,gene,0.929,24814167
52009,anti-VEGF,gene,0.953,24814167
52010,thromboembolic adverse,disease,0.961,24809388
52011,VEGF,gene,0.7773,24809388
52012,neovascular age-related macular degeneration,disease,1.0,24809388
52013,VEGF,gene,0.8525,24809388
52014,age-related macular degeneration,disease,0.9995,24809388
52015,wet-AMD,disease,1.0,24809388
52016,anti-VEGF,gene,0.933,24809388
52017,VEGF,gene,0.993,24809388
52018,VEGF,gene,0.998,24809388
52019,thromboembolic events,disease,0.9834,24809388
52020,VEGF,gene,0.509,24809388
52021,stroke,disease,1.0,24809388
52022,heart attack,disease,1.0,24809388
52023,VEGF,gene,0.8286,24809388
52024,arterial thrombotic,disease,0.99,24809388
52025,VEGF,gene,0.9263,24809388
52026,VEGF,gene,0.996,24803395
52027,diabetic retinopathy,disease,1.0,24803395
52028,wet macular degeneration,disease,0.9985,24803395
52029,age-related macular degeneration,disease,1.0,24801396
52030,age-related macular degeneration,disease,1.0,24801396
52031,AMD,disease,1.0,24801396
52032,AMD,disease,1.0,24801396
52033,AMD,disease,1.0,24801396
52034,choroidal neovascularization,disease,1.0,24801396
52035,CNV,disease,1.0,24801396
52036,geographic atrophy,disease,1.0,24801396
52037,GA,disease,1.0,24801396
52038,late AMD,disease,0.961,24801396
52039,atrophy of the retinal pigment epithelium,disease,1.0,24801396
52040,RPE,cell_type,0.4915,24801396
52041,GA,disease,1.0,24801396
52042,CNV,disease,1.0,24801396
52043,RPE,cell_type,0.583,24801396
52044,CNV,DNA,0.5635,24801396
52045,GA,disease,0.9375,24801396
52046,atrophic,disease,0.999,24801396
52047,RPE,cell_line,0.5205,24801396
52048,RPE band,cell_type,0.5615,24801396
52049,atrophy,disease,0.9995,24801396
52050,CNV,disease,0.9995,24801396
52051,GA,disease,0.997,24801396
52052,advanced GA,disease,0.8115,24801396
52053,CNV,disease,1.0,24801396
52054,RPE atrophy,disease,1.0,24801396
52055,AMD,disease,0.9927,24801396
52056,aflibercept,gene,0.9873,24795335
52057,Age-related macular degeneration,disease,1.0,24795335
52058,AMD,disease,1.0,24795335
52059,vision loss,disease,0.999,24795335
52060,Wet AMD,disease,1.0,24795335
52061,choroidal neovascularisation,disease,0.9995,24795335
52062,macular oedema,disease,1.0,24795335
52063,ME,disease,1.0,24795335
52064,pigment epithelium detachments,disease,1.0,24795335
52065,PED,DNA,0.6685,24795335
52066,bevacizumab,gene,0.935,24795335
52067,ranibizumab,gene,0.9277,24795335
52068,aflibercept,gene,0.992,24795335
52069,wet AMD,disease,0.9995,24795335
52070,patients,species,0.994,24795335
52071,wet AMD,disease,0.995,24795335
52072,patients,species,0.99,24795335
52073,patients,species,0.9883,24795335
52074,bevacizumab,gene,0.877,24795335
52075,ranibizumab,gene,0.5396,24795335
52076,patients,species,0.991,24795335
52077,aflibercept,gene,0.9023,24795335
52078,patients,species,0.9927,24795335
52079,aflibercept,gene,0.986,24795335
52080,patients,species,0.9937,24795335
52081,patients,species,0.99,24795335
52082,SRF,DNA,0.506,24795335
52083,to aflibercept,gene,0.4456,24795335
52084,ranibizumab,drug,0.563,24795335
52085,aflibercept,gene,0.945,24795335
52086,patients,species,0.985,24795335
52087,aflibercept,gene,0.991,24795335
52088,aflibercept,gene,0.99,24795335
52089,ocular infections,disease,0.999,24795335
52090,aflibercept,gene,0.9966,24795334
52091,aflibercept,gene,0.9946,24795334
52092,ranibizumab,gene,0.7896,24795334
52093,bevacizumab,gene,0.783,24795334
52094,patients,species,0.9717,24795334
52095,neovascular age-related macular degeneration,disease,1.0,24795334
52096,AMD,disease,1.0,24795334
52097,patients,species,0.97,24795334
52098,neovascular AMD,disease,1.0,24795334
52099,ranibizumab,gene,0.9053,24795334
52100,bevacizumab,gene,0.79,24795334
52101,aflibercept,gene,0.927,24795334
52102,intraretinal,disease,0.577,24795334
52103,neovascular AMD,disease,1.0,24795334
52104,aflibercept,gene,0.9673,24795334
52105,aflibercept,gene,0.9854,24795334
52106,patients,species,0.971,24795334
52107,antivascular endothelial growth factor,gene,0.9976,24795334
52108,VEGF,gene,0.998,24795334
52109,aflibercept,gene,0.988,24795334
52110,aflibercept,gene,0.979,24795334
52111,patients,species,0.987,24795334
52112,anti-VEGF,gene,0.9614,24795334
52113,aflibercept,gene,0.958,24795334
52114,patients,species,0.9746,24795334
52115,anti-VEGF,gene,0.974,24795334
52116,aflibercept,gene,0.9795,24795334
52117,advanced colorectal cancer,disease,1.0,24793846
52118,K-RAS,gene,0.684,24793846
52119,Colorectal cancer,disease,1.0,24793846
52120,CRC,disease,1.0,24793846
52121,cancer,disease,1.0,24793846
52122,CRC,disease,0.9995,24793846
52123,K-RAS gene,gene,0.8545,24793846
52124,metastatic colorectal cancer,disease,1.0,24793846
52125,mCRC,disease,1.0,24793846
52126,tumour,disease,0.97,24793846
52127,epidermal growth factor receptor,gene,0.995,24793846
52128,EGFR,gene,0.9546,24793846
52129,K-RAS,DNA,0.662,24793846
52130,K-RAS mutations,gene,0.926,24793846
52131,EGFR,gene,0.9824,24793846
52132,panitumumab,gene,0.783,24793846
52133,cetuximab,gene,0.653,24793846
52134,K-RAS,gene,0.6377,24793846
52135,EGFR,gene,0.9487,24793846
52136,K-RAS,gene,0.6836,24793846
52137,CRC,disease,0.9976,24793846
52138,K-RAS gene,gene,0.8374,24793846
52139,mCRC,disease,0.6133,24793846
52140,vascular endothelial growth factor,gene,0.999,24793846
52141,VEGF,gene,0.995,24793846
52142,anti-VEGF antibody,gene,0.7686,24793846
52143,bevacizumab,gene,0.4382,24793846
52144,mCRC,disease,0.999,24793846
52145,bevacizumab,gene,0.585,24793846
52146,K-RAS,gene,0.6714,24793846
52147,EGFR,gene,0.5054,24793846
52148,mCRC,disease,0.961,24793846
52149,K-RAS gene,gene,0.853,24793846
52150,mCRC,disease,0.9604,24793846
52151,Aflibercept,gene,0.9834,24789465
52152,inflammatory choroidal neovascularization,disease,1.0,24789465
52153,ranibizumab,gene,0.9053,24789465
52154,vascular endothelial growth factor,gene,0.995,24788977
52155,macular oedema,disease,1.0,24788977
52156,central retinal vein occlusion,disease,1.0,24788977
52157,Central retinal vein occlusion,disease,1.0,24788977
52158,CRVO,disease,1.0,24788977
52159,retinal vascular disorder,disease,1.0,24788977
52160,macular oedema,disease,1.0,24788977
52161,vascular endothelial growth factor,gene,0.948,24788977
52162,VEGF,gene,0.546,24788977
52163,VEGF,gene,0.931,24788977
52164,macular oedema,disease,1.0,24788977
52165,CRVO,disease,1.0,24788977
52166,VEGF,gene,0.9946,24788977
52167,Diabetic Retinopathy,disease,1.0,24788977
52168,VEGF,gene,0.8623,24788977
52169,aflibercept,gene,0.9897,24788977
52170,VEGF Trap-Eye,gene,0.941,24788977
52171,bevacizumab,gene,0.7563,24788977
52172,pegaptanib sodium,drug,0.9985,24788977
52173,Macugen,drug,0.979,24788977
52174,ranibizumab,gene,0.7666,24788977
52175,anti-VEGF,gene,0.8794,24788977
52176,VEGF,gene,0.554,24788977
52177,anti-VEGF,gene,0.949,24788977
52178,VEGF,gene,0.794,24788977
52179,CRVO,disease,1.0,24788977
52180,macular oedema,disease,0.976,24788977
52181,VEGF,gene,0.513,24788977
52182,aflibercept,gene,0.991,24777708
52183,age-related macular degeneration,disease,1.0,24777708
52184,bevacizumab,gene,0.853,24777708
52185,ranibizumab,gene,0.6357,24777708
52186,Age-related macular degeneration,disease,1.0,24777708
52187,AMD,disease,1.0,24777708
52188,blinding disease,disease,1.0,24777708
52189,blindness,disease,0.9995,24777708
52190,anti-vascular endothelial growth factors,gene,0.9873,24777708
52191,anti-VEGFs,gene,0.9814,24777708
52192,blindness,disease,0.9995,24777708
52193,Aflibercept,gene,0.9697,24777708
52194,anti-VEGF,gene,0.907,24777708
52195,ranibizumab,gene,0.5024,24777708
52196,aflibercept,gene,0.9907,24777708
52197,bevacizumab,gene,0.731,24777708
52198,ranibizumab,gene,0.6284,24777708
52199,aflibercept,gene,0.972,24777708
52200,bevacizumab,gene,0.923,24777708
52201,ranibizumab,gene,0.659,24777708
52202,AMD,disease,1.0,24777708
52203,aflibercept,gene,0.951,24777708
52204,bevacizumab,gene,0.71,24777708
52205,ranibizumab,gene,0.739,24777708
52206,aflibercept,gene,0.992,24777708
52207,bevacizumab,gene,0.7417,24777708
52208,blindness,disease,1.0,24777708
52209,low-vision,disease,1.0,24777708
52210,Aflibercept,gene,0.9595,24777708
52211,AMD,disease,0.9995,24777708
52212,ranibizumab,gene,0.8477,24777708
52213,aflibercept,gene,0.9917,24777708
52214,bevacizumab,gene,0.8677,24777708
52215,aflibercept,gene,0.966,24777708
52216,aflibercept,gene,0.986,24771183
52217,choroidal neovascularization,disease,1.0,24771183
52218,wet age-related macular degeneration,disease,0.959,24771183
52219,aflibercept,gene,0.9624,24771183
52220,choroidal neovascularization,disease,1.0,24771183
52221,CNV,disease,0.9995,24771183
52222,age-related macular degeneration,disease,1.0,24771183
52223,AMD,disease,1.0,24771183
52224,PATIENTS,species,0.957,24771183
52225,CNV,disease,1.0,24771183
52226,fluorescein,drug,0.999,24771183
52227,hemorrhage,disease,0.9995,24771183
52228,CNV,disease,0.9395,24771183
52229,retinal angiomatous proliferation,disease,1.0,24771183
52230,polypoidal choroidal vasculopathy,disease,0.924,24771183
52231,pigment epithelial detachments,cell_type,0.574,24771183
52232,rip of the,disease,0.844,24771183
52233,aflibercept,gene,0.9746,24771183
52234,CNV,disease,0.999,24771183
52235,Aflibercept,gene,0.9385,24771183
52236,pigment epithelial,cell_type,0.4817,24771183
52237,pigment,disease,0.752,24771183
52238,exudative AMD,disease,0.9995,24771183
52239,metastatic colorectal cancer,disease,0.9966,24768040
52240,metastatic colorectal cancer,disease,1.0,24768040
52241,mCRC,disease,1.0,24768040
52242,bevacizumab,gene,0.874,24768040
52243,ziv-aflibercept,gene,0.9863,24768040
52244,regorafenib,drug,0.988,24768040
52245,mCRC,disease,0.9946,24768040
52246,bevacizumab,gene,0.9062,24768040
52247,mCRC,disease,0.966,24768040
52248,FOLFOX,drug,0.7363,24768040
52249,folinic acid,drug,0.9995,24768040
52250,5-fluorouracil,drug,0.9995,24768040
52251,oxaliplatin,drug,0.9995,24768040
52252,folinic acid,drug,0.9995,24768040
52253,5-fluorouracil,drug,0.9995,24768040
52254,irinotecan,drug,0.9985,24768040
52255,epidermal growth factor receptor,gene,0.9966,24768040
52256,cetuximab,gene,0.905,24768040
52257,panitumumab,gene,0.925,24768040
52258,wild-type KRAS,gene,0.7847,24768040
52259,ziv-aflibercept,gene,0.9805,24768040
52260,FOLFIRI,drug,0.946,24768040
52261,mCRC,disease,0.917,24768040
52262,Regorafenib,drug,0.995,24768040
52263,mCRC,disease,0.999,24768040
52264,mCRC,disease,0.9624,24768040
52265,glioblastoma multiforme,disease,1.0,24759636
52266,malignant gliomas,disease,1.0,24759636
52267,gliomas,disease,1.0,24759636
52268,tumor,disease,1.0,24759636
52269,intracranial,disease,0.9404,24759636
52270,glioma,disease,0.679,24759636
52271,sunitinib,drug,0.9966,24759636
52272,VEGF,gene,0.9897,24759636
52273,B20,gene,0.615,24759636
52274,bevacizumab,gene,0.9204,24759636
52275,tumor cell,cell_type,0.604,24759636
52276,tumor,disease,0.9995,24759636
52277,tumor,disease,0.993,24759636
52278,tumor,disease,0.9956,24759636
52279,tumor,disease,0.9985,24759636
52280,tumor cell,cell_type,0.577,24759636
52281,tumor,disease,0.9976,24759636
52282,Vascular endothelial growth factor,gene,0.998,24759636
52283,VEGF,gene,0.998,24759636
52284,B20,gene,0.668,24759636
52285,sunitinib,drug,0.9966,24759636
52286,tumor,disease,0.9985,24759636
52287,tumor,disease,0.6616,24759636
52288,AATx,gene,0.9067,24759636
52289,prostate cancer,disease,1.0,24759579
52290,tumor,disease,1.0,24759579
52291,tumor-associated stromal cells,cell_type,0.9126,24759579
52292,tumor,disease,0.8916,24759579
52293,tumor,disease,1.0,24759579
52294,malignancies,disease,1.0,24759579
52295,endothelial cells,cell_type,0.9297,24759579
52296,solid tumors,disease,1.0,24759579
52297,"kidney, non-small cell lung, colon and brain cancers",disease,1.0,24759579
52298,patients,species,0.97,24759579
52299,metastatic prostate cancer,disease,1.0,24759579
52300,cancer,disease,1.0,24759579
52301,patient,species,0.9697,24744930
52302,metastatic colorectal cancer,disease,1.0,24744930
52303,liver metastases,disease,0.9907,24744930
52304,patients,species,0.958,24744930
52305,metastatic colorectal cancer,disease,1.0,24744930
52306,mCRC,disease,1.0,24744930
52307,patients,species,0.981,24744930
52308,5-fluorouracil,drug,0.9995,24744930
52309,oxaliplatin,drug,0.9985,24744930
52310,FOLFOX,drug,0.9214,24744930
52311,bevacizumab,gene,0.7153,24744930
52312,patients,species,0.9844,24744930
52313,bevacizumab,gene,0.7466,24744930
52314,patients,species,0.986,24744930
52315,bevacizumab,gene,0.864,24744930
52316,FOLFIRI,drug,0.966,24744930
52317,aflibercept,gene,0.976,24744930
52318,Neurotoxicity,disease,0.994,24744930
52319,oxaliplatin,drug,0.9995,24744930
52320,mCRC,disease,1.0,24744930
52321,patient,species,0.988,24744930
52322,liver metastases,disease,0.9917,24744930
52323,capecitabine,drug,0.9995,24744930
52324,oxaliplatin,drug,0.9995,24744930
52325,XELOX,drug,0.991,24744930
52326,oxaliplatin,drug,0.9995,24744930
52327,patient,species,0.9824,24744930
52328,FOLFIRI,drug,0.9604,24744930
52329,aflibercept,gene,0.9604,24744930
52330,VEGF,gene,0.8228,24741610
52331,diabetic macular edema,disease,1.0,24741610
52332,Diabetic retinopathy,disease,1.0,24741610
52333,DR,disease,1.0,24741610
52334,vision loss,disease,0.999,24741610
52335,patients,species,0.983,24741610
52336,DR,disease,,24741610
52337,diabetic macular edema,disease,1.0,24741610
52338,DME,disease,1.0,24741610
52339,vision impairment,disease,0.999,24741610
52340,visual loss,disease,0.6606,24741610
52341,vascular endothelial growth factor,gene,0.9985,24741610
52342,VEGF,gene,0.9956,24741610
52343,DR,disease,,24741610
52344,DME,disease,1.0,24741610
52345,anti-VEGF,gene,0.8794,24741610
52346,DME,disease,1.0,24741610
52347,pegaptanib,drug,0.984,24741610
52348,ranibizumab,drug,0.568,24741610
52349,bevacizumab,gene,0.8667,24741610
52350,aflibercept,gene,0.956,24741610
52351,DME,disease,1.0,24741610
52352,anti-VEGF,gene,0.7744,24741610
52353,DME,disease,1.0,24741610
52354,anti-VEGF,gene,0.906,24741610
52355,DME,disease,1.0,24741610
52356,aflibercept,gene,0.9937,24740170
52357,Eylea,gene,0.7607,24740170
52358,patients,species,0.9775,24740170
52359,macular,disease,0.511,24740170
52360,Aflibercept,gene,0.5034,24740170
52361,human,species,0.9844,24740170
52362,vascular endothelial growth factor,gene,0.9976,24740170
52363,VEGF,gene,0.905,24740170
52364,VEGF-A,gene,0.9976,24740170
52365,VEGF-B,gene,0.998,24740170
52366,placental growth factor,gene,0.9976,24740170
52367,P1GF,gene,0.9937,24740170
52368,Aflibercept,gene,0.9795,24740170
52369,VEGF-A,gene,0.9976,24740170
52370,ranibizumab,gene,0.897,24740170
52371,bevacizumab,gene,0.728,24740170
52372,aflibercept,gene,0.989,24740170
52373,patients,species,0.9746,24740170
52374,macular oedema,disease,1.0,24740170
52375,central retinal vein occlusion,disease,1.0,24740170
52376,CRVO,disease,1.0,24740170
52377,patients,species,0.97,24740170
52378,aflibercept,gene,0.9805,24740170
52379,Diabetic Retinopathy,disease,1.0,24740170
52380,aflibercept,gene,0.982,24740170
52381,aflibercept,gene,0.9766,24740170
52382,aflibercept,gene,0.967,24740170
52383,macular oedema,disease,1.0,24740170
52384,CRVO,disease,1.0,24740170
52385,aflibercept,gene,0.9814,24706352
52386,exudative age-related macular degeneration,disease,1.0,24706352
52387,aflibercept,gene,0.986,24706352
52388,vascular endothelial growth factor,gene,0.998,24706352
52389,exudative age-related macular degeneration,disease,1.0,24706352
52390,aflibercept,gene,0.985,24706352
52391,ranibizumab,gene,0.9097,24706352
52392,bevacizumab,gene,0.806,24706352
52393,patients,species,0.975,24706352
52394,exudative age-related macular degeneration,disease,0.999,24706352
52395,aflibercept,gene,0.975,24706352
52396,bevacizumab,gene,0.5356,24706352
52397,aflibercept,gene,0.9863,24706352
52398,bevacizumab,gene,0.7075,24706352
52399,aflibercept,gene,0.976,24706352
52400,aflibercept,gene,0.962,24706352
52401,ranibizumab,gene,0.6367,24706352
52402,bevacizumab,gene,0.5254,24706352
52403,aflibercept,gene,0.9707,24706352
52404,aflibercept,gene,0.9746,24706352
52405,aflibercept,gene,0.971,24706352
52406,Aflibercept,gene,0.9736,24706352
52407,patients,species,0.98,24706352
52408,bevacizumab,gene,0.775,24706352
52409,aflibercept,gene,0.972,24706352
52410,bevacizumab,gene,0.679,24706352
52411,vascular endothelial growth factor,gene,0.998,24705878
52412,antivascular endothelial growth factor-A,gene,0.9985,24705878
52413,VEGF,gene,0.9995,24705878
52414,VEGF,gene,0.9805,24705878
52415,VEGF,gene,0.9966,24705878
52416,recombinant Sticky-trap,gene,0.97,24705878
52417,photoreceptors,cell_type,0.5513,24705878
52418,patients,species,0.9424,24705878
52419,diabetic retinopathy,disease,1.0,24705878
52420,retinopathy of pre-maturity,disease,1.0,24705878
52421,Malignant ascites,disease,1.0,24692682
52422,ovarian cancer,disease,1.0,24692682
52423,Ovarian cancer,disease,1.0,24692682
52424,OC,disease,1.0,24692682
52425,gynecological malignancy,disease,1.0,24692682
52426,gynecological cancer,disease,1.0,24692682
52427,Malignant ascites,disease,1.0,24692682
52428,OC,disease,,24692682
52429,patients,species,0.974,24692682
52430,OC,disease,,24692682
52431,Tumor cells,cell_type,0.828,24692682
52432,OC,disease,,24692682
52433,malignant ascites,disease,0.998,24692682
52434,patient,species,0.925,24692682
52435,peritoneal effusions,disease,0.933,24692682
52436,malignant ascites,disease,1.0,24692682
52437,anti-epithelial cell adhesion molecule,gene,0.9985,24692682
52438,anti-cluster of differentiation 3 monoclonal antibody catumaxumab,gene,0.938,24692682
52439,malignant ascites,disease,1.0,24692682
52440,bevacizumab,gene,0.846,24692682
52441,malignant ascites,disease,1.0,24692682
52442,Vascular endothelial growth factor (VEGF,gene,0.865,24692682
52443,aflibercept,gene,0.9863,24692682
52444,VEGF-receptor,gene,0.9595,24692682
52445,Aflibercept,gene,0.9707,24692682
52446,ascites,disease,0.999,24692682
52447,ascites,disease,0.9995,24692682
52448,ascites,disease,0.9995,24692682
52449,patient,species,0.969,24692682
52450,ascites,disease,0.991,24692682
52451,tumor,disease,1.0,24692682
52452,aflibercept,gene,0.9946,24688047
52453,bevacizumab,gene,0.8193,24688047
52454,patient,species,0.974,24688047
52455,recombinant fusion protein,gene,0.742,24688047
52456,aflibercept,gene,0.769,24688047
52457,ziv-aflibercept,gene,0.992,24688047
52458,VEGF-A,gene,0.9976,24688047
52459,VEGF-B,gene,0.996,24688047
52460,placental growth factor,gene,0.998,24688047
52461,PlGF,gene,0.9873,24688047
52462,bevacizumab,gene,0.7056,24688047
52463,VEGF-A,gene,0.9946,24688047
52464,VEGF,gene,0.9985,24688047
52465,PlGF,gene,0.997,24688047
52466,aflibercept,gene,0.9907,24688047
52467,bevacizumab,gene,0.7524,24688047
52468,patient-derived xenograft (PDX) colorectal,cell_line,0.6816,24688047
52469,patient,species,0.9565,24688047
52470,colorectal cancer,disease,1.0,24688047
52471,PDX colorectal,cell_line,0.579,24688047
52472,colorectal cancer tumors,disease,1.0,24688047
52473,aflibercept,gene,0.985,24688047
52474,bevacizumab,gene,0.626,24688047
52475,aflibercept,gene,0.9937,24688047
52476,bevacizumab,gene,0.705,24688047
52477,mouse,species,0.987,24688047
52478,human,species,0.9946,24688047
52479,VEGF-A,gene,0.999,24688047
52480,PlGF,gene,0.993,24688047
52481,tumors,disease,1.0,24688047
52482,Aflibercept,gene,0.977,24688047
52483,tumor,disease,0.9995,24688047
52484,bevacizumab,gene,0.7944,24688047
52485,aflibercept,gene,0.993,24688047
52486,aflibercept,gene,0.992,24688047
52487,bevacizumab,gene,0.52,24688047
52488,hVEGF,DNA,0.4854,24688047
52489,hVEGF-A,gene,0.995,24688047
52490,mVEGF-A,gene,0.9937,24688047
52491,mPlGF,gene,0.9956,24688047
52492,hPlGF,gene,0.997,24688047
52493,Tumor cells,cell_type,0.8574,24688047
52494,Tumor,disease,0.8,24688047
52495,VEGF,gene,0.9946,24688047
52496,PlGF,gene,0.986,24688047
52497,tumor,disease,0.985,24688047
52498,hVEGF-A,gene,0.9946,24688047
52499,mVEGF-A,gene,0.993,24688047
52500,bevacizumab,drug,0.5923,24688047
52501,mVEGF-A,gene,0.982,24688047
52502,aflibercept,gene,0.9897,24688047
52503,PlGF,gene,0.9805,24688047
52504,VEGFR-1,gene,0.991,24688047
52505,colorectal cancer,disease,1.0,24688047
52506,aflibercept,gene,0.989,24688047
52507,bevacizumab,gene,0.8647,24688047
52508,aflibercept,gene,0.9927,24679444
52509,macular edema,disease,1.0,24679444
52510,central retinal vein,disease,0.9243,24679444
52511,aflibercept,gene,0.9937,24679444
52512,macular edema,disease,1.0,24679444
52513,central retinal vein occlusion,disease,1.0,24679444
52514,CRVO,disease,1.0,24679444
52515,PARTICIPANTS,species,0.787,24679444
52516,patients,species,0.9663,24679444
52517,macular edema,disease,1.0,24679444
52518,CRVO,disease,1.0,24679444
52519,Patients,species,0.9463,24679444
52520,patients,species,0.976,24679444
52521,patients,species,0.9634,24679444
52522,patients,species,0.9844,24679444
52523,patients,species,0.966,24679444
52524,BCVA,DNA,0.508,24679444
52525,vitreous hemorrhage,disease,1.0,24679444
52526,prostate cancer,disease,1.0,24658665
52527,metastatic castration-resistant prostate cancer,disease,1.0,24658665
52528,mCRPC,disease,1.0,24658665
52529,androgen,drug,0.996,24658665
52530,abiraterone acetate,drug,0.8604,24658665
52531,cabazitaxel,drug,0.996,24658665
52532,radium,drug,0.9673,24658665
52533,-,DNA,0.488,24658665
52534,castrate-resistant prostate cancer,disease,1.0,24658665
52535,androgen,drug,0.9995,24658665
52536,androgen,drug,0.9995,24658665
52537,TAK700,drug,0.999,24658665
52538,androgen,drug,0.9995,24658665
52539,androgen receptor,gene,0.9946,24658665
52540,ARN-509,drug,0.999,24658665
52541,ODM-201,drug,0.9937,24658665
52542,AR,gene,,24658665
52543,EPI-001,drug,0.9976,24658665
52544,AR,gene,,24658665
52545,AZD-3514,drug,0.999,24658665
52546,androgen,drug,0.987,24658665
52547,TOK-,drug,0.997,24658665
52548,galeterone,drug,0.994,24658665
52549,CTLA-4,gene,0.9946,24658665
52550,cabozantinib,drug,0.9976,24658665
52551,Met,gene,0.9956,24658665
52552,VEGFR2,gene,0.997,24658665
52553,tasquinimod,drug,0.995,24658665
52554,docetaxel,drug,0.9976,24658665
52555,bevacizumab,gene,0.9453,24658665
52556,aflibercept,gene,0.977,24658665
52557,lenalinomide,drug,0.999,24658665
52558,SRC kinase,gene,0.9775,24658665
52559,dasatinib,drug,0.9976,24658665
52560,endothelin receptor,gene,0.9976,24658665
52561,atrasentan,drug,0.999,24658665
52562,zibotentan,drug,0.9976,24658665
52563,calcitriol,drug,0.998,24658665
52564,DN,drug,1.0,24658665
52565,docetaxel,drug,0.9976,24658665
52566,clusterin,gene,0.987,24658665
52567,custirsen,drug,0.997,24658665
52568,bone metastases,disease,0.987,24658665
52569,zoledronic acid,drug,0.9985,24658665
52570,denosumab,gene,0.618,24658665
52571,aflibercept,gene,0.985,24631334
52572,VEGF,gene,0.992,24631334
52573,vascular endothelial growth factor,gene,0.9985,24631334
52574,VEGF,gene,0.9907,24631334
52575,retinal endothelial cells,cell_type,0.9185,24631334
52576,REC,gene,0.923,24631334
52577,diabetic retinopathy,disease,1.0,24631334
52578,VEGF-A,gene,0.9985,24631334
52579,placenta growth factor,gene,0.998,24631334
52580,PlGF,gene,0.9917,24631334
52581,immortalized bovine REC,cell_line,0.814,24631334
52582,bovine,species,0.9463,24631334
52583,(i)BREC,cell_line,0.795,24631334
52584,VEGF-A165,gene,0.997,24631334
52585,Diabetic macular edema,disease,1.0,24631334
52586,REC,cell_line,0.6865,24631334
52587,REC,cell_type,0.876,24631334
52588,VEGF-A,gene,0.997,24631334
52589,PlGF,gene,0.9917,24631334
52590,VEGF-A,gene,0.9956,24631334
52591,VEGF-A,gene,0.997,24631334
52592,iBREC,cell_type,0.791,24631334
52593,recombinant protein aflibercept,gene,0.9746,24631334
52594,VEGF-trap,gene,0.9883,24631334
52595,VEGF-A,gene,0.998,24631334
52596,PlGF,gene,0.9893,24631334
52597,PlGF,gene,0.992,24631334
52598,iBREC barrier,cell_line,0.6885,24631334
52599,aflibercept,gene,0.991,24631334
52600,iBREC,cell_line,0.952,24631334
52601,iBREC,cell_type,0.783,24631334
52602,aflibercept,gene,0.983,24631334
52603,iBREC,cell_line,0.9067,24631334
52604,VEGF-A,gene,0.998,24631334
52605,PlGF,gene,0.993,24631334
52606,aflibercept,gene,0.9844,24631334
52607,VEGF-A,gene,0.9966,24631334
52608,iBREC,cell_line,0.939,24631334
52609,iBREC,cell_type,0.852,24631334
52610,VEGF-A,gene,0.998,24631334
52611,rituximab,gene,0.9277,24631334
52612,VEGF-A,gene,0.996,24631334
52613,IgG domain,gene,0.924,24631334
52614,aflibercept,gene,0.9585,24631334
52615,VEGF-A,gene,0.9956,24631334
52616,iBREC,cell_line,0.951,24631334
52617,VEGF-A165,gene,0.998,24631334
52618,claudin-1,gene,0.9336,24631334
52619,VEGF-A,gene,0.9976,24631334
52620,aflibercept,gene,0.9814,24631334
52621,aflibercept,gene,0.9927,24631334
52622,iBREC,cell_line,0.9536,24631334
52623,iBREC,cell_type,0.7715,24631334
52624,aflibercept,gene,0.989,24631334
52625,aflibercept,gene,0.995,24631334
52626,iBREC,cell_line,0.952,24631334
52627,Aflibercept,gene,0.952,24631334
52628,iBREC,cell_type,0.8726,24631334
52629,VEGF-A,gene,0.996,24631334
52630,DR,disease,,24631334
52631,DME,drug,0.6304,24631334
52632,vascular endothelial growth factor decoy receptor,gene,0.9854,24622811
52633,vascular endothelial growth factor decoy receptor,gene,0.9346,24622811
52634,VEGF Trap,gene,0.9844,24622811
52635,nude mice,species,0.722,24622811
52636,human melanoma cell line,cell_line,0.9277,24622811
52637,human,species,0.9976,24622811
52638,melanoma,disease,0.997,24622811
52639,DB-1,cell_line,0.9463,24622811
52640,VEGF Trap,gene,0.987,24622811
52641,endothelial cells,cell_type,0.928,24622811
52642,CD31,gene,0.9917,24622811
52643,cyclooxygenase-2,gene,0.993,24622811
52644,COX-2,gene,0.9956,24622811
52645,VEGF,gene,0.995,24622811
52646,Glut1,gene,0.991,24622811
52647,tumor,disease,0.962,24622811
52648,VEGF,gene,0.9907,24622811
52649,mice,species,0.9854,24622811
52650,PIHI,disease,0.7627,24622811
52651,CD31,gene,0.9766,24622811
52652,COX-2,gene,0.991,24622811
52653,VEGF,gene,0.996,24622811
52654,VEGF Trap,gene,0.954,24622811
52655,DB-1 human melanoma xenograft model,cell_line,0.86,24622811
52656,human,species,0.9907,24622811
52657,melanoma,disease,0.993,24622811
52658,metastatic colorectal cancer,disease,1.0,24616571
52659,Colorectal cancer,disease,1.0,24616571
52660,patients,species,0.985,24616571
52661,metastatic,disease,0.6416,24616571
52662,colorectal cancer,disease,0.885,24616571
52663,patient,species,0.94,24616571
52664,bevacizumab,gene,0.963,24616571
52665,cetuximab,gene,0.9653,24616571
52666,aflibercept,gene,0.988,24616571
52667,panitumumab,gene,0.936,24616571
52668,regorafenib,drug,0.9795,24616571
52669,FOLFOX,drug,0.9727,24616571
52670,XELOX,drug,0.7524,24616571
52671,FOLFIRI,drug,0.7837,24616571
52672,Metastatic colorectal cancer,disease,0.9995,24616571
52673,patients,species,0.9946,24616571
52674,metastatic colorectal cancer,disease,0.9946,24616571
52675,metastatic colorectal cancer,disease,1.0,24616571
52676,patients,species,0.991,24616571
52677,aflibercept,gene,0.9844,24614949
52678,aflibercept,gene,0.984,24614949
52679,patients,species,0.8784,24614949
52680,neovascular AMD,disease,1.0,24614949
52681,VEGF,gene,0.6943,24614949
52682,ranibizumab,gene,0.8027,24614949
52683,bevacizumab,gene,0.534,24614949
52684,ranibizumab,gene,0.9165,24614949
52685,bevacizumab,gene,0.6694,24614949
52686,aflibercept,gene,0.8936,24614949
52687,patients,species,0.9844,24614949
52688,aflibercept,gene,0.978,24614949
52689,aflibercept,gene,0.994,24614949
52690,PED,DNA,0.5527,24614949
52691,aflibercept,gene,0.9917,24614949
52692,PED,disease,0.9976,24614949
52693,aflibercept,gene,0.956,24614949
52694,aflibercept,gene,0.9844,24614949
52695,CRT,DNA,0.47,24614949
52696,anti-VEGF,gene,0.9473,24614949
52697,Retinal edema,disease,1.0,24614949
52698,PEDs,disease,0.996,24614949
52699,aflibercept,gene,0.9795,24614949
52700,patients,species,0.9707,24614949
52701,ranibizumab,gene,0.8584,24614949
52702,bevacizumab,gene,0.65,24614949
52703,vascular endothelial growth factor,gene,0.9834,24602183
52704,vascular endothelial growth factor,gene,0.9897,24602183
52705,VEGF,gene,0.9976,24602183
52706,ocular disorders,disease,0.996,24602183
52707,neovascular age-related macular degeneration,disease,1.0,24602183
52708,nAMD,disease,1.0,24602183
52709,diabetic macular oedema,disease,1.0,24602183
52710,DMO,disease,1.0,24602183
52711,macular oedema,disease,1.0,24602183
52712,retinal vein occlusion,disease,1.0,24602183
52713,RVO,disease,1.0,24602183
52714,choroidal neovascularization,disease,1.0,24602183
52715,visual impairment,disease,1.0,24602183
52716,blindness,disease,1.0,24602183
52717,Ranibizumab,gene,0.926,24602183
52718,Lucentis,gene,0.717,24602183
52719,bevacizumab,gene,0.844,24602183
52720,bevacizumab,drug,0.6914,24602183
52721,Bevacizumab,gene,0.8125,24602183
52722,ranibizumab,gene,0.5415,24602183
52723,bevacizumab,gene,0.7905,24602183
52724,VEGF,gene,0.895,24602183
52725,metastatic colorectal cancer,disease,0.999,24597359
52726,colorectal cancer,disease,1.0,24597359
52727,regorafenib,drug,0.995,24597359
52728,aflibercept,gene,0.977,24597359
52729,Aflibercept,gene,0.9736,24597359
52730,bevacizumab,gene,0.9204,24597359
52731,metastatic colorectal cancer,disease,0.9995,24597359
52732,human,species,0.732,24597359
52733,human VEGFR-2,gene,0.9365,24597359
52734,human,species,0.949,24597359
52735,VEGF,gene,0.9907,24597359
52736,serous retinal pigment epithelial,cell_type,0.4902,24591809
52737,serous retinal pigment epithelial detachments,disease,0.9956,24591809
52738,aflibercept,gene,0.981,24591809
52739,polypoidal choroidal vasculopathy,disease,1.0,24591809
52740,aflibercept,gene,0.98,24591809
52741,retinal pigment epithelial detachment,disease,1.0,24591809
52742,PED,disease,1.0,24591809
52743,polypoidal choroidal vasculopathy,disease,1.0,24591809
52744,PCV,disease,1.0,24591809
52745,PEDs,disease,0.998,24591809
52746,PCV,disease,1.0,24591809
52747,aflibercept,gene,0.9673,24591809
52748,ranibizumab,gene,0.571,24591809
52749,RPE,cell_type,0.603,24591809
52750,PEDs,disease,0.919,24591809
52751,aflibercept,gene,0.9883,24591809
52752,fibrovascular PED,disease,0.946,24591809
52753,retinal hemorrhage,disease,0.999,24591809
52754,PED,disease,1.0,24591809
52755,aflibercept,gene,0.9897,24591809
52756,RPE,cell_type,0.557,24591809
52757,serous PED,disease,0.7495,24591809
52758,aflibercept,gene,0.9824,24591809
52759,PCV,disease,1.0,24591809
52760,diabetic macular edema,disease,1.0,24573663
52761,Macular edema,disease,1.0,24573663
52762,vision loss,disease,0.996,24573663
52763,diabetes,disease,1.0,24573663
52764,diabetic macular edema,disease,1.0,24573663
52765,DME,disease,0.8945,24573663
52766,DME,disease,0.999,24573663
52767,triamcinolone,drug,0.996,24573663
52768,vascular,DNA,0.496,24573663
52769,vascular endothelial growth factor,gene,0.9985,24573663
52770,VEGF,gene,0.998,24573663
52771,triamcinolone,drug,0.9883,24573663
52772,VEGF,gene,0.996,24573663
52773,triamcinolone,drug,0.9927,24573663
52774,VEGF,gene,0.996,24573663
52775,VEGF,gene,0.997,24573663
52776,triamcinolone,drug,0.9907,24573663
52777,VEGF,gene,0.9907,24573663
52778,VEGF,gene,0.988,24573663
52779,VEGF,gene,0.995,24573663
52780,bevacizumab,gene,0.8457,24573663
52781,ranibizumab,gene,0.5156,24573663
52782,DME,disease,1.0,24573663
52783,VEGF,gene,0.9956,24573663
52784,Aflibercept,gene,0.959,24552305
52785,neovascular age-related macular degeneration,disease,1.0,24552305
52786,neovascular age-related macular degeneration,disease,1.0,24552305
52787,AMD,disease,1.0,24552305
52788,Lucentis,gene,0.479,24552305
52789,Avastin,gene,0.4983,24552305
52790,aflibercept,gene,0.985,24552305
52791,VEGF Trap-Eye,gene,0.9478,24552305
52792,aflibercept,gene,0.9644,24552305
52793,anti-,gene,0.7256,24552305
52794,vascular endothelial growth factor,gene,0.8853,24552305
52795,AMD,disease,0.999,24552305
52796,aflibercept,gene,0.9756,24552305
52797,bevacizumab,gene,0.677,24552305
52798,ranibizumab,drug,0.4995,24552305
52799,ranibizumab,gene,0.819,24552305
52800,bevacizumab,gene,0.568,24552305
52801,aflibercept,gene,0.9707,24552305
52802,central macular edema,disease,1.0,24552305
52803,aflibercept,gene,0.9336,24552305
52804,aflibercept,gene,0.9683,24552305
52805,aflibercept,gene,0.943,24552305
52806,AMD,disease,0.999,24552305
52807,ocular hypertension,disease,1.0,24552305
52808,aflibercept,gene,0.989,24552305
52809,VEGF,gene,0.6807,24550366
52810,oxygen,drug,0.9995,24550366
52811,retinopathy,disease,0.8403,24550366
52812,VEGF,gene,0.996,24550366
52813,VEGF,gene,0.9927,24550366
52814,premature,cell_type,0.4846,24550366
52815,VEGF,gene,0.546,24550366
52816,mouse,species,0.9067,24550366
52817,retinopathy,disease,1.0,24550366
52818,mice,species,0.927,24550366
52819,oxygen,drug,1.0,24550366
52820,VEGF,gene,0.9907,24550366
52821,aflibercept,gene,0.9673,24550366
52822,VEGF,gene,0.994,24550366
52823,Aflibercept,gene,0.9224,24550366
52824,VEGF,gene,0.9917,24550366
52825,metastatic colorectal cancer,disease,0.999,24534706
52826,fluoropyrimidines,drug,0.9995,24534706
52827,oxaliplatin,drug,0.9995,24534706
52828,irinotecan,drug,0.999,24534706
52829,metastatic colorectal cancer,disease,1.0,24534706
52830,mCRC,disease,1.0,24534706
52831,cetuximab,gene,0.954,24534706
52832,ziv-aflibercept,gene,0.988,24534706
52833,regorafenib,drug,0.9473,24534706
52834,fluoropyrimidine,drug,0.999,24534706
52835,oxaliplatin,drug,1.0,24534706
52836,irinotecan,drug,0.9985,24534706
52837,5-fluorouracil,drug,0.9995,24534706
52838,5-FU,drug,0.9995,24534706
52839,5-FU,drug,0.9966,24534706
52840,Capecitabine,drug,0.9995,24534706
52841,5-FU,drug,0.999,24534706
52842,oxaliplatin,drug,1.0,24534706
52843,irinotecan,drug,0.9995,24534706
52844,oxaliplatin,drug,0.9995,24534706
52845,irinotecan,drug,0.998,24534706
52846,bevacizumab,gene,0.8613,24534706
52847,ziv-aflibercept,gene,0.983,24534706
52848,epidermal growth factor receptor,gene,0.9985,24534706
52849,cetuximab,gene,0.63,24534706
52850,panitumumab,gene,0.86,24534706
52851,mCRC,disease,0.982,24534706
52852,KRAS,DNA,0.8223,24534706
52853,KRAS mutational,gene,0.773,24534706
52854,aflibercept,gene,0.9507,24522032
52855,docetaxel,drug,0.9976,24522032
52856,prednisone,drug,0.998,24522032
52857,metastatic castration-resistant prostate cancer,disease,1.0,24522032
52858,Aflibercept,gene,0.9595,24518078
52859,exudative age-related macular degeneration,disease,0.9995,24518078
52860,ranibizumab,gene,0.6636,24518078
52861,aflibercept,gene,0.985,24518078
52862,exudative age-related macular degeneration,disease,0.998,24518078
52863,AMD,disease,1.0,24518078
52864,aflibercept,gene,0.986,24518078
52865,Diabetic Retinopathy,disease,0.962,24518078
52866,aflibercept,gene,0.9824,24518078
52867,antivascular endothelial growth factor-A,gene,0.9863,24518078
52868,anti-VEGF,gene,0.9775,24518078
52869,ETDRS,DNA,0.559,24518078
52870,BCVA,cell_type,0.4204,24518078
52871,aflibercept,gene,0.9844,24518078
52872,Aflibercept,gene,0.8823,24518078
52873,ranibizumab,gene,0.911,24518078
52874,wet AMD,disease,0.998,24518078
52875,Aflibercept,gene,0.921,24518078
52876,macular oedema,disease,1.0,24513867
52877,central retinal vein occlusion,disease,1.0,24513867
52878,macular oedema,disease,1.0,24513867
52879,central retinal vein occlusion,disease,1.0,24513867
52880,CRVO,disease,1.0,24513867
52881,PARTICIPANTS,species,0.8994,24513867
52882,CRVO,disease,1.0,24513867
52883,aflibercept,gene,0.9766,24513867
52884,triamcinolone,drug,0.9995,24513867
52885,bevacizumab,gene,0.565,24513867
52886,pegaptanib,drug,0.9985,24513867
52887,dexamethasone,drug,0.9995,24513867
52888,bevacizumab,gene,0.841,24513867
52889,ranibizumab,gene,0.7754,24513867
52890,aflibercept,gene,0.97,24513867
52891,triamcinolone,drug,0.9956,24513867
52892,pegaptanib,drug,0.9995,24513867
52893,dexamethasone,drug,0.9985,24513867
52894,Steroids,drug,0.919,24513867
52895,cataract,disease,0.9995,24513867
52896,bevacizumab,gene,0.866,24513867
52897,ranibizumab,gene,0.8784,24513867
52898,aflibercept,gene,0.981,24513867
52899,pegaptanib,drug,0.9966,24513867
52900,non-ischaemic CRVO,disease,0.887,24513867
52901,Bevacizumab,gene,0.8354,24513867
52902,ranibizumab,gene,0.8555,24513867
52903,aflibercept,gene,0.9395,24513867
52904,triamcinolone,drug,0.995,24513867
52905,macular oedema,disease,1.0,24513867
52906,CRVO,disease,1.0,24513867
52907,ischaemic CRVO,disease,1.0,24513867
52908,metastatic colorectal cancer,disease,1.0,24511107
52909,metastatic colorectal cancer,disease,1.0,24511107
52910,mCRC,disease,1.0,24511107
52911,mCRC,disease,0.9976,24511107
52912,fluoropyrimidine,drug,0.9995,24511107
52913,oxaliplatin,drug,0.9995,24511107
52914,bevacizumab,gene,0.925,24511107
52915,bevacizumab,gene,0.6265,24511107
52916,bevacizumab,gene,0.7354,24511107
52917,anti-EGFR monoclonal antibody,gene,0.9556,24511107
52918,cetuximab,gene,0.6504,24511107
52919,panitumumab,gene,0.5586,24511107
52920,anti-EGFR antibody,gene,0.989,24511107
52921,Anti-,gene,0.8594,24511107
52922,EGFR antibody,gene,0.6826,24511107
52923,KRAS,gene,0.9897,24511107
52924,mCRC,disease,0.9995,24511107
52925,bevacizumab,gene,0.636,24511107
52926,anti-,gene,0.6597,24511107
52927,EGFR,gene,0.626,24511107
52928,colorectal liver metastases,disease,1.0,24510986
52929,hepatocellular carcinoma,disease,1.0,24510986
52930,liver metastases,disease,1.0,24510986
52931,neoplastic,disease,0.8794,24510986
52932,primary liver cancer,disease,1.0,24510986
52933,liver metastases,disease,0.9995,24510986
52934,colorectal tumors,disease,1.0,24510986
52935,DC,cell_type,0.7563,24510986
52936,doxorubicin,drug,0.9995,24510986
52937,irinotecan,drug,0.9985,24510986
52938,bevacizumab,gene,0.9316,24510986
52939,aflibercept,gene,0.9893,24510986
52940,regorafenib,drug,0.985,24510986
52941,hypertension,disease,0.9995,24493142
52942,cancer,disease,1.0,24493142
52943,aflibercept,gene,0.914,24493142
52944,Aflibercept,gene,0.928,24493142
52945,metastatic colorectal cancer,disease,0.9976,24493142
52946,tumors,disease,1.0,24493142
52947,Hypertension,disease,1.0,24493142
52948,aflibercept,gene,0.97,24493142
52949,cancer,disease,1.0,24493142
52950,hypertension,disease,0.9966,24493142
52951,hypertension,disease,0.998,24493142
52952,aflibercept,gene,0.987,24493142
52953,cancer,disease,1.0,24493142
52954,hypertension,disease,0.9995,24493142
52955,hypertension,disease,0.9927,24493142
52956,aflibercept,gene,0.9805,24493142
52957,bevacizumab,gene,0.7676,24493142
52958,aflibercept,gene,0.9805,24493142
52959,hypertension,disease,0.9355,24493142
52960,cardiovascular complication,disease,0.885,24493142
52961,VEGF,gene,0.99,24483136
52962,chorioretinal vascular disorders,disease,1.0,24483136
52963,exudative age-related macular degeneration,disease,1.0,24483136
52964,diabetic macular edema,disease,1.0,24483136
52965,retinal vein occlusions,disease,1.0,24483136
52966,Pegaptanib,drug,0.9966,24483136
52967,VEGF165,gene,0.998,24483136
52968,VEGF-A isoforms,gene,0.996,24483136
52969,aflibercept,gene,0.9883,24483136
52970,VEGF-A,gene,0.9976,24483136
52971,VEGF-B,gene,0.9976,24483136
52972,placental growth factor,gene,0.9966,24483136
52973,VEGF165,gene,0.998,24483136
52974,VEGF,gene,0.7534,24483136
52975,bevacizumab,gene,0.919,24483136
52976,aflibercept,gene,0.981,24483136
52977,Fc fragments,gene,0.7407,24483136
52978,VEGF,gene,0.9966,24483136
52979,endothelial cells,cell_type,0.934,24483136
52980,VEGF,gene,0.804,24483136
52981,cancer,disease,1.0,24482243
52982,Tumours,disease,1.0,24482243
52983,vascular endothelial growth factor,gene,0.9985,24482243
52984,VEGF,gene,0.993,24482243
52985,VEGF ligand family,gene,0.995,24482243
52986,solid cancers,disease,1.0,24482243
52987,VEGF,gene,0.996,24482243
52988,tumour,disease,1.0,24482243
52989,VEGF,gene,0.9956,24482243
52990,bevacizumab,gene,0.797,24482243
52991,sunitinib,drug,0.985,24482243
52992,aflibercept,gene,0.948,24482243
52993,VEGF,gene,0.9946,24482243
52994,cancers,disease,1.0,24482243
52995,tumours,disease,1.0,24482243
52996,VEGF,gene,0.9946,24482243
52997,tumour,disease,1.0,24482243
52998,tumour,disease,1.0,24482243
52999,metastatic colon cancer,disease,1.0,24472471
53000,patients,species,0.9756,24472471
53001,metastatic,disease,0.7915,24472471
53002,colorectal cancer,disease,0.9136,24472471
53003,patients,species,0.99,24472471
53004,patient,species,0.9746,24472471
53005,patients,species,0.9863,24472471
53006,oligometastatic cancer,disease,1.0,24472471
53007,patients,species,0.937,24472471
53008,cancer,disease,0.8926,24472471
53009,5-fluoruracil,drug,0.9995,24472471
53010,leucovorin,drug,0.999,24472471
53011,patients,species,0.9717,24472471
53012,bevacizumab,gene,0.924,24472471
53013,atherothrombotic complications,disease,0.994,24472471
53014,EGFR,gene,0.9883,24472471
53015,KRAS wild type cancers,disease,0.957,24472471
53016,KRAS,gene,0.9854,24472471
53017,patient,species,0.981,24472471
53018,aflibercept,gene,0.988,24472471
53019,regorafenib,drug,0.9688,24472471
53020,patients,species,0.9873,24472471
53021,patients,species,0.983,24472471
53022,metastatic colorectal cancer,disease,1.0,24472471
53023,ranibizumab,gene,0.635,24457369
53024,aflibercept,gene,0.9507,24457369
53025,Fc,gene,,24457369
53026,ranibizumab,gene,0.8945,24457369
53027,aflibercept,gene,0.9805,24457369
53028,monkey,species,0.6875,24457369
53029,cynomolgus monkeys,species,0.9233,24457369
53030,ranibizumab,gene,0.8433,24457369
53031,aflibercept,gene,0.982,24457369
53032,monkeys,species,0.5337,24457369
53033,fluorescein,drug,0.999,24457369
53034,haemoglobin,gene,0.9976,24457369
53035,endothelial,cell_type,0.4556,24457369
53036,ranibizumab,gene,0.897,24457369
53037,aflibercept,gene,0.977,24457369
53038,ganglion,cell_line,0.4783,24457369
53039,ganglion cells,cell_type,0.8545,24457369
53040,retinal pigment epithelium,cell_type,0.5083,24457369
53041,RPE,cell_type,0.7686,24457369
53042,haemolysis,disease,0.9053,24457369
53043,aflibercept,gene,0.985,24457369
53044,RPE cells,cell_type,0.8647,24457369
53045,haemolysis,disease,0.997,24457369
53046,aflibercept,gene,0.9688,24457369
53047,Ranibizumab,gene,0.8394,24457369
53048,aflibercept,gene,0.9863,24457369
53049,neuronal and RPE cells,cell_type,0.7666,24457369
53050,Aflibercept,gene,0.981,24457369
53051,haemolysis,disease,0.9663,24457369
53052,RPE cell,cell_type,0.879,24457369
53053,Fc,gene,,24457369
53054,aflibercept,gene,0.9707,24457369
53055,Aflibercept,gene,0.9917,24445500
53056,VEGF receptor,gene,0.8315,24445500
53057,Aflibercept,gene,0.9824,24445500
53058,ziv-aflibercept,gene,0.984,24445500
53059,Zaltrap,gene,0.7583,24445500
53060,human,species,0.905,24445500
53061,vascular endothelial growth factors A and B,gene,0.998,24445500
53062,placental growth factor,gene,0.996,24445500
53063,tumors,disease,1.0,24445500
53064,tumor,disease,1.0,24445500
53065,aflibercept,gene,0.912,24445500
53066,metastatic colorectal cancer,disease,1.0,24445500
53067,5-fluorouracil,drug,0.9995,24445500
53068,leucovorin,drug,0.999,24445500
53069,irinotecan,drug,0.9956,24445500
53070,patients,species,0.9893,24445500
53071,oxaliplatin,drug,0.999,24445500
53072,aflibercept,gene,0.966,24445500
53073,cancer,disease,1.0,24445500
53074,patients,species,0.9927,24445500
53075,patients,species,0.9766,24424314
53076,HER2-positive metastatic breast cancer,disease,0.997,24424314
53077,HER2,gene,0.9736,24424314
53078,Ziv-aflibercept,gene,0.969,24421416
53079,Vincristine Sulfate,drug,0.999,24421416
53080,cancer,disease,0.9995,24421416
53081,malignant,DNA,0.4346,24421416
53082,malignant diseases,disease,1.0,24421416
53083,oxaliplatin,drug,0.9995,24403498
53084,Oxaliplatin,drug,0.999,24403498
53085,fluoropyrimidines,drug,0.999,24403498
53086,advanced colorectal cancer,disease,1.0,24403498
53087,stage III colon cancer,disease,0.8794,24403498
53088,Oxaliplatin,drug,0.9995,24403498
53089,irinotecan,drug,0.9985,24403498
53090,vascular endothelial growth factor,gene,0.997,24403498
53091,VEGF,gene,0.998,24403498
53092,bevacizumab,gene,0.765,24403498
53093,aflibercept,gene,0.9683,24403498
53094,anti-,gene,0.6074,24403498
53095,epidermal growth factor receptor,gene,0.9062,24403498
53096,EGFR,gene,0.9956,24403498
53097,cetuximab,gene,0.8086,24403498
53098,panitumumab,gene,0.9033,24403498
53099,advanced colorectal cancer,disease,1.0,24403498
53100,patients,species,0.9893,24403498
53101,EGFR,gene,0.743,24403498
53102,KRAS,gene,0.9697,24403498
53103,oxaliplatin,drug,0.9995,24403498
53104,Metastatic Colorectal Cancer,disease,0.9995,24392302
53105,colorectal cancer,disease,1.0,24392302
53106,CRC,disease,1.0,24392302
53107,cancer,disease,1.0,24392302
53108,men,species,0.9355,24392302
53109,women,species,0.978,24392302
53110,Metastatic,disease,0.589,24392302
53111,patients,species,0.965,24392302
53112,metastatic colorectal cancer,disease,1.0,24392302
53113,mCRC,disease,1.0,24392302
53114,mCRC,disease,0.947,24392302
53115,vascular endothelial growth factor,gene,0.9985,24392302
53116,VEGF,gene,0.9976,24392302
53117,aflibercept,gene,0.9805,24392302
53118,Aflibercept,gene,0.976,24392302
53119,VEGF,gene,0.9966,24392302
53120,mCRC,disease,0.987,24392302
53121,aflibercept,gene,0.962,24390630
53122,cancer,disease,1.0,24390630
53123,patients,species,0.9917,24390630
53124,Aflibercept,gene,0.938,24390630
53125,humanized,species,0.6567,24390630
53126,vascular endothelial growth factor,gene,0.9927,24390630
53127,VEGF,gene,0.9995,24390630
53128,tumors,disease,0.575,24390630
53129,cancer,disease,1.0,24390630
53130,patients,species,0.9927,24390630
53131,aflibercept,gene,0.9805,24390630
53132,aflibercept,gene,0.927,24390630
53133,cancer,disease,1.0,24390630
53134,patients,species,0.994,24390630
53135,patients,species,0.9893,24390630
53136,solid tumors,disease,1.0,24390630
53137,aflibercept,gene,0.9727,24390630
53138,aflibercept,gene,0.979,24390630
53139,FAEs,disease,0.556,24390630
53140,patients,species,0.9883,24390630
53141,FAEs,disease,0.9937,24390630
53142,hemorrhage,disease,0.999,24390630
53143,GI perforation,disease,0.999,24390630
53144,aflibercept,gene,0.973,24390630
53145,FAEs,disease,0.9834,24390630
53146,aflibercept,gene,0.97,24390630
53147,Central Retinal Vein Occlusion,disease,0.999,24381819
53148,macular edema,disease,1.0,24381819
53149,central retinal vein occlusion,disease,1.0,24381819
53150,CRVO,disease,1.0,24381819
53151,SECs,cell_type,0.71,24381819
53152,cystoid macular edema,disease,1.0,24381819
53153,cystoid macular edema,disease,1.0,24381819
53154,CRVO,disease,1.0,24381819
53155,Vascular endothelial growth factor,gene,0.999,24379921
53156,Aflibercept,gene,0.991,24379921
53157,Diabetic retinopathy,disease,1.0,24379921
53158,DR,disease,1.0,24379921
53159,visual loss,disease,0.9995,24379921
53160,Diabetic macular edema,disease,1.0,24379921
53161,DME,disease,1.0,24379921
53162,DR,disease,,24379921
53163,patients,species,0.971,24379921
53164,DR,disease,,24379921
53165,DME,disease,1.0,24379921
53166,vascular endothelial growth factor,gene,0.9985,24379921
53167,VEGF,gene,0.9985,24379921
53168,aflibercept,gene,0.9844,24379921
53169,EYLEA,gene,0.75,24379921
53170,VEGF,gene,0.995,24379921
53171,DME,disease,1.0,24379921
53172,aflibercept,gene,0.981,24379921
53173,vascular endothelial growth factor A,gene,0.9976,24379921
53174,VEGF-A,gene,0.997,24379921
53175,VEGF,gene,0.9946,24379921
53176,aflibercept,gene,0.9873,24379921
53177,Aflibercept,gene,0.955,24379921
53178,VEGF,gene,0.997,24379921
53179,DME,disease,1.0,24379921
53180,retinal vascular diseases,disease,1.0,24379921
53181,aflibercept,gene,0.9585,24379921
53182,DME,disease,0.9873,24379921
53183,vascular endothelial growth factor,gene,0.9644,24376538
53184,Central retinal vein occlusion,disease,1.0,24376538
53185,CRVO,disease,1.0,24376538
53186,vascular endothelial growth factor,gene,0.891,24376538
53187,macular edema,disease,1.0,24376538
53188,ME,disease,1.0,24376538
53189,VEGF,gene,0.6655,24376538
53190,Diabetic Retinopathy,disease,0.9946,24376538
53191,anti-VEGF,gene,0.9756,24376538
53192,patients,species,0.9766,24376538
53193,Aflibercept,gene,0.9507,24376538
53194,BCVA,DNA,0.4668,24376538
53195,BCVA,DNA,0.4744,24376538
53196,CRVO-ME,disease,0.9688,24376538
53197,people,species,0.971,24376538
53198,aflibercept,gene,0.976,26117932
53199,Aflibercept,gene,0.9937,26117932
53200,Eylea,gene,0.7954,26117932
53201,antiVEGF,gene,0.8945,26117932
53202,age related macular degeneration,disease,1.0,26117932
53203,AMD,disease,1.0,26117932
53204,macular edema,disease,1.0,26117932
53205,central retinal vein occlusion,disease,1.0,26117932
53206,patients,species,0.9873,26117932
53207,AMD,disease,1.0,26117932
53208,ME,disease,,26117932
53209,myopic and idiopatic choroidal neovascularisation,disease,1.0,26117932
53210,central serous choroidopathy,disease,1.0,26117932
53211,CSC,disease,1.0,26117932
53212,diabetic macular edema,disease,1.0,26117932
53213,DME,drug,0.9224,26117932
53214,macular edema,disease,1.0,26117932
53215,Ziv-aflibercept,gene,0.9175,24368879
53216,metastatic colorectal cancer,disease,0.9995,24368879
53217,patients,species,0.958,24368879
53218,metastatic colorectal cancer,disease,0.9526,24368879
53219,Ziv-aflibercept,gene,0.8115,24368879
53220,vascular endothelial growth factor (VEGF)-A,gene,0.997,24368879
53221,VEGF-B,gene,0.993,24368879
53222,PlGF,gene,0.996,24368879
53223,5-fluorouracil,drug,0.999,24368879
53224,leucovorin,drug,0.999,24368879
53225,irinotecan,drug,0.9985,24368879
53226,FOLFIRI,drug,0.9824,24368879
53227,patients,species,0.985,24368879
53228,colorectal cancer,disease,1.0,24368879
53229,oxaliplatin,drug,0.9995,24368879
53230,fluoropyrimidine,drug,0.9907,24368879
53231,tumor,disease,0.997,24368879
53232,ziv-aflibercept,gene,0.987,24368879
53233,bevacizumab,gene,0.7124,24368879
53234,regorafenib,drug,0.972,24368879
53235,ranibizumab,gene,0.6465,24362854
53236,aflibercept,gene,0.9785,24362854
53237,patients,species,0.978,24362854
53238,exudative age-related macular degeneration,disease,1.0,24362854
53239,ranibizumab,gene,0.8716,24362854
53240,patients,species,0.9766,24362854
53241,aflibercept,gene,0.977,24362854
53242,ranibizumab,gene,0.7886,24362854
53243,aflibercept,gene,0.9785,24362854
53244,ranibizumab,gene,0.8237,24362854
53245,aflibercept,gene,0.9497,24362854
53246,patients,species,0.976,24362854
53247,ranibizumab,gene,0.8633,24362854
53248,ranibizumab,gene,0.881,24362854
53249,ranibizumab,gene,0.839,24362854
53250,aflibercept,gene,0.993,24362854
53251,aflibercept,gene,0.9897,24362854
53252,ranibizumab,gene,0.5923,24362854
53253,aflibercept,gene,0.952,24362854
53254,ranibizumab,gene,0.7046,24362854
53255,aflibercept,gene,0.979,24362854
53256,Aflibercept,gene,0.933,24362854
53257,patients,species,0.9834,24362854
53258,neovascular age-related macular degeneration,disease,1.0,24362854
53259,ranibizumab,gene,0.751,24362854
53260,ranibizumab,gene,0.8486,24356074
53261,neovascular age-related macular degeneration,disease,1.0,24356074
53262,aflibercept,gene,0.9814,24356074
53263,patients,species,0.9883,24356074
53264,ranibizumab,gene,0.7383,24356074
53265,patients,species,0.9834,24356074
53266,nave neovascular age-related macular degeneration,disease,0.999,24356074
53267,ranibizumab,gene,0.654,24356074
53268,ranibizumab,gene,0.7183,24356074
53269,patients,species,0.98,24356074
53270,women,species,0.97,24356074
53271,men,species,0.9756,24356074
53272,patients,species,0.9746,24356074
53273,ranibizumab,gene,0.7905,24356074
53274,ranibizumab,gene,0.872,24356074
53275,patients,species,0.988,24356074
53276,vascular endothelial growth factor,gene,0.997,24347979
53277,Macular degeneration,disease,0.9795,24347979
53278,blindness,disease,0.9995,24347979
53279,neovascular age-related macular degeneration,disease,0.998,24347979
53280,vascular endothelial growth factor,gene,0.9976,24347979
53281,VEGF,gene,0.9976,24347979
53282,VEGF,gene,0.792,24347979
53283,patients,species,0.992,24347979
53284,inflammation,disease,0.9854,24347979
53285,endophthalmitis,disease,1.0,24347979
53286,intraocular inflammation,disease,1.0,24347979
53287,vitreous hemorrhage,disease,1.0,24347979
53288,Bevacizumab,gene,0.8477,24347979
53289,ranibizumab,gene,0.778,24347979
53290,aflibercept,gene,0.9697,24347979
53291,Dysphonia,disease,1.0,24343672
53292,patients,species,0.9434,24343672
53293,malignancies,disease,1.0,24343672
53294,dysphonia,disease,1.0,24343672
53295,dysphonia,disease,1.0,24343672
53296,bevacizumab,gene,0.962,24343672
53297,aflibercept,gene,0.984,24343672
53298,sunitinib,drug,0.9985,24343672
53299,sorafenib,drug,0.999,24343672
53300,pazopanib,drug,0.999,24343672
53301,axitinib,drug,0.9976,24343672
53302,regorafenib,drug,0.9966,24343672
53303,dysphonia,disease,1.0,24343672
53304,dysphonia,disease,1.0,24343672
53305,patients,species,0.9917,24343672
53306,axitinib,drug,0.996,24343672
53307,aflibercept,gene,0.933,24343672
53308,regorafenib,drug,0.994,24343672
53309,dysphonia,disease,1.0,24343672
53310,Tumor,disease,1.0,24333721
53311,VEGF,gene,0.984,24333721
53312,VEGF-C,gene,0.9956,24333721
53313,VEGF,gene,0.985,24333721
53314,vascular endothelial growth factor,gene,0.999,24333721
53315,cancer,disease,1.0,24333721
53316,tumor,disease,1.0,24333721
53317,VEGF,gene,0.937,24333721
53318,mouse Lewis lung carcinoma (LLC) cell line,cell_line,0.96,24333721
53319,mouse,species,0.9893,24333721
53320,Lewis lung carcinoma,disease,0.941,24333721
53321,VEGF,gene,0.9985,24333721
53322,VEGF-Trap,gene,0.9785,24333721
53323,non,cell_line,0.529,24333721
53324,non-resistant,cell_type,0.4604,24333721
53325,tumor cells,cell_type,0.704,24333721
53326,tumor,disease,0.9985,24333721
53327,VEGF-C,gene,0.996,24333721
53328,resistant tumor cells,cell_line,0.6733,24333721
53329,tumor,disease,0.842,24333721
53330,VEGF-C,gene,0.997,24333721
53331,resistant cells,cell_line,0.5615,24333721
53332,endothelial cell,cell_type,0.775,24333721
53333,VEGF-Trap,gene,0.9727,24333721
53334,tumors,disease,1.0,24333721
53335,VEGF,gene,0.9116,24333721
53336,VEGF-C,gene,0.995,24333721
53337,macular oedema,disease,1.0,24330277
53338,Macular oedema,disease,1.0,24330277
53339,central retinal vein occlusion,disease,1.0,24330277
53340,vision loss,disease,0.9946,24330277
53341,anti-vascular endothelial growth factor,gene,0.982,24330277
53342,PARTICIPANTS,species,0.726,24330277
53343,Patients,species,0.9546,24330277
53344,anti-vascular endothelial growth factor,gene,0.974,24330277
53345,Diabetic Retinopathy,disease,1.0,24330277
53346,anti-vascular endothelial growth factor,gene,0.954,24330277
53347,Diabetic Retinopathy,disease,1.0,24330277
53348,anti-vascular endothelial growth factor,gene,0.949,24330277
53349,macular oedema,disease,1.0,24330277
53350,central retinal vein occlusion,disease,1.0,24330277
53351,vascular endothelial growth factor,gene,0.9414,24330277
53352,neovascular age-related macular degeneration,disease,1.0,24319688
53353,blindness,disease,0.997,24319688
53354,age-related macular degeneration,disease,1.0,24319688
53355,AMD,disease,1.0,24319688
53356,vascular endothelial growth factor,gene,0.9985,24319688
53357,VEGF,gene,0.996,24319688
53358,retinal vascular diseases,disease,1.0,24319688
53359,VEGF,gene,0.933,24319688
53360,ranibizumab,gene,0.862,24319688
53361,aflibercept,gene,0.977,24319688
53362,neovascular AMD,disease,1.0,24319688
53363,aflibercept,gene,0.9595,24317870
53364,vascular endothelial growth factor,gene,0.8877,24310208
53365,wet,disease,0.96,24310208
53366,age-related macular degeneration,disease,0.984,24310208
53367,anti-vascular endothelial growth factor,gene,0.982,24310208
53368,anti-VEGF,gene,0.9644,24310208
53369,aflibercept,gene,0.9854,24310208
53370,ranibizumab,gene,0.8315,24310208
53371,age-related macular degeneration,disease,1.0,24310208
53372,AMD,disease,1.0,24310208
53373,ranibizumab,gene,0.8335,24310208
53374,aflibercept,gene,0.966,24310208
53375,wet AMD,disease,0.9956,24310208
53376,VEGF,gene,0.6504,24310208
53377,anti-VEGF,gene,0.8486,24310208
53378,aflibercept,gene,0.9644,24310208
53379,aflibercept,gene,0.94,24310208
53380,ranibizumab,drug,0.5234,24310208
53381,aflibercept,gene,0.9927,24310208
53382,ranibizumab,drug,0.626,24310208
53383,aflibercept,gene,0.991,24310208
53384,ranibizumab,gene,0.5625,24310208
53385,aflibercept,gene,0.988,24310208
53386,ranibizumab,drug,0.6406,24310208
53387,ranibizumab,drug,0.6196,24310208
53388,aflibercept,gene,0.971,24310208
53389,ranibizumab,drug,0.774,24310208
53390,Aflibercept,gene,0.9023,24310208
53391,ranibizumab,drug,0.5254,24310208
53392,VEGF,gene,0.9863,24310208
53393,wet AMD,disease,0.9985,24310208
53394,VEGF,gene,0.4993,24310208
53395,metastatic colorectal cancer,disease,0.9995,24307789
53396,Colorectal cancer,disease,1.0,24307789
53397,CRC,disease,1.0,24307789
53398,cancer,disease,1.0,24307789
53399,cancer,disease,1.0,24307789
53400,Metastatic,disease,0.8,24307789
53401,mCRC,disease,0.9795,24307789
53402,5-fluorouracil,drug,0.9995,24307789
53403,leucovorin,drug,0.9995,24307789
53404,oxaliplatin,drug,0.9995,24307789
53405,irinotecan,drug,0.9985,24307789
53406,vascular endothelial growth factor,gene,0.999,24307789
53407,epidermal growth factor receptor,gene,0.9976,24307789
53408,bevacizumab,gene,0.5366,24307789
53409,cetuximab,gene,0.5776,24307789
53410,mCRC,disease,0.954,24307789
53411,aflibercept,gene,0.99,24307789
53412,mCRC,disease,0.9805,24307789
53413,mCRC,disease,0.99,24307789
53414,Vitreous inflammation,disease,1.0,24307762
53415,anti-VEGF,gene,0.534,24307762
53416,Vascular endothelial growth factor,gene,0.9985,24307762
53417,VEGF,gene,0.995,24307762
53418,VEGF,gene,0.994,24307762
53419,neovascular retinal diseases,disease,1.0,24307762
53420,VEGF,gene,0.6294,24307762
53421,bevacizumab,gene,0.8496,24307762
53422,ranibizumab,gene,0.779,24307762
53423,pegaptanib,drug,0.969,24307762
53424,aflibercept,gene,0.951,24307762
53425,VEGF,gene,0.7188,24307762
53426,sterile endophthalmitis,disease,0.9995,24307762
53427,sterile endophthalmitis,disease,1.0,24307762
53428,sterile endophthalmitis,disease,0.999,24307762
53429,aflibercept,gene,0.965,24298632
53430,metastatic colorectal cancer,disease,0.9995,24298632
53431,ziv-aflibercept,gene,0.9824,24292447
53432,cisplatin,drug,0.9995,24292447
53433,pemetrexed,drug,0.999,24292447
53434,advanced/metastatic non-squamous non-small cell,disease,0.996,24292447
53435,lung cancer,disease,1.0,24292447
53436,ziv-aflibercept,gene,0.9775,24292447
53437,cisplatin,drug,0.9995,24292447
53438,pemetrexed,drug,0.9995,24292447
53439,non-small cell lung cancer,disease,1.0,24292447
53440,NSCLC,disease,1.0,24292447
53441,non-squamous NSCLC,disease,0.9585,24292447
53442,ziv-aflibercept,gene,0.9604,24292447
53443,pemetrexed,drug,0.9995,24292447
53444,cisplatin,drug,0.9995,24292447
53445,ziv-aflibercept,gene,0.9785,24292447
53446,reversible posterior leukoencephalopathy syndrome,disease,1.0,24292447
53447,RPLS,disease,1.0,24292447
53448,ziv-aflibercept,gene,0.9604,24292447
53449,nausea,disease,0.995,24292447
53450,fatigue,disease,0.991,24292447
53451,hypertension,disease,0.998,24292447
53452,RPLS,disease,0.9995,24292447
53453,hypertension,disease,1.0,24292447
53454,NSCLC,disease,0.9985,24292447
53455,ziv-aflibercept,gene,0.974,24292447
53456,cisplatin,drug,0.9995,24292447
53457,pemetrexed,drug,0.9995,24292447
53458,NSCLC,disease,1.0,24292447
53459,VEGF,gene,0.868,24290332
53460,diabetic macular edema,disease,1.0,24290332
53461,vascular endothelial growth factor,gene,0.997,24290332
53462,diabetic macular edema,disease,1.0,24290332
53463,DME,disease,1.0,24290332
53464,DME,disease,1.0,24290332
53465,aflibercept,gene,0.9785,24290332
53466,bevacizumab,gene,0.8784,24290332
53467,pegaptanib,drug,0.949,24290332
53468,ranibizumab,drug,0.541,24290332
53469,triamcinolone,drug,0.9985,24290332
53470,anti-vascular endothelial growth factor,gene,0.9043,24290332
53471,VEGF,gene,0.997,24290332
53472,VEGF pair,DNA,0.5312,24290332
53473,VEGF,gene,0.9937,24290332
53474,BCVA,DNA,0.4763,24290332
53475,VEGFs,gene,0.6533,24290332
53476,MI,disease,0.9937,24290332
53477,stroke,disease,0.9995,24290332
53478,aflibercept,gene,0.9775,24290332
53479,pegaptanib,drug,0.9805,24290332
53480,ranibizumab,gene,0.5884,24290332
53481,bevacizumab,gene,0.7812,24290332
53482,VEGF,gene,0.7046,24290332
53483,VEGF,gene,0.6606,24290332
53484,bevacizumab,gene,0.8,24290332
53485,diabetic macular edema,disease,1.0,24278988
53486,Diabetic macular edema,disease,1.0,24278988
53487,DME,disease,1.0,24278988
53488,vision loss,disease,0.9346,24278988
53489,type 2 diabetic,disease,1.0,24278988
53490,diabetic macular edema,disease,1.0,24278988
53491,vascular endothelial growth factor,gene,0.9966,24278988
53492,ranibizumab,gene,0.6694,24278988
53493,ranibizumab,gene,0.7124,24278988
53494,diabetic macular edema,disease,1.0,24278988
53495,metastatic colorectal cancer,disease,0.9688,24273599
53496,metastatic colorectal cancer,disease,0.999,24273599
53497,bevacizumab,gene,0.8037,24273599
53498,cetuximab,gene,0.9062,24273599
53499,panitumumab,gene,0.8945,24273599
53500,tumor,disease,0.948,24273599
53501,aflibercept,gene,0.965,24273599
53502,regorafenib,drug,0.9688,24273599
53503,mTOR,gene,0.995,24273599
53504,TNF,gene,0.9897,24273599
53505,diabetic macular edema,disease,1.0,24269850
53506,diabetic macular edema,disease,1.0,24269850
53507,DME,disease,1.0,24269850
53508,DME,disease,1.0,24269850
53509,diabetic macular edema,disease,1.0,24269850
53510,diabetic maculopathy,disease,1.0,24269850
53511,DME,disease,1.0,24269850
53512,anti-,gene,0.526,24269850
53513,VEGF,gene,0.624,24269850
53514,ranibizumab,gene,0.74,24269850
53515,Diabetic Retinopathy,disease,0.9746,24269850
53516,ETDRS,DNA,0.436,24269850
53517,ranibizumab,gene,0.7324,24269850
53518,visual,disease,0.5747,24269850
53519,ranibizumab,gene,0.5317,24269850
53520,Ranibizumab,gene,0.771,24269850
53521,bevacizumab,gene,0.86,24269850
53522,aflibercept,gene,0.9834,24269850
53523,pegaptanib,drug,0.993,24269850
53524,DME,disease,1.0,24269850
53525,VEGF,gene,0.939,24269850
53526,VEGF,gene,0.951,24269850
53527,visual impairment,disease,1.0,24269850
53528,DME,disease,0.9097,24269850
53529,aflibercept,gene,0.992,24269436
53530,age-related macular degeneration,disease,0.999,24269436
53531,ranibizumab,gene,0.714,24269436
53532,bevacizumab,gene,0.501,24269436
53533,stroke,disease,0.7515,24268853
53534,aflibercept,gene,0.988,24268853
53535,Ziv-aflibercept,gene,0.969,24259608
53536,Zaltrap,gene,0.7305,24259608
53537,metastatic colorectal cancer,disease,0.997,24259608
53538,ziv-aflibercept,gene,0.985,24259608
53539,FOLFIRI,drug,0.962,24259608
53540,metastatic colorectal cancer,disease,1.0,24259608
53541,mCRC,disease,1.0,24259608
53542,oxaliplatin,drug,0.9995,24259608
53543,ziv-aflibercept,gene,0.98,24259608
53544,colorectal cancer,disease,1.0,24259608
53545,Ziv,drug,0.5234,24259608
53546,Ziv-aflibercept,gene,0.966,24259608
53547,vascular endothelial growth factor,gene,0.998,24259608
53548,mCRC,disease,0.8203,24259608
53549,FOLFIRI,drug,0.9844,24259608
53550,ziv-aflibercept,gene,0.9766,24259608
53551,ziv-aflibercept,gene,0.9727,24259608
53552,bevacizumab,gene,0.678,24259608
53553,ziv-aflibercept,gene,0.9766,24259608
53554,FOLFIRI,drug,0.9233,24259608
53555,FOLFIRI,drug,0.9404,24259608
53556,mCRC,disease,0.996,24259608
53557,oxaliplatin,drug,0.999,24259608
53558,ziv-aflibercept,gene,0.975,24259608
53559,ziv-aflibercept,gene,0.9565,24259608
53560,anemia,disease,1.0,24259608
53561,diarrhea,disease,1.0,24259608
53562,neutropenia,disease,1.0,24259608
53563,Ziv-aflibercept,gene,0.9443,24259608
53564,FOLFIRI,drug,0.942,24259608
53565,mCRC,disease,0.985,24259608
53566,oxaliplatin,drug,0.9995,24259608
53567,Aflibercept,gene,0.987,24256894
53568,Ranibizumab,gene,0.952,24256894
53569,RVO,disease,1.0,24256639
53570,retinal venous occlusion,disease,1.0,24256639
53571,Retinal vein occlusions,disease,1.0,24256639
53572,loss of vision,disease,0.9995,24256639
53573,retinal vascular disease,disease,1.0,24256639
53574,diabetic retinopathy,disease,1.0,24256639
53575,systemic hypertension,disease,1.0,24256639
53576,arteriolarsclerosis,disease,1.0,24256639
53577,diabetes,disease,1.0,24256639
53578,hyperlipidaemia,disease,1.0,24256639
53579,blood hyperviscosity,disease,1.0,24256639
53580,thrombophilia,disease,1.0,24256639
53581,ocular hypertension,disease,1.0,24256639
53582,glaucoma,disease,1.0,24256639
53583,visual loss,disease,0.9995,24256639
53584,macular oedema,disease,1.0,24256639
53585,retinal ischaemia,disease,1.0,24256639
53586,anti-vascular endothelial growth factors,gene,0.9004,24256639
53587,age-related macular degeneration,disease,1.0,24219407
53588,neovascular age-related macular degeneration,disease,0.9976,24219407
53589,vascular endothelial growth factor,gene,0.993,24219407
53590,VEGF,gene,0.997,24219407
53591,endophthalmitis,disease,1.0,24219407
53592,bevacizumab,gene,0.9126,24219407
53593,ranibizumab,gene,0.922,24219407
53594,aflibercept,gene,0.974,24219407
53595,anti-VEGF,gene,0.903,24219407
53596,liposomes,cell_type,0.519,24219407
53597,VEGF Trap,gene,0.8125,24206925
53598,Age-related macular degeneration,disease,1.0,24206925
53599,AMD,disease,1.0,24206925
53600,visual impairment,disease,1.0,24206925
53601,vascular endothelial growth factor,gene,0.998,24206925
53602,VEGF,gene,0.994,24206925
53603,neovascular AMD,disease,0.9995,24206925
53604,VEGF,gene,0.918,24206925
53605,pegaptanib,drug,0.945,24206925
53606,VEGF Trap-,gene,0.856,24206925
53607,Aflibercept,gene,0.979,24206925
53608,exudative AMD,disease,0.9995,24206925
53609,VEGF,gene,0.995,24206925
53610,ranibizumab,gene,0.9155,24206925
53611,bevacizumab,gene,0.8613,24206925
53612,VEGF,gene,0.996,24206925
53613,bovine,species,0.9863,24206925
53614,oxygen,drug,0.989,24206925
53615,silver,drug,0.999,24206925
53616,silver chloride,drug,0.996,24206925
53617,VEGF,gene,0.9966,24206925
53618,VEGF,gene,0.996,24206925
53619,apoptotic cells,cell_type,0.879,24206925
53620,terminal deoxynucleotidyl transferase,gene,0.9946,24206925
53621,uridine 5'-triphosphate,drug,0.999,24206925
53622,biotin,drug,0.9736,24206925
53623,VEGF,gene,0.991,24206925
53624,VEGF,gene,0.9946,24206925
53625,VEGF Trap,gene,0.8765,24206925
53626,VEGF,gene,0.995,24206925
53627,VEGF,gene,0.995,24206925
53628,macular edema,disease,1.0,24205253
53629,branch and central retinal vein occlusion,disease,1.0,24205253
53630,macular edema,disease,1.0,24205253
53631,CRVO,disease,0.66,24205253
53632,branch retinal vein occlusion,disease,1.0,24205253
53633,BRVO,disease,1.0,24205253
53634,macular edema,disease,0.9995,24205253
53635,CRVO,disease,1.0,24205253
53636,BRVO,disease,1.0,24205253
53637,VEGF,gene,0.596,24205253
53638,bevacizumab,gene,0.5303,24205253
53639,aflibercept,gene,0.968,24205253
53640,triamcinolone,drug,0.9995,24205253
53641,dexamethasone,drug,0.999,24205253
53642,aflibercept,gene,0.949,24205253
53643,bevacizumab,gene,0.6357,24205253
53644,Ranibizumab,gene,0.8223,24205253
53645,Triamcinolone,drug,0.999,24205253
53646,Ranibizumab,gene,0.8516,24205253
53647,dexamethasone,drug,0.9927,24205253
53648,endophthalmitis,disease,1.0,24205253
53649,VEGF,gene,0.9326,24205253
53650,cataract,disease,1.0,24205253
53651,VEGF,gene,0.9346,24205253
53652,Dexamethasone,drug,0.988,24205253
53653,VEGF,gene,0.7383,24205253
53654,metastatic colorectal cancer,disease,0.9946,24204124
53655,metastatic colorectal cancer,disease,1.0,24204124
53656,mCRC,disease,1.0,24204124
53657,bevacizumab,gene,0.7334,24204124
53658,cancer cells,cell_type,0.753,24204124
53659,cancer,disease,0.999,24204124
53660,mCRC,disease,0.989,24204124
53661,mCRC,disease,0.9683,24204124
53662,mCRC,disease,0.984,24204124
53663,bevacizumab,gene,0.856,24204124
53664,cetuximab,gene,0.715,24204124
53665,Aflibercept,gene,0.946,24204124
53666,folinic acid,drug,0.9995,24204124
53667,leucovorin,drug,0.9995,24204124
53668,fluorouracil,drug,0.9995,24204124
53669,irinotecan,drug,0.9985,24204124
53670,FOLFIRI,drug,0.8687,24204124
53671,mCRC,disease,0.988,24204124
53672,mCRC,disease,0.994,24204124
53673,-,DNA,0.4158,24204124
53674,KRAS,DNA,0.571,24204124
53675,panitumumab,gene,0.812,24204124
53676,folinic acid,drug,0.9995,24204124
53677,leucovorin,drug,0.9995,24204124
53678,fluorouracil,drug,0.9995,24204124
53679,oxaliplatin,drug,0.9995,24204124
53680,FOLFOX,drug,0.9604,24204124
53681,FOLFIRI,drug,0.794,24204124
53682,regorafenib,drug,0.9956,24204124
53683,FOLFOX,drug,0.964,24204124
53684,FOLFIRI,drug,0.8315,24204124
53685,mCRC,disease,0.9395,24204124
53686,mCRC,disease,0.9526,24204124
53687,malignancies,disease,1.0,24204124
53688,Aflibercept,gene,0.9385,24179482
53689,metastatic colorectal cancer,disease,0.9995,24179482
53690,metastatic,disease,0.845,24179482
53691,colorectal cancer,disease,0.869,24179482
53692,Bevacizumab,gene,0.5264,24179482
53693,vascular endothelial growth factor (VEGF) A,gene,0.997,24179482
53694,metastatic colorectal cancer,disease,0.999,24179482
53695,Aflibercept,gene,0.9585,24179482
53696,human vascular endothelial growth factor receptor 1,gene,0.997,24179482
53697,VEGFR1,gene,0.996,24179482
53698,VEGFR2 extracellular domains,gene,0.8613,24179482
53699,VEGF A,gene,0.999,24179482
53700,VEGF B,gene,0.998,24179482
53701,placental growth factor 1,gene,0.9985,24179482
53702,PlGF1,gene,0.9966,24179482
53703,PlGF2,gene,0.9985,24179482
53704,aflibercept,gene,0.9927,24179482
53705,hypertension,disease,1.0,24179482
53706,proteinuria,disease,1.0,24179482
53707,fatigue,disease,0.9995,24179482
53708,headache,disease,1.0,24179482
53709,aflibercept,gene,0.9907,24179482
53710,metastatic colorectal cancer,disease,1.0,24179482
53711,HER2,gene,0.9976,24176949
53712,VEGF,gene,0.996,24176949
53713,HER2-overexpressing gastric cancer xenografts,cell_line,0.8057,24176949
53714,HER2-overexpressing gastric cancer,disease,0.953,24176949
53715,HER2,gene,0.437,24176949
53716,Gastric cancer,disease,1.0,24176949
53717,human epidermal growth factor 2,gene,0.9976,24176949
53718,HER2,gene,0.9746,24176949
53719,anti-HER2 antibody,gene,0.803,24176949
53720,trastuzumab,gene,0.5156,24176949
53721,advanced gastric cancer,disease,0.9995,24176949
53722,Vascular endothelial growth factor,gene,0.9976,24176949
53723,VEGF,gene,0.9966,24176949
53724,gastric cancer,disease,1.0,24176949
53725,VEGF antibody,gene,0.6777,24176949
53726,gastric cancer,disease,1.0,24176949
53727,trastuzumab,gene,0.9717,24176949
53728,VEGF-Trap,gene,0.9854,24176949
53729,VEGF-A,gene,0.999,24176949
53730,VEGF-B,gene,0.999,24176949
53731,placental growth factor,gene,0.998,24176949
53732,PlGF,gene,0.9907,24176949
53733,trastuzumab,gene,0.9805,24176949
53734,VEGF-Trap,gene,0.9277,24176949
53735,gastric cancer,disease,1.0,24176949
53736,trastuzumab,gene,0.9834,24176949
53737,VEGF,gene,0.995,24176949
53738,tumor,disease,0.9985,24176949
53739,tumor,disease,1.0,24176949
53740,tumor cells,cell_type,0.8604,24176949
53741,tumor,disease,0.9907,24176949
53742,proliferating tumor cells,cell_type,0.877,24176949
53743,apoptotic cells,cell_type,0.666,24176949
53744,tumor,disease,0.9775,24176949
53745,trastuzumab,gene,0.979,24176949
53746,VEGF-Trap,gene,0.9614,24176949
53747,trastuzumab,gene,0.97,24176949
53748,VEGF-Trap,gene,0.951,24176949
53749,gastric cancer,disease,1.0,24176949
53750,trastuzumab,gene,0.9824,24176949
53751,VEGF-Trap,gene,0.9087,24176949
53752,HER2-overexpressing gastric cancer,disease,0.9375,24176949
53753,HER2,gene,0.9917,24176949
53754,colorectal cancer,disease,1.0,24158967
53755,Metastatic colorectal cancer,disease,1.0,24158967
53756,mCRC,disease,1.0,24158967
53757,mCRC,disease,0.9683,24158967
53758,anti-,gene,0.7437,24158967
53759,vascular endothelial growth factor,gene,0.876,24158967
53760,VEGF,gene,0.9873,24158967
53761,bevacizumab,gene,0.4941,24158967
53762,anti-epidermal growth factor receptor,gene,0.8594,24158967
53763,EGFR,gene,0.992,24158967
53764,cetuximab,gene,0.7344,24158967
53765,panitumumab,gene,0.857,24158967
53766,bevacizumab,gene,0.767,24158967
53767,VEGF,gene,0.55,24158967
53768,anti-EGFR antibody,gene,0.8555,24158967
53769,ziv-aflibercept,gene,0.9707,24158967
53770,regorafenib,drug,0.9346,24158967
53771,mCRC,disease,0.977,24158967
53772,CRC,disease,0.9976,24158967
53773,CRC,disease,0.998,24158967
53774,endophthalmitis,disease,0.9995,24144453
53775,endophthalmitis,disease,0.9995,24144453
53776,PARTICIPANTS,species,0.7705,24144453
53777,patients,species,0.993,24144453
53778,ranibizumab,gene,0.7754,24144453
53779,bevacizumab,gene,0.89,24144453
53780,aflibercept,gene,0.955,24144453
53781,retinal vascular diseases,disease,1.0,24144453
53782,patients,species,0.993,24144453
53783,Endophthalmitis,disease,1.0,24144453
53784,endophthalmitis,disease,1.0,24144453
53785,Patients,species,0.9697,24144453
53786,endophthalmitis,disease,1.0,24144453
53787,endophthalmitis,disease,1.0,24144453
53788,endophthalmitis,disease,1.0,24144453
53789,endophthalmitis,disease,1.0,24144453
53790,endophthalmitis,disease,1.0,24144453
53791,endophthalmitis,disease,1.0,24144453
53792,endophthalmitis,disease,1.0,24144453
53793,endophthalmitis,disease,1.0,24144453
53794,endophthalmitis,disease,1.0,24144453
53795,aflibercept,gene,0.991,24144450
53796,neovascular age-related macular,disease,1.0,24144450
53797,aflibercept,gene,0.988,24144450
53798,patients,species,0.918,24144450
53799,neovascular age-related macular degeneration,disease,1.0,24144450
53800,AMD,disease,1.0,24144450
53801,vascular endothelial growth factor,gene,0.9707,24144450
53802,PARTICIPANTS,species,0.777,24144450
53803,patients,species,0.95,24144450
53804,neovascular AMD,disease,0.9995,24144450
53805,aflibercept,gene,0.973,24144450
53806,patients,species,0.972,24144450
53807,Diabetic Retinopathy,disease,0.999,24144450
53808,fluorescein,drug,0.999,24144450
53809,indocyanine green,drug,0.9956,24144450
53810,patients,species,0.99,24144450
53811,CRT,DNA,0.739,24144450
53812,CRT,DNA,0.4639,24144450
53813,CRT,DNA,0.499,24144450
53814,patient,species,0.993,24144450
53815,patients,species,0.9927,24144450
53816,patients,species,0.9805,24144450
53817,patients,species,0.981,24144450
53818,aflibercept,gene,0.9727,24144450
53819,neovascular AMD,disease,1.0,24144450
53820,Aflibercept,gene,0.9795,24140268
53821,fluorouracil,drug,0.999,24140268
53822,leucovorin,drug,0.999,24140268
53823,irinotecan,drug,0.998,24140268
53824,metastatic colorectal cancer,disease,1.0,24140268
53825,aflibercept,gene,0.992,24140268
53826,ziv-aflibercept,gene,0.974,24140268
53827,5-fluorouracil,drug,0.9995,24140268
53828,leucovorin,drug,0.999,24140268
53829,irinotecan,drug,0.9985,24140268
53830,FOLFIRI,drug,0.9697,24140268
53831,metastatic colorectal cancer,disease,1.0,24140268
53832,mCRC,disease,1.0,24140268
53833,oxaliplatin,drug,0.9995,24140268
53834,FOLFIRI,drug,0.8584,24140268
53835,aflibercept,gene,0.9297,24140268
53836,bevacizumab,gene,0.8564,24140268
53837,aflibercept,gene,0.9863,24140268
53838,bevacizumab,gene,0.812,24140268
53839,bevacizumab,gene,0.8716,24140268
53840,liver metastases,disease,0.7437,24140268
53841,liver metastases,disease,0.9937,24140268
53842,aflibercept,gene,0.977,24140268
53843,FOLFIRI,drug,0.6826,24140268
53844,mCRC,disease,0.937,24140268
53845,oxaliplatin,drug,0.9995,24140268
53846,bevacizumab,gene,0.7983,24140268
53847,Ziv-aflibercept,gene,0.9775,24128964
53848,metastatic PURPOSE,disease,0.996,24128964
53849,ziv-,gene,0.7246,24128964
53850,aflibercept,gene,0.953,24128964
53851,metastatic colorectal cancer,disease,1.0,24128964
53852,mCRC,disease,1.0,24128964
53853,Ziv-aflibercept,gene,0.9844,24128964
53854,Zaltrap,gene,0.7485,24128964
53855,tumor cells,cell_type,0.8125,24128964
53856,tumor,disease,0.9995,24128964
53857,vascular endothelial growth factor (VEGF) receptors,gene,0.926,24128964
53858,tumor,disease,1.0,24128964
53859,VEGF,gene,0.997,24128964
53860,bevacizumab,gene,0.57,24128964
53861,Ziv-aflibercept,gene,0.9746,24128964
53862,fluorouracil,drug,0.9995,24128964
53863,irinotecan,drug,0.999,24128964
53864,leucovorin,drug,0.9995,24128964
53865,patients,species,0.9824,24128964
53866,mCRC,disease,0.9683,24128964
53867,oxaliplatin,drug,0.9995,24128964
53868,ziv-aflibercept,gene,0.9834,24128964
53869,patient,species,0.958,24128964
53870,patients,species,0.9834,24128964
53871,bevacizumab,gene,0.8906,24128964
53872,ziv-aflibercept,gene,0.97,24128964
53873,neutropenia,disease,1.0,24128964
53874,hypertension,disease,0.9995,24128964
53875,diarrhea,disease,1.0,24128964
53876,hemorrhage,disease,0.998,24128964
53877,ziv-aflibercept,gene,0.9863,24128964
53878,bevacizumab,gene,0.869,24128964
53879,mCRC,disease,0.993,24128964
53880,ziv-aflibercept,gene,0.987,24128964
53881,irinotecan,drug,0.9985,24128964
53882,mCRC,disease,0.9697,24128964
53883,patients,species,0.9917,24128964
53884,irinotecan,drug,0.998,24128964
53885,ziv-aflibercept,gene,0.9824,24128964
53886,tumor,disease,1.0,24128964
53887,aflibercept,gene,0.993,24127346
53888,patients,species,0.978,24127346
53889,platinum,drug,0.999,24127346
53890,advanced ovarian BACKGROUND,disease,0.546,24127346
53891,aflibercept,gene,0.9917,24127346
53892,patients,species,0.9736,24127346
53893,"platinum-resistant ovarian, peritoneal, or fallopian tube",disease,0.9946,24127346
53894,platinum,drug,0.999,24127346
53895,topotecan,drug,0.997,24127346
53896,doxorubicin,drug,0.7334,24127346
53897,Patients,species,0.9844,24127346
53898,aflibercept,gene,0.965,24127346
53899,Solid Tumor,disease,0.9653,24127346
53900,tumor,disease,0.999,24127346
53901,patients,species,0.9785,24127346
53902,patients,species,0.976,24127346
53903,patients,species,0.9863,24127346
53904,patients,species,0.983,24127346
53905,patients,species,0.9805,24127346
53906,patients,species,0.989,24127346
53907,patients,species,0.984,24127346
53908,hypertension,disease,1.0,24127346
53909,proteinuria,disease,1.0,24127346
53910,fatigue,disease,1.0,24127346
53911,gastrointestinal perforation,disease,1.0,24127346
53912,patients,species,0.988,24127346
53913,Aflibercept,gene,0.901,24127346
53914,platinum-resistant,disease,0.982,24109193
53915,platinum,drug,0.9995,24109193
53916,ovarian cancer,disease,0.8477,24109193
53917,Ovarian cancer,disease,1.0,24109193
53918,OC,disease,1.0,24109193
53919,gynecologic cancer,disease,1.0,24109193
53920,Platinum,drug,0.9995,24109193
53921,OC,disease,0.9956,24109193
53922,paclitaxel,drug,0.999,24109193
53923,topotecan,drug,0.995,24109193
53924,doxorubicin,drug,0.9805,24109193
53925,gemcitabine,drug,0.999,24109193
53926,vascular endothelial growth factor,gene,0.997,24109193
53927,bevacizumab,gene,0.844,24109193
53928,aflibercept,gene,0.9604,24109193
53929,iniparib,drug,0.9077,24109193
53930,olaparib,drug,0.9863,24109193
53931,folate,drug,0.9995,24109193
53932,pemetrexed,drug,1.0,24109193
53933,farletuzumab,drug,0.9575,24109193
53934,vintafolide,drug,0.9995,24109193
53935,platinum,drug,1.0,24109193
53936,OC,disease,1.0,24109193
53937,OC,disease,0.9966,24109193
53938,aflibercept,gene,0.992,24084500
53939,neovascular age-related macular degeneration,disease,1.0,24084500
53940,aflibercept,gene,0.9927,24084500
53941,patients,species,0.912,24084500
53942,neovascular age-related macular degeneration,disease,1.0,24084500
53943,AMD,drug,0.989,24084500
53944,PARTICIPANTS,species,0.8076,24084500
53945,patients,species,0.8877,24084500
53946,neovascular AMD,disease,1.0,24084500
53947,patients,species,0.906,24084500
53948,ranibizumab,gene,0.8613,24084500
53949,aflibercept,gene,0.9683,24084500
53950,aflibercept,gene,0.955,24084500
53951,aflibercept,gene,0.942,24084500
53952,patients,species,0.8535,24084500
53953,BCVA,DNA,0.481,24084500
53954,BCVA,cell_type,0.398,24084500
53955,Rq4,DNA,0.4976,24084500
53956,Patients,species,0.9443,24084500
53957,Rq4,DNA,0.7515,24084500
53958,2q4,DNA,0.4246,24084500
53959,2q8,DNA,0.409,24084500
53960,arterial thromboembolic events,disease,0.951,24084500
53961,aflibercept,gene,0.9824,24084500
53962,aflibercept,gene,0.993,24084500
53963,Aflibercept,gene,0.9824,24084497
53964,Macular Edema,disease,1.0,24084497
53965,aflibercept,gene,0.9917,24084497
53966,macular edema,disease,1.0,24084497
53967,CRVO,disease,1.0,24084497
53968,PARTICIPANTS,species,0.7554,24084497
53969,patients,species,0.9766,24084497
53970,macular edema,disease,1.0,24084497
53971,CRVO,disease,1.0,24084497
53972,Patients,species,0.9746,24084497
53973,aflibercept,gene,0.942,24084497
53974,aflibercept,gene,0.9873,24084497
53975,aflibercept,gene,0.9707,24084497
53976,patients,species,0.9805,24084497
53977,patients,species,0.988,24084497
53978,patients,species,0.985,24084497
53979,aflibercept,gene,0.9634,24084497
53980,Aflibercept,gene,0.959,24084497
53981,patients,species,0.9927,24084497
53982,patients,species,0.9873,24084497
53983,BCVA,cell_type,0.4187,24084497
53984,Aflibercept,gene,0.956,24084497
53985,patients,species,0.99,24084497
53986,aflibercept,gene,0.959,24084497
53987,macular edema,disease,1.0,24084497
53988,eye pain,disease,0.999,24084497
53989,aflibercept,gene,0.9756,24084497
53990,aflibercept,gene,0.9697,24084497
53991,aflibercept,gene,0.9824,24062151
53992,tears,disease,0.9194,24062151
53993,anti-vascular endothelial growth factor,gene,0.936,24062151
53994,VEGF,gene,0.998,24062151
53995,pigment epithelium detachment,disease,1.0,24062151
53996,PED,disease,1.0,24062151
53997,age-related macular degeneration,disease,1.0,24062151
53998,AMD,disease,1.0,24062151
53999,Aflibercept,gene,0.9346,24062151
54000,exsudative AMD,disease,0.9966,24062151
54001,patient,species,0.9727,24062151
54002,RIP,disease,0.9995,24062151
54003,aflibercept,gene,0.949,24062151
54004,PED,disease,1.0,24062151
54005,Patients,species,0.9844,24062151
54006,aflibercept,gene,0.954,24062151
54007,metastatic colorectal cancer,disease,1.0,24050123
54008,metastatic colorectal cancer,disease,1.0,24050123
54009,mCRC,disease,1.0,24050123
54010,aflibercept,gene,0.9814,24050123
54011,FOLFIRI,drug,0.9414,24050123
54012,oxaliplatin,drug,0.9995,24050123
54013,bevacizumab,gene,0.604,24050123
54014,bevacizumab,gene,0.532,24050123
54015,oncologists,cell_type,0.4258,24050123
54016,mCRC,disease,0.9897,24050123
54017,bevacizumab,gene,0.7637,24050123
54018,Aflibercept,gene,0.98,24047539
54019,Zaltrap,gene,0.823,24047539
54020,metastatic colorectal cancer,disease,0.9995,24047539
54021,Aflibercept,gene,0.984,24047539
54022,Zaltrap,gene,0.8794,24047539
54023,aflibercept,gene,0.995,24047539
54024,VEGF,gene,0.997,24047539
54025,PIGF receptor,gene,0.9946,24047539
54026,Folinic Acid,drug,0.9995,24047539
54027,5FU,drug,0.9966,24047539
54028,irinotecan,drug,0.994,24047539
54029,FOLFIRI,drug,0.973,24047539
54030,metastatic colorectal cancer,disease,0.999,24047539
54031,oxaliplatin,drug,0.999,24047539
54032,aflibercept,gene,0.9834,24047539
54033,FOLFIRI,drug,0.9736,24047539
54034,FOLFIRI,drug,0.9546,24047539
54035,aflibercept,gene,0.9766,24047539
54036,FOLFIRI,drug,0.981,24047539
54037,vascular endothelial growth factor,gene,0.926,24047539
54038,Aflibercept,gene,0.9688,24047539
54039,bevacizumab,gene,0.9365,24047539
54040,patients,species,0.9517,24047539
54041,metastatic colorectal cancer,disease,0.999,24047539
54042,aflibercept,gene,0.978,24045663
54043,FOLFIRI,drug,0.9604,24045663
54044,FOLFIRI,drug,0.9775,24045663
54045,metastatic colorectal cancer,disease,1.0,24045663
54046,cancer,disease,1.0,24045663
54047,aflibercept,gene,0.966,24045663
54048,ziv-aflibercept,gene,0.978,24045663
54049,fluorouracil,drug,0.628,24045663
54050,leucovorin,drug,0.998,24045663
54051,irinotecan,drug,0.9966,24045663
54052,FOLFIRI,drug,0.9946,24045663
54053,FOLFIRI,drug,0.959,24045663
54054,metastatic colorectal cancer,disease,1.0,24045663
54055,mCRC,disease,1.0,24045663
54056,oxaliplatin,drug,0.9995,24045663
54057,aflibercept,gene,0.974,24045663
54058,FOLFIRI,drug,0.977,24045663
54059,FOLFIRI,drug,0.9766,24045663
54060,aflibercept,gene,0.981,24045663
54061,aflibercept,gene,0.9766,24045663
54062,Aflibercept,gene,0.984,24043464
54063,colorectal cancer,disease,1.0,24043464
54064,metastatic Metastatic colorectal cancer,disease,0.94,24011538
54065,mCRC,disease,1.0,24011538
54066,patients,species,0.983,24011538
54067,mCRC,disease,0.973,24011538
54068,mCRC,disease,0.9966,24011538
54069,bevacizumab,gene,0.6123,24011538
54070,cetuximab,gene,0.9473,24011538
54071,panitumumab,gene,0.898,24011538
54072,bevacizumab,gene,0.7295,24011538
54073,cetuximab,gene,0.772,24011538
54074,panitumumab,gene,0.87,24011538
54075,bevacizumab,gene,0.8936,24011538
54076,cetuximab,gene,0.923,24011538
54077,panitumumab,gene,0.9053,24011538
54078,patients,species,0.9565,24011538
54079,mCRC,disease,0.9956,24011538
54080,Kirsten ras oncogene,gene,0.9985,24011538
54081,KRAS,gene,0.9976,24011538
54082,cetuximab,gene,0.8247,24011538
54083,panitumumab,gene,0.831,24011538
54084,cetuximab,gene,0.93,24011538
54085,panitumumab,gene,0.9316,24011538
54086,regorafenib,drug,0.898,24011538
54087,aflibercept,gene,0.9604,24011538
54088,VEGF-Trap,gene,0.963,24005035
54089,CD4,cell_line,0.782,24005035
54090,CD4+ T cells,cell_type,0.734,24005035
54091,CD4+,gene,0.967,24005035
54092,psoriasis-like skin,disease,0.9746,24005035
54093,metastatic colorectal cancer,disease,0.996,23997941
54094,tumor,disease,0.885,23997941
54095,metastatic colorectal cancer,disease,0.9697,23997941
54096,bevacizumab,gene,0.909,23997941
54097,ziv-aflibercept,gene,0.9873,23997941
54098,regorafenib,drug,0.985,23997941
54099,vascular endothelial growth factor A,gene,0.9937,23997941
54100,VEGF-A,gene,0.9976,23997941
54101,metastatic colorectal cancer,disease,0.9985,23997941
54102,5-fluorouracil,drug,0.9985,23997941
54103,bevacizumab,gene,0.9014,23997941
54104,cancer,disease,0.9185,23997941
54105,metastatic colorectal cancer,disease,0.9995,23997941
54106,Ziv-aflibercept,gene,0.975,23997941
54107,metastatic colorectal cancer,disease,0.9995,23997941
54108,VEGF-A,gene,0.9976,23997941
54109,vascular endothelial growth factor proteins,gene,0.997,23997941
54110,VEGF-B,gene,0.972,23997941
54111,PIGF,gene,0.9927,23997941
54112,placental growth factor,gene,0.998,23997941
54113,Regorafenib,drug,0.9966,23997941
54114,tyrosine,drug,0.942,23997941
54115,tyrosine kinases,gene,0.998,23997941
54116,VEGF receptors,gene,0.997,23997941
54117,metastatic colorectal cancer,disease,0.9985,23997941
54118,cancers,disease,1.0,23997941
54119,bevacizumab,gene,0.877,23997941
54120,fluoropyrimidine,drug,0.989,23997941
54121,bevacizumab,gene,0.747,23997941
54122,metastatic colorectal cancer,disease,0.9985,23997941
54123,lower GI cancers,disease,1.0,23996476
54124,gastrointestinal malignancies,disease,1.0,23996476
54125,dermatologic,disease,0.5044,23996476
54126,patients,species,0.9927,23996476
54127,rash,disease,0.999,23996476
54128,dermatologic AEs,disease,0.6245,23996476
54129,Patients,species,0.9907,23996476
54130,patients,species,0.9824,23996476
54131,patients,species,0.9854,23996476
54132,Aflibercept,gene,0.9697,23990705
54133,wet AMD,disease,0.999,23990705
54134,Vascular endothelial growth factor,gene,0.998,23990705
54135,VEGF,gene,0.996,23990705
54136,endothelial cells,cell_type,0.9316,23990705
54137,age-related macular degeneration,disease,0.9966,23990705
54138,choroidal neovascularization,disease,1.0,23990705
54139,VEGF,gene,0.9946,23990705
54140,VEGF,gene,0.952,23990705
54141,VEGF,gene,0.995,23990705
54142,VEGF,gene,0.658,23990705
54143,Aflibercept,gene,0.982,23990705
54144,EYLEA,gene,0.817,23990705
54145,VEGF,gene,0.989,23990705
54146,VEGF,gene,0.7446,23990705
54147,wet maculopathy,disease,1.0,23990705
54148,VEGF,gene,0.9937,23990705
54149,VEGF,gene,0.8076,23990705
54150,VEGF,gene,0.9937,23990705
54151,age-related macular degeneration,disease,1.0,23990705
54152,VEGF,gene,0.9863,23990705
54153,wet AMD,disease,0.9995,23990705
54154,VEGF,gene,0.984,23990705
54155,diabetic retinopathy,disease,1.0,23990705
54156,VEGF-,gene,0.958,23990705
54157,Trap eye,disease,0.9985,23990705
54158,retinal vein occlusions,disease,1.0,23990705
54159,aflibercept,gene,0.975,23990705
54160,VEGF,gene,0.9946,23990705
54161,VEGF,gene,0.9946,23990705
54162,ranibizumab,gene,0.6743,23990705
54163,ranibizumab,gene,0.825,23990705
54164,aflibercept,gene,0.9917,23966764
54165,polypoidal choroidal vasculopathy,disease,1.0,23966764
54166,aflibercept,gene,0.9907,23966764
54167,ranibizumab,gene,0.846,23966764
54168,polypoidal choroidal vasculopathy,disease,1.0,23966764
54169,PCV,disease,1.0,23966764
54170,PATIENTS,species,0.9243,23966764
54171,patients,species,0.9473,23966764
54172,PCV,disease,1.0,23966764
54173,ranibizumab,gene,0.71,23966764
54174,ranibizumab,gene,0.747,23966764
54175,aflibercept,gene,0.9263,23966764
54176,ranibizumab,gene,0.8696,23966764
54177,CRT,DNA,0.524,23966764
54178,aflibercept,gene,0.962,23966764
54179,patients,species,0.9575,23966764
54180,PCV,disease,1.0,23966764
54181,ranibizumab,gene,0.536,23966764
54182,endophthalmitis,disease,1.0,23945639
54183,endophthalmitis,disease,1.0,23945639
54184,EO,disease,1.0,23945639
54185,vascular endothelial growth factor,gene,0.998,23945639
54186,patients,species,0.9805,23945639
54187,vascular endothelial growth factor,gene,0.874,23945639
54188,EO,disease,,23945639
54189,intraocular inflammation,disease,1.0,23945639
54190,patient,species,0.9688,23945639
54191,ranibizumab,gene,0.769,23945639
54192,bevacizumab,gene,0.714,23945639
54193,aflibercept,gene,0.9854,23945639
54194,pegaptanib,drug,0.996,23945639
54195,EO,disease,,23945639
54196,IVIs,disease,0.9937,23945639
54197,EO,disease,,23945639
54198,patients,species,0.9946,23945639
54199,EO,disease,,23945639
54200,antivascular endothelial growth factor,gene,0.913,23929309
54201,Antivascular endothelial,disease,0.7036,23929309
54202,Antivascular endothelial growth factor,gene,0.8975,23929309
54203,age-related macular degeneration,disease,0.9995,23929309
54204,wAMD,disease,0.9985,23929309
54205,wAMD,disease,1.0,23929309
54206,anti-VEGF,gene,0.944,23929309
54207,patients,species,0.969,23929309
54208,bevacizumab,gene,0.807,23929309
54209,aflibercept,gene,0.976,23929309
54210,ranibizumab,gene,0.5605,23929309
54211,bevacizumab,gene,0.552,23929309
54212,Bevacizumab,gene,0.862,23929309
54213,ranibizumab,gene,0.6416,23929309
54214,patient,species,0.97,23929309
54215,aflibercept,gene,0.9917,23929309
54216,anti-VEGF,gene,0.931,23929309
54217,VEGF,gene,0.9956,23908970
54218,VEGF,gene,0.994,23908970
54219,tumor,disease,1.0,23908970
54220,vascular endothelial growth factor,gene,0.9985,23908970
54221,VEGF,gene,0.996,23908970
54222,tumor,disease,1.0,23908970
54223,VEGF,DNA,0.508,23908970
54224,VEGF family,gene,0.9946,23908970
54225,VEGF,gene,0.996,23908970
54226,tumor,disease,1.0,23908970
54227,mouse,species,0.845,23908970
54228,tumor,disease,0.7476,23908970
54229,human tumor xenografts,cell_line,0.612,23908970
54230,human,species,0.9956,23908970
54231,tumor,disease,0.9995,23908970
54232,human,species,0.995,23908970
54233,VEGF121,gene,0.9985,23908970
54234,VEGF165,gene,0.998,23908970
54235,mouse,species,0.984,23908970
54236,VEGF120,gene,0.9985,23908970
54237,VEGF164,gene,0.9956,23908970
54238,VEGF isoforms,gene,0.998,23908970
54239,VEGFR1,gene,0.9946,23908970
54240,VEGFR2,gene,0.9946,23908970
54241,NRP1,gene,0.9966,23908970
54242,NRP2,gene,0.9937,23908970
54243,soluble VEGFR1,gene,0.799,23908970
54244,sFlt-1,gene,0.9966,23908970
54245,-2-macroglobulin,gene,0.994,23908970
54246,VEGF Trap,gene,0.993,23908970
54247,VEGF Trap,gene,0.9917,23908970
54248,mouse,species,0.9976,23908970
54249,human VEGF,gene,0.9395,23908970
54250,human,species,0.999,23908970
54251,parenchymal cells,cell_type,0.757,23908970
54252,myocytes,cell_type,0.8174,23908970
54253,tumor cells,cell_type,0.738,23908970
54254,tumor,disease,0.988,23908970
54255,endothelial cells,cell_type,0.891,23908970
54256,VEGF,gene,0.9873,23908970
54257,tumor,cell_type,0.4802,23908970
54258,tumor,disease,0.9995,23908970
54259,VEGF,gene,0.87,23908970
54260,VEGF,gene,0.9956,23908970
54261,VEGF Trap,gene,0.94,23908970
54262,aflibercept,gene,0.9956,23908970
54263,mice,species,0.954,23908970
54264,hypertension,disease,1.0,23899982
54265,proteinuria,disease,1.0,23899982
54266,wound,disease,0.594,23899982
54267,hemorrhage,disease,0.999,23899982
54268,thromboembolic,disease,0.997,23899982
54269,hypersensitivity reactions,disease,1.0,23899982
54270,gastrointestinal perforation,disease,1.0,23899982
54271,nausea,disease,0.999,23899982
54272,vomiting,disease,0.979,23899982
54273,diarrhea,disease,1.0,23899982
54274,constipation,disease,1.0,23899982
54275,fatigue,disease,0.9995,23899982
54276,neuropathy,disease,1.0,23899982
54277,mucositis,disease,1.0,23899982
54278,hand-foot syndrome,disease,1.0,23899982
54279,hypersensitivity reactions,disease,1.0,23899982
54280,myelosuppression,disease,1.0,23899982
54281,Patients,species,0.9756,23899982
54282,metastatic colorectal cancer,disease,1.0,23899982
54283,mCRC,disease,1.0,23899982
54284,Patient,species,0.965,23899982
54285,Oncology nurses,cell_type,0.4497,23899982
54286,patients,species,0.987,23899982
54287,aflibercept,gene,0.9756,23899982
54288,bevacizumab,gene,0.913,23899982
54289,patients,species,0.9644,23899982
54290,mCRC,disease,0.987,23899982
54291,VEGF,gene,0.998,23891860
54292,PlGF,gene,0.995,23891860
54293,retinal endothelial cells,cell_type,0.911,23891860
54294,retinal endothelial cells,cell_type,0.901,23891860
54295,REC,cell_line,0.8677,23891860
54296,diabetic retinopathy,disease,1.0,23891860
54297,DR,disease,1.0,23891860
54298,endothelial growth factor A165,gene,0.951,23891860
54299,VEGF165,gene,0.9985,23891860
54300,basic fibroblast growth factor,gene,0.997,23891860
54301,bFGF,gene,0.9976,23891860
54302,insulin-like growth factor,gene,0.999,23891860
54303,IGF-1,gene,0.998,23891860
54304,tight-,gene,0.6567,23891860
54305,claudin-3,gene,0.9873,23891860
54306,claudin-5,gene,0.986,23891860
54307,ZO-1,gene,0.992,23891860
54308,immortalized bovine REC,cell_line,0.9478,23891860
54309,immortalized bovine REC,cell_type,0.508,23891860
54310,bovine,species,0.8574,23891860
54311,iBREC,cell_line,0.931,23891860
54312,VEGF,DNA,0.59,23891860
54313,VEGF family,gene,0.9966,23891860
54314,VEGF121,gene,0.9985,23891860
54315,placental growth factor,gene,0.9966,23891860
54316,PlGF-1,gene,0.997,23891860
54317,PlGF-2,gene,0.998,23891860
54318,viral VEGF-E,gene,0.9937,23891860
54319,VEGF receptors,gene,0.995,23891860
54320,iBREC,cell_line,0.9565,23891860
54321,iBREC,cell_type,0.7173,23891860
54322,TJ-proteins,gene,0.9937,23891860
54323,PlGF-1,gene,0.997,23891860
54324,PlGF-2,gene,0.998,23891860
54325,VEGF121,gene,0.996,23891860
54326,bFGF,gene,0.992,23891860
54327,IGF-1,gene,0.9956,23891860
54328,IGF-1,gene,0.998,23891860
54329,VEGF-specific Fab fragment ranibizumab,gene,0.8916,23891860
54330,aflibercept,gene,0.64,23891860
54331,VEGF,gene,0.995,23891860
54332,PlGF,gene,0.9956,23891860
54333,VEGF-E,gene,0.998,23891860
54334,iBREC,cell_type,0.8306,23891860
54335,VEGF121,gene,0.997,23891860
54336,claudin,DNA,0.5293,23891860
54337,claudin-1,gene,0.979,23891860
54338,PlGF-1,gene,0.997,23891860
54339,PlGF-2,gene,0.9976,23891860
54340,VEGF165,gene,0.997,23891860
54341,VEGF121,gene,0.998,23891860
54342,bFGF,gene,0.9956,23891860
54343,IGF-1,gene,0.9985,23891860
54344,TER,gene,0.9155,23891860
54345,claudin-1,gene,0.9883,23891860
54346,ranibizumab,gene,0.75,23891860
54347,VEGF,gene,0.9854,23891860
54348,ranibizumab,gene,0.6016,23891860
54349,aflibercept,gene,0.9795,23891860
54350,claudin-1,gene,0.9917,23891860
54351,VEGF-A,gene,0.997,23891860
54352,PlGF,gene,0.996,23891860
54353,iBREC,cell_line,0.937,23891860
54354,VEGF165,gene,0.9985,23891860
54355,VEGF121,gene,0.998,23891860
54356,iBREC,cell_line,0.956,23891860
54357,iBREC,cell_type,0.8623,23891860
54358,VEGF receptor 2,gene,0.997,23891860
54359,neuropilin-1,gene,0.996,23891860
54360,VEGF-E,gene,0.9956,23891860
54361,VEGF165,gene,0.9966,23891860
54362,PlGF-1/-2,gene,0.996,23891860
54363,TER,cell_line,0.507,23891860
54364,claudin-1,gene,0.9756,23891860
54365,VEGF,gene,0.9937,23874680
54366,gemcitabine,drug,0.998,23874680
54367,tumor,disease,0.9683,23874680
54368,cancer,disease,1.0,23874680
54369,vascular endothelial growth factor,gene,0.999,23874680
54370,VEGF,gene,0.9985,23874680
54371,vascular endothelial growth factor,gene,0.998,23874680
54372,VEGF-Trap,gene,0.84,23874680
54373,gemcitabine,drug,0.998,23874680
54374,tumor,disease,1.0,23874680
54375,luciferase-expressing,cell_line,0.537,23874680
54376,luciferase,gene,0.997,23874680
54377,Lewis lung carcinoma,disease,0.9995,23874680
54378,LLC,disease,1.0,23874680
54379,mice,species,0.9023,23874680
54380,tumor,disease,0.9595,23874680
54381,mice,species,0.9316,23874680
54382,VEGF-Trap,gene,0.9883,23874680
54383,gemcitabine,drug,0.9995,23874680
54384,VEGF-Trap,gene,0.9883,23874680
54385,gemcitabine,drug,0.9995,23874680
54386,Tumor,disease,0.8745,23874680
54387,Tumor,disease,0.5093,23874680
54388,CD31,gene,0.9775,23874680
54389,Ki-67,gene,0.9097,23874680
54390,apoptotic cells,cell_type,0.877,23874680
54391,Cyclin D1,gene,0.9985,23874680
54392,Pro-Caspase-3,gene,0.9946,23874680
54393,Bcl-2,gene,0.9927,23874680
54394,MMP2,gene,0.9873,23874680
54395,MMP9,gene,0.9795,23874680
54396,tumor,disease,0.998,23874680
54397,VEGF-Trap,gene,0.942,23874680
54398,gemcitabine,drug,0.9985,23874680
54399,tumor,disease,0.9995,23874680
54400,mouse,species,0.9507,23874680
54401,VEGF-Trap,gene,0.9536,23874680
54402,gemcitabine,drug,0.9985,23874680
54403,VEGF-Trap,gene,0.9497,23874680
54404,gemcitabine,drug,0.9995,23874680
54405,tumor,disease,0.995,23874680
54406,tumor,disease,0.999,23874680
54407,VEGF-Trap,gene,0.9736,23874680
54408,gemcitabine,drug,0.998,23874680
54409,tumor,disease,0.994,23874680
54410,lung cancer,disease,1.0,23874680
54411,VEGF-Trap,gene,0.987,23874680
54412,gemcitabine,drug,0.9995,23874680
54413,human,species,0.9976,23874680
54414,lung cancer,disease,1.0,23874680
54415,Retinal pigment,cell_type,0.4534,23836958
54416,aflibercept,gene,0.9897,23836958
54417,retinal pigment epithelium (RPE) tear,disease,0.978,23836958
54418,aflibercept,gene,0.9917,23836958
54419,Fluorescein,drug,0.9927,23836958
54420,choroidal neovascularization,disease,0.9995,23836958
54421,serous retinal detachment,disease,1.0,23836958
54422,fibrovascular pigment epithelial detachment,disease,1.0,23836958
54423,age-related macular degeneration,disease,1.0,23836958
54424,pigment epithelial detachment,disease,1.0,23836958
54425,aflibercept,gene,0.9717,23836958
54426,RPE defect,disease,0.9966,23836958
54427,fluorescein,drug,0.9966,23836958
54428,RPE tear,disease,0.892,23836958
54429,aflibercept,gene,0.9863,23836958
54430,serous retinal detachment,disease,1.0,23836958
54431,RPE tears,disease,0.975,23836958
54432,age-related macular degeneration,disease,1.0,23836958
54433,aflibercept,gene,0.958,23836958
54434,age-related macular degeneration,disease,1.0,23836958
54435,pigment epithelial detachment,disease,1.0,23836958
54436,RPE tear,disease,0.994,23836958
54437,ranibizumab,gene,0.7,23836955
54438,diabetic macular edema,disease,1.0,23836955
54439,Diabetic retinopathy,disease,1.0,23836955
54440,blindness,disease,0.999,23836955
54441,vision loss,disease,0.97,23836955
54442,diabetic macular edema,disease,1.0,23836955
54443,DME,disease,1.0,23836955
54444,DME,disease,1.0,23836955
54445,vascular endothelial growth factor,gene,0.9976,23836955
54446,VEGF,gene,0.992,23836955
54447,macular edema,disease,1.0,23836955
54448,VEGF,gene,0.996,23836955
54449,aflibercept,gene,0.925,23836955
54450,ranibizumab,gene,0.7993,23836955
54451,age-related macular degeneration,disease,1.0,23836955
54452,DME,disease,1.0,23836955
54453,DME,disease,0.9995,23836955
54454,ranibizumab,gene,0.7847,23836955
54455,triamcinolone acetonide,drug,0.971,23836955
54456,ranibizumab,gene,0.5806,23836955
54457,VEGF,gene,0.6343,23836955
54458,DME,disease,1.0,23836955
54459,VEGF,gene,0.5464,23836955
54460,DME,disease,1.0,23836955
54461,Ziv-aflibercept,gene,0.9688,23836346
54462,Zaltrap,gene,0.762,23836346
54463,metastatic colorectal cancer,disease,0.9956,23836346
54464,neovascular age-related macular degeneration,disease,1.0,23819948
54465,Age-related macular degeneration,disease,1.0,23819948
54466,AMD,disease,1.0,23819948
54467,eye disease,disease,0.9995,23819948
54468,visual impairment,disease,1.0,23819948
54469,Neovascular AMD,disease,1.0,23819948
54470,advanced AMD,disease,0.999,23819948
54471,neovascular AMD,disease,1.0,23819948
54472,neovascular AMD,disease,1.0,23819948
54473,vascular endothelial growth factor,gene,0.998,23819948
54474,VEGF,gene,0.997,23819948
54475,VEGF,gene,0.979,23819948
54476,VEGF,gene,0.994,23819948
54477,neovascular AMD,disease,1.0,23819948
54478,VEGF,gene,0.8237,23819948
54479,anti-,gene,0.6953,23819948
54480,VEGF,gene,0.69,23819948
54481,ranibizumab,gene,0.876,23819948
54482,bevacizumab,gene,0.8535,23819948
54483,aflibercept,gene,0.934,23819948
54484,loss of vision,disease,0.943,23819948
54485,neovascular AMD,disease,1.0,23819948
54486,VEGF,gene,0.9966,23819948
54487,neovascular AMD,disease,1.0,23819948
54488,neovascular AMD,disease,0.9897,23819948
54489,retinal disease,disease,0.9995,26106919
54490,retinal disease,disease,0.9995,26106919
54491,ocriplasmin,gene,0.977,26106919
54492,retinal vascular disease,disease,1.0,26106919
54493,ranibizumab,gene,0.9194,26106919
54494,aflibercept,gene,0.9688,26106919
54495,macular edema,disease,1.0,26106919
54496,diabetic retinopathy,disease,1.0,26106919
54497,retinal vein occlusion,disease,1.0,26106919
54498,retinal vascular disease,disease,1.0,26106919
54499,dry age-related macular degeneration,disease,1.0,26106919
54500,VEGF,gene,0.9766,23807861
54501,metastatic colorectal cancer,disease,1.0,23807861
54502,mCRC,disease,1.0,23807861
54503,vascular endothelial growth factor (VEGF)-A,gene,0.998,23807861
54504,cancer,disease,1.0,23807861
54505,VEGF,gene,0.994,23807861
54506,VEGF-B,gene,0.9907,23807861
54507,placental growth factor,gene,0.996,23807861
54508,VEGF-A,gene,0.9966,23807861
54509,VEGF,gene,0.9966,23807861
54510,aflibercept,gene,0.991,23807861
54511,ziv-aflibercept,gene,0.9717,23807861
54512,VEGF receptors,gene,0.9966,23807861
54513,tyrosine,drug,0.9966,23807861
54514,tyrosine kinase,gene,0.992,23807861
54515,tyrosine,drug,0.966,23807861
54516,tyrosine kinase,gene,0.9556,23807861
54517,VEGF,gene,0.9966,23807861
54518,bevacizumab,gene,0.813,23807861
54519,aflibercept,gene,0.9873,23807861
54520,ramucirumab,gene,0.8047,23807861
54521,IMC-18F1,drug,0.9844,23807861
54522,bevacizumab,gene,0.943,23807861
54523,aflibercept,gene,0.9795,23807861
54524,colorectal and other cancers,disease,1.0,23807861
54525,vascular endothelial growth factor,gene,0.9956,23791369
54526,neovascular age-related macular degeneration,disease,1.0,23791369
54527,gynecological cancer,disease,1.0,23782133
54528,gynecological cancers,disease,1.0,23782133
54529,cancers,disease,0.9824,23782133
54530,cancers,disease,1.0,23782133
54531,cancers,disease,1.0,23782133
54532,gynecological cancer,disease,1.0,23782133
54533,ovarian cancer,disease,1.0,23782133
54534,cervical cancer,disease,1.0,23782133
54535,uterine leiomysarcoma,disease,1.0,23782133
54536,endometrial cancer,disease,1.0,23782133
54537,bevacizumab,gene,0.5337,23782133
54538,volociximab,gene,0.857,23782133
54539,aflibercept,gene,0.981,23782133
54540,temsirolimus,drug,0.998,23782133
54541,enzastaurin,drug,0.995,23782133
54542,trebananib,drug,0.999,23782133
54543,sunitinib,drug,0.999,23782133
54544,imatinib,drug,0.999,23782133
54545,pazopanib,drug,0.9995,23782133
54546,sorafenib,drug,0.9995,23782133
54547,nintedanib,drug,0.999,23782133
54548,gynecological cancers,disease,1.0,23782133
54549,gynecological cancer,disease,1.0,23782133
54550,Aflibercept,gene,0.939,23769799
54551,polypoidal choroidal vasculopathy,disease,1.0,23769799
54552,advanced,disease,0.5923,23767831
54553,endometrial cancer,disease,0.9824,23767831
54554,endometrial cancer,disease,1.0,23767831
54555,vascular endothelial growth factor,gene,0.998,23767831
54556,VEGF,gene,0.996,23767831
54557,sunitinib,drug,0.9995,23767831
54558,sorafenib,drug,0.999,23767831
54559,thalidomide,drug,0.999,23767831
54560,Bevacizumab,gene,0.8755,23767831
54561,patients,species,0.993,23767831
54562,endometrioid,disease,1.0,23767831
54563,serous carcinoma,disease,1.0,23767831
54564,bevacizumab,gene,0.7656,23767831
54565,aflibercept,gene,0.981,23767831
54566,women,species,0.828,23767831
54567,patients,species,0.97,23767831
54568,women,species,0.8403,23767831
54569,Fibroblast Growth Factor Receptor (FGFR)-2,gene,0.995,23767831
54570,primary endometrial carcinoma,disease,0.981,23767831
54571,Dovitinib,drug,0.9985,23767831
54572,tyrosine,drug,0.871,23767831
54573,tyrosine kinase,gene,0.93,23767831
54574,VEGF receptor,gene,0.9976,23767831
54575,VEGFR,gene,0.997,23767831
54576,FGFRs,gene,0.9966,23767831
54577,malignancies,disease,1.0,23767831
54578,endometrial cancer,disease,1.0,23767831
54579,Aflibercept,gene,0.8765,23766432
54580,exudative AMD,disease,0.999,23766432
54581,aflibercept,gene,0.989,23766432
54582,ranibizumab,gene,0.734,23766432
54583,bevacizumab,gene,0.7974,23766432
54584,aflibercept,gene,0.9883,23766432
54585,exudative age-related macular degeneration,disease,1.0,23766432
54586,AMD,disease,1.0,23766432
54587,ranibizumab,gene,0.718,23766432
54588,bevacizumab,gene,0.843,23766432
54589,exudative AMD,disease,0.9995,23766432
54590,ranibizumab,gene,0.7393,23766432
54591,bevacizumab,gene,0.5366,23766432
54592,aflibercept,gene,0.99,23766432
54593,aflibercept,gene,0.9883,23766432
54594,aflibercept,gene,0.988,23766432
54595,exudative AMD,disease,0.9985,23766432
54596,aflibercept,gene,0.9473,23766432
54597,patients,species,0.989,23766432
54598,ranibizumab,gene,0.838,23766432
54599,bevacizumab,gene,0.8745,23766432
54600,aflibercept,gene,0.995,23766432
54601,aflibercept,gene,0.9907,23766432
54602,aflibercept,gene,0.991,23766432
54603,exudative AMD,disease,0.977,23766432
54604,ranibizumab,gene,0.865,23766432
54605,bevacizumab,gene,0.797,23766432
54606,aflibercept,gene,0.9697,23766432
54607,Aflibercept,gene,0.9688,23766432
54608,exudative AMD,disease,0.9995,23766432
54609,ranibizumab,gene,0.8623,23766432
54610,bevacizumab,gene,0.559,23766432
54611,salivary vascular endothelial growth factor,gene,0.959,23758212
54612,VEGF,gene,0.9937,23758212
54613,palatal mucosal wound,disease,0.9995,23758212
54614,cutaneous wounds,disease,0.994,23758212
54615,vascular endothelial growth factor,gene,0.9976,23758212
54616,VEGF,gene,0.996,23758212
54617,salivary,RNA,0.4814,23758212
54618,salivary VEGF,gene,0.678,23758212
54619,salivary VEGF,gene,0.9043,23758212
54620,murine,species,0.971,23758212
54621,palatal,disease,0.6875,23758212
54622,VEGF,gene,0.9946,23758212
54623,sialoadenectomy,disease,0.466,23758212
54624,murine,species,0.5986,23758212
54625,VEGF-Trap,gene,0.964,23758212
54626,salivary VEGF,gene,0.701,23758212
54627,VEGF,gene,0.996,23758212
54628,SMG sialoadenectomy,disease,0.823,23758212
54629,SMG,gene,0.8364,23758212
54630,salivary,RNA,0.476,23758212
54631,salivary VEGF,gene,0.688,23758212
54632,salivary VEGF,gene,0.832,23758212
54633,VEGF,gene,0.992,23758212
54634,VEGF-Trap,gene,0.984,23758212
54635,VEGF,gene,0.994,23758212
54636,SMG sialoadenectomy,disease,0.96,23758212
54637,salivary-VEGF,gene,0.661,23758212
54638,wounds,disease,0.9644,23758212
54639,VEGF,gene,0.9253,23749885
54640,patients,species,0.9697,23749885
54641,colorectal,disease,1.0,23749885
54642,bevacizumab,gene,0.7847,23749885
54643,patients,species,0.9185,23749885
54644,metastatic colorectal cancer,disease,0.999,23749885
54645,bevacizumab,gene,0.8716,23749885
54646,bevacizumab,gene,0.856,23749885
54647,aflibercept,gene,0.962,23749885
54648,FOLFIRI,drug,0.9736,23749885
54649,irinotecan,drug,0.9995,23749885
54650,5-FU,drug,0.999,23749885
54651,leucovorin,drug,0.9976,23749885
54652,oxaliplatin,drug,0.9995,23749885
54653,bevacizumab,gene,0.784,23749885
54654,regorafenib,drug,0.9897,23749885
54655,vascular endothelial growth factor,gene,0.915,23749885
54656,VEGF,gene,0.988,23749885
54657,patients,species,0.988,23749885
54658,colon cancer,disease,1.0,23749885
54659,bevacizumab,gene,0.889,23749885
54660,VEGF,gene,0.9556,23749885
54661,metastatic colorectal cancer,disease,0.9927,23749885
54662,metastatic colorectal cancer,disease,1.0,23743737
54663,patients,species,0.9517,23743737
54664,metastatic colorectal cancer,disease,1.0,23743737
54665,mCRC,disease,1.0,23743737
54666,irinotecan,drug,0.9946,23743737
54667,oxaliplatin,drug,0.9995,23743737
54668,vascular endothelial growth factor,gene,0.9976,23743737
54669,VEGF,gene,0.999,23743737
54670,bevacizumab,gene,0.954,23743737
54671,aflibercept,gene,0.97,23743737
54672,epidermal growth factor receptor antibodies,gene,0.9707,23743737
54673,cetuximab,gene,0.9004,23743737
54674,panitumumab,gene,0.8076,23743737
54675,tyrosine,drug,0.9956,23743737
54676,tyrosine kinase,gene,0.9785,23743737
54677,vatalanib,drug,0.9985,23743737
54678,VEGF,gene,0.998,23743737
54679,aflibercept,gene,0.9883,23743737
54680,bevacizumab,gene,0.837,23743737
54681,bevacizumab,gene,0.849,23743737
54682,mCRC,disease,0.971,23743737
54683,patients,species,0.993,23743737
54684,patients,species,0.9795,23743737
54685,bevacizumab,gene,0.882,23743737
54686,mCRC,disease,0.975,23743737
54687,patient,species,0.9893,23743737
54688,Aflibercept,gene,0.982,23742877
54689,docetaxel,drug,0.9985,23742877
54690,prednisone,drug,0.9946,23742877
54691,Docetaxel,drug,0.9985,23742877
54692,prednisone,drug,0.9956,23742877
54693,men,species,0.5254,23742877
54694,metastatic castrate-resistant prostate cancer,disease,1.0,23742877
54695,Aflibercept,gene,0.9727,23742877
54696,human,species,0.668,23742877
54697,VEGF,gene,0.9863,23742877
54698,placental growth factor,gene,0.9976,23742877
54699,aflibercept,gene,0.9927,23742877
54700,docetaxel,drug,0.999,23742877
54701,prednisone,drug,0.996,23742877
54702,men,species,0.763,23742877
54703,metastatic castrate-resistant prostate cancer,disease,1.0,23742877
54704,docetaxel,drug,0.9985,23742877
54705,prednisone,drug,0.9985,23742877
54706,Men,species,0.8657,23742877
54707,metastatic castrate-resistant prostate cancer,disease,1.0,23742877
54708,docetaxel,drug,0.9976,23742877
54709,prednisone,drug,0.9897,23742877
54710,aflibercept,gene,0.948,23742877
54711,Patients,species,0.9824,23742877
54712,Aflibercept,gene,0.971,23742877
54713,men,species,0.93,23742877
54714,men,species,0.9556,23742877
54715,aflibercept,gene,0.9897,23742877
54716,gastrointestinal disorders,disease,1.0,23742877
54717,haemorrhagic events,disease,0.9985,23742877
54718,hypertension,disease,1.0,23742877
54719,fatigue,disease,0.9995,23742877
54720,aflibercept,gene,0.986,23742877
54721,Aflibercept,gene,0.972,23742877
54722,docetaxel,drug,0.998,23742877
54723,prednisone,drug,0.9976,23742877
54724,men,species,0.746,23742877
54725,metastatic castrate-resistant prostate cancer,disease,1.0,23742877
54726,Docetaxel,drug,0.999,23742877
54727,prednisone,drug,0.995,23742877
54728,men,species,0.915,23742877
54729,colorectal cancer,disease,1.0,23730520
54730,aflibercept,gene,0.979,23730520
54731,regorafenib,drug,0.9707,23730520
54732,colorectal,disease,0.98,23730520
54733,vascular growth factor receptor,gene,0.9985,23730520
54734,VEGF,gene,0.998,23730520
54735,metastatic colorectal,disease,0.998,23730520
54736,cancer,disease,1.0,23730520
54737,patients,species,0.9907,23730520
54738,bevacizumab,gene,0.804,23730520
54739,bevacizumab,gene,0.8984,23730520
54740,Aflibercept,gene,0.9795,23730520
54741,"VEGF-A, -B",gene,0.9976,23730520
54742,PlGF,gene,0.876,23730520
54743,irinotecan,drug,0.998,23730520
54744,metastatic colorectal cancer,disease,1.0,23730520
54745,patients,species,0.9863,23730520
54746,Regorafenib,drug,0.998,23730520
54747,metastatic colorectal cancer,disease,1.0,23730520
54748,patients,species,0.9854,23730520
54749,aflibercept,gene,0.987,23730520
54750,regorafenib,drug,0.9766,23730520
54751,colorectal,disease,0.9995,23730520
54752,cancer,disease,1.0,23730520
54753,patients,species,0.9907,23730520
54754,age,disease,0.93,23725499
54755,age-related ocular diseases,disease,0.988,23725499
54756,ocular diseases,disease,0.998,23725499
54757,neovascular age-related macular degeneration,disease,0.9995,23725499
54758,diabetic retinopathy,disease,1.0,23725499
54759,glaucoma,disease,1.0,23725499
54760,dry eye disease,disease,1.0,23725499
54761,age-related ocular diseases,disease,0.998,23725499
54762,age-related macular degeneration,disease,1.0,23725499
54763,glaucoma,disease,1.0,23725499
54764,diabetic retinopathy,disease,1.0,23725499
54765,dry eye,disease,1.0,23725499
54766,metastatic,disease,0.8867,23704235
54767,colorectal cancer,disease,0.931,23704235
54768,advanced colorectal cancer,disease,1.0,23704235
54769,CRC,disease,1.0,23704235
54770,irinotecan,drug,0.999,23704235
54771,oxaliplatin,drug,0.9995,23704235
54772,regorafenib,drug,0.973,23704235
54773,ziv-aflibercept,gene,0.951,23704235
54774,metastatic CRC,disease,0.7275,23704235
54775,patient,species,0.9873,23714474
54776,patient,species,0.9893,23714474
54777,KRAS mutations,gene,0.848,23714474
54778,epidermal growth factor receptor,gene,0.998,23714474
54779,EGFR,gene,0.9956,23714474
54780,regorafenib,drug,0.9927,23714474
54781,aflibercept,gene,0.9727,23714474
54782,bevacizumab,gene,0.8965,23714474
54783,Tumor,disease,0.999,23714474
54784,tumor,disease,0.999,23714474
54785,tumors,disease,1.0,23714474
54786,tumors,disease,1.0,23714474
54787,RNA,RNA,0.7007,23714474
54788,colorectal cancer,disease,1.0,23714474
54789,patient,species,0.974,23714474
54790,Aflibercept,gene,0.8853,23706500
54791,exudative age-related macular degeneration,disease,1.0,23706500
54792,aflibercept,gene,0.9883,23706500
54793,exudative age-related macular degeneration,disease,1.0,23706500
54794,AMD,disease,1.0,23706500
54795,bevacizumab,gene,0.8345,23706500
54796,ranibizumab,gene,0.828,23706500
54797,patients,species,0.9727,23706500
54798,exudative AMD,disease,1.0,23706500
54799,choroidal neovascularization,disease,1.0,23706500
54800,CNV,disease,1.0,23706500
54801,ranibizumab,gene,0.6616,23706500
54802,aflibercept,gene,0.9727,23706500
54803,patients,species,0.975,23706500
54804,patient,species,0.967,23706500
54805,patients,species,0.983,23706500
54806,bevacizumab,gene,0.9165,23706500
54807,aflibercept,gene,0.983,23706500
54808,Aflibercept,gene,0.93,23706500
54809,patients,species,0.9736,23706500
54810,neovascular age-related macular degeneration,disease,1.0,23706500
54811,intraretinal or subretinal fluid,disease,0.9995,23706500
54812,bevacizumab,gene,0.858,23706500
54813,ranibizumab,gene,0.8,23706500
54814,aflibercept,gene,0.9824,23686000
54815,bevacizumab,gene,0.673,23686000
54816,Vascular endothelial growth factor,gene,0.9976,23686000
54817,VEGF,gene,0.997,23686000
54818,retinal diseases,disease,1.0,23686000
54819,age-related macular degeneration,disease,1.0,23686000
54820,VEGF,gene,0.992,23686000
54821,bevacizumab,gene,0.4922,23686000
54822,patients,species,0.9834,23686000
54823,aflibercept,gene,0.9883,23686000
54824,VEGF Trap-Eye,gene,0.887,23686000
54825,aflibercept,gene,0.989,23686000
54826,aflibercept,gene,0.989,23686000
54827,ranibizumab,gene,0.705,23686000
54828,bevacizumab,gene,0.5435,23686000
54829,caspase 3/7,gene,0.99,23686000
54830,ocular cell lines,cell_line,0.877,23686000
54831,ARPE19 cells,cell_line,0.941,23686000
54832,RGC-5 cells,cell_line,0.9604,23686000
54833,RGC,cell_type,0.596,23686000
54834,661W cells,cell_line,0.969,23686000
54835,Aflibercept,gene,0.9727,23686000
54836,cell line,cell_line,0.9243,23686000
54837,aflibercept,gene,0.995,23686000
54838,bevacizumab,gene,0.816,23686000
54839,ranibizumab,gene,0.603,23686000
54840,aflibercept,gene,0.99,23686000
54841,retinal cell lines,cell_line,0.963,23686000
54842,wet AMD,disease,0.992,23676221
54843,VEGF,gene,0.623,23676221
54844,Aflibercept,gene,0.9536,23673531
54845,macular edema,disease,1.0,23673531
54846,aflibercept,gene,0.977,23673531
54847,macular edema,disease,1.0,23673531
54848,central retinal vein occlusion,disease,1.0,23673531
54849,CRVO,disease,1.0,23673531
54850,aflibercept,gene,0.996,23673531
54851,VEGF,gene,0.998,23673531
54852,age-related macular degeneration,disease,1.0,23673531
54853,diabetic macular edema,disease,1.0,23673531
54854,aflibercept,gene,0.9834,23673531
54855,patients,species,0.972,23673531
54856,macular edema,disease,1.0,23673531
54857,CRVO,disease,1.0,23673531
54858,patients,species,0.9893,23673531
54859,patients,species,0.981,23673531
54860,aflibercept,gene,0.9443,23673531
54861,patients,species,0.9805,23673531
54862,aflibercept,gene,0.9727,23673531
54863,vascular endothelial growth factor,gene,0.9985,23673531
54864,VEGF,gene,0.999,23673531
54865,macular edema,disease,1.0,23673531
54866,CRVO,disease,1.0,23673531
54867,aflibercept,gene,0.978,23673531
54868,aflibercept,gene,0.994,23673444
54869,patients,species,0.936,23673444
54870,Aflibercept,gene,0.9697,23673444
54871,Zaltrap,gene,0.795,23673444
54872,vascular endothelial growth factor,gene,0.998,23673444
54873,VEGF,gene,0.97,23673444
54874,VEGF,gene,0.996,23673444
54875,tumor,disease,0.999,23673444
54876,aflibercept,gene,0.995,23673444
54877,patients,species,0.9424,23673444
54878,solid tumors,disease,1.0,23673444
54879,cancer,disease,1.0,23673444
54880,patients,species,0.9883,23673444
54881,aflibercept,gene,0.8955,23673444
54882,aflibercept,gene,0.995,23673444
54883,aflibercept,gene,0.989,23673444
54884,VEGF,gene,0.993,23673444
54885,aflibercept,gene,0.9927,23673444
54886,aflibercept,gene,0.9893,23673444
54887,aflibercept,gene,0.991,23673444
54888,women,species,0.9507,23673444
54889,Patients,species,0.989,23673444
54890,albumin,gene,0.997,23673444
54891,ALB,gene,0.9917,23673444
54892,alkaline phosphatase,gene,0.995,23673444
54893,ALK,gene,0.991,23673444
54894,patient,species,0.992,23673444
54895,Pancreatic cancer,disease,1.0,23673444
54896,aflibercept,gene,0.9883,23673444
54897,VEGF,gene,0.995,23673444
54898,VEGF,gene,0.997,23673444
54899,Aflibercept,gene,0.9766,23673444
54900,ALB,gene,0.9893,23673444
54901,ALK,gene,0.995,23673444
54902,pancreatic cancer,disease,1.0,23673444
54903,aflibercept,gene,0.9814,23673444
54904,aflibercept,gene,0.9897,23668679
54905,patients,species,0.978,23668679
54906,neovascular age-related macular degeneration,disease,1.0,23668679
54907,AMD,disease,1.0,23668679
54908,bevacizumab,gene,0.89,23668679
54909,ranibizumab,gene,0.806,23668679
54910,aflibercept,gene,0.9805,23668679
54911,Patients,species,0.9683,23668679
54912,patients,species,0.979,23668679
54913,bevacizumab,gene,0.8066,23668679
54914,ranibizumab,gene,0.87,23668679
54915,aflibercept,gene,0.977,23668679
54916,aflibercept,gene,0.9927,23668679
54917,patients,species,0.9536,23668679
54918,chronic neovascular AMD,disease,0.9946,23668679
54919,aflibercept,gene,0.9873,23668679
54920,aflibercept,gene,0.9785,23664153
54921,neovascular age-related macular degeneration,disease,1.0,23664153
54922,aflibercept,gene,0.9683,23664153
54923,neovascular age-related macular degeneration,disease,1.0,23664153
54924,bevacizumab,gene,0.772,23664153
54925,ranibizumab,gene,0.7505,23664153
54926,patients,species,0.968,23664153
54927,neovascular age-related macular degeneration,disease,1.0,23664153
54928,bevacizumab,gene,0.617,23664153
54929,aflibercept,gene,0.896,23664153
54930,aflibercept,gene,0.9863,23664153
54931,patients,species,0.9863,23664153
54932,anti-vascular endothelial growth factor,gene,0.975,23664153
54933,Aflibercept,gene,0.9707,23664153
54934,neovascular age-related macular degeneration,disease,1.0,23664153
54935,patients,species,0.9883,23664153
54936,bevacizumab,gene,0.662,23664153
54937,Neovascular age-related macular degeneration,disease,1.0,23642783
54938,neovascular age-related macular degeneration,disease,1.0,23642783
54939,AMD,disease,1.0,23642783
54940,vascular endothelial growth factor,gene,0.8677,23642783
54941,VEGF,gene,0.9985,23642783
54942,bevacizumab,gene,0.821,23642783
54943,ranibizumab,gene,0.662,23642783
54944,VEGF,gene,0.66,23642783
54945,aflibercept,gene,0.9727,23642783
54946,patients,species,0.9707,23642783
54947,AMD,disease,0.9995,23642783
54948,patient,species,0.9937,23642782
54949,aflibercept,gene,0.983,23642782
54950,Age-Related Macular Degeneration,disease,1.0,23642782
54951,Age-Related Choroidal Neovascularization,disease,0.998,23642782
54952,neovascular age-related macular degeneration,disease,1.0,23642781
54953,neovascular age-related macular degeneration,disease,1.0,23642781
54954,AMD,disease,1.0,23642781
54955,patients,species,0.992,23642781
54956,neovascular AMD,disease,1.0,23642781
54957,neovascular AMD,disease,1.0,23642781
54958,AMD,disease,1.0,23642781
54959,aflibercept,gene,0.9673,23642781
54960,vascular endothelial growth factor,gene,0.906,23642781
54961,VEGF,gene,0.9985,23642781
54962,neovascular AMD,disease,1.0,23642781
54963,neovascular AMD,disease,1.0,23642781
54964,VEGF,gene,0.885,23642781
54965,patients,species,0.9756,23642781
54966,patient,species,0.9863,23642781
54967,metastatic colorectal cancer,disease,0.9814,23645285
54968,colorectal cancer,disease,1.0,23645285
54969,CRC,disease,1.0,23645285
54970,cancer,disease,1.0,23645285
54971,CRC,disease,0.999,23645285
54972,vascular endothelial growth factor,gene,0.9976,23645285
54973,VEGF,gene,0.9966,23645285
54974,epidermal growth factor receptor,gene,0.9956,23645285
54975,EGFR,gene,0.997,23645285
54976,bevacizumab,gene,0.4978,23645285
54977,VEGF,gene,0.987,23645285
54978,cetuximab,gene,0.739,23645285
54979,panitumumab,gene,0.6577,23645285
54980,EGFR,gene,0.989,23645285
54981,metastatic CRC,disease,0.9995,23645285
54982,mCRC,disease,1.0,23645285
54983,EGFR,gene,0.714,23645285
54984,VEGF,gene,0.6743,23645285
54985,Aflibercept,gene,0.9487,23645285
54986,regorafenib,drug,0.988,23645285
54987,patients,species,0.9404,23645285
54988,mCRC,disease,0.971,23645285
54989,anti-VEGF,gene,0.9673,23645285
54990,anti-EGFR,gene,0.8115,23645285
54991,CRC,disease,0.999,23645285
54992,patients,species,0.9927,23645285
54993,Aflibercept,gene,0.9727,23642742
54994,sterile inflammation,disease,0.9995,23642742
54995,aflibercept,gene,0.9863,23642329
54996,gemcitabine,drug,0.9995,23642329
54997,patients,species,0.964,23642329
54998,advanced pancreatic cancer,disease,1.0,23642329
54999,PATIENTS,species,0.9355,23642329
55000,Patients,species,0.954,23642329
55001,metastatic pancreatic cancer,disease,1.0,23642329
55002,aflibercept,gene,0.9424,23642329
55003,gemcitabine,drug,0.9985,23642329
55004,patients,species,0.965,23642329
55005,patients,species,0.993,23642329
55006,gemcitabine,drug,0.999,23642329
55007,gemcitabine,drug,0.999,23642329
55008,aflibercept,gene,0.9663,23642329
55009,aflibercept,gene,0.9746,23642329
55010,aflibercept,gene,0.993,23642329
55011,gemcitabine,drug,0.9995,23642329
55012,patients,species,0.8794,23642329
55013,metastatic pancreatic cancer,disease,1.0,23642329
55014,Age-related macular degeneration,disease,1.0,23573745
55015,metastatic colorectal cancer,disease,1.0,23562587
55016,Colorectal cancer,disease,1.0,23562587
55017,CRC,disease,1.0,23562587
55018,cancer,disease,1.0,23562587
55019,metastatic CRC,disease,0.998,23562587
55020,mCRC,disease,0.9995,23562587
55021,tumor,disease,1.0,23562587
55022,bevacizumab,gene,0.6206,23562587
55023,vascular endothelial growth factor,gene,0.998,23562587
55024,VEGF,gene,0.9956,23562587
55025,mCRC,disease,0.993,23562587
55026,Aflibercept,gene,0.9863,23562587
55027,VEGF-A,gene,0.9985,23562587
55028,VEGF-B,gene,0.9995,23562587
55029,placental growth factor,gene,0.996,23562587
55030,mCRC,disease,0.99,23562587
55031,bevacizumab,gene,0.6313,23562587
55032,aflibercept,gene,0.9873,23562587
55033,anti-VEGF,gene,0.7603,23562587
55034,neovascular age-related macular degeneration,disease,1.0,23560774
55035,Neovascular age-related macular degeneration,disease,1.0,23560774
55036,AMD,disease,1.0,23560774
55037,legal blindness,disease,1.0,23560774
55038,VEGF,gene,0.99,23560774
55039,VEGF,gene,0.6387,23560774
55040,triamcinolone acetonide,drug,0.9985,23560774
55041,verteporfin,drug,0.9956,23560774
55042,pegaptanib sodium,drug,0.998,23560774
55043,bevacizumab,gene,0.909,23560774
55044,ranibizumab,gene,0.9043,23560774
55045,aflibercept,gene,0.975,23560774
55046,VEGF,gene,0.9097,23560774
55047,neovascular AMD,disease,1.0,23560774
55048,patients,species,0.9844,23560774
55049,VEGF,gene,0.5107,23560774
55050,patients,species,0.9893,23560774
55051,retinal pigment epithelial detachments,disease,0.528,23558214
55052,aflibercept,gene,0.985,23558214
55053,neovascular age-related macular degeneration,disease,1.0,23558214
55054,bevacizumab,gene,0.8423,23558214
55055,aflibercept,gene,0.9795,23558214
55056,neovascular age-related macular degeneration,disease,1.0,23558214
55057,AMD,disease,1.0,23558214
55058,retinal pigment epithelial detachment,disease,1.0,23558214
55059,PED,disease,1.0,23558214
55060,bevacizumab,gene,0.792,23558214
55061,ranibizumab,gene,0.5703,23558214
55062,neovascular AMD,disease,1.0,23558214
55063,PEDs,disease,0.9995,23558214
55064,aflibercept,gene,0.9854,23558214
55065,bevacizumab,gene,0.8257,23558214
55066,ranibizumab,gene,0.5527,23558214
55067,PEDs,disease,0.9873,23558214
55068,subretinal fluid,disease,0.8413,23558214
55069,choroidal neovascularization,disease,0.9995,23558214
55070,neovascular AMD,disease,1.0,23558214
55071,aflibercept,gene,0.987,23558214
55072,bevacizumab,gene,0.59,23558214
55073,SRF,disease,0.9956,23558214
55074,PEDs,disease,0.9927,23558214
55075,aflibercept,gene,0.9863,23558214
55076,aflibercept,gene,0.9785,23558214
55077,serous PED,disease,0.9995,23558214
55078,neovascular AMD,disease,1.0,23558214
55079,bevacizumab,gene,0.585,23558214
55080,aflibercept,gene,0.991,23558214
55081,PED,disease,0.9976,23558214
55082,neovascular AMD,disease,1.0,23558214
55083,aflibercept,gene,0.985,23550025
55084,doxorubicin,drug,0.999,23550025
55085,acute myeloid leukemia,disease,1.0,23550025
55086,cancer,disease,1.0,23550025
55087,VEGF,gene,0.998,23550025
55088,aflibercept,gene,0.982,23550025
55089,doxorubicin,drug,0.9995,23550025
55090,DOX,drug,0.9985,23550025
55091,acute myeloid leukemia,disease,1.0,23550025
55092,AML,disease,1.0,23550025
55093,Mice,species,0.888,23550025
55094,human HL-60 and HEL-luciferase leukemia cells,cell_line,0.918,23550025
55095,HEL,gene,0.5356,23550025
55096,luciferase,gene,0.83,23550025
55097,aflibercept,gene,0.98,23550025
55098,doxorubicin,drug,0.9995,23550025
55099,Leukemia,disease,1.0,23550025
55100,DOX,drug,0.9985,23550025
55101,aflibercept,gene,0.972,23550025
55102,aflibercept,gene,0.992,23550025
55103,DOX,drug,0.992,23550025
55104,DOX,drug,0.988,23550025
55105,DOX,drug,0.998,23550025
55106,aflibercept,gene,0.973,23550025
55107,DOX,drug,0.999,23550025
55108,DOX,drug,0.999,23550025
55109,tumor,disease,0.9897,23550025
55110,growth retardation,disease,1.0,23550025
55111,DOX,drug,0.999,23550025
55112,TRAP,drug,0.9995,23550025
55113,leukemia,disease,1.0,23550025
55114,anti-VEGF,gene,0.9688,23550025
55115,AML,disease,0.508,23550025
55116,hematological malignancies,disease,1.0,23550025
55117,aflibercept,gene,0.9863,23549101
55118,neovascular age-related macular degeneration,disease,1.0,23549101
55119,aflibercept,gene,0.983,23549101
55120,neovascular age-related macular degeneration,disease,1.0,23549101
55121,aflibercept,gene,0.9873,23549101
55122,subretinal and/or intraretinal fluid,disease,0.9365,23549101
55123,ranibizumab,gene,0.567,23549101
55124,aflibercept,gene,0.978,23549101
55125,pigment epithelial detachment,disease,0.988,23549101
55126,vascular endothelial growth factor,gene,0.993,23549101
55127,aflibercept,gene,0.986,23549101
55128,subfoveal fluid,disease,0.6484,23549101
55129,ranibizumab,gene,0.814,23549101
55130,Ranibizumab,gene,0.7773,23539234
55131,neovascular age-related macular,disease,1.0,23539234
55132,Ranibizumab,gene,0.6104,23539234
55133,neovascular age-related macular degeneration,disease,1.0,23539234
55134,AMD,disease,1.0,23539234
55135,ranibizumab,gene,0.857,23539234
55136,verteporfin,drug,0.9966,23539234
55137,classic choroidal neovascularization,disease,0.837,23539234
55138,CNV,disease,1.0,23539234
55139,neovascular AMD,disease,1.0,23539234
55140,CNV,disease,0.9966,23539234
55141,neovascular AMD,disease,1.0,23539234
55142,ranibizumab,gene,0.8423,23539234
55143,ranibizumab,gene,0.794,23539234
55144,aflibercept,gene,0.991,23539234
55145,ranibizumab,gene,0.5557,23539234
55146,bevacizumab,gene,0.6294,23539234
55147,Bevacizumab,gene,0.871,23539234
55148,ranibizumab,gene,0.746,23539234
55149,VEGF,gene,0.6475,23539234
55150,aflibercept,gene,0.9897,23539234
55151,bevacizumab,gene,0.9077,23539234
55152,ranibizumab,drug,0.688,23539234
55153,neovascular AMD,disease,1.0,23539234
55154,ocular disease,disease,0.6997,23515639
55155,antivascular endothelial growth factor,gene,0.9976,23515639
55156,anti-VEGF,gene,0.971,23515639
55157,colonic carcinomas,disease,1.0,23515639
55158,anti-VEGFs,gene,0.8643,23515639
55159,exudative macular degeneration,disease,1.0,23515639
55160,retinopathy of prematurity,disease,1.0,23515639
55161,exudative macular eegeneration,disease,1.0,23515639
55162,colorectal cancer,disease,1.0,23513885
55163,ganitumab,gene,0.5654,23510984
55164,FOLFIRI,drug,0.749,23510984
55165,mutant,disease,0.589,23510984
55166,mutant KRAS,gene,0.9243,23510984
55167,metastatic colorectal cancer,disease,0.9756,23510984
55168,mutant KRAS,gene,0.512,23510984
55169,metastatic colorectal cancer,disease,0.9116,23510984
55170,mCRC,disease,1.0,23510984
55171,bevacizumab,gene,0.8228,23510984
55172,aflibercept,gene,0.94,23510984
55173,human death receptor 5,gene,0.997,23510984
55174,type 1 insulin-like growth factor receptor,gene,0.9985,23510984
55175,mutant KRAS,gene,0.9434,23510984
55176,mCRC,disease,0.884,23510984
55177,PATIENTS,species,0.955,23510984
55178,mutant,gene,0.939,23510984
55179,KRAS,gene,0.664,23510984
55180,metastatic adenocarcinoma of the colon or rectum,disease,0.995,23510984
55181,fluoropyrimidine,drug,0.996,23510984
55182,oxaliplatin,drug,0.9985,23510984
55183,ganitumab,gene,0.87,23510984
55184,neutropenia,disease,1.0,23510984
55185,diarrhea,disease,1.0,23510984
55186,FOLFIRI,drug,0.6406,23510984
55187,aflibercept,gene,0.981,23503202
55188,patients,species,0.99,23503202
55189,Wet age-related macular degeneration,disease,0.999,23503202
55190,AMD,disease,1.0,23503202
55191,vision loss,disease,0.998,23503202
55192,vascular endothelial growth factor,gene,0.9595,23503202
55193,VEGF,gene,0.9985,23503202
55194,VEGF,gene,0.975,23503202
55195,Ranibizumab,gene,0.88,23503202
55196,VEGF,gene,0.7993,23503202
55197,Aflibercept,gene,0.9155,23503202
55198,VEGF,gene,0.993,23503202
55199,aflibercept,gene,0.968,23503202
55200,aflibercept,gene,0.971,23503202
55201,wet AMD,disease,0.9463,23503202
55202,vascular endothelial growth factor,gene,0.9985,23492430
55203,VEGF,gene,0.998,23492430
55204,neovascular age-related macular degeneration,disease,1.0,23492430
55205,NVAMD,disease,1.0,23492430
55206,ranibizumab,gene,0.898,23492430
55207,patients,species,0.9434,23492430
55208,NVAMD,disease,1.0,23492430
55209,VEGF,gene,0.996,23492430
55210,Wet AMD,disease,0.9995,23492430
55211,patients,species,0.965,23492430
55212,aflibercept,gene,0.9653,23492430
55213,ranibizumab,gene,0.8257,23492430
55214,AMD,disease,0.999,23492430
55215,bevacizumab,gene,0.8145,23492430
55216,ranibizumab,gene,0.516,23492430
55217,patients,species,0.967,23492430
55218,VEGF,gene,0.8667,23492430
55219,NVAMD,disease,1.0,23492430
55220,VEGF,gene,0.993,23492430
55221,Patients,species,0.9204,23492430
55222,NVAMD,disease,1.0,23492430
55223,VEGF,gene,0.506,23492430
55224,VEGF,gene,0.586,23492430
55225,Aflibercept,gene,0.9805,23473589
55226,VEGF Trap-Eye,gene,0.8965,23473589
55227,exudative age-related macular degeneration,disease,1.0,23473589
55228,Aflibercept,gene,0.966,23473589
55229,VEGF,gene,0.9946,23473589
55230,exudative age-related macular degeneration,disease,1.0,23473589
55231,VEGF receptors 1 and 2,gene,0.996,23473589
55232,VEGF-A,gene,0.999,23473589
55233,VEGF-B,gene,0.999,23473589
55234,PlGF,gene,0.9907,23473589
55235,VEGF,gene,0.985,23473589
55236,vascular endothelial cells,cell_type,0.9097,23473589
55237,aflibercept,gene,0.988,23473589
55238,ranibizumab,gene,0.5547,23473589
55239,aflibercept,gene,0.987,23473589
55240,Aflibercept,gene,0.95,23473589
55241,exudative age-related macular degeneration,disease,1.0,23473589
55242,diabetic macular oedema,disease,1.0,23457327
55243,VEGF,gene,0.852,23457327
55244,diabetic macular oedema,disease,1.0,23457327
55245,DMO,disease,1.0,23457327
55246,PARTICIPANTS,species,0.8276,23457327
55247,triamcinolone,drug,1.0,23457327
55248,dexamethasone,drug,0.9995,23457327
55249,fluocinolone,drug,0.9985,23457327
55250,bevacizumab,gene,0.8765,23457327
55251,ranibizumab,gene,0.8286,23457327
55252,pegaptanib,drug,0.949,23457327
55253,aflibercept,gene,0.9414,23457327
55254,DMO,disease,1.0,23457327
55255,VEGF,gene,0.6724,23457327
55256,steroids,drug,0.7495,23457327
55257,triamcinolone,drug,1.0,23457327
55258,dexamethasone,drug,0.9995,23457327
55259,fluocinolone,drug,0.999,23457327
55260,Steroids,drug,0.9385,23457327
55261,cataracts,disease,1.0,23457327
55262,steroid,drug,0.978,23457327
55263,anti-VEGFs,gene,0.632,23457327
55264,bevacizumab,gene,0.518,23457327
55265,Steroid,drug,0.881,23457327
55266,cataract,disease,1.0,23457327
55267,DMO,disease,1.0,23457327
55268,Aflibercept,gene,0.962,23444216
55269,Aflibercept,gene,0.947,23444216
55270,anti-VEGF,gene,0.976,23444216
55271,antiplacental growth factor,gene,0.8633,23444216
55272,PlGF,gene,0.9937,23444216
55273,5-fluorouracil,drug,0.9995,23444216
55274,leucovorin,drug,0.9985,23444216
55275,irinotecan,drug,0.998,23444216
55276,FOLFIRI,drug,0.9263,23444216
55277,metastatic colorectal cancer,disease,1.0,23444216
55278,oxaliplatin,drug,0.9995,23444216
55279,aflibercept,gene,0.984,23444216
55280,FOLFIRI,drug,0.9453,23444216
55281,aflibercept,gene,0.964,23444216
55282,FOLFIRI,drug,0.957,23444216
55283,aflibercept,gene,0.9385,23444216
55284,FOLFIRI,drug,0.6655,23444216
55285,aflibercept,gene,0.9844,23444216
55286,aflibercept,gene,0.991,23444216
55287,5-fluorouracil,drug,0.9995,23444216
55288,leucovorin,drug,0.999,23444216
55289,oxaliplatin,drug,0.9995,23444216
55290,mCRC,disease,0.963,23444216
55291,VEGF receptor,gene,0.9717,23444216
55292,aflibercept,gene,0.9946,23444216
55293,VEGF-Trap,gene,0.995,23444216
55294,VEGF-A,gene,0.9985,23444216
55295,VEGF-B,gene,0.999,23444216
55296,PlGF-1,gene,0.9985,23444216
55297,PlGF,gene,0.985,23444216
55298,aflibercept,gene,0.9927,23444216
55299,anti-,gene,0.706,23444216
55300,VEGF,gene,0.714,23444216
55301,VEGF,gene,0.996,23432698
55302,metastatic colorectal cancer,disease,0.9604,23432698
55303,VEGF,gene,0.997,23432698
55304,metastatic colorectal cancer,disease,1.0,23432698
55305,mCRC,disease,1.0,23432698
55306,VEGFA,gene,0.997,23432698
55307,bevacizumab,gene,0.8984,23432698
55308,mCRC,disease,0.9717,23432698
55309,VEGF,DNA,0.5693,23432698
55310,VEGF family,gene,0.998,23432698
55311,tumor,disease,0.9995,23432698
55312,Aflibercept,gene,0.9805,23432698
55313,VEGFA,gene,0.999,23432698
55314,VEGFB,gene,0.999,23432698
55315,PlGF,gene,0.99,23432698
55316,bevacizumab,gene,0.946,23432698
55317,aflibercept,gene,0.9795,23432698
55318,mCRC,disease,0.986,23432698
55319,VEGF,gene,0.9595,23430681
55320,neovascular age-related macular degeneration,disease,1.0,23430681
55321,aflibercept,gene,0.994,23429593
55322,cancer,disease,1.0,23429593
55323,docetaxel,drug,0.997,23429593
55324,aflibercept,gene,0.9585,23429593
55325,cancer,disease,1.0,23429593
55326,solid tumor,disease,1.0,23429593
55327,aflibercept,gene,0.969,23429593
55328,docetaxel,drug,0.999,23429593
55329,vascular endothelial growth factor,gene,0.998,23429593
55330,aflibercept,gene,0.9746,23429593
55331,aflibercept,gene,0.953,23429593
55332,28 aflibercept,gene,0.6357,23429593
55333,aflibercept,gene,0.9727,23429593
55334,aflibercept,gene,0.984,23429593
55335,aflibercept,gene,0.9956,23429593
55336,aflibercept,gene,0.9673,23429593
55337,diabetic macular edema,disease,1.0,23419295
55338,Diabetic macular edema,disease,1.0,23419295
55339,DME,disease,1.0,23419295
55340,vision loss,disease,0.9985,23419295
55341,Diabetic Retinopathy,disease,1.0,23419295
55342,ranibizumab,gene,0.779,23419295
55343,DME,disease,1.0,23419295
55344,RIDE,DNA,0.659,23419295
55345,vascular endothelial growth factor,gene,0.9956,23419295
55346,bevacizumab,gene,0.812,23419295
55347,aflibercept,gene,0.9795,23419295
55348,DME,disease,1.0,23419295
55349,patients,species,0.967,23419295
55350,visual loss,disease,0.993,23419295
55351,DME,disease,1.0,23419295
55352,vascular endothelial growth factor,gene,0.9966,23419295
55353,aflibercept,gene,0.9873,23413903
55354,neovascular age-related macular degeneration,disease,1.0,23413903
55355,Neovascular age-related macular degeneration,disease,0.9995,23413903
55356,AMD,disease,1.0,23413903
55357,legal blindness,disease,1.0,23413903
55358,patients,species,0.9897,23413903
55359,VEGF,gene,0.751,23413903
55360,AMD,disease,1.0,23413903
55361,VEGF,gene,0.899,23413903
55362,Aflibercept,gene,0.975,23413903
55363,Eylea,gene,0.7876,23413903
55364,VEGF,gene,0.9927,23413903
55365,VEGF,gene,0.9893,23413903
55366,neovascular AMD,disease,1.0,23413903
55367,aflibercept,gene,0.975,23413903
55368,ranibizumab,gene,0.7603,23413903
55369,Lucentis,gene,0.6997,23413903
55370,AMD,disease,1.0,23413903
55371,aflibercept,gene,0.987,23413903
55372,aflibercept,gene,0.9814,23413903
55373,ocular neovascular diseases,disease,0.9976,23413903
55374,choroidal neovascular abnormalities,disease,1.0,23411901
55375,Aflibercept,gene,0.9575,23394730
55376,central retinal vein occlusion,disease,1.0,23394730
55377,age-related macular degeneration,disease,1.0,23393060
55378,age-related macular degeneration,disease,1.0,23393060
55379,AMD,disease,1.0,23393060
55380,choroidal neovascularization,disease,1.0,23393060
55381,CNV,disease,1.0,23393060
55382,CNV,disease,0.9995,23393060
55383,vascular endothelial growth factor,gene,0.997,23393060
55384,VEGF,gene,0.996,23393060
55385,Bevacizumab,gene,0.896,23393060
55386,ranibizumab,gene,0.639,23393060
55387,wet AMD,disease,0.9995,23393060
55388,ranibizumab,gene,0.5254,23393060
55389,aflibercept,gene,0.981,23393060
55390,aflibercept,gene,0.984,23393060
55391,pigment epithelium-derived factor,gene,0.995,23393060
55392,ankyrin repeat proteins,gene,0.9536,23393060
55393,recurrent glioblastoma,disease,0.9956,23345034
55394,patients,species,0.9736,23345034
55395,aflibercept,gene,0.9385,23345034
55396,patients,species,0.9653,23345034
55397,recurrent glioblastoma,disease,0.99,23345034
55398,aflibercept,gene,0.9746,23345034
55399,hypertension,disease,1.0,23345034
55400,proteinuria,disease,1.0,23345034
55401,thromboembolism,disease,1.0,23345034
55402,fatigue,disease,1.0,23345034
55403,pts,species,0.92,23345034
55404,IL-13,gene,0.993,23345034
55405,IL-1b,gene,0.9937,23345034
55406,IL-6,gene,0.966,23345034
55407,IL-10,gene,0.981,23345034
55408,fatigue,disease,0.985,23345034
55409,patients,species,0.993,23345034
55410,patients,species,0.99,23345034
55411,patient,species,0.9814,23345034
55412,IL6,gene,0.982,23345034
55413,IL10,gene,0.956,23345034
55414,IL13,gene,0.9775,23345034
55415,IL-13,gene,0.9937,23345034
55416,endothelial dysfunction,disease,0.9976,23345034
55417,patients,species,0.962,23345034
55418,fatigue,disease,0.992,23345034
55419,IL-6,gene,0.9756,23345034
55420,IL-10,gene,0.963,23345034
55421,Aflibercept,gene,0.9307,23342231
55422,age-related macular degeneration,disease,1.0,23342231
55423,neovascular age-related macular degeneration,disease,1.0,23342231
55424,AMD,disease,1.0,23342231
55425,vascular endothelial growth factor,gene,0.998,23342231
55426,VEGF,gene,0.997,23342231
55427,patients,species,0.9624,23342231
55428,neovascular AMD,disease,0.9995,23342231
55429,VEGF,gene,0.825,23342231
55430,Aflibercept,gene,0.984,23342231
55431,VEGF-A,gene,0.9985,23342231
55432,VEGF-B,gene,0.9985,23342231
55433,placental growth factor,gene,0.9976,23342231
55434,neovascular AMD,disease,1.0,23342231
55435,VEGF,gene,0.995,23342231
55436,Age-related Macular Degeneration,disease,1.0,23342231
55437,aflibercept,gene,0.972,23342231
55438,patients,species,0.972,23342231
55439,ranibizumab,gene,0.587,23342231
55440,Aflibercept,gene,0.9683,23342231
55441,Eylea,gene,0.7715,23342231
55442,neovascular AMD,disease,1.0,23342231
55443,Aflibercept,gene,0.986,23317499
55444,VEGF,gene,0.998,23317499
55445,multiple tumors,disease,0.9927,23317499
55446,VEGF,gene,0.997,23317499
55447,vascular endothelial growth factor,gene,0.998,23317499
55448,solid tumor,disease,1.0,23317499
55449,tumor,disease,0.99,23317499
55450,VEGF,gene,0.993,23317499
55451,VEGF,gene,0.994,23317499
55452,cancer,disease,1.0,23317499
55453,VEGF,gene,0.993,23317499
55454,Aflibercept,gene,0.9824,23317499
55455,VEGF-Trap,gene,0.8955,23317499
55456,colorectal cancer,disease,1.0,23317499
55457,VEGF-A,gene,0.999,23317499
55458,VEGF-B,gene,0.999,23317499
55459,placental growth factor,gene,0.9985,23317499
55460,VEGF-Trap,gene,0.9536,23317499
55461,tumor,disease,0.9927,23317499
55462,tumor,disease,0.999,23317499
55463,aflibercept,gene,0.982,23317499
55464,ovarian cancer,disease,1.0,23317499
55465,breast cancer,disease,1.0,23317499
55466,non-small cell lung cancer,disease,1.0,23317499
55467,pancreatic cancer,disease,1.0,23317499
55468,glioblastoma,disease,1.0,23317499
55469,adenocarcinoma,disease,1.0,23317499
55470,renal cell cancer,disease,1.0,23317499
55471,xenograft models,cell_line,0.651,23317499
55472,aflibercept,gene,0.993,23312881
55473,irinotecan,drug,0.9995,23312881
55474,5-fluorouracil,drug,0.9995,23312881
55475,leucovorin,drug,0.9995,23312881
55476,advanced solid tumours,disease,1.0,23312881
55477,aflibercept,gene,0.958,23312881
55478,irinotecan,drug,0.998,23312881
55479,5-fluorouracil,drug,0.9995,23312881
55480,leucovorin,drug,0.9995,23312881
55481,LV5FU2,drug,0.9995,23312881
55482,PATIENTS,species,0.9663,23312881
55483,advanced solid tumours,disease,0.995,23312881
55484,aflibercept,gene,0.982,23312881
55485,irinotecan,drug,0.999,23312881
55486,LV5FU2,drug,0.6255,23312881
55487,aflibercept,gene,0.9795,23312881
55488,irinotecan,drug,0.999,23312881
55489,LV5FU2,drug,0.542,23312881
55490,aflibercept,gene,0.6343,23312881
55491,aflibercept,gene,0.648,23312881
55492,aflibercept,gene,0.7314,23312881
55493,neutropenia,disease,1.0,23312881
55494,fatigue,disease,0.999,23312881
55495,hypertension,disease,1.0,23312881
55496,anti-aflibercept antibodies,gene,0.977,23312881
55497,vascular endothelial growth factor,gene,0.9976,23312881
55498,aflibercept,gene,0.895,23312881
55499,aflibercept,gene,0.9897,23312881
55500,Aflibercept,gene,0.528,23312881
55501,irinotecan,drug,0.999,23312881
55502,antitumour,disease,0.9497,23312881
55503,colorectal cancer,disease,1.0,23306912
55504,regorafenib,drug,0.996,23306912
55505,aflibercept,gene,0.988,23306912
55506,bevacizumab,gene,0.9443,23306912
55507,cetuximab,gene,0.9556,23306912
55508,panitumumab,gene,0.948,23306912
55509,colorectal cancer,disease,1.0,23306912
55510,regorafenib,drug,0.986,23306912
55511,aflibercept,gene,0.931,23306912
55512,mCRC,disease,0.989,23306912
55513,Regorafenib,drug,0.9976,23306912
55514,oncogenic receptor tyrosine kinase,gene,0.799,23306912
55515,tyrosine,drug,0.9536,23306912
55516,RTK,gene,0.992,23306912
55517,Aflibercept,gene,0.9688,23306912
55518,vascular endothelial growth factor,gene,0.9873,23306912
55519,VEGF,gene,0.975,23306912
55520,human VEGF receptors 1 and 2,gene,0.972,23306912
55521,human IgG1 immunoglobulin,gene,0.9834,23306912
55522,bevacizumab,gene,0.534,23306912
55523,colorectal cancer,disease,1.0,23306912
55524,metastatic colorectal cancer,disease,1.0,23303214
55525,metastatic colorectal cancer,disease,1.0,23303214
55526,mCRC,disease,1.0,23303214
55527,mCRC,disease,0.998,23303214
55528,mCRC,disease,0.9985,23303214
55529,fluoropyrimidine,drug,0.993,23303214
55530,panitumumab,gene,0.9126,23303214
55531,cetuximab,gene,0.8984,23303214
55532,bevacizumab,gene,0.864,23303214
55533,aflibercept,gene,0.972,23303214
55534,anti-EGFR,gene,0.933,23303214
55535,mCRC,disease,0.997,23303214
55536,mCRC,disease,0.987,23303214
55537,VEGF,gene,0.9917,23298885
55538,macular oedema,disease,1.0,23298885
55539,central retinal vein occlusion,disease,1.0,23298885
55540,VEGF,gene,0.993,23298885
55541,macular oedema,disease,1.0,23298885
55542,central retinal vein occlusion,disease,1.0,23298885
55543,CRVO,disease,1.0,23298885
55544,VTE,drug,0.9907,23298885
55545,Diabetic Retinopathy,disease,1.0,23298885
55546,VTE,disease,1.0,23298885
55547,VTE,disease,0.9995,23298885
55548,VTE,disease,0.999,23298885
55549,eye pain,disease,0.9854,23298885
55550,conjunctival haemorrhage,disease,1.0,23298885
55551,CONCLUSIONS,drug,0.794,23298885
55552,VTE,drug,0.4653,23298885
55553,CRVO,disease,1.0,23298885
55554,VTE,disease,0.9834,23298885
55555,CRVO,disease,1.0,23298885
55556,aflibercept,gene,0.985,23266881
55557,ocular cells,cell_type,0.6807,23266881
55558,vascular endothelial growth factor,gene,0.998,23266881
55559,aflibercept,gene,0.986,23266881
55560,human trabecular meshwork cells,cell_type,0.866,23266881
55561,human,species,0.9766,23266881
55562,hTMC,cell_type,0.8247,23266881
55563,human scleral fibroblasts,cell_type,0.834,23266881
55564,human,species,0.943,23266881
55565,hFibro,cell_type,0.803,23266881
55566,retinal pigment epithelial cell line,cell_line,0.957,23266881
55567,ARPE-19,cell_line,0.9556,23266881
55568,aflibercept,gene,0.9663,23266881
55569,confluent cell cultures,cell_line,0.721,23266881
55570,Ranibizumab,gene,0.727,23266881
55571,MTT,drug,1.0,23266881
55572,calcein,drug,0.9985,23266881
55573,aflibercept,gene,0.9893,23266881
55574,hTMC,cell_line,0.71,23266881
55575,hFibro,cell_line,0.541,23266881
55576,ARPE-19,cell_line,0.9087,23266881
55577,Aflibercept,gene,0.842,23266881
55578,Aflibercept,gene,0.9766,23266881
55579,hTMC,cell_line,0.5024,23266881
55580,hFibro,cell_line,0.6577,23266881
55581,ARPE-19,cell_line,0.9097,23266881
55582,ARPE-19 cells,cell_line,0.7266,23266881
55583,aflibercept,gene,0.9937,23266881
55584,-,gene,0.4526,23266881
55585,vascular endothelial growth factor,gene,0.8203,23266881
55586,aflibercept,gene,0.987,23266881
55587,human,species,0.987,23266881
55588,VEGF,gene,0.9937,23238831
55589,tumor,disease,1.0,23238831
55590,tumor,disease,1.0,23238831
55591,Vascular endothelial growth factor,gene,0.9985,23238831
55592,VEGF,gene,0.992,23238831
55593,tumor,disease,0.9995,23238831
55594,VEGF,gene,0.995,23238831
55595,tumor,disease,0.999,23238831
55596,tumor,disease,1.0,23238831
55597,tumors,disease,1.0,23238831
55598,VEGF,gene,0.748,23238831
55599,VEGF,gene,0.737,23238831
55600,VEGF,gene,0.996,23238831
55601,tumor vessels,cell_type,0.4922,23238831
55602,tumor,disease,0.9995,23238831
55603,aflibercept,gene,0.9917,23238831
55604,VEGF Trap,gene,0.974,23238831
55605,ziv-aflibercept,gene,0.962,23238831
55606,tumor,disease,1.0,23238831
55607,VEGF,gene,0.8506,23238831
55608,Colo205 human,cell_line,0.68,23238831
55609,colorectal carcinoma,disease,0.923,23238831
55610,C6 rat,cell_line,0.626,23238831
55611,rat,species,0.946,23238831
55612,HT1080 human fibrosarcoma,cell_line,0.9526,23238831
55613,tumor,disease,1.0,23238831
55614,tumor,disease,0.999,23238831
55615,tumor,disease,0.9995,23238831
55616,tumor,disease,1.0,23238831
55617,vascular gene,DNA,0.9033,23238831
55618,VEGF,gene,0.75,23238831
55619,VEGF,gene,0.4878,23238831
55620,castration-resistant prostate cancer,disease,1.0,23236591
55621,castration resistant prostate cancer,disease,1.0,23236591
55622,CRPC,disease,1.0,23236591
55623,metastatic prostate cancer,disease,1.0,23236591
55624,androgen,drug,0.9995,23236591
55625,androgen receptor,gene,0.9956,23236591
55626,prostate cancer,disease,1.0,23236591
55627,docetaxel,drug,0.9995,23236591
55628,prednisone,drug,0.998,23236591
55629,mCRPC,disease,0.916,23236591
55630,cabazitaxel,drug,0.9966,23236591
55631,abiraterone acetate,drug,0.796,23236591
55632,radium-223 chloride,drug,0.978,23236591
55633,MDV3100,drug,0.9688,23236591
55634,TAK-700,drug,0.999,23236591
55635,cabozantinib,drug,0.999,23236591
55636,tasquinimod,drug,0.9976,23236591
55637,PROSTVAC-VF,DNA,0.483,23236591
55638,docetaxel,drug,0.9995,23236591
55639,custirsen,drug,0.999,23236591
55640,aflibercept,gene,0.9854,23236591
55641,dasatinib,drug,0.9946,23236591
55642,zibotentan,drug,0.998,23236591
55643,metastatic CRPC,disease,0.986,23236591
55644,mCRPC,disease,0.959,23236591
55645,vascular endothelial growth factor,gene,0.9937,23235642
55646,diabetic macular oedema,disease,1.0,23235642
55647,Diabetic macular oedema,disease,1.0,23235642
55648,DMO,disease,1.0,23235642
55649,diabetic retinopathy,disease,1.0,23235642
55650,DMO,disease,1.0,23235642
55651,clinically significant,disease,0.629,23235642
55652,macular oedema,disease,0.991,23235642
55653,CSMO,disease,0.998,23235642
55654,vascular endothelial growth factor,gene,0.99,23235642
55655,VEGF,gene,0.7725,23235642
55656,DMO,disease,1.0,23235642
55657,VEGF,gene,0.8076,23235642
55658,DMO,disease,1.0,23235642
55659,DMO,disease,1.0,23235642
55660,pegaptanib,drug,0.9985,23235642
55661,ranibizumab,gene,0.5347,23235642
55662,pegaptanib,drug,0.9673,23235642
55663,bevacizumab,gene,0.5405,23235642
55664,ranibizumab,drug,0.789,23235642
55665,aflibercept,gene,0.937,23235642
55666,bevacizumab,gene,0.8154,23235642
55667,ranibizumab,gene,0.57,23235642
55668,aflibercept,gene,0.9194,23235642
55669,arterial thromboembolic events,disease,0.9995,23235642
55670,DMO,disease,1.0,23235642
55671,ranibizumab,gene,0.817,23235642
55672,DMO,disease,1.0,23235642
55673,age-related macular degeneration,disease,1.0,23222393
55674,age-related macular degeneration,disease,1.0,23222393
55675,age-related macular degeneration,disease,1.0,23222393
55676,AMD,disease,1.0,23222393
55677,VEGF,gene,0.9966,23222393
55678,steroids,drug,0.788,23222393
55679,bevacizumab,gene,0.7227,23222393
55680,ranibizumab,gene,0.8076,23222393
55681,VEGF-,gene,0.9863,23222393
55682,age-related macular degeneration,disease,1.0,23222393
55683,vascular endothelial growth factor,gene,0.997,23222393
55684,vision,disease,0.9136,23222393
55685,scarring,disease,0.9956,23222393
55686,aflibercept,gene,0.9917,23218699
55687,macular edema,disease,1.0,23218699
55688,central retinal vein occlusion,disease,1.0,23218699
55689,aflibercept,gene,0.978,23218699
55690,VEGF,gene,0.996,23218699
55691,macular edema,disease,1.0,23218699
55692,central retinal vein occlusion,disease,1.0,23218699
55693,CRVO,disease,1.0,23218699
55694,macular edema,disease,1.0,23218699
55695,CRVO,disease,0.9995,23218699
55696,aflibercept,gene,0.9575,23218699
55697,aflibercept,gene,0.935,23218699
55698,ETDRS,DNA,0.495,23218699
55699,NEI VFQ,DNA,0.566,23218699
55700,conjunctival hemorrhage,disease,0.9995,23218699
55701,eye pain,disease,0.986,23218699
55702,aflibercept,gene,0.9766,23218699
55703,macular edema,disease,1.0,23218699
55704,CRVO,disease,1.0,23218699
55705,aflibercept,gene,0.96,23218699
55706,aflibercept,gene,0.9893,23218699
55707,VEGF-receptor,gene,0.9263,23216053
55708,colorectal cancer,disease,1.0,23216053
55709,metastatic colorectal cancer,disease,1.0,23216053
55710,mCRC,disease,1.0,23216053
55711,colorectal cancer,disease,1.0,23216053
55712,CRC,disease,1.0,23216053
55713,Bevacizumab,gene,0.886,23216053
55714,mCRC,disease,0.942,23216053
55715,VEGF,gene,0.996,23216053
55716,bevacizumab,gene,0.896,23216053
55717,mCRC,disease,0.999,23216053
55718,mCRC,disease,0.899,23216053
55719,aflibercept,gene,0.989,23216053
55720,regorafenib,drug,0.9863,23216053
55721,mCRC,disease,0.953,23216053
55722,mCRC,disease,0.9946,23216053
55723,Aflibercept,gene,0.9595,23199019
55724,lung cancer,disease,1.0,23199019
55725,solid tumors,disease,0.9995,23199019
55726,vascular endothelial growth factor,gene,0.998,23199019
55727,VEGF,gene,0.995,23199019
55728,VEGF-A,gene,0.9966,23199019
55729,platinum,drug,0.9995,23199019
55730,non-small-cell lung cancer,disease,1.0,23199019
55731,NSCLC,disease,0.9995,23199019
55732,Aflibercept,gene,0.9883,23199019
55733,VEGF Trap,gene,0.9927,23199019
55734,recombinant VEGF receptor-antibody protein,gene,0.837,23199019
55735,VEGF-A,gene,0.992,23199019
55736,bevacizumab,gene,0.8965,23199019
55737,VEGF-B,gene,0.996,23199019
55738,placental growth factor,gene,0.9976,23199019
55739,PlGF,gene,0.992,23199019
55740,aflibercept,gene,0.9863,23199019
55741,lung cancer,disease,1.0,23199019
55742,Aflibercept,gene,0.9707,23199019
55743,metastatic colorectal cancer,disease,0.9995,23199019
55744,lung cancer,disease,1.0,23199019
55745,patients,species,0.9854,23199019
55746,aflibercept,gene,0.9897,23179335
55747,FOLFIRI,drug,0.654,23179335
55748,patients,species,0.909,23179335
55749,Aflibercept,gene,0.9736,23179335
55750,vascular endothelial growth factor,gene,0.9966,23179335
55751,VEGF)-A,gene,0.99,23179335
55752,VEGF-B,gene,0.998,23179335
55753,placental growth factor,gene,0.998,23179335
55754,PlGF,gene,0.983,23179335
55755,aflibercept,gene,0.987,23179335
55756,5-fluorouracil,drug,0.9976,23179335
55757,levofolinate,drug,0.9897,23179335
55758,irinotecan,drug,0.9976,23179335
55759,FOLFIRI,drug,0.9976,23179335
55760,patients,species,0.9727,23179335
55761,metastatic colorectal cancer,disease,1.0,23179335
55762,mCRC,disease,1.0,23179335
55763,patients,species,0.9736,23179335
55764,aflibercept,gene,0.9756,23179335
55765,patients,species,0.9897,23179335
55766,aflibercept,gene,0.9814,23179335
55767,aflibercept,gene,0.739,23179335
55768,FOLFIRI,drug,0.8647,23179335
55769,leukopenia,disease,1.0,23179335
55770,neutropenia,disease,1.0,23179335
55771,anemia,disease,1.0,23179335
55772,diarrhea,disease,1.0,23179335
55773,fatigue,disease,0.9995,23179335
55774,decreased appetite,disease,0.9644,23179335
55775,stomatitis,disease,1.0,23179335
55776,dysphonia,disease,1.0,23179335
55777,nausea,disease,0.9995,23179335
55778,epistaxis,disease,1.0,23179335
55779,neutropenia,disease,1.0,23179335
55780,hypertension,disease,1.0,23179335
55781,aflibercept,gene,0.9946,23179335
55782,VEGF,gene,0.987,23179335
55783,aflibercept,gene,0.8975,23179335
55784,aflibercept,gene,0.99,23179335
55785,FOLFIRI,drug,0.98,23179335
55786,aflibercept,gene,0.9844,23179335
55787,FOLFIRI,drug,0.6064,23179335
55788,patients,species,0.947,23179335
55789,mCRC,disease,0.952,23179335
55790,Angiopoietin-2,gene,0.991,23149917
55791,Tie2,gene,0.992,23149917
55792,tumor,disease,1.0,23149917
55793,angiopoietins,gene,0.9966,23149917
55794,Ang1,gene,0.9624,23149917
55795,ANGPT1,gene,0.9985,23149917
55796,Ang2,gene,0.998,23149917
55797,ANGPT2,gene,0.9985,23149917
55798,endothelial cell-specific receptor tyrosine kinase Tie2,gene,0.968,23149917
55799,tyrosine,drug,0.8477,23149917
55800,TEK,gene,0.9966,23149917
55801,Ang1,gene,0.997,23149917
55802,Tie2,gene,0.995,23149917
55803,blood vessel,cell_type,0.465,23149917
55804,Ang2,gene,0.997,23149917
55805,tumor endothelial cells,cell_type,0.8887,23149917
55806,Tie2,gene,0.987,23149917
55807,VEGF,gene,0.9937,23149917
55808,tumor,disease,1.0,23149917
55809,Ang2-specific antibody,gene,0.9146,23149917
55810,REGN910,gene,0.8037,23149917
55811,Tie2,gene,0.9937,23149917
55812,Ang1,gene,0.9673,23149917
55813,Ang2,gene,0.9907,23149917
55814,tumor,disease,1.0,23149917
55815,Tie2,gene,0.99,23149917
55816,Ang2,gene,0.993,23149917
55817,Tie2,gene,0.9956,23149917
55818,REGN910,drug,0.9976,23149917
55819,tumors,disease,1.0,23149917
55820,genes,DNA,0.842,23149917
55821,Tie2,gene,0.987,23149917
55822,REGN910,drug,0.997,23149917
55823,Tie2,gene,0.984,23149917
55824,REGN910,drug,0.9824,23149917
55825,VEGF,gene,0.9956,23149917
55826,aflibercept,gene,0.972,23149917
55827,tumor,disease,0.971,23149917
55828,tumor cell,cell_type,0.704,23149917
55829,tumor,disease,1.0,23149917
55830,tumor,disease,1.0,23149917
55831,Ang2,gene,0.996,23149917
55832,Ang2,gene,0.9966,23149917
55833,tumor endothelial cells,cell_line,0.7705,23149917
55834,tumor endothelial cells,cell_type,0.9146,23149917
55835,tumor,disease,0.828,23149917
55836,Tie2,gene,0.9834,23149917
55837,VEGF,gene,0.993,23149917
55838,Ang2,gene,0.996,23149917
55839,VEGF,gene,0.885,23149917
55840,Ziv-aflibercept,gene,0.9727,23149898
55841,VEGF-A-,gene,0.9985,23149898
55842,ziv-aflibercept,gene,0.9766,23149898
55843,patients,species,0.907,23149898
55844,metastatic colorectal cancer,disease,1.0,23149898
55845,mCRC,disease,1.0,23149898
55846,bevacizumab,gene,0.821,23149898
55847,non-small-cell lung cancer,disease,1.0,23149898
55848,VEGF,gene,0.992,23149898
55849,mCRC,disease,0.981,23149898
55850,patients,species,0.983,23149898
55851,metastatic colorectal cancer,disease,0.9985,23118806
55852,cancers,disease,1.0,23118806
55853,metastatic colorectal cancer,disease,1.0,23118806
55854,mCRC,disease,1.0,23118806
55855,primary tumors,disease,0.9995,23118806
55856,tumors,disease,1.0,23118806
55857,oxygen,drug,0.986,23118806
55858,tumors,disease,1.0,23118806
55859,tumor blood vessels,cell_type,0.506,23118806
55860,tumor,disease,0.998,23118806
55861,vascular endothelial growth factor,gene,0.998,23118806
55862,VEGF,gene,0.9976,23118806
55863,cancers,disease,1.0,23118806
55864,bevacizumab,gene,0.948,23118806
55865,mCRC,disease,0.894,23118806
55866,VEGF,DNA,0.663,23118806
55867,VEGF family,gene,0.9985,23118806
55868,VEGF receptors,gene,0.998,23118806
55869,tyrosine,drug,0.91,23118806
55870,tyrosine kinase,gene,0.9707,23118806
55871,mCRC,disease,0.9385,23118806
55872,patients,species,0.993,23118806
55873,metastatic colorectal cancer,disease,0.9937,23102896
55874,aflibercept,gene,0.979,23102896
55875,colorectal cancer,disease,1.0,23102896
55876,CRC,disease,1.0,23102896
55877,cancer,disease,1.0,23102896
55878,cancer,disease,1.0,23102896
55879,patients,species,0.9736,23102896
55880,metastatic colorectal cancer,disease,1.0,23102896
55881,mCRC,disease,1.0,23102896
55882,vascular endothelial growth factors,gene,0.999,23102896
55883,VEGFs,gene,0.9966,23102896
55884,mCRC,disease,0.9966,23102896
55885,bevacizumab,gene,0.4993,23102896
55886,VEGF-A,gene,0.996,23102896
55887,mCRC,disease,0.9907,23102896
55888,VEGF,DNA,0.4885,23102896
55889,VEGF-A,gene,0.997,23102896
55890,patients,species,0.99,23102896
55891,VEGF-A,gene,0.997,23102896
55892,Aflibercept,gene,0.986,23102896
55893,ziv-aflibercept,gene,0.981,23102896
55894,Zaltrap,gene,0.784,23102896
55895,angiogenic,DNA,0.4824,23102896
55896,VEGF-A,gene,0.9985,23102896
55897,VEGF-B,gene,0.998,23102896
55898,placental growth factor,gene,0.9976,23102896
55899,mCRC,disease,0.909,23102896
55900,patients,species,0.943,23102896
55901,oxaliplatin,drug,0.9995,23102896
55902,aflibercept,gene,0.989,23102896
55903,irinotecan,drug,0.999,23102896
55904,fluorouracil,drug,0.999,23102896
55905,VEGF,gene,0.8794,23102896
55906,aflibercept,gene,0.9893,23102896
55907,patients,species,0.943,23102896
55908,mCRC,disease,0.9688,23102896
55909,aflibercept,gene,0.9824,23084240
55910,VEGF,gene,0.997,23084240
55911,age-related macular degeneration,disease,1.0,23084240
55912,VEGF,gene,0.9966,23084240
55913,Wet AMD,disease,0.953,23084240
55914,neovascular age-related macular degeneration,disease,1.0,23084240
55915,AMD,disease,1.0,23084240
55916,aflibercept,gene,0.9575,23084240
55917,VEGF Trap,gene,0.873,23084240
55918,ranibizumab,gene,0.544,23084240
55919,PARTICIPANTS,species,0.7925,23084240
55920,Patients,species,0.9917,23084240
55921,choroidal neovascularization,disease,1.0,23084240
55922,CNV,disease,0.998,23084240
55923,juxtafoveal lesions,disease,0.999,23084240
55924,AMD,disease,0.9995,23084240
55925,Patients,species,0.9224,23084240
55926,aflibercept,gene,0.964,23084240
55927,ranibizumab,gene,0.5293,23084240
55928,aflibercept,gene,0.956,23084240
55929,ranibizumab,gene,0.603,23084240
55930,patients,species,0.9863,23084240
55931,Diabetic Retinopathy,disease,0.9976,23084240
55932,aflibercept,gene,0.93,23084240
55933,ranibizumab,gene,0.7383,23084240
55934,ranibizumab,gene,0.704,23084240
55935,aflibercept,gene,0.955,23084240
55936,aflibercept,gene,0.9893,23084240
55937,aflibercept,gene,0.9897,23084240
55938,AMD,disease,0.999,23084240
55939,cancer,disease,0.795,23083501
55940,VEGF,gene,0.9946,23083501
55941,MBC,disease,0.994,23083501
55942,Aflibercept,gene,0.981,23083501
55943,VEGF-Trap,gene,0.996,23083501
55944,humanized,species,0.5386,23083501
55945,VEGF-A,gene,0.998,23083501
55946,VEGF-B,gene,0.999,23083501
55947,PIGF-1 and -2,gene,0.998,23083501
55948,PATIENTS,species,0.9595,23083501
55949,patients,species,0.9937,23083501
55950,patients,species,0.9897,23083501
55951,anthracycline,drug,0.9995,23083501
55952,taxane,drug,0.998,23083501
55953,Aflibercept,gene,0.9326,23083501
55954,patients,species,0.906,23083501
55955,estrogen,drug,0.999,23083501
55956,estrogen receptor,gene,0.995,23083501
55957,HER2,gene,0.982,23083501
55958,trastuzumab,gene,0.974,23083501
55959,hypertension,disease,1.0,23083501
55960,fatigue,disease,0.999,23083501
55961,dyspnea,disease,1.0,23083501
55962,headache,disease,1.0,23083501
55963,left ventricular dysfunction,disease,1.0,23083501
55964,Aflibercept,gene,0.9775,23083501
55965,patients,species,0.9795,23083501
55966,MBC,drug,0.8125,23083501
55967,VEGF,gene,0.83,23083501
55968,retinopathy of prematurity,disease,1.0,23078830
55969,vascular endothelial growth factor,gene,0.9956,23078830
55970,ROP,disease,0.9956,23078830
55971,childhood blindness,disease,1.0,23078830
55972,infants,species,0.7646,23078830
55973,ROP,disease,0.998,23078830
55974,vascular endothelial growth factor,gene,0.999,23078830
55975,VEGF,gene,0.79,23078830
55976,VEGF,gene,0.9927,23078830
55977,anti-VEGF,gene,0.8984,23078830
55978,ROP,disease,0.9834,23078830
55979,infants,species,0.8213,23078830
55980,bevacizumab,gene,0.943,23073991
55981,Metastatic colorectal cancer,disease,1.0,23073991
55982,cancer,disease,1.0,23073991
55983,capecitabine,drug,0.9995,23073991
55984,irinotecan,drug,0.9995,23073991
55985,oxaliplatin,drug,0.9995,23073991
55986,bevacizumab,gene,0.8354,23073991
55987,cetuximab,gene,0.8716,23073991
55988,panitumumab,gene,0.9395,23073991
55989,aflibercept,gene,0.9497,23073991
55990,reforafenib,drug,0.9946,23073991
55991,patients,species,0.9785,23073991
55992,patients,species,0.9927,23073991
55993,patients,species,0.995,23073991
55994,bevacizumab,gene,0.751,23073991
55995,diabetic macular edema,disease,1.0,23062655
55996,diabetic macular edema,disease,1.0,23062655
55997,DME,disease,1.0,23062655
55998,PARTICIPANTS,species,0.8047,23062655
55999,vascular endothelial growth factor,gene,0.978,23062655
56000,VEGF,gene,0.996,23062655
56001,DME,disease,1.0,23062655
56002,triamcinolone,drug,0.9917,23062655
56003,DME,disease,0.9453,23062655
56004,anti-VEGF,gene,0.8906,23062655
56005,aflibercept,gene,0.941,23062655
56006,DME,disease,1.0,23062655
56007,vascular endothelial growth factor,gene,0.9956,23061805
56008,Central retinal vein occlusion,disease,0.998,23061805
56009,CRVO,disease,1.0,23061805
56010,visual loss,disease,0.9995,23061805
56011,retinal hypoxia,disease,0.936,23061805
56012,vascular endothelial growth factor,gene,0.998,23061805
56013,VEGF,gene,0.997,23061805
56014,VEGF,gene,0.9956,23061805
56015,macular oedema,disease,1.0,23061805
56016,macular oedema,disease,1.0,23061805
56017,CRVO,disease,1.0,23061805
56018,VEGF,gene,0.992,23061805
56019,Bevacizumab,gene,0.4993,23061805
56020,VEGF,gene,0.993,23061805
56021,bevacizumab,gene,0.8564,23061805
56022,patients,species,0.9844,23061805
56023,bevacizumab,gene,0.826,23061805
56024,Aflibercept,gene,0.9897,23061805
56025,VEGF Trap-Eye,gene,0.9883,23061805
56026,Aflibercept,gene,0.9707,23061805
56027,VEGF,gene,0.9976,23061805
56028,placental growth factor,gene,0.998,23061805
56029,PlGF,gene,0.99,23061805
56030,VEGF,gene,0.998,23061805
56031,PlGF,gene,0.9927,23061805
56032,aflibercept,gene,0.99,23061805
56033,VEGF,gene,0.7554,23061805
56034,aflibercept,gene,0.9844,23061805
56035,macular oedema,disease,1.0,23061805
56036,CRVO,disease,1.0,23061805
56037,patients,species,0.9766,23061805
56038,aflibercept,gene,0.967,23061805
56039,patients,species,0.9795,23061805
56040,aflibercept,gene,0.949,23061805
56041,patients,species,0.988,23061805
56042,patients,species,0.9824,23061805
56043,aflibercept,gene,0.931,23061805
56044,aflibercept,gene,0.9736,23061805
56045,patients,species,0.977,23061805
56046,Patients,species,0.952,23061805
56047,patients,species,0.9907,23061805
56048,VEGF,gene,0.993,23061805
56049,patients,species,0.9644,23061805
56050,macular oedema,disease,1.0,23061805
56051,CRVO,disease,1.0,23061805
56052,VEGF,gene,0.8945,23061805
56053,aflibercept,gene,0.985,23061342
56054,Zaltrap,gene,0.5996,23061342
56055,metastatic colorectal cancer,disease,0.969,23061342
56056,metastatic colorectal cancer,disease,0.9995,23057939
56057,colorectal and other cancers,disease,1.0,23057939
56058,Vascular endothelial growth factor (VEGF)-A,gene,0.9976,23057939
56059,VEGF receptor (VEGFR)-2,gene,0.9966,23057939
56060,VEGF,gene,0.994,23057939
56061,VEGF-A,gene,0.998,23057939
56062,VEGF-B,gene,0.998,23057939
56063,placental growth factor,gene,0.996,23057939
56064,VEGFR-1,gene,0.994,23057939
56065,VEGF-C,gene,0.997,23057939
56066,VEGF-D,gene,0.9966,23057939
56067,VEGFR-2,gene,0.997,23057939
56068,VEGFR-3,gene,0.996,23057939
56069,VEGF,gene,0.996,23057939
56070,angiopoietin,gene,0.9985,23057939
56071,Tie,gene,0.9814,23057939
56072,Notch,gene,0.9863,23057939
56073,hypoxia-inducible factor,gene,0.96,23057939
56074,integrin,gene,0.8823,23057939
56075,tumor,disease,1.0,23057939
56076,cancers,disease,1.0,23057939
56077,bevacizumab,gene,0.932,23057939
56078,aflibercept,gene,0.991,23057939
56079,ziv-aflibercept,gene,0.982,23057939
56080,colorectal and other cancers,disease,1.0,23057939
56081,cancer,disease,1.0,23053262
56082,cancer,disease,0.9995,23053262
56083,tumors,disease,1.0,23053262
56084,tumor,disease,1.0,23053262
56085,Bevacizumab,gene,0.4949,23053262
56086,vascular endothelial growth factor A,gene,0.9976,23053262
56087,VEGF-A,gene,0.997,23053262
56088,metastatic colorectal cancer,disease,0.9956,23053262
56089,VEGF-A,gene,0.996,23053262
56090,ziv-aflibercept,gene,0.9546,23053262
56091,aflibercept,gene,0.994,23053262
56092,VEGF Trap,gene,0.982,23053262
56093,Ziv-aflibercept,gene,0.9175,23053262
56094,VEGF-A,gene,0.999,23053262
56095,VEGF-B,gene,0.999,23053262
56096,PlGF,gene,0.9976,23053262
56097,ziv,drug,0.759,23053262
56098,cancer,disease,1.0,23053262
56099,Circulating endothelial cells,cell_type,0.915,23053262
56100,hypertension,disease,1.0,23053262
56101,Aflibercept,gene,0.974,23038609
56102,neovascular age-related macular degeneration,disease,1.0,23038609
56103,Aflibercept,gene,0.9634,23038609
56104,vascular endothelial growth factor,gene,0.998,23038609
56105,VEGF,gene,0.996,23038609
56106,VEGF-A,gene,0.9946,23038609
56107,VEGF-B,gene,0.996,23038609
56108,placental growth factor,gene,0.9917,23038609
56109,aflibercept,gene,0.9937,23038609
56110,wet (neovascular) age-related macular degeneration,disease,0.9907,23038609
56111,ranibizumab,gene,0.62,23038609
56112,aflibercept,gene,0.948,23038609
56113,ranibizumab,gene,0.7095,23038609
56114,aflibercept,gene,0.991,23038609
56115,ranibizumab,gene,0.541,23038609
56116,aflibercept,gene,0.94,23038609
56117,ranibizumab,gene,0.833,23038609
56118,Aflibercept,gene,0.972,23038609
56119,ranibizumab,gene,0.827,23038609
56120,Gastrointestinal Cancer,disease,0.999,23024990
56121,aflibercept,gene,0.988,22991959
56122,rabbit,species,0.926,22991959
56123,aflibercept,gene,0.991,22991959
56124,rabbit,species,0.9873,22991959
56125,Dutch-belted rabbits,species,0.6455,22991959
56126,I-124,drug,0.84,22991959
56127,aflibercept,gene,0.9917,22991959
56128,aflibercept,gene,0.9863,22991959
56129,I-124 aflibercept,gene,0.9487,22991959
56130,I-124 aflibercept,gene,0.9824,22991959
56131,I-124 aflibercept,gene,0.9604,22991959
56132,aflibercept,gene,0.9536,22977191
56133,metastatic colorectal cancer,disease,0.999,22977191
56134,Aflibercept,gene,0.835,22977191
56135,VEGF receptor (VEGFR) 1,gene,0.9614,22977191
56136,VEGFR2 extracellular domains,gene,0.8984,22977191
56137,aflibercept,gene,0.9775,22977191
56138,metastatic colorectal cancer,disease,1.0,22977191
56139,MCRC,disease,1.0,22977191
56140,bevacizumab,gene,0.653,22977191
56141,bevacizumab,gene,0.6416,22977191
56142,Aflibercept,gene,0.929,22977191
56143,bevacizumab,gene,0.879,22977191
56144,bevacizumab,gene,0.9116,22977191
56145,bevacizumab,gene,0.863,22977191
56146,bevacizumab,gene,0.7915,22977191
56147,hypertension,disease,1.0,22977191
56148,proteinuria,disease,1.0,22977191
56149,fatigue,disease,0.9995,22977191
56150,headache,disease,1.0,22977191
56151,VEGF,gene,0.9946,22977191
56152,aflibercept,gene,0.9854,22977191
56153,aflibercept,gene,0.996,22977191
56154,endogenous VEGF,gene,0.901,22977191
56155,Aflibercept,gene,0.768,22977191
56156,MCRC,disease,0.9756,22977191
56157,aflibercept,gene,0.982,22977191
56158,VEGF,gene,0.991,22973088
56159,age-related macular degeneration,disease,1.0,22973088
56160,aflibercept,gene,0.9814,22973088
56161,Age-related macular degeneration,disease,1.0,22973088
56162,AMD,disease,1.0,22973088
56163,blindness,disease,0.9995,22973088
56164,AMD,disease,1.0,22973088
56165,ageing,disease,0.6616,22973088
56166,photoreceptor outer segments,cell_type,0.5967,22973088
56167,apolipoproteins,gene,0.9355,22973088
56168,Bruch,cell_type,0.4783,22973088
56169,chronic ischemia,disease,0.7334,22973088
56170,inflammation,disease,0.999,22973088
56171,vascular endothelial growth factor,gene,0.999,22973088
56172,VEGF,gene,0.998,22973088
56173,pegaptanib,drug,0.93,22973088
56174,bevacizumab,gene,0.678,22973088
56175,ranibizumab,gene,0.717,22973088
56176,VEGF,gene,0.996,22973088
56177,exudative AMD,disease,1.0,22973088
56178,Aflibercept,gene,0.981,22973088
56179,VEGF-A,gene,0.999,22973088
56180,placental growth factor,gene,0.998,22973088
56181,aflibercept,gene,0.961,22973088
56182,aflibercept,gene,0.986,22973088
56183,ranibizumab,gene,0.7495,22973088
56184,aflibercept,gene,0.9897,22973088
56185,Aflibercept,gene,0.968,22973088
56186,VEGF,gene,0.9365,22973088
56187,Aflibercept,gene,0.991,22965962
56188,Docetaxel,drug,0.9985,22965962
56189,Docetaxel,drug,0.998,22965962
56190,platinum,drug,0.9995,22965962
56191,advanced,disease,0.6,22965962
56192,aflibercept,gene,0.981,22965962
56193,ziv-aflibercept,gene,0.9565,22965962
56194,vascular endothelial growth factor,gene,0.998,22965962
56195,VEGF,gene,0.9946,22965962
56196,docetaxel,drug,0.9985,22965962
56197,platinum,drug,1.0,22965962
56198,nonsquamous non-small-cell lung cancer,disease,0.992,22965962
56199,PATIENTS,species,0.968,22965962
56200,(ziv-)aflibercept,gene,0.9263,22965962
56201,docetaxel,drug,0.996,22965962
56202,bevacizumab,gene,0.749,22965962
56203,(Ziv-)Aflibercept,gene,0.985,22965962
56204,(ziv-)aflibercept,gene,0.9863,22965962
56205,(ziv-)aflibercept,gene,0.958,22965962
56206,(ziv-)aflibercept,gene,0.9375,22965962
56207,neutropenia,disease,1.0,22965962
56208,fatigue,disease,0.9976,22965962
56209,stomatitis,disease,1.0,22965962
56210,hypertension,disease,0.9995,22965962
56211,(ziv-),drug,0.9785,22965962
56212,aflibercept,gene,0.935,22965962
56213,docetaxel,drug,0.999,22965962
56214,(ziv-)aflibercept,gene,0.937,22965962
56215,anti-VEGF,gene,0.952,22965962
56216,aflibercept,gene,0.9927,22949147
56217,fluorouracil,drug,1.0,22949147
56218,leucovorin,drug,0.9995,22949147
56219,irinotecan,drug,0.999,22949147
56220,metastatic colorectal cancer,disease,1.0,22949147
56221,mCRC,disease,1.0,22949147
56222,fluoropyrimidine,drug,0.9985,22949147
56223,fluorouracil,drug,1.0,22949147
56224,leucovorin,drug,0.9985,22949147
56225,irinotecan,drug,0.9985,22949147
56226,FOLFIRI,drug,0.992,22949147
56227,fluorouracil,drug,1.0,22949147
56228,leucovorin,drug,0.9995,22949147
56229,oxaliplatin,drug,0.9995,22949147
56230,bevacizumab,gene,0.7183,22949147
56231,epidermal growth factor receptor monoclonal,gene,0.9897,22949147
56232,aflibercept,gene,0.989,22949147
56233,ziv-aflibercept,gene,0.9814,22949147
56234,FOLFIRI,drug,0.894,22949147
56235,patients,species,0.9224,22949147
56236,mCRC,disease,0.987,22949147
56237,oxaliplatin,drug,0.9995,22949147
56238,patients,species,0.9883,22949147
56239,bevacizumab,gene,0.815,22949147
56240,PATIENTS,species,0.955,22949147
56241,Patients,species,0.9746,22949147
56242,aflibercept,gene,0.954,22949147
56243,patients,species,0.977,22949147
56244,patients,species,0.984,22949147
56245,FOLFIRI,drug,0.9805,22949147
56246,aflibercept,gene,0.982,22949147
56247,FOLFIRI,drug,0.966,22949147
56248,FOLFIRI,drug,0.97,22949147
56249,Aflibercept,gene,0.9565,22949147
56250,bevacizumab,gene,0.8696,22949147
56251,patients,species,0.9844,22949147
56252,aflibercept,gene,0.9795,22949147
56253,FOLFIRI,drug,0.8047,22949147
56254,FOLFIRI,drug,0.916,22949147
56255,aflibercept,gene,0.968,22949147
56256,FOLFIRI,drug,0.991,22949147
56257,vascular endothelial growth factor,gene,0.9116,22949147
56258,Aflibercept,gene,0.971,22949147
56259,FOLFIRI,drug,0.853,22949147
56260,FOLFIRI,drug,0.808,22949147
56261,patients,species,0.869,22949147
56262,mCRC,disease,0.9956,22949147
56263,oxaliplatin,drug,0.9995,22949147
56264,VEGF,gene,0.922,22907145
56265,diabetic macular edema,disease,1.0,22907145
56266,Diabetic macular edema,disease,1.0,22907145
56267,DME,disease,1.0,22907145
56268,vision loss,disease,0.9966,22907145
56269,patients,species,0.9316,22907145
56270,diabetes mellitus,disease,1.0,22907145
56271,Diabetic retinopathy,disease,1.0,22907145
56272,diabetic,disease,1.0,22907145
56273,patients,species,0.982,22907145
56274,DME,disease,0.999,22907145
56275,visual,disease,0.809,22907145
56276,DME,disease,1.0,22907145
56277,anti-vascular endothelial growth factor,gene,0.988,22907145
56278,anti-VEGF,gene,0.994,22907145
56279,VEGF,gene,0.9897,22907145
56280,endothelial cell,gene,0.5356,22907145
56281,DME,disease,1.0,22907145
56282,VEGF,gene,0.8813,22907145
56283,DME,disease,1.0,22907145
56284,aflibercept,gene,0.983,22922531
56285,endometrial cancer,disease,1.0,22922531
56286,Aflibercept,gene,0.9717,22922531
56287,vascular endothelial growth factor,gene,0.998,22922531
56288,placental growth factor,gene,0.9956,22922531
56289,aflibercept,gene,0.9897,22922531
56290,endometrial cancer,disease,1.0,22922531
56291,Aflibercept,gene,0.839,22922531
56292,hemorrhage,disease,1.0,22922531
56293,GI perforation,disease,0.9927,22922531
56294,arterial rupture,disease,0.9883,22922531
56295,FGF1,gene,0.9927,22922531
56296,CONCLUSIONS Aflibercept,gene,0.8657,22922531
56297,aflibercept,gene,0.9863,22921183
56298,irinotecan,drug,0.999,22921183
56299,5-fluorouracil,drug,0.9995,22921183
56300,leucovorin,drug,0.999,22921183
56301,advanced solid tumours,disease,1.0,22921183
56302,aflibercept,gene,0.9917,22921183
56303,irinotecan,drug,0.9995,22921183
56304,5-fluorouracil,drug,0.9995,22921183
56305,leucovorin,drug,0.9995,22921183
56306,LV5FU2,drug,0.999,22921183
56307,PATIENTS,species,0.9634,22921183
56308,advanced solid tumours,disease,0.9995,22921183
56309,aflibercept,gene,0.9775,22921183
56310,irinotecan,drug,0.992,22921183
56311,aflibercept,gene,0.9863,22921183
56312,DLTs,disease,0.613,22921183
56313,proteinuria,disease,1.0,22921183
56314,acute nephrotic syndrome,disease,1.0,22921183
56315,thrombotic microangiopathy,disease,1.0,22921183
56316,stomatitis,disease,0.9995,22921183
56317,oesophagitis reflux,disease,0.9995,22921183
56318,febrile neutropenia,disease,0.9995,22921183
56319,stomatitis,disease,0.9966,22921183
56320,abdominal pain,disease,0.9707,22921183
56321,neutropenia,disease,1.0,22921183
56322,hypertension,disease,1.0,22921183
56323,diarrhoea,disease,1.0,22921183
56324,anti-aflibercept antibodies,gene,0.977,22921183
56325,aflibercept,gene,0.9946,22921183
56326,aflibercept 4,gene,0.966,22921183
56327,irinotecan,drug,0.9985,22921183
56328,vascular endothelial growth factor,gene,0.9966,22917890
56329,diabetic macular edema,disease,1.0,22917890
56330,vascular endothelial growth factor,gene,0.989,22917890
56331,VEGF,gene,0.9985,22917890
56332,diabetic macular edema,disease,1.0,22917890
56333,DME,disease,1.0,22917890
56334,pegaptanib sodium,drug,0.9834,22917890
56335,DME,disease,1.0,22917890
56336,VEGF,gene,0.9595,22917890
56337,VEGF,gene,0.954,22917890
56338,DME,disease,0.9917,22917890
56339,diabetic macular edema,disease,1.0,22913868
56340,diabetic macular edema,disease,1.0,22913868
56341,triamcinolone,drug,0.9824,22913868
56342,triamcinolone,drug,0.9956,22913868
56343,fluocinolone acetonide,drug,0.9995,22913868
56344,cataract,disease,1.0,22913868
56345,ranibizumab,gene,0.8223,22913868
56346,bevacizumab,gene,0.8174,22913868
56347,Aflibercept,gene,0.9473,22913868
56348,Corneal neovascularization,disease,1.0,22898649
56349,VEGF,gene,0.9727,22898649
56350,Corneal neovascularization,disease,1.0,22898649
56351,corneal scarring,disease,0.9995,22898649
56352,inflammation,disease,0.986,22898649
56353,edema,disease,0.999,22898649
56354,Corneal neovascularization,disease,0.999,22898649
56355,Vascular endothelial growth factor,gene,0.9985,22898649
56356,VEGF,gene,0.997,22898649
56357,VEGF,gene,0.9067,22898649
56358,neovascular age-related macular degeneration,disease,0.9995,22898649
56359,diabetic retinopathy,disease,1.0,22898649
56360,macular edema,disease,1.0,22898649
56361,neovascular glaucoma,disease,1.0,22898649
56362,neovascular diseases,disease,0.9976,22898649
56363,corneal neovascularization,disease,1.0,22898649
56364,VEGF,gene,0.894,22898649
56365,bevacizumab,gene,0.5073,22898649
56366,VEGF,gene,0.9937,22898649
56367,siRNA,RNA,0.412,22898649
56368,tyrosine,drug,0.9795,22898649
56369,tyrosine kinase,gene,0.7163,22898649
56370,TNF superfamily,gene,0.9976,22885470
56371,advanced endometrial adenocarcinoma,disease,0.685,22885470
56372,EAC,disease,1.0,22885470
56373,tumor,disease,1.0,22885470
56374,malignant cells,cell_type,0.886,22885470
56375,malignant,disease,0.9453,22885470
56376,Bevacizumab,gene,0.5806,22885470
56377,anti-VEGF,gene,0.8164,22885470
56378,temsirolimus,drug,0.9976,22885470
56379,mTOR,gene,0.997,22885470
56380,aflibercept,gene,0.8984,22885470
56381,VEGF,gene,0.997,22885470
56382,EAC,disease,1.0,22885470
56383,tumor necrosis factor (TNF) superfamily,DNA,0.5454,22885470
56384,tumor,disease,0.524,22885470
56385,tumor necrosis factor (,gene,0.998,22885470
56386,TNF) superfamily,gene,0.6465,22885470
56387,TNF superfamily,gene,0.9976,22885470
56388,EAC,disease,1.0,22885470
56389,EAC,disease,0.999,22885470
56390,TNF,gene,0.985,22885470
56391,infliximab,gene,0.8438,22885470
56392,adalimumab,gene,0.7764,22885470
56393,etanercept,gene,0.72,22885470
56394,certolizumab,gene,0.785,22885470
56395,bortezomib,drug,0.9995,22885470
56396,rituximab,gene,0.8916,22885470
56397,NF-B,gene,0.992,22885470
56398,FAS,gene,0.9917,22885470
56399,CD95,gene,0.998,22885470
56400,TNF-related apoptosis-inducing ligand,gene,0.998,22885470
56401,TRAIL,gene,0.992,22885470
56402,conatumumab,gene,0.5664,22885470
56403,EAC,disease,1.0,22885470
56404,TNF superfamily,gene,0.9976,22885470
56405,EAC,disease,0.9995,22885470
56406,Aflibercept,gene,0.978,22869868
56407,pediatric,species,0.4558,22869868
56408,solid tumors,disease,0.995,22869868
56409,adult,disease,0.9526,22869868
56410,solid tumors,disease,0.964,22869868
56411,childhood cancers,disease,1.0,22869868
56412,aflibercept,gene,0.9814,22869868
56413,thromboembolic adverse,disease,0.98,22866908
56414,VEGF,gene,0.766,22866908
56415,neovascular age-related macular degeneration,disease,1.0,22866908
56416,choroid neovascularization,disease,1.0,22866908
56417,CNV,disease,1.0,22866908
56418,VEGF-A,gene,0.9976,22866908
56419,VEGF,gene,0.9624,22866908
56420,neovascular age-related macular degeneration,disease,1.0,22866908
56421,AMD,disease,1.0,22866908
56422,myocardial infarction,disease,1.0,22866908
56423,transient ischemic attacks,disease,1.0,22866908
56424,deep vein thrombosis,disease,1.0,22866908
56425,pulmonary embolism,disease,1.0,22866908
56426,thromboflebitis,disease,1.0,22866908
56427,VEGF,gene,0.91,22866908
56428,thromboembolic events,disease,0.908,22866908
56429,VEGF,gene,0.8486,22866908
56430,pegaptanib,drug,0.9043,22866908
56431,ranibizumab,gene,0.715,22866908
56432,aflibercept,gene,0.9116,22866908
56433,AMD,disease,1.0,22866908
56434,bevacizumab,gene,0.927,22866908
56435,VEGF,gene,0.9385,22866908
56436,CNV,disease,0.9946,22866908
56437,anti-VEGF,gene,0.8994,22866908
56438,thromboembolic,disease,0.99,22866908
56439,VEGF-Trap,gene,0.9004,22824831
56440,breast tumor,disease,0.9995,22824831
56441,Vascular endothelial growth factor,gene,0.998,22824831
56442,VEGF,gene,0.9956,22824831
56443,tumor,disease,1.0,22824831
56444,VEGF,gene,0.9956,22824831
56445,tumor,disease,1.0,22824831
56446,VEGF-Trap,gene,0.931,22824831
56447,tumors,disease,1.0,22824831
56448,VEGF Trap protein,gene,0.9277,22824831
56449,mouse,species,0.932,22824831
56450,VEGF,gene,0.991,22824831
56451,Trap,gene,0.701,22824831
56452,primary,disease,0.8564,22824831
56453,tumor,disease,0.9487,22824831
56454,4T1 tumors,disease,0.9985,22824831
56455,tumor cell,cell_type,0.7686,22824831
56456,tumor,disease,0.999,22824831
56457,VEGF-Trap,gene,0.732,22824831
56458,VEGF,gene,0.9907,22824831
56459,aFGF,gene,0.955,22824831
56460,bFGF,gene,0.9844,22824831
56461,angiopoietin-1,gene,0.996,22824831
56462,VEGF,gene,0.9946,22824831
56463,Trap,gene,0.5176,22824831
56464,tumor,disease,1.0,22824831
56465,Aflibercept,gene,0.959,22813448
56466,age-related macular degeneration,disease,1.0,22813448
56467,anti-vascular endothelial growth factor,gene,0.9507,22813448
56468,VEGF,gene,0.996,22813448
56469,aflibercept,gene,0.9683,22813448
56470,Eylea,gene,0.6787,22813448
56471,VEGF,gene,0.992,22813448
56472,aflibercept,gene,0.9897,22813448
56473,exudative age-related macular degeneration,disease,1.0,22813448
56474,Aflibercept,gene,0.9844,22813448
56475,VEGF receptors,gene,0.9824,22813448
56476,VEGF-A,gene,0.9985,22813448
56477,VEGF-B,gene,0.998,22813448
56478,aflibercept,gene,0.615,22813448
56479,choroidal neovascularization,disease,0.9976,22813448
56480,choroidal neovascularization,disease,0.812,22813448
56481,exudative age-related macular degeneration,disease,0.9995,22813448
56482,aflibercept,gene,0.9805,22813448
56483,VEGF,gene,0.6235,22813448
56484,Vascular Endothelial Growth Factor,gene,0.9995,22813448
56485,VEGF,gene,0.996,22813448
56486,Wet Age-Related Macular Degeneration 1 and 2,disease,0.9414,22813448
56487,aflibercept,gene,0.9893,22813448
56488,ranibizumab,gene,0.727,22813448
56489,aflibercept,gene,0.9897,22813448
56490,Aflibercept,gene,0.6245,22813448
56491,exudative age-related macular degeneration,disease,1.0,22813448
56492,ranibizumab,gene,0.674,22813448
56493,aflibercept,gene,0.985,22813448
56494,ranibizumab,gene,0.7285,22813448
56495,aflibercept,gene,0.9624,22805331
56496,aflibercept,gene,0.9565,22805331
56497,aflibercept,gene,0.9814,22805331
56498,pemetrexed,drug,0.9995,22805331
56499,cisplatin,drug,0.9995,22805331
56500,Aflibercept,gene,0.9165,22805331
56501,pemetrexed,drug,0.9995,22805331
56502,cisplatin,drug,0.996,22805331
56503,antiaflibercept antibodies,gene,0.941,22805331
56504,aflibercept,gene,0.9414,22805331
56505,patients,species,0.9873,22805331
56506,patient,species,0.982,22805331
56507,hypophosphatemia,disease,0.997,22805331
56508,fatigue,disease,0.9995,22805331
56509,anaemia,disease,1.0,22805331
56510,nausea,disease,0.9995,22805331
56511,hyponatremia,disease,1.0,22805331
56512,neutropenia,disease,1.0,22805331
56513,vascular endothelial growth factor,gene,0.916,22805331
56514,hypertension,disease,1.0,22805331
56515,pulmonary embolism,disease,1.0,22805331
56516,patients,species,0.984,22805331
56517,neurocognitive disturbance,disease,0.9985,22805331
56518,reversible posterior leukoencephalopathy syndrome,disease,1.0,22805331
56519,RPLS,disease,1.0,22805331
56520,aflibercept,gene,0.9756,22805331
56521,pemetrexed,drug,0.9995,22805331
56522,cisplatin,drug,0.9995,22805331
56523,aflibercept,gene,0.9717,22805331
56524,pemetrexed,drug,0.9995,22805331
56525,cisplatin,drug,0.9995,22805331
56526,aflibercept,gene,0.9937,22791883
56527,VEGF Trap,gene,0.988,22791883
56528,children,species,0.9385,22791883
56529,Aflibercept,gene,0.9736,22791883
56530,VEGF,gene,0.996,22791883
56531,aflibercept,gene,0.8696,22791883
56532,children,species,0.9746,22791883
56533,solid tumors,disease,1.0,22791883
56534,aflibercept,gene,0.819,22791883
56535,patients,species,0.9775,22791883
56536,patients,species,0.967,22791883
56537,intratumoral hemorrhage,disease,0.9604,22791883
56538,tumor pain,disease,0.992,22791883
56539,tissue necrosis,disease,0.8,22791883
56540,patients,species,0.9907,22791883
56541,DLTs,disease,0.8857,22791883
56542,hypertension,disease,1.0,22791883
56543,fatigue,disease,0.9995,22791883
56544,patients,species,0.9688,22791883
56545,hepatocellular carcinoma,disease,1.0,22791883
56546,hepatoblastoma,disease,1.0,22791883
56547,clear cell sarcoma,disease,1.0,22791883
56548,aflibercept,gene,0.9917,22791883
56549,VEGF,gene,0.9956,22791883
56550,placental growth factor,gene,0.9976,22791883
56551,PlGF,gene,0.992,22791883
56552,aflibercept,gene,0.9727,22791883
56553,aflibercept,gene,0.695,22791883
56554,children,species,0.983,22791883
56555,aflibercept,gene,0.9927,22791883
56556,Tumor pain,disease,0.964,22791883
56557,hemorrhage,disease,0.9985,22791883
56558,aflibercept,gene,0.982,22790797
56559,docetaxel,drug,0.997,22790797
56560,aflibercept,gene,0.988,22790797
56561,vascular endothelial growth factor,gene,0.9985,22790797
56562,VEGF,gene,0.9985,22790797
56563,docetaxel,drug,0.9976,22790797
56564,cisplatin,drug,0.999,22790797
56565,patients,species,0.9756,22790797
56566,advanced solid tumours,disease,1.0,22790797
56567,Patients,species,0.9336,22790797
56568,aflibercept,gene,0.976,22790797
56569,docetaxel,drug,0.9976,22790797
56570,cisplatin,drug,0.9995,22790797
56571,aflibercept,gene,0.9663,22790797
56572,febrile neutropenia,disease,1.0,22790797
56573,Granulocyte colony-stimulating factor,gene,0.9976,22790797
56574,aflibercept,gene,0.9697,22790797
56575,patients,species,0.9863,22790797
56576,neutropenia,disease,1.0,22790797
56577,stomatitis,disease,1.0,22790797
56578,asthenia,disease,1.0,22790797
56579,fatigue,disease,0.994,22790797
56580,hypertension,disease,1.0,22790797
56581,VEGF,gene,0.9937,22790797
56582,epistaxis,disease,1.0,22790797
56583,dysphonia,disease,1.0,22790797
56584,proteinuria,disease,1.0,22790797
56585,hypertension,disease,1.0,22790797
56586,patients,species,0.9893,22790797
56587,Aflibercept,gene,0.966,22790797
56588,docetaxel,drug,0.999,22790797
56589,cisplatin,drug,0.9995,22790797
56590,antitumour,disease,0.847,22790797
56591,VEGF,gene,0.9956,22783753
56592,cancer,disease,1.0,22783753
56593,eye disease,disease,0.9976,22783753
56594,Ranibizumab,gene,0.833,22783753
56595,VEGF-Trap,gene,0.967,22783753
56596,aflibercept,gene,0.9893,22783753
56597,VEGF family,gene,0.9976,22783753
56598,VEGF-A,gene,0.9966,22783753
56599,aflibercept,gene,0.9785,22783753
56600,VEGF-A,gene,0.9976,22783753
56601,VEGF,gene,0.994,22783753
56602,VEGFR-1,gene,0.9956,22783753
56603,VEGFR-2,gene,0.9883,22783753
56604,VEGF-Trap,gene,0.989,22783753
56605,VEGF-B,gene,0.998,22783753
56606,PIGF,gene,0.9956,22783753
56607,VEGF-A,gene,0.998,22783753
56608,VEGFR-1,gene,0.991,22783753
56609,VEGFR-2,gene,0.9927,22783753
56610,cancer,disease,1.0,22783753
56611,nAMD,disease,1.0,22783753
56612,Fc fragment,gene,0.9004,22783753
56613,VEGF-Trap,gene,0.9604,22783753
56614,aflibercept,gene,0.9937,22775078
56615,patients,species,0.993,22775078
56616,aflibercept,gene,0.991,22775078
56617,vascular endothelial growth factor,gene,0.9985,22775078
56618,neovascular age-related macular degeneration,disease,0.9995,22775078
56619,AMD,disease,1.0,22775078
56620,patients,species,0.9814,22775078
56621,choroidal neovascularization,disease,1.0,22775078
56622,CNV,disease,1.0,22775078
56623,aflibercept,gene,0.961,22775078
56624,CNV,disease,1.0,22775078
56625,patients,species,0.9854,22775078
56626,patients,species,0.985,22775078
56627,patients,species,0.973,22775078
56628,ocular inflammation,disease,1.0,22775078
56629,aflibercept,gene,0.9775,22775078
56630,aflibercept,gene,0.9707,22775078
56631,neovascular AMD,disease,1.0,22775078
56632,patients,species,0.9917,22775078
56633,tumors,disease,1.0,22773560
56634,cancer,disease,1.0,22773560
56635,vascular endothelial growth factor (VEGF)-A,gene,0.9976,22773560
56636,tumors,disease,1.0,22773560
56637,tumor,disease,0.9995,22773560
56638,tumor,disease,0.9995,22773560
56639,metastatic colorectal cancer,disease,1.0,22773560
56640,bevacizumab,gene,0.9214,22773560
56641,patients,species,0.97,22773560
56642,VEGF-A,gene,0.996,22773560
56643,tumor,disease,1.0,22773560
56644,VEGF family members,gene,0.995,22773560
56645,tumor,disease,1.0,22773560
56646,colorectal cancer,disease,1.0,22763196
56647,cancer,disease,1.0,22763196
56648,malignancies,disease,1.0,22763196
56649,colorectal cancer,disease,1.0,22763196
56650,bevacizumab,gene,0.9424,22763196
56651,aflibercept,gene,0.962,22763196
56652,tumor cells,cell_type,0.838,22763196
56653,tumor,disease,0.9814,22763196
56654,tumor,disease,1.0,22763196
56655,colorectal cancer,disease,1.0,22763196
56656,tumor,disease,0.9663,22763196
56657,castrate-resistant prostate cancer,disease,1.0,22672122
56658,Castrate-resistant prostate cancer,disease,1.0,22672122
56659,CRPC,disease,1.0,22672122
56660,androgens,drug,0.9985,22672122
56661,CRPC,disease,0.986,22672122
56662,docetaxel,drug,0.9976,22672122
56663,androgen,drug,0.998,22672122
56664,cabazitaxel,drug,0.995,22672122
56665,CRPC,disease,0.8774,22672122
56666,denosumab,gene,0.529,22672122
56667,CRPC,disease,0.999,22672122
56668,bone metastases,disease,0.79,22672122
56669,zoledronic acid,drug,0.9946,22672122
56670,bisphosphonate,drug,0.981,22672122
56671,CRPC,disease,0.876,22672122
56672,androgen,drug,0.9995,22672122
56673,androgen receptor,gene,0.9917,22672122
56674,MDV3100,drug,0.99,22672122
56675,PROSTVAC,DNA,0.521,22672122
56676,endothelin-A receptor,gene,0.999,22672122
56677,zibotentan,drug,0.997,22672122
56678,tyrosine,drug,0.7803,22672122
56679,tyrosine kinase,gene,0.9766,22672122
56680,dasatinib,drug,0.9976,22672122
56681,sorafenib,drug,0.998,22672122
56682,cabozantinib,drug,0.9976,22672122
56683,aflibercept,gene,0.963,22672122
56684,clusterin,gene,0.9917,22672122
56685,custirsen,drug,0.987,22672122
56686,CRPC,disease,0.923,22672122
56687,CRPC,disease,0.9985,22672122
56688,tumor,disease,0.999,22692562
56689,tumor blood vessel,cell_type,0.61,22692562
56690,tumor,disease,0.4934,22692562
56691,VEGF-A,gene,0.9976,22692562
56692,mouse,species,0.9834,22692562
56693,tumors,disease,0.981,22692562
56694,cancer,disease,1.0,22692562
56695,blood vessels,cell_type,0.4685,22692562
56696,mouse,species,0.9136,22692562
56697,cancers,disease,0.999,22692562
56698,tumor,disease,0.9946,22692562
56699,mice,species,0.935,22692562
56700,VEGF-A(164),gene,0.9966,22692562
56701,tumor,disease,1.0,22692562
56702,tumor surrogate blood vessels,cell_type,0.567,22692562
56703,tumor,disease,0.9873,22692562
56704,angiogenic blood vessels,cell_type,0.5874,22692562
56705,GMP,disease,0.6157,22692562
56706,capillaries,cell_type,0.583,22692562
56707,vascular malformations,disease,1.0,22692562
56708,VM,disease,1.0,22692562
56709,angiogenic vessels,cell_type,0.575,22692562
56710,blood vessel types,cell_type,0.5044,22692562
56711,MV,cell_type,0.478,22692562
56712,GMP,cell_type,0.5957,22692562
56713,"""",cell_type,0.3972,22692562
56714,cancers,disease,0.9927,22692562
56715,VEGF,gene,0.99,22692562
56716,VEGFR,gene,0.992,22692562
56717,cancers,disease,0.9785,22692562
56718,late,cell_type,0.4617,22692562
56719,cancer,disease,0.955,22692562
56720,VEGF,gene,0.997,22692562
56721,VEGFR,gene,0.9927,22692562
56722,diabetic macular edema,disease,1.0,22688778
56723,castration-resistant prostate cancer,disease,1.0,22666217
56724,castration-resistant prostate cancer,disease,1.0,22666217
56725,CRPC,disease,1.0,22666217
56726,cabazitaxel,drug,0.9873,22666217
56727,abiraterone,drug,0.802,22666217
56728,CRPC,disease,0.999,22666217
56729,androgen,drug,0.9985,22666217
56730,Radium-223,drug,0.9507,22666217
56731,MDV3100,drug,0.9863,22666217
56732,TAK-700,drug,0.999,22666217
56733,cabozantinib,drug,0.999,22666217
56734,tasquinimod,drug,0.9976,22666217
56735,PROSTVAC-VF,DNA,0.483,22666217
56736,docetaxel,drug,0.999,22666217
56737,custirsen,drug,0.998,22666217
56738,aflibercept,gene,0.977,22666217
56739,dasatinib,drug,0.9966,22666217
56740,zibotentan,drug,0.998,22666217
56741,CRPC,disease,0.9976,22666217
56742,Aflibercept,gene,0.956,22645720
56743,neovascular age-related macular degeneration,disease,1.0,22645720
56744,Age-related macular degeneration,disease,1.0,22645720
56745,AMD,disease,1.0,22645720
56746,vascular endothelial growth factor,gene,0.9985,22645720
56747,VEGF,gene,0.995,22645720
56748,neovascular AMD,disease,1.0,22645720
56749,VEGF,gene,0.5493,22645720
56750,aflibercept,gene,0.9756,22645720
56751,VEGF,gene,0.5796,22645720
56752,VEGF,gene,0.9946,22645720
56753,placenta growth factor,gene,0.9985,22645720
56754,neovascular AMD,disease,1.0,22645720
56755,ranibizumab,gene,0.934,22645720
56756,bevacizumab,gene,0.854,22645720
56757,aflibercept,gene,0.9614,22645720
56758,neovascular AMD,disease,1.0,22645720
56759,bevacizumab,gene,0.881,22612461
56760,VEGF,gene,0.8604,22612461
56761,colorectal cancer,disease,1.0,22612461
56762,colorectal cancer,disease,1.0,22612461
56763,CRC,disease,1.0,22612461
56764,CRC,disease,0.998,22612461
56765,Bevacizumab,gene,0.9224,22612461
56766,patients,species,0.9136,22612461
56767,metastatic CRC,disease,1.0,22612461
56768,mCRC,disease,1.0,22612461
56769,cancer,disease,1.0,22612461
56770,VEGF,gene,0.9966,22612461
56771,mCRC,disease,0.965,22612461
56772,aflibercept,gene,0.9897,22612461
56773,regorafenib,drug,0.978,22612461
56774,mCRC,disease,0.8735,22612461
56775,patients,species,0.992,22612461
56776,advanced urothelial cancer of the bladder,disease,1.0,22583418
56777,advanced urothelial cancer of the bladder,disease,1.0,22583418
56778,bladder cancer,disease,1.0,22583418
56779,patient,species,0.9663,22583418
56780,bevacizumab,gene,0.961,22583418
56781,aflibercept,gene,0.9863,22583418
56782,sunitinib,drug,0.999,22583418
56783,sorafenib,drug,0.999,22583418
56784,gefitinib,drug,0.9985,22583418
56785,lapatinib,drug,0.997,22583418
56786,trastuzumab,gene,0.9697,22583418
56787,pazopanib,drug,0.9995,22583418
56788,cetuximab,gene,0.726,22583418
56789,everolimus,drug,0.997,22583418
56790,bevacizumab,gene,0.9165,22583418
56791,trastuzumab,gene,0.9834,22583418
56792,patients,species,0.976,22583418
56793,advanced bladder cancer,disease,1.0,22583418
56794,epithelial cancers,disease,1.0,22583418
56795,VEGF,gene,0.9443,22570554
56796,bevacizumab,gene,0.96,22570554
56797,aflibercept,gene,0.977,22570554
56798,metastatic colorectal cancer,disease,1.0,22570554
56799,mCRC,disease,1.0,22570554
56800,advanced solid tumors,disease,0.9995,22570554
56801,patients,species,0.9595,22570554
56802,mCRC,disease,0.901,22570554
56803,antivascular endothelial growth factor,gene,0.994,22570554
56804,anti-VEGF,gene,0.9805,22570554
56805,bevacizumab,gene,0.894,22570554
56806,aflibercept,gene,0.9727,22570554
56807,antiendothelial cell growth factor receptor,gene,0.934,22570554
56808,anti-EGFR,gene,0.9478,22570554
56809,cetuximab,gene,0.8047,22570554
56810,panitumumab,gene,0.7524,22570554
56811,Aflibercept,gene,0.9546,22570554
56812,mCRC,disease,0.9946,22570554
56813,aflibercept,gene,0.974,22570554
56814,anti-VEGF,gene,0.7285,22570554
56815,bevacizumab,gene,0.8545,22570554
56816,aflibercept,gene,0.9795,22570554
56817,VEGF,gene,0.959,22570554
56818,mCRC,disease,0.992,22570554
56819,aflibercept,gene,0.991,22546405
56820,VEGF-Trap,gene,0.9863,22546405
56821,urothelial cancer,disease,0.841,22546405
56822,Cancer,disease,0.91,22546405
56823,VEGF,gene,0.9946,22537617
56824,diabetic macular edema,disease,1.0,22537617
56825,Vascular Endothelial Growth Factor,gene,0.9985,22537617
56826,VEGF,gene,0.9985,22537617
56827,diabetic macular edema,disease,1.0,22537617
56828,DME,disease,1.0,22537617
56829,PARTICIPANTS,species,0.542,22537617
56830,Diabetic,disease,1.0,22537617
56831,DME,disease,0.942,22537617
56832,VEGF,gene,0.9897,22537617
56833,Diabetic Retinopathy,disease,0.9756,22537617
56834,VEGF,gene,0.9883,22537617
56835,VEGF,gene,0.988,22537617
56836,ETDRS,DNA,0.5806,22537617
56837,VEGF,gene,0.9917,22537617
56838,VEGF,gene,0.9893,22537617
56839,Vascular Endothelial Growth Factor,gene,0.9985,22537617
56840,VEGF Trap,gene,0.754,22537617
56841,conjunctival hemorrhage,disease,1.0,22537617
56842,eye pain,disease,0.9946,22537617
56843,ocular hyperemia,disease,0.9995,22537617
56844,hypertension,disease,1.0,22537617
56845,nausea,disease,1.0,22537617
56846,congestive heart failure,disease,1.0,22537617
56847,VEGF Trap,gene,0.8335,22537617
56848,Vascular Endothelial Growth Factor,gene,0.999,22537617
56849,DME,disease,1.0,22537617
56850,vascular endothelial growth factor,gene,0.996,22517123
56851,retinal vein occlusions,disease,1.0,22517123
56852,Retinal vein occlusion,disease,1.0,22517123
56853,RVO,disease,1.0,22517123
56854,arterial insufficiency,disease,1.0,22517123
56855,retinal ischemia,disease,1.0,22517123
56856,Retinal ischemia,disease,0.9995,22517123
56857,vascular endothelial growth factor,gene,0.9985,22517123
56858,VEGF,gene,0.9917,22517123
56859,macular edema,disease,1.0,22517123
56860,VEGF,gene,0.995,22517123
56861,retinal hemorrhages,disease,1.0,22517123
56862,capillary nonperfusion,disease,1.0,22517123
56863,VEGF-binding protein,gene,0.833,22517123
56864,macular edema,disease,1.0,22517123
56865,retinal hemorrhages,disease,1.0,22517123
56866,edema,disease,0.723,22517123
56867,edema,disease,0.9985,22517123
56868,nonperfusion,disease,0.963,22517123
56869,VEGF,gene,0.9937,22517123
56870,RVO,disease,1.0,22517123
56871,Diabetic macular edema,disease,1.0,22517122
56872,Diabetic retinopathy,disease,1.0,22517122
56873,diabetes mellitus,disease,1.0,22517122
56874,visual loss,disease,1.0,22517122
56875,Diabetic macular edema,disease,1.0,22517122
56876,DME,disease,1.0,22517122
56877,visual deterioration,disease,1.0,22517122
56878,visual impairment,disease,1.0,22517122
56879,DME,disease,1.0,22517122
56880,Vascular endothelial growth factor,gene,0.997,22517122
56881,VEGF,gene,0.9917,22517122
56882,diabetic,disease,1.0,22517122
56883,DME,disease,1.0,22517122
56884,VEGF,gene,0.9927,22517122
56885,diabetic retinopathy,disease,1.0,22517122
56886,VEGF,gene,0.9946,22517122
56887,retinal endothelial cells,cell_type,0.8877,22517122
56888,accumulation of fluid in,disease,0.7124,22517122
56889,VEGF,gene,0.991,22517122
56890,DME,disease,1.0,22517122
56891,VEGF,gene,0.9917,22517122
56892,VEGF,gene,0.994,22517122
56893,VEGF,gene,0.6357,22517122
56894,DME,disease,1.0,22517122
56895,Neovascular age-related macular degeneration,disease,1.0,22517121
56896,Neovascular age-related macular degeneration,disease,0.991,22517121
56897,AMD,disease,1.0,22517121
56898,blindness,disease,0.9985,22517121
56899,VEGF,gene,0.684,22517121
56900,pegaptanib,drug,0.9985,22517121
56901,ranibizumab,gene,0.6216,22517121
56902,aflibercept,gene,0.975,22517121
56903,bevacizumab,gene,0.5664,22517121
56904,VEGF,gene,0.9897,22517121
56905,neovascular AMD,disease,1.0,22517121
56906,VEGF,gene,0.8647,22517121
56907,choroidal neovascularization,disease,1.0,22517121
56908,VEGF,gene,0.8013,22517121
56909,choroidal neovascularization,disease,1.0,22517121
56910,VEGF,gene,0.78,22517121
56911,vascular endothelial growth factors,gene,0.997,22517120
56912,Vascular endothelial growth factor,gene,0.9966,22517120
56913,VEGF,gene,0.989,22517120
56914,retinal disorders,disease,0.992,22517120
56915,age-related macular degeneration,disease,1.0,22517120
56916,diabetic,disease,1.0,22517120
56917,macular edema,disease,1.0,22517120
56918,proliferative diabetic retinopathy,disease,1.0,22517120
56919,VEGF,gene,0.69,22517120
56920,pegaptanib,drug,0.9976,22517120
56921,Macugen,drug,0.9854,22517120
56922,aflibercept,gene,0.991,22517120
56923,VEGF Trap-Eye,gene,0.699,22517120
56924,bevacizumab,gene,0.512,22517120
56925,vascular endothelial growth factor,gene,0.9946,22515701
56926,diabetic macular edema,disease,1.0,22515701
56927,Diabetic mellitus,disease,1.0,22515701
56928,blindness,disease,0.9985,22515701
56929,chronic hyperglycemia,disease,0.9966,22515701
56930,vascular endothelial growth factor,gene,0.997,22515701
56931,VEGF,gene,0.9897,22515701
56932,VEGF,gene,0.9956,22515701
56933,endothelial cell,cell_type,0.8164,22515701
56934,vasodilation,disease,0.9976,22515701
56935,inflammatory cells,cell_type,0.8735,22515701
56936,diabetic macular edema,disease,1.0,22515701
56937,DME,disease,1.0,22515701
56938,DME,disease,1.0,22515701
56939,vision loss,disease,0.938,22515701
56940,diffuse edema,disease,1.0,22515701
56941,VEGF,gene,0.996,22515701
56942,pegaptanib,drug,0.9253,22515701
56943,ranibizumab,gene,0.6357,22515701
56944,aflibercept,gene,0.9336,22515701
56945,exudative macular degeneration,disease,1.0,22515701
56946,chorioretinal disorders,disease,0.9995,22515701
56947,DME,disease,1.0,22515701
56948,VEGF,gene,0.831,22515701
56949,Hemorrhagic pseudoaneurysm,disease,1.0,22510046
56950,aflibercept,gene,0.9614,22510046
56951,metastatic thyroid cancer,disease,1.0,22510046
56952,aflibercept,gene,0.9873,22510046
56953,metastatic differentiated thyroid cancer,disease,0.9805,22510046
56954,hemorrhagic abdominal pseudoaneurysm,disease,0.9995,22510046
56955,PATIENT,species,0.94,22510046
56956,aflibercept,gene,0.995,22510046
56957,VEGF-Trap,gene,0.98,22510046
56958,metastatic thyroid cancer,disease,1.0,22510046
56959,vascular disease,disease,1.0,22510046
56960,sorafenib,drug,0.999,22510046
56961,aflibercept,gene,0.9873,22510046
56962,abdominal pain,disease,0.9746,22510046
56963,nausea,disease,0.9956,22510046
56964,vomiting,disease,0.712,22510046
56965,pseudoaneurysm,disease,0.9526,22510046
56966,pseudoaneurysm,disease,0.9917,22510046
56967,hemorrhagic and thrombotic complications,disease,1.0,22510046
56968,hemorrhage of aberrant vasculature,disease,0.9595,22510046
56969,non-small cell lung cancer,disease,1.0,22481432
56970,non-small cell lung cancer,disease,1.0,22481432
56971,NSCLC,disease,1.0,22481432
56972,NSCLC,disease,0.9995,22481432
56973,Bevacizumab,gene,0.644,22481432
56974,anti-VEGF antibody,gene,0.9536,22481432
56975,advanced NSCLC,disease,0.7227,22481432
56976,carboplatin,drug,0.999,22481432
56977,paclitaxel,drug,0.9966,22481432
56978,bevacizumab,gene,0.909,22481432
56979,tyrosine,drug,0.944,22481432
56980,tyrosine kinase,gene,0.9946,22481432
56981,vandetanib,drug,0.999,22481432
56982,sorafenib,drug,0.9985,22481432
56983,ASA404,drug,0.998,22481432
56984,aflibercept,gene,0.972,22481432
56985,cediranib,drug,0.996,22481432
56986,BIBF 1120,drug,0.998,22481432
56987,sunitinib,drug,0.9985,22481432
56988,pazopanib,drug,0.998,22481432
56989,brivanib,drug,0.9966,22481432
56990,ABT-869,drug,0.9995,22481432
56991,axitinib,drug,0.9883,22481432
56992,ABT-751,drug,0.9976,22481432
56993,NPI-2358,drug,0.999,22481432
56994,Aflibercept,gene,0.962,22460118
56995,aflibercept,gene,0.9873,22460118
56996,Eylea,gene,0.7593,22460118
56997,vascular endothelial growth factor family,gene,0.997,22460118
56998,patients,species,0.983,22460118
56999,neovascular age-related macular degeneration,disease,1.0,22460118
57000,neovascular age-related macular degeneration,disease,1.0,22450218
57001,neovascular age-related macular degeneration,disease,1.0,22450218
57002,ranibizumab,gene,0.675,22450218
57003,bevacizumab,gene,0.831,22450218
57004,ranibizumab,gene,0.826,22450218
57005,neovascular age-related macular degeneration,disease,1.0,22450218
57006,AMD,disease,1.0,22450218
57007,Aflibercept,gene,0.944,22450218
57008,vascular endothelial growth factor,gene,0.9736,22450218
57009,VEGF,gene,0.9976,22450218
57010,VEGF,gene,0.88,22450218
57011,VEGF,gene,0.7993,22450218
57012,neovascular AMD,disease,1.0,22450218
57013,Aflibercept,gene,0.9526,22450218
57014,VEGF,gene,0.5786,22450218
57015,Aflibercept,gene,0.9883,22446028
57016,VEGF Trap-eye,gene,0.6943,22446028
57017,VEGF,gene,0.7583,22446028
57018,Vascular endothelial growth factor,gene,0.999,22440275
57019,macular edema,disease,1.0,22440275
57020,central retinal vein occlusion,disease,1.0,22440275
57021,vascular endothelial growth factor,gene,0.999,22440275
57022,VEGF,gene,0.9946,22440275
57023,macular edema,disease,1.0,22440275
57024,central retinal vein occlusion,disease,1.0,22440275
57025,CRVO,disease,1.0,22440275
57026,PARTICIPANTS,species,0.5005,22440275
57027,macular edema,disease,1.0,22440275
57028,CRVO,disease,1.0,22440275
57029,VEGF Trap,gene,0.763,22440275
57030,neovascularization of the anterior segment,disease,0.9995,22440275
57031,optic disc,DNA,0.4873,22440275
57032,VEGF,gene,0.997,22440275
57033,VEGF Trap,gene,0.9136,22440275
57034,VEGF,gene,0.9946,22440275
57035,VEGF Trap,gene,0.9043,22440275
57036,Conjunctival hemorrhage,disease,1.0,22440275
57037,eye pain,disease,0.9995,22440275
57038,VEGF,gene,0.988,22440275
57039,VEGF Trap,gene,0.867,22440275
57040,macular edema,disease,1.0,22440275
57041,CRVO,disease,1.0,22440275
57042,patients,species,0.9897,22429837
57043,advanced prostate cancer,disease,1.0,22429837
57044,men,species,0.798,22429837
57045,metastatic castration-resistant prostate cancer,disease,1.0,22429837
57046,mCRPC,disease,1.0,22429837
57047,patients,species,0.9897,22429837
57048,androgen-independent prostate cancer,disease,1.0,22429837
57049,androgen,drug,0.998,22429837
57050,hormone refractory prostate cancer,disease,1.0,22429837
57051,CRPC,disease,1.0,22429837
57052,mCRPC,disease,0.998,22429837
57053,patients,species,0.942,22429837
57054,prostate cancer,disease,1.0,22429837
57055,prostate-specific antigen,gene,0.998,22429837
57056,MDV3100,drug,0.9985,22429837
57057,cabazitaxel,drug,0.9995,22429837
57058,mCRPC,disease,0.9404,22429837
57059,patients,species,0.9805,22429837
57060,advanced prostate cancer,disease,1.0,22429837
57061,abiraterone acetate,drug,0.823,22429837
57062,aflibercept,gene,0.979,22429837
57063,bevacizumab,gene,0.623,22429837
57064,cabazitaxel,drug,0.995,22429837
57065,custirsen,drug,0.995,22429837
57066,MDV3100,drug,0.824,22429837
57067,zibotentan,drug,0.988,22429837
57068,patients,species,0.9634,22429837
57069,advanced prostate cancer,disease,1.0,22429837
57070,patients,species,0.973,22429837
57071,metastatic castration-resistant prostate cancer,disease,1.0,22429837
57072,mCRPC,disease,1.0,22429837
57073,prostate-specific antigen,gene,0.998,22429837
57074,docetaxel,drug,0.9917,22429837
57075,abiraterone acetate,drug,0.868,22429837
57076,MDV3100,drug,0.9976,22429837
57077,cabazitaxel,drug,0.9985,22429837
57078,aflibercept,gene,0.9897,22429837
57079,zibotentan,drug,0.999,22429837
57080,bevacizumab,gene,0.785,22429837
57081,mCRPC,disease,0.812,22429837
57082,bevacizumab,gene,0.785,22413865
57083,glioblastoma,disease,1.0,22413865
57084,glioblastoma,disease,1.0,22413865
57085,glioblastoma,disease,1.0,22413865
57086,VEGF,gene,0.9966,22413865
57087,VEGF antibody bevacizumab,gene,0.855,22413865
57088,VEGF receptor fusion protein,gene,0.9814,22413865
57089,aflibercept,gene,0.882,22413865
57090,tyrosine,drug,0.8496,22413865
57091,tyrosine kinase,gene,0.683,22413865
57092,cediranib,drug,0.988,22413865
57093,enzastaurin,drug,0.979,22413865
57094,integrin,gene,0.9355,22413865
57095,Enzastaurin,drug,0.9976,22413865
57096,cediranib,drug,0.9966,22413865
57097,glioblastoma,disease,0.984,22413865
57098,aflibercept,gene,0.934,22413865
57099,bevacizumab,gene,0.6567,22413865
57100,bevacizumab,gene,0.9517,22413865
57101,cilengitide,drug,0.9497,22413865
57102,glioblastoma,disease,1.0,22413865
57103,vascular endothelial growth factor,gene,0.9976,22374154
57104,VEGF,gene,0.996,22374154
57105,patients,species,0.9507,22374154
57106,neovascular age-related macular degeneration,disease,1.0,22374154
57107,patients,species,0.9854,22374154
57108,VEGF,gene,0.9775,22374154
57109,ranibizumab,gene,0.6357,22374154
57110,bevacizumab,gene,0.833,22374154
57111,aflibercept,gene,0.9683,22374154
57112,VEGF Trap-eye,gene,0.8354,22374154
57113,ranibizumab,gene,0.8843,22374154
57114,bevacizumab,gene,0.742,22374154
57115,ranibizumab,gene,0.781,22374154
57116,bevacizumab,gene,0.498,22374154
57117,ranibizumab,gene,0.884,22374154
57118,bevacizumab,gene,0.715,22374154
57119,VTE,drug,0.7085,22374154
57120,patients,species,0.9897,22374154
57121,bevacizumab,gene,0.8677,22374154
57122,ranibizumab,gene,0.7266,22374154
57123,ranibizumab,gene,0.708,22374154
57124,ranibizumab,gene,0.932,22374154
57125,VEGF,gene,0.912,22374154
57126,VEGF,gene,0.7607,22374154
57127,VEGF,gene,0.8823,22374154
57128,patients,species,0.9883,22374154
57129,VTE,drug,0.7026,22374154
57130,anti-VEGF,gene,0.609,22374154
57131,VEGF,gene,0.9893,22374154
57132,ranibizumab,gene,0.744,22374154
57133,bevacizumab,gene,0.7026,22374154
57134,Aflibercept,gene,0.962,22370387
57135,vemurafenib,drug,0.9937,22370387
57136,Aflibercept,gene,0.936,22354219
57137,age-related macular degeneration,disease,1.0,22354219
57138,vascular endothelial growth factor,gene,0.999,22302382
57139,VEGF,gene,0.9956,22302382
57140,VEGF-A,gene,0.9966,22302382
57141,vascular leak,disease,0.7466,22302382
57142,cancers,disease,1.0,22302382
57143,eye diseases,disease,0.994,22302382
57144,VEGF,gene,0.996,22302382
57145,anti-VEGF antibodies,gene,0.9863,22302382
57146,ranibizumab,gene,0.8623,22302382
57147,bevacizumab,gene,0.8384,22302382
57148,VEGF Trap,gene,0.9893,22302382
57149,aflibercept,gene,0.9937,22302382
57150,VEGF receptors,gene,0.8325,22302382
57151,VEGF Trap,gene,0.968,22302382
57152,human VEGF-A,gene,0.933,22302382
57153,human,species,0.9897,22302382
57154,Ranibizumab,gene,0.936,22302382
57155,bevacizumab,gene,0.828,22302382
57156,human,species,0.9927,22302382
57157,VEGF Trap,gene,0.992,22302382
57158,VEGF-A,gene,0.997,22302382
57159,bevacizumab,gene,0.9385,22302382
57160,ranibizumab,gene,0.7803,22302382
57161,VEGF Trap,gene,0.977,22302382
57162,VEGFR1,gene,0.9946,22302382
57163,VEGFR2,gene,0.9927,22302382
57164,VEGF-A,gene,0.996,22302382
57165,calcium,drug,0.822,22302382
57166,human endothelial cells,cell_type,0.8506,22302382
57167,human,species,0.955,22302382
57168,ranibizumab,gene,0.6343,22302382
57169,VEGF Trap,gene,0.9893,22302382
57170,VEGF-B,gene,0.997,22302382
57171,VEGFR1,gene,0.995,22302382
57172,HUVEC,cell_line,0.7188,22302382
57173,PlGF,gene,0.991,22302382
57174,VEGF Trap,gene,0.9917,22302382
57175,VEGF-A,gene,0.9976,22302382
57176,VEGF-,gene,0.995,22302382
57177,PlGF,gene,0.994,22302382
57178,aflibercept,gene,0.993,22300011
57179,neovascular (wet) age-related macular INTRODUCTION,disease,1.0,22300011
57180,Age-related macular degeneration,disease,1.0,22300011
57181,AMD,disease,1.0,22300011
57182,blindness,disease,0.9966,22300011
57183,vision,disease,0.733,22300011
57184,Vascular endothelial growth factor,gene,0.998,22300011
57185,VEGF,gene,0.996,22300011
57186,VEGF,gene,0.995,22300011
57187,wet AMD,disease,0.955,22300011
57188,aflibercept,gene,0.9775,22300011
57189,human,species,0.995,22300011
57190,VEGF-A,gene,0.9844,22300011
57191,placental growth factor,gene,0.9966,22300011
57192,PGF,gene,0.996,22300011
57193,VEGF receptors,gene,0.996,22300011
57194,aflibercept,gene,0.9717,22300011
57195,wet AMD,disease,0.9946,22300011
57196,aflibercept,gene,0.968,22300011
57197,ranibizumab,gene,0.873,22300011
57198,aflibercept,gene,0.9956,22300011
57199,wet AMD,disease,0.8716,22300011
57200,advanced prostate cancer,disease,1.0,22295041
57201,advanced prostate cancer,disease,1.0,22295041
57202,docetaxel,drug,0.998,22295041
57203,patients,species,0.968,22295041
57204,metastatic castration-resistant prostate cancer,disease,0.9976,22295041
57205,CRPC,disease,1.0,22295041
57206,OS,disease,,22295041
57207,patients,species,0.9663,22295041
57208,advanced prostate cancer,disease,0.999,22295041
57209,taxane,drug,0.998,22295041
57210,cabazitaxel,drug,0.999,22295041
57211,abiraterone acetate,drug,0.9907,22295041
57212,androgen,drug,0.998,22295041
57213,docetaxel,drug,0.998,22295041
57214,receptor activator of nuclear factor B ligand,gene,0.9985,22295041
57215,RANKL,gene,0.9976,22295041
57216,SREs,DNA,0.4937,22295041
57217,zoledronic acid,drug,0.992,22295041
57218,patients,species,0.9775,22295041
57219,bone metastases,disease,0.9995,22295041
57220,CRPC,disease,0.7646,22295041
57221,androgen,drug,1.0,22295041
57222,androgen receptor,gene,0.9927,22295041
57223,MDV3100,drug,0.9995,22295041
57224,androgen,drug,0.998,22295041
57225,thalidomide,drug,0.9995,22295041
57226,lenalidomine,drug,0.999,22295041
57227,aflibercept,gene,0.9404,22295041
57228,tasquinimod,drug,0.9976,22295041
57229,radium-223,drug,0.8545,22295041
57230,PROSTVAC,DNA,0.772,22295041
57231,metastatic prostate cancer,disease,1.0,22295041
57232,metastatic prostate cancer,disease,1.0,22295041
57233,mice,species,0.9272,22281302
57234,hematopoietic stem cell,cell_type,0.8223,22281302
57235,mice,species,0.9136,22281302
57236,vascular endothelial growth factor,gene,0.999,22281302
57237,VEGF,gene,0.997,22281302
57238,VEGF,gene,0.9917,22281302
57239,VEGF,gene,0.992,22281302
57240,epithelial ovarian cancer,disease,1.0,22266932
57241,EOC,disease,1.0,22266932
57242,EOC,disease,1.0,22266932
57243,EOC,disease,0.9956,22266932
57244,EOC,disease,0.9897,22266932
57245,EOC,disease,0.9204,22266932
57246,patient,species,0.9595,22266932
57247,Bevacizumab,gene,0.6323,22266932
57248,anti-vascular endothelial growth factor,gene,0.9585,22266932
57249,VEGF,gene,0.8413,22266932
57250,EOC,disease,0.984,22266932
57251,patient,species,0.957,22266932
57252,bevacizumab,gene,0.818,22266932
57253,aflibercept,gene,0.986,22266932
57254,VEGF Trap,gene,0.991,22266932
57255,VEGF,gene,0.979,22266932
57256,tyrosine,drug,0.968,22266932
57257,tyrosine kinase,gene,0.984,22266932
57258,BIBF 1120,drug,0.9985,22266932
57259,cediranib,drug,0.9995,22266932
57260,pazopanib,drug,0.999,22266932
57261,sorafenib,drug,0.999,22266932
57262,AMG 386,drug,0.8223,22266932
57263,angiopoietin,gene,0.9966,22266932
57264,VEGF,gene,0.995,22266932
57265,hypertension,disease,1.0,22266932
57266,proteinuria,disease,1.0,22266932
57267,thromboses,disease,1.0,22266932
57268,gastrointestinal perforation,disease,1.0,22266932
57269,patients,species,0.9395,22266932
57270,EOC,disease,0.9976,22266932
57271,aflibercept,gene,0.978,22264850
57272,cancer,disease,1.0,22264850
57273,Aflibercept,gene,0.98,22264850
57274,vascular endothelial growth factor (VEGF)-Trap,gene,0.942,22264850
57275,VEGF-A,gene,0.998,22264850
57276,VEGF-B,gene,0.998,22264850
57277,placental growth factor,gene,0.9966,22264850
57278,VEGF,gene,0.9946,22264850
57279,tumor,disease,1.0,22264850
57280,aflibercept,gene,0.9844,22264850
57281,tumor,disease,0.921,22264850
57282,ascites,disease,0.988,22264850
57283,aflibercept,gene,0.973,22264850
57284,cancers,disease,1.0,22264850
57285,aflibercept,gene,0.9717,22264850
57286,aflibercept,gene,0.9814,22264850
57287,patients,species,0.957,22264850
57288,metastatic pancreatic cancer,disease,1.0,22264850
57289,aflibercept,gene,0.976,22264850
57290,FOLFIRI,drug,0.956,22264850
57291,FOLFIRI,drug,0.988,22264850
57292,patients,species,0.947,22264850
57293,metastatic colorectal cancer,disease,0.999,22264850
57294,oxaliplatin,drug,0.9985,22264850
57295,aflibercept,gene,0.972,22264850
57296,advanced epithelial ovarian cancer,disease,1.0,22263801
57297,Epithelial ovarian cancer,disease,1.0,22263801
57298,EOC,disease,1.0,22263801
57299,ovarian cancers,disease,1.0,22263801
57300,patients,species,0.987,22263801
57301,women,species,0.778,22263801
57302,advanced EOC,disease,0.9976,22263801
57303,tumor,disease,0.764,22263801
57304,advanced EOC,disease,0.9976,22263801
57305,patients,species,0.9927,22263801
57306,patients,species,0.993,22263801
57307,EOC,disease,1.0,22263801
57308,patients,species,0.9287,22263801
57309,EOC,disease,0.985,22263801
57310,High-grade EOC,disease,0.9575,22263801
57311,vascular endothelial growth factor,gene,0.999,22263801
57312,VEGF,gene,0.998,22263801
57313,tumor,disease,0.9785,22263801
57314,VEGF protein,gene,0.994,22263801
57315,bevacizumab,gene,0.876,22263801
57316,aflibercept,gene,0.985,22263801
57317,VEGF receptor-2,gene,0.997,22263801
57318,monoclonal antibodies,gene,0.639,22263801
57319,tyrosine,drug,0.983,22263801
57320,tyrosine kinase,gene,0.9077,22263801
57321,cediranib,drug,0.9995,22263801
57322,pazopanib,drug,0.999,22263801
57323,sorafenib,drug,0.9995,22263801
57324,BIBF-1120,drug,0.999,22263801
57325,aflibercept,gene,0.986,22261804
57326,aflibercept,gene,0.9663,22261804
57327,docetaxel,drug,0.996,22261804
57328,patients,species,0.96,22261804
57329,advanced solid,disease,0.898,22261804
57330,tumors,disease,0.575,22261804
57331,patients,species,0.9834,22261804
57332,metastatic or nonresectable cancer,disease,0.7427,22261804
57333,docetaxel,drug,0.9966,22261804
57334,Patients,species,0.979,22261804
57335,aflibercept,gene,0.9844,22261804
57336,docetaxel,drug,0.9985,22261804
57337,the,gene,0.7944,22261804
57338,aflibercept,gene,0.7744,22261804
57339,docetaxel,drug,0.999,22261804
57340,antitumor,disease,0.927,22261804
57341,patients,species,0.9785,22261804
57342,breast cancer,disease,1.0,22261804
57343,neutropenic infection,disease,1.0,22261804
57344,dysphonia,disease,1.0,22261804
57345,hypertension,disease,0.9937,22261804
57346,aflibercept,gene,0.973,22261804
57347,aflibercept,gene,0.9883,22261804
57348,docetaxel,drug,0.9985,22261804
57349,Aflibercept,gene,0.974,22261804
57350,neutropenia,disease,1.0,22261804
57351,leukopenia,disease,1.0,22261804
57352,hypertension,disease,1.0,22261804
57353,stomatitis,disease,1.0,22261804
57354,vascular endothelial growth factor,gene,0.9966,22261804
57355,epistaxis,disease,1.0,22261804
57356,proteinuria,disease,1.0,22261804
57357,dysphonia,disease,1.0,22261804
57358,hypertension,disease,0.9995,22261804
57359,patients,species,0.9795,22261804
57360,patients,species,0.9824,22261804
57361,patients,species,0.963,22261804
57362,aflibercept,gene,0.9795,22261804
57363,Aflibercept,gene,0.9414,22253552
57364,metastatic colorectal cancer,disease,0.999,22253552
57365,Colorectal cancer,disease,1.0,22253552
57366,cancer,disease,1.0,22253552
57367,colorectal cancer,disease,1.0,22253552
57368,Bevacizumab,gene,0.926,22253552
57369,patients,species,0.88,22253552
57370,metastatic colorectal cancer,disease,1.0,22253552
57371,cancer,disease,1.0,22253552
57372,Aflibercept,gene,0.955,22253552
57373,metastatic colorectal cancer,disease,0.9995,22253552
57374,colorectal cancer,disease,1.0,22253552
57375,aflibercept,gene,0.981,22253552
57376,aflibercept,gene,0.989,22229217
57377,vascular endothelial growth factor,gene,0.999,22212972
57378,Vascular endothelial growth factor,gene,0.9985,22212972
57379,VEGF,gene,0.9966,22212972
57380,VEGF families,gene,0.997,22212972
57381,Bevacizumab,gene,0.5347,22212972
57382,VEGF,gene,0.995,22212972
57383,advanced carcinomas,disease,1.0,22212972
57384,exudative age-related macular degeneration,disease,0.999,22212972
57385,diabetic retinopathy,disease,1.0,22212972
57386,retinal vein occlusions,disease,1.0,22212972
57387,retinopathy of prematurity,disease,1.0,22212972
57388,chorioretinal vascular disorders,disease,1.0,22212972
57389,Pegaptanib,drug,0.9824,22212972
57390,ranibizumab,gene,0.6187,22212972
57391,aflibercept,gene,0.9927,22212972
57392,VEGF Trap-Eye,gene,0.868,22212972
57393,thromboembolic events,disease,0.999,22212972
57394,patients,species,0.989,22212972
57395,Patients,species,0.9736,22212972
57396,VEGF,gene,0.9907,22212972
57397,vascular endothelial growth factors,gene,0.998,22212972
57398,VEGF,gene,0.9897,22212972
57399,age-related macular degeneration,disease,1.0,22212972
57400,diabetic retinopathy,disease,1.0,22212972
57401,retina vein occlusions,disease,1.0,22212972
57402,retinopathy of prematurity,disease,1.0,22212972
57403,ranibizumab,gene,0.55,22212972
57404,VEGF Trap,gene,0.836,22212972
57405,castration-resistant prostate cancer,disease,1.0,22209376
57406,metastatic castration-resistant prostate cancer,disease,1.0,22209376
57407,mCRPC,disease,1.0,22209376
57408,abiraterone acetate,drug,0.904,22209376
57409,cabazitaxel,drug,0.996,22209376
57410,MDV,DNA,0.53,22209376
57411,radium-223,drug,0.879,22209376
57412,androgen,drug,0.999,22209376
57413,tubulin,gene,0.996,22209376
57414,bone,disease,0.907,22209376
57415,mCRPC,disease,0.959,22209376
57416,prostate cancer,disease,1.0,22209376
57417,mCRPC,disease,0.9727,22209376
57418,androgen,drug,0.998,22209376
57419,MDV3100,drug,0.9995,22209376
57420,TAK700,drug,0.9966,22209376
57421,Src,gene,0.998,22209376
57422,dasatinib,drug,0.999,22209376
57423,Met,gene,0.9937,22209376
57424,cabozantinib,drug,0.9995,22209376
57425,clusterin,gene,0.9946,22209376
57426,custirsen,drug,0.9995,22209376
57427,aflibercept,gene,0.9814,22209376
57428,tasquinimod,drug,0.9907,22209376
57429,Aflibercept,gene,0.957,24392297
57430,Vascular Endothelial Growth Factor,gene,0.998,24392297
57431,age-related macular degeneration,disease,1.0,24392297
57432,AMD,disease,1.0,24392297
57433,visual loss,disease,1.0,24392297
57434,AMD,disease,1.0,24392297
57435,argon,drug,0.5557,24392297
57436,VEGF,gene,0.9976,24392297
57437,aflibercept,gene,0.99,24392297
57438,VEGF Trap-Eye,gene,0.967,24392297
57439,VEGF,gene,0.908,24392297
57440,neovascular AMD,disease,1.0,24392297
57441,retinal vascular diseases,disease,1.0,24392297
57442,VEGF,gene,0.993,24392297
57443,VEGF,gene,0.778,24392297
57444,neovascular AMD,disease,1.0,24392297
57445,VEGF Trap,gene,0.819,24392297
57446,VEGF-A,gene,0.9956,24392297
57447,placental growth factor,gene,0.9985,24392297
57448,PlGF,gene,0.994,24392297
57449,VEGF Trap,gene,0.903,24392297
57450,neovascular AMD,disease,1.0,24392297
57451,VEGF,gene,0.847,24392297
57452,VEGF,gene,0.9966,24392297
57453,neovascular AMD,disease,1.0,24392297
57454,VEGF,gene,0.983,24392297
57455,patients,species,0.9824,24392297
57456,AMD,disease,1.0,24392297
57457,VEGF Trap,gene,0.808,23461161
57458,age-related macular degeneration,disease,1.0,23461161
57459,central retinal vein occlusion,disease,1.0,23461161
57460,diabetic macular edema,disease,1.0,23461161
57461,choroidal neovascularization,disease,1.0,23461161
57462,pathologic myopia,disease,0.773,23461161
57463,Vascular endothelial growth factor,gene,0.9976,23461161
57464,VEGF,gene,0.9907,23461161
57465,choroidal and retinal neovascularization,disease,1.0,23461161
57466,VEGF,gene,0.9536,23461161
57467,ocular disease,disease,0.9756,23461161
57468,VEGF,gene,0.9927,23461161
57469,macular degeneration,disease,1.0,23461161
57470,central retinal vain occlusion,disease,1.0,23461161
57471,diabetic macular edema,disease,1.0,23461161
57472,choroidal neovascularization,disease,1.0,23461161
57473,aflibercept,gene,0.9795,22192729
57474,malignant ascites,disease,1.0,22192729
57475,VEGF,gene,0.995,22192729
57476,patients,species,0.947,22192729
57477,malignant ovarian ascites,disease,1.0,22192729
57478,aflibercept,gene,0.987,22192729
57479,VEGF,gene,0.9956,22192729
57480,placental growth factor,gene,0.998,22192729
57481,malignant ascites,disease,1.0,22192729
57482,patients,species,0.9556,22192729
57483,advanced chemoresistant ovarian cancer,disease,0.9985,22192729
57484,aflibercept,gene,0.9795,22192729
57485,Patients,species,0.953,22192729
57486,patients,species,0.9863,22192729
57487,patients,species,0.9893,22192729
57488,aflibercept,gene,0.9736,22192729
57489,patients,species,0.9946,22192729
57490,patients,species,0.984,22192729
57491,or,gene,,22192729
57492,aflibercept,gene,0.5254,22192729
57493,aflibercept,gene,0.9863,22192729
57494,aflibercept,gene,0.9873,22192729
57495,patients,species,0.986,22192729
57496,dyspnoea,disease,1.0,22192729
57497,aflibercept,gene,0.9917,22192729
57498,fatigue,disease,0.999,22192729
57499,asthenia,disease,1.0,22192729
57500,dehydration,disease,1.0,22192729
57501,aflibercept,gene,0.991,22192729
57502,intestinal perforations,disease,0.9985,22192729
57503,intestinal fistula,disease,1.0,22192729
57504,sepsis,disease,0.9995,22192729
57505,VEGF,gene,0.9917,22192729
57506,malignant ascites,disease,1.0,22192729
57507,bowel perforation,disease,0.9673,22192729
57508,patients,species,0.992,22192729
57509,cancer,disease,0.999,22192729
57510,VEGF,gene,0.99,22192729
57511,advanced ovarian cancer,disease,1.0,22192729
57512,abdominal carcinomatosis,disease,1.0,22192729
57513,patient,species,0.9536,22192729
57514,VEGF Trap,gene,0.8423,22192728
57515,malignant ascites,disease,1.0,22192728
57516,VEGF-Trap,gene,0.898,22190279
57517,cancer,disease,1.0,22190279
57518,9L gliosarcomas,disease,0.8335,22190279
57519,VEGF-Trap,gene,0.9727,22190279
57520,Vascular Endothelial Growth Factor-A,gene,0.998,22190279
57521,VEGF-A,gene,0.9985,22190279
57522,Placental Growth Factor,gene,0.9966,22190279
57523,PGF,gene,0.9966,22190279
57524,Rats,species,0.9727,22190279
57525,9L tumors,disease,0.9634,22190279
57526,VEGF,DNA,0.471,22190279
57527,VEGF-Trap,gene,0.867,22190279
57528,plasma,cell_type,0.525,22190279
57529,blood plasma,cell_type,0.668,22190279
57530,tumor,disease,0.987,22190279
57531,VEGF-Trap,gene,0.809,22190279
57532,VEGF-Trap,gene,0.814,22190279
57533,tumor,disease,0.759,22190279
57534,VEGF,gene,0.983,22190279
57535,Aflibercept,gene,0.9424,22180543
57536,macular degeneration,disease,1.0,22180543
57537,tumor,disease,1.0,22152931
57538,non-small cell lung cancer,disease,1.0,22152931
57539,NSCLC,disease,1.0,22152931
57540,small cell lung cancer,disease,1.0,22152931
57541,SCLC,disease,1.0,22152931
57542,malignant pleural mesothelioma,disease,1.0,22152931
57543,MM,disease,1.0,22152931
57544,bevacizumab,gene,0.8687,22152931
57545,stage IV non-squamous NSCLC,disease,0.968,22152931
57546,VEGFR,gene,0.974,22152931
57547,cediranib,drug,0.997,22152931
57548,aflibercept,gene,0.96,22152931
57549,vandetanib,drug,0.997,22152931
57550,pazopanib,drug,0.9985,22152931
57551,SCLC,disease,0.9062,22152931
57552,MM,disease,,22152931
57553,bevacizumab,gene,0.892,22152931
57554,bevacizumab,gene,0.7715,22152931
57555,stage IV non-squamous NSCLC,disease,0.9897,22152931
57556,VEGFR,gene,0.9775,22152931
57557,castration-resistant prostate cancer,disease,1.0,22074657
57558,recurrent prostate cancer,disease,1.0,22074657
57559,CaP,disease,1.0,22074657
57560,androgen,drug,0.9976,22074657
57561,castration-resistant prostate cancer,disease,1.0,22074657
57562,CRPC,disease,1.0,22074657
57563,CRPC,disease,0.9976,22074657
57564,cabazitaxel,drug,0.9907,22074657
57565,radium 223,drug,0.8936,22074657
57566,CRPC,disease,0.9976,22074657
57567,MDV3100,drug,0.4714,22074657
57568,TAK 700,drug,0.965,22074657
57569,ipilimumab,gene,0.588,22074657
57570,docetaxel,drug,0.999,22074657
57571,prednisone,drug,0.993,22074657
57572,docetaxel,drug,0.9985,22074657
57573,aflibercept,gene,0.96,22074657
57574,dasatinib,drug,0.993,22074657
57575,lenalidomide,drug,0.992,22074657
57576,custirsen,drug,0.9985,22074657
57577,denosumab,gene,0.5254,22074657
57578,bone metastases,disease,0.9976,22074657
57579,solid tumor malignancies,disease,1.0,22074657
57580,zoledronic acid,drug,0.9976,22074657
57581,aflibercept,gene,0.991,22138373
57582,VEGF Trap,gene,0.947,22138373
57583,patients,species,0.9673,22138373
57584,aflibercept,gene,0.9956,22138373
57585,VEGF Trap,gene,0.9946,22138373
57586,vascular endothelial growth factor isoforms,gene,0.9917,22138373
57587,women,species,0.868,22138373
57588,gynecologic soft tissue sarcoma,disease,1.0,22138373
57589,Patients,species,0.9717,22138373
57590,uterine leiomyosarcoma,disease,1.0,22138373
57591,carcinosarcoma,disease,1.0,22138373
57592,Aflibercept,gene,0.7905,22138373
57593,patients,species,0.984,22138373
57594,uterine leiomyosarcoma,disease,1.0,22138373
57595,patients,species,0.9775,22138373
57596,carcinosarcoma,disease,1.0,22138373
57597,uterine,disease,0.931,22138373
57598,leiomyosarcoma,disease,1.0,22138373
57599,patients,species,0.979,22138373
57600,carcinosarcoma,disease,1.0,22138373
57601,patients,species,0.9727,22138373
57602,patients,species,0.984,22138373
57603,aflibercept,gene,0.9707,22138373
57604,hypertension,disease,1.0,22138373
57605,fatigue,disease,0.9995,22138373
57606,headache,disease,0.9995,22138373
57607,abdominal pain,disease,0.999,22138373
57608,aflibercept,gene,0.979,22138373
57609,patients,species,0.944,22138373
57610,uterine leiomyosarcoma,disease,1.0,22138373
57611,women,species,0.663,22138373
57612,carcinosarcoma,disease,1.0,22138373
57613,Vascular endothelial growth factor,gene,0.9985,22130231
57614,VEGF,gene,0.996,22130231
57615,VEGF receptors,gene,0.9966,22130231
57616,tumor,disease,0.9883,22130231
57617,Vascular endothelial growth factor,gene,0.996,22130231
57618,VEGF,gene,0.9897,22130231
57619,VEGFRs,gene,0.9824,22130231
57620,VEGF family,gene,0.9985,22130231
57621,VEGF-A,gene,0.999,22130231
57622,VEGF,gene,0.996,22130231
57623,VEGF-B,gene,0.999,22130231
57624,VEGF-C,gene,0.999,22130231
57625,VEGF-D,gene,0.999,22130231
57626,placental growth factor,gene,0.997,22130231
57627,PlGF,gene,0.989,22130231
57628,VEGFR subtypes,gene,0.833,22130231
57629,VEGFR,gene,0.9907,22130231
57630,VEGFR-1,gene,0.9976,22130231
57631,VEGFR-2,gene,0.996,22130231
57632,VEGFR-3,gene,0.9966,22130231
57633,platelet-derived growth factor receptors,gene,0.9976,22130231
57634,immunoglobulin-like domains,gene,0.9956,22130231
57635,tyrosine,drug,0.987,22130231
57636,tyrosine kinase domain,gene,0.9927,22130231
57637,VEGF-A,gene,0.9976,22130231
57638,VEGFR-1,gene,0.9985,22130231
57639,VEGFR-2,gene,0.9976,22130231
57640,VEGF-B,gene,0.999,22130231
57641,PlGF,gene,0.988,22130231
57642,VEFGR-1,gene,0.9956,22130231
57643,VEGF-C,gene,0.9976,22130231
57644,VEGF-D,gene,0.999,22130231
57645,VEGFR-3,gene,0.99,22130231
57646,VEGFR-1,gene,0.9976,22130231
57647,fms-like tyrosine kinase-1,gene,0.9985,22130231
57648,Flt-1,gene,0.996,22130231
57649,tumor,disease,0.988,22130231
57650,monocytes,cell_type,0.843,22130231
57651,macrophages,cell_type,0.6787,22130231
57652,VEGFR-2,gene,0.997,22130231
57653,KDR,gene,0.9966,22130231
57654,Flk-1,gene,0.9966,22130231
57655,mice,species,0.992,22130231
57656,tumor,disease,0.998,22130231
57657,VEGFR-3,gene,0.996,22130231
57658,Flt-4,gene,0.995,22130231
57659,VEGF-A,gene,0.998,22130231
57660,VEGFR-2,gene,0.995,22130231
57661,VEGF-A,gene,0.998,22130231
57662,aflibercept,gene,0.993,22130231
57663,VEGF-Trap,gene,0.9956,22130231
57664,VEGFR-1,gene,0.8765,22130231
57665,VEGFR-2,gene,0.9927,22130231
57666,Fc,gene,0.6743,22130231
57667,immunoglobulin G,gene,0.967,22130231
57668,IgG,gene,0.9893,22130231
57669,VEGF-A,gene,0.9966,22130231
57670,tumor,disease,1.0,22130231
57671,VEGFR,gene,0.989,22130231
57672,tyrosine,drug,0.5674,22130231
57673,sunitinib,drug,0.998,22130231
57674,sorafenib,drug,0.999,22130231
57675,tumor,disease,0.504,22130231
57676,VEGFR,gene,0.99,22130231
57677,VEGF,gene,0.9736,22130231
57678,cancer,disease,1.0,22130231
57679,aflibercept,gene,0.971,22112608
57680,advanced epithelial ovarian cancer,disease,1.0,22112608
57681,malignant ascites,disease,1.0,22112608
57682,aflibercept,gene,0.987,22112608
57683,"vascular endothelial growth factor (VEGF) A, B",gene,0.9976,22112608
57684,placental growth factor,gene,0.9976,22112608
57685,PlGF,gene,0.991,22112608
57686,Aflibercept,gene,0.9634,22112608
57687,ascites,disease,0.9995,22112608
57688,tumor,disease,0.9985,22112608
57689,ovarian cancer,disease,1.0,22112608
57690,aflibercept,gene,0.9883,22112608
57691,advanced chemo-resistant epithelial ovarian cancer,disease,0.923,22112608
57692,malignant ascites,disease,1.0,22112608
57693,aflibercept,gene,0.878,22112608
57694,Aflibercept,gene,0.9014,22112608
57695,aflibercept,gene,0.925,22112608
57696,hypertension,disease,1.0,22112608
57697,headache,disease,1.0,22112608
57698,anorexia,disease,1.0,22112608
57699,dysphonia,disease,1.0,22112608
57700,hypertension,disease,0.9995,22112608
57701,weight,disease,0.936,22112608
57702,intestinal perforation,disease,0.999,22112608
57703,Aflibercept,gene,0.7417,22112608
57704,malignant ascites,disease,1.0,22112608
57705,VEGF,gene,0.7476,22112608
57706,non-small-cell lung cancer,disease,1.0,22056889
57707,tumor,disease,1.0,22056889
57708,non-small-cell,disease,1.0,22056889
57709,lung cancer,disease,0.9985,22056889
57710,NSCLC,disease,1.0,22056889
57711,anti-vascular endothelial growth factor,gene,0.921,22056889
57712,VEGF,gene,0.9473,22056889
57713,bevacizumab,gene,0.5054,22056889
57714,advanced NSCLC,disease,0.8154,22056889
57715,bevacizumab,gene,0.862,22056889
57716,NSCLC,disease,1.0,22056889
57717,hemorrhage,disease,0.9976,22056889
57718,venous thromboembolism,disease,1.0,22056889
57719,hypertension,disease,1.0,22056889
57720,proteinuria,disease,1.0,22056889
57721,VEGF,gene,0.996,22056889
57722,aflibercept,gene,0.9927,22056889
57723,VEGF Trap,gene,0.986,22056889
57724,tyrosine,drug,0.9463,22056889
57725,tyrosine kinase,gene,0.984,22056889
57726,tumor,disease,0.8936,22056889
57727,NSCLC,disease,1.0,22056889
57728,bevacizumab,gene,0.946,22056889
57729,aflibercept,gene,0.983,22056889
57730,advanced NSCLC,disease,0.994,22056889
57731,metastatic breast cancer,disease,0.9995,22006669
57732,hormone receptor-positive breast cancer,disease,1.0,22006669
57733,trastuzumab,gene,0.963,22006669
57734,lapatinib,drug,0.997,22006669
57735,human epidermal,cell_line,0.6396,22006669
57736,human epidermal growth factor receptor 2 (HER2)-positive tumors,disease,0.875,22006669
57737,human epidermal growth factor receptor 2,gene,0.9814,22006669
57738,human,species,0.6704,22006669
57739,HER2,gene,0.9893,22006669
57740,metastatic breast cancer,disease,0.9995,22006669
57741,MBC,disease,1.0,22006669
57742,anti-,gene,0.831,22006669
57743,VEGF,gene,0.6743,22006669
57744,vascular endothelial growth factor,gene,0.961,22006669
57745,bevacizumab,gene,0.5967,22006669
57746,MBC,disease,0.996,22006669
57747,HER2,gene,0.997,22006669
57748,pertuzumab,gene,0.9785,22006669
57749,trastuzumab,gene,0.985,22006669
57750,VEGF,gene,0.995,22006669
57751,aflibercept,gene,0.9575,22006669
57752,epidermal growth factor receptor,gene,0.9956,22006669
57753,HER2,gene,0.997,22006669
57754,afatinib,drug,0.9927,22006669
57755,BIBW 2992,drug,0.9966,22006669
57756,neratinib,drug,0.984,22006669
57757,tyrosine,drug,0.9956,22006669
57758,tyrosine kinase,gene,0.993,22006669
57759,sunitinib,drug,0.999,22006669
57760,pazopanib,drug,0.998,22006669
57761,rapamycin,drug,0.9995,22006669
57762,everolimus,drug,0.9995,22006669
57763,poly (ADP-ribose),drug,0.999,22006669
57764,poly (ADP-ribose) polymerase 1,gene,0.9595,22006669
57765,iniparib,drug,0.9834,22006669
57766,olaparib,drug,0.9985,22006669
57767,MBC,disease,0.9956,22006669
57768,patient,species,0.9937,22006669
57769,aflibercept,gene,0.9937,22002018
57770,VEGF,gene,0.998,22002018
57771,cancer,disease,0.903,22002018
57772,Aflibercept,gene,0.937,22002018
57773,vascular endothelial growth factor,gene,0.9976,22002018
57774,VEGF,gene,0.996,22002018
57775,VEGF,gene,0.99,22002018
57776,aflibercept,gene,0.99,22002018
57777,patients,species,0.9556,22002018
57778,advanced solid tumors,disease,0.984,22002018
57779,aflibercept,gene,0.974,22002018
57780,Aflibercept,gene,0.9937,21999177
57781,VEGF-TRAP,gene,0.992,21999177
57782,VEGF,gene,0.93,21999177
57783,vascular endothelial growth factor,gene,0.9985,21999177
57784,VEGF,gene,0.996,21999177
57785,human,species,0.938,21999177
57786,VEGF,gene,0.9956,21999177
57787,tumor,disease,1.0,21999177
57788,exudative age-related macular degeneration,disease,0.9966,21999177
57789,proliferative,disease,0.9062,21999177
57790,diabetic retinopathy,disease,0.914,21999177
57791,retinopathy of prematurity,disease,1.0,21999177
57792,VEGF,gene,0.997,21999177
57793,macular edema,disease,1.0,21999177
57794,VEGF,gene,0.819,21999177
57795,tyrosine,drug,0.9644,21999177
57796,aflibercept,gene,0.985,21999177
57797,VEGF-Trap,gene,0.9937,21999177
57798,VEGF,gene,0.9956,21999177
57799,binding sequences,DNA,0.648,21999177
57800,VEGFR1,gene,0.9746,21999177
57801,VEGFR2,gene,0.994,21999177
57802,Aflibercept,gene,0.957,21999177
57803,tumor,disease,1.0,21999177
57804,choroidal neovascularization,disease,1.0,21999177
57805,aflibercept,gene,0.9565,21999177
57806,patients,species,0.974,21999177
57807,advanced carcinomas,disease,0.9995,21999177
57808,patients,species,0.9473,21999177
57809,aflibercept,gene,0.9937,21999177
57810,irinotecan,drug,0.999,21999177
57811,5-FU,drug,0.999,21999177
57812,metastatic colorectal cancer,disease,1.0,21999177
57813,aflibercept,gene,0.9937,21999177
57814,patients,species,0.956,21999177
57815,exudative age-related macular degeneration,disease,1.0,21999177
57816,ranibizumab,gene,0.9097,21999177
57817,aflibercept,gene,0.983,21999177
57818,retinal vein occlusions,disease,1.0,21999177
57819,diabetic macular edema,disease,1.0,21999177
57820,exudative macular degeneration,disease,1.0,21999177
57821,docetaxel,drug,0.999,21992853
57822,aflibercept,gene,0.9893,21992853
57823,patients,species,0.9653,21992853
57824,recurrent ovarian,disease,0.677,21992853
57825,women,species,0.7314,21992853
57826,ovarian cancer,disease,1.0,21992853
57827,aflibercept,gene,0.995,21992853
57828,docetaxel,drug,0.998,21992853
57829,patients,species,0.9814,21992853
57830,"epithelial ovarian, primary peritoneal, or fallopian tube carcinoma",disease,1.0,21992853
57831,Aflibercept,gene,0.9424,21992853
57832,aflibercept,gene,0.9854,21992853
57833,docetaxel,drug,0.9736,21992853
57834,Patients,species,0.9683,21992853
57835,aflibercept,gene,0.984,21992853
57836,docetaxel,drug,0.9956,21992853
57837,Solid Tumors,disease,0.889,21992853
57838,patients,species,0.987,21992853
57839,aflibercept,gene,0.9917,21992853
57840,docetaxel,drug,0.9966,21992853
57841,aflibercept,gene,0.991,21992853
57842,patients,species,0.9863,21992853
57843,platinum,drug,1.0,21992853
57844,platinum,drug,1.0,21992853
57845,patients,species,0.989,21992853
57846,patients,species,0.9883,21992853
57847,neutropenia,disease,1.0,21992853
57848,patients,species,0.9946,21992853
57849,leucopenia,disease,1.0,21992853
57850,patients,species,0.9937,21992853
57851,fatigue,disease,0.999,21992853
57852,patients,species,0.9873,21992853
57853,dyspnoea,disease,1.0,21992853
57854,patients,species,0.9873,21992853
57855,stomatitis,disease,1.0,21992853
57856,patients,species,0.989,21992853
57857,aflibercept,gene,0.9883,21992853
57858,hypertension,disease,0.9937,21992853
57859,patients,species,0.9927,21992853
57860,proteinuria,disease,0.999,21992853
57861,patient,species,0.985,21992853
57862,aflibercept,gene,0.9956,21992853
57863,docetaxel,drug,0.997,21992853
57864,ovarian cancer,disease,1.0,21992853
57865,Gynecologic Cancer,disease,0.8916,21992853
57866,vascular endothelial growth factor,gene,0.998,21961001
57867,ovarian cancer,disease,1.0,21961001
57868,ovarian cancer,disease,1.0,21961001
57869,gynecologic malignancy,disease,1.0,21961001
57870,Vascular endothelial growth factor,gene,0.998,21961001
57871,VEGF,gene,0.994,21961001
57872,ovarian cancer,disease,1.0,21961001
57873,malignant ascites,disease,1.0,21961001
57874,VEGF,gene,0.989,21961001
57875,VEGF,gene,0.989,21961001
57876,bevacizumab,gene,0.818,21961001
57877,aflibercept,gene,0.9795,21961001
57878,sunitinib,drug,0.9966,21961001
57879,epithelial ovarian cancer,disease,1.0,21961001
57880,Tumor-surrogate blood vessel subtypes,cell_type,0.5923,21937680
57881,VEGF,gene,0.9946,21937680
57882,VEGFR,gene,0.9824,21937680
57883,tumor,disease,0.993,21937680
57884,Tumor,disease,0.7754,21937680
57885,tumor cell,cell_type,0.4595,21937680
57886,VEGF,gene,0.9854,21937680
57887,VEGF,gene,0.9907,21937680
57888,VEGFR,gene,0.992,21937680
57889,Human,species,0.992,21937680
57890,cancers,disease,0.9985,21937680
57891,vascular malformations,disease,1.0,21937680
57892,VM,disease,1.0,21937680
57893,mice,species,0.925,21937680
57894,tumor cells,cell_type,0.616,21937680
57895,tumor,disease,0.9995,21937680
57896,expression vectors,DNA,0.8115,21937680
57897,VEGF-A(164),gene,0.9473,21937680
57898,VEGF,gene,0.976,21937680
57899,Aflibercept,gene,0.9927,21937680
57900,VEGF Trap,gene,0.9814,21937680
57901,VEGF-A(164),gene,0.9473,21937680
57902,VEGF Trap,gene,0.9893,21937680
57903,VEGF-A(164),gene,0.8438,21937680
57904,tumor,disease,0.9756,21937680
57905,MVs,cell_type,0.8467,21937680
57906,endothelial cells,cell_type,0.4575,21937680
57907,VEGFR-2,gene,0.99,21937680
57908,VEGF Trap,gene,0.974,21937680
57909,VMs,disease,0.9995,21937680
57910,FAs,disease,0.9966,21937680
57911,DVs,disease,0.9985,21937680
57912,VEGFR-2,gene,0.9893,21937680
57913,blood vessel subtypes,cell_type,0.5366,21937680
57914,VEGF,gene,0.699,21937680
57915,VEGFR,gene,0.992,21937680
57916,human,species,0.996,21937680
57917,cancers,disease,1.0,21937680
57918,late,cell_type,0.9253,21937680
57919,Aflibercept,gene,0.9795,21880788
57920,VEGF Trap,gene,0.9736,21880788
57921,melanoma,disease,0.995,21880788
57922,Aflibercept,gene,0.8174,21880788
57923,VEGF receptor,gene,0.9297,21880788
57924,melanoma,disease,1.0,21880788
57925,melanoma,disease,0.952,21880788
57926,Aflibercept,gene,0.944,21880788
57927,uveal melanoma,disease,0.8926,21880788
57928,cutaneous,disease,0.544,21880788
57929,hypertension,disease,0.9995,21880788
57930,proteinuria,disease,1.0,21880788
57931,aflibercept,gene,0.9854,21880788
57932,hypertension,disease,0.9727,21880788
57933,aflibercept,gene,0.9775,21880788
57934,Aflibercept,gene,0.5083,21880788
57935,metastatic melanoma,disease,1.0,21880788
57936,aflibercept,gene,0.9795,21880788
57937,choroidal neovascularization,disease,1.0,21825187
57938,VEGF,gene,0.9946,21825187
57939,VEGF Trap,gene,0.9746,21825187
57940,aflibercept,gene,0.994,21825187
57941,choroidal neovascularization,disease,1.0,21825187
57942,CNV,disease,1.0,21825187
57943,VEGF,gene,0.991,21825187
57944,CNV,DNA,0.4744,21825187
57945,cynomolgus monkeys,species,0.88,21825187
57946,VEGF Trap,gene,0.9795,21825187
57947,laser sites,DNA,0.6606,21825187
57948,VEGF Trap,gene,0.956,21825187
57949,VEGF Trap,gene,0.961,21825187
57950,CNV,disease,0.9814,21825187
57951,VEGF Trap,gene,0.8535,21825187
57952,ocular inflammation,disease,0.996,21825187
57953,VEGF Trap,gene,0.975,21825187
57954,VEGF Trap,gene,0.881,21825187
57955,CNV,disease,0.997,21825187
57956,CNV,disease,0.5444,21825187
57957,age-related macular degeneration,disease,1.0,21825187
57958,metastatic colorectal cancer,disease,0.995,21752724
57959,metastatic colorectal cancer,disease,0.9995,21752724
57960,mCRC,disease,1.0,21752724
57961,bevacizumab,gene,0.8335,21752724
57962,cetuximab,gene,0.949,21752724
57963,panitumumab,gene,0.9653,21752724
57964,mCRC,disease,0.977,21752724
57965,aflibercept,gene,0.977,21752724
57966,receptor tyrosine kinase,gene,0.9443,21752724
57967,tyrosine,drug,0.9463,21752724
57968,regorafenib,drug,0.9897,21752724
57969,brivanib,drug,0.9937,21752724
57970,Akt,gene,0.9927,21752724
57971,perifosine,drug,0.966,21752724
57972,mCRC,disease,0.992,21752724
57973,mCRC,disease,0.9575,21752724
57974,castration-resistant prostate cancer,disease,1.0,21748753
57975,prostate cancer,disease,1.0,21748753
57976,castration-resistant prostate cancer,disease,1.0,21748753
57977,CRPC,disease,1.0,21748753
57978,tumor,disease,0.844,21748753
57979,CRPC,disease,0.9946,21748753
57980,CRPC,disease,0.9736,21748753
57981,CRPC,disease,0.9985,21748753
57982,CRPC,disease,0.9956,21748753
57983,androgen,drug,0.999,21748753
57984,abiraterone,drug,0.621,21748753
57985,TAK-700,drug,0.9985,21748753
57986,androgen,drug,1.0,21748753
57987,androgen-receptor,gene,0.991,21748753
57988,MDV3100,drug,0.996,21748753
57989,aflibercept,gene,0.8945,21748753
57990,tasquinimod,drug,0.9883,21748753
57991,endothelin,gene,0.989,21748753
57992,zibotentan,drug,0.998,21748753
57993,atrasentan,drug,0.9985,21748753
57994,Src tyrosine kinase,gene,0.96,21748753
57995,tyrosine,drug,0.948,21748753
57996,dasatinib,drug,0.986,21748753
57997,radium-223,drug,0.8525,21748753
57998,ProstVac,DNA,0.516,21748753
57999,cabazitaxel,drug,0.9995,21748753
58000,taxane,drug,0.997,21748753
58001,RANK-L,gene,0.9966,21748753
58002,CRPC,disease,0.9966,21748753
58003,tumor,disease,1.0,21748753
58004,CRPC,disease,0.997,21748753
58005,nonsmall cell lung cancer,disease,1.0,21740083
58006,vascular endothelial growth factor,gene,0.999,21740083
58007,advanced nonsmall cell lung cancer,disease,0.9355,21740083
58008,aflibercept,gene,0.9775,21740083
58009,tyrosine,drug,0.9976,21740083
58010,tyrosine kinase,gene,0.996,21740083
58011,sorafenib,drug,0.9985,21740083
58012,sunitinib,drug,0.9976,21740083
58013,BIBF 1120,drug,0.995,21740083
58014,bleeding,disease,0.933,21740083
58015,hemorrhage,disease,0.9985,21740083
58016,venous and arterial thromboembolic events,disease,0.9995,21740083
58017,gastrointestinal perforation,disease,1.0,21740083
58018,hypertension,disease,1.0,21740083
58019,proteinuria,disease,1.0,21740083
58020,glioblastoma,disease,1.0,21632852
58021,VEGF,gene,0.894,21632852
58022,aflibercept,gene,0.9478,21632852
58023,VEGF,gene,0.976,21632852
58024,myeloid cells,cell_type,0.7437,21632852
58025,glioblastoma,disease,1.0,21632852
58026,aflibercept,gene,0.9307,21632852
58027,VEGF,gene,0.9976,21632852
58028,placental growth factor,gene,0.9985,21632852
58029,PlGF,gene,0.9927,21632852
58030,recurrent glioblastoma,disease,0.994,21632852
58031,aflibercept,gene,0.9746,21632852
58032,peripheral blood mononuclear cells,cell_type,0.937,21632852
58033,myeloid cells,cell_type,0.9136,21632852
58034,VEGF,gene,0.9937,21632852
58035,aflibercept,gene,0.9653,21632852
58036,PlGF,gene,0.9893,21632852
58037,PlGF,gene,0.987,21632852
58038,CTACK,gene,0.993,21632852
58039,CCL27,gene,0.9766,21632852
58040,MCP3,gene,0.9966,21632852
58041,CCL7,gene,0.96,21632852
58042,MIF,gene,0.986,21632852
58043,IP-10,gene,0.991,21632852
58044,CXCL10,gene,0.9326,21632852
58045,VEGFR1(+) monocytes,cell_line,0.7827,21632852
58046,VEGFR1(,gene,0.986,21632852
58047,Tumor,disease,0.9736,21632852
58048,matrix metalloproteinase 9,gene,0.9946,21632852
58049,VEGF,gene,0.9937,21632852
58050,aflibercept,gene,0.931,21632852
58051,monocyte lineage,cell_type,0.6426,21632852
58052,myeloid cells,cell_type,0.8804,21632852
58053,glioma,disease,1.0,21632852
58054,aflibercept,gene,0.9727,21606416
58055,malignant glioma,disease,1.0,21606416
58056,Brain Tumor,disease,1.0,21606416
58057,recurrent,disease,0.7847,21606416
58058,glioblastoma,disease,0.9307,21606416
58059,aflibercept,gene,0.984,21606416
58060,VEGF Trap,gene,0.9854,21606416
58061,VEGF,gene,0.994,21606416
58062,placental growth factor,gene,0.997,21606416
58063,malignant glioma,disease,0.9844,21606416
58064,PATIENTS,species,0.9395,21606416
58065,glioblastoma,disease,1.0,21606416
58066,anaplastic glioma,disease,1.0,21606416
58067,temozolomide,drug,0.995,21606416
58068,temozolomide,drug,0.9985,21606416
58069,Aflibercept,gene,0.836,21606416
58070,glioblastoma,disease,1.0,21606416
58071,anaplastic glioma,disease,1.0,21606416
58072,glioblastoma,disease,1.0,21606416
58073,anaplastic glioma,disease,1.0,21606416
58074,anaplastic glioma,disease,1.0,21606416
58075,glioblastoma,disease,1.0,21606416
58076,fatigue,disease,1.0,21606416
58077,hypertension,disease,1.0,21606416
58078,lymphopenia,disease,1.0,21606416
58079,CNS ischemias,disease,1.0,21606416
58080,systemic hemorrhage,disease,0.972,21606416
58081,Aflibercept,gene,0.974,21606416
58082,tumor,disease,0.999,21606416
58083,Aflibercept,gene,0.964,21606416
58084,malignant glioma,disease,0.9985,21606416
58085,aflibercept,gene,0.993,21575034
58086,AIM Aflibercept,gene,0.7544,21575034
58087,VEGF-Trap,gene,0.992,21575034
58088,VEGF,gene,0.9946,21575034
58089,cancer,disease,1.0,21575034
58090,aflibercept,gene,0.985,21575034
58091,VEGF,gene,0.995,21575034
58092,aflibercept,gene,0.9556,21575034
58093,aflibercept,gene,0.993,21575034
58094,aflibercept,gene,0.991,21575034
58095,aflibercept,gene,0.991,21575034
58096,aflibercept,gene,0.9927,21575034
58097,VEGF,gene,0.995,21575034
58098,aflibercept,gene,0.9897,21575034
58099,aflibercept,gene,0.968,21575034
58100,aflibercept,gene,0.9907,21575034
58101,aflibercept,gene,0.9907,21575034
58102,aflibercept,gene,0.989,21575034
58103,VEGF,gene,0.996,21575034
58104,neovascular age-related macular degeneration,disease,1.0,21546514
58105,age-related macular degeneration,disease,1.0,21546514
58106,AMD,disease,1.0,21546514
58107,wet-AMD,disease,1.0,21546514
58108,choroidal neovascularisation,disease,1.0,21546514
58109,outer retinal cells,cell_type,0.7983,21546514
58110,retinal pigment epithelium,cell_type,0.548,21546514
58111,RPE,cell_type,0.675,21546514
58112,neovascularisation,disease,0.992,21546514
58113,chronic inflammation of the,disease,1.0,21546514
58114,Vascular endothelial growth factors,gene,0.999,21546514
58115,VEGFs,gene,0.9946,21546514
58116,ranibizumab,gene,0.613,21546514
58117,bevacizumab,gene,0.6216,21546514
58118,VEGF Trap,gene,0.9727,21546514
58119,pegaptanib sodium,drug,0.998,21546514
58120,Pigment epithelium-derived factor,gene,0.9956,21546514
58121,Hepatocyte growth factor,gene,0.992,21546514
58122,HGF,gene,0.9937,21546514
58123,epithelial and endothelial cells,cell_type,0.885,21546514
58124,anti-HGF monoclonal,gene,0.8774,21546514
58125,Platelet-derived growth factor,gene,0.999,21546514
58126,fibroblasts,cell_type,0.8706,21546514
58127,retinal RPE,cell_line,0.581,21546514
58128,retinal RPE cells,cell_type,0.877,21546514
58129,VEGF Trap,gene,0.893,21546514
58130,platelet-derived growth factor-D monoclonal antibody,gene,0.9565,21546514
58131,Fibroblast growth factor-2,gene,0.9976,21546514
58132,anti-FGF antibodies,gene,0.987,21546514
58133,anti-VEGF,gene,0.813,21546514
58134,Tumour necrosis factor alpha,gene,0.9937,21546514
58135,choroidal neovascularisation,disease,1.0,21546514
58136,infliximab,gene,0.911,21546514
58137,wet-AMD,disease,0.9995,21546514
58138,VEGF Trap,gene,0.7666,21546089
58139,diabetic macular edema,disease,1.0,21546089
58140,vascular endothelial growth factor,gene,0.998,21546089
58141,VEGF,gene,0.9956,21546089
58142,diabetic macular edema,disease,1.0,21546089
58143,DME,disease,1.0,21546089
58144,PARTICIPANTS,species,0.538,21546089
58145,diabetic,disease,1.0,21546089
58146,macular edema,disease,1.0,21546089
58147,VEGF,gene,0.9946,21546089
58148,VEGF,gene,0.9976,21546089
58149,VEGF,gene,0.9976,21546089
58150,VEGF,gene,0.996,21546089
58151,VEGF,gene,0.992,21546089
58152,Diabetic,disease,1.0,21546089
58153,Retinopathy,disease,0.9956,21546089
58154,VEGF,gene,0.9834,21546089
58155,VEGF Trap,gene,0.747,21546089
58156,VEGF,gene,0.9927,21546089
58157,VEGF Trap,gene,0.79,21546089
58158,VEGF Trap,gene,0.8813,21546089
58159,VEGF,gene,0.7812,21546089
58160,VEGF Trap,gene,0.746,21546089
58161,DME,disease,1.0,21546089
58162,dopamine-resistant prolactinomas,disease,0.9883,21406548
58163,dopamine,drug,0.4702,21406548
58164,Prolactin-secreting adenomas,disease,1.0,21406548
58165,Prolactin,gene,0.4539,21406548
58166,pituitary tumors,disease,1.0,21406548
58167,dopamine,drug,0.9443,21406548
58168,adenomas,disease,1.0,21406548
58169,dopamine,drug,0.998,21406548
58170,dopamine D2 receptors,gene,0.992,21406548
58171,D2Rs,gene,0.9546,21406548
58172,D2R,gene,0.9863,21406548
58173,Drd2(-/-),gene,0.79,21406548
58174,mice,species,0.9272,21406548
58175,hyperprolactinemia,disease,0.9937,21406548
58176,pituitary hyperplasia,disease,1.0,21406548
58177,dopamine,drug,0.991,21406548
58178,prolactinomas,disease,0.9927,21406548
58179,D2Rs,gene,0.9575,21406548
58180,vascular endothelial growth factor,gene,0.9985,21406548
58181,VEGF,gene,0.9937,21406548
58182,prolactinomas,disease,1.0,21406548
58183,Drd2,DNA,0.527,21406548
58184,Drd2(-/-),gene,0.9585,21406548
58185,mice,species,0.9204,21406548
58186,mVEGF R1,gene,0.9946,21406548
58187,Flt-1,gene,0.9956,21406548
58188,)/,gene,0.9844,21406548
58189,Fc,gene,0.66,21406548
58190,VEGF,gene,0.997,21406548
58191,TRAP,gene,0.5225,21406548
58192,Drd2,DNA,0.459,21406548
58193,Drd2(-/-),gene,0.975,21406548
58194,mice,species,0.9395,21406548
58195,VEGF,gene,0.996,21406548
58196,prolactin,gene,0.9917,21406548
58197,lactotrope,cell_type,0.6245,21406548
58198,tumor,disease,0.5728,21406548
58199,in situ prolactinomas,disease,0.9995,21406548
58200,cluster of differentiation molecule 31,gene,0.986,21406548
58201,proliferating cell nuclear antigen,gene,0.997,21406548
58202,dopamine-resistant prolactinomas,disease,0.691,21406548
58203,dopamine,drug,0.674,21406548
58204,transplanted adenomas,disease,0.648,21406548
58205,VEGF protein,gene,0.9478,21406548
58206,VEGF,gene,0.5967,21406548
58207,mice,species,0.966,21406548
58208,VEGF receptor 2,gene,0.9966,21406548
58209,pituitary adenomas,disease,1.0,21406548
58210,VEGF,gene,0.9946,21406548
58211,dopamine,drug,0.996,21406548
58212,prolactinomas,disease,0.9995,21406548
58213,Aflibercept,gene,0.9863,21380563
58214,B-cell lymphoma,disease,1.0,21380563
58215,Diffuse large B-cell lymphoma,disease,1.0,21380563
58216,lymphomas,disease,1.0,21380563
58217,lymphoma,disease,1.0,21380563
58218,B-cell lymphoma,disease,1.0,21380563
58219,lymphoma cell,cell_line,0.771,21380563
58220,lymphoma,disease,0.9995,21380563
58221,Aflibercept,gene,0.983,21380563
58222,Aflibercept,gene,0.9556,21380563
58223,Aflibercept,gene,0.981,21380563
58224,Aflibercept,gene,0.92,21380563
58225,CHOP,gene,0.848,21380563
58226,Aflibercept,gene,0.9756,21380563
58227,lymphoma cells,cell_line,0.9053,21380563
58228,lymphoma,disease,0.9985,21380563
58229,lymphoma cells,cell_type,0.9263,21380563
58230,lymphoma,disease,0.7886,21380563
58231,B-cell lymphoma,disease,1.0,21380563
58232,Aflibercept,gene,0.978,21380563
58233,lymphoma,disease,1.0,21380563
58234,VEGF,gene,0.9917,21357392
58235,oxygen,drug,0.9995,21357392
58236,retinopathy,disease,0.905,21357392
58237,dog,species,0.816,21357392
58238,vascular endothelial growth factor,gene,0.999,21357392
58239,VEGF,gene,0.995,21357392
58240,neovascularization,disease,0.9995,21357392
58241,NV,disease,0.9985,21357392
58242,canine,species,0.8125,21357392
58243,oxygen-induced retinopathy,disease,0.958,21357392
58244,oxygen,drug,0.9995,21357392
58245,OIR,disease,1.0,21357392
58246,dogs,species,0.8086,21357392
58247,O(2),drug,0.992,21357392
58248,VEGF Trap,gene,0.966,21357392
58249,human FC,gene,0.9746,21357392
58250,hFc,gene,0.9893,21357392
58251,oxygen,drug,1.0,21357392
58252,dogs,species,0.6953,21357392
58253,NV,disease,0.9995,21357392
58254,oxygen,drug,0.9995,21357392
58255,VEGF Trap,gene,0.8867,21357392
58256,hFc,gene,0.958,21357392
58257,retinopathy of prematurity,disease,1.0,21357392
58258,ROP,disease,0.9995,21357392
58259,superficial capillaries,cell_type,0.6035,21357392
58260,VEGF Trap,gene,0.954,21357392
58261,oxygen,drug,0.9995,21357392
58262,VEGF Trap,gene,0.872,21357392
58263,intravitreal NV,disease,0.83,21357392
58264,hFc,gene,0.965,21357392
58265,OIR,disease,0.9995,21357392
58266,VEGF Trap,gene,0.979,21357392
58267,NV,disease,0.998,21357392
58268,VEGF Trap,gene,0.896,21357392
58269,OIR,disease,0.9995,21357392
58270,VEGF Trap,gene,0.976,21357392
58271,NV,disease,0.9814,21357392
58272,NV,disease,0.9985,21357392
58273,VEGF,gene,0.9946,21357392
58274,ROP,disease,0.9995,21357392
58275,cancer,disease,1.0,21196204
58276,cancer,disease,1.0,21196204
58277,tumor,disease,1.0,21196204
58278,cancer,disease,1.0,21196204
58279,cancer,disease,1.0,21196204
58280,VEGF,gene,0.9985,21196204
58281,anti,DNA,0.545,21196204
58282,cancer,disease,1.0,21196204
58283,tumor,disease,1.0,21196204
58284,tumor,disease,0.9756,21196204
58285,tumor,disease,0.9824,21196204
58286,tumor,disease,1.0,21196204
58287,VEGF,gene,0.993,21079419
58288,VEGF Trap,gene,0.9736,21079419
58289,vascular endothelial cell,cell_type,0.9087,21079419
58290,tumors,disease,1.0,21079419
58291,Vascular endothelial growth factor (VEGF) A,gene,0.995,21079419
58292,tumor,disease,1.0,21079419
58293,cancer,disease,0.935,21079419
58294,endothelial cell,cell_type,0.803,21079419
58295,VEGF,gene,0.9966,21079419
58296,mouse,species,0.977,21079419
58297,tumor,disease,1.0,21079419
58298,ERK,gene,0.995,21079419
58299,STAT3,gene,0.9927,21079419
58300,AKT,gene,0.993,21079419
58301,Phospho(p)-ERK,gene,0.9766,21079419
58302,p-STAT3,gene,0.978,21079419
58303,tumor,disease,1.0,21079419
58304,p-AKT,gene,0.9907,21079419
58305,tumor,disease,0.984,21079419
58306,K1735 tumors,cell_line,0.8115,21079419
58307,VEGF,gene,0.991,21079419
58308,p-ERK,gene,0.9897,21079419
58309,p-STAT3,gene,0.989,21079419
58310,p-AKT,gene,0.9775,21079419
58311,K1735,cell_line,0.6987,21079419
58312,Colo-205 tumors,disease,0.868,21079419
58313,VEGF,gene,0.996,21079419
58314,VEGF Trap,gene,0.9805,21079419
58315,aflibercept,gene,0.992,21079419
58316,tumor endothelial,cell_type,0.62,21079419
58317,p-ERK,gene,0.948,21079419
58318,p-STAT3,gene,0.966,21079419
58319,p-AKT,gene,0.996,21079419
58320,endothelial,gene,0.638,21079419
58321,p-ERK,gene,0.8726,21079419
58322,p-STAT3,gene,0.988,21079419
58323,p-AKT,gene,0.9927,21079419
58324,tumor,disease,0.9985,21079419
58325,normal,cell_type,0.4897,21079419
58326,VEGF,gene,0.9937,21079419
58327,vascular endothelial growth factor,gene,0.998,21074022
58328,marmoset,species,0.7373,21074022
58329,vascular endothelial growth factor,gene,0.998,21074022
58330,VEGF,gene,0.9946,21074022
58331,marmosets,species,0.8086,21074022
58332,aflibercept,gene,0.9624,21074022
58333,VEGF,gene,0.9966,21074022
58334,Fc protein,gene,0.956,21074022
58335,progesterone,drug,0.9927,21074022
58336,chorionic gonadotropin,gene,0.9956,21074022
58337,CG,gene,0.9756,21074022
58338,Fc,drug,0.9756,21074022
58339,progesterone,drug,0.9946,21074022
58340,CG,gene,0.94,21074022
58341,aflibercept,gene,0.95,21074022
58342,progesterone,drug,0.995,21074022
58343,CG,gene,0.988,21074022
58344,VEGF,gene,0.995,21074022
58345,progesterone,drug,0.7817,21074022
58346,monoclonal,gene,0.822,21051951
58347,Fc fusion protein,gene,0.937,21051951
58348,AIN-457,drug,0.9785,21051951
58349,bapineuzumab,gene,0.707,21051951
58350,brentuximab vedotin,gene,0.902,21051951
58351,briakinumab,gene,0.5195,21051951
58352,dalotuzumab,gene,0.56,21051951
58353,epratuzumab,gene,0.675,21051951
58354,farletuzumab,gene,0.6606,21051951
58355,girentuximab,gene,0.7446,21051951
58356,WX-G250,gene,0.698,21051951
58357,naptumomab,drug,0.5776,21051951
58358,necitumumab,gene,0.9077,21051951
58359,obinutuzumab,gene,0.8716,21051951
58360,otelixizumab,gene,0.654,21051951
58361,pagibaximab,gene,0.6855,21051951
58362,pertuzumab,gene,0.8447,21051951
58363,REGN88,gene,0.6724,21051951
58364,reslizumab,gene,0.582,21051951
58365,solanezumab,gene,0.4878,21051951
58366,T1h,gene,0.934,21051951
58367,teplizumab,gene,0.4956,21051951
58368,trastuzumab emtansine,gene,0.953,21051951
58369,tremelimumab,gene,0.6343,21051951
58370,vedolizumab,gene,0.554,21051951
58371,Fc,gene,0.985,21051951
58372,aflibercept,gene,0.989,21051951
58373,AMG-386,gene,0.911,21051951
58374,Factor VIII,gene,0.9966,21051951
58375,Factor IX,gene,0.995,21051951
58376,-,DNA,0.4363,21051951
58377,Fc,gene,0.8687,21051951
58378,Fc,gene,0.9644,21051951
58379,Aflibercept,gene,0.9717,20924124
58380,anthracycline,drug,0.9966,20924124
58381,acute myeloid leukemia,disease,1.0,20924124
58382,vascular endothelial growth factor,gene,0.9985,20924124
58383,VEGF,gene,0.9946,20924124
58384,aflibercept,gene,0.9863,20924124
58385,VEGF receptor,gene,0.992,20924124
58386,VEGFR) 1/2,gene,0.772,20924124
58387,VEGF,gene,0.994,20924124
58388,bevacizumab,gene,0.876,20924124
58389,aflibercept,gene,0.9917,20924124
58390,doxorubicin,drug,0.998,20924124
58391,human VEGF-expressing acute myeloid leukemia (AML) cell lines,cell_line,0.962,20924124
58392,VEGF,gene,0.5933,20924124
58393,primary cells,cell_type,0.898,20924124
58394,immunodeficient,disease,0.998,20924124
58395,mice,species,0.972,20924124
58396,Aflibercept,gene,0.958,20924124
58397,VEGF,gene,0.993,20924124
58398,VEGFR,gene,0.9927,20924124
58399,AML,disease,0.9976,20924124
58400,hypoxia,disease,0.8184,20924124
58401,VEGF,gene,0.993,20924124
58402,VEGF-A,gene,0.9946,20924124
58403,AML cells,cell_line,0.817,20924124
58404,AML,disease,0.998,20924124
58405,aflibercept,gene,0.9414,20924124
58406,Aflibercept,gene,0.9487,20924124
58407,AML,disease,0.9985,20924124
58408,leukemia,disease,0.973,20924124
58409,AML,disease,0.7275,20924124
58410,NOD/SCID/IL2R,cell_line,0.6772,20924124
58411,SCID,gene,0.6006,20924124
58412,IL2R,gene,0.8516,20924124
58413,mice,species,0.96,20924124
58414,aflibercept,gene,0.996,20924124
58415,doxorubicin,drug,0.9995,20924124
58416,aflibercept,gene,0.9956,20924124
58417,doxorubicin,drug,0.999,20924124
58418,anthracycline,drug,0.9976,20924124
58419,aflibercept,gene,0.9946,20924124
58420,doxorubicin,drug,0.9995,20924124
58421,leukemia,disease,0.995,20924124
58422,aflibercept,gene,0.992,20924124
58423,anthracycline,drug,0.9966,20924124
58424,AML,disease,1.0,20924124
58425,VEGF,gene,0.9917,20875616
58426,aflibercept,gene,0.9927,20875616
58427,cancer,disease,1.0,20875616
58428,solid tumor,disease,0.9995,20875616
58429,vascular endothelial growth factor-Trap,gene,0.996,20875616
58430,VEGF-Trap,gene,0.996,20875616
58431,aflibercept,gene,0.9946,20875616
58432,VEGF receptor-1,gene,0.998,20875616
58433,VEGF receptor-2,gene,0.9985,20875616
58434,Fc segment,gene,0.754,20875616
58435,immunoglobulin G1,gene,0.9087,20875616
58436,VEGF,gene,0.9966,20875616
58437,tumor,disease,1.0,20875616
58438,VEGF-Trap,gene,0.9595,20875616
58439,tumor,disease,0.9937,20875616
58440,tumor,disease,0.998,20875616
58441,VEGF-Trap,gene,0.895,20875616
58442,VEGF,gene,0.9937,20875616
58443,Trap,gene,0.618,20875616
58444,tumor,disease,0.9937,20875616
58445,solid tumors,disease,1.0,20875616
58446,VEGF,gene,0.989,20875616
58447,VEGF,gene,0.8423,20845250
58448,diabetic macular oedema,disease,1.0,20845250
58449,Diabetic macular edema,disease,1.0,20845250
58450,DME,disease,1.0,20845250
58451,proliferative retinopathy,disease,1.0,20845250
58452,blindness,disease,0.9995,20845250
58453,patients,species,0.8604,20845250
58454,DME,disease,1.0,20845250
58455,ischaemic diabetic maculopathy,disease,1.0,20845250
58456,vascular endothelial growth factor,gene,0.999,20845250
58457,VEGF,gene,0.999,20845250
58458,oedema,disease,1.0,20845250
58459,VEGF antibody fragments,gene,0.7563,20845250
58460,age-associated macular degeneration,disease,1.0,20845250
58461,AMD,disease,1.0,20845250
58462,VEGF,gene,0.7603,20845250
58463,VEGF,gene,0.6562,20845250
58464,Aflibercept,gene,0.9937,20709650
58465,VEGF Trap,gene,0.974,20709650
58466,VEGF,gene,0.9595,20709650
58467,cancer,disease,1.0,20709650
58468,vascular endothelial growth factor,gene,0.9985,20709650
58469,VEGF,gene,0.9976,20709650
58470,cancer,disease,1.0,20709650
58471,cancer,disease,1.0,20709650
58472,cancer,disease,1.0,20709650
58473,VEGF,gene,0.997,20709650
58474,VEGF,gene,0.9976,20709650
58475,hypertension,disease,1.0,20709650
58476,proteinuria,disease,1.0,20709650
58477,thrombosis,disease,1.0,20709650
58478,hemorrhage,disease,1.0,20709650
58479,Aflibercept,gene,0.9634,20709650
58480,VEGF,gene,0.9976,20709650
58481,solid tumors,disease,1.0,20709650
58482,aflibercept,gene,0.9697,20709650
58483,aflibercept,gene,0.992,20709650
58484,VEGF Trap,gene,0.986,20709650
58485,hypertension,disease,1.0,20709650
58486,proteinuria,disease,1.0,20709650
58487,hemorrhage,disease,1.0,20709650
58488,thrombosis,disease,1.0,20709650
58489,[C]RAC,drug,0.9995,20664824
58490,(18)F-Fluoromisonidazole,drug,0.9995,20664824
58491,89-12,drug,0.998,20664824
58492,9-[F],drug,0.9966,20664824
58493,Fluoropropyl-(+)-dihydrotetrabenazine,drug,0.9995,20664824
58494,Adalimumab,gene,0.9097,20664824
58495,Adecatumumab,gene,0.6963,20664824
58496,ADXS-11-001,gene,0.7637,20664824
58497,Aflibercept,gene,0.951,20664824
58498,Agatolimod sodium,drug,0.991,20664824
58499,AGS-004,drug,0.8184,20664824
58500,Alglucosidase,gene,0.6777,20664824
58501,Aliskiren fumarate,drug,0.999,20664824
58502,Alvocidib hydrochloride,drug,0.998,20664824
58503,AMG-108,drug,0.9966,20664824
58504,AMG-853,drug,0.998,20664824
58505,Apixaban,drug,0.999,20664824
58506,Aripiprazole,drug,0.9956,20664824
58507,Armodafinil,drug,0.997,20664824
58508,Atazanavir sulfate,drug,0.992,20664824
58509,Atomoxetine hydrochloride,drug,0.994,20664824
58510,Bevacizumab,gene,0.594,20664824
58511,insulin aspart,gene,0.7856,20664824
58512,Bortezomib,drug,0.9995,20664824
58513,Bosentan,drug,0.998,20664824
58514,Caspofungin acetate,drug,0.998,20664824
58515,Cediranib,drug,0.9995,20664824
58516,Cetuximab,gene,0.865,20664824
58517,Choriogonadotropin alfa,gene,0.995,20664824
58518,Cinacalcet hydrochloride,drug,0.989,20664824
58519,Cizolirtine citrate,drug,0.9985,20664824
58520,Clofarabine,drug,0.998,20664824
58521,Cocaine,drug,0.9995,20664824
58522,CX,drug,0.664,20664824
58523,Darbepoetin alfa,gene,0.9536,20664824
58524,Dasatinib,drug,0.9966,20664824
58525,Decitabine,drug,0.9976,20664824
58526,Denosumab,gene,0.4993,20664824
58527,Desvenlafaxine succinate,drug,0.9966,20664824
58528,Dexamethasone sodium phosphate,drug,0.9985,20664824
58529,Dienogest,drug,0.9985,20664824
58530,Diphencyprone,drug,0.999,20664824
58531,Doripenem,drug,0.998,20664824
58532,Dutasteride,drug,0.9966,20664824
58533,E-7010,drug,0.9937,20664824
58534,Ecallantide,drug,0.936,20664824
58535,Ecstasy,drug,0.999,20664824
58536,Eicosapentaenoic acid,drug,0.9995,20664824
58537,docosahexaenoic acid,drug,0.9995,20664824
58538,Emtricitabine,drug,1.0,20664824
58539,Enfuvirtide,drug,0.782,20664824
58540,Erlotinib hydrochloride,drug,0.993,20664824
58541,Eszopiclone,drug,0.9995,20664824
58542,Etonogestrel,drug,0.999,20664824
58543,ethinyl estradiol,drug,0.9995,20664824
58544,Etoricoxib,drug,0.9995,20664824
58545,Everolimus,drug,0.999,20664824
58546,Everolimus,drug,0.999,20664824
58547,coronary stent,DNA,0.4998,20664824
58548,EVT,DNA,0.528,20664824
58549,Ezetimibe,drug,0.9985,20664824
58550,Ezetimibe,drug,0.999,20664824
58551,simvastatin,drug,0.998,20664824
58552,Ferumoxytol,drug,0.9995,20664824
58553,Fesoterodine fumavate,drug,0.999,20664824
58554,Filgrastim,gene,0.803,20664824
58555,Fingolimod hydrochloride,drug,0.965,20664824
58556,Fluticasone furoate,drug,0.999,20664824
58557,Fluval P,drug,0.9824,20664824
58558,Fluzone,drug,0.9956,20664824
58559,Fondaparinux sodium,drug,0.9565,20664824
58560,Fulvestrant,drug,0.9985,20664824
58561,Fungichromin,drug,0.995,20664824
58562,Gamma-hydroxybutyrate sodium,drug,0.9976,20664824
58563,Gefitinib,drug,0.9985,20664824
58564,GHB-01L1,drug,0.999,20664824
58565,GLY-230,drug,0.998,20664824
58566,GSK-1349572,drug,0.9976,20664824
58567,Hydrocodone bitartrate,drug,0.999,20664824
58568,IC-51,drug,0.9976,20664824
58569,Icatibant acetate,drug,0.996,20664824
58570,Imatinib mesylate,drug,0.998,20664824
58571,Immunoglobulin,gene,0.9937,20664824
58572,Indetanib,drug,0.997,20664824
58573,human insulin,gene,0.7314,20664824
58574,Insulin glargine,gene,0.8984,20664824
58575,Insulin glulisine,gene,0.9375,20664824
58576,Interferon-beta,gene,0.991,20664824
58577,Ispinesib mesylate,drug,0.9946,20664824
58578,Ixabepilone,drug,0.999,20664824
58579,Laromustine,drug,0.9985,20664824
58580,Latanoprost,drug,0.95,20664824
58581,timolol maleate,drug,0.9937,20664824
58582,L-Citrulline,drug,0.998,20664824
58583,Lenalidomide,drug,0.9976,20664824
58584,Linezolid,drug,0.9995,20664824
58585,Lopinavir,drug,0.9995,20664824
58586,ritonavir,drug,0.998,20664824
58587,Lutropin alfa,gene,0.992,20664824
58588,MDX-,gene,0.4954,20664824
58589,MDX-1388,gene,0.6147,20664824
58590,Methoxy polyethylene glycol,drug,0.998,20664824
58591,epoetin-beta,gene,0.9585,20664824
58592,Metreleptin,drug,0.9985,20664824
58593,Micafungin sodium,drug,0.9956,20664824
58594,Mometasone furoate,drug,0.999,20664824
58595,oxymetazoline hydrochloride,drug,0.9976,20664824
58596,Mycophenolic acid sodium salt,drug,0.983,20664824
58597,Nabiximols,drug,0.996,20664824
58598,Natalizumab,gene,0.558,20664824
58599,Nemonoxacin,drug,0.998,20664824
58600,Norelgestromin,drug,0.999,20664824
58601,ethinyl estradiol,drug,0.9976,20664824
58602,Oblimersen sodium,drug,0.976,20664824
58603,Ocriplasmin,drug,0.7036,20664824
58604,Olmesartan medoxomil,drug,0.999,20664824
58605,Omacetaxine mepesuccinate,drug,0.999,20664824
58606,Paclitaxel,drug,0.999,20664824
58607,Pagoclone,drug,0.9966,20664824
58608,Paliperidone,drug,0.9985,20664824
58609,Panitumumab,gene,0.878,20664824
58610,Pazopanib hydrochloride,drug,0.9985,20664824
58611,PCV7,drug,0.8594,20664824
58612,Pegaptanib octasodium,drug,0.9985,20664824
58613,Peginterferon alfa-2a,gene,0.9966,20664824
58614,Peginterferon alfa-2b,gene,0.99,20664824
58615,ribavirin,drug,0.999,20664824
58616,Pegvisomant,drug,0.999,20664824
58617,Pemetrexed disodium,drug,0.9966,20664824
58618,Perifosine,drug,0.999,20664824
58619,Pimecrolimus,drug,0.9995,20664824
58620,Pitavastatin calcium,drug,0.9893,20664824
58621,Plerixafor hydrochloride,drug,0.996,20664824
58622,Plitidepsin,drug,0.9985,20664824
58623,Posaconazole,drug,0.9966,20664824
58624,Pregabalin,drug,0.9995,20664824
58625,Progesterone capriate,drug,0.999,20664824
58626,Raltegravir potassium,drug,0.9863,20664824
58627,Ranelic acid distrontium salt,drug,0.737,20664824
58628,Rasburicase,gene,0.9546,20664824
58629,Recombinant Bet V1,gene,0.9927,20664824
58630,Recombinant human insulin,gene,0.9917,20664824
58631,rhFSH,gene,0.9927,20664824
58632,Rolofylline,drug,0.999,20664824
58633,Romidepsin,drug,0.9966,20664824
58634,Romiplostim,drug,0.8657,20664824
58635,Rosuvastatin,drug,0.9976,20664824
58636,calcium,drug,0.81,20664824
58637,Sapacitabine,drug,0.9995,20664824
58638,Sevelamer carbonate,drug,0.998,20664824
58639,Sinecatechins,drug,0.9995,20664824
58640,Sirolimus,drug,0.4421,20664824
58641,Sitagliptin phosphate monohydrate,drug,0.9995,20664824
58642,SN-29244,drug,0.998,20664824
58643,Sorafenib,drug,0.9966,20664824
58644,Sugammadex sodium,drug,0.941,20664824
58645,Sunitinib malate,drug,0.9985,20664824
58646,Tadalafil,drug,0.9775,20664824
58647,Tafenoquine,drug,0.9985,20664824
58648,Talnetant,drug,0.998,20664824
58649,Tapentadol hydrochloride,drug,0.998,20664824
58650,Tasocitinib citrate,drug,0.999,20664824
58651,Insulin,gene,0.943,20664824
58652,Telcagepant,drug,0.9604,20664824
58653,Tenofovir disoproxil fumarate,drug,0.9985,20664824
58654,Ticagrelor,drug,0.996,20664824
58655,Tigecycline,drug,0.998,20664824
58656,Tiotropium bromide,drug,0.999,20664824
58657,Tipifarnib,drug,0.9976,20664824
58658,TS,drug,0.518,20664824
58659,Ulipristal acetate,drug,0.9946,20664824
58660,Ustekinumab,gene,0.5137,20664824
58661,Vandetanib,drug,0.9995,20664824
58662,Varenicline tartrate,drug,0.9985,20664824
58663,Vicriviroc,drug,0.999,20664824
58664,Voriconazole,drug,0.9995,20664824
58665,Vorinostat,drug,0.9995,20664824
58666,Zoledronic acid monohydrate,drug,0.9956,20664824
58667,Aflibercept,gene,0.9863,20646741
58668,VEGF-Trap,gene,0.9727,20646741
58669,urothelial cancer,disease,0.9453,20646741
58670,Cancer,disease,0.508,20646741
58671,aflibercept,gene,0.9873,20646741
58672,vascular endothelial growth factor isoforms,gene,0.9976,20646741
58673,urothelial cancer,disease,1.0,20646741
58674,advanced urothelial cancer,disease,1.0,20646741
58675,platinum,drug,0.9995,20646741
58676,vascular endothelial growth factor,gene,0.998,20646741
58677,urothelial cancer,disease,1.0,20646741
58678,urothelial cancer,disease,0.996,20646741
58679,platinum,drug,0.9995,20646741
58680,Aflibercept,gene,0.9404,20646741
58681,fatigue,disease,1.0,20646741
58682,hypertension,disease,1.0,20646741
58683,proteinuria,disease,1.0,20646741
58684,pulmonary hemorrhage,disease,1.0,20646741
58685,pain,disease,0.8955,20646741
58686,hyponatremia,disease,1.0,20646741
58687,anorexia,disease,1.0,20646741
58688,lymphopenia,disease,1.0,20646741
58689,CONCLUSIONS,gene,0.4778,20646741
58690,Aflibercept,gene,0.662,20646741
58691,vascular endothelial growth factor,gene,0.9976,20646741
58692,urothelial carcinoma,disease,1.0,20646741
58693,platinum,drug,0.998,20646741
58694,cancer,disease,1.0,20616958
58695,tumors,disease,1.0,20616958
58696,cancer,disease,1.0,20616958
58697,vascular endothelial growth factor,gene,0.997,20616958
58698,VEGF,gene,0.992,20616958
58699,Sunitinib,drug,0.998,20616958
58700,sorafenib,drug,0.9995,20616958
58701,tyrosine,drug,0.968,20616958
58702,tyrosine kinase receptors,gene,0.996,20616958
58703,Thalidomide,drug,0.9976,20616958
58704,basic fibroblast growth factor-2,gene,0.9966,20616958
58705,bFGF,gene,0.9917,20616958
58706,Aflibercept,gene,0.986,20616958
58707,VEGF-trap,gene,0.9893,20616958
58708,VEGF,gene,0.997,20616958
58709,blood vessels,cell_type,0.4548,20616958
58710,cancer,disease,1.0,20616958
58711,vascular endothelial growth factor,gene,0.6084,20593550
58712,Aflibercept,gene,0.916,20593550
58713,platinum,drug,0.9995,20593550
58714,erlotinib,drug,0.9985,20593550
58715,adenocarcinoma of the lung,disease,0.999,20593550
58716,Aflibercept,gene,0.952,20593550
58717,vascular endothelial growth factor,gene,0.998,20593550
58718,VEGF,gene,0.839,20593550
58719,VEGF-A,gene,0.998,20593550
58720,placental growth factor,gene,0.9946,20593550
58721,lung cancer,disease,1.0,20593550
58722,aflibercept,gene,0.9907,20593550
58723,platinum,drug,0.9995,20593550
58724,erlotinib,drug,0.9985,20593550
58725,lung adenocarcinoma,disease,0.995,20593550
58726,platinum,drug,1.0,20593550
58727,erlotinib,drug,0.997,20593550
58728,lung adenocarcinoma,disease,0.9707,20593550
58729,Aflibercept,gene,0.775,20593550
58730,dyspnea,disease,1.0,20593550
58731,hypertension,disease,1.0,20593550
58732,proteinuria,disease,1.0,20593550
58733,hemoptysis,disease,0.9946,20593550
58734,tracheoesophageal fistula,disease,1.0,20593550
58735,cerebral ischemia,disease,1.0,20593550
58736,reversible posterior leukoencephalopathy,disease,1.0,20593550
58737,Aflibercept,gene,0.896,20593550
58738,lung adenocarcinoma,disease,1.0,20593550
58739,aflibercept,gene,0.9854,20593550
58740,lung cancer,disease,1.0,20593550
58741,prostate cancer,disease,1.0,20564864
58742,metastatic prostate cancer,disease,1.0,20564864
58743,advanced prostate cancer,disease,1.0,20564864
58744,MDV3100,drug,0.8423,20564864
58745,Cabazitaxel,drug,0.9976,20564864
58746,Bevacizumab,gene,0.874,20564864
58747,Aflibercept,gene,0.9478,20564864
58748,rat,species,0.99,20538989
58749,choroidal neovascularization,disease,1.0,20538989
58750,CNV,disease,1.0,20538989
58751,age-related macular degeneration,disease,1.0,20538989
58752,AMD,disease,1.0,20538989
58753,choroidal neovascularization,disease,1.0,20538989
58754,CNV,disease,1.0,20538989
58755,CNV,disease,0.9995,20538989
58756,vascular endothelial growth factor,gene,0.9985,20538989
58757,VEGF,gene,0.9985,20538989
58758,CNV,disease,0.984,20538989
58759,inflammation,disease,0.9995,20538989
58760,fibrosis,disease,1.0,20538989
58761,CNV,disease,0.997,20538989
58762,Sprague-Dawley rats,species,0.8037,20538989
58763,CNV,disease,0.9995,20538989
58764,leukocyte,cell_type,0.7734,20538989
58765,collagen,gene,0.9937,20538989
58766,VEGF Trap,gene,0.9814,20538989
58767,VEGF receptors 1 and 2,gene,0.996,20538989
58768,VEGF-A,gene,0.9966,20538989
58769,placental growth factor,gene,0.997,20538989
58770,VEGF Trap,gene,0.983,20538989
58771,CNV,disease,0.999,20538989
58772,CNV,disease,0.9995,20538989
58773,VEGF Trap,gene,0.913,20538989
58774,VEGF Trap,gene,0.9893,20538989
58775,leukocyte,cell_type,0.506,20538989
58776,CNV,disease,0.999,20538989
58777,CNV,disease,1.0,20538989
58778,CNV lesions,disease,0.9995,20538989
58779,VEGF,gene,0.994,20538989
58780,CNV,disease,0.999,20538989
58781,VEGF,gene,0.9966,20538989
58782,VEGF receptor 1,gene,0.998,20538989
58783,CNV,disease,1.0,20538989
58784,inflammation,disease,0.878,20538989
58785,fibrosis,disease,0.996,20538989
58786,(-)-Epigallocatechin gallate,drug,0.9995,20383346
58787,Abafungin,drug,0.903,20383346
58788,ACE-031,drug,0.9937,20383346
58789,Adapalene,drug,0.9985,20383346
58790,benzoyl peroxide,drug,0.9995,20383346
58791,AE-37,drug,0.929,20383346
58792,Aflibercept,gene,0.8774,20383346
58793,Albiglutide,gene,0.522,20383346
58794,Aliskiren fumarate,drug,0.999,20383346
58795,ALT-801,drug,0.9927,20383346
58796,AN-2728,drug,0.8003,20383346
58797,Anacetrapib,drug,0.998,20383346
58798,API,drug,0.9736,20383346
58799,Aprepitant,drug,0.9976,20383346
58800,ARQ-197,drug,0.9766,20383346
58801,Ascorbic acid,drug,0.998,20383346
58802,Atazanavir sulfate,drug,0.9834,20383346
58803,ATN-224,drug,0.997,20383346
58804,AVI-4658,drug,0.999,20383346
58805,Azacitidine,drug,0.999,20383346
58806,Azelnidipine,drug,0.998,20383346
58807,Belinostat,drug,0.995,20383346
58808,Bevacizumab,gene,0.835,20383346
58809,BI-2536,drug,0.997,20383346
58810,Bortezomib,drug,0.9995,20383346
58811,Bovine lactoferrin,gene,0.985,20383346
58812,Bovine,species,0.9053,20383346
58813,Bryostatin 1,drug,0.881,20383346
58814,Budesonide,drug,0.9985,20383346
58815,formoterol fumarate,drug,0.997,20383346
58816,Canfosfamide hydrochloride,drug,0.998,20383346
58817,Cediranib,drug,0.9995,20383346
58818,Clofarabine,drug,0.999,20383346
58819,Cocaine,drug,0.9995,20383346
58820,Darbepoetin alfa,gene,0.9775,20383346
58821,Dasatinib,drug,0.9985,20383346
58822,Denosumab,gene,0.5283,20383346
58823,Doripenem,drug,0.9946,20383346
58824,Dovitinib Lactate,drug,0.9976,20383346
58825,Dronedarone hydrochloride,drug,0.997,20383346
58826,Drospirenone,drug,0.9995,20383346
58827,estradiol,drug,0.9995,20383346
58828,Dutasteride,drug,0.998,20383346
58829,Entinostat,drug,0.9927,20383346
58830,Enzastaurin hydrochloride,drug,0.996,20383346
58831,Erlotinib hydrochloride,drug,0.9966,20383346
58832,Everolimus,drug,0.997,20383346
58833,Exenatide,gene,0.6655,20383346
58834,Ezetimibe,drug,0.997,20383346
58835,Ezetimibe,drug,0.9985,20383346
58836,simvastatin,drug,0.998,20383346
58837,Fampridine,drug,0.9966,20383346
58838,Fenretinide,drug,0.999,20383346
58839,FFR,gene,0.5293,20383346
58840,factor VIIa,gene,0.927,20383346
58841,Fingolimod hydrochloride,drug,0.9883,20383346
58842,Frovatriptan,drug,0.99,20383346
58843,Gefitinib,drug,0.999,20383346
58844,Gimatecan,drug,0.9995,20383346
58845,GP-2,gene,0.9897,20383346
58846,GM-CSF,gene,0.9937,20383346
58847,Iloperidone,drug,0.9976,20383346
58848,Imatinib mesylate,drug,0.9985,20383346
58849,Ivabradine hydrochloride,drug,0.997,20383346
58850,Lactobacillus,species,0.549,20383346
58851,Lapatinib ditosylate,drug,0.9985,20383346
58852,LC-07,drug,0.9976,20383346
58853,Lenalidomide,drug,0.9985,20383346
58854,Linifanib,drug,0.998,20383346
58855,doxorubicin,drug,0.979,20383346
58856,vincristine,drug,0.9917,20383346
58857,Litenimod,drug,0.9995,20383346
58858,Lutein,drug,0.997,20383346
58859,M-,drug,0.767,20383346
58860,MDX-1401,drug,0.994,20383346
58861,MEDI-528,drug,0.7544,20383346
58862,Midostaurin,drug,0.997,20383346
58863,Miglustat,drug,0.985,20383346
58864,MK-0657,drug,0.996,20383346
58865,Natalizumab,gene,0.565,20383346
58866,Nesiritide,gene,0.5557,20383346
58867,NGR-TNF,gene,0.964,20383346
58868,Niacin,drug,0.9995,20383346
58869,simvastatin,drug,0.999,20383346
58870,Obatoclax mesylate,drug,0.9834,20383346
58871,Olaparib,drug,0.998,20383346
58872,Omacetaxine mepesuccinate,drug,0.998,20383346
58873,Paclitaxel,drug,0.9995,20383346
58874,Paclitaxel,drug,0.9995,20383346
58875,Palonosetron hydrochloride,drug,0.997,20383346
58876,Pazopanib hydrochloride,drug,0.9976,20383346
58877,Pegfilgrastim,gene,0.9004,20383346
58878,Pemetrexed disodium,drug,0.999,20383346
58879,PER,drug,0.558,20383346
58880,Perifosine,drug,0.9985,20383346
58881,PF-02341066,drug,0.999,20383346
58882,Pimecrolimus,drug,0.9985,20383346
58883,Pitrakinra,drug,0.98,20383346
58884,Plerixafor hydrochloride,drug,0.997,20383346
58885,Posaconazole,drug,0.992,20383346
58886,Rasburicase,gene,0.983,20383346
58887,human relaxin H2,gene,0.991,20383346
58888,ReoT3D,gene,0.772,20383346
58889,Retaspimycin hydrochloride,drug,0.9966,20383346
58890,Riferminogene,drug,0.9917,20383346
58891,Rindopepimut,drug,0.998,20383346
58892,Romiplostim,drug,0.9814,20383346
58893,Ronacaleret hydrochloride,drug,0.9814,20383346
58894,Rosuvastatin calcium,drug,0.971,20383346
58895,Rotigotine,drug,0.9985,20383346
58896,Sagopilone,drug,0.999,20383346
58897,sALP-FcD10,gene,0.961,20383346
58898,SAR-245409,drug,0.999,20383346
58899,SCH-697243,drug,0.998,20383346
58900,Selumetinib,drug,0.9995,20383346
58901,Sirolimus,drug,1.0,20383346
58902,SIR,drug,0.5386,20383346
58903,Sitagliptin phosphate monohydrate,drug,0.9995,20383346
58904,Sitaxentan sodium,drug,0.999,20383346
58905,Sorafenib,drug,0.9976,20383346
58906,Sunitinib malate,drug,0.9985,20383346
58907,Tadalafil,drug,0.9956,20383346
58908,Tandutinib,drug,0.9844,20383346
58909,Tasimelteon,drug,0.9937,20383346
58910,Temsirolimus,drug,0.998,20383346
58911,Teriparatide,drug,0.7896,20383346
58912,Tiotropium bromide,drug,0.9985,20383346
58913,TIV,drug,0.8096,20383346
58914,Trabectedin,drug,0.999,20383346
58915,TRU,drug,0.8574,20383346
58916,Vadimezan,drug,0.9976,20383346
58917,Val8,drug,0.8438,20383346
58918,Val8-GLP-,gene,0.9707,20383346
58919,Vandetanib,drug,0.999,20383346
58920,Vernakalant hydrochloride,drug,0.9946,20383346
58921,Voreloxin,drug,0.999,20383346
58922,Voriconazole,drug,0.999,20383346
58923,Vorinostat,drug,0.9995,20383346
58924,Yttrium 90,drug,0.98,20383346
58925,90Y,drug,0.984,20383346
58926,ibritumomab tiuxetan,drug,0.8286,20383346
58927,Zeaxanthin,drug,0.999,20383346
58928,Ziprasidone hydrochloride,drug,0.9976,20383346
58929,Zosuquidar trihydrochloride,drug,0.998,20383346
58930,Docetaxel,drug,0.9995,20351071
58931,castration-resistant prostate cancer,disease,0.9995,20351071
58932,metastatic prostate cancer,disease,1.0,20351071
58933,docetaxel,drug,0.9976,20351071
58934,bisphosphonates,drug,0.996,20351071
58935,docetaxel,drug,0.9976,20351071
58936,docetaxel,drug,0.999,20351071
58937,castration-resistant prostate cancer,disease,1.0,20351071
58938,CRPC,disease,1.0,20351071
58939,docetaxel,drug,0.9985,20351071
58940,prostate,cell_type,0.4194,20351071
58941,docetaxel,drug,0.9985,20351071
58942,CRPC,disease,0.991,20351071
58943,tyrosine,drug,0.9536,20351071
58944,tyrosine kinase,gene,0.991,20351071
58945,BCL-2,gene,0.995,20351071
58946,vitamin D,drug,0.9995,20351071
58947,prostate-specific antigen,gene,0.9966,20351071
58948,tumor,disease,1.0,20351071
58949,docetaxel,drug,0.9985,20351071
58950,docetaxel,drug,0.999,20351071
58951,bevacizumab,gene,0.9424,20351071
58952,aflibercept,gene,0.9805,20351071
58953,dasatinib,drug,0.9873,20351071
58954,zibotentan,drug,0.9995,20351071
58955,atrasentan,drug,0.999,20351071
58956,lenalidomide,drug,0.9937,20351071
58957,Docetaxel,drug,0.9995,20351071
58958,CRPC,disease,0.9946,20351071
58959,docetaxel,drug,0.999,20351071
58960,ovarian cancer,disease,1.0,20226736
58961,epithelial ovarian cancer,disease,1.0,20226736
58962,ovarian and other malignancies,disease,1.0,20226736
58963,ovarian cancer,disease,1.0,20226736
58964,angiogenic neoplasms,disease,0.712,20226736
58965,ovarian cancer,disease,1.0,20226736
58966,vascular endothelial growth factor,gene,0.9976,20210371
58967,age-related macular degeneration,disease,1.0,20210371
58968,cancer,disease,1.0,20210371
58969,age-related macular degeneration,disease,1.0,20210371
58970,AMD,disease,1.0,20210371
58971,psoriasis,disease,1.0,20210371
58972,rheumatoid arthritis,disease,1.0,20210371
58973,diabetic,disease,1.0,20210371
58974,retinopathy,disease,0.932,20210371
58975,Vascular endothelial growth factor,gene,0.9985,20210371
58976,VEGF,gene,0.9937,20210371
58977,AMD,disease,1.0,20210371
58978,diabetic retinopathy,disease,1.0,20210371
58979,cancer,disease,1.0,20210371
58980,AMD,disease,1.0,20210371
58981,disease of the macula,disease,0.9385,20210371
58982,blindness,disease,0.9917,20210371
58983,AMD,disease,1.0,20210371
58984,AMD,disease,0.9995,20210371
58985,neovascular AMD,disease,1.0,20210371
58986,VEGF,gene,0.993,20210371
58987,VEGF,gene,0.9873,20210371
58988,RNA aptamer,RNA,0.5947,20210371
58989,pegaptanib,drug,0.9297,20210371
58990,ranibizumab,gene,0.715,20210371
58991,bevacizumab,gene,0.787,20210371
58992,VEGF receptor,gene,0.981,20210371
58993,aflibercept,gene,0.9546,20210371
58994,small interfering RNA,RNA,0.639,20210371
58995,AGN 211745,drug,0.998,20210371
58996,sirolimus,drug,0.997,20210371
58997,tyrosine,drug,0.9966,20210371
58998,tyrosine kinase,gene,0.991,20210371
58999,vatalanib,drug,0.9956,20210371
59000,pazopanib,drug,0.9976,20210371
59001,TG 100801,drug,0.993,20210371
59002,TG 101095,drug,0.991,20210371
59003,AG 013958,drug,0.9927,20210371
59004,AL 39324,drug,0.9966,20210371
59005,vision,disease,0.6753,20210371
59006,neovascular AMD,disease,1.0,20210371
59007,AMD,disease,1.0,20210371
59008,vision,disease,0.8,20210371
59009,VEGF,gene,0.995,20210371
59010,[Methoxy-(11)C]PD-153035,drug,0.9995,20140276
59011,2-Methoxyestradiol,drug,0.9995,20140276
59012,Adalimumab,gene,0.848,20140276
59013,Adecatumumab,gene,0.6753,20140276
59014,Adefovir dipivoxil,drug,0.995,20140276
59015,ADH-,gene,0.805,20140276
59016,Aflibercept,gene,0.942,20140276
59017,AIR-human growth hormone,gene,0.983,20140276
59018,Aliskiren fumarate,drug,0.998,20140276
59019,AMG-221,drug,0.855,20140276
59020,Amlodipine besylate,drug,0.997,20140276
59021,olmesartan medoxomil,drug,0.998,20140276
59022,Aprepitant,drug,0.998,20140276
59023,Bavituximab,gene,0.572,20140276
59024,Bevacizumab,gene,0.8677,20140276
59025,Bexarotene,drug,0.9946,20140276
59026,BIBW-2992,drug,0.999,20140276
59027,BMS-690514,drug,0.9995,20140276
59028,Bortezomib,drug,0.9995,20140276
59029,Bosentan,drug,0.9985,20140276
59030,Briakinumab,gene,0.6265,20140276
59031,Capecitabine,drug,0.999,20140276
59032,Certolizumab,drug,0.538,20140276
59033,Cetuximab,gene,0.783,20140276
59034,Cholecalciferol,drug,0.9995,20140276
59035,Choline fenofibrate,drug,0.982,20140276
59036,Chorionic gonadotropin,gene,0.989,20140276
59037,Cixutumumab,gene,0.5083,20140276
59038,Clopidogrel,drug,0.9985,20140276
59039,CP-690550 citrate,drug,0.9136,20140276
59040,Dabigatran,drug,0.998,20140276
59041,Dacetuzumab,gene,0.63,20140276
59042,Dapagliflozin,drug,0.997,20140276
59043,Darbepoetin alfa,gene,0.9785,20140276
59044,Dasatinib,drug,0.9976,20140276
59045,Denosumab,gene,0.7324,20140276
59046,Efavirenz,drug,0.999,20140276
59047,Elisidepsin,drug,0.988,20140276
59048,Enzastaurin hydrochloride,drug,0.9956,20140276
59049,Eribulin mesilate,drug,0.991,20140276
59050,Erlotinib hydrochloride,drug,0.997,20140276
59051,Everolimus,drug,0.998,20140276
59052,Exenatide,gene,0.871,20140276
59053,Fenobam,drug,0.994,20140276
59054,Figitumumab,gene,0.5044,20140276
59055,Filibuvir,drug,0.9937,20140276
59056,Fondaparinux sodium,drug,0.994,20140276
59057,Gefitinib,drug,0.997,20140276
59058,Golimumab,gene,0.541,20140276
59059,Ifosfamide,drug,0.9966,20140276
59060,Imatinib mesylate,drug,0.9985,20140276
59061,Ipilimumab,gene,0.5757,20140276
59062,Ivabradine hydrochloride,drug,0.998,20140276
59063,Ixabepilone,drug,0.9985,20140276
59064,Lapatinib ditosylate,drug,0.999,20140276
59065,Lenalidomide,drug,0.999,20140276
59066,Levocetirizine dihydrochloride,drug,0.999,20140276
59067,vincristine,drug,0.952,20140276
59068,Liraglutide,gene,0.856,20140276
59069,M-118,drug,0.8926,20140276
59070,Masitinib mesylate,drug,0.999,20140276
59071,Metformin hydrochloride,drug,0.9985,20140276
59072,Micafungin sodium,drug,0.996,20140276
59073,Moxifloxacin hydrochloride,drug,0.999,20140276
59074,Neratinib,drug,0.9995,20140276
59075,Oblimersen sodium,drug,0.9746,20140276
59076,Olmesartan medoxomil,drug,0.999,20140276
59077,Paclitaxel,drug,0.9995,20140276
59078,Palifosfamide lysine,drug,0.996,20140276
59079,Panobinostat,drug,0.9985,20140276
59080,Patupilone,drug,0.9976,20140276
59081,Peginterferon alfa-2a,gene,0.9937,20140276
59082,Pegylated arginine,drug,0.796,20140276
59083,Piclozotan hydrochloride hydrate,drug,0.9976,20140276
59084,Pixantrone maleate,drug,0.999,20140276
59085,Prasterone,drug,0.9966,20140276
59086,Prasugrel,drug,0.9985,20140276
59087,Prednisone,drug,0.999,20140276
59088,Progesterone,drug,0.997,20140276
59089,Prucalopride,drug,0.999,20140276
59090,pVGI,DNA,0.8296,20140276
59091,VEGF-2,gene,0.661,20140276
59092,Retigabine,drug,0.999,20140276
59093,rhFSH,gene,0.9946,20140276
59094,Rituximab,gene,0.8896,20140276
59095,Rivaroxaban,drug,0.998,20140276
59096,Rosuvastatin,drug,0.9985,20140276
59097,calcium,drug,0.9995,20140276
59098,Salinosporamide A,drug,0.9995,20140276
59099,Selumetinib,drug,0.999,20140276
59100,Somatropin,gene,0.9634,20140276
59101,Sorafenib,drug,0.9956,20140276
59102,SSR-244738,drug,0.9985,20140276
59103,Sunitinib malate,drug,0.9985,20140276
59104,Tamoxifen citrate,drug,0.9985,20140276
59105,Telavancin hydrochloride,drug,0.988,20140276
59106,Telmisartan,drug,0.999,20140276
59107,Telmisartan,drug,0.999,20140276
59108,amlodipine,drug,0.998,20140276
59109,Telmisartan,drug,0.9985,20140276
59110,hydrochlorothiazide,drug,0.9985,20140276
59111,Temsirolimus,drug,0.999,20140276
59112,Tenofovir disoproxil fumarate,drug,0.999,20140276
59113,Tipifarnib,drug,0.9985,20140276
59114,Tolvaptan,drug,0.9956,20140276
59115,Trastuzumab,gene,0.854,20140276
59116,Trastuzumab,gene,0.957,20140276
59117,MCC-DM1,gene,0.6875,20140276
59118,Travoprost,drug,0.9805,20140276
59119,Valsartan,drug,0.9995,20140276
59120,amlodipine besylate,drug,0.999,20140276
59121,Valsartan,drug,0.999,20140276
59122,amlodipine besylate,drug,0.9985,20140276
59123,hydrochlorothiazide,drug,0.998,20140276
59124,Valsartan,drug,0.9995,20140276
59125,hydrochlorothiazide,drug,0.999,20140276
59126,Vandetanib,drug,0.999,20140276
59127,Vorinostat,drug,0.9985,20140276
59128,Thrombospondin-1,gene,0.9937,20080874
59129,follicular atresia,disease,1.0,20080874
59130,Thrombospondin-1,gene,0.998,20080874
59131,TSP-1,gene,0.99,20080874
59132,TSP-1,gene,0.9863,20080874
59133,preantral/early antral follicles,cell_type,0.716,20080874
59134,rat,species,0.977,20080874
59135,TSP-1,gene,0.9946,20080874
59136,follicles,cell_type,0.524,20080874
59137,caspase-3,gene,0.863,20080874
59138,granulosa cells,cell_type,0.859,20080874
59139,TSP-1,gene,0.9893,20080874
59140,follicular,cell_type,0.4836,20080874
59141,TSP-1,gene,0.993,20080874
59142,granulosa cells,cell_type,0.8223,20080874
59143,granulosa cells,cell_type,0.828,20080874
59144,TSP-1,gene,0.995,20080874
59145,caspase-3/7,gene,0.981,20080874
59146,TSP-1,gene,0.9883,20080874
59147,granulosa cells,cell_type,0.884,20080874
59148,TSP-1,gene,0.9927,20080874
59149,TSP-1,gene,0.9897,20080874
59150,granulosa cells,cell_type,0.913,20080874
59151,abnormal follicles,cell_type,0.607,20080874
59152,polycystic ovary syndrome,disease,1.0,20080874
59153,aflibercept,gene,0.978,20028764
59154,advanced solid tumors,disease,0.989,20028764
59155,vascular endothelial growth factor Trap,gene,0.5317,20028764
59156,aflibercept,gene,0.9907,20028764
59157,advanced solid tumors,disease,0.9688,20028764
59158,aflibercept,gene,0.946,20028764
59159,aflibercept,gene,0.98,20028764
59160,aflibercept,gene,0.8564,20028764
59161,proteinuria,disease,1.0,20028764
59162,fatigue,disease,1.0,20028764
59163,nausea,disease,0.9995,20028764
59164,myalgia,disease,1.0,20028764
59165,anorexia,disease,1.0,20028764
59166,hypertension,disease,1.0,20028764
59167,voice hoarseness,disease,1.0,20028764
59168,dehydration,disease,1.0,20028764
59169,cerebral ischemia,disease,1.0,20028764
59170,proteinuria,disease,1.0,20028764
59171,hypertension,disease,1.0,20028764
59172,leukopenia,disease,1.0,20028764
59173,pulmonary embolism,disease,0.8916,20028764
59174,aflibercept,gene,0.9766,20028764
59175,vascular endothelial growth factor,gene,0.998,20028764
59176,antiaflibercept antibodies,gene,0.981,20028764
59177,aflibercept,gene,0.9536,20028764
59178,antitumor,disease,0.8516,20028764
59179,anastomotic complications,disease,0.9927,19953576
59180,vascular endothelial growth factor,gene,0.9985,19953576
59181,VEGF,gene,0.9966,19953576
59182,bevacizumab,gene,0.8823,19953576
59183,aflibercept,gene,0.968,19953576
59184,aflibercept,gene,0.9775,19953576
59185,bevacizumab,gene,0.852,19953576
59186,gastrointestinal anastomotic complications,disease,0.9004,19953576
59187,rectal cancer,disease,1.0,19953576
59188,vascular endothelial growth factor,gene,0.514,19949018
59189,aflibercept,gene,0.9595,19949018
59190,advanced solid tumors,disease,0.988,19949018
59191,Vascular endothelial growth factor,gene,0.9956,19949018
59192,VEGF,gene,0.884,19949018
59193,aflibercept,gene,0.992,19949018
59194,human VEGF receptors 1 and 2,gene,0.9717,19949018
59195,human immunoglobulin G,gene,0.993,19949018
59196,VEGF Trap,gene,0.6035,19949018
59197,PATIENTS,species,0.9316,19949018
59198,solid tumors,disease,1.0,19949018
59199,non-Hodgkin's lymphoma,disease,1.0,19949018
59200,VEGF,gene,0.8657,19949018
59201,VEGF Trap,gene,0.973,19949018
59202,VEGF Trap,gene,0.978,19949018
59203,tumor,disease,0.818,19949018
59204,rectal ulceration,disease,1.0,19949018
59205,proteinuria,disease,1.0,19949018
59206,hypertension,disease,1.0,19949018
59207,VEGF Trap,gene,0.9653,19949018
59208,VEGF Trap,gene,0.979,19949018
59209,VEGF,gene,0.9946,19949018
59210,VEGF Trap,gene,0.966,19949018
59211,VEGF Trap,gene,0.9326,19949018
59212,VEGF,gene,0.991,19949018
59213,vascular endothelial growth factor,gene,0.998,19949005
59214,cancer,disease,1.0,19789343
59215,VEGF,gene,0.997,19789343
59216,estrogen,drug,0.9985,19789343
59217,K14,gene,0.4717,19789343
59218,HPV16,species,0.7104,19789343
59219,mice,species,0.9507,19789343
59220,premalignancy,disease,1.0,19789343
59221,dysplasia,disease,1.0,19789343
59222,stromal,cell_line,0.6187,19789343
59223,stromal inflammatory cells,cell_type,0.879,19789343
59224,cervical carcinogenesis,disease,0.9272,19789343
59225,estrogen,drug,0.9995,19789343
59226,K14,gene,0.4976,19789343
59227,-HPV16,DNA,0.4465,19789343
59228,HPV16,species,0.695,19789343
59229,mice,species,0.972,19789343
59230,premalignant dysplastic,disease,0.839,19789343
59231,mice,species,0.9707,19789343
59232,mice,species,0.9575,19789343
59233,vascular endothelial growth factor,gene,0.6255,19789343
59234,mice,species,0.952,19789343
59235,mice,species,0.9834,19789343
59236,cervical dysplasia,disease,1.0,19789343
59237,premalignant cervical dysplasia,disease,1.0,19789343
59238,vascular endothelial growth factor,gene,0.9976,19754219
59239,cancer,disease,1.0,19754219
59240,vascular endothelial growth factor,gene,0.998,19754219
59241,VEGF,gene,0.9956,19754219
59242,cancer,disease,1.0,19754219
59243,VEGF family members,gene,0.9424,19754219
59244,VEGF-A,gene,0.998,19754219
59245,VEGF,gene,0.9937,19754219
59246,anti-VEGF antibody,gene,0.9487,19754219
59247,solid cancers,disease,1.0,19754219
59248,"colorectal, lung, and breast cancers",disease,1.0,19754219
59249,glioblastoma,disease,1.0,19754219
59250,renal cell carcinoma,disease,1.0,19754219
59251,bevacizumab,gene,0.915,19754219
59252,colorectal cancer,disease,1.0,19754219
59253,Bevacizumab,gene,0.9424,19754219
59254,growth factor receptor kinase,gene,0.941,19754219
59255,erlotinib,drug,0.973,19754219
59256,bevacizumab,gene,0.668,19754219
59257,VEGF,gene,0.993,19754219
59258,IMC-18F1,gene,0.9556,19754219
59259,VEGF receptors,gene,0.9297,19754219
59260,VEGFR-2,gene,0.9673,19754219
59261,VEGFR-1,gene,0.9946,19754219
59262,Aflibercept,gene,0.9897,19754219
59263,VEGF-Trap,gene,0.9927,19754219
59264,VEGF ligand,gene,0.9854,19754219
59265,VEGF,gene,0.852,19754219
59266,VEGF single nucleotide polymorphisms,DNA,0.744,19754219
59267,VEGF single nucleotide,gene,0.8765,19754219
59268,bevacizumab,gene,0.7773,19754219
59269,VEGF,gene,0.949,19754219
59270,cancers,disease,1.0,19754219
59271,bevacizumab,gene,0.6836,19754219
59272,tumors,disease,0.931,19754219
59273,platelet-derived growth factor-C,gene,0.9985,19754219
59274,PDGF-C,gene,0.997,19754219
59275,Bombina,drug,0.4907,19754219
59276,prokineticin-2,gene,0.994,19754219
59277,VEGFR-3,gene,0.9927,19754219
59278,tumors,disease,0.978,19754219
59279,vascular endothelial growth factor,gene,0.998,19712924
59280,vascular endothelial growth factor,gene,0.973,19712924
59281,vascular endothelial growth factor,gene,0.9976,19712924
59282,VEGF,gene,0.99,19712924
59283,VEGF,gene,0.9966,19712924
59284,VEGF,gene,0.996,19712924
59285,neovascular age-related macular degeneration,disease,0.9897,19712924
59286,VEGF,gene,0.9004,19712924
59287,VEGF,gene,0.996,19712924
59288,thromboembolic events,disease,0.758,19712924
59289,ocular diseases,disease,0.9966,19712924
59290,neovascular age-related macular degeneration,disease,1.0,19712924
59291,VEGF Trap,gene,0.7925,19694600
59292,neovascular age-related macular degeneration,disease,1.0,19694600
59293,Age-related macular degeneration,disease,1.0,19694600
59294,AMD,disease,1.0,19694600
59295,AMD,disease,1.0,19694600
59296,neovascular AMD,disease,1.0,19694600
59297,legal blindness,disease,1.0,19694600
59298,neovascular AMD,disease,0.999,19694600
59299,VEGF,gene,0.849,19694600
59300,neovascular AMD,disease,1.0,19694600
59301,VEGF,gene,0.5244,19694600
59302,ranibizumab,gene,0.6167,19694600
59303,aflibercept,gene,0.9863,19694600
59304,VEGF Trap-Eye,gene,0.9277,19694600
59305,VEGF-A,gene,0.9985,19694600
59306,placental growth factors-1,gene,0.997,19694600
59307,VEGF Trap-Eye,gene,0.7495,19694600
59308,neovascular AMD,disease,1.0,19694600
59309,VEGF Trap,gene,0.823,19694600
59310,VEGF,gene,0.8613,19694600
59311,neovascular AMD,disease,0.9985,19694600
59312,VEGF Trap,gene,0.829,19694600
59313,Aflibercept,gene,0.9653,19519199
59314,epithelial ovarian carcinoma,disease,1.0,19519199
59315,VEGF,gene,0.993,19519199
59316,VEGF,gene,0.993,19519199
59317,aflibercept,gene,0.993,19519199
59318,VEGF-Trap,gene,0.9956,19519199
59319,epithelial ovarian carcinoma,disease,1.0,19519199
59320,epithelial ovarian carcinoma,disease,1.0,19519199
59321,aflibercept,gene,0.9937,19519199
59322,epithelial ovarian carcinoma,disease,1.0,19519199
59323,VEGF,gene,0.985,19483401
59324,diabetic,disease,1.0,19472529
59325,diabetic retinopathies,disease,1.0,19472529
59326,VEGF,gene,0.909,19442162
59327,traumatic,disease,0.9917,19442162
59328,spinal cord injury,disease,0.8857,19442162
59329,microvascular dysfunction,disease,1.0,19442162
59330,traumatic spinal cord injury,disease,0.97,19442162
59331,SCI,disease,1.0,19442162
59332,vascular endothelial growth factor,gene,0.996,19442162
59333,VEGF,gene,0.993,19442162
59334,neurodegenerative disorders,disease,1.0,19442162
59335,SCI,disease,0.9995,19442162
59336,VEGF,gene,0.995,19442162
59337,SCI,disease,0.9985,19442162
59338,VEGF,gene,0.8374,19442162
59339,VEGF,gene,0.997,19442162
59340,mice,species,0.881,19442162
59341,SCI,disease,0.8677,19442162
59342,VEGF,gene,0.993,19442162
59343,VEGF Trap,gene,0.899,19442162
59344,Griffonia simplicifolia,species,0.9756,19442162
59345,VEGF,gene,0.9946,19442162
59346,endothelial plasticity,cell_type,0.48,19442162
59347,SCI,disease,0.9956,19442162
59348,VEGF,gene,0.9717,19442162
59349,VEGF,gene,0.926,19442162
59350,traumatic SCI,disease,0.955,19442162
59351,traumatically injured,disease,0.7905,19442162
59352,VEGF,gene,0.9946,19442162
59353,affected spinal microvessels,cell_type,0.5723,19442162
59354,SERCA2a,gene,0.652,19271026
59355,ABT-263,drug,0.9736,19271026
59356,Adalimumab,gene,0.6055,19271026
59357,Aflibercept,gene,0.7637,19271026
59358,Afobazole,drug,0.997,19271026
59359,Aliskiren fumarate,drug,0.999,19271026
59360,Atazanavir,drug,0.999,19271026
59361,ritonavir,drug,0.998,19271026
59362,Aviscumine,drug,0.981,19271026
59363,Axitinib,drug,0.997,19271026
59364,Azacitidine,drug,0.998,19271026
59365,Bevacizumab,gene,0.5645,19271026
59366,Biphasic insulin aspart,gene,0.759,19271026
59367,Bortezomib,drug,0.9995,19271026
59368,Briobacept,drug,0.989,19271026
59369,Carmoterol hydrochloride,drug,0.997,19271026
59370,CCX-282,drug,0.9756,19271026
59371,Ceftobiprole medocaril,drug,0.9985,19271026
59372,Cetuximab,gene,0.881,19271026
59373,Darifenacin hydrobromide,drug,0.999,19271026
59374,Dasatinib,drug,0.9976,19271026
59375,Denosumab,gene,0.7427,19271026
59376,Doripenem,drug,0.9966,19271026
59377,Duloxetine hydrochloride,drug,0.998,19271026
59378,E-7080,drug,0.994,19271026
59379,Epratuzumab,gene,0.502,19271026
59380,Erlotinib hydrochloride,drug,0.9966,19271026
59381,Everolimus,drug,0.998,19271026
59382,Exenatide,gene,0.821,19271026
59383,Ezetimibe,drug,0.9995,19271026
59384,simvastatin,drug,0.9985,19271026
59385,Gefitinib,drug,0.999,19271026
59386,gamma-Hydroxybutyrate sodium,drug,0.996,19271026
59387,Imatinib mesylate,drug,0.999,19271026
59388,Insulin detemir,gene,0.9375,19271026
59389,Insulin glulisine,gene,0.9385,19271026
59390,IVX-0142,drug,0.9775,19271026
59391,Laquinimod sodium,drug,0.9907,19271026
59392,Linezolid,drug,0.9995,19271026
59393,Lopinavir,drug,0.9995,19271026
59394,ritonavir,drug,0.998,19271026
59395,Ocrelizumab,gene,0.9478,19271026
59396,Omalizumab,gene,0.9575,19271026
59397,Parecoxib,drug,0.997,19271026
59398,Pemetrexed disodium,drug,0.999,19271026
59399,Pregabalin,drug,0.999,19271026
59400,Rosuvastatin calcium,drug,0.9766,19271026
59401,Rotigotine,drug,0.999,19271026
59402,Sorafenib,drug,0.996,19271026
59403,Sugammadex sodium,drug,0.8965,19271026
59404,Tapentadol hydrochloride,drug,0.994,19271026
59405,Tenofovir disoproxil fumarate,drug,0.9995,19271026
59406,emtricitabine,drug,0.999,19271026
59407,Tocilizumab,gene,0.5796,19271026
59408,Ustekinumab,gene,0.669,19271026
59409,Valsartan,drug,0.9995,19271026
59410,amlodipine besylate,drug,0.971,19271026
59411,Varenicline tartrate,drug,0.999,19271026
59412,Vatalanib succinate,drug,0.997,19271026
59413,Vildagliptin,drug,0.999,19271026
59414,Vorinostat,drug,0.999,19271026
59415,Aflibercept,gene,0.9624,19236257
59416,tumour,disease,1.0,19236257
59417,vascular endothelial growth factors,gene,0.9976,19236257
59418,cancer,disease,1.0,19236257
59419,VEGF,gene,0.997,19236257
59420,cancer,disease,1.0,19236257
59421,VEGF,gene,0.994,19236257
59422,VEGF,gene,0.972,19236257
59423,VEGFR-1,gene,0.9976,19236257
59424,VEGFR-2,gene,0.997,19236257
59425,VEGF,gene,0.9917,19236257
59426,tyrosine,drug,0.8325,19236257
59427,VEGFRs,gene,0.9966,19236257
59428,aflibercept,gene,0.979,19236257
59429,VEGFR-1,gene,0.994,19236257
59430,VEGFR-2,gene,0.9805,19236257
59431,Fc,gene,0.7295,19236257
59432,IgG1,gene,0.9844,19236257
59433,Aflibercept,gene,0.9546,19236257
59434,aflibercept,gene,0.98,19236257
59435,cancer,disease,1.0,19236257
59436,vascular endothelial growth factor,gene,0.9985,19224901
59437,VEGF,gene,0.995,19224901
59438,mice,species,0.969,19224901
59439,mice,species,0.865,19224901
59440,vascular endothelial,DNA,0.4824,19224901
59441,vascular endothelial growth factor-A,gene,0.9995,19224901
59442,VEGF,gene,0.994,19224901
59443,mouse,species,0.9663,19224901
59444,Fc protein,gene,0.969,19224901
59445,VEGF Trap,gene,0.9297,19224901
59446,haem,DNA,0.4692,19224901
59447,lymph,cell_type,0.4102,19224901
59448,Wound,disease,0.9155,19221694
59449,DCF,drug,0.9976,19221694
59450,VEGF,gene,0.994,19221694
59451,Hypertension,disease,1.0,19221694
59452,proteinuria,disease,1.0,19221694
59453,thromboembolic or bleeding events,disease,0.9976,19221694
59454,VEGF,gene,0.992,19221694
59455,Wound,disease,0.958,19221694
59456,DCF,drug,0.9995,19221694
59457,VEGF,gene,0.9736,19221694
59458,VEGF-Trap,gene,0.9565,19221694
59459,vascular endothelial growth factor,gene,0.999,19174400
59460,diabetic macular oedema,disease,1.0,19174400
59461,vascular endothelial growth factor,gene,0.9985,19174400
59462,VEGF,gene,0.9976,19174400
59463,diabetic macular oedema,disease,1.0,19174400
59464,DMO,disease,1.0,19174400
59465,DMO,disease,1.0,19174400
59466,VEGF,gene,0.9927,19174400
59467,VEGF,gene,0.996,19174400
59468,cellulitis of the left foot,disease,1.0,19174400
59469,VEGF Trap,gene,0.7793,19174400
59470,VEGF,gene,0.993,19174400
59471,VEGF,gene,0.9956,19174400
59472,DMO,disease,1.0,19174400
59473,Vascular endothelial growth factor,gene,0.9985,19174397
59474,diabetic macular oedema,disease,1.0,19174397
59475,(+)-Dapoxetine hydrochloride,drug,0.9966,19088949
59476,(S)-Tenatoprazole sodium salt monohydrate,drug,0.9966,19088949
59477,Acotiamide,drug,0.998,19088949
59478,hydrochloride hydrate,drug,0.7974,19088949
59479,ADV-TK,gene,0.7153,19088949
59480,AE-37,gene,0.8164,19088949
59481,Aflibercept,gene,0.966,19088949
59482,Albinterferon alfa-2b,gene,0.998,19088949
59483,Aliskiren fumarate,drug,0.999,19088949
59484,Asenapine maleate,drug,0.998,19088949
59485,Axitinib,drug,0.99,19088949
59486,Becatecarin,drug,0.7183,19088949
59487,Calcipotriol,drug,0.9995,19088949
59488,betamethasone dipropionate,drug,0.999,19088949
59489,Casopitant mesylate,drug,0.9917,19088949
59490,Cediranib,drug,0.999,19088949
59491,CMD-193,drug,0.994,19088949
59492,Cositecan,drug,0.9976,19088949
59493,Darinaparsin,drug,0.995,19088949
59494,Denosumab,gene,0.498,19088949
59495,DP-b99,drug,0.9746,19088949
59496,Duloxetine hydrochloride,drug,0.993,19088949
59497,Elacytarabine,drug,0.978,19088949
59498,EMD-273063,drug,0.999,19088949
59499,Enzastaurin hydrochloride,drug,0.994,19088949
59500,Eplerenone,drug,0.999,19088949
59501,Eribulin mesilate,drug,0.994,19088949
59502,Esomeprazole magnesium,drug,0.924,19088949
59503,Etravirine,drug,0.9995,19088949
59504,Everolimus,drug,0.9976,19088949
59505,Ezetimibe,drug,0.9985,19088949
59506,Faropenem daloxate,drug,0.9927,19088949
59507,Febuxostat,drug,0.9985,19088949
59508,Fenretinide,drug,0.9985,19088949
59509,Ghrelin,gene,0.945,19088949
59510,I,drug,0.9375,19088949
59511,I-131-3F8,drug,0.793,19088949
59512,Iclaprim,drug,0.9985,19088949
59513,Iguratimod,drug,0.998,19088949
59514,Iloperidone,drug,0.998,19088949
59515,Imatinib mesylate,drug,0.999,19088949
59516,Inalimarev,drug,0.9976,19088949
59517,Falimarev,drug,0.998,19088949
59518,Indacaterol,drug,0.9976,19088949
59519,Ispinesib mesylate,drug,0.996,19088949
59520,Ixabepilone,drug,0.9976,19088949
59521,Lapatinib ditosylate,drug,0.999,19088949
59522,Laquinimod sodium,drug,0.997,19088949
59523,Larotaxel dehydrate,drug,0.995,19088949
59524,Linezolid,drug,0.9985,19088949
59525,LOR-2040,drug,0.999,19088949
59526,Mapatumumab,gene,0.6177,19088949
59527,MKC-1,drug,0.9976,19088949
59528,Motesanib diphosphate,drug,0.999,19088949
59529,Mycophenolic acid sodium salt,drug,0.997,19088949
59530,NK-012,drug,0.997,19088949
59531,Olanzapine pamoate,drug,0.9976,19088949
59532,Ortataxel,drug,0.7983,19088949
59533,Paclitaxel,drug,0.9995,19088949
59534,Paclitaxel poliglumex,drug,0.9478,19088949
59535,Paliperidone palmitate,drug,0.9985,19088949
59536,Panitumumab,gene,0.8804,19088949
59537,Patupilone,drug,0.996,19088949
59538,PCV-9,drug,0.9263,19088949
59539,Pegfilgrastim,gene,0.851,19088949
59540,Peginterferon alfa-2a,gene,0.993,19088949
59541,Peginterferon alfa-2b,gene,0.985,19088949
59542,Pertuzumab,gene,0.6445,19088949
59543,Picoplatin,drug,0.999,19088949
59544,Pimavanserin tartrate,drug,0.999,19088949
59545,Pimecrolimus,drug,0.9985,19088949
59546,Plerixafor,drug,0.997,19088949
59547,PM-02734,drug,0.991,19088949
59548,PR1,DNA,0.563,19088949
59549,Prasugrel,drug,0.995,19088949
59550,Pregabalin,drug,0.999,19088949
59551,Progesterone caproate,drug,0.9995,19088949
59552,Prucalopride,drug,0.999,19088949
59553,Pumosetrag hydrochloride,drug,0.973,19088949
59554,RAV-12,drug,0.999,19088949
59555,RB-007,drug,0.849,19088949
59556,Recombinant human erythropoietin alfa,gene,0.9976,19088949
59557,Rimonabant,drug,0.999,19088949
59558,Romidepsin,drug,0.9985,19088949
59559,SAR-109659,drug,0.999,19088949
59560,Satraplatin,drug,0.999,19088949
59561,Sodium butyrate,drug,0.9985,19088949
59562,Tadalafil,drug,0.9956,19088949
59563,Talampanel,drug,0.998,19088949
59564,Tanespimycin,drug,0.999,19088949
59565,Tarenflurbil,drug,0.999,19088949
59566,Tariquidar,drug,0.997,19088949
59567,Taurine,drug,0.9966,19088949
59568,Tecovirimat,drug,0.998,19088949
59569,Telatinib,drug,0.994,19088949
59570,Telavancin hydrochloride,drug,0.9946,19088949
59571,Telcagepant,drug,0.998,19088949
59572,Terameprocol,drug,0.9985,19088949
59573,Tesofensine,drug,0.9985,19088949
59574,Tetrodotoxin,drug,0.996,19088949
59575,Tezampanel,drug,0.997,19088949
59576,Tipifarnib,drug,0.9985,19088949
59577,TPI-287,drug,0.9985,19088949
59578,Valspodar,drug,0.9956,19088949
59579,Vatalanib succinate,drug,0.9976,19088949
59580,VCL-CB01,drug,0.9995,19088949
59581,vCP1452,drug,0.9976,19088949
59582,Vorinostat,drug,0.9985,19088949
59583,XL-228,drug,0.9956,19088949
59584,Ziprasidone hydrochloride,drug,0.998,19088949
59585,anti-integrins,gene,0.9907,19024488
59586,retinol,drug,0.9976,19024488
59587,blindness,disease,0.9976,19024488
59588,non-small cell lung cancer,disease,1.0,18845495
59589,non-small cell lung cancer,disease,1.0,18845495
59590,NSCLC,disease,1.0,18845495
59591,Bevacizumab,gene,0.5854,18845495
59592,recombinant,gene,0.598,18845495
59593,anti-vascular endothelial growth factor,gene,0.926,18845495
59594,NSCLC,disease,0.4558,18845495
59595,bevacizumab,gene,0.908,18845495
59596,NSCLC,disease,0.9995,18845495
59597,NSCLC,disease,1.0,18845495
59598,tyrosine,drug,0.994,18845495
59599,tyrosine kinase,gene,0.992,18845495
59600,NSCLC,disease,0.9995,18845495
59601,VEGF Trap,gene,0.9277,18708344
59602,cancer,disease,1.0,18708344
59603,glioblastomas,disease,1.0,18708344
59604,primary brain tumor,disease,1.0,18708344
59605,Vascular endothelial growth factor,gene,0.9985,18708344
59606,VEGF,gene,0.9946,18708344
59607,primary malignant brain tumors,disease,0.998,18708344
59608,VEGF Trap,gene,0.9805,18708344
59609,VEGF,gene,0.993,18708344
59610,intracranial,disease,0.8125,18708344
59611,glioma,disease,0.8066,18708344
59612,VEGF Trap,gene,0.9614,18708344
59613,gliomas,disease,1.0,18708344
59614,VEGF Trap,gene,0.981,18708344
59615,tumor,disease,1.0,18708344
59616,VEGF Trap,gene,0.81,18708344
59617,tumor,disease,0.96,18708344
59618,VEGF Trap,gene,0.947,18708344
59619,glioblastoma,disease,1.0,18708344
59620,VEGF Trap,gene,0.9634,18708344
59621,tumor,disease,1.0,18708344
59622,Aflibercept,gene,0.9614,18588357
59623,VEGF Trap,gene,0.9736,18588357
59624,VEGF Trap,gene,0.9272,18588357
59625,VEGF Trap,gene,0.9556,18588357
59626,vascular endothelial growth factor,gene,0.998,18499749
59627,estradiol,drug,0.999,18499749
59628,marmoset,species,0.62,18499749
59629,vascular endothelial growth factor,gene,0.9985,18499749
59630,VEGF,gene,0.9937,18499749
59631,estradiol,drug,0.9995,18499749
59632,stromal and epithelial cell,cell_type,0.7866,18499749
59633,marmoset,species,0.8735,18499749
59634,marmosets,species,0.8647,18499749
59635,VEGF,gene,0.996,18499749
59636,VEGF Trap,gene,0.9736,18499749
59637,aflibercept,gene,0.989,18499749
59638,estradiol,drug,0.998,18499749
59639,VEGF Trap,gene,0.796,18499749
59640,estradiol,drug,0.9976,18499749
59641,epithelial cell,cell_type,0.5483,18499749
59642,bromodeoxyuridine,drug,0.9937,18499749
59643,proliferating cells,cell_type,0.8145,18499749
59644,CD31,gene,0.9565,18499749
59645,endothelial cells,cell_type,0.8896,18499749
59646,endothelial cell,cell_type,0.8945,18499749
59647,Endothelial,cell_type,0.573,18499749
59648,VEGF,gene,0.9897,18499749
59649,estrogen,drug,0.999,18499749
59650,Estradiol,drug,0.999,18499749
59651,VEGF Trap,gene,0.838,18499749
59652,marmosets,species,0.8237,18499749
59653,endothelial cell,cell_type,0.8965,18499749
59654,VEGF Trap,gene,0.981,18499749
59655,stromal cell,cell_type,0.7515,18499749
59656,stromal cell,cell_type,0.6074,18499749
59657,Estrogen,drug,0.999,18499749
59658,VEGF,gene,0.997,18499749
59659,stromal,cell_type,0.4539,18499749
59660,estradiol,drug,0.9995,18499749
59661,estrogen,drug,0.9995,18499749
59662,VEGF,gene,0.9927,18499749
59663,PDGF,gene,0.9985,18420995
59664,FGF-2,gene,0.997,18420995
59665,PDGF,gene,0.9976,18420995
59666,FGF-2,gene,0.998,18420995
59667,endothelial,cell_type,0.4849,18420995
59668,FGF-2,gene,0.9985,18420995
59669,PDGF-BB proteins,gene,0.9927,18420995
59670,Anti-FGF-2,gene,0.9883,18420995
59671,anti-PDGF,gene,0.984,18420995
59672,coronary ostial,DNA,0.532,18420995
59673,smooth muscle,cell_type,0.641,18420995
59674,VEGF,gene,0.9897,18420995
59675,aflibercept,gene,0.991,18420995
59676,VEGF-Trap,gene,0.9946,18420995
59677,VEGFR-1 and -2 chimera,gene,0.9946,18420995
59678,coronary stem,cell_type,0.556,18420995
59679,FGF-2,gene,0.9985,18420995
59680,PDGF,gene,0.995,18420995
59681,VEGF,gene,0.995,18420995
59682,vascular endothelial growth factor,gene,0.9976,18388198
59683,primate,species,0.913,18388198
59684,hypoxia-inducible factor-1alpha,gene,0.997,18388198
59685,follicle,cell_type,0.636,18388198
59686,Vascular endothelial growth factor,gene,0.9985,18388198
59687,VEGF,gene,0.9956,18388198
59688,VEGF,gene,0.996,18388198
59689,VEGF,gene,0.995,18388198
59690,hypoxia-inducible factor (HIF)-1alpha,gene,0.9976,18388198
59691,marmoset,species,0.9653,18388198
59692,VEGF,gene,0.993,18388198
59693,VEGF Trap,gene,0.9814,18388198
59694,aflibercept,gene,0.9863,18388198
59695,HIF-1alpha,gene,0.996,18388198
59696,chorionic gonadotropin,gene,0.995,18388198
59697,HIF-1alpha,gene,0.9854,18388198
59698,preantral and antral follicles,cell_type,0.825,18388198
59699,nuclear HIF-1alpha,gene,0.9487,18388198
59700,granulosa cells,cell_type,0.8364,18388198
59701,HIF-1alpha,gene,0.988,18388198
59702,VEGF,gene,0.9907,18388198
59703,luteal,cell_type,0.5146,18388198
59704,HIF-1alpha,gene,0.9355,18388198
59705,HIF-1alpha,gene,0.911,18388198
59706,theca cells,cell_type,0.747,18388198
59707,VEGF Trap,gene,0.9585,18388198
59708,HIF-1alpha,gene,0.9805,18388198
59709,granulosa cells,cell_type,0.8496,18388198
59710,HIF-1alpha,gene,0.995,18388198
59711,VEGF Trap,gene,0.883,18388198
59712,follicle,cell_type,0.5986,18388198
59713,HIF-1alpha,gene,0.9946,18388198
59714,VEGF,gene,0.5034,18388198
59715,VEGF,gene,0.991,18076206
59716,diabetic microvascular complications,disease,0.9956,18076206
59717,diabetes mellitus,disease,1.0,18076206
59718,type 1 diabetes mellitus,disease,1.0,18076206
59719,diabetic microvascular complications,disease,0.999,18076206
59720,retinopathy,disease,1.0,18076206
59721,nephropathy,disease,1.0,18076206
59722,neuropathy,disease,1.0,18076206
59723,vascular endothelial growth factor,gene,0.998,18076206
59724,VEGF,gene,0.9937,18076206
59725,diabetic microvascular complications,disease,0.9995,18076206
59726,VEGF,gene,0.995,18076206
59727,age-related macular degeneration,disease,0.998,18076206
59728,macular edema,disease,1.0,18076206
59729,VEGF,gene,0.9907,18076206
59730,bevasiranib,drug,0.96,18076206
59731,VEGF,gene,0.947,18076206
59732,pegaptanib,drug,0.9814,18076206
59733,VEGF receptor,gene,0.9844,18076206
59734,aflibercept,gene,0.9946,18076206
59735,VEGF-TRAP,gene,0.9893,18076206
59736,VEGF,gene,0.992,18076206
59737,midostaurin,drug,0.9873,18076206
59738,VEGF,gene,0.994,18076206
59739,diabetic retinopathy,disease,1.0,18076206
59740,diabetic nephropathy,disease,1.0,18076206
59741,VEGF,gene,0.99,18076206
59742,diabetic neuropathy,disease,1.0,18076206
59743,chronic neuropathies,disease,1.0,18076206
59744,VEGF,gene,0.9907,18076206
